PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adhikary, A; Chakraborty, S; Mazumdar, M; Ghosh, S; Mukherjee, S; Manna, A; Mohanty, S; Nakka, KK; Joshi, S; De, A; Chattopadhyay, S; Sa, G; Das, T				Adhikary, Arghya; Chakraborty, Samik; Mazumdar, Minakshi; Ghosh, Swatilekha; Mukherjee, Shravanti; Manna, Argha; Mohanty, Suchismita; Nakka, Kiran Kumar; Joshi, Shruti; De, Abhijit; Chattopadhyay, Samit; Sa, Gaurisankar; Das, Tanya			Inhibition of Epithelial to Mesenchymal Transition by E-cadherin Up-regulation via Repression of Slug Transcription and Inhibition of E-cadherin Degradation DUAL ROLE OF SCAFFOLD/MATRIX ATTACHMENT REGION-BINDING PROTEIN 1 (SMAR1) IN BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-SIGNIFICANCE; ATTACHMENT REGIONS; TUMOR PROGRESSION; GENE-EXPRESSION; INVASION; PROTEIN; MDM2; METASTASIS; ADHESION; SNAIL	The evolution of the cancer cell into a metastatic entity is the major cause of death in patients with cancer. It has been acknowledged that aberrant activation of a latent embryonic program, known as the epithelial-mesenchymal transition (EMT), can endow cancer cells with the migratory and invasive capabilities associated with metastatic competence for which E-cadherin switch is a well-established hallmark. Discerning the molecular mechanisms that regulate E-cadherin expression is therefore critical for understanding tumor invasiveness and metastasis. Here we report that SMAR1 overexpression inhibits EMT and decelerates the migratory potential of breast cancer cells by up-regulating E-cadherin in a bidirectional manner. While SMAR1-dependent transcriptional repression of Slug by direct recruitment of SMAR1/HDAC1 complex to the matrix attachment region site present in the Slug promoter restores E-cadherin expression, SMAR1 also hinders E-cadherin-MDM2 interaction thereby reducing ubiquitination and degradation of E-cadherin protein. Consistently, siRNA knockdown of SMAR1 expression in these breast cancer cells results in a coordinative action of Slug-mediated repression of E-cadherin transcription, as well as degradation of E-cadherin protein through MDM2, up-regulating breast cancer cell migration. These results indicate a crucial role for SMAR1 in restraining breast cancer cell migration and suggest the candidature of this scaffold matrix-associated region-binding protein as a tumor suppressor.	[Adhikary, Arghya; Chakraborty, Samik; Mazumdar, Minakshi; Ghosh, Swatilekha; Mukherjee, Shravanti; Manna, Argha; Mohanty, Suchismita; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Nakka, Kiran Kumar; Joshi, Shruti; Chattopadhyay, Samit] NCCS, Pune 411007, Maharashtra, India; [De, Abhijit] ACTREC, Tata Mem Ctr, Mol Funct Imaging Lab, Bombay 410210, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Das, T (corresponding author), Bose Inst, Div Mol Med, P-1-12 Calcutta Improvement Trust Scheme 7 M, Kolkata 700054, W Bengal, India.	tanya@jcbose.ac.in	Nakka, Kiran/CAJ-3374-2022; DE, ABHIJIT/AAR-5631-2021; Chakraborty, Samik/Q-1779-2018	DE, ABHIJIT/0000-0002-5818-0206; Nakka, Kiran/0000-0002-8418-9343; Chakraborty, Samik/0000-0002-5232-0474	DST; CSIR; UGC, Govt of India	DST(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC, Govt of India(University Grants Commission, India)	This work was supported by grants from DST, CSIR, and UGC, Govt of India.	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Cheng JC, 2013, ONCOGENE, V32, P1041, DOI 10.1038/onc.2012.127; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hajra KM, 2002, CANCER RES, V62, P1613; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Hsieh CY, 2013, TOXICOL IN VITRO, V27, P1, DOI 10.1016/j.tiv.2012.10.001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lukas J, 2001, CANCER RES, V61, P3212; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; Moll UM, 2003, MOL CANCER RES, V1, P1001; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pavithra L, 2009, J MOL BIOL, V388, P691, DOI 10.1016/j.jmb.2009.03.033; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P1079; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Singh K, 2009, J BIOL CHEM, V284, P1267, DOI 10.1074/jbc.M801088200; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06	40	72	73	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25431	25444		10.1074/jbc.M113.527267	http://dx.doi.org/10.1074/jbc.M113.527267			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086032	Green Published, hybrid			2022-12-28	WOS:000342130800004
J	Oguin, TH; Sharma, S; Stuart, AD; Duan, S; Scott, SA; Jones, CK; Daniels, JS; Lindsley, CW; Thomas, PG; Brown, HA				Oguin, Thomas H., III; Sharma, Shalini; Stuart, Amanda D.; Duan, Susu; Scott, Sarah A.; Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.; Thomas, Paul G.; Brown, H. Alex			Phospholipase D Facilitates Efficient Entry of Influenza Virus, Allowing Escape from Innate Immune Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; CHEMICAL MODULATION; MEMBRANE; ENDOCYTOSIS; INFECTION; DESIGN	Lipid metabolism plays a fundamental role during influenza virus replication, although key regulators of lipid-dependent trafficking and virus production remain inadequately defined. This report demonstrates that infection by influenza virus stimulates phospholipase D (PLD) activity and that PLD co-localizes with influenza during infection. Both chemical inhibition and RNA interference of PLD delayed viral entry and reduced viral titers in vitro. Although there may be contributions by both major isoenzymes, the effects on viral infectivity appear to be more dependent on the PLD2 isoenzyme. In vivo, PLD2 inhibition reduced virus titer and correlated with significant increases in transcription of innate antiviral effectors. The reduction in viral titer downstream of PLD2 inhibition was dependent on Rig-I (retinoic acid-inducible gene-1), IRF3, and MxA (myxovirus resistance gene A) but not IRF7. Inhibition of PLD2 accelerated the accumulation of MxA in foci as early as 30 min postinfection. Together these data suggest that PLD facilitates the rapid endocytosis of influenza virus, permitting viral escape from innate immune detection and effectors that are capable of limiting lethal infection.	[Oguin, Thomas H., III; Duan, Susu; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Oguin, Thomas H., III] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Sharma, Shalini] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar 125004, Haryana, India; [Stuart, Amanda D.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Scott, Sarah A.; Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Jones, Carrie K.; Daniels, J. Scott; Lindsley, Craig W.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	St Jude Children's Research Hospital; University of Memphis; Lala Lajpat Rai University of Veterinary & Animal Sciences; University of Cambridge; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Thomas, PG (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Paul.Thomas@stjude.org; alex.brown@vanderbilt.edu	Thomas, Paul G./H-1063-2018	Thomas, Paul G./0000-0001-7955-0256; Oguin, Thomas/0000-0001-8959-4025	National Institutes of Health [U54MH084659, P01ESO013125]; NIAID [HHSN2722008000058C, HHSN266200700005C]; Medical Research Council [RG53985]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54MH084659, P01ESO013125, and HHSN2722008000058C and HHSN266200700005C from the NIAID. This work was also supported by Medical Research Council Grant RG53985.	Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Czarny M, 2000, FEBS LETT, V467, P326, DOI 10.1016/S0014-5793(00)01174-1; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Lam V, 2005, BIOTECHNOL BIOENG, V90, P793, DOI 10.1002/bit.20467; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Myers DS, 2011, BBA-MOL CELL BIOL L, V1811, P748, DOI 10.1016/j.bbalip.2011.05.015; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Padron D, 2006, MOL BIOL CELL, V17, P598, DOI 10.1091/mbc.E05-05-0389; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Scott SA, 2014, BBA-MOL CELL BIOL L, V1841, P1060, DOI 10.1016/j.bbalip.2014.01.009; Scott SA, 2013, J BIOL CHEM, V288, P20477, DOI 10.1074/jbc.M113.451708; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Yang LQ, 2010, MOL PHARMACOL, V78, P105, DOI 10.1124/mol.109.063107	35	37	38	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25405	25417		10.1074/jbc.M114.558817	http://dx.doi.org/10.1074/jbc.M114.558817			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25065577	Green Published, hybrid			2022-12-28	WOS:000342130800002
J	Zhang, JB; Martinoia, E; De Angeli, A				Zhang, Jingbo; Martinoia, Enrico; De Angeli, Alexis			Cytosolic Nucleotides Block and Regulate the Arabidopsis Vacuolar Anion Channel AtALMT9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ALUMINUM TOLERANCE; GUARD-CELLS; ROOT-TIPS; FRACTIONATION; MECHANISM; PROVIDE	The aluminum-activated malate transporters (ALMTs) form a membrane protein family exhibiting different physiological roles in plants, varying from conferring tolerance to environmental Al3+ to the regulation of stomatal movement. The regulation of the anion channels of the ALMT family is largely unknown. Identifying intracellular modulators of the activity of anion channels is fundamental to understanding their physiological functions. In this study we investigated the role of cytosolic nucleotides in regulating the activity of the vacuolar anion channel AtALMT9. We found that cytosolic nucleotides modulate the transport activity of AtALMT9. This modulation was based on a direct block of the pore of the channel at negative membrane potentials (open channel block) by the nucleotide and not by a phosphorylation mechanism. The block by nucleotides of AtALMT9-mediated currents was voltage dependent. The blocking efficiency of intracellular nucleotides increased with the number of phosphate groups and ATP was the most effective cellular blocker. Interestingly, the ATP block induced a marked modification of the current-voltage characteristic of AtALMT9. In addition, increased concentrations of vacuolar anions were able to shift the ATP block threshold to a more negative membrane potential. The block of AtALMT9-mediated anion currents by ATP at negative membrane potentials acts as a gate of the channel and vacuolar anion tune this gating mechanism. Our results suggest that anion transport across the vacuolar membrane in plant cells is controlled by cytosolic nucleotides and the energetic status of the cell.	[Zhang, Jingbo; Martinoia, Enrico; De Angeli, Alexis] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [De Angeli, Alexis] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France	University of Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Martinoia, E (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	enrico.martinoia@botinst.uzh.ch; alexis.de-angeli@isv.cnrs-gif.fr	Zhang, Jing/GWZ-7332-2022; Martinoia, Enrico/AAH-8712-2021		Chinese Scholarship Council; Swiss National Foundation	Chinese Scholarship Council(China Scholarship Council); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by grants from the Chinese Scholarship Council (to J. Z.) and the Swiss National Foundation (to E. M. and A. D. A).	Colcombet J, 2001, J BIOL CHEM, V276, P36139, DOI 10.1074/jbc.M103126200; De Angeli A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2815; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Delhaize E, 2004, P NATL ACAD SCI USA, V101, P15249, DOI 10.1073/pnas.0406258101; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; GOUT E, 1992, J BIOL CHEM, V267, P13903; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HEDRICH R, 1993, EMBO J, V12, P897, DOI 10.1002/j.1460-2075.1993.tb05730.x; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Martinoia E, 2012, ANNU REV PLANT BIOL, V63, P183, DOI 10.1146/annurev-arplant-042811-105608; Meyer S, 2011, PLANT J, V67, P247, DOI 10.1111/j.1365-313X.2011.04587.x; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Mumm P, 2013, MOL PLANT, V6, P1550, DOI 10.1093/mp/sst008; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Raschke K, 2003, PLANTA, V217, P651, DOI 10.1007/s00425-003-1034-3; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SchulzLessdorf B, 1996, PLANT J, V10, P993, DOI 10.1046/j.1365-313X.1996.10060993.x; Thomine S, 1997, J MEMBRANE BIOL, V159, P71, DOI 10.1007/s002329900270; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; XIA JH, 1995, PLANT PHYSIOL, V108, P589, DOI 10.1104/pp.108.2.589; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; YAZAKI Y, 1988, PLANT CELL PHYSIOL, V29, P919; Zhang JB, 2013, PLANT PHYSIOL, V163, P830, DOI 10.1104/pp.113.219832	32	16	17	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25581	25589		10.1074/jbc.M114.576108	http://dx.doi.org/10.1074/jbc.M114.576108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25028514	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000342130800019
J	Favrot, L; Lajiness, DH; Ronning, DR				Favrot, Lorenza; Lajiness, Daniel H.; Ronning, Donald R.			Inactivation of the Mycobacterium tuberculosis Antigen 85 Complex by Covalent, Allosteric Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; RESISTANCE; MECHANISM; PROTEINS; BIOSYNTHESIS; ENVELOPE; THERAPY; EBSELEN; TARGETS; TRYPSIN	The rise of multidrug-resistant and totally drug-resistant tuberculosis and the association with an increasing number of HIV-positive patients developing tuberculosis emphasize the necessity to find new antitubercular targets and drugs. The antigen 85 (Ag85) complex from Mycobacterium tuberculosis plays important roles in the biosynthesis of major components of the mycobacterial cell envelope. For this reason, Ag85 has emerged as an attractive drug target. Recently, ebselen was identified as an effective inhibitor of the Ag85 complex through covalent modification of a cysteine residue proximal to the Ag85 active site and is therefore a covalent, allosteric inhibitor. To expand the understanding of this process, we have solved the x-ray crystal structures of Ag85C covalently modified with ebselen and other thiol-reactive compounds, p-chloromercuribenzoic acid and iodoacetamide, as well as the structure of a cysteine to glycine mutant. All four structures confirm that chemical modification or mutation at this particular cysteine residue leads to the disruption of the active site hydrogen-bonded network essential for Ag85 catalysis. We also describe x-ray crystal structures of Ag85C single mutants within the catalytic triad and show that a mutation of any one of these three residues promotes the same conformational change observed in the cysteine-modified forms. These results provide evidence for active site dynamics that may afford new strategies for the development of selective and potent Ag85 inhibitors.	[Favrot, Lorenza; Lajiness, Daniel H.; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	donald.ronning@utoledo.edu		Ronning, Donald/0000-0003-2583-8849	National Institutes of Health (NIH) [AI089653, AI105084]; DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NCI, NIH [Y1-CO-1020]; NIGMS, NIH [Y1-GM-1104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084, R15AI089653] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI089653 and AI105084. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). GM/CA has been funded in whole or in part with Federal funds from NCI, NIH, Grant Y1-CO-1020 and NIGMS, NIH, Grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BARRON ESG, 1945, J BIOL CHEM, V157, P221; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Boucau J, 2009, ANAL BIOCHEM, V385, P120, DOI 10.1016/j.ab.2008.10.018; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Favrot L, 2012, EXPERT REV ANTI-INFE, V10, P1023, DOI [10.1586/eri.12.91, 10.1586/ERI.12.91]; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harth G, 1996, INFECT IMMUN, V64, P3038, DOI 10.1128/IAI.64.8.3038-3047.1996; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Leiros HKS, 2001, ACTA CRYSTALLOGR D, V57, P488, DOI 10.1107/S0907444901000646; Loewenberg S, 2012, LANCET, V379, P205, DOI 10.1016/S0140-6736(12)60085-3; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parnham M, 2000, EXPERT OPIN INV DRUG, V9, P607, DOI 10.1517/13543784.9.3.607; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, GLYCOCONJUGATE J, V26, P589, DOI 10.1007/s10719-008-9211-z; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12	47	31	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25031	25040		10.1074/jbc.M114.582445	http://dx.doi.org/10.1074/jbc.M114.582445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028518	Green Published, hybrid			2022-12-28	WOS:000341985300027
J	Lennon, FE; Mirzapoiazova, T; Mambetsariev, N; Mambetsariev, B; Salgia, R; Singleton, PA				Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Nurbek; Mambetsariev, Bolot; Salgia, Ravi; Singleton, Patrick A.			Transactivation of the Receptor-tyrosine Kinase Ephrin Receptor A2 Is Required for the Low Molecular Weight Hyaluronan-mediated Angiogenesis That Is implicated in Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; CD44; Endothelial Cell; Hyaluronan; Hyaluronate; Ras Homolog Gene Family; Member A (RhoA); Dbs; EphA2; PATJ; Anginex	NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELLS; GROWTH-FACTOR; SIGNALING PATHWAYS; EPHA RECEPTOR; ADHESION MOLECULES; VASCULAR-DISEASE; UP-REGULATION; CD44; OLIGOSACCHARIDES	Background: Hyaluronan (HA)-mediated angiogenesis has been implicated in tumor progression. Results: LMW-HA-mediated transactivation of EphA2 is required for PATJ and Dbs membrane recruitment and subsequent RhoA activation required for angiogenesis. Conclusion: EphA2 plays a crucial role in HA-mediated angiogenesis. Significance: Targeting downstream effectors of LMW-HA could be a useful therapeutic intervention for angiogenesis-associated diseases including various malignancies. Angiogenesis or the formation of new blood vessels is important in the growth and metastatic potential of various cancers. Therefore, understanding the mechanism(s) by which angiogenesis occurs can have important therapeutic implications in numerous malignancies. We and others have demonstrated that low molecular weight hyaluronan (LMW-HA, approximate to 2500 Da) promotes endothelial cell (EC) barrier disruption and angiogenesis. However, the mechanism(s) by which this occurs is poorly defined. Our data indicate that treatment of human EC with LMW-HA induced CD44v10 association with the receptor-tyrosine kinase, EphA2, transactivation (tyrosine phosphorylation) of EphA2, and recruitment of the PDZ domain scaffolding protein, PATJ, to the cell periphery. Silencing (siRNA) CD44, EphA2, PATJ, or Dbs (RhoGEF) expression blocked LMW-HA-mediated angiogenesis (EC proliferation, migration, and tubule formation). In addition, silencing EphA2, PATJ, Src, or Dbs expression blocked LMW-HA-mediated RhoA activation. To translate our in vitro findings, we utilized a novel anginex/liposomal targeting of murine angiogenic endothelium with either CD44 or EphA2 siRNA and observed inhibition of LMW-HA-induced angiogenesis in implanted Matrigel plugs. Taken together, these results indicate LMW-HA-mediated transactivation of EphA2 is required for PATJ and Dbs membrane recruitment and subsequent RhoA activation required for angiogenesis. These results suggest that targeting downstream effectors of LMW-HA could be a useful therapeutic intervention for angiogenesis-associated diseases including tumor progression.	[Singleton, Patrick A.] Univ Chicago, Dept Med, Chicago, IL 60657 USA; [Lennon, Frances E.; Mirzapoiazova, Tamara; Mambetsariev, Nurbek; Mambetsariev, Bolot; Singleton, Patrick A.] Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60657 USA; [Salgia, Ravi] Univ Chicago, Sect Hematol & Oncol, Chicago, IL 60657 USA	University of Chicago; University of Chicago; University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Dept Med, MC 6076,I-503C,5841 South Maryland Ave, Chicago, IL 60657 USA.	psinglet@mail.bsd.uchicago.edu			National Institutes of Health (NHLBI) [RO1-HL 095723]; American Heart Association National Scientist Development Grant [0730277N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095723] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association National Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-HL 095723 (NHLBI; to P. A. S.). This work was also supported by the American Heart Association National Scientist Development Grant 0730277N (to P. A. S.).	Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Brandwijk RJMGE, 2007, BIOCONJUGATE CHEM, V18, P785, DOI 10.1021/bc060316h; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Carpenter TC, 2012, AM J RESP CELL MOL, V46, P40, DOI 10.1165/rcmb.2011-0044OC; Chan B, 2009, THROMB RES, V123, P745, DOI 10.1016/j.thromres.2008.07.010; Cheng N, 2002, MOL CANCER RES, V1, P2; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Dings RPM, 2010, BIOCONJUGATE CHEM, V21, P20, DOI 10.1021/bc900287y; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Folkman J, 1974, Symp Soc Dev Biol, V30, P43; FOLKMAN J, 1991, ANN SURG, V214, P414, DOI 10.1097/00000658-199110000-00006; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Griffioen AW, 2001, BIOCHEM J, V354, P233, DOI 10.1042/0264-6021:3540233; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Itano N, 2008, CANCER SCI, V99, P1720, DOI 10.1111/j.1349-7006.2008.00885.x; Kostenko EV, 2006, MOL CELL BIOL, V26, P8964, DOI 10.1128/MCB.00670-06; Krupinski J, 2007, BIOMARK INSIGHTS, V2, P361; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; Lennon FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091577; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Leong Tai Teck, 2005, Curr Rheumatol Rep, V7, P325, DOI 10.1007/s11926-005-0044-5; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Olofsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090921; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Sainz-Jaspeado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071449; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Semerano L, 2011, JOINT BONE SPINE, V78, P118, DOI 10.1016/j.jbspin.2010.06.004; Shimizu T, 2012, CURR PHARM DESIGN, V18, P303, DOI 10.2174/138161212799040367; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wang YZ, 2011, EXP BIOL MED, V236, P84, DOI 10.1258/ebm.2010.010206; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WHITEHEAD I, 1995, ONCOGENE, V10, P713; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yamauchi J, 2002, BIOCHEM BIOPH RES CO, V296, P85, DOI 10.1016/S0006-291X(02)00839-2; Zhou N, 2011, MICROVASC RES, V82, P113, DOI 10.1016/j.mvr.2011.06.005	75	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24043	24058		10.1074/jbc.M114.554766	http://dx.doi.org/10.1074/jbc.M114.554766			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023279	Green Published, hybrid			2022-12-28	WOS:000341505600005
J	Ulmer, JE; Vilen, EM; Namburi, RB; Benjdia, A; Beneteau, J; Malleron, A; Bonnaffe, D; Driguez, PA; Descroix, K; Lassalle, G; Le Narvor, C; Sandstrom, C; Spillmann, D; Berteau, O				Ulmer, Jonathan E.; Vilen, Eric Morssing; Namburi, Ramesh Babu; Benjdia, Alhosna; Beneteau, Julie; Malleron, Annie; Bonnaffe, David; Driguez, Pierre-Alexandre; Descroix, Karine; Lassalle, Gilbert; Le Narvor, Christine; Sandstrom, Corine; Spillmann, Dorothe; Berteau, Olivier			Characterization of Glycosaminoglycan (GAG) Sulfatases from the Human Gut Symbiont Bacteroides thetaiotaomicron Reveals the First GAG-specific Bacterial Endosulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Chondroitin Sulfate; Enzyme Mechanism; Glycosaminoglycan; Heparan Sulfate; Bacteroides thetaiotaomicron; Bacterial Metabolism; Enzyme Mechanism; Microbiota; Sulfatase	CHONDROITIN SULFATE; FLAVOBACTERIUM-HEPARINUM; RECOMBINANT EXPRESSION; MATURATING ENZYMES; MOLECULAR-CLONING; 2-O-SULFATASE; COFACTOR; FITNESS; COLI	Background: Sulfatases are emerging as key adaptive tools of commensal bacteria to their host. Results: The first bacterial endo-O-sulfatase and three exo-O-sulfatases from the human commensal Bacteroides thetaiotaomicron, specific for glycosaminoglycans, have been discovered and characterized. Conclusion: Commensal bacteria possess a unique array of highly specific sulfatases to metabolize host glycans. Significance: Bacterial sulfatases are much more diverse than anticipated. Despite the importance of the microbiota in human physiology, the molecular bases that govern the interactions between these commensal bacteria and their host remain poorly understood. We recently reported that sulfatases play a key role in the adaptation of a major human commensal bacterium, Bacteroides thetaiotaomicron, to its host (Benjdia, A., Martens, E. C., Gordon, J. I., and Berteau, O. (2011) J. Biol. Chem. 286, 25973-25982). We hypothesized that sulfatases are instrumental for this bacterium, and related Bacteroides species, to metabolize highly sulfated glycans (i.e. mucins and glycosaminoglycans (GAGs)) and to colonize the intestinal mucosal layer. Based on our previous study, we investigated 10 sulfatase genes induced in the presence of host glycans. Biochemical characterization of these potential sulfatases allowed the identification of GAG-specific sulfatases selective for the type of saccharide residue and the attachment position of the sulfate group. Although some GAG-specific bacterial sulfatase activities have been described in the literature, we report here for the first time the identity and the biochemical characterization of four GAG-specific sulfatases. Furthermore, contrary to the current paradigm, we discovered that B. thetaiotaomicron possesses an authentic GAG endosulfatase that is active at the polymer level. This type of sulfatase is the first one to be identified in a bacterium. Our study thus demonstrates that bacteria have evolved more sophisticated and diverse GAG sulfatases than anticipated and establishes how B. thetaiotaomicron, and other major human commensal bacteria, can metabolize and potentially tailor complex host glycans.	[Ulmer, Jonathan E.; Benjdia, Alhosna; Beneteau, Julie; Berteau, Olivier] INRA, ChemSyBio, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Ulmer, Jonathan E.; Benjdia, Alhosna; Beneteau, Julie; Berteau, Olivier] AgroParisTech, ChemSyBio, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Vilen, Eric Morssing; Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem & Biotechnol, SE-75007 Uppsala, Sweden; [Namburi, Ramesh Babu; Spillmann, Dorothe] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, SE-75123 Uppsala, Sweden; [Malleron, Annie; Bonnaffe, David; Le Narvor, Christine] Univ Paris 11, ICMMO, LabEx LERMIT, G2M,LCOM,UMR 8182,CNRS,UPS, F-91405 Orsay, France; [Driguez, Pierre-Alexandre; Descroix, Karine; Lassalle, Gilbert] Sanofi R&D, Early Candidate Unit, F-31036 Toulouse, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Swedish University of Agricultural Sciences; Uppsala University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sanofi-Aventis; Sanofi France	Spillmann, D (corresponding author), Uppsala Univ, IMBIM, SE-75123 Uppsala, Sweden.	dorothe.spillmann@imbim.uu.se; olivier.berteau@jouy.inra.fr	Benjdia, Alhosna/AAM-7415-2021; Berteau, Olivier/AAF-9080-2019	Benjdia, Alhosna/0000-0002-3544-2541; Berteau, Olivier/0000-0002-3434-5168	European Community within a consortium PolyModE [KBBE-2007-3-3-07]; Swedish Cancer Foundation; Foundation for Proteoglycan Research at Uppsala University	European Community within a consortium PolyModE; Swedish Cancer Foundation; Foundation for Proteoglycan Research at Uppsala University	This work was supported in part by European Community within a consortium PolyModE KBBE-2007-3-3-07.; Supported by grants from the Swedish Cancer Foundation and the Foundation for Proteoglycan Research at Uppsala University.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; DeBeer T, 1996, EUR J BIOCHEM, V240, P789; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Driguez PA, 2013, MODERN SYNTHETIC MET, P191; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Gargiulo V, 2009, GLYCOBIOLOGY, V19, P1485, DOI 10.1093/glycob/cwp123; Guerrini M, 2002, GLYCOBIOLOGY, V12, P713, DOI 10.1093/glycob/cwf084; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; HWA V, 1992, APPL ENVIRON MICROB, V58, P869, DOI 10.1128/AEM.58.3.869-876.1992; JAURAND G, 1994, CARBOHYD RES, V255, P295, DOI 10.1016/S0008-6215(00)90986-8; Karamanos NK, 2013, FEBS J, V280, P2119, DOI 10.1111/febs.12262; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Loft KJ, 2009, CHEMBIOCHEM, V10, P565, DOI 10.1002/cbic.200800656; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lubineau A, 1999, EUR J ORG CHEM, V1999, P2523; Malleron A, 2012, CARBOHYD RES, V353, P96, DOI 10.1016/j.carres.2012.03.033; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; PETITOU M, 1988, J BIOL CHEM, V263, P8685; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Viskov C, 2009, J THROMB HAEMOST, V7, P1143, DOI 10.1111/j.1538-7836.2009.03447.x; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297	43	58	64	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24289	24303		10.1074/jbc.M114.573303	http://dx.doi.org/10.1074/jbc.M114.573303			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002587	Green Published, hybrid			2022-12-28	WOS:000341505600025
J	Bernatik, O; Sedova, K; Schille, C; Ganji, RS; Cervenka, I; Trantirek, L; Schambony, A; Zdrahal, Z; Bryja, V				Bernatik, Ondrej; Sedova, Katerina; Schille, Carolin; Ganji, Ranjani Sri; Cervenka, Igor; Trantirek, Lukas; Schambony, Alexandra; Zdrahal, Zbynek; Bryja, Vitezslav			Functional Analysis of Dishevelled-3 Phosphorylation Identifies Distinct Mechanisms Driven by Casein Kinase 1 epsilon and Frizzled5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Mass Spectrometry (MS); Phosphorylation; Post-translational Modification (PTM); Wnt Pathway; Casein Kinase 1E; Dishevelled-3; Frizzled5	PLANAR CELL POLARITY; BETA-CATENIN; WNT/BETA-CATENIN; PDZ DOMAIN; I-EPSILON; WNT PATHWAY; PROTEIN; DROSOPHILA; DVL; FAMILY	Background: Phosphorylation of Dishevelled (Dvl) by casein kinase 1E (CK1E) is a key event in Wnt signal transduction. Results: Dvl3 residues phosphorylated by CK1E were identified by proteomics and analyzed functionally. Conclusion: Individual phosphorylation events control different aspects of Dvl biology. Significance: CK1E and Fzd5, a Wnt receptor, act on Dvl via distinct mechanism, suggesting that CK1E is not directly downstream of Frizzled5. Dishevelled-3 (Dvl3), a key component of the Wnt signaling pathways, acts downstream of Frizzled (Fzd) receptors and gets heavily phosphorylated in response to pathway activation by Wnt ligands. Casein kinase 1E (CK1E) was identified as the major kinase responsible for Wnt-induced Dvl3 phosphorylation. Currently it is not clear which Dvl residues are phosphorylated and what is the consequence of individual phosphorylation events. In the present study we employed mass spectrometry to analyze in a comprehensive way the phosphorylation of human Dvl3 induced by CK1E. Our analysis revealed >50 phosphorylation sites on Dvl3; only a minority of these sites was found dynamically induced after co-expression of CK1E, and surprisingly, phosphorylation of one cluster of modified residues was down-regulated. Dynamically phosphorylated sites were analyzed functionally. Mutations within PDZ domain (S280A and S311A) reduced the ability of Dvl3 to activate TCF/LEF (T-cell factor/lymphoid enhancer factor)-driven transcription and induce secondary axis in Xenopus embryos. In contrast, mutations of clustered Ser/Thr in the Dvl3 C terminus prevented ability of CK1E to induce electrophoretic mobility shift of Dvl3 and its even subcellular localization. Surprisingly, mobility shift and subcellular localization changes induced by Fzd5, a Wnt receptor, were in all these mutants indistinguishable from wild type Dvl3. In summary, our data on the molecular level (i) support previous the assumption that CK1E acts via phosphorylation of distinct residues as the activator as well as the shut-off signal of Wnt/-catenin signaling and (ii) suggest that CK1E acts on Dvl via different mechanism than Fzd5.	[Bernatik, Ondrej; Ganji, Ranjani Sri; Cervenka, Igor; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bernatik, Ondrej; Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Sedova, Katerina; Zdrahal, Zbynek] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Sedova, Katerina; Zdrahal, Zbynek] Masaryk Univ, Cent European Inst Technol CEITEC, Res Grp Prote, Brno 62500, Czech Republic; [Schille, Carolin; Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Trantirek, Lukas] Masaryk Univ, Cent European Inst Technol CEITEC, Struct Biol Program, Brno 62500, Czech Republic; [Trantirek, Lukas] Univ Utrecht, NL-3584 CH Utrecht, Netherlands	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno; Masaryk University Brno; University of Erlangen Nuremberg; Masaryk University Brno; Utrecht University	Bryja, V (corresponding author), Masaryk Univ, Fac Sci, Inst Expt Biol, Kotlarska 2, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Bryja, Vítězslav/P-4217-2019; Bryja, Vít?zslav/H-1925-2014; Zdrahal, Zbynek/D-9491-2012; Trantirek, Lukas/F-9923-2014; Ganji, Ranjani/AGD-5702-2022	Bryja, Vítězslav/0000-0002-9136-5085; Bryja, Vít?zslav/0000-0002-9136-5085; Bernatik, Ondrej/0000-0002-2188-332X; Zdrahal, Zbynek/0000-0003-3044-5548; Schambony, Alexandra/0000-0001-8771-5487	Ministry of Education, Youth, and Sports of the Czech Republic [MSM0021622430]; Czech Science Foundation [204/09/0498, 13-31488P]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/20.0042]; project CEITEC (Central European Institute of Technology) from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; CEITEC Open Access project - Ministry of Education, Youth, and Sports of the Czech Republic [LM2011020]; German Research Foundation (DFG) [SCHA 965/6-1]; VIDI-Career Development (Netherlands Organization for Scientific Research)	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; project CEITEC (Central European Institute of Technology) from European Regional Development Fund; CEITEC Open Access project - Ministry of Education, Youth, and Sports of the Czech Republic; German Research Foundation (DFG)(German Research Foundation (DFG)); VIDI-Career Development (Netherlands Organization for Scientific Research)	This work was supported by grants from the Ministry of Education, Youth, and Sports of the Czech Republic (MSM0021622430), the Czech Science Foundation (204/09/0498; 13-31488P), and from the European Social Fund and the state budget of the Czech Republic (CZ.1.07/2.3.00/20.0042). The MS/MS analysis was supported by the project CEITEC (Central European Institute of Technology) (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund and by a CEITEC Open Access project (LM2011020) funded by the Ministry of Education, Youth, and Sports of the Czech Republic under the activity "Projects of major infrastructures for research, development and innovations." In vivo work was supported by a research grant from the German Research Foundation (DFG; to A. S. (SCHA 965/6-1)).; Supported by VIDI-Career Development (Netherlands Organization for Scientific Research).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bryja V, 2005, STEM CELLS, V23, P965, DOI 10.1634/stemcells.2004-0174; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; CHAKRABARTI A, 1992, DEVELOPMENT, V115, P355; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Foldynova-Trantirkova S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2581; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Hu TH, 2010, J BIOL CHEM, V285, P13561, DOI 10.1074/jbc.M109.075945; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Ma Li, 2010, J Mol Signal, V5, P19, DOI 10.1186/1750-2187-5-19; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nieuwkoop P. D., 1975, NORMAL TABLES XENOPU, P162; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Singh J, 2010, GENE DEV, V24, P2157, DOI 10.1101/gad.1961010; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Smietana K, 2011, ACTA BIOCHIM POL, V58, P243; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu CC, 2012, J PROTEOME RES, V11, P3829, DOI 10.1021/pr300314d; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847	53	41	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23520	23533		10.1074/jbc.M114.590638	http://dx.doi.org/10.1074/jbc.M114.590638			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993822	Green Published, hybrid			2022-12-28	WOS:000341505000023
J	Vidilaseris, K; Shimanovskaya, E; Esson, HJ; Morriswood, B; Dong, G				Vidilaseris, Keni; Shimanovskaya, Ekaterina; Esson, Heather J.; Morriswood, Brooke; Dong, Gang			Assembly Mechanism of Trypanosoma brucei BILBO1, a Multidomain Cytoskeletal Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Cytoskeleton; Electron Microscopy (EM); Protein Assembly; Trypanosoma brucei; EF-hand; Leucine Zipper; TbBILBO1; Coiled Coil; Flagellar Pocket Collar	VARIANT SURFACE GLYCOPROTEIN; ANTIPARALLEL COILED COILS; TRANSFER-RNA SYNTHETASE; LEUCINE-ZIPPER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BINDING PROTEINS; FLAGELLAR POCKET; OPTIMIZATION; DIMERIZATION	Background: TbBILBO1 is the only known protein component of the flagellar pocket collar, but its assembly remains unknown. Results: Structural dissections of the three different domains of TbBILBO1 revealed their roles in protein assembly. Conclusion: TbBILBO1 forms a linear filament that interacts laterally to form a fibrous bundle. Significance: The data show how two types of coiled coil act together to assemble TbBILBO1 into long filaments. Trypanosoma brucei BILBO1 (TbBILBO1) is an essential component of the flagellar pocket collar of trypanosomes. We recently reported the high resolution structure of the N-terminal domain of TbBILBO1. Here, we provide further structural dissections of its other three constituent domains: EF-hand, coiled coil, and leucine zipper. We found that the EF-hand changes its conformation upon calcium binding, the central coiled coil forms an antiparallel dimer, and the C-terminal leucine zipper appears to contain targeting information. Furthermore, interdimer interactions between adjacent leucine zippers allow TbBILBO1 to form extended filaments in vitro. These filaments were additionally found to condense into fibers through lateral interactions. Based on these experimental data, we propose a mechanism for TbBILBO1 assembly at the flagellar pocket collar.	Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; Med Univ Vienna, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Morriswood, B (corresponding author), Univ Vienna, Dr Bohrgasse 9-3, A-1030 Vienna, Austria.	brooke.morriswood@univie.ac.at; gang.dong@meduniwien.ac.at	Vidilaseris, Keni/Q-1243-2019; Morriswood, Brooke/AAY-9714-2020	Vidilaseris, Keni/0000-0002-6453-6600; Morriswood, Brooke/0000-0001-7031-3801; Dong, Gang/0000-0001-9745-8103	Max F. Perutz Laboratories; Austrian Science Fund [P24383-B21]; Osterreichischer Austauschdienst graduate scholarship; Austrian Science Fund (FWF) [P 24383] Funding Source: researchfish	Max F. Perutz Laboratories; Austrian Science Fund(Austrian Science Fund (FWF)); Osterreichischer Austauschdienst graduate scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by funding from the Max F. Perutz Laboratories and by Grant P24383-B21 from the Austrian Science Fund (to G. D.).; Supported by an Osterreichischer Austauschdienst graduate scholarship from 2009 to 2012.	Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BARRY JD, 1979, J CELL SCI, V37, P287; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Diao JS, 2010, PROTEIN SCI, V19, P319, DOI 10.1002/pro.316; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; DUBIN PL, 1989, J CHROMATOGR, V479, P159, DOI 10.1016/S0021-9673(01)83327-6; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Han BG, 2002, FEBS LETT, V521, P24, DOI 10.1016/S0014-5793(02)02780-1; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lu Q, 2012, P NATL ACAD SCI USA, V109, P17388, DOI 10.1073/pnas.1208642109; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Oakley MG, 1997, BIOCHEMISTRY-US, V36, P2544, DOI 10.1021/bi962391t; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Vidilaseris K, 2014, J BIOL CHEM, V289, P3724, DOI 10.1074/jbc.M113.529032; Welburn SC, 2012, ADV PARASIT, V79, P299, DOI 10.1016/B978-0-12-398457-9.00004-4; Zheng CL, 2010, BLOOD, V115, P1081, DOI 10.1182/blood-2009-09-241877; Zuccola HJ, 1998, STRUCTURE, V6, P821, DOI 10.1016/S0969-2126(98)00084-7	41	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23870	23881		10.1074/jbc.M114.554659	http://dx.doi.org/10.1074/jbc.M114.554659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25031322	Green Published, hybrid			2022-12-28	WOS:000341505000053
J	Rakhshandehroo, M; Gijzel, SMW; Siersbaek, R; Broekema, MF; de Haar, C; Schipper, HS; Boes, M; Mandrup, S; Kalkhoven, E				Rakhshandehroo, Maryam; Gijzel, Sanne M. W.; Siersbaek, Rasmus; Broekema, Marjoleine F.; de Haar, Colin; Schipper, Henk S.; Boes, Marianne; Mandrup, Susanne; Kalkhoven, Eric			CD1d-mediated Presentation of Endogenous Lipid Antigens by Adipocytes Requires Microsomal Triglyceride Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; ADIPOSE-TISSUE; IMMUNE CELLS; MACROPHAGE POLARIZATION; INSULIN-RESISTANCE; CD1D EXPRESSION; ALPHA-CHAIN; C/EBP-BETA; ACTIVATION	Obesity-induced adipose tissue (AT) dysfunction results in a chronic low-grade inflammation that predisposes to the development of insulin resistance and type 2 diabetes. During the development of obesity, the AT-resident immune cell profile alters to create a pro-inflammatory state. Very recently, CD1d-restricted invariant (i) natural killerT(NKT) cells, a unique subset of lymphocytes that are reactive to so called lipid antigens, were implicated in AT homeostasis. Interestingly, recent data also suggest that human and mouse adipocytes can present such lipid antigens to iNKT cells in a CD1d-dependent fashion, but little is known about the lipid antigen presentation machinery in adipocytes. Here we show that CD1d, as well as the lipid antigen loading machinery genes pro-saposin (Psap), Niemann Pick type C2 (Npc2), alpha-galactosidase (Gla), are up-regulated in early adipogenesis, and are transcriptionally controlled by CCAAT/enhancer-binding protein (C/EBP)-beta and -delta. Moreover, adipocyte-induced Th1 and Th2 cytokine release by iNKT cells also occurred in the absence of exogenous ligands, suggesting the display of endogenous lipid antigen-D1d complexes by 3T3-L1 adipocytes. Furthermore, we identified microsomal triglyceride transfer protein, which we show is also under the transcriptional regulation of C/EBP beta and -delta, as a novel player in the presentation of endogenous lipid antigens by adipocytes. Overall, our findings indicate that adipocytes can function as non-professional lipid antigen presenting cells, which may present an important aspect of adipocyte-immune cell communication in the regulation of whole body energy metabolism and immune homeostasis.	[Rakhshandehroo, Maryam; Gijzel, Sanne M. W.; Broekema, Marjoleine F.; Schipper, Henk S.; Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands; [de Haar, Colin; Schipper, Henk S.; Boes, Marianne] Univ Med Ctr Utrecht, Dept Pediat Immunol, NL-3584 CG Utrecht, Netherlands; [Siersbaek, Rasmus; Mandrup, Susanne] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Southern Denmark	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands.	e.kalkhoven@umcutrecht.nl	Gijzel, Sanne M.W./P-8184-2015	Boes, Marianne/0000-0003-2590-1692; Siersbaek, Rasmus Damtoft/0000-0002-8481-2182; Schipper, Henk/0000-0003-1997-8060; Mandrup, Susanne/0000-0002-0961-5787; de Haar, Colin/0000-0003-4358-2410	Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW); Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Technology Programme of the Ministry of Economic Affairs; European Foundation for the Study of Diabetes (EFSD)/Lilly research grant	Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW)(Technologiestichting STW); Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Technology Programme of the Ministry of Economic Affairs; European Foundation for the Study of Diabetes (EFSD)/Lilly research grant	This work was supported by the Dutch Technology Foundation Stichting voor de Technische Wetenschappen (STW), the Applied Science Division of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), the Technology Programme of the Ministry of Economic Affairs, and a European Foundation for the Study of Diabetes (EFSD)/Lilly research grant.	BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Exley M. A., 2010, CURR PROTOC IMMUNOL, V14; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Ferrante AW, 2013, DIABETES OBES METAB, V15, P34, DOI 10.1111/dom.12154; Freigang S, 2012, J CLIN INVEST, V122, P3943, DOI 10.1172/JCI62267; Geng YB, 2005, J IMMUNOL, V175, P1022, DOI 10.4049/jimmunol.175.2.1022; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Powell K, 2007, NATURE, V447, P525, DOI 10.1038/447525a; Rakhshandehroo M, 2013, CELL MOL LIFE SCI, V70, P4711, DOI 10.1007/s00018-013-1414-1; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sikder H, 2009, J IMMUNOL, V183, P1657, DOI 10.4049/jimmunol.0900057; Skold M, 2005, J IMMUNOL, V175, P3584, DOI 10.4049/jimmunol.175.6.3584; Subramanian S, 2013, J LIPID RES, V54, P2831, DOI 10.1194/jlr.M041020; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109	57	24	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22128	22139		10.1074/jbc.M114.551242	http://dx.doi.org/10.1074/jbc.M114.551242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966328	Green Published, hybrid			2022-12-28	WOS:000340593500028
J	Reese, ML; Shah, N; Boothroyd, JC				Reese, Michael L.; Shah, Niket; Boothroyd, John C.			The Toxoplasma Pseudokinase ROP5 Is an Allosteric Inhibitor of the Immunity-related GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; GTPase; Innate Immunity; Parasitology; Protein Kinase	PSEUDOACTIVE SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MGBP2 CONTROLS; VIRULENCE; RESISTANCE; COMPLEX; BINDING; PROTEIN; FAMILY	Background: Competition between pathogens and their hosts drives the evolution of molecules that give either organism an edge. Results: Structural and biochemical data show how the parasite pseudokinase ROP5 inhibits the murine GTPase IRGa6. Conclusion: The surfaces of both ROP5 and IRG proteins that interact in the complex are under strong selective pressure. Significance: This highlights an extreme case of evolutionary competition. The Red Queen hypothesis proposes that there is an evolutionary arms race between host and pathogen. One possible example of such a phenomenon could be the recently discovered interaction between host defense proteins known as immunity-related GTPases (IRGs) and a family of rhoptry pseudokinases (ROP5) expressed by the protozoan parasite, Toxoplasma gondii. Mouse IRGs are encoded by an extensive and rapidly evolving family of over 20 genes. Similarly, the ROP5 family is highly polymorphic and consists of 4-10 genes, depending on the strain of Toxoplasma. IRGs are known to be avidly bound and functionally inactivated by ROP5 proteins, but the molecular basis of this interaction/inactivation has not previously been known. Here we show that ROP5 uses a highly polymorphic surface to bind adjacent to the nucleotide-binding domain of an IRG and that this produces a profound allosteric change in the IRG structure. This has two dramatic effects: 1) it prevents oligomerization of the IRG, and 2) it alters the orientation of two threonine residues that are targeted by the Toxoplasma Ser/Thr kinases, ROP17 and ROP18. ROP5s are highly specific in the IRGs that they will bind, and the fact that it is the most highly polymorphic surface of ROP5 that binds the IRG strongly supports the notion that these two protein families are co-evolving in a way predicted by the Red Queen hypothesis.	[Reese, Michael L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Shah, Niket] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Shah, Niket] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Fairchild Bldg D305,299 Campus Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Reese, Michael/0000-0001-9401-9594; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [AI73756]; Canadian Institutes of Health Research postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI73756.; Supported by a Canadian Institutes of Health Research postdoctoral fellowship.	Al-Zeer MA, 2013, AUTOPHAGY, V9, P50, DOI 10.4161/auto.22482; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fleckenstein MC, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001358; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Haldar AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003414; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Li SQ, 2005, STRUCTURE, V13, P1643, DOI 10.1016/j.str.2005.07.019; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lilue JT, 2013, ELIFE, V2, DOI 10.7554/eLife.01298; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Pawlowski N, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-7; Pfeffer SR, 2012, BIOCHEM SOC T, V40, P1373, DOI 10.1042/BST20120168; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Reese ML, 2012, TRENDS PARASITOL, V28, P53, DOI 10.1016/j.pt.2011.12.004; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Talevich E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-117; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27849	27858		10.1074/jbc.M114.567057	http://dx.doi.org/10.1074/jbc.M114.567057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25118287	hybrid, Green Published			2022-12-28	WOS:000342852800041
J	Borre, L; Andreassen, TF; Shi, L; Weinstein, H; Gether, U				Borre, Lars; Andreassen, Thorvald F.; Shi, Lei; Weinstein, Harel; Gether, Ulrik			The Second Sodium Site in the Dopamine Transporter Controls Cation Permeation and Is Regulated by Chloride	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN TRANSPORTER; PLASMA-MEMBRANE; BINDING-SITES; ION-BINDING; NEUROTRANSMITTER; SUBSTRATE; RELEASE; LEUT; NA+; AMPHETAMINE	The dopamine transporter (DAT) belongs to the family of neurotransmitter: sodium symporters and controls dopamine (DA) homeostasis by mediating Na+- and Cl--dependent reuptake of DA. Here we used two-electrode voltage clamp measurements in Xenopus oocytes together with targeted mutagenesis to investigate the mechanistic relationship between DAT ion binding sites and transporter conductances. In Li+, DAT displayed a cocaine-sensitive cation leak current similar to 10-fold larger than the substrate-induced current in Na+. Mutation of Na+ coordinating residues in the first (Na1) and second (Na2) binding sites suggested that the Li+ leak depends on Li+ interaction with Na2 rather than Na1. DA caused a marked inhibition of the Li+ leak, consistent with the ability of the substrate to interact with the Li+-occupied state of the transporter. The leak current in Li+ was also potently inhibited by low millimolar concentrations of Na+, which according to our mutational data conceivably depended on high affinity binding to Na1. The Li+ leak was further regulated by Cl- that most likely increases Li+ permeation by allosterically lowering Na2 affinity. Interestingly, mutational lowering of Na2 affinity by substituting Asp-420 with asparagine dramatically increased cation permeability in Na+ to a level higher than seen in Li+. In addition to reveal a functional link between the bound Cl- and the cation bound in the Na2 site, the data support a key role of Na2 in determining cation permeability of the transporter and thereby possibly in regulating the opening probability of the inner gate.	[Borre, Lars; Andreassen, Thorvald F.; Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Mol Neuropharmacol Lab,Fac Hlth & Med Sci,Panum I, DK-2200 Copenhagen N, Denmark; [Shi, Lei; Weinstein, Harel] Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Inst Computat Biomed, Weill Med Coll, New York, NY 10021 USA	Lundbeckfonden; University of Copenhagen; Cornell University; Cornell University	Borre, L (corresponding author), Panum Inst 18 6, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark.	lbo29917134@gmail.com; gether@sund.ku.dk	Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019	Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Lundbeck Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G. and H. W.). This work was also supported by the Danish Medical Research Council (to U. G.), University of Copenhagen BioScaRT Program of Excellence (to U. G.), Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the Novo Nordisk Foundation (to U. G.), Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (to U. G.), and The Lundbeck Foundation (to L. B.).	Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; COSTA PF, 1989, J PHYSIOL-LONDON, V413, P199, DOI 10.1113/jphysiol.1989.sp017649; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Galli A, 1997, J NEUROSCI, V17, P3401; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; GIROS B, 1992, MOL PHARMACOL, V42, P383; GU H, 1994, J BIOL CHEM, V269, P7124; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Meinild AK, 2012, AM J PHYSIOL-CELL PH, V302, pC1661, DOI 10.1152/ajpcell.00446.2011; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Porzgen P, 2001, MOL PHARMACOL, V59, P83; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; WALL SC, 1995, MOL PHARMACOL, V47, P544; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	52	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25764	25773		10.1074/jbc.M114.574269	http://dx.doi.org/10.1074/jbc.M114.574269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063810	Green Published, hybrid			2022-12-28	WOS:000342130800034
J	Jagannathan, S; Hsu, JCC; Reid, DW; Chen, Q; Thompson, WJ; Moseley, AM; Nicchitta, CV				Jagannathan, Sujatha; Hsu, Jack C. -C.; Reid, David W.; Chen, Qiang; Thompson, Will J.; Moseley, Arthur M.; Nicchitta, Christopher V.			Multifunctional Roles for the Protein Translocation Machinery in RNA Anchoring to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MEMBRANE-PROTEINS; MICROSOMAL-MEMBRANES; RIBOSOME RECEPTOR; DIRECT ASSOCIATION; STATISTICAL-MODEL; BINDING PROTEINS; LOCALIZATION; TRANSLATION; IDENTIFICATION	Signal sequence-encoding mRNAs undergo translation-dependent localization to the endoplasmic reticulum (ER) and at the ER are anchored via translation on Sec61-bound ribosomes. Recent investigations into the composition and membrane association characteristics of ER-associated mRNAs have, however, revealed both ribosome-dependent (indirect) and ribosome-independent (direct) modes of mRNA association with the ER. These findings raise important questions regarding our understanding of how mRNAs are selected, localized, and anchored to the ER. Using semi-intact tissue culture cells, we performed a polysome solubilization screen and identified conditions that distinguish polysomes engaged in the translation of distinct cohorts of mRNAs. To gain insight into the molecular basis of direct mRNA anchoring to the ER, we performed RNA-protein UV photocross-linking studies in rough microsomes and demonstrate that numerous ER integral membrane proteins display RNA binding activity. Quantitative proteomic analyses of HeLa cytosolic and ER-bound polysome fractions identified translocon components as selective polysome-interacting proteins. Notably, the Sec61 complex was highly enriched in polysomes engaged in the translation of endomembrane organelle proteins, whereas translocon accessory proteins, such as ribophorin I, were present in all subpopulations of ER-associated polysomes. Analyses of the protein composition of oligo(dT)-selected UV photocross-linked ER protein-RNA adducts identified Sec61 alpha,beta and ribophorin I as ER-poly(A) mRNA-binding proteins, suggesting unexpected roles for the protein translocation and modification machinery in mRNA anchoring to the ER. In summary, we propose that multiple mechanisms of mRNA and ribosome association with ER operate to enable an mRNA transcriptome-wide function for the ER in protein synthesis.	[Jagannathan, Sujatha; Chen, Qiang; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hsu, Jack C. -C.; Reid, David W.; Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Thompson, Will J.; Moseley, Arthur M.] Duke Univ, Med Ctr, Duke Prote Core Facil, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu		Hsu, Chun Chieh/0000-0003-4380-8723; Jagannathan, Sujatha/0000-0001-9039-2631	National Institutes of Health [GM101533]; Duke University School of Medicine; National Institutes of Health, NCRR, Shared Instrumentation Grant [1S10RR027528-0]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University School of Medicine; National Institutes of Health, NCRR, Shared Instrumentation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101533 (to C. V. N.). This work was also supported by a bridge-funding award from the Duke University School of Medicine (to C. V. N.). The DeltaVision system was purchased with funding from National Institutes of Health, NCRR, Shared Instrumentation Grant 1S10RR027528-0.	Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; Bai JZ, 2008, CELL BIOL INT, V32, P473, DOI 10.1016/j.cellbi.2007.10.002; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Blower MD, 2013, INT REV CEL MOL BIO, V302, P1, DOI 10.1016/B978-0-12-407699-0.00001-7; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARDELLI J, 1976, J CELL BIOL, V70, P47, DOI 10.1083/jcb.70.1.47; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cui XYA, 2013, J BIOL CHEM, V288, P29633, DOI 10.1074/jbc.M113.482505; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Dimitrov L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013243; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Dowell JA, 2008, ANAL CHEM, V80, P6715, DOI 10.1021/ac8007994; FREIDLIN PJ, 1980, BIOCHEM BIOPH RES CO, V93, P521, DOI 10.1016/0006-291X(80)91108-0; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Hamilton RS, 2011, METHODS MOL BIOL, V714, P447, DOI 10.1007/978-1-61779-005-8_27; HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KIKUCHI Y, 1978, P NATL ACAD SCI USA, V75, P1270, DOI 10.1073/pnas.75.3.1270; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; KRUPPA J, 1977, J CELL BIOL, V74, P414, DOI 10.1083/jcb.74.2.414; LANDE MA, 1975, J CELL BIOL, V65, P513, DOI 10.1083/jcb.65.3.513; Langley R, 1998, DNA CELL BIOL, V17, P449, DOI 10.1089/dna.1998.17.449; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; LODISH HF, 1977, J CELL BIOL, V74, P358, DOI 10.1083/jcb.74.2.358; LONGUET M, 1979, BIOCHIMIE, V61, P1113; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mathias RA, 2011, METHODS, V54, P396, DOI 10.1016/j.ymeth.2011.01.006; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Morris AR, 2010, WIRES SYST BIOL MED, V2, P162, DOI 10.1002/wsbm.54; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nicchitta CV, 2005, BIOCHEM CELL BIOL, V83, P687, DOI 10.1139/O05-147; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Ogawa-Goto K, 2002, J VIROL, V76, P2350, DOI 10.1128/JVI.76.5.2350-2362.2002; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; RAPOPORT TA, 1989, BIOCHEM SOC T, V17, P325, DOI 10.1042/bst0170325; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song YP, 2010, J PROTEOME RES, V9, P1195, DOI 10.1021/pr900146t; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; Stephens S, 2007, THEATER HEUTE, P47; Suh J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-333; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; VEIS A, 1985, P NATL ACAD SCI USA, V82, P3693, DOI 10.1073/pnas.82.11.3693; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Weil D, 2013, BBA-GENE REGUL MECH, V1829, P725, DOI 10.1016/j.bbagrm.2013.01.002; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	96	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25907	25924		10.1074/jbc.M114.580688	http://dx.doi.org/10.1074/jbc.M114.580688			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063809	Green Published, hybrid			2022-12-28	WOS:000342130800046
J	Li, XF; Lytton, J				Li, Xiao-Fang; Lytton, Jonathan			An Essential Role for the K+-dependent Na+/Ca2+-exchanger, NCKX4, in Melanocortin-4-receptor-dependent Satiety	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; INTRACELLULAR FREE CALCIUM; MELANOCORTIN-4 RECEPTOR; NA+/CA2+ EXCHANGERS; CA2+ CLEARANCE; FOOD-INTAKE; MICE; ACTIVATION; HOMEOSTASIS; MUTATIONS	K+-dependent Na+/Ca2+-exchangers are broadly expressed in various tissues, and particularly enriched in neurons of the brain. The distinct physiological roles for the different members of this Ca2+ transporter family are, however, not well described. Here we show that gene-targeted mice lacking the K+-dependent Na+/Ca2+-exchanger, NCKX4 (gene slc24a4 or Nckx4), display a remarkable anorexia with severe hypophagia and weight loss. Feeding and satiety are coordinated centrally by melanocortin-4 receptors (MC4R) in neurons of the hypothalamic paraventricular nucleus (PVN). The hypophagic response of Nckx4 knock-out mice is accompanied by hyperactivation of neurons in the PVN, evidenced by high levels of c-Fos expression. The activation of PVN neurons in both fasted Nckx4 knock-out and glucose-injected wild-type animals is blocked by Ca2+ removal and MC4R antagonists. In cultured hypothalamic neurons, melanocyte stimulating hormone induces an MC4R-dependent and sustained Ca2+ signal, which requires phospholipase C activity and plasma membrane Ca2+ entry. The Ca2+ signal is enhanced in hypothalamic neurons from Nckx4 knock-out animals, and is depressed in cells in which NCKX4 is overexpressed. Finally, MC4R-dependent oxytocin expression in the PVN, a key essential step in satiety, is prevented by blocking phospholipase C activation or Ca2+ entry. These findings highlight an essential, and to our knowledge previously unknown, role for Ca2+ signaling in the MC4R pathway that leads to satiety, and a novel non-redundant role for NCKX4-mediated Ca2+ extrusion in controlling MC4R signaling and feeding behavior. Together, these findings highlight a novel pathway that potentially could be exploited to develop much needed new therapeutics to tackle eating disorders and obesity.	Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Fac Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4Z6, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Lytton, J (corresponding author), Univ Calgary, Hlth Res Innovat Ctr, Rm GAC64,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jlytton@ucalgary.ca		Lytton, Jonathan/0000-0003-4770-2512	Canadian Institutes of Health Research [FRN 97876]; Tier 1 Canada Research Chair; Alberta Innovates-Health Solutions Medical Scientist award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); Alberta Innovates-Health Solutions Medical Scientist award	This work was supported in part by Canadian Institutes of Health Research Grant FRN 97876 (to J. L.).; Supported by a Tier 1 Canada Research Chair and an Alberta Innovates-Health Solutions Medical Scientist award. To whom correspondence should be addressed: University of Calgary, Health Research Innovation Centre, Rm. GAC64, 3280 Hospital Dr. NW, Calgary, AB T2N 4Z6, Canada.	Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Ausubel FM, 2012, CURRENT PROTOCOLS MO; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kim MH, 2003, J NEUROSCI, V23, P11673; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee SH, 2002, J NEUROSCI, V22, P6891; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marth JD, 1996, J CLIN INVEST, V97, P1999, DOI 10.1172/JCI118634; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mountjoy KG, 2001, PHYSIOL GENOMICS, V5, P11, DOI 10.1152/physiolgenomics.2001.5.1.11; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Newman EA, 2006, J SURG RES, V132, P201, DOI 10.1016/j.jss.2006.02.003; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Sabatier Nancy, 2013, Front Endocrinol (Lausanne), V4, P35, DOI 10.3389/fendo.2013.00035; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Singru PS, 2007, ENDOCRINOLOGY, V148, P638, DOI 10.1210/en.2006-1233; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; Tateyama M, 2006, P NATL ACAD SCI USA, V103, P1124, DOI 10.1073/pnas.0505925103; Tsuzuki T, 1998, NUCLEIC ACIDS RES, V26, P988, DOI 10.1093/nar/26.4.988; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yang X, 2013, BIOSCIENCE REP, V33, P939, DOI 10.1042/BSR20130099; Zhang Hai, 2013, PLoS One, V8, pe61477, DOI 10.1371/journal.pone.0061477	55	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25445	25459		10.1074/jbc.M114.564450	http://dx.doi.org/10.1074/jbc.M114.564450			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25096581	Green Published, hybrid			2022-12-28	WOS:000342130800005
J	Smith, MH; Rodriguez, EH; Weissman, JS				Smith, Melanie H.; Rodriguez, Edwin H.; Weissman, Jonathan S.			Misfolded Proteins Induce Aggregation of the Lectin Yos9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; STAPHYLOCOCCAL NUCLEASE; UNFOLDED PROTEIN; 131-RESIDUE FRAGMENT; MOLECULAR CHAPERONE; BINDING-SPECIFICITY; PEPTIDE-BINDING	A substantial fraction of nascent proteins delivered into the endoplasmic reticulum (ER) never reach their native conformations. Eukaryotes use a series of complementary pathways to efficiently recognize and dispose of these terminally misfolded proteins. In this process, collectively termed ER-associated degradation (ERAD), misfolded proteins are retrotranslocated to the cytosol, polyubiquitinated, and degraded by the proteasome. Although there has been great progress in identifying ERAD components, how these factors accurately identify substrates remains poorly understood. The targeting of misfolded glycoproteins in the ER lumen for ERAD requires the lectin Yos9, which recognizes the glycan species found on terminally misfolded proteins. In a role that remains poorly characterized, Yos9 also binds the protein component of ERAD substrates. Here, we identified a 45-kDa domain of Yos9, consisting of residues 22-421, that is proteolytically stable, highly structured, and able to fully support ERAD in vivo. In vitro binding studies show that Yos9(22-421) exhibits sequence-specific recognition of linear peptides from the ERAD substrate, carboxypeptidase Y G255R (CPY*), and binds a model unfolded peptide Delta EspP and protein Delta 131 Delta in solution. Binding of Yos9 to these substrates results in their cooperative aggregation. Although the physiological consequences of this substrate-induced aggregation remain to be seen, it has the potential to play a role in the regulation of ERAD.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biosci, Grad Grp Biophys,Ctr RNA Syst Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biosci, Ctr RNA Syst Biol, 1700 4th St, San Francisco, CA 94158 USA.	Jonathan.Weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Smith, Melanie/0000-0003-2464-8429	National Institutes of Health [U01 GM098254]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, U01GM098254, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 GM098254 (to J. S. W.).	ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Carter John Mark, 2004, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0904s60; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dam TK, 2004, METHOD ENZYMOL, V379, P107; deCrouyChanel A, 1996, J BIOL CHEM, V271, P15486, DOI 10.1074/jbc.271.26.15486; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hanna J, 2012, J BIOL CHEM, V287, P8633, DOI 10.1074/jbc.M111.317644; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Izawa T, 2012, MOL BIOL CELL, V23, P1283, DOI 10.1091/mbc.E11-08-0722; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Plemper RK, 1999, J CELL SCI, V112, P4123; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Wang Y, 1995, BIOCHEMISTRY-US, V34, P15895, DOI 10.1021/bi00049a004; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	45	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25670	25677		10.1074/jbc.M114.583344	http://dx.doi.org/10.1074/jbc.M114.583344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086047	Green Published, hybrid			2022-12-28	WOS:000342130800026
J	Nawrotek, A; Guimaraes, BG; Velours, C; Subtil, A; Knossow, M; Gigant, B				Nawrotek, Agata; Guimaraes, Beatriz G.; Velours, Christophe; Subtil, Agathe; Knossow, Marcel; Gigant, Benoit			Biochemical and Structural Insights into Microtubule Perturbation by CopN from Chlamydia pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION GENES; TUBULIN; PROTEIN; STATHMIN; COMPLEX; SHIGELLA; DETERMINANTS; MECHANISMS; EXPRESSION; COLCHICINE	Although the actin network is commonly hijacked by pathogens, there are few reports of parasites targeting microtubules. The proposed member of the LcrE protein family from some Chlamydia species (e.g. pCopN from C. pneumoniae) binds tubulin and inhibits microtubule assembly in vitro. From the pCopN structure and its similarity with that of MxiC from Shigella, we definitively confirm CopN as the Chlamydia homolog of the LcrE family of bacterial proteins involved in the regulation of type III secretion. We have also investigated the molecular basis for the pCopN effect on microtubules. We show that pCopN delays microtubule nucleation and acts as a pure tubulin-sequestering protein at steady state. It targets the beta subunit interface involved in the tubulin longitudinal self-association in a way that inhibits nucleotide exchange. pCopN contains three repetitions of a helical motif flanked by disordered N-and C-terminal extensions. We have identified the pCopN minimal tubulin-binding region within the second and third repeats. Together with the intriguing observation that C. trachomatis CopN does not bind tubulin, our data support the notion that, in addition to the shared function of type III secretion regulation, these proteins have evolved different functions in the host cytosol. Our results provide a mechanistic framework for understanding the C. pneumoniae CopN-specific inhibition of microtubule assembly.	[Nawrotek, Agata; Velours, Christophe; Knossow, Marcel; Gigant, Benoit] CNRS, LEBS, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Guimaraes, Beatriz G.] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Subtil, Agathe] Inst Pasteur, Unite Biol Interact Cellulaires, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gigant, B (corresponding author), CNRS, LEBS, Bat 34,1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	gigant@lebs.cnrs-gif.fr	Guimarães, Beatriz Gomes/Z-6242-2019; Nawrotek, Agata/AAG-2860-2019; Subtil, Agathe/C-7464-2017	Guimarães, Beatriz Gomes/0000-0002-8546-2460; Subtil, Agathe/0000-0002-7481-4846; Nawrotek, Agata/0000-0001-7708-6381; Gigant, Benoit/0000-0002-5946-6759	Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche [ANR-12-BSV8-0002-01]; CNRS	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer (to B. G.), by Agence Nationale de la Recherche Grant ANR-12-BSV8-0002-01 (to B. G.), and by CNRS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amayed P, 2000, BIOCHEMISTRY-US, V39, P12295, DOI 10.1021/bi000279w; Archuleta TL, 2011, J BIOL CHEM, V286, P33992, DOI 10.1074/jbc.M111.258426; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Bricogne G., 2011, BUSTER VERSION 2 8 0; Carabeo R, 2011, CELL MICROBIOL, V13, P1460, DOI 10.1111/j.1462-5822.2011.01651.x; Carlier MF, 1997, BIOPHYS J, V73, P418, DOI 10.1016/S0006-3495(97)78081-0; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; HARRIS NL, 1994, J MOL BIOL, V236, P1356, DOI 10.1016/0022-2836(94)90063-9; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Joseph SS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00001; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mignot I, 2012, J BIOL CHEM, V287, P31085, DOI 10.1074/jbc.M112.383869; Mouilleron S, 2012, STRUCTURE, V20, P1960, DOI 10.1016/j.str.2012.08.031; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Schubot FD, 2004, ACTA CRYSTALLOGR D, V60, P1981, DOI [10.1107/S0907444904023005, 10.1107/S090744490402.1005]; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood DO, 2014, CURR OPIN MICROBIOL, V17, P11, DOI 10.1016/j.mib.2013.10.006; YARBROUGH LR, 1985, BIOCHEMISTRY-US, V24, P1708, DOI 10.1021/bi00328a021; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	56	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25199	25210		10.1074/jbc.M114.568436	http://dx.doi.org/10.1074/jbc.M114.568436			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25056950	Green Published, hybrid			2022-12-28	WOS:000341985300040
J	Ryu, J; Kaul, Z; Yoon, AR; Liu, Y; Yaguchi, T; Na, Y; Ahn, HM; Gao, R; Choi, IK; Yun, CO; Kaul, SC; Wadhwa, R				Ryu, Jihoon; Kaul, Zeenia; Yoon, A-Rum; Liu, Ye; Yaguchi, Tomoko; Na, Youjin; Ahn, Hyo Min; Gao, Ran; Choi, Il-Kyu; Yun, Chae-Ok; Kaul, Sunil C.; Wadhwa, Renu			Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; TUMOR-SUPPRESSOR P53; HNRNP K-PROTEIN; HSP70 FAMILY; CANCER-CELLS; CYTOPLASMIC SEQUESTRATION; GLUCOSE DEPRIVATION; PARKINSONS-DISEASE; COLORECTAL-CANCER; LEUKEMIA-CELLS	The Hsp70 family protein mortalin is an essential chaperone that is frequently enriched in cancer cells and exists in various subcellular sites, including the mitochondrion, plasma membrane, endoplasmic reticulum, and cytosol. Although the molecular mechanisms underlying its multiple subcellular localizations are not yet clear, their functional significance has been revealed by several studies. In this study, we examined the nuclear fractions of human cells and found that the malignantly transformed cells have more mortalin than the normal cells. We then generated a mortalin mutant that lacked a mitochondrial targeting signal peptide. It was largely localized in the nucleus, and, hence, is called nuclear mortalin (mot-N). Functional characterization of mot-N revealed that it efficiently protects cancer cells against endogenous and exogenous oxidative stress. Furthermore, compared with the full-length mortalin overexpressing cancer cells, mot-N derivatives showed increased malignant properties, including higher proliferation rate, colony forming efficacy, motility, and tumor forming capacity both in in vitro and in vivo assays. We demonstrate that mot-N promotes carcinogenesis and cancer cell metastasis by inactivation of tumor suppressor protein p53 functions and by interaction and functional activation of telomerase and heterogeneous ribonucleoprotein K (hnRNP-K) proteins.	[Ryu, Jihoon; Kaul, Zeenia; Liu, Ye; Yaguchi, Tomoko; Ahn, Hyo Min; Gao, Ran; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan; [Ryu, Jihoon; Kaul, Zeenia; Liu, Ye; Yaguchi, Tomoko; Ahn, Hyo Min; Gao, Ran; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Dept Biotechnol DBT, Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan; [Ryu, Jihoon; Yoon, A-Rum; Na, Youjin; Ahn, Hyo Min; Choi, Il-Kyu; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Kaul, Zeenia] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hanyang University; University System of Ohio; Ohio State University	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, 222 Wangsimni Ro, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr; s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Yun, Chae-Ok/P-3698-2015; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192; Gao, Ran/0000-0001-8712-429X; Liu, Ye/0000-0002-4845-6643; Yun, Chae-Ok/0000-0002-9466-4531	Japanese Society for the Promotion of Science, Japan; Ministry of Knowledge Economy [10030051]; Korea Science Engineering Foundation [2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879]	Japanese Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by grants-in-aid for scientific research (Kakenhi) from the Japanese Society for the Promotion of Science, Japan (to S. C. K.); by Ministry of Knowledge Economy Grant 10030051 (to C.-O. Y.); and by Korea Science Engineering Foundation Grants 2010-0029220, 2013K1A1A2A02050188, and 2013M3A9D3045879 (to C.-O. Y.).	Ando K, 2014, GASTRIC CANCER, V17, P255, DOI 10.1007/s10120-013-0279-1; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chen J, 2014, INT J ONCOL, V44, P247, DOI 10.3892/ijo.2013.2161; Chiasserini D, 2011, MOVEMENT DISORD, V26, P1639, DOI 10.1002/mds.23647; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Flachbartova Z, 2013, ACTA VIROL, V57, P2, DOI 10.4149/av_2013_01_3; Fujiki T, 2007, ONCOGENE, V26, P5258, DOI 10.1038/sj.onc.1210331; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Gestl EE, 2012, BIOCHEM BIOPH RES CO, V423, P411, DOI 10.1016/j.bbrc.2012.05.139; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; He ZY, 2010, WORLD J GASTROENTERO, V16, P4670, DOI 10.3748/wjg.v16.i37.4670; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Kanai M, 2007, GENES CELLS, V12, P797, DOI 10.1111/j.1365-2443.2007.01091.x; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; Kaul SC, 1998, ONCOGENE, V17, P907, DOI 10.1038/sj.onc.1202017; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Li Hong-Yan, 2011, Shengli Xuebao, V63, P69; Li LP, 2011, PROTEOMICS, V11, P429, DOI 10.1002/pmic.200900819; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Mizukoshi E, 2001, BIOCHEM BIOPH RES CO, V280, P1203, DOI 10.1006/bbrc.2001.4225; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Ostrowski J, 2003, BRIT J CANCER, V89, P1493, DOI 10.1038/sj.bjc.6601250; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Papanikolaou V, 2009, INT J ONCOL, V35, P1141, DOI 10.3892/ijo_00000430; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Pilzer D, 2010, INT J CANCER, V126, P1428, DOI 10.1002/ijc.24888; Qu MY, 2011, BRAIN RES, V1368, P336, DOI 10.1016/j.brainres.2010.10.068; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Rozenberg P, 2013, INT J CANCER, V133, P514, DOI 10.1002/ijc.28029; Sataranatarajan K, 2008, CELL SIGNAL, V20, P969, DOI 10.1016/j.cellsig.2008.01.016; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2004, J GENE MED, V6, P439, DOI 10.1002/jgm.530; Wadhwa R, 2002, CANCER RES, V62, P4434; Wadhwa R, 2000, CANCER RES, V60, P6818; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Wu PK, 2013, MOL CELL BIOL, V33, P4051, DOI 10.1128/MCB.00021-13; Xu J, 1999, ONCOL RES, V11, P429; Yang L, 2011, J MOL BIOL, V414, P654, DOI 10.1016/j.jmb.2011.09.009; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Yoo JY, 2010, J GENE MED, V12, P586, DOI 10.1002/jgm.1471	50	44	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24832	24844		10.1074/jbc.M114.565929	http://dx.doi.org/10.1074/jbc.M114.565929			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012652	Green Published, hybrid			2022-12-28	WOS:000341985300010
J	Berry, R; Vivian, JP; Deuss, FA; Balaji, GR; Saunders, PM; Lin, J; Littler, DR; Brooks, AG; Rossjohn, J				Berry, Richard; Vivian, Julian P.; Deuss, Felix A.; Balaji, Gautham R.; Saunders, Philippa M.; Lin, Jie; Littler, Dene R.; Brooks, Andrew G.; Rossjohn, Jamie			The Structure of the Cytomegalovirus-Encoded m04 Glycoprotein, a Prototypical Member of the m02 Family of Immunoevasins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein Structure; Immunoglobulin-like Domain; Immunology; Natural Killer Cells (NK Cells); Viral Protein	KILLER-CELL RECEPTORS; IMMUNOGLOBULIN-LIKE RECEPTOR; COMPLEX CLASS-I; MURINE CYTOMEGALOVIRUS; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; IMMUNE EVASION; VIRAL IMMUNOEVASIN; SEQUENCE; RECOGNITION	Background: Cytomegalovirus-encoded m02 family members are involved in immune evasion. Results: m04 binds murine MHC-I via an Ig-V-like ectodomain. Conclusion: m04 is the prototype of the m02 family, whose members mimic proteins derived from the host immune system. Significance: The results provide insight into the structural scaffold that defines a large family of immunoevasins. The ability of CMVs to evade the immune system of the host is dependent on the expression of a wide array of glycoproteins, many of which interfere with natural killer cell function. In murine CMV, two large protein families mediate this immune-evasive function. Although it is established that the m145 family members mimic the structure of MHC-I molecules, the structure of the m02 family remains unknown. The most extensively studied m02 family member is m04, a glycoprotein that escorts newly assembled MHC-I molecules to the cell surface, presumably to avoid missing self recognition. Here we report the crystal structure of the m04 ectodomain, thereby providing insight into this large immunoevasin family. m04 adopted a -sandwich immunoglobulin variable (Ig-V)-like fold, despite sharing very little sequence identity with the Ig-V superfamily. In addition to the Ig-V core, m04 possesses several unique structural features that included an unusual -strand topology, a number of extended loops and a prominent -helix. The m04 interior was packed by a myriad of hydrophobic residues that form distinct clusters around two conserved tryptophan residues. This hydrophobic core was well conserved throughout the m02 family, thereby indicating that murine CMV encodes a number of Ig-V-like molecules. We show that m04 binds a range of MHC-I molecules with low affinity in a peptide-independent manner. Accordingly, the structure of m04, which represents the first example of an murine CMV encoded Ig-V fold, provides a basis for understanding the structure and function of this enigmatic and large family of immunoevasins.	[Berry, Richard; Vivian, Julian P.; Deuss, Felix A.; Balaji, Gautham R.; Littler, Dene R.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Saunders, Philippa M.; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Melbourne; Cardiff University	Berry, R (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	Richard.berry@monash.edu; Jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Balaji, Gautham/0000-0002-7436-4689; Littler, Dene/0000-0001-5904-1905; Vivian, Julian/0000-0002-9400-4437; berry, richard/0000-0001-7043-0469; Deuss, Felix/0000-0002-0386-4336; Brooks, Andrew/0000-0002-4085-9683	Australian Research Council; National Health and Medical Research Council of Australia; National Health and Medical Research Council Peter Doherty Fellowship; Australian Research Council Discovery Early Career Researcher Award; National Health and Medical Research Council Australia Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the Australian Research Council and the National Health and Medical Research Council of Australia, a National Health and Medical Research Council Peter Doherty Fellowship (to R. B.), an Australian Research Council Discovery Early Career Researcher Award (to J. P. V.), and a National Health and Medical Research Council Australia Fellowship (to J. R.).	Adams EJ, 2007, P NATL ACAD SCI USA, V104, P10128, DOI 10.1073/pnas.0703735104; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Clements CS, 2006, ACTA CRYSTALLOGR F, V62, P70, DOI 10.1107/S1744309105041473; Corbett AJ, 2007, J GEN VIROL, V88, P758, DOI 10.1099/vir.0.82623-0; Corbett AJ, 2011, J IMMUNOL, V186, P1713, DOI 10.4049/jimmunol.1003308; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; French AR, 2004, IMMUNITY, V20, P747, DOI 10.1016/j.immuni.2004.05.006; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtappels R, 2006, J VIROL, V80, P7613, DOI 10.1128/JVI.00723-06; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kielczewska A, 2009, J EXP MED, V206, P515, DOI 10.1084/jem.20080954; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Loenen WAM, 2001, SEMIN IMMUNOL, V13, P41, DOI 10.1006/smim.2001.0294; Mans J, 2007, J BIOL CHEM, V282, P35247, DOI 10.1074/jbc.M706782200; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Natarajan K, 2006, J MOL BIOL, V358, P157, DOI 10.1016/j.jmb.2006.01.068; Nemoviova I., 2014, ACTA CRYSTALLOGR D, V70, P851; Oliveira SA, 2002, J VIROL, V76, P885, DOI 10.1128/JVI.76.2.885-894.2002; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Petersen JL, 2003, J IMMUNOL, V171, P4473, DOI 10.4049/jimmunol.171.9.4473; Pyzik M, 2011, J EXP MED, V208, P1105, DOI 10.1084/jem.20101831; Rawlinson WD, 1996, J VIROL, V70, P8833, DOI 10.1128/JVI.70.12.8833-8849.1996; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Romasanta PN, 2014, J BIOL CHEM, V289, P5083, DOI 10.1074/jbc.M113.532929; Sissons JGP, 2002, SPRINGER SEMIN IMMUN, V24, P169, DOI 10.1007/s00281-002-0104-0; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yang ZR, 2008, P NATL ACAD SCI USA, V105, P10095, DOI 10.1073/pnas.0804551105	46	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23753	23763		10.1074/jbc.M114.584128	http://dx.doi.org/10.1074/jbc.M114.584128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24982419	Green Published, hybrid			2022-12-28	WOS:000341505000043
J	Broselid, S; Berg, KA; Chavera, TA; Kahn, R; Clarke, WP; Olde, B; Leeb-Lundberg, LMF				Broselid, Stefan; Berg, Kelly A.; Chavera, Teresa A.; Kahn, Robin; Clarke, William P.; Olde, Bjoern; Leeb-Lundberg, L. M. Fredrik			G protein-coupled Receptor 30 (GPR30) Forms a Plasma Membrane Complex with Membrane-associated Guanylate Kinases (MAGUKs) and Protein Kinase A-anchoring Protein 5 (AKAP5) That Constitutively Inhibits cAMP Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; ADENYLYL-CYCLASE; PDZ PROTEINS; AMPA RECEPTORS; TRAFFICKING; PSD-95; ENDOCYTOSIS; OCCURS; PKA	GPR30, or G protein-coupled estrogen receptor, is a G protein-coupled receptor reported to bind 17 beta-estradiol (E-2), couple to the G proteins G(s) and G(i/o), and mediate non-genomic estrogenic responses. However, controversies exist regarding the receptor pharmacological profile, effector coupling, and subcellular localization. We addressed the role of the type I PDZ motif at the receptor C terminus in receptor trafficking and coupling to cAMP production in HEK293 cells and CHO cells ectopically expressing the receptor and in Madin-Darby canine kidney cells expressing the native receptor. GPR30 was localized both intracellularly and in the plasma membrane and subject to limited basal endocytosis. E-2 and G-1, reported GPR30 agonists, neither stimulated nor inhibited cAMP production through GPR30, nor did they influence receptor localization. Instead, GPR30 constitutively inhibited cAMP production stimulated by a heterologous agonist independently of G(i/o). Moreover, siRNA knockdown of native GPR30 increased cAMP production. Deletion of the receptor PDZ motif interfered with inhibition of cAMP production and increased basal receptor endocytosis. GPR30 interacted with membrane-associated guanylate kinases, including SAP97 and PSD-95, and protein kinase A-anchoring protein (AKAP) 5 in the plasma membrane in a PDZ-dependent manner. Knockdown of AKAP5 or St-Ht31 treatment, to disrupt AKAP interaction with the PKA RII beta regulatory subunit, decreased inhibition of cAMP production, and St-Ht31 increased basal receptor endocytosis. Therefore, GPR30 forms a plasma membrane complex with a membrane-associated guanylate kinase and AKAP5, which constitutively attenuates cAMP production in response to heterologous agonists independently of G(i/o) and retains receptors in the plasma membrane.	[Broselid, Stefan; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Kahn, Robin] Lund Univ, Dept Nephrol, S-22184 Lund, Sweden; [Olde, Bjoern] Lund Univ, Dept Cardiol, S-22184 Lund, Sweden; [Berg, Kelly A.; Chavera, Teresa A.; Clarke, William P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	Lund University; Lund University; Lund University; University of Texas System; University of Texas Health San Antonio	Leeb-Lundberg, LMF (corresponding author), Lund Univ, Dept Expt Med Sci, BMC A12, S-22184 Lund, Sweden.	fredrik.leeb-lundberg@med.lu.se	Clarke, William/L-3999-2019	Clarke, William/0000-0002-8861-8256; Broselid, Stefan/0000-0001-5489-460X	Swedish Cancer Foundation; Swedish Research Council; NovoNordisk Foundation; Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk Foundation(Novo Nordisk Foundation); Alfred Osterlund Foundation; Gunnar Nilsson Cancer Foundation	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the NovoNordisk Foundation, the Alfred Osterlund Foundation, and the Gunnar Nilsson Cancer Foundation (to L. M. F. L. L.).	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BERG KA, 1994, MOL PHARMACOL, V46, P477; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Dunn HA, 2013, J BIOL CHEM, V288, P15023, DOI 10.1074/jbc.M113.473660; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Langer G, 2010, STEROIDS, V75, P603, DOI 10.1016/j.steroids.2009.12.006; Lenhart PM, 2013, J MOL ENDOCRINOL, V51, P191, DOI 10.1530/JME-13-0021; Li X, 2013, J BIOL CHEM, V288, P33797, DOI 10.1074/jbc.M113.470559; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	47	43	44	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22117	22127		10.1074/jbc.M114.566893	http://dx.doi.org/10.1074/jbc.M114.566893			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962572	Green Published, hybrid			2022-12-28	WOS:000340593500027
J	Tao, WJ; Chen, Q; Zhou, WJ; Wang, YP; Wang, L; Zhang, Z				Tao, Wenjuan; Chen, Quan; Zhou, Wenjie; Wang, Yunping; Wang, Lu; Zhang, Zhi			Persistent Inflammation-induced Up-regulation of Brain-derived Neurotrophic Factor (BDNF) Promotes Synaptic Delivery of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor GluA1 Subunits in Descending Pain Modulatory Circuits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; ANTERIOR CINGULATE CORTEX; GLUTAMATE RECEPTORS; PERIAQUEDUCTAL GRAY; NEUROPATHIC PAIN; AMPA RECEPTORS; MESSENGER-RNA; GLUR1 SUBUNIT; PHOSPHORYLATION; EXPRESSION	The enhanced AMP A receptor phosphorylation at GluA1 serine 831 sites in the central pain-modulating system plays a pivotal role in descending pain facilitation after inflammation, but the underlying mechanisms remain unclear. Weshow here that, in the rat brain stem, in the nucleus raphe magnus, which is a critical relay in the descending pain-modulating system of the brain, persistent inflammatory pain induced by complete Freund adjuvant (CFA) can enhance AMPA receptor-mediated excitatory postsynaptic currents and the GluA2-lacking AMPA receptor-mediated rectification index. Western blot analysis showed an increase in GluA1 phosphorylation at Ser-831 but not at Ser-845. This was accompanied by an increase in distribution of the synaptic GluA1 subunit. In parallel, the level of histone H3 acetylation at bdnf gene promoter regions was reduced significantly 3 days after CFA injection, as indicated by ChIP assays. This was correlated with an increase in BDNF mRNA levels and BDNF protein levels. Sequestering endogenous extracellular BDNF with TrkB-IgG in the nucleus raphe magnus decreased AMPA receptor-mediated synaptic transmission and GluA1 phosphorylation at Ser-831 3 days after CFA injection. Under the same conditions, blockade of TrkB receptor functions, phospholipase C, or PKC impaired GluA1 phosphorylation at Ser-831 and decreased excitatory postsynaptic currents mediated by GluA2-lacking AMPA receptors. Taken together, these results suggest that epigenetic up-regulation of BDNF by peripheral inflammation induces GluR1 phosphorylation at Ser-831 sites through activation of the phospholipase C-PKC signaling cascade, leading to the trafficking of GluA1 to pain-modulating neuronal synapses.	[Tao, Wenjuan; Chen, Quan; Zhou, Wenjie; Wang, Yunping; Wang, Lu; Zhang, Zhi] Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Tao, Wenjuan] Anhui Coll Tradit Chinese Med, Dept Pharm, Wuhu 241000, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University of Chinese Medicine	Zhang, Z (corresponding author), Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China.	zhizhang@ustc.edu.cn			973 Program [2014CB548100]; National Natural Science Foundation of China [31100802, 91332109]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grant 2014CB548100 and by National Natural Science Foundation of China Grants 31100802 and 91332109 (to Z. Z.).	Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bie BH, 2005, J NEUROSCI, V25, P3824, DOI 10.1523/JNEUROSCI.5010-04.2005; Bie BH, 2012, NEUROPSYCHOPHARMACOL, V37, P2780, DOI 10.1038/npp.2012.144; Bie BH, 2011, EUR J PHARMACOL, V653, P26, DOI 10.1016/j.ejphar.2010.11.027; Biggs JE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-44; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Block F, 2003, SCHMERZ, V17, P261, DOI 10.1007/s00482-003-0218-x; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Conner JM, 1997, J NEUROSCI, V17, P2295; Descalzi G, 2009, MOL NEUROBIOL, V40, P253, DOI 10.1007/s12035-009-8085-9; Du JL, 2009, P NATL ACAD SCI USA, V106, P18890, DOI 10.1073/pnas.0910659106; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Garry EA, 2004, PAIN, V109, P210, DOI 10.1016/j.pain.2004.04.002; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Guan Y, 2004, NEUROSCI LETT, V366, P201, DOI 10.1016/j.neulet.2004.05.051; Guan Y, 2003, PAIN, V104, P401, DOI 10.1016/S0304-3959(03)00048-4; Guan Y, 2002, J PHARMACOL EXP THER, V300, P513, DOI 10.1124/jpet.300.2.513; Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ho YC, 2013, J NEUROSCI, V33, P7825, DOI 10.1523/JNEUROSCI.5583-12.2013; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; King VR, 1999, NEUROSCIENCE, V92, P935, DOI 10.1016/S0306-4522(99)00072-X; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Ma JY, 2006, PAIN, V122, P163, DOI 10.1016/j.pain.2006.01.031; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Nakata H, 2007, FEBS LETT, V581, P2047, DOI 10.1016/j.febslet.2007.04.041; Narisawa-Saito M, 1999, NEUROSCIENCE, V88, P1009, DOI 10.1016/S0306-4522(98)00496-5; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; Pan ZZ, 1997, NATURE, V389, P382, DOI 10.1038/38730; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Radhakrishnan R, 2009, NEUROSCI LETT, V457, P141, DOI 10.1016/j.neulet.2009.03.086; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Tao YX, 2012, NEUROSCI BULL, V28, P111, DOI 10.1007/s12264-012-1204-z; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Wei F, 1999, J NEUROSCI, V19, P9346; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yamada T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-67; Zhang L, 2010, PAIN, V149, P107, DOI 10.1016/j.pain.2010.01.017; Zhang Z, 2013, MOL PHARMACOL, V84, P511, DOI 10.1124/mol.113.086496; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010	59	25	27	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22196	22204		10.1074/jbc.M114.580381	http://dx.doi.org/10.1074/jbc.M114.580381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966334	hybrid, Green Published			2022-12-28	WOS:000340593500034
J	Ishino, S; Yamagami, T; Kitamura, M; Kodera, N; Mori, T; Sugiyama, S; Ando, T; Goda, N; Tenno, T; Hiroaki, H; Ishino, Y				Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio; Goda, Natsuko; Tenno, Takeshi; Hiroaki, Hidekazu; Ishino, Yoshizumi			Multiple Interactions of the Intrinsically Disordered Region between the Helicase and Nuclease Domains of the Archaeal Hef Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FANCONI-ANEMIA PATHWAY; CROSS-LINK REPAIR; HYPERTHERMOPHILIC ARCHAEON; PYROCOCCUS-FURIOSUS; UNSTRUCTURED REGIONS; DNA-REPAIR; ENDONUCLEASE; DYNAMICS; COMPLEX; SYSTEM	Hef is an archaeal protein that probably functions mainly in stalled replication fork repair. The presence of an unstructured region was predicted between the two distinct domains of the Hef protein. We analyzed the interdomain region of Thermococcus kodakarensis Hef and demonstrated its disordered structure by CD, NMR, and high speed atomic force microscopy (AFM). To investigate the functions of this intrinsically disordered region (IDR), we screened for proteins interacting with the IDR of Hef by a yeast two-hybrid method, and 10 candidate proteins were obtained. We found that PCNA1 and a RecJ-like protein specifically bind to the IDR in vitro. These results suggested that the Hef protein interacts with several different proteins that work together in the pathways downstream from stalled replication fork repair by converting the IDR structure depending on the partner protein.	[Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Ishino, Yoshizumi] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 8128581, Japan; [Ishino, Sonoko; Yamagami, Takeshi; Kitamura, Makoto; Ishino, Yoshizumi] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan; [Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Bio AFM Frontier Res Ctr, Kanazawa, Ishikawa 9201192, Japan; [Kodera, Noriyuki; Mori, Tetsuya; Sugiyama, Shyogo; Ando, Toshio] Kanazawa Univ, Coll Sci & Engn, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Goda, Natsuko; Tenno, Takeshi; Hiroaki, Hidekazu] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan	Kyushu University; Kyushu University; Kanazawa University; Kanazawa University; Nagoya University	Ishino, Y (corresponding author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp	Hiroaki, Hidekazu/G-9564-2012; ANDO, Toshio/E-7054-2015; HIROAKI, HIDEKAZU/N-1658-2019; Kodera, Noriyuki/AAJ-1797-2020; Kodera, Noriyuki/E-6569-2015	ANDO, Toshio/0000-0001-8819-154X; HIROAKI, HIDEKAZU/0000-0003-1621-5893; Kodera, Noriyuki/0000-0003-4880-8423; Ishino, Yoshizumi/0000-0001-9419-0826; Ishino, Sonoko/0000-0002-1833-1735	Ministry of Education, Culture, Sports, Science and Technology of Japan [21113005, 23310152, 26242075, 21113002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 21113005, 23310152, and 26242075 (to Y. I.) and 21113002 (to T. A.).	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; FORMANKAY JD, 1992, BIOCHEMISTRY-US, V31, P3442, DOI 10.1021/bi00128a019; Franchitto A, 2011, CELL CYCLE, V10, P4039, DOI 10.4161/cc.10.23.18409; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Fukuchi S, 2009, NUCLEIC ACIDS RES, V37, pD333, DOI 10.1093/nar/gkn855; Fukuchi S, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-26; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hashimoto M, 2013, BIOPHYS J, V104, P2222, DOI 10.1016/j.bpj.2013.04.007; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kiyonari S, 2008, J BIOL CHEM, V283, P24185, DOI 10.1074/jbc.M802837200; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kuba Y, 2012, GENES CELLS, V17, P923, DOI 10.1111/gtc.12007; Lestini R, 2013, NUCLEIC ACIDS RES, V41, P10358, DOI 10.1093/nar/gkt816; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Newman M, 2005, EMBO J, V24, P895, DOI 10.1038/sj.emboj.7600581; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nishino T, 2003, STRUCTURE, V11, P445, DOI 10.1016/S0969-2126(03)00046-7; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Pluchon PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079707; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Roberts JA, 2003, MOL MICROBIOL, V48, P361, DOI 10.1046/j.1365-2958.2003.03444.x; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tori K, 2007, J BACTERIOL, V189, P5652, DOI 10.1128/JB.00073-07; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vogel C, 2004, J MOL BIOL, V336, P809, DOI 10.1016/j.jmb.2003.12.026; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Weathers EA, 2004, FEBS LETT, V576, P348, DOI 10.1016/j.febslet.2004.09.036; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yuan H, 2013, NUCLEIC ACIDS RES, V41, P5817, DOI 10.1093/nar/gkt275	53	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21627	21639		10.1074/jbc.M114.554998	http://dx.doi.org/10.1074/jbc.M114.554998			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947516	Green Published, hybrid			2022-12-28	WOS:000340558300037
J	Tamma, G; Ranieri, M; Di Mise, A; Centrone, M; Svelto, M; Valenti, G				Tamma, Grazia; Ranieri, Marianna; Di Mise, Annarita; Centrone, Mariangela; Svelto, Maria; Valenti, Giovanna			Glutathionylation of the Aquaporin-2 Water Channel A NOVEL POST-TRANSLATIONAL MODIFICATION MODULATED BY THE OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aquaporin; Glutathionylation; Kidney; Oxidative Stress; Post-translational Modification (PTM); AQP2; CaSR; Water Reabsorption	ACTIVATION; PHOSPHORYLATION	Background: The trafficking of the vasopressin-dependent water channel AQP2 is regulated by post-translational modifications as phosphorylations and ubiquitylation. Results: AQP2 is subjected to S-glutathionylation, which is modulated by ROS production. Conclusion: AQP2 is sensitive to oxidative stress. Significance: Identifying this novel post-translational modification is crucial to understand renal diseases characterized by oxidative stress and AQP2-dependent water balance disturbance. Aquaporin-2 (AQP2) is the vasopressin-regulated water channel that controls renal water reabsorption and urine concentration. AQP2 undergoes different regulated post-translational modifications, including phosphorylation and ubiquitylation, which are fundamental for controlling AQP2 cellular localization, stability, and function. The relationship between AQP2 and S-glutathionylation is of potential interest because reactive oxygen species (ROS), produced under renal failure or nephrotoxic drugs, may influence renal function as well as the expression and the activity of different transporters and channels, including aquaporins. Here, we show for the first time that AQP2 is subjected to S-glutathionylation in kidney and in HEK-293 cells stably expressing AQP2. S-Glutathionylation is a redox-dependent post-translational modification controlling several signal transduction pathways and displaying an acute effect on free cytosolic calcium concentration. Interestingly, we found that in fresh kidney slices, the increased AQP2 S-glutathionylation correlated with tert-butyl hydroperoxide-induced ROS generation. Moreover, we also found that cells expressing wild-type human calcium-sensing receptor (hCaSR-wt) and its gain of function (hCaSR-R990G; hCaSR-N124K) had a significant decrease in AQP2 S-glutathionylation secondary to reduced ROS levels and reduced basal intracellular calcium concentration compared with mock cells. Together, these new findings provide fundamental insight into cell biological aspects of AQP2 function and may be relevant to better understand and explain pathological states characterized by an oxidative stress and AQP2-dependent water reabsorption disturbs.	[Tamma, Grazia; Ranieri, Marianna; Di Mise, Annarita; Centrone, Mariangela; Svelto, Maria; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Tamma, Grazia; Svelto, Maria; Valenti, Giovanna] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [Svelto, Maria; Valenti, Giovanna] Univ Bari Aldo Moro, Ctr Eccellenza Genom Campo Biomed & Agr, I-70121 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Tamma, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Amendola 165-A, I-70125 Bari, Italy.	grazia.tamma@uniba.it	Ranieri, Marianna/J-9421-2018; Di Mise, Annarita/AAP-4176-2020; Svelto, Maria/P-6186-2014; Tamma, Grazia/F-8823-2016	Ranieri, Marianna/0000-0003-3118-5813; Tamma, Grazia/0000-0002-8890-0278; DI MISE, Annarita/0000-0002-8132-4917; VALENTI, GIOVANNA/0000-0003-0233-0778	University of Bari, Italy (Idea Giovani); Research Program of National Interest projects [Tamma01373409Prin]; Telethon Grant [GGP13227]	University of Bari, Italy (Idea Giovani); Research Program of National Interest projects; Telethon Grant(Fondazione Telethon)	This work was supported by a grant from University of Bari, Italy (Idea Giovani 2011), by Research Program of National Interest projects (to G. T.) (Tamma01373409Prin), and by Telethon Grant GGP13227 (to G. V.).	Brown D, 2008, CURR OPIN NEPHROL HY, V17, P491, DOI 10.1097/MNH.0b013e3283094eb1; Chen YJ, 2014, BIOINFORMATICS, V30, P2386, DOI 10.1093/bioinformatics/btu301; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Feraille E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087239; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Huddleston AT, 2008, J NEUROPHYSIOL, V99, P1565, DOI 10.1152/jn.00659.2007; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Procino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033145; Ranieri M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079113; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Tamma G., 2014, J AM SOC NE IN PRESS; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Ungvari Z, 2003, CIRCULATION, V108, P1253, DOI 10.1161/01.CIR.0000079165.84309.4D; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Zaffagnini M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014142	26	24	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27807	27813		10.1074/jbc.M114.586024	http://dx.doi.org/10.1074/jbc.M114.586024			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25112872	Green Published, hybrid			2022-12-28	WOS:000342852800037
J	Solsona, C; Kahn, TB; Badilla, CL; Alvarez-Zaldiernas, C; Blasi, J; Fernandez, JM; Alegre-Cebollada, J				Solsona, Carles; Kahn, Thomas B.; Badilla, Carmen L.; Alvarez-Zaldiernas, Cristina; Blasi, Juan; Fernandez, Julio M.; Alegre-Cebollada, Jorge			Altered Thiol Chemistry in Human Amyotrophic Lateral Sclerosis-linked Mutants of Superoxide Dismutase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND; WILD-TYPE; CU,ZN-SUPEROXIDE DISMUTASE; FAMILIAL ALS; BIOPHYSICAL PROPERTIES; PROTEIN IMPORT; SINGLE PROTEIN; MOTOR-NEURONS; METAL-IONS; SOD1	Neurodegenerative diseases share a common characteristic, the presence of intracellular or extracellular deposits of protein aggregates in nervous tissues. Amyotrophic Lateral Sclerosis (ALS) is a severe and fatal neurodegenerative disorder, which affects preferentially motoneurons. Changes in the redox state of superoxide dismutase 1 (SOD1) are associated with the onset and development of familial forms of ALS. In human SOD1 (hSOD1), a conserved disulfide bond and two free cysteine residues can engage in anomalous thiol/disulfide exchange resulting in non-native disulfides, a hallmark of ALS that is related to protein misfolding and aggregation. Because of the many competing reaction pathways, traditional bulk techniques fall short at quantifying individual thiol/disulfide exchange reactions. Here, we adapt recently developed single-bond chemistry techniques to study individual disulfide isomerization reactions in hSOD1. Mechanical unfolding of hSOD1 leads to the formation of a polypeptide loop held by the disulfide. This loop behaves as a molecular jump rope that brings reactive Cys-111 close to the disulfide. Using force-clamp spectroscopy, we monitor nucleophilic attack of Cys-111 at either sulfur of the disulfide and determine the selectivity of the reaction. Disease-causing mutations G93A and A4V show greatly altered reactivity patterns, which may contribute to the progression of familial ALS.	[Solsona, Carles; Alvarez-Zaldiernas, Cristina; Blasi, Juan] Univ Barcelona, Lab Cellular & Mol Neurobiol, Dept Pathol & Expt Therapeut, Fac Med, Barcelona 08907, Spain; [Solsona, Carles; Alvarez-Zaldiernas, Cristina; Blasi, Juan] Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain; [Kahn, Thomas B.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kahn, Thomas B.; Badilla, Carmen L.; Fernandez, Julio M.; Alegre-Cebollada, Jorge] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Alegre-Cebollada, Jorge] CNIC, Vasc Biol & Inflammat Dept, Madrid 28029, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Columbia University; Columbia University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Solsona, C (corresponding author), Univ Barcelona, Lab Cellular & Mol Neurobiol, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain.	solsona@ub.edu	Blasi, Juan/K-7943-2014; Alegre-Cebollada, Jorge/I-4301-2014	Blasi, Juan/0000-0002-0482-9444; Alegre-Cebollada, Jorge/0000-0003-0542-0170	National Institutes of Health [HL66030, HL61228]; Spanish Ministry of Economy and Competitiveness [SAF2011-28485, SAF2011-27566]; European Union FEDER from the Spanish Ministry of Education [PR2011-0339]; Government of Catalonia [SGR2009/152]; National Institutes of Health Training Program in Molecular Biophysics [T32GM008281]; European Union FEDER; National Institutes of Health Grant [AI106072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI106072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union FEDER from the Spanish Ministry of Education; Government of Catalonia(Generalitat de Catalunya); National Institutes of Health Training Program in Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FEDER(European Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.) and Grants SAF2011-28485 from the Spanish Ministry of Economy and Competitiveness and European Union FEDER PR2011-0339 from the Spanish Ministry of Education, and Government of Catalonia SGR2009/152 (to C. S.).; Supported by the National Institutes of Health Training Program in Molecular Biophysics (T32GM008281).; Recipient of Grant SAF2011-27566, Spanish Ministry of Economy and Competitiveness and European Union FEDER.; Supported by National Institutes of Health Grant AI106072.	Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Das A, 2013, J MOL BIOL, V425, P850, DOI 10.1016/j.jmb.2012.12.022; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Galaleldeen A, 2009, ARCH BIOCHEM BIOPHYS, V492, P40, DOI 10.1016/j.abb.2009.09.020; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Juneja T, 1997, NEUROLOGY, V48, P55, DOI 10.1212/WNL.48.1.55; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Liang J, 2009, ACS NANO, V3, P1628, DOI 10.1021/nn900294n; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Pickles S, 2012, AMYOTROPH LATERAL SC, V13, P333, DOI 10.3109/17482968.2012.648645; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Shariff K, 2004, BIOPHYS J, V86, P3647, DOI 10.1529/biophysj.104.040865; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; You Z, 2010, BIOCHEMISTRY-US, V49, P1191, DOI 10.1021/bi901844d	65	13	13	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26722	26732		10.1074/jbc.M114.565333	http://dx.doi.org/10.1074/jbc.M114.565333			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096579	Green Published, hybrid			2022-12-28	WOS:000342853900005
J	Aghazadeh, Y; Ye, XY; Blonder, J; Papadopoulos, V				Aghazadeh, Yasaman; Ye, Xiaoying; Blonder, Josip; Papadopoulos, Vassilios			Protein Modifications Regulate the Role of 14-3-3 gamma Adaptor Protein in cAMP-induced Steroidogenesis in MA-10 Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BIOSYNTHESIS; FUNCTIONAL SPECIFICITY; CHOLESTEROL TRANSPORT; CRYSTAL-STRUCTURE; LIGAND-BINDING; IN-VIVO; PHOSPHORYLATION; ISOFORM; 14-3-3-PROTEINS; ACTIVATION	The 14-3-3 protein family comprises adaptors and scaffolds that regulate intracellular signaling pathways. The 14-3-3 gamma isoform is a negative regulator of steroidogenesis that is hormonally induced and transiently functions at the initiation of steroidogenesis by delaying maximal steroidogenesis in MA-10 mouse tumor Leydig cells. Treatment of MA-10 cells with the cAMP analog 8-bromo-cAMP (8-Br-cAMP), which stimulates steroidogenesis, triggers the interaction of 14-3-3 gamma with the steroidogenic acute regulatory protein (STAR) in the cytosol, limiting STAR activity to basal levels. Over time, this interaction ceases, allowing for a 2-fold induction in STAR activity and maximal increase in the rate of steroid formation. The 14-3-3 gamma/ STAR pattern of interaction was found to be opposite that of the 14-3-3 gamma homodimerization pattern. Phosphorylation and acetylation of 14-3-3 gamma showed similar patterns to homodimerization and STAR binding, respectively. 14-3-3 gamma Ser(58) phosphorylation and 14-3-3 gamma Lys(49) acetylation were blocked using trans-activator of HIV transcription factor 1 peptides coupled to 14-3-3 gamma sequences containing Ser(58) or Lys(49). Blocking either one of these modifications further induced 8-Br-cAMP-induced steroidogenesis while reducing lipid storage, suggesting that the stored cholesterol is used for steroid formation. Taken together, these results indicate that Ser(58) phosphorylation and Lys(49) acetylation of 14-3-3 gamma occur in a coordinated time-dependent manner to regulate 14-3-3 gamma homodimerization. 14-3-3 gamma Ser(58) phosphorylation is required for STAR interactions under control conditions, and 14-3-3 gamma Lys(49) acetylation is important for the cAMP-dependent induction of these interactions.	[Aghazadeh, Yasaman; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Aghazadeh, Yasaman; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Ye, Xiaoying; Blonder, Josip] NCI, Prot Characterizat Lab, Canc Res Technol Program, Leidos Biomed Res Inc,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1650 Cedar Ave,C10-148, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Le Fonds de la recherche du Quebec-Sante	Le Fonds de la recherche du Quebec-Sante	We thank Dr. Mario Ascoli (University of Iowa, Iowa City, IA) for supplying the MA-10 cell line and Dr. Buck Hales (Southern Illinois University) for supplying the STAR antibody. The Research Institute of McGill University Health Centre was supported by a center grant from Le Fonds de la recherche du Quebec-Sante.	Aghazadeh Y, 2012, J BIOL CHEM, V287, P15380, DOI 10.1074/jbc.M112.339580; Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1998, ENDOCR RES, V24, P463, DOI 10.3109/07435809809032634; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069702; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Hamaguchi A, 2003, J BIOL CHEM, V278, P41557, DOI 10.1074/jbc.M305294200; Han DD, 2010, BIOCHEM BIOPH RES CO, V396, P401, DOI 10.1016/j.bbrc.2010.04.104; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kramer B, 1997, PROTEINS, P221; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; MARAIS R, 1995, STRUCTURE, V3, P751, DOI 10.1016/S0969-2126(01)00209-X; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703; Wang C, 2009, J ANDROL, V30, P1, DOI 10.2164/jandrol.108.006486; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Xiao B, 1996, ACTA CRYSTALLOGR D, V52, P203, DOI 10.1107/S0907444995009516; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	49	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26542	26553		10.1074/jbc.M114.569079	http://dx.doi.org/10.1074/jbc.M114.569079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086053	Green Published, hybrid			2022-12-28	WOS:000342128800045
J	Cai, MJ; Liu, W; Pei, XY; Li, XR; He, HJ; Wang, JX; Zhao, XF				Cai, Mei-Juan; Liu, Wen; Pei, Xu-Yang; Li, Xiang-Ru; He, Hong-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan			Juvenile Hormone Prevents 20-Hydroxyecdysone-induced Metamorphosis by Regulating the Phosphorylation of a Newly Identified Broad Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STATUS-QUO ACTION; RED FLOUR BEETLE; TRANSCRIPTION FACTORS; INSECT METAMORPHOSIS; TRIBOLIUM-CASTANEUM; MANDUCA-SEXTA; DROSOPHILA METAMORPHOSIS; HELICOVERPA-ARMIGERA; METHOPRENE-TOLERANT	The steroid hormone 20-hydroxyecdysone (20E) initiates insect molting and metamorphosis. By contrast, juvenile hormone (JH) prevents metamorphosis. However, the mechanism by which JH inhibits metamorphosis remains unclear. In this study, we propose that JH induces the phosphorylation of Broad isoform Z7 (BrZ7), a newly identified protein, to inhibit 20E-mediated metamorphosis in the lepidopteran insect Helicoverpa armigera. The knockdown of BrZ7 in larvae inhibited metamorphosis by repressing the expression of the 20E response gene. BrZ7 was weakly expressed and phosphorylated during larval growth but highly expressed and non-phosphorylated during metamorphosis. JH regulated the rapid phosphorylation of BrZ7 via a G-protein-coupled receptor-, phospholipase C-, and protein kinase C-triggered pathway. The phosphorylated BrZ7 bound to the 5'-regulatory region of calponin to regulate its expression in the JH pathway. Exogenous JH induced BrZ7 phosphorylation to prevent metamorphosis by suppressing 20E-related gene transcription. JH promoted non-phosphorylated calponin interacting with ultraspiracle protein to activate the JH pathway and antagonize the 20E pathway. This study reveals one of the possible mechanisms by which JH counteracts 20E-regulated metamorphosis by inducing the phosphorylation of BrZ7.	[Cai, Mei-Juan; Liu, Wen; Pei, Xu-Yang; Li, Xiang-Ru; He, Hong-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol,Minis, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Liu, Wen/S-8027-2019; Zhao, Xiao-Fan/AGW-9886-2022	Liu, Wen/0000-0002-4985-0618; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31230067]; National Basic Research Program of China (973 Program) [2012CB114101]; Ph.D. Programs Foundation of the Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China (973 Program) Grant 2012CB114101, and Ph.D. Programs Foundation of the Ministry of Education of China Grant 20120131110025.	Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Cai MJ, 2012, APOPTOSIS, V17, P1327, DOI 10.1007/s10495-012-0761-y; Deng H, 2011, INSECT MOL BIOL, V20, P45, DOI 10.1111/j.1365-2583.2010.01041.x; DIBELLO PR, 1991, GENETICS, V129, P385; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Fang F, 2005, FEBS J, V272, P1577, DOI 10.1111/j.1742-4658.2005.04578.x; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; Gorelick-Feldman J, 2010, STEROIDS, V75, P632, DOI 10.1016/j.steroids.2010.03.008; Ijiro T, 2004, INSECT BIOCHEM MOLEC, V34, P963, DOI 10.1016/j.ibmb.2004.06.005; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KARIM FD, 1993, DEVELOPMENT, V118, P977; Kim Y, 1999, INSECT BIOCHEM MOLEC, V29, P943, DOI 10.1016/S0965-1748(99)00070-3; KISS I, 1988, GENETICS, V118, P247; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; Rauch P, 1998, INSECT BIOCHEM MOLEC, V28, P265, DOI 10.1016/S0965-1748(98)00026-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Schooley D.A., 1984, P373; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wang CX, 2012, AMINO ACIDS, V43, P963, DOI 10.1007/s00726-011-1159-9; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Yang DT, 2008, MOL BIOL REP, V35, P405, DOI 10.1007/s11033-007-9100-8; Yang XH, 2011, MOL CELL ENDOCRINOL, V333, P172, DOI 10.1016/j.mce.2010.12.029; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	49	31	33	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26630	26641		10.1074/jbc.M114.581876	http://dx.doi.org/10.1074/jbc.M114.581876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25096576	Green Published, hybrid			2022-12-28	WOS:000342128800053
J	Sakai, H; Kado, S; Taketomi, A; Sakane, F				Sakai, Hiromichi; Kado, Sayaka; Taketomi, Akinobu; Sakane, Fumio			Diacylglycerol Kinase delta Phosphorylates Phosphatidylcholine-specific Phospholipase C-dependent, Palmitic Acid-containing Diacylglycerol Species in Response to High Glucose Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; INTRACELLULAR LEVELS; PHOSPHATIDIC-ACID; MOLECULAR-CLONING; MUSCLE-CELLS; ACTIVATION; ADIPOCYTES; INHIBITION; MECHANISM; SYNTHASE	Decreased expression of diacylglycerol (DG) kinase (DGK) delta in skeletal muscles is closely related to the pathogenesis of type 2 diabetes. To identify DG species that are phosphorylated by DGK delta in response to high glucose stimulation, we investigated high glucose-dependent changes in phosphatidic acid (PA) molecular species in mouse C2C12 myoblasts using a newly established liquid chromatography/MS method. We found that the suppression of DGK delta 2 expression by DGK delta-specific siRNAs significantly inhibited glucose-dependent increases in 30:0-, 32:0-, and 34:0-PA and moderately attenuated 30:1-, 32:1-, and 34:1-PA. Moreover, overexpression of DGK delta 2 also enhanced the production of these PA species. MS/MS analysis revealed that these PA species commonly contain palmitic acid (16:0). D609, an inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC), significantly inhibited the glucose-stimulated production of the palmitic acid-containing PA species. Moreover, PC-PLC was co-immunoprecipitated with DGK delta 2. These results strongly suggest that DGK delta preferably metabolizes palmitic acid-containing DG species supplied from the PC-PLC pathway, but not arachidonic acid (20:4)-containing DG species derived from the phosphatidylinositol turnover, in response to high glucose levels.	[Sakai, Hiromichi; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Kado, Sayaka] Chiba Univ, Ctr Analyt Instrumentat, Inage Ku, Chiba 2638522, Japan; [Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Chiba University; Chiba University; Hokkaido University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	sakane@faculty.chiba-u.jp	Sakai, Hiromichi/K-8457-2019; Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Grants-in-Aid for Scientific Research [26291017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Science and Technology Agency; the Naito Foundation; the Hamaguchi Foundation for the Advancement of Biochemistry; the Daiichi-Sankyo Foundation of Life Science; the Terumo Life Science Foundation; the Futaba Electronic Memorial Foundation; the Daiwa Securities Health Foundation; the Ono Medical Research Foundation; the Japan Foundation for Applied Enzymology; and the Food Science Institute Foundation.	Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Callender HL, 2007, ANAL CHEM, V79, P263, DOI 10.1021/ac061083q; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; CRAVEN PA, 1990, DIABETES, V39, P667, DOI 10.2337/diabetes.39.6.667; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; Hodgkin MN, 1998, TRENDS BIOCHEM SCI, V23, P200, DOI 10.1016/S0968-0004(98)01200-6; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Lowe CE, 2013, OBESITY, V21, P1823, DOI 10.1002/oby.20297; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Mizuno S, 2012, FEBS OPEN BIO, V2, P267, DOI 10.1016/j.fob.2012.08.006; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Pizer ES, 2000, CANCER RES, V60, P213; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Sakai H, 2007, J BIOL CHEM, V282, P19692, DOI 10.1074/jbc.M611056200; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; SCHUTZE S, 1991, J EXP MED, V174, P975, DOI 10.1084/jem.174.5.975; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shulga YV, 2013, BIOCHEMISTRY-US, V52, P7766, DOI 10.1021/bi401178y; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Takeuchi M, 2012, BBA-MOL CELL RES, V1823, P2210, DOI 10.1016/j.bbamcr.2012.08.019; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	43	37	38	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26607	26617		10.1074/jbc.M114.590950	http://dx.doi.org/10.1074/jbc.M114.590950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25112873	hybrid, Green Published			2022-12-28	WOS:000342128800051
J	Beautrait, A; Michalski, KR; Lopez, TS; Mannix, KM; McDonald, DJ; Cutter, AR; Medina, CB; Hebert, AM; Francis, CJ; Bouvier, M; Tesmer, JJG; Sterne-Marr, R				Beautrait, Alexandre; Michalski, Kevin R.; Lopez, Thomas S.; Mannix, Katelynn M.; McDonald, Devin J.; Cutter, Amber R.; Medina, Christopher B.; Hebert, Aaron M.; Francis, Charnelle J.; Bouvier, Michel; Tesmer, John J. G.; Sterne-Marr, Rachel			Mapping the Putative G Protein-coupled Receptor (GPCR) Docking Site on GPCR Kinase 2 INSIGHTS FROM INTACT CELL PHOSPHORYLATION AND RECRUITMENT ASSAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; LIGHT-DEPENDENT PHOSPHORYLATION; RESONANCE ENERGY-TRANSFER; CARBOXYL-TERMINAL TAIL; BETA(2)-ADRENERGIC RECEPTOR; RHODOPSIN KINASE; HOMOLOGY DOMAIN; ACTIVATION; PURIFICATION; DESENSITIZATION	G protein-coupled receptor kinases (GRKs) phosphorylate agonist-occupied receptors initiating the processes of desensitization and beta-arrestin-dependent signaling. Interaction of GRKs with activated receptors serves to stimulate their kinase activity. The extreme N-terminal helix (alpha N), the kinase small lobe, and the active site tether (AST) of the AGC kinase domain have previously been implicated in mediating the allosteric activation. Expanded mutagenesis of the alpha N and AST allowed us to further assess the role of these two regions in kinase activation and receptor phosphorylation in vitro and in intact cells. We also developed a bioluminescence resonance energy transfer-based assay to monitor the recruitment of GRK2 to activated alpha(2A)-adrenergic receptors (alpha(2A)ARs) in living cells. The bioluminescence resonance energy transfer signal exhibited a biphasic response to norepinephrine concentration, suggesting that GRK2 is recruited to G beta gamma and alpha(2A)AR with EC50 values of 15 nM and 8 mu M, respectively. We show that mutations in alpha N (L4A, V7E, L8E, V11A, S12A, Y13A, and M17A) and AST (G475I, V477D, and I485A) regions impair or potentiate receptor phosphorylation and/or recruitment. We suggest that a surface of GRK2, including Leu(4), Val(7), Leu(8), Val(11), and Ser(12), directly interacts with receptors, whereas residues such as Asp(10), Tyr(13), Ala(16), Met(17), Gly(475), Val(477), and Ile(485) are more important for kinase domain closure and activation. Taken together with data on GRK1 and GRK6, our data suggest that all three GRK subfamilies make conserved interactions with G protein-coupled receptors, but there may be unique interactions that influence selectivity.	[Beautrait, Alexandre; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Beautrait, Alexandre; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Michalski, Kevin R.; Lopez, Thomas S.; Mannix, Katelynn M.; McDonald, Devin J.; Cutter, Amber R.; Medina, Christopher B.; Hebert, Aaron M.] Siena Coll, Dept Chem & Biochem, Loudonville, NY 12211 USA; [Francis, Charnelle J.; Sterne-Marr, Rachel] Siena Coll, Dept Biol, Loudonville, NY 12211 USA; [Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA	Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sterne-Marr, R (corresponding author), Siena Coll, Dept Biol, 515 Loudon Rd, Loudonville, NY 12211 USA.	sternemarr@siena.edu	Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100; Tesmer, John/0000-0003-1125-3727; Medina, Christopher/0000-0001-7441-9232; Mannix, Katelynn/0000-0003-4541-5050; DiPiazza, Amber/0000-0001-5610-0172; Beautrait, Alexandre/0000-0001-8418-799X	National Science Foundation [MCB0744739]; Canadian Institutes of Health Research (CIHR) [10501]; Groupe de Recherche Universitaire sur le Medicament; Fonds de la Recherche en Sante du Quebec; National Institutes of Health [HL071818, HL086865, DK20572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Universitaire sur le Medicament; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB0744739 (to R. S.-M.), Canadian Institutes of Health Research (CIHR) Grant #10501 (to M. B.), postdoctoral fellowships from Groupe de Recherche Universitaire sur le Medicament and Fonds de la Recherche en Sante du Quebec (to A. B.), and National Institutes of Health Grants HL071818 and HL086865 (to J. T.). DNA sequencing was carried out in part at the DNA Sequencing Core of the Michigan Diabetes Research and Training Center supported by National Institutes of Health Grant DK20572.	Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Homan KT, 2013, CURR MED CHEM, V20, P39; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Jones TA, 1994, 1 MAP FINAL MODEL, P1; Jorgensen R, 2008, MOL PHARMACOL, V73, P349, DOI 10.1124/mol.107.038877; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; KIM CM, 1993, J BIOL CHEM, V268, P15412; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; KONG GH, 1994, J BIOL CHEM, V269, P13084; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; LOUDON RP, 1994, J BIOL CHEM, V269, P22691; Luttrell LM, 2002, J CELL SCI, V115, P455; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; SHICHI H, 1978, J BIOL CHEM, V253, P7040; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sterne-Marr R, 2013, METHOD ENZYMOL, V521, P347, DOI 10.1016/B978-0-12-391862-8.00019-3; Sterne-Marr R, 2009, BIOCHEMISTRY-US, V48, P4285, DOI 10.1021/bi900151g; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Thal DM, 2012, ACS CHEM BIOL, V7, P1830, DOI 10.1021/cb3003013; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Wang WCH, 2008, PHARMACOGENET GENOM, V18, P729, DOI 10.1097/FPC.0b013e32830967e9; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522	54	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25262	25275		10.1074/jbc.M114.593178	http://dx.doi.org/10.1074/jbc.M114.593178			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25049229	Green Published, hybrid			2022-12-28	WOS:000341985300045
J	Laprairie, RB; Bagher, AM; Kelly, MEM; Dupre, DJ; Denovan-Wright, EM				Laprairie, Robert B.; Bagher, Amina M.; Kelly, Melanie E. M.; Dupre, Denis J.; Denovan-Wright, Eileen M.			Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CB1 RECEPTOR; HUNTINGTONS-DISEASE; ENDOCANNABINOID SYSTEM; DOWN-REGULATION; MAP KINASE; G-PROTEINS; AGONIST; CANNABIDIOL; INTERNALIZATION	Modulation of type 1 cannabinoid receptor (CB1) activity has been touted as a potential means of treating addiction, anxiety, depression, and neurodegeneration. Different agonists of CB1 are known to evoke varied responses in vivo. Functional selectivity is the ligand-specific activation of certain signal transduction pathways at a receptor that can signal through multiple pathways. To understand cannabinoid-specific functional selectivity, different groups have examined the effect of individual cannabinoids on various signaling pathways in heterologous expression systems. In the current study, we compared the functional selectivity of six cannabinoids, including two endocannabinoids (2-arachidonyl glycerol (2-AG) and anandamide (AEA)), two synthetic cannabinoids (WIN55,212-2 and CP55,940), and two phytocannabinoids (cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC)) on arrestin2-, G alpha(i/o)-, G beta gamma-, G alpha(s)-, and G alpha(q)-mediated intracellular signaling in the mouse STHdh(Q7/Q7) cell culture model of striatal medium spiny projection neurons that endogenously express CB1. In this system, 2-AG, THC, and CP55,940 were more potent mediators of arrestin2 recruitment than other cannabinoids tested. 2-AG, AEA, and WIN55,212-2, enhanced G alpha(i/o) and G beta gamma signaling, with 2-AG and AEA treatment leading to increased total CB1 levels. 2-AG, AEA, THC, and WIN55,212-2 also activated G alpha(q)-dependent pathways. CP55,940 and CBD both signaled through G alpha(s). CP55,940, but not CBD, activated downstream G alpha(s) pathways via CB1 targets. THC and CP55,940 promoted CB1 internalization and decreased CB1 protein levels over an 18-h period. These data demonstrate that individual cannabinoids display functional selectivity at CB1 leading to activation of distinct signaling pathways. To effectively match cannabinoids with therapeutic goals, these compounds must be screened for their signaling bias.	[Laprairie, Robert B.; Bagher, Amina M.; Kelly, Melanie E. M.; Dupre, Denis J.; Denovan-Wright, Eileen M.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada	Dalhousie University	Denovan-Wright, EM (corresponding author), Dalhousie Univ, Dept Pharmacol, Rm 6E,5850 Coll St, Halifax, NS B3H 4R2, Canada.	emdenova@dal.ca	Bagher, Amina M/GRF-5174-2022; Dupre, Denis J/AAI-2631-2021; Bagher, Amina/F-1702-2018; Bagher, Amina M./AAF-1099-2021	Bagher, Amina M/0000-0002-1850-5686; Dupre, Denis J/0000-0001-6401-6157; Bagher, Amina/0000-0002-1850-5686; 	Canadian Institutes of Health Research (CIHR) [ROP-97185]; Nova Scotia Health Research Foundation; Huntington Society of Canada (HSC); CIHR [MOP-97768]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-355310-2013]; HSC; Killam Trusts; Canadian Consortium for the Investigation of Cannabinoids; Dalhousie University; King Abdull Aziz University, Jeddah, Saudi Arabia	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Huntington Society of Canada (HSC); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); HSC; Killam Trusts; Canadian Consortium for the Investigation of Cannabinoids; Dalhousie University; King Abdull Aziz University, Jeddah, Saudi Arabia	This work was supported by Partnership Grant ROP-97185 from the Canadian Institutes of Health Research (CIHR), the Nova Scotia Health Research Foundation, and the Huntington Society of Canada (HSC) (to E. M. D.-W.), Operating Grant MOP-97768 from CIHR (to M. E. M. K.), and Grant RGPIN-355310-2013 from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to D. J. D.).; Supported by studentships from CIHR, HSC, Killam Trusts, the Nova Scotia Health Research Foundation, and the Canadian Consortium for the Investigation of Cannabinoids.; Supported by scholarships from Dalhousie University and King Abdull Aziz University, Jeddah, Saudi Arabia.	Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Bagher AM, 2013, EUR J PHARMACOL, V721, P341, DOI 10.1016/j.ejphar.2013.09.002; Bakshi K, 2007, FEBS LETT, V581, P5009, DOI 10.1016/j.febslet.2007.09.030; Blazquez C, 2011, BRAIN, V134, P119, DOI 10.1093/brain/awq278; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Bosier B, 2008, BRIT J PHARMACOL, V155, P24, DOI 10.1038/bjp.2008.230; Bosier B, 2007, J NEUROCHEM, V102, P1996, DOI 10.1111/j.1471-4159.2007.04679.x; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Bosier B, 2008, FEBS LETT, V582, P3861, DOI 10.1016/j.febslet.2008.10.022; Breivogel CS, 1998, J BIOL CHEM, V273, P16865, DOI 10.1074/jbc.273.27.16865; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Coutts AA, 2001, J NEUROSCI, V21, P2425; Cupini LM, 2008, NEUROBIOL DIS, V30, P186, DOI 10.1016/j.nbd.2008.01.003; Daigle TL, 2008, NEUROPHARMACOLOGY, V54, P36, DOI 10.1016/j.neuropharm.2007.06.005; Dalton GD, 2012, BRIT J PHARMACOL, V165, P2497, DOI 10.1111/j.1476-5381.2011.01455.x; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Dupre DJ, 2007, CELL SIGNAL, V19, P2068, DOI 10.1016/j.cellsig.2007.05.015; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; Fernandez-Ruiz J, 2004, NEUROTOX RES, V6, P389, DOI 10.1007/BF03033314; Georgieva T, 2008, EUR J PHARMACOL, V581, P19, DOI 10.1016/j.ejphar.2007.11.053; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Gu GB, 1996, J NEUROSCI, V16, P3035; Hudson BD, 2010, BRIT J PHARMACOL, V160, P627, DOI 10.1111/j.1476-5381.2010.00681.x; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jin WZ, 1999, J NEUROSCI, V19, P3773; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Kearn CS, 1999, J NEUROCHEM, V72, P2379, DOI 10.1046/j.1471-4159.1999.0722379.x; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V99, P718, DOI 10.1016/j.pbb.2011.06.022; Knowles RB, 1999, J NEUROPATH EXP NEUR, V58, P1090, DOI 10.1097/00005072-199910000-00007; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Laprairie RB, 2013, NEUROPHARMACOLOGY, V72, P47, DOI 10.1016/j.neuropharm.2013.04.006; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lazenka MF, 2013, LIFE SCI, V92, P446, DOI 10.1016/j.lfs.2012.08.023; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Magen I, 2009, J HEPATOL, V51, P528, DOI 10.1016/j.jhep.2009.04.021; McIntosh BT, 2007, BRIT J PHARMACOL, V152, P1111, DOI 10.1038/sj.bjp.0707495; MCKENZIE FR, 1991, BIOCHEM J, V275, P175, DOI 10.1042/bj2750175; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; Mukhopadhyay S, 2005, MOL PHARMACOL, V67, P2016, DOI 10.1124/mol.104.003558; Nguyen PT, 2012, BIOL PSYCHIAT, V71, P714, DOI 10.1016/j.biopsych.2011.11.027; Obara Y, 2008, CELL SIGNAL, V20, P1275, DOI 10.1016/j.cellsig.2008.02.016; Pazos MR, 2008, CURR PHARM DESIGN, V14, P2317, DOI 10.2174/138161208785740108; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; RYAN W, 1995, LIFE SCI, V56, P2013, DOI 10.1016/0024-3205(95)00183-7; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302; Singh SN, 2011, BIOCHEMISTRY-US, V50, P2223, DOI 10.1021/bi1018144; SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; van der Lee MMC, 2009, J BIOMOL SCREEN, V14, P811, DOI 10.1177/1087057109337937; Varga E V, 2008, Curr Mol Pharmacol, V1, P273; Vrecl M, 2009, J BIOMOL SCREEN, V14, P371, DOI 10.1177/1087057109333101; Wiley JL, 1998, J PHARMACOL EXP THER, V285, P995; Wu DF, 2008, J NEUROCHEM, V104, P1132, DOI 10.1111/j.1471-4159.2007.05063.x; Wu HY, 2012, J NEUROSCI, V32, P5298, DOI 10.1523/JNEUROSCI.0227-12.2012	66	97	98	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24845	24862		10.1074/jbc.M114.557025	http://dx.doi.org/10.1074/jbc.M114.557025			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037227	Green Published, hybrid			2022-12-28	WOS:000341985300011
J	DebRoy, A; Vogel, SM; Soni, D; Sundivakkam, PC; Malik, AB; Tiruppathi, C				DebRoy, Auditi; Vogel, Stephen M.; Soni, Dheeraj; Sundivakkam, Premanand C.; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Cooperative Signaling via Transcription Factors NF-kappa B and AP1/c-Fos Mediates Endothelial Cell STIM1 Expression and Hyperpermeability in Response to Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 Transcription Factor (AP-1); Calcium; Endothelium; Gene Regulation; NF-B Transcription Factor; p38 MAPK; Permeability; Sepsis; Thrombin	PROTEASE-ACTIVATED RECEPTOR-1; RESPIRATORY-DISTRESS-SYNDROME; TRPC1 EXPRESSION; MAPK PATHWAYS; SEVERE SEPSIS; CA2+ INFLUX; ENTRY; ORAI1; INFLAMMATION; THROMBIN	Background: STIM1 activates store-operated Ca2+ entry (SOCE). The transcriptional regulation of STIM1 during sepsis is not known. Results: STIM1 expression occurs downstream of TLR4 via activation of NF-B and p38-mediated c-Fos expression in endothelial cells. Conclusion: Cooperative signaling of NF-B and p38 MAPK downstream of TLR4 is essential for STIM1 expression during sepsis. Significance: Selective p38 inhibitors may represent a potential therapeutic strategy to prevent sepsis-mediated lung vascular leaks. Stromal interacting molecule 1 (STIM1) regulates store-operated Ca2+ entry (SOCE). Here we show that STIM1 expression in endothelial cells (ECs) is increased during sepsis and, therefore, contributes to hyperpermeability. LPS induced STIM1 mRNA and protein expression in human and mouse lung ECs. The induced STIM1 expression was associated with augmented SOCE as well as a permeability increase in both in vitro and in vivo models. Because activation of both the NF-B and p38 MAPK signaling pathways downstream of TLR4 amplifies vascular inflammation, we studied the influence of these two pathways on LPS-induced STIM1 expression. Inhibition of either NF-B or p38 MAPK activation by pharmacological agents prevented LPS-induced STIM1 expression. Silencing of the NF-B proteins (p65/RelA or p50/NF-B1) or the p38 MAPK isoform p38 prevented LPS-induced STIM1 expression and increased SOCE in ECs. In support of these findings, we found NF-B and AP1 binding sites in the 5-regulatory region of human and mouse STIM1 genes. Further, we demonstrated that LPS induced time-dependent binding of the transcription factors NF-B (p65/RelA) and AP1 (c-Fos/c-Jun) to the STIM1 promoter. Interestingly, silencing of c-Fos, but not c-Jun, markedly reduced LPS-induced STIM1 expression in ECs. We also observed that silencing of p38 prevented c-Fos expression in response to LPS in ECs, suggesting that p38 signaling mediates the expression of c-Fos. These results support the proposal that cooperative signaling of both NF-B and AP1 (via p38) amplifies STIM1 expression in ECs and, thereby, contributes to the lung vascular hyperpermeability response during sepsis.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tiruppathi, C (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC868, 835 S Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu	Soni, Dheeraj/P-5496-2017	Soni, Dheeraj/0000-0002-5555-2051; Malik, Asrar/0000-0002-8205-7128	National Institutes of Health Grant [P01HL077806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL077806 (Project 3).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Baghai-Ravary R., 2006, ADV SEPSIS, V5, P42; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965; Ferreiro I, 2010, J BIOL CHEM, V285, P31819, DOI 10.1074/jbc.M110.155846; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Huang QJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-18; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Kandasamy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063465; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Lowry JL, 2013, J BIOL CHEM, V288, P4174, DOI 10.1074/jbc.M112.436022; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mayer R.J., 2006, DRUG DISCOV TODAY TH, V3, P49; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tiruppathi C, 2014, NAT IMMUNOL, V15, P239, DOI 10.1038/ni.2823; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020	51	40	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24188	24201		10.1074/jbc.M114.570051	http://dx.doi.org/10.1074/jbc.M114.570051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016017	Green Published, hybrid			2022-12-28	WOS:000341505600017
J	Meister, J; Le Duc, D; Ricken, A; Burkhardt, R; Thiery, J; Pfannkuche, H; Polte, T; Grosse, J; Schoneberg, T; Schulz, A				Meister, Jaroslawna; Le Duc, Diana; Ricken, Albert; Burkhardt, Ralph; Thiery, Joachim; Pfannkuche, Helga; Polte, Tobias; Grosse, Johannes; Schoeneberg, Torsten; Schulz, Angela			The G Protein-coupled Receptor P2Y(14) Influences Insulin Release and Smooth Muscle Function in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptor (GPCR); Gene Knockout; Glucose Metabolism; Pancreatic Islet; Signal Transduction	UDP-GLUCOSE; EXPRESSION ANALYSIS; GPR105 KIAA0001; P2Y RECEPTORS; CELLS; GENE; ISLETS; SENSITIVITY; DEFICIENCY; ACTIVATION	Background: The relevance of the widely expressed GPCR P2Y(14) is only partially understood. Results: Analysis of P2Y(14)-KO mice revealed decreased gastrointestinal emptying, reduced glucose tolerance, and insulin release. Conclusion: P2Y(14) function is required for proper intestine emptying and adequate glucose response. Significance: P2Y(14) plays a role in smooth muscle function and maintaining energy homeostasis by influencing insulin release. UDP sugars were identified as extracellular signaling molecules, assigning a new function to these compounds in addition to their well defined role in intracellular substrate metabolism and storage. Previously regarded as an orphan receptor, the G protein-coupled receptor P2Y(14) (GPR105) was found to bind extracellular UDP and UDP sugars. Little is known about the physiological functions of this G protein-coupled receptor. To study its physiological role, we used a gene-deficient mouse strain expressing the bacterial LacZ reporter gene to monitor the physiological expression pattern of P2Y(14). We found that P2Y(14) is mainly expressed in pancreas and salivary glands and in subpopulations of smooth muscle cells of the gastrointestinal tract, blood vessels, lung, and uterus. Among other phenotypical differences, knock-out mice showed a significantly impaired glucose tolerance following oral and intraperitoneal glucose application. An unchanged insulin tolerance suggested altered pancreatic islet function. Transcriptome analysis of pancreatic islets showed that P2Y(14) deficiency significantly changed expression of components involved in insulin secretion. Insulin secretion tests revealed a reduced insulin release from P2Y(14)-deficient islets, highlighting P2Y(14) as a new modulator of proper insulin secretion.	[Meister, Jaroslawna; Le Duc, Diana; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Meister, Jaroslawna; Schulz, Angela] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Fac Med, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, D-04103 Leipzig, Germany; [Burkhardt, Ralph; Thiery, Joachim] Univ Leipzig, Inst Lab Med, Fac Med, D-04103 Leipzig, Germany; [Pfannkuche, Helga] Univ Leipzig, Inst Vet Physiol, Fac Vet Med, D-04109 Leipzig, Germany; [Polte, Tobias] UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, D-04318 Leipzig, Germany; [Polte, Tobias] Univ Leipzig, Med Ctr, Dept Dermatol Venerol & Allergol, D-04109 Leipzig, Germany; [Grosse, Johannes] Takeda Cambridge Ltd, Cambridge CB4 0PZ, England	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Schoneberg, T (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de		Burkhardt, Ralph/0000-0003-1924-1202; Le Duc, Diana/0000-0001-7289-2552	Deutsche Forschungsgemeinschaft [Scho 624/7-1, FOR 748]; IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung) [FZ: 01EO1001]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung)	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho 624/7-1, FOR 748 and the IFB Adiposity Diseases, University Leipzig (Bundesministerium fur Bildung und Forschung, FZ: 01EO1001).	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Alsaqati M, 2014, BRIT J PHARMACOL, V171, P701, DOI 10.1111/bph.12473; Amisten S, 2013, PHARMACOL THERAPEUT, V139, P359, DOI 10.1016/j.pharmthera.2013.05.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Bassil AK, 2009, AM J PHYSIOL-GASTR L, V296, pG923, DOI 10.1152/ajpgi.90363.2008; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; Charlton ME, 1997, BRAIN RES, V764, P141, DOI 10.1016/S0006-8993(97)00438-1; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Engel KMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029400; Freeman K, 2001, GENOMICS, V78, P124, DOI 10.1006/geno.2001.6662; Gao ZG, 2010, BIOCHEM PHARMACOL, V79, P873, DOI 10.1016/j.bcp.2009.10.024; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Hamel M, 2011, J BIOMOL SCREEN, V16, P1098, DOI 10.1177/1087057111415525; Han P, 1999, J BIOL CHEM, V274, P22337, DOI 10.1074/jbc.274.32.22337; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Komuro T, 2006, J PHYSIOL-LONDON, V576, P653, DOI 10.1113/jphysiol.2006.116624; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Kook SH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.218; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lu YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE50, DOI 10.1152/ajpendo.00596.2005; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Mitsukawa K, 2008, CELL MOL LIFE SCI, V65, P1796, DOI 10.1007/s00018-008-8153-8; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Pausch MH, 2004, BIOCHEM BIOPH RES CO, V324, P171, DOI 10.1016/j.bbrc.2004.09.034; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Radenkovic G, 2010, CELL TISSUE RES, V340, P427, DOI 10.1007/s00441-010-0957-9; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sassmann A, 2010, J CLIN INVEST, V120, P2184, DOI 10.1172/JCI41541; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Schuit FC, 1996, HORM RES, V46, P99, DOI 10.1159/000185004; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322; Scrivens M, 2005, PHARMACOL RES, V51, P533, DOI 10.1016/j.phrs.2005.02.001; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Shimoda H, 2000, ARCH HISTOL CYTOL, V63, P217, DOI 10.1679/aohc.63.217; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; Thor D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-46; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yesil P, 2009, ISLETS, V1, P185, DOI 10.4161/isl.1.3.9556	56	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23353	23366		10.1074/jbc.M114.580803	http://dx.doi.org/10.1074/jbc.M114.580803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993824	Green Published, hybrid			2022-12-28	WOS:000341505000011
J	Wilson, JL; Vachon, VK; Sunita, S; Schwartz, SL; Conn, GL				Wilson, Jo L.; Vachon, Virginia K.; Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.			Dissection of the Adenoviral VA RNA(I) Central Domain Structure Reveals Minimum Requirements for RNA-mediated Inhibition of PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-ASSOCIATED RNA; PROTEIN-KINASE PKR; SELECTIVE 2'-HYDROXYL ACYLATION; STRANDED-RNA; TERTIARY STRUCTURE; BINDING DOMAIN; NONCODING RNA; ACTIVATION; STEM; EVOLUTION	Virus-associated RNA I (VA RNA(I)) is a short (similar to 160-nucleotide) non-coding RNA transcript employed by adenoviruses to subvert the innate immune system protein double-stranded RNA-activated protein kinase (PKR). The central domain of VA RNA(I) is proposed to contain a complex tertiary structure that contributes to its optimal inhibitory activity against PKR. Here we use a combination of VA RNA(I) mutagenesis, structural analyses, as well as PKR activity and binding assays to dissect this tertiary structure and assess its functional role. Our results support the existence of a pH-and Mg2+-dependent tertiary structure involving pseudoknot formation within the central domain. Unexpectedly, this structure appears to play no direct role in PKR inhibition. Deletion of central domain sequences within a minimal but fully active construct lacking the tertiary structure reveals a crucial role in PKR binding and inhibition for nucleotides in the 5' half of the central domain. Deletion of the central domain 3' half also significantly impacts activity but appears to arise indirectly by reducing its capacity to assist in optimally presenting the 5' half sequence. Collectively, our results identify regions of VA RNA(I) critical for PKR inhibition and reveal that the requirements for an effective RNA inhibitor of PKR are simpler than appreciated previously.	[Wilson, Jo L.; Vachon, Virginia K.; Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Subramanian, Sunita/F-9818-2015	subramanian, sunita/0000-0002-0858-9193; Schwartz, Samantha/0000-0002-3378-0184	National Institutes of Health [R21-AI097803]; Emory University Research Council [URC 2010050]; National Science Foundation MRI Program [104177]; Winship Cancer Institute shared resource program; Biochemistry Department of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Council; National Science Foundation MRI Program(National Science Foundation (NSF)); Winship Cancer Institute shared resource program; Biochemistry Department of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grant R21-AI097803. This work was also supported by Emory University Research Council Grant URC 2010050. The Auto-iTC<INF>200</INF> instrument was purchased with support from National Science Foundation MRI Program Grant 104177, the Winship Cancer Institute shared resource program, and the Biochemistry Department of Emory University.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; CLARKE PA, 1994, NUCLEIC ACIDS RES, V22, P4364, DOI 10.1093/nar/22.21.4364; CLARKE PA, 1995, RNA, V1, P7; Coventry VK, 2008, NUCLEIC ACIDS RES, V36, P1645, DOI 10.1093/nar/gkn020; DESAI SY, 1995, J BIOL CHEM, V270, P3454, DOI 10.1074/jbc.270.7.3454; Dzananovic E, 2014, J STRUCT BIOL, V185, P48, DOI 10.1016/j.jsb.2013.11.007; FOWLKES DM, 1980, CELL, V22, P405, DOI 10.1016/0092-8674(80)90351-7; FURTADO MR, 1989, J VIROL, V63, P3423, DOI 10.1128/JVI.63.8.3423-3434.1989; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GHADGE GD, 1994, J VIROL, V68, P4137, DOI 10.1128/JVI.68.7.4137-4151.1994; GHADGE GD, 1991, P NATL ACAD SCI USA, V88, P7140, DOI 10.1073/pnas.88.16.7140; Hargittai MRS, 2000, RNA, V6, P1672, DOI 10.1017/S135583820000128X; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Launer-Felty K, 2014, J MOL BIOL, V426, P1285, DOI 10.1016/j.jmb.2013.12.019; Launer-Felty K, 2010, J MOL BIOL, V402, P638, DOI 10.1016/j.jmb.2010.08.015; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; MA YL, 1993, J VIROL, V67, P6605, DOI 10.1128/JVI.67.11.6605-6617.1993; Ma YL, 1996, RNA, V2, P937; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MELLITS KH, 1988, EMBO J, V7, P2849, DOI 10.1002/j.1460-2075.1988.tb03141.x; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Peery T, 1997, METHODS, V11, P371, DOI 10.1006/meth.1996.0435; Petrov AI, 2011, NUCLEIC ACIDS RES, V39, pW50, DOI 10.1093/nar/gkr249; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Spanggord RJ, 2002, BIOCHEMISTRY-US, V41, P4511, DOI 10.1021/bi0120594; Spanggord RJ, 2001, BIOCHEMISTRY-US, V40, P4272, DOI 10.1021/bi002512w; Vachon Virginia K, 2012, Methods Mol Biol, V941, P157, DOI 10.1007/978-1-62703-113-4_12; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Wahid AM, 2009, NUCLEIC ACIDS RES, V37, P5830, DOI 10.1093/nar/gkp595; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249	41	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23233	23245		10.1074/jbc.M114.550046	http://dx.doi.org/10.1074/jbc.M114.550046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970889	hybrid, Green Published			2022-12-28	WOS:000341017200059
J	Zhai, PF; Wang, F; Su, R; Lin, HS; Jiang, CL; Yang, GH; Yu, J; Zhang, JW				Zhai, Peng-Fei; Wang, Fang; Su, Rui; Lin, Hai-Shuang; Jiang, Chong-Liang; Yang, Gui-Hua; Yu, Jia; Zhang, Jun-Wu			The Regulatory Roles of MicroRNA-146b-5p and Its Target Platelet-derived Growth Factor Receptor alpha (PDGFRA) in Erythropoiesis and Megakaryocytopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ERYTHROID-DIFFERENTIATION; MOUSE DEVELOPMENT; EPITHELIAL-CELLS; IMMUNE FUNCTION; K562 CELLS; EXPRESSION; ACTIVATION; MICRORNAS; GENE	Emerging evidence has shown that microRNAs have key roles in regulating various normal physiological processes, whereas their deregulated expression is correlated with various diseases. The miR-146 family includes miR-146a and miR-146b, with a distinct expression spectrum in different hematopoietic cells. Recent work indicated that miR-146a has a close relationship with inflammation and autoimmune diseases. miR-146-deficient mice have developed some abnormal hematopoietic phenotypes, suggesting the potential functions of miR-146 in hematopoietic development. In this study, we found that miR-146b was consistently up-regulated in both K562 and CD34(+) hematopoietic stem/progenitor cells (HSPCs) undergoing either erythroid or megakaryocytic differentiation. Remarkably, erythroid and megakaryocytic maturation of K562 cells was induced by excess miR-146b but inhibited by decreased miR-146b levels. More importantly, an mRNA encoding receptor tyrosine kinase, namely platelet-derived growth factor receptor alpha (PDGFRA), was identified and validated as a direct target of miR-146b in hematopoietic cells. Gain-of-function and loss-of-function assays showed that PDGFRA functioned as a negative regulator in erythroid and megakaryocytic differentiation. miR-146b could ultimately affect the expression of the GATA-1 gene, which is regulated by HEY1 (Hairy/enhancer-of-split related with YRPW motif protein 1), a transcriptional repressor, via inhibition of the PDGFRA/JNK/JUN/HEY1 pathway. Lentivirus-mediated gene transfer also demonstrated that the overexpression of miR-146b promoted erythropoiesis and megakaryocytopoiesis of HSPCs via its regulation on the PDGFRA gene and effects on GATA-1 expression. Moreover, we confirmed that the binding of GATA-1 to the miR-146b promoter and induction of miR-146b during hematopoietic maturation were dependent on GATA-1. Therefore, miR-146b, PDGFRA, and GATA-1 formed a regulatory circuit to promote erythroid and megakaryocytic differentiation.	Chinese Acad Med Sci, Inst Basic Med Sci, Key State Lab Med Mol Biol, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [Zhang, Jun-Wu] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, JW (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	junwu_zhang@pumc.edu.cn	Su, Rui/Y-8157-2018	Su, Rui/0000-0002-4807-6229	National Natural Science Foundation of China [30871249, 31171311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 30871249 and 31171311.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Besancon F, 1998, P NATL ACAD SCI USA, V95, P8081, DOI 10.1073/pnas.95.14.8081; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bruchova-Votavova H, 2010, LEUKEMIA LYMPHOMA, V51, P686, DOI 10.3109/10428191003629362; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao YH, 2005, CELL CYCLE, V4, P228; Chen J, 2014, BIOCHEM J, V458, P171, DOI 10.1042/BJ20130628; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Erovic BM, 2012, ENDOCR PATHOL, V23, P221, DOI 10.1007/s12022-012-9222-y; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Kafasla P, 2012, WIRES SYST BIOL MED, V4, P509, DOI 10.1002/wsbm.1179; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin CC, 2014, MOL NEUROBIOL, V49, P658, DOI 10.1007/s12035-013-8547-y; Lokker NA, 1997, J BIOL CHEM, V272, P33037, DOI 10.1074/jbc.272.52.33037; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin CS, 2011, GENOME MED, V3, DOI 10.1186/gm299; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; Smith Clayton, 2003, Cancer Control, V10, P9; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Tsatsanis C, 2000, INT J MOL MED, V5, P583; Vignais ML, 1999, MOL CELL BIOL, V19, P3727; Wang F, 2011, CELL RES, V21, P1196, DOI 10.1038/cr.2011.79; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xiong W, 2010, CURR EYE RES, V35, P389, DOI 10.3109/02713680903584686; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Yuan JY, 2009, J CELL MOL MED, V13, P4551, DOI 10.1111/j.1582-4934.2008.00585.x; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	52	43	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22600	22613		10.1074/jbc.M114.547380	http://dx.doi.org/10.1074/jbc.M114.547380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982425	Green Published, hybrid			2022-12-28	WOS:000341017200007
J	Munoz, S; Manjon, E; Sanchez, Y				Munoz, Sofia; Manjon, Elvira; Sanchez, Yolanda			The Putative Exchange Factor Gef3p Interacts with Rho3p GTPase and the Septin Ring during Cytokinesis in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; DIVISION-SITE; EXOCYST COMPLEX; FORMIN FOR3P; MEMBRANE; INTEGRITY; BINDING; CDC42P; ROLES; SEPARATION	The small GTP-binding proteins of the Rho family and its regulatory proteins play a central role in cytokinetic actomyosin ring assembly and cytokinesis. Here we show that the fission yeast guanine nucleotide exchange factor Gef3p interacts with Rho3p at the division site. Gef3p contains a putative DH homology domain and a BAR/IMD-like domain. The protein localized to the division site late in mitosis, where it formed a ring that did not constrict with actomyosin ring (cytokinetic actomyosin ring) invagination; instead, it split into a double ring that resembled the septin ring. Gef3p co-localized with septins and Mid2p and required septins and Mid2p for its localization. Gef3p interacts physically with the GTP-bound form of Rho3p. Although Gef3p is not essential for cell separation, the simultaneous disruption of gef3(+) and Rho3p-interacting proteins, such as Sec8p, an exocyst component, Apm1p, a subunit of the clathrin adaptor complex or For3p, an actin-polymerizing protein, yielded cells with strong defects in septation and polarity respectively. Our results suggest that interactions between septins and Rho-GEFs provide a new targeting mechanism for GTPases in cytokinesis, in this case probably contributing to Rho3p function in vesicle tethering and vesicle trafficking in the later steps of cell separation.	Univ Salamanca, Inst Biol Func & Genom IBFG, Consejo Super Invest Cient, Salamanca 37007, Spain; Univ Salamanca, Dept Microbiol & Genet, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Salamanca	Sanchez, Y (corresponding author), Univ Salamanca, Inst Biol Func & Genom, CSIC, C Zacarias Gonzalez S-N, Salamanca 37007, Spain.	ysm@usal.es	Manjón, Elvira/B-7357-2017; Muñoz, Sofía/T-6030-2019; Muñoz, Sofía/GQI-2567-2022; Sanchez, Yolanda/L-2847-2014	Manjón, Elvira/0000-0001-5682-3143; Muñoz, Sofía/0000-0001-5512-2468; Sanchez, Yolanda/0000-0002-7650-9319	Ramon Areces Foundation	Ramon Areces Foundation	We thank P. Perez, P. M. Coll, H. Valdivieso, J. C. Ribas, and C. Rodriguez-Vazquez de Aldana from the IBFG, Spain, F. Chang from Columbia University, M. Balasubramanian from the Mechanobiology Institute, Singapore, and J. Bahler from Wellcome Trust UK for providing plasmids and strains. We recognize P. Bolanos for initiating this work. Text was revised by N. Skinner. Instituto de Biologia Funcional y Genomica acknowledges the institutional support granted by the Ramon Areces Foundation during 2011 and 2012.	An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Balasubramanian MK, 2012, CYTOSKELETON, V69, P942, DOI 10.1002/cm.21082; Barral Y., 2008, SEPTINS, P101; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Bendezu FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040248; Bendezu FO, 2011, MOL BIOL CELL, V22, P44, DOI 10.1091/mbc.E10-08-0720; Berlin A, 2003, J CELL BIOL, V160, P1083, DOI 10.1083/jcb.200212016; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; de Kreuk Bart-Jan, 2012, Small GTPases, V3, P45, DOI 10.4161/sgtp.18960; Estravis M, 2011, TRAFFIC, V12, P1744, DOI 10.1111/j.1600-0854.2011.01275.x; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Garcia P, 2006, MOL BIOL CELL, V17, P1620, DOI 10.1091/mbc.E05-10-0933; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; Garcia P, 2009, GENETICS, V181, P1321, DOI 10.1534/genetics.108.094839; Garcia P, 2009, MOL BIOL CELL, V20, P721, DOI 10.1091/mbc.E08-07-0673; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hirata D, 1998, J CELL SCI, V111, P149; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Iwaki N, 2003, BIOCHEM BIOPH RES CO, V312, P414, DOI 10.1016/j.bbrc.2003.10.140; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin-Cuadrado AB, 2005, MOL BIOL CELL, V16, P4867, DOI 10.1091/mbc.E04-12-1114; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell-Falvey JL, 2005, J CELL SCI, V118, P5563, DOI 10.1242/jcs.02664; Mutoh T, 2005, GENES CELLS, V10, P1189, DOI 10.1111/j.1365-2443.2005.00908.x; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Nakano K, 2011, TRAFFIC, V12, P726, DOI 10.1111/j.1600-0854.2011.01190.x; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; Spiliotis ET, 2012, TRAFFIC, V13, P195, DOI 10.1111/j.1600-0854.2011.01268.x; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Tajadura V, 2004, J CELL SCI, V117, P6163, DOI 10.1242/jcs.01530; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wolfe BA, 2009, GENE DEV, V23, P896, DOI 10.1101/gad.1801209; Wu JQ, 2010, GENETICS, V186, P897, DOI 10.1534/genetics.110.119842; Ye YF, 2012, MOL BIOL CELL, V23, P1181, DOI 10.1091/mbc.E11-09-0800; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Yu YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01866; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	69	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21995	22007		10.1074/jbc.M114.548792	http://dx.doi.org/10.1074/jbc.M114.548792			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24947517	Green Published, hybrid			2022-12-28	WOS:000340593500016
J	Singh, D; Vaughan, R; Kao, CC				Singh, Divyendu; Vaughan, Robert; Kao, C. Cheng			LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH IDENTIFICATION OF A PEPTIDE ANTAGONIST OF LL-37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosome; Innate Immunity; pH Regulation; RNA-binding Protein; Toll-like Receptor (TLR); pH	RESONANCE ENERGY-TRANSFER; DOUBLE-STRANDED-RNA; ANTIMICROBIAL PEPTIDE; CATHELICIDIN LL-37; VITAMIN-D; ASTHMA; RECOGNITION; MICROSCOPY; CATHEPSINS; CLEAVAGE	Background: How LL-37 delivers double-stranded RNA (dsRNA) to activate TLR3 signaling is poorly understood. Results: LL-37 was found to traffic to endosomes with RNA and releases the dsRNA upon endosome acidification. A peptide derived from LL-37 could antagonize LL-37dsRNA trafficking. Conclusion: LL-37 trafficking of dsRNA is regulated by pH. Significance: This work establishes the mechanism of LL-37 enhancement of dsRNA-activated TLR3 signaling. LL-37 is a peptide secreted by human epithelial cells that can lyse bacteria, suppress signaling by Toll-like receptor 4 (TLR4), and enhance signaling to double-stranded RNA (dsRNA) by TLR3. How LL-37 interacts with dsRNA to affect signal transduction by TLR3 is not completely understood. We determined that LL-37 binds dsRNA and traffics to endosomes and releases the dsRNA in a pH-dependent manner. Using dynamic light scattering spectroscopy and cell-based FRET experiments, LL-37 was found to form higher order complexes independent of dsRNA binding. Upon acidification LL-37 will dissociate from a larger complex. In cells, LL-37 has a half-live of approximate to 1 h. LL-37 half-life was increased by inhibiting endosome acidification or inhibiting cathepsins, which include proteases whose activity are activated by endosome acidification. Residues in LL-37 that contact poly(I:C) and facilitate oligomerization in vitro were mapped. Peptide LL-29, which contains the oligomerization region of LL-37, inhibited LL-37 enhancement of TLR3 signal transduction. LL-29 prevented LL-37poly(I:C) co-localization to endosomes containing TLR3. These results shed light on the requirements for LL-37 enhancement of TLR3 signaling.	[Singh, Divyendu; Vaughan, Robert; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu						Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Dombrowski Y, 2012, EXP DERMATOL, V21, P327, DOI 10.1111/j.1600-0625.2012.01459.x; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gambichler T, 2011, REGUL PEPTIDES, V167, P163, DOI 10.1016/j.regpep.2011.02.001; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kim SK, 2010, J KOREAN MED SCI, V25, P1506, DOI 10.3346/jkms.2010.25.10.1506; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Martin T John, 2014, J Bone Metab, V21, P8, DOI 10.11005/jbm.2014.21.1.8; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Perez-Vargas J, 2014, J VIROL, V88, P9287, DOI 10.1128/JVI.00935-14; Phelps MA, 2004, MOL PHARMACEUT, V1, P257, DOI 10.1021/mp0499510; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Rohde G, 2014, CLIN EXP ALLERGY, V44, P930, DOI 10.1111/cea.12313; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sun J, 2013, ALLERGY, V68, P304, DOI 10.1111/all.12087; Takiguchi T, 2014, BRIT J DERMATOL, V171, P492, DOI 10.1111/bjd.12942; Vaughan R, 2012, RNA, V18, P1541, DOI 10.1261/rna.031914.111; Wan M, 2014, J LEUKOCYTE BIOL, V95, P971, DOI 10.1189/jlb.0513304; Xhindoli D, 2014, BIOCHEM J, V457, P263, DOI 10.1042/BJ20131048	35	32	32	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27614	27624		10.1074/jbc.M114.582973	http://dx.doi.org/10.1074/jbc.M114.582973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25092290	Green Published, hybrid			2022-12-28	WOS:000342852800022
J	Boyd-Tressler, A; Penuela, S; Laird, DW; Dubyak, GR				Boyd-Tressler, Andrea; Penuela, Silvia; Laird, Dale W.; Dubyak, George R.			Chemotherapeutic Drugs Induce ATP Release via Caspase-gated Pannexin-1 Channels and a Caspase/Pannexin-1-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTE SEPARATE PATHWAYS; CALHM1 ION-CHANNEL; MAXI-ANION-CHANNEL; MODULATOR 1 CALHM1; T-CELL-ACTIVATION; FIND-ME SIGNAL; A(2A) RECEPTORS; A-BETA; APOPTOSIS; AUTOPHAGY	Anti-tumor immune responses have been linked to the regulated release of ATP from apoptotic cancer cells to engage P2 purinergic receptor signaling cascades in nearby leukocytes. We used the Jurkat T cell acute lymphocytic leukemia model to characterize the role of pannexin-1 (Panx1) channels in the release of nucleotides during chemotherapeutic drug-induced apoptosis. Diverse pro-apoptotic drugs, including topoisomerase II inhibitors, kinase inhibitors, and proteosome inhibitors, induced functional activation of Panx1 channels via caspase-3-mediated cleavage of the Panx1 autoinhibitory C-terminal domain. The caspase-activated Panx1 channels mediated efflux of ATP, but also ADP and AMP, with the latter two comprising > 90% of the released adenine nucleotide pool as cells transitioned from the early to late stages of apoptosis. Chemotherapeutic drugs also activated an alternative caspase-and Panx1-independent pathway for ATP release from Jurkat cells in the presence of benzyloxycarbonyl-VAD, a pan-caspase inhibitor. Comparison of Panx1 levels indicated much higher expression in leukemic T lymphocytes than in normal, untransformed T lymphoblasts. This suggests that signaling roles for Panx1 may be amplified in leukemic leukocytes. Together, these results identify chemotherapy-activated pannexin-1 channels and ATP release as possible mediators of paracrine interaction between dying tumor cells and the effector leukocytes that mediate immunogenic anti-tumor responses.	[Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Boyd-Tressler, Andrea; Dubyak, George R.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Dubyak, George R.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A SC1, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Western University (University of Western Ontario)	Dubyak, GR (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	george.dubyak@case.edu	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015; Penuela, Silvia/A-6961-2010	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Dubyak, George/0000-0001-9720-4226	National Institutes of Health [R01-GM36387, T32-GM008803]; Canadian Institutes of Health Research [MOP130530]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387, T32GM008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM36387 (to G. R. D.). This work was also supported by Canadian Institutes of Health Research MOP130530 (to S. P. and D. W. L.).; Supported in part by National Institutes of Health Training Grant T32-GM008803.	Adamson SE, 2014, FEBS LETT, V588, P1416, DOI 10.1016/j.febslet.2014.03.009; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; An SZ, 1999, MOL PHARMACOL, V55, P787; Bao BA, 2012, J BIOL CHEM, V287, P8407, DOI 10.1074/jbc.M111.306522; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beavis PA, 2013, P NATL ACAD SCI USA, V110, P14711, DOI 10.1073/pnas.1308209110; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiu YH, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.27545; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Dourado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099596; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dubyak GR, 2012, AM J PHYSIOL-CELL PH, V303, pC913, DOI 10.1152/ajpcell.00285.2012; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Dubyak GR, 2000, J AUTONOM NERV SYST, V81, P64, DOI 10.1016/S0165-1838(00)00155-7; Eguchi Y, 1997, CANCER RES, V57, P1835; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferrari D, 1998, J EXP MED, V188, P979, DOI 10.1084/jem.188.5.979; Franko JL, 2009, J LEUKOCYTE BIOL, V85, P526, DOI 10.1189/jlb.0808505; Gehi R, 2011, J BIOL CHEM, V286, P27639, DOI 10.1074/jbc.M111.260711; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gleiss B, 2002, FEBS LETT, V519, P153, DOI 10.1016/S0014-5793(02)02743-6; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Hampp R, 1985, METHOD ENZYMAT AN, VVII, P370; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Imo T, 2013, CELL DEATH DIFFER, V20, P343, DOI 10.1038/cdd.2012.149; Islam MR, 2012, AM J PHYSIOL-CELL PH, V303, pC924, DOI 10.1152/ajpcell.00459.2011; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Katagiri K, 2004, J BIOL CHEM, V279, P11875, DOI 10.1074/jbc.M310717200; Kepp O, 2009, CURR OPIN ONCOL, V21, P71, DOI 10.1097/CCO.0b013e32831bc375; Koroskenyi K, 2011, J IMMUNOL, V186, P7144, DOI 10.4049/jimmunol.1002284; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Litvin O, 2006, J CELL MOL MED, V10, P613, DOI 10.1111/j.1582-4934.2006.tb00424.x; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Loi S, 2013, P NATL ACAD SCI USA, V110, P11091, DOI 10.1073/pnas.1222251110; Ma WH, 2012, PFLUG ARCH EUR J PHY, V463, P585, DOI 10.1007/s00424-012-1077-z; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Manns J, 2011, FASEB J, V25, P3250, DOI 10.1096/fj.10-177527; Martins I, 2014, CELL DEATH DIFFER, V21, P79, DOI 10.1038/cdd.2013.75; Martins I, 2012, AUTOPHAGY, V8, P413, DOI 10.4161/auto.19009; Martins I, 2009, CELL CYCLE, V8, P3723, DOI 10.4161/cc.8.22.10026; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Poon IKH, 2014, NATURE, V507, P329, DOI 10.1038/nature13147; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sandilos JK, 2012, J PHYSIOL-LONDON, V590, P6257, DOI 10.1113/jphysiol.2012.240911; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Siebert AP, 2013, J BIOL CHEM, V288, P6140, DOI 10.1074/jbc.M112.409789; Sivaramakrishnan V, 2012, J CELL SCI, V125, P4567, DOI 10.1242/jcs.107318; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Suh KS, 2013, CRIT REV ONCOL HEMAT, V87, P306, DOI 10.1016/j.critrevonc.2013.02.005; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Wang YD, 2013, AUTOPHAGY, V9, P1624, DOI 10.4161/auto.25873; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yamaguchi H, 2014, ELIFE, V3, DOI 10.7554/eLife.02172; Yegutkin GG, 2011, EUR J IMMUNOL, V41, P1231, DOI 10.1002/eji.201041292; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	86	54	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27246	27263		10.1074/jbc.M114.590240	http://dx.doi.org/10.1074/jbc.M114.590240			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112874	hybrid, Green Published			2022-12-28	WOS:000342853900047
J	Kuge, H; Akahori, K; Yagyu, K; Honke, K				Kuge, Hideaki; Akahori, Kana; Yagyu, Ken-ichi; Honke, Koichi			Functional Compartmentalization of the Plasma Membrane of Neurons by a Unique Acyl Chain Composition of Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; DOPAMINE TRANSPORTER; DIFFUSION BARRIER; LIPIDS; METABOLISM; EXTRACTION; EXPRESSION	In neurons, the plasma membrane is functionally separated into several distinct segments. Neurons form these domains by delivering selected components to and by confining them within each segment of the membrane. Although some mechanisms of the delivery are elucidated, that of the confinement is unclear. We show here that 1-oleoyl-2-palmitoyl-phosphatidylcholine (OPPC), a unique molecular species of phospholipids, is concentrated at the protrusion tips of several neuronal culture cells and the presynaptic area of neuronal synapses of the mouse brain. In PC12 cells, NGF-stimulated neuronal differentiation induces a phospholipase A1 activity at the protrusion tips, which co-localizes with the OPPC domain. Inhibition of the phospholipase A1 activity leads to suppression of phospholipid remodeling in the tip membrane and results in disappearance of the OPPC at the tips. In these cells, confinement of dopamine transporter and G alpha(o) proteins to the tip was also disrupted. These findings link the lateral distribution of the molecular species of phospholipids to the formation of functional segments in the plasma membrane of neurons and to the mechanism of protein confinement at the synapse.	[Kuge, Hideaki; Akahori, Kana; Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Kuge, Hideaki; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan; [Yagyu, Ken-ichi] Kochi Univ, Sch Med, Ctr Sci Res, Nankoku, Kochi 7838505, Japan	Kochi University; Kochi University; Kochi University	Kuge, H (corresponding author), Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan.	kugeh@kochi-u.ac.jp; khonke@kochi-u.ac.jp		Kuge, Hideaki/0000-0001-6202-9202	CREST, Japan Science and Technology Agency	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by CREST, Japan Science and Technology Agency (to K. H.).	Al-Saad KA, 2003, J AM SOC MASS SPECTR, V14, P373, DOI 10.1016/S1044-0305(03)00068-0; [Anonymous], 2000, PRACT APPROACH SER; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chaurand P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.004259; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Cvacka J, 2003, RAPID COMMUN MASS SP, V17, P2203, DOI 10.1002/rcm.1178; Darrow AL, 2011, J LIPID RES, V52, P374, DOI 10.1194/jlr.D007971; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; Kadota T, 1996, J HISTOCHEM CYTOCHEM, V44, P989, DOI 10.1177/44.9.8773564; Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; TAMAKI H, 1994, J HISTOCHEM CYTOCHEM, V42, P1285, DOI 10.1177/42.9.8064136; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1996, NATURE, V379, P213, DOI 10.1038/379213a0; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	40	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26783	26793		10.1074/jbc.M114.571075	http://dx.doi.org/10.1074/jbc.M114.571075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096572	Green Published, hybrid			2022-12-28	WOS:000342853900011
J	Sarell, CJ; Karamanos, TK; White, SJ; Bunka, DHJ; Kalverda, AP; Thompson, GS; Barker, AM; Stockley, PG; Radford, SE				Sarell, Claire J.; Karamanos, Theodoros K.; White, Simon J.; Bunka, David H. J.; Kalverda, Arnout P.; Thompson, Gary S.; Barker, Amy M.; Stockley, Peter G.; Radford, Sheena E.			Distinguishing Closely Related Amyloid Precursors Using an RNA Aptamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-MICROGLOBULIN; PROTEIN; FIBRILS; BETA-2-MICROGLOBULIN; STATE; SELECTION; DNA; POLYMERIZATION; SPECIFICITY; AGGREGATION	Although amyloid fibrils assembled in vitro commonly involve a single protein, fibrils formed in vivo can contain multiple protein sequences. The amyloidogenic protein human beta(2)-microglobulin (h beta(2)m) can co-polymerize with its N-terminally truncated variant (Delta N6) in vitro to form hetero-polymeric fibrils that differ from their homo-polymeric counterparts. Discrimination between the different assembly precursors, for example by binding of a biomolecule to one species in a mixture of conformers, offers an opportunity to alter the course of co-assembly and the properties of the fibrils formed. Here, using h beta(2)m and its amyloidogenic counterpart, Delta N6, we describe selection of a 2'F-modified RNA aptamer able to distinguish between these very similar proteins. SELEX with a N30 RNA pool yielded an aptamer (B6) that binds h beta(2)m with an EC50 of similar to 200 nM. NMR spectroscopy was used to assign the H-1-N-15 HSQC spectrum of the B6-h beta(2)m complex, revealing that the aptamer binds to the face of h beta(2)m containing the A, B, E, and D beta-strands. In contrast, binding of B6 to Delta N6 is weak and less specific. Kinetic analysis of the effect of B6 on co-polymerization of h beta(2)m and Delta N6 revealed that the aptamer alters the kinetics of co-polymerization of the two proteins. The results reveal the potential of RNA aptamers as tools for elucidating the mechanisms of co-assembly in amyloid formation and as reagents able to discriminate between very similar protein conformers with different amyloid propensity.	[Stockley, Peter G.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Stockley, Peter G.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Stockley, PG (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	p.g.stockley@leeds.ac.uk; s.e.radford@leeds.ac.uk	Barker, Amy/ABF-5790-2021; White, Simon/AAC-5819-2019	Barker, Amy/0000-0003-1626-0934; White, Simon/0000-0002-9227-9461; Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039; Karamanos, Theodoros/0000-0003-2297-540X	Wellcome Trust [094232]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank members of our research groups for helpful discussion and comments. We also acknowledge The Wellcome Trust for funding the NMR facility (094232).	ADAMS CJ, 1994, TETRAHEDRON LETT, V35, P765, DOI 10.1016/S0040-4039(00)75812-6; Baker CM, 2007, BIOPOLYMERS, V85, P456, DOI 10.1002/bip.20682; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Bunka DHJ, 2007, J BIOL CHEM, V282, P34500, DOI 10.1074/jbc.M703679200; Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chen CHB, 2008, P NATL ACAD SCI USA, V105, P15908, DOI 10.1073/pnas.0808360105; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Diomede L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052314; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Farrar CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089901; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Huang YZ, 2012, MOL PHARMACOL, V82, P623, DOI 10.1124/mol.112.078220; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kupce E, 2003, PROG NUCL MAG RES SP, V42, P95, DOI 10.1016/S0079-6565(03)00022-0; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P54; Lee CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400580; Leontovich AM, 2002, BIOINFORMATICS, V18, P838, DOI 10.1093/bioinformatics/18.6.838; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Mashima T, 2013, NUCLEIC ACIDS RES, V41, P1355, DOI 10.1093/nar/gks1132; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Montagna G, 2013, AMYLOID, V20, P173, DOI 10.3109/13506129.2013.803463; MURRAY JB, 1994, ANAL BIOCHEM, V218, P177, DOI 10.1006/abio.1994.1157; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Rahimi F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007694; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Rockey WM, 2011, BIOORGAN MED CHEM, V19, P4080, DOI 10.1016/j.bmc.2011.05.010; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Sarell CJ, 2013, J BIOL CHEM, V288, P7327, DOI 10.1074/jbc.M112.447524; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Su YC, 2014, J AM CHEM SOC, V136, P6313, DOI 10.1021/ja4126092; Takahashi T, 2009, MOL BIOSYST, V5, P986, DOI 10.1039/b903391b; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	5	5	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26859	26871		10.1074/jbc.M114.595066	http://dx.doi.org/10.1074/jbc.M114.595066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100729	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000342853900017
J	Chu, LL; Huo, YD; Liu, X; Yao, P; Thomas, K; Jiang, H; Zhu, TG; Zhang, GL; Chaudhry, M; Adams, G; Thompson, W; Dou, Z; Jin, CJ; He, P; Yao, XB				Chu, Lingluo; Huo, Yuda; Liu, Xing; Yao, Phil; Thomas, Kelwyn; Jiang, Hao; Zhu, Tongge; Zhang, Guanglan; Chaudhry, Maryam; Adams, Gregory; Thompson, Winston; Dou, Zhen; Jin, Changjiang; He, Ping; Yao, Xuebiao			The Spatiotemporal Dynamics of Chromatin Protein HP1 alpha Is Essential for Accurate Chromosome Segregation during Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B; HISTONE H3; HETEROCHROMATIN PROTEIN-1; KINETOCHORE PROTEIN; MITOTIC CHECKPOINT; OUTER KINETOCHORE; INNER CENTROMERE; DNA-DAMAGE; HP1; PHOSPHORYLATION	Heterochromatin protein 1 alpha (HP1 alpha) is involved in regulation of chromatin plasticity, DNA damage repair, and centromere dynamics. HP1 alpha detects histone dimethylation and trimethylation of Lys-9 via its chromodomain. HP1 alpha localizes to heterochromatin in interphase cells but is liberated from chromosomal arms at the onset of mitosis. However, the structural determinants required for HP1 alpha localization in interphase and the regulation of HP1 alpha dynamics have remained elusive. Here we show that centromeric localization of HP1 alpha depends on histone H3 Lys-9 trimethyltransferase SUV39H1 activity in interphase but not in mitotic cells. Surprisingly, HP1 alpha liberates from chromosome arms in early mitosis. To test the role of this dissociation, we engineered an HP1 alpha construct that persistently localizes to chromosome arms. Interestingly, persistent localization of HP1 alpha to chromosome arms perturbs accurate kinetochore-microtubule attachment due to an aberrant distribution of chromosome passenger complex and Sgo1 from centromeres to chromosome arms that prevents resolution of sister chromatids. Further analyses showed that Mis14 and perhaps other PXVXL-containing proteins are involved in directing localization of HP1 alpha to the centromere in mitosis. Taken together, our data suggest a model in which spatiotemporal dynamics of HP1 alpha localization to centromere is governed by two distinct structural determinants. These findings reveal a previously unrecognized but essential link between HP1 alpha-interacting molecular dynamics and chromosome plasticity in promoting accurate cell division.	[Chu, Lingluo; Huo, Yuda; Liu, Xing; Jiang, Hao; Zhu, Tongge; Adams, Gregory; Dou, Zhen; Jin, Changjiang; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China; [Chu, Lingluo; Huo, Yuda; Liu, Xing; Jiang, Hao; Zhu, Tongge; Adams, Gregory; Dou, Zhen; Jin, Changjiang; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Xing; Yao, Phil; Zhu, Tongge; Chaudhry, Maryam; Adams, Gregory; Thompson, Winston; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Thomas, Kelwyn] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA; [Zhang, Guanglan; He, Ping] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Yao, Phil] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Morehouse School of Medicine; Morehouse School of Medicine; University System of Georgia; University of Georgia	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China.	heping-20088@163.com; yaoxb@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014	Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2012CB917204, 2013CB911203, 2014CB964803]; Anhui Province Key Project [08040102005]; International Collaboration Grant [31320103904]; Chinese Natural Science Foundation [31171300, 31301120, 91313303, 31301121, 31301105, 31371363, 81270466, 90913016, MOE20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2012CB917204, 2013CB911203, and 2014CB964803; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 31320103904; Chinese Natural Science Foundation Grants 31171300, 31301120, 91313303, 31301121, 31301105, 31371363, 81270466, 90913016, and MOE20113402130010; and Fundamental Research Funds for Central Universities Grant WK2060190018.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Inoue A, 2008, MUTAT RES-GEN TOX EN, V657, P48, DOI 10.1016/j.mrgentox.2008.08.010; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kwon SH, 2010, GENE DEV, V24, P2133, DOI 10.1101/gad.1959110; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Studencka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002940; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340	49	10	10	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26249	26262		10.1074/jbc.M114.581504	http://dx.doi.org/10.1074/jbc.M114.581504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104354	Green Published, hybrid			2022-12-28	WOS:000342128800020
J	Oleinik, NV; Helke, KL; Kistner-Griffin, E; Krupenko, NI; Krupenko, SA				Oleinik, Natalia V.; Helke, Kristi L.; Kistner-Griffin, Emily; Krupenko, Natalia I.; Krupenko, Sergey A.			Rho GTPases RhoA and Rac1 Mediate Effects of Dietary Folate on Metastatic Potential of A549 Cancer Cells through the Control of Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLIC-ACID SUPPLEMENTATION; MIGRATION; ACTIVATION; GENE; METHYLATION; DEFICIENCY; INVASION; REORGANIZATION; METABOLISM; INSIGHTS	Folate, an important nutrient in the human diet, has been implicated in cancer, but its role in metastasis is not established. We have shown previously that the withdrawal of medium folate leads to the inhibition of migration and invasion of A549 lung carcinoma cells. Here we have demonstrated that medium folate regulates the function of Rho GTPases by enabling their carboxyl methylation and translocation to plasma membrane. Conversely, the lack of folate leads to the retention of these proteins in endoplasmic reticulum. Folate also promoted the switch from inactive (GDP-bound) to active (GTP-bound) GTPases, resulting in the activation of downstream kinases p21-activated kinase and LIM kinase and phosphorylation of the actin-depolymerizing factor cofilin. We have further demonstrated that in A549 cells two GTPases, RhoA and Rac1, but not Cdc42, are immediate sensors of folate status: the siRNA silencing of RhoA or Rac1 blocked effects of folate on cofilin phosphorylation and cellular migration and invasion. The finding that folate modulates metastatic potential of cancer cells was confirmed in an animal model of lung cancer using tail vein injection of A549 cells in SCID mice. A folate-rich diet enhanced lung colonization and distant metastasis to lymph nodes and decreased overall survival (35 versus 63 days for mice on a folate-restricted diet). High folate also promoted epithelial-mesenchymal transition in cancer cells and experimental mouse tumors. Our study provides experimental evidence for a mechanism of metastasis promotion by dietary folate and highlights the interaction between nutrients and metastasis-related signaling.	[Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Helke, Kristi L.] Med Univ S Carolina, Charleston, SC 29425 USA; [Kistner-Griffin, Emily; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Krupenko, SA (corresponding author), Univ N Carolina, Dept Nutr, UNC Nutr Res Inst, 500 Laureate Way, Kannapolis, NC 28081 USA.	sergey_krupenko@unc.edu		Helke, Kris/0000-0001-9746-0764	National Institutes of Health Cancer Center Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA095030, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Philips and Matsuda for providing corresponding plasmids. The Cell and Molecular Imaging Core Facility was supported in part by National Institutes of Health Cancer Center Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Baggott JE, 2012, CANCER EPIDEMIOL, V36, P78, DOI 10.1016/j.canep.2011.05.003; BALAGHI M, 1995, AM J CLIN NUTR, V61, P90, DOI 10.1093/ajcn/61.1.90; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BUNNI MA, 1991, ARCH BIOCHEM BIOPHYS, V286, P633, DOI 10.1016/0003-9861(91)90092-W; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069389; Collazo J, 2014, CANCER RES, V74, P2362, DOI 10.1158/0008-5472.CAN-13-3058; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Garcia-Rodriguez S, 2003, FREE RADICAL BIO MED, V35, P428, DOI 10.1016/S0891-5849(03)00321-6; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Hou TC, 2013, BIOCHEM PHARMACOL, V85, P376, DOI 10.1016/j.bcp.2012.11.011; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kocher B, 2013, CANCER DISCOV, V3, P616, DOI 10.1158/2159-8290.CD-12-0503; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lucock M, 2009, CURR OPIN CLIN NUTR, V12, P555, DOI 10.1097/MCO.0b013e32833192bc; Meadows GG, 2012, CANCER METAST REV, V31, P441, DOI 10.1007/s10555-012-9369-5; Molloy Anne M, 2012, Subcell Biochem, V56, P105, DOI 10.1007/978-94-007-2199-9_7; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Oleinik NV, 2006, BIOCHEM PHARMACOL, V72, P256, DOI 10.1016/j.bcp.2006.04.005; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Pogribny IP, 2002, CANCER LETT, V187, P69, DOI 10.1016/S0304-3835(02)00408-1; Reece RJ, 2006, BIOCHEM SOC SYMP, V73, P85; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ross S. A., 2010, Experimental Oncology, V32, P137; Salem S, 2012, BRIT J PHARMACOL, V166, P2036, DOI 10.1111/j.1476-5381.2012.01885.x; SCHMITZ JC, 1994, BIOCHEM PHARMACOL, V48, P319, DOI 10.1016/0006-2952(94)90103-1; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; TERZIS AJA, 1993, INT J CANCER, V54, P112, DOI 10.1002/ijc.2910540118; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wang TP, 2012, CARCINOGENESIS, V33, P1158, DOI 10.1093/carcin/bgs138; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2003, P NATL ACAD SCI USA, V100, P6529, DOI 10.1073/pnas.1135239100; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	66	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26383	26394		10.1074/jbc.M114.569657	http://dx.doi.org/10.1074/jbc.M114.569657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086046	Green Published, hybrid			2022-12-28	WOS:000342128800030
J	Shimizu, Y; Nishitsuji, H; Marusawa, H; Ujino, S; Takaku, H; Shimotohno, K				Shimizu, Yuko; Nishitsuji, Hironori; Marusawa, Hiroyuki; Ujino, Saneyuki; Takaku, Hiroshi; Shimotohno, Kunitada			The RNA-editing Enzyme APOBEC1 Requires Heterogeneous Nuclear Ribonucleoprotein Q Isoform 6 for Efficient Interaction with Interleukin-8 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; APO-B; COMPLEMENTATION FACTOR; MOLECULAR-CLONING; GRY-RBP; DEMETHYLATION; INVOLVEMENT; EXPRESSION; CARCINOMA; COMPONENT	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 1 (APOBEC1) is an intestine-specific RNA-binding protein. However, inflammation or exposure to DNA-damaging agents can induce ectopic APOBEC1 expression, which can result in hepatocellular hyperplasia in animal models. To identify its RNA targets, FLAG-tagged APOBEC1 was immunoprecipitated from transfected HuH7.5 hepatocellular carcinoma cells and analyzed using DNA microarrays. The interleukin-8 (IL8) mRNA was the most abundant co-precipitated RNA. Exogenous APOBEC1 expression increased IL8 production by extending the half-life of the IL8 mRNA. A cluster of AU-rich elements in the 3'-UTR of IL8 was essential to the APOBEC1-mediated increase in IL8 production. Notably, IL8 mRNA did not co-immunoprecipitate with APOBEC1 from lysates of other cell types at appreciable levels; therefore, other factors may enhance the association between APOBEC1 and IL8 mRNA in a cell type-specific manner. A yeast two-hybrid analysis and siRNA screen were used to identify proteins that enhance the interaction between APOBEC1 and IL8 mRNA. Heterogeneous nuclear ribonucleoprotein Q(hnRNPQ) was essential to the APOBEC1/IL8 mRNA association in HuH7.5 cells. Of the seven hnRNPQ isoforms, only hnRNPQ6 enabled APOBEC1 to bind to IL8 mRNA when overexpressed in HEK293 cells, which expressed the lowest level of endogenous hnRNPQ6 among the cell types examined. The results of a reporter assay using a luciferase gene fused to the IL8 3'-UTR were consistent with the hypothesis that hnRNPQ6 is required for APOBEC1-enhanced IL8 production. Collectively, these data indicate that hnRNPQ6 promotes the interaction of APOBEC1 with IL8 mRNA and the subsequent increase in IL8 production.	[Shimizu, Yuko; Nishitsuji, Hironori; Ujino, Saneyuki; Shimotohno, Kunitada] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan; [Marusawa, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan	National Center for Global Health & Medicine - Japan; Kyoto University; Chiba Institute of Technology	Shimizu, Y (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai, Ichikawa, Chiba 2728516, Japan.	lbshimizuyk@hospk.ncgm.go.jp		Marusawa, Hiroyuki/0000-0002-4286-2712	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology; MEXT	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported in part by the MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2011-2015.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Anant S, 2001, J BIOL CHEM, V276, P47338, DOI 10.1074/jbc.M104911200; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Ashur-Fabian O, 2010, CELL CYCLE, V9, P3761, DOI 10.4161/cc.9.18.12993; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Chen XJ, 2013, EUR REV MED PHARMACO, V17, P2949; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Greeve J, 1999, ONCOGENE, V18, P6357, DOI 10.1038/sj.onc.1203039; GREEVE J, 1993, J LIPID RES, V34, P1367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Lau PP, 2003, J BIOL CHEM, V278, P52988, DOI 10.1074/jbc.M310153200; Lau PP, 1997, J BIOL CHEM, V272, P1452, DOI 10.1074/jbc.272.3.1452; Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679; Lau PP, 2001, J BIOL CHEM, V276, P46445, DOI 10.1074/jbc.M109215200; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Quaresma AJC, 2006, BIOCHEM BIOPH RES CO, V350, P288, DOI 10.1016/j.bbrc.2006.09.044; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Richardson N, 1998, J BIOL CHEM, V273, P31707, DOI 10.1074/jbc.273.48.31707; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; SHAH RR, 1991, J BIOL CHEM, V266, P16301; Valdmanis PN, 2015, ONCOGENE, V34, P94, DOI 10.1038/onc.2013.523; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321	28	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26226	26238		10.1074/jbc.M114.563221	http://dx.doi.org/10.1074/jbc.M114.563221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100733	Green Published, hybrid			2022-12-28	WOS:000342128800018
J	Lin, CS; Uboldi, AD; Marapana, D; Czabotar, PE; Epp, C; Bujard, H; Taylor, NL; Perugini, MA; Hodder, AN; Cowman, AF				Lin, Clara S.; Uboldi, Alessandro D.; Marapana, Danushka; Czabotar, Peter E.; Epp, Christian; Bujard, Hermann; Taylor, Nicole L.; Perugini, Matthew A.; Hodder, Anthony N.; Cowman, Alan F.			The Merozoite Surface Protein 1 Complex Is a Platform for Binding to Human Erythrocytes by Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; SERINE-PROTEASE; CELL INVASION; MALARIA; ANTIBODIES; PARASITE; ANTIGEN; IDENTIFICATION; RESPONSES; INHIBIT	Plasmodium falciparum is the causative agent of the most severe form of malaria in humans. The merozoite, an extracellular stage of the parasite lifecycle, invades erythrocytes in which they develop. The most abundant protein on the surface of merozoites is merozoite surface protein 1 (MSP1), which consists of four processed fragments. Studies indicate that MSP1 interacts with other peripheral merozoite surface proteins to form a large complex. Successful invasion of merozoites into host erythrocytes is dependent on this protein complex; however, the identity of all components and its function remain largely unknown. We have shown that the peripheral merozoite surface proteins MSPDBL1 and MSPDBL2 are part of the large MSP1 complex. Using surface plasmon resonance, we determined the binding affinities of MSPDBL1 and MSPDBL2 to MSP1 to be in the range of 2-4 x 10(-7) M. Both proteins bound to three of the four proteolytically cleaved fragments of MSP1 (p42, p38, and p83). In addition, MSPDBL1 and MSPDBL2, but not MSP1, bound directly to human erythrocytes. This demonstrates that the MSP1 complex acts as a platform for display of MSPDBL1 and MSPDBL2 on the merozoite surface for binding to receptors on the erythrocyte and invasion.	[Lin, Clara S.; Uboldi, Alessandro D.; Marapana, Danushka; Czabotar, Peter E.; Hodder, Anthony N.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Lin, Clara S.; Marapana, Danushka; Czabotar, Peter E.; Hodder, Anthony N.; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Epp, Christian] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Bujard, Hermann] Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Taylor, Nicole L.; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3082, Australia	Walter & Eliza Hall Institute; University of Melbourne; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; La Trobe University	Hodder, AN (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	hodder@wehi.edu.au; cowman@wehi.edu.au		Czabotar, Peter/0000-0002-2594-496X	National Health and Medical Research Council of Australia [637406]; Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia Grant 637406, by Victorian State Government Operational Infrastructure Support, and by the Australian Government National Health and Medical Research Council Independent Research Institutes Infrastructure Support Scheme.	Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Boyle MJ, 2013, INT J PARASITOL, V43, P1, DOI 10.1016/j.ijpara.2012.11.002; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Fan YT, 2013, J PROTEOMICS, V78, P148, DOI 10.1016/j.jprot.2012.11.020; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2012, J BIOL CHEM, V287, P32922, DOI 10.1074/jbc.M112.350504; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; HOLDER AA, 1994, PARASITOL TODAY, V10, P182, DOI 10.1016/0169-4758(94)90025-6; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kauth CW, 2003, J BIOL CHEM, V278, P22257, DOI 10.1074/jbc.M302299200; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; NICHOLLS SC, 1988, MOL BIOCHEM PARASIT, V28, P11, DOI 10.1016/0166-6851(88)90174-0; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; OEUVRAY C, 1994, BLOOD, V84, P1594; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sakamoto H, 2012, VACCINE, V30, P1972, DOI 10.1016/j.vaccine.2012.01.010; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Singh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005410; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; Tetteh KKA, 2013, INFECT IMMUN, V81, P3835, DOI 10.1128/IAI.00301-13; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Van Tyne D, 2013, ANTIMICROB AGENTS CH, V57, P2937, DOI 10.1128/AAC.02574-12; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77	50	35	35	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25655	25669		10.1074/jbc.M114.586495	http://dx.doi.org/10.1074/jbc.M114.586495			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074930	Green Published, hybrid			2022-12-28	WOS:000342130800025
J	Nguyen, KQN; Tsou, WI; Calarese, DA; Kimani, SG; Singh, S; Hsieh, S; Liu, YZ; Lu, B; Wu, Y; Garforth, SJ; Almo, SC; Kotenko, SV; Birge, RB				Nguyen, Khanh-Quynh N.; Tsou, Wen-I; Calarese, Daniel A.; Kimani, Stanley G.; Singh, Sukhwinder; Hsieh, Shelly; Liu, Yongzhang; Lu, Bin; Wu, Yi; Garforth, Scott J.; Almo, Steve C.; Kotenko, Sergei V.; Birge, Raymond B.			Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; TAM RECEPTORS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; AXL; EXPRESSION; ACTIVATION; CLEARANCE; GROWTH; PHAGOCYTOSIS	MERTK, a member of the TAM (TYRO3, AXL, and MERTK) receptor tyrosine kinases, has complex and diverse roles in cell biology. On the one hand, knock-out of MERTK results in age-dependent autoimmunity characterized by failure of apoptotic cell clearance, while on the other, MERTK overexpression in cancer drives classical oncogene pathways leading to cell transformation. To better understand the interplay between cell transformation and efferocytosis, we stably expressed MERTK in human MCF10A cells, a non-tumorigenic breast epithelial cell line devoid of endogenous MERTK. While stable expression of MERTK in MCF10A resulted in enhanced motility and AKT-mediated chemoprotection, MERTK-10A cells did not form stable colonies in soft agar, or enhance proliferation compared with parental MCF10A cells. Concomitant to chemoresistance, MERTK also stimulated efferocytosis in a gain-of-function capacity. However, unlike AXL, MERTK activation was highly dependent on apoptotic cells, suggesting MERTK may preferentially interface with phosphatidylserine. Consistent with this idea, knockdown of MERTK in breast cancer cells MDA-MB 231 reduced efferocytosis, while transient or stable expression of MERTK stimulated apoptotic cell clearance in all cell lines tested. Moreover, human breast cancer cells with higher endogenous MERTK showed higher levels of efferocytosis that could be blocked by soluble TAM receptors. Finally, through MERTK, apoptotic cells induced PD-L1 expression, an immune checkpoint blockade, suggesting that cancer cells may adopt MERTK-driven efferocytosis as an immune suppression mechanism for their advantage. These data collectively identify MERTK as a significant link between cancer progression and efferocytosis, and a potentially unrealized tumor-promoting event when MERTK is overexpressed in epithelial cells.	[Nguyen, Khanh-Quynh N.; Tsou, Wen-I; Kimani, Stanley G.; Kotenko, Sergei V.; Birge, Raymond B.] Rutgers Biomed & Hlth Sci, Univ Hosp Canc Ctr, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Tsou, Wen-I; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, Ctr Immun & Inflammat, New Jersey Med Sch, Newark, NJ 07103 USA; [Singh, Sukhwinder] Rutgers Biomed & Hlth Sci, Dept Pathol & Lab Med, Flow Cytometry & Immunol Core Lab, Newark, NJ 07103 USA; [Calarese, Daniel A.; Garforth, Scott J.; Almo, Steve C.] Yeshiva Univ, Dept Biochem, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Hsieh, Shelly] Rutgers, Yeshiva Univ, New Jersey Med Sch, Newark, NJ 07103 USA; [Liu, Yongzhang; Lu, Bin] Wenzhou Med Univ, Inst Biophys, Wenzhou 325035, Peoples R China; [Liu, Yongzhang; Lu, Bin] Wenzhou Med Univ, Attardi Inst Mitochondrial Biomed, Sch Life Sci, Wenzhou 325035, Peoples R China; [Wu, Yi] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Jiangsu, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Wenzhou Medical University; Wenzhou Medical University; Soochow University - China	Kotenko, SV (corresponding author), Rutgers, Dept Biochem & Mol Biol, Ctr Canc, New Jersey Med Sch, 205 South Orange Ave, Newark, NJ 07103 USA.	kotenkse@njms.rutgers.edu; birgera@njms.rutgers.edu		Hsieh, Shelly/0000-0002-2500-3860; Singh, Sukhwinder/0000-0002-7061-0096; Kimani, Stanley/0000-0003-3627-8162	National Institutes of Health [R01 165077]; NIH [R01 AI104669, GM094662, GM094665]; Rutgers-NJMS Translational Research Award; Bridge Research Grant; Albert Einstein College of Medicine Cancer Center [P30 CA013330]; National Natural Science Foundation of China [31070710]; Zhejiang Qianjiang Talent Project B Grant [2010R10045]; Key Science and Technology Innovation Team of Zhejiang Province Grant [2010R50048]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U01GM094665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers-NJMS Translational Research Award; Bridge Research Grant; Albert Einstein College of Medicine Cancer Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Qianjiang Talent Project B Grant; Key Science and Technology Innovation Team of Zhejiang Province Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 165077 (to R. B. B.), NIH R01 AI104669 (to S. V. K.), the Rutgers-NJMS Translational Research Award and Bridge Research Grant (to R. B. B. and S. V. K.), NIH Grants GM094662 and GM094665 (to S. C. A.), the Albert Einstein College of Medicine Cancer Center P30 CA013330 Grant, the National Natural Science Foundation of China Grant (No. 31070710) and Zhejiang Qianjiang Talent Project B Grant (No. 2010R10045) (to B. L.), and the Key Science and Technology Innovation Team of Zhejiang Province Grant (2010R50048).	Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Basso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054824; Behrens EM, 2003, EUR J IMMUNOL, V33, P2160, DOI 10.1002/eji.200324076; Berghoff AS, 2014, CLIN NEUROPATHOL, V33, P42, DOI 10.5414/NP300698; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeRose P, 2011, IMMUNOTHERAPY-UK, V3, P933, DOI [10.2217/IMT.11.87, 10.2217/imt.11.87]; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Fisher PW, 2005, BIOCHEM J, V387, P727, DOI 10.1042/BJ20040859; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gerber DE, 2011, CLIN CANCER RES, V17, P6888, DOI 10.1158/1078-0432.CCR-11-1074; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; He J, 2007, CLIN CANCER RES, V13, P5211, DOI 10.1158/1078-0432.CCR-07-0793; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Nguyen KQ, 2013, AUTOIMMUNITY, V46, P294, DOI 10.3109/08916934.2013.794515; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064812; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Maeda R, 2014, J THORAC ONCOL, V9, P179, DOI 10.1097/JTO.0000000000000044; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; TOSHIMA J, 1995, BIOCHEM BIOPH RES CO, V209, P656, DOI 10.1006/bbrc.1995.1549; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wu CW, 2002, ANTICANCER RES, V22, P1071; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Wu YM, 2004, CANCER RES, V64, P7311, DOI 10.1158/0008-5472.CAN-04-0972	67	59	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25737	25749		10.1074/jbc.M114.570838	http://dx.doi.org/10.1074/jbc.M114.570838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074939	hybrid, Green Published			2022-12-28	WOS:000342130800032
J	Arora, G; Tiwari, P; Mandal, RS; Gupta, A; Sharma, D; Saha, S; Singh, R				Arora, Garima; Tiwari, Prabhakar; Mandal, Rahul Shubhra; Gupta, Arpit; Sharma, Deepak; Saha, Sudipto; Singh, Ramandeep			High Throughput Screen Identifies Small Molecule Inhibitors Specific for Mycobacterium tuberculosis Phosphoserine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; ESCHERICHIA-COLI; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEIN; ENZYMES; PATHWAY; GROWTH; DISCOVERY	The emergence of drug-resistant strains of Mycobacterium tuberculosis makes identification and validation of newer drug targets a global priority. Phosphoserine phosphatase (PSP), a key essential metabolic enzyme involved in conversion of O-phospho-L-serine to L-serine, was characterized in this study. The M. tuberculosis genome harbors all enzymes involved in L-serine biosynthesis including two PSP homologs: Rv0505c (SerB1) and Rv3042c (SerB2). In the present study, we have biochemically characterized SerB2 enzyme and developed malachite green-based high throughput assay system to identify SerB2 inhibitors. We have identified 10 compounds that were structurally different from known PSP inhibitors, and few of these scaffolds were highly specific in their ability to inhibit SerB2 enzyme, were noncytotoxic against mammalian cell lines, and inhibited M. tuberculosis growth in vitro. Surface plasmon resonance experiments demonstrated the relative binding for these inhibitors. The two best hits identified in our screen, clorobiocin and rosaniline, were bactericidal in activity and killed intracellular bacteria in a dose-dependent manner. We have also identified amino acid residues critical for these SerB2-small molecule interactions. This is the first study where we validate that M. tuberculosis SerB2 is a drug-gable and suitable target to pursue for further high throughput assay system screening.	[Arora, Garima; Tiwari, Prabhakar; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Gurgaon 122016, Haryana, India; [Arora, Garima] Symbiosis Int Univ, Symbiosis Sch Biomed Sci, Lavale 412115, Maharashtra, India; [Mandal, Rahul Shubhra] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata 700010, W Bengal, India; [Gupta, Arpit; Sharma, Deepak] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata 700054, W Bengal, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Symbiosis International University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Department of Science & Technology (India); Bose Institute	Singh, R (corresponding author), Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, 496 UdyogVihar,Phase 3, Gurgaon 122016, Haryana, India.	ramandeep@thsti.res.in	International, Symbiosis School of Biological Sciences Symbiosis/AAD-7708-2019; Saha, Sudipto/AAF-1034-2020	Mandal, Rahul/0000-0001-8939-3362; Singh, Ramandeep/0000-0003-2705-3826; Saha, Sudipto/0000-0001-9433-8894	Department of Biotechnology (DBT) of the Government of India; Department of Biotechnology [BT/HRD/35/02/18/2009, BT/RLF/Re-entry/11/2011]; DBT Research Fellowship [BT/HRD/35/02/18/2009, BT/PR15074/GBD/27/297/2011]; Indian Council of Medical Research (ICMR) (IRIS) [2013: 19440]; DBT Research Fellowship; ICMR Grant IRIS [2013-1551G]	Department of Biotechnology (DBT) of the Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; DBT Research Fellowship; Indian Council of Medical Research (ICMR) (IRIS); DBT Research Fellowship; ICMR Grant IRIS	This work was supported by intramural funding to Translational Health Science and Technology Institute from the Department of Biotechnology (DBT) of the Government of India, Department of Biotechnology Ramalingaswamy fellowships BT/HRD/35/02/18/2009 (to R. S.) and BT/RLF/Re-entry/11/2011 (to S. S.), DBT Research Fellowship BT/HRD/35/02/18/2009 (to G. A.), Indian Council of Medical Research (ICMR) fellowship (IRIS ID 2013: 19440 to G. A.), DBT Research Fellowship BT/PR15074/GBD/27/297/2011 (to P. T.), and ICMR Grant IRIS ID: 2013-1551G (to R. S. M.).	Anderle C, 2008, ANTIMICROB AGENTS CH, V52, P1982, DOI 10.1128/AAC.01235-07; Anthony KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020374; Awasthy D, 2012, MICROBIOL-SGM, V158, P319, DOI 10.1099/mic.0.054064-0; Bai G, 2011, MOL MICROBIOL, V82, P180, DOI 10.1111/j.1365-2958.2011.07806.x; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Durrant JD, 2010, J MED CHEM, V53, P5025, DOI 10.1021/jm100456a; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Green KD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00208; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Hawkinson JE, 1996, EUR J PHARMACOL, V307, P219, DOI 10.1016/0014-2999(96)00253-1; Hawkinson JE, 1997, EUR J PHARMACOL, V337, P315, DOI 10.1016/S0014-2999(97)01304-6; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Hirabayashi Y, 2008, PROG LIPID RES, V47, P188, DOI 10.1016/j.plipres.2008.01.003; Ho CL, 1999, J BIOL CHEM, V274, P11007, DOI 10.1074/jbc.274.16.11007; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Jung SK, 2012, BIOORG MED CHEM LETT, V22, P2084, DOI 10.1016/j.bmcl.2012.01.011; Kishor C, 2013, J MED CHEM, V56, P5295, DOI 10.1021/jm400395p; Kitabatake M, 2000, J BACTERIOL, V182, P143, DOI 10.1128/JB.182.1.143-145.2000; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; LARGEN M, 1975, J BACTERIOL, V121, P239, DOI 10.1128/JB.121.1.239-249.1975; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lee Y, 2013, BIOCHEM PHARMACOL, V86, P222, DOI 10.1016/j.bcp.2013.05.004; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; PIZER LI, 1965, J BACTERIOL, V89, P1145, DOI 10.1128/JB.89.4.1145-1150.1965; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Poyraz O, 2013, J MED CHEM, V56, P6457, DOI 10.1021/jm400710k; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAITOU N, 1987, BIOL EVOL, V4, P406; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Shen HB, 2009, FEBS J, V276, P144, DOI 10.1111/j.1742-4658.2008.06763.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2004, J BIOL CHEM, V279, P13166, DOI 10.1074/jbc.M311393200; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; ULANE R, 1972, J BACTERIOL, V109, P34, DOI 10.1128/JB.109.1.34-43.1972; Wang D, 2013, J CHEM INF MODEL, V53, P343, DOI 10.1021/ci3004545; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X	54	23	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25149	25165		10.1074/jbc.M114.597682	http://dx.doi.org/10.1074/jbc.M114.597682			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037224	hybrid, Green Published			2022-12-28	WOS:000341985300036
J	Babasola, O; Rees-Milton, KJ; Bebe, S; Wang, JX; Anastassiades, TP				Babasola, Oladunni; Rees-Milton, Karen J.; Bebe, Siziwe; Wang, Jiaxi; Anastassiades, Tassos P.			Chemically Modified N-Acylated Hyaluronan Fragments Modulate Proinflammatory Cytokine Production by Stimulated Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIALLY DEACETYLATED HYALURONAN; TOLL-LIKE RECEPTOR-4; MOLECULAR-WEIGHT; RHEUMATOID-ARTHRITIS; KAPPA-B; MOUSE CHONDROCYTES; COLORIMETRIC ASSAY; U937 MACROPHAGES; DENDRITIC CELLS; DOWN-REGULATION	Low molecular mass hyaluronans are known to induce inflammation. To determine the role of the acetyl groups of low molecular mass hyaluronan in stimulating the production of proinflammatory cytokines, partial N-deacetylation was carried out by hydrazinolysis. This resulted in 19.7 +/- 3.5% free NH2 functional groups, which were then acylated by reacting with an acyl anhydride, including acetic anhydride. Hydrazinolysis resulted in bond cleavage of the hyaluronan chain causing a reduction of the molecular mass to 30-214 kDa. The total NH2 and N-acetyl moieties in the reacetylated hyaluronan were 0% and 98.7 +/- 1.5% respectively, whereas for butyrylated hyaluronan, the total NH2, N-acetyl, and N-butyryl moieties were 0, 82.2 +/- 4.6, and 22.7 +/- 3.8%, respectively, based on H-1 NMR. We studied the effect of these polymers on cytokine production by cultured human macrophages (THP-1 cells). The reacetylated hyaluronan stimulated proinflammatory cytokine production to levels similar to LPS, whereas partially deacetylated hyaluronan had no stimulatory effect, indicating the critical role of the N-acetyl groups in the stimulation of proinflammatory cytokine production. Butyrylated hyaluronan significantly reduced the stimulatory effect on cytokine production by the reacetylated hyaluronan or LPS but had no stimulatory effect of its own. The other partially N-acylated hyaluronan derivatives tested showed smaller stimulatory effects than reacetylated hyaluronan. Antibody and antagonist experiments suggest that the acetylated and partially butyrylated lower molecular mass hyaluronans exert their effects through the TLR-4 receptor system. Selectively N-butyrylated lower molecular mass hyaluronan shows promise as an example of a novel semisynthetic anti-inflammatory molecule.	[Babasola, Oladunni; Rees-Milton, Karen J.; Bebe, Siziwe; Anastassiades, Tassos P.] Queens Univ, Dept Med, Div Rheumatol, Kingston, ON K7L 3N6, Canada; [Wang, Jiaxi] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Anastassiades, TP (corresponding author), Queens Univ, Arthrit Ctr, Dept Med, Etherington Hall,94 Stuart St, Kingston, ON K7L 3N6, Canada.	anastass@queensu.ca			National Sciences and Engineering Research Council of Canada (NSERC) Strategic Grant [381564-09]	National Sciences and Engineering Research Council of Canada (NSERC) Strategic Grant	This work was supported by National Sciences and Engineering Research Council of Canada (NSERC) Strategic Grant 381564-09.	ANASTASSIADES TP, 1973, BIOCHEM PHARMACOL, V22, P3013, DOI 10.1016/0006-2952(73)90188-3; Black KE, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-23; Campo GM, 2012, GENE, V494, P24, DOI 10.1016/j.gene.2011.11.064; Campo GM, 2011, BBA-MOL BASIS DIS, V1812, P1170, DOI 10.1016/j.bbadis.2011.06.006; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; Cowman MK, 2011, ANAL BIOCHEM, V417, P50, DOI 10.1016/j.ab.2011.05.023; Crescenzi V, 2002, BIOPOLYMERS, V64, P86, DOI 10.1002/bip.10131; Crescenzi V, 2002, MACROMOL BIOSCI, V2, P272, DOI 10.1002/1616-5195(200208)2:6<272::AID-MABI272>3.0.CO;2-V; DAHL LB, 1988, ANAL BIOCHEM, V175, P397, DOI 10.1016/0003-2697(88)90563-5; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Fam H, 2009, BIORHEOLOGY, V46, P31, DOI 10.3233/BIR-2009-0521; Ferraccioli G, 2010, MOL MED, V16, P552, DOI 10.2119/molmed.2010.00067; Fitzgerald KA, 2000, J IMMUNOL, V164, P2053, DOI 10.4049/jimmunol.164.4.2053; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Julovi SM, 2004, ARTHRITIS RHEUM-US, V50, P516, DOI 10.1002/art.20004; Larionova NI, 2009, CARBOHYD POLYM, V75, P724, DOI 10.1016/j.carbpol.2008.10.009; Lesley J, 2000, J BIOL CHEM, V275, P26967; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; Matsuno H, 1999, INFLAMM RES, V48, P154, DOI 10.1007/s000110050439; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sadowitz B, 2012, J SURG RES, V173, pE63, DOI 10.1016/j.jss.2011.09.025; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; Shimizu M, 2003, J RHEUMATOL, V30, P1164; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; WADA T, 1994, J BIOACT COMPAT POL, V9, P429, DOI 10.1177/088391159400900405; Weldon S, 2004, ATHEROSCLEROSIS, V174, P261, DOI 10.1016/j.atherosclerosis.2004.02.007; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5; Yasuda T, 2011, J PHARMACOL SCI, V115, P509, DOI 10.1254/jphs.10244FP; Zhang WX, 2013, GLYCOCONJUGATE J, V30, P577, DOI 10.1007/s10719-012-9457-3	40	28	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24779	24791		10.1074/jbc.M113.515783	http://dx.doi.org/10.1074/jbc.M113.515783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053413	Green Published, hybrid			2022-12-28	WOS:000341985300005
J	Helm, JR; Bentley, M; Thorsen, KD; Wang, T; Foltz, L; Oorschot, V; Klumperman, J; Hay, JC				Helm, Jared R.; Bentley, Marvin; Thorsen, Kevin D.; Wang, Ting; Foltz, Lauren; Oorschot, Viola; Klumperman, Judith; Hay, Jesse C.			Apoptosis-linked Gene-2 (ALG-2)/Sec31 Interactions Regulate Endoplasmic Reticulum (ER)-to-Golgi Transport A POTENTIAL EFFECTOR PATHWAY FOR LUMINAL CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Protein; Endoplasmic Reticulum (ER); Golgi; Membrane Trafficking; Secretion; Vesicles; Endoplasmic Reticulum to Golgi Transport	INTRACELLULAR MEMBRANE TRAFFICKING; GOLGI INTERMEDIATE COMPARTMENT; UNFOLDED PROTEIN RESPONSE; COPII VESICLE FUSION; P24 PROTEINS; EXIT SITES; MAMMALIAN-CELLS; CARGO RECEPTORS; CA2+-DEPENDENT MANNER; SECRETORY PATHWAY	Background: Whether ER to Golgi transport requires calcium, the source of calcium, and its mechanism is unknown. Results: A requirement for luminal calcium is demonstrated, and evidence is presented for a molecular effector pathway. Conclusion: Luminal calcium may regulate transport by activating these protein interactions. Significance: The described calcium effector pathway may lead to greater insight into calcium action at multiple transport steps. Luminal calcium released from secretory organelles has been suggested to play a regulatory role in vesicle transport at several steps in the secretory pathway; however, its functional roles and effector pathways have not been elucidated. Here we demonstrate for the first time that specific luminal calcium depletion leads to a significant decrease in endoplasmic reticulum (ER)-to-Golgi transport rates in intact cells. Ultrastructural analysis revealed that luminal calcium depletion is accompanied by increased accumulation of intermediate compartment proteins in COPII buds and clusters of unfused COPII vesicles at ER exit sites. Furthermore, we present several lines of evidence suggesting that luminal calcium affected transport at least in part through calcium-dependent interactions between apoptosis-linked gene-2 (ALG-2) and the Sec31A proline-rich region: 1) targeted disruption of ALG-2/Sec31A interactions caused severe defects in ER-to-Golgi transport in intact cells; 2) effects of luminal calcium and ALG-2/Sec31A interactions on transport mutually required each other; and 3) Sec31A function in transport required luminal calcium. Morphological phenotypes of disrupted ALG-2/Sec31A interactions were characterized. We found that ALG-2/Sec31A interactions were not required for the localization of Sec31A to ER exit sites per se but appeared to acutely regulate the stability and trafficking of the cargo receptor p24 and the distribution of the vesicle tether protein p115. These results represent the first outline of a mechanism that connects luminal calcium to specific protein interactions regulating vesicle trafficking machinery.	[Hay, Jesse C.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Hay, Jesse C.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Oorschot, Viola; Klumperman, Judith] Univ Med Ctr Utrecht, Cell Microscopy Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	University of Montana System; University of Montana; University of Montana System; University of Montana; Utrecht University; Utrecht University Medical Center	Hay, JC (corresponding author), Univ Montana, Div Biol Sci, 32 Campus Dr,HS104, Missoula, MT 59812 USA.	jesse.hay@umontana.edu	Wang, Ting/GSN-9679-2022	Bentley, Marvin/0000-0002-1754-0332; Foltz, Lauren/0000-0002-7141-8493	National Institutes of Health [GM106323, NS067834]; University of Montana Center for Structural and Functional Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Montana Center for Structural and Functional Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM106323 (to J. C. H.) and Fellowship NS067834 (to J. R. H.). This work was also supported by the University of Montana Center for Structural and Functional Neuroscience.	Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025; Ahluwalia JP, 2001, J BIOL CHEM, V276, P34148, DOI 10.1074/jbc.M105398200; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Amodio G, 2009, INT J BIOCHEM CELL B, V41, P2511, DOI 10.1016/j.biocel.2009.08.006; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bartoszewski S, 2004, MECH DEVELOP, V121, P1259, DOI 10.1016/j.mod.2004.05.006; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Contreras I, 2004, PLANT CELL PHYSIOL, V45, P1779, DOI 10.1093/pcp/pch200; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Flanagan JJ, 2006, J BIOL CHEM, V281, P2281, DOI 10.1074/jbc.M511695200; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Higashio H, 2002, BIOCHEM BIOPH RES CO, V296, P568, DOI 10.1016/S0006-291X(02)00923-3; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Maki M., 2007, CALCIUM BIND PROTEIN, V2, P4; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rotter J, 2002, J CELL SCI, V115, P1049; Sato M, 2002, BIOCHEM BIOPH RES CO, V296, P560, DOI 10.1016/S0006-291X(02)00922-1; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trahey Meg, 2010, F1000 Biol Rep, V2, P47; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200	75	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23609	23628		10.1074/jbc.M114.561829	http://dx.doi.org/10.1074/jbc.M114.561829			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006245	hybrid, Green Published			2022-12-28	WOS:000341505000030
J	Rajabi, HN; Takahashi, C; Ewen, ME				Rajabi, Hasan N.; Takahashi, Chiaki; Ewen, Mark E.			Retinoblastoma Protein and MyoD Function Together to Effect the Repression of Fra-1 and in Turn Cyclin D1 during Terminal Cell Cycle Arrest Associated with Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Gene Regulation; Myogenesis; Transcription Enhancer; Transcription Factor; Fra-1; MyoD; pRb; Terminal Cell Cycle Arrest	SKELETAL-MUSCLE DIFFERENTIATION; GENE-EXPRESSION; KINASE-ACTIVITY; MYOBLAST DIFFERENTIATION; SUPPRESSES APOPTOSIS; C-FOS; RB; ACTIVATION; TRANSCRIPTION; RAS	Background: Repression of cyclin D1 is required for terminal cell cycle arrest associated with myogenesis. Results: pRb and MyoD function together to block induction of Fra-1 and in turn cyclin D1. Conclusion: MyoD and pRb cooperate to effect transcriptional repression during myogenesis. Significance: The findings reveal a link between MyoD, pRb, Fra-1, and cyclin D1, the latter three of which are often deregulated in cancer. The acquisition of skeletal muscle-specific function and terminal cell cycle arrest represent two important features of the myogenic differentiation program. These cellular processes are distinct and can be separated genetically. The lineage-specific transcription factor MyoD and the retinoblastoma protein pRb participate in both of these cellular events. Whether and how MyoD and pRb work together to effect terminal cell cycle arrest is uncertain. To address this question, we focused on cyclin D1, whose stable repression is required for terminal cell cycle arrest and execution of myogenesis. MyoD and pRb are both required for the repression of cyclin D1; their actions, however, were found not to be direct. Rather, they operate to regulate the immediate early gene Fra-1, a critical player in mitogen-dependent induction of cyclin D1. Two conserved MyoD-binding sites were identified in an intronic enhancer of Fra-1 and shown to be required for the stable repression of Fra-1 and, in turn, cyclin D1. Localization of MyoD alone to the intronic enhancer of Fra-1 in the absence of pRb was not sufficient to elicit a block to Fra-1 induction; pRb was also recruited to the intronic enhancer in a MyoD-dependent manner. These observations suggest that MyoD and pRb work together cooperatively at the level of the intronic enhancer of Fra-1 during terminal cell cycle arrest. This work reveals a previously unappreciated link between a lineage-specific transcription factor, a tumor suppressor, and a proto-oncogene in the control of an important facet of myogenic differentiation.	[Rajabi, Hasan N.; Takahashi, Chiaki; Ewen, Mark E.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Ewen, Mark E.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Harvard University; Dana-Farber Cancer Institute; Kanazawa University; Tufts Medical Center	Ewen, ME (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St,5609, Boston, MA 02111 USA.	mewen@tuftsmedicalcenter.org			National Institutes of Health [R01 CA065842]; Department of Defense Breast Cancer Research Program Fellowship [DAMD17-01-1-0224]; NATIONAL CANCER INSTITUTE [R01CA065842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA065842 (to M. E. E.). This work was also supported by Department of Defense Breast Cancer Research Program Fellowship DAMD17-01-1-0224 (to H. N. R.).	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BERGERS G, 1995, MOL CELL BIOL, V15, P3748; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chen TT, 2000, MOL CELL BIOL, V20, P5571, DOI 10.1128/MCB.20.15.5571-5580.2000; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lee KY, 1999, MOL CELL BIOL, V19, P7724; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran JL, 2002, PHYSIOL GENOMICS, V10, P103, DOI 10.1152/physiolgenomics.00011.2002; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schreiber M, 1997, ONCOGENE, V15, P1171, DOI 10.1038/sj.onc.1201460; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; SHAPIRO GI, 1995, CANCER RES, V55, P6200; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; TROUCHE D, 1993, NATURE, V363, P79, DOI 10.1038/363079a0; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang JM, 1999, EMBO J, V18, P6983, DOI 10.1093/emboj/18.24.6983; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhu J, 1998, BIOINFORMATICS, V14, P25, DOI 10.1093/bioinformatics/14.1.25; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	69	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23417	23427		10.1074/jbc.M113.532572	http://dx.doi.org/10.1074/jbc.M113.532572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006242	Green Published, hybrid			2022-12-28	WOS:000341505000016
J	Eckey, K; Wrobel, E; Strutz-Seebohm, N; Pott, L; Schmitt, N; Seebohm, G				Eckey, Karina; Wrobel, Eva; Strutz-Seebohm, Nathalie; Pott, Lutz; Schmitt, Nicole; Seebohm, Guiscard			Novel K(v)7.1-Phosphatidylinositol 4,5-Bisphosphate Interaction Sites Uncovered by Charge Neutralization Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; POTASSIUM CHANNELS; K+ CHANNEL; BIOPHYSICAL PROPERTIES; UNRELATED PATIENTS; MISSENSE MUTATION; STRUCTURAL BASIS; KCNQ1; PIP2; ACTIVATION	K(v)7.1 to K(v)7.5 alpha-subunits belong to the family of voltage-gated potassium channels (K-v). Assembled with the beta-subunit KCNE1, K(v)7.1 conducts the slowly activating potassium current I-Ks, which is one of the major currents underlying repolarization of the cardiac action potential. A known regulator of K(v)7 channels is the lipid phosphatidylinositol 4,5-bisphosphate (PIP2). PIP2 increases the macroscopic current amplitude by stabilizing the open conformation of 7.1/KCNE1 channels. However, knowledge about the exact nature of the interaction is incomplete. The aim of this study was the identification of the amino acids responsible for the interaction between K(v)7.1 and PIP2. We generated 13 charge neutralizing point mutations at the intracellular membrane border and characterized them electro-physiologically in complex with KCNE1 under the influence of diC(8)-PIP2. Electrophysiological analysis of corresponding long QT syndrome mutants suggested impaired PIP2 regulation as the cause for channel dysfunction. To clarify the underlying structural mechanism of PIP2 binding, molecular dynamics simulations of K(v)7.1/KCNE1 complexes containing two PIP2 molecules in each subunit at specific sites were performed. Here, we identified a subset of nine residues participating in the interaction of PIP2 and K(v)7.1/KCNE1. These residues may form at least two binding pockets per subunit, leading to the stabilization of channel conformations upon PIP2 binding.	[Eckey, Karina] Ruhr Univ Bochum, Dept Biochem, I Cat Channel Grp, D-44801 Bochum, Germany; [Eckey, Karina; Seebohm, Guiscard] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44801 Bochum, Germany; [Eckey, Karina; Seebohm, Guiscard] Ruhr Univ Bochum, Res Sch, D-44801 Bochum, Germany; [Pott, Lutz] Ruhr Univ Bochum, Inst Physiol, D-44801 Bochum, Germany; [Wrobel, Eva; Strutz-Seebohm, Nathalie; Seebohm, Guiscard] Univ Hosp Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, D-48149 Munster, Germany; [Schmitt, Nicole] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, DK-1165 Copenhagen, Denmark	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Munster; Danmarks Grundforskningsfond; University of Copenhagen	Seebohm, G (corresponding author), Univ Hosp Munster, Dept Cardiovasc Med, IfGH Myocellular Electrophysiol, D-48149 Munster, Germany.	guiscard.seebohm@ukmuenster.de	Schmitt, Nicole/B-8725-2012	Schmitt, Nicole/0000-0001-9482-9749; Pott, Lutz/0000-0002-4000-4132	Deutsche Forschungsgemeinschaft [1077/3-1]; International Graduate School of Neuroscience (Ruhr University Bochum); Ruhr University Bochum Research School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Neuroscience (Ruhr University Bochum); Ruhr University Bochum Research School	This work was supported by Deutsche Forschungsgemeinschaft Grant 1077/3-1 and by student grants of the International Graduate School of Neuroscience (Ruhr University Bochum) and the Ruhr University Bochum Research School (to K. E.).	Angelo K, 2002, BIOPHYS J, V83, P1997, DOI 10.1016/S0006-3495(02)73961-1; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FRASER GR, 1964, ANN HUM GENET, V28, P133, DOI 10.1111/j.1469-1809.1964.tb00469.x; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kanovsky J, 2010, HEART RHYTHM, V7, P531, DOI 10.1016/j.hrthm.2009.11.034; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; LOPEZ HS, 1989, EUR J NEUROSCI, V1, P529, DOI 10.1111/j.1460-9568.1989.tb00360.x; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Millat G, 2006, CLIN GENET, V70, P214, DOI 10.1111/j.1399-0004.2006.00671.x; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Nebl T, 2000, CURR BIOL, V10, pR351, DOI 10.1016/S0960-9822(00)00465-6; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; ROMANO C, 1963, Minerva Pediatr, V15, P1155; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sechi AS, 2000, J CELL SCI, V113, P3685; Seebohm G, 2005, CELL PHYSIOL BIOCHEM, V16, P255, DOI 10.1159/000089851; Seebohm G, 2001, PFLUG ARCH EUR J PHY, V442, P891; Seebohm G., 2014, PFLUGERS AR IN PRESS; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; WARD O C, 1964, J Ir Med Assoc, V54, P103; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wrobel E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00142; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang T, 2009, CIRC-ARRHYTHMIA ELEC, V2, P417, DOI 10.1161/CIRCEP.109.850149; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	59	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22749	22758		10.1074/jbc.M114.589796	http://dx.doi.org/10.1074/jbc.M114.589796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947509	Green Published, hybrid			2022-12-28	WOS:000341017200020
J	Gerhold, JM; Sedman, T; Visacka, K; Slezakova, J; Tomaska, L; Nosek, J; Sedman, J				Gerhold, Joachim M.; Sedman, Tiina; Visacka, Katarina; Slezakova, Judita; Tomaska, Lubomir; Nosek, Jozef; Sedman, Juhan			Replication Intermediates of the Linear Mitochondrial DNA of Candida parapsilosis Suggest a Common Recombination Based Mechanism for Yeast Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROLLING-CIRCLE REPLICATION; CHENOPODIUM-ALBUM L.; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION INITIATION; LAGGING-STRAND; PLASMID MP1; GENOME; MAINTENANCE; SEQUENCES; PROTEIN	Variation in the topology of mitochondrial DNA (mtDNA) in eukaryotes evokes the question if differently structured DNAs are replicated by a common mechanism. RNA-primed DNA synthesis has been established as a mechanism for replicating the circular animal/mammalian mtDNA. In yeasts, circular mtDNA molecules were assumed to be templates for rolling circle DNA-replication. We recently showed that in Candida albicans, which has circular mapping mtDNA, recombination driven replication is a major mechanism for replicating a complex branched mtDNA network. Careful analyses of C. albicans-mtDNA did not reveal detectable amounts of circular DNA molecules. In the present study we addressed the question of how the unit sized linear mtDNA of Candida parapsilosis terminating at both ends with arrays of tandem repeats (mitochondrial telomeres) is replicated. Originally, we expected to find replication intermediates diagnostic of canonical bi-directional replication initiation at the centrally located bi-directional promoter region. However, we found that the linear mtDNA of Candida parapsilosis also employs recombination for replication initiation. The most striking findings were that the mitochondrial telomeres appear to be hot spots for recombination driven replication, and that stable RNA: DNA hybrids, with a potential role in mtDNA replication, are also present in the mtDNA preparations.	[Gerhold, Joachim M.; Sedman, Tiina; Sedman, Juhan] Univ Tartu, Inst Mol & Cell Biol, Dept Biochem, EE-51014 Tartu, Estonia; [Visacka, Katarina; Slezakova, Judita; Tomaska, Lubomir] Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia; [Nosek, Jozef] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	University of Tartu; Comenius University Bratislava; Comenius University Bratislava	Gerhold, JM (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Biochem, Riia 23c, EE-51014 Tartu, Estonia.	gerhold@ut.ee	Tomaska, Lubomir/I-3071-2014; Gerhold, Joachim M/B-7276-2012; Nosek, Jozef/A-7581-2008; Prochazkova, Katarina/ABE-1222-2021; Gerhold, Joachim/N-3033-2019; Sedman, Juhan/H-1820-2011	Tomaska, Lubomir/0000-0003-4886-1910; Gerhold, Joachim M/0000-0002-4972-1947; Nosek, Jozef/0000-0002-1020-5451; Prochazkova, Katarina/0000-0003-4147-6577; Gerhold, Joachim/0000-0002-4972-1947; Sedman, Juhan/0000-0003-2081-1452	Estonian Science Foundation [ETF 8449, 8845]; Estonian Institutional Funding Grant [IUT14021]; Slovak Research and Development Agency [APVV 0123-10, 0035-11]; Slovak Grant Agency [VEGA 1/0405/11, 1/0311/12]	Estonian Science Foundation; Estonian Institutional Funding Grant; Slovak Research and Development Agency(Slovak Research and Development Agency); Slovak Grant Agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This work was supported by Estonian Science Foundation Grants ETF 8449 and 8845, the Estonian Institutional Funding Grant IUT14021, Slovak Research and Development Agency Grants APVV 0123-10 and 0035-11, and Slovak Grant Agency Grants VEGA 1/0405/11 and 1/0311/12.	Backert S, 1997, NUCLEIC ACIDS RES, V25, P582, DOI 10.1093/nar/25.3.582; Backert S, 1996, CURR GENET, V29, P427, DOI 10.1007/BF02221510; Backert S, 2002, EMBO J, V21, P3128, DOI 10.1093/emboj/cdf311; Backert S, 1996, MOL CELL BIOL, V16, P6285; Backert S, 2000, PLASMID, V43, P166, DOI 10.1006/plas.1999.1437; Backert S, 2000, CURR GENET, V37, P304, DOI 10.1007/s002940050532; BALDACCI G, 1982, EMBO J, V1, P987, DOI 10.1002/j.1460-2075.1982.tb01282.x; BALDACCI G, 1984, EMBO J, V3, P2115, DOI 10.1002/j.1460-2075.1984.tb02099.x; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bendich AJ, 2010, MOL CELL, V39, P831, DOI 10.1016/j.molcel.2010.09.005; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; DEZAMAROCZY M, 1984, GENE, V32, P439, DOI 10.1016/0378-1119(84)90019-2; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; DEZAMAROCZY M, 1979, FEBS LETT, V108, P429, DOI 10.1016/0014-5793(79)80580-3; DIECKMANN CL, 1987, EMBO J, V6, P4197, DOI 10.1002/j.1460-2075.1987.tb02767.x; FANGMAN WL, 1989, MOL CELL BIOL, V9, P1917, DOI 10.1128/MCB.9.5.1917; FANGMAN WL, 1990, MOL CELL BIOL, V10, P10, DOI 10.1128/MCB.10.1.10; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Fricova D, 2010, MICROBIOL-SGM, V156, P2153, DOI 10.1099/mic.0.038646-0; FUKUHARA H, 1993, MOL CELL BIOL, V13, P2309, DOI 10.1128/MCB.13.4.2309; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Graves T, 1998, NUCLEIC ACIDS RES, V26, P1309, DOI 10.1093/nar/26.5.1309; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Joers P, 2007, FEMS YEAST RES, V7, P118, DOI 10.1111/j.1567-1364.2006.00132.x; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Lecrenier N, 2000, GENE, V246, P37, DOI 10.1016/S0378-1119(00)00107-4; Ling F, 2007, MOL CELL BIOL, V27, P1133, DOI 10.1128/MCB.00770-06; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MacAlpine DM, 1998, P NATL ACAD SCI USA, V95, P6739, DOI 10.1073/pnas.95.12.6739; MALESZKA R, 1992, CURR GENET, V22, P341, DOI 10.1007/BF00317933; MALESZKA R, 1992, BIOCHEM BIOPH RES CO, V186, P1669, DOI 10.1016/S0006-291X(05)81600-6; MALESZKA R, 1991, EMBO J, V10, P3923, DOI 10.1002/j.1460-2075.1991.tb04962.x; NOSEK J, 1995, MOL GEN GENET, V247, P61, DOI 10.1007/BF00425822; Nosek J, 2005, J BIOL CHEM, V280, P10840, DOI 10.1074/jbc.M409295200; Nosek J, 2004, MOL GENET GENOMICS, V272, P173, DOI 10.1007/s00438-004-1046-0; Nosek J, 2003, CURR GENET, V44, P73, DOI 10.1007/s00294-003-0426-z; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 2001, J MOL BIOL, V310, P549, DOI 10.1006/jmbi.2001.4783; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Paquin B, 2000, MOL BIOL EVOL, V17, P1760, DOI 10.1093/oxfordjournals.molbev.a026274; Petersen RF, 2002, J MOL BIOL, V318, P627, DOI 10.1016/S0022-2836(02)00037-2; PISKUR J, 1989, MOL GEN GENET, V218, P161, DOI 10.1007/BF00330579; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Sedman T, 2000, MOL CELL BIOL, V20, P1816, DOI 10.1128/MCB.20.5.1816-1824.2000; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Tomaska L, 2000, NUCLEIC ACIDS RES, V28, P4479, DOI 10.1093/nar/28.22.4479; Tomaska L, 2002, MITOCHONDRION, V1, P455, DOI 10.1016/S1567-7249(02)00009-0; Valach M, 2011, NUCLEIC ACIDS RES, V39, P4202, DOI 10.1093/nar/gkq1345; Visacka K, 2009, MICROBIOL-SGM, V155, P1226, DOI 10.1099/mic.0.025759-0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814; XU BJ, 1992, NUCLEIC ACIDS RES, V20, P1053, DOI 10.1093/nar/20.5.1053; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; ZINN AR, 1988, P NATL ACAD SCI USA, V85, P2686, DOI 10.1073/pnas.85.8.2686; Zuo XM, 2002, GENETICS, V160, P1389	65	20	20	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22659	22670		10.1074/jbc.M114.552828	http://dx.doi.org/10.1074/jbc.M114.552828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24951592	Green Published, hybrid			2022-12-28	WOS:000341017200012
J	Arcovito, A; Chiarella, S; Della Longa, S; Di Matteo, A; Lo Sterzo, C; Scaglione, GL; Federici, L				Arcovito, Alessandro; Chiarella, Sara; Della Longa, Stefano; Di Matteo, Adele; Lo Sterzo, Carlo; Scaglione, Giovanni Luca; Federici, Luca			Synergic Role of Nucleophosmin Three-helix Bundle and a Flanking Unstructured Tail in the Interaction with G-quadruplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DENATURED STATE; MOLECULAR-DYNAMICS; NUCLEOLAR PROTEIN; RIBOSOMAL-RNA; LEUKEMIA; COMPLEX; BINDING; RECOGNITION; MUTATIONS	Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, mainly localized at nucleoli, that plays a number of functions in ribosome biogenesis and export, cell cycle control, and response to stress stimuli. NPM1 is the most frequently mutated gene in acute myeloid leukemia; mutations map to the C-terminal domain of the protein and cause its denaturation and aberrant cytoplasmic translocation. NPM1 C-terminal domain binds G-quadruplex regions at ribosomal DNA and at gene promoters, including the well characterized sequence from the nuclease-hypersensitive element III region of the c-MYC promoter. These activities are lost by the leukemic variant. Here we analyze the NPM1/G-quadruplex interaction, focusing on residues belonging to both the NPM1 terminal three-helix bundle and a lysine-rich unstructured tail, which has been shown to be necessary for high affinity recognition. We performed extended site-directed mutagenesis and measured binding rate constants through surface plasmon resonance analysis. These data, supported by molecular dynamics simulations, suggest that the unstructured tail plays a double role in the reaction mechanism. On the one hand, it facilitates the formation of an encounter complex through long range electrostatic interactions; on the other hand, it directly contacts the G-quadruplex scaffold through multiple and transient electrostatic interactions, significantly enlarging the contact surface.	[Arcovito, Alessandro; Scaglione, Giovanni Luca] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, I-00168 Rome, Italy; [Chiarella, Sara; Federici, Luca] Fdn Univ DAnnunzio, CeSI Ctr Sci Invecchiamento, I-66013 Chieti, Italy; [Chiarella, Sara; Lo Sterzo, Carlo] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Della Longa, Stefano] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, I-67100 Laquila, Italy; [Di Matteo, Adele] CNR, Ist Biol Med Mol & NanoBiotecnol, I-00185 Rome, Italy; [Federici, Luca] Univ G dAnnunzio, Dipartimento Sci Sperimentali & Clin, I-66013 Chieti, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); G d'Annunzio University of Chieti-Pescara	Federici, L (corresponding author), Univ G dAnnunzio, Dipartimento Sci Sperimentali & Clin, CeSI Ctr Sci Invecchiamento, Via Vestini 31, I-66013 Chieti, Italy.	lfederici@unich.it	Arcovito, Alessandro/I-5552-2012; Di Matteo, Adele/AAC-8338-2019; Scaglione, Giovanni Luca/ABD-6776-2020	Arcovito, Alessandro/0000-0002-8384-4844; Di Matteo, Adele/0000-0002-5921-7365; Scaglione, Giovanni Luca/0000-0001-5622-7843; della longa, stefano/0000-0002-8157-9530	Associazione Italiana Ricerca sul Cancro Grant [AIRC IG2011-11712]; Italian Ministry of University and Research (Universita Cattolica Sacro Cuore, Rome) [Linea D.1]	Associazione Italiana Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (Universita Cattolica Sacro Cuore, Rome)	This work was supported by Associazione Italiana Ricerca sul Cancro Grant AIRC IG2011-11712 (to L. F.). and the Italian Ministry of University and Research (Linea D.1, 2012 Universita Cattolica Sacro Cuore, Rome) (to A. A.).	Banuelos S, 2013, FEBS LETT, V587, P2254, DOI 10.1016/j.febslet.2013.05.055; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chiarella S, 2013, BIOCHEM BIOPH RES CO, V435, P64, DOI 10.1016/j.bbrc.2013.04.038; Chiarella S, 2013, NUCLEIC ACIDS RES, V41, P3228, DOI 10.1093/nar/gkt001; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2011, BLOOD REV, V25, P247, DOI 10.1016/j.blre.2011.06.001; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; Gallo A, 2012, J BIOL CHEM, V287, P26539, DOI 10.1074/jbc.M112.371013; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Guo X, 2012, BIOCOMPUT-PAC SYM, P104; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Hisaoka M, 2014, NUCLEIC ACIDS RES, V42, P1180, DOI 10.1093/nar/gkt897; KANG YJ, 1975, CANCER RES, V35, P1470; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Marasco D, 2013, BIOCHEM BIOPH RES CO, V430, P523, DOI 10.1016/j.bbrc.2012.12.002; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Scaloni F, 2010, P NATL ACAD SCI USA, V107, P5447, DOI 10.1073/pnas.0910516107; Scaloni F, 2009, FASEB J, V23, P2360, DOI 10.1096/fj.08-128306; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Scognamiglio PL, 2014, BBA-GEN SUBJECTS, V1840, P2050, DOI 10.1016/j.bbagen.2014.02.017; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wulff JE, 2007, J AM CHEM SOC, V129, P14444, DOI 10.1021/ja075327f	36	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21230	21241		10.1074/jbc.M114.565010	http://dx.doi.org/10.1074/jbc.M114.565010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24952945	Green Published, hybrid			2022-12-28	WOS:000340558300003
J	Tanaka, KJ; Ogawa, K; Takagi, M; Imamoto, N; Matsumoto, K; Tsujimoto, M				Tanaka, Kimio J.; Ogawa, Kenji; Takagi, Masatoshi; Imamoto, Naoko; Matsumoto, Ken; Tsujimoto, Masafumi			RAP55, a cytoplasmic mRNP component, represses translation in Xenopus oocytes (vol 281, pg 40096, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022				Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20490	20490		10.1074/jbc.A114.060905	http://dx.doi.org/10.1074/jbc.A114.060905			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	25063841	hybrid, Green Published			2022-12-28	WOS:000339396600009
J	Haddad, N; Matos, RG; Pinto, T; Rannou, P; Cappelier, JM; Prevost, H; Arraiano, CM				Haddad, Nabila; Matos, Rute G.; Pinto, Teresa; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve; Arraiano, Cecilia M.			The RNase R from Campylobacter jejuni Has Unique Features and Is Involved in the First Steps of Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Campylobacter; Invasion; Ribonuclease; RNA Catalysis; RNA Metabolism; Foodborne Pathogen	RIBONUCLEASE-II; POLYNUCLEOTIDE PHOSPHORYLASE; EXORIBONUCLEASE; DEGRADATION; SURVIVAL; TEMPERATURE; MECHANISM; DOMAINS; GROWTH; CATALYSIS	Background: Members of the RNB family are involved in virulence; nothing is known about the Campylobacter jejuni homologue. Results:Cj-RNase R is active in several conditions. It is also important for adhesion and invasion. Conclusion: RNase R is important for C. jejuni biology and infection. Significance: RNase R could be targeted to reduce infection by this pathogen. Bacterial pathogens must adapt/respond rapidly to changing environmental conditions. Ribonucleases (RNases) can be crucial factors contributing to the fast adaptation of RNA levels to different environmental demands. It has been demonstrated that the exoribonuclease polynucleotide phosphorylase (PNPase) facilitates survival of Campylobacter jejuni in low temperatures and favors swimming, chick colonization, and cell adhesion/invasion. However, little is known about the mechanism of action of other ribonucleases in this microorganism. Members of the RNB family of enzymes have been shown to be involved in virulence of several pathogens. We have searched C. jejuni genome for homologues and found one candidate that displayed properties more similar to RNase R (Cj-RNR). We show here that Cj-RNR is important for the first steps of infection, the adhesion and invasion of C. jejuni to eukaryotic cells. Moreover, Cj-RNR proved to be active in a wide range of conditions. The results obtained lead us to conclude that Cj-RNR has an important role in the biology of this foodborne pathogen.	[Haddad, Nabila; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve] Univ Nantes, Oniris, LUNAM Univ, F-44200 Nantes, France; [Haddad, Nabila; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve] INRA, Securite Aliments & Microbiol UMR1014, F-44322 Nantes, France; [Matos, Rute G.; Pinto, Teresa; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; INRAE; Universidade Nova de Lisboa	Haddad, N (corresponding author), Oniris, UMR SECALIM INRA1014, Rue Geraudiere, F-44322 Nantes, France.	nabila.haddad@oniris-nantes.fr; cecilia@itqb.unl.pt	Matos, Rute/J-4983-2013	PREVOST, Herve/0000-0001-9384-8382; Matos Luis, Rute/0000-0002-9788-7562; Arraiano, Cecilia/0000-0003-1934-9301; Pinto, Teresa/0000-0002-7553-618X; Haddad, Nabila/0000-0001-7944-4824	Region Pays de la Loire through the program grant GENICAMP	Region Pays de la Loire through the program grant GENICAMP(Region Pays de la Loire)	We thank Andreia Aires for technical support at Instituto de Tecnologia Quimica e Biologica (ITQB) and Christopher M. Burns for discussion about construction of the plasmid overexpressing C. jejuni RNase R. RNA research in UMR1014 SECALIM was funded by the Region Pays de la Loire through the program grant GENICAMP.	Alluri RK, 2012, J BIOL CHEM, V287, P23427, DOI 10.1074/jbc.M111.324970; Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; DEMEDICIS E, 1986, APPL ENVIRON MICROB, V52, P567; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haddad N, 2013, BIOSCIENCE REP, V33, P889, DOI 10.1042/BSR20130090; Haddad N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00030; Haddad N, 2010, CURR MICROBIOL, V61, P500, DOI 10.1007/s00284-010-9644-z; Haddad N, 2009, APPL ENVIRON MICROB, V75, P7310, DOI 10.1128/AEM.01366-09; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Kelly AF, 2003, APPL ENVIRON MICROB, V69, P4975, DOI 10.1128/AEM.69.8.4975-4978.2003; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee A, 1998, J FOOD PROTECT, V61, P1609, DOI 10.4315/0362-028X-61.12.1609; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Matos RG, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00065; Matos RG, 2012, BBA-GEN SUBJECTS, V1820, P1543, DOI 10.1016/j.bbagen.2012.06.009; Matos RG, 2011, PROTEINS, V79, P1853, DOI 10.1002/prot.23010; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Nyati KK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852195; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park S.F., 2005, CAMPYLOBACTER MOL CE; Pogacar MS, 2009, INT J FOOD MICROBIOL, V129, P68, DOI 10.1016/j.ijfoodmicro.2008.11.010; Reis FP, 2013, WIRES RNA, V4, P607, DOI 10.1002/wrna.1180; Riddle Mark S, 2012, Curr Gastroenterol Rep, V14, P395, DOI 10.1007/s11894-012-0278-0; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; Tsao MY, 2009, J BACTERIOL, V191, P2691, DOI 10.1128/JB.01182-08; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wyszynska A, 2007, ACTA BIOCHIM POL, V54, P143	51	16	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27814	27824		10.1074/jbc.M114.561795	http://dx.doi.org/10.1074/jbc.M114.561795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100732	Green Published, hybrid			2022-12-28	WOS:000342852800038
J	Sah, RP; Garg, SK; Dixit, AK; Dudeja, V; Dawra, RK; Saluja, AK				Sah, Raghuwansh P.; Garg, Sushil K.; Dixit, Ajay K.; Dudeja, Vikas; Dawra, Rajinder K.; Saluja, Ashok K.			Endoplasmic Reticulum Stress Is Chronically Activated in Chronic Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER Stress; NF-kappa B (NF-KB); Pancreas; Unfolded Protein Response (UPR); Chronic Pancreatitis; Trypsinogen Activation	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ACINAR-CELLS; HEREDITARY PANCREATITIS; TRYPSINOGEN ACTIVATION; MESSENGER-RNA; ER STRESS; OXIDATIVE STRESS; CATHEPSIN-B; PATHOGENESIS	Background: The nature of endoplasmic reticulum (ER) stress in chronic pancreatitis (CP) is not known. Results: ER stress is activated early, independently of trypsinogen activation, and remains sustained in CP. Conclusion: Pathologic ER stress activation may be a novel pathogenic mechanism of CP. Significance: ER stress is a key event independent of the traditional central event of pancreatitis-trypsinogen activation. The pathogenesis of chronic pancreatitis (CP) is poorly understood. Endoplasmic reticulum (ER) stress has now been recognized as a pathogenic event in many chronic diseases. However, ER stress has not been studied in CP, although pancreatic acinar cells seem to be especially vulnerable to ER dysfunction because of their dependence on high ER volume and functionality. Here, we aim to investigate ER stress in CP, study its pathogenesis in relation to trypsinogen activation (widely regarded as the key event of pancreatitis), and explore its mechanism, time course, and downstream consequences during pancreatic injury. CP was induced in mice by repeated episodes of acute pancreatitis (AP) based on caerulein hyperstimulation. ER stress leads to activation of unfolded protein response components that were measured in CP and AP. We show sustained up-regulation of unfolded protein response components ATF4, CHOP, GRP78, and XBP1 in CP. Overexpression of GRP78 and ATF4 in human CP confirmed the experimental findings. We used novel trypsinogen-7 knock-out mice (T-/-), which lack intra-acinar trypsinogen activation, to clarify the relationship of ER stress to intra-acinar trypsinogen activation in pancreatic injury. Comparable activation of ER stress was seen in wild type and T-/- mice. Induction of ER stress occurred through pathologic calcium signaling very early in the course of pancreatic injury. Our results establish that ER stress is chronically activated in CP and is induced early in pancreatic injury through pathologic calcium signaling independent of trypsinogen activation. ER stress may be an important pathogenic mechanism in pancreatitis that needs to be explored in future studies.	[Sah, Raghuwansh P.; Garg, Sushil K.; Dixit, Ajay K.; Dudeja, Vikas; Dawra, Rajinder K.; Saluja, Ashok K.] Univ Minnesota, Div Basic & Translat Res, Dept Surg, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Saluja, AK (corresponding author), 420 Delaware St SE,Mayo Mail Code 195, Minneapolis, MN 55455 USA.	asaluja@umn.edu	Dixit, Ajay/AAH-7171-2021		National Institutes of Health [DK093047, DK058694, DK092145]; Department of Surgery, University of Minnesota; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093047, R01DK092145, R01DK058694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery, University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK093047, DK058694, and DK092145 (to A. K. S.) and intramural support from the Department of Surgery, University of Minnesota.	Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Beer S, 2014, GUT, V63, P860, DOI 10.1136/gutjnl-2013-305981; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Braganza JM, 2011, LANCET, V377, P1184, DOI 10.1016/S0140-6736(10)61852-1; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Gaiser S, 2011, GUT, V60, P1379, DOI 10.1136/gut.2010.226175; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Gorelick FS, 2009, CLIN GASTROENTEROL H, V7, pS10, DOI 10.1016/j.cgh.2009.07.036; Guda Nalini M, 2011, Curr Gastroenterol Rep, V13, P140, DOI 10.1007/s11894-011-0176-x; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hasty AH, 2012, J CLIN INVEST, V122, P3859, DOI 10.1172/JCI65173; Hietaranta AJ, 2001, BIOCHEM BIOPH RES CO, V280, P388, DOI 10.1006/bbrc.2000.4120; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kereszturi E, 2009, J BIOL CHEM, V284, P33392, DOI 10.1074/jbc.M109.056812; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kitamura M, 2009, ANTIOXID REDOX SIGN, V11, P2353, DOI 10.1089/ARS.2008.2391; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; LaRusch J, 2011, CURR OPIN GASTROEN, V27, P467, DOI 10.1097/MOG.0b013e328349e2f8; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lugea A, 2011, GASTROENTEROLOGY, V140, P987, DOI 10.1053/j.gastro.2010.11.038; Mahurkar S, 2006, GUT, V55, P1270, DOI 10.1136/gut.2005.087403; Ohmuraya M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00126; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Paliwal S, 2013, GUT, V62, P1602, DOI 10.1136/gutjnl-2012-302448; Pandol SJ, 2010, DIGEST DIS, V28, P776, DOI 10.1159/000327212; Petersen OH, 2009, BRAZ J MED BIOL RES, V42, P9, DOI 10.1590/S0100-879X2009000100003; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rakonczay Z, 2008, GUT, V57, P259, DOI 10.1136/gut.2007.124115; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Sah RP, 2011, CURR OPIN GASTROEN, V27, P444, DOI 10.1097/MOG.0b013e328349e346; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schnur A, 2014, GUT, V63, P337, DOI 10.1136/gutjnl-2012-304331; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whitcomb DC, 2010, ANNU REV MED, V61, P413, DOI 10.1146/annurev.med.041608.121416; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	70	56	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27551	27561		10.1074/jbc.M113.528174	http://dx.doi.org/10.1074/jbc.M113.528174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25077966	hybrid, Green Published			2022-12-28	WOS:000342852800017
J	Li, ZY; Lin, F; Zhuo, CH; Deng, GP; Chen, ZJ; Yin, SY; Gao, ZM; Piccioni, M; Tsun, A; Cai, SJ; Zheng, SG; Zhang, Y; Li, B				Li, Zhiyuan; Lin, Fang; Zhuo, Changhua; Deng, Guoping; Chen, Zuojia; Yin, Shuying; Gao, Zhimei; Piccioni, Miranda; Tsun, Andy; Cai, Sanjun; Zheng, Song Guo; Zhang, Yu; Li, Bin			PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL FUNCTION; MEDIATED SUPPRESSION; CUTTING EDGE; IN-VIVO; IDENTIFICATION; DIFFERENTIATE; ACTIVATION; MECHANISMS; STABILITY; RESPONSES	Previous reports have suggested that human CD4(+) CD25(hi)FOXP3(+) T regulatory cells (Tregs) have functional plasticity and may differentiate into effector T cells under inflammation. The molecular mechanisms underlying these findings remain unclear. Here we identified the residue serine 422 of human FOXP3 as a phosphorylation site that regulates its function, which is not present in murine Foxp3. PIM1 kinase, which is highly expressed in human Tregs, was found to be able to interact with and to phosphorylate human FOXP3 at serine 422. T cell receptor (TCR) signaling inhibits PIM1 induction, whereas IL-6 promotes PIM1 expression in in vitro expanded human Tregs. PIM1 negatively regulates FOXP3 chromatin binding activity by specifically phosphorylating FOXP3 at Ser422. Our data also suggest that phosphorylation of FOXP3 at the Ser418 site could prevent FOXP3 phosphorylation at Ser422 mediated by PIM1. Knockdown of PIM1 in in vitro expanded human Tregs promoted FOXP3-induced target gene expression, including CD25, CTLA4, and glucocorticoid-induced tumor necrosis factor receptor (GITR), or weakened FOXP3-suppressed IL-2 gene expression and enhanced the immunosup-pressive activity of Tregs. Furthermore, PIM1-specific inhibitor boosted FOXP3 DNA binding activity in in vitro expanded primary Tregs and also enhanced their suppressive activity toward the proliferation of T effector cells. Taken together, our findings suggest that PIM1 could be a new potential therapeutic target in the prevention and treatment of human-specific autoimmune diseases because of its ability to modulate the immunosuppressive activity of human Tregs.	[Li, Zhiyuan; Lin, Fang; Chen, Zuojia; Yin, Shuying; Gao, Zhimei; Piccioni, Miranda; Tsun, Andy; Li, Bin] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Mol Immunol, Shanghai 200031, Peoples R China; [Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200032, Peoples R China; [Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zhuo, Changhua] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Surg Oncol, Fuzhou 350014, Peoples R China; [Deng, Guoping] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Zheng, Song Guo] Penn State Univ, Hershey Coll Med, Dept Med, Div Rheumatol, Carlisle, PA 17013 USA; [Zhang, Yu] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; Fudan University; Fujian Medical University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Shanghai Jiao Tong University	Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China.	sh_zhangyu@hotmail.com; binli@sibs.ac.cn	Piccioni, Miranda/X-4530-2018; ZHUO, CHANGHUA/H-7592-2012; Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021	Piccioni, Miranda/0000-0002-4434-6770; ZHUO, CHANGHUA/0000-0002-5900-9048; lI, Bin/0000-0002-7640-8884	National Basic Research Program of China (973 Program) Grants [2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 81271835, 31200646, 81302532, 31350110505, SMCST 11ZR1404900]; Chinese Academy of Sciences Fellowship for Young International Scientists [2013Y1SB0005]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant [2012KIP204]	National Basic Research Program of China (973 Program) Grants(National Basic Research Program of China); Chinese Academy of Sciences Fellowship for Young International Scientists; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant	This work was supported by National Basic Research Program of China (973 Program) Grants 2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 81271835, 31200646, 81302532, 31350110505, and SMCST 11ZR1404900; by Chinese Academy of Sciences Fellowship for Young International Scientists 2013Y1SB0005; and by Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2012KIP204.	Alvarado Y, 2012, EXPERT REV HEMATOL, V5, P81, DOI [10.1586/EHM.11.69, 10.1586/ehm.11.69]; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang Z, 2001, J Vet Sci, V2, P167; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	37	74	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26872	26881		10.1074/jbc.M114.586651	http://dx.doi.org/10.1074/jbc.M114.586651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096571	hybrid, Green Published			2022-12-28	WOS:000342853900018
J	Samson, AL; Knaupp, AS; Kass, I; Kleifeld, O; Marijanovic, EM; Hughes, VA; Lupton, CJ; Buckle, AM; Bottomley, SP; Medcalf, RL				Samson, Andre L.; Knaupp, Anja S.; Kass, Itamar; Kleifeld, Oded; Marijanovic, Emilia M.; Hughes, Victoria A.; Lupton, Chris J.; Buckle, Ashley M.; Bottomley, Stephen P.; Medcalf, Robert L.			Oxidation of an Exposed Methionine Instigates the Aggregation of Glyceraldehyde-3-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; NUCLEAR TRANSLOCATION; PROTEIN AGGREGATION; ALPHA-CRYSTALLIN; CROSS-LINKS; GAPDH; MECHANISM; INTERACT; STRESS; IDENTIFICATION	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a ubiquitous and abundant protein that participates in cellular energy production. GAPDH normally exists in a soluble form; however, following necrosis, GAPDH and numerous other intracellular proteins convert into an insoluble disulfide-cross-linked state via the process of "nucleocytoplasmic coagulation." Here, free radical-induced aggregation of GAPDH was studied as an in vitro model of nucleocytoplasmic coagulation. Despite the fact that disulfide cross-linking is a prominent feature of GAPDH aggregation, our data show that it is not a primary rate-determining step. To identify the true instigating event of GAPDH misfolding, we mapped the post-translational modifications that arise during its aggregation. Solvent accessibility and energy calculations of the mapped modifications within the context of the high resolution native GAPDH structure suggested that oxidation of methionine 46 may instigate aggregation. We confirmed this by mutating methionine 46 to leucine, which rendered GAPDH highly resistant to free radical-induced aggregation. Molecular dynamics simulations suggest that oxidation of methionine 46 triggers a local increase in the conformational plasticity of GAPDH that likely promotes further oxidation and eventual aggregation. Hence, methionine 46 represents a "linchpin" whereby its oxidation is a primary event permissive for the subsequent misfolding, aggregation, and disulfide cross-linking of GAPDH. A critical role for linchpin residues in nucleocytoplasmic coagulation and other forms of free radical-induced protein misfolding should now be investigated. Furthermore, because disulfide-cross-linked aggregates of GAPDH arise in many disorders and because methionine 46 is irrelevant to native GAPDH function, mutation of methionine 46 in models of disease should allow the unequivocal assessment of whether GAPDH aggregation influences disease progression.	[Samson, Andre L.; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Samson, Andre L.; Knaupp, Anja S.; Kass, Itamar; Kleifeld, Oded; Marijanovic, Emilia M.; Hughes, Victoria A.; Lupton, Chris J.; Buckle, Ashley M.; Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Knaupp, Anja S.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Knaupp, Anja S.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Kass, Itamar] Monash Univ, Victorian Life Sci Computat Ctr, Clayton, Vic 3800, Australia	Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; Monash University; Monash University	Samson, AL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	andre.samson@monash.edu; robert.medcalf@monash.edu	Kass, Itamar/P-5724-2014; Medcalf, Robert L/E-9632-2011; Buckle, Ashley/P-8366-2016	Kass, Itamar/0000-0002-5368-937X; Buckle, Ashley/0000-0003-2943-9044; Samson, Andre/0000-0002-0637-2716; Lupton, Christopher Joseph/0000-0002-4617-4853; Knaupp, Anja/0000-0003-0493-7872	Faculty of Medicine, Nursing and Health Sciences early career development grant; Australian National Health and Medical Research Council (NHMRC) grant; Victorian Life Sciences Computation Initiative Grant [VR0303]; NHMRC senior research fellowship	Faculty of Medicine, Nursing and Health Sciences early career development grant; Australian National Health and Medical Research Council (NHMRC) grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative Grant; NHMRC senior research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Faculty of Medicine, Nursing and Health Sciences early career development grant (to A. L. S.), an Australian National Health and Medical Research Council (NHMRC) grant (to R. L. M., S. P. B., and A. L. S.), and Victorian Life Sciences Computation Initiative Grant VR0303 (to A. L. S. and I. K.) for use of its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia.; Supported by an NHMRC senior research fellowship.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; DURCHSCHSLAG H, 1971, EUR J BIOCHEM, V19, P9, DOI 10.1111/j.1432-1033.1971.tb01282.x; DURRIEU C, 1987, MOL CELL BIOCHEM, V74, P55; Ferns JE, 2012, NEUROCHEM RES, V37, P244, DOI 10.1007/s11064-011-0601-4; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Han X, 2011, J PROTEOME RES, V10, P2930, DOI 10.1021/pr200153k; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Koudelka T, 2012, J AGR FOOD CHEM, V60, P4144, DOI 10.1021/jf205168t; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mitomi Y, 2012, J BIOL CHEM, V287, P34764, DOI 10.1074/jbc.M112.387035; Mulinacci F, 2013, EUR J PHARM BIOPHARM, V85, P42, DOI 10.1016/j.ejpb.2013.03.015; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Naletova IN, 2006, BBA-PROTEINS PROTEOM, V1764, P831, DOI 10.1016/j.bbapap.2006.02.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polyakova OV, 2005, PROTEIN SCI, V14, P921, DOI 10.1110/ps.041211205; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seidler NW, 2013, ADV EXP MED BIOL, V985, P1, DOI 10.1007/978-94-007-4716-6_1; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Tanaka N, 2011, J BIOL CHEM, V286, P5884, DOI 10.1074/jbc.M110.176396; Tornvall U, 2010, ANAL METHODS-UK, V2, P1638, DOI 10.1039/c0ay00375a; Torosantucci R, 2013, MOL PHARMACEUT, V10, P2311, DOI 10.1021/mp300665u; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yan H, 2006, MOL VIS, V12, P1153; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	55	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26922	26936		10.1074/jbc.M114.570275	http://dx.doi.org/10.1074/jbc.M114.570275			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25086035	Green Published, hybrid			2022-12-28	WOS:000342853900023
J	Gao, Y; Nelson, SW				Gao, Yang; Nelson, Scott W.			Autoinhibition of Bacteriophage T4 Mre11 by Its C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; DNA CLEAVAGE; NUCLEASE; RECOMBINATION; MECHANISM; INSIGHTS; REVEALS; CHECKPOINT	Mre11 and Rad50 form a stable complex (MR) and work cooperatively in repairing DNA double strand breaks. In the bacteriophage T4, Rad50 (gene product 46) enhances the nuclease activity of Mre11 (gene product 47), and Mre11 and DNA in combination stimulate the ATPase activity of Rad50. The structural basis for the cross-activation of the MR complex has been elusive. Various crystal structures of the MR complex display limited protein-protein interfaces that mainly exist between the C terminus of Mre11 and the coiled-coil domain of Rad50. To test the role of the C-terminal Rad50 binding domain (RBD) in Mre11 activation, we constructed a series of C-terminal deletions and mutations in bacteriophage T4 Mre11. Deletion of the RBD in Mre11 eliminates Rad50 binding but only has moderate effect on its intrinsic nuclease activity; however, the additional deletion of the highly acidic flexible linker that lies between RBD and the main body of Mre11 increases the nuclease activity of Mre11 by 20-fold. Replacement of the acidic residues in the flexible linker with alanine elevates the Mre11 activity to the level of the MR complex when combined with deletion of RBD. Nuclease activity kinetics indicate that Rad50 association and deletion of the C terminus of Mre11 both enhance DNA substrate binding. Additionally, a short peptide that contains the flexible linker and RBD of Mre11 acts as an inhibitor of Mre11 nuclease activity. These results support a model where the Mre11 RBD and linker domain act as an autoinhibitory domain when not in complex with Rad50. Complex formation with Rad50 alleviates this inhibition due to the tight association of the RBD and the Rad50 coiled-coil.	[Gao, Yang; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu	Gao, Yang/O-3445-2016		Carver Trust [10-3603]; Iowa State University; National Science Foundation [MCB-1121693]; Direct For Biological Sciences [1121693] Funding Source: National Science Foundation	Carver Trust; Iowa State University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.), Iowa State University institutional support (to S. W. N), and National Science Foundation Grant MCB-1121693 (to S. W. N).	Albrecht DW, 2012, J BIOL CHEM, V287, P31371, DOI 10.1074/jbc.M112.392316; Almond JR, 2013, GENETICS, V195, P739, DOI 10.1534/genetics.113.154872; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen C, 2013, P NATL ACAD SCI USA, V110, P20605, DOI 10.1073/pnas.1306328110; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Herdendorf TJ, 2011, BIOCHEMISTRY-US, V50, P6030, DOI 10.1021/bi200184w; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MICKELSON C, 1981, J VIROL, V40, P65, DOI 10.1128/JVI.40.1.65-77.1981; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Povirk LR, 2006, DNA REPAIR, V5, P1199, DOI 10.1016/j.dnarep.2006.05.016; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Sambrook J., 1989, MOL CLONING LAB MANU, V2, P32; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Szczepek M, 2009, MOL MICROBIOL, V72, P1011, DOI 10.1111/j.1365-2958.2009.06702.x; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Noort J, 2003, P NATL ACAD SCI USA, V100, P7581, DOI 10.1073/pnas.1330706100; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Woodworth DL, 1996, GENETICS, V143, P1081; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008	51	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26505	26513		10.1074/jbc.M114.583625	http://dx.doi.org/10.1074/jbc.M114.583625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077970	hybrid, Green Published			2022-12-28	WOS:000342128800041
J	Werner, KM; Perez, LJ; Ghosh, R; Semmelhack, MF; Bassler, BL				Werner, Kristen M.; Perez, Lark J.; Ghosh, Rajarshi; Semmelhack, Martin F.; Bassler, Bonnie L.			Caenorhabditis elegans Recognizes a Bacterial Quorum-sensing Signal Molecule through the AWC(ON) Neuron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE; ESCHERICHIA-COLI; DAUER LARVA; EL-TOR; AUTOINDUCER; CHEMOTAXIS; GENES; IDENTIFICATION; BIOSYNTHESIS; PHEROMONES	In a process known as quorum sensing, bacteria use chemicals called autoinducers for cell-cell communication. Population-wide detection of autoinducers enables bacteria to orchestrate collective behaviors. In the animal kingdom detection of chemicals is vital for success in locating food, finding hosts, and avoiding predators. This behavior, termed chemotaxis, is especially well studied in the nematode Caenorhabditis elegans. Here we demonstrate that the Vibrio cholerae autoinducer (S)-3-hydroxytridecan-4-one, termed CAI-1, influences chemotaxis in C. elegans. C. elegans prefers V. cholerae that produces CAI-1 over a V. cholerae mutant defective for CAI-1 production. The position of the CAI-1 ketone moiety is the key feature driving CAI-1-directed nematode behavior. CAI-1 is detected by the C. elegans amphid sensory neuron AWC(ON). Laser ablation of the AWC(ON) cell, but not other amphid sensory neurons, abolished chemoattraction to CAI-1. These analyses define the structural features of a bacterial-produced signal and the nematode chemosensory neuron that permit cross-kingdom interaction.	[Werner, Kristen M.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Semmelhack, Martin F.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Perez, Lark J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ 08028 USA; [Ghosh, Rajarshi] Baylor Coll Med, Dept Pediat Oncol, Houston, TX 77030 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Rowan University; Baylor College of Medicine; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu		Perez, Lark/0000-0002-6920-7996; Bassler, Bonnie/0000-0002-0043-746X	National Institutes of Health [5R01GM065859]; Howard Hughes Medical Institute; National Science Foundation [MCB-0343821]; Div Of Molecular and Cellular Bioscience [0948112] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM065859 (to B. L. B.). This work was also supported by the Howard Hughes Medical Institute and National Science Foundation Grant MCB-0343821 (to B. L. B.)	Artyukhin AB, 2013, J BIOL CHEM, V288, P18778, DOI 10.1074/jbc.C113.477000; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann Cornelia I, 2006, WormBook, P1; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bolitho ME, 2011, BIOORGAN MED CHEM, V19, P6906, DOI 10.1016/j.bmc.2011.09.021; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Choe A, 2012, P NATL ACAD SCI USA, V109, P20949, DOI 10.1073/pnas.1218302109; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Ng WL, 2011, MOL MICROBIOL, V79, P1407, DOI 10.1111/j.1365-2958.2011.07548.x; Ng WL, 2010, P NATL ACAD SCI USA, V107, P5575, DOI 10.1073/pnas.1001392107; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; THOMAS JH, 1990, GENETICS, V124, P855; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Zagoriy V, 2010, CHEM BIODIVERS, V7, P2016, DOI 10.1002/cbdv.201000012; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	51	21	22	0	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26566	26573		10.1074/jbc.M114.573832	http://dx.doi.org/10.1074/jbc.M114.573832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092291	Green Published, hybrid			2022-12-28	WOS:000342128800047
J	Tsou, WI; Nguyen, KQN; Calarese, DA; Garforth, SJ; Antes, AL; Smirnov, SV; Almo, SC; Birge, RB; Kotenko, SV				Tsou, Wen-I; Nguyen, Khanh-Quynh N.; Calarese, Daniel A.; Garforth, Scott J.; Antes, Anita L.; Smirnov, Sergey V.; Almo, Steve C.; Birge, Raymond B.; Kotenko, Sergei V.			Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-S; APOPTOTIC CELLS; DENDRITIC CELLS; TAM RECEPTORS; GROWTH-FACTOR; GAS6; PHOSPHATIDYLSERINE; IDENTIFICATION; RECOGNITION; ADHESION	TYRO3, AXL, and MER receptors (TAMs) are three homologous type I receptor-tyrosine kinases that are activated by endogenous ligands, protein S (PROS1) and growth arrest-specific gene 6 (GAS6). These ligands can either activate TAMs as soluble factors, or, in turn, opsonize phosphatidylserine (PS) on apoptotic cells (ACs) and serve as bridging molecules between ACs and TAMs. Abnormal expression and activation of TAMs have been implicated in promoting proliferation and survival of cancer cells, as well as in suppressing anti-tumor immunity. Despite the fact that TAM receptors share significant similarity, little is known about the specificity of interaction between TAM receptors and their ligands, particularly in the context of ACs, and about the functional diversity of TAM receptors. To study ligand-mediated activation of TAMs, we generated a series of reporter cell lines expressing chimeric TAM receptors. Using this system, we found that each TAM receptor has a unique pattern of interaction with and activation by GAS6 and PROS1, which is also differentially affected by the presence of ACs, PS-containing lipid vesicles and enveloped virus. We also demonstrated that gamma-carboxylation of ligands is essential for the full activation of TAMs and that soluble immunoglobulin-like TAM domains act as specific ligand antagonists. These studies demonstrate that, despite their similarity, TYRO3, AXL, and MER are likely to perform distinct functions in both immunoregulation and the recognition and removal of ACs.	[Tsou, Wen-I; Nguyen, Khanh-Quynh N.; Antes, Anita L.; Smirnov, Sergey V.; Birge, Raymond B.; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ 07103 USA; [Tsou, Wen-I; Smirnov, Sergey V.; Kotenko, Sergei V.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Calarese, Daniel A.; Garforth, Scott J.; Almo, Steve C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Almo, Steve C.] Yeshiva Univ, Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Birge, RB (corresponding author), Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@njms.rutgers.edu; kotenkse@njms.rutgers.edu			National Institutes of Health [R01AI104669, R01NCI165077, GM094662, GM094665]; Rutgers University; NJMS translational research award bridge grant;  [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U01GM094665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University; NJMS translational research award bridge grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01AI104669 (to S. V. K.) and R01NCI165077 (to R. B. B.), Rutgers University, NJMS translational research award & bridge grant (to S. V. K. and R. B. B.), National Institutes of Health Grants GM094662 & GM094665 (to S. C. A.), and P30CA013330 to Cancer Center of the Albert Einstein College of Medicine.	Bandyopadhyay PK, 2008, VITAM HORM, V78, P157, DOI 10.1016/S0083-6729(07)00008-8; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; DAHLBACK B, 1990, J BIOL CHEM, V265, P18481; Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Gerber DE, 2011, CLIN CANCER RES, V17, P6888, DOI 10.1158/1078-0432.CCR-11-1074; Giorda KM, 2013, DNA CELL BIOL, V32, P557, DOI 10.1089/dna.2013.2159; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRIFFIN JH, 1992, BLOOD, V79, P3203; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; LAI C, 1994, ONCOGENE, V9, P2567; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mercer J, 2011, CELL HOST MICROBE, V9, P255, DOI 10.1016/j.chom.2011.04.002; Moerdyk-Schauwecker M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-166; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Muthukumaran G, 1997, J BIOL CHEM, V272, P4993, DOI 10.1074/jbc.272.8.4993; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nguyen KQN, 2014, J BIOL CHEM, V289, P25737, DOI 10.1074/jbc.M114.570838; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Rahman ZSM, 2010, J IMMUNOL, V185, P5859, DOI 10.4049/jimmunol.1001187; Recarte-Pelz P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4199; Robins RS, 2013, BLOOD, V121, P692, DOI 10.1182/blood-2012-05-433730; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; SOH J, 1993, P NATL ACAD SCI USA, V90, P8737, DOI 10.1073/pnas.90.18.8737; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	57	137	142	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25750	25763		10.1074/jbc.M114.569020	http://dx.doi.org/10.1074/jbc.M114.569020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074926	hybrid, Green Published			2022-12-28	WOS:000342130800033
J	Zhang, DQ; Tong, X; Arthurs, B; Guha, A; Rui, LY; Kamath, A; Inoki, K; Yin, L				Zhang, Deqiang; Tong, Xin; Arthurs, Blake; Guha, Anirvan; Rui, Liangyou; Kamath, Avani; Inoki, Ken; Yin, Lei			Liver Clock Protein BMAL1 Promotes de Novo Lipogenesis through Insulin-mTORC2-AKT Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC LIPID-METABOLISM; ROTATING SHIFT WORK; ARNT-LIKE PROTEIN-1; MTOR COMPLEX 2; CIRCADIAN CLOCK; FATTY LIVER; INSULIN-RESISTANCE; MUTANT MICE; RICTOR; DISEASE	The clock protein BMAL1 (brain and muscle Arnt-like protein 1) participates in circadian regulation of lipid metabolism, but its contribution to insulin AKT-regulated hepatic lipid synthesis is unclear. Here we used both Bmal1(-/-) and acute liver-specific Bmal1-depleted mice to study the role of BMAL1 in refeeding-induced de novo lipogenesis in the liver. Both global deficiency and acute hepatic depletion of Bmal1 reduced lipogenic gene expression in the liver upon refeeding. Conversely, Bmal1 overexpression in mouse liver by adenovirus was sufficient to elevate the levels of mRNA of lipogenic enzymes. Bmal1(-/-) primary mouse hepatocytes displayed decreased levels of de novo lipogenesis and lipogenic enzymes, supporting the notion that BMAL1 regulates lipid synthesis in hepatocytes in a cell-autonomous manner. Both refed mouse liver and insulin-treated primary mouse hepatocytes showed impaired AKT activation in the case of either Bmal1 deficiency or Bmal1 depletion by adenoviral shRNA. Restoring AKT activity by a constitutively active mutant of AKT nearly normalized de novo lipogenesis in Bmal1(-/-) hepatocytes. Finally, Bmal1 deficiency or knockdown decreased the protein abundance of RICTOR, the key component of the mTORC2 complex, without affecting the gene expression of key factors of insulin signaling. Thus, our study uncovered a novel metabolic function of hepatic BMAL1 that promotes de novo lipogenesis via the insulin-mTORC2-AKT signaling during refeeding.	[Zhang, Deqiang; Tong, Xin; Arthurs, Blake; Guha, Anirvan; Rui, Liangyou; Kamath, Avani; Inoki, Ken; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	Leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	Guha, Anirvan/0000-0001-6018-1438; TONG, XIN/0000-0002-4832-8940	National Institutes of Health from NIDDK [K99/R00 DK077449, R01 DK099593, 094014]; Michigan Gastrointestinal Hormone Research Core Center [5P3ODKO34933]; University of Michigan Diabetes and Research Training Center [P60DK020572]; STEP Program at the University of Michigan - National Institutes of Health [R25 DK088752]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, K99DK077449, R01DK099593, R01DK094014, P30DK020572, R00DK077449, R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Michigan Gastrointestinal Hormone Research Core Center; University of Michigan Diabetes and Research Training Center; STEP Program at the University of Michigan - National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K99/R00 DK077449 and R01 DK099593 (to L. Y.) and R01 Grant 094014 (to L. R.) from NIDDK, pilot grants from the Michigan Gastrointestinal Hormone Research Core Center (5P3ODKO34933) and from the University of Michigan Diabetes and Research Training Center (P60DK020572) (to L. Y.), and by a pilot grant from the University of Michigan Diabetes and Research Training Center P60DK020572 (to X. T.).; Supported by the STEP Program at the University of Michigan funded by National Institutes of Health Grant R25 DK088752 (NIDDK).	Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559; Ahmadieh H, 2014, DIABETES RES CLIN PR, V104, P53, DOI 10.1016/j.diabres.2014.01.003; Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kennaway DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065255; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Shearn CT, 2013, FREE RADICAL BIO MED, V65, P680, DOI 10.1016/j.freeradbiomed.2013.07.011; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tong X, 2013, J BIOL CHEM, V288, P5417, DOI 10.1074/jbc.M112.433482; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Weickert MO, 2006, DIABETOLOGIA, V49, P1732, DOI 10.1007/s00125-006-0295-3; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	68	69	72	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25925	25935		10.1074/jbc.M114.567628	http://dx.doi.org/10.1074/jbc.M114.567628			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063808	Green Published, hybrid			2022-12-28	WOS:000342130800047
J	Ishida, A; Akita, K; Mori, Y; Tanida, S; Toda, M; Inoue, M; Nakada, H				Ishida, Akiko; Akita, Kaoru; Mori, Yugo; Tanida, Shuhei; Toda, Munetoyo; Inoue, Mizue; Nakada, Hiroshi			Negative Regulation of Toll-like Receptor-4 Signaling through the Binding of Glycosylphosphatidylinositol-anchored Glycoprotein, CD14, with the Sialic Acid-binding Lectin, CD33	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; IMMUNE-RESPONSES; LIPID RAFTS; KAPPA-B; LPS; LIPOPOLYSACCHARIDE; ACTIVATION; SIGLECS; ANTIGEN; TLR4	When monocyte-derived immature dendritic cells (imDCs) were stimulated with LPS in the presence of anti-CD33/Siglec-3 mAb, the production of IL-12 and phosphorylation of NF-kappa B decreased significantly. The cell surface proteins of imDCs were chemically cross-linked, and CD33-linked proteins were analyzed by SDS-PAGE and immunoblotting. It was CD14 that was found to be cross-linked with CD33. A proximity ligation assay also indicated that CD33 was colocalized with CD14 on the cell surface of imDCs. Sialic acid-dependent binding of CD33 to CD14 was confirmed by a plate assay using recombinant CD33 and CD14. Three types of cells (HEK293T cells expressing the LPS receptor complex (Toll-like receptor (TLR) cells), and the LPS receptor complex plus either wild-type CD33 (TLR/CD33WT cells) or mutated CD33 without sialic acid-binding activity (TLR/CD33RA cells)) were prepared, and then the binding and uptake of LPS were investigated. Although the level of LPS bound on the cell surface was similar among these cells, the uptake of LPS was reduced in TLR/CD33WT cells. A higher level of CD14-bound LPS and a lower level of TLR4-bound LPS were detected in TLR/CD33WT cells compared with the other two cell types, probably due to reduced presentation of LPS from CD14 to TLR4. Phosphorylation of NF-kappa B after stimulation with LPS was also compared. Wild-type CD33 but not mutated CD33 significantly reduced the phosphorylation of NF-kappa B. These results suggest that CD14 is an endogenous ligand for CD33 and that ligation of CD33 with CD14 modulates with the presentation of LPS from CD14 to TLR4, leading to down-regulation of TLR4-mediated signaling.	[Ishida, Akiko; Akita, Kaoru; Mori, Yugo; Tanida, Shuhei; Toda, Munetoyo; Inoue, Mizue; Nakada, Hiroshi] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan	Kyoto Sangyo University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Private University Strategic Research Foundation Support Program	Private University Strategic Research Foundation Support Program	This work was supported by a Private University Strategic Research Foundation Support Program.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Boyd CR, 2009, J IMMUNOL, V183, P7703, DOI 10.4049/jimmunol.0902780; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8625, DOI 10.1074/jbc.275.12.8625; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; FERRERO E, 1990, J IMMUNOL, V145, P331; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; TCHILIAN EZ, 1994, BLOOD, V83, P3188; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Triantafilou M, 2004, J CELL SCI, V117, P4007, DOI 10.1242/jcs.01270; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	33	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25341	25350		10.1074/jbc.M113.523480	http://dx.doi.org/10.1074/jbc.M113.523480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059667	Green Published, hybrid			2022-12-28	WOS:000341985300052
J	Okamura, A; Koyanagi, S; Dilxiat, A; Kusunose, N; Chen, JJ; Matsunaga, N; Shibata, S; Ohdo, S				Okamura, Ayako; Koyanagi, Satoru; Dilxiat, Adila; Kusunose, Naoki; Chen, Jia Jun; Matsunaga, Naoya; Shibata, Shigenobu; Ohdo, Shigehiro			Bile Acid-regulated Peroxisome Proliferator-activated Receptor-alpha (PPAR alpha) Activity Underlies Circadian Expression of Intestinal Peptide Absorption Transporter PepT1/Slc15a1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; NUCLEAR RECEPTOR; DIURNAL RHYTHM; COTRANSPORTER; METABOLISM; PACEMAKER; BIOLOGY; PEPT-1; CLOCK	Digested proteins are mainly absorbed as small peptides composed of two or three amino acids. The intestinal absorption of small peptides is mediated via only one transport system: the proton-coupled peptide transporter-1 (PepT1) encoded from the soluble carrier protein Slc15a1. In mammals, intestinal expression of PepT1/Slc15a1 oscillates during the daily feeding cycle. Although the oscillation in the intestinal expression of PepT1/Slc15a1 is suggested to be controlled by molecular components of circadian clock, we demonstrated here that bile acids regulated the oscillation of PepT1/Slc15a1 expression through modulating the activity of peroxisome proliferator-activated receptor alpha (PPAR alpha). Nocturnally active mice mainly consumed their food during the dark phase. PPAR alpha activated the intestinal expression of Slc15a1 mRNA during the light period, and protein levels of PepT1 peaked before the start of the dark phase. After food intake, bile acids accumulated in intestinal epithelial cells. Intestinal accumulated bile acids interfered with recruitment of co-transcriptional activator CREB-binding protein/p300 on the promoter region of Slc15a1 gene, thereby suppressing PPAR alpha-mediated transactivation of Slc15a1. The time-dependent suppression of PPAR alpha-mediated transactivation by bile acids caused an oscillation in the intestinal expression of PepT1/Slc15a1 during the daily feeding cycle that led to circadian changes in the intestinal absorption of small peptides. These findings suggest a molecular clock-independent mechanism by which bile acid-regulated PPAR alpha activity governs the circadian expression of intestinal peptide transporter.	[Okamura, Ayako; Koyanagi, Satoru; Dilxiat, Adila; Kusunose, Naoki; Chen, Jia Jun; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Fukuoka 8128582, Japan; [Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Tokyo 1628480, Japan	Kyushu University; Waseda University	Ohdo, S (corresponding author), Kyushu Univ, Dept Pharmaceut, Fac Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; matsunaga2, naoya2/0000-0001-6226-8473	Japan Society for the Promotion of Science [25136716, 25253038, 25670079, 26670317]; Grants-in-Aid for Scientific Research [26670317, 26861456] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 25136716 (to S. O.), Grant-in-aid for Scientific Research (A) 25253038 (to S. O.), Grant-in-aid for Challenging Exploratory Research 25670079 (to S. O.), and 26670317 (to S. K.) from the Japan Society for the Promotion of Science.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ashida K, 2002, AM J PHYSIOL-GASTR L, V282, pG617, DOI 10.1152/ajpgi.00344.2001; Berlioz F, 2000, J PHARMACOL EXP THER, V294, P466; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Caldelas I, 2003, NEUROSCIENCE, V116, P583, DOI 10.1016/S0306-4522(02)00654-1; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Feillet CA, 2006, J PHYSIOL-PARIS, V100, P252, DOI 10.1016/j.jphysparis.2007.05.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gangopadhyay A, 2002, AM J PHYSIOL-GASTR L, V283, pG133, DOI 10.1152/ajpgi.00445.2001; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Herrera-Ruiz D, 2003, J PHARM SCI-US, V92, P691, DOI 10.1002/jps.10303; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MATTHEWS DM, 1975, PHYSIOL REV, V55, P537, DOI 10.1152/physrev.1975.55.4.537; Meredith D, 2006, J MEMBRANE BIOL, V213, P79, DOI 10.1007/s00232-006-0876-6; Nielsen CU, 2001, AM J PHYSIOL-GASTR L, V281, pG191, DOI 10.1152/ajpgi.2001.281.1.G191; Ogihara H, 1996, BIOCHEM BIOPH RES CO, V220, P848, DOI 10.1006/bbrc.1996.0493; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Pan XY, 2003, J PHARMACOL EXP THER, V307, P626, DOI 10.1124/jpet.103.055939; Ripperger JA, 2000, GENE DEV, V14, P679; Ritskes-Hoitinga M., 2004, LAB MOUSE, P463; Saito H, 2008, AM J PHYSIOL-GASTR L, V295, pG395, DOI 10.1152/ajpgi.90317.2008; Shimakura J, 2006, AM J PHYSIOL-GASTR L, V291, pG851, DOI 10.1152/ajpgi.00171.2006; Son DO, 2004, BIOFACTORS, V21, P395, DOI 10.1002/biof.552210177	35	31	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25296	25305		10.1074/jbc.M114.577023	http://dx.doi.org/10.1074/jbc.M114.577023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25016014	hybrid, Green Published			2022-12-28	WOS:000341985300048
J	Olsen, JA; Ahring, PK; Kastrup, JS; Gajhede, M; Balle, T				Olsen, Jeppe A.; Ahring, Philip K.; Kastrup, Jette S.; Gajhede, Michael; Balle, Thomas			Structural and Functional Studies of the Modulator NS9283 Reveal Agonist-like Mechanism of Action at alpha 4 beta 2 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATOR; CYS-LOOP RECEPTORS; ACH-BINDING PROTEIN; SUBUNIT INTERFACES; IN-VIVO; PHARMACOLOGY; EFFICACY; SUBTYPES; SYSTEM; SITES	Modulation of Cys loop receptor ion channels is a proven drug discovery strategy, but many underlying mechanisms of the mode of action are poorly understood. We report the x-ray structure of the acetylcholine-binding protein from Lymnaea stagnalis with NS9283, a stoichiometry selective positive modulator that targets the alpha 4-alpha 4 interface of alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs). Together with homology modeling, mutational data, quantum mechanical calculations, and pharmacological studies on alpha 4 beta 2 nAChRs, the structure reveals a modulator binding mode that overlaps the alpha 4-alpha 4 interface agonist (acetylcholine)-binding site. Analysis of contacts to residues known to govern agonist binding and function suggests that modulation occurs by an agonist-like mechanism. Selectivity for alpha 4-alpha 4 over alpha 4-beta 2 interfaces is determined mainly by steric restrictions from Val-136 on the beta 2-subunit and favorable interactions between NS9283 and His-142 at the complementary side of alpha 4. In the concentration ranges where modulation is observed, its selectivity prevents NS9283 from directly activating nAChRs because activation requires coordinated action from more than one interface. However, we demonstrate that in a mutant receptor with one natural and two engineered alpha 4-alpha 4 interfaces, NS9283 is an agonist. Modulation via extracellular binding sites is well known for benzodiazepines acting at gamma-aminobutyric acid type A receptors. Like NS9283, benzodiazepines increase the apparent agonist potency with a minimal effect on efficacy. The shared modulatory profile along with a binding site located in an extracellular subunit interface suggest that modulation via an agonist-like mechanism may be a common mechanism of action that potentially could apply to Cys loop receptors beyond the alpha 4 beta 2 nAChRs.	[Olsen, Jeppe A.] NeuroSearch AS, DK-2750 Ballerup, Denmark; [Olsen, Jeppe A.; Kastrup, Jette S.; Gajhede, Michael] Univ Copenhagen, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Olsen, Jeppe A.; Ahring, Philip K.; Balle, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Saniona AB, DK-2750 Ballerup, Denmark	University of Copenhagen; University of Sydney	Balle, T (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	thomas.balle@sydney.edu.au		Balle, Thomas/0000-0002-0233-8350; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA Research School at the University of Copenhagen, Denmark; IMK Almene Fond, Denmark; Australian National Health and Medical Research Council [APP1069417]	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA Research School at the University of Copenhagen, Denmark; IMK Almene Fond, Denmark; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation, the DRA Research School at the University of Copenhagen, Denmark, the IMK Almene Fond, Denmark, and Australian National Health and Medical Research Council Grant APP1069417. J. A. O. and P. K. A. declare that at the time the described work was carried out they were employed by NeuroSearch A/S or Saniona AB, respectively. This does not alter the authors' adherence to all policies on sharing data and materials.	Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallivan JP, 1999, ORG LETT, V1, P103, DOI 10.1021/ol990577p; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hogg RC, 2004, CNS NEUROL DISORD-DR, V3, P123, DOI 10.2174/1568007043482507; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mirza NR, 2008, J PHARMACOL EXP THER, V327, P954, DOI 10.1124/jpet.108.138859; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nielsen SF, 2000, J MED CHEM, V43, P2217, DOI 10.1021/jm990973d; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Pandya A, 2011, BIOCHEM PHARMACOL, V82, P952, DOI 10.1016/j.bcp.2011.04.020; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shahsavar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040757; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Ussing CA, 2013, J MED CHEM, V56, P940, DOI 10.1021/jm301409f; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	30	30	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24911	24921		10.1074/jbc.M114.568097	http://dx.doi.org/10.1074/jbc.M114.568097			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24982426	Green Published, hybrid			2022-12-28	WOS:000341985300016
J	Wang, RX; Wang, JD; Acharya, D; Paul, AM; Bai, FW; Huang, FQ; Guo, YL				Wang, Ruoxing; Wang, Jundi; Acharya, Dhiraj; Paul, Amber M.; Bai, Fengwei; Huang, Faqing; Guo, Yan-Lin			Antiviral Responses in Mouse Embryonic Stem Cells DIFFERENTIAL DEVELOPMENT OF CELLULAR MECHANISMS IN TYPE I INTERFERON PRODUCTION AND RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ENDOTHELIAL-CELLS; VIRUS-INFECTION; SELF-RENEWAL; CHIKUNGUNYA VIRUS; VIRAL-INFECTIONS; INNATE IMMUNITY; VASCULAR CELLS; MAP KINASE; TNF-ALPHA	We have recently reported that mouse embryonic stem cells (mESCs) are deficient in expressing type I interferons (IFNs) in response to viral infection and synthetic viral RNA analogs (Wang, R., Wang, J., Paul, A. M., Acharya, D., Bai, F., Huang, F., and Guo, Y. L. (2013) J. Biol. Chem. 288, 15926-15936). Here, we report that mESCs are able to respond to type I IFNs, express IFN-stimulated genes, and mediate the antiviral effect of type I IFNs against La Crosse virus and chikungunya virus. The major signaling components in the IFN pathway are expressed in mESCs. Therefore, the basic molecular mechanisms that mediate the effects of type I IFNs are functional in mESCs; however, these mechanisms may not yet be fully developed as mESCs express lower levels of IFN-stimulated genes and display weaker antiviral activity in response to type I IFNs when compared with fibroblasts. Further analysis demonstrated that type I IFNs do not affect the stem cell state of mESCs. We conclude that mESCs are deficient in type I IFN expression, but they can respond to and mediate the cellular effects of type I IFNs. These findings represent unique and uncharacterized properties of mESCs and are important for understanding innate immunity development and ESC physiology.	[Wang, Ruoxing; Wang, Jundi; Acharya, Dhiraj; Paul, Amber M.; Bai, Fengwei; Guo, Yan-Lin] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Huang, Faqing] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	University of Southern Mississippi; University of Southern Mississippi	Guo, YL (corresponding author), Univ So Mississippi, Dept Biol Sci, 118 Coll Dr 5018, Hattiesburg, MS 39406 USA.	yanlin.guo@usm.edu		Paul, Amber/0000-0002-1657-3618	National Institutes of Health [HL082731, 1R15GM109299-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL082731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476, R15GM109299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082731 (to Y.-L.G.) and 1R15GM109299-01A1 (to Y.-L.G.).	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dalton S, 2009, CELL STEM CELL, V4, P9, DOI 10.1016/j.stem.2008.12.003; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Dissing-Olesen L, 2008, J PHARMACOL EXP THER, V326, P338, DOI 10.1124/jpet.108.138263; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Glaser DE, 2011, J VASC RES, V48, P415, DOI 10.1159/000324752; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; Guo YL, 1999, AM J PHYSIOL-RENAL, V276, pF390, DOI 10.1152/ajprenal.1999.276.3.F390; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hong XX, 2013, J BIOL CHEM, V288, P16196, DOI 10.1074/jbc.M112.435461; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; JORDANA M, 1994, EUR RESPIR J, V7, P2212, DOI 10.1183/09031936.94.07122212; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KUBES M, 1994, J INTERFERON RES, V14, P57, DOI 10.1089/jir.1994.14.57; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rajan S, 2008, J CELL BIOCHEM, V105, P477, DOI 10.1002/jcb.21845; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; Soldan SS, 2010, VIROLOGY, V404, P139, DOI 10.1016/j.virol.2010.04.012; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Streitenfeld H, 2003, J VIROL, V77, P5507, DOI 10.1128/JVI.77.9.5507-5511.2003; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Torres J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036405; Wang RX, 2014, STEM CELLS DEV, V23, P594, DOI 10.1089/scd.2013.0417; Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438; Wang RX, 2012, EXP CELL RES, V318, P2094, DOI 10.1016/j.yexcr.2012.05.017; Wash R, 2012, J GEN VIROL, V93, P2118, DOI 10.1099/vir.0.043406-0; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08; Zampetaki A, 2007, AM J PHYSIOL-CELL PH, V293, pC1226, DOI 10.1152/ajpcell.00152.2007; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055	65	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25186	25198		10.1074/jbc.M113.537746	http://dx.doi.org/10.1074/jbc.M113.537746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24966329	hybrid, Green Published			2022-12-28	WOS:000341985300039
J	Gaudette, BT; Iwakoshi, NN; Boise, LH				Gaudette, Brian T.; Iwakoshi, Neal N.; Boise, Lawrence H.			Bcl-x(L) Protein Protects from C/EBP Homologous Protein (CHOP)-dependent Apoptosis during Plasma Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Proteins; Differentiation; ER Stress; Lymphocyte; UPR; Plasma Cell	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; MESSENGER-RNA; TRANSCRIPTION FACTORS; B-CELLS; KINASE; MCL-1; XBP-1; DEATH; ATF6	Background: UPR-associated death signals are activated during plasma cell differentiation. Results: Bcl-x(L) sequesters Bim during plasma cell differentiation, preventing apoptosis. Conclusion: Bcl-x(L) dependence during plasma cell differentiation protects the cell from the UPR activation necessary for ER remodeling. Significance: Bcl-2 family dynamics are crucial for both the development of plasma cells and the treatment of diseases of abnormal plasma cells. Although it is known that the unfolded protein response (UPR) plays a significant role in the process of plasma cell differentiation, the contribution of the individual sensors of the UPR to this process remains unclear. In this study we examine the death signals and compensatory survival signals activated during B cell activation and the first stages of plasma cell differentiation. During in vitro differentiation of both primary murine B cells and the Bcl1 cell line, we demonstrate that in addition to activation of the physiological UPR, changes in the expression of several Bcl-2 proteins occur, which are consistent with a lowering of the apoptotic threshold of the cell. Specifically, we observed decreased expression of Bcl-2 and Mcl-1 and increased expression of the proapoptotic protein Bim. However, these changes were countered by Bcl-x(L) induction, which is necessary to protect differentiating cells both from ER stress-induced death by tunicamycin and from the death signals inherent in differentiation. Consistent with differentiating cells becoming dependent on Bcl-x(L) for survival, the addition of ABT-737 resulted in apoptosis in differentiating cells through the inhibition of sequestration of Bim. Confirming this result, differentiation in the context of RNAi-mediated Bcl-x(L) knockdown also induced apoptosis. This cell death is C/EBP homologous protein (CHOP)-dependent, connecting these events to the UPR. Thus plasma cell differentiation proceeds through a Bcl-x(L)-dependent intermediate.	[Gaudette, Brian T.; Boise, Lawrence H.] Emory Univ, Dept Hematol & Med Oncol, Dept Cell Biol, Atlanta, GA 30322 USA; [Gaudette, Brian T.; Boise, Lawrence H.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Iwakoshi, Neal N.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Iwakoshi, Neal N.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Boise, LH (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Dept Cell Biol, 1365C Clifton Rd NE,Ste C4012, Atlanta, GA 30322 USA.	lboise@emory.edu	Boise, Lawrence/AAD-2314-2019	Gaudette, Brian/0000-0001-6627-3085; Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [R01 CA127910, R01 CA129968]; T. J. Martell Foundation; NATIONAL CANCER INSTITUTE [R01CA127910, R01CA129968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. J. Martell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA127910 and R01 CA129968 as well as funding from the T. J. Martell Foundation (to L. H. B.).	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; Gass JN, 2004, TRENDS IMMUNOL, V25, P17, DOI 10.1016/j.it.2003.11.004; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunn KE, 2004, MOL IMMUNOL, V41, P919, DOI 10.1016/j.molimm.2004.04.023; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Ma YJ, 2010, CELL STRESS CHAPERON, V15, P281, DOI 10.1007/s12192-009-0142-9; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	41	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23629	23640		10.1074/jbc.M114.569376	http://dx.doi.org/10.1074/jbc.M114.569376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023286	hybrid, Green Published			2022-12-28	WOS:000341505000031
J	Miles, ZD; Roberts, SA; McCarty, RM; Bandarian, V				Miles, Zachary D.; Roberts, Sue A.; McCarty, Reid M.; Bandarian, Vahe			Biochemical and Structural Studies of 6-Carboxy-5,6,7,8-tetrahydropterin Synthase Reveal the Molecular Basis of Catalytic Promiscuity within the Tunnel-fold Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Kinetics; Enzyme Mechanism; Enzyme Structure; Enzyme Turnover	6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE; SYNECHOCOCCUS SP PCC-7942; TETRAHYDROBIOPTERIN BIOSYNTHESIS; SEPIAPTERIN REDUCTASE; ENZYMATIC-SYNTHESIS; KINETIC-DATA; UDP-GLUCOSE; 6-PYRUVOYL-TETRAHYDROPTERIN; EVOLUTION; GLUCOSYLTRANSFERASE	Background: The bacterial homolog, 6-carboxy-5,6,7,8-tetrahydropterin synthase, of the eukaryotic 6-pyruvoyltetrahydropterin synthase enzyme acts on the same substrate but produces different products. Results: Structural and biochemical studies trace the differential reactivity to four residues. Conclusion: Differential reactivity between the enzyme homologs is a result of small changes in the enzyme active site. Significance: This work furthers our understanding of how novel activities may arise from common protein-folds. 6-Pyruvoyltetrahydropterin synthase (PTPS) homologs in both mammals and bacteria catalyze distinct reactions using the same 7,8-dihydroneopterin triphosphate substrate. The mammalian enzyme converts 7,8-dihydroneopterin triphosphate to 6-pyruvoyltetrahydropterin, whereas the bacterial enzyme catalyzes the formation of 6-carboxy-5,6,7,8-tetrahydropterin. To understand the basis for the differential activities we determined the crystal structure of a bacterial PTPS homolog in the presence and absence of various ligands. Comparison to mammalian structures revealed that although the active sites are nearly structurally identical, the bacterial enzyme houses a His/Asp dyad that is absent from the mammalian protein. Steady state and time-resolved kinetic analysis of the reaction catalyzed by the bacterial homolog revealed that these residues are responsible for the catalytic divergence. This study demonstrates how small variations in the active site can lead to the emergence of new functions in existing protein folds.	[Miles, Zachary D.; Roberts, Sue A.; McCarty, Reid M.; Bandarian, Vahe] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Bandarian, V (corresponding author), 1041 E Lowell St, Tucson, AZ 85721 USA.	vahe@email.arizona.edu			DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, T32GM008804, R01GM072623] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, NIGMS Grant P41GM103393.	Bracher A, 1998, J BIOL CHEM, V273, P28132, DOI 10.1074/jbc.273.43.28132; BURGISSER DM, 1995, J MOL BIOL, V253, P358, DOI 10.1006/jmbi.1995.0558; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho SH, 1998, BBA-GEN SUBJECTS, V1379, P53, DOI 10.1016/S0304-4165(97)00081-0; Choi YK, 2001, FEBS LETT, V502, P73, DOI 10.1016/S0014-5793(01)02667-9; Chung HJ, 2000, BBA-GEN SUBJECTS, V1524, P183, DOI 10.1016/S0304-4165(00)00156-2; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; DeLano W.L, PYMOL MOL GRAPHICS S; Deng H, 2000, J BIOL CHEM, V275, P30139, DOI 10.1074/jbc.M004464200; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GHISLA S, 1990, EUR J BIOCHEM, V187, P651, DOI 10.1111/j.1432-1033.1990.tb15349.x; Iino T, 2003, ARCH BIOCHEM BIOPHYS, V416, P180, DOI 10.1016/S0003-9861(03)00295-9; Iino T, 2000, ARCH BIOCHEM BIOPHYS, V373, P442, DOI 10.1006/abbi.1999.1561; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAUFMAN S, 1993, ANNU REV NUTR, V13, P261, DOI 10.1146/annurev.nu.13.070193.001401; Kong JS, 2006, FEBS LETT, V580, P4900, DOI 10.1016/j.febslet.2006.08.006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee YG, 2010, APPL ENVIRON MICROB, V76, P7658, DOI 10.1128/AEM.01083-10; MAHARAJ G, 1990, BIOCHEMISTRY-US, V29, P4554, DOI 10.1021/bi00471a008; MATSUBARA M, 1966, BIOCHIM BIOPHYS ACTA, V122, P202, DOI 10.1016/0926-6593(66)90062-2; McCarty RM, 2012, BIOORG CHEM, V43, P15, DOI 10.1016/j.bioorg.2012.01.001; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P2301, DOI 10.1021/bi9001437; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILSTIEN S, 1989, BIOCHEM BIOPH RES CO, V165, P845, DOI 10.1016/S0006-291X(89)80043-9; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAR H, 1994, EMBO J, V13, P1255, DOI 10.1002/j.1460-2075.1994.tb06377.x; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PARK YS, 1991, BIOCHEM BIOPH RES CO, V175, P738, DOI 10.1016/0006-291X(91)91628-P; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phillips G, 2012, ACS CHEM BIOL, V7, P197, DOI 10.1021/cb200329f; Ploom T, 1999, J MOL BIOL, V286, P851, DOI 10.1006/jmbi.1998.2511; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Schomaker V, 1998, ACTA CRYSTALLOGR B, V54, P507, DOI 10.1107/S0108768198003243; SMITH GK, 1987, ARCH BIOCHEM BIOPHYS, V255, P254, DOI 10.1016/0003-9861(87)90392-4; SWITCHENKO AC, 1984, BIOCHEM BIOPH RES CO, V120, P754, DOI 10.1016/S0006-291X(84)80171-0; TAKIKAWA SI, 1986, EUR J BIOCHEM, V161, P295, DOI 10.1111/j.1432-1033.1986.tb10446.x; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; VAN QL, 1988, BIOCHEM BIOPH RES CO, V151, P512, DOI 10.1016/0006-291X(88)90623-7; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23641	23652		10.1074/jbc.M114.555680	http://dx.doi.org/10.1074/jbc.M114.555680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990950	Green Published, hybrid			2022-12-28	WOS:000341505000032
J	Li, H; Hu, D; Fan, HM; Zhang, Y; LeSage, GD; Caudle, Y; Stuart, C; Liu, ZM; Yin, DL				Li, Hui; Hu, Dan; Fan, Huimin; Zhang, Ying; LeSage, Gene D.; Caudle, Yi; Stuart, Charles; Liu, Zhongmin; Yin, Deling			beta-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-triggered Inflammatory Signaling via Targeting p38 MAPK and Interleukin 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-10 PRODUCTION; ACTIVATED MACROPHAGES; PROTEIN; CELLS; BETA-ARRESTIN-2; TRANSDUCTION; MIGRATION; SCAFFOLD; PATHWAYS; GLYCOPROTEIN	The control of IL-10 production in Toll-like receptor (TLR) signals remains to be elucidated. Here, we report that beta-arrestin 2 positively regulates TLR-triggered IL-10 production in a p38 mitogen-activated protein kinase (MAPK)-dependent mechanism. In vitro studies with cells including peritoneal macrophages and HEK293/TLR4 cells have demonstrated that beta-arrestin 2 forms complexes with p38 and facilitates p38 activation after lipopolysaccharide (LPS) stimulation. Deficiency of beta-arrestin 2 and inhibition of p38 MAPK activity both ameliorate TLR4-stimulated IL-10 response. Additionally, in vivo experiments show that mice lacking beta-arrestin 2 produce less amount of IL-10, and are more susceptible to LPS-induced septic shock which is further enhanced by blocking IL-10 signal. These results reveal a novel mechanism by which beta-arrestin 2 negatively regulates TLR4-mediated inflammatory reactions.	[Li, Hui; Hu, Dan; LeSage, Gene D.; Caudle, Yi; Stuart, Charles; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Hu, Dan] Wuhan Univ, Dept Neurol, Renmin Hosp, Wuhan 430060, Peoples R China; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai 200120, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	East Tennessee State University; Wuhan University; Tongji University; Johns Hopkins University	Liu, ZM (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Cardiovasc & Thorac Surg, Shanghai 200120, Peoples R China.	zhongmin_liu@sina.com; yin@etsu.edu		Yin, Deling/0000-0003-3215-7566	National Institutes of Health [NIDA020120, NIGM094740]; National Natural Science Foundation of China [81370433]; Fundamental Research Funds for the Central Universities of China [121020]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported in part by Research Grants NIDA020120 and NIGM094740 from the National Institutes of Health (to D. Y.). This work was also supported in part by the National Natural Science Foundation of China (81370433) (to Z. L.). This work was also supported in part by the Fundamental Research Funds for the Central Universities of China (121020) (to D. H.).	Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Dai H, 2012, J NEUROIMMUNOL, V245, P1, DOI 10.1016/j.jneuroim.2012.01.005; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hofmann SR, 2012, CLIN IMMUNOL, V145, P69, DOI 10.1016/j.clim.2012.07.012; Katholnig K, 2013, J IMMUNOL, V190, P1519, DOI 10.4049/jimmunol.1202683; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Komori H, 2012, J BIOL CHEM, V287, P30688, DOI 10.1074/jbc.M112.353771; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Ley S, 2013, ONCOGENE, V32, P631, DOI 10.1038/onc.2012.77; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Matsuda R, 2012, INVEST OPHTH VIS SCI, V53, P7235, DOI 10.1167/iovs.12-10587; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Morris GE, 2012, AM J PHYSIOL-CELL PH, V302, pC723, DOI [10.1152/ajpcell.00202.2011, 10.1152/ajpcell.00202.2011.]; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Porter KJ, 2010, J CELL PHYSIOL, V225, P406, DOI 10.1002/jcp.22289; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seregin SS, 2010, VIRUS RES, V147, P123, DOI 10.1016/j.virusres.2009.10.023; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Xia R, 2010, J INTERF CYTOK RES, V30, P155, DOI 10.1089/jir.2009.0017; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428	40	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23075	23085		10.1074/jbc.M114.591495	http://dx.doi.org/10.1074/jbc.M114.591495			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25012660	Green Published, hybrid			2022-12-28	WOS:000341017200045
J	Wu, ZQ				Wu, Zhiqiang			CX3CR1((+)) B Cells Show Immune Suppressor Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT TGF-BETA; INTEGRIN ALPHAVBETA6; EPITHELIAL-CELLS; T-CELLS; FRACTALKINE; EXPRESSION; TOLERANCE; DISEASE	The immune regulatory functions of B cells are not fully understood yet. The present study aims to characterize a sub-type of B cells that expresses CX3CR1. In this study, peripheral blood samples were collected from patients with food allergies and healthy subjects. Peripheral B cells were analyzed by flow cytometry. T cell proliferation was assessed by carboxyfluorescein succinimidyl ester dilution assay. The results showed that the CX3CR1(+) B cells were detected in the peripheral blood samples of healthy subjects and were significantly less in patients with food allergies. CX3CR1(+) B cells expressed high levels of TGF-beta and integrin alpha v beta 6. CX3CR1(+) B cells could efficiently suppress other effector CD4(+) T cell activation. We conclude that human peripheral CX3CR1(+) B cells have immune suppressor properties.	Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Gastroenterol, Beijing 100037, Peoples R China	Chinese People's Liberation Army General Hospital	Wu, ZQ (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Gastroenterol, Beijing 100037, Peoples R China.	zhiqiangwu32@163.com			Beijing Scientific Foundation [131107002213040]	Beijing Scientific Foundation	This work was supported by the clinical research program of Beijing Scientific Foundation through Grant 131107002213040.	Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Chorny A, 2012, IMMUNOL RES, V54, P4, DOI 10.1007/s12026-012-8307-5; Corcione A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008485; Culina S, 2013, EUR J ENDOCRINOL, V168, pR19, DOI 10.1530/EJE-12-0693; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Feng BS, 2009, N AM J MED SCI, V1, P200, DOI 10.4297/najms.2009.4200; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Jeong YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046553; Liu T, 2012, CLIN EXP ALLERGY, V42, P375, DOI 10.1111/j.1365-2222.2011.03869.x; Liu ZQ, 2013, ALLERGY, V68, P1241, DOI 10.1111/all.12218; Louvet C, 2004, TRANSPLANTATION, V78, P1259, DOI 10.1097/01.TP.0000140482.20336.77; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Maeda S, 2012, VET IMMUNOL IMMUNOP, V148, P226, DOI 10.1016/j.vetimm.2012.04.021; Morimura S, 2013, AM J PATHOL, V182, P1640, DOI 10.1016/j.ajpath.2013.01.023; Natarajan P, 2012, MUCOSAL IMMUNOL, V5, P691, DOI 10.1038/mi.2012.42; Oberg HH, 2011, EUR J CELL BIOL, V90, P582, DOI 10.1016/j.ejcb.2010.11.012; Ozkurede VU, 2012, CLIN EXP IMMUNOL, V167, P382, DOI 10.1111/j.1365-2249.2011.04535.x; Rius C, 2013, THORAX, V68, P177, DOI 10.1136/thoraxjnl-2012-202212; Saban DR, 2010, J IMMUNOL, V185, P4691, DOI 10.4049/jimmunol.1001133; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sung MJ, 2010, CELL PHYSIOL BIOCHEM, V26, P431, DOI 10.1159/000320566; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Yang M, 2012, AM J PATHOL, V180, P2375, DOI 10.1016/j.ajpath.2012.03.010; Yang SB, 2012, CANCER IMMUNOL IMMUN, V61, P335, DOI 10.1007/s00262-011-1108-1; Zhou R, 2013, SCAND ACTUAR J, V2013, P1, DOI 10.1080/03461238.2010.507582	26	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22630	22635		10.1074/jbc.M114.569459	http://dx.doi.org/10.1074/jbc.M114.569459			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970890	hybrid, Green Published			2022-12-28	WOS:000341017200009
J	Nagashima, T; Shimodaira, H; Ide, K; Nakakuki, T; Tani, Y; Takahashi, K; Yumoto, N; Hatakeyama, M				Nagashima, Takeshi; Shimodaira, Hidetoshi; Ide, Kaori; Nakakuki, Takashi; Tani, Yukitaka; Takahashi, Kaoru; Yumoto, Noriko; Hatakeyama, Mariko			Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation (vol 282, pg 4045, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Shimodaira, Hidetoshi/B-9127-2008	Shimodaira, Hidetoshi/0000-0002-3371-7724				Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20491	20491		10.1074/jbc.A114.608653	http://dx.doi.org/10.1074/jbc.A114.608653			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	25063842	hybrid, Green Published			2022-12-28	WOS:000339396600010
J	Agosto, MA; Zhang, ZX; He, F; Anastassov, IA; Wright, SJ; McGehee, J; Wensel, TG				Agosto, Melina A.; Zhang, Zhixian; He, Feng; Anastassov, Ivan A.; Wright, Sara J.; McGehee, Jennifer; Wensel, Theodore G.			Oligomeric State of Purified Transient Receptor Potential Melastatin-1 (TRPM1), a Protein Essential for Dim Light Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; BLUE NATIVE ELECTROPHORESIS; RETINAL BIPOLAR CELLS; RICH REPEAT PROTEIN; METABOTROPIC GLUTAMATE-RECEPTOR; AMPA RECEPTOR; ELECTRON CRYOMICROSCOPY; MONOCLONAL-ANTIBODIES; SIGNALING CASCADE; CATION CHANNEL	Transient receptor potential melastatin-1 (TRPM1) is essential for the light-induced depolarization of retinal ON bipolar cells. TRPM1 likely forms a multimeric channel complex, although almost nothing is known about the structure or subunit composition of channels formed by TRPM1 or any of its close relatives. Recombinant TRPM1 was robustly expressed in insect cells, but only a small fraction was localized to the plasma membrane. Similar intracellular localization was observed when TRPM1 was heterologously expressed in mammalian cells. TRPM1 was affinity-purified from Sf9 cells and complexed with amphipol, followed by detergent removal. In blue native gels and size exclusion chromatography, TRPM1 migrated with a mobility consistent with detergent-or amphipol-bound dimers. Cross-linking experiments were also consistent with a dimeric subunit stoichiometry, and cryoelectron microscopy and single particle analysis without symmetry imposition yielded a model with approximate 2-fold symmetrical features. Finally, electron microscopy of TRPM1-antibody complexes revealed a large particle that can accommodate TRPM1 and two antibody molecules. Taken together, these data indicate that purified TRPM1 is mostly dimeric. The three-dimensional structure of TRPM1 dimers is characterized by a small putative transmembrane domain and a larger domain with a hollow cavity. Blue native gels of solubilized mouse retina indicate that TRPM1 is present in two distinct complexes: one similar in size to the recombinant protein and one much larger. Because dimers are likely not functional ion channels, these results suggest that additional partner subunits participate in forming the transduction channel required for dim light vision and the ON pathway.	[Agosto, Melina A.; Zhang, Zhixian; He, Feng; Anastassov, Ivan A.; Wright, Sara J.; McGehee, Jennifer; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, BCM 125,1 Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu		Anastassov, Ivan/0000-0002-0653-0446; Wensel, Theodore/0000-0003-3518-9352; Agosto, Melina/0000-0002-3647-1926	National Institutes of Health [R01 EY07981, R01 EY11900, T32 EY007102, F32 EY200672, K12 GM084897, T32 DK007696, P30 EY002520, P30 CA125123, P41 GM103832]; Welch Foundation; Knights Templar Eye Foundation; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102, F32EY024815, R01EY007981, F32EY020067, R01EY011900, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099, K12GM084897, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Knights Templar Eye Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY07981 and R01 EY11900 (to T. G. W.); T32 EY007102 and F32 EY200672 (to M. A. A.); K12 GM084897 (to S. J. W.); T32 DK007696 (to J. M.); P30 EY002520, a Vision Research Core grant; P30 CA125123; and P41 GM103832, a Center grant. This work was also supported by the Welch Foundation and the Knights Templar Eye Foundation.	Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bojang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033137; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Eswar N., 2006, BIOINFORMATICS, V15, DOI 10.1002/0471250953.BI0506S15; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Huynh KW, 2014, STRUCTURE, V22, P260, DOI 10.1016/j.str.2013.11.008; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Labeit S, 2011, FASEB J, V25, P822, DOI 10.1096/fj.10-157412; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; LEMAIRE M, 1986, ANAL BIOCHEM, V154, P525, DOI 10.1016/0003-2697(86)90025-4; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukasiewicz PD, 2005, PROG BRAIN RES, V147, P205, DOI 10.1016/S0079-6123(04)47016-2; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; Nakajima Y, 2009, J BIOCHEM, V145, P811, DOI 10.1093/jb/mvp038; Nakamura M, 2010, MOL VIS, V16, P425; Nawy S, 1999, J NEUROSCI, V19, P2938; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Neuille M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090342; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; O'Connor E, 2005, HUM MOL GENET, V14, P1877, DOI 10.1093/hmg/ddi194; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Orlandi C, 2013, INVEST OPHTH VIS SCI, V54, P7153, DOI 10.1167/iovs.13-12907; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Ray TA, 2014, J NEUROSCI, V34, P6334, DOI 10.1523/JNEUROSCI.4044-13.2014; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shen Y, 2012, P NATL ACAD SCI USA, V109, P8752, DOI 10.1073/pnas.1117433109; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Snellman J, 2008, PROG RETIN EYE RES, V27, P450, DOI 10.1016/j.preteyeres.2008.03.003; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vardi N, 1998, J COMP NEUROL, V395, P43; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	78	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27019	27033		10.1074/jbc.M114.593780	http://dx.doi.org/10.1074/jbc.M114.593780			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112866	Green Published, hybrid			2022-12-28	WOS:000342853900030
J	de la Cruz-Herrera, CF; Campagna, M; Garcia, MA; Marcos-Villar, L; Lang, V; Baz-Martinez, M; Gutierrez, S; Vidal, A; Rodriguez, MS; Esteban, M; Rivas, C				de la Cruz-Herrera, Carlos F.; Campagna, Michela; Garcia, Maria A.; Marcos-Villar, Laura; Lang, Valerie; Baz-Martinez, Maite; Gutierrez, Sylvia; Vidal, Anxo; Rodriguez, Manuel S.; Esteban, Mariano; Rivas, Carmen			Activation of the Double-stranded RNA-dependent Protein Kinase PKR by Small Ubiquitin-like Modifier (SUMO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; IN-VITRO; SUMOYLATION; BINDING; PHOSPHORYLATION; DIMERIZATION; INFECTION; UBC9; GENE; MUTATIONS	The dsRNA-dependent kinase PKR is an interferon-inducible protein with ability to phosphorylate the alpha subunit of the eukaryotic initiation factor (eIF)-2 complex, resulting in a shutoff of general translation, induction of apoptosis, and inhibition of virus replication. Here we analyzed the modification of PKR by the small ubiquitin-like modifiers SUMO1 and SUMO2 and evaluated the consequences of PKR SUMOylation. Our results indicate that PKR is modified by both SUMO1 and SUMO2, in vitro and in vivo. We identified lysine residues Lys-60, Lys-150, and Lys-440 as SUMOylation sites in PKR. We show that SUMO is required for efficient PKR-dsRNA binding, PKR dimerization, and eIF2 alpha phosphorylation. Furthermore, we demonstrate that SUMO potentiates the inhibition of protein synthesis induced by PKR in response to dsRNA, whereas a PKR SUMOylation mutant is impaired in its ability to inhibit protein synthesis and shows reduced capability to control vesicular stomatitis virus replication and to induce apoptosis in response to vesicular stomatitis virus infection. In summary, our data demonstrate the important role of SUMO in processes mediated by the activation of PKR.	[de la Cruz-Herrera, Carlos F.; Campagna, Michela; Marcos-Villar, Laura; Esteban, Mariano; Rivas, Carmen] CSIC, Ctr Nacl Biotecnol, Dept Biol Mol & Celular, E-28049 Madrid, Spain; [Garcia, Maria A.] Hosp Univ Virgen de la Nieves, Unidad Invest, Granada 18014, Spain; [Lang, Valerie; Rodriguez, Manuel S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian 20009, Gipuzkoa, Spain; [Baz-Martinez, Maite; Vidal, Anxo; Rivas, Carmen] Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain; [Gutierrez, Sylvia] CSIC, Confocal Serv, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Vidal, Anxo] Univ Santiago de Compostela, Dept Fisiol, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Universitario Virgen de las Nieves; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidade de Santiago de Compostela	Rivas, C (corresponding author), Univ Santiago de Compostela, Ctr Invest Med Mol CIMUS, Inst Invest Sanitarias IDIS, E-15782 Santiago De Compostela, Spain.	crivas@cnb.csic.es	Vidal, Anxo/B-5010-2015; Rivas, Carmen/AAB-6278-2019; RODRIGUEZ, Manuel S./D-5439-2018; Rivas, Carmen/L-3162-2017; Garcia, Maria Angel MA/I-5116-2016; Gutierrez-Erlandsson, Sylvia/K-7551-2014; Esteban, Mariano/ABG-5375-2020; Baz-Martínez, Maite/L-4626-2017	Vidal, Anxo/0000-0002-0866-4202; Rivas, Carmen/0000-0002-0518-7199; Rivas, Carmen/0000-0002-0518-7199; Garcia, Maria Angel MA/0000-0003-2003-3769; Gutierrez-Erlandsson, Sylvia/0000-0002-5895-868X; Esteban, Mariano/0000-0003-0846-2827; Baz-Martínez, Maite/0000-0001-9160-7833; de la Cruz-Herrera, Carlos/0000-0002-7493-5154	Ministry of Economy and Competitiveness of Spain [BFU-2011-27064]; La Caixa fellowship; Juan de la Cierva Programme	Ministry of Economy and Competitiveness of Spain(Spanish Government); La Caixa fellowship(La Caixa Foundation); Juan de la Cierva Programme	This work was supported by Grant BFU-2011-27064 from the Ministry of Economy and Competitiveness of Spain.; Supported by a La Caixa fellowship.; Supported by the Juan de la Cierva Programme.	Anderson E, 2011, J MOL BIOL, V413, P973, DOI 10.1016/j.jmb.2011.09.025; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Cai RR, 1998, J BIOL CHEM, V273, P11274, DOI 10.1074/jbc.273.18.11274; Campagna M, 2011, CELL DEATH DIFFER, V18, P72, DOI 10.1038/cdd.2010.77; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Durbin RK, 2002, VIRAL IMMUNOL, V15, P41, DOI 10.1089/088282402317340224; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gonzalez-Santamaria J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.135; Gonzalez-Santamaria J, 2011, J VIROL, V85, P12890, DOI 10.1128/JVI.05628-11; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang JI, 2009, VIRUS RES, V142, P51, DOI 10.1016/j.virusres.2009.01.007; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Marcos-Villar L, 2013, CELL CYCLE, V12, P2809, DOI 10.4161/cc.25868; Marcos-Villar L, 2009, J VIROL, V83, P8849, DOI 10.1128/JVI.00339-09; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Okumura F, 2013, J BIOL CHEM, V288, P2839, DOI 10.1074/jbc.M112.401851; Palacios S, 2005, MOL BIOL CELL, V16, P2822, DOI 10.1091/mbc.E04-11-1005; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1996, J BIOL CHEM, V271, P25657, DOI 10.1074/jbc.271.41.25657; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Perkins DJ, 2010, MBIO, V1, DOI 10.1128/mBio.00239-10; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; Su QZ, 2006, P NATL ACAD SCI USA, V103, P63, DOI 10.1073/pnas.0508207103; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Wilson VG, 2012, BIOMOLECULES, V2, P203, DOI 10.3390/biom2020203; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yue ZY, 1997, VIROLOGY, V234, P364, DOI 10.1006/viro.1997.8664; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	44	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26357	26367		10.1074/jbc.M114.560961	http://dx.doi.org/10.1074/jbc.M114.560961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25074923	hybrid, Green Published			2022-12-28	WOS:000342128800028
J	Guan, X; Duan, YH; Zeng, QW; Pan, HJ; Qian, Y; Li, DL; Cao, XH; Liu, MY				Guan, Xin; Duan, Yanhong; Zeng, Qingwen; Pan, Hongjie; Qian, Yu; Li, Dali; Cao, Xiaohua; Liu, Mingyao			Lgr4 Protein Deficiency Induces Ataxia-like Phenotype in Mice and Impairs Long Term Depression at Cerebellar Parallel Fiber-Purkinje Cell Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR 48; WNT/BETA-CATENIN; TRANSGENIC MICE; GENETIC ENHANCEMENT; DOWN-REGULATION; PLASTICITY; DEGENERATION; MEMORY; INACTIVATION; EXPRESSION	Cerebellar dysfunction causes ataxia characterized by loss of balance and coordination. Until now, the molecular and neuronal mechanisms of several types of inherited cerebellar ataxia have not been completely clarified. Here, we report that leucine-rich G protein-coupled receptor 4 (Lgr4/Gpr48) is highly expressed in Purkinje cells (PCs) in the cerebellum. Deficiency of Lgr4 leads to an ataxia-like phenotype in mice. Histologically, no obvious morphological changes were observed in the cerebellum of Lgr4 mutant mice. However, the number of PCs was slightly but significantly reduced in Lgr4(-/-) mice. In addition, in vitro electrophysiological analysis showed an impaired long term depression (LTD) at parallel fiber-PC (PF-PC) synapses in Lgr4(-/-) mice. Consistently, immunostaining experiments showed that the level of phosphorylated cAMP-responsive element-binding protein (Creb) was significantly decreased in Lgr4(-/-) PCs. Furthermore, treatment with forskolin, an adenylyl cyclase agonist, rescued phospho-Creb in PCs and reversed the impairment in PF-PC LTD in Lgr4(-/-) cerebellar slices, indicating that Lgr4 is an upstream regulator of Creb signaling, which is underlying PF-PC LTD. Together, our findings demonstrate for first time an important role for Lgr4 in motor coordination and cerebellar synaptic plasticity and provide a potential therapeutic target for certain types of inherited cerebellar ataxia.	[Guan, Xin; Pan, Hongjie; Qian, Yu; Li, Dali; Liu, Mingyao] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Guan, Xin; Pan, Hongjie; Qian, Yu; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Duan, Yanhong; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Key Lab Brain Funct Genom, Minist Educ, Shanghai 200241, Peoples R China; [Liu, Mingyao] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Li, DL (corresponding author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.	dlli@bio.ecnu.edu.cn; xhcao@brain.ecnu.edu.cn; myliu@bio.ecnu.edu.cn		Liu, Mingyao/0000-0001-7339-5048; Li, Dali/0000-0002-0046-8493	State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [31371455, 30930055, 31070993, 31271200]; Science and Technology Commission of Shanghai Municipality [12XD1406100, 14140900300]	State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by State Key Development Programs of China Grants 2012CB910400 (to M. L.) and 2010CB945403 (to D. L.), National Natural Science Foundation of China Grants 31371455, 30930055, 31070993, and 31271200, and Science and Technology Commission of Shanghai Municipality Grants 12XD1406100 and 14140900300.	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Blom JMC, 2002, NEUROPSYCHOPHARMACOL, V26, P605, DOI 10.1016/S0893-133X(01)00401-8; Brault V, 2001, DEVELOPMENT, V128, P1253; Cao XH, 2008, NEURON, V60, P353, DOI 10.1016/j.neuron.2008.08.027; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter RJ, 1999, J NEUROSCI, V19, P3248; Clark HB, 1997, J NEUROSCI, V17, P7385; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cryan JF, 2004, P NATL ACAD SCI USA, V101, P8186, DOI 10.1073/pnas.0401080101; Dar MS, 2011, PHARMACOL BIOCHEM BE, V98, P341, DOI 10.1016/j.pbb.2010.12.020; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Evans GJO, 2007, BIOL CELL, V99, P363, DOI 10.1042/BC20070010; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FEDDERSEN RM, 1995, MOL CELL NEUROSCI, V6, P153, DOI 10.1006/mcne.1995.1014; Gilman S, 1996, ANN NEUROL, V39, P241, DOI 10.1002/ana.410390214; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Lonchamp E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030180; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nishihara E, 2003, J NEUROSCI, V23, P213; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STRICK PL, 1985, SCIENCE, V229, P547, DOI 10.1126/science.229.4713.547; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas JD, 1998, DEV BRAIN RES, V105, P159, DOI 10.1016/S0165-3806(97)00164-8; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Wen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064451; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816	56	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26492	26504		10.1074/jbc.M114.564138	http://dx.doi.org/10.1074/jbc.M114.564138			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25063812	Green Published, hybrid			2022-12-28	WOS:000342128800040
J	Homma, Y; Kanno, S; Sasaki, K; Nishita, M; Yasui, A; Asano, T; Ohashi, K; Mizuno, K				Homma, Yuta; Kanno, Shin-ichiro; Sasaki, Kazutaka; Nishita, Michiru; Yasui, Akira; Asano, Tomoichiro; Ohashi, Kazumasa; Mizuno, Kensaku			Insulin Receptor Substrate-4 Binds to Slingshot-1 Phosphatase and Promotes Cofilin Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ACTIN REORGANIZATION; LIM-KINASE; SIGNALING PATHWAY; BREAST-CANCER; PROTEIN; CELL; PHOSPHORYLATION; MICE; ACTIVATION; EXPRESSION	Cofilin plays an essential role in cell migration and morphogenesis by enhancing actin filament dynamics via its actin filament- severing activity. Slingshot-1 (SSH1) is a protein phosphatase that plays a crucial role in regulating actin dynamics by dephosphorylating and reactivating cofilin. In this study, we identified insulin receptor substrate (IRS)-4 as a novel SSH1-binding protein. Co-precipitation assays revealed the direct endogenous binding of IRS4 to SSH1. IRS4, but not IRS1 or IRS2, was bound to SSH1. IRS4 was bound to SSH1 mainly through the unique region (amino acids 335-400) adjacent to the C terminus of the phosphotyrosine-binding domain of IRS4. The N-terminal A, B, and phosphatase domains of SSH1 were bound to IRS4 independently. Whereas in vitro phosphatase assays revealed that IRS4 does not directly affect the cofilin phosphatase activity of SSH1, knockdown of IRS4 increased cofilin phosphorylation in cultured cells. Knockdown of IRS4 decreased phosphatidylinositol 3-kinase (PI3K) activity, and treatment with an inhibitor of PI3K increased cofilin phosphorylation. Akt preferentially phosphorylated SSH1 at Thr-826, but expression of a non-phosphorylatable T826A mutant of SSH1 did not affect insulin-induced cofilin dephosphorylation, and an inhibitor of Akt did not increase cofilin phosphorylation. These results suggest that IRS4 promotes cofilin dephosphorylation through sequential activation of PI3K and SSH1 but not through Akt. In addition, IRS4 co-localized with SSH1 in F-actin-rich membrane protrusions in insulin-stimulated cells, which suggests that the association of IRS4 with SSH1 contributes to localized activation of cofilin in membrane protrusions.	[Homma, Yuta; Sasaki, Kazutaka; Nishita, Michiru; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Kanno, Shin-ichiro; Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome Canc & Aging, Sendai, Miyagi 9808575, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima 7348553, Japan	Tohoku University; Tohoku University; Hiroshima University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019; Ohashi, Kazumasa/U-7028-2019; Homma, Yuta/O-1029-2019; Homma, Yuta/T-3089-2018; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Homma, Yuta/0000-0002-3676-6089; Homma, Yuta/0000-0002-3676-6089; 	Ministry of Education, Culture, Science, Sports and Technology of Japan [24121702, 24370051]	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants for Scientific Research 24121702 and 24370051 (to K. M.) from the Ministry of Education, Culture, Science, Sports and Technology of Japan.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Hoxhaj G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073327; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Shimwell NJ, 2009, ONCOGENE, V28, P686, DOI 10.1038/onc.2008.417; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Uchida T, 2000, MOL CELL BIOL, V20, P126, DOI 10.1128/MCB.20.1.126-138.2000; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	33	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26302	26313		10.1074/jbc.M114.565945	http://dx.doi.org/10.1074/jbc.M114.565945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100728	Green Published, hybrid			2022-12-28	WOS:000342128800024
J	Robertson, WE; Rose, KL; Hudson, BG; Vanacore, RM				Robertson, Wesley E.; Rose, Kristie L.; Hudson, Billy G.; Vanacore, Roberto M.			Supramolecular Organization of the alpha 121-alpha 565 Collagen IV Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; DIFFERENTIAL EXPRESSION; STRUCTURAL BASIS; ALPORT SYNDROME; CHAINS; IDENTIFICATION; ALPHA-5; COL4A1; KIDNEY; GENES	Collagen IV is a family of 6 chains (alpha 1-alpha 6), that form triple-helical protomers that assemble into supramolecular networks. Two distinct networks with chain compositions of alpha 121 and alpha 345 have been established. These oligomerize into separate alpha 121 and alpha 345 networks by a homotypic interaction through their trimeric noncollagenous (NC1) domains, forming alpha 121 and alpha 345 NC1 hexamers, respectively. These are stabilized by novel sulfilimine (-S=N-) cross-links, a covalent cross-link that forms between Met(93) and Hyl(211) at the trimer-trimer interface. A third network with a composition of alpha 1256 has been proposed, but its supramolecular organization has not been established. In this study we investigated the supramolecular organization of this network by determining the chain identity of sulfilimine-cross-linked NC1 domains derived from the alpha 1256 NC1 hexamer. High resolution mass spectrometry analyses of peptides revealed that sulfilimine bonds specifically cross-link alpha 1 to alpha 5 and alpha 2 to alpha 6 NC1 domains, thus providing the spatial orientation between interacting alpha 121 and alpha 565 trimers. Using this information, we constructed a three-dimensional homology model in which the alpha 565 trimer shows a good chemical and structural complementarity to the alpha 121 trimer. Our studies provide the first chemical evidence for an alpha 565 protomer and its heterotypic interaction with the alpha 121 protomer. Moreover, our findings, in conjunction with our previous studies, establish that the six collagen IV chains are organized into three canonical protomers alpha 121, alpha 345, and alpha 565 forming three distinct networks: alpha 121, alpha 345, and alpha 121-alpha 565, each of which is stabilized by sulfilimine bonds between their C-terminal NC1 domains.	[Robertson, Wesley E.; Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Hudson, Billy G.; Vanacore, Roberto M.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Rose, Kristie L.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Rose, Kristie L.] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Prote Lab, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Vanacore, RM (corresponding author), Vanderbilt Univ, Dept Med, 1161 21st Ave S,B-3113 MCN, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100; Robertson, Wesley/0000-0001-9812-8288	National Institutes of Health [S10 RR027714]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mohamed Rafi and Parvin Todd for technical expertise. We are also very grateful to Salisha Hill and Hayes McDonald from the Vanderbilt Mass Spectrometry Center for assistance with MS analysis of some of our samples. We thank Suraj Adhikary for helpful comments with molecular modeling. The LTQ Orbitrap Velos mass spectrometer used in these studies was purchased with funds from National Institutes of Health Grant S10 RR027714 awarded to the Vanderbilt proteomics shared resource.	Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hino S, 1996, PEDIATR NEPHROL, V10, P742, DOI 10.1007/s004670050206; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; KASHTAN CE, 1990, PEDIATR NEPHROL, V4, P523, DOI 10.1007/BF00869840; Kashtan CE, 2010, NEPHROL DIAL TRANSPL, V25, P3554, DOI 10.1093/ndt/gfq271; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Lyons O T A, 2007, Ann Vasc Surg, V21, P816, DOI 10.1016/j.avsg.2007.06.004; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Seki T, 1998, HISTOCHEM CELL BIOL, V110, P359, DOI 10.1007/s004180050296; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008	35	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25601	25610		10.1074/jbc.M114.571844	http://dx.doi.org/10.1074/jbc.M114.571844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25006246	Green Published, hybrid			2022-12-28	WOS:000342130800021
J	Trevitt, CR; Hosszu, LLP; Batchelor, M; Panico, S; Terry, C; Nicoll, AJ; Risse, E; Taylor, WA; Sandberg, MK; Al-Doujaily, H; Linehan, JM; Saibil, HR; Scott, DJ; Collinge, J; Waltho, JP; Clarke, AR				Trevitt, Clare R.; Hosszu, Laszlo L. P.; Batchelor, Mark; Panico, Silvia; Terry, Cassandra; Nicoll, Andrew J.; Risse, Emmanuel; Taylor, William A.; Sandberg, Malin K.; Al-Doujaily, Huda; Linehan, Jacqueline M.; Saibil, Helen R.; Scott, David J.; Collinge, John; Waltho, Jonathan P.; Clarke, Anthony R.			N-terminal Domain of Prion Protein Directs Its Oligomeric Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTERMEDIATE STATES; SCRAPIE; CONVERSION; STABILITY; PRPSC; SUSCEPTIBILITY; CONFORMATION; POLYMORPHISM; TRANSITION	The self-association of prion protein (PrP) is a critical step in the pathology of prion diseases. It is increasingly recognized that small non-fibrillar beta-sheet-rich oligomers of PrP may be of crucial importance in the prion disease process. Here, we characterize the structure of a well defined beta-sheet-rich oligomer, containing similar to 12 PrP molecules, and often enclosing a central cavity, formed using full-length recombinant PrP. The N-terminal region of prion protein (residues 23-90) is required for the formation of this distinct oligomer; a truncated form comprising residues 91-231 forms a broad distribution of aggregated species. No infectivity or toxicity was found using cell and animal model systems. This study demonstrates that examination of the full repertoire of conformers and assembly states that can be accessed by PrP under specific experimental conditions should ideally be done using the full-length protein.	[Trevitt, Clare R.; Hosszu, Laszlo L. P.; Batchelor, Mark; Terry, Cassandra; Nicoll, Andrew J.; Risse, Emmanuel; Taylor, William A.; Sandberg, Malin K.; Al-Doujaily, Huda; Linehan, Jacqueline M.; Collinge, John; Clarke, Anthony R.] UCL Inst Neurol, MRC Prion Unit, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Panico, Silvia; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England; [Scott, David J.] ISIS Spallat Neutron & Muon Source, Didcot OX11 0FA, Oxon, England; [Scott, David J.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England; [Waltho, Jonathan P.] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; University of London; Birkbeck University London; University of Nottingham; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Sheffield	Clarke, AR (corresponding author), UCL Inst Neurol, MRC Prion Unit, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	a.r.clarke@prion.ucl.ac.uk	Terry, Cassandra/AAP-1280-2021	Terry, Cassandra/0000-0002-8611-8821; Scott, David/0000-0002-6726-2078; Panico, Silvia/0000-0002-2196-0727; Waltho, Jonathan/0000-0002-7402-5492	Medical Research Council; Biotechnology and Biological Sciences Research Council [BB/K016245/1] Funding Source: researchfish; Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: researchfish; BBSRC [BB/K016245/1] Funding Source: UKRI; MRC [MC_U123160656, MC_U123192748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Creighton T. E., 1993, PROTEINS STRUCTURES; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Gerber R, 2008, J MOL BIOL, V381, P212, DOI 10.1016/j.jmb.2008.05.057; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 2010, BIOCHEMISTRY-US, V49, P8729, DOI 10.1021/bi100572j; Hosszu LLP, 2009, J BIOL CHEM, V284, P21981, DOI 10.1074/jbc.M809173200; Hosszu LLP, 2005, BIOCHEMISTRY-US, V44, P16649, DOI 10.1021/bi051277k; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kazlauskaite J, 2005, BIOCHEM BIOPH RES CO, V328, P292, DOI 10.1016/j.bbrc.2004.12.172; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Larda ST, 2013, J AM CHEM SOC, V135, P10533, DOI 10.1021/ja404584s; LASZLO L, 1992, J PATHOL, V166, P333, DOI 10.1002/path.1711660404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LIBERSKI PP, 1991, J COMP PATHOL, V105, P377, DOI 10.1016/S0021-9975(08)80107-7; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P19563, DOI 10.1073/pnas.1211764109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Reed MAC, 2003, J MOL BIOL, V330, P1189, DOI 10.1016/S0022-2836(03)00625-9; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Wadsworth Jonathan D. F., 2008, V459, P197, DOI 10.1007/978-1-59745-234-2_14; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	80	16	16	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25497	25508		10.1074/jbc.M114.566588	http://dx.doi.org/10.1074/jbc.M114.566588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074940	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000342130800012
J	Yu, HJ; Rathore, SS; Gulbranson, DR; Shen, JS				Yu, Haijia; Rathore, Shailendra S.; Gulbranson, Daniel R.; Shen, Jingshi			The N- and C-terminal Domains of Tomosyn Play Distinct Roles in Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor Binding and Fusion Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; T-SNARE; EXOCYTOSIS; MUNC18C; SYNTAXIN; MECHANISMS; REVEALS; RECONSTITUTION	Tomosyn negatively regulates SNARE-dependent exocytic pathways including insulin secretion, GLUT4 exocytosis, and neurotransmitter release. The molecular mechanism of tomosyn, however, has not been fully elucidated. Here, we reconstituted SNARE-dependent fusion reactions in vitro to recapitulate the tomosyn-regulated exocytic pathways. We then expressed and purified active full-length tomosyn and examined how it regulates the reconstituted SNARE-dependent fusion reactions. Using these defined fusion assays, we demonstrated that tomosyn negatively regulates SNARE-mediated membrane fusion by inhibiting the assembly of the ternary SNARE complex. Tomosyn recognizes the t-SNARE complex and prevents its pairing with the v-SNARE, therefore arresting the fusion reaction at a pre-docking stage. The inhibitory function of tomosyn is mediated by its C-terminal domain (CTD) that contains an R-SNARE-like motif, confirming previous studies carried out using truncated tomosyn fragments. Interestingly, the N-terminal domain (NTD) of tomosyn is critical (but not sufficient) to the binding of tomosyn to the syntaxin monomer, indicating that full-length tomosyn possesses unique features not found in the widely studied CTD fragment. Finally, we showed that the inhibitory function of tomosyn is dominant over the stimulatory activity of the Sec1/Munc18 protein in fusion. We suggest that tomosyn uses its CTD to arrest SNARE-dependent fusion reactions, whereas its NTD is required for the recruitment of tomosyn to vesicle fusion sites through syntaxin interaction.	[Yu, Haijia; Rathore, Shailendra S.; Gulbranson, Daniel R.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Yu, Haijia/GXV-5159-2022; Gulbranson, Daniel/AAE-4807-2020; Gulbranson, Daniel/AAE-4338-2020	Yu, Haijia/0000-0002-7193-8034; YU, HAIJIA/0000-0002-3049-7850; SHEN, JINGSHI/0000-0001-9595-1148	National Institutes of Health [R01DK095367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK095367 (to J. S.).	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Eliasson L, 2008, J PHYSIOL-LONDON, V586, P3313, DOI 10.1113/jphysiol.2008.155317; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Gracheva Elena O, 2010, Front Synaptic Neurosci, V2, P141, DOI 10.3389/fnsyn.2010.00141; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu Zhitao, 2013, Elife, V2, pe00967, DOI 10.7554/eLife.00967; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rathore SS, 2011, MOL BIOL CELL, V22, P2612, DOI 10.1091/mbc.E11-03-0190; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Yu HJ, 2013, J BIOL CHEM, V288, P18885, DOI 10.1074/jbc.M113.465450; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	75	18	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25571	25580		10.1074/jbc.M114.591487	http://dx.doi.org/10.1074/jbc.M114.591487			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063806	Green Published, hybrid			2022-12-28	WOS:000342130800018
J	Bai, XH; Chen, HJ; Jiang, YL; Wen, ZS; Huang, YB; Cheng, W; Li, Q; Qi, L; Zhang, JR; Chen, YX; Zhou, CZ				Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Wen, Zhensong; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Zhang, Jing-Ren; Chen, Yuxing; Zhou, Cong-Zhao			Structure of Pneumococcal Peptidoglycan Hydrolase LytB Reveals Insights into the Bacterial Cell Wall Remodeling and Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Enzyme Structure; Peptidoglycan; Streptococcus; Structural Biology; Cell Wall Remodeling	CRYSTAL-STRUCTURE; N-ACETYLGLUCOSAMINIDASE; LISTERIA-MONOCYTOGENES; MUREIN HYDROLASE; VIRULENCE FACTOR; AUTOLYSIN LYTA; DOMAIN; ACID; PROTEIN; SPECIFICITY	Background: The pneumococcal endo--N-acetylglucosaminidase LytB is required for cell division and colonization. Results: Structural analysis revealed that the catalytic domain of LytB consists of three structurally distinct modules. Conclusion: All three modules of LytB are necessary for its optimal activity toward peptidoglycan hydrolysis and for pneumococcal adhesion to respiratory epithelial cells. Significance: Provided is the structural insight into LytB-mediated pneumococcal cell wall remodeling and pathogenesis. Streptococcus pneumoniae causes a series of devastating infections in humans. Previous studies have shown that the endo--N-acetylglucosaminidase LytB is critical for pneumococcal cell division and nasal colonization, but the biochemical mechanism of LytB action remains unknown. Here we report the 1.65 crystal structure of the catalytic domain (residues Lys-375-Asp-658) of LytB (termed LytB(CAT)), excluding the choline binding domain. LytB(CAT) consists of three structurally independent modules: SH3b, WW, and GH73. These modules form a T-shaped pocket that accommodates a putative tetrasaccharide-pentapeptide substrate of peptidoglycan. Structural comparison and simulation revealed that the GH73 module of LytB harbors the active site, including the catalytic residue Glu-564. In vitro assays of hydrolytic activity indicated that LytB prefers the peptidoglycan from the lytB-deficient pneumococci, suggesting the existence of a specific substrate of LytB in the immature peptidoglycan. Combined with in vitro cell-dispersing and in vivo cell separation assays, we demonstrated that all three modules are necessary for the optimal activity of LytB. Further functional analysis showed that the full catalytic activity of LytB is required for pneumococcal adhesion to and invasion into human lung epithelial cells. Structure-based alignment indicated that the unique modular organization of LytB is highly conserved in its orthologs from Streptococcus mitis group and Gemella species. These findings provided structural insights into the pneumococcal cell wall remodeling and novel hints for the rational design of therapeutic agents against pneumococcal growth and thereby the related diseases.	[Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Bai, Xiao-Hui; Chen, Hui-Jie; Jiang, Yong-Liang; Huang, Yubin; Cheng, Wang; Li, Qiong; Qi, Lei; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wen, Zhensong; Zhang, Jing-Ren] Tsinghua Univ, Sch Med, Ctr Infect Dis Res, Beijing 100084, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Zhang, JR (corresponding author), Tsinghua Univ, Sch Med, Ctr Infect Dis Res, Beijing 100084, Peoples R China.	zhanglab@tsinghua.edu.cn; cyxing@ustc.edu.cn; zcz@ustc.edu.cn	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Chen, Yuxing/0000-0002-7560-1922; Jiang, YongLiang/0000-0001-5441-4936	Ministry of Science and Technology of China [2013CB835300, 2014CB910100, 2012CB518702]; National Natural Science Foundation of China [31270781, U1332114]; Grand Challenges Exploration of the Bill and Melinda Gates Foundation [OPP1021992]; Tsinghua University Collaborative Research Program [2011Z23153]; Center for Marine Medicine and Rescue of Tsinghua University Grant [20124812029]; Collaborative Innovation Center for Biotherapy; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grand Challenges Exploration of the Bill and Melinda Gates Foundation; Tsinghua University Collaborative Research Program; Center for Marine Medicine and Rescue of Tsinghua University Grant; Collaborative Innovation Center for Biotherapy; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Ministry of Science and Technology of China Grants 2013CB835300, 2014CB910100, and 2012CB518702, National Natural Science Foundation of China Grants 31270781 and U1332114, Grand Challenges Exploration of the Bill and Melinda Gates Foundation Grant OPP1021992, Tsinghua University Collaborative Research Program Grant 2011Z23153, Center for Marine Medicine and Rescue of Tsinghua University Grant 20124812029, the 2011 Collaborative Innovation Center for Biotherapy, and the Fundamental Research Funds for the Central Universities.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atilano ML, 2014, ELIFE, V3, DOI 10.7554/eLife.02277; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Claverys JP, 2007, NAT REV MICROBIOL, V5, P219, DOI 10.1038/nrmicro1613; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Tornero C, 2002, J MOL BIOL, V321, P163, DOI 10.1016/S0022-2836(02)00596-X; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Hashimoto W, 2009, BIOCHEM BIOPH RES CO, V381, P16, DOI 10.1016/j.bbrc.2009.01.186; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez R, 2000, RES MICROBIOL, V151, P437, DOI 10.1016/S0923-2508(00)00172-8; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Mellroth P, 2014, MBIO, V5, DOI 10.1128/mBio.01120-13; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MOSSER JL, 1970, J BIOL CHEM, V245, P287; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musher DM, 2010, PRINCIPLES PRACTICE, P2623; Neidhardt F. C., 1990, PHYSL BACTERIAL CELL, P507; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paton James C., 2008, P421; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Ramos-Sevillano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023626; Romero P, 2007, J BIOL CHEM, V282, P17729, DOI 10.1074/jbc.M611795200; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Varea J, 2000, J BIOL CHEM, V275, P26842; Vollmer W, 2007, MOL BIOL STREPTOCOCC, P531; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vos P, 2011, FIRMICUTES, V3, DOI [DOI 10.1007/978-0-387-68489-5, 10.1007/978-0-387-68489-5]; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yuan ZQ, 2011, IMMUNOL RES, V51, P108, DOI 10.1007/s12026-011-8234-x; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; ZHOU RQ, 1988, ANAL BIOCHEM, V171, P141, DOI 10.1016/0003-2697(88)90134-0	64	37	39	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23403	23416		10.1074/jbc.M114.579714	http://dx.doi.org/10.1074/jbc.M114.579714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002590	Green Published, hybrid			2022-12-28	WOS:000341505000015
J	Seo, YA; Lee, S; Hennigar, SR; Kelleher, SL				Seo, Young Ah; Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.			Prolactin (PRL)-stimulated Ubiquitination of ZnT2 Mediates a Transient Increase in Zinc Secretion Followed by ZnT2 Degradation in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mammary Gland; Prolactin; Protein Degradation; Secretion; Ubiquitination; Zinc Transporter; ZnT2	KAPPA-B-ALPHA; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE; GENE-EXPRESSION; BINDING-SITE; PRL RECEPTOR; IN-VIVO; TRANSPORTER; PROTEIN; INTERNALIZATION	Background: ZnT2 regulates zinc export from mammary cells. Results: Prolactin stimulates ZnT2 ubiquitination, targeting ZnT2 to vesicles and activating zinc accumulation to transiently enhance zinc secretion dependent upon Lys(4)/Lys(6), after which ZnT2 is degraded. Conclusion: Prolactin is a critical regulator of transient ZnT2-mediated zinc secretion. Significance: This work provides insight into post-translational hormonal mechanisms that regulate zinc transport. The zinc transporter ZnT2 imports zinc into secretory vesicles and regulates zinc export from the mammary epithelial cell. Mutations in ZnT2 substantially impair zinc secretion into milk. The lactogenic hormone prolactin (PRL) transcriptionally increases ZnT2 expression through the Jak2/STAT5 signaling pathway, increasing zinc accumulation in secretory vesicles and zinc secretion. Herein, we report that PRL post-translationally stimulated ZnT2 ubiquitination, which altered ZnT2 trafficking and augmented vesicular zinc accumulation and secretion from mammary epithelial cells in a transient manner. Ubiquitination then down-regulated zinc secretion by stimulating degradation of ZnT2. Mutagenesis of two N-terminal lysine residues (K4R and K6R) inhibited ZnT2 ubiquitination, vesicular zinc accumulation and secretion, and protein degradation. These findings establish that PRL post-translationally regulates ZnT2-mediated zinc secretion in a multifactorial manner, first by enhancing zinc accumulation in vesicles to transiently enhance zinc secretion and then by activating ubiquitin-dependent ZnT2 degradation. This provides insight into novel mechanisms through which ZnT2 and zinc transport is tightly regulated in mammary epithelial cells.	[Lee, Sooyeon; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cell & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Seo, Young Ah; Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Seo, Young Ah] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Seo, Young Ah] Harvard Univ, Sch Publ Hlth, Dept Complex Dis & Nutr, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kelleher, SL (corresponding author), 500 Univ Dr, Hershey, PA USA.	slk39@psu.edu	Seo, Young Ah/AAT-5022-2020	Seo, Young Ah/0000-0003-3884-0665; Lee, Sooyeon/0000-0002-1076-3314	National Institutes of Health [R01 HD058614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD058614 (to S. L. K.).	Al-Sakkaf KA, 1997, J MOL ENDOCRINOL, V19, P347, DOI 10.1677/jme.0.0190347; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Barberon M, 2011, P NATL ACAD SCI USA, V108, pE450, DOI 10.1073/pnas.1100659108; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002; De Domenico I, 2009, P NATL ACAD SCI USA, V106, P3800, DOI 10.1073/pnas.0900453106; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Goupille O, 2000, MOL CELL ENDOCRINOL, V159, P133, DOI 10.1016/S0303-7207(99)00197-5; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Isasa Marta, 2012, Methods Mol Biol, V910, P337, DOI 10.1007/978-1-61779-965-5_15; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Jantarajit W, 2007, AM J PHYSIOL-ENDOC M, V293, pE372, DOI 10.1152/ajpendo.00142.2007; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lkhider M, 2001, J CELL SCI, V114, P1883; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; McManaman JL, 2000, ARCH BIOCHEM BIOPHYS, V373, P318, DOI 10.1006/abbi.1999.1573; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Moore H.-P. H., 2002, Archives of Physiology and Biochemistry, V110, P16, DOI 10.1076/apab.110.1.16.903; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; OLLIVIERBOUSQUET M, 1978, CELL TISSUE RES, V187, P25, DOI 10.1007/BF00220616; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PICCOLETTI R, 1994, BIOCHEM J, V303, P429, DOI 10.1042/bj3030429; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Selvaraj NG, 2000, MOL ENDOCRINOL, V14, P2054, DOI 10.1210/me.14.12.2054; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Swaminathan G, 2008, J ENDOCRINOL, V196, pR1, DOI 10.1677/JOE-07-0554; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Winklehner-Jennewein P, 1998, GENE, V217, P127, DOI 10.1016/S0378-1119(98)00380-1	54	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23653	23661		10.1074/jbc.M113.531145	http://dx.doi.org/10.1074/jbc.M113.531145			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016022	hybrid, Green Published			2022-12-28	WOS:000341505000033
J	Tavares, CDJ; Ferguson, SB; Giles, DH; Wang, QT; Wellmann, RM; O'Brien, JP; Warthaka, M; Brodbelt, JS; Ren, PY; Dalby, KN				Tavares, Clint D. J.; Ferguson, Scarlett B.; Giles, David H.; Wang, Qiantao; Wellmann, Rebecca M.; O'Brien, John P.; Warthaka, Mangalika; Brodbelt, Jennifer S.; Ren, Pengyu; Dalby, Kevin N.			The Molecular Mechanism of Eukaryotic Elongation Factor 2 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium; Calmodulin (CaM); Phosphorylation; Translation; CaMK-III; Thr-348; eEF-2; eEF-2K; Phosphate-binding Pocket	CALMODULIN-DEPENDENT PHOSPHORYLATION; MR 100,000 SUBSTRATE; FACTOR-II KINASE; PROTEIN-SYNTHESIS; ALPHA-KINASES; IDENTIFICATION; SITE; PURIFICATION; TRANSLATION; AUTOPHAGY	Background: Eukaryotic elongation factor 2 kinase (eEF-2K) regulates protein translation elongation rates. Results: eEF-2K activation involves a two-step process of calmodulin binding and rapid Thr-348 autophosphorylation. Conclusion: Activation of eEF-2K involves two distinct allosteric steps, both of which potentially induce a conformational change. Significance: This mechanism provides a framework for understanding how eEF-2K integrates inputs from multiple upstream signaling pathways. Calmodulin (CaM)-dependent eukaryotic elongation factor 2 kinase (eEF-2K) impedes protein synthesis through phosphorylation of eukaryotic elongation factor 2 (eEF-2). It is subject to complex regulation by multiple upstream signaling pathways, through poorly described mechanisms. Precise integration of these signals is critical for eEF-2K to appropriately regulate protein translation rates. Here, an allosteric mechanism comprising two sequential conformations is described for eEF-2K activation. First, Ca2+/CaM binds eEF-2K with high affinity (K-d(CaM)(app) = 24 +/- 5 nm) to enhance its ability to autophosphorylate Thr-348 in the regulatory loop (R-loop) by > 10(4)-fold (k(auto) = 2.6 +/- 0.3 s(-1)). Subsequent binding of phospho-Thr-348 to a conserved basic pocket in the kinase domain potentially drives a conformational transition of the R-loop, which is essential for efficient substrate phosphorylation. Ca2+/CaM binding activates autophosphorylated eEF-2K by allosterically enhancing k(cat)(app) for peptide substrate phosphorylation by 10(3)-fold. Thr-348 autophosphorylation results in a 25-fold increase in the specificity constant (k(cat)(app)/K-m(Pep-S)(app)), with equal contributions from k(cat)(app) and K-m(Pep-S)(app), suggesting that peptide substrate binding is partly impeded in the unphosphorylated enzyme. In cells, Thr-348 autophosphorylation appears to control the catalytic output of active eEF-2K, contributing more than 5-fold to its ability to promote eEF-2 phosphorylation. Fundamentally, eEF-2K activation appears to be analogous to an amplifier, where output volume may be controlled by either toggling the power switch (switching on the kinase) or altering the volume control (modulating stability of the active R-loop conformation). Because upstream signaling events have the potential to modulate either allosteric step, this mechanism allows for exquisite control of eEF-2K output.	[Tavares, Clint D. J.; Dalby, Kevin N.] Univ Texas Austin, Grad Program Cell & Mol Biol, Austin, TX 78712 USA; [Tavares, Clint D. J.; Ferguson, Scarlett B.; Giles, David H.; Wang, Qiantao; Wellmann, Rebecca M.; Warthaka, Mangalika; Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Wang, Qiantao; Ren, Pengyu] Univ Texas Austin, Cockrell Sch Engn, Dept Biomed Engn, Austin, TX 78712 USA; [O'Brien, John P.; Brodbelt, Jennifer S.] Univ Texas Austin, Coll Nat Sci, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Tavares, CDJ (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, 107 W Dean Keeton,Biomed Engn Bldg, Austin, TX 78712 USA.	clinttavares@utexas.edu; dalby@austin.utexas.edu	Dalby, Kevin N/A-1905-2013; Ren, Pengyu/Q-6872-2017	Dalby, Kevin N/0000-0001-9272-5129; Ren, Pengyu/0000-0002-5613-1910	National Institutes of Health [GM59802, R21 GM099028, GM106137]; Welch Foundation [F-1390, F-1155]; Robert A. Welch Foundation [F-1691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106137, R21GM099028, R01GM059802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59802 (to K. N. D.). This work was also supported by Welch Foundation Grant F-1390 (to K. N. D.).; Supported by Welch Foundation Grant F-1155 and National Institutes of Health Grant R21 GM099028.; Supported by Robert A. Welch Foundation Grant F-1691 and National Institutes of Health Grant GM106137.	Abramczyk O, 2011, PROTEIN EXPRES PURIF, V79, P237, DOI 10.1016/j.pep.2011.05.005; BAGAGLIO DM, 1994, CELL GROWTH DIFFER, V5, P1403; BAGAGLIO DM, 1993, CANCER RES, V53, P2260; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Crawley SW, 2008, BBA-PROTEINS PROTEOM, V1784, P908, DOI 10.1016/j.bbapap.2008.03.001; Crawley SW, 2011, J BIOL CHEM, V286, P2607, DOI 10.1074/jbc.M110.177014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Devkota AK, 2012, BIOCHEMISTRY-US, V51, P2100, DOI 10.1021/bi201787p; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Knebel A, 2002, BIOCHEM J, V367, P525, DOI 10.1042/BJ20020916; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Meloche S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003163; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MITSUI K, 1993, J BIOL CHEM, V268, P13422; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Parmer TG, 1999, BRIT J CANCER, V79, P59, DOI 10.1038/sj.bjc.6690012; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; Pigott CR, 2012, BIOCHEM J, V442, P105, DOI 10.1042/BJ20111536; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Py BF, 2009, AUTOPHAGY, V5, P393, DOI 10.4161/auto.5.3.7762; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Rigden DJ, 2004, J MOL BIOL, V343, P971, DOI 10.1016/j.jmb.2004.08.077; Ruys SPD, 2012, BIOCHEM J, V442, P681, DOI 10.1042/BJ20111530; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tavares CDJ, 2012, BIOCHEMISTRY-US, V51, P2232, DOI 10.1021/bi201788e; Tekedereli I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041171; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wiseman SL, 2013, J BIOL CHEM, V288, P17803, DOI 10.1074/jbc.M113.477182; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Ye QL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000525; Zhang L, 2011, ACTA PHARMACOL SIN, V32, P361, DOI 10.1038/aps.2010.213	61	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23901	23916		10.1074/jbc.M114.577148	http://dx.doi.org/10.1074/jbc.M114.577148			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012662	Green Published, hybrid			2022-12-28	WOS:000341505000056
J	Mendez-Lucas, A; Hyrossova, P; Novellasdemunt, L; Vinals, F; Perales, JC				Mendez-Lucas, Andres; Hyrossova, Petra; Novellasdemunt, Laura; Vinals, Francesc; Perales, Jose C.			Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) Is a Pro-survival, Endoplasmic Reticulum (ER) Stress Response Gene Involved in Tumor Cell Adaptation to Nutrient Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE SYNTHETASE GENE; UNFOLDED PROTEIN RESPONSE; CANCER-CELLS; ACTIVATION; TRANSCRIPTION; EXPRESSION; KINASE; METABOLISM; HYPOXIA; PATHWAY	Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), encoded by the nuclear PCK2 gene, links TCA cycle intermediates and glycolytic pools through the conversion of mitochondrial oxaloacetate into phosphoenolpyruvate. In the liver PEPCK-M adjoins its profusely studied cytosolic isoform (PEPCK-C) potentiating gluconeogenesis and TCA flux. However, PEPCK-M is present in a variety of non-gluconeogenic tissues, including tumors of several origins. Despite its potential relevance to cancer metabolism, the mechanisms responsible for PCK2 gene regulation have not been elucidated. The present study demonstrates PEPCK-M overexpression in tumorigenic cells as well as the mechanism for the modulation of PCK2 abundance under several stress conditions. Amino acid limitation and ER stress inducers, conditions that activate the amino acid response (AAR) and the unfolded protein response (UPR), stimulate PCK2 gene transcription. Both the AAR and UPR lead to increased synthesis of ATF4, which mediates PCK2 transcriptional up-regulation through its binding to a putative ATF/CRE composite site within the PCK2 promoter functioning as an amino acid response element. In addition, activation of the GCN2-eIF2 alpha-ATF4 and PERK-eIF2 alpha-ATF4 signaling pathways are responsible for increased PEPCK-M levels. Finally, PEPCK-M knockdown using either siRNA or shRNA were sufficient to reduce MCF7 mammary carcinoma cell growth and increase cell death under glutamine deprivation or ER stress conditions. Our data demonstrate that this enzyme has a critical role in the survival program initiated upon stress and shed light on an unexpected and important role of mitochondrial PEPCK in cancer metabolism.	[Mendez-Lucas, Andres; Hyrossova, Petra; Novellasdemunt, Laura; Vinals, Francesc; Perales, Jose C.] Univ Barcelona, Dept Ciencies Fisiol 2, E-08907 Barcelona, Spain	University of Barcelona	Perales, JC (corresponding author), Univ Barcelona, Dept Ciencies Fisiol 2, Feixa Llarga S-N, E-08907 Barcelona, Spain.	jperales@ub.edu	Lucas, Andres Mendez/AAG-7488-2020; Viñals, Francesc/F-5928-2016; PERALES, JOSE C/J-7457-2017; PERALES, JOSE C. C/D-5586-2012; Vinals, Francesc/P-6278-2019; Hyroššová, Petra/AAT-6171-2021; PERALES, JOSE C./AAC-3156-2019	Lucas, Andres Mendez/0000-0002-0725-4375; Viñals, Francesc/0000-0002-9918-6751; PERALES, JOSE C/0000-0001-7363-2226; PERALES, JOSE C. C/0000-0001-7363-2226; Hyroššová, Petra/0000-0003-2337-2627; PERALES, JOSE C./0000-0001-7363-2226; Novellasdemunt Vilaseca, Laura/0000-0003-1590-9842	Ministerio de Economia and y Competitividad; FEDER [BFU2012-37177]; Ministerio de Educacion y Ciencia (FPU); Ministerio de Economia y Competitividad (FPI)	Ministerio de Economia and y Competitividad; FEDER(European Commission); Ministerio de Educacion y Ciencia (FPU)(Spanish Government); Ministerio de Economia y Competitividad (FPI)	This work was supported by a grant from the Ministerio de Economia and y Competitividad and FEDER (BFU2012-37177 (to J. C. P.)).; Recipient of fellowships from Ministerio de Educacion y Ciencia (FPU).; Recipient of a fellowship from the Ministerio de Economia y Competitividad (FPI).	Amelio I, 2014, ONCOGENE, V33, P5039, DOI 10.1038/onc.2013.456; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; CHANG HC, 1966, J BIOL CHEM, V241, P2413; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Crosby JS, 2000, BLOOD, V96, P3241; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kung C, 2012, CHEM BIOL, V19, P1187, DOI 10.1016/j.chembiol.2012.07.021; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Leung-Pineda V, 2002, J BIOL CHEM, V277, P16585, DOI 10.1074/jbc.M110972200; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Park JW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-160; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Sood R, 2000, GENETICS, V154, P787; Stark R, 2014, J BIOL CHEM, V289, P7257, DOI 10.1074/jbc.C113.544759; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018	49	114	122	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22090	22102		10.1074/jbc.M114.566927	http://dx.doi.org/10.1074/jbc.M114.566927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973213	Green Published, hybrid			2022-12-28	WOS:000340593500025
J	Yun, N; Lee, YM; Kim, C; Shibayama, H; Tanimura, A; Hamanaka, Y; Kanakura, Y; Park, IS; Jo, A; Shin, JH; Ju, C; Kim, WK; Oh, YJ				Yun, Nuri; Lee, Young Mook; Kim, Chiho; Shibayama, Hirohiko; Tanimura, Akira; Hamanaka, Yuri; Kanakura, Yuzuru; Park, Il-Seon; Jo, Areum; Shin, Joo-Ho; Ju, Chung; Kim, Won-Ki; Oh, Young J.			Anamorsin, a Novel Caspase-3 Substrate in Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN BIOGENESIS; FAS-INDUCED APOPTOSIS; DOPAMINERGIC-NEURONS; OXIDATIVE STRESS; CELL-DEATH; MULTIDRUG-RESISTANCE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CANCER CELLS; ROCK-I	Activated caspases play a central role in the execution of apoptosis by cleaving endogenous substrates. Here, we developed a high throughput screening method to identify novel substrates for caspase-3 in a neuronal cell line. Critical steps in our strategy consist of two-dimensional electrophoresis-based protein separation and in vitro caspase-3 incubation of immobilized proteins to sort out direct substrates. Among 46 putative substrates identified in MN9D neuronal cells, we further evaluated whether caspase-3-mediated cleavage of anamorsin, a recently recognized cell death-defying factor in hematopoiesis, is a general feature of apoptosis. In vitro and cell-based cleavage assays indicated that anamorsin was specifically cleaved by caspase-3 but not by other caspases, generating 25- and 10-kDa fragments. Thus, in apoptosis of neuronal and non-neuronal cells induced by various stimuli including staurosporine, etoposide, or 6-hydroxydopamine, the cleavage of anamorsin was found to be blocked in the presence of caspase inhibitor. Among four tetrapeptide consensus DXXD motifs existing in anamorsin, we mapped a specific cleavage site for caspase-3 at DSVD209 down arrow L. Intriguingly, the 25-kDa cleaved fragment of anamorsin was also detected in post-mortem brains of Alzheimer and Parkinson disease patients. Although the RNA interference-mediated knockdown of anamorsin rendered neuronal cells more vulnerable to staurosporine treatment, reintroduction of full-length anamorsin into an anamorsin knock-out stromal cell line made cells resistant to staurosporine-induced caspase activation, indicating the antiapoptotic function of anamorsin. Taken together, our approach seems to be effective to identify novel substrates for caspases and has the potential to provide meaningful insights into newly identified substrates involved in neurodegenerative processes.	[Yun, Nuri; Lee, Young Mook; Kim, Chiho; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Shibayama, Hirohiko; Tanimura, Akira; Hamanaka, Yuri; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Park, Il-Seon] Chosun Univ, Dept Cellular & Mol Med, Coll Med, Kwangju 501759, South Korea; [Jo, Areum; Shin, Joo-Ho] Sungkyunkwan Univ, Sch Med, Div Pharmacol, Dept Mol Cell Biol,Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea; [Ju, Chung; Kim, Won-Ki] Korea Univ, Dept Neurosci, Coll Med, Seoul 136705, South Korea	Yonsei University; Osaka University; Chosun University; Sungkyunkwan University (SKKU); Korea University; Korea University Medicine (KU Medicine)	Kim, WK (corresponding author), Korea Univ, Dept Neurosci, Coll Med, Anamdong 5 Ga, Seoul 136705, South Korea.	wonki@korea.ac.kr; yjoh@yonsei.ac.kr	Shin, Joo-Ho/P-1417-2018	Yun, Nuri/0000-0003-1853-1304; Tanimura, Akira/0000-0002-2039-5543	National Research Foundation of Korea (NRF) [2008-0061888]; NRF Bio and Medical Technology Development Program - Ministry of Science, Information/Communication Technology, and Future Planning [2011-0019440]; Grants-in-Aid for Scientific Research [25293220] Funding Source: KAKEN	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF Bio and Medical Technology Development Program - Ministry of Science, Information/Communication Technology, and Future Planning; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Research Foundation of Korea (NRF) Grant 2008-0061888 (to Y. J. O.) and NRF Bio and Medical Technology Development Program Grant 2011-0019440 (to W.-K. K.) funded by the Ministry of Science, Information/Communication Technology, and Future Planning.	Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Camins A, 2009, CURR DRUG METAB, V10, P433, DOI 10.2174/138920009788898028; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Demon D, 2009, TRENDS BIOTECHNOL, V27, P680, DOI 10.1016/j.tibtech.2009.09.007; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Gerner C, 2002, CELL DEATH DIFFER, V9, P671, DOI 10.1038/sj.cdd.4401010; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Green KA, 2004, J BIOL CHEM, V279, P25149, DOI 10.1074/jbc.M402395200; Han BS, 2003, J NEUROSCI, V23, P5069; Hao ZM, 2006, CANCER BIOL THER, V5, P261, DOI 10.4161/cbt.5.3.2381; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Johnson CE, 2008, CELL, V134, P720, DOI 10.1016/j.cell.2008.08.019; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kang HJ, 2005, NEUROBIOL DIS, V18, P450, DOI 10.1016/j.nbd.2004.12.004; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; Karki P, 2007, BIOCHEM BIOPH RES CO, V356, P1056, DOI 10.1016/j.bbrc.2007.03.102; Lee AY, 2004, PROTEOMICS, V4, P3429, DOI 10.1002/pmic.200400979; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Love S, 2000, NEUROPATH APPL NEURO, V26, P55, DOI 10.1046/j.1365-2990.2000.00218.x; Lu D, 2012, MOLECULES, V17, P7595, DOI 10.3390/molecules17067595; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Maeda K, 2007, J VET MED SCI, V69, P989, DOI 10.1292/jvms.69.989; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Murata K, 2007, IN VITRO CELL DEV-AN, V43, P235, DOI 10.1007/s11626-007-9048-y; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Park IS, 2004, BBA-PROTEINS PROTEOM, V1700, P5, DOI 10.1016/j.bbapap.2004.03.008; Park KA, 2011, J NEURAL TRANSM, V118, P433, DOI 10.1007/s00702-010-0490-8; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Saito Y, 2011, BIOCHEM BIOPH RES CO, V405, P303, DOI 10.1016/j.bbrc.2011.01.033; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Soler N, 2012, FEBS J, V279, P2108, DOI 10.1111/j.1742-4658.2012.08597.x; Talanian RV, 1997, J BIOL CHEM, V272, P9677; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yun N, 2013, BIOCHEM BIOPH RES CO, V432, P533, DOI 10.1016/j.bbrc.2013.02.017; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	53	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22183	22195		10.1074/jbc.M114.552679	http://dx.doi.org/10.1074/jbc.M114.552679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973211	Green Published, hybrid			2022-12-28	WOS:000340593500033
J	Lidsky, M; Antoun, G; Speicher, P; Adams, B; Turley, R; Augustine, C; Tyler, D; Ali-Osman, F				Lidsky, Michael; Antoun, Gamil; Speicher, Paul; Adams, Bartley; Turley, Ryan; Augustine, Christi; Tyler, Douglas; Ali-Osman, Francis			Mitogen-activated Protein Kinase (MAPK) Hyperactivation and Enhanced NRAS Expression Drive Acquired Vemurafenib Resistance in V600E BRAF Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						c-Jun N-terminal Kinase (JNK); Extracellular Signal-regulated Kinase (ERK); Melanoma; Mitogen-activated Protein Kinase (MAPK); p38; Acquired Drug Resistance; NRAS; Vemurafenib	GLUTATHIONE-S-TRANSFERASE; METASTATIC MELANOMA; MEDIATES RESISTANCE; IMPROVED SURVIVAL; MEK INHIBITION; B-RAF; PATHWAY; GROWTH; PHOSPHORYLATION; MUTATIONS	Background: The response to vemurafenib in V600E BRAF+ve melanoma is short lived due to acquisition of vemurafenib resistance. Results: NRAS expression and increased MAPK activation drive vemurafenib resistance in V600E BRAF+ve melanoma. Conclusion: Resistance to vemurafenib in melanoma is complex and can be mitigated by MAPK and NRAS inhibition. Significance: These findings could lead to improved therapy of V600E BRAF+ve melanoma by targeting MAPKs and NRAS. Although targeting the V600E activating mutation in the BRAF gene, the most common genetic abnormality in melanoma, has shown clinical efficacy in melanoma patients, response is, invariably, short lived. To better understand mechanisms underlying this acquisition of resistance to BRAF-targeted therapy in previously responsive melanomas, we induced vemurafenib resistance in two V600E BRAF+ve melanoma cell lines, A375 and DM443, by serial in vitro vemurafenib exposure. The resulting approximately 10-fold more vemurafenib-resistant cell lines, A375rVem and D443rVem, had higher growth rates and showed differential collateral resistance to cisplatin, melphalan, and temozolomide. The acquisition of vemurafenib resistance was associated with significantly increased NRAS levels in A375rVem and D443rVem, increased activation of the prosurvival protein, AKT, and the MAPKs, ERK, JNK, and P38, which correlated with decreased levels of the MAPK inhibitor protein, GSTP1. Despite the increased NRAS, whole exome sequencing showed no NRAS gene mutations. Inhibition of all three MAPKs and siRNA-mediated NRAS suppression both reversed vemurafenib resistance significantly in A375rVem and DM443rVem. Together, the results indicate a mechanism of acquired vemurafenib resistance in V600E BRAF+ve melanoma cells that involves increased activation of all three human MAPKs and the PI3K pathway, as well as increased NRAS expression, which, contrary to previous reports, was not associated with mutations in the NRAS gene. The data highlight the complexity of the acquired vemurafenib resistance phenotype and the challenge of optimizing BRAF-targeted therapy in this disease. They also suggest that targeting the MAPKs and/or NRAS may provide a strategy to mitigate such resistance in V600E BRAF+ve melanoma.	[Lidsky, Michael; Speicher, Paul; Turley, Ryan; Augustine, Christi; Tyler, Douglas] Duke Univ, Med Ctr, Dept Surg, Div Surg Oncol, Durham, NC 27710 USA; [Antoun, Gamil; Adams, Bartley; Ali-Osman, Francis] Duke Univ, Med Ctr, Dept Surg, Div Surg Sci, Durham, NC 27710 USA	Duke University; Duke University	Ali-Osman, F (corresponding author), Duke Univ, Med Ctr, Dept Surg, 421 Med Sci Res Bldg 1, Durham, NC 27710 USA.	francis.aliosman@duke.edu	Lidsky, Michael E./AAM-8307-2020	Lidsky, Michael E./0000-0003-0500-2016	National Institutes of Health [5R01CA153050, 1R01CA127872]; Veterans Affairs merit review grant; NATIONAL CANCER INSTITUTE [R01CA153050, T32CA093245, R01CA127872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit review grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01CA153050 and 1R01CA127872. This work was also supported by a Veterans Affairs merit review grant.	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Ali-Osman Francis, 1996, P63; Anderson C M, 1995, Oncology (Williston Park), V9, P1149; Anderson C. M., 1995, ONCOLOGY HUNTINGT, V9, P1167; Anderson C. M., 1995, ONCOLOGY HUNTINGT, V9, P1163; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Bhatt RS, 2010, CANCER-AM CANCER SOC, V116, P1751, DOI 10.1002/cncr.24902; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buery RR, 2011, ONCOL REP, V26, P783, DOI 10.3892/or.2011.1385; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2002, J CELL BIOCHEM, V87, P103, DOI 10.1002/jcb.10275; Lopez-Bergami P, 2010, J BIOL CHEM, V285, P903, DOI 10.1074/jbc.M109.075630; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Okamura T, 2009, J BIOL CHEM, V284, P16979, DOI 10.1074/jbc.M808153200; Qin JZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-15; Satyamoorthy K, 2003, CANCER RES, V63, P756; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; TEW KD, 1994, CANCER RES, V54, P4313; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Yadav V, 2012, J BIOL CHEM, V287, P28087, DOI 10.1074/jbc.M112.377218	44	34	34	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27714	27726		10.1074/jbc.M113.532432	http://dx.doi.org/10.1074/jbc.M113.532432			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25063807	hybrid, Green Published			2022-12-28	WOS:000342852800030
J	Ho, CH; Wang, HC; Ko, TP; Chang, YC; Wang, AHJ				Ho, Chun-Han; Wang, Hao-Ching; Ko, Tzu-Ping; Chang, Yuan-Chih; Wang, Andrew H-J.			The T4 Phage DNA Mimic Protein Arn Inhibits the DNA Binding Activity of the Bacterial Histone-like Protein H-NS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FOREIGN DNA; IN-VIVO; GENE; DOCKING; CLUSPRO; BACTERIOPHAGE-T4; OLIGOMERIZATION; GLYCOSYLASE; RESISTANCE	The T4 phage protein Arn (Anti restriction nuclease) was identified as an inhibitor of the restriction enzyme McrBC. However, until now its molecular mechanism remained unclear. In the present study we used structural approaches to investigate biological properties of Arn. A structural analysis of Arn revealed that its shape and negative charge distribution are similar to dsDNA, suggesting that this protein could act as a DNA mimic. In a subsequent proteomic analysis, we found that the bacterial histone-like protein H-NS interacts with Arn, implying a new function. An electrophoretic mobility shift assay showed that Arn prevents H-NS from binding to the Escherichia coli hns and T4 p8.1 promoters. In vitro gene expression and electron microscopy analyses also indicated that Arn counteracts the gene-silencing effect of H-NS on a reporter gene. Because McrBC and H-NS both participate in the host defense system, our findings suggest that T4 Arn might knock down these mechanisms using its DNA mimicking properties.	[Ho, Chun-Han; Wang, Andrew H-J.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Ho, Chun-Han; Wang, Hao-Ching; Ko, Tzu-Ping; Wang, Andrew H-J.] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Ko, Tzu-Ping; Wang, Andrew H-J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Wang, Hao-Ching; Wang, Andrew H-J.] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei 110, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	ahjwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016	CHANG, Yuan-Chih/0000-0002-0289-3768; Wang, Hao-Ching/0000-0003-2396-717X	Core Facilities for Protein Structural Analysis - National Core Facilities Program for Biotechnology [NSC 100-2325-B-001-029, NSC 101-2319-B-001-003]	Core Facilities for Protein Structural Analysis - National Core Facilities Program for Biotechnology	This work was supported by the Core Facilities for Protein Structural Analysis funded by National Core Facilities Program for Biotechnology (NSC 100-2325-B-001-029 and NSC 101-2319-B-001-003).	Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Ali SS, 2011, J BACTERIOL, V193, P4881, DOI 10.1128/JB.05198-11; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2001, BIOCHIMIE, V83, P231; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DHARMALINGAM K, 1982, J BACTERIOL, V149, P694, DOI 10.1128/JB.149.2.694-699.1982; Dryden DTF, 2006, BIOCHEM SOC T, V34, P317, DOI 10.1042/BST0340317; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; Hansen AM, 2005, MOL MICROBIOL, V56, P719, DOI 10.1111/j.1365-2958.2005.04567.x; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim BC, 1997, MOL CELLS, V7, P694; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; McMahon SA, 2009, NUCLEIC ACIDS RES, V37, P4887, DOI 10.1093/nar/gkp478; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sommer N, 2000, MICROBIOL-SGM, V146, P2643, DOI 10.1099/00221287-146-10-2643; Stella S, 2006, J MOL BIOL, V355, P169, DOI 10.1016/j.jmb.2005.10.034; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Walkinshaw MD, 2002, MOL CELL, V9, P187, DOI 10.1016/S1097-2765(02)00435-5; Wang HC, 2014, BIOCHEMISTRY-US, V53, P2865, DOI 10.1021/bi5002689; Wang HC, 2014, NUCLEIC ACIDS RES, V42, P1354, DOI 10.1093/nar/gkt964; Wang HC, 2013, NUCLEIC ACIDS RES, V41, P5127, DOI 10.1093/nar/gkt201; Wang HC, 2012, NUCLEIC ACIDS RES, V40, P5718, DOI 10.1093/nar/gks177; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Zuber S, 2007, J BACTERIOL, V189, P8206, DOI 10.1128/JB.00838-07	47	21	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27046	27054		10.1074/jbc.M114.590851	http://dx.doi.org/10.1074/jbc.M114.590851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118281	Green Published, hybrid			2022-12-28	WOS:000342853900032
J	Suits, MDL; Pluvinage, B; Law, A; Liu, Y; Palma, AS; Chai, WG; Feizi, T; Boraston, AB				Suits, Michael D. L.; Pluvinage, Benjamin; Law, Adrienne; Liu, Yan; Palma, Angelina S.; Chai, Wengang; Feizi, Ten; Boraston, Alisdair B.			Conformational Analysis of the Streptococcus pneumoniae Hyaluronate Lyase and Characterization of Its Hyaluronan-specific Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; GENOME-BASED IDENTIFICATION; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; VIRULENCE FACTORS; STRUCTURAL BASIS; PROTEIN; SURFACE; CRYSTALLOGRAPHY; RECOGNITION	For a subset of pathogenic microorganisms, including Streptococcus pneumoniae, the recognition and degradation of host hyaluronan contributes to bacterial spreading through the extracellular matrix and enhancing access to host cell surfaces. The hyaluronate lyase (Hyl) presented on the surface of S. pneumoniae performs this role. Using glycan microarray screening, affinity electrophoresis, and isothermal titration calorimetry we show that the N-terminal module of Hyl is a hyaluronan-specific carbohydrate-binding module (CBM) and the founding member of CBM family 70. The 1.2 angstrom resolution-ray crystal structure of CBM70 revealed it to have a beta-sandwich fold, similar to other CBMs. The electrostatic properties of the binding site, which was identified by site-directed mutagenesis, are distinct from other CBMs and complementary to its acidic ligand, hyaluronan. Dynamic light scattering and solution small angle x-ray scattering revealed the full-length Hyl protein to exist as a monomer/dimer mixture in solution. Through a detailed analysis of the small angle x-ray scattering data, we report the pseudoatomic solution structures of the monomer and dimer forms of the full-length multimodular Hyl.	[Suits, Michael D. L.; Pluvinage, Benjamin; Law, Adrienne; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Liu, Yan; Palma, Angelina S.; Chai, Wengang; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Palma, Angelina S.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Chem, REQUIMTE, P-2829516 Caparica, Portugal	University of Victoria; Imperial College London; Universidade Nova de Lisboa	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013	Palma, Angelina S/0000-0001-5797-6555; Boraston, Alisdair/0000-0001-6417-0592; Feizi, Ten/0000-0001-6495-0329; Liu, Yan/0000-0002-2566-6867	Canadian Institutes of Health Research Operating Grant [FRN 86610]; UK Research Councils Basic Technology Initiative Glycoarrays Grant [GRS/79268]; UK Research Councils Translational Grant [EP/G037604/1]; Wellcome Trust [WT093378MA/Z/10/Z, WT099197/Z/12/ZMA]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program [P41RR001209]; NIGMS, National Institutes of Health; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); UK Research Councils Basic Technology Initiative Glycoarrays Grant; UK Research Councils Translational Grant; Wellcome Trust(Wellcome TrustEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Canadian Institutes of Health Research Operating Grant FRN 86610. This work was also supported by UK Research Councils Basic Technology Initiative Glycoarrays Grant GRS/79268 and Translational Grant EP/G037604/1 and Wellcome Trust Grants WT093378MA/Z/10/Z and WT099197/Z/12/ZMA (to T. F.). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health, NCRR, Biomedical Technology Program Grant P41RR001209, and NIGMS, National Institutes of Health.	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2011, J MOL BIOL, V411, P1017, DOI 10.1016/j.jmb.2011.06.035; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOSTYUKOVA NN, 1995, FEMS IMMUNOL MED MIC, V10, P133, DOI 10.1111/j.1574-695X.1995.tb00022.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Lucas R, 2013, TOXINS, V5, P1244, DOI 10.3390/toxins5071244; Lundell A, 2004, STRUCTURE, V12, P1495, DOI 10.1016/j.str.2004.05.021; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Petoukhov MV, 2006, EUR BIOPHYS J BIOPHY, V35, P567, DOI 10.1007/s00249-006-0063-9; Petoukhov MV, 2013, BIOCHEMISTRY-US, V52, P6844, DOI 10.1021/bi400731u; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pluvinage B, 2013, J MOL BIOL, V425, P334, DOI 10.1016/j.jmb.2012.11.005; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RAPPORT MM, 1951, J BIOL CHEM, V192, P283; Rigden DJ, 2003, PROTEINS, V52, P203, DOI 10.1002/prot.10405; Rigden DJ, 2003, CRIT REV BIOCHEM MOL, V38, P143, DOI 10.1080/713609215; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stoll MS, 2009, P BEILST S GLYC BIOI, P123; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THOMPSON RT, 1948, J CLIN INVEST, V27, P558; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	54	10	10	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27264	27277		10.1074/jbc.M114.578435	http://dx.doi.org/10.1074/jbc.M114.578435			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100731	hybrid, Green Published			2022-12-28	WOS:000342853900048
J	Zhong, Y; Morris, DH; Jin, L; Patel, MS; Karunakaran, SK; Fu, YJ; Matuszak, EA; Weiss, HL; Chait, BT; Wang, QJ				Zhong, Yu; Morris, Deanna H.; Jin, Lin; Patel, Mittul S.; Karunakaran, Senthil K.; Fu, You-Jun; Matuszak, Emily A.; Weiss, Heidi L.; Chait, Brian T.; Wang, Qing Jun			Nrbf2 Protein Suppresses Autophagy by Modulating Atg14L Protein-containing Beclin 1-Vps34 Complex Architecture and Reducing Intracellular Phosphatidylinositol-3 Phosphate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; REGULATES AUTOPHAGY; 3-KINASE COMPLEXES; UP-REGULATION; KINASE; YEAST; GENE; TUMORIGENESIS; RECEPTOR; DOMAIN	Autophagy is a tightly regulated lysosomal degradation pathway for maintaining cellular homeostasis and responding to stresses. Beclin 1 and its interacting proteins, including the class III phosphatidylinositol-3 kinase Vps34, play crucial roles in autophagy regulation in mammals. We identified nuclear receptor binding factor 2 (Nrbf2) as a Beclin 1-interacting protein from Becn1(-/-); Becn1-EGFP/+ mouse liver and brain. We also found that Nrbf2-Beclin 1 interaction required the N terminus of Nrbf2. We next used the human retinal pigment epithelial cell line RPE-1 as a model system and showed that transiently knocking down Nrbf2 by siRNA increased autophagic flux under both nutrient-rich and starvation conditions. To investigate the mechanism by which Nrbf2 regulates autophagy, we demonstrated that Nrbf2 interacted and colocalized with Atg14L, suggesting that Nrbf2 is a component of the Atg14L-containing Beclin 1-Vps34 complex. Moreover, ectopically expressed Nrbf2 formed cytosolic puncta that were positive for isolation membrane markers. These results suggest that Nrbf2 is involved in autophagosome biogenesis. Furthermore, we showed that Nrbf2 deficiency led to increased intracellular phosphatidylinositol-3 phosphate levels and diminished Atg14L-Vps34/Vps15 interactions, suggesting that Nrbf2-mediated Atg14L-Vps34/Vps15 interactions likely inhibit Vps34 activity. Therefore, we propose that Nrbf2 may interact with the Atg14L-containing Beclin 1-Vps34 protein complex to modulate protein-protein interactions within the complex, leading to suppression of Vps34 activity, autophagosome biogenesis, and autophagic flux. This work reveals a novel aspect of the intricate mechanism for the Beclin 1-Vps34 protein-protein interaction network to achieve precise control of autophagy.	[Zhong, Yu; Morris, Deanna H.; Jin, Lin; Patel, Mittul S.; Karunakaran, Senthil K.; Fu, You-Jun; Wang, Qing Jun] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Matuszak, Emily A.; Wang, Qing Jun] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Weiss, Heidi L.; Wang, Qing Jun] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	University of Kentucky; University of Kentucky; University of Kentucky; Rockefeller University	Wang, QJ (corresponding author), Univ Kentucky Coll Med, Dept Mol & Cellular Biochem, B163 BBSRB,741 S Limestone, Lexington, KY 40536 USA.	qingjun.wang@uky.edu		Wang, Qingjun/0000-0002-1959-4107	National Institutes of Health [P20GM103486, RR00862, RR022220]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486, P41GM103314, P41GM109824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20GM103486 (to Q. J. W.) and RR00862 and RR022220 (to B. T. C.). This work was also supported by the Ellison Medical Foundation (to Q. J. W.).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Araki Y, 2013, J CELL BIOL, V203, P299, DOI 10.1083/jcb.201304123; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cao YY, 2014, BIOCHEM J, V461, P315, DOI 10.1042/BJ20140515; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Flores AM, 2004, J INVEST DERMATOL, V123, P1092, DOI 10.1111/j.0022-202X.2004.23424.x; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Lu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4920; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Menzies F.M., 2012, CURR PROTOC CELL BIO; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; STACK JH, 1994, J BIOL CHEM, V269, P31552; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Yasumo H, 2000, BBA-GENE STRUCT EXPR, V1490, P189, DOI 10.1016/S0167-4781(99)00244-4; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	63	58	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26021	26037		10.1074/jbc.M114.561134	http://dx.doi.org/10.1074/jbc.M114.561134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086043	Green Published, hybrid			2022-12-28	WOS:000342128800003
J	Hulikova, A; Aveyard, N; Harris, AL; Vaughan-Jones, RD; Swietach, P				Hulikova, Alzbeta; Aveyard, Nicholas; Harris, Adrian L.; Vaughan-Jones, Richard D.; Swietach, Pawel			Intracellular Carbonic Anhydrase Activity Sensitizes Cancer Cell pH Signaling to Dynamic Changes in CO2 Partial Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA XENOGRAFTS; BLOOD-FLOW; SPONTANEOUS FLUCTUATIONS; TEMPORAL HETEROGENEITY; VENTRICULAR MYOCYTE; PROTEOMIC ANALYSIS; OXYGEN-TENSION; R3230AC TUMORS; POOR-PROGNOSIS; SOLID TUMORS	Carbonic anhydrase (CA) enzymes catalyze the chemical equilibration among CO2, HCO3- and H+. Intracellular CA (CA(i)) isoforms are present in certain types of cancer, and growing evidence suggests that low levels correlate with disease severity. However, their physiological role remains unclear. Cancer cell CA(i) activity, measured as cytoplasmic CO2 hydration rate (k(f)), ranged from high in colorectal HCT116 (similar to 2 s(-1)), bladder RT112 and colorectal HT29, moderate in fibrosarcoma HT1080 to negligible (i.e. spontaneous k(f) = 0.18 s(-1)) in cervical HeLa and breast MDA-MB-468 cells. CA(i) activity in cells correlated with CAII immunoreactivity and enzymatic activity in membrane-free lysates, suggesting that soluble CAII is an important intracellular isoform. CA(i) catalysis was not obligatory for supporting acid extrusion by H+ efflux or HCO3- influx, nor for maintaining intracellular pH (pH(i)) uniformity. However, in the absence of CA(i) activity, acid loading from a highly alkaline pH(i) was rate-limited by HCO3- supply from spontaneous CO2 hydration. In solid tumors, time-dependence of blood flow can result in fluctuations of CO2 partial pressure (pCO(2)) that disturb cytoplasmic CO2-HCO3--H+ equilibrium. In cancer cells with high CA(i) activity, extracellular pCO(2) fluctuations evoked faster and larger pH(i) oscillations. Functionally, these resulted in larger pH-dependent intracellular [Ca2+] oscillations and stronger inhibition of the mTORC1 pathway reported by S6 kinase phosphorylation. In contrast, the pH(i) of cells with low CA(i) activity was less responsive to pCO(2) fluctuations. Such low pass filtering would "buffer" cancer cell pH(i) from non-steady-state extracellular pCO(2). Thus, CA(i) activity determines the coupling between pCO(2) (a function of tumor perfusion) and pH(i) (a potent modulator of cancer cell physiology).	[Hulikova, Alzbeta; Aveyard, Nicholas; Vaughan-Jones, Richard D.; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford; University of Oxford	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Harris, Adrian L/ABA-3343-2020	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409; Aveyard, Nicholas/0000-0002-3519-7582	Association for International Cancer Research; Cancer Research UK via the Oxford Cancer Research Centre; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; Worldwide Cancer Research [12-0027] Funding Source: researchfish	Association for International Cancer Research; Cancer Research UK via the Oxford Cancer Research Centre; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Worldwide Cancer Research	This work was supported in part by the Association for International Cancer Research (to P. S. and A. H.) and Cancer Research UK via the Oxford Cancer Research Centre (to P. S. and A. H.).	Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Baudelet C, 2006, NMR BIOMED, V19, P69, DOI 10.1002/nbm.1002; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Bhujwalla ZM, 2002, NMR BIOMED, V15, P114, DOI 10.1002/nbm.743; Boron WF, 2010, BBA-PROTEINS PROTEOM, V1804, P410, DOI 10.1016/j.bbapap.2009.10.021; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Braun RD, 1999, AM J PHYSIOL-HEART C, V277, pH551, DOI 10.1152/ajpheart.1999.277.2.H551; Brurberg KG, 2004, INT J RADIAT ONCOL, V58, P403, DOI 10.1016/j.ijrobp.2003.09.049; Brurberg KG, 2003, BRIT J CANCER, V89, P350, DOI 10.1038/sj.bjc.6601047; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cardenas-Navia LI, 2004, CANCER RES, V64, P6010, DOI 10.1158/0008-5472.CAN-03-0947; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; CHAPLIN DJ, 1995, BRIT J CANCER, V71, P1210, DOI 10.1038/bjc.1995.235; Chiang WL, 2002, CANCER LETT, V188, P199, DOI 10.1016/S0304-3835(02)00078-2; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Dewhirst MW, 1998, INT J RADIAT ONCOL, V42, P723, DOI 10.1016/S0360-3016(98)00304-6; Dewhirst MW, 1998, SEMIN RADIAT ONCOL, V8, P143, DOI 10.1016/S1053-4296(98)80040-4; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; EISNER DA, 1989, PFLUG ARCH EUR J PHY, V413, P553, DOI 10.1007/BF00594188; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Garcia-Martin ML, 2006, MAGN RESON MED, V55, P309, DOI 10.1002/mrm.20773; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; GULLINO PM, 1965, JNCI-J NATL CANCER I, V34, P857; Hulikova A, 2014, FASEB J, V28, P2762, DOI 10.1096/fj.13-241752; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Johnson DE, 2011, J PHYSIOL-LONDON, V589, P1551, DOI 10.1113/jphysiol.2010.201483; JUNGE W, 1987, BIOCHIM BIOPHYS ACTA, V890, P1, DOI 10.1016/0005-2728(87)90061-2; Kimura H, 1996, CANCER RES, V56, P5522; Lanzen J, 2006, CANCER RES, V66, P2219, DOI 10.1158/0008-5472.CAN-03-2958; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leem CH, 1998, J PHYSIOL-LONDON, V509, P471, DOI 10.1111/j.1469-7793.1998.471bn.x; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Magat J, 2010, MED PHYS, V37, P5434, DOI 10.1118/1.3484056; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mancarella S, 2011, J BIOL CHEM, V286, P44788, DOI 10.1074/jbc.M111.303081; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Mesquita RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037322; Nordfors K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-148; Parkkila S, 2010, MODERN PATHOL, V23, P743, DOI 10.1038/modpathol.2009.189; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Schroeder MA, 2013, P NATL ACAD SCI USA, V110, pE958, DOI 10.1073/pnas.1213471110; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; SEVICK EM, 1988, CANCER RES, V48, P1201; Sheng WW, 2013, J SURG ONCOL, V107, P536, DOI 10.1002/jso.23282; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Spitzer KW, 2002, J PHYSIOL-LONDON, V541, P159, DOI 10.1113/jphysiol.2001.013268; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Swietach P, 2003, PROG BIOPHYS MOL BIO, V83, P69, DOI 10.1016/S0079-6107(03)00027-0; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VAUPEL P, 1989, CANCER RES, V49, P6449; Villafuerte FC, 2014, J PHYSIOL-LONDON, V592, P991, DOI 10.1113/jphysiol.2013.265439; Wang N, 2012, TUMORI, V98, P783, DOI 10.1700/1217.13504; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5; Wykoff CC, 2000, CANCER RES, V60, P7075; Zhou R, 2013, INT J ONCOL, V43, P611, DOI 10.3892/ijo.2013.1972	73	31	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25418	25430		10.1074/jbc.M114.547844	http://dx.doi.org/10.1074/jbc.M114.547844			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25059669	Green Published, hybrid			2022-12-28	WOS:000342130800003
J	Okudaira, N; Ishizaka, Y; Nishio, H				Okudaira, Noriyuki; Ishizaka, Yukihito; Nishio, Hajime			Retrotransposition of Long Interspersed Element 1 Induced by Methamphetamine or Cocaine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; HUMAN LINE-1 PROTEIN; L1 RETROTRANSPOSITION; TERM-MEMORY; NUCLEOTIDE ELEMENT-1; SOMATIC MOSAICISM; NUCLEUS-ACCUMBENS; CELLS; CREB; BRAIN	Long interspersed element 1 (L1) is a retroelement constituting similar to 17% of the human genome. A single human cell has 80-100 copies of L1 capable of retrotransposition (L1-RTP), similar to 10% of which are "hot L1" copies, meaning they are primed for "jumping" within the genome. Recent studies demonstrated induction of L1 activity by drugs of abuse or low molecular weight compounds, but little is known about the underlying mechanism. The aim of this study was to identify the mechanism and effects of methamphetamine (METH) and cocaine on L1-RTP. Our results revealed that METH and cocaine induced L1-RTP in neuronal cell lines. This effect was found to be reverse transcriptase-dependent. However, METH and cocaine did not induce double-strand breaks. RNA interference experiments combined with add-back of siRNA-resistant cDNAs revealed that the induction of L1-RTP by METH or cocaine depends on the activation of cAMP response element-binding protein (CREB). METH or cocaine recruited the L1-encoded open reading frame 1 (ORF1) to chromatin in a CREB-dependent manner. These data suggest that the cellular cascades underlying METH-and cocaine-induced L1-RTP are different from those behind L1-RTP triggered by DNA damage; CREB is involved in drug-induced L1-RTP. L1-RTP caused by drugs of abuse is a novel type of genomic instability, and analysis of this phenomenon might be a novel approach to studying substance-use disorders.	[Okudaira, Noriyuki; Nishio, Hajime] Hyogo Coll Med, Dept Legal Med, Nishinomiya, Hyogo 6638501, Japan; [Ishizaka, Yukihito] Natl Ctr Global Hlth & Med, Dept Intractable Dis, Shinjuku Ku, Tokyo 1628655, Japan	Hyogo College of Medicine; National Center for Global Health & Medicine - Japan	Okudaira, N (corresponding author), Hyogo Coll Med, Dept Legal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	noku@hyo-med.ac.jp			The Sumitomo Foundation [120102]; Takeda Science Foundation; Naito Foundation, Japan	The Sumitomo Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation, Japan(Naito Memorial Foundation)	This work was supported in part by a Grant for Basic Science Research Projects from The Sumitomo Foundation (120102), the Takeda Science Foundation, and the Naito Foundation, Japan.	Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Bundo M, 2014, NEURON, V81, P306, DOI 10.1016/j.neuron.2013.10.053; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Cao GF, 2013, NEUROPHARMACOLOGY, V67, P144, DOI 10.1016/j.neuropharm.2012.10.020; Castells X, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD007380.PUB3; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Dietrich JB, 2009, CELL TISSUE RES, V336, P385, DOI 10.1007/s00441-009-0777-y; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Georgiou I, 2009, HUM MOL GENET, V18, P1221, DOI 10.1093/hmg/ddp022; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Haile CN, 2009, AM J DRUG ALCOHOL AB, V35, P161, DOI 10.1080/00952990902825447; Han WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021637; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Haoudi A, 2004, J BIOMED BIOTECHNOL, P185, DOI 10.1155/S1110724304403131; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Hondebrink L, 2012, NEUROTOXICOLOGY, V33, P255, DOI 10.1016/j.neuro.2011.09.003; Iijima K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-83; Ishizaka Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00191; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; McDaid J, 2006, MOL PHARMACOL, V70, P2064, DOI 10.1124/mol.106.023051; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Okudaira N, 2013, ONCOGENE, V32, P4903, DOI 10.1038/onc.2012.516; Okudaira N, 2011, CANCER SCI, V102, P2000, DOI 10.1111/j.1349-7006.2011.02060.x; Okudaira N, 2010, P NATL ACAD SCI USA, V107, P18487, DOI 10.1073/pnas.1001252107; Pennypacker K R, 1995, J Fla Med Assoc, V82, P551; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Russell K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-48; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1	62	23	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25476	25485		10.1074/jbc.M114.559419	http://dx.doi.org/10.1074/jbc.M114.559419			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25053411	Green Published, hybrid			2022-12-28	WOS:000342130800010
J	Swanson, CJ; Sivaramakrishnan, S				Swanson, Carter J.; Sivaramakrishnan, Sivaraj			Harnessing the Unique Structural Properties of Isolated alpha-Helices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMOOTH-MUSCLE CALDESMON; RIBOSOMAL-PROTEIN L9; X-RAY-SCATTERING; MYOSIN-VI; FUSION PROTEIN; STABLE HELIX; SALT BRIDGES; LIVE CELLS; PEPTIDES; DOMAINS	The alpha-helix is a ubiquitous secondary structural element that is almost exclusively observed in proteins when stabilized by tertiary or quaternary interactions. However, beginning with the unexpected observations of alpha-helix formation in the isolated C-peptide in ribonuclease A, there is growing evidence that a significant percentage (0.2%) of all proteins contain isolated stable single alpha-helical domains (SAH). These SAH domains provide unique structural features essential for normal protein function. A subset of SAH domains contain a characteristic ER/K motif, composed of a repeating sequence of similar to 4 consecutive glutamic acids followed by similar to 4 consecutive basic arginine or lysine (R/K) residues. The ER/K alpha-helix, also termed the ER/K linker, has been extensively characterized in the context of the myosin family of molecular motors and is emerging as a versatile structural element for protein and cellular engineering applications. Here, we review the structure and function of SAH domains, as well as the tools to identify them in natural proteins. We conclude with a discussion of recent studies that have successfully used the modular ER/K linker for engineering chimeric myosin proteins with altered mechanical properties, as well as synthetic polypeptides that can be used to monitor and systematically modulate protein interactions within cells.	[Swanson, Carter J.; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu			National Institutes of Health [1DP2 CA186752-01, 1-R01-GM-105646-01-A1]; American Heart Association (AHA) Scientist Development Grant Award [13SDG14270009]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) Scientist Development Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1DP2 CA186752-01 and 1-R01-GM-105646-01-A1 and the American Heart Association (AHA) Scientist Development Grant Award (13SDG14270009) (to S. S.).	Amet N, 2009, PHARM RES-DORDR, V26, P523, DOI 10.1007/s11095-008-9767-0; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Bai Y, 2006, PHARM RES-DORDR, V23, P2116, DOI 10.1007/s11095-006-9059-5; BIERZYNSKI A, 1982, P NATL ACAD SCI-BIOL, V79, P2470, DOI 10.1073/pnas.79.8.2470; BRYAN J, 1989, J BIOL CHEM, V264, P13873; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kreuzer SM, 2013, BIOPHYS J, V105, P951, DOI 10.1016/j.bpj.2013.05.064; Kuhlman B, 1997, J MOL BIOL, V270, P640, DOI 10.1006/jmbi.1997.1146; LASH JA, 1986, J BIOL CHEM, V261, P6155; Liu DS, 2005, BIOCHEM J, V392, P47, DOI 10.1042/BJ20050688; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Nagy S, 2010, J BIOL CHEM, V285, P26608, DOI 10.1074/jbc.M110.104661; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Ritt M, 2013, J BIOL CHEM, V288, P8875, DOI 10.1074/jbc.M112.421164; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P5929, DOI 10.1073/pnas.95.11.5929; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Sivaramakrishnan S, 2009, BIOPHYS J, V97, P2993, DOI 10.1016/j.bpj.2009.09.009; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Sunitha Margaret S, 2012, BMC Res Notes, V5, P530, DOI 10.1186/1756-0500-5-530; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Wu YJ, 2009, J CHROMATOGR B, V877, P4015, DOI 10.1016/j.jchromb.2009.10.009; Zagrovic B, 2005, J MOL BIOL, V353, P232, DOI 10.1016/j.jmb.2005.08.053; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390	44	44	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25460	25467		10.1074/jbc.R114.583906	http://dx.doi.org/10.1074/jbc.R114.583906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25059657	Green Published, hybrid			2022-12-28	WOS:000342130800006
J	Li, MWM; Wang, JL; Zhao, YO; Fikrig, E				Li, Michelle W. M.; Wang, Jiuling; Zhao, Yang O.; Fikrig, Erol			Innexin AGAP001476 Is Critical for Mediating Anti-Plasmodium Responses in Anopheles Mosquitoes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; MALARIA; COMPLEMENT; IMMUNITY; MIDGUT; TRANSMISSION; INFECTION; DEFENSE	The Toll and IMD pathways are known to be induced upon Plasmodium berghei and Plasmodium falciparum infection, respectively. It is unclear how Plasmodium or other pathogens in the blood meal and their invasion of the midgut epithelium would trigger the innate immune responses in immune cells, in particular hemocytes. Gap junctions, which can mediate both cell-to-cell and cell-to-extracellular communication, may participate in this signal transduction. This study examined whether innexins, gap junction proteins in insects, are involved in anti-Plasmodium responses in Anopheles gambiae. Inhibitor studies using carbenoxolone indicated that blocking innexons resulted in an increase in Plasmodium oocyst number and infection prevalence. This was accompanied by a decline in TEP1 levels in carbenoxolone-treated mosquitoes. Innexin AGAP001476 mRNA levels in midguts were induced during Plasmodium infection and a knockdown of AGAP001476, but not AGAP006241, caused an induction in oocyst number. Silencing AGAP001476 caused a concurrent increase in vitellogenin levels, a TEP1 inhibitor, in addition to a reduced level of TEP1-LRIM1-APL1C complex in hemolymph. Both vitellogenin and TEP1 are regulated by Cactus under the Toll pathway. Simultaneous knockdown of cactus and AGAP001476 failed to reverse the near refractoriness induced by the knockdown of cactus, suggesting that the AGAP001476-mediated anti-Plasmodium response is Cactus-dependent. These data demonstrate a critical role for innexin AGAP001476 in mediating innate immune responses against Plasmodium through Toll pathway in mosquitoes.	[Li, Michelle W. M.; Wang, Jiuling; Zhao, Yang O.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Li, Michelle W. M.; Zhao, Yang O.; Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Howard Hughes Medical Institute	Li, MWM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA.	wingmanmichelle.li@yale.edu	Li, Michelle W M/N-4914-2019; Li, Wing Man Michelle/B-8295-2008	Li, Michelle W M/0000-0002-9778-984X; Li, Wing Man Michelle/0000-0002-9778-984X				Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Angrisano F, 2012, INT J PARASITOL, V42, P519, DOI 10.1016/j.ijpara.2012.02.004; [Anonymous], METH AN RES MAN; Bao L, 2007, FEBS LETT, V581, P5703, DOI 10.1016/j.febslet.2007.11.030; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Billingsley PF, 2008, TRENDS PARASITOL, V24, P396, DOI 10.1016/j.pt.2008.06.003; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bohrmann J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-111; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Cirimotich CM, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/891342; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clayton AM, 2014, J INNATE IMMUN, V6, P169, DOI 10.1159/000353602; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver Lindsey, 2007, J Vis Exp, P230, DOI 10.3791/230; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Li MWM, 2013, ADV EXP MED BIOL, V763, P260; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Magnusson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021572; Mead EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-366; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Ojo KK, 2012, J CLIN INVEST, V122, P2301, DOI 10.1172/JCI61822; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; VANDERBE.JP, 1966, J PARASITOL, V52, P559, DOI 10.2307/3276326; Verselis VK, 2013, NEUROPHARMACOLOGY, V75, P517, DOI 10.1016/j.neuropharm.2013.03.020; WHO, 2012, WORLD MALARIA REPORT 2012, P1	36	11	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24885	24897		10.1074/jbc.M114.554519	http://dx.doi.org/10.1074/jbc.M114.554519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25035430	Green Published, hybrid			2022-12-28	WOS:000341985300014
J	Kirschner, KM; Braun, JF; Jacobi, CL; Rudigier, LJ; Persson, AB; Scholz, H				Kirschner, Karin M.; Braun, Julian F. W.; Jacobi, Charlotte L.; Rudigier, Lucas J.; Persson, Anja Bondke; Scholz, Holger			Amine Oxidase Copper-containing 1 (AOC1) Is a Downstream Target Gene of the Wilms Tumor Protein, WT1, during Kidney Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Polyamine; Transcription Regulation; Tumor Suppressor Gene	AMILORIDE-BINDING-PROTEIN; TRKB NEUROTROPHIN RECEPTOR; DIAMINE OXIDASE; SUPPRESSOR WT1; ORNITHINE-DECARBOXYLASE; SEX DETERMINATION; TRANSCRIPTIONAL ACTIVATOR; PROGENITOR CELLS; PORCINE KIDNEY; BOVINE SERUM	Background: Polyamines and their diamine precursor putrescine are ubiquitous organic polycations involved in cell growth and proliferation. Results: The Wilms tumor suppressor, WT1, stimulates transcription of the AOC1 gene, which encodes the key enzyme for putrescine breakdown. Conclusion: WT1-dependent regulation of putrescine degradation, mediated by AOC1, has a role in kidney morphogenesis. Significance: The findings provide novel insights into transcriptional mechanisms controlling genitourinary development. Amine oxidase copper-containing 1 (AOC1; formerly known as amiloride-binding protein 1) is a secreted glycoprotein that catalyzes the degradation of putrescine and histamine. Polyamines and their diamine precursor putrescine are ubiquitous to all organisms and fulfill pivotal functions in cell growth and proliferation. Despite the importance of AOC1 in regulating polyamine breakdown, very little is known about the molecular mechanisms that control its expression. We report here that the Wilms tumor protein, WT1, which is necessary for normal kidney development, activates transcription of the AOC1 gene. Expression of a firefly luciferase reporter under control of the proximal AOC1 promoter was significantly enhanced by co-transfection of a WT1 expression construct. Binding of WT1 protein to a cis-regulatory element in the AOC1 promoter was confirmed by electrophoretic mobility shift assay and chromatin immunoprecipitation. Antisense inhibition of WT1 protein translation strongly reduced Aoc1 transcripts in cultured murine embryonic kidneys and gonads. Aoc1 mRNA levels correlated with WT1 protein in several cell lines. Double immunofluorescent staining revealed a co-expression of WT1 and AOC1 proteins in the developing genitourinary system of mice and rats. Strikingly, induced changes in polyamine homeostasis affected branching morphogenesis of cultured murine embryonic kidneys in a developmental stage-specific manner. These findings suggest that WT1-dependent control of polyamine breakdown, which is mediated by changes in AOC1 expression, has a role in kidney organogenesis.	[Kirschner, Karin M.; Braun, Julian F. W.; Jacobi, Charlotte L.; Rudigier, Lucas J.; Persson, Anja Bondke; Scholz, Holger] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636; Jacobi, Charlotte/0000-0001-6398-2812	Deutsche Forschungsgemeinschaft [Scho634/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho634/8-1.	Abdulhussein AA, 2014, AMINO ACIDS, V46, P655, DOI 10.1007/s00726-013-1553-6; Balitskaya O. V., 1992, Voprosy Onkologii (St. Petersburg), V38, P674; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BEAVEN MA, 1980, BIOCHEM PHARMACOL, V29, P2897, DOI 10.1016/0006-2952(80)90033-7; BIEGANSKI T, 1982, INT J BIOCHEM, V14, P949, DOI 10.1016/0020-711X(82)90080-5; BIEGANSKI T, 1983, BIOCHIM BIOPHYS ACTA, V756, P196, DOI 10.1016/0304-4165(83)90092-2; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; CHASSANDE O, 1994, J BIOL CHEM, V269, P14484; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; FEUERSTEIN BG, 1991, J CELL BIOCHEM, V46, P37, DOI 10.1002/jcb.240460107; GAHL WA, 1982, BIOCHEM J, V202, P603, DOI 10.1042/bj2020603; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Kim GH, 2009, CAN J NEUROL SCI, V36, P14, DOI 10.1017/S0317167100006247; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; Klocker J, 2005, INFLAMM RES, V54, pS54, DOI 10.1007/s00011-004-0425-7; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Li RS, 1999, EXP CELL RES, V247, P257, DOI 10.1006/excr.1998.4361; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Loikkanen I, 2005, DIFFERENTIATION, V73, P303, DOI 10.1111/j.1432-0436.2005.00036.x; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; MATTHEWS HR, 1993, BIOESSAYS, V15, P561, DOI 10.1002/bies.950150811; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; MIZUGUCHI H, 1994, J BIOCHEM-TOKYO, V116, P631, DOI 10.1093/oxfordjournals.jbchem.a124572; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moore AW, 1999, DEVELOPMENT, V126, P1845; MOREL F, 1992, BIOCHEM BIOPH RES CO, V187, P178, DOI 10.1016/S0006-291X(05)81476-7; Moshier JA, 1996, NUCLEIC ACIDS RES, V24, P1149, DOI 10.1093/nar/24.6.1149; NOVOTNY WF, 1994, J BIOL CHEM, V269, P9921; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; Raithel M, 1999, INFLAMM RES, V48, pS75; Schwelberger HG, 1998, INFLAMM RES, V47, pS58; Schwelberger HG, 1997, BBA-PROTEIN STRUCT M, V1340, P152, DOI 10.1016/S0167-4838(97)00039-3; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Sebela M, 2007, J NEURAL TRANSM, V114, P793, DOI 10.1007/s00702-007-0690-z; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tantini B, 2006, J MOL CELL CARDIOL, V40, P775, DOI 10.1016/j.yjmcc.2006.03.002; Wagner KD, 2001, J AM SOC NEPHROL, V12, P1188, DOI 10.1681/ASN.V1261188; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wagner N, 2005, DEVELOPMENT, V132, P1327, DOI 10.1242/dev.01682; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; WOLFF DJ, 1995, ARCH BIOCHEM BIOPHYS, V316, P290, DOI 10.1006/abbi.1995.1040; Zahedi K, 2011, METHODS MOL BIOL, V720, P379, DOI 10.1007/978-1-61779-034-8_24; Zheng QS, 2014, REPRODUCTION, V147, P45, DOI 10.1530/REP-13-0299	67	17	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24452	24462		10.1074/jbc.M114.564336	http://dx.doi.org/10.1074/jbc.M114.564336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037221	Green Published, hybrid			2022-12-28	WOS:000341505600038
J	Tamura, S; Matsumoto, N; Takeba, R; Fujiki, Y				Tamura, Shigehiko; Matsumoto, Naomi; Takeba, Ryota; Fujiki, Yukio			AAA Peroxins and Their Recruiter Pex26p Modulate the Interactions of Peroxins Involved in Peroxisomal Protein Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Peroxisome; Protein Complex; Protein Targeting; Scaffold Protein; AAA Peroxins; Pex14p; Pex26p; Protein Import	SIGNAL TYPE-1 RECEPTOR; BIOGENESIS DISORDERS; MEMBRANE-PROTEIN; PTS1 RECEPTOR; CONSERVED CYSTEINE; CELL MUTANTS; PEX14P; PEX5P; MATRIX; COMPLEMENTATION	Background: Pex26p and AAA peroxins are required for the peroxisome biogenesis. Results: Pex26p directly binds to Pex14p and acts as a scaffold protein to specify the molecular target of AAA peroxins. Conclusion: AAA peroxins modulate the interaction between Pex26p and Pex14p on peroxisome membrane. Significance: Functional modulation by Pex26p and AAA peroxins of the interaction between peroxins makes important contribution to peroxisome biogenesis. Pex1p and Pex6p are required for the relocation of the import receptor Pex5p from the peroxisomal membrane to the cytosol. We herein show that mammalian Pex26p directly binds to Pex14p, the initial docking receptor of Pex5p, and interacts with Pex5p via Pex14p. The binding affinity of Pex26p to Pex14p is altered by Pex5p. Further evidence suggests that the N-terminal region in Pex26p acts as a scaffold protein to recruit Pex14pPex5p complex together with Pex1pPex6p complexes on peroxisomes. Pex26p binding to Pex14p was suppressed by overexpression of Pex1p and Pex6p in an ATP-dependent manner, whereas Pex14p was not competed out by Pex1p and Pex6p from Pex26p mutant defective in peroxisomal matrix protein import. These results suggested that peroxisome biogenesis requires Pex1p- and Pex6p-regulated dissociation of Pex14p from Pex26p. Pex1p homo-oligomer directly binds to Pex5p as assessed by a surface plasmon resonance-based assay. Moreover, cytosolic Pex1p is likely to maintain the functional oligomer of Pex5p. Taken together, in the peroxisomal protein import, AAA peroxins modulate the interaction between Pex26p and Pex14p on peroxisome membrane as well as Pex5p oligomer in the cytosol.	[Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Tamura, Shigehiko] Kyushu Univ, Fac Arts & Sci, Fukuoka 8128581, Japan; [Tamura, Shigehiko; Matsumoto, Naomi; Takeba, Ryota] Kyushu Univ, Grad Sch Syst Life Sci, Grad Sch, Fukuoka 8128581, Japan	Kyushu University; Kyushu University; Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp	Matsumoto, Naomi/AAD-3468-2022; Matsumoto, Naomi/AFL-4833-2022		Global Center of Excellence (GCOE) program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Science and Technology Agency of Japan; Takeda Science Foundation; Japan Foundation for Applied Enzymology;  [21570116];  [24570134];  [20370039];  [24247038];  [25116717];  [25112518];  [26116007]	Global Center of Excellence (GCOE) program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; 	This work was supported in part by Grants-in-aid for Scientific Research 21570116 and 24570134 (to S. T.) and 20370039, 24247038, 25116717, 25112518, and 26116007 (to Y. F.); by the Global Center of Excellence (GCOE) program and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by a CREST (Core Research for Evolutional Science and Technology) grant (to Y. F.) from the Science and Technology Agency of Japan, and grants (to Y. F.) from Takeda Science Foundation and Japan Foundation for Applied Enzymology.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Beyer A, 1997, PROTEIN SCI, V6, P2043; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; Furuki S, 2006, J BIOL CHEM, V281, P1317, DOI 10.1074/jbc.M510044200; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Johnson MA, 2001, YEAST, V18, P621, DOI 10.1002/yea.711; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Komori M, 1999, FEBS LETT, V457, P397, DOI 10.1016/S0014-5793(99)01087-X; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Matsumoto N, 2003, AM J HUM GENET, V73, P233, DOI 10.1086/377004; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nashiro C, 2011, TRAFFIC, V12, P774, DOI 10.1111/j.1600-0854.2011.01182.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2001, J BIOL CHEM, V276, P2858, DOI 10.1074/jbc.M007730200; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; Tamura S, 2001, BIOCHEM J, V357, P417, DOI 10.1042/0264-6021:3570417; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Thoms S, 2012, J MED GENET, V49, P314, DOI 10.1136/jmedgenet-2012-100899; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Weller S, 2005, AM J HUM GENET, V76, P987, DOI 10.1086/430637; Will GK, 1999, MOL CELL BIOL, V19, P2265; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	42	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24336	24346		10.1074/jbc.M114.588038	http://dx.doi.org/10.1074/jbc.M114.588038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016021	Green Published, hybrid			2022-12-28	WOS:000341505600029
J	Burnett, BJ; Altman, RB; Ferguson, A; Wasserman, MR; Zhou, Z; Blanchard, SC				Burnett, Benjamin J.; Altman, Roger B.; Ferguson, Angelica; Wasserman, Michael R.; Zhou, Zhou; Blanchard, Scott C.			Direct Evidence of an Elongation Factor-Tu/Ts.GTP.Aminoacyl-tRNA Quaternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein; Guanine Nucleotide Exchange Factor (GEF); Protein Synthesis; Translation; Translation Elongation Factor; Elongation Factor Ts; Elongation Factor Tu; Guanosine Nucleotide Exchange Factor; Ternary Complex	AMINOACYL-TRANSFER-RNA; DIFFERENT GROWTH-RATES; CENTER-DOT-GTP; FACTOR TU-GTP; FACTOR EF-TU; ESCHERICHIA-COLI; FACTOR-TS; TERNARY COMPLEX; NUCLEOTIDE EXCHANGE; BACTERIAL RIBOSOME	Background: Elongation factor-Tu (EF-Tu) chaperones aminoacyl-tRNA (aa-tRNA) to the elongating ribosome as a ternary complex with GTP. Results: EF-Ts facilitates EF-TuGTP binding to aa-tRNA through direct, transient interactions. Conclusion: EF-Ts accelerates the formation and decay of ternary complex through the formation of a transient EF-Tu/TsGTPaa-tRNA quaternary complex. Significance: These newly described interactions of EF-Ts may serve to regulate ternary complex abundance in the cell. During protein synthesis, elongation factor-Tu (EF-Tu) bound to GTP chaperones the entry of aminoacyl-tRNA (aa-tRNA) into actively translating ribosomes. In so doing, EF-Tu increases the rate and fidelity of the translation mechanism. Recent evidence suggests that EF-Ts, the guanosine nucleotide exchange factor for EF-Tu, directly accelerates both the formation and dissociation of the EF-Tu-GTP-Phe-tRNA(Phe) ternary complex (Burnett, B. J., Altman, R. B., Ferrao, R., Alejo, J. L., Kaur, N., Kanji, J., and Blanchard, S. C. (2013) J. Biol. Chem. 288, 13917-13928). A central feature of this model is the existence of a quaternary complex of EF-Tu/TsGTPaa-tRNA(aa). Here, through comparative investigations of phenylalanyl, methionyl, and arginyl ternary complexes, and the development of a strategy to monitor their formation and decay using fluorescence resonance energy transfer, we reveal the generality of this newly described EF-Ts function and the first direct evidence of the transient quaternary complex species. These findings suggest that EF-Ts may regulate ternary complex abundance in the cell through mechanisms that are distinct from its guanosine nucleotide exchange factor functions.	[Burnett, Benjamin J.; Altman, Roger B.; Wasserman, Michael R.; Zhou, Zhou; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Ferguson, Angelica; Blanchard, Scott C.] Weill Cornell Med Coll, Triinst Program Chem Biol, New York, NY 10065 USA	Cornell University; Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, Triinst Program Chem Biol, 1300 York Ave, New York, NY 10065 USA.	scb2005@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Altman, Russ/0000-0003-3859-2905	National Institutes of Health [GM079238, GM098859, MH099491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238, R01GM098859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC012026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079238, GM098859, and MH099491 (to S. C. B.).	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BREMER H, 1996, ESCHERICHIA COLI SAL, P1559; Burnett BJ, 2013, J BIOL CHEM, V288, P13917, DOI 10.1074/jbc.M113.460014; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Chapman SJ, 2012, J BIOL CHEM, V287, P1229, DOI 10.1074/jbc.M111.294850; CONDON C, 1992, EMBO J, V11, P4175, DOI 10.1002/j.1460-2075.1992.tb05511.x; Dale T, 2004, BIOCHEMISTRY-US, V43, P6159, DOI 10.1021/bi036290o; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ehrenberg M, 2013, BIOCHIMIE, V95, P643, DOI 10.1016/j.biochi.2012.11.012; FERSHT A, 1985, ENZYME STRUCTURE MEC, P128; FURANO AV, 1975, P NATL ACAD SCI USA, V72, P4780, DOI 10.1073/pnas.72.12.4780; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; GORDON J, 1970, BIOCHEMISTRY-US, V9, P912, DOI 10.1021/bi00806a028; GORDON J, 1970, BIOCHEMISTRY-US, V9, P4233, DOI 10.1021/bi00823a028; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; Johansson M, 2008, CURR OPIN MICROBIOL, V11, P141, DOI 10.1016/j.mib.2008.02.015; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MIYAJIMA A, 1978, J BIOCHEM, V83, P453, DOI 10.1093/oxfordjournals.jbchem.a131932; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RIBEIRO S, 1995, ANAL BIOCHEM, V228, P330, DOI 10.1006/abio.1995.1359; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Rodnina MV, 1995, BIOCHEM CELL BIOL, V73, P1221, DOI 10.1139/o95-132; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; ROMERO G, 1985, J BIOL CHEM, V260, P6167; Sanderson LE, 2007, BIOCHEMISTRY-US, V46, P6194, DOI 10.1021/bi602548v; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; THOMPSON RC, 1982, J BIOL CHEM, V257, P6677; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wohlgemuth SE, 2013, NUCLEIC ACIDS RES, V41, P8021, DOI 10.1093/nar/gkt602; YAMAMOTO M, 1976, CELL, V8, P129, DOI 10.1016/0092-8674(76)90194-X; YEGIAN CD, 1966, P NATL ACAD SCI USA, V55, P839, DOI 10.1073/pnas.55.4.839; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; ZECHMEISTER L, 1953, EXPERIENTIA, V9, P16, DOI 10.1007/BF02147696	62	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23917	23927		10.1074/jbc.M114.583385	http://dx.doi.org/10.1074/jbc.M114.583385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990941	Green Published, hybrid			2022-12-28	WOS:000341505000057
J	Halpern, KB; Vana, T; Walker, MD				Halpern, Keren Bahar; Vana, Tal; Walker, Michael D.			Paradoxical Role of DNA Methylation in Activation of FoxA2 Gene Expression during Endoderm Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; DNA Methylation; Polycomb; Transcription; Transcription Enhancer; Endoderm	EMBRYONIC STEM-CELLS; DEFINITIVE ENDODERM; TRANSCRIPTION FACTORS; MOLECULAR-BASIS; HUMAN GENOME; BETA-CELLS; IN-VIVO; MOUSE; SEQUENCE; MICE	Background: The transcription factor FoxA2 is a key mediator of endoderm development and pancreas gene expression. Results: DNA methylation is paradoxically associated with active expression of the FoxA2 gene. Conclusion: Developmental control genes such as FoxA2 may be regulated by a novel genetic mechanism. Significance: Clarification of this mechanism may provide a better understanding of how developmental pathways are activated. The transcription factor FoxA2 is a master regulator of endoderm development and pancreatic beta cell gene expression. To elucidate the mechanisms underlying the activation of the FoxA2 gene during differentiation, we have compared the epigenetic status of undifferentiated human embryonic stem cells (hESCs), hESC-derived early endoderm stage cells (CXCR4+ cells), and pancreatic islet cells. Unexpectedly, a CpG island in the promoter region of the FoxA2 gene displayed paradoxically high levels of DNA methylation in expressing tissues (CXCR4+, islets) and low levels in nonexpressing tissues. This CpG island region was found to repress reporter gene expression and bind the Polycomb group protein SUZ12 and the DNA methyltransferase (DNMT)3b preferentially in undifferentiated hESCs as compared with CXCR4+ or islets cells. Consistent with this, activation of FoxA2 gene expression, but not CXCR4 or SOX17, was strongly inhibited by 5-aza-2-deoxycytidine and by knockdown of DNMT3b. We hypothesize that in nonexpressing tissues, the lack of DNA methylation allows the binding of DNA methyltransferases and repressing proteins, such as Polycomb group proteins; upon differentiation, DNMT activation leads to CpG island methylation, causing loss of repressor protein binding. These results suggest a novel and unexpected role for DNA methylation in the activation of FoxA2 gene expression during differentiation.	[Halpern, Keren Bahar; Vana, Tal; Walker, Michael D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Rehovot, Israel.	m.walker@weizmann.ac.il			Juvenile Diabetes Research Foundation; Israel Science Foundation; Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute	This work was supported by grants from the Juvenile Diabetes Research Foundation, the Israel Science Foundation, and the Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute (to M. D. W.).	ANG SL, 1993, DEVELOPMENT, V119, P1301; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Niesen MI, 2005, J BIOL CHEM, V280, P38914, DOI 10.1074/jbc.M504633200; Nishizaki Y, 2001, MECH DEVELOP, V102, P57, DOI 10.1016/S0925-4773(01)00281-7; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; PANI L, 1992, MOL CELL BIOL, V12, P552, DOI 10.1128/MCB.12.2.552; POLLACK Y, 1980, P NATL ACAD SCI-BIOL, V77, P6463, DOI 10.1073/pnas.77.11.6463; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Sharivkin R, 2012, MOL CELL PROTEOMICS, V11, P586, DOI 10.1074/mcp.M111.016840; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Varghese S, 2007, CANCER RES, V67, P9371, DOI 10.1158/0008-5472.CAN-07-0674; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	45	60	62	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23882	23892		10.1074/jbc.M114.573469	http://dx.doi.org/10.1074/jbc.M114.573469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016019	Green Published, hybrid			2022-12-28	WOS:000341505000054
J	Chen, LP; Ma, L; Bai, Q; Zhu, XN; Zhang, JM; Wei, Q; Li, DC; Gao, C; Li, J; Zhang, ZB; Liu, CX; He, ZN; Zeng, XW; Zhang, AH; Qu, WD; Zhuang, ZX; Chen, W; Xiao, YM				Chen, Liping; Ma, Lu; Bai, Qing; Zhu, Xiaonian; Zhang, Jinmiao; Wei, Qing; Li, Daochuan; Gao, Chen; Li, Jie; Zhang, Zhengbao; Liu, Caixia; He, Zhini; Zeng, Xiaowen; Zhang, Aihua; Qu, Weidong; Zhuang, Zhixiong; Chen, Wen; Xiao, Yongmei			Heavy Metal-induced Metallothionein Expression Is Regulated by Specific Protein Phosphatase 2A Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; HUMAN HEPATOCELLULAR CARCINOMAS; SIGNAL-TRANSDUCTION CASCADES; GENE-EXPRESSION; OXIDATIVE STRESS; FACTOR MTF-1; RESPONSIVE TRANSCRIPTION; GUANGDONG PROVINCE; CADMIUM TOXICITY; ZINC HOMEOSTASIS	Induction of metallothionein (MT) expression is involved in metal homeostasis and detoxification. To identify the key pathways that regulate metal-induced cytotoxicity, we investigate how phosphorylated metal-responsive transcription factor-1 (MTF-1) contributed to induction of MT expression. Immortal human embryonic kidney cells (HEK cells) were treated with seven kinds of metals including cadmium chloride (CdCl2), zinc sulfate (ZnSO4), copper sulfate(CuSO4), lead acetate (PbAc), nickel sulfate (NiSO4), sodium arsenite (NaAsO2), and potassium bichromate (K2Cr2O7). The MT expression was induced in a dose-response and time-dependent manner upon various metal treatments. A cycle of phosphorylation and dephosphorylation was required for translocation of MTF-1 from cytoplasm to nucleus, leading to the up-regulation of MTs expression. Protein phosphatase 2A (PP2A) participated in regulating MT expression through dephosphorylation of MTF-1. A loss-of-function screen revealed that the specific PP2A complexes containing PR110 were involved in metal-induced MT expression. Suppression of PP2A PR110 in HEK cells resulted in the persistent MTF-1 phosphorylation and the disturbance of MTF-1 nuclear translocation, which was concomitant with a significant decrease of MT expression and enhanced cytotoxicity in HEK cells. Notably, MTF-1 was found in complex with specific PP2A complexes containing the PR110 subunit upon metal exposure. Furthermore, we identify that the dephosphorylation of MTF-1 at residue Thr-254 is directly regulated by PP2A PR110 complexes and responsible for MTF-1 activation. Taken together, these findings delineate a novel pathway that determines cytotoxicity in response to metal treatments and provide new insight into the role of PP2A in cellular stress response.	[Chen, Liping; Ma, Lu; Bai, Qing; Zhu, Xiaonian; Zhang, Jinmiao; Wei, Qing; Li, Daochuan; Gao, Chen; Li, Jie; Zhang, Zhengbao; Liu, Caixia; He, Zhini; Zeng, Xiaowen; Chen, Wen; Xiao, Yongmei] Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Aihua] Guiyang Med Univ, Sch Publ Hlth, Dept Toxicol, Guiyang 550004, Peoples R China; [Qu, Weidong] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Zhuang, Zhixiong] Shenzhen Ctr Dis Control & Prevent, Dept Toxicol, Shenzhen 518001, Peoples R China	Sun Yat Sen University; Guizhou Medical University; Fudan University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Chen, W (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Prevent Med, Guangzhou 510080, Guangdong, Peoples R China.	chenwen@mail.sysu.edu.cn; xiaoym@mail.sysu.edu.cn		He, Zhini/0000-0002-9185-5500	National Key Basic Research and Development Program [2010CB912803, 2012CB525003]; National Nature Science Foundation of China (NSFC) [81325017, 81072284, 30901211, 81172603, 81273127]; National "Twelfth Five-Year" Plan for Science and Technology [2014BAI12B02]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS; Natural Science Foundation of Guangdong Province [S2012040007713]	National Key Basic Research and Development Program(National Basic Research Program of China); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Key Basic Research and Development Program (2010CB912803 and 2012CB525003), the National Nature Science Foundation of China (NSFC) (81325017, 81072284, 30901211, 81172603, and 81273127), the National "Twelfth Five-Year" Plan for Science and Technology (2014BAI12B02), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS (2010), and the Natural Science Foundation of Guangdong Province (S2012040007713).	AbdelMageed AB, 1997, CANCER GENE THER, V4, P199; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; Anderson RS, 1999, DEV COMP IMMUNOL, V23, P443, DOI 10.1016/S0145-305X(99)00029-4; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Baillat G, 2001, MOL BIOL CELL, V12, P663, DOI 10.1091/mbc.12.3.663; Bao QS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-217; Brandao R, 2006, CELL BIOL TOXICOL, V22, P429, DOI 10.1007/s10565-006-0119-8; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Conrad CC, 1997, J TOXICOL ENV HEALTH, V52, P527; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; DeLisle RC, 1996, AM J PHYSIOL-CELL PH, V271, pC1103, DOI 10.1152/ajpcell.1996.271.4.C1103; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; ECKER DJ, 1986, J BIOL CHEM, V261, P6895; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Ghoshal K, 2001, PROG NUCLEIC ACID RE, V66, P357; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; GOERING PL, 1983, TOXICOL APPL PHARM, V70, P195, DOI 10.1016/0041-008X(83)90095-9; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; HART BA, 1993, CANCER LETT, V75, P121, DOI 10.1016/0304-3835(93)90196-G; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Huang P C, 1987, Experientia Suppl, V52, P439; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jiang HM, 2004, BIOCHEM J, V382, P33, DOI 10.1042/BJ20040504; Jin RX, 2002, CARCINOGENESIS, V23, P81, DOI 10.1093/carcin/23.1.81; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Knapen D, 2007, AQUAT TOXICOL, V82, P163, DOI 10.1016/j.aquatox.2007.02.008; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; Li XY, 2004, J BIOL CHEM, V279, P765, DOI 10.1074/jbc.M307907200; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Ma T, 2004, WORLD J GASTROENTERO, V10, P172, DOI 10.3748/wjg.v10.i2.172; Mao J, 2012, CARCINOGENESIS, V33, P2568, DOI 10.1093/carcin/bgs287; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Miura N, 2007, YAKUGAKU ZASSHI, V127, P665, DOI 10.1248/yakushi.127.665; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Murphy BJ, 1999, CANCER RES, V59, P1315; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Papetti P, 2009, ENVIRON MONIT ASSESS, V159, P589, DOI 10.1007/s10661-008-0725-4; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Pearce LL, 2000, J NUTR, V130, p1467S, DOI 10.1093/jn/130.5.1467S; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Shariati F, 2011, BIOL TRACE ELEM RES, V143, P281, DOI 10.1007/s12011-010-8877-9; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Song MO, 2014, EXP CELL RES, V322, P39, DOI 10.1016/j.yexcr.2014.01.013; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304; Wang M, 2011, BIOL TRACE ELEM RES, V142, P362, DOI 10.1007/s12011-010-8802-2; Wang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-319; YAMADA H, 1991, CHEM-BIOL INTERACT, V78, P347, DOI 10.1016/0009-2797(91)90064-E; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091	60	44	51	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22413	22426		10.1074/jbc.M114.548677	http://dx.doi.org/10.1074/jbc.M114.548677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962574	hybrid, Green Published			2022-12-28	WOS:000340593500051
J	Ahmed, AU; Sarvestani, ST; Gantier, MP; Williams, BRG; Hannigan, GE				Ahmed, Afsar U.; Sarvestani, Soroush T.; Gantier, Michael P.; Williams, Bryan R. G.; Hannigan, Gregory E.			Integrin-linked Kinase Modulates Lipopolysaccharide- and Helicobacter pylori-induced Nuclear Factor kappa B-activated Tumor Necrosis Factor-alpha Production via Regulation of p65 Serine 536 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; Inflammation; Innate Immunity; Lipopolysaccharide (LPS); NF-kappa B; Phosphatidylinositide 3-Kinase (PI 3-Kinase); Small Molecule; Tumor Necrosis Factor (TNF); Integrin-linked Kinase (ILK); p65	INFLAMMATORY RESPONSES; PROTEIN-KINASE; PROINFLAMMATORY CYTOKINES; GENE-EXPRESSION; INNATE IMMUNITY; CELL-SURVIVAL; UP-REGULATION; CANCER-CELLS; IKK-BETA; PATHWAY	Background: Aberrantly elevated integrin-linked kinase (ILK) activity is associated with inflammatory diseases and tumors. Results: In response to bacterial stimulus and infection, ILK modulates pro-inflammatory cytokine TNF- production and activates nuclear factor B signaling via p65 Ser-536 phosphorylation. Conclusion: ILK promotes pro-inflammatory signaling during immune responses to diverse stimuli. Significance: ILK is a potential therapeutic target for inflammatory diseases. Integrin-linked kinase (ILK) is a ubiquitously expressed and highly conserved serine-threonine protein kinase that regulates cellular responses to a wide variety of extracellular stimuli. ILK is involved in cell-matrix interactions, cytoskeletal organization, and cell signaling. ILK signaling has also been implicated in oncogenesis and progression of cancers. However, its role in the innate immune system remains unknown. Here, we show that ILK mediates pro-inflammatory signaling in response to lipopolysaccharide (LPS). Pharmacological or genetic inhibition of ILK in mouse embryonic fibroblasts and macrophages selectively blocks LPS-induced production of the pro-inflammatory cytokine tumor necrosis factor (TNF-). ILK is required for LPS-induced activation of nuclear factor B (NF-B) and transcriptional induction of TNF-. The modulation of LPS-induced TNF- synthesis by ILK does not involve the classical NF-B pathway, because IB- degradation and p65 nuclear translocation are both unaffected by ILK inhibition. Instead, ILK is involved in an alternative activation of NF-B signaling by modulating the phosphorylation of p65 at Ser-536. Furthermore, ILK-mediated alternative NF-B activation through p65 Ser-536 phosphorylation also occurs during Helicobacter pylori infection in macrophages and gastric cancer cells. Moreover, ILK is required for H. pylori-induced TNF- secretion in macrophages. Although ILK-mediated phosphorylation of p65 at Ser-536 is independent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway during LPS stimulation, upon H. pylori infection this event is dependent on the PI3K/Akt pathway. Our findings implicate ILK as a critical regulatory molecule for the NF-B-mediated pro-inflammatory signaling pathway, which is essential for innate immune responses against pathogenic microorganisms.	[Hannigan, Gregory E.] MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic 3168, Australia; Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University	Williams, BRG (corresponding author), MIMR PHI Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	bryan.williams@mimr-phi.org; greg.hannigan@mimr-phi.org	Gantier, Michael/B-7512-2011; Williams, Bryan R. G./A-5021-2009; Gantier, Michael/H-7954-2019; Sarvestani, Soroush Tajadine/H-6495-2019; Ahmed, Afsar/I-7084-2013	Gantier, Michael/0000-0003-3740-698X; Williams, Bryan R. G./0000-0002-4969-1151; Gantier, Michael/0000-0003-3740-698X; Ahmed, Afsar Uddin/0000-0001-8788-6518; Ahmed, Afsar/0000-0001-9209-7089	Government of Victoria; Ron Evans Cancer Research Fellowship	Government of Victoria; Ron Evans Cancer Research Fellowship	This work was supported in part by the Operational Infrastructure Support Program of the Government of Victoria.; Supported by a Ron Evans Cancer Research Fellowship.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Agouni A, 2007, CARCINOGENESIS, V28, P1893, DOI 10.1093/carcin/bgm106; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Chen DH, 2013, ACTA HISTOCHEM, V115, P128, DOI 10.1016/j.acthis.2012.05.004; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; del Nogal M, 2012, APOPTOSIS, V17, P1261, DOI 10.1007/s10495-012-0769-3; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Huang X, 2013, WORLD J GASTROENTERO, V19, P5085, DOI 10.3748/wjg.v19.i31.5085; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kalra J, 2010, ONCOGENE, V29, P6343, DOI 10.1038/onc.2010.366; Kalra J, 2011, CANCER BIOL THER, V11, P826, DOI 10.4161/cbt.11.9.15183; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li L, 2007, ADV EXP MED BIOL, V598, P49; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Makino K, 2004, ONCOGENE, V23, P3883, DOI 10.1038/sj.onc.1207485; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Medvedev AE, 1998, J IMMUNOL, V160, P4535; Muranyi AL, 2010, LEUKEMIA RES, V34, P1358, DOI 10.1016/j.leukres.2010.01.006; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Piotrowski J, 1997, SCAND J GASTROENTERO, V32, P203, DOI 10.3109/00365529709000195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Slomiany BL, 1999, BIOCHEM BIOPH RES CO, V258, P17, DOI 10.1006/bbrc.1999.0578; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Suganuma M, 2006, J BIOCHEM MOL BIOL, V39, P1; Suganuma M, 2012, CANCER LETT, V322, P133, DOI 10.1016/j.canlet.2012.03.027; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yee NK, 2013, EUR J IMMUNOL, V43, P779, DOI 10.1002/eji.201242550	74	39	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27776	27793		10.1074/jbc.M114.574541	http://dx.doi.org/10.1074/jbc.M114.574541			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100717	Green Published, hybrid			2022-12-28	WOS:000342852800035
J	Wang, T; Cook, I; Falany, CN; Leyh, TS				Wang, Ting; Cook, Ian; Falany, Charles N.; Leyh, Thomas S.			Paradigms of Sulfotransferase Catalysis THE MECHANISM OF SULT2A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ESTROGEN SULFOTRANSFERASE; SUBSTRATE-INHIBITION; DEHYDROEPIANDROSTERONE SULFOTRANSFERASE; 3'-PHOSPHOADENOSINE 5'-PHOSPHATE; KINETIC CHARACTERIZATION; PHENOL SULFOTRANSFERASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; HEPARAN-SULFATE; HUMAN-BRAIN	Human cytosolic sulfotransferases (SULTs) regulate the activities of thousands of signaling small molecules via transfer of the sulfuryl moiety (-SO3) from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyls and primary amines of acceptors. Sulfonation controls the affinities of ligands for their targets, and thereby regulates numerous receptors, which, in turn, regulate complex cellular responses. Despite their biological and medical relevance, basic SULT mechanism issues remain unresolved. To settle these issues, and to create an in-depth model of SULT catalysis, the complete kinetic mechanism of a representative member of the human SULT family, SULT2A1, was determined. The mechanism is composed of eight enzyme forms that interconvert via 22 rate constants, each of which was determined independently. The result is a complete quantitative description of the mechanism that accurately predicts complex enzymatic behavior. This is the first description of a SULT mechanism at this resolution, and it reveals numerous principles of SULT catalysis and resolves previously ambiguous issues. The structures and catalytic behaviors SULTs are highly conserved; hence, the mechanism presented here should prove paradigmatic for the family.	[Falany, Charles N.] Univ Alabama Birmingham, Dept Pharmacol, Sch Med, Birmingham, AL 35294 USA; [Falany, Charles N.] Univ Alabama Birmingham, Dept Toxicol, Sch Med, Birmingham, AL 35294 USA; [Wang, Ting; Cook, Ian; Leyh, Thomas S.] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu	Wang, Ting/J-7577-2015		National Institutes of Health [GM38953, GM54469]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038953, R01GM106158, R29GM038953, R01GM054469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38953 (to C. N. F.) and GM54469 (to T. S. L.).	Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Anderson JAM, 2001, J BIOL CHEM, V276, P9755, DOI 10.1074/jbc.M010048200; Argiolas A, 2001, BJU INT, V88, P18, DOI 10.1046/j.1464-4096.2001.00124.x; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; BARNES S, 1986, J LIPID RES, V27, P1111; Bevc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022265; Bischoff ED, 2010, J LIPID RES, V51, P900, DOI [10.1194/jlr.M900096-JLR200, 10.1194/jlr.M900096]; Blanchard RL, 2004, PHARMACOGENETICS, V14, P199, DOI 10.1097/00008571-200403000-00009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; FALANY CN, 1989, BIOCHEM J, V260, P641, DOI 10.1042/bj2600641; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Gulcan HO, 2011, ARCH BIOCHEM BIOPHYS, V507, P232, DOI 10.1016/j.abb.2010.12.027; Kotov A, 1999, J STEROID BIOCHEM, V68, P137, DOI 10.1016/S0960-0760(99)00022-9; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lee KA, 2003, J BIOL CHEM, V278, P44593, DOI 10.1074/jbc.M308312200; LEYTE A, 1991, J BIOL CHEM, V266, P740; Li L, 2007, J CYST FIBROS, V6, P23, DOI 10.1016/j.jcf.2006.05.001; Lipscombe RJ, 1998, J LEUKOCYTE BIOL, V63, P342, DOI 10.1002/jlb.63.3.342; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Lu LY, 2008, MOL PHARMACOL, V73, P660, DOI 10.1124/mol.107.041038; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Nagar S, 2006, MOL PHARMACOL, V69, P2084, DOI 10.1124/mol.105.019240; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Pauff SM, 2013, J ORG CHEM, V78, P711, DOI 10.1021/jo302065u; Poeppel P, 2005, FEBS J, V272, P1179, DOI 10.1111/j.1742-4658.2005.04553.x; Robertson JFR, 2004, BRIT J CANCER, V90, pS7, DOI 10.1038/sj.bjc.6601630; Saeki Y, 1998, J BIOCHEM-TOKYO, V124, P55, DOI 10.1093/oxfordjournals.jbchem.a022097; Sakakibara Y, 1998, J BIOL CHEM, V273, P33929, DOI 10.1074/jbc.273.51.33929; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; STEVENTON GB, 1989, NEUROLOGY, V39, P883, DOI 10.1212/WNL.39.7.883; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; Tyapochkin E, 2008, BIOCHEMISTRY-US, V47, P11894, DOI 10.1021/bi801211t; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; WHITTEMORE RM, 1986, ARCH BIOCHEM BIOPHYS, V249, P464, DOI 10.1016/0003-9861(86)90023-8; WHITTEMORE RM, 1985, BIOCHEMISTRY-US, V24, P2477, DOI 10.1021/bi00331a013; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	50	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26474	26480		10.1074/jbc.M114.573501	http://dx.doi.org/10.1074/jbc.M114.573501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25056952	Green Published, hybrid			2022-12-28	WOS:000342128800038
J	Yoshida, T; Yamashita, M; Horimai, C; Hayashi, M				Yoshida, Tadashi; Yamashita, Maho; Horimai, Chihiro; Hayashi, Matsuhiko			Kruppel-like Factor 4 Protein Regulates Isoproterenol-induced Cardiac Hypertrophy by Modulating Myocardin Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; IN-VIVO; GENE-EXPRESSION; DIFFERENTIATION MARKERS; OXIDIZED PHOSPHOLIPIDS; CONDITIONAL DELETION; KRUPPEL-LIKE-FACTOR-4; ACTIVATION; RECEPTOR; MICE	Kruppel-like factor 4 (KLF4) plays an important role in vascular diseases, including atherosclerosis and vascular injury. Although KLF4 is expressed in the heart in addition to vascular cells, the role of KLF4 in cardiac disease has not been fully determined. The goals of this study were to investigate the role of KLF4 in cardiac hypertrophy and to determine the underlying mechanisms. Cardiomyocyte-specific Klf4 knockout (CM Klf4 KO) mice were generated by the Cre/LoxP technique. Cardiac hypertrophy was induced by chronic infusion of the beta-adrenoreceptor agonist isoproterenol (ISO). Results showed that ISO-induced cardiac hypertrophy was enhanced in CM Klf4 KO mice compared with control mice. Accelerated cardiac hypertrophy in CM Klf4 KO mice was accompanied by the augmented cellular enlargement of cardiomyocytes as well as the exaggerated expression of fetal cardiac genes, including atrial natriuretic factor (Nppa). Additionally, induction of myocardin, a transcriptional cofactor regulating fetal cardiac genes, was enhanced in CM Klf4 KO mice. Interestingly, KLF4 regulated Nppa expression by modulating the expression and activity of myocardin, providing a mechanical basis for accelerated cardiac hypertrophy in CM Klf4 KO mice. Moreover, we showed that KLF4 mediated the antihypertrophic effect of trichostatin A, a histone deacetylase inhibitor, because ISO-induced cardiac hypertrophy in CM Klf4 KO mice was attenuated by olmesartan, an angiotensin II type 1 antagonist, but not by trichostatin A. These results provide novel evidence that KLF4 is a regulator of cardiac hypertrophy by modulating the expression and the activity of myocardin.	[Yoshida, Tadashi; Yamashita, Maho; Horimai, Chihiro; Hayashi, Matsuhiko] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Tokyo 1608582, Japan	Keio University	Yoshida, T (corresponding author), Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Y. and M. H.) and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. Y.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Ido A, 2003, J CARDIOVASC PHARM, V41, pS133; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Kee HJ, 2009, J MOL CELL CARDIOL, V47, P770, DOI 10.1016/j.yjmcc.2009.08.022; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lorell BH, 2000, CIRCULATION, V102, P470; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000622; Yoshida T, 2014, J ATHEROSCLER THROMB, V21, P402; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360; Yoshida T, 2010, J BIOL CHEM, V285, P21175, DOI 10.1074/jbc.M110.112482; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhang GX, 2007, J MOL CELL CARDIOL, V42, P804, DOI 10.1016/j.yjmcc.2007.01.012; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	39	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26107	26118		10.1074/jbc.M114.582809	http://dx.doi.org/10.1074/jbc.M114.582809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100730	Green Published, hybrid			2022-12-28	WOS:000342128800008
J	Cao, HN; Walton, JD; Brumm, P; Phillips, GN				Cao, Hongnan; Walton, Jonathan D.; Brumm, Phil; Phillips, George N., Jr.			Structure and Substrate Specificity of a Eukaryotic Fucosidase from Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-FUCOSIDASE; HYDROLASE FAMILY 29; XYLOGLUCAN OLIGOSACCHARIDES; FUCOSYLATED XYLOGLUCAN; GLYCOSYLATION PATHWAYS; THERMOTOGA-MARITIMA; ESSENTIAL RESIDUES; CRYSTAL-STRUCTURE; L-FUCOSE; IDENTIFICATION	The secreted glycoside hydrolase family 29 (GH29) alpha-L-fucosidase from plant pathogenic fungus Fusarium graminearum (FgFCO1) actively releases fucose from the xyloglucan fragment. We solved crystal structures of two active-site conformations, i.e. open and closed, of apoFgFCO1 and an open complex with product fucose at atomic resolution. The closed conformation supports catalysis by orienting the conserved general acid/base Glu-288 nearest the predicted glycosidic position, whereas the open conformation possibly represents an unreactive state with Glu-288 positioned away from the catalytic center. A flexible loop near the substrate binding site containing a non-conserved GGSFT sequence is ordered in the closed but not the open form. We also identified a novel C-terminal beta gamma-crystallin domain in FgFCO1 devoid of calcium binding motif whose homologous sequences are present in various glycoside hydrolase families. N-Glycosylated FgFCO1 adopts a monomeric state as verified by solution small angle x-ray scattering in contrast to reported multimeric fucosidases. Steady-state kinetics shows that FgFCO1 prefers alpha 1,2 over alpha 1,3/4 linkages and displays minimal activity with p-nitrophenyl fucoside with an acidic pH optimum of 4.6. Despite a retaining GH29 family fold, the overall specificity of FgFCO1 most closely resembles inverting GH95 alpha-fucosidase, which displays the highest specificity with two natural substrates harboring the Fuc alpha 1-2Gal glycosidic linkage, a xyloglucan-derived nonasaccharide, and 2'-fucosyllactose. Furthermore, FgFCO1 hydrolyzes H-disaccharide (lacking a + 2 subsite sugar) at a rate 10(3)-fold slower than 2'-fucosyllactose. We demonstrated the structurally dynamic active site of FgFCO1 with flexible general acid/base Glu, a common feature shared by several bacterial GH29 fucosidases to various extents.	[Cao, Hongnan; Phillips, George N., Jr.] Rice Univ, Houston, TX 77005 USA; [Cao, Hongnan; Phillips, George N., Jr.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Walton, Jonathan D.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Brumm, Phil] C5 6 Technol Corp, Middleton, WI 53562 USA	Rice University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Michigan State University; United States Department of Energy (DOE)	Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, MS140, Houston, TX 77005 USA.	georgep@rice.edu		Cao, Hongnan/0000-0003-2496-1298	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-+06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; National Institutes of Health [P41RR02301, RR02781, RR08438]; Biomedical Research Training Program/Center for Research Resources [P41GM66326(NIGMS)]; University of Wisconsin; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; National Institutes of Health Protein Structure Initiative Grant [U54 GM079401]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR008438, S10RR002781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326, U01GM098248] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Training Program/Center for Research Resources; University of Wisconsin; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health Protein Structure Initiative Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the LS-CAT beamline for help and advice on data collection. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-+06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor under Grant 085P1000817. We also thank Dr. Sam Butcher and Dr. Jordan Burke of the Biochemistry Department, University of Wisconsin-Madison, for generously collecting SAXS data and advising on data analysis. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grants P41RR02301 (Biomedical Research Training Program/Center for Research Resources) and P41GM66326(NIGMS). Additional equipment was purchased with funds from the University of Wisconsin, the National Institutes of Health Grants Grant RR02781 and RR08438, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and the United States Department of Agriculture. We thank Dr. Johnnie Walker and Dr. Brian Fox from the University of Wisconsin-Madison for advice on affinity gel electrophoresis assays. We thank Dr. Philip Gao from University of Kansas for graciously synthesizing crystallin domain of FgFCO1. Dr. Cao is especially thankful to Dr. Craig Bingman, Kate Helmich, and Bob Smith from the University of Wisconsin-Madison for valuable advice on crystallography and thermofluor assays and Dr. Ragothaman Yennamalli and Fengbin Wang from Rice University for helpful comments. We thank the Mass Spectrometry/Proteomics Facility of the Biotechnology Center at UW-Madison for the MALDI TOF analysis and the Iowa State University Protein Facility for the N-terminal sequencing. We acknowledge use of facilities acquired in part by the National Institutes of Health Protein Structure Initiative Grant U54 GM079401.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALHADEFF JA, 1977, MOL CELL BIOCHEM, V18, P33, DOI 10.1007/BF00215277; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobucci-Ponzano B, 2005, BIOCHEMISTRY-US, V44, P6331, DOI 10.1021/bi047495f; DAWSON G, 1977, ARCH BIOCHEM BIOPHYS, V184, P12, DOI 10.1016/0003-9861(77)90321-6; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; DICIOCCIO RA, 1982, J BIOL CHEM, V257, P714; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Intra J, 2007, GENE, V392, P34, DOI 10.1016/j.gene.2006.11.002; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Joly C, 2002, J EXP BOT, V53, P1429, DOI 10.1093/jexbot/53.373.1429; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusaykin Mikhail, 2008, Biotechnology Journal, V3, P904, DOI 10.1002/biot.200700054; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard R, 2008, PHYTOCHEMISTRY, V69, P1983, DOI 10.1016/j.phytochem.2008.03.024; LEVY S, 1991, PLANT J, V1, P195; Liu SW, 2009, BIOCHEMISTRY-US, V48, P110, DOI 10.1021/bi801529t; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDOUGALL GJ, 1989, PLANT PHYSIOL, V89, P883, DOI 10.1104/pp.89.3.883; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishitani K, 1997, INT REV CYTOL, V173, P157; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Paper JM, 2013, APPL MICROBIOL BIOT, V97, P5371, DOI 10.1007/s00253-012-4423-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Purkiss AG, 2002, J BIOL CHEM, V277, P4199, DOI 10.1074/jbc.M110083200; Roberts SM, 2012, METHOD ENZYMOL, V510, P141, DOI 10.1016/B978-0-12-415931-0.00008-2; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Shaikh FA, 2013, BIOCHEMISTRY-US, V52, P5857, DOI 10.1021/bi400183q; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TANAKA K, 1970, FEBS LETT, V9, P45, DOI 10.1016/0014-5793(70)80307-6; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; van Bueren AL, 2010, CHEMBIOCHEM, V11, P1971, DOI 10.1002/cbic.201000339; van Bueren AL, 2010, J AM CHEM SOC, V132, P1804, DOI 10.1021/ja908908q; Vanhooren PT, 1999, J CHEM TECHNOL BIOT, V74, P479, DOI 10.1002/(SICI)1097-4660(199906)74:6<479::AID-JCTB76>3.0.CO;2-E; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vincken JP, 1996, CARBOHYD RES, V288, P219, DOI 10.1016/0008-6215(96)00096-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Willems PJ, 1999, EUR J HUM GENET, V7, P60, DOI 10.1038/sj.ejhg.5200272; YORK WS, 1984, PLANT PHYSIOL, V75, P295, DOI 10.1104/pp.75.2.295; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Zeleny R, 2006, PHYTOCHEMISTRY, V67, P641, DOI 10.1016/j.phytochem.2006.01.021	78	27	27	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25624	25638		10.1074/jbc.M114.583286	http://dx.doi.org/10.1074/jbc.M114.583286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086049	hybrid, Green Published			2022-12-28	WOS:000342130800023
J	Sanematsu, K; Kusakabe, Y; Shigemura, N; Hirokawa, T; Nakamura, S; Imoto, T; Ninomiya, Y				Sanematsu, Keisuke; Kusakabe, Yuko; Shigemura, Noriatsu; Hirokawa, Takatsugu; Nakamura, Seiji; Imoto, Toshiaki; Ninomiya, Yuzo			Molecular Mechanisms for Sweet-suppressing Effect of Gymnemic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE TASTE RECEPTOR; HUMAN T1R3; PROTEIN; GENE; IDENTIFICATION; RESPONSES; CYCLODEXTRINS; SYLVESTRE; SUBUNITS; STIMULI	Gymnemic acids are triterpene glycosides that selectively suppress taste responses to various sweet substances in humans but not in mice. This sweet-suppressing effect of gymnemic acids is diminished by rinsing the tongue with gamma-cyclodextrin (gamma-CD). However, little is known about the molecular mechanisms underlying the sweet-suppressing effect of gymnemic acids and the interaction between gymnemic acids versus sweet taste receptor and/or gamma-CD. To investigate whether gymnemic acids directly interact with human (h) sweet receptor hT1R2 + hT1R3, we used the sweet receptor T1R2 + T1R3 assay in transiently transfected HEK293 cells. Similar to previous studies in humans and mice, gymnemic acids (100 mu g/ml) inhibited the [Ca2+](i) responses to sweet compounds in HEK293 cells heterologously expressing hT1R2 + hT1R3 but not in those expressing the mouse (m) sweet receptor mT1R2 + mT1R3. The effect of gymnemic acids rapidly disappeared after rinsing the HEK293 cells with gamma-CD. Using mixed species pairings of human and mouse sweet receptor subunits and chimeras, we determined that the transmembrane domain of hT1R3 was mainly required for the sweet-suppressing effect of gymnemic acids. Directed mutagenesis in the transmembrane domain of hT1R3 revealed that the interaction site for gymnemic acids shared the amino acid residues that determined the sensitivity to another sweet antagonist, lactisole. Glucuronic acid, which is the common structure of gymnemic acids, also reduced sensitivity to sweet compounds. In our models, gymnemic acids were predicted to dock to a binding pocket within the transmembrane domain of hT1R3.	[Sanematsu, Keisuke; Shigemura, Noriatsu; Ninomiya, Yuzo] Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Res & Dev Ctr Taste & Odor Sensing, Fukuoka 8128582, Japan; [Sanematsu, Keisuke; Nakamura, Seiji] Kyushu Univ, Sect Oral & Maxillofacial Oncol, Grad Sch Dent Sci, Res & Dev Ctr Taste & Odor Sensing, Fukuoka 8128582, Japan; [Ninomiya, Yuzo] Kyushu Univ, Div Sensory Physiol, Res & Dev Ctr Taste & Odor Sensing, Fukuoka 8128582, Japan; [Kusakabe, Yuko] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Imoto, Toshiaki] Tottori Univ, Div Integrat Physiol, Dept Funct Morphol & Regulatory Sci, Yonago, Tottori 6838503, Japan	Kyushu University; Kyushu University; Kyushu University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Tottori University	Ninomiya, Y (corresponding author), Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yuninom@dent.kyushu-u.ac.jp	Kusakabe, Yuko/AAA-1944-2019	Shigemura, Noriatsu/0000-0002-3061-6362	KAKENHI [18109013, 18077004, 23249081, 23792128, 25861759]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in whole or part by KAKENHI Grants 18109013, 18077004, and 23249081(to Y. N.) and 23792128 and 25861759 (to K. S.).	Assadi-Porter FM, 2010, J MOL BIOL, V398, P584, DOI 10.1016/j.jmb.2010.03.017; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; DIAMANT H, 1965, ACTA PHYSIOL SCAND, V64, P67, DOI 10.1111/j.1748-1716.1965.tb04154.x; HELLEKANT G, 1976, ACTA PHYSIOL SCAND, V98, P136, DOI 10.1111/j.1748-1716.1976.tb00233.x; Hellekant G, 1998, PHYSIOL BEHAV, V65, P191, DOI 10.1016/S0031-9384(97)00532-5; HELLEKANT G, 1985, ACTA PHYSIOL SCAND, V124, P399, DOI 10.1111/j.1748-1716.1985.tb07675.x; Hellekant G, 1996, PHYSIOL BEHAV, V60, P469, DOI 10.1016/S0031-9384(96)80021-7; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Imoto T., 1990, SEIBUTSU BUTSURI, V30, P146; INOUE Y, 1981, B CHEM SOC JPN, V54, P809, DOI 10.1246/bcsj.54.809; INOUE Y, 1981, J AM CHEM SOC, V103, P7393, DOI 10.1021/ja00414a085; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Izutani Y, 2005, FEBS J, V272, P6154, DOI 10.1111/j.1742-4658.2005.05014.x; Izutani Y, 2005, FEBS LETT, V579, P4333, DOI 10.1016/j.febslet.2005.06.070; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kanetkar P, 2007, J CLIN BIOCHEM NUTR, V41, P77, DOI 10.3164/jcbn.2007010; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; KURIHARA Y, 1992, CRIT REV FOOD SCI, V32, P231, DOI 10.1080/10408399209527598; KURIHARA Y, 1969, LIFE SCI PT 1 PHYSI, V8, P537, DOI 10.1016/0024-3205(69)90449-4; LI S, 1992, CHEM REV, V92, P1457, DOI 10.1021/cr00014a009; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nagaoka T., 1990, SEITO GIJUTSU KENKYU, V38, P61; Nakamura Y, 1999, J NUTR, V129, P1214, DOI 10.1093/jn/129.6.1214; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Porchezhian E, 2003, PHARMAZIE, V58, P5; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sanchez R, 2000, METH MOL B, V143, P97; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shigemura N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006717; Suenaga M, 2008, J COMPUT CHEM-JPN, V7, P33, DOI 10.2477/jccj.H1920; Suenaga M, 2005, J COMPUT CHEM-JPN, V4, P24; SUTTISRI R, 1995, J ETHNOPHARMACOL, V47, P9, DOI 10.1016/0378-8741(95)01248-C; WARREN RM, 1959, J APPL PHYSIOL, V14, P40, DOI 10.1152/jappl.1959.14.1.40; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107	52	36	37	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25711	25720		10.1074/jbc.M114.560409	http://dx.doi.org/10.1074/jbc.M114.560409			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25056955	Green Published, hybrid			2022-12-28	WOS:000342130800030
J	Wong, CM; Wang, YD; Lee, JTH; Huang, Z; Wu, DH; Xu, AM; Lam, KSL				Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Wu, Donghai; Xu, Aimin; Lam, Karen Siu Ling			Adropin Is a Brain Membrane-bound Protein Regulating Physical Activity via the NB-3/Notch Signaling Pathway in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION MOLECULE NB-3; GESTATIONAL DIABETES-MELLITUS; ENDOTHELIAL FUNCTION; MOTOR COORDINATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; PURKINJE-CELLS; DEFICIENCY; OBESITY; PLASMA	Adropin is a highly conserved polypeptide that has been suggested to act as an endocrine factor that plays important roles in metabolic regulation, insulin sensitivity, and endothelial functions. However, in this study, we provide evidence demonstrating that adropin is a plasma membrane protein expressed abundantly in the brain. Using a yeast two-hybrid screening approach, we identified NB-3/Contactin 6, a brain-specific, non-canonical, membrane-tethered Notch1 ligand, as an interaction partner of adropin. Furthermore, this interaction promotes NB3-induced activation of Notch signaling and the expression of Notch target genes. We also generated and characterized adropin knockout mice to explore the role of adropin in vivo. Adropin knockout mice exhibited decreased locomotor activity and impaired motor coordination coupled with defective synapse formation, a phenotype similar to NB-3 knockout mice. Taken together, our data suggest that adropin is a membrane-bound protein that interacts with the brain-specific Notch1 ligand NB3. It regulates physical activity and motor coordination via the NB-3/Notch signaling pathway and plays an important role in cerebellum development in mice.	[Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Chi-Ming; Wang, Yudong; Lee, Jimmy Tsz Hang; Huang, Zhe; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Chi-Ming; Xu, Aimin; Lam, Karen Siu Ling] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wu, Donghai] Guangzhou Inst Biomed & Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Wong, CM (corresponding author), Univ Hong Kong, Dept Med, Li Ka Shing Fac Med, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	wispwong@hku.hk; amxu@hkucc.hku.hk	Wong, Chi-Ming/A-7627-2013	Wong, Chi-Ming/0000-0002-0025-7135; Huang, Zhe/0000-0003-4943-3723; Lee, Jimmy Tsz Hang/0000-0003-1208-8356	RGC Collaborative Research Fund [HKU2/CRF/12R]; University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology; National 973 Basic Research Program of China [2011CB504004, 2010CB945500]	RGC Collaborative Research Fund(Hong Kong Research Grants Council); University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology; National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by RGC Collaborative Research Fund Grant HKU2/CRF/12R, matching funds from the University of Hong Kong for the State Key Laboratory of Pharmaceutical Biotechnology, and by National 973 Basic Research Program of China (2011CB504004 and 2010CB945500).	Aydin S, 2013, PEPTIDES, V47, P66, DOI 10.1016/j.peptides.2013.07.001; Aydin S, 2013, MOL CELL BIOCHEM, V380, P73, DOI 10.1007/s11010-013-1660-4; Barski JJ, 2003, J NEUROSCI, V23, P3469; Bizzoca A, 2003, DEVELOPMENT, V130, P29, DOI 10.1242/dev.00183; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Butler AA, 2012, J CLIN ENDOCR METAB, V97, P3783, DOI 10.1210/jc.2012-2194; Celik A, 2013, CARDIOVASC THER, V31, P174, DOI 10.1111/1755-5922.12025; Celik E, 2013, J PERINAT MED, V41, P375, DOI 10.1515/jpm-2012-0227; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; Gozal D, 2013, J PEDIATR-US, V163, P1122, DOI 10.1016/j.jpeds.2013.05.040; Hu QD, 2006, DEV NEUROSCI-BASEL, V28, P25, DOI 10.1159/000090750; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Imayoshi I, 2011, MOL NEUROBIOL, V44, P7, DOI 10.1007/s12035-011-8186-0; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Klein SM, 2012, J NEUROSCI METH, V203, P292, DOI 10.1016/j.jneumeth.2011.10.001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar KG, 2012, OBESITY, V20, P1394, DOI 10.1038/oby.2012.31; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lerman I, 2002, J APPL PHYSIOL, V92, P2245, DOI 10.1152/japplphysiol.01045.2001; Lian WL, 2011, INTERNAL MED, V50, P1523, DOI 10.2169/internalmedicine.50.5163; Lovren F, 2010, CIRCULATION, V122, pS185, DOI 10.1161/CIRCULATIONAHA.109.931782; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qiu X, 2014, PEPTIDES, V52, P19, DOI 10.1016/j.peptides.2013.11.013; Sakurai K, 2010, NEUROSCI LETT, V473, P102, DOI 10.1016/j.neulet.2010.02.027; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; Sayin O, 2014, J PEDIATR ENDOCR MET, V27, P479, DOI 10.1515/jpem-2013-0296; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; St-Onge MP, 2014, OBESITY, V22, P1056, DOI 10.1002/oby.20631; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Topuz M, 2013, J INVEST MED, V61, P1161, DOI 10.2310/JIM.0000000000000003; Wu LZ, 2014, CLIN CHEM LAB MED, V52, P751, DOI 10.1515/cclm-2013-0844; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650	38	69	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25976	25986		10.1074/jbc.M114.576058	http://dx.doi.org/10.1074/jbc.M114.576058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074942	Green Published, hybrid			2022-12-28	WOS:000342130800051
J	Zhang, Z; Li, M; Lu, R; Alioua, A; Stefani, E; Toro, L				Zhang, Zhu; Li, Min; Lu, Rong; Alioua, Abderrahmane; Stefani, Enrico; Toro, Ligia			The Angiotensin II Type 1 Receptor (AT1R) Closely Interacts with Large Conductance Voltage- and Ca2+-activated K+ (BK) Channels and Inhibits Their Activity Independent of G-protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY SMOOTH-MUSCLE; SIGNAL-TRANSDUCTION; POTASSIUM CHANNELS; PHOSPHORYLATION; MODULATION; ARTERY; CA2+	Angiotensin II (ANG-II) and BK channels play important roles in the regulation of blood pressure. In arterial smooth muscle, ANG-II inhibits BK channels, but the underlying molecular mechanisms are unknown. Here, we first investigated whether ANG-II utilizes its type 1 receptor (AT1R) to modulate BK activity. Pharmacological, biochemical, and molecular evidence supports a role for AT1R. In renal arterial myocytes, the AT1R antagonist losartan (10 mu M) abolished the ANG-II (1 mu M)-induced reduction of whole cell BK currents, and BK channels and ANG-II receptors were found to co-localize at the cell periphery. We also found that BK inhibition via ANG-II-activated AT1R was independent of G-protein activation (assessed with 500 mu M GDP beta S). In BK-expressing HEK293T cells, ANG-II (1 mu M) also induced a reduction of BK currents, which was contingent on AT1R expression. The molecular mechanisms of AT1R and BK channel coupling were investigated in co-transfected cells. Co-immunoprecipitation showed formation of a macromolecular complex, and live immunolabeling demonstrated that both proteins co-localized at the plasma membrane with high proximity indexes as in arterial myocytes. Consistent with a close association, we discovered that the sole AT1R expression could decrease BK channel voltage sensitivity. Truncated BK proteins revealed that the voltage-sensing conduction cassette is sufficient for BK-AT1R association. Finally, C-terminal yellow and cyan fluorescent fusion proteins, AT1R-YFP and BK-CFP, displayed robust co-localized Forster resonance energy transfer, demonstrating intermolecular interactions at their C termini. Overall, our results strongly suggest that AT1R regulates BK channels through a close protein-protein interaction involving multiple BK regions and independent of G-protein activation.	[Zhang, Zhu; Li, Min; Lu, Rong; Alioua, Abderrahmane; Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Stefani, Enrico; Toro, Ligia] Univ Calif Los Angeles, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Toro, L (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, BH 528 CHS Box 957115, Los Angeles, CA 90095 USA.	ltoro@ucla.edu			National Institutes of Health [HL107418, HL096740, HL088640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107418, R01HL088640, R01HL096740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107418 and HL096740 (to L. T. and E. S.) and HL088640 (to E. S.).	Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Bascands JL, 2001, HYPERTENSION, V38, P1294, DOI 10.1161/hy1201.096540; Bollag WB, 2008, MOL CELL ENDOCRINOL, V296, P53, DOI 10.1016/j.mce.2008.08.022; Goette A, 2008, EUROPACE, V10, P238, DOI 10.1093/europace/eum283; Grimm PR, 2010, KIDNEY INT, V78, P956, DOI 10.1038/ki.2010.272; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hayabuchi Y, 2006, J MOL CELL CARDIOL, V41, P972, DOI 10.1016/j.yjmcc.2006.07.010; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; KUME H, 1992, P NATL ACAD SCI USA, V89, P11051, DOI 10.1073/pnas.89.22.11051; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Matsumoto T, 2010, J PHARMACOL SCI, V112, P299, DOI 10.1254/jphs.09308FP; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Min LJ, 2009, AGEING RES REV, V8, P113, DOI 10.1016/j.arr.2008.12.002; Park WS, 2008, ARCH PHARM RES, V31, P1291, DOI 10.1007/s12272-001-2109-y; Perez GJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1769, DOI 10.1152/ajpcell.2001.281.6.C1769; RUILOPE LM, 1994, HYPERTENSION, V23, P3, DOI 10.1161/01.HYP.23.1.3; Sailer CA, 2006, EUR J NEUROSCI, V24, P442, DOI 10.1111/j.1460-9568.2006.04936.x; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; SCORNIK FS, 1993, AM J PHYSIOL, V265, pH1460, DOI 10.1152/ajpheart.1993.265.4.H1460; Sorensen CM, 2011, PFLUG ARCH EUR J PHY, V462, P655, DOI 10.1007/s00424-011-1018-2; Sumners C, 2002, CLIN EXP PHARMACOL P, V29, P483, DOI 10.1046/j.1440-1681.2002.03660.x; Sun JJ, 2008, LIFE SCI, V82, P600, DOI 10.1016/j.lfs.2007.12.015; TORO L, 1990, J GEN PHYSIOL, V96, P373, DOI 10.1085/jgp.96.2.373; TORO L, 1990, AM J PHYSIOL, V258, pH912, DOI 10.1152/ajpheart.1990.258.3.H912; Touyz RM, 1997, HYPERTENSION, V30, P222, DOI 10.1161/01.HYP.30.2.222; Touyz RM, 2000, PHARMACOL REV, V52, P639; TWITCHELL WA, 1994, MOL PHARMACOL, V46, P793; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zhou XB, 2008, J BIOL CHEM, V283, P21036, DOI 10.1074/jbc.M800447200	38	20	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25678	25689		10.1074/jbc.M114.595603	http://dx.doi.org/10.1074/jbc.M114.595603			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070892	Green Published, hybrid			2022-12-28	WOS:000342130800027
J	Dan, HC; Ebbs, A; Pasparakis, M; Van Dyke, T; Basseres, DS; Baldwin, AS				Dan, Han C.; Ebbs, Aaron; Pasparakis, Manolis; Van Dyke, Terry; Basseres, Daniela S.; Baldwin, Albert S.			Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by I kappa B Kinase alpha (IKK alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; DOMAIN PHOSPHORYLATION; FEEDBACK INHIBITION; GENETIC-ANALYSIS; CANCER; PTEN; RHEB; TUMORIGENESIS; SUPPRESSION; BETA	The serine/threonine protein kinase Akt promotes cell survival, growth, and proliferation through phosphorylation of different downstream substrates. A key effector of Akt is the mammalian target of rapamycin (mTOR). Akt is known to stimulate mTORC1 activity through phosphorylation of tuberous sclerosis complex 2 (TSC2) and PRAS40, both negative regulators of mTOR activity. We previously reported that I kappa B kinase alpha (IKK alpha), a component of the kinase complex that leads to NF-kappa B activation, plays an important role in promoting mTORC1 activity downstream of activated Akt. Here, we demonstrate IKK alpha-dependent regulation of mTORC1 using multiple PTEN null cancer cell lines and an animal model with deletion of IKK alpha. Importantly, IKK alpha is shown to phosphorylate mTOR at serine 1415 in a manner dependent on Akt to promote mTORC1 activity. These results demonstrate that IKK alpha is an effector of Akt in promoting mTORC1 activity.	[Dan, Han C.; Ebbs, Aaron; Basseres, Daniela S.; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany; [Van Dyke, Terry] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA; [Dan, Han C.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Cologne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Bassères, Daniela S/C-6623-2013	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Bassères, Daniela S/0000-0001-7745-3567	National Institutes of Health [CA75080, AI35098, CA73756, K99CA149178]; Department of Defense Postdoctoral (DOD) Fellowship [PC060420]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R00CA149178, K99CA149178, R01CA073756, R01CA075080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Postdoctoral (DOD) Fellowship(United States Department of Defense); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA75080 (to A. S. B.), AI35098 (to A. S. B.), CA73756 (to A. S. B.), and K99CA149178 (to H. C. D.). Additional support was provided by Department of Defense Postdoctoral (DOD) Fellowship PC060420 (to H. C. D.) and by the Samuel Waxman Cancer Research Foundation (to A. S. B.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Dan HC, 2008, J IMMUNOL, V180, P7582, DOI 10.4049/jimmunol.180.11.7582; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinis JM, 2012, MOL CELL BIOL, V32, P2479, DOI 10.1128/MCB.00106-12; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Ozes ON, 1999, NATURE, V401, P82; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	58	82	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25227	25240		10.1074/jbc.M114.554881	http://dx.doi.org/10.1074/jbc.M114.554881			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	24990947	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000341985300042
J	Gonzalez-Gronow, M; Gomez, CF; de Ridder, GG; Ray, R; Pizzo, SV				Gonzalez-Gronow, Mario; Gomez, Cristian Farias; de Ridder, Gustaaf G.; Ray, Rupa; Pizzo, Salvatore V.			Binding of Tissue-type Plasminogen Activator to the Glucose-regulated Protein 78 (GRP78) Modulates Plasminogen Activation and Promotes Human Neuroblastoma Cell Proliferation in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; LONG-TERM POTENTIATION; SURFACE GRP78; SYNAPTIC PLASTICITY; TRANSGENIC MICE; ANNEXIN-II; RECEPTOR; EXPRESSION; HIPPOCAMPUS; KRINGLE-5	The glucose-regulated protein 78 (GRP78) is a plasminogen (Pg) receptor on the cell surface. In this study, we demonstrate that GRP78 also binds the tissue-type plasminogen activator (t-PA), which results in a decrease in K-m and an increase in the V-max for both its amidolytic activity and activation of its substrate, Pg. This results in accelerated Pg activation when GRP78, t-PA, and Pg are bound together. The increase in t-PA activity is the result of a mechanism involving a t-PA lysine-dependent binding site in the GRP78 amino acid sequence (98)LIGRTWNDPSVQQDIKFL(115). We found that GRP78 is expressed on the surface of neuroblastoma SK-N-SH cells where it is co-localized with the voltage-dependent anion channel (VDAC), which is also a t-PA-binding protein in these cells. We demonstrate that both Pg and t-PA serve as a bridge between GRP78 and VDAC bringing them together to facilitate Pg activation. t-PA induces SK-N-SH cell proliferation via binding to GRP78 on the cell surface. Furthermore, Pg binding to the COOH-terminal region of GRP78 stimulates cell proliferation via its microplasminogen domain. This study confirms previous findings from our laboratory showing that GRP78 acts as a growth factor-like receptor and that its association with t-PA, Pg, and VDAC on the cell surface may be part of a system controlling cell growth.	[Gonzalez-Gronow, Mario; Gomez, Cristian Farias] Univ Catolica Norte, Dept Biol Sci, Lab Environm Neurotoxicol, Fac Med, Coquimbo 1781421, Chile; [Gonzalez-Gronow, Mario; de Ridder, Gustaaf G.; Ray, Rupa; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Universidad Catolica del Norte; Duke University	Gonzalez-Gronow, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Box 3712, Durham, NC 27710 USA.	gonza002@mc.duke.edu			Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130451]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1130451.	Cai WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053152; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; Das R, 2010, TRENDS CARDIOVAS MED, V20, P120, DOI 10.1016/j.tcm.2010.10.002; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gonzalez-Gronow M, 2013, J BIOL CHEM, V288, P498, DOI 10.1074/jbc.M112.412502; Gonzalez-Gronow M, 2010, J NEUROIMMUNOL, V227, P153, DOI 10.1016/j.jneuroim.2010.06.001; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; HERBERT JM, 1994, J BIOL CHEM, V269, P3076; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma ZF, 2007, BIOTECHNOL LETT, V29, P517, DOI 10.1007/s10529-006-9290-5; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Misra UK, 2010, BIOCHEM BIOPH RES CO, V392, P538, DOI 10.1016/j.bbrc.2010.01.058; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mizutani A, 1996, BRAIN RES, V739, P276, DOI 10.1016/S0006-8993(96)00834-7; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nicholl SM, 2005, J SURG RES, V127, P39, DOI 10.1016/j.jss.2005.03.004; Ono Y, 2013, BIOCHEM BIOPH RES CO, V434, P904, DOI 10.1016/j.bbrc.2013.04.055; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Ortolano S, 2013, RECENT PATENTS ENDOC, V7, P65, DOI 10.2174/187221413804660962; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Reuning U, 1998, INT J ONCOL, V13, P893; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Samson AL, 2009, BLOOD, V114, P1937, DOI 10.1182/blood-2009-02-203448; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Selim MA, 2011, MELANOMA RES, V21, P323, DOI 10.1097/CMR.0b013e3283471042; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/BST0300222; Tsirka SE, 1997, J NEUROSCI, V17, P543; Tsirka SE, 1997, P NATL ACAD SCI USA, V94, P9779, DOI 10.1073/pnas.94.18.9779; VARADI A, 1981, BIOCHEM BIOPH RES CO, V103, P97, DOI 10.1016/0006-291X(81)91665-X; WOHL RC, 1980, J BIOL CHEM, V255, P2005; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063	45	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25166	25176		10.1074/jbc.M114.589341	http://dx.doi.org/10.1074/jbc.M114.589341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059665	Green Published, hybrid			2022-12-28	WOS:000341985300037
J	Stracka, D; Jozefczuk, S; Rudroff, F; Sauer, U; Hall, MN				Stracka, Daniele; Jozefczuk, Szymon; Rudroff, Florian; Sauer, Uwe; Hall, Michael N.			Nitrogen Source Activates TOR (Target of Rapamycin) Complex 1 via Glutamine and Independently of Gtr/Rag Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE PHOSPHOPROTEOME REVEALS; YEAST SACCHAROMYCES-CEREVISIAE; AMINO-ACID; MASS-SPECTROMETRY; GROWTH-CONTROL; QUANTITATIVE METABOLOMICS; CATABOLITE REPRESSION; GENE-EXPRESSION; CELL-GROWTH; RAG GTPASES	The evolutionary conserved TOR complex 1 (TORC1) activates cell growth in response to nutrients. In yeast, TORC1 responds to the nitrogen source via a poorly understood mechanism. Leucine, and perhaps other amino acids, activates TORC1 via the small GTPases Gtr1 and Gtr2, orthologs of the mammalian Rag GTPases. Here we investigate the activation of TORC1 by the nitrogen source and how this might be related to TORC1 activation by Gtr/Rag. The quality of the nitrogen source, as defined by its ability to promote growth and glutamine accumulation, directly correlates with its ability to activate TORC1 as measured by Sch9 phosphorylation. Preferred nitrogen sources stimulate rapid, sustained Sch9 phosphorylation and glutamine accumulation. Inhibition of glutamine synthesis reduces TORC1 activity and growth. Poor nitrogen sources stimulate rapid but transient Sch9 phosphorylation. A Gtr1 deficiency prevents the transient stimulation of TORC1 but does not affect the sustained TORC1 activity in response to good nitrogen sources. These findings suggest that the nitrogen source must be converted to glutamine, the preferred nitrogen source in yeast, to sustain TORC1 activity. Furthermore, sustained TORC1 activity is independent of Gtr/Rag. Thus, the nitrogen source and Gtr/Rag activate TORC1 via different mechanisms.	[Stracka, Daniele; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Jozefczuk, Szymon; Rudroff, Florian; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch	Sauer, Uwe/Y-3556-2019	Rudroff, Florian/0000-0002-6680-8200; Hall, Michael N/0000-0002-2998-0757	SystemsX.ch, Swiss National Science Foundation; Louis Jeantet Foundation; Canton of Basel	SystemsX.ch, Swiss National Science Foundation; Louis Jeantet Foundation; Canton of Basel	This work was supported by SystemsX.ch, Swiss National Science Foundation, The Louis Jeantet Foundation, and the Canton of Basel.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Ewald JC, 2009, ANAL CHEM, V81, P3623, DOI 10.1021/ac900002u; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; TERSCHURE EG, 1995, J BACTERIOL, V177, P6672, DOI 10.1128/jb.177.22.6672-6675.1995; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; VANDERPL.JB, 1974, BIOCHEM BIOPH RES CO, V56, P580, DOI 10.1016/0006-291X(74)90643-3; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	51	119	120	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25010	25020		10.1074/jbc.M114.574335	http://dx.doi.org/10.1074/jbc.M114.574335			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063813	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000341985300025
J	Yuen, EY; Qin, LY; Wei, J; Liu, WH; Liu, AY; Yan, Z				Yuen, Eunice Y.; Qin, Luye; Wei, Jing; Liu, Wenhua; Liu, Aiyi; Yan, Zhen			Synergistic Regulation of Glutamatergic Transmission by Serotonin and Norepinephrine Reuptake Inhibitors in Prefrontal Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPRESSION; PYRAMIDAL NEURONS; WORKING-MEMORY; CORTEX; ACTIVATION; ANXIETY; PHARMACOLOGY; NORADRENALINE	The monoamine system in the prefrontal cortex has been implicated in various mental disorders and has been the major target of anxiolytics and antidepressants. Clinical studies show that serotonin and norepinephrine reuptake inhibitors (SNRIs) produce better therapeutic effects than single selective reuptake inhibitors, but the underlying mechanisms are largely unknown. Here, we found that low dose SNRIs, by acting on 5-HT1A and alpha(2)-adrenergic receptors, synergistically reduced AMPA receptor (AMPAR)-mediated excitatory postsynaptic currents and AMPAR surface expression in prefrontal cortex pyramidal neurons via a mechanism involving Rab5/dynamin-mediated endocytosis of AMPARs. The synergistic effect of SNRIs on AMPARs was blocked by inhibition of activator of G protein signaling 3, a G protein modulator that prevents reassociation of G(i) protein alpha subunit and prolongs the beta gamma-mediated signaling pathway. Moreover, the depression of AMPAR-mediated excitatory postsynaptic currents by SNRIs required p38 kinase activity, which was increased by 5-HT1A and alpha(2)-adrenergic receptor co-activation in an activator of G protein signaling 3-dependent manner. These results have revealed a potential mechanism for the synergy between the serotonin and norepinephrine systems in the regulation of glutamatergic transmission in cortical neurons.	[Yuen, Eunice Y.; Qin, Luye; Wei, Jing; Liu, Wenhua; Liu, Aiyi; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Wei, Jing; Yan, Zhen] Vet Affairs Western New York Healthcare Syst, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Qin, Luye/GON-8565-2022		National Institutes of Health [MH101690, DA037618]; Veterans Affairs Merit Award [1I01BX001633]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH101690, R25MH077823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037618] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants MH101690 and DA037618 (to Z.Y.). This work was also supported by Veterans Affairs Merit Award 1I01BX001633 (to Z.Y.).	Andrade R, 1998, ANN NY ACAD SCI, V861, P190, DOI 10.1111/j.1749-6632.1998.tb10191.x; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Bradley AJ, 2013, J PSYCHOPHARMACOL, V27, P740, DOI 10.1177/0269881113494937; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Crupi R, 2011, CURR MED CHEM, V18, P4284, DOI 10.2174/092986711797200417; Drevets WC, 1999, BIOL PSYCHIAT, V46, P1375, DOI 10.1016/S0006-3223(99)00189-4; Escriba PV, 2004, NEUROPSYCHOPHARMACOL, V29, P1512, DOI 10.1038/sj.npp.1300459; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jobe PC, 2005, EPILEPSY BEHAV, V7, P602, DOI 10.1016/j.yebeh.2005.07.014; Kia HK, 1996, J COMP NEUROL, V365, P289; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Lemonde S, 2003, J NEUROSCI, V23, P8788; Ninan PT, 1999, J CLIN PSYCHIAT, V60, P12; Nutt DJ, 2002, INT CLIN PSYCHOPHARM, V17, pS1; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Posternak MA, 2005, J CLIN PSYCHIAT, V66, P705, DOI 10.4088/JCP.v66n0605; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rausch JL, 2006, NEUROPSYCHOPHARMACOL, V31, P2274, DOI 10.1038/sj.npp.1301088; Schramm NL, 2001, J NEUROSCI, V21, P4875, DOI 10.1523/JNEUROSCI.21-13-04875.2001; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Tran PV, 2003, J CLIN PSYCHOPHARM, V23, P78, DOI 10.1097/00004714-200302000-00011; Wakeno M, 2008, J CLIN PSYCHOPHARM, V28, P518, DOI 10.1097/JCP.0b013e31818455fc; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Yuen EY, 2008, J BIOL CHEM, V283, P17194, DOI 10.1074/jbc.M801713200; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	43	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25177	25185		10.1074/jbc.M114.567610	http://dx.doi.org/10.1074/jbc.M114.567610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25056951	hybrid, Green Published			2022-12-28	WOS:000341985300038
J	Bai, Q; Parris, RS; Burton, EA				Bai, Qing; Parris, Ritika S.; Burton, Edward A.			Different Mechanisms Regulate Expression of Zebrafish Myelin Protein Zero (P0) in Myelinating Oligodendrocytes and Its Induction following Axonal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; Myelin; Oligodendrocyte; Regenerative Medicine; Transcription Regulation; Protein Zero; Zebrafish	RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT ZEBRAFISH; OPTIC-NERVE; TRANSGENIC ZEBRAFISH; REGENERATION; NEURONS; GROWTH; GENE; PROMOTER	Background: Zebrafish CNS oligodendrocytes up-regulate axon growth-promoting genes following axonal injury. Results: Separate cis-regulatory elements mediate mpz expression in myelinating oligodendrocytes and its transcriptional induction by axonal damage. Conclusion: Different mechanisms specify oligodendroglial mpz expression in the intact and injured CNS. Significance: Mechanisms underlying the zebrafish repair response might be exploited to enhance axonal regeneration in the mammalian CNS. Zebrafish CNS axons regenerate robustly following injury; it is thought that CNS oligodendrocytes contribute to this response by expressing growth-promoting molecules. We characterized the mpz gene, which encodes myelin protein zero and is up-regulated in oligodendroglia following axonal injury. The 2.5-kb mpz mRNA is expressed from a single TATA box promoter. Four independent Tg(mpz:egfp) transgenic zebrafish lines, in which GFP was expressed under the mpz promoter and 10 kb of genomic 5-flanking sequence, showed transgene expression in CNS oligodendrocytes from larval development through adulthood. Following optic nerve crush injury, the mpz:egfp transgene was strongly up-regulated in oligodendrocytes along the regenerating retinotectal projection, mirroring up-regulation of endogenous mpz mRNA. GFP-expressing oligodendroglia were significantly more abundant in the regenerating optic pathway, resulting from both transgene induction in oligodendroglial precursors and the birth of new cells. Up-regulation of the mpz:egfp transgene was not dependent on axonal regeneration, suggesting that the primary signal may be axonal loss, debris, or microglial infiltration. Deletion experiments indicated that an oligodendroglial enhancer located in the region from -6 to -10 kb with respect to the mpz transcriptional start site is dissociable from the cis-regulatory element mediating the mpz transcriptional response to axonal injury, which is located between -1 and -4 kb. These data show that different mechanisms regulate expression of zebrafish mpz in myelinating oligodendrocytes and its induction following axonal injury. The underlying molecular events could potentially be exploited to enhance axonal repair following mammalian CNS injury. The transgenic lines and cis-regulatory constructs reported here will facilitate identification of the relevant signaling pathways.	[Bai, Qing; Parris, Ritika S.; Burton, Edward A.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15213 USA; [Bai, Qing; Parris, Ritika S.; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15240 USA; [Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Dept Neurol, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center	Burton, EA (corresponding author), Univ Pittsburgh, Dept Neurol, 7015 BST 3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	eab25@pitt.edu	Burton, Edward/ABB-1324-2021; Burton, Edward/AAO-9677-2021	Burton, Edward/0000-0002-8072-4636; 	National Institutes of Health, NINDS [NS058369]; Ethel Vincent Charitable Trust; National Institutes of Health Training Grant [AG21885]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058369] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ethel Vincent Charitable Trust; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant NS058369. This work was also supported by the Ethel Vincent Charitable Trust.; Supported by National Institutes of Health Training Grant AG21885.	Ankerhold R, 1999, J NEUROBIOL, V41, P572, DOI 10.1002/(SICI)1097-4695(199912)41:4<572::AID-NEU12>3.3.CO;2-#; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Bai Q, 2006, BRAIN RES, V1113, P33, DOI 10.1016/j.brainres.2006.07.057; Bai Q, 2011, J COMP NEUROL, V519, P1580, DOI 10.1002/cne.22587; Bai Q, 2009, NEUROSCI LETT, V449, P252, DOI 10.1016/j.neulet.2008.10.101; BASTMEYER M, 1991, J NEUROSCI, V11, P626; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Bormann P, 1998, J NEUROSCI RES, V52, P405, DOI 10.1002/(SICI)1097-4547(19980515)52:4<405::AID-JNR4>3.0.CO;2-D; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chung AY, 2013, MOL CELLS, V36, P82, DOI 10.1007/s10059-013-0087-9; Diekmann H, 2005, MOL BIOL EVOL, V22, P1635, DOI 10.1093/molbev/msi158; Goldman D, 2000, NEUROREPORT, V11, P3859, DOI 10.1097/00001756-200011270-00051; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, DEV DYNAM, V239, P3336, DOI 10.1002/dvdy.22455; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Park HC, 2005, J NEUROSCI, V25, P6836, DOI 10.1523/JNEUROSCI.0981-05.2005; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweitzer J, 2003, GLIA, V41, P301, DOI 10.1002/glia.10192; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Thisse Thisse Christine B, 2004, FAST RELEASE CLONES; Udvadia AJ, 2008, GENE EXPR PATTERNS, V8, P382, DOI 10.1016/j.gep.2008.05.002; YAZAKI T, 1994, NEUROSCI LETT, V176, P13, DOI 10.1016/0304-3940(94)90859-1; Yoshida M, 2005, J NEUROSCI RES, V81, P1, DOI 10.1002/jnr.20516	37	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24114	24128		10.1074/jbc.M113.545426	http://dx.doi.org/10.1074/jbc.M113.545426			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028515	Green Published, hybrid			2022-12-28	WOS:000341505600011
J	Vassilopoulos, A; Xiao, CY; Chisholm, C; Chen, WP; Xu, XL; Lahusen, TJ; Bewley, C; Deng, CX				Vassilopoulos, Athanassios; Xiao, Cuiying; Chisholm, Cristine; Chen, Weiping; Xu, Xiaoling; Lahusen, Tyler J.; Bewley, Carole; Deng, Chu-Xia			Synergistic Therapeutic Effect of Cisplatin and Phosphatidylinositol 3-Kinase (PI3K) Inhibitors in Cancer Growth and Metastasis of Brca1 Mutant Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cancer Stem Cells; Cytoskeleton; Drug Resistance; Tumor Metastases; PI3K Signaling	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; STEM-CELLS; INITIATING CELLS; ERM PROTEINS; IDENTIFICATION; RESISTANCE; PATHWAY; PHOSPHORYLATION; CYTOSKELETON	Background: Metastasis is a serious problem that claims the lives of breast cancer patients. Results: Rapamycin and cisplatin synergistically inhibit CSC-mediated primary and metastatic cancer growth by blocking mTOR signaling and cytoskeletal remodeling. Conclusion: Cancer stem cells are involved in both primary and metastatic cancer growth of Brca1 tumors through distinct signaling pathways. Significance: Targeting cancer stem cell-specific pathways may reveal new therapeutic strategies. Drug resistance and cancer metastasis are two major problems in cancer research. During a course of therapeutic treatment in Brca1-associated tumors, we found that breast cancer stem cells (CSCs) exhibit an intrinsic ability to metastasize and acquire drug resistance through distinct signaling pathways. Microarray analysis indicated that the cytoskeletal remodeling pathway was differentially regulated in CSCs, and this was further evidenced by the inhibitory role of reagents that impair this pathway in the motility of cancer cells. We showed that cisplatin treatment, although initially inhibiting cancer growth, preventing metastasis through blocking cytoskeletal remodeling, and retarding CSC motility, eventually led to drug resistance associated with a marked increase in the number of CSCs. This event was at least partially attributed to the activation of PI3K signaling, and it could be significantly inhibited by co-treatment with rapamycin. These results provide strong evidence that cytoskeletal rearrangement and PI3K/AKT signaling play distinct roles in mediating CSC mobility and viability, respectively, and blocking both pathways synergistically may inhibit primary and metastatic cancer growth.	[Vassilopoulos, Athanassios; Xiao, Cuiying; Chisholm, Cristine; Xu, Xiaoling; Lahusen, Tyler J.; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil, NIH, Bethesda, MD 20892 USA; [Bewley, Carole] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), Bldg 10,Rm 9N105,10 Ctr Dr, Bethesda, MD 20814 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; Chen, Wei/GZK-7348-2022	Bewley, Carole/0000-0003-2203-0852	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056009, ZIADK031135, ZIADK056011] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDDK.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albert S, 2010, EXPERT OPIN INV DRUG, V19, P919, DOI 10.1517/13543784.2010.499121; Anders C, 2008, ONCOLOGY-NY, V22, P1233; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brodie SG, 2001, ONCOGENE, V20, P7514, DOI 10.1038/sj.onc.1204929; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dine J, 2013, CANCER METAST REV, V32, P25, DOI 10.1007/s10555-012-9403-7; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Jain P, 2011, FRONT BIOSCI-LANDMRK, V16, P1824, DOI 10.2741/3824; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Lam L, 2009, BREAST CANCER RES TR, V118, P605, DOI 10.1007/s10549-008-0231-y; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Metaferia BB, 2007, J AM CHEM SOC, V129, P2434, DOI 10.1021/ja068538d; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Sunayama J, 2010, STEM CELLS, V28, P1930, DOI 10.1002/stem.521; Tassone P, 2009, CANCER BIOL THER, V8, P648, DOI 10.4161/cbt.8.7.7968; Vassilopoulos A, 2014, ONCOGENE, V33, P5477, DOI 10.1038/onc.2013.516; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Xiang T, 2011, ONCOGENE, V30, P2443, DOI 10.1038/onc.2010.603; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	49	20	20	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24202	24214		10.1074/jbc.M114.567552	http://dx.doi.org/10.1074/jbc.M114.567552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006250	Green Published, hybrid			2022-12-28	WOS:000341505600018
J	Leung, A; Parks, BW; Du, J; Trac, C; Setten, R; Chen, Y; Brown, K; Lusis, AJ; Natarajan, R; Schones, DE				Leung, Amy; Parks, Brian W.; Du, Juan; Trac, Candi; Setten, Ryan; Chen, Yin; Brown, Kevin; Lusis, Aldons J.; Natarajan, Rama; Schones, Dustin E.			Open Chromatin Profiling in Mice Livers Reveals Unique Chromatin Variations Induced by High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Diet; Gene Regulation; Liver Metabolism; Metabolic Disease; Gene-environment Interaction	TRANSCRIPTION FACTOR; GENE; ENHANCERS; OBESITY; MUSCLE; SITES; SEQ	Background: Metabolic diseases result from a combination of multiple genetic and environmental factors. Results: High fat diet leads to chromatin remodeling in mice liver tissue in a strain-dependent manner. Conclusion: Diet can induce changes in the epigenome thereby contributing to metabolic disease. Significance: Environmental factors can contribute to complex disease progression through modifications to chromatin. Metabolic diseases result from multiple genetic and environmental factors. We report here that one manner in which environmental factors can contribute to metabolic disease progression is through modification to chromatin. We demonstrate that high fat diet leads to chromatin remodeling in the livers of C57BL/6J mice, as compared with mice fed a control diet, and that these chromatin changes are associated with changes in gene expression. We further show that the regions of greatest variation in chromatin accessibility are targeted by liver transcription factors, including HNF4, CCAAT/enhancer-binding protein (CEBP/), and FOXA1. Repeating the chromatin and gene expression profiling in another mouse strain, DBA/2J, revealed that the regions of greatest chromatin change are largely strain-specific and that integration of chromatin, gene expression, and genetic data can be used to characterize regulatory regions. Our data indicate dramatic changes in the epigenome due to diet and demonstrate strain-specific dynamics in chromatin remodeling.	[Leung, Amy; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Duarte, CA 91010 USA; [Du, Juan; Trac, Candi; Brown, Kevin; Schones, Dustin E.] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Du, Juan; Setten, Ryan; Chen, Yin; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Parks, Brian W.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of California System; University of California Los Angeles	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91016 USA.	rnatarajan@coh.org; dschones@coh.org		Setten, Ryan/0000-0002-0956-7084	National Cancer Institute of the National Institutes of Health [P30CA33572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864, K22HL101950, R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094311, T32DK007571, R01DK065073] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Kirti Bhatt for assistance with staining and other members of the Schones and Natarajan laboratories for helpful discussions and comments. Research reported in this publication included work performed in the Pathology and Integrative Genomics Cores of the City of Hope supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572.	Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Funkat A, 2004, J NUTR, V134, P3264, DOI 10.1093/jn/134.12.3264; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hall RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089279; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hosseini M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003570; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mair M, 2011, FRONT BIOSCI-LANDMRK, V16, P2794, DOI 10.2741/3886; Martinez MJ, 2007, BIOINFORMATICS, V23, P21, DOI 10.1093/bioinformatics/btl531; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Reddy MA, 2011, CARDIOVASC RES, V90, P421, DOI 10.1093/cvr/cvr024; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2005, BIOINFORMATICS, V21, pI403, DOI 10.1093/bioinformatics/bti1043; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Widiker S, 2010, J APPL GENET, V51, P193, DOI 10.1007/BF03195727; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	43	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23557	23567		10.1074/jbc.M114.581439	http://dx.doi.org/10.1074/jbc.M114.581439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006255	Green Published, hybrid			2022-12-28	WOS:000341505000026
J	Gomez-Cambronero, J				Gomez-Cambronero, Julian			Phospholipase D in Cell Signaling: From a Myriad of Cell Functions to Cancer Growth and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; ADP-RIBOSYLATION FACTOR; INDUCED DOWN-REGULATION; STRESS FIBER FORMATION; PHOSPHATIDIC-ACID; NUCLEOTIDE EXCHANGE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SPHINGOSINE KINASE-1; GLIOBLASTOMA CELLS; BINDING PROTEINS	Phospholipase D (PLD) enzymes play a double vital role in cells: they maintain the integrity of cellular membranes and they participate in cell signaling including intracellular protein trafficking, cytoskeletal dynamics, cell migration, and cell proliferation. The particular involvement of PLD in cell migration is accomplished: (a) through the actions of its enzymatic product of reaction, phosphatidic acid, and its unique shape-binding role on membrane geometry; (b) through a particular guanine nucleotide exchange factor (GEF) activity (the first of its class assigned to a phospholipase) in the case of the mammalian isoform PLD2; and (c) through protein-protein interactions with a wide network of molecules: Wiskott-Aldrich syndrome protein (WASp), Grb2, ribosomal S6 kinase (S6K), and Rac2. Further, PLD interacts with a variety of kinases (PKC, FES, EGF receptor (EGFR), and JAK3) that are activated by it, or PLD becomes the target substrate. Out of these myriads of functions, PLD is becoming recognized as a major player in cell migration, cell invasion, and cancer metastasis. This is the story of the evolution of PLD from being involved in a large number of seemingly unrelated cellular functions to its most recent role in cancer signaling, a subfield that is expected to grow exponentially.	[Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health from the American Heart Association [HL056653-14, 13GRNT17230097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health from the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant by HL056653-14 and 13GRNT17230097 from the American Heart Association (to J. G.-C.). This is the first article in the Thematic Minireview Series "Phospholipase D and Cancer."	Ali WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055325; Bae CD, 1998, J BIOL CHEM, V273, P11596, DOI 10.1074/jbc.273.19.11596; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Bruntz RC, 2014, J BIOL CHEM, V289, P600, DOI 10.1074/jbc.M113.532978; Chae YC, 2010, MOL CELL BIOL, V30, P5086, DOI 10.1128/MCB.00443-10; Chen JS, 2004, J BIOL CHEM, V279, P22076, DOI 10.1074/jbc.M311033200; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Choi WS, 2004, MOL CELL BIOL, V24, P6980, DOI 10.1128/MCB.24.16.6980-6992.2004; Cipriano R, 2014, ONCOGENE, V33, P3298, DOI 10.1038/onc.2013.293; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Corrotte M, 2006, TRAFFIC, V7, P365, DOI 10.1111/j.1600-0854.2006.00389.x; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Di Fulvio M, 2008, CELL SIGNAL, V20, P176, DOI 10.1016/j.cellsig.2007.10.009; Di Fulvio M, 2007, J MOL BIOL, V367, P814, DOI 10.1016/j.jmb.2007.01.021; Divecha N, 2000, EMBO J, V19, P5440, DOI 10.1093/emboj/19.20.5440; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; Gomez-Cambronero Julian, 2012, Small GTPases, V3, P202, DOI 10.4161/sgtp.20887; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2013, CELL SIGNAL, V25, P198, DOI 10.1016/j.cellsig.2012.08.010; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Huang HY, 2009, BBA-MOL CELL BIOL L, V1791, P839, DOI 10.1016/j.bbalip.2009.05.012; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jang IH, 2003, J BIOL CHEM, V278, P18184, DOI 10.1074/jbc.M208438200; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jang YH, 2014, CELL DEATH DIFFER, V21, P533, DOI 10.1038/cdd.2013.174; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kang DW, 2013, ONCOGENE, V32, P3531, DOI 10.1038/onc.2012.358; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Kang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012109; Kang DW, 2010, CANCER RES, V70, P4233, DOI 10.1158/0008-5472.CAN-09-3470; Kang DW, 2009, EXP MOL MED, V41, P678, DOI 10.3858/emm.2009.41.9.074; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kim YR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-144; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kulkarni A, 2014, CHEM BIOL DRUG DES, V84, P270, DOI 10.1111/cbdd.12319; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lee HY, 2008, CELL SIGNAL, V20, P1787, DOI 10.1016/j.cellsig.2008.06.009; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Luquain C, 2003, J LIPID RES, V44, P1963, DOI 10.1194/jlr.M300188-JLR200; Mahankali M, 2013, J CELL SCI, V126, P1416, DOI 10.1242/jcs.117960; Mahankali M, 2012, J BIOL CHEM, V287, P41417, DOI 10.1074/jbc.M112.383596; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Marguerite V, 2013, INT J BIOCHEM CELL B, V45, P213, DOI 10.1016/j.biocel.2012.09.018; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; O'Reilly MC, 2013, J MED CHEM, V56, P2695, DOI 10.1021/jm301782e; Oh KJ, 2007, J CELL BIOCHEM, V101, P1409, DOI 10.1002/jcb.21260; Oishi K, 2001, J BIOL CHEM, V276, P18096, DOI 10.1074/jbc.M010646200; Otani Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027544; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Peng HJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206672; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Powner DJ, 2002, FEBS LETT, V531, P62, DOI 10.1016/S0014-5793(02)03410-5; Pye DS, 2013, J IMMUNOL, V191, P1496, DOI 10.4049/jimmunol.1203484; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Saito M, 2007, ONCOL REP, V18, P1329; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schwartz N, 2014, HORM CANCER-US, V5, P22, DOI 10.1007/s12672-013-0161-y; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Son JC, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.75; Speranza FJ, 2013, J LEUKOCYTE BIOL, V94, P953, DOI 10.1189/jlb.0313174; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Toschi A, 2008, ONCOGENE, V27, P2746, DOI 10.1038/sj.onc.1210927; WANG XM, 1994, J BIOL CHEM, V269, P20312; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x; Yamazaki M, 1999, J BIOL CHEM, V274, P6035, DOI 10.1074/jbc.274.10.6035; Ye Q, 2013, J BIOL CHEM, V288, P9881, DOI 10.1074/jbc.M113.450593; Ye Q, 2013, J MOL BIOL, V425, P755, DOI 10.1016/j.jmb.2012.11.035; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	98	50	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22557	22566		10.1074/jbc.R114.574152	http://dx.doi.org/10.1074/jbc.R114.574152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990944	hybrid, Green Published			2022-12-28	WOS:000341017200002
J	Lee, T; Di Paola, D; Malina, A; Mills, JR; Kreps, A; Grosse, F; Tang, HL; Zannis-Hadjopoulos, M; Larsson, O; Pelletier, J				Lee, Teresa; Di Paola, Domenic; Malina, Abba; Mills, John R.; Kreps, Amina; Grosse, Frank; Tang, Hengli; Zannis-Hadjopoulos, Maria; Larsson, Ola; Pelletier, Jerry			Suppression of the DHX9 Helicase Induces Premature Senescence in Human Diploid Fibroblasts in a p53-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; WERNER SYNDROME PROTEIN; DNA-DAMAGE RESPONSE; RNA-POLYMERASE-II; CELL-CYCLE ARREST; GENE-EXPRESSION; IN-VIVO; MOLECULAR DETERMINANTS; CHECKPOINT RESPONSE; DEPENDENT MANNER	DHX9 is an ATP-dependent DEXH box helicase with a multitude of cellular functions. Its ability to unwind both DNA and RNA, as well as aberrant, noncanonical polynucleotide structures, has implicated it in transcriptional and translational regulation, DNA replication and repair, and maintenance of genome stability. We report that loss of DHX9 in primary human fibroblasts results in premature senescence, a state of irreversible growth arrest. This is accompanied by morphological defects, elevation of senescence-associated beta-galactosidase levels, and changes in gene expression closely resembling those encountered during replicative (telomere-dependent) senescence. Activation of the p53 signaling pathway was found to be essential to this process. ChIP analysis and investigation of nascent DNA levels revealed that DHX9 is associated with origins of replication and that its suppression leads to a reduction of DNA replication. Our results demonstrate an essential role of DHX9 in DNA replication and normal cell cycle progression.	[Lee, Teresa; Di Paola, Domenic; Malina, Abba; Mills, John R.; Kreps, Amina; Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Grosse, Frank] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Zannis-Hadjopoulos, Maria; Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Larsson, Ola] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden	McGill University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); State University System of Florida; Florida State University; McGill University; McGill University; Karolinska Institutet	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	jerry.pelletier@mcgill.ca		Malina, Abba/0000-0002-8511-9005; Larsson, Ola/0000-0003-1412-1308	National Institutes of Health [CA163291]; Canadian Institutes of Health Research [MOP-115126]; Swedish Research Council; Swedish Cancer Society; Strategic Training Initiative in Chemical Biology; Systems Biology training program fellowships from the Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R56CA094233, R01CA163291, R01CA094233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Strategic Training Initiative in Chemical Biology; Systems Biology training program fellowships from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA163291 (to J. P.). This work was also supported by Canadian Institutes of Health Research Grant MOP-115126, the Swedish Research Council and Swedish Cancer Society grants (to O. L.), and the Strategic Training Initiative in Chemical Biology and the Systems Biology training program fellowships from the Canadian Institutes of Health Research (to T. L.).	Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Barde Isabelle, 2010, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s53; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Darzynkiewicz Z., 2001, CURR PROTOCOL CYTOM, V2; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Di Paola D, 2006, CANCER RES, V66, P5094, DOI 10.1158/0008-5472.CAN-05-3951; Di Paola D, 2012, J CELL BIOCHEM, V113, P1333, DOI 10.1002/jcb.24006; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fu VX, 2004, J BIOL CHEM, V279, P52218, DOI 10.1074/jbc.M405015200; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Jain A, 2013, NUCLEIC ACIDS RES, V41, P10345, DOI 10.1093/nar/gkt804; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Jee HJ, 2013, CANCER LETT, V335, P175, DOI 10.1016/j.canlet.2013.02.012; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; KOHN RR, 1975, SCIENCE, V188, P203, DOI 10.1126/science.188.4185.203-b; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Liu MZ, 2013, GENE DEV, V27, P2543, DOI 10.1101/gad.224170.113; Liu Z, 2007, EXP CELL RES, V313, P3743, DOI 10.1016/j.yexcr.2007.07.037; Luo HM, 2013, INT J ONCOL, V43, P1999, DOI 10.3892/ijo.2013.2141; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mills JR, 2013, BLOOD, V121, P3402, DOI 10.1182/blood-2012-06-434365; Monasor A, 2013, CELL CYCLE, V12, P1948, DOI 10.4161/cc.25017; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Pichierri P, 2011, AGING-US, V3, P311, DOI 10.18632/aging.100293; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Robles SJ, 1999, BIOCHEM PHARMACOL, V58, P675, DOI 10.1016/S0006-2952(99)00127-6; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Taylor WR, 1999, ONCOGENE, V18, P283, DOI 10.1038/sj.onc.1202516; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016; Zhang SS, 1997, J BIOL CHEM, V272, P11487; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; ZHANG SS, 1991, J BIOL CHEM, V266, P20483; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	75	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22798	22814		10.1074/jbc.M114.568535	http://dx.doi.org/10.1074/jbc.M114.568535			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990949	Green Published, hybrid			2022-12-28	WOS:000341017200024
J	Rizvi, S; Mertens, JC; Bronk, SF; Hirsova, P; Dai, HM; Roberts, LR; Kaufmann, SH; Gores, GJ				Rizvi, Sumera; Mertens, Joachim C.; Bronk, Steven F.; Hirsova, Petra; Dai, Haiming; Roberts, Lewis R.; Kaufmann, Scott H.; Gores, Gregory J.			Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR-ACTIVITY; CELL; DEATH; BAX; INHIBITION; EXPRESSION; EVOLUTION; PATHWAY; POTENT; PUMA	Desmoplastic malignancies such as cholangiocarcinoma (CCA) are characterized by a dense stroma containing an abundance of myofibroblasts termed cancer-associated fibroblasts (CAF). The CAF phenotype represents an "activated state" in which cells are primed for cell death triggered by BH3 mimetics. Accordingly, this primed state may be therapeutically exploited. To elucidate the mechanisms underlying this poorly understood apoptotic priming, we examined the role of platelet-derived growth factor (PDGF) in CAF priming for cell death given its prominent role in CAF activation. PDGF isomers PDGF-B and PDGF-D are abundantly expressed in CCA cells derived from human specimens. Either isomer sensitizes myofibroblasts to cell death triggered by BH3 mimetics. Similar apoptotic sensitization was observed with co-culture of myofibroblasts and CCA cells. Profiling of Bcl-2 proteins expressed by PDGF-primed myofibroblasts demonstrated an increase in cellular levels of Puma. PDGF-mediated increases in cellular Puma levels induced proapoptotic changes in Bak, which resulted in its binding to Bcl-2. Short hairpin RNA-mediated down-regulation of Puma conferred resistance to PDGF-mediated apoptotic priming. Conversely, the BH3 mimetic navitoclax disrupted Bcl-2/Bak heterodimers, allowing Bak to execute the cell death program. Treatment with a Bcl-2-specific BH3 mimetic, ABT-199, reduced tumor formation and tumor burden in a murine model of cholangiocarcinoma. Collectively, these findings indicate that apoptotic priming of CAF by PDGF occurs via Puma-mediated Bak activation, which can be converted to active full-blown apoptosis by navitoclax or ABT-199 for therapeutic benefit.	[Rizvi, Sumera; Bronk, Steven F.; Hirsova, Petra; Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Mertens, Joachim C.] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Dai, Haiming; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; University of Zurich; University Zurich Hospital; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Hirsova, Petra/B-8943-2018	Hirsova, Petra/0000-0003-0494-0924; Dai, Haiming/0000-0002-0484-7407; Roberts, Lewis/0000-0001-7885-8574; Mertens, Joachim C./0000-0003-2007-0308; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [DK59427, T32DK007198, RO1 CA165076, RO1 CA166704, DK84567]; Mayo Foundation; American Liver Foundation; International Liver Cancer Association; Swiss National Science Foundation (Schweizerischer Nationalfond SNF) [PBSKP3_130612/1]; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA165076, R01CA166741] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007198, R01DK059427, P30DK084567, R56DK059427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; American Liver Foundation; International Liver Cancer Association; Swiss National Science Foundation (Schweizerischer Nationalfond SNF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59427 (to G. J. G.), T32DK007198 (to S. R.), RO1 CA165076 (to L. R. R.), RO1 CA166704 (to S. H. K.), and DK84567 (to Optical Microscopy Core for the Mayo Center for Cell Signaling in Gastroenterology). This work was also supported by the Mayo Foundation.; Supported by the American Liver Foundation and International Liver Cancer Association.; A scholar of the Swiss National Science Foundation (Schweizerischer Nationalfond SNF; Grant PBSKP3_130612/1) and the Bangerter-Rhyner Foundation.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Cadamuro M, 2013, HEPATOLOGY, V58, P1042, DOI 10.1002/hep.26384; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Cheng JW, 2013, J CELL BIOCHEM, V114, P1510, DOI 10.1002/jcb.24492; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2014, J BIOL CHEM, V289, P89, DOI 10.1074/jbc.M113.505701; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Di Martino MT, 2013, ONCOTARGET, V4, P242, DOI 10.18632/oncotarget.820; Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Hamada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00331; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hwang RF, 2012, MOL CANCER RES, V10, P1147, DOI 10.1158/1541-7786.MCR-12-0022; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KIM HRC, 1995, P NATL ACAD SCI USA, V92, P9500, DOI 10.1073/pnas.92.21.9500; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mertens JC, 2013, CANCER RES, V73, P897, DOI 10.1158/0008-5472.CAN-12-2130; Mott JL, 2008, MOL CANCER THER, V7, P2339, DOI 10.1158/1535-7163.MCT-08-0285; O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464; Okabe H, 2009, ANN SURG ONCOL, V16, P2555, DOI 10.1245/s10434-009-0568-4; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Sandow JJ, 2012, CELL DEATH DIFFER, V19, P633, DOI 10.1038/cdd.2011.131; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; YANO H, 1992, CANCER, V69, P1664, DOI 10.1002/1097-0142(19920401)69:7<1664::AID-CNCR2820690705>3.0.CO;2-P	50	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22835	22849		10.1074/jbc.M114.563064	http://dx.doi.org/10.1074/jbc.M114.563064			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973208	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000341017200026
J	Sol, A; Skvirsky, Y; Nashef, R; Zelentsova, K; Burstyn-Cohen, T; Blotnick, E; Muhlrad, A; Bachrach, G				Sol, Asaf; Skvirsky, Yaniv; Nashef, Rizan; Zelentsova, Katya; Burstyn-Cohen, Tal; Blotnick, Edna; Muhlrad, Andras; Bachrach, Gilad			Actin Enables the Antimicrobial Action of LL-37 Peptide in the Presence of Microbial Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE BACTERIAL-INFECTION; HUMAN CATHELICIDIN LL-37; INNATE IMMUNE-RESPONSE; F-ACTIN; HOST-DEFENSE; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL PEPTIDES; CONFORMATIONAL-CHANGES; CYSTIC-FIBROSIS; IN-VITRO	Host defense peptides play an important host-protective role by their microcidal action, immunomodulatory functions, and tissue repair activities. Proteolysis is a common strategy of pathogens used to neutralize host defense peptides. Here, we show that actin, the most abundant structural protein in eukaryotes, binds the LL-37 host defense peptide, protects it from degradation by the proteases of Pseudomonas aeruginosa and Porphyromonas gingivalis, and enables its antimicrobial activity despite the presence of the proteases. Co-localization of LL-37 with extracellular actin was observed in necrotized regions of samples from oral lesions. Competition assays, cross-linking experiments, limited proteolysis, and mass spectrometry revealed that LL-37 binds by specific hydrophobic interactions to the His-40-Lys-50 segment of actin, located in the DNase I binding loop. The integrity of the binding site of both LL-37 and actin is a prerequisite to the binding. Our results demonstrate that actin, presumably released by dead cells and abundant in infected sites, might be utilized by the immune system to enhance spatio-temporal immunity in an attempt to arrest infection and control inflammation.	[Sol, Asaf; Skvirsky, Yaniv; Zelentsova, Katya; Burstyn-Cohen, Tal; Muhlrad, Andras; Bachrach, Gilad] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel; [Nashef, Rizan] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Oral & Maxillofacial Surg, IL-91120 Jerusalem, Israel; [Blotnick, Edna] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Bachrach, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, IL-91120 Jerusalem, Israel.	giladba@ekmd.huji.ac.il	Burstyn-Cohen, Tal/K-8846-2012	Burstyn-Cohen, Tal/0000-0002-2324-2921; Bachrach, Gilad/0000-0003-1350-2280; Sol, Asaf/0000-0002-8731-2490	Israel Science Foundation [208/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 208/10.	Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181; Bachrach G, 2008, ANTIMICROB AGENTS CH, V52, P638, DOI 10.1128/AAC.01271-07; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Baron AC, 1999, J PERIODONTAL RES, V34, P437, DOI 10.1111/j.1600-0765.1999.tb02279.x; Benchaar SA, 2007, BIOCHEMISTRY-US, V46, P225, DOI 10.1021/bi0610754; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; de Haar SF, 2006, INFECT IMMUN, V74, P5284, DOI 10.1128/IAI.02016-05; Devine DA, 2002, CURR PHARM DESIGN, V8, P703, DOI 10.2174/1381612023395501; Devine DA, 1999, MICROBIOL-UK, V145, P965, DOI 10.1099/13500872-145-4-965; Eli-Berchoer L, 2000, J MUSCLE RES CELL M, V21, P405, DOI 10.1023/A:1005649604515; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; Gutner M, 2009, INFECT IMMUN, V77, P5558, DOI 10.1128/IAI.00648-09; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hegyi G, 1998, BIOCHEMISTRY-US, V37, P17784, DOI 10.1021/bi981285j; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; Hollands A, 2012, J BIOL CHEM, V287, P40891, DOI 10.1074/jbc.M112.404582; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Morioka Y, 2008, J IMMUNOL, V181, P3915, DOI 10.4049/jimmunol.181.6.3915; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Muhlrad A, 2011, BIOPHYS CHEM, V155, P45, DOI 10.1016/j.bpc.2011.02.008; MUSZBEK L, 1975, ARCH BIOCHEM BIOPHYS, V167, P99, DOI 10.1016/0003-9861(75)90445-2; MUSZBEK L, 1974, P NATL ACAD SCI USA, V71, P2208, DOI 10.1073/pnas.71.6.2208; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Puklo M, 2008, ORAL MICROBIOL IMMUN, V23, P328, DOI 10.1111/j.1399-302X.2008.00433.x; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rosen G, 2012, INFECT IMMUN, V80, P1107, DOI 10.1128/IAI.05903-11; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sol A, 2013, INFECT IMMUN, V81, P3577, DOI 10.1128/IAI.01288-12; Sol A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050078; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thomassin JL, 2012, INFECT IMMUN, V80, P483, DOI 10.1128/IAI.05674-11; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	60	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22926	22941		10.1074/jbc.M114.579672	http://dx.doi.org/10.1074/jbc.M114.579672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947511	Green Published, hybrid			2022-12-28	WOS:000341017200033
J	Zhang, YX; Shimizu, H; Siu, KL; Mahajan, A; Chen, JN; Cai, H				Zhang, Yixuan; Shimizu, Hirohito; Siu, Kin Lung; Mahajan, Aman; Chen, Jau-Nian; Cai, Hua			NADPH Oxidase 4 Induces Cardiac Arrhythmic Phenotype in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-FIBRILLATION; OXIDATIVE STRESS; CARDIOVASCULAR-SYSTEM; MODEL; NOX4; DYSFUNCTION; SUPEROXIDE; ACTIVATION; EXPRESSION; INCREASES	Oxidative stress has been implicated in cardiac arrhythmia, although a causal relationship remains undefined. We have recently demonstrated a marked up-regulation of NADPH oxidase isoform 4 (NOX4) in patients with atrial fibrillation, which is accompanied by overproduction of reactive oxygen species (ROS). In this study, we investigated the impact on the cardiac phenotype of NOX4 overexpression in zebrafish. One-cell stage embryos were injected with NOX4 RNA prior to video recording of a GFP-labeled (myl7:GFP zebrafish line) beating heart in real time at 24-31 h post-fertilization. Intriguingly, NOX4 embryos developed cardiac arrhythmia that is characterized by irregular heartbeats. When quantitatively analyzed by an established LQ-1 program, the NOX4 embryos displayed much more variable beat-to-beat intervals (mean S. D. of beat-to-beat intervals was 0.027 s/beat in control embryos versus 0.038 s/beat in NOX4 embryos). Both the phenotype and the increased ROS in NOX4 embryos were attenuated by NOX4 morpholino co-injection, treatments of the embryos with polyethylene glycol-conjugated superoxide dismutase, or NOX4 inhibitors fulvene-5, 6-dimethylaminofulvene, and proton sponge blue. Injection of NOX4-P437H mutant RNA had no effect on the cardiac phenotype or ROS production. In addition, phosphorylation of calcium/calmodulin- dependent protein kinase II was increased in NOX4 embryos but diminished by polyethylene glycol-conjugated superoxide dismutase, whereas its inhibitor KN93 or AIP abolished the arrhythmic phenotype. Taken together, our data for the first time uncover a novel pathway that underlies the development of cardiac arrhythmia, namely NOX4 activation, subsequent NOX4-specific NADPH-driven ROS production, and redox-sensitive CaMKII activation. These find-ings may ultimately lead to novel therapeutics targeting cardiac arrhythmia.	[Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Med, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Anesthesiol, Los Angeles, CA 90095 USA; [Zhang, Yixuan; Siu, Kin Lung; Mahajan, Aman; Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Med, Los Angeles, CA 90095 USA; [Shimizu, Hirohito; Chen, Jau-Nian] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol & Med, 650 Charles E Young Dr, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu	Zhang, Yixuan/I-8007-2014; Chen, Jau-Nian/AAM-7808-2020	Zhang, Yixuan/0000-0001-7317-7235; Chen, Jau-Nian/0000-0001-8807-3607	National Institutes of Health from NHLBI [HL077440, HL088975, HL108701, HL119968, HL096980]; American Heart Association [12EIA8990025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108701, R01HL096980, R01HL077440, R01HL119968, R01HL088975] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077440 and HL088975 (to H. C.), HL108701 (to H. C. and D. G. H.), HL119968 (to H. C.), and HL096980 (to J. N. C.) from NHLBI. This work was also supported by American Heart Association Established Investigator Award 12EIA8990025 (to H. C.).	Ago T, 2010, CIRC RES, V106, P1253, DOI 10.1161/CIRCRESAHA.109.213116; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Chang JP, 2011, CARDIOVASC PATHOL, V20, P99, DOI 10.1016/j.carpath.2009.12.005; Chen JN, 1996, DEVELOPMENT, V123, P293; Chen JN, 1996, DEVELOPMENT, V122, P3809; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; DINAUER MC, 1989, J CLIN INVEST, V84, P2012, DOI 10.1172/JCI114393; Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108; Elahi MM, 2008, EUR J CARDIOV PREV R, V15, P735, DOI 10.1097/HJR.0b013e328317f38a; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Kang KA, 2006, J RADIAT RES, V47, P61, DOI 10.1269/jrr.47.61; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kim YM, 2008, J AM COLL CARDIOL, V51, P68, DOI 10.1016/j.jacc.2007.07.085; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Langenbacher AD, 2005, P NATL ACAD SCI USA, V102, P17699, DOI 10.1073/pnas.0502679102; Li JY, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0271-7; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Nguyen Catherine T, 2008, Drug Discov Today Dis Models, V5, P135; Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; Rothschild SC, 2009, DEV BIOL, V330, P175, DOI 10.1016/j.ydbio.2009.03.024; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zhang J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00140; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020; Zhang YY, 2013, AQUAT TOXICOL, V142, P26, DOI 10.1016/j.aquatox.2013.07.014	41	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23200	23208		10.1074/jbc.M114.587196	http://dx.doi.org/10.1074/jbc.M114.587196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962575	Green Published, hybrid			2022-12-28	WOS:000341017200056
J	Qiao, H; Liu, Y; Veach, RA; Wylezinski, L; Hawiger, J				Qiao, Huan; Liu, Yan; Veach, Ruth A.; Wylezinski, Lukasz; Hawiger, Jacek			The Adaptor CRADD/RAIDD Controls Activation of Endothelial Cells by Proinflammatory Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LUNG MICROVASCULAR ENDOTHELIA; FAMILY KINASE ACTIVATION; PARACELLULAR PATHWAY; IMMUNE-RESPONSES; BARRIER FUNCTION; GROWTH-FACTOR; PROTEIN; BCL10; RECEPTOR	A hallmark of inflammation, increased vascular permeability, is induced in endothelial cells by multiple agonists through stimulus-coupled assembly of the CARMA3 signalosome, which contains the adaptor protein BCL10. Previously, we reported that BCL10 in immune cells is targeted by the "death" adaptor CRADD/RAIDD (CRADD), which negatively regulates nuclear factor kappa B (NF kappa B)-dependent cytokine and chemokine expression in T cells (Lin, Q., Liu, Y., Moore, D. J., Elizer, S. K., Veach, R. A., Hawiger, J., and Ruley, H. E. (2012) J. Immunol. 188, 2493-2497). This novel anti-inflammatory CRADD-BCL10 axis prompted us to analyze CRADD expression and its potential anti-inflammatory action in non-immune cells. We focused our study on microvascular endothelial cells because they play a key role in inflammation. We found that CRADD-deficient murine endothelial cells display heightened BCL10-mediated expression of the pleotropic proinflammatory cytokine IL-6 and chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2) in response to LPS and thrombin. Moreover, these agonists also induce significantly increased permeability in cradd(-/-), as compared with cradd(+/+), primary murine endothelial cells. CRADD-deficient cells displayed more F-actin polymerization with concomitant disruption of adherens junctions. In turn, increasing intracellular CRADD by delivery of a novel recombinant cell-penetrating CRADD protein (CP-CRADD) restored endothelial barrier function and suppressed the induction of IL-6 and MCP-1 evoked by LPS and thrombin. Likewise, CP-CRADD enhanced barrier function in CRADD-sufficient endothelial cells. These results indicate that depletion of endogenous CRADD compromises endothelial barrier function in response to inflammatory signals. Thus, we define a novel function for CRADD in endothelial cells as an inducible suppressor of BCL10, a key mediator of responses to proinflammatory agonists.	[Qiao, Huan; Liu, Yan; Veach, Ruth A.; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, Nashville, TN 37232 USA; [Wylezinski, Lukasz; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave S, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		Wylezinski, Lukasz/0000-0001-6481-8379; Veach, Ruth Ann/0000-0003-0038-8802	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health [P30DK058404]; Vanderbilt Ingram Cancer Center by National Institutes of Health [P30CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085833, T32HL069765, R01HL069452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015752] Funding Source: NIH RePORTER	Vanderbilt University Medical Center's Digestive Disease Research Center - National Institutes of Health; Vanderbilt Ingram Cancer Center by National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Fluorescence microscopy and analysis was performed in part through the use of the VUMC Cell Imaging Shared Resource. Cell Imaging and other Core Services were funded in part through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404 and the Vanderbilt Ingram Cancer Center supported by National Institutes of Health Grant P30CA068485.	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bhattacharyya S, 2007, AM J PHYSIOL-GASTR L, V293, pG429, DOI 10.1152/ajpgi.00149.2007; Bhattacharyya S, 2010, EXP CELL RES, V316, P3317, DOI 10.1016/j.yexcr.2010.05.004; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Colgan OC, 2007, AM J PHYSIOL-HEART C, V292, pH3190, DOI 10.1152/ajpheart.01177.2006; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; DiGiandomenico A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1162191; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fletcher TC, 2010, J BIOL CHEM, V285, P18727, DOI 10.1074/jbc.M109.095216; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hawiger J, 2011, CRIT CARE, V15, DOI 10.1186/cc10482; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Herwig MC, 2013, PATHOBIOLOGY, V80, P245, DOI 10.1159/000347062; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kenne E, 2011, THROMB HAEMOSTASIS, V105, P783, DOI 10.1160/TH10-10-0635; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin Q, 2012, J IMMUNOL, V188, P2493, DOI 10.4049/jimmunol.1101502; Liu AG, 2012, J BIOL CHEM, V287, P16132, DOI 10.1074/jbc.M111.310102; Londono D, 2011, J IMMUNOL, V186, P7176, DOI 10.4049/jimmunol.1100060; Major CD, 2003, ARTERIOSCL THROM VAS, V23, P931, DOI 10.1161/01.ATV.0000070100.47907.26; Marion S, 2012, DEV CELL, V23, P954, DOI 10.1016/j.devcel.2012.09.021; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Qiao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035746; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Rueda D, 2007, J IMMUNOL, V178, P4373, DOI 10.4049/jimmunol.178.7.4373; SCHREIBER AB, 1985, P NATL ACAD SCI USA, V82, P6138, DOI 10.1073/pnas.82.18.6138; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Sun Jiyuan, 2010, World J Biol Chem, V1, P353, DOI 10.4331/wjbc.v1.i12.353; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang YX, 2013, INT J MOL MED, V32, P568, DOI 10.3892/ijmm.2013.1420; Wegener Elmar, 2007, Sci STKE, V2007, ppe21, DOI 10.1126/stke.3842007pe21; Yuan D, 2012, J APPL PHYSIOL, V113, P1110, DOI 10.1152/japplphysiol.00102.2012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	60	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21973	21983		10.1074/jbc.M114.588723	http://dx.doi.org/10.1074/jbc.M114.588723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958727	hybrid, Green Published			2022-12-28	WOS:000340593500014
J	Morris, MC; Gilliam, EA; Button, J; Li, LW				Morris, Matthew C.; Gilliam, Elizabeth A.; Button, Julia; Li, Liwu			Dynamic Modulation of Innate Immune Response by Varying Dosages of Lipopolysaccharide (LPS) in Human Monocytic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; CYTOKINE PRODUCTION; PROTEIN-KINASE; INDUCED IL-6; INHIBITION; INFLAMMATION; MACROPHAGES; ACTIVATION	Innate monocytes and macrophages can be dynamically programmed into distinct states depending upon the strength of external stimuli. Innate programming may bear significant relevance to the pathogenesis and resolution of human inflammatory diseases. However, systems analyses with regard to the dynamic programming of innate leukocytes are lacking. In this study, we focused on the dynamic responses of human promonocytic THP-1 cells to lipopolysaccharide (LPS). We observed that varying dosages of LPS differentially modulate the expression of selected pro-and anti-inflammatory mediators such as IL-6 and IL-33. Super-low dosages of LPS preferentially induced the pro-inflammatory mediator IL-6, while higher dosages of LPS induced both IL-6 and IL-33. Mechanistically, we demonstrated that super-low and high doses of LPS cause differential activation of GSK3 and Akt, as well as the transcription factors FoxO1 and CREB. Inhibition of GSK3 enabled THP-1 cells to express IL-33 when challenged with super-low dose LPS. On the other hand, activation of CREB with adenosine suppressed IL-6 expression. Taken together, our study reveals a dynamic modulation of monocytic cells in response to varying dosages of endotoxin, and may shed light on our understanding of the dynamic balance that controls pathogenesis and resolution of inflammatory diseases.	[Morris, Matthew C.; Button, Julia; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Gilliam, Elizabeth A.; Li, Liwu] Virginia Tech, Carill Sch Med, Roanoke, VA 24016 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, 970 Washington St SW, Blacksburg, VA 24061 USA.	lwli@vt.edu		Li, Liwu/0000-0001-8870-5299; Morris, Matthew/0000-0002-1236-1255	National Institutes of Health [R01 HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL115835 (to L. L.).	Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Babcock AS, 2013, TOXICOL APPL PHARM, V266, P157, DOI 10.1016/j.taap.2012.10.011; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Erridge C, 2009, J INNATE IMMUN, V1, P340, DOI 10.1159/000191413; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Huet O, 2014, CLIN SCI, V126, P31, DOI 10.1042/CS20120668; Jang S, 2010, BRAIN RES, V1313, P25, DOI 10.1016/j.brainres.2009.12.012; Kim DH, 2014, ARCH PHARM RES, V37, P813, DOI 10.1007/s12272-013-0223-2; Lee J.S., 2011, P NATL ACAD SCI US, V108; Li JQ, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/657182; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Livingston M, 2004, INFLAMM RES, V53, P171, DOI 10.1007/s00011-004-1248-2; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Morris M, 2012, ARCH IMMUNOL THER EX, V60, P13, DOI 10.1007/s00005-011-0155-9; Motegi A, 2006, J LEUKOCYTE BIOL, V79, P463, DOI 10.1189/jlb.0705396; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Park S. H., 2011, NAT IMMUNOL; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rastogi R, 2013, J BIOL CHEM, V288, P33966, DOI 10.1074/jbc.M113.492702; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Sivapalaratnam S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-64; Slofstra SH, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-13; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Tejera MM, 2013, J IMMUNOL, V191, P187, DOI 10.4049/jimmunol.1300331; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Wu SS, 2006, CELL SIGNAL, V18, P1932, DOI 10.1016/j.cellsig.2006.02.013; Yamaguchi Y, 2011, EUR J PAIN, V15, P724, DOI 10.1016/j.ejpain.2011.01.001	54	46	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21584	21590		10.1074/jbc.M114.583518	http://dx.doi.org/10.1074/jbc.M114.583518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24970893	Green Published, hybrid			2022-12-28	WOS:000340558300033
J	Kong, B; Wang, Q; Fung, E; Xue, K; Tsang, BK				Kong, Bao; Wang, Qi; Fung, Ella; Xue, Kai; Tsang, Benjamin K.			p53 Is Required for Cisplatin-induced Processing of the Mitochondrial Fusion Protein L-Opa1 That Is Mediated by the Mitochondrial Metallopeptidase Oma1 in Gynecologic Cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OVARIAN-CANCER; INHIBITORY PROTEIN; CELLS; OPA1; APOPTOSIS; FISSION; RESISTANCE; STRESS; DRP1; PHOSPHORYLATION	Mitochondria are highly dynamic organelles, and mitochondrial fission is a crucial step of apoptosis. Although Oma1 is believed to be responsible for long form Opa1 (L-Opa1) processing during mitochondrial fragmentation, whether and how Oma1 is involved in L-Opa1 processing and participates in the regulation of chemoresistance is unknown. Chemosensitive and chemoresistant ovarian (OVCA) and cervical (CECA) cancer cells were treated with cisplatin (CDDP). Mitochondrial dynamics and protein contents were assessed by immunofluorescence and Western blot, respectively. The requirements of Oma1 and p53 for CDDP-induced L-Opa1 processing, mitochondrial fragmentation, and apoptosis were examined by siRNA or cDNA. CDDP induces L-Opa1 processing and mitochondrial fragmentation in chemosensitive but not in chemoresistant cells. CDDP induced Oma1 40-kDa form increases in OV2008 cells, not in C13* cells. Oma1 knockdown inhibited L-Opa1 processing, mitochondrial fragmentation, and apoptosis. Silencing p53 expression attenuated the effects of CDDP in Oma1 (40 kDa) increase, L-Opa1 processing, mitochondrial fragmentation, and apoptosis in chemosensitive OVCA cells, whereas reconstitution of p53 in p53 mutant or null chemoresistant OVCA cells induced Oma1 (40 kDa) increase, L-Opa1 processing, mitochondrial fragmentation, and apoptosis irrespective of the presence of CDDP. Prohibitin 1 (Phb1) dissociates from Opa1-Phb1 complex and binds phosphorylated p53 (serine 15) in response to CDDP in chemosensitive but not chemoresistant CECA cells. These findings demonstrate that (a) p53 and Oma1 mediate L-Opa1 processing, (b) mitochondrial fragmentation is involved in CDDP-induced apoptosis in OVCA and CECA cells, and (c) dysregulated mitochondrial dynamics may in part be involved in the pathophysiology of CDDP resistance.	[Kong, Bao; Wang, Qi; Fung, Ella; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON K1H 8L6, Canada; [Kong, Bao; Wang, Qi; Fung, Ella; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada; [Kong, Bao; Wang, Qi; Fung, Ella; Tsang, Benjamin K.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON K1H 8L6, Canada; [Kong, Bao; Wang, Qi; Fung, Ella; Xue, Kai; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada; [Xue, Kai] Nanjing Med Univ, State Key Lab Reprod Med, Clin Reprod Med Ctr, Nanjing 210029, Jiangsu, Peoples R China	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Nanjing Medical University	Tsang, BK (corresponding author), Ottawa Gen Hosp, Ottawa Hosp Res Inst, Gen Campus,501 Smyth Rd,Mail Box 511, Ottawa, ON K1H 8L6, Canada.	btsang@ohri.ca		Tsang, Benjamin K./0000-0003-1213-3946	Canadian Institutes of Health Research [MOP-126144]; China Scholarship Council; Canadian Institutes of Health Research training program in Reproduction, Early Development; Impact on Health (CIHR-REDIH) postdoctoral scholarship; Cambridge University Newnham U. S. Travel Bursary; Bank of Montreal Research Grant on Women's Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council); Canadian Institutes of Health Research training program in Reproduction, Early Development(Canadian Institutes of Health Research (CIHR)); Impact on Health (CIHR-REDIH) postdoctoral scholarship; Cambridge University Newnham U. S. Travel Bursary; Bank of Montreal Research Grant on Women's Health	This work was supported by Canadian Institutes of Health Research Grant MOP-126144.; A recipient of a doctoral scholarship from the China Scholarship Council.; A recipient of a Canadian Institutes of Health Research training program in Reproduction, Early Development, and the Impact on Health (CIHR-REDIH) postdoctoral scholarship.; A recipient of the Cambridge University Newnham U. S. Travel Bursary and the Bank of Montreal Research Grant on Women's Health.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Chander H, 2010, EMBO REP, V11, P220, DOI 10.1038/embor.2010.2; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Kigawa J, 2001, Hum Cell, V14, P165; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shibue T, 2006, EMBO J, V25, P4952, DOI 10.1038/sj.emboj.7601359; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Yamaguchi R, 2009, BBA-BIOENERGETICS, V1787, P963, DOI 10.1016/j.bbabio.2009.02.005; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425	35	58	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27134	27145		10.1074/jbc.M114.594812	http://dx.doi.org/10.1074/jbc.M114.594812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112877	Green Published, hybrid			2022-12-28	WOS:000342853900039
J	Lee, ICJ; Leung, T; Tan, I				Lee, Irene Cheng Jie; Leung, Thomas; Tan, Ivan			Adaptor Protein LRAP25 Mediates Myotonic Dystrophy Kinase-related Cdc42-binding Kinase (MRCK) Regulation of LIMK1 Protein in Lamellipodial F-actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ARP2/3 COMPLEX; COFILIN PHOSPHORYLATION; PHOSPHOLIPASE-C; STRESS FIBERS; MYOSIN-II; ADF/COFILIN; ACTIVATION; REORGANIZATION; ACTOMYOSIN	Myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) has been shown to localize to the lamella of mammalian cells through its interaction with an adaptor protein, leucine repeat adaptor protein 35a (LRAP35a), which links it with myosin 18A (MYO18A) for activation of the lamellar actomyosin network essential for cell migration. Here, we report the identification of another adaptor protein LRAP25 that mediates MRCK association with LIM kinase 1 (LIMK1). The lamellipodium-localized LRAP25-MRCK complex is essential for the regulation of local LIMK1 and its downstream F-actin regulatory factor cofilin. Functionally, inhibition of either MRCK or LRAP25 resulted in a marked suppression of LIMK1 activity and down-regulation of cofilin phosphorylation in response to aluminum fluoride induction in B16-F1 cells, which eventually resulted in deregulation of lamellipodial F-actin and reorganization of cytoskeletal structures causing defects in cell polarization and motility. These biochemical and functional characterizations thus underline the functional relevance of the LRAP25-MRCK complex in LIMK1-cofilin signaling and the importance of LRAP adaptors as key determinants of MRCK cellular localization and downstream specificities.	[Lee, Irene Cheng Jie; Leung, Thomas; Tan, Ivan] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lee, Irene Cheng Jie; Leung, Thomas] Natl Univ Singapore, Dept Anat, Singapore 119260, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Tan, I (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	kntan@imcb.a-star.edu.sg	LEE, IRENE CHENG JIE/AAV-2915-2020	LEE, IRENE CHENG JIE/0000-0001-6862-6438	Agency of Science and Technology Research (A-STAR), Singapore	Agency of Science and Technology Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by funding from Agency of Science and Technology Research (A-STAR), Singapore.	Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Cohen PTW, 2002, J CELL SCI, V115, P241; Condeelis J, 2005, BIOL CELL, V97, P97; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Golovkina TV, 1998, J VIROL, V72, P3066, DOI 10.1128/JVI.72.4.3066-3071.1998; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kokura K, 2003, J BIOL CHEM, V278, P20133, DOI 10.1074/jbc.M210855200; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PARIS S, 1987, J BIOL CHEM, V262, P1970; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sakuma-Takagi M, 1999, BIOCHEM BIOPH RES CO, V263, P737, DOI 10.1006/bbrc.1999.1462; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Sumi T, 2001, J BIOL CHEM, V276, P23092, DOI 10.1074/jbc.C100196200; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tan I, 2003, GENE, V304, P107, DOI 10.1016/S0378-1119(02)01185-X; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tan I, 2011, FEBS LETT, V585, P1260, DOI 10.1016/j.febslet.2011.03.054; Tan I, 2009, CELL ADHES MIGR, V3, P256, DOI 10.4161/cam.3.3.8212; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	55	12	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26989	27003		10.1074/jbc.M114.588079	http://dx.doi.org/10.1074/jbc.M114.588079			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107909	hybrid, Green Published			2022-12-28	WOS:000342853900028
J	Fan, J; Kang, HB; Shan, CL; Elf, S; Lin, RT; Xie, JX; Gu, TL; Aguiar, M; Lonning, S; Chung, TW; Arellano, M; Khoury, HJ; Shin, DM; Khuri, FR; Boggon, TJ; Kang, SM; Chen, J				Fan, Jun; Kang, Hee-Bum; Shan, Changliang; Elf, Shannon; Lin, Ruiting; Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Boggon, Titus J.; Kang, Sumin; Chen, Jing			Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINE; TYROSINE PHOSPHORYLATION; CANCER-CELLS; TUMOR-GROWTH; LEUKEMIA; COMPLEX; METABOLISM; KINASE; ORGANIZATION; CHROMOSOME	The mitochondrial pyruvate dehydrogenase complex (PDC) plays a crucial role in regulation of glucose homoeostasis in mammalian cells. PDC flux depends on catalytic activity of the most important enzyme component pyruvate dehydrogenase (PDH). PDH kinase inactivates PDC by phosphorylating PDH at specific serine residues, including Ser-293, where as dephosphorylation of PDH by PDH phosphatase restores PDC activity. The current understanding suggests that Ser-293 phosphorylation of PDH impedes active site accessibility to its substrate pyruvate. Here, we report that phosphorylation of a tyrosine residue Tyr-301 also inhibits PDH alpha 1 (PDHA1) by blocking pyruvate binding through a novel mechanism in addition to Ser-293 phosphorylation. In addition, we found that multiple oncogenic tyrosine kinases directly phosphorylate PDHA1 at Tyr-301, and Tyr-301 phosphorylation of PDHA1 is common in EGF-stimulated cells as well as diverse human cancer cells and primary leukemia cells from human patients. Moreover, expression of a phosphorylation-deficient PDHA1 Y301F mutant in cancer cells resulted in increased oxidative phosphorylation, decreased cell proliferation under hypoxia, and reduced tumor growth in mice. Together, our findings suggest that phosphorylation at distinct serine and tyrosine residues inhibits PDHA1 through distinct mechanisms to impact active site accessibility, which act in concert to regulate PDC activity and promote the Warburg effect.	[Fan, Jun; Kang, Hee-Bum; Shan, Changliang; Elf, Shannon; Lin, Ruiting; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Emory University; Yale University	Fan, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	jfan3@emory.edu; jchen@emory.edu	Shan, changliang/L-9029-2016; Shin, Dong Moon/G-9649-2013; LIN, RUITING/K-9743-2016; Khuri, Fadlo R./AAU-4942-2020	Shin, Dong Moon/0000-0002-8245-4174; LIN, RUITING/0000-0003-4274-4588; Khuri, Fadlo R./0000-0002-8638-7618; Chung, Tae-Wook/0000-0001-5243-5020; Kang, Hee-Bum/0000-0002-3781-6893; Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health [CA140515, CA183594, CA174786, CA175316]; National Institutes of Health SPORE in Head and Neck Cancer [P50CA128613]; Pharmacological Sciences Training Grant [T32 GM008602]; Department of Defense [W81XWH-12-1-0217]; Charles Harris Run For Leukemia, Inc.; Hematology Tissue Bank of the Emory University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA175316, R01CA174786, R01CA183594, R01CA140515, P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SPORE in Head and Neck Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; Department of Defense(United States Department of Defense); Charles Harris Run For Leukemia, Inc.; Hematology Tissue Bank of the Emory University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA140515, CA183594, CA174786 (to J. C.), CA175316 (to S. K.), the Career Development Fellow Award (to J. F.) from National Institutes of Health SPORE in Head and Neck Cancer P50CA128613 (to D. M. S.) and the Pharmacological Sciences Training Grant T32 GM008602 (to S. E.), Department of Defense Grant W81XWH-12-1-0217 (to J. C.), Charles Harris Run For Leukemia, Inc. (to H. J. K.) and the Hematology Tissue Bank of the Emory University School of Medicine (to H. J. K.). J. X., T.-L. G., M. A., and S. L. are employees of Cell Signaling Technology, Inc.	[Anonymous], 1996, J Cell Biochem Suppl, V24, P1; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Ciszak E. M., 2003, J BIOL; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Gu TL, 2006, BLOOD, V108, P4202, DOI 10.1182/blood-2006-06-026666; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; PAPAYANNOPOULOU T, 1983, BLOOD, V62, P832; Pezzato E, 2009, AMINO ACIDS, V36, P449, DOI 10.1007/s00726-008-0099-5; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shan CL, 2014, J BIOL CHEM, V289, P21413, DOI 10.1074/jbc.M114.581124; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	32	53	59	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26533	26541		10.1074/jbc.M114.593970	http://dx.doi.org/10.1074/jbc.M114.593970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104357	Green Published, hybrid			2022-12-28	WOS:000342128800044
J	Kim, KH; Jun, YW; Park, Y; Lee, JA; Suh, BC; Lim, CS; Lee, YS; Kaang, BK; Jang, DJ				Kim, Kun-Hyung; Jun, Yong-Woo; Park, Yongsoo; Lee, Jin-A; Suh, Byung-Chang; Lim, Chae-Seok; Lee, Yong-Seok; Kaang, Bong-Kiun; Jang, Deok-Jin			Intracellular Membrane Association of the Aplysia cAMP Phosphodiesterase Long and Short Forms via Different Targeting Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; TERMINAL SPLICE REGION; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DROSOPHILA-MELANOGASTER; ELECTROSTATIC SWITCH; HIGH-AFFINITY; LOCALIZATION; UNIQUE; MEMORY	Phosphodiesterases (PDEs) play key roles in cAMP compartmentalization, which is required for intracellular signaling processes, through specific subcellular targeting. Previously, we showed that the long and short forms of Aplysia PDE4 (ApPDE4), which are localized to the membranes of distinct subcellular organelles, play key roles in 5-hydroxytryptamine-induced synaptic facilitation in Aplysia sensory and motor synapses. However, the molecular mechanism of the isoform-specific distinct membrane targeting was not clear. In this study, we further investigated the molecular mechanism of the membrane targeting of the ApPDE4 long and short forms. We found that the membrane targeting of the long form was mediated by hydrophobic interactions, mainly via 16 amino acids at the N-terminal region, whereas the short form was targeted solely to the plasma membrane, mainly by nonspecific electrostatic interactions between their N termini and the negatively charged lipids such as the phosphatidylinositol polyphosphates PI4P and PI(4,5) P2, which are embedded in the inner leaflet of the plasma membrane. Moreover, oligomerization of the long or short form by interaction of their respective upstream conserved region domains, UCR1 and UCR2, enhanced their plasma membrane targeting. These results suggest that the long and short forms of ApPDE4 are distinctly targeted to intracellular membranes through their direct association with the membranes via hydrophobic and electrostatic interactions, respectively.	[Kim, Kun-Hyung; Jun, Yong-Woo; Jang, Deok-Jin] Kyungpook Natl Univ, Dept Ecol Sci, Coll Ecol & Environm, Sangju Si 742711, Kyungbuk, South Korea; [Park, Yongsoo] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Lee, Jin-A] Hannam Univ, Dept Biotechnol, Coll Life Sci & Nanotechnol, Taejon 305811, South Korea; [Suh, Byung-Chang] Daegu Gyeongbuk Inst Sci & Technol DGIST, Dept Brain Sci, Taegu 711873, South Korea; [Lim, Chae-Seok; Kaang, Bong-Kiun] Seoul Natl Univ, Dept Biol Sci, Coll Nat Sci, Seoul 151747, South Korea; [Lee, Yong-Seok] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 156756, South Korea	Kyungpook National University; Max Planck Society; Hannam University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Seoul National University (SNU); Chung Ang University	Kaang, BK (corresponding author), 599 Gwanangno, Seoul 151747, South Korea.	kaang@snu.ac.kr; jangdj@knu.ac.kr	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051	NRF - Ministry of Education, Science, and Technology [2013-R1A1A2012804]; National Honor Scientist Program of Korea; NRF [2011-0022813]; Korean Ministry of Education, Science, and Technology [2012R1A1A2044699]	NRF - Ministry of Education, Science, and Technology(National Research Foundation of Korea); National Honor Scientist Program of Korea; NRF; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through NRF Grant 2013-R1A1A2012804 funded by the Ministry of Education, Science, and Technology (to D. J. J.) and by the National Honor Scientist Program of Korea (to D. J. J. and B. K. K.).; Supported by Basic Science Research Program through the NRF Grant 2011-0022813.; Supported by Korean Ministry of Education, Science, and Technology 2012R1A1A2044699.	Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Beard MB, 1999, FEBS LETT, V460, P173, DOI 10.1016/S0014-5793(99)01335-6; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; BOLGER G, 1993, MOL CELL BIOL, V13, P6558, DOI 10.1128/MCB.13.10.6558; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huston E, 2006, J CELL SCI, V119, P3799, DOI 10.1242/jcs.03106; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jang DJ, 2011, MOL CELLS, V31, P175, DOI 10.1007/s10059-011-0025-7; Jang DJ, 2010, LEARN MEMORY, V17, P469, DOI 10.1101/lm.1899410; Jun M. H., 2014, BMB REP IN PRESS; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee SH, 2012, J NEUROSCI, V32, P16296, DOI 10.1523/JNEUROSCI.1872-12.2012; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; OConnell JC, 1996, BIOCHEM J, V318, P255, DOI 10.1042/bj3180255; Park H, 2005, J NEUROSCI, V25, P9037, DOI 10.1523/JNEUROSCI.1989-05.2005; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Rutten K, 2006, NEUROBIOL LEARN MEM, V85, P132, DOI 10.1016/j.nlm.2005.09.002; Shakur Y, 2000, J BIOL CHEM, V275, P38749, DOI 10.1074/jbc.M001734200; SHAKUR Y, 1993, BIOCHEM J, V292, P677, DOI 10.1042/bj2920677; Smith KJ, 1996, J BIOL CHEM, V271, P16703, DOI 10.1074/jbc.271.28.16703; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	48	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25797	25811		10.1074/jbc.M114.572222	http://dx.doi.org/10.1074/jbc.M114.572222			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077971	Green Published, hybrid			2022-12-28	WOS:000342130800037
J	Ledderose, C; Bao, Y; Lidicky, M; Zipperle, J; Li, LL; Strasser, K; Shapiro, NI; Junger, WG				Ledderose, Carola; Bao, Yi; Lidicky, Markus; Zipperle, Johannes; Li, Linglin; Strasser, Katharina; Shapiro, Nathan I.; Junger, Wolfgang G.			Mitochondria Are Gate-keepers of T Cell Function by Producing the ATP That Drives Purinergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANNEXIN-1 HEMICHANNELS; IMMUNE SYNAPSE; ACTIVATION; CALCIUM; RECEPTORS; RELEASE; SEPSIS; IMMUNOSUPPRESSION; METABOLISM; EXPRESSION	T cells play a central role in host defense. ATP release and autocrine feedback via purinergic receptors has been shown to regulate T cell function. However, the sources of the ATP that drives this process are not known. We found that stimulation of T cells triggers a spike in cellular ATP production that doubles intracellular ATP levels in < 30 s and causes prolonged ATP release into the extracellular space. Cell stimulation triggered rapid mitochondrial Ca2+ uptake, increased oxidative phosphorylation, a drop in mitochondrial membrane potential (Delta psi(m)), and the accumulation of active mitochondria at the immune synapse of stimulated T cells. Inhibition of mitochondria with CCCP, KCN, or rotenone blocked intracellular ATP production, ATP release, intracellular Ca2+ signaling, induction of the early activation marker CD69, and IL-2 transcription in response to cell stimulation. These findings demonstrate that rapid activation of mitochondrial ATP production fuels the purinergic signaling mechanisms that regulate T cells and define their role in host defense.	[Ledderose, Carola; Bao, Yi; Lidicky, Markus; Zipperle, Johannes; Li, Linglin; Strasser, Katharina; Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Shapiro, Nathan I.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Emergency Med, Boston, MA 02215 USA; [Lidicky, Markus] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Paracelsus Private Medical University; Ludwig Boltzmann Institute	Junger, WG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Feldberg 870,330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Shapiro, Nathan/F-1718-2016; li, li/GPX-3938-2022; Bao, Yi/J-5418-2013; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Strasser, Katharina/0000-0001-6962-5285; Zipperle, Johannes/0000-0002-8222-3413; Bao, Yi/0000-0003-0748-1575	National Institutes of Health [GM-51477, GM-60475, AI-080582, T32GM103702]; Harvard Digestive Disease Center; German Research Foundation (DFG) [LE-3209/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM103702, R01GM060475, R01GM051477, R29GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Disease Center; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by Grants GM-51477, GM-60475, AI-080582, and T32GM103702 from the National Institutes of Health (to W. G. J.), by The Harvard Digestive Disease Center, and by a fellowship from the German Research Foundation (DFG), LE-3209/1-1 (to C. L.).	Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chaudry IH, 2009, BRIT J SURG, V96, P1097, DOI 10.1002/bjs.6697; Chida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060561; Choi O, 2012, J IMMUNOL, V188, P3920, DOI 10.4049/jimmunol.1102587; Dehkordy SF, 2012, J CLIN IMMUNOL, V32, P1, DOI 10.1007/s10875-011-9593-8; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; FAIST E, 1993, J TRAUMA, V34, P846, DOI 10.1097/00005373-199306000-00016; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOYT DB, 1994, SHOCK, V2, P23, DOI 10.1097/00024382-199407000-00005; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwindling C, 2010, J IMMUNOL, V184, P184, DOI 10.4049/jimmunol.0902872; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhang YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005000	51	68	68	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25936	25945		10.1074/jbc.M114.575308	http://dx.doi.org/10.1074/jbc.M114.575308			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070895	Green Published, hybrid			2022-12-28	WOS:000342130800048
J	Parks, EE; Ceresa, BP				Parks, Eileen E.; Ceresa, Brian P.			Cell Surface Epidermal Growth Factor Receptors Increase Src and c-Cbl Activity and Receptor Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; EGF RECEPTOR; EPITHELIAL-CELLS; SIGNAL PROPAGATION; PLASMA-MEMBRANE; MICE LACKING; ACTIVATION; TYROSINE; MECHANISMS; KINASE	There is an established role for the endocytic pathway in regulation of epidermal growth factor receptor (EGFR) signaling to downstream effectors. However, because ligand-mediated EGFR endocytosis utilizes multiple "moving parts," dissecting the spatial versus temporal contributions has been challenging. Blocking all endocytic trafficking can have unintended effects on other receptors as well as give rise to compensatory mechanisms, both of which impact interpretation of EGFR signaling. To overcome these limitations, we used epidermal growth factor (EGF) conjugated to polystyrene beads (EGF beads). EGF beads simultaneously activate the EGFR while blocking its endocytosis and allow analysis of EGFR signaling from the plasma membrane. Human telomerase immortalized corneal epithelial (hTCEpi) cells were used to model normal epithelial cell biology. In hTCEpi cells, both cell surface and intracellular EGFRs exhibited dose-dependent increases in effector activity after 15 min of ligand stimulation, but only the serine phosphorylation of signal transducer and activator of transcription 3 (STAT3) was statistically significant when accounting for receptor phosphorylation. However, over time with physiological levels of receptor phosphorylation, cell surface receptors produced either enhanced or sustained mitogen-activated protein kinase kinase (MEK), Casitas B-lineage lymphoma (c-Cbl), and the pro-oncogene Src activity. These increases in effector communication by cell surface receptors resulted in an increase in EGFR ubiquitylation with sustained ligand incubation. Together, these data indicate that spatial regulation of EGFR signaling may be an important regulatory mechanism in receptor down-regulation.	[Parks, Eileen E.; Ceresa, Brian P.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA	University of Louisville	Ceresa, BP (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA.	brian.ceresa@louisville.edu			National Institutes of Health [R01GM092874, R01EY021497]; NATIONAL EYE INSTITUTE [R01EY021497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM092874 and R01EY021497 (to B. P. C.).	de Melker AA, 2004, J BIOL CHEM, V279, P55465, DOI 10.1074/jbc.M409765200; de Melker AA, 2001, J CELL SCI, V114, P2167; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hansen LA, 1997, AM J PATHOL, V150, P1959; Hsueh YJ, 2011, INVEST OPHTH VIS SCI, V52, P4685, DOI 10.1167/iovs.10-6103; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Johannessen LE, 2000, EXP CELL RES, V260, P136, DOI 10.1006/excr.2000.5004; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Peterson JL, 2014, INVEST OPHTH VIS SCI, V55, P2870, DOI 10.1167/iovs.13-12943; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rush JS, 2014, INVEST OPHTH VIS SCI, V55, P4691, DOI 10.1167/iovs.14-14133; Rush JS, 2013, MOL CELL ENDOCRINOL, V381, P188, DOI 10.1016/j.mce.2013.07.029; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Singh AB, 2007, J BIOL CHEM, V282, P32890, DOI 10.1074/jbc.M702677200; Smit GDV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000217; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stefonek TJ, 2007, WOUND REPAIR REGEN, V15, P847, DOI 10.1111/j.1524-475X.2007.00288.x; Tullo AB, 2005, EYE, V19, P729, DOI 10.1038/sj.eye.6701630; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361; Zhang L, 2003, MOL VIS, V9, P584	41	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25537	25545		10.1074/jbc.M114.579581	http://dx.doi.org/10.1074/jbc.M114.579581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074934	Green Published, hybrid			2022-12-28	WOS:000342130800015
J	Papsdorf, K; Sacherl, J; Richter, K				Papsdorf, Katharina; Sacherl, Julia; Richter, Klaus			The Balanced Regulation of Hsc70 by DNJ-13 and UNC-23 Is Required for Muscle Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; HSP70 CHAPERONES; SEDIMENTATION-VELOCITY; C-ELEGANS; PROTEIN; FAMILY; MUTATION; MUTANTS; FILAMIN; PATHWAY	The molecular chaperone Hsc70 assists in the folding of non-native proteins together with its J domain-and BAG domain-containing cofactors. In Caenorhabditis elegans, two BAG domain-containing proteins can be identified, one of them being UNC-23, whose mutation induces severe motility dysfunctions. Using reporter strains, we find that the full-length UNC-23, in contrast to C-terminal fragments, localizes specifically to the muscular attachment sites. C-terminal fragments of UNC-23 instead perform all Hsc70-related functions, like ATPase stimulation and regulation of folding activity, albeit with lower affinity than BAG-1. Interestingly, overexpression of CFP-Hsc70 can induce muscular defects in wild-type nematodes that phenocopy the knockout of its cofactor UNC-23. Strikingly, the motility dysfunction in the unc-23 mutated strain can be cured specifically by down-regulation of the antagonistic Hsc70 cochaperone DNJ-13, implying that the severe phenotype is caused by misregulation of the Hsc70 cycle. These findings point out that the balanced action of cofactors in the ATP-driven cycle of Hsc70 is crucial for the contribution of Hsc70 to muscle functionality.	[Richter, Klaus] Tech Univ Munich, Dept Biotechnol, D-85748 Garching, Germany; Tech Univ Munich, CIPSM, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich	Richter, K (corresponding author), Tech Univ Munich, Dept Biotechnol, Lichtenbergstr 4, D-85748 Garching, Germany.	klaus.richter@richterlab.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642; Papsdorf, Katharina/0000-0001-9873-7585	Deutsche Forschungsgemeinschaft [RI1873/1-3]; Graduate School of the Technische Universitat Munchen; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of the Technische Universitat Munchen; National Institutes of Health Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Deutsche Forschungsgemeinschaft Grant RI1873/1-3 (to K. R.) and the Graduate School of the Technische Universitat Munchen (to K. P.). The Caenorhabditis Genetics Center is supported by the National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440).	ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; BRENNER S, 1974, GENETICS, V77, P71; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Eddy Sean R, 2009, Genome Inform, V23, P205; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meissner B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019937; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Rahmani P., 2002, THESIS U BRIT COLUMB; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Seebacher J, 2006, J PROTEOME RES, V5, P2270, DOI 10.1021/pr060154z; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Stafford W. F. I., 1994, EMERG BIOCH BIOPHYS, P119; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033980; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ulbricht A, 2013, AUTOPHAGY, V9, P920, DOI 10.4161/auto.24213; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	50	7	8	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25250	25261		10.1074/jbc.M114.565234	http://dx.doi.org/10.1074/jbc.M114.565234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053410	Green Published, hybrid			2022-12-28	WOS:000341985300044
J	Yang, YM; Lee, J; Jo, H; Park, S; Chang, I; Muallem, S; Shin, DM				Yang, Yu-Mi; Lee, Jiae; Jo, Hae; Park, Soonhong; Chang, Inik; Muallem, Shmuel; Shin, Dong Min			Homer2 Protein Regulates Plasma Membrane Ca2+-ATPase-mediated Ca2+ Signaling in Mouse Parotid Gland Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POLARIZED EXPRESSION; HIPPOCAMPAL-NEURONS; PURKINJE NEURONS; IP3 RECEPTORS; CALCIUM-PUMP; KINASE-A; INTERACTS; CHANNELS; FAMILY	Homer proteins are scaffold molecules with a domain structure consisting of an N-terminal Ena/VASP homology 1 protein-binding domain and a C-terminal leucine zipper/coiled-coil domain. The Ena/VASP homology 1 domain recognizes proline-rich motifs and binds multiple Ca2+ -signaling proteins, including G protein-coupled receptors, inositol 1,4,5-triphosphate receptors, ryanodine receptors, and transient receptor potential channels. However, their role in Ca(2+)signaling in nonexcitable cells is not well understood. In this study, we investigated the role of Homer2 on Ca(2+)signaling in parotid gland acinar cells using Homer2-deficient (Homer2(-/-)) mice. Homer2 is localized at the apical pole in acinar cells. Deletion of Homer2 did not affect inositol 1,4,5-triphosphate receptor localization or channel activity and did not affect the expression and activity of sarco/endoplasmic reticulum Ca2+-ATPase pumps. In contrast, Homer2 deletion markedly increased expression of plasma membrane Ca2+-ATPase (PMCA) pumps, in particular PMCA4, at the apical pole. Accordingly, Homer2 deficiency increased Ca(2+)extrusion by acinar cells. These findings were supported by co-immunoprecipitation of Homer2 and PMCA in wild-type parotid cells and transfected human embryonic kidney 293 (HEK293) cells. We identified a Homer-binding PPXXF-like motif in the N terminus of PMCA that is required for interaction with Homer2. Mutation of the PPXXF-like motif did not affect the interaction of PMCA with Homer1 but inhibited its interaction with Homer2 and increased Ca(2+)clearance by PMCA. These findings reveal an important regulation of PMCA by Homer2 that has a central role on PMCA-mediated Ca(2+)signaling in parotid acinar cells.	[Yang, Yu-Mi; Lee, Jiae; Park, Soonhong; Chang, Inik; Shin, Dong Min] Yonsei Univ, Coll Dent, PLUS Project BK21, Dept Oral Biol, Seoul 120752, South Korea; [Jo, Hae] Kyung Hee Univ, Coll Life Sci, Gyeonggi 446701, South Korea; [Jo, Hae] Kyung Hee Univ, Grad Sch Biotechnol, Gyeonggi 446701, South Korea; [Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; Kyung Hee University; Kyung Hee University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Shin, DM (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol, 50 Yonsei Ro, Seoul 120752, South Korea.	dmshin@yuhs.ac		Shin, Dong Min/0000-0001-6042-0435	Korea government (MSIP) [NRF-2012R1A2A1A01003487]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER	Korea government (MSIP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the grant (NRF-2012R1A2A1A01003487) from the Korea government (MSIP).	Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; Floyd R, 2007, CELL CALCIUM, V42, P467, DOI 10.1016/j.ceca.2007.05.011; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Gorr SU, 2005, J DENT RES, V84, P500, DOI 10.1177/154405910508400604; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; Homann V, 2006, HISTOCHEM CELL BIOL, V125, P583, DOI 10.1007/s00418-005-0100-2; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Kurnellas MP, 2007, MOL CELL NEUROSCI, V34, P178, DOI 10.1016/j.mcn.2006.10.010; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Salm EJ, 2012, BIOCHEM BIOPH RES CO, V424, P76, DOI 10.1016/j.bbrc.2012.06.069; Sandona D, 2003, NEUROCHEM RES, V28, P1151, DOI 10.1023/A:1024264025401; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sgambato-Faure V, 2006, BIOCHEM BIOPH RES CO, V343, P630, DOI 10.1016/j.bbrc.2006.03.020; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Szumlinski KK, 2006, CURR OPIN NEUROBIOL, V16, P251, DOI 10.1016/j.conb.2006.05.002; Takemura H, 1999, BIOCHEM BIOPH RES CO, V259, P656, DOI 10.1006/bbrc.1999.0818; Tojyo Y, 1997, CELL CALCIUM, V22, P455, DOI 10.1016/S0143-4160(97)90073-7; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519; Zhao XS, 2001, EMBO J, V20, P2680, DOI 10.1093/emboj/20.11.2680	44	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24971	24979		10.1074/jbc.M114.577221	http://dx.doi.org/10.1074/jbc.M114.577221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25049230	Green Published, hybrid			2022-12-28	WOS:000341985300022
J	Ceraudo, E; Galanth, C; Carpentier, E; Banegas-Font, I; Schonegge, AM; Alvear-Perez, R; Iturrioz, X; Bouvier, M; Llorens-Cortes, C				Ceraudo, Emilie; Galanth, Cecile; Carpentier, Eric; Banegas-Font, Inmaculada; Schonegge, Anne-Marie; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Bouvier, Michel; Llorens-Cortes, Catherine			Biased Signaling Favoring G(i) over beta-Arrestin Promoted by an Apelin Fragment Lacking the C-terminal Phenylalanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Cell Signaling; Extracellular Signal-regulated Kinase (ERK); G Protein; G Protein-coupled Receptor (GPCR); Mitogen-activated Protein Kinase (MAPK); Pertussis Toxin; Apelin; Apelin Receptor	RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; ENDOGENOUS LIGAND APELIN; HUMAN APJ RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; FUNCTIONAL SELECTIVITY; CONFORMATIONAL-CHANGES; CARDIAC CONTRACTILITY; ERK1/2 ACTIVATION; REGULATED KINASES	Background: Apelin receptor represents a therapeutic target for cardiovascular diseases. Results: Apelin 17 activates ERK1/2 in a -arrestin-dependent and G protein-dependent manner, whereas apelin 17 with deleted C-terminal phenylalanine only signals through the G protein. Conclusion: Biased signaling promoted by an apelin fragment lacking the C-terminal phenylalanine is favoring G(i) over -arrestin. Significance: Apelin receptor -arrestin signaling may account for apelin hypotensive activity. Apelin plays a prominent role in body fluid and cardiovascular homeostasis. We previously showed that the C-terminal Phe of apelin 17 (K17F) is crucial for triggering apelin receptor internalization and decreasing blood pressure (BP) but is not required for apelin binding or G(i) protein coupling. Based on these findings, we hypothesized that the important role of the C-terminal Phe in BP decrease may be as a G(i)-independent but -arrestin-dependent signaling pathway that could involve MAPKs. For this purpose, we have used apelin fragments K17F and K16P (K17F with the C-terminal Phe deleted), which exhibit opposite profiles on apelin receptor internalization and BP. Using BRET-based biosensors, we showed that whereas K17F activates G(i) and promotes -arrestin recruitment to the receptor, K16P had a much reduced ability to promote -arrestin recruitment while maintaining its G(i) activating property, revealing the biased agonist character of K16P. We further show that both -arrestin recruitment and apelin receptor internalization contribute to the K17F-stimulated ERK1/2 activity, whereas the K16P-promoted ERK1/2 activity is entirely G(i)-dependent. In addition to providing new insights on the structural basis underlying the functional selectivity of apelin peptides, our study indicates that the -arrestin-dependent ERK1/2 activation and not the G(i)-dependent signaling may participate in K17F-induced BP decrease.	[Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] INSERM, U1050, Lab Cent Neuropeptides Regulat Body Fluid Homeost, F-75005 Paris, France; [Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] Coll France, Ctr Interdisciplinary Res Biol, F-75005 Paris, France; [Ceraudo, Emilie; Galanth, Cecile; Banegas-Font, Inmaculada; Alvear-Perez, Rodrigo; Iturrioz, Xavier; Llorens-Cortes, Catherine] CNRS, UMR 7241, F-75005 Paris, France; [Carpentier, Eric; Schonegge, Anne-Marie; Bouvier, Michel] Univ Montreal, Dept Biochem, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Carpentier, Eric; Schonegge, Anne-Marie; Bouvier, Michel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3T 1J4, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Universite de Montreal	Llorens-Cortes, C (corresponding author), Coll France, CIRB, INSERM, U1050, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	c.llorens-cortes@college-de-france.fr	Llorens-Cortès, catherine/AAL-3893-2021; Bouvier, Michel/H-2758-2014; Llorens-Cortes, Catherine/E-5839-2016; ITURRIOZ, Xavier/Q-4406-2017; Iturrioz, Xavier/AAS-3555-2020	Llorens-Cortès, catherine/0000-0002-7667-0401; Bouvier, Michel/0000-0003-1128-0100; Llorens-Cortes, Catherine/0000-0002-7667-0401; ITURRIOZ, Xavier/0000-0001-7143-8323; Iturrioz, Xavier/0000-0001-7143-8323; Banegas Font, Inmaculada/0000-0002-1910-3726	Institut National de la Sante et de la Recherche Medicale; College de France; Agence Nationale pour la Recherche Physique et Chimie du Vivant; Fondation pour la Recherche Medicale; Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); College de France; Agence Nationale pour la Recherche Physique et Chimie du Vivant(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the College de France and the Agence Nationale pour la Recherche Physique et Chimie du Vivant. This work was also supported by funds from the Fondation pour la Recherche Medicale (to I. B.-F.) and the Cardiovasculaires-Obesite-Rein-Diabete from Region Ile-de-France (to E. C.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Blanchard A, 2013, J CLIN ENDOCR METAB, V98, P2084, DOI 10.1210/jc.2012-3794; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Brailoiu GC, 2002, NEUROSCI LETT, V327, P193, DOI 10.1016/S0304-3940(02)00411-1; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Iturrioz X, 2010, J BIOL CHEM, V285, P32627, DOI 10.1074/jbc.M110.127167; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P1095, DOI 10.1046/j.1365-2826.2003.01102.x; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xu TR, 2008, BIOCHEM J, V413, P51, DOI 10.1042/BJ20080685; Zhou NM, 2003, VIROLOGY, V307, P22, DOI 10.1016/S0042-6822(02)00021-1; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522	65	56	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24599	24610		10.1074/jbc.M113.541698	http://dx.doi.org/10.1074/jbc.M113.541698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012663	hybrid, Green Published			2022-12-28	WOS:000341505600050
J	Piacente, F; De Castro, C; Jeudy, S; Molinaro, A; Salis, A; Damonte, G; Bernardi, C; Abergel, C; Tonetti, MG				Piacente, Francesco; De Castro, Cristina; Jeudy, Sandra; Molinaro, Antonio; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Abergel, Chantal; Tonetti, Michela G.			Giant Virus Megavirus chilensis Encodes the Biosynthetic Pathway for Uncommon Acetamido Sugars	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Virus Structure; Nuclear Magnetic Resonance (NMR); Mass Spectrometry (MS); Gas Chromatography-Mass Spectrometry (GC-MS); Carbohydrate Metabolism; N-Acetyl-L-Rhamnosamine; Megavirus Chilensis; UDP-N-acetylglucosamine	GDP-L-FUCOSE; PSEUDOMONAS-AERUGINOSA; HELICOBACTER-PYLORI; PSEUDAMINIC ACID; D-GLUCOSE; MIMIVIRUS; ENZYMES; 4,6-DEHYDRATASE; IDENTIFICATION; BACILLOSAMINE	Background: Much evidence indicates that giant viruses, including Megavirus chilensis, possibly encode autonomous glycosylation systems. Results: The Megavirus genome encodes proteins involved in the synthesis of 2-acetamido-2,6-dideoxy hexoses. Conclusion:N-Acetyl-rhamnosamine that is found in the virion glycans is produced by a novel viral biosynthetic pathway. Significance: These results will help in understanding the origin and function of the virally encoded glycosylation machineries. Giant viruses mimicking microbes, by the sizes of their particles and the heavily glycosylated fibrils surrounding their capsids, infect Acanthamoeba sp., which are ubiquitous unicellular eukaryotes. The glycans on fibrils are produced by virally encoded enzymes, organized in gene clusters. Like Mimivirus, Megavirus glycans are mainly composed of virally synthesized N-acetylglucosamine (GlcNAc). They also contain N-acetylrhamnosamine (RhaNAc), a rare sugar; the enzymes involved in its synthesis are encoded by a gene cluster specific to Megavirus close relatives. We combined activity assays on two enzymes of the pathway with mass spectrometry and NMR studies to characterize their specificities. Mg534 is a 4,6-dehydratase 5-epimerase; its three-dimensional structure suggests that it belongs to a third subfamily of inverting dehydratases. Mg535, next in the pathway, is a bifunctional 3-epimerase 4-reductase. The sequential activity of the two enzymes leads to the formation of UDP-l-RhaNAc. This study is another example of giant viruses performing their glycan synthesis using enzymes different from their cellular counterparts, raising again the question of the origin of these pathways.	[Piacente, Francesco; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela G.] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Piacente, Francesco; Salis, Annalisa; Damonte, Gianluca; Bernardi, Cinzia; Tonetti, Michela G.] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [De Castro, Cristina; Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, Naples, Italy; [Jeudy, Sandra; Abergel, Chantal] Aix Marseille Univ, CNRS, UMR7256, Struct & Genom Informat Lab,IMM, FR-13288 Marseille, France; [Salis, Annalisa] Univ Genoa, Dept Hearth Environm & Life Sci DISTAV, I-16132 Genoa, Italy	University of Genoa; University of Genoa; University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Genoa	Abergel, C (corresponding author), CNRS UPR 2589, Case 934, FR-13288 Marseille, France.	Chantal.Abergel@igs.cnrs-mrs.fr; tonetti@unige.it	Bernardi, Cinzia/K-3416-2018; De Castro, Cristina/I-5899-2012; Tonetti, Michela/F-3039-2018; Piacente, Francesco/J-8295-2016; TONETTI, MICHELA/AAF-3404-2021; Salis, Annalisa/R-9241-2018	Bernardi, Cinzia/0000-0001-9342-5929; De Castro, Cristina/0000-0002-5147-1756; Piacente, Francesco/0000-0001-5470-5987; TONETTI, MICHELA/0000-0002-8829-7173; Salis, Annalisa/0000-0002-3082-2908; Molinaro, Antonio/0000-0002-3456-7369; Abergel, Chantal/0000-0003-1875-4049; jeudy, sandra/0000-0002-5297-0135	CNRS; IBISA; Provence-Alpes-Cote d'Azur region; Regione Liguria; Regione Liguria (P.O. C.R.O. FSE, Asse IV Capitale umano, ob. specifico I/6 programma) [20]	CNRS(Centre National de la Recherche Scientifique (CNRS)); IBISA; Provence-Alpes-Cote d'Azur region(Region Provence-Alpes-Cote d'Azur); Regione Liguria(Regione Liguria); Regione Liguria (P.O. C.R.O. FSE, Asse IV Capitale umano, ob. specifico I/6 programma)	This work was supported in part by CNRS, IBISA, and the Provence-Alpes-Cote d'Azur region (to C. A.). This work was also supported in part by Regione Liguria (to M. T.).; Supported by a fellowship from Regione Liguria (P.O. C.R.O. FSE 2007-2013, Asse IV Capitale umano, ob. specifico I/6 programma n. 20).	ABERGEL C, 1991, J BIOL CHEM, V266, P20131; Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Audic S, 1997, PROTEINS, V29, P252, DOI 10.1002/(SICI)1097-0134(199710)29:2<252::AID-PROT12>3.0.CO;2-N; BECKER A, 1993, MOL GEN GENET, V238, P145, DOI 10.1007/BF00279541; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Creuzenet C, 2002, J BIOL CHEM, V277, P26769, DOI 10.1074/jbc.M202882200; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; Dong C, 2003, BIOCHEM SOC T, V31, P532, DOI 10.1042/BST0310532; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1997, RECENT ADV PHASING, P97; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fruscione F, 2008, J BIOL CHEM, V283, P184, DOI 10.1074/jbc.M706614200; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Kneidinger B, 2003, BIOCHEM J, V371, P989, DOI 10.1042/BJ20030099; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; McNally DJ, 2006, CHEMBIOCHEM, V7, P1865, DOI 10.1002/cbic.200600298; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; Miyafusa T, 2013, BIOSCIENCE REP, V33, P463, DOI 10.1042/BSR20130017; Miyafusa T, 2012, BIOCHEM J, V443, P671, DOI 10.1042/BJ20112049; Morrison JP, 2008, BIOORG CHEM, V36, P312, DOI 10.1016/j.bioorg.2008.08.004; Morrison MJ, 2014, BIOCHEMISTRY-US, V53, P624, DOI 10.1021/bi401546r; Mulrooney EF, 2005, J BIOL CHEM, V280, P19535, DOI 10.1074/jbc.M500612200; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piacente F, 2014, GLYCOBIOLOGY, V24, P51, DOI 10.1093/glycob/cwt089; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Remko M, 2006, J CHEM INF MODEL, V46, P1194, DOI 10.1021/ci0504667; Saadi H, 2013, CLIN INFECT DIS, V57, pE127, DOI 10.1093/cid/cit354; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; Yoosuf N, 2014, VIRUS GENES, V48, P218, DOI 10.1007/s11262-013-1016-x	43	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24428	24439		10.1074/jbc.M114.588947	http://dx.doi.org/10.1074/jbc.M114.588947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035429	Green Published, hybrid			2022-12-28	WOS:000341505600036
J	Simhadri, S; Peterson, S; Patel, DS; Huo, YY; Cai, H; Bowman-Colin, C; Miller, S; Ludwig, T; Ganesan, S; Bhaumik, M; Bunting, SF; Jasin, M; Xia, B				Simhadri, Srilatha; Peterson, Shaun; Patel, Dharm S.; Huo, Yanying; Cai, Hong; Bowman-Colin, Christian; Miller, Shoreh; Ludwig, Thomas; Ganesan, Shridar; Bhaumik, Mantu; Bunting, Samuel F.; Jasin, Maria; Xia, Bing			Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; DNA Damage Response; Homologous Recombination; Meiosis; Spermatogenesis; BRCA2; FANCN; Fanconi Anemia; PALB2; Male Infertility	RAD51 FILAMENT FORMATION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; FANCONI-ANEMIA; DNA-REPAIR; MOUSE MEIOSIS; PALB2; BRCA2; CANCER; SPERMATOGENESIS	Background: BRCA1 and PALB2 interact with each other to promote homologous recombination and DNA double strand break repair. Results: Mice with abrogated PALB2-BRCA1 interaction show male fertility defect. Conclusion: PALB2 and BRCA1 function together to ensure normal male meiosis. Significance: This work demonstrates the importance of the PALB2-BRCA1 interaction in vivo and reveals a novel role of PALB2 in sex chromosome synapsis. PALB2 links BRCA1 and BRCA2 in homologous recombinational repair of DNA double strand breaks (DSBs). Mono-allelic mutations in PALB2 increase the risk of breast, pancreatic, and other cancers, and biallelic mutations cause Fanconi anemia (FA). Like Brca1 and Brca2, systemic knock-out of Palb2 in mice results in embryonic lethality. In this study, we generated a hypomorphic Palb2 allele expressing a mutant PALB2 protein unable to bind BRCA1. Consistent with an FA-like phenotype, cells from the mutant mice showed hypersensitivity and chromosomal breakage when treated with mitomycin C, a DNA interstrand crosslinker. Moreover, mutant males showed reduced fertility due to impaired meiosis and increased apoptosis in germ cells. Interestingly, mutant meiocytes showed a significant defect in sex chromosome synapsis, which likely contributed to the germ cell loss and fertility defect. Our results underscore the in vivo importance of the PALB2-BRCA1 complex formation in DSB repair and male meiosis.	[Simhadri, Srilatha; Huo, Yanying; Cai, Hong; Ganesan, Shridar; Bhaumik, Mantu; Xia, Bing] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Simhadri, Srilatha; Huo, Yanying; Cai, Hong; Xia, Bing] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08901 USA; [Miller, Shoreh; Bhaumik, Mantu] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Ganesan, Shridar] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA; [Peterson, Shaun; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, Sloan Kettering Inst, New York, NY 10065 USA; [Patel, Dharm S.; Bunting, Samuel F.] Rutgers State Univ, Sch Arts & Sci, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bowman-Colin, Christian] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ludwig, Thomas] Ohio State Univ, Dept Mol & Cellular Biochem, Wexner Med Ctr, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University	Xia, B (corresponding author), Rutgers Canc Inst New Jersey, Dept Radiat Oncol, 195 Little Albany St, New Brunswick, NJ 08903 USA.	xiabi@cinj.rutgers.edu	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585; HUO, YANYING/0000-0003-4747-4951; Peterson, Shaun/0000-0002-0906-8939; Patel, Dharm/0000-0003-1804-838X	NCI CCSG Grant [P30CA072720]; Robert Wood Johnson Foundation [67038]; NATIONAL CANCER INSTITUTE [R00CA160574, R01CA138804, R01CA169182, P30CA072720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339, R01GM105421] Funding Source: NIH RePORTER	NCI CCSG Grant; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Florent le Masson for valuable technical assistance, Scott Keeney for critical comments on the manuscript, and Reena Shakya for helpful discussions. We thank the Transgenic and Knockout Mouse Shared Resource of the Rutgers Cancer Institute of New Jersey, which is supported by an NCI CCSG Grant (P30CA072720) and by a Robert Wood Johnson Foundation grant to the Child Health Institute of New Jersey (Grant 67038).	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bakker ST, 2013, DIS MODEL MECH, V6, P40, DOI 10.1242/dmm.009795; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bouwman P, 2011, J PATHOL, V224, P10, DOI 10.1002/path.2861; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Buisson R, 2012, NUCLEIC ACIDS RES, V40, P10312, DOI 10.1093/nar/gks807; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Cressman VL, 1999, MOL CELL BIOL, V19, P7061; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hayakawa T, 2010, J CELL SCI, V123, P1124, DOI 10.1242/jcs.060178; HEYTING C, 1991, METHOD CELL BIOL, V35, P177; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Hunter N., 2007, TOPICS CURRENT GENET; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kauppi L, 2013, GENE DEV, V27, P873, DOI 10.1101/gad.213652.113; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kolas NK, 2005, CHROMOSOMA, V114, P92, DOI 10.1007/s00412-005-0334-8; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oliver AW, 2009, EMBO REP, V10, P990, DOI 10.1038/embor.2009.126; Rantakari P, 2010, HUM MOL GENET, V19, P3021, DOI 10.1093/hmg/ddq207; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tischkowitz M, 2011, J PATHOL, V224, P301, DOI 10.1002/path.2903; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuan SSF, 1999, CANCER RES, V59, P3547; Zhang F, 2012, J CELL SCI, V125, P6049, DOI 10.1242/jcs.111872; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	51	48	49	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24617	24629		10.1074/jbc.M114.566141	http://dx.doi.org/10.1074/jbc.M114.566141			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016020	hybrid, Green Published			2022-12-28	WOS:000341505600052
J	Lenoir, M; Sugawara, M; Kaur, J; Ball, LJ; Overduin, M				Lenoir, Marc; Sugawara, Masae; Kaur, Jaswant; Ball, Linda J.; Overduin, Michael			Structural Insights into the Activation of the RhoA GTPase by the Lymphoid Blast Crisis (Lbc) Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Guanine Nucleotide Exchange Factor (GEF); Nuclear Magnetic Resonance; Oncogene; Protein Structure; Protein-Protein Interaction; Ras Homolog Gene Family; Member A (RhoA); Rho GTPases; AKAP; Lbc	GUANINE-NUCLEOTIDE-EXCHANGE; PROTEIN-KINASE-A; AKAP-LBC; P115 RHOGEF; CYCLIC-AMP; PH DOMAINS; SCATTERING; COMPLEX; BINDING; DH	Background: The Lbc oncoprotein stimulates deregulated GTPase activity in RhoA. Results: Although the Lbc DH domain can independently activate GTP exchange by RhoA, its PH domain also presents surfaces for DH and activated RhoA interaction. Conclusion: Multiple sites on both structural domains of the Lbc scaffold control RhoA. Significance: New sites for mechanism-based design of modulators of Lbc action are revealed. The small GTPase RhoA promotes deregulated signaling upon interaction with lymphoid blast crisis (Lbc), the oncogenic form of A-kinase anchoring protein 13 (AKAP13). The onco-Lbc protein is a hyperactive Rho-specific guanine nucleotide exchange factor (GEF), but its structural mechanism has not been reported despite its involvement in cardiac hypertrophy and cancer causation. The pleckstrin homology (PH) domain of Lbc is located at the C-terminal end of the protein and is shown here to specifically recognize activated RhoA rather than lipids. The isolated dbl homology (DH) domain can function as an independent activator with an enhanced activity. However, the DH domain normally does not act as a solitary Lbc interface with RhoA-GDP. Instead it is negatively controlled by the PH domain. In particular, the DH helical bundle is coupled to the structurally dependent PH domain through a helical linker, which reduces its activity. Together the two domains form a rigid scaffold in solution as evidenced by small angle x-ray scattering and H-1,C-13,N-15-based NMR spectroscopy. The two domains assume a chair shape with its back possessing independent GEF activity and the PH domain providing a broad seat for RhoA-GTP docking rather than membrane recognition. This provides structural and dynamical insights into how DH and PH domains work together in solution to support regulated RhoA activity. Mutational analysis supports the bifunctional PH domain mediation of DH-RhoA interactions and explains why the tandem domain is required for controlled GEF signaling.	[Lenoir, Marc; Sugawara, Masae; Kaur, Jaswant; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Ball, Linda J.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Ball, Linda J.] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	University of Birmingham; University of Oxford; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Overduin, M (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	m.overduin@bham.ac.uk	Ball, Linda J/E-8454-2011; Overduin, Michael/AAG-3632-2020	Ball, Linda J/0000-0002-0948-6954; Overduin, Michael/0000-0002-3114-6585; Lenoir, Marc/0000-0001-7410-2323	Wellcome Trust; European Union Bio-NMR; BBSRC [BB/H024697/1, BB/E013198/1, BB/I013865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/10714, BB/I013865/1, BB/E013198/1, BB/H024697/1, BB/C511513/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union Bio-NMR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sara Whittaker and the staff of The Henry Wellcome Building for Biological NMR Spectroscopy (HWB. NMR), which is funded by the Wellcome Trust and European Union Bio-NMR; Shurene Bishop (Structural Genomics Consortium, Oxford, UK); Mitsuhiko Ikura (University of Toronto); John D. Scott (University of Washington) for discussions and constructs; and Ruben Abagyan and Irina Kufareva (University of California, San Diego) for the MODA software.	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Burmeister BT, 2012, J BIOL CHEM, V287, P40535, DOI 10.1074/jbc.M112.385641; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; del Vescovo CD, 2013, MOL CELL BIOL, V33, P14, DOI 10.1128/MCB.00887-12; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasmi-Seabrook GMC, 2010, J BIOL CHEM, V285, P5137, DOI 10.1074/jbc.M109.064691; Klussmann E., 2014, European Patent, Patent No. 2682118; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Mayers CM, 2010, J BIOL CHEM, V285, P12344, DOI 10.1074/jbc.M110.106856; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rogers R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.057; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz MA, 1996, EMBO J, V15, P6525, DOI 10.1002/j.1460-2075.1996.tb01043.x; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Sugawara M, 2009, BIOMOL NMR ASSIGN, V3, P215, DOI 10.1007/s12104-009-9178-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TOKSOZ D, 1994, ONCOGENE, V9, P621; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Wirtenberger M, 2006, CARCINOGENESIS, V27, P593, DOI 10.1093/carcin/bgi245; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	55	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23992	24004		10.1074/jbc.M114.561787	http://dx.doi.org/10.1074/jbc.M114.561787			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993829	Green Published, hybrid			2022-12-28	WOS:000341505000063
J	Kim, J; Kwak, HJ; Cha, JY; Jeong, YS; Rhee, SD; Kim, KR; Cheon, HG				Kim, Juyoung; Kwak, Hyun Jeong; Cha, Ji-Young; Jeong, Yun-Seung; Rhee, Sang Dahl; Kim, Kwang Rok; Cheon, Hyae Gyeong			Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; PROTEIN-KINASE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; NEGATIVE REGULATOR; DIABETES-MELLITUS; RESPIRATORY-CHAIN; GENE-EXPRESSION; MECHANISM	Metformin, a well known antidiabetic agent that improves peripheral insulin sensitivity, also elicits anti-inflammatory actions, but its mechanism is unclear. Here, we investigated the mechanism responsible for the anti-inflammatory effect of metformin action in lipopolysaccharide (LPS)-stimulated murine macrophages. Metformin inhibited LPS-induced production of tumor necrosis factor-alpha (TNF-alpha) and interleukin- 6 (IL-6) in a concentration-dependent manner and in parallel induction of activating transcription factor-3 (ATF3), a transcription factor and member of the cAMP-responsive element-binding protein family. ATF-3 knockdown abolished the inhibitory effects of metformin on LPS-induced proinflammatory cytokine production accompanied with reversal of metformin-induced suppression of mitogen-activated protein kinase (MAPK) phosphorylation. Conversely, AMP-activated protein kinase (AMPK) phosphorylation and NF-kappa B suppression by metformin were unaffected by ATF-3 knockdown. ChIP-PCR analysis revealed that LPS-induced NF-kappa B enrichments on the promoters of IL-6 and TNF-alpha were replaced by ATF-3 upon metformin treatment. AMPK knockdown blunted all the effects of metformin (ATF-3 induction, proinflammatory cytokine inhibition, and MAPK inactivation), suggesting that AMPK activation by metformin is required for and precedes ATF-3 induction. Oral administration of metformin to either mice with LPS-induced endotoxemia or ob/ob mice lowered the plasma and tissue levels of TNF-alpha and IL-6 and increased ATF-3 expression in spleen and lungs. These results suggest that metformin exhibits anti-inflammatory action in macrophages at least in part via pathways involving AMPK activation and ATF-3 induction.	[Kim, Juyoung; Kwak, Hyun Jeong; Cheon, Hyae Gyeong] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Pharmacol & Pharmaceut Sci, Inchon 406799, South Korea; [Cha, Ji-Young; Jeong, Yun-Seung] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Dept Mol Med, Inchon 406799, South Korea; [Rhee, Sang Dahl; Kim, Kwang Rok] Korea Res Inst Chem Technol, Bioorgan Sci Div, Taejon 305343, South Korea; [Cheon, Hyae Gyeong] Gil Med Ctr, Gachon Med Res Inst, Inchon 405760, South Korea	Gachon University; Gachon University; Korea Research Institute of Chemical Technology (KRICT); Gachon University	Cheon, HG (corresponding author), Gachon Univ, Sch Med, Dept Pharmacol & Pharmaceut Sci, Yeonsu 3 Dong, Inchon 406799, South Korea.	hgcheon@gachon.ac.kr		Cha, JI-Young/0000-0002-8557-6214	Basic Science Research Program of the Korean National Research Foundation (NRF) - Korean Ministry of Education and Technology [2010-0007517]	Basic Science Research Program of the Korean National Research Foundation (NRF) - Korean Ministry of Education and Technology	This work was supported by the Basic Science Research Program of the Korean National Research Foundation (NRF) funded by the Korean Ministry of Education and Technology (Grant 2010-0007517).	Burcelin R, 2012, PHYSIOLOGY, V27, P300, DOI 10.1152/physiol.00023.2012; Caballero AE, 2004, J CLIN ENDOCR METAB, V89, P3943, DOI 10.1210/jc.2004-0019; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Dandona P, 2004, J CLIN ENDOCR METAB, V89, P5043, DOI 10.1210/jc.2004-0436; De Jager J, 2005, J INTERN MED, V257, P100; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; GALUSKA D, 1994, DIABETOLOGIA, V37, P826, DOI 10.1007/BF00404340; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Hai T, 1999, GENE EXPRESSION, V7, P321; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim YD, 2012, DIABETOLOGIA, V55, P1482, DOI 10.1007/s00125-012-2494-4; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nguyen TT, 2010, J BIOL CHEM, V285, P17011, DOI 10.1074/jbc.M109.068817; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	37	138	143	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23246	23255		10.1074/jbc.M114.577908	http://dx.doi.org/10.1074/jbc.M114.577908			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973221	Green Published, hybrid			2022-12-28	WOS:000341017200060
J	Meijles, DN; Fan, LM; Howlin, BJ; Li, JM				Meijles, Daniel N.; Fan, Lampson M.; Howlin, Brendan J.; Li, Jian-Mei			Molecular Insights of p47(phox) Phosphorylation Dynamics in the Regulation of NADPH Oxidase Activation and Superoxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; SH3 DOMAINS; OXIDATIVE STRESS; ANGIOTENSIN-II; NOX FAMILY; PROTEIN; BINDING; SUBUNIT; ALPHA; PATHOPHYSIOLOGY	Phagocyte superoxide production by a multicomponent NADPH oxidase is important in host defense against microbial invasion. However inappropriate NADPH oxidase activation causes inflammation. Endothelial cells express NADPH oxidase and endothelial oxidative stress due to prolonged NADPH oxidase activation predisposes many diseases. Discovering the mechanism of NADPH oxidase activation is essential for developing novel treatment of these diseases. The p47(phox) is a key regulatory subunit of NADPH oxidase; however, due to the lack of full protein structural information, the mechanistic insight of p47(phox) phosphorylation in NADPH oxidase activation remains incomplete. Based on crystal structures of three functional domains, we generated a computational structural model of the full p47(phox) protein. Using a combination of in silico phosphorylation, molecular dynamics simulation and protein/protein docking, we discovered that the C-terminal tail of p47(phox) is critical for stabilizing its autoinhibited structure. Ser-379 phosphorylation disrupts H-bonds that link the C-terminal tail to the autoinhibitory region (AIR) and the tandem Src homology 3 (SH3) domains, allowing the AIR to undergo phosphorylation to expose the SH3 pocket for p22(phox) binding. These findings were confirmed by site-directed mutagenesis and gene transfection of p47(phox-/-) coronary microvascular cells. Compared with wild-type p47(phox) cDNA transfected cells, the single mutation of S379A completely blocked p47(phox) membrane translocation, binding to p22(phox) and endothelial O-2 radical anion. production in response to acute stimulation of PKC. p47(phox) C-terminal tail plays a key role in stabilizing intramolecular interactions at rest. Ser-379 phosphorylation is a molecular switch which initiates p47(phox) conformational changes and NADPH oxidase-dependent superoxide production by cells.	[Meijles, Daniel N.; Li, Jian-Mei] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Fan, Lampson M.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Meijles, Daniel N.; Howlin, Brendan J.] Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 7XH, Surrey, England	University of Surrey; University of Oxford; University of Surrey	Li, JM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, AY Bldg, Guildford GU2 7XH, Surrey, England.	j.li@surrey.ac.uk	Howlin, Brendan J/F-3343-2011; Meijles, Daniel/J-6457-2014	Howlin, Brendan J/0000-0002-9398-7152; Meijles, Daniel/0000-0002-5557-3549; Li, Jian-Mei/0000-0002-3294-3818	University of Surrey Seed Fund; Wellcome Trust [07863/Z/05/Z]	University of Surrey Seed Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the University of Surrey Seed Fund and the Wellcome Trust (Grant 07863/Z/05/Z).	Autore F, 2010, BIOPHYS J, V99, P3716, DOI 10.1016/j.bpj.2010.09.008; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Du JJ, 2013, BRIT J PHARMACOL, V170, P1064, DOI 10.1111/bph.12336; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Fan LM, 2014, J PHARMACOL TOX MET, V70, P40, DOI 10.1016/j.vascn.2014.03.173; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2003, J BIOL CHEM, V278, P12094, DOI 10.1074/jbc.M209793200; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li JM, 2001, J MOL CELL CARDIOL, V33, P1119, DOI 10.1006/jmcc.2001.1372; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; MCPHAIL LC, 1994, J EXP MED, V180, P2011, DOI 10.1084/jem.180.6.2011; Meijles DN, 2012, COMPUT BIOL CHEM, V39, P6, DOI 10.1016/j.compbiolchem.2012.05.001; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Wass MN, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.3; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shen HD, 2011, IMMUNOL CELL BIOL, V89, P225, DOI 10.1038/icb.2010.77; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Teng L, 2012, ARTERIOSCL THROM VAS, V32, P1488, DOI 10.1161/ATVBAHA.112.247775; Watanabe Y, 2006, COMPUT BIOL CHEM, V30, P303, DOI 10.1016/j.compbiolchem.2006.04.004	38	46	49	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22759	22770		10.1074/jbc.M114.561159	http://dx.doi.org/10.1074/jbc.M114.561159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970888	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000341017200021
J	Saha, K; Sambo, D; Richardson, BD; Lin, LM; Butler, B; Villarroel, L; Khoshbouei, H				Saha, Kaustuv; Sambo, Danielle; Richardson, Ben D.; Lin, Landon M.; Butler, Brittany; Villarroel, Laura; Khoshbouei, Habibeh			Intracellular Methamphetamine Prevents the Dopamine-induced Enhancement of Neuronal Firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DOPAMINE; TRANSMEMBRANE SEGMENT; TRANSPORTER FUNCTION; DEPENDENT MECHANISM; AMPHETAMINE ACTION; IMPULSE ACTIVITY; PLASMA-MEMBRANE; CROSS-LINKING; MICE LACKING; IN-VIVO	The dysregulation of the dopaminergic system is implicated in multiple neurological and neuropsychiatric disorders such as Parkinson disease and drug addiction. The primary target of psychostimulants such as amphetamine and methamphetamine is the dopamine transporter (DAT), the major regulator of extracellular dopamine levels in the brain. However, the behavioral and neurophysiological correlates of methamphetamine and amphetamine administration are unique from one another, thereby suggesting these two compounds impact dopaminergic neurotransmission differentially. We further examined the unique mechanisms by which amphetamine and methamphetamine regulate DAT function and dopamine neurotransmission; in the present study we examined the impact of extracellular and intracellular amphetamine and methamphetamine on the spontaneous firing of cultured midbrain dopaminergic neurons and isolated DAT-mediated current. In dopaminergic neurons the spontaneous firing rate was enhanced by extracellular application of amphetamine > dopamine > methamphetamine and was DAT-dependent. Amphetamine > methamphetamine similarly enhanced DAT-mediated inward current, which was sensitive to isosmotic substitution of Na+ or Cl- ion. Although isosmotic substitution of extracellular Na+ ions blocked amphetamine and methamphetamine-induced DAT-mediated inward current similarly, the removal of extracellular Cl- ions preferentially blocked amphetamine-induced inward current. The intracellular application of methamphetamine, but not amphetamine, prevented the dopamine-induced increase in the spontaneous firing of dopaminergic neurons and the corresponding DAT-mediated inward current. The results reveal a new mechanism for methamphetamine-induced dysregulation of dopaminergic neurons.	Univ Florida, McKnight Brain Inst, Coll Med, Dept Neurosci, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Coll Med, Dept Psychiat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khoshbouei, H (corresponding author), Univ Florida, McKnight Brain Inst, Dept Neurosci, Dept Psychiat, 1149 Newell Dr,POB 100244, Gainesville, FL 32611 USA.	habibeh@ufl.edu	Richardson, Ben/GNP-5689-2022	Richardson, Ben/0000-0003-0403-4956; Khoshbouei, Habibeh/0000-0002-1533-8771; SAHA, KAUSTUV/0000-0002-2931-1422	National Institutes of Health [DA026947, NS071122]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA026947 and NS071122.	[Anonymous], 2006, NAT I DRUG AB NIDA R; Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BUKAUSKAS FF, 1992, EXP PHYSIOL, V77, P903, DOI 10.1113/expphysiol.1992.sp003657; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FISCHER JF, 1976, P W PHARMACOL SOC, V19, P179; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; GU H, 1994, J BIOL CHEM, V269, P7124; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; HORNYKIEWICZ O, 1986, NEW ENGL J MED, V315, P347, DOI 10.1056/NEJM198608073150602; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1998, J NEUROSCI, V18, P1979; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KEEFE KA, 1992, NEUROSCIENCE, V47, P325, DOI 10.1016/0306-4522(92)90248-Z; KEEFE KA, 1993, J NEURAL TRANSM-GEN, V91, P223, DOI 10.1007/BF01245233; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Leviel V, 2011, J NEUROCHEM, V118, P475, DOI 10.1111/j.1471-4159.2011.07335.x; McCutcheon JE, 2012, J NEUROPHYSIOL, V108, P1620, DOI 10.1152/jn.00077.2012; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; NIEOULLON A, 1977, NATURE, V266, P375, DOI 10.1038/266375a0; OBIANWU HO, 1968, J PHARM PHARMACOL, V20, P585, DOI 10.1111/j.2042-7158.1968.tb09818.x; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pierce RC, 1997, J NEUROSCI, V17, P3254; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rodriguez-Menchaca AA, 2012, BRIT J PHARMACOL, V165, P2749, DOI 10.1111/j.1476-5381.2011.01728.x; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sitte HH, 1998, J NEUROCHEM, V71, P1289; SNYDER SH, 1973, ANN NY ACAD SCI, V205, P310, DOI 10.1111/j.1749-6632.1973.tb43188.x; Sonders MS, 1997, J NEUROSCI, V17, P960; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; WALL SC, 1995, MOL PHARMACOL, V47, P544; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; WISE CD, 1973, SCIENCE, V181, P344, DOI 10.1126/science.181.4097.344; WONG DT, 1972, J PHARM PHARMACOL, V24, P171, DOI 10.1111/j.2042-7158.1972.tb08958.x; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zhu J, 2008, CNS NEUROL DISORD-DR, V7, P393, DOI 10.2174/187152708786927877	55	29	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22246	22257		10.1074/jbc.M114.563056	http://dx.doi.org/10.1074/jbc.M114.563056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962577	Green Published, hybrid			2022-12-28	WOS:000340593500038
J	Tian, T; Zhu, YL; Zhou, YY; Liang, GF; Wang, YY; Hu, FH; Xiao, ZD				Tian, Tian; Zhu, Yan-Liang; Zhou, Yue-Yuan; Liang, Gao-Feng; Wang, Yuan-Yuan; Hu, Fei-Hu; Xiao, Zhong-Dang			Exosome Uptake through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 Delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR TRAFFICKING; TGF-BETA; MICRORNAS; PATHWAYS; CELLS; INTERNALIZATION; IDENTIFICATION; ART	Exosomes are nanoscale membrane vesicles secreted from many types of cells. Carrying functional molecules, exosomes transfer information between cells and mediate many physiological and pathological processes. In this report, utilizing selective inhibitors, molecular tools, and specific endocytosis markers, the cellular uptake of PC12 cell-derived exosomes was imaged by high-throughput microscopy and statistically analyzed. It was found that the uptake was through clathrin-mediated endocytosis and macropinocytosis. Furthermore, PC12 cell-derived exosomes can enter and deliver microRNAs (miRNAs) into bone marrow-derived mesenchymal stromal cells (BMSCs), and decrease the expression level of transforming growth factor beta receptor II (TGF beta RII) and tropomyosin-1 (TPM1) through miR-21. These results show the pathway of exosome internalization and demonstrate that tumor cell-derived exosomes regulate target gene expression in normal cells.	[Tian, Tian; Zhu, Yan-Liang; Zhou, Yue-Yuan; Liang, Gao-Feng; Wang, Yuan-Yuan; Hu, Fei-Hu; Xiao, Zhong-Dang] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Tian, Tian] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University	Xiao, ZD (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	zdxiao@seu.edu.cn	Lv, Yuanjie/AER-0767-2022		National Basic Research Program of China (973 Program) [2013CB932902]; NSFC [61071047, 31371003]; Natural Science Foundation of Jiangsu Province [BK2012122, BK20130886]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130092110030]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Basic Research Program of China (973 Program: 2013CB932902), NSFC (No. 61071047, 31371003), the Natural Science Foundation of Jiangsu Province (No. BK2012122, BK20130886), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20130092110030).	Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Cai ZJ, 2012, CELL RES, V22, P607, DOI 10.1038/cr.2011.196; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Staals RHJ, 2010, ADV EXP MED BIOL, V702, P132, DOI 10.1007/978-1-4419-7841-7_11; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yuyama K, 2009, J NEUROCHEM, V109, P1250, DOI 10.1111/j.1471-4159.2009.06046.x; Zhang F, 2009, TRAFFIC, V10, P411, DOI 10.1111/j.1600-0854.2009.00879.x; Zhang WS, 2009, CELL SIGNAL, V21, P237, DOI 10.1016/j.cellsig.2008.10.008; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	41	386	398	10	124	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22258	22267		10.1074/jbc.M114.588046	http://dx.doi.org/10.1074/jbc.M114.588046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951588	hybrid, Green Published			2022-12-28	WOS:000340593500039
J	Tsukahara, T; Emori, M; Murata, K; Hirano, T; Muroi, N; Kyono, M; Toji, S; Watanabe, K; Torigoe, T; Kochin, V; Asanuma, H; Matsumiya, H; Yamashita, K; Himi, T; Ichimiya, S; Wada, T; Yamashita, T; Hasegawa, T; Sato, N				Tsukahara, Tomohide; Emori, Makoto; Murata, Kenji; Hirano, Takahisa; Muroi, Norihiro; Kyono, Masanori; Toji, Shingo; Watanabe, Kazue; Torigoe, Toshihiko; Kochin, Vitaly; Asanuma, Hiroko; Matsumiya, Hiroshi; Yamashita, Keiji; Himi, Tetsuo; Ichimiya, Shingo; Wada, Takuro; Yamashita, Toshihiko; Hasegawa, Tadashi; Sato, Noriyuki			Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-IMMUNOTHERAPY TARGET; ABERRANT EXPRESSION; PROTEIN; IDENTIFICATION; INDUCTION; EPITOPES; POTENCY	Osteosarcoma is a rare but highly malignant tumor occurring most frequently in adolescents. The prognosis of non-responders to chemotherapy is still poor, and new treatment modalities are needed. To develop peptide-based immunotherapy, we previously identified autologous cytotoxic T lymphocyte-defined osteosarcoma antigen papillomavirus binding factor (PBF) in the context of HLA-B55 and the cytotoxic T lymphocyte epitope (PBF A2.2) presented by HLA-A2. PBF and HLA class I are expressed in similar to 90 and 70% of various sarcomas, respectively. However, the expression status of peptide PBF A2.2 presented by HLA-A2 on osteosarcoma cells has remained unknown because it is difficult to generate a specific probe that reacts with the HLA.peptide complex. For detection and qualification of the HLA-A*02:01.PBF A2.2 peptide complex on osteosarcoma cells, we tried to isolate a single chain variable fragment (scFv) antibody directed to the HLA-*A0201.PBF A2.2 complex using a naive scFv phage display library. As a result, scFv clone D12 with high affinity (K-D = 1.53 x 10(-9) M) was isolated. D12 could react with PBF A2.2 peptide-pulsed T2 cells and HLA-A2+PBF+ osteosarcoma cell lines and simultaneously demonstrated that the HLA.peptide complex was expressed on osteosarcoma cells. In conclusion, scFv clone D12 might be useful to select candidate patients for PBF A2.2 peptide-based immunotherapy and develop antibody-based immunotherapy.	[Tsukahara, Tomohide; Murata, Kenji; Torigoe, Toshihiko; Kochin, Vitaly; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Hirano, Takahisa; Muroi, Norihiro; Kyono, Masanori] Sapporo Med Univ, Sch Med, MD PhD Program, Sapporo, Hokkaido 0608556, Japan; [Ichimiya, Shingo] Sapporo Med Univ, Sch Med, Dept Immunol, Frontier Med Res Ctr, Sapporo, Hokkaido 0608556, Japan; [Emori, Makoto; Murata, Kenji; Wada, Takuro; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 0608543, Japan; [Toji, Shingo; Watanabe, Kazue] Med & Biol Labs Co Ltd, Ina Lab, Ina, Saitama 3960002, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ Hosp, Div Surg Pathol, Sapporo, Hokkaido 0608543, Japan; [Matsumiya, Hiroshi; Yamashita, Keiji; Himi, Tetsuo] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608543, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Tsukahara, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, West 17,South 1, Sapporo, Hokkaido 0608556, Japan.	tukahara@sapmed.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [21249025, 20390403, 22689041, 25462344]; Management Expenses Grants from Government [23-A-10, 23-A-44]; Northern Advancement Center for Science and Technology [H24-S-5]; Takeda Science Foundation [2010-Kenkyu-Shorei]; Suhara Memorial Foundation [H24-12]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Management Expenses Grants from Government; Northern Advancement Center for Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suhara Memorial Foundation	This work was supported by grants from Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) 21249025 (to N. S.), 20390403 (to T. W.), and 22689041 and 25462344 (to T. Tsukahara); Management Expenses Grants 23-A-10 (to T. W.) and 23-A-44 (to N. S.) from the Government to the National Cancer Center; and Northern Advancement Center for Science and Technology Grant H24-S-5, Takeda Science Foundation Grant 2010-Kenkyu-Shorei, and Suhara Memorial Foundation Grant H24-12 (to T. Tsukahara).	Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Bossi G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26840; CAMPBELL CJ, 1975, J BONE JOINT SURG AM, VA 57, P143, DOI 10.2106/00004623-197557020-00001; Dahan R, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.2; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fletcher C.D., 2002, WHO CLASSIFICATION T, P120; Hariu H, 2005, CLIN CANCER RES, V11, P1000; Hasegawa R, 2013, EXP CELL RES, V319, P68, DOI 10.1016/j.yexcr.2012.11.003; Hirohashi Y, 2002, CLIN CANCER RES, V8, P1731; Honma I, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-103; Ida K, 2004, J IMMUNOL, V173, P1436, DOI 10.4049/jimmunol.173.2.1436; Inoda S, 2011, EXP MOL PATHOL, V90, P55, DOI 10.1016/j.yexmp.2010.10.001; Jordanovski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074911; Kawaguchi S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-31; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; Lewis VO, 2007, J BONE JOINT SURG AM, V89A, P1399, DOI 10.2106/JBJS.G.00075; Maki RG, 2006, CURR OPIN ONCOL, V18, P363, DOI 10.1097/01.cco.0000228743.72165.86; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Michaeli Y, 2009, J IMMUNOL, V182, P6328, DOI 10.4049/jimmunol.0801898; Morita R, 2014, CANCER SCI, V105, P389, DOI 10.1111/cas.12362; Nabeta Yuki, 2003, J Orthop Sci, V8, P554, DOI 10.1007/s00776-003-0663-5; Nahshol O, 2008, ANAL BIOCHEM, V383, P52, DOI 10.1016/j.ab.2008.08.017; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; PARKER KC, 1994, J IMMUNOL, V152, P163; Purbhoo MA, 2006, J IMMUNOL, V176, P7308, DOI 10.4049/jimmunol.176.12.7308; Sato N, 2009, PATHOL INT, V59, P205, DOI 10.1111/j.1440-1827.2009.02353.x; Sato Y, 2002, J IMMUNOL, V169, P1611, DOI 10.4049/jimmunol.169.3.1611; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V464, P90, DOI 10.1016/j.abb.2007.04.017; Southam C M, 1972, Proc Natl Cancer Conf, V7, P91; The Japanese Orthopaedic Association (JOA) Musculoskeletal Tumor Committee, 2000, GEN RUL CLIN PATH ST, P52; Tsukahara T, 2006, J ORTHOP RES, V24, P94, DOI 10.1002/jor.20019; Tsukahara T, 2004, CANCER RES, V64, P5442, DOI 10.1158/0008-5472.CAN-04-0522; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Tsukahara T, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-44; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Tsukahara Tomohide, 2008, Current Immunology Reviews, V4, P235, DOI 10.2174/157339508786447959; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; WADA T, 1988, CANCER RES, V48, P2273	40	6	7	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22035	22047		10.1074/jbc.M114.568725	http://dx.doi.org/10.1074/jbc.M114.568725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962571	Green Published, hybrid			2022-12-28	WOS:000340593500021
J	Francis, H; McDaniel, K; Han, YY; Liu, XP; Kennedy, L; Yang, FQ; McCarra, J; Zhou, TH; Glaser, S; Venter, J; Huang, L; Levine, P; Lai, JM; Liu, CG; Alpini, G; Meng, FY				Francis, Heather; McDaniel, Kelly; Han, Yuyan; Liu, Xiuping; Kennedy, Lindsey; Yang, Fuquan; McCarra, Jennifer; Zhou, Tianhao; Glaser, Shannon; Venter, Julie; Huang, Li; Levine, Phillip; Lai, Jia-Ming; Liu, Chang-Gong; Alpini, Gianfranco; Meng, Fanyin			Regulation of the Extrinsic Apoptotic Pathway by MicroRNA-21 in Alcoholic Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alcohol; Interleukin 6 (IL-6); Liver Injury; MicroRNA (miRNA); STAT3; DR5; FASLG; Alcoholic Liver Diseases	PROMOTES APOPTOSIS; GENE-EXPRESSION; STEATOHEPATITIS; MIR-34A; CELLS; CANCER; REGENERATION; SURVIVAL; NETWORK; LIGAND	Background: miR-21 is an anti-apoptotic microRNA, and its role in alcoholic liver disease (ALD) is unknown. Results: miR-21, increased in ALD and regulated by IL-6/Stat3, is essential for transformation, survival, and liver fibrosis. Conclusion: miR-21 plays a protective role against alcoholic hepatitis through the anti-extrinsic apoptotic pathway. Significance: Understanding the recovery function of miR-21 may have important implications for patients with ALD. IL-6/Stat3 is associated with the regulation of transcription of key cellular regulatory genes (microRNAs) during different types of liver injury. This study evaluated the role of IL-6/Stat3 in regulating miRNA and miR-21 in alcoholic liver disease. By microarray, we identified that ethanol feeding significantly up-regulated 0.8% of known microRNAs in mouse liver compared with controls, including miR-21. Similarly, the treatment of normal human hepatocytes (N-Heps) and hepatic stellate cells (HSCs) with ethanol and IL-6 significantly increased miR-21 expression. Overexpression of miR-21 decreased ethanol-induced apoptosis in both N-Heps and HSCs. The expression level of miR-21 was significantly increased after Stat3 activation in N-Heps and HSCs, in support of the concept that the 5-promoter region of miR-21 is regulated by Stat3. Using real time PCR, we confirmed that miR-21 activation is associated with ethanol-linked Stat3 binding of the miR-21 promoter. A combination of bioinformatics, PCR array, dual-luciferase reporter assay, and Western blot analysis revealed that Fas ligand (TNF superfamily, member 6) (FASLG) and death receptor 5 (DR5) are the direct targets of miR-21. Furthermore, inhibition of miR-21 by specific Vivo-Morpholino and knock-out of IL-6 in ethanol-treated mice also increased the expression of DR5 and FASLG in vivo during alcoholic liver injury. The identification of miR-21 as an important regulator of hepatic cell survival, transformation, and remodeling in vitro, as well as its upstream modulators and downstream targets, will provide insight into the involvement of altered miRNA expression in contributing to alcoholic liver disease progression and testing novel therapeutic approaches for human alcoholic liver diseases.	[Francis, Heather; McDaniel, Kelly; Kennedy, Lindsey; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Res, Temple, TX 76504 USA; [Francis, Heather; McDaniel, Kelly; Han, Yuyan; Kennedy, Lindsey; McCarra, Jennifer; Zhou, Tianhao; Glaser, Shannon; Venter, Julie; Levine, Phillip; Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med, Temple, TX 76504 USA; [Francis, Heather; McDaniel, Kelly; Han, Yuyan; Kennedy, Lindsey; McCarra, Jennifer; Zhou, Tianhao; Glaser, Shannon; Venter, Julie; Levine, Phillip; Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA; [Francis, Heather; McDaniel, Kelly; Han, Yuyan; Kennedy, Lindsey; McCarra, Jennifer; Zhou, Tianhao; Glaser, Shannon; Venter, Julie; Levine, Phillip; Alpini, Gianfranco; Meng, Fanyin] Scott & White Hosp, Temple, TX 76504 USA; [Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Expt Therapeut, Houston, TX 77030 USA; [Yang, Fuquan] China Med Univ, Shengjing Hosp, Dept Hepatobiliary Surg, Shenyang 100004, Peoples R China; [Huang, Li; Lai, Jia-Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University; Sun Yat Sen University	Alpini, G (corresponding author), Scott & White Mem Hosp & Clin, Dept Med, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.	galpini@tamu.edu; fmeng@tamu.edu	Han, Yuyan/A-2291-2014; Zhou, Tianhao/AAO-3542-2021	Han, Yuyan/0000-0002-9982-9286; Zhou, Tianhao/0000-0002-5722-6954; Mcdaniel, Kelly/0000-0003-4328-8844	National Institutes of Health [P50AA011999]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411, T32DK007698, R01DK076898, R01DK054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001760, I01BX001724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	We express our deepest appreciation to Dr. Hidekazu Tsukamoto and the tissue sharing program of the Southern California Research Center for ALPD and Cirrhosis (supported by National Institutes of Health Grant P50AA011999) for their assistance with the animal studies in this project. We also acknowledge Glen Cryer and Gina Dupar in the Publications Department for editing assistance.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Beraza N, 2007, GASTROENTEROLOGY, V132, P2504, DOI 10.1053/j.gastro.2007.03.045; Beraza N, 2011, GUT, V60, P387, DOI 10.1136/gut.2010.223834; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Dippold RP, 2012, AM J PHYSIOL-GASTR L, V303, pG733, DOI 10.1152/ajpgi.00019.2012; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Gong J, 2013, ONCOGENE, V32, P3071, DOI 10.1038/onc.2012.318; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Hu SJ, 2011, CIRCULATION, V124, pS27, DOI 10.1161/CIRCULATIONAHA.111.017954; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Ma XD, 2013, CARCINOGENESIS, V34, P1216, DOI 10.1093/carcin/bgt044; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Mathurin P, 2008, GASTROEN CLIN BIOL, V32, pS179, DOI 10.1016/j.gcb.2008.04.007; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Meng FY, 2012, HEPATOLOGY, V55, P209, DOI 10.1002/hep.24673; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Page S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056009; Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tsukamoto Hide, 2008, V447, P33, DOI 10.1007/978-1-59745-242-7_3; Tumang JR, 2002, CELL IMMUNOL, V217, P47, DOI 10.1016/S0008-8749(02)00513-0; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang Y, 2010, ALCOHOL CLIN EXP RES, V34, P567, DOI 10.1111/j.1530-0277.2009.01122.x; Xiong S, 2008, AM J PHYSIOL-GASTR L, V295, pG512, DOI 10.1152/ajpgi.90327.2008; Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909	43	68	71	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27526	27539		10.1074/jbc.M114.602383	http://dx.doi.org/10.1074/jbc.M114.602383			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25118289	Green Published, hybrid			2022-12-28	WOS:000342852800015
J	Vaghi, V; Polacchini, A; Baj, G; Pinheiro, VLM; Vicario, A; Tongiorgi, E				Vaghi, Valentina; Polacchini, Alessio; Baj, Gabriele; Pinheiro, Vera L. M.; Vicario, Annalisa; Tongiorgi, Enrico			Pharmacological Profile of Brain-derived Neurotrophic Factor (BDNF) Splice Variant Translation Using a Novel Drug Screening Assay A "QUANTITATIVE CODE"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain-derived Neurotrophic Factor (BDNF); Drug Screening; Neurotransmitter; Signaling; Translation; In Vitro Assay; Splice Variants	FACTOR MESSENGER-RNA; BAC TRANSGENIC MICE; GENE-EXPRESSION; RAT HIPPOCAMPUS; TOTAL NUMBER; IN-VIVO; PROTEIN; TRANSCRIPTION; NEURONS; CELLS	Background: Brain-derived neurotrophic factor is encoded by multiple transcripts with specific brain localization. Results: BDNF transcripts display a different ability to translate, basally and after stimulation. Conclusion:BDNF mRNA variants represent a quantitative code to regulate expression of the protein. Significance: This cell-based assay allows identification of compounds able to modulate BDNF variants having local effects in specific brain regions. The neurotrophin brain-derived neurotrophic factor (BDNF) is a key regulator of neuronal development and plasticity. BDNF is a major pharmaceutical target in neurodevelopmental and psychiatric disorders. However, pharmacological modulation of this neurotrophin is challenging because BDNF is generated by multiple, alternatively spliced transcripts with different 5- and 3UTRs. Each BDNF mRNA variant is transcribed independently, but translation regulation is unknown. To evaluate the translatability of BDNF transcripts, we developed an in vitro luciferase assay in human neuroblastoma cells. In unstimulated cells, each BDNF 5- and 3UTR determined a different basal translation level of the luciferase reporter gene. However, constructs with either a 5UTR or a 3UTR alone showed poor translation modulation by BDNF, KCl, dihydroxyphenylglycine, AMPA, NMDA, dopamine, acetylcholine, norepinephrine, or serotonin. Constructs consisting of the luciferase reporter gene flanked by the 5UTR of one of the most abundant BDNF transcripts in the brain (exons 1, 2c, 4, and 6) and the long 3UTR responded selectively to stimulation with the different receptor agonists, and only transcripts 2c and 6 were increased by the antidepressants desipramine and mirtazapine. We propose that BDNF mRNA variants represent a quantitative code for regulated expression of the protein. Thus, to discriminate the efficacy of drugs in stimulating BDNF synthesis, it is appropriate to use variant-specific in vitro screening tests.	[Vaghi, Valentina; Polacchini, Alessio; Baj, Gabriele; Pinheiro, Vera L. M.; Vicario, Annalisa; Tongiorgi, Enrico] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy	University of Trieste	Tongiorgi, E (corresponding author), Univ Trieste, Dept Life Sci, Via Giorgieri 5, I-34127 Trieste, Italy.	tongi@units.it	; Baj, Gabriele/H-4228-2012	Tongiorgi, Enrico/0000-0003-0485-0603; POLACCHINI, ALESSIO/0000-0001-7555-1024; Baj, Gabriele/0000-0002-2625-9454	Telethon Grant [GGP08258]; MIUR Grant [2010N8PBAA]; Compagnia San Paolo; Fondazione Kathleen Foreman Casali-Trieste; FRA-UniTS; Beneficentia Stiftung-Vaduz (Lichtenstein)	Telethon Grant(Fondazione Telethon); MIUR Grant(Ministry of Education, Universities and Research (MIUR)); Compagnia San Paolo(Compagnia di San Paolo); Fondazione Kathleen Foreman Casali-Trieste; FRA-UniTS; Beneficentia Stiftung-Vaduz (Lichtenstein)	This work was supported by Telethon Grant GGP08258, MIUR Grant PRIN 2010-11 2010N8PBAA, and Compagnia San Paolo. The assay and the results presented in this paper are related to patent application number PCT/EP2010/067081.; Supported by Fondazione Kathleen Foreman Casali-Trieste, FRA-UniTS 2012, and Beneficentia Stiftung-Vaduz (Lichtenstein).	Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Allen GFG, 2013, NEUROCHEM INT, V62, P684, DOI 10.1016/j.neuint.2012.12.004; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baj G, 2013, HIPPOCAMPUS, V23, P413, DOI 10.1002/hipo.22100; Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bowling H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004331; Bustos G, 2009, J NEUROSCI RES, V87, P2308, DOI 10.1002/jnr.22063; Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Castren E, 2012, J NEUROSCI, V32, P14074, DOI 10.1523/JNEUROSCI.3287-12.2012; Cattaneo E., 2002, U. S. Patent, Patent No. [20050123922 A1, 20050123922]; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Deng WB, 2004, P NATL ACAD SCI USA, V101, P7751, DOI 10.1073/pnas.0307850101; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Donnici L, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-61; Doshi KJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-105; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunston JA, 2004, GENOMICS, V84, P565, DOI 10.1016/j.ygeno.2004.06.002; Fukuyama K, 2013, PSYCHOPHARMACOLOGY, V229, P617, DOI 10.1007/s00213-013-3122-9; Gangarossa G, 2012, NEUROPHARMACOLOGY, V63, P1107, DOI 10.1016/j.neuropharm.2012.06.062; Garzon D, 2002, J NEUROCHEM, V82, P1058, DOI 10.1046/j.1471-4159.2002.01030.x; Guillemot F, 2007, TRANSGENIC RES, V16, P223, DOI 10.1007/s11248-006-9060-0; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Heinrich G., 2003, U. S. Patent, Patent No. [US 7491910 B2, 7491910]; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jin AH, 2014, BIOCHEMISTRY-US, V53, P1, DOI 10.1021/bi400882s; Koppel I, 2010, GENESIS, V48, P214, DOI 10.1002/dvg.20606; Koppel I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-68; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin-Montaneza E, 2010, NEUROREPORT, V21, P1034, DOI 10.1097/WNR.0b013e32833f7b7b; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Moussa CEH, 2004, BIOCHEMISTRY-US, V43, P5539, DOI 10.1021/bi036114f; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Rogers DA, 2013, PEDIATR RES, V74, P517, DOI 10.1038/pr.2013.146; Ruiz A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.134; Russo-Neustadt AA, 2004, NEUROPSYCHOPHARMACOL, V29, P2189, DOI 10.1038/sj.npp.1300514; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Tongiorgi E, 2004, J NEUROSCI, V24, P6842, DOI 10.1523/JNEUROSCI.5471-03.2004; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tongiorgi E, 2008, NEUROSCI RES, V61, P335, DOI 10.1016/j.neures.2008.04.013; Tongiorgi Enrico, 2008, Novartis Found Symp, V289, P136; Tropea D, 2001, EUR J NEUROSCI, V13, P709, DOI 10.1046/j.0953-816x.2000.01436.x; Tsukahara T, 1998, NEUROCHEM INT, V33, P201, DOI 10.1016/S0197-0186(97)00112-5; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Yanow SK, 1998, J NEUROCHEM, V70, P572; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099	60	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27702	27713		10.1074/jbc.M114.586719	http://dx.doi.org/10.1074/jbc.M114.586719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25074925	Green Published, hybrid			2022-12-28	WOS:000342852800029
J	Kojima, S; Nikaido, H				Kojima, Seiji; Nikaido, Hiroshi			High Salt Concentrations Increase Permeability through OmpC Channels of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILITY; PORIN CHANNELS; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; BACTERIAL PORINS; MOLECULAR-BASIS; BETA-LACTAMS; ANTIBIOTICS; PERMEATION; TRANSPORT	OmpF and OmpC porin channels are responsible for the passage of small hydrophilic solutes across the outer membrane of Escherichia coli. Although these channels are two of the most extensively studied porin channels, what had yet remained elusive was the reason why OmpC shows markedly lower permeability than OmpF, despite having little difference in its channel size. The OmpC channel, however, is known to contain a larger number of ionizable residues than the OmpF channel. In this study, we examined the channel property of OmpF and OmpC using the intact cell of E. coli, and we found that the permeability of several beta-lactams and lactose through OmpC became increased to the level comparable with OmpF with up to 0.3 M salt that may increase the Debye-Huckel shielding or with 2% ethanol or 0.3 M urea that may perturb the short range ordering of water molecules. Replacing 10 pore-lining residues that show different ionization behavior between OmpC and OmpF led to substantial conversion of channel property with respect to their permeability and response to external salt concentration. We thus propose that the overall configuration of ionizable residues in the channel that may orient water molecules and the electrostatic profile of the channel play a decisive role in defining the channel property of the OmpC porin rather than its channel size.	[Kojima, Seiji; Nikaido, Hiroshi] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Nikaido, H (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 426 Barker Hall MC3202, Berkeley, CA 94720 USA.	nhiroshi@berkeley.edu	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592	National Institutes of Health [RO1 AI-009644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI-009644 (to H. N.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; JAFFE A, 1982, ANTIMICROB AGENTS CH, V22, P942, DOI 10.1128/AAC.22.6.942; JAURIN B, 1981, NATURE, V290, P221, DOI 10.1038/290221a0; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOVICK RP, 1962, BIOCHEM J, V83, P236, DOI 10.1042/bj0830236; OZAWA Y, 1983, J BACTERIOL, V154, P669, DOI 10.1128/JB.154.2.669-675.1983; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHNAITMAN CA, 1984, J BACTERIOL, V159, P555, DOI 10.1128/JB.159.2.555-563.1984; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SCHULZ GE, 1992, JERUS SYM Q, V25, P403; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Takatsuka Y, 2006, J BACTERIOL, V188, P7284, DOI 10.1128/JB.00683-06; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; VONMEYEN.K, 1971, J BACTERIOL, V107, P878, DOI 10.1128/JB.107.3.878-888.1971; WRIGHT JK, 1984, EUR J BIOCHEM, V138, P497, DOI 10.1111/j.1432-1033.1984.tb07944.x; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014	39	42	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26464	26473		10.1074/jbc.M114.585869	http://dx.doi.org/10.1074/jbc.M114.585869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086034	Green Published, hybrid			2022-12-28	WOS:000342128800037
J	Krejciova, Z; Barria, MA; Jones, M; Ironside, JW; Jeffrey, M; Gonzalez, L; Head, MW				Krejciova, Zuzana; Barria, Marcelo A.; Jones, Michael; Ironside, James W.; Jeffrey, Martin; Gonzalez, Lorenzo; Head, Mark W.			Genotype-dependent Molecular Evolution of Sheep Bovine Spongiform Encephalopathy (BSE) Prions in Vitro Affects Their Zoonotic Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; PRP ACCUMULATION; INFECTED SHEEP; GREAT-BRITAIN; SCRAPIE; PROTEIN; TRANSMISSION; VARIANT; BRAIN	Prion diseases are rare fatal neurological conditions of humans and animals, one of which (variant Creutzfeldt-Jakob disease) is known to be a zoonotic form of the cattle disease bovine spongiform encephalopathy (BSE). What makes one animal prion disease zoonotic and others not is poorly understood, but it appears to involve compatibility between the prion strain and the host prion protein sequence. Concerns have been raised that the United Kingdom sheep flock may have been exposed to BSE early in the cattle BSE epidemic and that serial BSE transmission in sheep might have resulted in adaptation of the agent, which may have come to phenotypically resemble scrapie while maintaining its pathogenicity for humans. We have modeled this scenario in vitro. Extrapolation from our results suggests that if BSE were to infect sheep in the field it may, with time and in some sheep genotypes, become scrapie-like at the molecular level. However, the results also suggest that if BSE in sheep were to come to resemble scrapie it would lose its ability to affect humans.	[Krejciova, Zuzana; Barria, Marcelo A.; Ironside, James W.; Head, Mark W.] Univ Edinburgh, Natl CJD Res & Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Jones, Michael] Scottish Natl Blood Transfus Serv, Edinburgh EH17 7QT, Midlothian, Scotland; [Jeffrey, Martin; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy, Edinburgh EH26 0PZ, Midlothian, Scotland	University of Edinburgh	Head, MW (corresponding author), Univ Edinburgh, Natl CJD Res & Surveillance Unit, Western Gen Hosp, Bryan Matthews Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	m.w.head@ed.ac.uk	Jeffrey, Martin/D-2251-2009; González, Lorenzo/A-5325-2010; Jones, Michael G.K./M-5932-2013	González, Lorenzo/0000-0003-4199-4526; Jones, Michael G.K./0000-0001-5002-0227; Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108; Barria Matus, Marcelo/0000-0003-4789-7401	Alliance BioSecure Research Foundation (Paris, France); MRC [G0900580, G0600953] Funding Source: UKRI; Medical Research Council [G0600953, G0900580] Funding Source: researchfish	Alliance BioSecure Research Foundation (Paris, France); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was largely supported by Grant "SheepBSE" from the Alliance BioSecure Research Foundation (Paris, France).	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Bellworthy SJ, 2008, VET REC, V162, P130, DOI 10.1136/vr.162.4.130-c; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Cutlip RC, 2001, CAN J VET RES, V65, P131; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill Andrew F., 2004, V11, P33; Hope J, 2013, CURR TOP MICROBIOL, V366, P37, DOI 10.1007/82_2012_264; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Hunter N, 2007, PRIONS IN HUMANS AND ANIMALS, P640; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jones M, 2009, EMERG INFECT DIS, V15, P2013, DOI 10.3201/eid1512.090194; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Moore RA, 2005, ARCH VIROL, P187; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2012, MICROBIOL IMMUNOL, V56, P541, DOI 10.1111/j.1348-0421.2012.00472.x; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; Priem J, 2014, J VIROL, V88, P2903, DOI 10.1128/JVI.02446-13; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Ronzon F, 2006, BIOCHEM BIOPH RES CO, V350, P872, DOI 10.1016/j.bbrc.2006.09.137; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Thorne L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-223; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	52	6	6	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26075	26088		10.1074/jbc.M114.582965	http://dx.doi.org/10.1074/jbc.M114.582965			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100723	hybrid, Green Published			2022-12-28	WOS:000342128800006
J	Philipp, M; Berger, IM; Just, S; Caron, MG				Philipp, Melanie; Berger, Ina M.; Just, Steffen; Caron, Marc G.			Overlapping and Opposing Functions of G Protein-coupled Receptor Kinase 2 (GRK2) and GRK5 during Heart Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; NF-KAPPA-B; IN-VIVO; BETA(1)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; ARRESTIN; PHOSPHORYLATION; DESENSITIZATION; EXPRESSION; TERMINUS	G protein-coupled receptor kinases 2 (GRK2) and 5 (GRK5) are fundamental regulators of cardiac performance in adults but are less well characterized for their function in the hearts of embryos. GRK2 and -5 belong to different subfamilies and function as competitors in the control of certain receptors and signaling pathways. In this study, we used zebrafish to investigate whether the fish homologs of GRK2 and -5, Grk2/3 and Grk5, also have unique, complementary, or competitive roles during heart development. We found that they differentially regulate the heart rate of early embryos and equally facilitate heart function in older embryos and that both are required to develop proper cardiac morphology. A loss of Grk2/3 results in dilated atria and hypoplastic ventricles, and the hearts of embryos depleted in Grk5 present with a generalized atrophy. This Grk5 morphant phenotype was associated with an overall decrease of early cardiac progenitors as well as a reduction in the area occupied by myocardial progenitor cells. In the case of Grk2/3, the progenitor decrease was confined to a subset of precursor cells with a committed ventricular fate. We attempted to rescue the GRK loss-of-function heart phenotypes by downstream activation of Hedgehog signaling. The Grk2/3 loss-of-function embryos were rescued by this approach, but Grk5 embryos failed to respond. In summary, we found that GRK2 and GRK5 control cardiac function as well as morphogenesis during development although with different morphological outcomes.	[Philipp, Melanie] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Berger, Ina M.; Just, Steffen] Univ Ulm, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Caron, Marc G.] Duke Univ Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Ulm University; Ulm University; Duke University; Duke University; Duke University	Philipp, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	melanie.philipp@uni-ulm.de	Philipp, Melanie/B-5198-2016	Philipp, Melanie/0000-0003-2714-965X	National Institutes of Health [5R37MH073853]; Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft; Boehringer Ingelheim Ulm University BioCenter (BIU); European Commission; Marie Curie Reintegration Grant [268333]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Ulm University BioCenter (BIU); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Reintegration Grant(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R37MH073853 (to M. G. C.). Work in the laboratory of M. P. is further supported by grants from the Deutsche Herzstiftung, the Deutsche Forschungsgemeinschaft, and the Boehringer Ingelheim Ulm University BioCenter (BIU).; Recipient of a Marie Curie Outgoing International Fellowship of the European Commission and a Marie Curie Reintegration Grant (Contract 268333). To whom correspondence should be addressed. Tel.: 49-731-500-23287; Fax: 49-731-500-23277; E-mail: melanie.philipp@uni-ulm.de.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BODMER R, 1993, DEVELOPMENT, V118, P719; Burkhalter MD, 2013, CELL REP, V4, P625, DOI 10.1016/j.celrep.2013.07.036; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen EP, 2001, ANN THORAC SURG, V71, P1320, DOI 10.1016/S0003-4975(00)01754-9; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Evron T, 2011, J BIOL CHEM, V286, P27676, DOI 10.1074/jbc.M111.234666; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Finn J, 2012, AQUAT TOXICOL, V122, P214, DOI 10.1016/j.aquatox.2012.06.013; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Fusco A, 2012, CELL SIGNAL, V24, P468, DOI 10.1016/j.cellsig.2011.09.026; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2013, J BIOL CHEM, V288, P35683, DOI 10.1074/jbc.M113.529347; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Khan M, 2014, MOL THER, V22, P178, DOI 10.1038/mt.2013.200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Meder B, 2011, MOL CELL BIOL, V31, P3424, DOI 10.1128/MCB.05269-11; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Sefton M, 2000, MECH DEVELOP, V98, P127, DOI 10.1016/S0925-4773(00)00441-X; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Steele SL, 2011, J EXP BIOL, V214, P1445, DOI 10.1242/jeb.052803; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Sun LW, 2014, ENVIRON TOXICOL, V29, P1367, DOI 10.1002/tox.21867; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	66	19	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26119	26130		10.1074/jbc.M114.551952	http://dx.doi.org/10.1074/jbc.M114.551952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104355	Green Published, hybrid			2022-12-28	WOS:000342128800009
J	Han, L; Yang, J; Wang, XW; Wu, QS; Yin, SY; Li, ZY; Zhang, J; Xing, Y; Chen, ZJ; Tsun, A; Li, D; Piccioni, M; Zhang, Y; Guo, Q; Jiang, LD; Bao, LM; Lv, L; Li, B				Han, Lei; Yang, Jing; Wang, Xiuwen; Wu, Qingsi; Yin, Shuying; Li, Zhiyuan; Zhang, Jing; Xing, Yue; Chen, Zuojia; Tsun, Andy; Li, Dan; Piccioni, Miranda; Zhang, Yu; Guo, Qiang; Jiang, Lindi; Bao, Liming; Lv, Ling; Li, Bin			The E3 Deubiquitinase USP17 Is a Positive Regulator of Retinoic Acid-related Orphan Nuclear Receptor gamma t (ROR gamma t) in Th17 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR FOXP3; GROWTH-FACTOR-BETA; T-H-17 CELLS; T(H)17 CELLS; DIFFERENTIATION; INFLAMMATION; INDUCTION; LINEAGE; PROLIFERATION	Stable retinoic acid-related orphan nuclear receptor gamma t (ROR gamma t) expression is pivotal for the development and function of Th17 cells. Here we demonstrate that expression of the transcription factor ROR gamma t can be regulated through deubiquitination, which prevents proteasome-mediated degradation. We establish that USP17 stabilizes ROR gamma t protein expression by reducing ROR gamma t polyubiquitination at its Lys-360 residue. In contrast, knockdown of endogenous USP17 in Th17 cells resulted in decreased ROR gamma t protein levels and down-regulation of Th17-related genes. Furthermore, USP17 expression was up-regulated in CD4(+) T cells from systemic lupus erythematosus patients. Our data reveal a molecular mechanism in which ROR gamma t expression in Th17 cells can be positively regulated by USP17, thereby modulating Th17 cell functions.	[Han, Lei; Wang, Xiuwen; Tsun, Andy; Li, Dan; Piccioni, Miranda; Lv, Ling] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200040, Peoples R China; [Yang, Jing; Yin, Shuying; Li, Zhiyuan; Zhang, Jing; Xing, Yue; Chen, Zuojia; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200032, Peoples R China; [Wu, Qingsi] Anhui Med Univ, Dept Immunol, Hefei 230032, Peoples R China; [Zhang, Yu] Shanghai Jiao Tong Univ, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China; [Guo, Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai 200127, Peoples R China; [Jiang, Lindi] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai 200032, Peoples R China; [Bao, Liming] Dartmouth Coll, Geisel Sch Med, Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03756 USA	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Anhui Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Dartmouth College	Lv, L (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	huashanlvling@sina.com; binli@sibs.ac.cn	Piccioni, Miranda/X-4530-2018; lI, Bin/AAR-4966-2021; Chen, Zuojia/AAM-9465-2020	Piccioni, Miranda/0000-0002-4434-6770; lI, Bin/0000-0002-7640-8884; xing, yue/0000-0001-5845-2286; Yang, Jing/0000-0001-6441-709X	National Basic Research Program of China (973 Program) [2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532, 81270714, 31300711, 31350110505]; National Science and Technology [2012ZX10002007-003, 2013ZX10003009-002, SMCST 11ZR1404900, 14JC1406100]; Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP204]; Chinese Academy of Sciences Fellowship for Young International Scientists [2013Y1SB0005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology; Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences Fellowship for Young International Scientists	This work was supported by National Basic Research Program of China (973 Program) Grants 2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532, 81270714, 31300711, and 31350110505 and by National Science and Technology Major Project Grants 2012ZX10002007-003, 2013ZX10003009-002, SMCST 11ZR1404900, and 14JC1406100. This work was also supported by the Knowledge Innovation Program of the Shanghai Institutes for Biological Sciences, by Chinese Academy of Sciences Grant 2012KIP204, and by Chinese Academy of Sciences Fellowship for Young International Scientists 2013Y1SB0005.	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Chen DY, 2012, LUPUS, V21, P1385, DOI 10.1177/0961203312457718; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pernis AB, 2009, J INTERN MED, V265, P644, DOI 10.1111/j.1365-2796.2009.02099.x; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Ratajewski M, 2012, J IMMUNOL, V189, P3034, DOI 10.4049/jimmunol.1200519; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Saito Y, 2014, ARTHRITIS RHEUMATOL, V66, P1185, DOI 10.1002/art.38324; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Tanaka T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001637; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yu YY, 2013, J IMMUNOL, V190, P3054, DOI 10.4049/jimmunol.1203275; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zhang J, 2013, J BIOL CHEM, V288, P9373, DOI 10.1074/jbc.M112.374744; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	46	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25546	25555		10.1074/jbc.M114.565291	http://dx.doi.org/10.1074/jbc.M114.565291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070893	hybrid, Green Published			2022-12-28	WOS:000342130800016
J	Peffers, MJ; Thorpe, CT; Collins, JA; Eong, R; Wei, TKJ; Screen, HRC; Clegg, PD				Peffers, Mandy J.; Thorpe, Chavaunne T.; Collins, John A.; Eong, Robin; Wei, Timothy K. J.; Screen, Hazel R. C.; Clegg, Peter D.			Proteomic Analysis Reveals Age-related Changes in Tendon Matrix Composition, with Age- and Injury-specific Matrix Fragmentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGITAL FLEXOR TENDON; ACHILLES-TENDON; MECHANICAL-PROPERTIES; COLLAGEN; PROTEIN; TENDINOPATHY; LIGAMENT; FIBRIL; COMP; GLYCOSAMINOGLYCANS	Energy storing tendons, such as the human Achilles and equine superficial digital flexor tendon (SDFT), are highly prone to injury, the incidence of which increases with aging. The cellular and molecular mechanisms that result in increased injury in aged tendons are not well established but are thought to result in altered matrix turnover. However, little attempt has been made to fully characterize the tendon proteome nor determine how the abundance of specific tendon proteins changes with aging and/or injury. The aim of this study was, therefore, to assess the protein profile of normal SDFTs from young and old horses using label-free relative quantification to identify differentially abundant proteins and peptide fragments between age groups. The protein profile of injured SDFTs from young and old horses was also assessed. The results demonstrate distinct proteomic profiles in young and old tendon, with alterations in the levels of proteins involved in matrix organization and regulation of cell tension. Furthermore, we identified several new peptide fragments (neopeptides) present in aged tendons, suggesting that there are age-specific cleavage patterns within the SDFT. Proteomic profile also differed between young and old injured tendon, with a greater number of neopeptides identified in young injured tendon. This study has increased the knowledge of molecular events associated with tendon aging and injury, suggesting that maintenance and repair of tendon tissue may be reduced in aged individuals and may help to explain why the risk of injury increases with aging.	[Peffers, Mandy J.; Thorpe, Chavaunne T.; Collins, John A.; Eong, Robin; Wei, Timothy K. J.; Clegg, Peter D.] Univ Liverpool, Dept Musculoskeletal Biol, Inst Ageing & Chron Dis, Neston CH64 7TE, Cheshire, England; [Thorpe, Chavaunne T.; Screen, Hazel R. C.] Queen Mary Univ London, Inst Bioengn, London E1 4NS, England; [Eong, Robin; Wei, Timothy K. J.] Ngee Ann Polytech, Sch Life Sci, Singapore 599489, Singapore	University of Liverpool; University of London; Queen Mary University London	Thorpe, CT (corresponding author), Queen Mary Univ London, Inst Bioengn, Sch Engn & Mat Sci, Mile End Rd, London E1 4NS, England.	c.thorpe@qmul.ac.uk	Peffers, Mandy Jayne/AAV-9411-2020; Thorpe, Chavaunne T/T-7289-2018; Screen, Hazel RC/A-2801-2014	Peffers, Mandy Jayne/0000-0001-6979-0440; Thorpe, Chavaunne T/0000-0001-7051-3504; Clegg, Peter/0000-0003-0632-0032	Horserace Betting Levy Board, UK [prj/752]; Biosciences and Biotechnology Research Council, UK [BB/K008412/1]; Wellcome Trust [WT088557MA]; Biotechnology and Biological Sciences Research Council [BB/K00672X/1, BB/K008412/1, BB/K006452/1, BB/K008781/1] Funding Source: researchfish; Medical Research Council [MR/K006312/1] Funding Source: researchfish; BBSRC [BB/K008781/1, BB/K006452/1, BB/K008412/1, BB/K00672X/1] Funding Source: UKRI; MRC [MR/K006312/1] Funding Source: UKRI	Horserace Betting Levy Board, UK; Biosciences and Biotechnology Research Council, UK; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a project grant from the Horserace Betting Levy Board, UK (prj/752) and the Biosciences and Biotechnology Research Council, UK (BB/K008412/1).; Supported by Wellcome Trust Integrated Veterinary Research Training Fellowship WT088557MA.	Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; Birch HL, 2008, MATRIX BIOL, V27, P182, DOI 10.1016/j.matbio.2007.10.004; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Clayton RAE, 2008, INJURY, V39, P1338, DOI 10.1016/j.injury.2008.06.021; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; Dakin SG, 2014, J BIOL CHEM, V289, P4919, DOI 10.1074/jbc.M113.511972; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Dwivedi RC, 2010, J PROTEOME RES, V9, P1144, DOI 10.1021/pr900608z; Ely ER, 2009, EQUINE VET J, V41, P372, DOI 10.2746/042516409X371224; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grant TM, 2013, J ANAT, V222, P573, DOI 10.1111/joa.12048; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Han GY, 2011, EXP BIOL MED, V236, P783, DOI 10.1258/ebm.2011.010358; Innes JF, 2010, RHEUMATOLOGY, V49, P1030, DOI 10.1093/rheumatology/kep465; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Jielile J, 2012, NEURAL REGEN RES, V7, P2801, DOI 10.3969/j.issn.1673-5374.2012.35.008; Jielile J, 2011, APPL BIOCHEM BIOTECH, V165, P1092, DOI 10.1007/s12010-011-9327-7; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Kasashima Y, 2004, EQUINE VET J, V36, P346, DOI 10.2746/0425164044890580; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; Kobayashi A, 1999, J COMP PATHOL, V120, P403, DOI 10.1053/jcpa.1998.0288; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Legerlotz K, 2010, J BIOMECH, V43, P2274, DOI 10.1016/j.jbiomech.2010.04.040; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Lodish H. B., 2000, MOL CELL BIOL, p806 ; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; McLean L, 2007, J CHEM ECOL, V33, P1997, DOI 10.1007/s10886-007-9354-6; Millar NL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/436203; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Patterson-Kane JC, 2009, VET J, V181, P79, DOI 10.1016/j.tvjl.2008.02.009; Peffers MJ, 2013, INT J MOL SCI, V14, P20658, DOI 10.3390/ijms141020658; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Rousseau JC, 2007, NAT CLIN PRACT RHEUM, V3, P346, DOI 10.1038/ncprheum0508; September AV, 2009, BRIT J SPORT MED, V43, P357, DOI 10.1136/bjsm.2008.048793; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Smith RKW, 2002, EQUINE VET J, V34, P726, DOI 10.2746/042516402776250423; Smith SM, 2012, CONNECT TISSUE RES, V53, P2, DOI 10.3109/03008207.2011.602766; Sodersten F, 2013, CONNECT TISSUE RES, V54, P62, DOI 10.3109/03008207.2012.734879; Tasheva ES, 2002, MOL VIS, V8, P407; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; Thorpe CT, 2013, EUR CELLS MATER, V25, P48, DOI 10.22203/eCM.v025a04; Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Tully LJ, 2014, EQUINE VET J, V46, P289, DOI 10.1111/evj.12134; WEBBON PM, 1977, EQUINE VET J, V9, P61, DOI 10.1111/j.2042-3306.1977.tb03981.x; Weist S, 2008, PROTEOMICS, V8, P3389, DOI 10.1002/pmic.200800236; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22; Zhang GY, 2003, J ANAT, V202, P411, DOI 10.1046/j.1469-7580.2003.00174.x	63	60	60	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25867	25878		10.1074/jbc.M114.566554	http://dx.doi.org/10.1074/jbc.M114.566554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077967	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000342130800043
J	Bradbury, P; Bach, CT; Paul, A; O'Neill, GM				Bradbury, Peta; Bach, Cuc T.; Paul, Andre; O'Neill, Geraldine M.			Src Kinase Determines the Dynamic Exchange of the Docking Protein NEDD9 (Neural Precursor Cell Expressed Developmentally Down-regulated Gene 9) at Focal Adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION; HEF1; FAK; PHOSPHORYLATION; PROMOTES; LOCALIZATION; EFFECTOR; PATHWAY; CYCLE	Dynamic exchange of molecules between the cytoplasm and integrin-based focal adhesions provides a rapid response system for modulating cell adhesion. Increased residency time of molecules that regulate adhesion turnover contributes to adhesion stability, ultimately determining migration speed across two-dimensional surfaces. In the present study we test the role of Src kinase in regulating dynamic exchange of the focal adhesion protein NEDD9/HEF1/Cas-L. Using either chemical inhibition or fibroblasts genetically null for Src together with fluorescence recovery after photobleaching (FRAP), we find that Src significantly reduces NEDD9 exchange at focal adhesions. Analysis of NEDD9 mutant constructs with the two major Src-interacting domains disabled revealed the greatest effects were due to the NEDD9 SH2 binding domain. This correlated with a significant change in two-dimensional migratory speed. Given the emerging role of NEDD9 as a regulator of focal adhesion stability, the time of NEDD9 association at the focal adhesions is key in modulating rates of migration and invasion. Our study suggests that Src kinase activity determines NEDD9 exchange at focal adhesions and may similarly modulate other focal adhesion-targeted Src substrates to regulate cell migration.	[Bradbury, Peta; Bach, Cuc T.; Paul, Andre; O'Neill, Geraldine M.] Childrens Hosp Westmead, Childrens Canc Res Unit, Kids Res Inst, Westmead, NSW 2145, Australia; [Bradbury, Peta; O'Neill, Geraldine M.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	O'Neill, GM (corresponding author), Childrens Hosp Westmead, Childrens Canc Res Unit, Locked Bag 4001, Westmead, NSW 2145, Australia.	geraldine.oneill@health.nsw.gov.au	Bradbury, Peta/A-4864-2017	Bradbury, Peta/0000-0001-6360-9591; O'Neill, Geraldine/0000-0001-9997-8794	NSW Cancer Council [RG12/06]; National Health and Medical Research Council [632515]; Sydney University Postgraduate Award; C4-fellowships from The Kids Cancer Project; Dooleys Lidcombe Catholic Club	NSW Cancer Council(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sydney University Postgraduate Award; C4-fellowships from The Kids Cancer Project; Dooleys Lidcombe Catholic Club	This work was supported by NSW Cancer Council Grant RG12/06 (to G. O.) and National Health and Medical Research Council Grant 632515 (to G. O.).; Holds a Sydney University Postgraduate Award.; Supported by C4-fellowships from The Kids Cancer Project.; Generously supported by Dooleys Lidcombe Catholic Club.	Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Baquiran JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069304; Carisey A, 2011, METHODS MOL BIOL, V769, P387, DOI 10.1007/978-1-61779-207-6_26; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Law SF, 1996, MOL CELL BIOL, V16, P3327; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohashi Y, 1998, J BIOL CHEM, V273, P6446, DOI 10.1074/jbc.273.11.6446; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Webb DJ, 2003, CURR OPIN CELL BIOL, V15, P614, DOI 10.1016/S0955-0674(03)00105-4; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035058	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24792	24800		10.1074/jbc.M113.544106	http://dx.doi.org/10.1074/jbc.M113.544106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059660	Green Published, hybrid			2022-12-28	WOS:000341985300006
J	Frescas, D; de Lange, T				Frescas, David; de Lange, Titia			Binding of TPP1 Protein to TIN2 Protein Is Required for POT1a,b Protein-mediated Telomere Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; DNA Damage Response; Mouse Genetics; Shelterin; Telomere	DYSKERATOSIS-CONGENITA; TRF2; COMPLEX; ATM; MAINTENANCE; MUTATIONS; TPP1/POT1	Background: Chromosome ends require the TPP1/POT1 heterodimers for protection. Results: A TIN2 mutant that fails to bind TPP1 resulted in phenotypes associated with TPP1/POT1 deletion. Conclusion: The TIN2-TPP1 link is the sole mechanism by which TPP1/POT1 heterodimers bind to shelterin to protect telomeres. Significance: The function of TIN2 is relevant to dyskeratosis congenita cases caused by TIN2 mutations. The single-stranded DNA binding proteins in mouse shelterin, POT1a and POT1b, accumulate at telomeres as heterodimers with TPP1, which binds TIN2 and thus links the TPP1/POT1 dimers with TRF1 and TRF2/Rap1. When TPP1 is tethered to TIN2/TRF1/TRF2, POT1a is thought to block replication protein A binding to the single-stranded telomeric DNA and prevent ataxia telangiectasia and Rad3-related kinase activation. Similarly, TPP1/POT1b tethered to TIN2 can control the formation of the correct single-stranded telomeric overhang. Consistent with this view, the telomeric phenotypes following deletion of POT1a,b or TPP1 are phenocopied in TIN2-deficient cells. However, the loading of TRF1 and TRF2/Rap1 is additionally compromised in TIN2 KO cells, leading to added phenotypes. Therefore, it could not be excluded that, in addition to TIN2, other components of shelterin contribute to the recruitment of TPP1/POT1a,b as suggested by previous reports. To test whether TIN2 is the sole link between TPP1/POT1a,b and telomeres, we defined the TPP1 interaction domain of TIN2 and generated a TIN2 allele that was unable to interact with TPP1 but retained its interaction with TRF1 and TRF2. We demonstrated that cells expressing TIN2TPP1 instead of wild-type TIN2 phenocopy the POT1a,b knockout setting without showing additional phenotypes. Therefore, these results are consistent with TIN2 being the only mechanism by which TPP1/POT1 heterodimers bind to shelterin and function in telomere protection.	[Frescas, David; de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Box 159,1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	National Institutes of Health Grants [5R37GM49046, 5RO1AG16642]; American Cancer Society postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society postdoctoral fellowship(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37GM49046 and 5RO1AG16642 (to D. F.). This work was also supported by an American Cancer Society postdoctoral fellowship (to D. F.).	Barrientos KS, 2008, MOL CELL BIOL, V28, P5251, DOI 10.1128/MCB.00048-08; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Frescas D, 2014, MOL CELL BIOL, V34, P1349, DOI 10.1128/MCB.01052-13; Frescas D, 2014, GENE DEV, V28, P153, DOI 10.1101/gad.233395.113; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sarper N, 2010, PEDIATR BLOOD CANCER, V55, P1185, DOI 10.1002/pbc.22624; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vulliamy T., 2010, CLIN GENET, V81, P634; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469	29	25	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24180	24187		10.1074/jbc.M114.592592	http://dx.doi.org/10.1074/jbc.M114.592592			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25056954	Green Published, hybrid			2022-12-28	WOS:000341505600016
J	Shanmugasundaram, K; Nayak, B; Shim, EH; Livi, CB; Block, K; Sudarshan, S				Shanmugasundaram, Karthigayan; Nayak, Bijaya; Shim, Eun-Hee; Livi, Carolina B.; Block, Karen; Sudarshan, Sunil			The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Metabolism; Hypoxia-inducible Factor (HIF); NF-B (NF-KB); Small Molecule; Small	RENAL-CELL CANCER; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; KIDNEY CANCER; HIF-ALPHA; HYPOXIA; HYDRATASE; HEREDITARY; KINASES; TBK1	Background: We examined alternative mechanisms by which fumarate levels contribute to hypoxia inducible factor (HIF)-1 accumulation and fumarate hydratase (FH)-deficient renal carcinogenesis. Results: Fumarate promotes HIF-1 transcription through Tank binding kinase 1 (TBK1)-dependent noncannonical activation of NF-B signaling. Conclusion: Fumarate-mediated, TBK-dependent accumulation of HIF-1 mediates cell invasion in FH-deficient RCC. Significance: TBK is a novel putative therapeutic target for the treatment of aggressive fumarate-driven tumors. Inactivating mutations of the gene encoding the tricarboxylic acid cycle enzyme fumarate hydratase (FH) have been linked to an aggressive variant of hereditary kidney cancer (hereditary leiomyomatosis and renal cell cancer). These tumors accumulate markedly elevated levels of fumarate. Fumarate is among a growing list of oncometabolites identified in cancers with mutations of genes involved in intermediary metabolism. FH-deficient tumors are notable for their pronounced accumulation of the transcription factor hypoxia inducible factor-1 (HIF-1) and aggressive behavior. To date, HIF-1 accumulation in hereditary leiomyomatosis and renal cell cancer tumors is thought to result from fumarate-dependent inhibition of prolyl hydroxylases and subsequent evasion from von Hippel-Lindau-dependent degradation. Here, we demonstrate a novel mechanism by which fumarate promotes HIF-1 mRNA and protein accumulation independent of the von Hippel-Lindau pathway. Here we demonstrate that fumarate promotes p65 phosphorylation and p65 accumulation at the HIF-1 promoter through non-canonical signaling via the upstream Tank binding kinase 1 (TBK1). Consistent with these data, inhibition of the TBK1/p65 axis blocks HIF-1 accumulation in cellular models of FH loss and markedly reduces cell invasion of FH-deficient RCC cancer cells. Collectively, our data demonstrate a novel mechanism by which pseudohypoxia is promoted in FH-deficient tumors and identifies TBK1 as a novel putative therapeutic target for the treatment of aggressive fumarate-driven tumors.	[Shanmugasundaram, Karthigayan; Nayak, Bijaya; Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Shim, Eun-Hee; Sudarshan, Sunil] Univ Alabama Birmingham, Dept Urol, Birmingham, AL 35294 USA; [Block, Karen] South Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Block, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	block@uthscsa.edu; sudarshan@uab.edu		Livi, Carolina/0000-0001-8389-2830; Shim, Eun-Hee/0000-0002-5151-3901	National Institutes of Health [K08 CA138774]; Urology Care Foundation; Astellas Pharma Rising Star Award; America Cancer Society [RSG-12-127-01 CNE]; Veterans Affairs Merit Grants [CPRIT RP120190, P30CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, K08CA138774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Urology Care Foundation; Astellas Pharma Rising Star Award(Astellas Pharmaceuticals); America Cancer Society; Veterans Affairs Merit Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 CA138774 (to S. S.), Urology Care Foundation and Astellas Pharma Rising Star Award, and America Cancer Society RSG-12-127-01 CNE (to S. S.) and Veterans Affairs Merit Grants CPRIT RP120190 and P30CA054174 (to K. B).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Grubb RL, 2007, J UROLOGY, V177, P2074, DOI 10.1016/j.juro.2007.01.155; Hutti JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041494; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049321; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; O'Flaherty L, 2010, HUM MOL GENET, V19, P3844, DOI 10.1093/hmg/ddq305; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Ooi A, 2011, CANCER CELL, V20, P511, DOI 10.1016/j.ccr.2011.08.024; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12	35	33	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24691	24699		10.1074/jbc.M114.568162	http://dx.doi.org/10.1074/jbc.M114.568162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028521	Green Published, hybrid			2022-12-28	WOS:000341505600058
J	Fisher, LA; Wang, L; Wu, L; Peng, AM				Fisher, Laura A.; Wang, Ling; Wu, Lan; Peng, Aimin			Phosphatase 1 Nuclear Targeting Subunit Is an Essential Regulator of M-phase Entry, Maintenance, and Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Mitosis; Phosphatase; Phosphoprotein Phosphatase 1 (PP1); Xenopus; APC; C; Pnuts	PROTEIN PHOSPHATASE-1; CYTOSTATIC FACTOR; METAPHASE ARREST; GREATWALL KINASE; MITOTIC EXIT; AURORA-B; PNUTS; MITOSIS; ANAPHASE; DEPHOSPHORYLATION	Background: Mitotic progression is regulated by reversible protein phosphorylation involving kinases and phosphatases. Results: Pnuts functions as a master regulator of mitosis by modulating PP1; Pnuts expression peaks in mitosis and is degraded at mitotic exit. Conclusion: This study reveals the function and regulation of a new and essential mitotic regulator. Significance: This study improves our understanding of M-phase regulation. Mitotic progression is regulated largely through dynamic and reversible protein phosphorylation that is modulated by opposing actions of protein kinases and phosphatases. In this study, we show that phosphatase 1 nuclear targeting subunit (Pnuts) functions as a master regulator of mitosis by modulating protein phosphatase 1 (PP1). Overexpression of Pnuts in Xenopus egg extracts inhibited both mitotic and meiotic exit. Immunodepletion of Pnuts from egg extracts revealed its essential functions in mitotic entry and maintenance. The level of Pnuts oscillates during the cell cycle and peaks in mitosis. Pnuts destruction during M-phase exit is mediated by the anaphase-promoting complex/cyclosome (APC/C)-targeted ubiquitination and proteolysis, and conserved destruction motifs of Pnuts. Disruption of Pnuts degradation delayed M-phase exit, suggesting it as an important mechanism to permit M-phase exit.	[Fisher, Laura A.; Wang, Ling; Wu, Lan; Peng, Aimin] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Peng, AM (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, Lincoln, NE 68583 USA.	Aimin.Peng@UNMC.edu			National Institutes of Health [1R01CA172574, 5P20GM103489]; NATIONAL CANCER INSTITUTE [R01CA172574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA172574 and 5P20GM103489 (to A. P.).	Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Araki M, 2005, GENE DEV, V19, P2458, DOI 10.1101/gad.1361905; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Crane Richard F., 2006, V322, P435; du Puch CBM, 2011, ARCH BIOCHEM BIOPHYS, V507, P296, DOI 10.1016/j.abb.2010.12.021; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jerebtsova M, 2011, MOL CELL BIOCHEM, V347, P79, DOI 10.1007/s11010-010-0614-3; Kavela S, 2013, CANCER RES, V73, P205, DOI 10.1158/0008-5472.CAN-12-1394; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lee SJ, 2009, EXP MOL MED, V41, P189, DOI 10.3858/emm.2009.41.3.022; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371; Peng AM, 2011, J BIOL CHEM, V286, P28996, DOI 10.1074/jbc.M111.257121; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Philpott Anna, 2004, V296, P95; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Torres JZ, 2010, MOL BIOL CELL, V21, P897, DOI 10.1091/mbc.E09-07-0598; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	47	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23745	23752		10.1074/jbc.M114.572149	http://dx.doi.org/10.1074/jbc.M114.572149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002584	hybrid, Green Published			2022-12-28	WOS:000341505000042
J	Lopez-Perrote, A; Alatwi, HE; Torreira, E; Ismail, A; Ayora, S; Downs, JA; Llorca, O				Lopez-Perrote, Andres; Alatwi, Hanan E.; Torreira, Eva; Ismail, Amani; Ayora, Silvia; Downs, Jessica A.; Llorca, Oscar			Structure of Yin Yang 1 Oligomers That Cooperate with RuvBL1-RuvBL2 ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAINS; ELECTRON-MICROSCOPY; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; YY1; COMPLEX; PROTEIN; DNA; REPAIR; CELLS	Yin Yang 1 (YY1) is a transcription factor regulating proliferation and differentiation and is involved in cancer development. Oligomers of recombinant YY1 have been observed before, but their structure and DNA binding properties are not well understood. Here we find that YY1 assembles several homo-oligomeric species built from the association of a bell-shaped dimer, a process we characterized by electron microscopy. Moreover, we find that YY1 self-association also occurs in vivo using bimolecular fluorescence complementation. Unexpectedly, these oligomers recognize several DNA substrates without the consensus sequence for YY1 in vitro, and DNA binding is enhanced in the presence of RuvBL1-RuvBL2, two essential AAA+ ATPases. YY1 oligomers bind RuvBL1-RuvBL2 hetero-oligomeric complexes, but YY1 interacts preferentially with RuvBL1. Collectively, these findings suggest that YY1-RuvBL1-RuvBL2 complexes could contribute to functions beyond transcription, and we show that YY1 and the ATPase activity of RuvBL2 are required for RAD51 foci formation during homologous recombination.	[Lopez-Perrote, Andres; Torreira, Eva; Llorca, Oscar] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Alatwi, Hanan E.; Ismail, Amani; Downs, Jessica A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Ayora, Silvia] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sussex; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Downs, JA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	J.A.Downs@sussex.ac.uk; ollorca@cib.csic.es	Ayora, Silvia/D-2552-2009; Llorca, Oscar/K-1144-2014; Llorca, Oscar/P-2784-2019	Ayora, Silvia/0000-0003-3121-1786; Llorca, Oscar/0000-0001-5705-0699; Llorca, Oscar/0000-0001-5705-0699; Ismail, Amani/0000-0002-1997-6826; Downs, Jessica/0000-0002-6600-849X; Lopez-Perrote, Andres/0000-0001-7872-3442	Spanish Government [SAF2011-22988, BES-2009-014133, BFU2012-39879-C02-02]; Cancer Research UK [CEA-C7905]; Cancer Research UK [16417] Funding Source: researchfish	Spanish Government(Spanish GovernmentEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by the Spanish Government (SAF2011-22988 (to O. L.), BES-2009-014133 (to A. L.-P.), BFU2012-39879-C02-02 (to S. A.)) and by Cancer Research UK (CEA-C7905 (to J. A. D.)).	Atchison ML, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00045; Bao YH, 2011, CELL, V144, P158, DOI 10.1016/j.cell.2010.12.024; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V51, P9, DOI 10.1007/s12013-008-9007-6; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Doetsch M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044125; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Ishii H, 2012, INT J ONCOL, V40, P1575, DOI 10.3892/ijo.2012.1362; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; LEWIS BA, 1995, J VIROL, V69, P1628, DOI 10.1128/JVI.69.3.1628-1636.1995; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nano N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0399; Nicholson Sarah, 2011, Critical Reviews in Oncogenesis, V16, P245; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Zecchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048440	49	26	27	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22614	22629		10.1074/jbc.M114.567040	http://dx.doi.org/10.1074/jbc.M114.567040			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990942	Green Published, hybrid			2022-12-28	WOS:000341017200008
J	Slenn, TJ; Morris, B; Havens, CG; Freeman, RM; Takahashi, TS; Walter, JC				Slenn, Tamara J.; Morris, Benjamin; Havens, Courtney G.; Freeman, Robert M., Jr.; Takahashi, Tatsuro S.; Walter, Johannes C.			Thymine DNA Glycosylase Is a CRL4(Cdt2) Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; E3 UBIQUITIN LIGASE; PIP BOX; RIBONUCLEOTIDE REDUCTASE; CDT1 PROTEOLYSIS; GENE-EXPRESSION; NUCLEAR ANTIGEN; REPLICATION; XENOPUS; PCNA	The E3 ubiquitin ligase CRL4(Cdt2) targets proteins for destruction in S phase and after DNA damage by coupling ubiquitylation to DNA-bound proliferating cell nuclear antigen (PCNA). Coupling to PCNA involves a PCNA-interacting peptide (PIP) degron motif in the substrate that recruits CRL4(Cdt2) while binding to PCNA. In vertebrates, CRL4(Cdt2) promotes degradation of proteins whose presence in S phase is deleterious, including Cdt1, Set8, and p21. Here, we show that CRL4(Cdt2) targets thymine DNA glycosylase (TDG), a base excision repair enzyme that is involved in DNA demethylation. TDG contains a conserved and nearly perfect match to the PIP degron consensus. TDG is ubiquitylated and destroyed in a PCNA-, Cdt2-, and PIP degron-dependent manner during DNA repair in Xenopus egg extract. The protein can also be destroyed during DNA replication in this system. During Xenopus development, TDG first accumulates during gastrulation, and its expression is down-regulated by CRL4(Cdt2). Our results expand the group of vertebrate CRL4(Cdt2) substrates to include a bona fide DNA repair enzyme.	[Slenn, Tamara J.; Morris, Benjamin; Havens, Courtney G.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Freeman, Robert M., Jr.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Takahashi, Tatsuro S.] Osaka Univ, Grad Sch Sci, Osaka, Japan; [Walter, Johannes C.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Osaka University; Harvard University; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Takahashi, Tatsuro/F-4669-2016; Takahashi, Tatsuro/AAD-9936-2020	Takahashi, Tatsuro/0000-0002-1947-7680; Takahashi, Tatsuro/0000-0002-1947-7680; Freeman, Robert/0000-0003-1463-9748; Walter, Johannes/0000-0002-4186-7570	National Institutes of Health [GM80676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676, R01GM026875, T32GM007598, R37GM026875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM80676 (to J. C. W.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Faber J, 1994, NORMAL TABLE XENOPUS; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Joseph RE, 2008, PROTEIN EXPRES PURIF, V60, P194, DOI 10.1016/j.pep.2008.04.001; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mansilla SF, 2013, NUCLEIC ACIDS RES, V41, P6942, DOI 10.1093/nar/gkt475; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Salguero I, 2012, CURR BIOL, V22, P720, DOI 10.1016/j.cub.2012.02.070; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sive H. L., 2010, EARLY DEV XENOPUS LA, P99; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Stokes MP, 2003, J CELL BIOL, V163, P245, DOI 10.1083/jcb.200306006; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsanov N, 2014, NUCLEIC ACIDS RES, V42, P3692, DOI 10.1093/nar/gkt1400; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466	67	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23043	23055		10.1074/jbc.M114.574194	http://dx.doi.org/10.1074/jbc.M114.574194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24947512	hybrid, Green Published			2022-12-28	WOS:000341017200042
J	Zhang, Y; Frohman, MA				Zhang, Yi; Frohman, Michael A.			Cellular and Physiological Roles for Phospholipase D1 in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INDUCED SUPEROXIDE GENERATION; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; PHOSPHATIDYLETHANOL ACCUMULATION; MOLECULAR-MECHANISMS; THROMBUS FORMATION; SIGNALING PATHWAY; BLOOD-VESSELS; D DEFINES; TGF-BETA	Phospholipase D enzymes have long been proposed to play multiple cell biological roles in cancer. With the generation of phospholipase D1 (PLD1)-deficient mice and the development of small molecule PLD-specific inhibitors, in vivo roles for PLD1 in cancer are now being defined, both in the tumor cells and in the tumor environment. We review here tools now used to explore in vivo roles for PLD1 in cancer and summarize recent findings regarding functions in angiogenesis and metastasis.	SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Frohman, MA (corresponding author), SUNY Stony Brook, 438 Ctr Mol Med, Stony Brook, NY 11794 USA.	Michael.frohman@stonybrook.edu			National Institutes of Health [GM100109]; Carol Baldwin Breast Cancer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Breast Cancer Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM100109 and a Carol Baldwin Breast Cancer Award (to M. A. F.). This is the second article in the Thematic Minireview Series "Phospholipase D and Cancer."	Ahn Myung-Ju, 2012, Int J Biomed Sci, V8, P121; Ali WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055325; Ammar MR, 2013, J NEUROSCI, V33, P19470, DOI 10.1523/JNEUROSCI.2283-13.2013; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Arun SN, 2013, J LIPID RES, V54, P581, DOI 10.1194/jlr.M027060; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; BOCCKINO SB, 1987, FEBS LETT, V225, P201, DOI 10.1016/0014-5793(87)81157-2; Bruntz RC, 2014, J BIOL CHEM, V289, P600, DOI 10.1074/jbc.M113.532978; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Cao MD, 2012, NMR BIOMED, V25, P1033, DOI 10.1002/nbm.2766; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Dhingra S, 2011, INT J CLIN EXP PATHO, V4, P134; Dircks L, 1999, PROG LIPID RES, V38, P461, DOI 10.1016/S0163-7827(99)00012-0; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gilbert LA, 2011, CANCER RES, V71, P5062, DOI 10.1158/0008-5472.CAN-11-0277; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Gomez-Cambronero Julian, 2014, Advances in Biological Regulation, V54, P197, DOI 10.1016/j.jbior.2013.08.006; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; Gozgit JM, 2007, BRIT J CANCER, V97, P809, DOI 10.1038/sj.bjc.6603926; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2013, CELL SIGNAL, V25, P198, DOI 10.1016/j.cellsig.2012.08.010; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; Jaafar R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-55; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kanaho Yasunori, 2013, Advances in Biological Regulation, V53, P128, DOI 10.1016/j.jbior.2012.09.001; Kang DW, 2013, ONCOGENE, V32, P3531, DOI 10.1038/onc.2012.358; Kang DW, 2011, INT J CANCER, V128, P805, DOI 10.1002/ijc.25402; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kim H, 2007, CELL BIOL INT, V31, P148, DOI 10.1016/j.cellbi.2006.09.020; Kim JH, 2006, J BIOL CHEM, V281, P15747, DOI 10.1074/jbc.M509844200; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; LaLonde MM, 2005, J CELL BIOL, V169, P471, DOI 10.1083/jcb.200502122; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; LISCOVITCH M, 1991, BIOCHEM J, V279, P319, DOI 10.1042/bj2790319; Liu HY, 2010, BBA-MOL CELL BIOL L, V1801, P1330, DOI 10.1016/j.bbalip.2010.08.012; Martelli C, 2012, MOL IMAGING BIOL, V14, P183, DOI 10.1007/s11307-011-0496-0; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Nakamura Y, 1996, J IMMUNOL, V156, P256; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Nobis M, 2013, FEBS J, V280, P5177, DOI 10.1111/febs.12348; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; Norton LJ, 2011, J CELL SCI, V124, P1973, DOI 10.1242/jcs.082008; O'Reilly MC, 2013, J MED CHEM, V56, P2695, DOI 10.1021/jm301782e; Pannequin J, 2007, MOL CANCER RES, V5, P1147, DOI 10.1158/1541-7786.MCR-07-0198; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pupovac A, 2013, PURINERG SIGNAL, V9, P609, DOI 10.1007/s11302-013-9371-6; Pye DS, 2013, J IMMUNOL, V191, P1496, DOI 10.4049/jimmunol.1203484; Redina OE, 1998, BIOCHEM J, V331, P845, DOI 10.1042/bj3310845; Redina OE, 1998, GENE, V222, P53, DOI 10.1016/S0378-1119(98)00465-X; REICH R, 1995, CLIN EXP METASTAS, V13, P134, DOI 10.1007/BF00133618; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; Sato T, 2013, MOL CELL BIOL, V33, P136, DOI 10.1128/MCB.00869-12; Schmukler E, 2014, ONCOTARGET, V5, P577, DOI 10.18632/oncotarget.1775; Schwarzbach CJ, 2012, STROKE, V43, P3029, DOI 10.1161/STROKEAHA.112.658625; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shen Q, 2011, INT J CLIN EXP PATHO, V4, P13; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Son JC, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.75; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sulzmaier FJ, 2012, ONCOGENE, V31, P3547, DOI 10.1038/onc.2011.514; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Thielmann I, 2012, J THROMB HAEMOST, V10, P2361, DOI 10.1111/j.1538-7836.2012.04924.x; Toschi A, 2010, CANCER LETT, V299, P72, DOI 10.1016/j.canlet.2010.08.006; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Vorland M, 2008, PLATELETS, V19, P211, DOI 10.1080/09537100701777329; Wallert M, 2011, J CELL BIOCHEM, V112, P3025, DOI 10.1002/jcb.23227; Ye Q, 2013, J BIOL CHEM, V288, P9881, DOI 10.1074/jbc.M113.450593; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhang QH, 2010, BLOOD, V116, P1377, DOI 10.1182/blood-2010-02-271478; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhong MG, 2003, BIOCHEM BIOPH RES CO, V302, P615, DOI 10.1016/S0006-291X(03)00229-8	104	30	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22567	22574		10.1074/jbc.R114.576876	http://dx.doi.org/10.1074/jbc.R114.576876			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990946	Green Published, hybrid			2022-12-28	WOS:000341017200003
J	Aggarwal, C; Jimenez, JC; Nanavati, D; Federle, MJ				Aggarwal, Chaitanya; Jimenez, Juan Cristobal; Nanavati, Dhaval; Federle, Michael J.			Multiple Length Peptide-Pheromone Variants Produced by Streptococcus pyogenes Directly Bind Rgg Proteins to Confer Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; COMPETENCE; MECHANISM; MUTANT	Streptococcus pyogenes, a human-restricted pathogen, accounts for substantial mortality related to infections worldwide. Recent studies indicate that streptococci produce and respond to several secreted peptide signaling molecules (pheromones), including those known as short hydrophobic peptides (SHPs), to regulate gene expression by a quorum-sensing mechanism. Upon transport into the bacterial cell, pheromones bind to and modulate activity of receptor proteins belonging to the Rgg family of transcription factors. Previously, we reported biofilm regulation by the Rgg2/3 quorum-sensing circuit in S. pyogenes. The aim of this study was to identify the composition of mature pheromones from cell-free culture supernatants that facilitate biofilm formation. Bioluminescent reporters were employed to detect active pheromones in culture supernatants fractionated by reverse-phase chromatography, and mass spectrometry was used to characterize their properties. Surprisingly, multiple SHPs that varied by length were detected. Synthetic peptides of each variant were tested individually using bioluminescence reporters and biofilm growth assays, and although activities differed widely among the group, peptides comprising the C-terminal eight amino acids of the full-length native peptide were most active. Direct Rgg/SHP interactions were determined using a fluorescence polarization assay that utilized FITC-labeled peptide ligands. Peptide receptor affinities were seen to be as low as 500 nM and their binding affinities directly correlated with observed bioactivity. Revelation of naturally produced pheromones along with determination of their affinity for cognate receptors are important steps forward in designing com-pounds whose purpose is positioned for future therapeutics aimed at treating infections through the interference of bacterial communication.	[Aggarwal, Chaitanya; Federle, Michael J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Jimenez, Juan Cristobal] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60607 USA; [Nanavati, Dhaval] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Federle, MJ (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Ctr Pharmaceut Biotechnol, 3152 MBRB,M-C 870,900 S Ashland Ave, Chicago, IL 60607 USA.	mfederle@uic.edu	Federle, Michael J./E-5522-2017		National Institutes of Health from NIAID [RO1-AI091779]; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases; Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases(Burroughs Wellcome Fund); Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-AI091779 from NIAID. This work was also supported by Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Diseases.; Supported in part by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust.	Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Bachmann H, 2008, APPL ENVIRON MICROB, V74, P4727, DOI 10.1128/AEM.00297-08; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; DeMuri GP, 2014, J PEDIAT INF DIS SOC, V3, P336, DOI 10.1093/jpids/piu030; Federle MJ, 2012, VIRULENCE, V3, P92, DOI 10.4161/viru.3.1.18652; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fleuchot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066042; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; HUSMANN LK, 1995, INFECT IMMUN, V63, P345, DOI 10.1128/IAI.63.1.345-348.1995; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Khan R, 2012, J BACTERIOL, V194, P3781, DOI 10.1128/JB.00624-12; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; McShan W. Michael, 1998, Methods in Cell Science, V20, P51, DOI 10.1023/A:1009773309163; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Romero Manuel, 2012, Recent Pat Biotechnol, V6, P2; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	31	34	34	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22427	22436		10.1074/jbc.M114.583989	http://dx.doi.org/10.1074/jbc.M114.583989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958729	hybrid, Green Published			2022-12-28	WOS:000340593500052
J	Hu, YH; Parvin, JD				Hu, Yiheng; Parvin, Jeffrey D.			Small Ubiquitin-like Modifier (SUMO) Isoforms and Conjugation-independent Function in DNA Double-strand Break Repair Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; CROSS-LINK REPAIR; HOMOLOGOUS RECOMBINATION; RAD52 SUMOYLATION; GENOTOXIC STRESS; E3 LIGASE; PROTEIN; CEREVISIAE; DAMAGE; BRCA1	Small ubiquitin-like modifier (SUMO) proteins act in DNA double-strand break (DSB) repair, but the pathway specificity of the three major isoforms has not been defined. In experiments in which we depleted the endogenous SUMO protein by RNAi, we found that SUMO1 functioned in all subpathways of either homologous recombination (HR) or non-homologous end joining (NHEJ), whereas SUMO2/3 was required for the major NHEJ pathway, called conservative NHEJ, but dispensable in other DSB repair pathways. To our surprise, we found that depletion of UBC9, the unique SUMO E2 enzyme, had no effect in HR or alternative NHEJ (Alt-NHEJ) but was required for conservative NHEJ. Consistent with this result, both non-conjugatable mutant and wild-type SUMO1 proteins functioned similarly in HR and Alt-NHEJ. These results detail the functional roles of specific SUMO isoforms in DSB repair in mammalian cells and reveal that SUMO1 functions in HR or Alt-NHEJ as a free protein and not as a protein conjugate.	[Hu, Yiheng; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parvin, JD (corresponding author), Ohio State Univ, Dept Biomed Informat, 460 W 12th Ave, Columbus, OH 43210 USA.	Jeffrey.Parvin@osumc.edu	Parvin, Jeffrey D/C-8955-2009		National Institutes of Health Grant [CA141090]; NATIONAL CANCER INSTITUTE [R01CA141090] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA141090 (to J. D. P.).	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guo WZ, 2009, ARCH BIOCHEM BIOPHYS, V486, P81, DOI 10.1016/j.abb.2009.03.011; Haber JE, 2008, P NATL ACAD SCI USA, V105, P405, DOI 10.1073/pnas.0711334105; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Li WH, 2000, NUCLEIC ACIDS RES, V28, P1145, DOI 10.1093/nar/28.5.1145; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Yamada K, 2012, BIOSCI BIOTECH BIOCH, V76, P1035, DOI 10.1271/bbb.120019; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444	50	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21289	21295		10.1074/jbc.C114.582122	http://dx.doi.org/10.1074/jbc.C114.582122			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24966330	Green Published, hybrid			2022-12-28	WOS:000340558300008
J	Farrokhnia, F; Aplin, JD; Westwood, M; Forbes, K				Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen			MicroRNA Regulation of Mitogenic Signaling Networks in the Human Placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; CELL-PROLIFERATION; UP-REGULATION; CANCER CELLS; GROWTH; TROPHOBLAST; CYTOTROPHOBLAST; INHIBITION; EXPRESSION; APOPTOSIS	Placental cell growth depends on an adaptable combination of an endogenous developmental program and the exogenous influence of maternal growth factors, both of which may be influenced by microRNA (miR)-dependent effects on gene expression. We have previously shown that global miR suppression in placenta accelerates proliferation and enhances levels of growth factor signaling mediators in cytotrophoblast. This study aimed to identify miRs involved in regulating placental growth. An initial array revealed 58 miR species whose expression differs between first trimester, when cytotrophoblast proliferation is rapid, and term, by which time proliferation has slowed. In silico analysis defined potential growth-regulatory miRs; among these, hsa-miR-145, hsa-miR-377, and hsa-let-7a were predicted to target known placental growth genes and were higher at term than in the first trimester, so they were selected for further analysis. Overexpression of miR-377 and let-7a, but not miR-145, in first trimester placental explants significantly reduced basal cytotrophoblast proliferation and expression of ERK and MYC. PCR arrays, in silico analysis, Western blotting, and 3 '-UTR luciferase reporter assays revealed targets of miR-145 within the insulin-like growth factor axis. Analysis of proliferation in placental explants overexpressing miR-145 demonstrated its role as a mediator of insulin-like growth factor-induced trophoblast proliferation. These findings identify miR-377 and let-7a in regulation of endogenous cell growth and miR-145 in the placental response to maternal stimulation and will aid the development of therapeutic strategies for problem pregnancies.	[Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England; [Farrokhnia, Farkhondeh; Aplin, John D.; Westwood, Melissa; Forbes, Karen] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Forbes, K (corresponding author), Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England.	karen.forbes@manchester.ac.uk	Westwood, Melissa/G-5954-2015; Aplin, John/AET-4363-2022; Forbes, Karen/V-4794-2017	Westwood, Melissa/0000-0001-9725-7010; Aplin, John/0000-0001-8777-9261; Forbes, Karen/0000-0002-3745-1337	Biochemical Society (United Kingdom) Guildford Bench Methodology Fund; National Institute for Health Research Manchester Biomedical Research Centre; Society for Endocrinology Early Career Grant; Manchester Biomedical Research Centre; Greater Manchester Comprehensive Local Research Network; University of Manchester Stepping Stones Fellowship	Biochemical Society (United Kingdom) Guildford Bench Methodology Fund; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Society for Endocrinology Early Career Grant; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Greater Manchester Comprehensive Local Research Network; University of Manchester Stepping Stones Fellowship	This work was supported by awards from the Biochemical Society (United Kingdom) Guildford Bench Methodology Fund, the National Institute for Health Research Manchester Biomedical Research Centre, and a Society for Endocrinology Early Career Grant. The Maternal and Fetal Health Research Centre is supported by funding from the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network.; Supported by a University of Manchester Stepping Stones Fellowship.	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Ambros V, 2011, CURR OPIN GENET DEV, V21, P511, DOI 10.1016/j.gde.2011.04.003; APLIN JD, 1991, J CELL SCI, V99, P681; Aplin JD, 2010, INT J DEV BIOL, V54, P323, DOI 10.1387/ijdb.082759ja; ARNHOLDT H, 1991, VIRCHOWS ARCH B, V60, P365, DOI 10.1007/BF02899568; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Forbes K, 2012, PLACENTA, V33, P581, DOI 10.1016/j.placenta.2012.03.006; Forbes K, 2009, PLACENTA, V30, P124, DOI 10.1016/j.placenta.2008.10.003; Forbes K, 2008, AM J PHYSIOL-CELL PH, V294, pC1313, DOI 10.1152/ajpcell.00035.2008; Forbes K, 2012, CELL MOL LIFE SCI, V69, P4029, DOI 10.1007/s00018-012-1067-5; Forbes K, 2010, ENDOCRINOLOGY, V151, P1723, DOI 10.1210/en.2009-0896; Forbes K, 2009, ENDOCRINOLOGY, V150, P4744, DOI 10.1210/en.2009-0166; Fu YY, 2010, HUM REPROD, V25, P623, DOI 10.1093/humrep/dep457; Goodman RH, 2000, GENE DEV, V14, P1553; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris LK, 2006, AM J PATHOL, V169, P1863, DOI 10.2353/ajpath.2006.060265; He XY, 2010, J CANCER RES CLIN, V136, P1023, DOI 10.1007/s00432-009-0747-5; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Kar M, 2007, HUM REPROD, V22, P2814, DOI 10.1093/humrep/dem284; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Liu YC, 2012, BIOCHEM BIOPH RES CO, V417, P371, DOI 10.1016/j.bbrc.2011.11.119; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Noguchi S, 2013, CANCER LETT, V328, P353, DOI 10.1016/j.canlet.2012.10.017; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Pu HH, 2012, PLACENTA, V33, P387, DOI 10.1016/j.placenta.2012.01.015; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Schneider H, 1996, PLACENTA, V17, P15, DOI 10.1016/S0143-4004(05)80639-3; Shin JK, 2009, J OBSTET GYNAECOL RE, V35, P888, DOI 10.1111/j.1447-0756.2009.01053.x; Shu JM, 2012, RNA BIOL, V9, P1275, DOI 10.4161/rna.21998; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhong M, 2010, CHEM-BIOL INTERACT, V184, P431, DOI 10.1016/j.cbi.2010.01.025; Zhong ZW, 2012, EXP THER MED, V4, P267, DOI 10.3892/etm.2012.580; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	48	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2014	289	44					30404	30416		10.1074/jbc.M114.587295	http://dx.doi.org/10.1074/jbc.M114.587295			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS9FY	25077964	Green Published, hybrid			2022-12-28	WOS:000344549700022
J	Dash, B; Li, MD; Lukas, RJ				Dash, Bhagirathi; Li, Ming D.; Lukas, Ronald J.			Roles for N-terminal Extracellular Domains of Nicotinic Acetylcholine Receptor (nAChR) beta 3 Subunits in Enhanced Functional Expression of Mouse alpha 6 beta 2 beta 3-and alpha 6 beta 4 beta 3-nAChRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; MODULATE DOPAMINE RELEASE; IN-VIVO; REPORTER MUTATION; ALPHA-6 SUBUNITS; BINDING-SITE; PHARMACOLOGY; RECOMBINANT; LOCOMOTION; SUBTYPES	Functional heterologous expression of naturally expressed mouse alpha 6*-nicotinic acetylcholine receptors (m alpha 6*-nAChRs; where "*" indicates the presence of additional subunits) has been difficult. Here we expressed and characterized wild-type (WT), gain-of-function, chimeric, or gain-of-function chimeric nAChR subunits, sometimes as hybrid nAChRs containing both human (h) and mouse (m) subunits, in Xenopus oocytes. Hybrid m alpha 6m beta 4h beta 3- (similar to 5-8-fold) or WT m alpha 6m beta 4m beta 3-nAChRs (similar to 2-fold) yielded higher function than m alpha 6m beta 4-nAChRs. Function was not detected when m alpha 6 and m beta 2 subunits were expressed together or in the additional presence of h beta 3 or m beta 3 subunits. However, function emerged upon expression of m alpha 6m beta 2m beta 3(V9'S)-nAChRs containing beta 3 subunits having gain-of- function V9'S (valine to serine at the 9'-position) mutations in transmembrane domain II and was further elevated 9-fold when h beta 3(V9'S) subunits were substituted for m beta 3(V9'S) subunits. Studies involving WT or gain-of-function chimeric mouse/human beta 3 subunits narrowed the search for domains that influence functional expression of m alpha 6*-nAChRs. Using h beta 3 subunits as templates for site-directed mutagenesis studies, substitution with m beta 3 subunit residues in extracellular N-terminal domain loops "C" (Glu(221) and Phe(223)), "E" (Ser(144) and Ser(148)), and "beta 2-beta 3" (Gln(94) and Glu(101)) increased function of m alpha 6m beta 2*-(similar to 2-3-fold) or m alpha 6m beta 4* (similar to 2-4-fold)-nAChRs. EC50 values for nicotine acting at m alpha 6m beta 4*-nAChR were unaffected by beta 3 subunit residue substitutions in loop C or E. Thus, amino acid residues located in primary (loop C) or complementary (loops beta 2-beta 3 and E) interfaces of beta 3 subunits are some of the molecular impediments for functional expression of m alpha 6m beta 2 beta 3- or m alpha 6m beta 4 beta 3-nAChRs.	[Dash, Bhagirathi; Li, Ming D.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22911 USA; [Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	University of Virginia; Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	Ronald.Lukas@DignityHealth.org		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA012844, DA026356, DA015389]; Barrow Neurological Foundation; External Research Program of Philip Morris USA Inc.; Philip Morris International; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389, R01DA026356, R01DA012844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barrow Neurological Foundation; External Research Program of Philip Morris USA Inc.; Philip Morris International; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA012844 and DA026356 (to M. D. L.) and DA015389 (to R. J. L.). This work was also supported by endowment and capitalization funds from the Barrow Neurological Foundation (to R. J. L.) and the External Research Program of Philip Morris USA Inc. and Philip Morris International (to R. J. L.). Portions of this work have been presented in abstract form: Dash, B., Bhakta, M., Whiteaker, P., Stitzel, J. A., Chang, Y., and Lukas, R. J. (2009) Gain-of-function mutants in human or mouse nAChR beta 3 subunits interchangeably activate either human or mouse alpha 6 beta 4*-nAChR but not human or mouse alpha 6 beta 2*-nAChR. Soc. Neurosci. Abstr. 35, 34.7.	Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-35; Dash B, 2012, J BIOL CHEM, V287, P14259, DOI 10.1074/jbc.M111.322610; Dash B, 2012, J NEUROCHEM, V121, P349, DOI 10.1111/j.1471-4159.2012.07685.x; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Dederer H, 2013, INSECT MOL BIOL, V22, P183, DOI 10.1111/imb.12014; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Exley R, 2011, P NATL ACAD SCI USA, V108, P7577, DOI 10.1073/pnas.1103000108; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grinevich VP, 2005, J PHARMACOL EXP THER, V312, P619, DOI 10.1124/jpet.104.075069; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Novere N, 1999, NEUROREPORT, V10, P2497, DOI 10.1097/00001756-199908200-00012; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Parker JC, 2003, BRIT J PHARMACOL, V138, P801, DOI 10.1038/sj.bjp.0705124; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Steinbach JH, 2011, MOL PHARMACOL, V79, P337, DOI 10.1124/mol.110.070102; Tomizawa M, 2005, INSECT BIOCHEM MOLEC, V35, P1347, DOI 10.1016/j.ibmb.2005.08.006; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Zwart R, 1997, MOL PHARMACOL, V52, P886, DOI 10.1124/mol.52.5.886	55	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28338	28351		10.1074/jbc.M114.566018	http://dx.doi.org/10.1074/jbc.M114.566018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25028511	Green Published, hybrid			2022-12-28	WOS:000343765400028
J	Dintner, S; Heermann, R; Fang, C; Jung, K; Gebhard, S				Dintner, Sebastian; Heermann, Ralf; Fang, Chong; Jung, Kirsten; Gebhard, Susanne			A Sensory Complex Consisting of an ATP-binding Cassette Transporter and a Two-component Regulatory System Controls Bacitracin Resistance in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Antimicrobial Peptide (AMP); Histidine Kinase; Membrane Protein; Protein-Protein Interaction; Bacitracin	DEPENDENT GENE-EXPRESSION; ESCHERICHIA-COLI; PHOSPHATE-TRANSPORT; STAPHYLOCOCCUS-AUREUS; ABC TRANSPORTERS; MYCOBACTERIUM-SMEGMATIS; ANTIMICROBIAL PEPTIDES; DETOXIFICATION MODULES; FIRMICUTES BACTERIA; SIGNAL-TRANSDUCTION	Background: BceS-like histidine kinases strictly require BceAB-like ABC transporters for sensing of peptide antibiotics. Results: BceAB of Bacillus subtilis interacted with BceS in vivo and in vitro and specifically bound the substrate peptide bacitracin. Conclusion: Complex formation with the ABC transporter affects the activity of the histidine kinase. Significance: Histidine kinase and ABC transporter form a sensory complex for the detection of peptide antibiotics. Resistance against antimicrobial peptides in many Firmicutes bacteria is mediated by detoxification systems that are composed of a two-component regulatory system (TCS) and an ATP-binding cassette (ABC) transporter. The histidine kinases of these systems depend entirely on the transporter for sensing of antimicrobial peptides, suggesting a novel mode of signal transduction where the transporter constitutes the actual sensor. The aim of this study was to investigate the molecular mechanisms of this unusual signaling pathway in more detail, using the bacitracin resistance system BceRS-BceAB of Bacillus subtilis as an example. To analyze the proposed communication between TCS and the ABC transporter, we characterized their interactions by bacterial two-hybrid analyses and could show that the permease BceB and the histidine kinase BceS interact directly. In vitro pulldown assays confirmed this interaction, which was found to be independent of bacitracin. Because it was unknown whether BceAB-type transporters could detect their substrate peptides directly or instead recognized the peptide-target complex in the cell envelope, we next analyzed substrate binding by the transport permease, BceB. Direct and specific binding of bacitracin by BceB was demonstrated by surface plasmon resonance spectroscopy. Finally, in vitro signal transduction assays indicated that complex formation with the transporter influenced the autophosphorylation activity of the histidine kinase. Taken together, our findings clearly show the existence of a sensory complex composed of TCS and ABC transporters and provide the first functional insights into the mechanisms of stimulus perception, signal transduction, and antimicrobial resistance employed by Bce-like detoxification systems.	[Dintner, Sebastian; Heermann, Ralf; Fang, Chong; Jung, Kirsten; Gebhard, Susanne] Univ Munich, Dept Biol 1, D-82152 Martinsried, Germany; [Jung, Kirsten] Univ Munich, Dept Biol 1, Munich Ctr Integrated Prot Sci, D-82152 Martinsried, Germany	University of Munich; University of Munich	Gebhard, S (corresponding author), Univ Munich, Dept Biol 1, Grosshaderner Str 2-4, D-82152 Martinsried, Germany.	susanne.gebhard@gmail.com	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022; Gebhard, Susanne/F-4154-2012	Heermann, Ralf/0000-0003-0631-6156; Gebhard, Susanne/0000-0003-4783-6115	Deutsche Forschungsgemeinschaft [GE2164/3-1, Exc114-2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant GE2164/3-1 and the Fonds der Chemischen Industrie (to the S. G. laboratory) and Deutsche Forschungsgemeinschaft Grant Exc114-2 (to the K. J. laboratory).	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Gebhard S, 2008, J BACTERIOL, V190, P1335, DOI 10.1128/JB.01764-07; Gebhard S, 2014, ANTIMICROB AGENTS CH, V58, P1425, DOI 10.1128/AAC.02111-13; Gebhard S, 2012, MOL MICROBIOL, V86, P1295, DOI 10.1111/mmi.12078; Gebhard S, 2011, MOL MICROBIOL, V81, P581, DOI 10.1111/j.1365-2958.2011.07747.x; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Graf S, 2014, J BACTERIOL, V196, P1084, DOI 10.1128/JB.01154-13; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haneburger I, 2012, J MOL BIOL, V424, P15, DOI 10.1016/j.jmb.2012.08.023; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Kallenberg F, 2013, J BACTERIOL, V195, P3287, DOI 10.1128/JB.00419-13; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kingston AW, 2014, MOL MICROBIOL, V93, P37, DOI 10.1111/mmi.12637; Kleefeld A, 2009, J BIOL CHEM, V284, P265, DOI 10.1074/jbc.M807856200; LUX R, 1995, P NATL ACAD SCI USA, V92, P11583, DOI 10.1073/pnas.92.25.11583; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Qi Y, 1997, J BACTERIOL, V179, P2534, DOI 10.1128/jb.179.8.2534-2539.1997; Radeck J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-29; Revilla-Guarinos A, 2013, APPL ENVIRON MICROB, V79, P3160, DOI 10.1128/AEM.00178-13; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Scheu PD, 2010, J BACTERIOL, V192, P3474, DOI 10.1128/JB.00082-10; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; STORM DR, 1973, J BIOL CHEM, V248, P3940; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Tetsch L, 2009, MOL MICROBIOL, V73, P982, DOI 10.1111/j.1365-2958.2009.06847.x; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Wanner BL, 1996, KIDNEY INT, V49, P964, DOI 10.1038/ki.1996.136; Witan J, 2012, MOL MICROBIOL, V85, P846, DOI 10.1111/j.1365-2958.2012.08143.x; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108; Yuan ZC, 2006, J BACTERIOL, V188, P1089, DOI 10.1128/JB.188.3.1089-1102.2006	46	52	54	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27899	27910		10.1074/jbc.M114.596221	http://dx.doi.org/10.1074/jbc.M114.596221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25118291	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000342852800045
J	He, JS; Zhu, QZ; Wani, G; Sharma, N; Han, CH; Qian, J; Pentz, K; Wang, QE; Wani, AA				He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Han, Chunhua; Qian, Jiang; Pentz, Kyle; Wang, Qi-en; Wani, Altaf A.			Ubiquitin-specific Protease 7 Regulates Nucleotide Excision Repair through Deubiquitinating XPC Protein and Preventing XPC Protein from Undergoing Ultraviolet Light-induced and VCP/p97 Protein-regulated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM GROUP-C; UV-SENSITIVE SYNDROME; DOUBLE-STRAND BREAKS; DNA-DAMAGE; INDUCED UBIQUITYLATION; MOLECULAR-MECHANISM; PYRIMIDINE DIMERS; IN-VIVO; CELLS; P97	Ubiquitin specific protease 7 (USP7) is a known deubiquitinating enzyme for tumor suppressor p53 and its downstream regulator, E3 ubiquitin ligase Mdm2. Here we report that USP7 regulates nucleotide excision repair (NER) via deubiquitinating xeroderma pigmentosum complementation groupC(XPC) protein, a critical damage recognition factor that binds to helix-distorting DNA lesions and initiates NER. XPC is ubiquitinated during the early stage of NER of UV light-induced DNA lesions. We demonstrate that transiently compromising cellular USP7 by siRNA and chemical inhibition leads to accumulation of ubiquitinated forms of XPC, whereas complete USP7 deficiency leads to rapid ubiquitin-mediated XPC degradation upon UV irradiation. We show that USP7 physically interacts with XPC in vitro and in vivo. Overexpression of wild-type USP7, but not its catalytically inactive or interaction-defective mutants, reduces the ubiquitinated forms of XPC. Importantly, USP7 efficiently deubiquitinates XPC-ubiquitin conjugates in deubiquitination assays in vitro. We further show that valosin-containing protein (VCP)/p97 is involved in UV light-induced XPC degradation in USP7-deficient cells. VCP/p97 is readily recruited to DNA damage sites and colocalizes with XPC. Chemical inhibition of the activity of VCP/p97 ATPase causes an increase in ubiquitinated XPC on DNA-damaged chromatin. Moreover, USP7 deficiency severely impairs the repair of cyclobutane pyrimidine dimers and, to a lesser extent, affects the repair of 6-4 photoproducts. Taken together, our findings uncovered an important role of USP7 in regulating NER via deubiquitinating XPC and by preventing its VCP/p97-regulated proteolysis.	[He, Jinshan; Zhu, Qianzheng; Wani, Gulzar; Sharma, Nidhi; Han, Chunhua; Qian, Jiang; Pentz, Kyle; Wang, Qi-en; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Zhu, QZ (corresponding author), Ohio State Univ, Dept Radiol, 720 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	zhu.49@osu.edu; wani.2@osu.edu	Zhu, Qianzheng/A-4902-2013		National Institute of Health Public Health Service Grants [ES2388, ES12991]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012991, R01ES002388] Funding Source: NIH RePORTER	National Institute of Health Public Health Service Grants; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institute of Health Public Health Service Grants ES2388 and ES12991.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Bartocci Cristina, 2013, Frontiers in Genetics, V4, P128, DOI 10.3389/fgene.2013.00128; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Ford JM, 1997, CURR TOP MICROBIOL, V221, P47; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hastak Kedar, 2012, Genes Cancer, V3, P131, DOI 10.1177/1947601912456288; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Shell SM, 2013, DNA REPAIR, V12, P947, DOI 10.1016/j.dnarep.2013.08.013; SHIVJI MKK, 1994, J BIOL CHEM, V269, P22749; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	42	63	64	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27278	27289		10.1074/jbc.M114.589812	http://dx.doi.org/10.1074/jbc.M114.589812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118285	hybrid, Green Published			2022-12-28	WOS:000342853900049
J	Kock, J; Kreher, S; Lehmann, K; Riedel, R; Bardua, M; Lischke, T; Jargosch, M; Haftmann, C; Bendfeldt, H; Hatam, F; Mashreghi, MF; Baumgrass, R; Radbruch, A; Chang, HD				Koeck, Juliana; Kreher, Stephan; Lehmann, Katrin; Riedel, Rene; Bardua, Markus; Lischke, Timo; Jargosch, Manja; Haftmann, Claudia; Bendfeldt, Hanna; Hatam, Farahnaz; Mashreghi, Mir-Farzin; Baumgrass, Ria; Radbruch, Andreas; Chang, Hyun-Dong			Nuclear Factor of Activated T Cells Regulates the Expression of Interleukin-4 in Th2 Cells in an All-or-none Fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NFAT1; LOCUS-CONTROL REGION; GENE-EXPRESSION; PROBABILISTIC REGULATION; IL-4 EXPRESSION; HELPER-CELLS; GATA-3; LYMPHOCYTES; MEMORY; DEPHOSPHORYLATION	Th2 memory lymphocytes have imprinted their Il4 genes epigenetically for expression in dependence of T cell receptor restimulation. However, in a given restimulation, not all Th cells with a memory for IL-4 expression express IL-4. Here, we show that in reactivated Th2 cells, the transcription factors NFATc2, NF-kB p65, c-Maf, p300, Brg1, STAT6, andGATA-3assemble at the Il4 promoter in Th2 cells expressing IL-4 but not in Th2 cells not expressing it. NFATc2 is critical for assembly of this transcription factor complex. Because NFATc2 translocation into the nucleus occurs in an all-or-none fashion, dependent on complete dephosphorylation by calcineurin, NFATc2 controls the frequencies of cells reexpressing Il4, translates analog differences in T cell receptor stimulation into a digital decision for Il4 reexpression, and instructs all reexpressing cells to express the same amount of IL-4. This analog-to-digital conversion may be critical for the immune system to respond to low concentrations of antigens.	[Koeck, Juliana; Kreher, Stephan; Lehmann, Katrin; Riedel, Rene; Bardua, Markus; Lischke, Timo; Jargosch, Manja; Haftmann, Claudia; Bendfeldt, Hanna; Hatam, Farahnaz; Mashreghi, Mir-Farzin; Baumgrass, Ria; Radbruch, Andreas; Chang, Hyun-Dong] German Rheumatism Res Ctr Berlin, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ)	Chang, HD (corresponding author), German Rheumatism Res Ctr Berlin, Charitepl 1, D-10117 Berlin, Germany.	chang@drfz.de	Mashreghi, Mir-Farzin/S-2911-2019; Chang, Hyun-Dong/T-3697-2017	Mashreghi, Mir-Farzin/0000-0002-8015-6907; Chang, Hyun-Dong/0000-0002-7341-4533; Radbruch, Andreas/0000-0001-5753-0000; Lischke, Timo/0000-0003-0413-4252; Baumgrass, Ria/0000-0002-3289-1608; Riedel, Rene/0000-0003-4752-0196	German Research Council (Deutsche Forschungsgemeinschaft) [SFB618, SFB TRR52]; European Research Council Advanced Grants [ERC-2010-AdG_20100317, 268987]; German Ministry of Education and Research Grant "IMPAM" [01EC1008B]; German Ministry of Education and Research e:Bio-Innovationswettbewerb Systembiologie	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); European Research Council Advanced Grants; German Ministry of Education and Research Grant "IMPAM"; German Ministry of Education and Research e:Bio-Innovationswettbewerb Systembiologie	This work was supported by the German Research Council (Deutsche Forschungsgemeinschaft SFB618 and SFB TRR52), the European Research Council Advanced Grants ERC-2010-AdG_20100317 and 268987, and the German Ministry of Education and Research Grant "IMPAM" (01EC1008B) and e:Bio-Innovationswettbewerb Systembiologie."	Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Chang HD, 2007, EUR J IMMUNOL, V37, P807, DOI 10.1002/eji.200636385; Frischbutter S, 2012, CYTOM PART A, V81A, P1005, DOI 10.1002/cyto.a.22204; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Guo LY, 2005, IMMUNITY, V23, P89, DOI 10.1016/j.immuni.2005.05.008; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Hofer T, 2002, P NATL ACAD SCI USA, V99, P9364, DOI 10.1073/pnas.142284699; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; KUPFER A, 1991, P NATL ACAD SCI USA, V88, P775, DOI 10.1073/pnas.88.3.775; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lohning M, 2003, P NATL ACAD SCI USA, V100, P12307, DOI 10.1073/pnas.2035254100; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Salazar C, 2005, FEBS LETT, V579, P621, DOI 10.1016/j.febslet.2004.12.029; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Tykocinski LO, 2005, J BIOL CHEM, V280, P28177, DOI 10.1074/jbc.M502038200; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26752	26761		10.1074/jbc.M114.587865	http://dx.doi.org/10.1074/jbc.M114.587865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25037220	Green Published, hybrid			2022-12-28	WOS:000342853900008
J	Kuiper, EG; Conn, GL				Kuiper, Emily G.; Conn, Graeme L.			Binding Induced RNA Conformational Changes Control Substrate Recognition and Catalysis by the Thiostrepton Resistance Methyltransferase (Tsr)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							23-S RIBOSOMAL-RNA; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; COMPLEX; SPOUT; STABILIZATION; MUTANTS; SITE	Ribosomal RNA (rRNA) post-transcriptional modifications are essential for ribosome maturation, translational fidelity, and are one mechanism used by both antibiotic-producing and pathogenic bacteria to resist the effects of antibiotics that target the ribosome. The thiostrepton producer Streptomyces azureus prevents self-intoxication by expressing the thiostrepton-resistance methyltransferase (Tsr), which methylates the 2'-hydroxyl of 23 S rRNA nucleotide adenosine 1067 within the thiostrepton binding site. Tsr is a homodimer with each protomer containing an L30e-like amino-terminal domain (NTD) and a SPOUT methyltransferase family catalytic carboxyl-terminal domain (CTD). We show that both enzyme domains are required for high affinity RNA substrate binding. The Tsr-CTD has intrinsic, weak RNA affinity that is necessary to direct the specific high-affinity Tsr-RNA interaction via NTDs, which have no detectable RNA affinity in isolation. RNA structure probing experiments identify the Tsr footprint on the RNA and structural changes in the substrate, induced specifically upon NTD binding, which are necessary for catalysis by the CTD. Additionally, we identify a key amino acid in each domain responsible for CTD-RNA binding and the observed NTD-dependent RNA structural changes. These studies allow us to develop a model for Tsr-RNA interaction in which the coordinated substrate recognition of each Tsr structural domain is an obligatory pre-catalytic recognition event. Our findings underscore the complexity of substrate recognition by RNA modification enzymes and the potential for direct involvement of the RNA substrate in controlling the process of its modification.	[Kuiper, Emily G.; Conn, Graeme L.] Emory Univ Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Conn, GL (corresponding author), 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu			National Institutes of Health [R01-AI088025, T32-GM008367]; United State Department of Agriculture National Institute of Food and Agriculture [2013-67011-21133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United State Department of Agriculture National Institute of Food and Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI088025 and T32-GM008367.; Supported by the Agriculture and Food Research Initiative Competitive Grant 2013-67011-21133 from the United State Department of Agriculture National Institute of Food and Agriculture.	Aminake MN, 2011, ANTIMICROB AGENTS CH, V55, P1338, DOI 10.1128/AAC.01096-10; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Burakovsky DE, 2012, NUCLEIC ACIDS RES, V40, P7885, DOI 10.1093/nar/gks508; Cameron DM, 2004, NUCLEIC ACIDS RES, V32, P3220, DOI 10.1093/nar/gkh644; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Conn GL, 2002, J MOL BIOL, V318, P963, DOI 10.1016/S0022-2836(02)00147-X; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; CUNDLIFFE E, 1978, NATURE, V272, P792, DOI 10.1038/272792a0; CUNDLIFFE E, 1979, NATURE, V278, P859, DOI 10.1038/278859a0; Draper D E, 2001, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1103s02; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Dunstan MS, 2009, J BIOL CHEM, V284, P17013, DOI 10.1074/jbc.M901618200; Dunstan MS, 2005, CHEM BIOL, V12, P201, DOI 10.1016/j.chembiol.2004.11.019; Forouhar F, 2003, PROTEINS, V53, P329, DOI 10.1002/prot.10510; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; LAING LG, 1994, J MOL BIOL, V237, P577, DOI 10.1006/jmbi.1994.1256; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Linpinsel Jo L, 2012, Methods Mol Biol, V941, P43, DOI 10.1007/978-1-62703-113-4_4; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; LU M, 1994, J MOL BIOL, V244, P572, DOI 10.1006/jmbi.1994.1753; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; O'Dwyer K, 2004, J BACTERIOL, V186, P2346, DOI 10.1128/JB.186.8.2346-2354.2004; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; THOMPSON J, 1979, EUR J BIOCHEM, V98, P261, DOI 10.1111/j.1432-1033.1979.tb13184.x; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIENEN B, 1979, J BIOL CHEM, V254, P8031; XING YY, 1995, J MOL BIOL, V249, P319, DOI 10.1006/jmbi.1995.0299; Yang HR, 2010, BIOCHEMISTRY-US, V49, P6440, DOI 10.1021/bi1005915; Zearfoss N Ruth, 2012, Methods Mol Biol, V941, P181, DOI 10.1007/978-1-62703-113-4_14; Zhang H, 2012, J MOL BIOL, V423, P576, DOI 10.1016/j.jmb.2012.08.016	38	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26189	26200		10.1074/jbc.M114.574780	http://dx.doi.org/10.1074/jbc.M114.574780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086036	Green Published, hybrid			2022-12-28	WOS:000342128800015
J	Morinaga, T; Abe, K; Nakayama, Y; Yamaguchi, N; Yamaguchi, N				Morinaga, Takao; Abe, Kohei; Nakayama, Yuji; Yamaguchi, Noritaka; Yamaguchi, Naoto			Activation of Lyn Tyrosine Kinase through Decreased Membrane Cholesterol Levels during a Change in Its Membrane Distribution upon Cell Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LUNG ADENOCARCINOMA CELLS; SRC FAMILY KINASES; PLASMA-MEMBRANE; C-SRC; PROTEIN COMPLEXES; ANOIKIS; RECEPTOR; CANCER; TRAFFICKING	Cellular membranes, which can serve as scaffolds for signal transduction, dynamically change their characteristics upon cell detachment. Src family kinases undergo post-translational lipid modification and are involved in a wide range of signaling events at the plasma membrane, such as cell proliferation, cell adhesion, and survival. Previously, we showed the differential membrane distributions among the members of Src family kinases by sucrose density gradient fractionation. However, little is known about the regulation of the membrane distribution of Src family kinases upon cell detachment. Here, we show that cell detachment shifts the main peak of the membrane distribution of Lyn, a member of Src family kinase, from the low density to the high density membrane fractions and enhances the kinase activity of Lyn. The change in Lyn distribution upon cell detachment involves both dynamin activity and a decrease in membrane cholesterol. Cell detachment activates Lyn through decreased membrane cholesterol levels during a change in its membrane distribution. Furthermore, cholesterol incorporation decreases Lyn activity and reduces the viability of suspension cells. These results suggest that cell detachment-induced Lyn activation through the change in the membrane distribution of Lyn plays an important role in survival of suspension cells.	[Morinaga, Takao; Abe, Kohei; Nakayama, Yuji; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Belsches A P, 1997, Front Biosci, V2, pd501; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Connelly SF, 2010, MOL CARCINOGEN, V49, P1007, DOI 10.1002/mc.20684; COOPER RA, 1975, J CLIN INVEST, V55, P115, DOI 10.1172/JCI107901; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; FLEISCHER B, 1969, J CELL BIOL, V43, P59, DOI 10.1083/jcb.43.1.59; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Ikeda K, 2009, BBA-GEN SUBJECTS, V1790, P1345, DOI 10.1016/j.bbagen.2009.07.009; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Norambuena A, 2011, MOL BIOL CELL, V22, P3456, DOI 10.1091/mbc.E11-04-0361; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Ravnskov U, 2012, QJM-INT J MED, V105, P383, DOI 10.1093/qjmed/hcr243; Ringerike T, 2002, J CELL SCI, V115, P1331; Sakuma Y, 2010, J PATHOL, V220, P574, DOI 10.1002/path.2676; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	52	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26327	26343		10.1074/jbc.M114.580001	http://dx.doi.org/10.1074/jbc.M114.580001			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104351	Green Published, hybrid			2022-12-28	WOS:000342128800026
J	Capell, A; Fellerer, K; Haass, C				Capell, Anja; Fellerer, Katrin; Haass, Christian			Progranulin Transcripts with Short and Long 5 ' Untranslated Regions (UTRs) Are Differentially Expressed via Posttranscriptional and Translational Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MUTATIONS; DEMENTIA; GENE; INITIATION; PROTEIN; PHENOTYPES; TDP-43; BACE1	Frontotemporal lobar degeneration is associated with cytoplasmic or nuclear deposition of the TAR DNA-binding protein 43 (TDP-43). Haploinsufficiency of progranulin (GRN) is a major genetic risk factor for frontotemporal lobar degeneration associated with TDP-43 deposition. Therefore, understanding the mechanisms that control cellular expression of GRN is required not only to understand disease etiology but also for the development of potential therapeutic strategies. We identified different GRN transcripts with short (38-93 nucleotides) or long (219 nucleotides) 5' UTRs and demonstrate a cellular mechanism that represses translation of GRN mRNAs with long 5' UTRs. The long 5' UTR of GRN mRNA contains an upstream open reading frame (uORF) that is absent in all shorter transcripts. Because such UTRs can be involved in translational control as well as in mRNA stability, we compared the expression of GRN in cells expressing cDNAs with and without 5' UTRs. This revealed a selective repression of GRN translation and a reduction of mRNA levels by the 219-nucleotide-long 5' UTR. The specific ability of this GRN 5' UTR to repress protein expression was further confirmed by its transfer to an independent reporter. Deletion analysis identified a short stretch between nucleotides 76 and 125 containing two start codons within one uORF that is required and sufficient for repression of protein expression. Mutagenesis of the two AUG codons within the uORF is sufficient to reduce translational repression. Therefore initiating ribosomes at the AUGs of the uORF fail to efficiently initiate translation at the start codon of GRN. In parallel the 5' UTR also affects mRNA stability; thus two independent mechanisms determine GRN expression via mRNA stability and translational efficiency.	[Capell, Anja; Fellerer, Katrin; Haass, Christian] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Capell, A (corresponding author), Univ Munich, German Ctr Neurodegenerat Dis, Schillerstr 44, D-80336 Munich, Germany.	anja.capell@mail03.med.uni-muenchen.de; christian.haass@mail03.med.uni-muenchen.de			European Research Council under the European Union [321366-Amyloid]	European Research Council under the European Union(European Research Council (ERC))	This work was supported by the European Research Council under the European Union Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement No. 321366-Amyloid (advanced grant to C. H.).	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Liu L, 1999, NAT GENET, V21, P128, DOI 10.1038/5082; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Puoti G., 2014, J ALZHEIMER IN PRESS; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49	32	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25879	25889		10.1074/jbc.M114.560128	http://dx.doi.org/10.1074/jbc.M114.560128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25056957	hybrid, Green Published			2022-12-28	WOS:000342130800044
J	Parker, BL; Shepherd, NE; Trefely, S; Hoffman, NJ; White, MY; Engholm-Keller, K; Hambly, BD; Larsen, MR; James, DE; Cordwell, SJ				Parker, Benjamin L.; Shepherd, Nicholas E.; Trefely, Sophie; Hoffman, Nolan J.; White, Melanie Y.; Engholm-Keller, Kasper; Hambly, Brett D.; Larsen, Martin R.; James, David E.; Cordwell, Stuart J.			Structural Basis for Phosphorylation and Lysine Acetylation Cross-talk in a Kinase Motif Associated with Myocardial Ischemia and Cardioprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; PERMEABILITY TRANSITION; GCN5-MEDIATED ACETYLATION; ARGININE METHYLATION; HISTONE H3; SIRT1; IDENTIFICATION; REPERFUSION; GLUCOSE	Myocardial ischemia and cardioprotection by ischemic preconditioning induce signal networks aimed at survival or cell death if the ischemic period is prolonged. These pathways are mediated by protein post-translational modifications that are hypothesized to cross-talk with and regulate each other. Phosphopeptides and lysine-acetylated peptides were quantified in isolated rat hearts subjected to ischemia or ischemic pre-conditioning, with and without splitomicin inhibition of lysine deacetylation. We show lysine acetylation (acetyl-Lys)-dependent activation of AMP-activated protein kinase, AKT, andPKA kinases during ischemia. Phosphorylation and acetyl-Lys sites mapped onto tertiary structures were proximal in >50% of proteins investigated, yet they were mutually exclusive in 50 ischemic pre-conditioning-and/or ischemia-associated peptides containing the KXXS basophilic protein kinase consensus motif. Modifications in this motif were modeled in the C terminus of muscle-type creatine kinase. Acetyl-Lys increased proximal dephosphorylation by 10-fold. Structural analysis of modified muscle-type creatine kinase peptide variants by two-dimensional NMR revealed stabilization via a lysine-phosphate salt bridge, which was disrupted by acetyl-Lys resulting in backbone flexibility and increased phosphatase accessibility.	[Parker, Benjamin L.; Hambly, Brett D.; Cordwell, Stuart J.] Univ Sydney, Sch Med Sci, Discipline Pathol, Sydney, NSW 2006, Australia; [Parker, Benjamin L.; Trefely, Sophie; Hoffman, Nolan J.; James, David E.] Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Parker, Benjamin L.; Hoffman, Nolan J.; James, David E.] Garvan Inst Med Res, Biol Mass Spectrometry Unit, Darlinghurst, NSW 2010, Australia; [Shepherd, Nicholas E.; White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [White, Melanie Y.; Engholm-Keller, Kasper; Hambly, Brett D.; James, David E.; Cordwell, Stuart J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Larsen, Martin R.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Sydney; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of Sydney; University of Sydney; University of Southern Denmark	Cordwell, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Hub Bldg D17, Sydney, NSW 2006, Australia.	stuart.cordwell@sydney.edu.au	Trefely, Sophie/AAL-9434-2020; Shepherd, Nicholas/H-6781-2016; Hambly, Brett D/B-1965-2009; Engholm-Keller, Kasper/B-7623-2018; Larsen, Martin Rossel/F-1411-2015	Shepherd, Nicholas/0000-0001-6234-4456; Hambly, Brett D/0000-0002-5988-562X; Engholm-Keller, Kasper/0000-0001-5988-2632; Larsen, Martin Rossel/0000-0001-6203-0123; Cordwell, Stuart/0000-0002-0995-0171; Hoffman, Nolan/0000-0001-5168-7082; White, Melanie/0000-0003-2571-2816; James, David/0000-0001-5946-5257	National Health and Medical Research Council of Australia [571002]; Lundbeck Foundation Junior Group Leader Fellowship; LTQ-Orbitrap Velos; Danish Natural Science Research Council [09-06-5989]; University of Sydney Medical Alumni; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lundbeck Foundation Junior Group Leader Fellowship; LTQ-Orbitrap Velos; Danish Natural Science Research Council(Danish Natural Science Research Council); University of Sydney Medical Alumni; Australian Research Council(Australian Research Council)	This work was supported in part by National Health and Medical Research Council of Australia Project Grant 571002 (to S. J. C. and B. D. H.), the Lundbeck Foundation Junior Group Leader Fellowship and LTQ-Orbitrap Velos (to M. R. L.), and the Danish Natural Science Research Council Grant 09-06-5989 (to M. R. L.).; Supported by a postgraduate award from the University of Sydney Medical Alumni.; Recipients of Australian Research Council Discovery Early Career Researcher Awards.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Barnett ME, 2007, CELL SIGNAL, V19, P1820, DOI 10.1016/j.cellsig.2007.05.014; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Diviani D, 2011, AM J PHYSIOL-HEART C, V301, pH1742, DOI 10.1152/ajpheart.00569.2011; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Engholm-Keller K, 2012, J PROTEOMICS, V75, P5749, DOI 10.1016/j.jprot.2012.08.007; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Ho PC, 2008, CELL SIGNAL, V20, P1911, DOI 10.1016/j.cellsig.2008.07.001; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; KARMAZYN M, 1993, CARDIOVASC RES, V27, P2079, DOI 10.1093/cvr/27.11.2079a; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KIRCHBERGER MA, 1972, J MOL CELL CARDIOL, V4, P673, DOI 10.1016/0022-2828(72)90120-4; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kubota K, 2009, NAT BIOTECHNOL, V27, P933, DOI 10.1038/nbt.1566; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Liu B, 1996, CIRC RES, V79, P940, DOI 10.1161/01.RES.79.5.940; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MARTIN DB, 1962, J BIOL CHEM, V237, P1787; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OLIVER MF, 1994, LANCET, V343, P155, DOI 10.1016/S0140-6736(94)90939-3; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; Rigbolt KTG, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.007450; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SODIPALLARES D, 1962, AM J CARDIOL, V9, P166, DOI 10.1016/0002-9149(62)90035-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yanes O, 2011, ANAL CHEM, V83, P2152, DOI 10.1021/ac102981k; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Yu YH, 2009, P NATL ACAD SCI USA, V106, P11606, DOI 10.1073/pnas.0905165106; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	104	37	37	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25890	25906		10.1074/jbc.M114.556035	http://dx.doi.org/10.1074/jbc.M114.556035			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25008320	hybrid, Green Published			2022-12-28	WOS:000342130800045
J	Backus, KM; Dolan, MA; Barry, CS; Joe, M; McPhie, P; Boshoff, HIM; Lowary, TL; Davis, BG; Barry, CE				Backus, Keriann M.; Dolan, Michael A.; Barry, Conor S.; Joe, Maju; McPhie, Peter; Boshoff, Helena I. M.; Lowary, Todd L.; Davis, Benjamin G.; Barry, Clifton E., III			The Three Mycobacterium tuberculosis Antigen 85 Isoforms Have Unique Substrates and Activities Determined by Non-active Site Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; CORYNEBACTERIUM-GLUTAMICUM; MYCOLYL TRANSFERASE; MOLECULAR-DYNAMICS; SMEGMATIS; COMPLEX; ARABINOGALACTAN; FIBRONECTIN; COMPONENTS; INHIBITION	The three isoforms of antigen 85 (A, B, and C) are the most abundant secreted mycobacterial proteins and catalyze transesterification reactions that synthesize mycolated arabinogalactan, trehalose monomycolate (TMM), and trehalose dimycolate (TDM), important constituents of the outermost layer of the cellular envelope of Mycobacterium tuberculosis. These three enzymes are nearly identical at the active site and have therefore been postulated to exist to evade host immunity. Distal to the active site is a second putative carbohydrate-binding site of lower homology. Mutagenesis of the three isoforms at this second site affected both substrate selectivity and overall catalytic activity in vitro. Using synthetic and natural substrates, we show that these three enzymes exhibit unique selectivity; antigen 85A more efficiently mycolates TMM to form TDM, whereas C (and to a lesser extent B) has a higher rate of activity using free trehalose to form TMM. This difference in substrate selectivity extends to the hexasaccharide fragment of cell wall arabinan. Mutation of secondary site residues from the most active isoform (C) into those present in A or B partially interconverts this substrate selectivity. These experiments in combination with molecular dynamics simulations reveal that differences in the N-terminal helix alpha 9, the adjacent Pro(216)-Phe(228) loop, and helix alpha 5 are the likely cause of changes in activity and substrate selectivity. These differences explain the existence of three isoforms and will allow for future work in developing inhibitors.	[Backus, Keriann M.; Boshoff, Helena I. M.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Dolan, Michael A.] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Backus, Keriann M.; Barry, Conor S.; Davis, Benjamin G.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [McPhie, Peter] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Davis, BG (corresponding author), Univ Oxford, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk; cbarry@niaid.nih.gov	JOE, MAJU/W-4332-2019; Barry, III, Clifton/H-3839-2012; Davis, Benjamin G/C-5281-2011; Lowary, Todd L/F-9608-2019; Barry, Clifton E/ABE-7992-2020	JOE, MAJU/0000-0003-0664-5275; Barry, III, Clifton/0000-0002-2927-270X; Davis, Benjamin G/0000-0002-5056-407X; Lowary, Todd L/0000-0002-8331-8211; Barry, Clifton E/0000-0002-2927-270X	Colorado State University [HHSN266200400091c]; National Institutes of Health, NIGMS [9P41GM103311]; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/J009725/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/T26542/01, EP/I500200/1, EP/G026688/1, EP/D023343/1, EP/D023335/1, EP/E000614/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; BBSRC [BB/E004350/1, BB/J009725/1] Funding Source: UKRI; EPSRC [EP/G026688/1, EP/E000614/1, EP/I500200/1] Funding Source: UKRI	Colorado State University; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Plasmids were obtained from Colorado State University tuberculosis research contract HHSN266200400091c. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health, NIGMS, Grant 9P41GM103311). Protein structures were analyzed in PyMOL (38).	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CS, 2011, J AM CHEM SOC, V133, P13232, DOI 10.1021/ja204249p; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bentley-Hibbert SI, 1999, INFECT IMMUN, V67, P581, DOI 10.1128/IAI.67.2.581-588.1999; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Brand S, 2003, ARCH MICROBIOL, V180, P33, DOI 10.1007/s00203-003-0556-1; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; D'Souza FW, 2000, J AM CHEM SOC, V122, P1251, DOI 10.1021/ja993543l; Daffe M, 2000, TRENDS MICROBIOL, V8, P438, DOI 10.1016/S0966-842X(00)01844-8; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; FUKUI Y, 1965, BIKEN J, V8, P189; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Joe M, 2007, J AM CHEM SOC, V129, P9885, DOI 10.1021/ja072892+; Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0; Kuo CJ, 2012, J BIOL CHEM, V287, P1892, DOI 10.1074/jbc.M111.298687; Lim JH, 1999, INFECT IMMUN, V67, P6187, DOI 10.1128/IAI.67.11.6187-6190.1999; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; McPhie P, 2008, ANAL BIOCHEM, V375, P379, DOI 10.1016/j.ab.2008.01.024; Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, MOL BIOSYST, V5, P945, DOI 10.1039/b902284h; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; TAKAYAMA K, 1979, ANTIMICROB AGENTS CH, V16, P240, DOI 10.1128/AAC.16.2.240; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; World Health Organization, 2013, GLOB TUB CONTR REP 2; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4	51	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25041	25053		10.1074/jbc.M114.581579	http://dx.doi.org/10.1074/jbc.M114.581579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028517	hybrid, Green Published			2022-12-28	WOS:000341985300028
J	Harrington, JM; Nishanova, T; Pena, SR; Hess, M; Scelsi, CL; Widener, J; Hajduk, SL				Harrington, John M.; Nishanova, Tuiumkan; Pena, Savannah Rose; Hess, Matthew; Scelsi, Chris L.; Widener, Justin; Hajduk, Stephen L.			A Retained Secretory Signal Peptide Mediates High Density Lipoprotein (HDL) Assembly and Function of Haptoglobin-related Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; TRYPANOSOME LYTIC FACTOR; RECEPTOR CLASS-B; HIGH-AFFINITY; HUMAN PLASMA; HUMAN SERUM; APOA-I; BINDING; PARAOXONASE-1; HEMOGLOBIN	Haptoglobin-related protein (Hpr) is a component of a minor subspecies of high density lipoproteins (HDL) that function in innate immunity. Here we show that assembly of Hpr into HDL is mediated by its retained N-terminal signal peptide, an unusual feature for a secreted protein and the major difference between Hpr and the soluble acute phase protein haptoglobin (Hp). The 18-amino acid signal peptide is necessary for binding to HDL and interacts directly with the hydrocarbon region of lipids. Utilizing model liposomes, we show that the rate of assembly and steady-state distribution of Hpr in lipid particles is mediated by the physical property of lipid fluidity. Dye release assays reveal that Hpr interacts more rapidly with fluid liposomes. Conversely, steady-state binding assays indicate that more rigid lipid compositions stabilize Hpr association. Lipid association also plays a role in facilitating hemoglobin binding by Hpr. Our data may offer an explanation for the distinct distribution of Hpr among HDL subspecies. Rather than protein-protein interactions mediating localization, direct interaction with phospholipids and sensitivity to lipid fluidity may be sufficient for localization of Hpr and may represent a mechanism of HDL subspeciation.	[Harrington, John M.; Nishanova, Tuiumkan; Pena, Savannah Rose; Hess, Matthew; Scelsi, Chris L.; Widener, Justin; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, 120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI039033]; National Institutes of Health National Research Service Award (NRSA); T32 training grant through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039033 (to S. L. H.).; Supported by a National Institutes of Health National Research Service Award (NRSA) and a T32 training grant through the NIAID.	Ahnstrom J, 2010, PROTEIN PEPTIDE LETT, V17, P1285, DOI 10.2174/092986610792231410; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; Deakin S, 2002, J BIOL CHEM, V277, P4301, DOI 10.1074/jbc.M107440200; Deakin SP, 2011, FREE RADICAL BIO MED, V50, P102, DOI 10.1016/j.freeradbiomed.2010.09.002; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Guha M, 2008, BIOCHEMISTRY-US, V47, P11393, DOI 10.1021/bi8014746; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2008, BIOCHEM J, V413, P305, DOI 10.1042/BJ20071357; Harrington JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044384; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; Harrington JM, 2009, J BIOL CHEM, V284, P13505, DOI 10.1074/jbc.M900151200; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; HWANG PK, 1979, J BIOL CHEM, V254, P2265; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; James RW, 2010, ARTERIOSCL THROM VAS, V30, P2121, DOI 10.1161/ATVBAHA.110.209122; Jiang ZHG, 2006, BIOCHEMISTRY-US, V45, P11799, DOI 10.1021/bi060600w; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; MCEVOY SM, 1988, J BIOL CHEM, V263, P15740; NAGEL RL, 1967, J BIOL CHEM, V242, P3428; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; POWNALL HJ, 1974, BIOCHEM BIOPH RES CO, V60, P779, DOI 10.1016/0006-291X(74)90308-8; Raper J, 1999, INFECT IMMUN, V67, P1910; Rosenblat M, 2006, ATHEROSCLEROSIS, V187, P74, DOI 10.1016/j.athersclerosis.2005.08.026; Shanthalingam S, 2009, P NATL ACAD SCI USA, V106, P15448, DOI 10.1073/pnas.0906775106; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Svetlovics JA, 2012, BIOPHYS J, V102, P2526, DOI 10.1016/j.bpj.2012.04.017; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wang LB, 2014, J LIPID RES, V55, P478, DOI 10.1194/jlr.M044743; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	39	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24811	24820		10.1074/jbc.M114.567578	http://dx.doi.org/10.1074/jbc.M114.567578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037218	hybrid, Green Published			2022-12-28	WOS:000341985300008
J	Shetty, SP; Shah, R; Copeland, PR				Shetty, Sumangala P.; Shah, Ravi; Copeland, Paul R.			Regulation of Selenocysteine Incorporation into the Selenium Transport Protein, Selenoprotein P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; AMINOACYL-TRANSFER RNA; RAT PLASMA; GLUTATHIONE-PEROXIDASE; TRANSLATION TERMINATION; ELONGATION-FACTOR; DIETARY SELENIUM; BINDING PROTEIN; MESSENGER-RNAS; UGA CODONS	Selenoproteins are unique as they contain selenium in their active site in the form of the 21st amino acid selenocysteine (Sec), which is encoded by an in-frame UGA stop codon. Sec incorporation requires both cis- and trans-acting factors, which are known to be sufficient for Sec incorporation in vitro, albeit with low efficiency. However, the abundance of the naturally occurring selenoprotein that contains 10 Sec residues (SEPP1) suggests that processive and efficient Sec incorporation occurs in vivo. Here, we set out to study native SEPP1 synthesis in vitro to identify factors that regulate processivity and efficiency. Deletion analysis of the long and conserved 3'-UTR has revealed that the incorporation of multiple Sec residues is inherently processive requiring only the SECIS elements but surprisingly responsive to the selenium concentration. We provide evidence that processive Sec incorporation is linked to selenium utilization and that reconstitution of known Sec incorporation factors in a wheat germ lysate does not permit multiple Sec incorporation events, thus suggesting a role for yet unidentified mammalian-specific processes or factors. The relationship between our findings and the channeling theory of translational efficiency is discussed.	[Shetty, Sumangala P.; Shah, Ravi; Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	paul.copeland@rutgers.edu	Shetty, Sumangala/T-9505-2017	Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [GM077073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM077073 (to P. R. C.)	BARANOV VI, 1993, METHOD ENZYMOL, V217, P123; Bellinger FP, 2008, J ALZHEIMERS DIS, V15, P465; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Bubenik JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062102; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; BURK RF, 1991, FASEB J, V5, P2274, DOI 10.1096/fasebj.5.9.1830557; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Cheng WH, 1997, J NUTR, V127, P675, DOI 10.1093/jn/127.5.675; Chittum HS, 1996, ARCH BIOCHEM BIOPHYS, V325, P124, DOI 10.1006/abbi.1996.0015; CHRISTENSEN MJ, 1995, J NUTR BIOCHEM, V6, P367, DOI 10.1016/0955-2863(95)80004-V; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; DEAGEN JT, 1993, ANAL BIOCHEM, V208, P176, DOI 10.1006/abio.1993.1025; Dewing AST, 2012, RNA BIOL, V9, P1361, DOI 10.4161/rna.22290; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Gonzalez-Flores JN, 2012, J BIOL CHEM, V287, P38936, DOI 10.1074/jbc.M112.415463; Gupta M, 2007, J BIOL CHEM, V282, P36797, DOI 10.1074/jbc.M707061200; Gupta N, 2013, J MOL BIOL, V425, P2415, DOI 10.1016/j.jmb.2013.04.016; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; HILL KE, 1991, J BIOL CHEM, V266, P10050; Himeno S, 1996, J BIOL CHEM, V271, P15769, DOI 10.1074/jbc.271.26.15769; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Kurokawa S., 2014, FREE RADIC BIOL MED; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Maiti B, 2009, HUM MUTAT, V30, P411, DOI 10.1002/humu.20879; Martin GW, 1996, RNA, V2, P171; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Meplan C, 2009, ANTIOXID REDOX SIGN, V11, P2631, DOI [10.1089/ars.2009.2533, 10.1089/ARS.2009.2533]; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Mostert V, 1998, ARCH BIOCHEM BIOPHYS, V357, P326, DOI 10.1006/abbi.1998.0809; MOTCHNIK PA, 1989, BIOCHIM BIOPHYS ACTA, V993, P27, DOI 10.1016/0304-4165(89)90138-4; MOTCHNIK PA, 1990, J INORG BIOCHEM, V40, P265, DOI 10.1016/0162-0134(90)80060-B; MOTSENBOCKER MA, 1984, J NUTR, V114, P279, DOI 10.1093/jn/114.2.279; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; READ R, 1990, J BIOL CHEM, V265, P17899; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; Turanov AA, 2013, NUCLEIC ACIDS RES, V41, P6952, DOI 10.1093/nar/gkt409; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; YANG JG, 1987, J BIOL CHEM, V262, P13372; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010	55	35	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25317	25326		10.1074/jbc.M114.590430	http://dx.doi.org/10.1074/jbc.M114.590430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063811	hybrid, Green Published			2022-12-28	WOS:000341985300050
J	Golubkov, VS; Prigozhina, NL; Zhang, Y; Stoletov, K; Lewis, JD; Schwartz, PE; Hoffman, RM; Strongin, AY				Golubkov, Vladislav S.; Prigozhina, Natalie L.; Zhang, Yong; Stoletov, Konstantin; Lewis, John D.; Schwartz, Phillip E.; Hoffman, Robert M.; Strongin, Alex Y.			Protein-tyrosine Pseudokinase 7 (PTK7) Directs Cancer Cell Motility and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Polarity; Matrix Metalloproteinase (MMP); Metastasis; Migration; Protein Kinase	TYPE-1 MATRIX-METALLOPROTEINASE; OFF-TRACK; EXTRACELLULAR-MATRIX; KINASE FAMILY; LEADING-EDGE; LUNG-CANCER; MEMBRANE; RECEPTOR; POLARITY; MT1-MMP	Background: In embryonic development, PTK7 regulates orientation of cells in a tissue plane. Results: PTK7 controls cellular protrusions and, as a result, directional cell motility and metastasis in fibrosarcoma HT1080 cells. Conclusion: Both PTK7 expression and proteolysis contribute to efficient cell motility and metastasis. Significance: PTK7 is a potential diagnostic biomarker with predictive value and a promising drug target in cancer. It is well established that widely expressed PTK7 is essential for vertebrate tissue morphogenesis. In cancer, the functionality of PTK7 is selectively regulated by membrane type-1 matrix metalloproteinase (MT1-MMP), ADAMs (a disintegrin domain and metalloproteinases), and -secretase proteolysis. Here, we established that the full-length membrane PTK7, its Chuzhoi mutant with the two functional MT1-MMP cleavage sites, and its L622D mutant with the single inactivated MT1-MMP cleavage site differentially regulate cell motility in a two-dimensional versus three-dimensional environment. We also demonstrated that in polarized cancer cells, the levels of PTK7 expression and proteolysis were directly linked to the structure and kinetics of cell protrusions, including lamellipodia and invadopodia. In the functionally relevant and widely accepted animal models of metastasis, mouse and chick embryo models, both the overexpression and knock-out of PTK7 in HT1080 cells abrogated metastatic dissemination. Our analysis of human tissue specimens confirmed intensive proteolysis of PTK7 in colorectal cancer tumors, but not in matching normal tissue. Our results provide convincing evidence that both PTK7 expression and proteolysis, rather than the level of the cellular full-length PTK7 alone, contribute to efficient directional cell motility and metastasis in cancer.	[Golubkov, Vladislav S.; Prigozhina, Natalie L.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Stoletov, Konstantin; Lewis, John D.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2E1, Canada; [Schwartz, Phillip E.] Prot Biotechnol Inc, Ramona, CA 92065 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	Sanford Burnham Prebys Medical Discovery Institute; Anti Cancer Inc; University of Alberta; University of California System; University of California San Diego	Golubkov, VS (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	vgolubkov@sanfordburnham.org; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Stoletov, Konstantin/0000-0002-7384-2917	National Institutes of Health Grants [R01CA83017, R01CA157328, R01DE022757, R03DA033979]; Alberta Innovates [201201250] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA083017, R01CA157328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033979] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Innovates; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA83017, R01CA157328, and R01DE022757 (to A. Y. S.) and R03DA033979 (to V. S. G.).	Andreeva A., 2014, DEV CELL; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baudrier-Regnier A, 2000, CANCER GENET CYTOGEN, V119, P80, DOI 10.1016/S0165-4608(99)00215-0; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fazilaty H, 2014, CLIN EXP METASTAS, V31, P595, DOI 10.1007/s10585-014-9642-9; Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472; Golubkov VS, 2012, J BIOL CHEM, V287, P42009, DOI 10.1074/jbc.M112.371153; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kim JH, 2014, ONCOL REP, V31, P2708, DOI 10.3892/or.2014.3164; Kimura H, 2010, J CELL BIOCHEM, V109, P58, DOI 10.1002/jcb.22379; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Liu YS, 2014, MOL CELL PROTEOMICS, V13, P1753, DOI 10.1074/mcp.M114.038273; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martin KH, 2012, JOVE-J VIS EXP, DOI 10.3791/4119; Monteiro P, 2013, J CELL BIOL, V203, P1063, DOI 10.1083/jcb.201306162; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Munoz-Soriano V, 2012, CURR GENOMICS, V13, P609, DOI 10.2174/138920212803759721; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Piao Z, 2001, GENE CHROMOSOME CANC, V30, P113, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1069>3.3.CO;2-Y; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Shin WS, 2013, CANCER SCI, V104, P1120, DOI 10.1111/cas.12194; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Su YA, 2010, J CANCER, V1, P38; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	59	43	44	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24238	24249		10.1074/jbc.M114.574459	http://dx.doi.org/10.1074/jbc.M114.574459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006253	Green Published, hybrid			2022-12-28	WOS:000341505600021
J	Mao, HZ; Ehrhardt, N; Bedoya, C; Gomez, JA; DeZwaan-McCabe, D; Mungrue, IN; Kaufman, RJ; Rutkowski, DT; Peterfy, M				Mao, Hui Z.; Ehrhardt, Nicole; Bedoya, Candy; Gomez, Javier A.; DeZwaan-McCabe, Diane; Mungrue, Imran N.; Kaufman, Randal J.; Rutkowski, D. Thomas; Peterfy, Miklos			Lipase Maturation Factor 1 (Lmf1) Is Induced by Endoplasmic Reticulum Stress Through Activating Transcription Factor 6 alpha (Atf6 alpha) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chaperone; Endoplasmic Reticulum (ER); Endoplasmic Reticulum Stress (ER Stress); Lipase; Unfolded Protein Response (UPR); Activating Transcription Factor 6; Lipase Maturation Factor 1	UNFOLDED PROTEIN RESPONSE; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; HEPATIC LIPOGENESIS; CELL-DEATH; EXPRESSION; DEFICIENCY; INDUCTION; SECRETION; GENES	Background: Lipase maturation factor 1 (Lmf1) plays an important role in plasma lipid metabolism, but its regulation remains uncharacterized. Results: Endoplasmic reticulum (ER) stress induces Lmf1 expression in cell lines and mouse liver. Atf6 deficiency abolishes, whereas active Atf6 stimulates this response. Conclusion: Lmf1 is an unfolded protein response (UPR) target through Atf6 signaling. Significance: Lmf1 regulation by the UPR suggests a possible role in ER homeostasis. Lipase maturation factor 1 (Lmf1) is a critical determinant of plasma lipid metabolism, as demonstrated by severe hypertriglyceridemia associated with its mutations in mice and human subjects. Lmf1 is a chaperone localized to the endoplasmic reticulum (ER) and required for the post-translational maturation and activation of several vascular lipases. Despite its importance in plasma lipid homeostasis, the regulation of Lmf1 remains unexplored. We report here that Lmf1 expression is induced by ER stress in various cell lines and in tunicamycin (TM)-injected mice. Using genetic deficiencies in mouse embryonic fibroblasts and mouse liver, we identified the Atf6 arm of the unfolded protein response as being responsible for the up-regulation of Lmf1 in ER stress. Experiments with luciferase reporter constructs indicated that ER stress activates the Lmf1 promoter through a GC-rich DNA sequence 264 bp upstream of the transcriptional start site. We demonstrated that Atf6 is sufficient to induce the Lmf1 promoter in the absence of ER stress, and this effect is mediated by the TM-responsive cis-regulatory element. Conversely, Atf6 deficiency induced by genetic ablation or a dominant-negative form of Atf6 abolished TM stimulation of the Lmf1 promoter. In conclusion, our results indicate that Lmf1 is an unfolded protein response target gene, and Atf6 signaling is sufficient and necessary for activation of the Lmf1 promoter. Importantly, the induction of Lmf1 by ER stress appears to be a general phenomenon not restricted to lipase-expressing cells, which suggests a lipase-independent cellular role for this protein in ER homeostasis.	[Mao, Hui Z.; Ehrhardt, Nicole; Peterfy, Miklos] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Bedoya, Candy; Peterfy, Miklos] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Gomez, Javier A.; DeZwaan-McCabe, Diane; Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Gomez, Javier A.; DeZwaan-McCabe, Diane; Rutkowski, D. Thomas] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Mungrue, Imran N.] Louisiana State Univ, Sch Med, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Kaufman, Randal J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Peterfy, Miklos] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Iowa; University of Iowa; Louisiana State University System; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Peterfy, M (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,D-2067, Los Angeles, CA 90048 USA.	mpeterfy@ucla.edu		Mungrue, Imran/0000-0002-0870-7161; Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health [HL094709, DK084058, DK088227, DK042394, HL052173, HL28481]; University of Iowa Cardiovascular Center Institutional Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL052173, K99HL094709, R00HL094709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R01DK088227, R01DK084058, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Cardiovascular Center Institutional Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL094709 (to I. N. M.), DK084058 (to D. T. R.), DK088227, DK042394, HL052173 (to R. J. K.), and HL28481 (to M. P.) and a University of Iowa Cardiovascular Center Institutional Training Grant (to D. D.-M.)	Abdelrahim M, 2005, J BIOL CHEM, V280, P16508, DOI 10.1074/jbc.C500030200; Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P256, DOI 10.3389/fgene.2013.00256; Arensdorf Angela M., 2013, Frontiers in Genetics, V4, P188, DOI 10.3389/fgene.2013.00188; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Ben-Zeev O, 2004, J BIOL CHEM, V279, P6171, DOI 10.1074/jbc.M310051200; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Ben-Zeev O, 2011, J LIPID RES, V52, P1162, DOI 10.1194/jlr.M011155; BENZEEV O, 1992, J BIOL CHEM, V267, P6219; Briquet-Laugier V, 1999, J LIPID RES, V40, P2044; Cefalu AB, 2009, J CLIN ENDOCR METAB, V94, P4584, DOI 10.1210/jc.2009-0594; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; Doolittle MH, 2010, CURR OPIN LIPIDOL, V21, P198, DOI 10.1097/MOL.0b013e32833854c0; Doolittle MH, 2010, CLIN LIPIDOL, V5, P117, DOI 10.2217/CLP.09.84; Doolittle MH, 2009, J BIOL CHEM, V284, P33623, DOI 10.1074/jbc.M109.049395; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hosseini M, 2012, ARTERIOSCL THROM VAS, V32, P1204, DOI 10.1161/ATVBAHA.112.245696; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Peterfy M, 2012, BBA-MOL CELL BIOL L, V1821, P790, DOI 10.1016/j.bbalip.2011.10.006; Racek T, 2008, J BIOL CHEM, V283, P34305, DOI 10.1074/jbc.M803925200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Wang SY, 2014, CURR OPIN LIPIDOL, V25, P125, DOI 10.1097/MOL.0000000000000056; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	10	10	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24417	24427		10.1074/jbc.M114.588764	http://dx.doi.org/10.1074/jbc.M114.588764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035425	Green Published, hybrid			2022-12-28	WOS:000341505600035
J	Ohara, K; Unno, H; Oshima, Y; Hosoya, M; Fujino, N; Hirooka, K; Takahashi, S; Yamashita, S; Kusunoki, M; Nakayama, T				Ohara, Kazuhiro; Unno, Hideaki; Oshima, Yasuhiro; Hosoya, Miho; Fujino, Naoto; Hirooka, Kazutake; Takahashi, Seiji; Yamashita, Satoshi; Kusunoki, Masami; Nakayama, Toru			Structural Insights into the Low pH Adaptation of a Unique Carboxylesterase from Ferroplasma ALTERING THE pH OPTIMA OF TWO CARBOXYLESTERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Carboxylesterase; Enzyme Mechanism; Enzyme Structure; Hydrolase; Ferroplasma acidiphilum; pH Adaptation; Serine Hydrolase	HORMONE-SENSITIVE LIPASE; CRYSTAL-STRUCTURE; ENZYMES; ACIDIPHILUM; ESTERASE; ARCHAEON; TOOLS	Background: Carboxylesterases typically have an alkaline pH optima, which limits their industrial application. Results: An acidophilic carboxylesterase was crystallized and changed into an alkaliphilic enzyme via quadruple mutations. Conclusion: The extended hydrogen bonds in the active site were important for adaptation to a low pH. Significance: The first structure of an acidophilic carboxylesterase revealed a novel strategy for the low pH adaptation of carboxylesterase. To investigate the mechanism for low pH adaptation by a carboxylesterase, structural and biochemical analyses of EstFa_R (a recombinant, slightly acidophilic carboxylesterase from Ferroplasma acidiphilum) and SshEstI (an alkaliphilic carboxylesterase from Sulfolobus shibatae DSM5389) were performed. Although a previous proteomics study by another group showed that the enzyme purified from F. acidiphilum contained an iron atom, EstFa_R did not bind to iron as analyzed by inductively coupled plasma MS and isothermal titration calorimetry. The crystal structures of EstFa_R and SshEstI were determined at 1.6- and 1.5- resolutions, respectively. EstFa_R had a catalytic triad with an extended hydrogen bond network that was not observed in SshEstI. Quadruple mutants of both proteins were created to remove or introduce the extended hydrogen bond network. The mutation on EstFa_R enhanced its catalytic efficiency and gave it an alkaline pH optimum, whereas the mutation on SshEstI resulted in opposite effects (i.e. a decrease in the catalytic efficiency and a downward shift in the optimum pH). Our experimental results suggest that the low pH optimum of EstFa_R activity was a result of the unique extended hydrogen bond network in the catalytic triad and the highly negatively charged surface around the active site. The change in the pH optimum of EstFa_R happened simultaneously with a change in the catalytic efficiency, suggesting that the local flexibility of the active site in EstFa_R could be modified by quadruple mutation. These observations may provide a novel strategy to elucidate the low pH adaptation of serine hydrolases.	[Takahashi, Seiji; Yamashita, Satoshi; Nakayama, Toru] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan; [Kusunoki, Masami] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi 4008511, Japan	Tohoku University; Nagasaki University; University of Yamanashi	Yamashita, S (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aobayama 6-6-11, Sendai, Miyagi 9808579, Japan.	satoshi0207@gmail.com	Hideaki, UNNO/ABG-9471-2020; Takahashi, Seiji/AAE-1509-2019; Hirooka, Kazutake/K-9827-2017	Hideaki, UNNO/0000-0001-5917-269X; Takahashi, Seiji/0000-0002-2288-4340; Hirooka, Kazutake/0000-0001-5879-936X				Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DeLano W.L, PYMOL MOL GRAPHICS S; Ejima K, 2004, J BIOSCI BIOENG, V98, P445, DOI 10.1263/jbb.98.445; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2008, P NATL ACAD SCI USA, V105, P8878, DOI 10.1073/pnas.0800071105; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Golyshina OV, 2006, ENVIRON MICROBIOL, V8, P416, DOI 10.1111/j.1462-2920.2005.00907.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; LEATHERBARROW RJ, 1990, TRENDS BIOCHEM SCI, V15, P455, DOI 10.1016/0968-0004(90)90295-M; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Mandrich L, 2008, PROTEINS, V71, P1721, DOI 10.1002/prot.21877; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oda K, 2012, J BIOCHEM, V151, P13, DOI 10.1093/jb/mvr129; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; ZHONG S, 1995, J AM CHEM SOC, V117, P7048, DOI 10.1021/ja00132a002	25	22	22	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24499	24510		10.1074/jbc.M113.521856	http://dx.doi.org/10.1074/jbc.M113.521856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25043762	Green Published, hybrid			2022-12-28	WOS:000341505600042
J	Zhang, PP; Wang, XL; Zhao, W; Qi, B; Yang, Q; Wan, HY; Shuang, ZY; Liu, M; Li, X; Li, SP; Tang, H				Zhang, Pei-Pei; Wang, Xiang-ling; Zhao, Wei; Qi, Bing; Yang, Qian; Wan, Hai-Ying; Shuang, Ze-yu; Liu, Min; Li, Xin; Li, Shengping; Tang, Hua			DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Epigenetics; Epithelial-Mesenchymal Transition (EMT); Hepatocellular Carcinoma; Invasion; Migration; Proliferation; KDM6B; miR-941; miRNAs	EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE H3K27 DEMETHYLASES; HUMAN CANCER-CELLS; HEPATOCELLULAR-CARCINOMA; JMJD3 CONTRIBUTES; TUMOR-SUPPRESSOR; DOWN-REGULATION; MICRORNA; GENE; METASTASIS	Background: Recent research has uncovered tumor suppressive and oncogenic potential of miRNAs. Results: miR-941 expression is regulated by DNA methylation, and is an important regulator of cell proliferation, migration, and invasion by directly targeting KDM6B in hepatocellular carcinoma (HCC). Conclusion: miR-941 may play an important role in suppressing tumor growth and metastasis in HCC. Significance: miR-941 may provide a potential biomarker for the diagnosis and treatment of HCC. MicroRNAs (miRNAs) have been shown to play important roles in carcinogenesis. However, their underlying mechanisms of action in hepatocellular carcinoma (HCC) are poorly understood. Recent evidence suggests that epigenetic silencing of miRNAs through tumor suppression by CpG island hypermethylation may be a common hallmark of human tumors. Here, we demonstrated that miR-941 was significantly down-regulated in HCC tissues and cell lines and was generally hypermethylated in HCC. The overexpression of miR-941 suppressed in vitro cell proliferation, migration, and invasion and inhibited the metastasis of HCC cells in vivo. Furthermore, the histone demethylase KDM6B (lysine (K)-specific demethylase 6B) was identified as a direct target of miR-941 and was negatively regulated by miR-941. The ectopic expression of KDM6B abrogated the phenotypic changes induced by miR-941 in HCC cells. We demonstrated that miR-941 and KDM6B regulated the epithelial-mesenchymal transition process and affected cell migratory/invasive properties.	[Zhang, Pei-Pei; Wang, Xiang-ling; Qi, Bing; Yang, Qian; Wan, Hai-Ying; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Zhang, Pei-Pei; Wang, Xiang-ling; Qi, Bing; Yang, Qian; Wan, Hai-Ying; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin 300070, Peoples R China; [Zhao, Wei] Tianjin Med Univ, Metab Dis Hosp, Minist Hlth, Dept Obes & Metab,Key Lab Hormones & Dev, Tianjin 300070, Peoples R China; [Zhao, Wei] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin 300070, Peoples R China; [Shuang, Ze-yu; Li, Shengping] Sun Yat Sen Univ, Dept Hepatobiliary Oncol, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510060, Guangdong, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Li, SP (corresponding author), 651 Dong Feng Rd East, Guangzhou 510060, Guangdong, Peoples R China.	lishp@sysucc.org.cn; htang2002@yahoo.com			National Natural Science Foundation of China [31270818, 91029714, 31071191]; Natural Science Foundation of Tianjin [12JCZDJC25100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China Grants 31270818, 91029714, and 31071191 and Natural Science Foundation of Tianjin Grant 12JCZDJC25100.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Anderton JA, 2011, ONCOGENE, V30, P2037, DOI 10.1038/onc.2010.579; Aran D, 2013, CELL, V154, P11, DOI 10.1016/j.cell.2013.06.018; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Diaz-Martin J, 2014, J PATHOL, V232, P319, DOI 10.1002/path.4289; Ding XM, 2014, CHIN J CANCER, V33, P140, DOI 10.5732/cjc.013.10094; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Goeppert B, 2010, HEPATOLOGY, V52, P2023, DOI 10.1002/hep.23939; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Han L, 2007, CANCER BIOL THER, V6, P1284; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hou YY, 2011, CANCER LETT, V307, P182, DOI 10.1016/j.canlet.2011.04.002; Ichi S, 2010, J BIOL CHEM, V285, P36922, DOI 10.1074/jbc.M110.126714; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kroepil F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046665; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; McLaughlin-Drubin ME, 2011, P NATL ACAD SCI USA, V108, P2130, DOI 10.1073/pnas.1009933108; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saito Y, 2014, HEPATOL RES, V44, P31, DOI 10.1111/hepr.12147; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shen YQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-470; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Watts GS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-47; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Zhang J. P., 2013, ONCOGENE, V33, P4069; Zhang JF, 2011, HEPATOLOGY, V54, P2137, DOI 10.1002/hep.24595; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506	49	35	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24724	24735		10.1074/jbc.M114.567818	http://dx.doi.org/10.1074/jbc.M114.567818			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25049231	hybrid, Green Published			2022-12-28	WOS:000341505600061
J	Lee, KM; Yang, SJ; Choi, JH; Park, CS				Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung			Functional Effects of a Pathogenic Mutation in Cereblon (CRBN) on the Regulation of Protein Synthesis via the AMPK-mTOR Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Gene Knockout; Mammalian Target of Rapamycin (mTOR); Protein Synthesis; Signal Transduction; Cereblon; Mental Deficit; Nonsense Mutation	TERM SYNAPTIC PLASTICITY; MAMMALIAN TARGET; TRANSLATIONAL CONTROL; DEPENDENT TRANSLATION; TUBEROUS-SCLEROSIS; MENTAL-RETARDATION; RAPAMYCIN PATHWAY; MEMORY FORMATION; CELLULAR-ENERGY; KINASE	Background: Deficiency or nonsense mutation of CRBN causes memory deficits. Results: Truncated CRBN has insufficient affinity for AMPK and cannot modulate the AMPK-mTOR pathway. Conclusion: CRBN modulates protein synthesis through the AMPK-mTOR pathway, and may be critical for certain forms of memory encoding. Significance: Our findings suggest the first plausible mechanism for the phenotype resulting from the CRBN mutation. Initially identified as a protein implicated in human mental deficit, cereblon (CRBN) was recently recognized as a negative regulator of adenosine monophosphate-activated protein kinase (AMPK) in vivo and in vitro. Here, we present results showing that CRBN can effectively regulate new protein synthesis through the mammalian target of rapamycin (mTOR) signaling pathway, a downstream target of AMPK. Whereas deficiency of Crbn repressed protein translation via activation of the AMPK-mTOR cascade in Crbn-knock-out mice, ectopic expression of the wild-type CRBN increased protein synthesis by inhibiting endogenous AMPK. Unlike the wild-type CRBN, a mutant CRBN found in human patients, which lacks the last 24 amino acids, failed to rescue mTOR-dependent repression of protein synthesis in Crbn-deficient mouse fibroblasts. These results provide the first evidence that Crbn can activate the protein synthesis machinery through the mTOR signaling pathway by inhibiting AMPK. In light of the fact that protein synthesis regulated by mTOR is essential for various forms of synaptic plasticity that underlie the cognitive functions of the brain, the results of this study suggest a plausible mechanism for CRBN involvement in higher brain function in humans, and they may help explain how a specific mutation in CRBN can affect the cognitive ability of patients.	[Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Lee, Kwang Min; Yang, Seung-Joo; Choi, Ja-Hyun; Park, Chul-Seung] Gwangju Inst Sci & Technol GIST, Natl Leading Res Lab, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Park, CS (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Cell Dynam Res Ctr, Kwangju 500712, South Korea.	cspark@gist.ac.kr		Park, Chul-Seung/0000-0003-0209-1412	Ministry for Health and Welfare [HI13C1412]; National Leading Research Laboratories [2011-0028665]; Ministry of Science, ICT & Future Planning/National Research Foundation of Korea [2007-0056157]	Ministry for Health and Welfare; National Leading Research Laboratories; Ministry of Science, ICT & Future Planning/National Research Foundation of Korea	This work was supported by grants for the Korea Healthcare Technology Research and Development Project (HI13C1412), Ministry for Health and Welfare, the National Leading Research Laboratories (2011-0028665), and the Science Research Center of Excellence Program (2007-0056157) of Ministry of Science, ICT & Future Planning/National Research Foundation of Korea (to C. S. P.).	Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Grimes WN, 2009, NAT NEUROSCI, V12, P585, DOI 10.1038/nn.2302; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Rajadhyaksha AM, 2012, BEHAV BRAIN RES, V226, P428, DOI 10.1016/j.bbr.2011.09.039; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; STANTON PK, 1984, J NEUROSCI, V4, P3080; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081	37	20	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23343	23352		10.1074/jbc.M113.523423	http://dx.doi.org/10.1074/jbc.M113.523423			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993823	hybrid, Green Published			2022-12-28	WOS:000341505000010
J	Vajjhala, PR; Kaiser, S; Smith, SJ; Ong, QR; Soh, SL; Stacey, KJ; Hill, JM				Vajjhala, Parimala R.; Kaiser, Sebastian; Smith, Sarah J.; Ong, Qi-Rui; Soh, Stephanie L.; Stacey, Katryn J.; Hill, Justine M.			Identification of Multifaceted Binding Modes for Pyrin and ASC Pyrin Domains Gives Insights into Pyrin Inflammasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Death Domain; Inflammation; Innate Immunity; Mutagenesis; Pattern Recognition Receptor (PRR); Protein Complex; Protein-Protein Interaction; Familial Mediterranean Fever; Inflammasome; Pyrin	FAMILIAL MEDITERRANEAN FEVER; CIRCULAR-DICHROISM; AUTOINFLAMMATORY DISORDER; CRYSTAL-STRUCTURE; PROTEIN DOMAIN; APOPTOSIS; NMR; MUTATIONS; DISEASES; COMPLEX	Background: Pyrin, ASC, and procaspase-1 associate to form an inflammasome that mediates inflammatory responses. Results: Multiple binding sites on the pyrin domains of ASC and pyrin mediate their interaction. Conclusion: Interaction between pyrin and ASC via multiple sites drives ASC clustering to form an inflammasome. Significance: These findings provide insight into the interaction modes of pyrin domains and inflammasome assembly. Inflammasomes are macromolecular complexes that mediate inflammatory and cell death responses to pathogens and cellular stress signals. Dysregulated inflammasome activation is associated with autoinflammatory syndromes and several common diseases. During inflammasome assembly, oligomerized cytosolic pattern recognition receptors recruit procaspase-1 and procaspase-8 via the adaptor protein ASC. Inflammasome assembly is mediated by pyrin domains (PYDs) and caspase recruitment domains, which are protein interaction domains of the death fold superfamily. However, the molecular details of their interactions are poorly understood. We have studied the interaction between ASC and pyrin PYDs that mediates ASC recruitment to the pyrin inflammasome, which is implicated in the pathogenesis of familial Mediterranean fever. We demonstrate that both the ASC and pyrin PYDs have multifaceted binding modes, involving three sites on pyrin PYD and two sites on ASC PYD. Molecular docking of pyrin-ASC PYD complexes showed that pyrin PYD can simultaneously interact with up to three ASC PYDs. Furthermore, ASC PYD can self-associate and interact with pyrin, consistent with previous reports that pyrin promotes ASC clustering to form a proinflammatory complex. Finally, the effects of familial Mediterranean fever-associated mutations, R42W and A89T, on structural and functional properties of pyrin PYD were investigated. The R42W mutation had a significant effect on structure and increased stability. Although the R42W mutant exhibited reduced interaction with ASC, it also bound less to the pyrin B-box domain responsible for autoinhibition and hence may be constitutively active. Our data give new insights into the binding modes of PYDs and inflammasome architecture.	[Vajjhala, Parimala R.; Kaiser, Sebastian; Smith, Sarah J.; Ong, Qi-Rui; Soh, Stephanie L.; Stacey, Katryn J.; Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Vajjhala, PR (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	p.vajjhala@uq.edu.au	Hill, Justine M/C-5781-2009	Stacey, Katryn/0000-0002-3992-7802	Australian National Health and Medical Research Council [511227]; R. D. Wright Biomedical Career Development Award [401748]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); R. D. Wright Biomedical Career Development Award	This work was supported by the Australian National Health and Medical Research Council through Project Grant 511227 and R. D. Wright Biomedical Career Development Award 401748 (to J. M. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 1997, CELL, V90, P797; ARNOLD GE, 1992, BIOCHEMISTRY-US, V31, P7948, DOI 10.1021/bi00149a028; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Ben-Chetrit E, 2009, ARTHRIT CARE RES, V61, P1447, DOI 10.1002/art.24458; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; de Jesus AA, 2013, CLIN IMMUNOL, V147, P155, DOI 10.1016/j.clim.2013.03.016; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Eliezer D, 2003, STRUCTURE, V11, P1190, DOI 10.1016/j.str.2003.09.008; Federici S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00351; French FMF Consortium, 1997, NAT GENET, V17, P25; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hesker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051105; Hill Justine A., 2008, V426, P437, DOI 10.1007/978-1-60327-058-8_29; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Masters SL, 2013, CLIN IMMUNOL, V147, P223, DOI 10.1016/j.clim.2012.12.006; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmid F. X., 1997, PROTEIN STRUCTURE PR, P293; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Su MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067843; Tidow N, 2000, BLOOD, V95, P1451, DOI 10.1182/blood.V95.4.1451.004k52_1451_1455; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2013, J BIOL CHEM, V288, P11378, DOI 10.1074/jbc.M112.448795; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	69	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23504	23519		10.1074/jbc.M114.553305	http://dx.doi.org/10.1074/jbc.M114.553305			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006247	Green Published, hybrid			2022-12-28	WOS:000341505000022
J	Chen, YY; Chuang, PY; Chen, CP; Chiu, YH; Lo, HF; Cheong, ML; Huang, JY; Kuo, PL; Chen, HW				Chen, Yao-Yu; Chuang, Pei-Yun; Chen, Chie-Pein; Chiu, Yueh-Ho; Lo, Hsiao-Fan; Cheong, Mei-Leng; Huang, Jyun-Yuang; Kuo, Pao-Lin; Chen, Hungwen			Functional Antagonism between High Temperature Requirement Protein A (HtrA) Family Members Regulates Trophoblast Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; EXPRESSION; CELLS; ENDOMETRIUM; PROTEOLYSIS; ATTACHMENT; INHIBITOR; PROTEASES; MODEL	Human trophoblast invasion of decidualized endometrium is essential for placentation and is tightly regulated and involves trophoblast-decidual cell interaction. High temperature requirement A4 (HtrA4) is a secreted serine protease highly expressed in the invasive extravillous trophoblasts that invade decidua. In contrast, both HtrA1 and HtrA3 have been shown to inhibit trophoblast invasion. Here we provide evidence that decidua-secreted HtrA1 and HtrA3 antagonize HtrA4-mediated trophoblast invasion. We demonstrated that HtrA1 and HtrA3 interact with and degrade HtrA4 and thereby inhibit trophoblast-like JAR cell invasion. Specifically, HtrA1 and HtrA3 expression is up-regulated under decidualization conditions in endometrial stromal and epithelial cells, T-HESCs and Ishikawa cells, respectively. Conditioned media from these two cell lines after decidualization treatment suppress HtrA4-expressing JAR cell invasion in an HtrA1- or HtrA3-dependent manner. Co-culture of the HtrA4-expressing JAR cells with decidualization stimuli-treated T-HESC or Ishikawa monolayer also impairs JAR cell invasion, which can be reversed by HtrA1 or HtrA3 knockdown, supporting that HtrA1 and HtrA3 are crucial for trophoblast-decidual cell interaction in the control of trophoblast invasion. Our study reveals a novel regulatory mechanism of trophoblast invasion through physical and functional interaction between HtrA family members.	[Chen, Yao-Yu; Chuang, Pei-Yun; Chiu, Yueh-Ho; Lo, Hsiao-Fan; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei 104, Taiwan; [Cheong, Mei-Leng] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei 106, Taiwan; [Huang, Jyun-Yuang; Kuo, Pao-Lin] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 704, Taiwan; [Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	National Taiwan University; Mackay Memorial Hospital; Cathay General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Academia Sinica - Taiwan	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022; CHEN, CHEN/HDM-6657-2022		Ministry of Science and Technology [103-2311-B-001-024]; Academia Sinica, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by grants (to H. C.) from the Ministry of Science and Technology (103-2311-B-001-024) and Academia Sinica, Taiwan.	Ajayi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.046; Benirschke K., 2001, PATHOLOGY HUMAN PLAC, P171; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Gellersen B, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106724; Gonzalez M, 2011, MOL HUM REPROD, V17, P421, DOI 10.1093/molehr/gar015; Inagaki A, 2012, PLACENTA, V33, P919, DOI 10.1016/j.placenta.2012.08.003; Irwin JC, 2001, J CLIN ENDOCR METAB, V86, P2060, DOI 10.1210/jc.86.5.2060; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Nie GY, 2006, DEV DYNAM, V235, P3448, DOI 10.1002/dvdy.20999; Nishida Masato, 2002, Hum Cell, V15, P104, DOI 10.1111/j.1749-0774.2002.tb00105.x; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Uchida H, 2012, J BIOL CHEM, V287, P4441, DOI 10.1074/jbc.M111.286138; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang H, 2013, TISSUE ENG PART C-ME, V19, P676, DOI [10.1089/ten.tec.2012.0616, 10.1089/ten.TEC.2012.0616]; Wang H, 2012, MOL HUM REPROD, V18, P33, DOI 10.1093/molehr/gar064; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	26	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22958	22968		10.1074/jbc.M114.576744	http://dx.doi.org/10.1074/jbc.M114.576744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25002585	Green Published, hybrid			2022-12-28	WOS:000341017200035
J	Joshi, S; Singh, AR; Durden, DL				Joshi, Shweta; Singh, Alok R.; Durden, Donald L.			MDM2 Regulates Hypoxic Hypoxia-inducible Factor 1 alpha Stability in an E3 Ligase, Proteasome, and PTEN-Phosphatidylinositol 3-Kinase-AKT-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INDUCED ANGIOGENESIS; ADVANCED SOLID TUMORS; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; 3-KINASE/AKT PATHWAY; ANTITUMOR-ACTIVITY; FACTOR EXPRESSION; HIF-ALPHA; PHASE-I; HIF-1-ALPHA	Hypoxia-inducible factor 1 (HIF1) is a heterodimeric transcription factor containing an inducibly expressed HIF1 alpha subunit and a constitutively expressed HIF1 beta subunit. Under hypoxic conditions, the HIF1 alpha subunit accumulates because of a decrease in the rate of proteolytic degradation, and the resulting HIF1 alpha-HIF1 beta heterodimers undergo post-translational modifications that promote transactivation. Previous reports suggest that amplified signaling through PI3K enhances HIF1-dependent gene expression; however, its role is controversial, and the mechanism is unclear. Using genetically engineered PTEN-deficient cell lines, we demonstrate that PTEN specifically inhibited the accumulation of HIF1 alpha in response to hypoxia. Furthermore, we report that in glioblastoma cell lines, inhibition of PI3K pathway, using pan as well as isoform-specific PI3K inhibitors SF1126, PF4691502, BEZ-235, GDC0941, and TGX221 blocked the induction of HIF1 alpha protein and its targets vascular endothelial growth factor, HK1, and GLUT1 mRNA in response to hypoxia. Herein, we describe the first evidence that HIF1 alpha can be degraded under hypoxic conditions via the 26 S proteasome and that MDM2 is the E3 ligase that induces the hypoxic degradation of HIF1 alpha. Moreover, the action of MDM2 on HIF1 alpha under hypoxia occurs in the cytoplasm and is controlled by the PTEN-PI3K-AKT signaling axis. These data strongly suggest a new role for PTEN in the regulation of HIF1 alpha and importantly that PI3K-AKT activation is required for the hypoxic stabilization of HIF1 alpha and that hypoxia alone is not sufficient to render HIF1 alpha resistant to proteasomal cleavage and degradation. Moreover, these findings suggest new therapeutic considerations for PI3K and/or AKT inhibitors for cancer therapeutics.	[Joshi, Shweta; Singh, Alok R.; Durden, Donald L.] UC San Diego Hlth Syst, Dept Pediat, Moores Canc Ctr, La Jolla, CA 92093 USA; [Durden, Donald L.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92123 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Durden, DL (corresponding author), UC San Diego Hlth Syst, Dept Pediat, Moores Canc Ctr, La Jolla, CA 92093 USA.	ddurden@ucsd.edu	Joshi, Shweta/D-4711-2015		National Institutes of Health [HL091385, CA94233]; Alex Lemonade Stand Foundation; Hyundai Hope Grant; Cricket corporation; NATIONAL CANCER INSTITUTE [R56CA094233, R01CA094233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex Lemonade Stand Foundation; Hyundai Hope Grant; Cricket corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091385 and CA94233 (to D. L. D.). This work was also supported by the Alex Lemonade Stand Foundation, a Hyundai Hope Grant, and the Cricket corporation (to D. L. D.).	Alvarez-Tejado M, 2002, J BIOL CHEM, V277, P13508, DOI 10.1074/jbc.M200017200; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Ding H, 2001, CANCER RES, V61, P3826; Feldser D, 1999, CANCER RES, V59, P3915; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mahadevan D, 2012, EUR J CANCER, V48, P3319, DOI 10.1016/j.ejca.2012.06.027; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Ravi R, 2000, GENE DEV, V14, P34; Rong Y, 2005, CANCER RES, V65, P1406, DOI 10.1158/0008-5472.CAN-04-3376; Ryan HE, 2000, CANCER RES, V60, P4010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Su JD, 2003, CANCER RES, V63, P3585; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yuan J, 2011, MOL CANCER THER, V10, P2189, DOI 10.1158/1535-7163.MCT-11-0185; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	54	63	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22785	22797		10.1074/jbc.M114.587493	http://dx.doi.org/10.1074/jbc.M114.587493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982421	Green Published, hybrid			2022-12-28	WOS:000341017200023
J	Takagi, M; Nishiyama, Y; Taguchi, A; Imamoto, N				Takagi, Masatoshi; Nishiyama, Yuko; Taguchi, Atsuko; Imamoto, Naoko			Ki67 Antigen Contributes to the Timely Accumulation of Protein Phosphatase 1 gamma on Anaphase Chromosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD-ASSOCIATED DOMAIN; POSITIVE BREAST-CANCER; KI-67 ANTIGEN; CELL-PROLIFERATION; MITOTIC EXIT; ANTIBODY KI-67; CYCLE; CHROMATIN; MITOSIS; AURORA	Ki67 is a protein widely used as cell-proliferation marker, with its cellular functions being hardly unveiled. In this paper, we present the direct interaction between Ki67 and PP1 gamma, a protein phosphatase showing characteristic accumulation on anaphase chromosomes via the canonical PP1-binding motif within Ki67. In cells depleted of Ki67, PP1 gamma is targeted to anaphase chromosomes less efficiently. Additionally, overexpression of Ki67, but not a mutant form without the ability to bind PP1 gamma, induced ectopic localization of PP1 gamma on metaphase chromosomes. These observations demonstrate that Ki67 is one factor that defines the cellular behavior of PP1 gamma in anaphase. To explore the specific roles of the subset of PP1 gamma recruited on chromosome via its interaction with Ki67 (PP1 gamma-Ki67), endogenous Ki67 was replaced with a Ki67 mutant deficient in its ability to interact with PP1 gamma. Although no obvious defects in the progression of mitosis were observed, the timing of dephosphorylation of the mutant Ki67 in anaphase was delayed, indicating that Ki67 itself is one of the substrates of PP1 gamma -Ki67.	[Takagi, Masatoshi; Nishiyama, Yuko; Taguchi, Atsuko; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	RIKEN	Takagi, M (corresponding author), RIKEN, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mtakagi@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science KAKENHI [24657124]; RIKEN Incentive Research Fund	RIKEN Special Project Funding for Basic Science in Cellular System Project Research; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Incentive Research Fund	This work was supported by RIKEN Special Project Funding for Basic Science in Cellular System Project Research (to N.I.), and Japan Society for the Promotion of Science KAKENHI Grant Number 24657124 and RIKEN Incentive Research Fund (to M.T.).	Ali HR, 2012, BRIT J CANCER, V106, P1798, DOI 10.1038/bjc.2012.167; Ali HR, 2012, J PATHOL, V226, P97, DOI 10.1002/path.2976; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bridger JM, 1998, CHROMOSOME RES, V6, P13, DOI 10.1023/A:1009210206855; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chamousset D, 2010, MOL BIOL CELL, V21, P4212, DOI 10.1091/mbc.E10-04-0287; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; GAUTIER T, 1992, CHROMOSOMA, V101, P502, DOI 10.1007/BF00352473; Gerdes J, 1990, Semin Cancer Biol, V1, P199; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gunawardena SR, 2008, J BIOL CHEM, V283, P398, DOI 10.1074/jbc.M706708200; HERNANDEZVERDUN D, 1994, BIOESSAYS, V16, P179, DOI 10.1002/bies.950160308; Kametaka A, 2002, GENES CELLS, V7, P1231, DOI 10.1046/j.1365-2443.2002.00596.x; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kill IR, 1996, J CELL SCI, V109, P1253; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; MacCallum DE, 2000, J PATHOL, V190, P537; MacCallum DE, 1999, EXP CELL RES, V252, P186, DOI 10.1006/excr.1999.4600; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Saiwaki T, 2005, EXP CELL RES, V308, P123, DOI 10.1016/j.yexcr.2005.04.010; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Starborg M, 1996, J CELL SCI, V109, P143; Sueishi M, 2000, J BIOL CHEM, V275, P28888, DOI 10.1074/jbc.M003879200; Takagi M, 1999, J CELL SCI, V112, P2463; Takagi M, 2001, J BIOL CHEM, V276, P25386, DOI 10.1074/jbc.M102227200; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2012, NUCLEUS-AUSTIN, V3, P138, DOI 10.4161/nucl.19267; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871	41	29	31	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22877	22887		10.1074/jbc.M114.556647	http://dx.doi.org/10.1074/jbc.M114.556647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25012651	hybrid, Green Published			2022-12-28	WOS:000341017200029
J	Liu, BT; Wang, TS; Mei, WH; Li, DD; Cai, R; Zuo, Y; Cheng, JK				Liu, Bingting; Wang, Tianshi; Mei, Wenhan; Li, Dongdong; Cai, Rong; Zuo, Yong; Cheng, Jinke			Small Ubiquitin-like Modifier (SUMO) Protein-specific Protease 1 De-SUMOylates Sharp-1 Protein and Controls Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; PPAR-GAMMA; C/EBP-ALPHA; ADIPOGENESIS; EXPRESSION; MYOGENESIS; PATHWAY	Adipocyte differentiation is regulated by a transcriptional cascade that mainly includes CCAAT/enhancer-binding protein family members and the nuclear receptor peroxisome proliferator- activated receptor gamma (PPAR gamma). Here we show the defects in adipocyte differentiation as well as PPAR gamma expression in Senp1(-/-) mouse embryonic fibroblast cells induced by adipogenic stimuli. We further determine that SENP1 is a specific de-SUMOylation protease for Sharp-1, a repressor for PPAR gamma transcription and adipogenesis. SENP1 enhances adipogenesis through de-SUMOylation of Sharp-1, which then releases Sharp-1 repression of PPAR gamma expression and adipocyte differentiation. These results reveal SENP1 as a novel regulator in adipogenesis.	[Liu, Bingting; Wang, Tianshi; Mei, Wenhan; Li, Dongdong; Cai, Rong; Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200030, Peoples R China; [Liu, Bingting; Wang, Tianshi; Zuo, Yong; Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Cell Biol, 280 Chongqing South Rd, Shanghai 200030, Peoples R China.	jkcheng@shsmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB912104, 2012CB910102]; National Natural Science Foundation of China [91019021, 81302296]; Shanghai Jiao Tong University School of Medicine [BXJ201207]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University School of Medicine	This work was supported by National Basic Research Program of China (973 Program) Grants 2010CB912104 (to J. C.) and 2012CB910102 (to Y. Z.), by National Natural Science Foundation of China Grants 91019021 (to J. C.) and 81302296 (to W. M.), and by Doctoral Innovation Fund of the Shanghai Jiao Tong University School of Medicine Grant BXJ201207 (to B. L.).	Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu YF, 2013, STAT INTERFACE, V6, P1; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Scroyen I, 2012, OBESITY, V20, P1168, DOI 10.1038/oby.2011.399; Van Hul M, 2012, CLIN EXP PHARMACOL P, V39, P49, DOI 10.1111/j.1440-1681.2011.05635.x; Vogel G, 2012, RNA BIOL, V9, P1129, DOI 10.4161/rna.21409; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YJ, 2013, J BIOL CHEM, V288, P17654, DOI 10.1074/jbc.M113.463257; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yan X, 2013, INT J OBESITY, V37, P568, DOI 10.1038/ijo.2012.69; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao X, 2013, GENE, V532, P263, DOI 10.1016/j.gene.2013.08.088	24	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22358	22364		10.1074/jbc.M114.571950	http://dx.doi.org/10.1074/jbc.M114.571950			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24942744	Green Published, hybrid			2022-12-28	WOS:000340593500046
J	Kimura, Y; Kawawaki, J; Kakiyama, Y; Shimoda, A; Tanaka, K				Kimura, Yoko; Kawawaki, Junko; Kakiyama, Yukie; Shimoda, Ayumi; Tanaka, Keiji			The ESCRT-III Adaptor Protein Bro1 Controls Functions of Regulator for Free Ubiquitin Chains 1 (Rfu1) in Ubiquitin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOA4 DEUBIQUITINATING ENZYME; MULTIVESICULAR BODY PATHWAY; SACCHAROMYCES-CEREVISIAE; ENDOCYTIC PATHWAY; HIGH-TEMPERATURES; STRUCTURAL BASIS; MVB PATHWAY; IN-VIVO; YEAST; ALIX	Yeast Rfu1 (regulator for free ubiquitin chain 1) localizes to endosomes and plays a role in ubiquitin homeostasis by inhibiting the activity of Doa4. We show that Bro1, a member of the class E vacuolar protein sorting proteins that recruits Doa4 to endosomes and stimulates Doa4 deubiquitinating activity, also recruits Rfu1 to endosomes for involvement in ubiquitin homeostasis. This recruitment was mediated by the direct interaction between a region containing the YPEL motif in Rfu1 and the V domain in Bro1, which could be analogous to the interaction between the mammalian Alix V domain and YPXnL motifs of viral and cellular proteins. Furthermore, overexpression of Bro1, particularly the V domain, prevented Rfu1 degradation in response to heat shock. Thus, Bro1, a Doa4 positive regulator, regulated Rfu1, a negative regulator of Doa4. Rfu1 degradation partly involved the proteasome and a ubiquitin ligase Rsp5, suggesting that Rfu1 stability was regulated by ubiquitin-proteasome pathways.	[Kimura, Yoko; Kawawaki, Junko; Kakiyama, Yukie; Shimoda, Ayumi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1138613, Japan; [Kimura, Yoko] Shizuoka Univ, Grad Sch Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Tokyo Metropolitan Institute of Medical Science; Shizuoka University	Kimura, Y (corresponding author), Shizuoka Univ, Grad Sch Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan.	kimura.yoko@shizuoka.ac.jp	Kimura, Yoko/E-6845-2013	Kimura, Yoko/0000-0002-3054-9753	Takeda Science Foundation; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids for Scientific Research (C) (to Y. K.), Specially Promoted Research, Scientific Research on Innovative Areas (to Y. K.), and the Takeda Science Foundation (to K. T.).	Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kimata Y, 1997, BIOCHEM BIOPH RES CO, V232, P69, DOI 10.1006/bbrc.1997.6235; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Krsmanovic T, 2004, FEBS LETT, V577, P215, DOI 10.1016/j.febslet.2004.10.006; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/EC.00024-07; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018	41	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21760	21769		10.1074/jbc.M114.550871	http://dx.doi.org/10.1074/jbc.M114.550871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962567	Green Published, hybrid			2022-12-28	WOS:000340558300049
J	Mathew, E; Collins, MA; Fernandez-Barrena, MG; Holtz, AM; Yan, W; Hogan, JO; Tata, Z; Allen, BL; Fernandez-Zapico, ME; di Magliano, MP				Mathew, Esha; Collins, Meredith A.; Fernandez-Barrena, Maite G.; Holtz, Alexander M.; Yan, Wei; Hogan, James O.; Tata, Zachary; Allen, Benjamin L.; Fernandez-Zapico, Martin E.; di Magliano, Marina Pasca			The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Fibroblast; Hedgehog Signaling Pathway; Inflammation; Macrophage; Pancreas; Pancreatic Cancer	DUCTAL ADENOCARCINOMA; INTRAEPITHELIAL NEOPLASIA; IN-VIVO; CANCER; MOUSE; HEDGEHOG; CELLS; REGENERATION; INDUCTION; GENES	Background:Gli1 is induced during pancreatic injury; its function remains unknown. Results: Loss of Gli1 in the stromal compartment impairs cytokine production, myeloid cell recruitment, and tissue repair. Conclusion:Gli1 regulates remodeling during pancreatic tissue recovery. Significance: This study defines a novel role for GLI1 in pancreas remodeling and expands the repertoire of target genes mediating GLI1 cellular functions. Pancreatic cancer, one of the deadliest human malignancies, is almost uniformly associated with a mutant, constitutively active form of the oncogene Kras. Studies in genetically engineered mouse models have defined a requirement for oncogenic KRAS in both the formation of pancreatic intraepithelial neoplasias, the most common precursor lesions to pancreatic cancer, and in the maintenance and progression of these lesions. Previous work using an inducible model allowing tissue-specific and reversible expression of oncogenic Kras in the pancreas indicates that inactivation of this GTPase at the pancreatic intraepithelial neoplasia stage promotes pancreatic tissue repair. Here, we extend these findings to identify GLI1, a transcriptional effector of the Hedgehog pathway, as a central player in pancreatic tissue repair upon Kras inactivation. Deletion of a single allele of Gli1 results in improper stromal remodeling and perdurance of the inflammatory infiltrate characteristic of pancreatic tumorigenesis. Strikingly, this partial loss of Gli1 affects activated fibroblasts in the pancreas and the recruitment of immune cells that are vital for tissue recovery. Analysis of the mechanism using expression and chromatin immunoprecipitation assays identified a subset of cytokines, including IL-6, mIL-8, Mcp-1, and M-csf (Csf1), as direct GLI1 target genes potentially mediating this phenomenon. Finally, we demonstrate that canonical Hedgehog signaling, a known regulator of Gli1 activity, is required for pancreas recovery. Collectively, these data delineate a new pathway controlling tissue repair and highlight the importance of GLI1 in regulation of the pancreatic microenvironment during this cellular process.	[Mathew, Esha; Collins, Meredith A.; Holtz, Alexander M.; Allen, Benjamin L.; di Magliano, Marina Pasca] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Holtz, Alexander M.; di Magliano, Marina Pasca] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Yan, Wei] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Yan, Wei] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Hogan, James O.; Tata, Zachary] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Holtz, Alexander M.; Allen, Benjamin L.; di Magliano, Marina Pasca] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mayo Clinic; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	di Magliano, MP (corresponding author), Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	marinapa@umich.edu	Fernandez-Barrena, Maite G/J-8040-2014	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Pasca di Magliano, Marina/0000-0001-9632-9035	National Institutes of Health [1R01CA151588-01, 1R21CA167122-01]; University of Michigan Biological Scholar Program; University of Michigan Comprehensive Cancer Center; National Institutes of Health Training Grant [T32 GM007315, T32 DK094775, 5-T32-HD007515]; National Institutes of Health Predoctoral Fellowship [1F31NS081806-01A1]; American Heart Association Scientist Development Grant [11SDG6380000]; National Institutes of Health from NCI [R01 CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526, R01CA151588, R21CA167122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK094775, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biological Scholar Program; University of Michigan Comprehensive Cancer Center; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA151588-01 (to M. P. d. M.) and 1R21CA167122-01 (to B. L. A. and M. P. d. M.). This work was also supported by the University of Michigan Biological Scholar Program, the University of Michigan Comprehensive Cancer Center.; Supported by National Institutes of Health Training Grant T32 GM007315.; Supported by National Institutes of Health Training Grant T32 DK094775.; Supported by National Institutes of Health Training Grant 5-T32-HD007515.; Supported by National Institutes of Health Predoctoral Fellowship 1F31NS081806-01A1.; Supported by American Heart Association Scientist Development Grant 11SDG6380000.; Supported by National Institutes of Health R01 CA136526 from NCI and Mayo Clinic Pancreatic SPORE Grant P50 CA102701.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Andoh A, 2000, GASTROENTEROLOGY, V119, P211, DOI 10.1053/gast.2000.8538; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Bai CB, 2002, DEVELOPMENT, V129, P4753; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bowers SLK, 2010, ANN NY ACAD SCI, V1188, P143, DOI 10.1111/j.1749-6632.2009.05094.x; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingerslev HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009304; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Lees CW, 2008, PLOS MED, V5, P1761, DOI 10.1371/journal.pmed.0050239; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Park HL, 2000, DEVELOPMENT, V127, P1593; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; SALUJA A, 1985, AM J PHYSIOL, V249, pG702, DOI 10.1152/ajpgi.1985.249.6.G702; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09	52	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27727	27743		10.1074/jbc.M114.556563	http://dx.doi.org/10.1074/jbc.M114.556563			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25104358	Green Published, hybrid			2022-12-28	WOS:000342852800031
J	Suico, MA; Fukuda, R; Miyakita, R; Koyama, K; Taura, M; Shuto, T; Kai, H				Suico, Mary Ann; Fukuda, Ryosuke; Miyakita, Rui; Koyama, Kosuke; Taura, Manabu; Shuto, Tsuyoshi; Kai, Hirofumi			The Transcription Factor MEF/Elf4 Is Dually Modulated by p53-MDM2 Axis and MEF-MDM2 Autoregulatory Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID ELF-1-LIKE FACTOR; REGULATES LYSOZYME TRANSCRIPTION; PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR-SUPPRESSOR P53; EPITHELIAL-CELLS; FACTOR MEF; HUMAN BETA-DEFENSIN-2; HEMATOPOIETIC-CELLS; CARCINOMA CELLS; ENDOGENOUS P53	Myeloid Elf-1-like factor (MEF) or Elf4 is an ETS transcription factor that activates innate immunity-associated genes such as lysozyme (LYZ), human beta-defensin 2 (H beta D2), and interleukin-8 (IL-8) in epithelial cells and is also known to influence cell cycle progression. MEF is transcriptionally activated by E2F1, but the E2F1-mediated transcriptional activation is inhibited by p53 through E2F1-p53 protein interaction. Although the transcriptional activation of MEF has been investigated in depth, its post-translational regulation is not well explored. By overexpressing MEF cDNA in human cell lines, here we show that MEF protein expression is suppressed by p53. By screening a number of E3 ligases regulated by p53, we found that MDM2 is involved in the effect of p53 on MEF. MDM2 is transcriptionally activated by p53 and interacts with MEF protein to enhance MEF degradation. MDM2 reduces MEF protein expression, as well as stability and function of MEF as transcriptional activator. Furthermore, MDM2 was able to down-regulate MEF in the absence of p53, indicating a p53-independent effect on MEF. Notably, MEF transcriptionally activates MDM2, which was previously demonstrated to be the mechanism by which MEF suppresses the p53 protein. These results reveal that in addition to the potential of MEF to down-regulate p53 by transcriptionally activating E3 ligase MDM2, MEF participates with MDM2 in a novel autoregulatory feedback loop to regulate itself. Taken together with the findings on the effect of p53 on MEF, these data provide evidence that the p53-MDM2-MEF axis is a feedback mechanism that exquisitely controls the balance of these transcriptional regulators.	[Suico, Mary Ann; Fukuda, Ryosuke; Miyakita, Rui; Koyama, Kosuke; Taura, Manabu; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan	Kumamoto University	Suico, MA (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	mann@gpo.kumamoto-u.ac.jp; hirokai@gpo.kumamoto-u.ac.jp	Taura, Manabu/Y-6844-2019	Taura, Manabu/0000-0001-9577-8007; Shuto, Tsuyoshi/0000-0003-1275-4988; Suico, Mary Ann/0000-0002-6751-8352	Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [22390015, 23590082]; Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT) 22390015 (to H. K.) and 23590082 (to M. S.) and the Program for Leading Graduate Schools "HIGO" (Health life science: Interdisciplinary and Glocal Oriented), MEXT, Japan.	Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kai H, 1999, J BIOL CHEM, V274, P20098, DOI 10.1074/jbc.274.29.20098; Koga T, 2005, FEBS LETT, V579, P2811, DOI 10.1016/j.febslet.2005.04.015; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Miyazaki Y, 1996, ONCOGENE, V13, P1721; Morissette MC, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-62; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sashida G, 2010, CELL CYCLE, V9, P3457, DOI 10.4161/cc.9.17.13000; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Seki Y, 2002, CANCER RES, V62, P6579; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Suico MA, 2004, J PHARMACOL SCI, V95, P466, DOI 10.1254/jphs.SC0040077; Suico MA, 2004, J BIOL CHEM, V279, P19091, DOI 10.1074/jbc.M312439200; Suico MA, 2002, BBA-GENE STRUCT EXPR, V1577, P113, DOI 10.1016/S0167-4781(02)00370-6; Suico MA, 2006, BIOCHEM BIOPH RES CO, V348, P880, DOI 10.1016/j.bbrc.2006.07.151; TAMURA T, 1995, ONCOGENE, V11, P1939; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	47	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26143	26154		10.1074/jbc.M114.580209	http://dx.doi.org/10.1074/jbc.M114.580209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25081543	Green Published, hybrid			2022-12-28	WOS:000342128800011
J	Mandal, SM; Mahata, D; Migliolo, L; Parekh, A; Addy, PS; Mandal, M; Basak, A				Mandal, Santi M.; Mahata, Denial; Migliolo, Ludovico; Parekh, Aditya; Addy, Partha S.; Mandal, Mahitosh; Basak, Amit			Glucose Directly Promotes Antifungal Resistance in the Fungal Pathogen, Candida spp.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC-PATIENTS; INFECTIONS	Effects of glucose on the susceptibility of antifungal agents were investigated against Candida spp. Increasing the concentration of glucose decreased the activity of antifungal agents; voriconazole was the most affected drugs followed by amphotericin B. No significant change has been observed for anidulafungin. Biophysical interactions between antifungal agents with glucose molecules were investigated using isothermal titration calorimetry, Fourier transform infrared, and H-1 NMR. Glucose has a higher affinity to bind with voriconazole by hydrogen bonding and decrease the susceptibility of antifungal agents during chemotherapy. In addition to confirming the results observed in vitro, theoretical docking studies demonstrated that voriconazole presented three important hydrogen bonds and amphotericin B presented two hydrogen bonds that stabilized the glucose. In vivo results also suggest that the physiologically relevant higher glucose level in the bloodstream of diabetes mellitus mice might interact with the available selective agents during antifungal therapy, thus decreasing glucose activity by complex formation. Thus, proper selection of drugs for diabetes mellitus patients is important to control infectious diseases.	[Mandal, Santi M.; Mahata, Denial; Parekh, Aditya; Addy, Partha S.; Mandal, Mahitosh; Basak, Amit] Indian Inst Technol, Sch Med Sci & Technol, Cent Res Facil, Dept Chem, Kharagpur 721302, W Bengal, India; [Migliolo, Ludovico] Univ Catolica Dom Bosco, Ctr Pesquisas Bioquim & Biofis, Programa Posgrad Biotecnol, BR-79117900 Campo Grande, Brazil; [Mandal, Santi M.] Vidyasagar Univ, Dept Microbiol, Midnapore 721102, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Universidade Catolica Dom Bosco (UCDB); Vidyasagar University	Mandal, SM (corresponding author), Indian Inst Technol, Sch Med Sci & Technol, Cent Res Facil, Dept Chem, Kharagpur 721302, W Bengal, India.	mandalsm@gmail.com; absk@chem.iitkgp.ernet.in	Mandal, Mahitosh/GMW-6195-2022; Mandal, Santi M./AAF-7156-2020; MIGLIOLO, LUDOVICO/AAV-6913-2021; Parekh, Aditya/N-1428-2015	Mandal, Mahitosh/0000-0003-3861-3323; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Parekh, Aditya/0000-0001-7577-2097; Mandal, Santi M/0000-0002-0119-7138; Addy, Partha/0000-0002-0516-7307	Department of Science and Technology (DST)	Department of Science and Technology (DST)(Department of Science & Technology (India))	Recipient of a J. C. Bose National Fellowship from the Department of Science and Technology (DST). To whom correspondence may be addressed.	Al-Attas SA, 2010, ANN SAUDI MED, V30, P101, DOI 10.4103/0256-4947.60514; Barnett J. A., 1981, Advances in Carbohydrate Chemistry and Biochemistry, V39, P347; Bartelink ML, 1998, DIABETES RES CLIN PR, V40, P15, DOI 10.1016/S0168-8227(98)00023-0; CLSI, 2007, M100S17 CLSI; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; HAUG JB, 1994, CLIN INFECT DIS, V19, P246, DOI 10.1093/clinids/19.2.246; Jiang SY, 2012, BIOCHEM BIOPH RES CO, V427, P666, DOI 10.1016/j.bbrc.2012.09.118; Kumar B V, 2005, J Assoc Physicians India, V53, P599; Mandal SM, 2011, PEPTIDES, V32, P1741, DOI 10.1016/j.peptides.2011.06.020; Molero G, 1998, Int Microbiol, V1, P95; Moosa MYS, 2004, ANTIMICROB AGENTS CH, V48, P161, DOI 10.1128/AAC.48.1.161-167.2004; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Samanta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058346; Willis AM, 1999, DIABETIC MED, V16, P675, DOI 10.1046/j.1464-5491.1999.00134.x; Wu K. K., 2008, CURRENT PROTOCOLS PH; Wu XG, 2011, J PHARM SCI-US, V100, P1745, DOI 10.1002/jps.22402	17	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25468	25473		10.1074/jbc.C114.571778	http://dx.doi.org/10.1074/jbc.C114.571778			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25053418	hybrid, Green Published			2022-12-28	WOS:000342130800007
J	Tomasella, A; Blangy, A; Brancolini, C				Tomasella, Andrea; Blangy, Anne; Brancolini, Claudio			A Receptor-interacting Protein 1 (RIP1)-independent Necrotic Death under the Control of Protein Phosphatase PP2A That Involves the Reorganization of Actin Cytoskeleton and the Action of Cofilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PROGRAMMED NECROSIS; POLY(ADP-RIBOSE) POLYMERASE-1; MEMBRANE PERMEABILIZATION; CASPASE ACTIVATION; SIGNALING COMPLEX; APOPTOSIS; UBIQUITIN; KINASE; 2A	Cell death by necrosis is emerging not merely as a passive phenomenon but as a cell-regulated process. Here, by using different necrotic triggers, we prove the existence of two distinct necrotic pathways. The mitochondrial reactive oxygen species generator 2,3-dimethoxy-1,4-naphthoquinone elicits necrosis characterized by the involvement of RIP1 and Drp1. However, G5, a non-selective isopeptidase inhibitor, triggers a distinct necrotic pathway that depends on the protein phosphatase PP2A and the actin cytoskeleton. PP2A catalytic subunit is stabilized by G5 treatment, and its activity is increased. Furthermore, PP2Ac accumulates into the cytoplasm during necrosis similarly to HMGB1. We have also defined in the actin-binding protein cofilin-1 a link between PP2A, actin cytoskeleton, and necrotic death. Cofilin-1-severing/depolymerization activity is negatively regulated by phosphorylation of serine 3. PP2A contributes to the dephosphorylation of serine 3 elicited by G5. Finally, a cofilin mutant that mimics phosphorylated Ser-3 can partially rescue necrosis in response to G5.	[Tomasella, Andrea; Brancolini, Claudio] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Blangy, Anne] Univ Montpellier, CNRS, CRBM, UMR 5237, F-34293 Montpellier 5, France	University of Udine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Brancolini, C (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, Ple Kolbe 4, I-33100 Udine, Italy.	claudio.brancolini@uniud.it		BRANCOLINI, Claudio/0000-0002-6597-5373; BLANGY, Anne/0000-0001-7043-0784	Associazione Italiana per la Ricerca sul Cancro [IG-10437]; FIRB [RBAP11S8C3_002]; Associazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (IG-10437) and FIRB (Progetto RBAP11S8C3_002) (to C. B.); Recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro.	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Blangy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045909; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fontanini A, 2009, J BIOL CHEM, V284, P8369, DOI 10.1074/jbc.M806113200; Foti C, 2009, MOL CANCER THER, V8, P3140, DOI 10.1158/1535-7163.MCT-09-0431; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim JE, 2014, CELL DEATH DIFFER, V21, P1036, DOI 10.1038/cdd.2014.17; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lecis D, 2012, BIOORGAN MED CHEM, V20, P6709, DOI 10.1016/j.bmc.2012.09.041; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Su Y. C., 2014, APOPTOSIS IN PRESS; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P135, DOI DOI 10.1038/NRM3737; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wegner Adam M., 2007, V365, P61; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200	52	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25699	25710		10.1074/jbc.M114.575134	http://dx.doi.org/10.1074/jbc.M114.575134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25096578	Green Published, hybrid			2022-12-28	WOS:000342130800029
J	Ivey, RA; Sajan, MP; Farese, RV				Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.			Requirements for Pseudosubstrate Arginine Residues during Autoinhibition and Phosphatidylinositol 3,4,5-(PO4)(3)-dependent Activation of Atypical PKC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GLUCOSE-TRANSPORT; RAT ADIPOCYTES; INOSITOL PHOSPHATES; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MIXED MICELLES; ZETA; ALPHA; TRANSLOCATION	Atypical PKC (aPKC) isoforms are activated by the phosphatidylinositol 3-kinase product phosphatidylinositol 3,4,5-(PO4)(3) (PIP3). How PIP3 activates aPKC is unknown. Although Akt activation involves PIP3 binding to basic residues in the Akt pleckstrin homology domain, aPKCs lack this domain. Here we examined the role of basic arginine residues common to aPKC pseudosubstrate sequences. Replacement of all five (or certain) arginine residues in the pseudosubstrate sequence of PKC-iota by site-directed mutagenesis led to constitutive activation and unresponsiveness to PIP3 in vitro or insulin in vivo. However, with the addition of the exogenous arginine-containing pseudosubstrate tridecapeptide to inhibit this constitutively active PKC-iota, PIP3-activating effects were restored. A similar restoration of responsiveness to PIP3 was seen when exogenous pseudosubstrate was used to inhibit mouse liver PKC-lambda/zeta maximally activated by insulin or ceramide and a truncated, constitutively active PKC-zeta mutant lacking all regulatory domain elements and containing "activating" glutamate residues at loop and autophosphorylation sites (Delta 1-247/T410E/T560E-PKC-zeta). NMR studies suggest that PIP3 binds directly to the pseudosubstrate. The ability of PIP3 to counteract the inhibitory effects of the exogenous pseudosubstrate suggests that basic residues in the pseudosubstrate sequence are required for maintaining aPKCs in an inactive state and are targeted by PIP3 for displacement from the substrate-binding site during kinase activation.	[Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.] James A Haley Vet Med Ctr, Med Serv, Tampa, FL 33612 USA; [Ivey, Robert A.; Sajan, Mini P.; Farese, Robert V.] James A Haley Vet Med Ctr, Res Serv, Tampa, FL 33612 USA; [Sajan, Mini P.; Farese, Robert V.] Univ S Florida, Coll Med, Div Endocrinol & Metab, Dept Internal Med, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida	Farese, RV (corresponding author), James A Haley Vet Med Ctr, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	rfarese@health.usf.edu	Farese, Robert/B-3605-2015		National Institutes of Health [RO1DK 065969-09]; Department of Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065969] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK 065969-09 (to R. V. F.). This work was also supported by funds from the Department of Veterans Affairs Merit Review Program (to R. V. F.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Fields A. P., 2007, BIOCHEM SOC T, V23, P1996; Graybill C, 2012, J BIOL CHEM, V287, P21003, DOI 10.1074/jbc.M112.360495; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Liu Q, 1998, J IMMUNOL, V160, P1393; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Sajan MP, 2012, DIABETOLOGIA, V55, P1446, DOI 10.1007/s00125-012-2477-5; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Sajan MP, 2004, J CLIN ENDOCR METAB, V89, P3994, DOI 10.1210/jc.2004-0106; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Standaert ML, 2002, DIABETES, V51, P2936, DOI 10.2337/diabetes.51.10.2936; Standaert ML, 2001, BIOCHEMISTRY-US, V40, P249, DOI 10.1021/bi0018234; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567	26	16	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25021	25030		10.1074/jbc.M114.565671	http://dx.doi.org/10.1074/jbc.M114.565671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25035426	Green Published, hybrid			2022-12-28	WOS:000341985300026
J	Kageyama, S; Sou, Y; Uemura, T; Kametaka, S; Saito, T; Ishimura, R; Kouno, T; Bedford, L; Mayer, RJ; Lee, MS; Yamamoto, M; Waguri, S; Tanaka, K; Komatsu, M				Kageyama, Shun; Sou, Yu-shin; Uemura, Takefumi; Kametaka, Satoshi; Saito, Tetsuya; Ishimura, Ryosuke; Kouno, Tsuguka; Bedford, Lynn; Mayer, R. John; Lee, Myung-Shik; Yamamoto, Masayuki; Waguri, Satoshi; Tanaka, Keiji; Komatsu, Masaaki			Proteasome Dysfunction Activates Autophagy and the Keap1-Nrf2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; CAUSES NEURODEGENERATION; PROTEIN-DEGRADATION; DEFICIENT MICE; UBIQUITIN; NRF2; P62; PHOSPHORYLATION; PROMOTES; HOMEOSTASIS	The ubiquitin-proteasome system and autophagy are crucially important for proteostasis in cells. These pathways are interdependent, and dysfunction in either pathway causes accumulation of ubiquitin-positive aggregates, a hallmark of human pathological conditions. To elucidate in vivo compensatory action(s) against proteasomal dysfunction, we developed mice with reduced proteasome activity in their livers. The mutant mice exhibited severe liver damage, accompanied by formation of aggregates positive for ubiquitin and p62/Sqstm1, an adaptor protein for both selective autophagy and the anti-oxidative Keap1-Nrf2 pathway. These aggregates were selectively entrapped by autophagosomes, and pathological features of livers with impaired proteasome activity were exacerbated by simultaneous suppression of autophagy. In contrast, concomitant loss of p62/Sqstm1 had no apparent effect on the liver pathology though p62/Sqstm1 was indispensable for the aggregates formation. Furthermore, defective proteasome function led to transcriptional activation of the Nrf2, which served as a physiological adaptation. Our in vivo data suggest that cells contain networks of cellular defense mechanisms against defective proteostasis.	[Kageyama, Shun; Saito, Tetsuya; Ishimura, Ryosuke; Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Chuo Ku, Niigata 9518510, Japan; [Kageyama, Shun; Sou, Yu-shin; Kouno, Tsuguka; Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Saito, Tetsuya; Ishimura, Ryosuke; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Uemura, Takefumi; Kametaka, Satoshi; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Bedford, Lynn; Mayer, R. John] Univ Nottingham, Sch Biomed Sci, Sch Life Sci, Queens Med Ctr,Lab Intracellular Proteolysis, Nottingham NG7 2UH, England; [Lee, Myung-Shik] Samsung Med Ctr, Dept Med, Seoul 135710, South Korea; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Niigata University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Fukushima Medical University; University of Nottingham; Sungkyunkwan University (SKKU); Samsung Medical Center; Tohoku University	Komatsu, M (corresponding author), Niigata Univ, Sch Med, Dept Biochem, Chuo Ku, Niigata 9518510, Japan.	komatsu-ms@med.niigata-u.ac.jp	Kametaka, Satoshi/AAA-7407-2020; Kametaka, Satoshi/GVT-6091-2022; Komatsu, Masaaki/B-8321-2011; Yamamoto, Masayuki/A-4873-2010	Kametaka, Satoshi/0000-0003-0659-6426; Komatsu, Masaaki/0000-0001-7672-7722; Yamamoto, Masayuki/0000-0002-9073-9436; Sou, Yu-shin/0000-0002-7219-9106	Funding Program for Next Generation World Leading Researchers Grant [LS132]; Takeda Science Foundation; Global Research Laboratory grant;  [25111006]; Parkinson&quot;s UK [F-0702] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Funding Program for Next Generation World Leading Researchers Grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Global Research Laboratory grant; ; Parkinson&quot;s UK(Parkinson&apos;s UK); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 25111006 (to M. K. and S. W.), Funding Program for Next Generation World Leading Researchers Grant LS132 (to M. K.), the Takeda Science Foundation (to T. K. and M. K.), and a Global Research Laboratory grant (to M-S. L. and M. K.).	Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Harada H, 2013, J NEUROSCI, V33, P14767, DOI 10.1523/JNEUROSCI.2954-12.2013; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Waguri S, 2009, METHOD ENZYMOL, V453, P181, DOI 10.1016/S0076-6879(08)04009-3; Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	41	77	80	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24944	24955		10.1074/jbc.M114.580357	http://dx.doi.org/10.1074/jbc.M114.580357			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25049227	Green Published, hybrid			2022-12-28	WOS:000341985300020
J	Lo, AWH; Moonens, K; De Kerpel, M; Brys, L; Pardon, E; Remaut, H; De Greve, H				Lo, Alvin W. H.; Moonens, Kristof; De Kerpel, Maia; Brys, Lea; Pardon, Els; Remaut, Han; De Greve, Henri			The Molecular Mechanism of Shiga Toxin Stx2e Neutralization by a Single-domain Antibody Targeting the Cell Receptor-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; MONOCLONAL-ANTIBODY; EDEMA DISEASE; SUBINHIBITORY CONCENTRATIONS; B-SUBUNIT; FRAGMENTS; PIGS; IDENTIFICATION; ENVIRONMENT; NANOBODIES	Shiga toxin Stx2e is the major known agent that causes edema disease in newly weaned pigs. This severe disease is characterized by neurological disorders, hemorrhagic lesions, and frequent fatal outcomes. Stx2e consists of an enzymatically active A subunit and five B subunits that bind to a specific glycolipid receptor on host cells. It is evident that antibodies binding to the A subunit or the B subunits of Shiga toxin variants may have the capability to inhibit their cytotoxicity. Here, we report the discovery and characterization of a VHH single domain antibody (nanobody) isolated from a llama phage display library that confers potent neutralizing capacity against Stx2e toxin. We further present the crystal structure of the complex formed between the nanobody (NbStx2e1) and the Stx2e toxoid, determined at 2.8 angstrom resolution. Structural analysis revealed that for each B subunit of Stx2e, one NbStx2e1 is interacting in a head-to-head orientation and directly competing with the glycolipid receptor binding site on the surface of the B subunit. The neutralizing NbStx2e1 can in the future be used to prevent or treat edema disease.	[Lo, Alvin W. H.; Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] Vrije Univ Brussel VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Lo, Alvin W. H.; Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Brys, Lea] Vrije Univ Brussel VIB, Lab Myeloid Cell Immunol, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	De Greve, H (corresponding author), VIB, Struct Biol Res Ctr, Pleinlaan 2, B-1050 Brussels, Belgium.	hdegreve@vub.ac.be		Remaut, Han/0000-0002-9775-4102; Pardon, Els/0000-0002-2466-0172	Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office [7/40]; VIB Young PI project grant; Odysseus program of the FWO-Vlaanderen	Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office; VIB Young PI project grant; Odysseus program of the FWO-Vlaanderen	Supported by Grant 7/40 of the Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office.; Supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Beutin L, 2008, APPL ENVIRON MICROB, V74, P4806, DOI 10.1128/AEM.00623-08; Chow SK, 2012, TOXINS, V4, P430, DOI 10.3390/toxins4060430; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; HADDAD JE, 1993, J BACTERIOL, V175, P4970, DOI 10.1128/JB.175.16.4970-4978.1993; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, VET MICROBIOL, V120, P193, DOI 10.1016/j.vetmic.2006.10.029; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; IMBERECHTS H, 1992, VET MICROBIOL, V31, P221, DOI 10.1016/0378-1135(92)90080-D; Kimura T, 2002, HYBRIDOMA HYBRIDOM, V21, P161, DOI 10.1089/153685902760173872; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128/AAC.00343-09; MACLEOD DL, 1991, VET PATHOL, V28, P66, DOI 10.1177/030098589102800109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; PERERA LP, 1988, J CLIN MICROBIOL, V26, P2127, DOI 10.1128/JCM.26.10.2127-2131.1988; PERERA LP, 1991, J BACTERIOL, V173, P1151, DOI 10.1128/jb.173.3.1151-1160.1991; Smith MJ, 2006, INFECT IMMUN, V74, P6992, DOI 10.1128/IAI.01247-06; STROCKBINE NA, 1988, J BACTERIOL, V170, P1116, DOI 10.1128/jb.170.3.1116-1122.1988; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; Thi KNO, 2010, TROP ANIM HEALTH PRO, V42, P1797, DOI 10.1007/s11250-010-9639-6; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Vernozy-Rozand C, 2004, APPL ENVIRON MICROB, V70, P2556, DOI 10.1128/AEM.70.4.2556-2559.2004; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889	38	18	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25374	25381		10.1074/jbc.M114.566257	http://dx.doi.org/10.1074/jbc.M114.566257			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053417	Green Published, hybrid			2022-12-28	WOS:000341985300055
J	Boswell-Casteel, RC; Johnson, JM; Duggan, KD; Roe-Zurz, Z; Schmitz, H; Burleson, C; Hays, FA				Boswell-Casteel, Rebba C.; Johnson, Jennifer M.; Duggan, Kelli D.; Roe-Zurz, Zygy; Schmitz, Hannah; Burleson, Carter; Hays, Franklin A.			FUN26 (Function Unknown Now 26) Protein from Saccharomyces cerevisiae Is a Broad Selectivity, High Affinity, Nucleoside and Nucleobase Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Protein; Membrane Transport; Membrane Transporter Reconstitution; Nucleoside; Nucleotide Transport; Transporter	INTEGRAL MEMBRANE-PROTEINS; CHROMOSOME-I DNA; MOLECULAR-CLONING; STREPTOCOCCUS-EQUISIMILIS; INTRACELLULAR MEMBRANES; HYALURONAN SYNTHASE; ENT FAMILY; YEAST; NITROBENZYLTHIOINOSINE; TRANSLOCATION	Background: FUN26 is a nucleoside transporter expressed in yeast vacuoles. Results: Proteoliposome studies of purified FUN26 reveal broad nucleoside and nucleobase uptake that is sensitive to C(2)-ribose modifications. Conclusion: FUN26 is a high affinity and broad selectivity nucleoside and nucleobase transporter. Significance: FUN26 has a unique substrate transport profile relative to other ENTs and retains activity following detergent solubilization and purification. Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that transport nucleosides and, to a lesser extent, nucleobases across cell membranes. ENTs modulate efficacy for a range of human therapeutics and function in a diffusion-controlled bidirectional manner. A detailed understanding of ENT function at the molecular level has remained elusive. FUN26 (function unknown now 26) is a putative ENT homolog from S. cerevisiae that is expressed in vacuole membranes. In the present system, proteoliposome studies of purified FUN26 demonstrate robust nucleoside and nucleobase uptake into the luminal volume for a broad range of substrates. This transport activity is sensitive to nucleoside modifications in the C(2)- and C(5)-positions on the ribose sugar and is not stimulated by a membrane pH differential. [H-3]Adenine nucleobase transport efficiency is increased approximate to 4-fold relative to nucleosides tested with no observed [H-3]adenosine or [H-3]UTP transport. FUN26 mutational studies identified residues that disrupt (G463A or G216A) or modulate (F249I or L390A) transporter function. These results demonstrate that FUN26 has a unique substrate transport profile relative to known ENT family members and that a purified ENT can be reconstituted in proteoliposomes for functional characterization in a defined system.	[Boswell-Casteel, Rebba C.; Johnson, Jennifer M.; Duggan, Kelli D.; Schmitz, Hannah; Burleson, Carter; Hays, Franklin A.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Hays, Franklin A.] Univ Oklahoma, Stephenson Oklahoma Canc Ctr, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Roe-Zurz, Zygy] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco	Hays, FA (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	Franklin-Hays@ouhsc.edu	Boswell-Casteel, Rebba/P-8651-2019	Johnson Hays, Jennifer/0000-0001-5855-7352	National Institutes of Health, NIGMS, Institutional Development Award (IDeA) [P20GM103639]; Oklahoma Center for the Advancement of Science [HR11-046]; University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant; American Heart Association Predoctoral Fellowship [13PRE17040024]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, P20GM103639] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS, Institutional Development Award (IDeA); Oklahoma Center for the Advancement of Science; University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health, NIGMS, Institutional Development Award (IDeA) under Grant P20GM103639. This work was also supported by Oklahoma Center for the Advancement of Science Grant HR11-046 (to F. A. H.), a University of Oklahoma Health Sciences Center College of Medicine Alumni Association seed grant (to F. A. H.), and American Heart Association Predoctoral Fellowship 13PRE17040024 (to R. C. B.-C.).	Arastu-Kapur S, 2003, J BIOL CHEM, V278, P33327, DOI 10.1074/jbc.M305141200; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P77; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; CASS CE, 1973, BIOCHIM BIOPHYS ACTA, V291, P734, DOI 10.1016/0005-2736(73)90477-X; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Clarke M, 2002, DANCING TIMES, V93, P27; COLEMAN KG, 1986, MOL CELL BIOL, V6, P4516, DOI 10.1128/MCB.6.12.4516; Damaraju VL, 2011, CHEMBIOCHEM, V12, P2774, DOI 10.1002/cbic.201100567; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; GATI WP, 1984, BIOCHEM PHARMACOL, V33, P3325, DOI 10.1016/0006-2952(84)90101-1; Greenhalf W, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt347; GRENSON M, 1969, EUR J BIOCHEM, V11, P249, DOI 10.1111/j.1432-1033.1969.tb00767.x; HAMMOND JR, 1994, J PHARMACOL EXP THER, V271, P906; Hammond JR, 1996, ARCH BIOCHEM BIOPHYS, V332, P313, DOI 10.1006/abbi.1996.0347; Hammond JR, 1997, BIOCHEM PHARMACOL, V53, P623, DOI 10.1016/S0006-2952(96)00857-X; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Hays Franklin A., 2009, Journal of Structural and Functional Genomics, V10, P9, DOI 10.1007/s10969-008-9046-7; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Indiveri C, 2010, METHODS MOL BIOL, V606, P55, DOI 10.1007/978-1-60761-447-0_5; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Jiang X, 2012, BIOCHEMISTRY-US, V51, P9480, DOI 10.1021/bi301329w; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; JUND R, 1977, J MEMBRANE BIOL, V36, P233, DOI 10.1007/BF01868153; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Kelly Libusha, 2009, Journal of Structural and Functional Genomics, V10, P269, DOI 10.1007/s10969-009-9069-8; Kumari K, 1997, J BIOL CHEM, V272, P32539, DOI 10.1074/jbc.272.51.32539; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Lum PY, 2000, CANCER CHEMOTH PHARM, V45, P273, DOI 10.1007/s002800050040; MATILE P, 1967, ARCH MIKROBIOL, V56, P148, DOI 10.1007/BF00408765; NAGY M, 1979, BIOCHIM BIOPHYS ACTA, V558, P221, DOI 10.1016/0005-2736(79)90062-2; POLAK A, 1973, EUR J BIOCHEM, V32, P276, DOI 10.1111/j.1432-1033.1973.tb02608.x; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Tlapak-Simmons VL, 2004, BIOCHEMISTRY-US, V43, P9234, DOI 10.1021/bi049468v; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2014, J BIOL CHEM, V289, P8799, DOI 10.1074/jbc.M113.546960; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; Vickers MF, 2004, NUCLEOS NUCLEOT NUCL, V23, P361, DOI 10.1081/NCN-120028333; VICKERS MF, 2000, EMERGING THERAPEUTIC, V4, P515; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Xie H, 2008, ACTA BIOCH BIOPH SIN, V40, P269, DOI 10.1111/j.1745-7270.2008.00400.x; Yao SYM, 2011, J BIOL CHEM, V286, P32552, DOI 10.1074/jbc.M111.236117; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	56	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24440	24451		10.1074/jbc.M114.553503	http://dx.doi.org/10.1074/jbc.M114.553503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035431	Green Published, hybrid			2022-12-28	WOS:000341505600037
J	Noda, C; Kimura, H; Arasaki, K; Matsushita, M; Yamamoto, A; Wakana, Y; Inoue, H; Tagaya, M				Noda, Chikano; Kimura, Hana; Arasaki, Kohei; Matsushita, Mitsuru; Yamamoto, Akitsugu; Wakana, Yuichi; Inoue, Hiroki; Tagaya, Mitsuo			Valosin-containing Protein-interacting Membrane Protein (VIMP) Links the Endoplasmic Reticulum with Microtubules in Concert with Cytoskeleton-linking Membrane Protein (CLIMP)-63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; Membrane Protein; Microtubule; Tubulin; CLIMP-63; VIMP	SYNTAXIN 5; ER; ORGANIZATION; COMPARTMENT; RELEASE; NETWORK	Background: The distribution and morphology of the mammalian endoplasmic reticulum (ER) are regulated by microtubules (MTs). Results: Valosin-containing protein (VCP)-interacting membrane protein (VIMP) interacts with both MTs and the rough ER-localized cytoskeleton-linking membrane protein (CLIMP)-63. Its overexpression or depletion affects ER structure. Conclusion: VIMP links the ER and MTs. Significance: VIMP not only recruits VCP to the ER but also regulates ER shape. The distribution and morphology of the endoplasmic reticulum (ER) in mammalian cells depend on both dynamic and static interactions of ER membrane proteins with microtubules (MTs). Cytoskeleton-linking membrane protein (CLIMP)-63 is exclusively localized in sheet-like ER membranes, typical structures of the rough ER, and plays a pivotal role in the static interaction with MTs. Our previous study showed that the 42-kDa ER-residing form of syntaxin 5 (Syn5L) regulates ER structure through the interactions with both CLIMP-63 and MTs. Here, we extend our previous study and show that the valosin-containing protein/p97-interacting membrane protein (VIMP)/SelS is also a member of the family of proteins that shape the ER by interacting with MTs. Depletion of VIMP causes the spreading of the ER to the cell periphery and affects an MT-dependent process on the ER. Although VIMP can interact with CLIMP-63 and Syn5L, it does not interact with MT-binding ER proteins (such as Reep1) that shape the tubular smooth ER, suggesting that different sets of MT-binding ER proteins are used to organize different ER subdomains.	[Noda, Chikano; Kimura, Hana; Arasaki, Kohei; Matsushita, Mitsuru; Wakana, Yuichi; Inoue, Hiroki; Tagaya, Mitsuo] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Life Sci, Hachioji, Tokyo 1920392, Japan; [Yamamoto, Akitsugu] Nagahama Inst Bio Sci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Tokyo University of Pharmacy & Life Sciences	Tagaya, M (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tagaya@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24657141, 25291029]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 24657141 and 25291029 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Gao HY, 2009, EXP CELL RES, V315, P1157, DOI 10.1016/j.yexcr.2009.01.027; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Iinuma T, 2009, J CELL SCI, V122, P1680, DOI 10.1242/jcs.036103; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lynes EM, 2011, BBA-MOL CELL RES, V1813, P1893, DOI 10.1016/j.bbamcr.2011.06.011; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Ogawa-Goto K, 2007, MOL BIOL CELL, V18, P3741, DOI 10.1091/mbc.E06-12-1125; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Tagaya M, 1996, J BIOL CHEM, V271, P466, DOI 10.1074/jbc.271.1.466; Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	36	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24304	24313		10.1074/jbc.M114.571372	http://dx.doi.org/10.1074/jbc.M114.571372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008318	Green Published, hybrid			2022-12-28	WOS:000341505600026
J	Sizemore, GM; Sizemore, ST; Seachrist, DD; Keri, RA				Sizemore, Gina M.; Sizemore, Steven T.; Seachrist, Darcie D.; Keri, Ruth A.			GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; Cytoskeleton; Extracellular Signal-regulated Kinase (ERK); GABA Receptor	GAMMA-AMINOBUTYRIC-ACID; COLON-CARCINOMA CELLS; MOLECULAR PHENOTYPE; TUMOR-CELLS; PCR ASSAY; EXPRESSION; METASTASIS; INVASION; MARKERS; PHOSPHORYLATION	Background:GABRP correlates with the basal-like breast cancer (BLBC)/triple negative subtype, but its function in this disease is poorly understood. Results: Silencing GABRP in BLBC cells decreases migration, BLBC-associated cytokeratins and ERK1/2 activation. Conclusion: A GABRP-ERK1/2-cytokeratin axis maintains BLBC migration. Significance: GABRP is a component of a cell-surface receptor, thus, targeting this signaling axis may have therapeutic potential in BLBC. Breast cancer is a heterogeneous disease comprised of distinct subtypes predictive of patient outcome. Tumors of the basal-like subtype have a poor prognosis due to inherent aggressiveness and the lack of targeted therapeutics. Basal-like tumors typically lack estrogen receptor-, progesterone receptor and HER2/ERBB2, or in other words they are triple negative (TN). Continued evaluation of basal-like breast cancer (BLBC) biology is essential to identify novel therapeutic targets. Expression of the pi subunit of the GABA(A) receptor (GABRP) is associated with the BLBC/TN subtype, and herein, we reveal its expression also correlates with metastases to the brain and poorer patient outcome. GABRP expression in breast cancer cell lines also demonstrates a significant correlation with the basal-like subtype suggesting that GABRP functions in the initiation and/or progression of basal-like tumors. To address this postulate, we stably silenced GABRP in two BLBC cell lines, HCC1187 and HCC70 cells. Decreased GABRP reduces in vitro tumorigenic potential and migration concurrent with alterations in the cytoskeleton, specifically diminished cellular protrusions and expression of the BLBC-associated cytokeratins, KRT5, KRT6B, KRT14, and KRT17. Silencing GABRP also decreases phosphorylation of extracellular regulated kinase 1/2 (ERK1/2) in both cell lines and selective inhibition of ERK1/2 similarly decreases the basal-like cytokeratins as well as migration. Combined, these data reveal a GABRP-ERK1/2-cytokeratin axis that maintains the migratory phenotype of basal-like breast cancer. GABRP is a component of a cell surface receptor, thus, these findings suggest that targeting this new signaling axis may have therapeutic potential in BLBC.	[Sizemore, Gina M.; Sizemore, Steven T.; Seachrist, Darcie D.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet, Sch Med, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	keri@case.edu	Sizemore, Gina/ABI-7542-2020; Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	Dept. of Defense Grants [W81XWH-09-1-0696, W81XWH-11-1-0185]; Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703] Funding Source: NIH RePORTER	Dept. of Defense Grants; Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Dept. of Defense Grants W81XWH-09-1-0696 (to S. T. S.) and W81XWH-11-1-0185 (to R. A. K.) and by the Case Comprehensive Cancer Center P30 CA043703 (to R. A. K.).	Abdul M, 2008, ACTA ONCOL, V47, P1546, DOI 10.1080/02841860801961265; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Azuma H, 2003, CANCER RES, V63, P8090; Backus J, 2005, J MOL DIAGN, V7, P327, DOI 10.1016/S1525-1578(10)60561-2; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Busch T, 2012, J CELL SCI, V125, P2148, DOI 10.1242/jcs.080127; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fowler CJ, 2004, TRENDS PHARMACOL SCI, V25, P59, DOI 10.1016/j.tips.2003.12.001; Gaedcke J, 2007, MODERN PATHOL, V20, P864, DOI 10.1038/modpathol.3800830; Garib V, 2005, EUR J ANAESTH, V22, P609, DOI 10.1017/S026502150500102X; Garib V, 2002, ACTA ANAESTH SCAND, V46, P836, DOI 10.1034/j.1399-6576.2002.460714.x; Haeseler G, 2008, BRIT J PHARMACOL, V155, P265, DOI 10.1038/bjp.2008.255; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Inamoto T, 2007, CANCER INVEST, V25, P574, DOI 10.1080/07357900701522471; Johnson SK, 2005, J PANCREAS, V6, P136; Joseph J, 2002, CANCER RES, V62, P6467; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; Luck AA, 2008, CLIN ONCOL-UK, V20, P40, DOI 10.1016/j.clon.2007.10.002; Mazurkiewicz M, 1999, J EXP CLIN CANC RES, V18, P247; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Neman J, 2014, P NATL ACAD SCI USA, V111, P984, DOI 10.1073/pnas.1322098111; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quezada M, 2006, FERTIL STERIL, V86, P1750, DOI 10.1016/j.fertnstert.2006.05.033; Rakha EA, 2011, CLIN ONCOL-UK, V23, P587, DOI 10.1016/j.clon.2011.03.013; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Reinholz MM, 2005, CLIN CANCER RES, V11, P3722, DOI 10.1158/1078-0432.CCR-04-1483; Sadeghi H, 2010, AM J PHYSIOL-ENDOC M, V298, pE889, DOI 10.1152/ajpendo.00577.2009; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Taylor AP, 2010, BRIT J CANCER, V103, P82, DOI 10.1038/sj.bjc.6605746; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zafrakas M, 2006, INT J CANCER, V118, P1453, DOI 10.1002/ijc.21517; Zehentner BK, 2006, MOL DIAGN THER, V10, P41, DOI 10.1007/BF03256441; Zehentner BK, 2002, CLIN CHEM, V48, P1225; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040797	55	43	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24102	24113		10.1074/jbc.M114.593582	http://dx.doi.org/10.1074/jbc.M114.593582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012653	Green Published, hybrid			2022-12-28	WOS:000341505600010
J	Foulquier, E; Pompeo, F; Freton, C; Cordier, B; Grangeasse, C; Galinier, A				Foulquier, Elodie; Pompeo, Frederique; Freton, Celine; Cordier, Baptiste; Grangeasse, Christophe; Galinier, Anne			PrkC-mediated Phosphorylation of Overexpressed YvcK Protein Regulates PBP1 Protein Localization in Bacillus subtilis mreB Mutant Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Bacillus; Cell Wall; Gluconeogenesis; Morphogenesis; Protein Phosphorylation	MYCOBACTERIUM-TUBERCULOSIS; SER/THR KINASE; DIVISION; GROWTH; BIOSYNTHESIS; BACTERIA; SYSTEM; IDENTIFICATION; MORPHOGENESIS; SPECIFICITY	Background: The YvcK protein is essential for Bacillus subtilis growth on gluconeogenic conditions; its overproduction rescues an mreB mutant. Results: PrkC phosphorylates YvcK; this phosphorylation is not required for growth on gluconeogenic conditions but is necessary for mreB rescue. Conclusion: YvcK phosphorylation is specifically involved in B. subtilis morphogenesis. Significance: This phosphorylation-based regulatory mechanism could be widespread in bacteria. The YvcK protein has been shown to be necessary for growth under gluconeogenic conditions in Bacillus subtilis. Amazingly, its overproduction rescues growth and morphology defects of the actin-like protein MreB deletion mutant by restoration of PBP1 localization. In this work, we observed that YvcK was phosphorylated at Thr-304 by the protein kinase PrkC and that phosphorylated YvcK was dephosphorylated by the cognate phosphatase PrpC. We show that neither substitution of this threonine with a constitutively phosphorylated mimicking glutamic acid residue or a phosphorylation-dead mimicking alanine residue nor deletion of prkC or prpC altered the ability of B. subtilis to grow under gluconeogenic conditions. However, we observed that a prpC mutant and a yvcK mutant were more sensitive to bacitracin compared with the WT strain. In addition, the bacitracin sensitivity of strains in which YvcK Thr-304 was replaced with either an alanine or a glutamic acid residue was also affected. We also analyzed rescue of the mreB mutant strain by overproduction of YvcK in which the phosphorylation site was substituted. We show that YvcK T304A overproduction did not rescue the mreB mutant aberrant morphology due to PBP1 mislocalization. The same observation was made in an mreB prkC double mutant overproducing YvcK. Altogether, these data show that YvcK may have two distinct functions: 1) in carbon source utilization independent of its phosphorylation level and 2) in cell wall biosynthesis and morphogenesis through its phosphorylation state.	[Foulquier, Elodie; Pompeo, Frederique; Freton, Celine; Cordier, Baptiste; Galinier, Anne] Aix Marseille Univ, Lab Chim Bacterienne, UMR 7283, Inst Microbiol Mediterranee,CNRS, F-13009 Marseille, France; [Freton, Celine; Grangeasse, Christophe] Univ Lyon, UMR 5086, CNRS, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Galinier, A (corresponding author), Aix Marseille Univ, Lab Chim Bacterienne, UMR 7283, Inst Microbiol Mediterranee,CNRS, F-13009 Marseille, France.	galinier@imm.cnrs.fr	Pompeo, Frederique/Q-5772-2017	Cordier, Baptiste/0000-0002-6042-9787; Grangeasse, Christophe/0000-0002-5484-4589	CNRS; Agence Nationale de la Recherche (P-loop); Aix-Marseille Universite; Agence Nationale de la Recherche (PiBaKi)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (P-loop)(French National Research Agency (ANR)); Aix-Marseille Universite; Agence Nationale de la Recherche (PiBaKi)(French National Research Agency (ANR))	This work was supported by CNRS, the Agence Nationale de la Recherche (P-loop and PiBaKi), and Aix-Marseille Universite.	Absalon C, 2009, MICROBIOL-SGM, V155, P932, DOI 10.1099/mic.0.022475-0; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Bird TH, 2011, ARCH MICROBIOL, V193, P451, DOI 10.1007/s00203-011-0676-y; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Foulquier E, 2011, MOL MICROBIOL, V80, P309, DOI 10.1111/j.1365-2958.2011.07587.x; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gilmour MW, 2003, MOL MICROBIOL, V49, P105, DOI 10.1046/j.1365-2958.2003.03551.x; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; Graupner M, 2002, BIOCHEMISTRY-US, V41, P3754, DOI 10.1021/bi011937v; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Obuchowski M, 2000, J BACTERIOL, V182, P5634, DOI 10.1128/JB.182.19.5634-5638.2000; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pompeo F, 2012, J BIOL CHEM, V287, P20830, DOI 10.1074/jbc.M112.340331; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Scheffers DJ, 2004, J BACTERIOL, V186, P5153, DOI 10.1128/jb.186.15.5153-5156.2004; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; STORM DR, 1973, J BIOL CHEM, V248, P3940; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3	38	30	30	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23662	23669		10.1074/jbc.M114.562496	http://dx.doi.org/10.1074/jbc.M114.562496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012659	Green Published, hybrid			2022-12-28	WOS:000341505000034
J	Kota, P; Buchner, G; Chakraborty, H; Dang, YL; He, H; Garcia, GJM; Kubelka, J; Gentzsch, M; Stutts, MJ; Dokholyan, NV				Kota, Pradeep; Buchner, Ginka; Chakraborty, Hirak; Dang, Yan L.; He, Hong; Garcia, Guilherme J. M.; Kubelka, Jan; Gentzsch, Martina; Stutts, M. Jackson; Dokholyan, Nikolay V.			The N-terminal Domain Allosterically Regulates Cleavage and Activation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; GAMMA-SUBUNIT; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; PROTEOLYTIC ACTIVATION; EXTRACELLULAR DOMAIN; ENAC; BINDING; INHIBITION; STABILITY; SITES	The epithelial sodium channel (ENaC) is activated upon endoproteolytic cleavage of specific segments in the extracellular domains of the alpha- and gamma-subunits. Cleavage is accomplished by intracellular proteases prior to membrane insertion and by surface-expressed or extracellular soluble proteases once ENaC resides at the cell surface. These cleavage events are partially regulated by intracellular signaling through an unknown allosteric mechanism. Here, using a combination of computational and experimental techniques, we show that the intracellular N terminus of gamma-ENaC undergoes secondary structural transitions upon interaction with phosphoinositides. From ab initio folding simulations of the N termini in the presence and absence of phosphatidylinositol 4,5-bisphosphate (PIP2), we found that PIP2 increases alpha-helical propensity in the N terminus of gamma-ENaC. Electrophysiology and mutation experiments revealed that a highly conserved cluster of lysines in the gamma-ENaC N terminus regulates accessibility of extracellular cleavage sites in gamma-ENaC. We also show that conditions that decrease PIP2 or enhance ubiquitination sharply limit access of the gamma-ENaC extracellular domain to proteases. Further, the efficiency of allosteric control of ENaC proteolysis is dependent on Tyr(370) in gamma-ENaC. Our findings provide an allosteric mechanism for ENaC activation regulated by the N termini and sheds light on a potential general mechanism of channel and receptor activation.	[Kota, Pradeep; Chakraborty, Hirak; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Dept Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Gentzsch, Martina] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Dang, Yan L.; He, Hong; Gentzsch, Martina; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Buchner, Ginka; Kubelka, Jan] Univ Wyoming, Dept Chem, Laramie, WY 82071 USA; [Garcia, Guilherme J. M.] Med Coll Wisconsin, Dept Otolaryngol & Human Commun, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wyoming; Medical College of Wisconsin	Dokholyan, NV (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dokh@unc.edu	Garcia, Guilherme/J-9555-2013; Dokholyan, Nikolay/D-8081-2018; Gentzsch, Martina/AAY-1815-2021	Garcia, Guilherme/0000-0003-2995-9226; Dokholyan, Nikolay/0000-0002-8225-4025; 	National Institutes of Health [P01 HL 110873-01]; National Science Foundation [0846140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 HL 110873-01. This work was also supported by National Science Foundation Career Grant 0846140 (to J. K.).	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Chakraborty H, 2012, BIOCHEMISTRY-US, V51, P1005, DOI 10.1021/bi300025c; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Haerteis S, 2012, J GEN PHYSIOL, V140, P375, DOI 10.1085/jgp.201110763; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Tong QS, 2005, AM J PHYSIOL-RENAL, V288, pF150, DOI 10.1152/ajprenal.00261.2004; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang ZR, 2010, PFLUG ARCH EUR J PHY, V459, P377, DOI 10.1007/s00424-009-0733-4; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	47	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23029	23042		10.1074/jbc.M114.570952	http://dx.doi.org/10.1074/jbc.M114.570952			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973914	hybrid, Green Published			2022-12-28	WOS:000341017200041
J	Lin, TF; Lin, IW; Chen, SC; Wu, HH; Yang, CS; Fang, HY; Chiu, MM; Jeng, CJ				Lin, Ting-Feng; Lin, I-Wen; Chen, Shu-Ching; Wu, Hao-Han; Yang, Chi-Sheng; Fang, Hsin-Yu; Chiu, Mei-Miao; Jeng, Chung-Jiuan			The Subfamily-specific Assembly of Eag and Erg K+ Channels Is Determined by Both the Amino and the Carboxyl Recognition Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; SUBUNIT STOICHIOMETRY; TERMINAL REGION; C-TERMINUS; SHAKER; TETRAMERIZATION; LOCALIZATION; PROTEIN; DISTAL; MOUSE	A functional voltage-gated K+ (Kv) channel comprises four pore-forming alpha-subunits, and only members of the same Kv channel subfamily may co-assemble to form heterotetramers. The ether-a-go-go family of Kv channels (KCNH) encompasses three distinct subfamilies: Eag (Kv10), Erg (Kv11), and Elk (Kv12). Members of different ether-a-go-go subfamilies, such as Eag and Erg, fail to form heterotetramers. Although a short stretch of amino acid sequences in the distal C-terminal section has been implicated in subfamily-specific subunit assembly, it remains unclear whether this region serves as the sole and/or principal subfamily recognition domain for Eag and Erg. Here we aim to ascertain the structural basis underlying the subfamily specificity of ether-a-go-go channels by generating various chimeric constructs between rat Eag1 and human Erg subunits. Biochemical and electrophysiological characterizations of the subunit interaction properties of a series of different chimeric and truncation constructs over the C terminus suggested that the putative C-terminal recognition domain is dispensable for subfamily-specific assembly. Further chimeric analyses over the N terminus revealed that the N-terminal region may also harbor a subfamily recognition domain. Importantly, exchanging either the N-terminal or the C-terminal domain alone led to a virtual loss of the intersubfamily assembly boundary. By contrast, simultaneously swapping both recognition domains resulted in a reversal of subfamily specificity. Our observations are consistent with the notion that both the N-terminal and the C-terminal recognition domains are required to sustain the subfamily-specific assembly of rat Eag1 and human Erg.	[Lin, Ting-Feng; Lin, I-Wen; Wu, Hao-Han; Yang, Chi-Sheng; Fang, Hsin-Yu; Chiu, Mei-Miao; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan; [Jeng, Chung-Jiuan] Natl Yang Ming Univ, Brain Res Ctr, Taipei 12212, Taiwan; [Chen, Shu-Ching] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, 155,Sect 2,Li Non St, Taipei 12212, Taiwan.	cjjeng@ym.edu.tw		Chen, Shu-Ching/0000-0001-9112-1526; Lin, Ting-Feng/0000-0003-0261-8309	National Science Council, Taiwan [NSC101-2320-B-010-038-MY3]; Aim for the Top University Plan, Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan, Ministry of Education, Taiwan	This work was supported by research grants from the National Science Council, Taiwan (Grant NSC101-2320-B-010-038-MY3) and from the Aim for the Top University Plan, Ministry of Education, Taiwan.	Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Chen IH, 2011, J BIOL CHEM, V286, P27183, DOI 10.1074/jbc.M111.233825; Choe CU, 2006, HUM MOL GENET, V15, P2888, DOI 10.1093/hmg/ddl230; Chuang CC, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-23; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Gong QM, 2004, J MOL CELL CARDIOL, V37, P1225, DOI 10.1016/j.yjmcc.2004.10.002; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hille B., 2001, ION CHANNELS EXCITAB, P131; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; LeesMiller JP, 1997, CIRC RES, V81, P719; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; London B, 1997, CIRC RES, V81, P870; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Sahoo N, 2010, FEBS LETT, V584, P3896, DOI 10.1016/j.febslet.2010.07.063; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	43	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22815	22834		10.1074/jbc.M114.574814	http://dx.doi.org/10.1074/jbc.M114.574814			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	25008323	hybrid, Green Published			2022-12-28	WOS:000341017200025
J	Antanasijevic, A; Basu, A; Bowlin, TL; Mishra, RK; Rong, LJ; Caffrey, M				Antanasijevic, Aleksandar; Basu, Arnab; Bowlin, Terry L.; Mishra, Rama K.; Rong, Lijun; Caffrey, Michael			Mutagenesis Studies of the H5 Influenza Hemagglutinin Stem Loop Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS HEMAGGLUTININ; RECEPTOR-BINDING; MEMBRANE-FUSION; PH; IDENTIFICATION; RESIDUES; ANTIBODY; PEPTIDE; COMPLEX; PROTEIN	Influenza outbreaks, particularly the pandemic 1918 H1 and avian H5 strains, are of high concern to public health. The hemagglutinin envelope protein of influenza plays a critical role in viral entry and thus is an attractive target for inhibition of virus entry. The highly conserved stem loop region of hemagglutinin has been shown to undergo critically important conformational changes during the entry process and, moreover, to be a site for inhibition of virus entry by antibodies, small proteins, and small drug-like molecules. In this work we probe the structure- function properties of the H5 hemagglutinin stem loop region by site-directed mutagenesis. We find that most mutations do not disrupt expression, proteolytic processing, incorporation into virus, or receptor binding; however, many of the mutations disrupt the entry process. We further assess the effects of mutations on inhibition of entry by a neutralizing monoclonal antibody (C179) and find examples of increased and decreased sensitivity to the antibody, consistent with the antibody binding site observed by x-ray crystallography. In addition, we tested the sensitivity of the mutants to MBX2329, a small molecule inhibitor of influenza entry. Interestingly, the mutants exhibit increased and decreased sensitivities to MBX2329, which gives further insight into the binding site of the compound on HA and potential mechanisms of escape. Finally, we have modeled the binding site of MBX2329 using molecular dynamics and find that the resulting structure is in good agreement with the mutagenesis results. Together these studies underscore the importance of the stem loop region to HA function and suggest potential sites for therapeutic intervention of influenza entry.	[Antanasijevic, Aleksandar; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Basu, Arnab; Bowlin, Terry L.] Microbiotix Inc, Worcester, MA 01605 USA; [Mishra, Rama K.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), 900 S Ashland, Chicago, IL 60607 USA.	caffrey@uic.edu			National Institutes of Health from DHHS [5R44AI072861, 1R21AI101676]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI072861, R21AI101676, R43AI072861] Funding Source: NIH RePORTER	National Institutes of Health from DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R44AI072861 and 1R21AI101676 from the DHHS. Molecular Modeling work was provided by the Center for Molecular Innovation and Drug Discovery, Northwestern University, supported by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust.	Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Casali M, 2008, PROTEIN ENG DES SEL, V21, P395, DOI 10.1093/protein/gzn018; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Jiang Haiqing, 2009, Virologica Sinica, V24, P121, DOI 10.1007/s12250-009-3015-6; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lagoja IM, 2008, MED RES REV, V28, P1, DOI 10.1002/med.20096; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Qiao H, 1998, J CELL BIOL, V141, P1335, DOI 10.1083/jcb.141.6.1335; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schrodinger LLC, 2012, MACR VERS 9 8; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tripos International, 2013, SYBYLX 1 3; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	31	6	7	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22237	22245		10.1074/jbc.M114.572974	http://dx.doi.org/10.1074/jbc.M114.572974			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24947513	hybrid, Green Published			2022-12-28	WOS:000340593500037
J	Ergel, B; Gill, ML; Brown, L; Yu, BM; Palmer, AG; Hunt, JF				Ergel, Burce; Gill, Michelle L.; Brown, Lewis; Yu, Bomina; Palmer, Arthur G., III; Hunt, John F.			Protein Dynamics Control the Progression and Efficiency of the Catalytic Reaction Cycle of the Escherichia coli DNA-Repair Enzyme AlkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Enzyme Mechanism; Nuclear Magnetic Resonance (NMR); Protein Dynamic; X-ray Crystallography; AlkB; Fe-2OG Dioxygenase; Catalytic Efficiency; Fluorescence Spectroscopy	ALPHA-KETOGLUTARATE DIOXYGENASE; SPIN FE(IV) INTERMEDIATE; TRIOSEPHOSPHATE ISOMERASE; NMR-SPECTROSCOPY; OXIDATIVE DEMETHYLATION; OXYGEN ACTIVATION; SUBSTRATE-BINDING; KINETIC-ANALYSIS; LOOP MOTION; HYDROXYLASE	Background: AlkB is an iron/2-oxoglutarate dioxygenase that repairs alkylated DNA. Results: Enzymological and biophysical methods are used to develop a quantitative mechanistic scheme. Conclusion: A conformational transition controls the order of substrate binding and the coupling of the two sequential sub-reactions catalyzed by AlkB. Significance: These results provide a striking example of the importance of protein dynamics for efficient catalysis of a multistep reaction. A central goal of enzymology is to understand the physicochemical mechanisms that enable proteins to catalyze complex chemical reactions with high efficiency. Recent methodological advances enable the contribution of protein dynamics to enzyme efficiency to be explored more deeply. Here, we utilize enzymological and biophysical studies, including NMR measurements of conformational dynamics, to develop a quantitative mechanistic scheme for the DNA repair enzyme AlkB. Like other iron/2-oxoglutarate-dependent dioxygenases, AlkB employs a two-step mechanism in which oxidation of 2-oxoglutarate generates a highly reactive enzyme-bound oxyferryl intermediate that, in the case of AlkB, slowly hydroxylates an alkylated nucleobase. Our results demonstrate that a microsecond-to-millisecond time scale conformational transition facilitates the proper sequential order of substrate binding to AlkB. Mutations altering the dynamics of this transition allow generation of the oxyferryl intermediate but promote its premature quenching by solvent, which uncouples 2-oxoglutarate turnover from nucleobase oxidation. Therefore, efficient catalysis by AlkB depends upon the dynamics of a specific conformational transition, establishing another paradigm for the control of enzyme function by protein dynamics.	[Ergel, Burce; Brown, Lewis; Yu, Bomina; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Gill, Michelle L.; Palmer, Arthur G., III] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr, 702A,MC2434, New York, NY 10027 USA.	jfhunt@biology.columbia.edu		Gill, Michelle/0000-0002-2861-355X	National Institutes of Health; Keck Foundation (New York State); New York City Economic Development Corp.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050291, F32GM089047, U54GM094597, U54GM074958, R01GM077360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation (New York State)(W.M. Keck Foundation); New York City Economic Development Corp.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Victor Wong for technical assistance and Brent Stockwell and Scott Banta for instrumentation access. We thank Christie Brouillette and Wendy Yang of the University of Alabama and Chi Wang and other members of the Hunt and Palmer laboratories for advice. The 900 MHz spectrometers were purchased with funds from the National Institutes of Health, the Keck Foundation (New York State), and the New York City Economic Development Corp.	ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; Barrett P, 2004, ASTRONOMICAL DATA AN; Besley NA, 1999, J AM CHEM SOC, V121, P9636, DOI 10.1021/ja990627l; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Bleijlevens B, 2012, BIOCHEMISTRY-US, V51, P3334, DOI 10.1021/bi201699e; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dinglay S, 2000, GENE DEV, V14, P2097; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Eser BE, 2007, J AM CHEM SOC, V129, P11334, DOI 10.1021/ja074446s; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Farid S, 2011, J AM CHEM SOC, V133, P11580, DOI 10.1021/ja2024367; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gill ML, 2011, J BIOMOL NMR, V51, P245, DOI 10.1007/s10858-011-9533-1; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hammes GG, 2011, BIOCHEMISTRY-US, V50, P10422, DOI 10.1021/bi201486f; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Holland PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008680; HOLME E, 1975, BIOCHEMISTRY-US, V14, P4999, DOI 10.1021/bi00693a033; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P334; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Massi F, 2006, BIOCHEMISTRY-US, V45, P10787, DOI 10.1021/bi060764c; McClendon S, 2005, BIOPHYS J, V89, P2024, DOI 10.1529/biophysj.105.062604; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; MYLLYLA R, 1977, EUR J BIOCHEM, V80, P349, DOI 10.1111/j.1432-1033.1977.tb11889.x; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Panay AJ, 2011, BIOCHEMISTRY-US, V50, P1928, DOI 10.1021/bi1019868; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; RICCI RW, 1976, J PHYS CHEM-US, V80, P974, DOI 10.1021/j100550a011; Riggs-Gelasco PJ, 2004, J AM CHEM SOC, V126, P8108, DOI 10.1021/ja048255q; Ryle MJ, 1999, BIOCHEMISTRY-US, V38, P15278, DOI 10.1021/bi9912746; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sillen A, 2000, PROTEIN SCI, V9, P158; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stafford KA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003218; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Xu YM, 2010, J MOL BIOL, V397, P233, DOI 10.1016/j.jmb.2009.10.043; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu B, 2009, P NATL ACAD SCI USA, V106, P14315, DOI 10.1073/pnas.0812938106; Zhou J, 1998, J AM CHEM SOC, V120, P13539, DOI 10.1021/ja983534x	68	29	38	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2014	289	43					29584	29601		10.1074/jbc.M114.575647	http://dx.doi.org/10.1074/jbc.M114.575647			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AS6JU	25043760	Green Published, hybrid			2022-12-28	WOS:000344370800010
J	van der Burgh, R; Pervolaraki, K; Turkenburg, M; Waterham, HR; Frenkel, J; Boes, M				van der Burgh, Robert; Pervolaraki, Kalliopi; Turkenburg, Marjolein; Waterham, Hans R.; Frenkel, Joost; Boes, Marianne			Unprenylated RhoA Contributes to IL-1 beta Hypersecretion in Mevalonate Kinase Deficiency Model through Stimulation of Rac1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Interleukin; Protein Isoprenylation; Ras Homolog Gene Family; Member A (RhoA); Ras-related C3 Botulinum Toxin Substrate 1 (Rac1); Small GTPase; Autoinflammatory-disorder; Mitochondrial Elongation	CELL-ADHESION; SMALL GTPASES; FAMILY; INHIBITION; ACTIVATION; BIOSYNTHESIS; PRENYLATION; CASPASE-1; AUTOPHAGY; MIGRATION	Background: Shortage of isoprenoids causes aberrant activity of prenylated small GTPases. Results: Inactivation of RhoA due to lack of prenylation leads to Rac1 activation and subsequent priming for IL-1 secretion. Conclusion: RhoA inactivation contributes to the pathology of isoprenoid deficiency. Significance: Insight into the multiple networks involving RhoA will benefit new intervention strategies in prenylation-related pathologies. Protein prenylation is a post-translational modification whereby non-sterol isoprenoid lipid chains are added, thereby modifying the molecular partners with which proteins interact. The autoinflammatory disease mevalonate kinase deficiency (MKD) is characterized by a severe reduction in protein prenylation. A major class of proteins that are affected are small GTPases, including Rac1 and RhoA. It is not clear how protein prenylation of small GTPases relates to GTP hydrolysis activity and downstream signaling. Here, we investigated the contribution of RhoA prenylation to the biochemical pathways that underlie MKD-associated IL-1 hypersecretion using human cell cultures, Rac1 and RhoA protein variants, and pharmacological inhibitors. We found that when unprenylated, the GTP-bound levels of RhoA decrease, causing a reduction in GTPase activity and increased protein kinase B (PKB) phosphorylation. Cells expressing unprenylated RhoA produce increased levels of interleukin 1 mRNA. Of other phenotypic cellular changes seen in MKD, increased mitochondrial potential and mitochondrial elongation, only mitochondrial elongation was observed. Finally, we show that pharmacological inactivation of RhoA boosts Rac1 activity, a small GTPase whose activity was earlier implied in MKD pathogenesis. Together, our data show that RhoA plays a pivotal role in MKD pathogenesis through Rac1/PKB signaling toward interleukin 1 production and elucidate the effects of protein prenylation in monocytes.	[van der Burgh, Robert; Pervolaraki, Kalliopi; Frenkel, Joost; Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, NL-3584 EA Utrecht, Netherlands; [Turkenburg, Marjolein; Waterham, Hans R.] Univ Amsterdam, Amsterdam Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam	Boes, M (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands.	mboes@umcutrecht.nl		Boes, Marianne/0000-0003-2590-1692				Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chatterjee M, 2011, INT J CANCER, V129, P61, DOI 10.1002/ijc.25655; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Henneman L, 2010, J INHERIT METAB DIS, V33, P625, DOI 10.1007/s10545-010-9173-8; Hiraoka M, 2004, LIFE SCI, V75, P1333, DOI 10.1016/j.lfs.2004.02.028; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Houten SM, 2003, J BIOL CHEM, V278, P5736, DOI 10.1074/jbc.M206564200; Huang S, 2001, J BIOL CHEM, V276, P40977, DOI 10.1074/jbc.M105242200; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kuijk LM, 2008, BLOOD, V112, P3563, DOI 10.1182/blood-2008-03-144667; Kuijk LM, 2008, MOL IMMUNOL, V45, P2158, DOI 10.1016/j.molimm.2007.12.008; Li DH, 2010, ENDOCRINOLOGY, V151, P4313, DOI 10.1210/en.2010-0044; LUTZ RJ, 1992, J BIOL CHEM, V267, P7983; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Nakagami H, 2003, ANN MED, V35, P398, DOI 10.1080/07853890310001294; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Turner SJ, 2008, BIOCHEM PHARMACOL, V75, P405, DOI 10.1016/j.bcp.2007.08.031; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Zhang J, 2013, INT J BIOCHEM CELL B, V45, P745, DOI 10.1016/j.biocel.2012.11.001	38	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27757	27765		10.1074/jbc.M114.571810	http://dx.doi.org/10.1074/jbc.M114.571810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25107911	hybrid, Green Published			2022-12-28	WOS:000342852800033
J	Ishii, M; Shibata, R; Kondo, K; Kambara, T; Shimizu, Y; Tanigawa, T; Bando, YK; Nishimura, M; Ouchi, N; Murohara, T				Ishii, Masakazu; Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Shimizu, Yuuki; Tanigawa, Tohru; Bando, Yasuko K.; Nishimura, Masahiro; Ouchi, Noriyuki; Murohara, Toyoaki			Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; STEM-CELLS; ANGIOGENESIS; ADIPONECTIN; PATHOPHYSIOLOGY; SITAGLIPTIN; REPERFUSION; PRESSURE	Dipeptidyl peptidase-4 inhibitors are known to lower glucose levels and are also beneficial in the management of cardiovascular disease. Here, we investigated whether a dipeptidyl peptidase-4 inhibitor, vildagliptin, modulates endothelial cell network formation and revascularization processes in vitro and in vivo. Treatment with vildagliptin enhanced blood flow recovery and capillary density in the ischemic limbs of wild-type mice, with accompanying increases in phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). In contrast to wildtype mice, treatment with vildagliptin did not improve blood flow in ischemic muscles of eNOS-deficient mice. Treatment with vildagliptin increased the levels of glucagon-like peptide-1 (GLP-1) and adiponectin, which have protective effects on the vasculature. Both vildagliptin and GLP-1 increased the differentiation of cultured human umbilical vein endothelial cells (HUVECs) into vascular-like structures, although vildagliptin was less effective than GLP-1. GLP-1 and vildagliptin also stimulated the phosphorylation of Akt and eNOS in HUVECs. Pretreatment with a PI3 kinase or NOS inhibitor blocked the stimulatory effects of both vildagliptin and GLP-1 on HUVEC differentiation. Furthermore, treatment with vildagliptin only partially increased the limb flow of ischemic muscle in adiponectin-deficient mice in vivo. GLP-1, but not vildagliptin, significantly increased adiponectin expression in differentiated 3T3-L1 adipocytes in vitro. These data indicate that vildagliptin promotes endothelial cell function via eNOS signaling, an effect that may be mediated by both GLP-1-dependent and GLP-1-independent mechanisms. The beneficial activity of GLP-1 for revascularization may also be partially mediated by its ability to increase adiponectin production.	[Ishii, Masakazu; Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Shimizu, Yuuki; Bando, Yasuko K.; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Tanigawa, Tohru] Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi 4801195, Japan; [Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Ishii, Masakazu; Nishimura, Masahiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Prosthodont, Kagoshima 8908544, Japan	Nagoya University; Aichi Medical University; Nagoya University; Kagoshima University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Bando, Yasuko K./M-4831-2014; Murohara, Toyoaki/M-4958-2014; Nishimura, Masahiro/ABD-7504-2020; OUCHI, Noriyuki/I-7306-2014	Bando, Yasuko K./0000-0003-4166-6784; Nishimura, Masahiro/0000-0001-5552-0693; 	Banyu Life Science Foundation International; Kanae Foundation; Kowa Life Science Foundation	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Kanae Foundation; Kowa Life Science Foundation	This work was supported by a grant-in-aid for Young Scientists B, Banyu Life Science Foundation International, the Kanae Foundation, and the Kowa Life Science Foundation (to R. S.).	Aronis KN, 2013, METABOLISM, V62, P1279, DOI 10.1016/j.metabol.2013.04.010; Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Chrysant SG, 2012, AM J CARDIOL, V109, P1681, DOI 10.1016/j.amjcard.2012.01.398; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Dai Y, 2013, ACTA DIABETOL, V50, P827, DOI 10.1007/s00592-013-0496-4; Ding L, 2012, ACTA PHARMACOL SIN, V33, P75, DOI 10.1038/aps.2011.149; Fadini GP, 2013, ATHEROSCLEROSIS, V229, P23, DOI 10.1016/j.atherosclerosis.2013.04.007; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Ishii M, 2011, ARTERIOSCL THROM VAS, V31, P2210, DOI 10.1161/ATVBAHA.111.231100; Jungraithmayr W, 2012, EUR J CARDIO-THORAC, V41, P1166, DOI 10.1093/ejcts/ezr180; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Kubota Y, 2012, J KOREAN MED SCI, V27, P1364, DOI 10.3346/jkms.2012.27.11.1364; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035007; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Miyagawa K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-160; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Murohara T, 2012, J AM COLL CARDIOL, V59, P277, DOI 10.1016/j.jacc.2011.09.050; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shah Z, 2011, VASC PHARMACOL, V55, P2, DOI 10.1016/j.vph.2011.03.001; Sheikh A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-47; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shimizu S, 2012, J MOL ENDOCRINOL, V49, P125, DOI 10.1530/JME-12-0039; Shimizu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000438; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; Takasawa W, 2010, BIOCHEM BIOPH RES CO, V401, P7, DOI 10.1016/j.bbrc.2010.08.112; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Wang CCL, 2012, AM J CARDIOL, V110, p58B, DOI 10.1016/j.amjcard.2012.08.036; Wang XM, 2013, CARDIOVASC DRUG THER, V27, P297, DOI 10.1007/s10557-013-6459-8; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026	37	45	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27235	27245		10.1074/jbc.M114.557835	http://dx.doi.org/10.1074/jbc.M114.557835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100725	hybrid, Green Published			2022-12-28	WOS:000342853900046
J	Jiang, YD; Thakran, S; Bheemreddy, R; Ye, EA; He, H; Walker, RJ; Steinle, JJ				Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Ye, Eun-Ah; He, Hui; Walker, Robert J.; Steinle, Jena J.			Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor alpha and Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TNF-ALPHA; MULLER CELLS; VASCULAR DAMAGE; HIGH GLUCOSE; RESISTANCE; PHOSPHORYLATION; EXPRESSION; SOCS-3; INFLAMMATION	Dysfunctional insulin signaling is a key component of type 2 diabetes. Little is understood of the effects of systemic diabetes on retinal insulin signaling. Anumber of agents are used to treat patients with type 2 diabetes to normalize glucose levels and improve insulin signaling; however, little has been done to investigate the effects of these agents on retinal insulin signal transduction. We hypothesized that pioglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist, would normalize retinal insulin signal transduction through reduced tumor necrosis factor alpha (TNF alpha) and suppressor of cytokine signaling 3 (SOCS3) activities in whole retina and retinal endothelial cells (REC) and Muller test this hypothesis, we used the BBZDR/Wor type 2 diabetic rat model, as well as REC and Muller cells cultured in normoglycemia and hyperglycemic conditions, to investigate the effects of pioglitazone on TNF alpha, SOCS3, and downstream insulin signal transduction proteins. We also evaluated pioglitazone's effects on retinal function using electroretinogram and markers of apoptosis. Data demonstrate that 2 months of pioglitazone significantly increased electroretinogram amplitudes in type 2 diabetic obese rats, which was associated with improved insulin receptor activation. These changes occurred in both REC and Muller cells treated with pioglitazone, suggesting that these two cell types are key to insulin resistance in the retina. Taken together, these data provide evidence of impaired insulin signaling in type 2 diabetes rats, which was improved by increasing PPAR gamma activity. Further investigations of PPAR gamma actions in the retina may provide improved treatment options.	[Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Ye, Eun-Ah; Walker, Robert J.; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [He, Hui; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Walker, Robert J.] Philander Smith Coll, Dept Biol, Little Rock, AR 72202 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Philander Smith College	Steinle, JJ (corresponding author), Hamilton Eye Inst, Dept Ophthalmol, 930 Madison Ave,Suite 768A, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu		Steinle, Jena/0000-0002-7539-2892	National Institutes of Health, NEI [R01-EY022330]; National Institutes of Health, PHS [3P30 EY013080]; Juvenile Diabetes Research Foundation [2-2011-597]; Oxnard Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022330, P30EY013080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health, PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oxnard Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants R01-EY022330 (to J. J. S.) and PHS 3P30 EY013080 (to Dianna Johnson). This work was also supported by Juvenile Diabetes Research Foundation Grant 2-2011-597 (to J. J. S.), the Oxnard Foundation (to J. J. S.), and Research to Prevent Blindness (to James C. Fleming).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Collino M, 2010, BRIT J PHARMACOL, V160, P1892, DOI 10.1111/j.1476-5381.2010.00671.x; Ding SY, 2005, ACTA PHARMACOL SIN, V26, P575, DOI 10.1111/j.1745-7254.2005.00090.x; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Ito I, 2006, INVEST OPHTH VIS SCI, V47, P683, DOI 10.1167/iovs.05-1012; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Jiang YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093788; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Joussen AM, 2009, MOL VIS, V15, P1418; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Malchiodi-Albedi F, 2008, PPAR RES, V2008, DOI 10.1155/2008/295784; Moezi L, 2014, INT J EXP PATHOL, V95, P78, DOI 10.1111/iep.12067; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schmidt RE, 2004, J NEUROPATH EXP NEUR, V63, P450, DOI 10.1093/jnen/63.5.450; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Yau H, 2013, CURR DIABETES REP, V13, P329, DOI 10.1007/s11892-013-0378-8; Zerani M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107383; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779; Zhang XY, 2013, INVEST OPHTH VIS SCI, V54, P3912, DOI 10.1167/iovs.13-11614; Zhu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068935	34	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26395	26405		10.1074/jbc.M114.583880	http://dx.doi.org/10.1074/jbc.M114.583880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086044	Green Published, hybrid			2022-12-28	WOS:000342128800031
J	Morales-Lazaro, SL; Serrano-Flores, B; Llorente, I; Hernandez-Garcia, E; Gonzalez-Ramirez, R; Banerjee, S; Miller, D; Gududuru, V; Fells, J; Norman, D; Tigyi, G; Escalante-Alcalde, D; Rosenbaum, T				Morales-Lazaro, Sara L.; Serrano-Flores, Barbara; Llorente, Itzel; Hernandez-Garcia, Enrique; Gonzalez-Ramirez, Ricardo; Banerjee, Souvik; Miller, Duane; Gududuru, Veeresh; Fells, James; Norman, Derek; Tigyi, Gabor; Escalante-Alcalde, Diana; Rosenbaum, Tamara			Structural Determinants of the Transient Receptor Potential 1 (TRPV1) Channel Activation by Phospholipid Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ion Channel; Lysophospholipid; Membrane Lipid; Physiology; Transient Receptor Potential Channels (TRP Channels)	CYCLIC PHOSPHATIDIC-ACID; LYSOPHOSPHATIDIC ACID; DIACYLGLYCEROL PYROPHOSPHATE; NEUROPATHIC PAIN; POTASSIUM CHANNELS; PIP2 ACTIVATION; ION-CHANNEL; FATTY-ACIDS; DOUBLE-BOND; PPAR-GAMMA	Background: The TRPV1 ion channel can be regulated by negatively charged lipids. Results: TRPV1 shows specificity for LPA analogs containing monounsaturated hydrocarbon chains with a negatively charged phosphate, cyclic phosphate, and thiophosphate headgroup. Conclusion: TRPV1 activation is highly restricted to natural lipids with oleyl or oleoyl side chains. Significance: Production of endogenous C18:1 lysophospholipids can selectively trigger activation of TRPV1 and nociceptive neuronal responses. The transient receptor potential vanilloid 1 (TRPV1) ion channel is a polymodal protein that responds to various stimuli, including capsaicin (the pungent compound found in chili peppers), extracellular acid, and basic intracellular pH, temperatures close to 42 degrees C, and several lipids. Lysophosphatidic acid (LPA), an endogenous lipid widely associated with neuropathic pain, is an agonist of the TRPV1 channel found in primary afferent nociceptors and is activated by other noxious stimuli. Agonists or antagonists of lipid and other chemical natures are known to possess specific structural requirements for producing functional effects on their targets. To better understand how LPA and other lipid analogs might interact and affect the function of TRPV1, we set out to determine the structural features of these lipids that result in the activation of TRPV1. By changing the acyl chain length, saturation, and headgroup of these LPA analogs, we established strict requirements for activation of TRPV1. Among the natural LPA analogs, we found that only LPA 18:1, alkylglycerophosphate 18:1, and cyclic phosphatidic acid 18:1, all with a monounsaturated C18 hydrocarbon chain activate TRPV1, whereas polyunsaturated and saturated analogs do not. Thus, TRPV1 shows a more restricted ligand specificity compared with LPA G-protein-coupled receptors. We synthesized fatty alcohol phosphates and thiophosphates and found that many of them with a single double bond in position 9, 10, or 11 and 9 cyclopropyl group can activate TRPV1 with efficacy similar to capsaicin. Finally, we developed a pharmacophore and proposed a mechanistic model for how these lipids could induce a conformational change that activates TRPV1.	[Morales-Lazaro, Sara L.; Serrano-Flores, Barbara; Llorente, Itzel; Hernandez-Garcia, Enrique; Escalante-Alcalde, Diana; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City 04510, DF, Mexico; [Gonzalez-Ramirez, Ricardo] Hosp Gen Dr Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Mexico City 14080, DF, Mexico; [Banerjee, Souvik; Miller, Duane] Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Gududuru, Veeresh] RxBio Inc, Memphis, TN 38163 USA; [Fells, James; Norman, Derek; Tigyi, Gabor] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	Universidad Nacional Autonoma de Mexico; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neurodesarrollo & Fisiol, Div Neurociencias, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Morales-Lázaro, Sara Luz/B-7333-2016; González-Ramírez, Ricardo/O-1792-2014	González-Ramírez, Ricardo/0000-0003-1399-8036; Escalante-Alcalde, Diana/0000-0003-0325-6602; Rosenbaum, Tamara/0000-0002-4791-3195	National Institutes of Health [CA-092160]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN204111]; Consejo Nacional de Ciencia y Tecnologia [129474]; Fundacion Miguel Aleman; Fundacion Marcos Moshinsky; Consejo Nacional de Ciencia y Tecnologia Grant [165897]; Van Vleet Endowment; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [I01BX007080];  [U01-AI-107331]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI107331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman; Fundacion Marcos Moshinsky; Consejo Nacional de Ciencia y Tecnologia Grant; Van Vleet Endowment; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-092160 (to G. T.). This work was also supported by grants from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) IN204111, Consejo Nacional de Ciencia y Tecnologia 129474, Fundacion Miguel Aleman and Fundacion Marcos Moshinsky (to T. R.), Consejo Nacional de Ciencia y Tecnologia Grant 165897 (to D. E.-A.), Grant U01-AI-107331, the Van Vleet Endowment (to G. T.), and by Award I01BX007080 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (to G. T.)	Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bartlett GJ, 2010, NAT CHEM BIOL, V6, P615, DOI [10.1038/NCHEMBIO.406, 10.1038/nchembio.406]; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r; Engler A, 2007, BIOCHEM BIOPH RES CO, V359, P884, DOI 10.1016/j.bbrc.2007.05.178; Gududuru V, 2014, U. S. Patent, Patent No. [8, 686,177 B2, 8686177]; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu GX, 2001, CIRC RES, V88, P918, DOI 10.1161/hh0901.089881; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Martinez-Seara H, 2007, J PHYS CHEM B, V111, P11162, DOI 10.1021/jp071894d; Morales-Lazaro SL, 2013, J PHYSIOL-LONDON, V591, P3109, DOI 10.1113/jphysiol.2013.251751; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Pan HL, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-85; Perillo VL, 2012, BBA-BIOMEMBRANES, V1818, P2511, DOI 10.1016/j.bbamem.2012.06.001; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rosenbaum Tamara, 2007, P69; Sadofsky LR, 2012, EXP LUNG RES, V38, P75, DOI 10.3109/01902148.2011.644027; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Senning EN, 2014, J BIOL CHEM, V289, P10999, DOI 10.1074/jbc.M114.553180; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Telezhkin V, 2012, J GEN PHYSIOL, V140, P41, DOI 10.1085/jgp.201210796; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; van Schooten B, 2006, BBA-MOL CELL BIOL L, V1761, P151, DOI 10.1016/j.bbalip.2005.12.010; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006	48	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24079	24090		10.1074/jbc.M114.572503	http://dx.doi.org/10.1074/jbc.M114.572503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035428	Green Published, hybrid			2022-12-28	WOS:000341505600008
J	Suzuki, Y; Jin, CH; Iwase, T; Yazawa, I				Suzuki, Yasuyo; Jin, Chenghua; Iwase, Tamaki; Yazawa, Ikuru			beta-III Tubulin Fragments Inhibit alpha-Synuclein Accumulation in Models of Multiple System Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-Synuclein; Neurodegeneration; Protein Aggregation; Protein-Protein Interaction; Tubulin; Multiple System Atrophy	DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; MOUSE MODEL; NEURODEGENERATIVE DISEASES; NEURONAL DEGENERATION; THERAPEUTIC PEPTIDES; PARKINSONS-DISEASE; FIBRIL FORMATION; OLIGODENDROCYTES; DELIVERY	Background: Neuronal and oligodendrocytic aggregation of insoluble -synuclein contributes to neuropathology in multiple system atrophy. Results: -Synuclein binds directly to -III tubulin. A fragment carrying the -synuclein-binding site inhibited -synuclein-III tubulin complex formation and intracellular -synuclein accumulation. Conclusion: Inhibition of -synuclein binding to -III tubulin may be an effective strategy for preventing -synuclein accumulation. Significance: Small -III tubulin fragments may inhibit neurodegeneration in multiple system atrophy. Multiple system atrophy (MSA) is a neurodegenerative disease caused by -synuclein aggregation in oligodendrocytes and neurons. Using a transgenic mouse model overexpressing human -synuclein in oligodendrocytes, we previously demonstrated that oligodendrocytic -synuclein inclusions induce neuronal -synuclein accumulation and progressive neuronal degeneration. -Synuclein binds to -III tubulin, leading to the neuronal accumulation of insoluble -synuclein in an MSA mouse model. The present study demonstrates that -synuclein co-localizes with -III tubulin in the brain tissue from patients with MSA and MSA model transgenic mice as well as neurons cultured from these mice. Accumulation of insoluble -synuclein in MSA mouse neurons was blocked by the peptide fragment -III tubulin (residues 235-282). We have determined the -synuclein-binding domain of -III tubulin and demonstrated that a short fragment containing this domain can suppress -synuclein accumulation in the primary cultured cells. Administration of a short -synuclein-binding fragment of -III tubulin may be a novel therapeutic strategy for MSA.	[Suzuki, Yasuyo; Jin, Chenghua; Yazawa, Ikuru] Natl Ctr Geriatr & Gerontol, Res Inst, Lab Res Resources, Obu, Aichi 4748511, Japan; [Iwase, Tamaki] Nagoya City Koseiin Med Welf Ctr, Dept Neurol, Nagoya, Aichi 4658610, Japan	National Center for Geriatrics & Gerontology	Yazawa, I (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Lab Res Resources, 35 Gengo, Obu, Aichi 4748511, Japan.	yazawaik@ncgg.go.jp		Suzuki, Yasuyo/0000-0002-5732-4888	Japan Foundation for Neuroscience and Mental Health; Japan Society for the Promotion of Science KAKENHI [25430058, 25830045]	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Foundation for Neuroscience and Mental Health and by Japan Society for the Promotion of Science KAKENHI Grants 25430058 and 25830045.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Arima K, 1998, ACTA NEUROPATHOL, V96, P439, DOI 10.1007/s004010050917; Asi YT, 2014, GLIA, V62, P964, DOI 10.1002/glia.22653; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; Fleming SM, 2011, MOL CELL NEUROSCI, V46, P597, DOI 10.1016/j.mcn.2010.12.011; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GRAHAM JG, 1969, J NEUROL NEUROSUR PS, V32, P28, DOI 10.1136/jnnp.32.1.28; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Ito H, 2012, BIOCHEM BIOPH RES CO, V428, P348, DOI 10.1016/j.bbrc.2012.10.057; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; LANTOS PL, 1994, J NEUROL NEUROSUR PS, V57, P129, DOI 10.1136/jnnp.57.2.129; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; Nakayama K, 2012, BIOCHEM BIOPH RES CO, V417, P1170, DOI 10.1016/j.bbrc.2011.12.092; Nakayama K, 2009, AM J PATHOL, V174, P1471, DOI 10.2353/ajpath.2009.080503; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Suzuki Y, 2014, AM J PATHOL, V184, P790, DOI 10.1016/j.ajpath.2013.11.018; Suzuki Y, 2010, FEBS J, V277, P4873, DOI 10.1111/j.1742-4658.2010.07893.x; Tiwari Sandip B., 2006, Current Drug Delivery, V3, P219, DOI 10.2174/156720106776359230; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yazawa I, 1999, BIOCHEM BIOPH RES CO, V260, P133, DOI 10.1006/bbrc.1999.0839	36	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24374	24382		10.1074/jbc.M114.557215	http://dx.doi.org/10.1074/jbc.M114.557215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028513	Green Published, hybrid			2022-12-28	WOS:000341505600032
J	Amorim, NA; da Silva, EML; de Castro, RO; da Silva-Januario, ME; Mendonca, LM; Bonifacino, JS; da Costa, LJ; daSilva, LLP				Amorim, Nathaly A.; da Silva, Eulalia M. L.; de Castro, Rodrigo O.; da Silva-Januario, Mara E.; Mendonca, Luiza M.; Bonifacino, Juan S.; da Costa, Luciana J.; daSilva, Luis L. P.			Interaction of HIV-1 Nef Protein with the Host Protein Alix Promotes Lysosomal Targeting of CD4 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosome; Human Immunodeficiency Virus (HIV); Intracellular Trafficking; Lysosome; Protein Sorting; Alix; Multivesicular Body (MVB); Nef	VIRUS TYPE-1 NEF; LONG-TERM SURVIVOR; DOWN-REGULATION; CELL-SURFACE; BETA-COP; INTRACELLULAR TRAFFICKING; MULTIVESICULAR BODIES; VIRAL REPLICATION; CLATHRIN ADAPTER; SORTING SIGNALS	Background: HIV-1 Nef targets the coreceptor CD4 to the multivesicular body (MVB) pathway for degradation via an unknown mechanism. Results: Nef interacts with Alix in late endosomes, and this is required for efficient lysosomal targeting of CD4. Conclusion: Nef utilizes Alix as an adaptor to target CD4 for lysosomal degradation. Significance: The study clarifies the mechanism by which Nef down-regulates expression of specific host-cell proteins. Nef is an accessory protein of human immunodeficiency viruses that promotes viral replication and progression to AIDS through interference with various host trafficking and signaling pathways. A key function of Nef is the down-regulation of the coreceptor CD4 from the surface of the host cells. Nef-induced CD4 down-regulation involves at least two independent steps as follows: acceleration of CD4 endocytosis by a clathrin/AP-2-dependent pathway and targeting of internalized CD4 to multivesicular bodies (MVBs) for eventual degradation in lysosomes. In a previous work, we found that CD4 targeting to the MVB pathway was independent of CD4 ubiquitination. Here, we report that this targeting depends on a direct interaction of Nef with Alix/AIP1, a protein associated with the endosomal sorting complexes required for transport (ESCRT) machinery that assists with cargo recruitment and intraluminal vesicle formation in MVBs. We show that Nef interacts with both the Bro1 and V domains of Alix. Depletion of Alix or overexpression of the Alix V domain impairs lysosomal degradation of CD4 induced by Nef. In contrast, the V domain overexpression does not prevent cell surface removal of CD4 by Nef or protein targeting to the canonical ubiquitination-dependent MVB pathway. We also show that the Nef-Alix interaction occurs in late endosomes that are enriched in internalized CD4. Together, our results indicate that Alix functions as an adaptor for the ESCRT-dependent, ubiquitin-independent targeting of CD4 to the MVB pathway induced by Nef.	[Amorim, Nathaly A.; da Silva, Eulalia M. L.; de Castro, Rodrigo O.; da Silva-Januario, Mara E.; daSilva, Luis L. P.] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cell & Mol Biol, BR-14049900 Ribeirao Preto, SP, Brazil; [Mendonca, Luiza M.; da Costa, Luciana J.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, BR-21941590 Rio De Janeiro, RJ, Brazil; [Bonifacino, Juan S.] Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	daSilva, LLP (corresponding author), Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cell & Mol Biol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	lldasilva@fmrp.usp.br	LP daSilva, Luis/A-9949-2010; Silva, Mara/HGC-4994-2022; Costa, Luciana J/B-7878-2013; daSilva, Luis LP/AAD-5657-2019	LP daSilva, Luis/0000-0003-3558-0087; Silva, Mara/0000-0001-6375-4502; daSilva, Luis LP/0000-0003-3558-0087; Bonifacino, Juan S./0000-0002-5673-6370	National Institutes of Health, NICHD [ZIA HD001607-22]; Sao Paulo Research Foundation (FAPESP) [2009/50650-6]; Brazilian National Council for Scientific and Technological Development (CNPq) [470707/2009-7]; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas FMRP-USP (FAEPA); FAPESP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008909, ZIAHD001607] Funding Source: NIH RePORTER	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas FMRP-USP (FAEPA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant ZIA HD001607-22 Intramural Program, NICHD (to J. S. B.). This work was also supported by Sao Paulo Research Foundation (FAPESP) Young Investigators Grant 2009/50650-6, the Brazilian National Council for Scientific and Technological Development (CNPq) Grant 470707/2009-7, and the Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas FMRP-USP (FAEPA).; Supported by FAPESP research training scholarships.	Aiken C, 1996, VIROLOGY, V217, P293, DOI 10.1006/viro.1996.0116; ANDERSON SJ, 1994, J VIROL, V68, P3092, DOI 10.1128/JVI.68.5.3092-3101.1994; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bowers K, 1997, INT J BIOCHEM CELL B, V29, P871, DOI 10.1016/S1357-2725(96)00154-9; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; da Costa LJ, 2009, VIROLOGY, V394, P47, DOI 10.1016/j.virol.2009.08.024; daSilva LLP, 2005, PLANT CELL, V17, P132, DOI 10.1105/tpc.104.026351; Dasilva LLP, 2006, PLANT CELL, V18, P1477, DOI 10.1105/tpc.105.040394; daSilva LLP, 2009, J VIROL, V83, P6578, DOI 10.1128/JVI.00548-09; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henry AG, 2011, TRAFFIC, V12, P170, DOI 10.1111/j.1600-0854.2010.01145.x; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Janvier K, 2001, J VIROL, V75, P3971, DOI 10.1128/JVI.75.8.3971-3976.2001; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Katoh K, 2004, ARCH BIOCHEM BIOPHYS, V421, P159, DOI 10.1016/j.abb.2003.09.038; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rasband W. S., 1997, IMAGEJ VERSION 1 47; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; SANFRIDSON A, 1994, J BIOL CHEM, V269, P3917; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Yamashita Y, 2008, J CELL SCI, V121, P1727, DOI 10.1242/jcs.024455	80	30	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27744	27756		10.1074/jbc.M114.560193	http://dx.doi.org/10.1074/jbc.M114.560193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25118280	Green Published, hybrid			2022-12-28	WOS:000342852800032
J	Bao, Y; Ledderose, C; Seier, T; Graf, AF; Brix, B; Chong, E; Junger, WG				Bao, Yi; Ledderose, Carola; Seier, Thomas; Graf, Amelie F.; Brix, Bianca; Chong, Eritza; Junger, Wolfgang G.			Mitochondria Regulate Neutrophil Activation by Generating ATP for Autocrine Purinergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; DISTINCT PHASES; RELEASE; APOPTOSIS; RECEPTORS; CALCIUM; PHAGOCYTOSIS; SUPEROXIDE; CHEMOTAXIS; MECHANISM	Polymorphonuclear neutrophils (PMNs) form the first line of defense against invading microorganisms. We have shown previously that ATP release and autocrine purinergic signaling via P2Y2 receptors are essential for PMN activation. Here we show that mitochondria provide the ATP that initiates PMN activation. Stimulation of formyl peptide receptors increases the mitochondrial membrane potential (Delta psi m) and triggers a rapid burst of ATP release from PMNs. This burst of ATP release can be blocked by inhibitors of mitochondrial ATP production and requires an initial formyl peptide receptor-induced Ca2+ signal that triggers mitochondrial activation. The burst of ATP release generated by the mitochondria fuels a first phase of purinergic signaling that boosts Ca2+ signaling, amplifies mitochondrial ATP production, and initiates functional PMN responses. Cells then switch to glycolytic ATP production, which fuels a second round of purinergic signaling that sustains Ca2+ signaling via P2X receptor-mediated Ca2+ influx and maintains functional PMN responses such as oxidative burst, degranulation, and phagocytosis.	[Bao, Yi; Ledderose, Carola; Seier, Thomas; Graf, Amelie F.; Brix, Bianca; Chong, Eritza; Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Seier, Thomas; Graf, Amelie F.] Paracelsus Med Univ, A-5020 Salzburg, Austria; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Paracelsus Private Medical University; Ludwig Boltzmann Institute	Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; Bao, Yi/J-5418-2013; Seier, Thomas/AAI-2324-2019	Junger, Wolfgang G/0000-0003-3350-8452; Bao, Yi/0000-0003-0748-1575	National Institutes of Health Grants [GM-51477, GM-60475, AI-072287, AI-080582]; Congressionally Directed Medical Research Program [PR043034]; Deutsche Forschungsgemeinschaft [LE-3209/1-1]; Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072287, R01AI080582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116162, R01GM051477, R01GM060475, R29GM051477] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program(United States Department of Defense); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-51477, GM-60475, AI-072287, and AI-080582 (to W. G. J.). This work was also supported by Congressionally Directed Medical Research Program PR043034 (to W. G. J.) and Deutsche Forschungsgemeinschaft Grant LE-3209/1-1 (to C. L.) and by support provided through the Harvard Digestive Diseases Center.	Alkayed F, 2012, J PHARMACOL SCI, V120, P288, DOI 10.1254/jphs.12173FP; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Brechard S, 2008, J LEUKOCYTE BIOL, V84, P1223, DOI 10.1189/jlb.0807553; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Burnstock G., 2012, PURINERG SIGNAL, P79; CHANDLER DE, 1987, BIOCHIM BIOPHYS ACTA, V931, P175, DOI 10.1016/0167-4889(87)90204-7; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2012, METHODS MOL BIOL, V844, P115, DOI 10.1007/978-1-61779-527-5_8; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Christie DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037144; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Corriden R, 2007, AM J PHYSIOL-CELL PH, V293, pC1420, DOI 10.1152/ajpcell.00271.2007; Delogu G, 2001, ACTA ANAESTH SCAND, V45, P87, DOI 10.1034/j.1399-6576.2001.450114.x; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Hu ZH, 2004, AM J PHYSIOL-CELL PH, V286, pC170, DOI 10.1152/ajpcell.00187.2003; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kaminski MM, 2012, BBA-MOL CELL RES, V1823, P1041, DOI 10.1016/j.bbamcr.2012.03.003; Kong CW, 2004, SHOCK, V21, P315, DOI 10.1097/00024382-200404000-00005; Kukulski F, 2011, J IMMUNOL, V187, P644, DOI 10.4049/jimmunol.1002680; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Liu B, 2011, CARDIOVASC RES, V91, P124, DOI 10.1093/cvr/cvr033; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; McGovern NN, 2011, J IMMUNOL, V186, P453, DOI 10.4049/jimmunol.1002213; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; SIMMS HH, 1994, SHOCK, V1, P10, DOI 10.1097/00024382-199401000-00003; Taneja R, 2004, CRIT CARE MED, V32, P1460, DOI 10.1097/01.CCM.0000129975.26905.77; Thompson AAR, 2013, BIOL CHEM, V394, P471, DOI 10.1515/hsz-2012-0335; Walmsley SR, 2006, BLOOD, V108, P3176, DOI 10.1182/blood-2006-04-018796; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	43	69	72	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26794	26803		10.1074/jbc.M114.572495	http://dx.doi.org/10.1074/jbc.M114.572495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25104353	Green Published, hybrid			2022-12-28	WOS:000342853900012
J	Chanmee, T; Ontong, P; Mochizuki, N; Kongtawelert, P; Konno, K; Itano, N				Chanmee, Theerawut; Ontong, Pawared; Mochizuki, Nobutoshi; Kongtawelert, Prachya; Konno, Kenjiro; Itano, Naoki			Excessive Hyaluronan Production Promotes Acquisition of Cancer Stem Cell Signatures through the Coordinated Regulation of Twist and the Transforming Growth Factor beta (TGF-beta)-Snail Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; STROMAL HYALURONAN; SIDE POPULATION; SYNTHASE HAS2; CARCINOMA; INVASION; SUBPOPULATION; METASTASIS; PHENOTYPE	The cancer stem cell (CSC) model suggests that a small subpopulation of cancer cells possesses the ability to self-renew and give rise to malignant progeny that drive cancer progression. Recent reports have also proposed the existence of certain extra- or intracellular signals that allow cancer progenitors to dynamically revert to a stem cell state. However, the mechanisms underlying cancer cell plasticity and CSC expansion are not entirely clear. Our previous studies using a hyaluronan synthase 2 (Has2) transgenic mouse model demonstrated that hyaluronan overproduction caused rapid development of aggressive breast carcinoma at a high incidence. Thus, we hypothesize that hyaluronan overproduction may accelerate cancer progression by expanding CSC subpopulations during cancer development. Primary cancer cells were established from mammary tumors developed in the transgenic mice and subjected to the Hoechst 33342 dye exclusion assay to sort side population (SP) from nonside population (non-SP) cells. Flow cytometric analysis demonstrated the enrichment of CD44(high)/CD24(low) CSC-like cells in the SP fraction of hyaluronan-overproducing cancer cells. This subpopulation exhibited several characteristics that were similar to CSCs, including cancer-initiating and mammosphere-forming abilities. Excess hyaluronan production drove the epithelial-to-mesenchymal transition process defined as the loss of epithelial phenotypes, up-regulation of transforming growth factor beta (TGF-beta), and induction of the epithelial-to-mesenchymal transition-related transcriptional factors Snail and Twist. Inhibition of TGF-beta-Snail signaling or silencing of Twist expression abrogated the entrance into a stem cell state. Taken together, our findings suggest that hyaluronan overproduction allows plastic cancer cell populations to revert to stem cell states via Twist and the TGF-beta-Snail signaling axis.	[Chanmee, Theerawut; Itano, Naoki] Kyoto Sangyo Univ, Inst Adv Technol, Kita Ku, Kyoto 6038555, Japan; [Ontong, Pawared; Itano, Naoki] Kyoto Sangyo Univ, Div Engn Biotechnol, Grad Sch Engn, Kita Ku, Kyoto 6038555, Japan; [Mochizuki, Nobutoshi; Itano, Naoki] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn & Stem Cells, Chiang Mai 50200, Thailand; [Konno, Kenjiro] Kyoto Sangyo Univ, Dept Anim Med Sci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Kyoto Sangyo University; Chiang Mai University; Kyoto Sangyo University	Konno, K (corresponding author), Kyoto Sangyo Univ, Dept Anim Med Sci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	kkonno@cc.kyoto-su.ac.jp; itanon@cc.kyoto-su.ac.jp	Xia, Bo/P-9380-2016	kongtawelert, prachya/0000-0002-5963-2796; Chanmee, Theerawut/0000-0001-6577-4216	Japan Society for the Promotion of Science KAKENHI [23590478, 26430125]; Kyoto Sangyo University Research Grant [C1301]; Royal Golden Jubilee Ph.D. Program Grant [PHD/0258/2549]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto Sangyo University Research Grant; Royal Golden Jubilee Ph.D. Program Grant	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 23590478 and 26430125 (to N. I.), Kyoto Sangyo University Research Grant C1301 (to N. I.), and The Royal Golden Jubilee Ph.D. Program Grant PHD/0258/2549 (to T. C.).	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Anttila MA, 2000, CANCER RES, V60, P150; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Auvinen P, 2014, BREAST CANCER RES TR, V143, P277, DOI 10.1007/s10549-013-2804-7; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Cheng JC, 2013, J BIOL CHEM, V288, P33181, DOI 10.1074/jbc.M113.488866; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1999, CANCER RES, V59, P2499; Ju SY, 2014, STEM CELL RES, V12, P86, DOI 10.1016/j.scr.2013.09.011; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mima K, 2012, CANCER RES, V72, P3414, DOI 10.1158/0008-5472.CAN-12-0299; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Porsch H, 2013, ONCOGENE, V32, P4355, DOI 10.1038/onc.2012.475; Qu CJ, 2014, INT J BIOCHEM CELL B, V48, P45, DOI 10.1016/j.biocel.2013.12.016; Saito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056587; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tan EJ, 2012, J BIOL CHEM, V287, P7134, DOI 10.1074/jbc.M111.291385; Tanaka H, 2009, ANTICANCER RES, V29, P2147; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Yang G, 2012, BRIT J CANCER, V106, P1512, DOI 10.1038/bjc.2012.126; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	43	62	63	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26038	26056		10.1074/jbc.M114.564120	http://dx.doi.org/10.1074/jbc.M114.564120			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077968	Green Published, hybrid			2022-12-28	WOS:000342128800004
J	Shulga, N; Pastorino, JG				Shulga, Nataly; Pastorino, John G.			Hexokinase II Binding to Mitochondria Is Necessary for Kupffer Cell Activation and Is Potentiated by Ethanol Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE-MONOPHOSPHATE SHUNT; ALCOHOLIC LIVER-DISEASE; PERMEABILITY TRANSITION; CYCLOPHILIN-D; AEROBIC GLYCOLYSIS; INDUCED CYTOTOXICITY; NLRP3 INFLAMMASOME; HYDROGEN-PEROXIDE; INNATE IMMUNITY; CANCER-CELLS	Ethanol exposure promotes the development of steatohepatitis, which can progress to end stage liver disease. Kupffer cells have been documented to play a key role in the genesis and progression of alcoholic liver disease with ethanol exposure enhancing Kupffer cell activation. In the present study, we identified the binding of hexokinase II to the mitochondria as a requirement for LPS-induced activation of Kupffer cells and its potentiation by ethanol. LPS and ethanol exposure induced a reduction in sirtuin-3 activity. In turn, the decline of sirtuin-3 activity led to the activation of cyclophilin-D, which mediated an increased binding of hexokinase II to the mitochondria. Suppression of cyclophilin-D expression or enforced detachment of hexokinase II from the mitochondria abrogated the LPS- and ethanol-induced stimulation of Kupffer cells, preventing NADPH oxidase and inflammasome activation. Moreover, activation of AMP-activated protein kinase restored sirtuin-3 activity, thereby preventing LPS and ethanol from stimulating the binding of hexokinase II to the mitochondria and precluding NADPH oxidase and inflammasome activation.	[Shulga, Nataly; Pastorino, John G.] Rowan Univ Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Pastorino, JG (corresponding author), Rowan Univ Sch Osteopath Med, Dept Mol Biol, Ctr Sci, Rm 316, Stratford, NJ 08084 USA.	pastorjg@rowan.edu			National Institutes of Health [5RO1AA012897-10]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1AA012897-10.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Birnbaum MJ, 2004, DEV CELL, V7, P781, DOI 10.1016/j.devcel.2004.11.016; Brand K, 1997, J BIOENERG BIOMEMBR, V29, P355, DOI 10.1023/A:1022498714522; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; COOPER MR, 1971, INFECT IMMUN, V3, P851, DOI 10.1128/IAI.3.6.851-853.1971; Dang CV, 2012, CANCER DISCOV, V2, P304, DOI 10.1158/2159-8290.CD-12-0069; DIETER MP, 1987, J LEUKOCYTE BIOL, V41, P212, DOI 10.1002/jlb.41.3.212; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; GLETTE J, 1982, ADV EXP MED BIOL, V141, P393; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; King AL, 2014, AM J PHYSIOL-GASTR L, V306, pG265, DOI 10.1152/ajpgi.00278.2013; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; McVicker BL, 2007, ALCOHOL CLIN EXP RES, V31, P122, DOI 10.1111/j.1530-0277.2006.00270.x; Minton K, 2013, NAT REV IMMUNOL, V13, P472, DOI 10.1038/nri3485; Nagy LE, 2003, EXP BIOL MED, V228, P882, DOI 10.1177/153537020322800803; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 1999, BIOCHEM BIOPH RES CO, V265, P405, DOI 10.1006/bbrc.1999.1696; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; REED PW, 1969, J BIOL CHEM, V244, P2459; RIST RJ, 1991, BIOCHEM J, V278, P129, DOI 10.1042/bj2780129; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; SAGONE AL, 1974, CELL IMMUNOL, V14, P443, DOI 10.1016/0008-8749(74)90195-6; Samuvel DJ, 2009, J IMMUNOL, V182, P2476, DOI 10.4049/jimmunol.0802059; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Shulga N, 2009, CELL CYCLE, V8, P3355, DOI 10.4161/cc.8.20.9853; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; TSAN MF, 1977, BLOOD, V50, P935; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228	48	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26213	26225		10.1074/jbc.M114.580175	http://dx.doi.org/10.1074/jbc.M114.580175			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25096575	hybrid, Green Published			2022-12-28	WOS:000342128800017
J	Mukherjee, M; Jing-Song, F; Ramachandran, S; Guy, GR; Sivaraman, J				Mukherjee, Manjeet; Jing-Song, Fan; Ramachandran, Sarath; Guy, Graeme R.; Sivaraman, J.			Dimeric Switch of Hakai-truncated Monomers during Substrate Recognition INSIGHTS FROM SOLUTION STUDIES AND NMR STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; SRC HOMOLOGY-2 DOMAIN; E-CADHERIN; SIGNAL-TRANSDUCTION; SH2 DOMAIN; TYROSINE KINASES; PROTEIN; DIMERIZATION; CELL; INHIBITORS	Hakai, an E3 ubiquitin ligase, disrupts cell-cell contacts in epithelial cells and is up-regulated in human colon and gastric adenocarcinomas. Hakai acts through its phosphotyrosine-binding (HYB) domain, which bears a dimeric fold that recognizes the phosphotyrosine motifs of E-cadherin, cortactin, DOK1, and other Src substrates. Unlike the monomeric nature of the SH2 and phosphotyrosine-binding domains, the architecture of the HYB domain consists of an atypical, zinc-coordinated tight homodimer. Here, we report a C-terminal truncation mutant of the HYB domain (HYB Delta C), comprising amino acids 106-194, which exists as a monomer in solution. The NMR structure revealed that this deletion mutant undergoes a dramatic structural change caused by a rearrangement of the atypical zinc-coordinated unit in the C terminus of the HYB domain to a C2H2-like zinc finger in HYB Delta C. Moreover, using isothermal titration calorimetry, we show that dimerization of HYB Delta C can be induced using a phosphotyrosine substrate peptide. This ligand-induced dimerization of HYB Delta C is further validated using analytical ultracentrifugation, size-exclusion chromatography, NMR relaxation studies, dynamic light scattering, and circular dichroism experiments. Overall, these observations suggest that the dimeric architecture of the HYB domain is essential for the phosphotyrosine-binding property of Hakai.	[Mukherjee, Manjeet; Jing-Song, Fan; Ramachandran, Sarath; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Guy, Graeme R.] Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sivaraman, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsjayar@nus.edu.sg		Mukherjee, Manjeet/0000-0002-3615-7574; J, Sivaraman/0000-0001-9781-5326	MOE (Tier 2) [R154000625112]	MOE (Tier 2)	This work was supported by MOE (Tier 2) Grant R154000625112.	Abella V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052568; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Andreola ML, 2009, CURR PHARM DESIGN, V15, P2508, DOI 10.2174/138161209788682244; Austin D J, 1994, Chem Biol, V1, P131, DOI 10.1016/1074-5521(94)90002-7; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burke TR, 2001, BIOPOLYMERS, V60, P32, DOI 10.1002/1097-0282(2001)60:1<32::AID-BIP1002>3.0.CO;2-I; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Goddard T.D., 2004, SPARKY 3; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; Huber KL, 2012, BIOPOLYMERS, V98, P451, DOI 10.1002/bip.22080; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kang X, 2012, P NATL ACAD SCI USA, V109, P14900, DOI 10.1073/pnas.1205241109; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lebon F, 2000, CURR MED CHEM, V7, P455, DOI 10.2174/0929867003375146; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Noh SJ, 2013, PATHOL RES PRACT, V209, P365, DOI 10.1016/j.prp.2013.03.011; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; Pece S, 2002, NAT CELL BIOL, V4, pE72, DOI 10.1038/ncb0402-e72; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sanchez-Vallet A, 2013, ELIFE, V2, DOI 10.7554/eLife.00790; Sawyer TK, 2002, MINI-REV MED CHEM, V2, P475, DOI 10.2174/1389557023405765; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Siouda M, 2012, MOL CELL BIOL, V32, P4877, DOI 10.1128/MCB.01050-12; Soler-Lopez M, 2004, MOL CELL, V13, P791, DOI 10.1016/S1097-2765(04)00130-3; Stein EG, 2003, J BIOL CHEM, V278, P13257, DOI 10.1074/jbc.M212026200; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	67	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25611	25623		10.1074/jbc.M114.592840	http://dx.doi.org/10.1074/jbc.M114.592840			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074933	Green Published, hybrid			2022-12-28	WOS:000342130800022
J	Amano, K; Densmore, M; Nishimura, R; Lanske, B				Amano, Katsuhiko; Densmore, Michael; Nishimura, Riko; Lanske, Beate			Indian Hedgehog Signaling Regulates Transcription and Expression of Collagen Type X via Runx2/Smads Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; RUNX2 CONTRIBUTES; GENE-REGULATION; GROWTH; IHH; OSTEOBLAST; CARTILAGE; ENHANCER; PROTEIN; GLI3	Indian hedgehog (Ihh) is essential for chondrocyte differentiation and endochondral ossification and acts with parathyroid hormone-related peptide in a negative feedback loop to regulate early chondrocyte differentiation and entry to hypertrophic differentiation. Independent of this function, we and others recently reported independent Ihh functions to promote chondrocyte hypertrophy and matrix mineralization in vivo and in vitro. However, the molecular mechanisms for these actions and their functional significance are still unknown. We recently discovered that Ihh overexpression in chondrocytes stimulated the expression of late chondrocyte differentiation markers and induced matrix mineralization. Focusing on collagen type X (Col10 alpha 1) expression and transcription, we observed that hedgehog downstream transcription factors GLI-Kruppel family members (Gli) 1/2 increased COL10A1 promoter activity and identified a novel Gli1/2 response element in the 250-bp basic promoter. In addition, we found that Ihh induced Runx2 expression in chondrocytes without up-regulating other modulators of chondrocyte maturation such as Mef2c, Foxa2, and Foxa3. Runx2 promoted Col10 alpha 1 expression in cooperation with Ihh. Further analyses using promoter assays, immunofluorescence, and binding assays showed the interaction of Gli1/2 in a complex with Runx2/Smads induces chondrocyte differentiation. Finally, we could demonstrate that Ihh promotes in vitro matrix mineralization using similar molecular mechanisms. Our data provide an in vitro mechanism for Ihh signaling to positively regulate Col10 alpha 1 transcription. Thus, Ihh signaling could be an important player for not only early chondrocyte differentiation but maturation and calcification of chondrocytes.	[Amano, Katsuhiko; Densmore, Michael; Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Amano, Katsuhiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg, Suita, Osaka 5650871, Japan; [Nishimura, Riko] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan	Harvard University; Harvard School of Dental Medicine; Osaka University; Osaka University	Lanske, B (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, 188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu		Lanske, Beate/0000-0003-4638-804X; Nishimura, Riko/0000-0001-7279-8363	National Institutes of Health [R01AR050560]; Harvard School of Dental Medicine; Japan Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard School of Dental Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AR050560. This work was also supported by institutional funds from Harvard School of Dental Medicine (to B. L.), postdoctoral fellowships for research abroad from the Japan Society for the Promotion of Science (to K. A.), and research fellowship for study abroad from the Uehara Memorial Foundation (to K. A.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Drissi MH, 2003, J CELL BIOCHEM, V90, P1287, DOI 10.1002/jcb.10677; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gebhard S, 2004, MATRIX BIOL, V23, P309, DOI 10.1016/j.matbio.2004.05.010; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Ionescu A, 2012, DEV CELL, V22, P927, DOI 10.1016/j.devcel.2012.03.011; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Maeda Y, 2010, BONE, V46, P472, DOI 10.1016/j.bone.2009.09.009; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Miao DS, 2004, EXP CELL RES, V294, P210, DOI 10.1016/j.yexcr.2003.10.021; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Mo R, 1997, DEVELOPMENT, V124, P113; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Park HL, 2000, DEVELOPMENT, V127, P1593; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Seriwatanachai D, 2011, FASEB J, V25, P3057, DOI 10.1096/fj.11-183277; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zheng QP, 2009, J BONE MINER RES, V24, P1022, DOI [10.1359/JBMR.081249, 10.1359/jbmr.081249]; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	45	48	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24898	24910		10.1074/jbc.M114.570507	http://dx.doi.org/10.1074/jbc.M114.570507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25028519	Green Published, hybrid			2022-12-28	WOS:000341985300015
J	Pydi, SP; Sobotkiewicz, T; Billakanti, R; Bhullar, RP; Loewen, MC; Chelikani, P				Pydi, Sai P.; Sobotkiewicz, Tyler; Billakanti, Rohini; Bhullar, Rajinder P.; Loewen, Michele C.; Chelikani, Prashen			Amino Acid Derivatives as Bitter Taste Receptor (T2R) Blockers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MAMMALIAN BRAIN; ACTIVATION; EXPRESSION; CELLS; HTAS2R16; MOUSE; GPCRS; GABA	In humans, the 25 bitter taste receptors (T2Rs) are activated by hundreds of structurally diverse bitter compounds. However, only five antagonists or bitter blockers are known. In this study, using molecular modeling guided site-directed mutagenesis, we elucidated the ligand-binding pocket of T2R4. We found seven amino acids located in the extracellular side of transmembrane 3 (TM3), TM4, extracellular loop 2 (ECL2), and ECL3 to be involved in T2R4 binding to its agonist quinine. ECL2 residues Asn-173 and Thr-174 are essential for quinine binding. Guided by a molecular model of T2R4, a number of amino acid derivatives were screened for their ability to bind to T2R4. These predictions were tested by calcium imaging assays that led to identification of gamma-aminobutryic acid (GABA) and N alpha, N alpha-bis(carboxymethyl)-L-lysine (BCML) as competitive inhibitors of quinine-activated T2R4 with an IC50 of 3.2 +/- 0.3 mu M and 59 +/- 18 nM, respectively. Interestingly, pharmacological characterization using a constitutively active mutant of T2R4 reveals that GABA acts as an antagonist, whereas BCML acts as an inverse agonist on T2R4. Site-directed mutagenesis confirms that the two novel bitter blockers share the same orthosteric site as the agonist quinine. The signature residues Ala-90 and Lys-270 play important roles in interacting with BCML and GABA, respectively. This is the first report to characterize a T2R endogenous antagonist and an inverse agonist. The novel bitter blockers will facilitate physiological studies focused on understanding the roles of T2Rs in extraoral tissues.	[Pydi, Sai P.; Sobotkiewicz, Tyler; Billakanti, Rohini; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R3E 0W4, Canada; [Pydi, Sai P.; Billakanti, Rohini; Chelikani, Prashen] Manitoba Inst Child Hlth, Winnipeg, MB R3E 0W4, Canada; [Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	University of Manitoba; National Research Council Canada	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, D319, Winnipeg, MB R3E 0W4, Canada.	Prashen.Chelikani@umanitoba.ca	Pydi, sai Prasad/M-9017-2016	Pydi, sai Prasad/0000-0001-7170-6519; Chelikani, Prashen/0000-0003-1129-7957	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; Manitoba Medical Service Foundation; Manitoba Health Research Council; Manitoba Health Research Council/Manitoba Institute of Child Health; Manitoba Medical Service Foundation Allen Rouse Career Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Medical Service Foundation; Manitoba Health Research Council; Manitoba Health Research Council/Manitoba Institute of Child Health; Manitoba Medical Service Foundation Allen Rouse Career Award	This work was supported in part by Discovery Grant RGPIN 356285 from Natural Sciences and Engineering Research Council of Canada and operating grants from Manitoba Medical Service Foundation and Manitoba Health Research Council (to P. C.).; Supported by studentships from Manitoba Health Research Council/Manitoba Institute of Child Health.; Supported by a Manitoba Medical Service Foundation Allen Rouse Career Award. To whom correspondence should be addressed: D319, Dept. of Oral Biology, University of Manitoba, Winnipeg, Manitoba R3E 0W4, Canada. Tel.: 204-789-3539; Fax: 204-789-3913; E-mail: Prashen. Chelikani@umanitoba.ca.	Behrens M, 2013, SEMIN CELL DEV BIOL, V24, P215, DOI 10.1016/j.semcdb.2012.08.006; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Bylund DB, 2014, BIOCHEM PHARMACOL, V87, P25, DOI 10.1016/j.bcp.2013.07.027; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chakraborty R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085937; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; ERDO SL, 1990, J NEUROCHEM, V54, P363, DOI 10.1111/j.1471-4159.1990.tb01882.x; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Pydi Sai P, 2014, Adv Pharmacol, V70, P303, DOI 10.1016/B978-0-12-417197-8.00010-9; Pydi SP, 2014, BBA-BIOMEMBRANES, V1838, P231, DOI 10.1016/j.bbamem.2013.08.009; Pydi SP, 2013, BIOCHEM BIOPH RES CO, V430, P179, DOI 10.1016/j.bbrc.2012.11.029; Pydi SP, 2012, J NEUROCHEM, V122, P537, DOI 10.1111/j.1471-4159.2012.07808.x; Sakurai T, 2010, BIOCHEM BIOPH RES CO, V402, P595, DOI 10.1016/j.bbrc.2010.10.059; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699	37	60	66	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25054	25066		10.1074/jbc.M114.576975	http://dx.doi.org/10.1074/jbc.M114.576975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059668	Green Published, hybrid			2022-12-28	WOS:000341985300029
J	Rossi, O; Pesce, I; Giannelli, C; Aprea, S; Caboni, M; Citiulo, F; Valentini, S; Ferlenghi, I; MacLennan, CA; D'Oro, U; Saul, A; Gerke, C				Rossi, Omar; Pesce, Isabella; Giannelli, Carlo; Aprea, Susanna; Caboni, Mariaelena; Citiulo, Francesco; Valentini, Sara; Ferlenghi, Ilaria; MacLennan, Calman Alexander; D'Oro, Ugo; Saul, Allan; Gerke, Christiane			Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications RELATIVE ACTIVATION OF TLR4 AND TLR2 PATHWAYS IN DIFFERENT MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; A BIOSYNTHESIS; LPXL MUTANTS; ACYL CHAINS; LIPOPOLYSACCHARIDE; ACYLATION; VIRULENCE; PROTEIN; HTRB	Outer membrane particles from Gram-negative bacteria are attractive vaccine candidates as they present surface antigens in their natural context. We previously developed a high yield production process for genetically derived particles, called generalized modules for membrane antigens (GMMA), from Shigella. As GMMA are derived from the outer membrane, they contain immunostimulatory components, especially lipopolysaccharide (LPS). We examined ways of reducing their reactogenicity by modifying lipid A, the endotoxic part of LPS, through deletion of late acyltransferase genes, msbB or htrB, in GMMA-producing Shigella sonnei and Shigella flexneri strains. GMMA with resulting penta-acylated lipid A from the msbB mutants showed a 600-fold reduced ability, and GMMA from the S. sonnei Delta htrB mutant showed a 60,000-fold reduced ability compared with GMMA with wild-type lipid A to stimulate human Toll-like receptor 4 (TLR4) in a reporter cell line. In human peripheral blood mononuclear cells, GMMA with penta-acylated lipid A showed a marked reduction in induction of inflammatory cytokines (S. sonnei Delta htrB, 800-fold; Delta msbB mutants, 300-fold). We found that the residual activity of these GMMA is largely due to non-lipid A-related TLR2 activation. In contrast, in the S. flexneri Delta htrB mutant, a compensatory lipid A palmitoleoylation resulted in GMMA with hexa-acylated lipid A with similar to 10-fold higher activity to stimulate peripheral blood mononuclear cells than GMMA with penta-acylated lipid A, mostly due to retained TLR4 activity. Thus, for use as vaccines, GMMA will likely require lipid A penta-acylation. The results identify the relative contributions of TLR4 and TLR2 activation by GMMA, which need to be taken into consideration for GMMA vaccine development.	[Rossi, Omar; Pesce, Isabella; Giannelli, Carlo; Caboni, Mariaelena; Citiulo, Francesco; MacLennan, Calman Alexander; Saul, Allan; Gerke, Christiane] Novartis Vaccines Inst Global Hlth, I-53100 Siena, Italy; [Aprea, Susanna; Valentini, Sara; Ferlenghi, Ilaria; D'Oro, Ugo] Novartis Vaccines, I-53100 Siena, Italy	Novartis; Novartis	Gerke, C (corresponding author), Novartis Vaccines Inst Global Hlth, Via Fiorentina 1, I-53100 Siena, Italy.	christiane.gerke@novartis.com	Rossi, Omar/AAT-6743-2020; Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; MacLennan, Calman A/L-9343-2014	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; MacLennan, Calman A/0000-0001-9694-0846; Citiulo, Francesco/0000-0003-2322-6742; Gerke, Christiane/0000-0001-9446-8031; Caboni, Mariaelena/0000-0002-9742-0022	European Union [261472 STOPENTERICS]	European Union(European Commission)	This work was supported by European Union Seventh Framework Programme FP7/2007-2013 under Grant 261472 STOPENTERICS.	Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; BATH UR, 1987, FEMS MICROBIOL LETT, V40, P189; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052515; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; FORMAL SB, 1966, J BACTERIOL, V92, P17, DOI 10.1128/JB.92.1.17-22.1966; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Koeberling O, 2014, VACCINE, V32, P2688, DOI 10.1016/j.vaccine.2014.03.068; Koeberling O, 2009, CLIN VACCINE IMMUNOL, V16, P156, DOI 10.1128/CVI.00403-08; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee SR, 2009, J MICROBIOL BIOTECHN, V19, P1271, DOI 10.4014/jmb.0901.055; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Liu B, 2008, FEMS MICROBIOL REV, V32, P627, DOI 10.1111/j.1574-6976.2008.00114.x; Livio S, 2014, CLIN INFECT DIS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micoli F, 2013, ANAL BIOCHEM, V434, P136, DOI 10.1016/j.ab.2012.10.038; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Nichols WA, 1997, J ENDOTOXIN RES, V4, P163, DOI 10.1177/096805199700400301; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ranallo RT, 2010, INFECT IMMUN, V78, P400, DOI 10.1128/IAI.00533-09; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schilling B, 2014, INNATE IMMUN-LONDON, V20, P269, DOI 10.1177/1753425913490534; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Seubert A, 2011, P NATL ACAD SCI USA, V108, P11169, DOI 10.1073/pnas.1107941108; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sprong T, 2011, INNATE IMMUN-LONDON, V17, P517, DOI 10.1177/1753425910383999; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P3660, DOI 10.1093/nar/18.12.3660; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200	50	53	59	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24922	24935		10.1074/jbc.M114.566570	http://dx.doi.org/10.1074/jbc.M114.566570			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25023285	Green Published, hybrid			2022-12-28	WOS:000341985300017
J	Messa, M; Colombo, L; del Favero, E; Cantu, L; Stoilova, T; Cagnotto, A; Rossi, A; Morbin, M; Di Fede, G; Tagliavini, F; Salmona, M				Messa, Massimo; Colombo, Laura; del Favero, Elena; Cantu, Laura; Stoilova, Tatiana; Cagnotto, Alfredo; Rossi, Alessandro; Morbin, Michela; Di Fede, Giuseppe; Tagliavini, Fabrizio; Salmona, Mario			The Peculiar Role of the A2V Mutation in Amyloid-beta (A beta) 1-42 Molecular Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Amyloid- (A); Protein Aggregation	ABERRANT PROTEIN OLIGOMERS; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; CORTICAL-NEURONS; MEMORY LOSS; IN-SILICO; DYNAMICS; PEPTIDE; TOXICITY; NEUROTOXICITY	Background: A2V mutation is associated with early onset AD-type dementia in homozygous individuals. Results: A2V mutation leads to a peculiar kinetics of A oligomerization. Conclusion: The A N-terminal region plays an important role in the molecular assembly. Significance: in the homozygous condition the A2V mutation led to aggregation, whereas in the heterozygous state the evolution and kinetics of the aggregation process was hindered. We recently reported a novel A precursor protein mutation (A673V), corresponding to position 2 of A1-42 peptides (A1-42(A2V)), that caused an early onset AD-type dementia in a homozygous individual. The heterozygous relatives were not affected as an indication of autosomal recessive inheritance of this mutation. We investigated the folding kinetics of native unfolded A1-42(A2V) in comparison with the wild type sequence (A1-42(WT)) and the equimolar solution of both peptides (A1-42(MIX)) to characterize the oligomers that are produced in the early phases. We carried out the structural characterization of the three preparations using electron and atomic force microscopy, fluorescence emission, and x-ray diffraction and described the soluble oligomer formation kinetics by laser light scattering. The mutation promoted a peculiar pathway of oligomerization, forming a connected system similar to a polymer network with hydrophobic residues on the external surface. A1-42(MIX) generated assemblies very similar to those produced by A1-42(WT), albeit with slower kinetics due to the difficulties of A1-42(WT) and A1-42(A2V) peptides in building up of stable intermolecular interaction.	[Messa, Massimo; Colombo, Laura; Stoilova, Tatiana; Cagnotto, Alfredo; Rossi, Alessandro; Salmona, Mario] IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, I-20156 Milan, Italy; [del Favero, Elena; Cantu, Laura] Univ Milan, Dept Med Biotechnol & Translat Med, I-20090 Segrate, Italy; [Morbin, Michela; Di Fede, Giuseppe; Tagliavini, Fabrizio] IRCCS Fdn Carlo Besta Neurol Inst, I-20133 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; IRCCS Istituto Neurologico Besta	Salmona, M (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Via Le Masa 19, I-20156 Milan, Italy.	mario.salmona@marionegri.it	Tagliavini, Fabrizio/AAO-7891-2021; salmona, mario/AAA-7116-2020; salmona, mario/ABI-4066-2020; DEL FAVERO, ELENA/R-4991-2017; Di Fede, Giuseppe/A-4471-2019; Cagnotto, Alfredo/AAB-3083-2020; Di Fede, Giuseppe/O-7772-2016; DEL FAVERO, ELENA/AAR-3567-2020; Di Fede, Giuseppe/K-1394-2016; colombo, laura/AAA-6716-2020	Tagliavini, Fabrizio/0000-0003-1039-7315; salmona, mario/0000-0002-9098-9873; DEL FAVERO, ELENA/0000-0002-6584-1869; Di Fede, Giuseppe/0000-0003-3537-6713; Cagnotto, Alfredo/0000-0002-1390-8240; Di Fede, Giuseppe/0000-0003-3537-6713; DEL FAVERO, ELENA/0000-0002-6584-1869; Di Fede, Giuseppe/0000-0003-3537-6713; colombo, laura/0000-0002-3243-0270; Morbin, Michela/0000-0001-8034-3123	Italian Ministry of Health [RF-2009-1473239]; Banca Intesa Sanpaolo Grant; Ministero dell'Istruzione dell'Universita e della Ricerca Grant [RBAP11FRE9]	Italian Ministry of Health(Ministry of Health, Italy); Banca Intesa Sanpaolo Grant; Ministero dell'Istruzione dell'Universita e della Ricerca Grant(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of Health (RF-2009-1473239), Banca Intesa Sanpaolo Grant 2012-2013, and Ministero dell'Istruzione dell'Universita e della Ricerca Grant RBAP11FRE9.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borreguero JM, 2005, P NATL ACAD SCI USA, V102, P6015, DOI 10.1073/pnas.0502006102; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen W, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2337628; Coin I, 2010, J PEPT SCI, V16, P223, DOI 10.1002/psc.1224; Cruz L, 2005, P NATL ACAD SCI USA, V102, P18258, DOI 10.1073/pnas.0509276102; Cruz L, 2012, J PHYS CHEM B, V116, P6311, DOI 10.1021/jp301619v; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Di Fede G, 2012, PROG NEUROBIOL, V99, P281, DOI 10.1016/j.pneurobio.2012.06.004; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Diomede L, 2014, NEUROBIOL DIS, V62, P521, DOI 10.1016/j.nbd.2013.10.024; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fawzi NL, 2008, J AM CHEM SOC, V130, P6145, DOI 10.1021/ja710366c; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hanson R.J., 1995, SOLVING LEAST SQUARE, V15; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; LAGO P, 1993, REV SCI INSTRUM, V64, P1797, DOI 10.1063/1.1144013; Lam AR, 2008, J AM CHEM SOC, V130, P17413, DOI 10.1021/ja804984h; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lindner P., 2002, NEUTRONS XRAYS LIGHT, P391; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Manzoni C, 2009, AMYLOID, V16, P71, DOI 10.1080/13506120902879848; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; Munz M, 2013, APPL SURF SCI, V279, P300, DOI 10.1016/j.apsusc.2013.04.089; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Sclip A, 2013, J MOL CELL BIOL, V5, P277, DOI 10.1093/jmcb/mjt015; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tai LM, 2013, J BIOL CHEM, V288, P5914, DOI 10.1074/jbc.M112.442103; Taniguchi A, 2009, CHEMBIOCHEM, V10, P710, DOI 10.1002/cbic.200800765; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552	53	48	48	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24143	24152		10.1074/jbc.M114.576256	http://dx.doi.org/10.1074/jbc.M114.576256			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037228	Green Published, hybrid			2022-12-28	WOS:000341505600013
J	Rhein, VF; Carroll, J; He, JY; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; He, Jiuya; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			Human METTL20 Methylates Lysine Residues Adjacent to the Recognition Loop of the Electron Transfer Flavoprotein in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transport System (ETS); Flavoprotein; Mitochondrial Metabolism; Protein Methylation; Electron Transfer Flavoprotein; Methyltransferase; Trimethyllysine	CULTURED HUMAN-FIBROBLASTS; AMINO-ACID-SEQUENCE; COMPLEX-I; POSTTRANSLATIONAL MODIFICATIONS; UBIQUINONE OXIDOREDUCTASE; PEPTIDE IDENTIFICATION; HISTONE DEMETHYLATION; TRANSFER DISSOCIATION; S-ADENOSYLMETHIONINE; ATP SYNTHASE	Background: The electron transfer flavoprotein (ETF) is a mobile electron carrier coupling mitochondrial fatty acid oxidation to respiration. Results: METTL20 is a mitochondrial lysine protein methylase that modifies Lys-199 and -202 of the electron transfer flavoprotein -subunit. Conclusion: METTL20 is a protein methylase in mitochondria that influences protein-protein interactions with ETF. Significance: Mitochondria contain lysine methyltransferase METTL20. In mammalian mitochondria, protein methylation is a relatively uncommon post-transcriptional modification, and the extent of the mitochondrial protein methylome, the modifying methyltransferases, and their substrates have been little studied. As shown here, the -subunit of the electron transfer flavoprotein (ETF) is one such methylated protein. The ETF is a heterodimer of - and -subunits. Lysine residues 199 and 202 of mature ETF are almost completely trimethylated in bovine heart mitochondria, whereas ETF is not methylated. The enzyme responsible for the modifications was identified as methyltransferase-like protein 20 (METTL20). In human 143B cells, the methylation of ETF is less extensive and is diminished further by suppression of METTL20. Tagged METTL20 expressed in HEK293T cells specifically associates with the ETF and promotes the trimethylation of ETF lysine residues 199 and 202. ETF serves as a mobile electron carrier linking dehydrogenases involved in fatty acid oxidation and one-carbon metabolism to the membrane-associated ubiquinone pool. The methylated residues in ETF are immediately adjacent to a protein loop that recognizes and binds to the dehydrogenases. Suppression of trimethylation of ETF in mouse C2C12 cells oxidizing palmitate as an energy source reduced the consumption of oxygen by the cells. These experiments suggest that the oxidation of fatty acids in mitochondria and the passage of electrons via the ETF may be controlled by modulating the protein-protein interactions between the reduced dehydrogenases and the -subunit of the ETF by trimethylation of lysine residues. METTL20 is the first lysine methyltransferase to be found to be associated with mitochondria.	[Rhein, Virginie F.; Carroll, Joe; He, Jiuya; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council (MRC), UK; MRC; Swiss National Funds [PBBSP3-130953]; Swiss Novartis Foundation; MRC [MC_U105663148] Funding Source: UKRI; Medical Research Council [MC_U105663148] Funding Source: researchfish	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Funds(Swiss National Science Foundation (SNSF)); Swiss Novartis Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC), UK.; Recipient of an MRC Career Development Fellowship and fellowships from the Swiss National Funds (Stipendium PBBSP3-130953) and the Swiss Novartis Foundation.	AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Carroll J, 2009, ANAL BIOCHEM, V395, P249, DOI 10.1016/j.ab.2009.08.006; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curcoy A, 2003, MOL GENET METAB, V78, P247, DOI 10.1016/S1096-7192(03)00024-6; DELANGE RJ, 1969, J BIOL CHEM, V244, P1385; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GORELICK RJ, 1982, BIOCHEMISTRY-US, V21, P6936, DOI 10.1021/bi00269a049; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; He MA, 2011, MOL GENET METAB, V102, P418, DOI 10.1016/j.ymgme.2010.12.005; Henriques BJ, 2010, BBA-MOL BASIS DIS, V1802, P1070, DOI 10.1016/j.bbadis.2010.07.015; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; IKEDA Y, 1986, J CLIN INVEST, V78, P997, DOI 10.1172/JCI112691; Ishizawa T, 2008, BIOCHEM BIOPH RES CO, V373, P99, DOI 10.1016/j.bbrc.2008.05.176; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; LUNDSTROM K, 1991, DNA CELL BIOL, V10, P181, DOI 10.1089/dna.1991.10.181; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MCKEAN MC, 1983, J BIOL CHEM, V258, P1866; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; STEENKAMP DJ, 1988, BIOCHEM J, V255, P869, DOI 10.1042/bj2550869; STEENKAMP DJ, 1982, BIOCHEM J, V203, P707, DOI 10.1042/bj2030707; Sun RX, 2010, J PROTEOME RES, V9, P6354, DOI 10.1021/pr100648r; Swaney DL, 2007, ANAL CHEM, V79, P477, DOI 10.1021/ac061457f; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	65	43	49	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24640	24651		10.1074/jbc.M114.580464	http://dx.doi.org/10.1074/jbc.M114.580464			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023281	Green Published, hybrid			2022-12-28	WOS:000341505600054
J	Shan, JX; Balasubramanian, MN; Donelan, W; Fu, LC; Hayner, J; Lopez, MC; Baker, HV; Kilberg, MS				Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Lopez, Maria-Cecilia; Baker, Henry V.; Kilberg, Michael S.			A Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK)-dependent Transcriptional Program Controls Activation of the Early Growth Response 1 (EGR1) Gene during Amino Acid Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Gene Transcription; Hepatocellular Carcinoma; Mitogen-activated Protein Kinase (MAPK); Transcription; ATF4; HepG2 Cells; Amino Acid Response; Asparagine Synthetase	HEPATOCELLULAR-CARCINOMA; COMPOSITE SITE; CELL-SURVIVAL; DEPRIVATION; EXPRESSION; BINDING; ATF4; PHOSPHORYLATION; TRANSLATION; INDUCTION	Background: Increased transcription by mammalian amino acid response (AAR) has been linked primarily to the GCN2/eIF2/ATF4 pathway. Results: Some cells contain a GCN2- and ATF4-independent AAR pathway that is MEK-dependent. Conclusion: A novel MEK pathway activates a specific subset of AA-responsive genes. Significance: The mammalian AAR network is more complex than previously thought, extending beyond the GCN2/eIF2/ATF4 pathway. Amino acid (AA) limitation in mammalian cells triggers a collection of signaling cascades jointly referred to as the AA response (AAR). In human HepG2 hepatocellular carcinoma, the early growth response 1 (EGR1) gene was induced by either AA deprivation or endoplasmic reticulum stress. AAR-dependent EGR1 activation was discovered to be independent of the well characterized GCN2-ATF4 pathway and instead dependent on MEK-ERK signaling, one of the MAPK pathways. ChIP showed that constitutively bound ELK1 at the EGR1 proximal promoter region was phosphorylated after AAR activation. Increased p-ELK1 binding was associated with increased de novo recruitment of RNA polymerase II to the EGR1 promoter. EGR1 transcription was not induced in HEK293T cells lacking endogenous MEK activity, but overexpression of exogenous constitutively active MEK in HEK293T cells resulted in increased basal and AAR-induced EGR1 expression. ChIP analysis of the human vascular endothelial growth factor A (VEGF-A) gene, a known EGR1-responsive gene, revealed moderate increases in AAR-induced EGR1 binding within the proximal promoter and highly inducible binding to a site within the first intron. Collectively, these data document a novel AA-activated MEK-ERK-ELK1 signaling mechanism.	[Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Shan, Jixiu; Balasubramanian, Mukundh N.; Donelan, William; Fu, Lingchen; Hayner, Jaclyn; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA; [Lopez, Maria-Cecilia; Baker, Henry V.] Univ Florida, Coll Med, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Lopez, Maria/HHC-3659-2022	Baker, Henry/0000-0002-8273-5320; Donelan, William/0000-0001-7742-8089	National Institutes of Health [DK92062, DK94729]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092062, R01DK094729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK92062 and DK94729 (to M. S. K.).	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Chaveroux C, 2010, BIOCHIMIE, V92, P736, DOI 10.1016/j.biochi.2010.02.020; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Deval C, 2009, FEBS J, V276, P707, DOI 10.1111/j.1742-4658.2008.06818.x; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fu LC, 2013, PHYSIOL GENOMICS, V45, P127, DOI 10.1152/physiolgenomics.00160.2012; Fu LC, 2011, J BIOL CHEM, V286, P36724, DOI 10.1074/jbc.M111.277673; Gjymishka A, 2008, J BIOL CHEM, V283, P27736, DOI 10.1074/jbc.M803781200; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kimball S. R., 2005, NUTR SIGNALING MAMMA; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ozen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042717; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peng W, 2012, SCI TRANSL MED, V4; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Scrable H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003738; Shan JX, 2012, J BIOL CHEM, V287, P36393, DOI 10.1074/jbc.M112.399600; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Thiaville MM, 2008, J BIOL CHEM, V283, P10848, DOI 10.1074/jbc.M708320200; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	52	24	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24665	24679		10.1074/jbc.M114.565028	http://dx.doi.org/10.1074/jbc.M114.565028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028509	hybrid, Green Published			2022-12-28	WOS:000341505600056
J	Barras, D; Chevalier, N; Zoete, V; Dempsey, R; Lapouge, K; Olayioye, MA; Michielin, O; Widmann, C				Barras, David; Chevalier, Nadja; Zoete, Vincent; Dempsey, Rosemary; Lapouge, Karine; Olayioye, Monilola A.; Michielin, Olivier; Widmann, Christian			A WXW Motif Is Required for the Anticancer Activity of the TAT-RasGAP(317-326) Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell-penetrating peptide (CPP); Deleted in Liver Cancer 1 (DLC1); Docking; GTPase-activating Protein (GAP); Peptides; RasGAP; TAT-RasGAP(317-326); Anticancer Peptide; Sensitizer	GTPASE-ACTIVATING PROTEIN; SUPPRESSOR PROTEIN; TUMOR-SUPPRESSOR; CELL-MIGRATION; DATA-BANK; RASGAP; CLEAVAGE; FRAGMENT; GROWTH; SITE	Background: TAT-RasGAP(317-326) is a Ras GTPase-activating protein (RasGAP)-derived peptide that requires deleted in liver cancer-1 (DLC1) for its antimetastatic activities. Results: A WXW motif within TAT-RasGAP(317-326) mediates RasGAP-DLC1 interaction. Conclusion: The tryptophan residues of TAT-RasGAP(317-326) are crucial for its activity Significance: The WXW motif could be used to design anticancer small molecules bearing TAT-RasGAP(317-326) activities. TAT-RasGAP(317-326), a cell-permeable 10-amino acid-long peptide derived from the N2 fragment of p120 Ras GTPase-activating protein (RasGAP), sensitizes tumor cells to apoptosis induced by various anticancer therapies. This RasGAP-derived peptide, by targeting the deleted in liver cancer-1 (DLC1) tumor suppressor, also hampers cell migration and invasion by promoting cell adherence and by inhibiting cell movement. Here, we systematically investigated the role of each amino acid within the RasGAP(317-326) sequence for the anticancer activities of TAT-RasGAP(317-326). We report here that the first three amino acids of this sequence, tryptophan, methionine, and tryptophan (WMW), are necessary and sufficient to sensitize cancer cells to cisplatin-induced apoptosis and to reduce cell migration. The WMW motif was found to be critical for the binding of fragment N2 to DLC1. These results define the interaction mode between the active anticancer sequence of RasGAP and DLC1. This knowledge will facilitate the design of small molecules bearing the tumor-sensitizing and antimetastatic activities of TAT-RasGAP(317-326).	[Barras, David; Chevalier, Nadja; Dempsey, Rosemary; Widmann, Christian] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; [Zoete, Vincent; Michielin, Olivier] SIB, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Lapouge, Karine] Univ Lausanne, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland; [Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Stuttgart	Widmann, C (corresponding author), Dept Physiol, Bugnon 7, CH-1005 Lausanne, Switzerland.	Christian.Widmann@unil.ch	Michielin, Olivier/ABE-7924-2020; Widmann, Christian/N-9851-2013	Lapouge, Karine/0000-0003-0620-9553; Widmann, Christian/0000-0002-6881-0363	Oncosuisse [KFS-02543-02-2010]	Oncosuisse	This work was supported by a grant from Oncosuisse (KFS-02543-02-2010). C. W. is a co-inventor of the TAT-RasGAP<INF>317-326</INF> compound as an antitumor agent (patent owned by the University of Lausanne) and may receive royalties from patent licensing if the compound is commercialized.	ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; Barras D, 2014, ONCOGENE, V33, P5163, DOI 10.1038/onc.2013.465; Barras D, 2014, CANCER METAST REV, V33, P87, DOI 10.1007/s10555-013-9458-0; Barras D, 2014, INT J CANCER, V135, P242, DOI 10.1002/ijc.28674; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Holeiter G, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.13; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Lapouge K, 2013, RNA BIOL, V10, P1031, DOI 10.4161/rna.24771; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Michod D, 2009, JNCI-J NATL CANCER I, V101, P828, DOI 10.1093/jnci/djp100; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Ng DCH, 2006, FEBS LETT, V580, P191, DOI 10.1016/j.febslet.2005.11.073; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; O'Neill MAA, 2011, INT J PHARMACEUT, V417, P83, DOI 10.1016/j.ijpharm.2011.01.038; Pomerance M, 1996, MOL CELL BIOL, V16, P3179; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Saladin PM, 2009, IDRUGS, V12, P779; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498	33	15	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23701	23711		10.1074/jbc.M114.576272	http://dx.doi.org/10.1074/jbc.M114.576272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008324	hybrid, Green Published			2022-12-28	WOS:000341505000038
J	Coulson-Thomas, VJ; Gesteira, TF; Hascall, V; Kao, W				Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Hascall, Vincent; Kao, Winston			Umbilical Cord Mesenchymal Stem Cells Suppress Host Rejection THE ROLE OF THE GLYCOCALYX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Hyaluronate; Inflammation; Mesenchymal Stem Cells (MSCs); Versican	INTER-ALPHA-INHIBITOR; WEIGHT HYALURONAN PROMOTES; STIMULATED GENE-6 TSG-6; ACUTE LUNG INJURY; EXTRACELLULAR-MATRIX; HEAVY-CHAINS; MACROPHAGE ACTIVATION; TRYPSIN INHIBITOR; PROTEINS; BINDING	Background: Umbilical cord mesenchymal stem cells (UMSCs) have unique immunosuppressive properties. Results: UMSCs express a rich glycocalyx, which confers their ability to modulate both macrophages and T-regulatory cells and to lead to inflammatory cell death. Conclusion: UMSCs actively modulate inflammatory cells by suppressing the immune response and evading rejection. Significance: Engineering cells to express this rich glycocalyx could increase transplantation success. Umbilical cord mesenchymal stem cells (UMSCs) have unique immunosuppressive properties enabling them to evade host rejection and making them valuable tools for cell therapy. We previously showed that human UMSCs survive xenograft transplantation and successfully correct the corneal clouding defects associated with the mouse model for the congenital metabolic disorder mucopolysaccharidosis VII. However, the precise mechanism by which UMSCs suppress the immune system remains elusive. This study aimed to determine the key components involved in the ability of the UMSCs to modulate the inflammatory system and to identify the inflammatory cells that are regulated by the UMSCs. Our results show that human UMSCs transplanted into the mouse stroma 24 h after an alkali burn suppress the severe inflammatory response and enable the recovery of corneal transparency within 2 weeks. Furthermore, we demonstrated in vitro that UMSCs inhibit the adhesion and invasion of inflammatory cells and also the polarization of M1 macrophages. UMSCs also induced the maturation of T-regulatory cells and led to inflammatory cell death. Moreover, UMSCs exposed to inflammatory cells synthesize a rich extracellular glycocalyx composed of the chondroitin sulfate-proteoglycan versican bound to a heavy chain (HC)-modified hyaluronan (HA) matrix (HC-HA). This matrix also contains TNF-stimulated gene 6 (TSG6), the enzyme that transfers HCs to HA, and pentraxin-3, which further stabilizes the matrix. Our results, both in vivo and in vitro, show that this glycocalyx confers the ability for UMSCs to survive the host immune system and to regulate the inflammatory cells.	Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Gesteira, Tarsis Ferreira] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Hascall, Vincent] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cleveland Clinic Foundation	Coulson-Thomas, VJ (corresponding author), Univ Cincinnati, 3230 Eden Ave,ML 0838, Cincinnati, OH 45267 USA.	vcoulsonthomas@gmail.com			National Institutes of Health from NEI [RO1 EY021768]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; Hyaluronan Matrices in Vascular Pathologies - National Institutes of Health from NHLBI [P01 HL107147]; NATIONAL EYE INSTITUTE [R01EY021768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; Hyaluronan Matrices in Vascular Pathologies - National Institutes of Health from NHLBI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY021768 from NEI. This work was also supported by Research to Prevent Blindness, Ohio Lions Eye Research Foundation, and by The Hyaluronan Matrices in Vascular Pathologies funded by National Institutes of Health Grant P01 HL107147 from NHLBI.	Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Cantor JO, 1999, CONNECT TISSUE RES, V40, P97, DOI 10.3109/03008209909029105; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Coulson-Thomas VJ, 2013, STEM CELLS, V31, P2116, DOI 10.1002/stem.1481; Culley FJ, 2003, EUR J IMMUNOL, V33, P1302, DOI 10.1002/eji.200323509; de la Motte CA, 2011, J HISTOCHEM CYTOCHEM, V59, P252, DOI 10.1369/0022155410397760; DIETRICH CP, 1977, J CHROMATOGR, V130, P299, DOI 10.1016/S0021-9673(00)89809-X; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fong CY, 2012, STEM CELL REV REP, V8, P195, DOI 10.1007/s12015-011-9289-8; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Liu GW, 2013, J CELL PHYSIOL, V228, P502, DOI 10.1002/jcp.24157; Liu HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010707; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; STEIN M, 1992, CLIN EXP ALLERGY, V22, P19, DOI 10.1111/j.1365-2222.1992.tb00110.x; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320; Xu J, 2008, J PATHOL, V214, P472, DOI 10.1002/path.2302; Xu JG, 2007, AM J PHYSIOL-LUNG C, V293, pL131, DOI 10.1152/ajplung.00431.2006; Yamagami S, 2005, CORNEA, V24, pS71, DOI 10.1097/01.ico.0000178732.42921.05; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	48	55	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23465	23481		10.1074/jbc.M114.557447	http://dx.doi.org/10.1074/jbc.M114.557447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24986866	hybrid, Green Published			2022-12-28	WOS:000341505000020
J	Zumbrennen-Bullough, KB; Wu, QF; Core, AB; Canali, S; Chen, WJ; Theurl, I; Meynard, D; Babitt, JL				Zumbrennen-Bullough, Kimberly B.; Wu, Qifang; Core, Amanda B.; Canali, Susanna; Chen, Wenjie; Theurl, Igor; Meynard, Delphine; Babitt, Jodie L.			MicroRNA-130a Is Up-regulated in Mouse Liver by Iron Deficiency and Targets the Bone Morphogenetic Protein (BMP) Receptor ALK2 to Attenuate BMP Signaling and Hepcidin Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Activin A Receptor; Type I (ACVR1); Bone Morphogenetic Protein (BMP); Iron Metabolism; MicroRNA (miRNA); Signal Transduction; SMAD Transcription Factor; ALK2; SMAD4; Hepcidin; miR-130a	EXPRESSION; HOMEOSTASIS; INFECTION; PATHWAY; TMPRSS6; ANEMIA; HFE; ID1	Background: Hepcidin controls systemic iron balance and is regulated by bone morphogenetic protein (BMP) signaling. Results: MicroRNA miR-130a is up-regulated by iron deficiency and targets BMP type I receptor ALK2 to suppress BMP signaling and hepcidin. Conclusion: miR-130a is a novel regulator of BMP signaling and hepcidin. Significance: This pathway may increase iron availability in the setting of iron deficiency. Systemic iron balance is controlled by the liver peptide hormone hepcidin, which is transcriptionally regulated by the bone morphogenetic protein (BMP)-SMAD pathway. In iron deficiency, liver BMP-SMAD signaling and hepcidin are suppressed as a compensatory mechanism to increase iron availability. MicroRNAs are small regulatory RNAs that have an increasingly recognized role in many biologic processes but are only recently implicated in iron homeostasis regulation. Here, we demonstrate that liver expression of the microRNA miR-130a is up-regulated by iron deficiency in mice. We identify the BMP6-SMAD signaling pathway as a functional target of miR-130a in hepatoma-derived Hep3B cells. Although the TGF-/BMP common mediator SMAD4 was previously reported to be an miR-130a target to inhibit TGF- signaling, we do not confirm SMAD4 as an miR-130a target in our biologic system. Instead, we determine that the BMP type I receptor ALK2 is a novel target of miR-130a and that miR-130a binds to two specific sites in the 3-untranslated region to reduce ALK2 mRNA stability. Moreover, we show in mice that the increased liver miR-130a during iron deficiency is associated with reduced liver Alk2 mRNA levels. Finally, we demonstrate that down-regulation of ALK2 by miR-130a has a functional effect to inhibit BMP6-induced hepcidin transcription in Hep3B cells. Our data suggest that iron deficiency increases liver miR-130a, which, by targeting ALK2, may contribute to reduce BMP-SMAD signaling, suppress hepcidin synthesis, and thereby promote iron availability.	[Zumbrennen-Bullough, Kimberly B.; Wu, Qifang; Core, Amanda B.; Canali, Susanna; Chen, Wenjie; Theurl, Igor; Meynard, Delphine; Babitt, Jodie L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Ctr Syst Biol, Program Anemia Signaling Res,Div Nephrol,Program, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Babitt, JL (corresponding author), Massachusetts Gen Hosp, 185 Cambridge St,CPZN-8208, Boston, MA 02114 USA.	babitt.jodie@mgh.harvard.edu	meynard, delphine/B-4236-2014	meynard, delphine/0000-0002-9927-5535; Theurl, Igor/0000-0003-3180-4784	National Institutes of Health [RO1-DK087727, T32 DK007540]; William F. Milton Fund from Harvard University; Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087727, T32DK007540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William F. Milton Fund from Harvard University; Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK087727 (to J. L. B.) and Training Grant T32 DK007540 (to K. Z. B. and A. B. C.). This work was also supported by the William F. Milton Fund from Harvard University and a Howard Goodman fellowship award from the Massachusetts General Hospital (to J. L. B.). J. L. B. has ownership interest in the start-up company Ferrumax Pharmaceuticals, which has licensed technology from the Massachusetts General Hospital based on work cited here and in prior publications.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Castoldi M, 2012, CELL MOL LIFE SCI, V69, P3945, DOI 10.1007/s00018-012-1031-4; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Corradini E, 2010, GASTROENTEROLOGY, V139, P1721, DOI 10.1053/j.gastro.2010.07.044; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hager M, 2011, BLOOD, V118, P6649, DOI 10.1182/blood-2011-03-339978; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Li YJ, 2012, CELL METAB, V15, P895, DOI 10.1016/j.cmet.2012.04.021; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mole DR, 2010, ANTIOXID REDOX SIGN, V12, P445, DOI 10.1089/ars.2009.2790; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sakamoto N, 2007, BIOCHEM BIOPH RES CO, V357, P467, DOI 10.1016/j.bbrc.2007.03.167; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Theurl I, 2011, HAEMATOL-HEMATOL J, V96, P1761, DOI 10.3324/haematol.2011.048926; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	35	30	31	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23796	23808		10.1074/jbc.M114.577387	http://dx.doi.org/10.1074/jbc.M114.577387			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002578	Green Published, hybrid			2022-12-28	WOS:000341505000047
J	Sim, L; Beeren, SR; Findinier, J; Dauvillee, D; Ball, SG; Henriksen, A; Palcic, MM				Sim, Lyann; Beeren, Sophie R.; Findinier, Justin; Dauvillee, David; Ball, Steven G.; Henriksen, Anette; Palcic, Monica M.			Crystal Structure of the Chlamydomonas Starch Debranching Enzyme Isoamylase ISA1 Reveals Insights into the Mechanism of Branch Trimming and Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE ENDOSPERM; AMYLOPECTIN BIOSYNTHESIS; HOMO-OLIGOMER; DATA QUALITY; REINHARDTII; MODEL; GLYCOGEN; MUTANTS; GRANULE; PLANTS	The starch debranching enzymes isoamylase 1 and 2 (ISA1 and ISA2) are known to exist in a large complex and are involved in the biosynthesis and crystallization of starch. It is suggested that the function of the complex is to remove misplaced branches of growing amylopectin molecules, which would otherwise prevent the association and crystallization of adjacent linear chains. Here, we investigate the function of ISA1 and ISA2 from starch producing alga Chlamydomonas. Through complementation studies, we confirm that the STA8 locus encodes for ISA2 and sta8 mutants lack the ISA1.ISA2 heteromeric complex. However, mutants retain a functional dimeric ISA1 that is able to partly sustain starch synthesis in vivo. To better characterize ISA1, we have overexpressed and purified ISA1 from Chlamydomonas reinhardtii (CrISA1) and solved the crystal structure to 2.3 angstrom and in complex with maltoheptaose to 2.4 angstrom Analysis of the homodimeric CrISA1 structure reveals a unique elongated structure with monomers connected end-to-end. The crystal complex reveals details about the mechanism of branch binding that explains the low activity of CrISA1 toward tightly spaced branches and reveals the presence of additional secondary surface carbohydrate binding sites.	[Sim, Lyann; Beeren, Sophie R.; Henriksen, Anette; Palcic, Monica M.] Carlsberg Lab, DK-1799 Copenhagen V, Denmark; [Findinier, Justin; Dauvillee, David; Ball, Steven G.] UMR 8576 CNRS USTL, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Sim, L (corresponding author), Ryerson Univ, Dept Chem & Biol, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	lya.sim@gmail.com	Beeren, Sophie R/B-6033-2015; Dauvillée, David/A-2174-2009	Beeren, Sophie R/0000-0002-6682-3603; Dauvillée, David/0000-0002-0751-9193; Ball, Steven/0000-0003-1629-1650; Henriksen, Anette/0000-0003-4051-5079	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Carlsberg Foundation.	Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; Bustos R, 2004, P NATL ACAD SCI USA, V101, P2215, DOI 10.1073/pnas.0305920101; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Dauvillee D, 2000, PLANT SCI, V157, P145, DOI 10.1016/S0168-9452(00)00256-9; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1710, DOI 10.1104/pp.125.4.1710; Dauvillee D, 2001, PLANT PHYSIOL, V125, P1723, DOI 10.1104/pp.125.4.1723; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubo A, 2010, PLANT PHYSIOL, V153, P956, DOI 10.1104/pp.110.155259; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; LIBESSART N, 1995, PLANT CELL, V7, P1117; Lin QH, 2013, NEW PHYTOL, V200, P1009, DOI 10.1111/nph.12446; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mouille G, 1996, PLANT CELL, V8, P1353; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nelson N, 1944, J BIOL CHEM, V153, P375; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Song HN, 2010, PROTEINS, V78, P1847, DOI 10.1002/prot.22697; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075223; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Utsumi Y, 2006, PLANTA, V225, P75, DOI 10.1007/s00425-006-0331-z; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p	52	36	37	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22991	23003		10.1074/jbc.M114.565044	http://dx.doi.org/10.1074/jbc.M114.565044			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24993830	hybrid, Green Published			2022-12-28	WOS:000341017200038
J	Terajima, M; Perdivara, I; Sricholpech, M; Deguchi, Y; Pleshko, N; Tomer, KB; Yamauchi, M				Terajima, Masahiko; Perdivara, Irina; Sricholpech, Marnisa; Deguchi, Yoshizumi; Pleshko, Nancy; Tomer, Kenneth B.; Yamauchi, Mitsuo			Glycosylation and Cross-linking in Bone Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; LYSYL HYDROXYLASE; OSTEOGENESIS IMPERFECTA; EHRLICH CHROMOGEN; ARTICULAR-CARTILAGE; MOLECULAR PACKING; FIBRILS; IDENTIFICATION; PROTEIN; FIBRILLOGENESIS	Fibrillar type I collagen is the major organic component in bone, providing a stable template for mineralization. During collagen biosynthesis, specific hydroxylysine residues become glycosylated in the form of galactosyl- and glucosylgalactosylhydroxylysine. Furthermore, key glycosylated hydroxylysine residues, alpha 1/2-87, are involved in covalent intermolecular cross-linking. Although cross-linking is crucial for the stability and mineralization of collagen, the biological function of glycosylation in cross-linking is not well understood. In this study, we quantitatively characterized glycosylation of non-cross-linked and cross-linked peptides by biochemical and nanoscale liquid chromatography-high resolution tandem mass spectrometric analyses. The results showed that glycosylation of non-crosslinked hydroxylysine is different from that involved in cross-linking. Among the cross-linked species involving alpha 1/2-87, divalent cross-links were glycosylated with both mono- and disaccharides, whereas the mature, trivalent cross-links were primarily monoglycosylated. Markedly diminished diglycosylation in trivalent cross-links at this locus was also confirmed in type II collagen. The data, together with our recent report (Sricholpech, M., Perdivara, I., Yokoyama, M., Nagaoka, H., Terajima, M., Tomer, K. B., and Yamauchi, M. (2012) Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J. Biol. Chem. 287, 22998-23009), indicate that the extent and pattern of glycosylation may regulate cross-link maturation in fibrillar collagen.	[Terajima, Masahiko; Deguchi, Yoshizumi; Yamauchi, Mitsuo] Univ N Carolina, North Carolina Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Sricholpech, Marnisa] Srinakharinwirot Univ, Fac Dent, Dept Oral Surg & Oral Med, Bangkok 10110, Thailand; [Pleshko, Nancy] Temple Univ, Dept Bioengn, Tissue Imaging & Spect Lab, Philadelphia, PA 19122 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Srinakharinwirot University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Yamauchi, M (corresponding author), Univ N Carolina, North Carolina Oral Hlth Inst, 385 S Columbia St, Chapel Hill, NC 27599 USA.	yamauchm@dentistry.unc.edu			National Institutes of Health [DE020909, AR060978]; National Institutes of Health, NIEHS [ES050171]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE020909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE020909 and AR060978 (to M. Y.) and the Intramural Research Program of National Institutes of Health, NIEHS, Project ES050171 (to K. B. T.).	AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Batge B, 1997, J BIOCHEM, V122, P109; Brady JD, 2001, J BIOL CHEM, V276, P18812, DOI 10.1074/jbc.M009506200; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Eriksen HA, 2004, BONE, V34, P720, DOI 10.1016/j.bone.2003.12.009; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Eyre DR, 2010, J BIOL CHEM, V285, P16675, DOI 10.1074/jbc.M110.111534; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1980, BIOCHEM BIOPH RES CO, V92, P403, DOI 10.1016/0006-291X(80)90347-2; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Henkel W, 2007, J PROTEOME RES, V6, P4269, DOI 10.1021/pr070318r; KUBOKI Y, 1981, BIOCHEM BIOPH RES CO, V102, P119, DOI 10.1016/0006-291X(81)91497-2; KUYPERS R, 1992, BIOCHEM J, V283, P129, DOI 10.1042/bj2830129; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Myers LK, 2004, J IMMUNOL, V172, P2970, DOI 10.4049/jimmunol.172.5.2970; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; Perdivara I, 2013, J AM SOC MASS SPECTR, V24, P1072, DOI 10.1007/s13361-013-0624-y; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; ROYCE PM, 1977, BIOCHIM BIOPHYS ACTA, V498, P132, DOI 10.1016/0304-4165(77)90094-0; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; SCOTT JE, 1981, BIOSCIENCE REP, V1, P611, DOI 10.1007/BF01116276; SCOTT JE, 1983, J BIOCHEM-TOKYO, V93, P921, DOI 10.1093/jb/93.3.921; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Song EW, 2013, J PROTEOME RES, V12, P3599, DOI 10.1021/pr400101t; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Suarez KN, 1996, CALCIFIED TISSUE INT, V58, P65, DOI 10.1007/s002239900012; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; VEIS A, 1993, J BONE MINER RES, V8, pS493; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; WEINER S, 1986, FEBS LETT, V206, P262, DOI 10.1016/0014-5793(86)80993-0; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1993, CONNECT TISSUE RES, V29, P81, DOI 10.3109/03008209309014236; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI DOI 10.1042/BSE0520113; Yamauchi M, 1988, COLLAGEN, P157; Yamauchi M., 1989, CONNECT TISSUE RES, V21, P168; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x	52	69	72	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22636	22647		10.1074/jbc.M113.528513	http://dx.doi.org/10.1074/jbc.M113.528513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958722	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000341017200010
J	Luhnsdorf, B; Epe, B; Khobta, A				Luehnsdorf, Bork; Epe, Bernd; Khobta, Andriy			Excision of Uracil from Transcribed DNA Negatively Affects Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; REPAIR ENZYME; STRANDED-DNA; BASE; DEAMINATION; GLYCOSYLASE; NUCLEAR; DAMAGE; CONSEQUENCES; ELONGATION	Uracil is an unavoidable aberrant base in DNA, the repair of which takes place by a highly efficient base excision repair mechanism. The removal of uracil from the genome requires a succession of intermediate products, including an abasic site and a single strand break, before the original DNA structure can be reconstituted. These repair intermediates are harmful for DNA replication and also interfere with transcription under cell-free conditions. However, their relevance for cellular transcription has not been proved. Here we investigated the influence of uracil incorporated into a reporter vector on gene expression in human cells. The expression constructs contained a single uracil opposite an adenine (to mimic dUTP misincorporation during DNA synthesis) or a guanine (imitating a product of spontaneous cytosine deamination). We found no evidence for a direct transcription arrest by uracil in either of the two settings because the vectors containing the base modification exhibited unaltered levels of enhanced GFP reporter gene expression at early times after delivery to cells. However, the gene expression showed a progressive decline during subsequent hours. In the case of U: A pairs, this effect was retarded significantly by knockdown of UNG1/2 but not by knockdown of SMUG1 or thymine-DNA glycosylase uracil-DNA glycosylases, proving that it is base excision by UNG1/2 that perturbs transcription of the affected gene. By contrast, the decline of expression of the U: G constructs was not influenced by either UNG1/2, SMUG1, or thymine-DNA glycosylase knockdown, strongly suggesting that there are substantial mechanistic or kinetic differences between the processing of U: A and U: G lesions in cells.	[Luehnsdorf, Bork; Epe, Bernd; Khobta, Andriy] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz	Khobta, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Staudingerweg 5, D-55128 Mainz, Germany.	khobta@uni-mainz.de	Khobta, Andriy/B-6622-2014	Khobta, Andriy/0000-0001-9165-3557	Deutsche Forschungsgemeinschaft [KH 263/1, KH 263/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KH 263/1 and KH 263/2 (to A. K.).	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Doseth B, 2011, J BIOL CHEM, V286, P16669, DOI 10.1074/jbc.M111.230052; EFTEDAL I, 1993, NUCLEIC ACIDS RES, V21, P2095, DOI 10.1093/nar/21.9.2095; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Helmrich A, 2013, NAT STRUCT MOL BIOL, V20, P412, DOI 10.1038/nsmb.2543; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Khobta A, 2012, MUTAT RES-FUND MOL M, V736, P5, DOI 10.1016/j.mrfmmm.2011.07.014; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Kitsera N, 2011, NUCLEIC ACIDS RES, V39, P5926, DOI 10.1093/nar/gkr163; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Prorok P, 2013, P NATL ACAD SCI USA, V110, pE3695, DOI 10.1073/pnas.1305624110; Roy D, 2010, MOL CELL BIOL, V30, P146, DOI 10.1128/MCB.00897-09; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; VERRI A, 1990, NUCLEIC ACIDS RES, V18, P5775, DOI 10.1093/nar/18.19.5775; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Warmerdam DO, 2010, MUTAT RES-REV MUTAT, V704, P2, DOI 10.1016/j.mrrev.2009.12.001; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007	37	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22008	22018		10.1074/jbc.M113.521807	http://dx.doi.org/10.1074/jbc.M113.521807			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951587	Green Published, hybrid			2022-12-28	WOS:000340593500017
J	Sommer, J; Garbers, C; Wolf, J; Trad, A; Moll, JM; Sack, M; Fischer, R; Grotzinger, J; Waetzig, GH; Floss, DM; Scheller, J				Sommer, Jan; Garbers, Christoph; Wolf, Janina; Trad, Ahmad; Moll, Jens M.; Sack, Markus; Fischer, Rainer; Groetzinger, Joachim; Waetzig, Georg H.; Floss, Doreen M.; Scheller, Juergen			Alternative Intronic Polyadenylation Generates the Interleukin-6 Trans-signaling Inhibitor sgp130-E10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; RHEUMATOID-ARTHRITIS; SOLUBLE GP130; IL-6 RECEPTOR; IN-VIVO; CYTOKINE; SERUM; IDENTIFICATION; ACTIVATION; EXPRESSION	Interleukin (IL)-6 signals via a receptor complex composed of the signal-transducing beta-receptor gp130 and the non-signaling membrane-bound or soluble IL-6 receptor alpha (IL-6R, sIL-6R), which is referred to as classic and trans-signaling, respectively. IL-6 trans-signaling is functionally associated with the development of chronic inflammatory diseases and cancer. Soluble gp130 (sgp130) variants are natural inhibitors of trans-signaling. Differential splicing yields sgp130 isoforms. Here, we describe that alternative intronic polyadenylation in intron 10 of the gp130 transcript results in a novel mRNA coding for an sgp130 protein isoform (sgp130-E10) of 70-80 kDa. The sgp130-E10 protein was expressed in vivo in human peripheral blood mononuclear cells. To assess the biological activity of sgp130-E10, we expressed this variant as Fc-tagged fusion protein (sgp130-E10Fc). Recombinant sgp130-E10Fc binds to a complex of IL-6 and sIL-6R, but not to IL-6 alone, and specifically inhibits IL-6 trans-signaling. Thus, it might play an important role in the regulation of trans-signaling in vivo.	[Sommer, Jan; Moll, Jens M.; Floss, Doreen M.; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Garbers, Christoph; Wolf, Janina; Trad, Ahmad; Groetzinger, Joachim] Univ Kiel, Fac Med, Inst Biochem, D-24118 Kiel, Germany; [Sack, Markus; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, D-52062 Aachen, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, D-24118 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel; RWTH Aachen University	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Sack, Markus/AAP-9252-2021; Waetzig, Georg/AAV-7486-2021; Scheller, Jürgen/K-5290-2015; Sack, Markus/K-6681-2013	Garbers, Christoph/0000-0003-4939-6950; Sack, Markus/0000-0002-7380-9228	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SCHE 907/2-1]; Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Ferring Pharmaceuticals A/S (Copenhagen, Denmark)	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (SCHE 907/2-1, Bonn, Germany) (to J. S.).; Supported by a grant from Ferring Pharmaceuticals A/S (Copenhagen, Denmark).	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Clement HW, 2010, J NEURAL TRANSM, V117, P13, DOI 10.1007/s00702-009-0327-5; Diamant M, 1997, FEBS LETT, V412, P379, DOI 10.1016/S0014-5793(97)00750-3; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Keul R, 1998, CYTOKINE, V10, P729, DOI 10.1006/cyto.1997.0343; Lateef Syed Salman, 2007, J Biomol Tech, V18, P173; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Robak T, 1998, MEDIAT INFLAMM, V7, P347, DOI 10.1080/09629359890875; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; SHARKEY AM, 1995, BIOL REPROD, V53, P974, DOI 10.1095/biolreprod53.4.974; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sommer J, 2012, J BIOL CHEM, V287, P13743, DOI 10.1074/jbc.M111.349167; Tanaka M, 2000, J CLIN INVEST, V106, P137, DOI 10.1172/JCI7479; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Uson J, 1997, J RHEUMATOL, V24, P2069; Vorlova S, 2011, MOL CELL, V43, P927, DOI 10.1016/j.molcel.2011.08.009; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Zhang JG, 1998, J BIOL CHEM, V273, P10798, DOI 10.1074/jbc.273.17.10798	27	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22140	22150		10.1074/jbc.M114.560938	http://dx.doi.org/10.1074/jbc.M114.560938			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973212	Green Published, hybrid			2022-12-28	WOS:000340593500029
J	Zhang, YB; Baranovskiy, AG; Tahirov, TH; Pavlov, YI				Zhang, Yinbo; Baranovskiy, Andrey G.; Tahirov, Tahir H.; Pavlov, Youri I.			The C-terminal Domain of the DNA Polymerase Catalytic Subunit Regulates the Primase and Polymerase Activities of the Human DNA Polymerase alpha-Primase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; EUKARYOTIC REPLISOME; ACCESSORY SUBUNITS; SACCHAROMYCES-CEREVISIAE; PRIMER SYNTHESIS; P58 SUBUNIT; ZETA; MUTAGENESIS; ARCHITECTURE; MECHANISM	The initiation of DNA synthesis during replication of the human genome is accomplished primarily by the DNA polymerase alpha-primase complex, which makes the RNA-DNA primers accessible to processive DNA pols. The structural information needed to understand the mechanism of regulation of this complex biochemical reaction is incomplete. The presence of two enzymes in one complex poses the question of how these two enzymes cooperate during priming of DNA synthesis. Yeast two-hybrid and direct pulldown assays revealed that the N-terminal domain of the large subunit of primase (p58N) directly interacts with the C-terminal domain of the catalytic subunit of pol alpha (p180C). We found that a complex of the C-terminal domain of the catalytic subunit of pol alpha with the second subunit (p180C-p70) stimulated primase activity, whereas the whole catalytically active heterodimer of pol alpha (p180 Delta N-p70) inhibited RNA synthesis by primase. Conversely, the pol alpha catalytic domain without the C-terminal part (p180 Delta N-core) possessed a much higher propensity to extend the RNA primer than the two-subunit pol alpha (p180 Delta N-p70), suggesting that p180C and/or p70 are involved in the negative regulation of DNA pol activity. We conclude that the interaction between p180C, p70, and p58 regulates the proper primase and polymerase function. The composition of the template DNA is another important factor determining the activity of the complex. We have found that pol alpha activity strongly depends on the sequence of the template and that homopyrimidine runs create a strong barrier for DNA synthesis by pol alpha	[Zhang, Yinbo; Baranovskiy, Andrey G.; Tahirov, Tahir H.; Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu; ypavlov@unmc.edu	; Pavlov, Youri/T-7532-2017	Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	National Institutes of Health [GM101167, CA129925]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM101167 (NIGMS; to T. H. T.) and CA129925 (NCI; to Y. I. P.).	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Aguirre JD, 2009, INORG CHEM, V48, P4435, DOI 10.1021/ic900164j; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bebenek A, 2002, GENETICS, V162, P1003; BOHN EW, 1974, CANCER RES, V34, P1977; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; CHOMILIER J, 1992, BIOPHYS CHEM, V45, P143, DOI 10.1016/0301-4622(92)87006-5; COPELAND WC, 1995, J BIOL CHEM, V270, P3905, DOI 10.1074/jbc.270.8.3905; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomez-Llorente Y, 2013, CELL REP, V5, P79, DOI 10.1016/j.celrep.2013.08.046; Hile SE, 2004, J MOL BIOL, V335, P745, DOI 10.1016/j.jmb.2003.10.075; Hogg Matthew, 2012, Subcell Biochem, V62, P237, DOI 10.1007/978-94-007-4572-8_13; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15345, DOI 10.1021/bi9810959; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lao-Sirieix SH, 2005, NAT STRUCT MOL BIOL, V12, P1137, DOI 10.1038/nsmb1013; Lawrence CW, 1996, CANCER SURV, V28, P21; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; MacNeill Stuart, 2012, Subcell Biochem, V62, P1, DOI 10.1007/978-94-007-4572-8_1; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Oguey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015931; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Tahirov Tahir H, 2012, Subcell Biochem, V62, P217, DOI 10.1007/978-94-007-4572-8_12; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Waisertreiger ISR, 2012, ENVIRON MOL MUTAGEN, V53, P699, DOI 10.1002/em.21735; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	61	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22021	22034		10.1074/jbc.M114.570333	http://dx.doi.org/10.1074/jbc.M114.570333			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962573	hybrid, Green Published			2022-12-28	WOS:000340593500020
J	Nokwe, CN; Zacharias, M; Yagi, H; Hora, M; Reif, B; Goto, Y; Buchner, J				Nokwe, Cardine N.; Zacharias, Martin; Yagi, Hisashi; Hora, Manuel; Reif, Bernd; Goto, Yuji; Buchner, Johannes			A Residue-specific Shift in Stability and Amyloidogenicity of Antibody Variable Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; LIGHT-CHAIN AMYLOIDOSIS; IMMUNOGLOBULIN DEPOSITION DISEASE; PRIMARY SYSTEMIC AMYLOIDOSIS; CRYSTAL-STRUCTURE; AL AMYLOIDOSIS; HEAVY-CHAIN; HYDROPHOBIC CORE; FOLDING PATHWAY; FAB FRAGMENT	Variable (V) domains of antibodies are essential for antigen recognition by our adaptive immune system. However, some variants of the light chain V domains (V-L) form pathogenic amyloid fibrils in patients. It is so far unclear which residues play a key role in governing these processes. Here, we show that the conserved residue 2 of V-L domains is crucial for controlling its thermodynamic stability and fibril formation. Hydrophobic side chains at position 2 stabilize the domain, whereas charged residues destabilize and lead to amyloid fibril formation. NMR experiments identified several segments within the core of the V-L domain to be affected by changes in residue 2. Furthermore, molecular dynamic simulations showed that hydrophobic side chains at position 2 remain buried in a hydrophobic pocket, and charged side chains show a high flexibility. This results in a predicted difference in the dissociation free energy of similar to 10 kJ mol(-1), which is in excellent agreement with our experimental values. Interestingly, this switch point is found only in V-L domains of the kappa family and not in V-L lambda or in V-H domains, despite a highly similar domain architecture. Our results reveal novel insight into the architecture of variable domains and the prerequisites for formation of amyloid fibrils. This might also contribute to the rational design of stable variable antibody domains.	[Nokwe, Cardine N.; Hora, Manuel; Reif, Bernd; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, Ctr Integrated Prot Sci, D-85748 Garching, Germany; [Yagi, Hisashi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808550, Japan; [Yagi, Hisashi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808550, Japan; [Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Div Prot Struct Biol, Suita, Osaka 5650871, Japan	Technical University of Munich; Technical University of Munich; Tottori University; Tottori University; Osaka University	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@tum.de	Hora, Manuel/G-7077-2018; Buchner, Johannes/A-2651-2010	Hora, Manuel/0000-0002-5156-0687; Reif, Bernd/0000-0001-7368-7198; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to J. B.) and by a grant from the Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY (to B. R.).	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Augustine JG, 2001, J BIOL CHEM, V276, P3287, DOI 10.1074/jbc.M005221200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Benitez-Cardoza CG, 2004, BIOCHEMISTRY-US, V43, P5195, DOI 10.1021/bi0361620; Billings KS, 2008, J MOL BIOL, V375, P560, DOI 10.1016/j.jmb.2007.10.056; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Buxbaum J, 1999, HEMATOL ONCOL CLIN N, V13, P1235, DOI 10.1016/S0889-8588(05)70123-4; BUXBAUM JN, 1990, ANN INTERN MED, V112, P455, DOI 10.7326/0003-4819-76-3-112-6-455; Case D. A., 2012, AMBER 12; Chacko S, 1996, J BIOL CHEM, V271, P12191, DOI 10.1074/jbc.271.21.12191; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOTY P, 1950, J CHEM PHYS, V18, P1211, DOI 10.1063/1.1747913; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Faber C, 1998, IMMUNOTECHNOLOGY, V3, P253, DOI 10.1016/S1380-2933(97)10003-3; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Feige MJ, 2010, J MOL BIOL, V399, P719, DOI 10.1016/j.jmb.2010.04.032; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Jones S, 2003, J MOL BIOL, V330, P935, DOI 10.1016/S0022-2836(03)00688-0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; KODANDAPANI R, 1995, J BIOL CHEM, V270, P2268, DOI 10.1074/jbc.270.5.2268; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LILIE H, 1995, FEBS LETT, V362, P43, DOI 10.1016/0014-5793(95)00203-L; Merlini G, 2008, ANN ONCOL, V19, P63, DOI 10.1093/annonc/mdn200; Miyazaki D, 2008, AMYLOID, V15, P125, DOI 10.1080/13506120802006229; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mukherjee S, 2011, BIOCHEMISTRY-US, V50, P5845, DOI 10.1021/bi200410c; Nowak M, 2004, PROTEINS, V55, P11, DOI 10.1002/prot.10606; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; Pozzi C, 2003, AM J KIDNEY DIS, V42, P1154, DOI 10.1053/j.ajkd.2003.08.040; Raffen R, 1999, PROTEIN SCI, V8, P509; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schiffer M, 1996, AM J PATHOL, V148, P1339; Simpson ER, 2009, J MOL BIOL, V392, P1326, DOI 10.1016/j.jmb.2009.07.075; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01	69	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26829	26846		10.1074/jbc.M114.582247	http://dx.doi.org/10.1074/jbc.M114.582247			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096580	Green Published, hybrid			2022-12-28	WOS:000342853900015
J	Zhang, LY; Zhang, YJ; Zhong, WW; Di, CX; Lin, XL; Xia, ZW				Zhang, Liya; Zhang, Yanjie; Zhong, Wenwei; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei			Heme Oxygenase-1 Ameliorates Dextran Sulfate Sodium-induced Acute Murine Colitis by Regulating Th17/Treg Cell Balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELLS; CARBON-MONOXIDE; AIRWAY INFLAMMATION; THERAPEUTIC TARGET; PROTECTIVE ROLE; UP-REGULATION; MOUSE MODEL; TH17 CELLS; EXPRESSION	Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a group of autoimmune diseases characterized by nonspecific inflammation in the gastrointestinal tract. Recent investigations suggest that activation of Th17 cells and/or deficiency of regulatory T cells (Treg) is involved in the pathogenesis of IBD. Heme oxygenase (HO)-1 is a protein with a wide range of anti-inflammatory and immune regulatory function, which exerts significantly protective roles in various T cell-mediated diseases. In this study, we aim to explore the immunological regulation of HO-1 in the dextran sulfate sodium-induced model of experimental murine colitis. BALB/c mice were administered 4% dextran sulfate sodium orally; some mice were intraperitoneally pretreated with HO-1 inducer hemin or HO-1 inhibitor stannum protoporphyrin IX. The results show that hemin enhances the colonic expression of HO-1 and significantly ameliorates the symptoms of colitis with improved histological changes, accompanied by a decreased proportion of Th17 cells and increased number of Tregs in mesenteric lymph node and spleen. Moreover, induction of HO-1 down-regulates retinoic acid-related orphan receptor gamma t expression and IL-17A levels, while promoting Treg-related forkhead box p3 (Foxp3) expression and IL-10 levels in colon. Further study in vitro revealed that up-regulated HO-1 switched the naive T cells to Tregs when cultured under a Th17-inducing environment, which involved in IL-6R blockade. Therefore, HO-1 may exhibit anti-inflammatory activity in the murine model of acute experimental colitis via regulating the balance between Th17 and Treg cells, thus providing a possible novel therapeutic target in IBD.	[Zhang, Liya; Zhang, Yanjie; Di, Caixia; Lin, Xiaoliang; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China; [Zhong, Wenwei] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xia, ZW (corresponding author), Ruijin Hosp, Dept Pediat, Ruijin 2nd Rd 197, Shanghai 200025, Peoples R China.	xzw63@hotmail.com			National Natural Science Foundation of China [81270084, 81070022, 30871022]; Shanghai Municipal Science and Technology Commission Foundation Grants [13XD1402800, 10410701000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Foundation Grants	This work was supported by National Natural Science Foundation of China Grants 81270084, 81070022, and 30871022 and Shanghai Municipal Science and Technology Commission Foundation Grants 13XD1402800 and 10410701000.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Almolki A, 2008, AM J PATHOL, V173, P981, DOI 10.2353/ajpath.2008.070863; Bach FH, 2002, WIEN KLIN WOCHENSCHR, V114, P1; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Barada KA, 2007, CYTOKINE, V37, P236, DOI 10.1016/j.cyto.2007.04.005; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blancou P, 2011, METHODS MOL BIOL, V677, P247, DOI 10.1007/978-1-60761-869-0_18; Boirivant M, 2012, ORAL DIS, V18, P1, DOI 10.1111/j.1601-0825.2011.01811.x; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chang TJ, 2008, AM J PHYSIOL-HEART C, V295, pH999, DOI 10.1152/ajpheart.01289.2007; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Chen X, 2014, J LEUKOCYTE BIOL, V95, P723, DOI 10.1189/jlb.1213633; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593; Desbuards N, 2007, THROMB HAEMOSTASIS, V98, P614, DOI 10.1160/TH06-12-0717; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gomes-Santos AC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/560817; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Huibregtse IL, 2007, GUT, V56, P584, DOI 10.1136/gut.2006.103523; Hyvelin JM, 2010, J VASC SURG, V51, P417, DOI 10.1016/j.jvs.2009.09.004; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Kim Jung Mogg, 2010, Korean J Gastroenterol, V55, P4; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li Z, 2010, INFLAMM BOWEL DIS, V16, P1299, DOI 10.1002/ibd.21229; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Olsen T, 2011, CYTOKINE, V56, P633, DOI 10.1016/j.cyto.2011.08.036; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Pae HO, 2003, BIOCHEM BIOPH RES CO, V306, P701, DOI 10.1016/S0006-291X(03)01037-4; Pae HO, 2008, RECENT PATENTS INFLA, V2, P159, DOI 10.2174/187221308786241929; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ricciardelli I, 2008, IMMUNOLOGY, V125, P178, DOI 10.1111/j.1365-2567.2008.02839.x; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Sheikh SZ, 2011, J IMMUNOL, V186, P5506, DOI 10.4049/jimmunol.1002433; Siakavellas SI, 2012, DISCOV MED, V14, P253; Singh K, 2013, J IMMUNOL, V190, P2544, DOI 10.4049/jimmunol.1202399; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P482, DOI 10.1016/j.coph.2009.05.008; Song XY, 2013, CYTOKINE, V62, P175, DOI 10.1016/j.cyto.2013.03.014; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Takagi T, 2011, DIGEST DIS SCI, V56, P1663, DOI 10.1007/s10620-010-1484-y; Takeda Y, 2004, CLIN EXP IMMUNOL, V138, P237, DOI 10.1111/j.1365-2249.2004.02594.x; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Varga C, 2007, EUR J PHARMACOL, V561, P164, DOI 10.1016/j.ejphar.2006.12.022; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Waldner Maximilian J, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0555s46; Wang WP, 2001, AM J PHYSIOL-GASTR L, V281, pG586, DOI 10.1152/ajpgi.2001.281.2.G586; Wu JY, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-77; Xia ZW, 2008, CURR PHARM DESIGN, V14, P454, DOI 10.2174/138161208783597326; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yoriki H, 2013, J GASTROEN HEPATOL, V28, P632, DOI 10.1111/jgh.12074; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Zhang YJ, 2013, J BIOL CHEM, V288, P34612, DOI 10.1074/jbc.M113.494369; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	70	69	76	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26847	26858		10.1074/jbc.M114.590554	http://dx.doi.org/10.1074/jbc.M114.590554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112868	Green Published, hybrid			2022-12-28	WOS:000342853900016
J	Borgal, L; Rinschen, MM; Dafinger, C; Hoff, S; Reinert, MJ; Lamkemeyer, T; Lienkamp, SS; Benzing, T; Schermer, B				Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Hoff, Sylvia; Reinert, Matthaeus J.; Lamkemeyer, Tobias; Lienkamp, Soeren S.; Benzing, Thomas; Schermer, Bernhard			Casein Kinase 1 alpha Phosphorylates the Wnt Regulator Jade-1 and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN DEGRADATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; EPITHELIAL-CELLS; PROTEIN-KINASE; STEM-CELLS; DISEASE; REPAIR; CK1; QUANTIFICATION	Tight regulation of Wnt/beta-catenin signaling is critical for vertebrate development and tissue maintenance, and deregulation can lead to a host of disease phenotypes, including developmental disorders and cancer. Proteins associated with primary cilia and centrosomes have been demonstrated to negatively regulate canonical Wnt signaling in interphase cells. The plant homeodomain zinc finger protein Jade-1 can act as an E3 ubiquitin ligase-targeting beta-catenin for proteasomal degradation and concentrates at the centrosome and ciliary basal body in addition to the nucleus in interphase cells. We demonstrate that the destruction complex component casein kinase 1 beta(CK1 alpha) phosphorylates Jade-1 at a conserved SLS motif and reduces the ability of Jade-1 to inhibit beta-catenin signaling. Consistently, Jade-1 lacking the SLS motif is more effective than wild-type Jade-1 in reducing beta-catenin-induced secondary axis formation in Xenopus laevis embryos in vivo. Interestingly, CK1 alpha also phosphorylates beta-catenin and the destruction complex component adenomatous polyposis coli at a similar SLS motif to the effect that beta-catenin is targeted for degradation. The opposing effect of Jade-1 phosphorylation by CK1 alpha suggests a novel example of the dual functions of CK1 alpha activity to either oppose or promote canonical Wnt signaling in a context-dependent manner.	[Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Reinert, Matthaeus J.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Reinert, Matthaeus J.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Rinschen, Markus M.; Lamkemeyer, Tobias; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Hoff, Sylvia; Lienkamp, Soeren S.] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany; [Lienkamp, Soeren S.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79108 Freiburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Freiburg; University of Freiburg	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Borgal, Lori/ABB-9343-2021; Lienkamp, Soeren/AAH-6296-2020; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Rinschen, Markus/N-7283-2019	Lienkamp, Soeren/0000-0003-2963-6865; Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342	Deutsche Forschungsgemeinschaft [SCHE1562-2, SFB832]; Koln Fortune Program / Faculty of Medicine (University of Cologne); Koln Fortune Program/Faculty of Medicine (University of Cologne); UoC Postdoc grant (University of Cologne); Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin); Deutsche Forschungsgemeinschaft (DFG) within clinical research unit (KFO) [201]; Emmy Noether Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune Program / Faculty of Medicine (University of Cologne); Koln Fortune Program/Faculty of Medicine (University of Cologne); UoC Postdoc grant (University of Cologne); Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin); Deutsche Forschungsgemeinschaft (DFG) within clinical research unit (KFO)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHE1562-2 (to B. S.) and SFB832 (to B. S. and T. B.).; Supported by the Koln Fortune Program / Faculty of Medicine (University of Cologne).; Supported by the Koln Fortune Program/Faculty of Medicine (University of Cologne), by a UoC Postdoc grant (University of Cologne), and by the Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin).; Supported by the Deutsche Forschungsgemeinschaft (DFG) within the clinical research unit (KFO) 201 and the Emmy Noether Program.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Borgal L, 2012, J BIOL CHEM, V287, P25370, DOI 10.1074/jbc.M112.385658; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dale T, 2006, NAT STRUCT MOL BIOL, V13, P9, DOI 10.1038/nsmb0106-9; del Valle-Perez B, 2011, MOL CELL BIOL, V31, P2877, DOI 10.1128/MCB.01466-10; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MARIN O, 1994, EUR J BIOCHEM, V223, P647, DOI 10.1111/j.1432-1033.1994.tb19037.x; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pulgar V, 1999, EUR J BIOCHEM, V260, P520, DOI 10.1046/j.1432-1327.1999.00195.x; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Wang GH, 2006, ANAL CHEM, V78, P5752, DOI 10.1021/ac060611v; Yamamoto S, 2013, AM J PHYSIOL-GASTR L, V305, pG241, DOI 10.1152/ajpgi.00480.2012; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	63	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26344	26356		10.1074/jbc.M114.562165	http://dx.doi.org/10.1074/jbc.M114.562165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100726	hybrid, Green Published			2022-12-28	WOS:000342128800027
J	Evans, SK; Burgess, KEV; Gray, JV				Evans, Stephanie K.; Burgess, Karl E. V.; Gray, Joseph V.			Recovery from Rapamycin DRUG-INSENSITIVE ACTIVITY OF YEAST TARGET OF RAPAMYCIN COMPLEX 1 (TORC1) SUPPORTS RESIDUAL PROLIFERATION THAT DILUTES RAPAMYCIN AMONG PROGENY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; FISSION YEAST; LIFE-SPAN; AUTOPHAGY; COMPLEX; TARGET; GROWTH; PERMEASE	The target of rapamycin complex 1 (TORC1) is a key conserved regulator of eukaryotic cell growth. The xenobiotic rapamycin is a potent inhibitor of the yeast complex. Surprisingly, the EGO complex, a nonessential in vivo activator of TORC1, is somehow required for yeast cells to recover efficiently from a period of treatment with rapamycin. Why? Here, we found that rapamycin is only a partial inhibitor of TORC1. We confirmed that saturating amounts of rapamycin do not fully inhibit proliferation of wild-type cells, and we found that the residual proliferation in the presence of the drug is dependent on the EGO complex and on the activity of TORC1. We found that this residual TORC1-dependent proliferation is key to recovery from rapamycin treatment. First, the residual proliferation rate correlates with the ability of cells to recover from treatment. Second, the residual proliferation rate persists long after washout of the drug and until cells recover. Third, the total observable pool of cell-associated rapamycin is extremely stable and decreases only with increasing cell number after washout of the drug. Finally, consideration of the residual proliferation rate alone accurately and quantitatively accounts for the kinetics of recovery of wild-type cells and for the nature and severity of the ego - mutant defect. Overall, our results revealed that rapamycin is a partial inhibitor of yeast TORC1, that persistence of the drug limits recovery, and that rapamycin is not detoxified by yeast but is passively diluted among progeny cells because of residual proliferation.	[Evans, Stephanie K.; Gray, Joseph V.] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Burgess, Karl E. V.] Univ Glasgow, Glasgow Poly, Translat Canc Res Ctr, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Glasgow	Gray, JV (corresponding author), Univ Glasgow, Bower Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	Joseph.Gray@glasgow.ac.uk		Burgess, Karl/0000-0002-0881-715X	Biotechnology and Biological Sciences Research Council; School of Life Sciences	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Life Sciences	This work was supported by a departmental training award Ph.D. studentship from the Biotechnology and Biological Sciences Research Council (to S. K. E.) and a research award from the School of Life Sciences (to J. V. G.).	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Geda P, 2008, YEAST, V25, P577, DOI 10.1002/yea.1610; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shin CS, 2011, AUTOPHAGY, V7, P854, DOI 10.4161/auto.7.8.15696; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	36	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26554	26565		10.1074/jbc.M114.589754	http://dx.doi.org/10.1074/jbc.M114.589754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104356	hybrid, Green Published			2022-12-28	WOS:000342128800046
J	Chen, XY; Wilson, JB; McChesney, P; Williams, SA; Kwon, Y; Longerich, S; Marriott, AS; Sung, P; Jones, NJ; Kupfer, GM				Chen, Xiaoyong; Wilson, James B.; McChesney, Patricia; Williams, Stacy A.; Kwon, Youngho; Longerich, Simonne; Marriott, Andrew S.; Sung, Patrick; Jones, Nigel J.; Kupfer, Gary M.			The Fanconi Anemia Proteins FANCD2 and FANCJ Interact and Regulate Each Other's Chromatin Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; HELICASE BRIP1; CORE COMPLEX; PATHWAY; BRCA1; BACH1; CANCER; PHOSPHORYLATION; BRCA2/FANCD1; FANCG/XRCC9	Fanconi anemia is a genetic disease resulting in bone marrow failure, birth defects, and cancer that is thought to encompass a defect in maintenance of genomic stability. Mutations in 16 genes (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N, O, P, and Q) have been identified in patients, with the Fanconi anemia subtype J (FA-J) resulting from homozygous mutations in the FANCJ gene. Here, we describe the direct interaction of FANCD2 with FANCJ. We demonstrate the interaction of FANCD2 and FANCJ in vivo and in vitro by immunoprecipitation in crude cell lysates and from fractions after gel filtration and with baculovirally expressed proteins. Mutation of the monoubiquitination site of FANCD2 (K561R) preserves interaction with FANCJ constitutively in a manner that impedes proper chromatin localization of FANCJ. FANCJ is necessary for FANCD2 chromatin loading and focus formation in response to mitomycin C treatment. Our results suggest not only that FANCD2 regulates FANCJ chromatin localization but also that FANCJ is necessary for efficient loading of FANCD2 onto chromatin following DNA damage caused by mitomycin C treatment.	[Chen, Xiaoyong; McChesney, Patricia; Williams, Stacy A.; Kupfer, Gary M.] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Pediat, New Haven, CT 06520 USA; [Kupfer, Gary M.] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Pathol, New Haven, CT 06520 USA; [Kwon, Youngho; Longerich, Simonne; Sung, Patrick] Yale Univ, Sch Med, Sect Hematol Oncol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Marriott, Andrew S.; Jones, Nigel J.] Univ Liverpool, Dept Biochem, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Wilson, James B.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L3 9TA, Merseyside, England	Yale University; Yale University; Yale University; University of Liverpool; University of Liverpool	Kupfer, GM (corresponding author), Yale Univ, Box 208604, New Haven, CT 06520 USA.	gary.kupfer@yale.edu	Jones, Nigel J/D-1997-2010		National Institutes of Health [R01-HL063776, R01-ES015252]; North West Cancer Research Fund [NWCRF-CR863, NWCRF-CR968]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North West Cancer Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL063776 (to G. M. K.) and R01-ES015252 (to P. S.). This work was also supported by North West Cancer Research Fund Grants NWCRF-CR863 and NWCRF-CR968 (to N. J. J.).	Alter BP, 2003, CANCER-AM CANCER SOC, V97, P425, DOI 10.1002/cncr.11046; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Collins N, 2005, INT J HEMATOL, V82, P176, DOI 10.1532/IJH97.05108; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Green AM, 2009, HEMATOL ONCOL CLIN N, V23, P193, DOI 10.1016/j.hoc.2009.01.008; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kitao H, 2006, J BIOL CHEM, V281, P21312, DOI 10.1074/jbc.M603290200; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2004, CELL CYCLE, V3, P179; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Thomashevski A, 2004, J BIOL CHEM, V279, P26201, DOI 10.1074/jbc.M400091200; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, DNA REPAIR, V3, P1063, DOI 10.1016/j.dnarep.2004.04.005; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xie J, 2010, CANCER PREV RES, V3, P1409, DOI 10.1158/1940-6207.CAPR-10-0118; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; Zhang F, 2010, CHROMOSOMA, V119, P637, DOI 10.1007/s00412-010-0285-6	50	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25774	25782		10.1074/jbc.M114.552570	http://dx.doi.org/10.1074/jbc.M114.552570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070891	Green Published, hybrid			2022-12-28	WOS:000342130800035
J	Huo, XD; Liu, S; Shao, T; Hua, H; Kong, QB; Wang, J; Luo, T; Jiang, YF				Huo, Xiaodong; Liu, Shu; Shao, Ting; Hua, Hui; Kong, Qingbin; Wang, Jiao; Luo, Ting; Jiang, Yangfu			GSK3 Protein Positively Regulates Type I Insulin-like Growth Factor Receptor through Forkhead Transcription Factors FOXO1/3/4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PANCREATIC-CANCER CELLS; FACTOR-KAPPA-B; GENE-EXPRESSION; BREAST-CANCER; WILMS-TUMOR; CYCLIN G2; KINASE; PHOSPHORYLATION; SURVIVAL	Glycogen synthase kinase-3 (GSK3) has either tumor-suppressive roles or pro-tumor roles in different types of human tumors. A number of GSK3 targets in diverse signaling pathways have been uncovered, such as tuberous sclerosis complex subunit 2 and beta-catenin. The O subfamily of forkhead/winged helix transcription factors (FOXO) is known as tumor suppressors that induce apoptosis. In this study, we find that FOXO binds to type I insulin-like growth factor receptor (IGF-IR) promoter and stimulates its transcription. GSK3 positively regulates the trans-activation activity of FOXO and stimulates IGF-IR expression. Although kinase-dead GSK3 beta cannot up-regulate IGF-IR, the constitutively active GSK3 beta induces IGF-IR expression in a FOXO-dependent manner. Serum starvation or Akt inhibition leads to an increase in IGF-IR expression, which could be blunted by GSK3 inhibition. GSK3 beta knockdown or GSK3 inhibitor suppresses IGF-I-induced IGF-IR, Akt, and ERK1/2 phosphorylation. Moreover, knockdown of GSK3 beta or FOXO1/3/4 leads to a decrease in cellular proliferation and abrogates IGFI-induced hepatoma cell proliferation. These results suggest that GSK3 and FOXO may positively regulate IGF-I signaling and hepatoma cell proliferation.	[Huo, Xiaodong; Liu, Shu; Shao, Ting; Kong, Qingbin; Jiang, Yangfu] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Sect Oncogene, Chengdu 610041, Peoples R China; [Hua, Hui] West China Hosp, Lab Stem Cell Biol, Chengdu 610041, Peoples R China; [Wang, Jiao] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu 610075, Peoples R China; [Luo, Ting] West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China	Sichuan University; Chengdu University of Traditional Chinese Medicine	Jiang, YF (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651				Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Flossmann-Kast BBM, 1998, CANCER RES, V58, P3551; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Genua M, 2009, CANCER RES, V69, P7270, DOI 10.1158/0008-5472.CAN-09-0088; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hellawell GO, 2002, CANCER RES, V62, P2942; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Karnieli E, 1996, J BIOL CHEM, V271, P19304, DOI 10.1074/jbc.271.32.19304; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Li ZD, 2012, J BIOL CHEM, V287, P17737, DOI 10.1074/jbc.M111.291708; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Qin L, 2011, J BIOCHEM, V150, P151, DOI 10.1093/jb/mvr066; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sakamaki J, 2012, J RECEPT SIG TRANSD, V32, P96, DOI 10.3109/10799893.2012.660531; Santamaria CM, 2009, LEUKEMIA RES, V33, P1706, DOI 10.1016/j.leukres.2009.04.024; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Svendsen AM, 2014, BIOCHEM J, V457, P69, DOI 10.1042/BJ20130490; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Tanno S, 2001, CANCER RES, V61, P589; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; WERNER H, 1995, INT J BIOCHEM CELL B, V27, P987, DOI 10.1016/1357-2725(95)00074-Y; Woodgett JR, 2012, JNCI-J NATL CANCER I, V104, P722, DOI 10.1093/jnci/djs223; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Zhang YR, 2012, P NATL ACAD SCI USA, V109, P5717, DOI 10.1073/pnas.1203210109	54	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24759	24770		10.1074/jbc.M114.580738	http://dx.doi.org/10.1074/jbc.M114.580738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053419	hybrid, Green Published			2022-12-28	WOS:000341985300003
J	Wilson, MR; Hou, ZJ; Matherly, LH				Wilson, Mike R.; Hou, Zhanjun; Matherly, Larry H.			Substituted Cysteine Accessibility Reveals a Novel Transmembrane 2-3 Reentrant Loop and Functional Role for Transmembrane Domain 2 in the Human Proton-coupled Folate Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATION; ESCHERICHIA-COLI; GENE PCFT-SLC46A1; LACTOSE PERMEASE; MALABSORPTION; IDENTIFICATION; TRANSLOCATION; BINDING; SLC46A1; IMPACT	The proton-coupled folate transporter (PCFT) is a folate-proton symporter highly expressed in solid tumors that can selectively target cytotoxic antifolates to tumors under acidic microenvironment conditions. Predicted topology models for PCFT suggest that the loop domain between transmembrane domains (TMDs) 2 and 3 resides in the cytosol. Mutations involving Asp-109 or Arg-113 in the TMD2-3 loop result in loss of activity. By structural homology to other solute carriers, TMD2 may form part of the PCFT substrate binding domain. In this study we mutated the seven cysteine (Cys) residues of human PCFT to serine, creating Cys-less PCFT. Thirty-three single-Cys mutants spanning TMD2 and the TMD2-3 loop in a Cys-less PCFT background were transfected into PCFT-null HeLa cells. All 33 mutants were detected by Western blotting, and 28 were active for [H-3] methotrexate uptake at pH 5.5. For the active residues, we performed pulldown assays with membrane-impermeable 2-aminoethyl methanethiosulfonate-biotin and streptavidin beads to determine their aqueous-accessibilities. Multiple residues in TMD2 and the TMD2-3 loop domain reacted with 2-aminoethyl methanethiosulfonate-biotin, establishing aqueous accessibilities. Pemetrexed pretreatment inhibited biotinylation of TMD2 mutants G93C and F94C, and biotinylation of these residues inhibited methotrexate transport activity. Our results suggest that the TMD 2-3 loop domain is aqueous-accessible and forms a novel reentrant loop structure. Residues in TMD2 form an aqueous transmembrane pathway for folate substrates, and Gly-93 and Phe-94 may contribute to a substrate binding domain. Characterization of PCFT structure is essential to understanding the transport mechanism including the critical determinants of substrate binding.	[Wilson, Mike R.; Hou, Zhanjun; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Hou, Zhanjun; Matherly, Larry H.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute	Matherly, LH (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@karmanos.org	/S-1117-2019	Wilson, Mike/0000-0002-7681-2457	National Institutes of Health [R01 CA53535];  [T32 CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531, R01CA053535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA53535 (NCI).; Supported by Pre-doctoral Training Grant T32 CA009531.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Atabay B, 2010, PEDIATR HEMAT ONCOL, V27, P614, DOI 10.3109/08880018.2010.481705; Borzutzky A, 2009, CLIN IMMUNOL, V133, P287, DOI 10.1016/j.clim.2009.08.006; Desmoulin SK, 2012, CANCER BIOL THER, V13, P1355, DOI 10.4161/cbt.22020; Desmoulin SK, 2010, MOL PHARMACOL, V78, P577, DOI 10.1124/mol.110.065896; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Hou ZJ, 2012, J BIOL CHEM, V287, P4982, DOI 10.1074/jbc.M111.306860; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inoue K, 2008, AM J PHYSIOL-GASTR L, V294, pG660, DOI 10.1152/ajpgi.00309.2007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Lasry I, 2009, BIOCHEM BIOPH RES CO, V386, P426, DOI 10.1016/j.bbrc.2009.06.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Mahadeo KM, 2011, J PEDIATR-US, V159, P623, DOI 10.1016/j.jpeds.2011.03.005; Matherly LH, 2014, DRUG METAB DISPOS, V42, P632, DOI 10.1124/dmd.113.055723; Meyer E, 2010, MOL GENET METAB, V99, P325, DOI 10.1016/j.ymgme.2009.11.004; Min SH, 2008, J PEDIATR-US, V153, P435, DOI 10.1016/j.jpeds.2008.04.009; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2011, MOL GENET METAB, V103, P33, DOI 10.1016/j.ymgme.2011.01.008; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; Stokstad ELR, 1990, HIST PERSPECTIVE KEY; Subramanian VS, 2008, AM J PHYSIOL-CELL PH, V294, pC233, DOI 10.1152/ajpcell.00468.2007; Umapathy NS, 2007, INVEST OPHTH VIS SCI, V48, P5299, DOI 10.1167/iovs.07-0288; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Unal ES, 2008, BBA-BIOMEMBRANES, V1778, P1407, DOI 10.1016/j.bbamem.2008.03.009; Yan CH, 2010, PROTEIN J, V29, P350, DOI 10.1007/s10930-010-9259-z; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; Zhao RB, 2012, AM J PHYSIOL-CELL PH, V303, pC673, DOI 10.1152/ajpcell.00123.2012; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	38	16	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25287	25295		10.1074/jbc.M114.578252	http://dx.doi.org/10.1074/jbc.M114.578252			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053408	Green Published, hybrid			2022-12-28	WOS:000341985300047
J	Phillips, MC				Phillips, Michael C.			Molecular Mechanisms of Cellular Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ABC Transporter; Cholesterol; High Density Lipoprotein (HDL); Macrophage; Phospholipid; Plasma Membrane; Scavenger Receptor; Efflux	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; BINDING CASSETTE TRANSPORTER; SCAVENGER RECEPTOR BI; PLASMA-MEMBRANE MICROSOLUBILIZATION; SR-BI; APOA-I; UNILAMELLAR VESICLES; ABCA1-MEDIATED EFFLUX; BIDIRECTIONAL FLUX	Most types of cells in the body do not express the capability of catabolizing cholesterol, so cholesterol efflux is essential for homeostasis. For instance, macrophages possess four pathways for exporting free (unesterified) cholesterol to extracellular high density lipoprotein (HDL). The passive processes include simple diffusion via the aqueous phase and facilitated diffusion mediated by scavenger receptor class B, type 1 (SR-BI). Active pathways are mediated by the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, which are membrane lipid translocases. The efflux of cellular phospholipid and free cholesterol to apolipoprotein A-I promoted by ABCA1 is essential for HDL biogenesis. Current understanding of the molecular mechanisms involved in these four efflux pathways is presented in this minireview.	Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Phillips, MC (corresponding author), Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, 3400 Civ Ctr Blvd,11-130 Translat Res Ct, Philadelphia, PA 19104 USA.	mcp3@mail.med.upenn.edu		Phillips, Michael/0000-0002-7147-8007	National Institutes of Health [HL22633]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL22633 (to M. C. P.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; BACKER JM, 1981, BIOCHEMISTRY-US, V20, P3805, DOI 10.1021/bi00516a021; BARRY PH, 1984, PHYSIOL REV, V64, P763, DOI 10.1152/physrev.1984.64.3.763; BATES SR, 1974, BIOCHIM BIOPHYS ACTA, V360, P38, DOI 10.1016/0005-2760(74)90178-7; Callan-Jones A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004648; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; Czarnecka H, 1996, J BIOL CHEM, V271, P2023, DOI 10.1074/jbc.271.4.2023; DAVIDSON WS, 1995, J BIOL CHEM, V270, P17106, DOI 10.1074/jbc.270.29.17106; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; de Beer MC, 2001, J LIPID RES, V42, P309; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Faulkner LE, 2008, J LIPID RES, V49, P1322, DOI 10.1194/jlr.M800048-JLR200; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; HARA H, 1991, J BIOL CHEM, V266, P3080; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; Kang MH, 2010, TRENDS CARDIOVAS MED, V20, P41, DOI 10.1016/j.tcm.2010.03.006; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2007, BIOCHEMISTRY-US, V46, P2233, DOI 10.1021/bi6023397; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lund-Katz S, 2013, J BIOL CHEM, V288, P23150, DOI 10.1074/jbc.M113.495523; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; Lyssenko NN, 2013, FASEB J, V27, P2880, DOI 10.1096/fj.12-216564; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; MCLEAN LR, 1984, BIOCHIM BIOPHYS ACTA, V776, P21, DOI 10.1016/0005-2736(84)90246-3; MCLEAN LR, 1984, BIOCHEMISTRY-US, V23, P4624, DOI 10.1021/bi00315a017; Meyer JM, 2013, CURR OPIN LIPIDOL, V24, P386, DOI 10.1097/MOL.0b013e3283638042; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; Mineo C, 2013, J LIPID RES, V54, P2315, DOI 10.1194/jlr.R039479; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; Phillips MC, 2013, J LIPID RES, V54, P2034, DOI 10.1194/jlr.R034025; Pownall H. J., 1987, PLASMA LIPOPROTEINS, P95; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rodrigueza WV, 1997, ARTERIOSCL THROM VAS, V17, P383, DOI 10.1161/01.ATV.17.2.383; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rothblat G H, 1986, Methods Enzymol, V129, P628; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; ROTHBLAT GH, 1982, J BIOL CHEM, V257, P4775; Sankaranarayanan S, 2013, J LIPID RES, V54, P671, DOI 10.1194/jlr.M031336; Sankaranarayanan S, 2009, J LIPID RES, V50, P275, DOI 10.1194/jlr.M800362-JLR200; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; STECK TL, 1988, J BIOL CHEM, V263, P13023; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Thuahnai ST, 2001, J BIOL CHEM, V276, P43801, DOI 10.1074/jbc.M106695200; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vedhachalam C, 2010, J BIOL CHEM, V285, P31965, DOI 10.1074/jbc.M110.126292; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Weibel GL, 2014, ARTERIOSCL THROM VAS, V34, P17, DOI 10.1161/ATVBAHA.113.302437; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Williams DL, 1999, CURR OPIN LIPIDOL, V10, P329, DOI 10.1097/00041433-199908000-00007; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200; Yokoyama S, 2012, BBA-MOL CELL BIOL L, V1821, P547, DOI 10.1016/j.bbalip.2011.07.017; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	99	375	391	9	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24020	24029		10.1074/jbc.R114.583658	http://dx.doi.org/10.1074/jbc.R114.583658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25074931	Green Published, hybrid			2022-12-28	WOS:000341505600002
J	Yanaka, S; Ueno, T; Shi, Y; Qi, JX; Gao, GF; Tsumoto, K; Sugase, K				Yanaka, Saeko; Ueno, Takamasa; Shi, Yi; Qi, Jianxun; Gao, George F.; Tsumoto, Kouhei; Sugase, Kenji			Peptide-dependent Conformational Fluctuation Determines the Stability of the Human Leukocyte Antigen Class I Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Major Histocompatibility Complex (MHC); Nuclear Magnetic Resonance (NMR); Protein Dynamic; Protein Stability; Thermodynamics	T-CELL-RECEPTOR; MHC CLASS-I; HLA CLASS-I; HEAT-CAPACITY; BINDING; MOLECULES; HLA-B27; HIV-1; HLA-B-ASTERISK-3501; POLYMORPHISM	Background: The stable presentation of HLA is necessary for effective T-cell activity in infectious diseases. Results: Conformational fluctuation analysis revealed a minor state of HLA. Conclusion: The minor state avoids the disintegration of HLA by tightly packing toward the peptide. The minor population correlates with the elongated presentation of HLA on the cell surface. Significance: We revealed the stabilization mechanism for HLA. In immune-mediated control of pathogens, human leukocyte antigen (HLA) class I presents various antigenic peptides to CD8(+) T-cells. Long-lived peptide presentation is important for efficient antigen-specific T-cell activation. Presentation time depends on the peptide sequence and the stability of the peptide-HLA complex (pHLA). However, the determinant of peptide-dependent pHLA stability remains elusive. Here, to reveal the pHLA stabilization mechanism, we examined the crystal structures of an HLA class I allomorph in complex with HIV-derived peptides and evaluated site-specific conformational fluctuations using NMR. Although the crystal structures of various pHLAs were almost identical independent of the peptides, fluctuation analyses identified a peptide-dependent minor state that would be more tightly packed toward the peptide. The minor population correlated well with the thermostability and cell surface presentation of pHLA, indicating that this newly identified minor state is important for stabilizing the pHLA and facilitating T-cell recognition.	[Yanaka, Saeko; Tsumoto, Kouhei] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan; [Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan; [Ueno, Takamasa] Kumamoto Univ, IRCMS, Kumamoto 8600811, Japan; [Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China; [Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Tsumoto, Kouhei] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1088693, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo 1088693, Japan; [Sugase, Kenji] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka 6188503, Japan	University of Tokyo; Kumamoto University; Kumamoto University; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Tokyo; University of Tokyo; Suntory Holdings Ltd	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp; sugase@sunbor.or.jp	Sugase, Kenji/AAF-4552-2021; Gao, George Fu/ABD-5229-2021; Yanaka, Saeko/AAU-4487-2020; Ueno, Takamasa/AAW-9491-2020; Ueno, Takamasa/F-5788-2013; Qi, Jianxun/ABF-1646-2021; Sugase, Kenji/S-3132-2016; Yanaka, Saeko/AAW-5301-2020	Sugase, Kenji/0000-0001-8623-7743; Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Sugase, Kenji/0000-0001-8623-7743; Yanaka, Saeko/0000-0002-3513-5701	Japanese Society for the Promotion of Science [11J06193]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Society for the Promotion of Science Research Grant 11J06193.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Bowerman NA, 2009, MOL IMMUNOL, V46, P3000, DOI 10.1016/j.molimm.2009.06.012; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escobar H, 2008, J IMMUNOL, V181, P4874, DOI 10.4049/jimmunol.181.7.4874; Garbi N, 2005, IMMUNOL REV, V207, P77, DOI 10.1111/j.0105-2896.2005.00303.x; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hourigan CS, 2006, EUR J IMMUNOL, V36, P3288, DOI 10.1002/eji.200636234; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Motozono C, 2009, J IMMUNOL, V182, P5528, DOI 10.4049/jimmunol.0803471; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Riquelme E, 2009, EUR J IMMUNOL, V39, P2259, DOI 10.1002/eji.200939341; SCHONBACH C, 1995, J IMMUNOL, V154, P5951; Shi Y, 2011, MOL IMMUNOL, V48, P2198, DOI 10.1016/j.molimm.2011.05.009; SILVER ML, 1991, NATURE, V350, P619, DOI 10.1038/350619a0; Singer DS, 1997, CRIT REV IMMUNOL, V17, P463; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sugase K, 2013, J BIOMOL NMR, V56, P275, DOI 10.1007/s10858-013-9747-5; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P11876, DOI 10.1021/bi001013s; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Ueno T, 2007, J IMMUNOL, V178, P5513, DOI 10.4049/jimmunol.178.9.5513; Walpole NG, 2010, J MOL BIOL, V397, P467, DOI 10.1016/j.jmb.2010.01.052; Winkler K, 2007, BIOPHYS J, V93, P2743, DOI 10.1529/biophysj.106.096602	61	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24680	24690		10.1074/jbc.M114.566174	http://dx.doi.org/10.1074/jbc.M114.566174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028510	Green Published, hybrid			2022-12-28	WOS:000341505600057
J	Schaedler, TA; Thornton, JD; Kruse, I; Schwarzlander, M; Meyer, AJ; van Veen, HW; Balk, J				Schaedler, Theresia A.; Thornton, Jeremy D.; Kruse, Inga; Schwarzlaender, Markus; Meyer, Andreas J.; van Veen, Hendrik W.; Balk, Janneke			A Conserved Mitochondrial ATP-binding Cassette Transporter Exports Glutathione Polysulfide for Cytosolic Metal Cofactor Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Arabidopsis; Iron-Sulfur Protein; Mitochondria; Yeast; Glutathione; Transportomics	IRON-SULFUR PROTEINS; HIGH-THROUGHPUT CLONING; ABC TRANSPORTER; LACTOCOCCUS-LACTIS; ARABIDOPSIS-THALIANA; OXIDATIVE STRESS; ETHYLMALONIC ENCEPHALOPATHY; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; P-GLYCOPROTEIN	Background: ABC transporters of mitochondria (ATM) are required for formation of cytosolic iron-sulfur clusters and molybdenum cofactor. Results:Arabidopsis ATM3 and yeast Atm1 transport radiolabeled glutathione disulfide (GSSG). Transport of glutathione trisulfide (GS-S-SG) was demonstrated by mass spectrometry. Conclusion: A mitochondrial transporter exports glutathione polysulfide. Significance: Identification of substrate(s) of ATMs defines their role in metal cofactor assembly and iron homeostasis. An ATP-binding cassette transporter located in the inner mitochondrial membrane is involved in iron-sulfur cluster and molybdenum cofactor assembly in the cytosol, but the transported substrate is unknown. ATM3 (ABCB25) from Arabidopsis thaliana and its functional orthologue Atm1 from Saccharomyces cerevisiae were expressed in Lactococcus lactis and studied in inside-out membrane vesicles and in purified form. Both proteins selectively transported glutathione disulfide (GSSG) but not reduced glutathione in agreement with a 3-fold stimulation of ATPase activity by GSSG. By contrast, Fe2+ alone or in combination with glutathione did not stimulate ATPase activity. Arabidopsis atm3 mutants were hypersensitive to an inhibitor of glutathione biosynthesis and accumulated GSSG in the mitochondria. The growth phenotype of atm3-1 was strongly enhanced by depletion of the mitochondrion-localized, GSH-dependent persulfide oxygenase ETHE1, suggesting that the physiological substrate of ATM3 contains persulfide in addition to glutathione. Consistent with this idea, a transportomics approach using mass spectrometry showed that glutathione trisulfide (GS-S-SG) was transported by Atm1. We propose that mitochondria export glutathione polysulfide, containing glutathione and persulfide, for iron-sulfur cluster assembly in the cytosol.	[Schaedler, Theresia A.; Thornton, Jeremy D.; Kruse, Inga; Balk, Janneke] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Schaedler, Theresia A.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Schwarzlaender, Markus; Meyer, Andreas J.] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53113 Bonn, Germany; [van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Kruse, Inga; Balk, Janneke] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Cambridge; University of Bonn; University of Cambridge; University of East Anglia	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Res Pk,44-1603-450621, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk; janneke.balk@jic.ac.uk	Meyer, Andreas J/C-4734-2013; Schwarzländer, Markus/HGE-3726-2022; van Veen, Hendrik W./A-4162-2008	Meyer, Andreas J/0000-0001-8144-4364; van Veen, Hendrik W./0000-0002-9658-8077; Schwarzlander, Markus/0000-0003-0796-8308; Kruse, Inga/0000-0003-1935-1647; Schaedler, Theresia/0000-0002-7247-4091	Biotechnology and Biological Sciences Research Council [BB/H00288X/1]; Biotechnology and Biological Sciences Research Council; University of East Anglia; Deutsche Forschungsgemeinschaft [SCHW 1719/1-1, ME 1567/5-1, Inst 217/651-1 FUGG]; Royal Society University Research Fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0657, BB/K008838/1] Funding Source: researchfish; BBSRC [BB/H00288X/1, BB/K008838/1, BBS/E/J/000C0657] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of East Anglia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Royal Society University Research Fellowship(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council Grant BB/H00288X/1.; Supported by a Biotechnology and Biological Sciences Research Council Institute Strategic Programme grant ( to the John Innes Centre).; Supported by a Dean's studentship from the University of East Anglia.; Supported by Deutsche Forschungsgemeinschaft through the Emmy Noether Programme Grant SCHW 1719/1-1.; Supported by Deutsche Forschungsgemeinschaft Grants ME 1567/5-1 and Inst 217/651-1 FUGG.; Supported by a Royal Society University Research Fellowship and by a start-up grant from the University of East Anglia. To whom correspondence may be addressed: John Innes Centre, Norwich Research Park, Norwich NR4 7UH, United Kingdom. Tel.: 44-1603-450621; E-mail: janneke.balk@jic.ac.uk.	Albrecht SC, 2014, J BIOMOL SCREEN, V19, P379, DOI 10.1177/1087057113499634; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bernard DG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0259; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Birke H, 2012, BIOCHEM J, V445, P275, DOI 10.1042/BJ20120038; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Csere P, 1998, FEBS LETT, V441, P266, DOI 10.1016/S0014-5793(98)01560-9; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Geertsma ER, 2011, BIOCHEMISTRY-US, V50, P3272, DOI 10.1021/bi200178z; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Holdorf MM, 2012, PLANT PHYSIOL, V160, P226, DOI 10.1104/pp.112.201855; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krussel L, 2014, PLANT PHYSIOL, V165, P92, DOI 10.1104/pp.114.239764; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lehmann M, 2009, MOL PLANT, V2, P390, DOI 10.1093/mp/ssn080; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mao QC, 1999, BBA-BIOMEMBRANES, V1461, P69, DOI 10.1016/S0005-2736(99)00150-9; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; WOOD JL, 1987, METHOD ENZYMOL, V143, P25	57	106	107	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23264	23274		10.1074/jbc.M114.553438	http://dx.doi.org/10.1074/jbc.M114.553438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006243	Green Published, hybrid			2022-12-28	WOS:000341505000001
J	De Paula, VS; Pomin, VH; Valente, AP				De Paula, Viviane S.; Pomin, Vitor H.; Valente, Ana Paula			Unique Properties of Human beta-Defensin 6 (hBD6) and Glycosaminoglycan Complex SANDWICH-LIKE DIMERIZATION AND COMPETITION WITH THE CHEMOKINE RECEPTOR 2 (CCR2) BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; HEPARIN-BINDING; CHEMOKINE; OLIGOMERIZATION; SULFATE; MACROMOLECULES; RECOGNITION; DYNAMICS	Defensins are components of the innate immune system that promote the directional migration and activation of dendritic cells, thereby modulating the adaptive immune response. Because matrix glycosaminoglycan (GAG) is known to be important for these functions, we characterized the structural features of human beta-defensin 6 (hBD6) and GAG interaction using a combination of structural and in silico analyses. Our results showed that GAG model compounds, a pentasaccharide (fondaparinux, FX) and an octasaccharide heparin derivative (dp8) bind to the alpha-helix and in the loops between the beta 2 and beta 3 strands, inducing the formation of a ternary complex with a 2:1 hBD6:FX stoichiometry. Competition experiments indicated an overlap of GAG and chemokine receptor CCR2 binding sites. An NMR-derived model of the ternary complex revealed that FX interacts with hBD6 along the dimerization interface, primarily contacting the alpha-helices and beta 2-beta 3 loops from each monomer. We further demonstrated that high-pressure NMR spectroscopy could capture an intermediate stage of hBD6-FX interaction, exhibiting features of a cooperative binding mechanism. Collectively, these data suggest a "sandwich-like" model in which two hBD6 molecules bind a single FX chain and provide novel structural insights into how defensin orchestrates leukocyte recruitment through GAG binding and G protein-coupled receptor activation. Despite the similarity to chemokines and hBD2, our data indicate different properties for the hBD6-GAG complex. This work adds significant information to the currently limited data available for the molecular structures and dynamics of defensin carbohydrate binding.	[De Paula, Viviane S.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941902 Rio De Janeiro, RJ, Brazil; [De Paula, Viviane S.; Pomin, Vitor H.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	De Paula, VS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Av Carlos Chagas Filho 373,CCS,Bloco K, BR-21941902 Rio De Janeiro, RJ, Brazil.	vpaula@cnrmn.bioqmed.ufr.br; valente@cnrmn.bioqmed.ufrj.br	Valente, Ana Paula/J-3010-2017; De Paula, Viviane/L-1947-2013	Valente, Ana Paula/0000-0001-7219-1123; De Paula, Viviane/0000-0003-3171-6477	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Institute of Structural Biology and Bioimaging (INBEB)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute of Structural Biology and Bioimaging (INBEB)	This research was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the National Institute of Structural Biology and Bioimaging (INBEB).	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Blaum BS, 2010, J AM CHEM SOC, V132, P6374, DOI 10.1021/ja1000517; Cordeiro Y, 2013, BIOPHYS CHEM, V183, P9, DOI 10.1016/j.bpc.2013.06.002; Crown SE, 2006, J BIOL CHEM, V281, P25438, DOI 10.1074/jbc.M601518200; De Paula VS, 2013, J MOL BIOL, V425, P4479, DOI 10.1016/j.jmb.2013.08.001; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hayafune M, 2014, P NATL ACAD SCI USA, V111, pE404, DOI 10.1073/pnas.1312099111; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; HRICOVINI M, 1995, CARBOHYD RES, V268, P159, DOI 10.1016/0008-6215(94)00334-C; Jansma AL, 2010, J BIOL CHEM, V285, P14424, DOI 10.1074/jbc.M109.091108; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kitahara R, 2013, PROG NUCL MAG RES SP, V71, P35, DOI 10.1016/j.pnmrs.2012.12.001; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003; Niraula TN, 2004, P NATL ACAD SCI USA, V101, P4089, DOI 10.1073/pnas.0305798101; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; Prabhakar Vikas, 2009, V534, P147, DOI 10.1007/978-1-59745-022-5_11; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seo ES, 2010, BIOCHEMISTRY-US, V49, P10486, DOI 10.1021/bi1011749; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2013, EUR J IMMUNOL, V43, P1412, DOI 10.1002/eji.201243138; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064	47	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22969	22979		10.1074/jbc.M114.572529	http://dx.doi.org/10.1074/jbc.M114.572529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970887	hybrid, Green Published			2022-12-28	WOS:000341017200036
J	Gavin, JM; Hoar, K; Xu, Q; Ma, JY; Lin, YF; Chen, JJ; Chen, W; Bruzzese, FJ; Harrison, S; Mallender, WD; Bump, NJ; Sintchak, MD; Bence, NF; Li, P; Dick, LR; Gould, AE; Chen, JJ				Gavin, James M.; Hoar, Kara; Xu, Qing; Ma, Jingya; Lin, Yafang; Chen, Jiejin; Chen, Wei; Bruzzese, Frank J.; Harrison, Sean; Mallender, William D.; Bump, Nancy J.; Sintchak, Michael D.; Bence, Neil F.; Li, Ping; Dick, Lawrence R.; Gould, Alexandra E.; Chen, Jesse J.			Mechanistic Study of Uba5 Enzyme and the Ufm1 Conjugation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ACTIVATING ENZYME; SUBSTRATE-ASSISTED INHIBITION; FOLD MODIFIER; PROTEIN-ACTIVATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUMO E1; INSIGHTS; NEDD8; UBIQUITIN-FOLD-MODIFIER-1	E1 enzymes activate ubiquitin or ubiquitin-like proteins (Ubl) via an adenylate intermediate and initiate the enzymatic cascade of Ubl conjugation to target proteins or lipids. Ubiquitin-fold modifier 1 (Ufm1) is activated by the E1 enzyme Uba5, and this pathway is proposed to play an important role in the endoplasmic reticulum (ER) stress response. However, the mechanisms of Ufm1 activation by Uba5 and subsequent transfer to the conjugating enzyme (E2), Ufc1, have not been studied in detail. In this work, we found that Uba5 activated Ufm1 via a two-step mechanism and formed a binary covalent complex of Uba5 similar to Ufm1 thioester. This feature contrasts with the three-step mechanism and ternary complex formation in ubiquitin-activating enzyme Uba1. Uba5 displayed random ordered binding with Ufm1 and ATP, and its ATP-pyrophosphate (PPi) exchange activity was inhibited by both AMP and PPi. Ufm1 activation and Uba5 similar to Ufm1 thioester formation were stimulated in the presence of Ufc1. Furthermore, binding of ATP to Uba5 similar to Ufm1 thioester was required for efficient transfer of Ufm1 from Uba5 to Ufc1 via transthiolation. Consistent with the two-step activation mechanism, the mechanism-based pan-E1 inhibitor, adenosine 5'-sulfamate (ADS), reacted with the Uba5 similar to Ufm1 thioester and formed a covalent, tight-binding Ufm1-ADS adduct in the active site of Uba5, which prevented further substrate binding or catalysis. ADS was also shown to inhibit the Uba5 conjugation pathway in the HCT116 cells through formation of the Ufm1-ADS adduct. This suggests that further development of more selective Uba5 inhibitors could be useful in interrogating the roles of the Uba5 pathway in cells.	[Gavin, James M.; Hoar, Kara; Xu, Qing; Ma, Jingya; Lin, Yafang; Chen, Jiejin; Chen, Wei; Bruzzese, Frank J.; Harrison, Sean; Mallender, William D.; Bump, Nancy J.; Sintchak, Michael D.; Bence, Neil F.; Li, Ping; Dick, Lawrence R.; Gould, Alexandra E.; Chen, Jesse J.] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	Gavin, JM (corresponding author), Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA.	james.gavin@takeda.com; jesse.chen@takeda.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; Burroughs AM, 2012, METHODS MOL BIOL, V832, P15, DOI 10.1007/978-1-61779-474-2_2; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Dou TH, 2005, MOL BIOL REP, V32, P265, DOI 10.1007/s11033-005-4822-y; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Liu Gaohua, 2009, Journal of Structural and Functional Genomics, V10, P127, DOI 10.1007/s10969-008-9054-7; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048587; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	42	25	25	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22648	22658		10.1074/jbc.M114.573972	http://dx.doi.org/10.1074/jbc.M114.573972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24966333	hybrid, Green Published			2022-12-28	WOS:000341017200011
J	Morgan, SJ; Deshpande, DA; Tiegs, BC; Misior, AM; Yan, HD; Hershfeld, AV; Rich, TC; Panettieri, RA; An, SS; Penn, RB				Morgan, Sarah J.; Deshpande, Deepak A.; Tiegs, Brian C.; Misior, Anna M.; Yan, Huandong; Hershfeld, Alena V.; Rich, Thomas C.; Panettieri, Reynold A.; An, Steven S.; Penn, Raymond B.			beta-Agonist-mediated Relaxation of Airway Smooth Muscle Is Protein Kinase A-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; K-CA CHANNELS; COUPLED RECEPTORS; BRONCHODILATOR SUBSENSITIVITY; ASTHMATIC-PATIENTS; EPAC; ACTIVATION; CELLS; ANALOGS; EFORMOTEROL	Inhaled beta-agonists are effective at reversing bronchoconstriction in asthma, but the mechanism by which they exert this effect is unclear and controversial. PKA is the historically accepted effector, although this assumption is made on the basis of associative and not direct evidence. Recent studies have asserted that exchange protein activated by cAMP (Epac), not PKA, mediates the relaxation of airway smooth muscle (ASM) observed with beta-agonist treatment. This study aims to clarify the role of PKA in the prorelaxant effects of beta-agonists on ASM. Inhibition of PKA activity via expression of the PKI and RevAB peptides results in increased beta-agonist-mediated cAMP release, abolishes the inhibitory effect of isoproterenol on histamine-induced intracellular calcium flux, and significantly attenuates histamine-stimulated MLC-20 phosphorylation. Analyses of ASM cell and tissue contraction demonstrate that PKA inhibition eliminates most, if not all, beta-agonist-mediated relaxation of contracted smooth muscle. Conversely, Epac knockdown had no effect on the regulation of contraction or procontractile signaling by isoproterenol. These findings suggest that PKA, not Epac, is the predominant and physiologically relevant effector through which beta-agonists exert their relaxant effects.	[Morgan, Sarah J.; Deshpande, Deepak A.; Tiegs, Brian C.; Yan, Huandong; Hershfeld, Alena V.; Penn, Raymond B.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Dept Med, Baltimore, MD 21201 USA; [Misior, Anna M.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC 27106 USA; [Rich, Thomas C.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Rich, Thomas C.] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Panettieri, Reynold A.] Univ Penn, Perelman Sch Med, Airways Biol Initiat, Dept Med,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Penn, Raymond B.] Thomas Jefferson Univ, Dept Med, Div Pulm & Crit Care Med, Ctr Translat Med,Jane & Leonard Korman Lung Ctr, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University School of Medicine; University of South Alabama; University of South Alabama; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jefferson University	Penn, RB (corresponding author), Thomas Jefferson Univ, Dept Med, Rm 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	Raymond.Penn@jefferson.edu	panettieri, reynold/AAG-9485-2019; An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888	National Institutes of Health [HL58506, AG041265, HL087560, HL114471]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058506, R01HL058506, P01HL066299, P01HL114471, R00HL087560, K99HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58506 (to R. B. P.), AG041265 and HL087560 (to D. A. D.), and HL114471 (to R. B. P., R. A. P., and S. S. A.).	ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Billington CK, 2003, RESP RES, V4; BUTT E, 1994, J BIOL CHEM, V269, P14509; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; GAVETT SH, 1993, AM J PHYSIOL, V265, pL493, DOI 10.1152/ajplung.1993.265.5.L493; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; JIANG H, 1992, J BIOL CHEM, V267, P1015; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; KUME H, 1994, J CLIN INVEST, V93, P371, DOI 10.1172/JCI116969; Laxman S, 2006, P NATL ACAD SCI USA, V103, P19194, DOI 10.1073/pnas.0608971103; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; NEWNHAM DM, 1995, THORAX, V50, P497, DOI 10.1136/thx.50.5.497; NEWNHAM DM, 1994, AM J MED, V97, P29, DOI 10.1016/0002-9343(94)90045-0; Ortega VE, 2010, CURR OPIN PHARMACOL, V10, P246, DOI 10.1016/j.coph.2010.04.009; PEARCE N, 1995, LANCET, V345, P41, DOI 10.1016/S0140-6736(95)91159-6; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Perez-Zoghbi JF, 2010, J GEN PHYSIOL, V135, P247, DOI 10.1085/jgp.200910365; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Roscioni SS, 2011, BRIT J PHARMACOL, V164, P958, DOI 10.1111/j.1476-5381.2011.01354.x; Roscioni SS, 2011, J CELL MOL MED, V15, P1551, DOI 10.1111/j.1582-4934.2010.01150.x; Roscioni SS, 2011, BRIT J PHARMACOL, V162, P193, DOI 10.1111/j.1476-5381.2010.01011.x; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Spicuzza L, 2001, BRIT J PHARMACOL, V133, P1201, DOI 10.1038/sj.bjp.0704213; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STOLLEY PD, 1978, PREV MED, V7, P519, DOI 10.1016/0091-7435(78)90265-7; Taylor DR, 2009, AM J RESP CRIT CARE, V179, P976, DOI 10.1164/rccm.200901-0055CC; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	46	55	57	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23065	23074		10.1074/jbc.M114.557652	http://dx.doi.org/10.1074/jbc.M114.557652			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973219	Green Published, hybrid			2022-12-28	WOS:000341017200044
J	Mueller, AM; Yoon, BH; Sadiq, SA				Mueller, Andre Michael; Yoon, Bo Hyung; Sadiq, Saud Ahmed			Inhibition of Hyaluronan Synthesis Protects against Central Nervous System (CNS) Autoimmunity and Increases CXCL12 Expression in the Inflamed CNS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE PROGENITOR MATURATION; MULTIPLE-SCLEROSIS; TH17 CELLS; T-CELLS; ENCEPHALOMYELITIS; 4-METHYLUMBELLIFERONE; ACID; EXTRAVASATION; REMYELINATION; DISEASE	Hyaluronan (HA) may have proinflammatory roles in the context of CNS autoimmunity. It accumulates in demyelinated multiple sclerosis (MS) lesions, promotes antigen presentation, and enhances T-cell activation and proliferation. HA facilitates lymphocyte binding to vessels and CNS infiltration at the CNS vascular endothelium. Furthermore, HA signals through Toll-like receptors 2 and 4 to stimulate inflammatory gene expression. We assessed the role of HA in experimental autoimmune encephalomyelitis (EAE), an animal model of MS by administration of 4-methylumbelliferone (4MU), a well established inhibitor of HA synthesis. 4MU decreased hyaluronan synthesis in vitro and in vivo. It was protective in active EAE of C57Bl/6 mice, decreased spinal inflammatory infiltrates and spinal infiltration of Th1 cells, and increased differentiation of regulatory T-cells. In adoptive transfer EAE, feeding of 4MU to donor mice significantly decreased the encephalitogenicity of lymph node cells. The transfer of proteolipid protein (PLP)-stimulated lymph node cells to 4MU-fed mice resulted in a delayed EAE onset and delayed spinal T-cell infiltration. Expression of CXCL12, an anti-inflammatory chemokine, is reduced in MS patients in CSF cells and in spinal cord tissue during EAE. Hyaluronan suppressed production of CXCL12, whereas 4MU increased spinal CXCL12 in naive animals and during neuroinflammation. Neutralization of CXCR4, the most prominent receptor of CXCL12, by administration of AMD3100 diminished the protective impact of 4MU in adoptive transfer EAE. In conclusion, hyaluronan exacerbates CNS autoimmunity, enhances encephalitogenic T-cell responses, and suppresses the protective chemokine CXCL12 in CNS tissue. Inhibition of hyaluronan synthesis with 4MU protects against an animal model of MS and may represent an important therapeutic option in MS and other neuroinflammatory diseases.	[Mueller, Andre Michael; Yoon, Bo Hyung; Sadiq, Saud Ahmed] Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA		Sadiq, SA (corresponding author), Tisch MS Res Ctr New York, 521 W 57th St, New York, NY 10019 USA.	ssadiq@tischms.org	Sadiq, Saud/AAA-9871-2020					Aarvak T, 1999, J IMMUNOL, V162, P1246; Ambrosini E, 2005, J NEUROPATH EXP NEUR, V64, P706, DOI 10.1097/01.jnen.0000173893.01929.fc; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Brennan FR, 1999, IMMUNOLOGY, V98, P427, DOI 10.1046/j.1365-2567.1999.00894.x; Brynedal B, 2010, NEUROBIOL DIS, V37, P613, DOI 10.1016/j.nbd.2009.11.014; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Guo NX, 2010, J BIOL CHEM, V285, P32012, DOI 10.1074/jbc.M110.127183; Hagemeier K, 2012, HISTOL HISTOPATHOL, V27, P277, DOI 10.14670/HH-27.277; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; HOARE K, 1993, CONNECT TISSUE RES, V30, P117, DOI 10.3109/03008209309041327; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Maeshima N, 2011, EUR J IMMUNOL, V41, P1108, DOI 10.1002/eji.201040870; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Miljkovic D, 2011, IMMUNOBIOLOGY, V216, P979, DOI 10.1016/j.imbio.2011.03.013; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Muller AM, 2012, J NEUROIMMUNOL, V251, P80, DOI 10.1016/j.jneuroim.2012.06.008; MULDER GJ, 1985, BIOCHEM PHARMACOL, V34, P1325, DOI 10.1016/0006-2952(85)90513-1; Mummert ME, 2002, J IMMUNOL, V169, P4322, DOI 10.4049/jimmunol.169.8.4322; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SKUNDRIC DS, 1993, J NEUROIMMUNOL, V46, P113, DOI 10.1016/0165-5728(93)90240-Y; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x; Winkler CW, 2012, J BIOL CHEM, V287, P33237, DOI 10.1074/jbc.M112.356287; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861	39	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22888	22899		10.1074/jbc.M114.559583	http://dx.doi.org/10.1074/jbc.M114.559583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973214	Green Published, hybrid			2022-12-28	WOS:000341017200030
J	van den Bosch, MWM; Palsson-Mcdermott, E; Johnson, DS; O'Neill, LAJ				van den Bosch, Mirjam W. M.; Palsson-Mcdermott, Eva; Johnson, Derek S.; O'Neill, Luke A. J.			LPS Induces the Degradation of Programmed Cell Death Protein 4 (PDCD4) to Release Twist2, Activating c-Maf Transcription to Promote Interleukin-10 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE INFLAMMATORY RESPONSE; MAMMALIAN TARGET; SUPPRESSOR PDCD4; KINASE-AKT; RAPAMYCIN; PATHWAY; IL-10; TRANSLATION; EXPRESSION; LIPOPOLYSACCHARIDE	Programmed cell death protein 4 (PDCD4) is a tumor suppressor and has also been shown to suppress production of the immunomodulatory cytokine IL-10. The precise role of PDCD4 in IL-10 induction in macrophages is still not fully understood. Incubation of macrophages with inhibitors of PI3K and mTOR blocked LPS-stimulated PDCD4 degradation and expression of c-Maf and IL-10 production. PDCD4 and the transcription factor Twist2 were shown to form a complex in untreated cells. LPS disrupted the complex allowing Twist2 to bind to the c-Maf promoter. PI3K and mTOR inhibitors prevented this disruption by stabilizing PDCD4 and thereby decreased Twist2 binding to the c-Maf promoter and induction of c-Maf mRNA. These results indicate a regulatory role for PDCD4 and Twist2 in LPS-induced IL-10 production in macrophages. LPS promotes PDCD4 degradation via a pathway involving PI3K and mTOR, releasing Twist2, which induces IL-10 via c-Maf.	[van den Bosch, Mirjam W. M.; Palsson-Mcdermott, Eva; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Johnson, Derek S.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	Trinity College Dublin; University of Pennsylvania	van den Bosch, MWM (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, 152-160 Pearse St, Dublin 2, Ireland.	vandenbm@tcd.ie		O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board/Marie Curie CoFund; European Research Council (based in Ireland)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board/Marie Curie CoFund; European Research Council (based in Ireland)	This work was supported by the Science Foundation Ireland, Health Research Board/Marie Curie CoFund, and the European Research Council (based in Ireland).	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baker AK, 2009, MOL IMMUNOL, V46, P2249, DOI 10.1016/j.molimm.2009.04.011; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Pengal RA, 2006, MOL IMMUNOL, V43, P1557, DOI 10.1016/j.molimm.2005.09.022; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433	27	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22980	22990		10.1074/jbc.M114.573089	http://dx.doi.org/10.1074/jbc.M114.573089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982420	Green Published, hybrid			2022-12-28	WOS:000341017200037
J	Weaver, J; Rye, HS				Weaver, Jeremy; Rye, Hays S.			The C-terminal Tails of the Bacterial Chaperonin GroEL Stimulate Protein Folding by Directly Altering the Conformation of a Substrate Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CENTRAL CAVITY; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; IN-VIVO; COMPLEX; POLYPEPTIDE; CYCLE; MECHANISM; EVOLUTION	Many essential cellular proteins fold only with the assistance of chaperonin machines like the GroEL-GroES system of Escherichia coli. However, the mechanistic details of assisted protein folding by GroEL-GroES remain the subject of ongoing debate. We previously demonstrated that GroEL-GroES enhances the productive folding of a kinetically trapped substrate protein through unfolding, where both binding energy and the energy of ATP hydrolysis are used to disrupt the inhibitory misfolded states. Here, we show that the intrinsically disordered yet highly conserved C-terminal sequence of the GroEL subunits directly contributes to substrate protein unfolding. Interactions between the C terminus and the non-native substrate protein alter the binding position of the substrate protein on the GroEL apical surface. The C-terminal tails also impact the conformational state of the substrate protein during capture and encapsulation on the GroEL ring. Importantly, removal of the C termini results in slower overall folding, reducing the fraction of the substrate protein that commits quickly to a productive folding pathway and slowing several kinetically distinct folding transitions that occur inside the GroEL-GroES cavity. The conserved C-terminal tails of GroEL are thus important for protein folding from the beginning to the end of the chaperonin reaction cycle.	[Weaver, Jeremy; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137; Weaver, Jeremy/0000-0002-5556-4757	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM065421 (to H. S. R.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Betancourt MR, 1999, J MOL BIOL, V287, P627, DOI 10.1006/jmbi.1999.2591; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Cetinbas M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003269; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Goldberg MS, 1997, P NATL ACAD SCI USA, V94, P1080, DOI 10.1073/pnas.94.4.1080; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17339, DOI 10.1073/pnas.0807418105; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JAMES DR, 1992, REV SCI INSTRUM, V63, P1710, DOI 10.1063/1.1143328; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Lin Z, 2013, J BIOL CHEM, V288, P30944, DOI 10.1074/jbc.M113.480178; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Motojima F, 2012, P NATL ACAD SCI USA, V109, P15740, DOI 10.1073/pnas.1204547109; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Williams TA, 2010, GENOME BIOL EVOL, V2, P609, DOI 10.1093/gbe/evq045; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	66	37	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23219	23232		10.1074/jbc.M114.577205	http://dx.doi.org/10.1074/jbc.M114.577205			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24970895	hybrid, Green Published			2022-12-28	WOS:000341017200058
J	Lackey, SWK; Taylor, RD; Go, NE; Wong, A; Sherman, EL; Nargang, FE				Lackey, Sebastian W. K.; Taylor, Rebecca D.; Go, Nancy E.; Wong, Annie; Sherman, E. Laura; Nargang, Frank E.			Evidence Supporting the 19 beta-Strand Model for Tom40 from Cysteine Scanning and Protease Site Accessibility Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; BLUE NATIVE ELECTROPHORESIS; BARREL PROTEINS; IMPORT PORE; CHANNEL; VDAC; COMPLEX; TRANSLOCASE; TOPOLOGY; SELECTIVITY	Most proteins found in mitochondria are translated in the cytosol and enter the organelle via the TOM complex (translocase of the outer mitochondrial membrane). Tom40 is the pore forming component of the complex. Although the three-dimensional structure of Tom40 has not been determined, the structure of porin, a related protein, has been shown to be a beta-barrel containing 19 membrane spanning beta-trands and an N-terminal alpha-helical region. The evolutionary relationship between the two proteins has allowed modeling of Tom40 into a similar structure by several laboratories. However, it has been suggested that the 19-strand porin structure does not represent the native form of the protein. If true, modeling of Tom40 based on the porin structure would also be invalid. We have used substituted cysteine accessibility mapping to identify several potential beta-trands in the Tom40 protein in isolated mitochondria. These data, together with protease accessibility studies, support the 19 beta-strand model for Tom40 with the C-terminal end of the protein localized to the intermembrane space.	[Lackey, Sebastian W. K.; Taylor, Rebecca D.; Go, Nancy E.; Wong, Annie; Sherman, E. Laura; Nargang, Frank E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Nargang, FE (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	frank.nargang@ualberta.ca			Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council (to F. E. N.).	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Bay DC, 2012, BBA-BIOMEMBRANES, V1818, P1502, DOI 10.1016/j.bbamem.2011.11.027; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Colombini M, 2012, CHEM REV, V112, P6373, DOI 10.1021/cr3002033; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gessmann D, 2011, BBA-BIOENERGETICS, V1807, P1647, DOI 10.1016/j.bbabio.2011.08.006; GOOD AG, 1989, PLANT PHYSIOL, V90, P1305, DOI 10.1104/pp.90.4.1305; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins SC, 2007, GENETICS, V177, P137, DOI 10.1534/genetics.107.075051; Imai K, 2008, CELL, V135, P1158, DOI 10.1016/j.cell.2008.12.017; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Mager F, 2011, J MEMBRANE BIOL, V242, P11, DOI 10.1007/s00232-011-9372-8; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Nargang Frank E, 2007, Methods Mol Biol, V372, P107, DOI 10.1007/978-1-59745-365-3_8; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sherman EL, 2006, J BIOL CHEM, V281, P22554, DOI 10.1074/jbc.M601630200; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; Song JM, 1996, J BIOENERG BIOMEMBR, V28, P153, DOI 10.1007/BF02110646; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Summers WAT, 2010, BIOCHEM CELL BIOL, V88, P425, DOI [10.1139/O09-115, 10.1139/o09-115]; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; THOMAS L, 1991, J STRUCT BIOL, V106, P161, DOI 10.1016/1047-8477(91)90085-B; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019	56	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21640	21650		10.1074/jbc.M114.578765	http://dx.doi.org/10.1074/jbc.M114.578765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947507	hybrid, Green Published			2022-12-28	WOS:000340558300038
J	Lukacs, P; Gawali, VS; Cervenka, R; Ke, S; Koenig, X; Rubi, L; Zarrabi, T; Hilber, K; Stary-Weinzinger, A; Todt, H				Lukacs, Peter; Gawali, Vaibhavkumar S.; Cervenka, Rene; Ke, Song; Koenig, Xaver; Rubi, Lena; Zarrabi, Touran; Hilber, Karlheinz; Stary-Weinzinger, Anna; Todt, Hannes			Exploring the Structure of the Voltage-gated Na+ Channel by an Engineered Drug Access Pathway to the Receptor Site for Local Anesthetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; BINDING-SITE; MOLECULAR DETERMINANTS; SLOW INACTIVATION; IONIC SELECTIVITY; LIDOCAINE BLOCK; SEGMENT IVS6; PORE	Despite the availability of several crystal structures of bacterial voltage-gated Na+ channels, the structure of eukaryotic Na+ channels is still undefined. We used predictions from available homology models and crystal structures to modulate an external access pathway for the membrane-impermeant local anesthetic derivative QX-222 into the internal vestibule of the mammalian rNa(V)1.4 channel. Potassium channel-based homology models predict amino acid Ile-1575 in domain IV segment 6 to be in close proximity to Lys-1237 of the domain III pore-loop selectivity filter. The mutation K1237E has been shown previously to increase the diameter of the selectivity filter. We found that an access pathway for external QX-222 created by mutations of Ile-1575 was abolished by the additional mutation K1237E, supporting the notion of a close spatial relationship between sites 1237 and 1575. Crystal structures of bacterial voltage-gated Na+ channels predict that the side chain of rNa(V)1.4 Trp-1531 of the domain IV pore-loop projects into the space between domain IV segment 6 and domain III pore-loop and, therefore, should obstruct the putative external access pathway. Indeed, mutations W1531A and W1531G allowed for exceptionally rapid access of QX-222. In addition, W1531G created a second non-selective ion-conducting pore, bypassing the outer vestibule but probably merging into the internal vestibule, allowing for control by the activation gate. These data suggest a strong structural similarity between bacterial and eukaryotic voltage-gated Na+ channels.	[Lukacs, Peter; Gawali, Vaibhavkumar S.; Cervenka, Rene; Koenig, Xaver; Rubi, Lena; Zarrabi, Touran; Hilber, Karlheinz; Todt, Hannes] Med Univ Vienna, Dept Neurophysiol & Neuropharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Ke, Song; Stary-Weinzinger, Anna] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna	Todt, H (corresponding author), Med Univ Vienna, Dept Neurophysiol & Neuropharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria.	hannes.todt@meduniwien.ac.at	Gawali, Vaibhavkumar/AAZ-3459-2021; Koenig, Xaver/Y-5588-2019; Stary-Weinzinger, Anna/A-3629-2014	Gawali, Vaibhavkumar/0000-0002-7917-4913; Koenig, Xaver/0000-0002-2423-4966; Stary-Weinzinger, Anna/0000-0002-9202-0484; Hilber, Karlheinz/0000-0002-3033-0874; Rubi, Lena/0000-0003-4793-3724	Austrian Science Fund (FWF) [P210006-B11, W1232-B11]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by Austrian Science Fund (FWF) Grants P210006-B11 and W1232-B11.	ALPERT LA, 1989, AM J PHYSIOL, V257, pH79, DOI 10.1152/ajpheart.1989.257.1.H79; Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Bai CX, 2003, NEUROSCI LETT, V337, P41, DOI 10.1016/S0304-3940(02)01288-0; Balser JR, 1996, J CLIN INVEST, V98, P2874, DOI 10.1172/JCI119116; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Boehm S, 1999, J NEUROSCI, V19, P737; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chiamvimonvat N, 1996, NEURON, V16, P1037, DOI 10.1016/S0896-6273(00)80127-0; Cordomi A, 2012, J CHEM THEORY COMPUT, V8, P948, DOI 10.1021/ct200491c; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dudley SC, 1995, BIOPHYS J, V69, P1657, DOI 10.1016/S0006-3495(95)80045-7; Fan Z, 1996, J PHYSIOL-LONDON, V496, P275, DOI 10.1113/jphysiol.1996.sp021684; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; Fukuda K, 2005, J PHYSIOL-LONDON, V564, P21, DOI 10.1113/jphysiol.2004.081646; Furini S, 2009, PROTEINS, V74, P437, DOI 10.1002/prot.22163; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke S, 2013, BIOCHEM BIOPH RES CO, V430, P1272, DOI 10.1016/j.bbrc.2012.12.055; Knape K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028778; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Lee PJ, 2001, CIRC RES, V89, P1014, DOI 10.1161/hh2301.100002; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; O'Reilly JP, 2000, BIOPHYS J, V78, P773, DOI 10.1016/S0006-3495(00)76635-5; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prutting S, 2011, J BIOL CHEM, V286, P20031, DOI 10.1074/jbc.M110.185405; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Sasaki K, 2004, MOL PHARMACOL, V66, P330, DOI 10.1124/mol.66.2.330; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; Sunami A, 2001, MOL PHARMACOL, V59, P684, DOI 10.1124/mol.59.4.684; Sunami A, 1997, P NATL ACAD SCI USA, V94, P14126, DOI 10.1073/pnas.94.25.14126; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Tsang SY, 2005, MOL PHARMACOL, V67, P424, DOI 10.1124/mol.67.2.424; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; Wang SY, 2003, BIOPHYS J, V85, P911, DOI 10.1016/S0006-3495(03)74530-5; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; Zarrabi T, 2010, J BIOL CHEM, V285, P39458, DOI 10.1074/jbc.M110.132886; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	58	6	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21770	21781		10.1074/jbc.M113.541763	http://dx.doi.org/10.1074/jbc.M113.541763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947510	hybrid, Green Published			2022-12-28	WOS:000340558300050
J	Sant'Anna, R; Braga, C; Varejao, N; Pimenta, KM; Grana-Montes, R; Alves, A; Cortines, J; Cordeiro, Y; Ventura, S; Foguel, D				Sant'Anna, Ricardo; Braga, Carolina; Varejao, Nathalia; Pimenta, Karinne M.; Grana-Montes, Ricardo; Alves, Aline; Cortines, Juliana; Cordeiro, Yraima; Ventura, Salvador; Foguel, Debora			The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SHEET PROTEINS; FIBRIL FORMATION; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; PRESSURE; SEQUENCE; PEPTIDE; POLYNEUROPATHY; CONFORMATION; DIVERSITY	Protein aggregation into beta-sheet-enriched amyloid fibrils is associated with an increasing number of human disorders. The adoption of such amyloid conformations seems to constitute a generic property of polypeptide chains. Therefore, during evolution, proteins have adopted negative design strategies to diminish their intrinsic propensity to aggregate, including enrichment of gatekeeper charged residues at the flanks of hydrophobic aggregation-prone segments. Wild type transthyretin (TTR) is responsible for senile systemic amyloidosis, and more than 100 mutations in the TTR gene are involved in familial amyloid polyneuropathy. The TTR 26-57 segment bears many of these aggressive amyloidogenic mutations as well as the binding site for heparin. We demonstrate here that Lys-35 acts as a gatekeeper residue in TTR, strongly decreasing its amyloidogenic potential. This protective effect is sequence-specific because Lys-48 does not affect TTR aggregation. Lys-35 is part of the TTR basic heparin-binding motif. This glycosaminoglycan blocks the protective effect of Lys-35, probably by neutralization of its side chain positive charge. A K35L mutation emulates this effect and results in the rapid self-assembly of the TTR 26-57 region into amyloid fibrils. This mutation does not affect the tetrameric protein stability, but it strongly increases its aggregation propensity. Overall, we illustrate how TTR is yet another amyloidogenic protein exploiting negative design to prevent its massive aggregation, and we show how blockage of conserved protective features by endogenous factors or mutations might result in increased disease susceptibility.	[Foguel, Debora] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo de Meis, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; [Cortines, Juliana] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941590 Rio De Janeiro, Brazil; [Grana-Montes, Ricardo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Autonomous University of Barcelona	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain.	salvador.ventura@uab.es; foguel@bioqmed.ufrj.br	Ventura, Salvador/C-7021-2008; Cortines, Juliana/V-3997-2019; Ventura, Salvador/AAY-3170-2021; Alves, Aline Araujo/AAR-9678-2020; Cordeiro, Yraima/J-7619-2012	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Alves, Aline Araujo/0000-0003-4360-7681; Cordeiro, Yraima/0000-0003-4278-212X; Foguel, Debora/0000-0001-7312-7115; Varejao, Nathalia/0000-0002-6952-8896; Grana-Montes, Ricardo/0000-0003-1932-1077	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Ministerio de Ciencia e Innovacion (Spain) [BFU2010-14901]; AGAUR (Generalitat de Catalunya) [2009-SGR-760]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award(ICREA)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ) (to D. F.) and by Ministerio de Ciencia e Innovacion (Spain) Grant BFU2010-14901 and AGAUR (Generalitat de Catalunya) Grant 2009-SGR-760 (to S. V.).; Recipient of an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award. To whom correspondence may be addressed. E-mail: salvador.ventura@uab.es.	Beerten J, 2012, PROTEIN ENG DES SEL, V25, P357, DOI 10.1093/protein/gzs031; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; de Groot NS, 2012, BIOCHEM SOC T, V40, P1032, DOI 10.1042/BST20120160; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Grana-Montes R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00438; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; JARVIS JA, 1994, INT J PEPT PROT RES, V44, P388; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; KELLY JW, 1994, AMYLOID, V1, P186, DOI 10.3109/13506129409148451; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Long D, 2012, OPHTHALMIC GENET, V33, P28, DOI 10.3109/13816810.2011.599356; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MURAKAMI T, 1992, BIOCHEM BIOPH RES CO, V187, P397, DOI 10.1016/S0006-291X(05)81506-2; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; REILLY MM, 1995, BRAIN, V118, P849, DOI 10.1093/brain/118.4.849; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Saraiva MJ, 2012, CURR MED CHEM, V19, P2304; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SILVA JL, 1989, J BIOL CHEM, V264, P15863; Soto C, 1996, BIOCHEM J, V314, P701, DOI 10.1042/bj3140701; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195	70	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28324	28337		10.1074/jbc.M114.563981	http://dx.doi.org/10.1074/jbc.M114.563981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25086037	Green Published, hybrid			2022-12-28	WOS:000343765400027
J	Tong, LY; Wu, SY				Tong, Lingying; Wu, Shiyong			The Role of Constitutive Nitric-oxide Synthase in Ultraviolet B Light-induced Nuclear Factor kappa B Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; CANCER CELLS; KINASE PERK; IN-VITRO; ALPHA; ACTIVATION; APOPTOSIS; UV; UBIQUITINATION	NF-kappa B is a transcription factor involved in many signaling pathways that also plays an important role in UV-induced skin tumorigenesis. LTV radiation can activate NF-kappa B, but the detailed mechanism remains unclear. In this study, we provided evidence that the activation of constitutive nitric-oxide synthase plays a role in regulation of I kappa B reduction and NF-kappa B activation in human keratinocyte HaCa'E cells in early phase (within 6 h) post-UVB. Treating the cells with L-NAME, a selective inhibitor of constitutive nitric-oxide synthase (cNOS), can partially reverse the I kappa B reduction and inhibit the DNA binding activity as well as nuclear translocation of NF-kappa B after UVB radiation. A luciferase reporter assay indicates that UVB-induced NF-kappa B activation is totally diminished in cNOS null cells. The cNOSmediated reduction of I kappa B is likely due to the imbalance of nitric oxide/peroxynitrite because treating the cells with lower (50 mu M), but not higher (100-500 mu m), concentration of S-nitrosoN-acetylpenicillamine (SNAP) can reverse the effect of L-NAME in partial restore I kappa B level post-LTVB. Our data also showed that NF-kappa B activity was required for maintaining a stable I kappa B kinase subunit (IKK alpha) level because treating the cells with NF-kappa B or cNOS inhibitors could reduce IKK alpha level upon UVB radiation. In addition, our data demonstrated that although NF-kappa B protects cells from UVB-induced death, its pro-survival activity was likely neutralized by the pro-death activity of peroxynitrite after UVB radiation.	Ohio Univ, Dept Chem & Biochem, Edison Biotechnol Inst, Athens, OH 45701 USA; Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Wu, SY (corresponding author), Edison Biotechnol Inst, Dept Chem & Biochem, 101 Konneker Labs,Bldg 25, Athens, OH 45701 USA.	wus1@ohio.edu			National Institutes of Health [RO1 CA86926]; Molecular and Cellular Program, Ohio University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular and Cellular Program, Ohio University	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA86926 (to S. W.). This work was also supported by Molecular and Cellular Program, Ohio University (to L. T.).	Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bischof G, 1997, CELL CALCIUM, V21, P135, DOI 10.1016/S0143-4160(97)90037-3; Boer R, 2000, MOL PHARMACOL, V58, P1026, DOI 10.1124/mol.58.5.1026; Brune B, 1999, CELL DEATH DIFFER, V6, P969, DOI 10.1038/sj.cdd.4400582; Cals-Grierson MM, 2004, NITRIC OXIDE-BIOL CH, V10, P179, DOI 10.1016/j.niox.2004.04.005; Chen WS, 2008, J CELL BIOCHEM, V105, P554, DOI 10.1002/jcb.21856; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Curry HA, 1999, J BIOL CHEM, V274, P23061, DOI 10.1074/jbc.274.33.23061; Dessinioti C, 2010, PHOTOCHEM PHOTOBIOL, V86, P481, DOI 10.1111/j.1751-1097.2010.00735.x; Dimmeler S, 1997, NITRIC OXIDE-BIOL CH, V1, P275, DOI 10.1006/niox.1997.0133; Elyassaki W, 2006, PHOTOCHEM PHOTOBIOL, V82, P787, DOI 10.1562/2005-12-09-RA-748; George KS, 2012, PHOTOCHEM PHOTOBIOL, V88, P1191, DOI 10.1111/j.1751-1097.2011.01038.x; Girotti AW, 1998, J LIPID RES, V39, P1529; Hansson A, 2005, INT J ONCOL, V27, P941; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Laszlo CF, 2008, PHOTOCHEM PHOTOBIOL, V84, P1564, DOI 10.1111/j.1751-1097.2008.00385.x; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liu W, 2010, NITRIC OXIDE-BIOL CH, V23, P199, DOI 10.1016/j.niox.2010.06.003; Lu W, 2009, J BIOL CHEM, V284, P24281, DOI 10.1074/jbc.M109.008821; Maddodi N, 2008, PHOTOCHEM PHOTOBIOL, V84, P528, DOI 10.1111/j.1751-1097.2007.00283.x; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Ou JH, 1997, NITRIC OXIDE-BIOL CH, V1, P404, DOI 10.1006/niox.1997.0136; Parker SH, 2006, MOL CELL BIOCHEM, V293, P173, DOI 10.1007/s11010-006-9239-y; SHAFFER JE, 1992, J PHARMACOL EXP THER, V260, P286; Shimazu T, 2011, AM J PHYSIOL-HEART C, V301, pH2061, DOI 10.1152/ajpheart.00525.2011; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Wang CC, 2009, J CELL BIOCHEM, V107, P933, DOI 10.1002/jcb.22196; Weller R, 2002, SKIN PHARMACOL APPL, V15, P348, DOI 10.1159/000064540; Wu LF, 2010, BIOCHEM CELL BIOL, V88, P705, DOI 10.1139/O10-008; Wu SY, 2010, PHOTOCHEM PHOTOBIOL, V86, P995, DOI 10.1111/j.1751-1097.2010.00767.x; Wu SY, 2010, PHOTOCHEM PHOTOBIOL, V86, P389, DOI 10.1111/j.1751-1097.2009.00682.x; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Yu LL, 2010, ONCOL REP, V24, P113, DOI 10.3892/or_00000835; Zhang JL, 2009, CELL PROLIFERAT, V42, P150, DOI 10.1111/j.1365-2184.2009.00588.x	45	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26658	26668		10.1074/jbc.M114.600023	http://dx.doi.org/10.1074/jbc.M114.600023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25112869	Green Published, hybrid			2022-12-28	WOS:000342128800055
J	Nyarko, A; Singarapu, KK; Figueroa, M; Manning, VA; Pandelova, I; Wolpert, TJ; Ciuffetti, LM; Barbar, E				Nyarko, Afua; Singarapu, Kiran K.; Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.; Barbar, Elisar			Solution NMR Structures of Pyrenophora tritici-repentis ToxB and Its Inactive Homolog Reveal Potential Determinants of Toxin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-SELECTIVE TOXIN; PTR TOXA; TAN SPOT; PROTEIN FUNCTION; GENE; PROGRAM; RESISTANCE; EFFECTORS; MUTANT; SERVER	Pyrenophora tritici-repentis Ptr ToxB (ToxB) is a proteinaceous host-selective toxin produced by Pyrenophora tritici-repentis (P. tritici-repentis), a plant pathogenic fungus that causes the disease tan spot of wheat. One feature that distinguishes ToxB from other host-selective toxins is that it has naturally occurring homologs in non-pathogenic P. tritici-repentis isolates that lack toxic activity. There are no high-resolution structures for any of the ToxB homologs, or for any protein with >30% sequence identity, and therefore what underlies activity remains an open question. Here, we present the NMR structures of ToxB and its inactive homolog Ptr toxb. Both proteins adopt a beta-sandwich fold comprising three strands in each half that are bridged together by two disulfide bonds. The inactive toxb, however, shows higher flexibility localized to the sequence-divergent beta-sandwich half. The absence of toxicactivity is attributed to a more open structure in the vicinity of one disulfide bond, higher flexibility, and residue differences in an exposed loop that likely impacts interaction with putative targets. We propose that activity is regulated by perturbations in a putative active site loop and changes in dynamics distant from the site of activity. Interestingly, the new structures identify AvrPiz-t, a secreted avirulence protein produced by the rice blast fungus, as a structural homolog to ToxB. This homology suggests that fungal proteins involved in either disease susceptibility such as ToxB or resistance such as AvrPiz-t may have a common evolutionary origin.	[Nyarko, Afua; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Singarapu, Kiran K.] Indian Inst Chem Technol, Ctr NMR & Struct Chem, Hyderabad 500007, Andhra Pradesh, India; [Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Figueroa, Melania; Manning, Viola A.; Pandelova, Iovanna; Wolpert, Thomas J.; Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Oregon State University; Oregon State University	Ciuffetti, LM (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu; barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019; Singarapu, Kiran/AAU-3435-2020; Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X; Barbar, Elisar/0000-0003-4892-5259	Agriculture and Food Research Initiative Competitive Grant [2010-65108-20548]; National Science Foundation [MCB 0818896]; Medical Research Foundation of Oregon grant; National Science Foundation Minority Postdoctoral Fellowship Award [0706881]; Department of Science and Technology (India) for the Ramanujan Fellowship	Agriculture and Food Research Initiative Competitive Grant; National Science Foundation(National Science Foundation (NSF)); Medical Research Foundation of Oregon grant; National Science Foundation Minority Postdoctoral Fellowship Award; Department of Science and Technology (India) for the Ramanujan Fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This work was supported by Agriculture and Food Research Initiative Competitive Grant 2010-65108-20548 (to L. M. C.), by the National Science Foundation Grant MCB 0818896 (to E. B.), a Medical Research Foundation of Oregon grant (to A. N.), and in part by a National Science Foundation Minority Postdoctoral Fellowship Award 0706881 (to M. F.).; Supported by the Department of Science and Technology (India) for the Ramanujan Fellowship.	Andrie RM, 2008, FUNGAL GENET BIOL, V45, P363, DOI 10.1016/j.fgb.2007.10.014; Andrie RM, 2011, MOL PLANT MICROBE IN, V24, P359, DOI 10.1094/MPMI-06-10-0142; Ballance GM, 1998, DEV PLANT PATHOL, V13, P177; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Betts MF, 2011, PHYSIOL MOL PLANT P, V75, P138, DOI 10.1016/j.pmpp.2011.03.002; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faris JD, 2013, THEOR APPL GENET, V126, P2197, DOI 10.1007/s00122-013-2157-y; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Goddard D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston CA, 2011, P NATL ACAD SCI USA, V108, pE973, DOI 10.1073/pnas.1104365108; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Kalodimos CG, 2012, ANN NY ACAD SCI, V1260, P81, DOI 10.1111/j.1749-6632.2011.06319.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2004, MOL PLANT MICROBE IN, V17, P491, DOI 10.1094/MPMI.2004.17.5.491; Manning VA, 2008, MOL PLANT MICROBE IN, V21, P315, DOI 10.1094/MPMI-21-3-0315; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Martinez JP, 2001, MOL PLANT MICROBE IN, V14, P675, DOI 10.1094/MPMI.2001.14.5.675; Meinhardt SW, 2002, PLANT PHYSIOL, V130, P1545, DOI 10.1104/pp.006684; Moreno MV, 2010, MANAGEMENT OF FUNGAL PLANT PATHOGENS, P275, DOI 10.1079/9781845936037.0275; Nagy ED, 2008, GENOME RES, V18, P1918, DOI 10.1101/gr.078766.108; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Zhang ZM, 2013, J BIOMOL NMR, V55, P219, DOI 10.1007/s10858-012-9695-5	41	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25946	25956		10.1074/jbc.M114.569103	http://dx.doi.org/10.1074/jbc.M114.569103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25063993	Green Published, hybrid			2022-12-28	WOS:000342130800049
J	Pan, CC; Kumar, S; Shah, N; Hoyt, DG; Hawinkels, LJAC; Mythreye, K; Lee, NY				Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Hawinkels, Lukas J. A. C.; Mythreye, Karthikeyan; Lee, Nam Y.			Src-mediated Post-translational Regulation of Endoglin Stability and Function Is Critical for Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; TGF-BETA RECEPTOR; TUMOR ANGIOGENESIS; BMP RECEPTORS; ANTIBODY; CANCER; PATHWAYS; KINASE; CD105; PHOSPHORYLATION	Endoglin is a transforming growth factor beta (TGF-beta) co-receptor essential for angiogenesis and tumor vascularization. Endoglin modulates the crucial balance between pro-and anti-angiogenic signaling by activin receptor-like kinase (ALK) 1, 5, and TGF-beta type II (T beta RII) receptors. Despite its established role in physiology and disease, the mechanism of endoglin down-regulation remains unknown. Here we report that the conserved juxtamembrane cytoplasmic tyrosine motif ((YIY614)-Y-612) is a critical determinant of angiogenesis. Src directly phosphorylates this motif to induce endoglin internalization and degradation via the lysosome. We identified epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) as Src-activators that induce endoglin turnover following (YIY614)-Y-612 phosphorylation. Interestingly, Src phosphorylation of endoglin-(YIY614)-Y-612 was also an important process for receptor down-regulation by TRACON105 (TRC105), an endoglin-targeting antibody currently in clinical trials. The regulation of (YIY614)-Y-612 phosphorylation was critical for angiogenesis, as both the phosphomimetic and unphosphorylatable mutants impaired endothelial functions including proliferation, migration, and capillary tube formation. Collectively, these findings establish Src and pro-angiogenic mitogens as critical mediators of endoglin stability and function.	[Pan, Christopher C.; Kumar, Sanjay; Shah, Nirav; Hoyt, Dale G.; Lee, Nam Y.] Ohio State Univ, Coll Pharm, Div Pharmacol, Columbus, OH 43210 USA; [Lee, Nam Y.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Mythreye, Karthikeyan] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Hawinkels, Lukas J. A. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 Leiden, Netherlands	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lee, NY (corresponding author), Ohio State Univ, Coll Pharm, Div Pharmacol, 500 West 12th Ave, Columbus, OH 43210 USA.	lee.5064@osu.edu	Karthikeyan, Mythreye/ABC-7345-2020; Lee, Nam/H-3073-2016; Hawinkels, Lukas/Q-5098-2019	Karthikeyan, Mythreye/0000-0001-5478-0098; Hawinkels, Lukas/0000-0002-2274-9325	National Institutes of Health [CA178443]; Patil Fellowship; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award [UL2011-5051]; NATIONAL CANCER INSTITUTE [R01CA178443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patil Fellowship; Dutch Cancer Society/Alp d'huZes-Bas Mulder Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA178443 (to N. Y. L.), the Patil Fellowship (to C. C. P.), and the Dutch Cancer Society/Alp d'huZes-Bas Mulder Award (UL2011-5051) (to L. H.).	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Huang F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-9; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; LAM KS, 1995, INT J PEPT PROT RES, V45, P587; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Li CG, 2003, ANTICANCER RES, V23, P1189; Lonn P, 2012, J BIOL CHEM, V287, P12867, DOI 10.1074/jbc.M111.307249; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Park SS, 2004, ONCOGENE, V23, P6272, DOI 10.1038/sj.onc.1207856; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perez-Gomez E, 2010, THESCIENTIFICWORLDJO, V10, P2367, DOI 10.1100/tsw.2010.230; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Takahashi T, 2003, MOL CELL BIOL, V23, P1817, DOI 10.1128/MCB.23.5.1817-1831.2003; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Tsujie M, 2006, INT J ONCOL, V29, P1087; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537	40	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25486	25496		10.1074/jbc.M114.578609	http://dx.doi.org/10.1074/jbc.M114.578609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070888	hybrid, Green Published			2022-12-28	WOS:000342130800011
J	Bhatnagar, S; Soni, MS; Wrighton, LS; Hebert, AS; Zhou, AS; Paul, PK; Gregg, T; Rabaglia, ME; Keller, MP; Coon, JJ; Attie, AD				Bhatnagar, Sushant; Soni, Mufaddal S.; Wrighton, Lindsay S.; Hebert, Alexander S.; Zhou, Amber S.; Paul, Pradyut K.; Gregg, Trillian; Rabaglia, Mary E.; Keller, Mark P.; Coon, Joshua J.; Attie, Alan D.			Phosphorylation and Degradation of Tomosyn-2 De-represses Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; NEUROTRANSMITTER RELEASE; AXONAL-TRANSPORT; BETA-CELLS; SYNAPSIN-I; PROTEIN; COMPLEX; LIGASE; INHIBITION	The abundance and functional activity of proteins involved in the formation of the SNARE complex are tightly regulated for efficient exocytosis. Tomosyn proteins are negative regulators of exocytosis. Tomosyn causes an attenuation of insulin secretion by limiting the formation of the SNARE complex. We hypothesized that glucose-dependent stimulation of insulin secretion from beta-cells must involve reversing the inhibitory action of tomosyn. Here, we show that glucose increases tomosyn protein turnover. Within 1 h of exposure to 15 mM glucose, similar to 50% of tomosyn was degraded. The degradation of tomosyn in response to high glucose was blocked by inhibitors of the proteasomal pathway. Using P-32 labeling and mass spectrometry, we showed that tomosyn-2 is phosphorylated in response to high glucose, phorbol esters, and analogs of cAMP, all key insulin secretagogues. We identified 11 phosphorylation sites in tomosyn-2. Site-directed mutagenesis was used to generate phosphomimetic (ser -> Asp) and loss-of-function (Ser -> Ala) mutants. The Ser -> Asp mutant had enhanced protein turnover compared with the Ser -> Ala mutant and wild type tomosyn-2. Additionally, the ser -> Asp tomosyn-2 mutant was ineffective at inhibiting insulin secretion. Using a proteomic screen for tomosyn-2-binding proteins, we identified Hrd-1, an E3-ubiquitin ligase. We showed that tomosyn-2 ubiquitination is increased by Hrd-1, and knockdown of Hrd-1 by short hairpin RNA resulted in increased abundance in tomosyn-2 protein levels. Taken together, our results reveal a mechanism by which enhanced phosphorylation of a negative regulator of secretion, tomosyn-2, in response to insulin secretagogues targets it to degradation by the Hrd-1 E3-ubiquitin ligase.	[Bhatnagar, Sushant; Soni, Mufaddal S.; Wrighton, Lindsay S.; Zhou, Amber S.; Paul, Pradyut K.; Gregg, Trillian; Rabaglia, Mary E.; Keller, Mark P.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Hebert, Alexander S.; Coon, Joshua J.] Univ Wisconsin, Dept Chem & Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	adattie@wisc.edu			National Institutes of Health [DK066369, DK58037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058037, R01DK066369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK066369 and DK58037 (to A. D. A.).	Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belgardt BF, 2014, NAT CELL BIOL, V16, P210, DOI 10.1038/ncb2925; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bhatnagar S, 2009, J BIOL CHEM, V284, P10023, DOI 10.1074/jbc.M808818200; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Chin LS, 2002, J BIOL CHEM, V277, P35071, DOI 10.1074/jbc.M203300200; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Costes S, 2009, DIABETES, V58, P1105, DOI 10.2337/db08-0926; Diaferia GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079458; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; EDDLESTONE GT, 1985, AM J PHYSIOL, V248, pC145, DOI 10.1152/ajpcell.1985.248.1.C145; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Francisco AB, 2011, J BIOL CHEM, V286, P22275, DOI 10.1074/jbc.M111.239418; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; PETRUCCI TC, 1991, J NEUROSCI, V11, P2938; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Weinberger A., 2004, REGULATORY MECH INTR, P145; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamasaki S, 2007, CELL CYCLE, V6, P1319, DOI 10.4161/cc.6.11.4277; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhou J, 2007, AM J PHYSIOL-ENDOC M, V293, pE538, DOI 10.1152/ajpendo.00070.2007	61	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25276	25286		10.1074/jbc.M114.575985	http://dx.doi.org/10.1074/jbc.M114.575985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25002582	Green Published, hybrid			2022-12-28	WOS:000341985300046
J	Turapov, O; Waddell, SJ; Burke, B; Glenn, S; Sarybaeva, AA; Tudo, G; Labesse, G; Young, DI; Young, M; Andrew, PW; Butcher, PD; Cohen-Gonsaud, M; Mukamolova, GV				Turapov, Obolbek; Waddell, Simon J.; Burke, Bernard; Glenn, Sarah; Sarybaeva, Asel A.; Tudo, Griselda; Labesse, Gilles; Young, Danielle I.; Young, Michael; Andrew, Peter W.; Butcher, Philip D.; Cohen-Gonsaud, Martin; Mukamolova, Galina V.			Oleoyl Coenzyme A Regulates Interaction of Transcriptional Regulator RaaS (Rv1219c) with DNA in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACID; TUBERCULOSIS; ACCUMULATION; FAMILY	We have recently shown that RaaS (regulator of antimicrobial-assisted survival), encoded by Rv1219c in Mycobacterium tuberculosis and by bcg_1279c in Mycobacterium bovis bacillus Calmette-Guerin, plays an important role in mycobacterial survival in prolonged stationary phase and during murine infection. Here, we demonstrate that long chain acyl-CoA derivatives (oleoyl-CoA and, to lesser extent, palmitoyl-CoA) modulate RaaS binding to DNA and expression of the downstream genes that encode ATP-dependent efflux pumps. Moreover, exogenously added oleic acid influences RaaS-mediated mycobacterial improvement of survival and expression of the RaaS regulon. Our data suggest that long chain acyl-CoA derivatives serve as biological indicators of the bacterial metabolic state. Dysregulation of efflux pumps can be used to eliminate non-growing mycobacteria.	[Turapov, Obolbek; Burke, Bernard; Glenn, Sarah; Sarybaeva, Asel A.; Andrew, Peter W.; Mukamolova, Galina V.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Waddell, Simon J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9PX, E Sussex, England; [Tudo, Griselda; Butcher, Philip D.] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, London SW17 0RE, England; [Labesse, Gilles; Cohen-Gonsaud, Martin] CNRS, Ctr Biochim Struct, UMR 5048, F-34090 Montpellier, France; [Labesse, Gilles; Cohen-Gonsaud, Martin] Univ Montpellier I, INSERM, U1054, F-34090 Montpellier, France; [Labesse, Gilles; Cohen-Gonsaud, Martin] Univ Montpellier 2, INSERM, U1054, F-34090 Montpellier, France; [Young, Danielle I.; Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales	University of Leicester; University of Brighton; University of Sussex; St Georges University London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Mukamolova, GV (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England.	gvm4@le.ac.uk	Burke, Bernard/C-5075-2019; Waddell, Simon J/A-9170-2013; Andrew, Peter W/G-7526-2012	Burke, Bernard/0000-0001-5483-800X; Waddell, Simon J/0000-0002-3684-9116; Tudo, Griselda/0000-0002-9241-7051; Cohen-Gonsaud, Martin/0000-0002-0150-9912; Labesse, Gilles/0000-0002-6861-3300; Mukamolova, Galina/0000-0001-5697-2018; Butcher, Philip/0000-0003-1223-9097	Colorado State University [HHSN266200400091C]; Colorado State University (National Institutes of Health from NIAID) [N01-AI-40091]; BBSRC [BB/H008586/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H008586/1] Funding Source: researchfish	Colorado State University; Colorado State University (National Institutes of Health from NIAID); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Natalie Garton and the Atelier de Bio & Chimie Informatique Structurale team for helpful discussions. M. tuberculosis DNA was provided by Colorado State University (Contract HHSN266200400091C, National Institutes of Health Grant N01-AI-40091 from NIAID).	Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cheah E. S., 2011, PLOS PATHOG, V7; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Dutta NK, 2014, MBIO, V5, DOI 10.1128/mBio.01066-13; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; KILBURN JO, 1981, ANTIMICROB AGENTS CH, V20, P401, DOI 10.1128/AAC.20.3.401; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar N, 2014, PROTEIN SCI, V23, P423, DOI 10.1002/pro.2424; Nazarova EV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P636, DOI 10.1134/S0006297911060034; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Turapov O, 2014, ANTIMICROB AGENTS CH, V58, P2798, DOI 10.1128/AAC.02774-13; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Waddell SJ, 2010, METHODS MOL BIOL, V642, P75, DOI 10.1007/978-1-60327-279-7_6; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; World Health Organization, 2013, GLOB TUB CONTR REP 2	26	3	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25241	25249		10.1074/jbc.M114.577338	http://dx.doi.org/10.1074/jbc.M114.577338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012658	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000341985300043
J	Baumann, H; Surrey, T				Baumann, Hella; Surrey, Thomas			Motor-mediated Cortical versus Astral Microtubule Organization in Lipid-monolayered Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ORGANIZATION; MICROFABRICATED CHAMBERS; EGG EXTRACTS; DYNAMICS; TUBULIN; DYNEIN; KINESIN-14; NUCLEATION; VESICLES; ASTERS	The correct spatial organization of microtubules is of crucial importance for determining the internal architecture of eukaryotic cells. Microtubules are arranged in space by a multitude of biochemical activities and by spatial constraints imposed by the cell boundary. The principles underlying the establishment of distinct intracellular architectures are only poorly understood. Here, we studied the effect of spatial confinement on the self-organization of purified motors and microtubules that are encapsulated in lipid-monolayered droplets in oil, varying in diameter from 5-100 mu m, which covers the size range of typical cell bodies. We found that droplet size alone had a major organizing influence. The presence of a microtubule-crosslinking motor protein decreased the number of accessible types of microtubule organizations. Depending on the degree of spatial confinement, the presence of the motor caused either the formation of a cortical array of bent microtubule bundles or the generation of single microtubule asters in the droplets. These are two of the most prominent forms of microtubule arrangements in plant and metazoan cells. Our results provide insights into the combined organizing influence of spatial constraints and cross-linking motor activities determining distinct microtubule architectures in a minimal biomimetic system. In the future, this simple lipid-monolayered droplet system characterized here can be expanded readily to include further biochemical activities or used as the starting point for the investigation of motor-mediated microtubule organization inside liposomes surrounded by a deformable lipid bilayer.	[Baumann, Hella; Surrey, Thomas] Canc Res UK, London Res Inst, London WC2A 3LY, England	Cancer Research UK	Surrey, T (corresponding author), Canc Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	thomas.surrey@cancer.org.uk	Surrey, Thomas/AAC-4608-2021	Surrey, Thomas/0000-0001-9082-1870	Boehringer-Ingelheim Fonds; Cancer Research UK; European Research Council; Cancer Research UK [14256] Funding Source: researchfish	Boehringer-Ingelheim Fonds(Boehringer Ingelheim); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	Supported by the Boehringer-Ingelheim Fonds.; Supported by Cancer Research UK and the European Research Council. To whom correspondence should be addressed. E-mail: thomas. surrey@cancer.org.uk.	Abu Shah E, 2014, ELIFE, V3, DOI 10.7554/eLife.01433; Allard JF, 2010, MOL BIOL CELL, V21, P278, DOI 10.1091/mbc.E09-07-0579; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; CARON JM, 1987, BIOCHEMISTRY-US, V26, P3681, DOI 10.1021/bi00386a063; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cosentino Lagomarsino M, 2007, BIOPHYS J, V92, P1046, DOI 10.1529/biophysj.105.076893; Deinum EE, 2013, CURR OPIN PLANT BIOL, V16, P688, DOI 10.1016/j.pbi.2013.10.001; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dogterom M, 2013, CURR OPIN CELL BIOL, V25, P23, DOI 10.1016/j.ceb.2012.12.002; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Faivre-Moskalenko C, 2002, P NATL ACAD SCI USA, V99, P16788, DOI 10.1073/pnas.252407099; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Fygenson DK, 1997, PHYS REV LETT, V79, P4497, DOI 10.1103/PhysRevLett.79.4497; Ghosh S, 2013, ACS CHEM BIOL, V8, P673, DOI 10.1021/cb300583p; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Griffiths AD, 2006, TRENDS BIOTECHNOL, V24, P395, DOI 10.1016/j.tibtech.2006.06.009; Hawkins RJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011911; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Lindeboom JJ, 2013, PLANT PHYSIOL, V161, P1189, DOI 10.1104/pp.112.204057; MCINTOSH TJ, 1994, ANNU REV BIOPH BIOM, V23, P27, DOI 10.1146/annurev.bb.23.060194.000331; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vorobiev I, 2001, P NATL ACAD SCI USA, V98, P10160, DOI 10.1073/pnas.181354198; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	48	20	20	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22524	22535		10.1074/jbc.M114.582015	http://dx.doi.org/10.1074/jbc.M114.582015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966327	hybrid, Green Published			2022-12-28	WOS:000340593500061
J	Leyme, A; Marivin, A; Casler, J; Nguyen, LT; Garcia-Marcos, M				Leyme, Anthony; Marivin, Arthur; Casler, Jason; Nguyen, Lien T.; Garcia-Marcos, Mikel			Different Biochemical Properties Explain Why Two Equivalent G alpha Subunit Mutants Cause Unrelated Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; ALBRIGHT-HEREDITARY-OSTEODYSTROPHY; ADENYLYL-CYCLASE; G(S ALPHA); SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; UVEAL MELANOMA; GTP HYDROLYSIS; MUTATION; ACTIVATION	There is an increasing number of disease-associated G alpha mutations identified from genome-wide sequencing campaigns or targeted efforts. Albright's Hereditary Osteodystrophy (AHO) was the first inherited disease associated with loss-of-function mutations in a G protein (G alpha s) and other studies revealed gain-of-function G alpha mutations in cancer. Here we attempted to solve the apparent quandary posed by the fact that the same mutation in two different G proteins appeared associated with both AHO and cancer. We first confirmed the presence of an inherited G alpha s-R265H mutation from a previously described clinical case report of AHO. This mutation is structurally analogous to G alpha o-R243H, an oncogenic mutant with increased activity in vitro and in cells due to rapid nucleotide exchange. We found that, contrary to G alpha o-R243H, G alpha s-R265H activity is compromised due to greatly impaired nucleotide binding in vitro and in cells. We obtained equivalent results when comparing another AHO mutation in G alpha s (D173N) with a counterpart cancer mutation in G alpha o (D151N). G alpha o-R243H binds nucleotides efficiently under steady-state conditions but releases GDP much faster than the WT protein, suggesting diminished affinity for the nucleotide. These results indicate that the same disease-linked mutation in two different G proteins affects a common biochemical feature (nucleotide affinity) but to a different grade depending on the G protein (mild decrease for G alpha o and severe for G alpha s). We conclude that G alpha s-R265H has dramatically impaired nucleotide affinity leading to the loss-of-function in AHO whereas G alpha o-R243H has a mild decrease in nucleotide affinity that causes rapid nucleotide turnover and subsequent hyperactivity in cancer.	[Leyme, Anthony; Marivin, Arthur; Casler, Jason; Nguyen, Lien T.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu			American Cancer Society [RGS-13-362-01-TBE]; Elsa U. Pardee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112631] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Elsa U. Pardee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Cancer Society (RGS-13-362-01-TBE) and the Elsa U. Pardee Foundation (to M. G. M.).	Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Aldred MA, 2006, J PEDIATR ENDOCR MET, V19, P635; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bastida Eizaguirre M, 2001, An Esp Pediatr, V54, P598; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P756, DOI 10.1016/j.bbamem.2006.09.027; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Freson K, 2008, J CLIN ENDOCR METAB, V93, P4851, DOI 10.1210/jc.2008-0883; Garcia-Marcos M, 2011, ONCOGENE, V30, P2691, DOI 10.1038/onc.2010.645; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; KROLL SD, 1992, J BIOL CHEM, V267, P23183; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MIRIC A, 1993, J CLIN ENDOCR METAB, V76, P1560, DOI 10.1210/jc.76.6.1560; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; PRASAD MVVSV, 1994, ONCOGENE, V9, P2425; ROSS EM, 1994, METHOD ENZYMOL, V237, P26; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Warner DR, 1999, J BIOL CHEM, V274, P4977, DOI 10.1074/jbc.274.8.4977; Warner DR, 1998, J BIOL CHEM, V273, P23976, DOI 10.1074/jbc.273.37.23976; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; WONG YH, 1995, ONCOGENE, V10, P1927; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Zurita AR, 2008, P NATL ACAD SCI USA, V105, P2363, DOI 10.1073/pnas.0712261105	52	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21818	21827		10.1074/jbc.M114.549790	http://dx.doi.org/10.1074/jbc.M114.549790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24982418	Green Published, hybrid			2022-12-28	WOS:000340593500002
J	Chung, H; Jung, H; Lee, JH; Oh, HY; Kim, OB; Han, IO; Oh, ES				Chung, Heesung; Jung, Hyejung; Lee, Jung-Hyun; Oh, Hye Yun; Kim, Ok Bin; Han, Inn-Oc; Oh, Eok-Soo			Keratinocyte-derived Laminin-332 Protein Promotes Melanin Synthesis via Regulation of Tyrosine Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-STIMULATING HORMONE; EXTRACELLULAR-MATRIX; CELL-MIGRATION; INTEGRIN; PIGMENTATION; PROLIFERATION; ACTIVATION; KINASE; GROWTH; MAPK	Melanocytes, which produce the pigment melanin, are known to be closely regulated by neighboring keratinocytes. However, how keratinocytes regulate melanin production is unclear. Here we report that melanin production in melanoma cells (B16F10 and MNT-1) was increased markedly on a keratinocyte-derived extracellular matrix compared with a melanoma cell-derived extracellular matrix. siRNA-mediated reduction of keratinocyte-derived laminin-332 expression decreased melanin synthesis in melanoma cells, and laminin-332, but not fibronectin, enhanced melanin content and alpha-melanocyte-stimulating hormone-regulated melanin production in melanoma cells. Similar effects were observed in human melanocytes. Interestingly, however, laminin-332 did not affect the expression or activity of tyrosinase. Instead, laminin-332 promoted the uptake of extracellular tyrosine and, subsequently, increased intracellular levels of tyrosine in both melanocytes and melanoma cells. Taken together, these data strongly suggest that keratinocyte-derived laminin-332 contributes to melanin production by regulating tyrosine uptake.	[Chung, Heesung; Jung, Hyejung; Lee, Jung-Hyun; Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Res Ctr Cellular Homeostasis, Seoul 120750, South Korea; [Oh, Hye Yun; Kim, Ok Bin] Ewha Womans Univ, Dept Life Sci, Interdisciplinary Program EcoCreat, Seoul 120750, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea	Ewha Womans University; Ewha Womans University; Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	OhES@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2010-0007336]; National Research Foundation of Korea by the Korean government [2012R1A5A1048236]; Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea [HI12C0050]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology(National Research Foundation of Korea); National Research Foundation of Korea by the Korean government(National Research Foundation of Korea); Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0007336; by National Research Foundation of Korea Grant 2012R1A5A1048236 funded by the Korean government; and by Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea Grant HI12C0050.	Ando H, 1999, J LIPID RES, V40, P1312; Ando H, 2012, J INVEST DERMATOL, V132, P1222, DOI 10.1038/jid.2011.413; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chen J, 2001, J BIOL CHEM, V276, P47901, DOI 10.1074/jbc.M107574200; Choma DP, 2004, J CELL SCI, V117, P3947, DOI 10.1242/jcs.01251; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Dores RM, 2011, ANN NY ACAD SCI, V1220, P34, DOI 10.1111/j.1749-6632.2010.05928.x; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Fuller BB, 2000, J INVEST DERMATOL, V114, P268, DOI 10.1046/j.1523-1747.2000.00860.x; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HUNT G, 1994, J CELL SCI, V107, P205; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Kiefer JA, 2001, MATRIX BIOL, V20, P429, DOI 10.1016/S0945-053X(01)00159-7; Kim DS, 2006, PIGM CELL RES, V19, P146, DOI 10.1111/j.1600-0749.2005.00287.x; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Potterf SB, 1998, BIOCHEM BIOPH RES CO, V248, P795, DOI 10.1006/bbrc.1998.9019; Primot A, 2010, PIGM CELL MELANOMA R, V23, P93, DOI 10.1111/j.1755-148X.2009.00652.x; Rodeck U, 1997, J CELL SCI, V110, P113; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Schwahn DJ, 2001, PIGM CELL RES, V14, P32, DOI 10.1034/j.1600-0749.2001.140106.x; Scott GA, 1999, EXP DERMATOL, V8, P212, DOI 10.1111/j.1600-0625.1999.tb00373.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Summers CG, 2009, OPTOMETRY VISION SCI, V86, P659, DOI 10.1097/OPX.0b013e3181a5254c; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; Vumma R, 2008, NEUROSCI LETT, V434, P56, DOI 10.1016/j.neulet.2008.01.028; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Ye Y, 2011, EXP DERMATOL, V20, P755, DOI 10.1111/j.1600-0625.2011.01297.x; Zou L, 2012, J BIOL CHEM, V287, P7190, DOI 10.1074/jbc.M111.304972	47	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21751	21759		10.1074/jbc.M113.541177	http://dx.doi.org/10.1074/jbc.M113.541177			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951591	hybrid, Green Published			2022-12-28	WOS:000340558300048
J	Kodera, C; Yorimitsu, T; Sato, K				Kodera, Chie; Yorimitsu, Tomohiro; Sato, Ken			Sec23 Homolog Nel1 Is a Novel GTPase-activating Protein for Sar1 but Does Not Function as a Subunit of the Coat Protein Complex II (COPII) Coat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT VESICLE FORMATION; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; SECRETORY PATHWAY; PICHIA-PASTORIS; BINDING PROTEIN; BUDDING YEAST; EXIT SITES	The coat protein complex II (COPII) generates transport carriers from the endoplasmic reticulum (ER) under the control of the small GTPase Sar1. Sec23 is well known as a structural component of the COPII coat and as a GTPase-activating protein (GAP) for Sar1. Here, we showed that Saccharomyces cerevisiae contains a novel Sec23 paralog, Nel1, which appears not to function as a subunit of the COPII coat. Nel1 does not associate with any of the COPII components, but it exhibits strong Sar1 GAP activity. We also demonstrated that the chromosomal deletion of NEL1 leads to a significant growth defect in the temperature-sensitive sar1D32G background, suggesting a possible functional link between these proteins. In contrast to Sec23, which is predominantly localized at ER exit sites on the ER membrane, a major proportion of Nel1 is localized throughout the cytosol. Our findings highlight a possible role of Nel1 as a novel GAP for Sar1.	[Kodera, Chie; Sato, Ken] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yorimitsu, Tomohiro; Sato, Ken] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo; University of Tokyo	Sato, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	kensato@bio.c.u-tokyo.ac.jp		KODERA, Chie/0000-0002-3078-8930	Ministry of Education, Culture, Sports, Science and Technology; Kurata Memorial Hitachi Science and Technology Foundation; Noda Institute for Scientific Research; Naito Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Memorial Hitachi Science and Technology Foundation; Noda Institute for Scientific Research(Noda Institute for Scientific Research); Naito Foundation(Naito Memorial Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant-in-aid for scientific research ( C), grant-in-aid for scientific research on innovation areas "Supramolecular Motility Machinery" and "Dynamical Ordering of Biomolecular Systems for Creation of Integrated Functions" from the Ministry of Education, Culture, Sports, Science and Technology, the Naito Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, and the Noda Institute for Scientific Research.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Esaki M, 2006, FEBS LETT, V580, P5215, DOI 10.1016/j.febslet.2006.08.058; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; James P, 1996, GENETICS, V144, P1425; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Michelsen K, 2006, TRAFFIC, V7, P903, DOI 10.1111/j.1600-0854.2006.00430.x; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; ORCI L, 1991, P NATL ACAD SCI USA, V88, P8611, DOI 10.1073/pnas.88.19.8611; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Saito Y, 1999, J BIOCHEM-TOKYO, V125, P130, DOI 10.1093/oxfordjournals.jbchem.a022249; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; Yamanushi T, 1996, J BIOCHEM-TOKYO, V120, P452; Yang YD, 2005, PLANT CELL, V17, P1513, DOI 10.1105/tpc.104.026757; Yorimitsu T, 2012, MOL BIOL CELL, V23, P2930, DOI 10.1091/mbc.E12-05-0356; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zou SS, 2012, GENETICS, V191, P451, DOI 10.1534/genetics.112.139378	41	3	3	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21423	21432		10.1074/jbc.M114.553917	http://dx.doi.org/10.1074/jbc.M114.553917			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947508	Green Published, hybrid			2022-12-28	WOS:000340558300021
J	Kai, X; Chellappa, V; Donado, C; Reyon, D; Sekigami, Y; Ataca, D; Louissaint, A; Mattoo, H; Joung, JK; Pillai, S				Kai, Xin; Chellappa, Vasant; Donado, Carlos; Reyon, Deepak; Sekigami, Yurie; Ataca, Dalya; Louissaint, Abner; Mattoo, Hamid; Joung, J. Keith; Pillai, Shiv			I kappa B Kinase beta(IKBKB) Mutations in Lymphomas That Constitutively Activate Canonical Nuclear Factor kappa B (NF kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARGINAL ZONE LYMPHOMA; CELL LYMPHOMA; GENOME; LYMPHOCYTES; NOTCH2; PROLIFERATION; REGULATOR; MULTIPLE; PATHWAY; TALENS	Somatic mutations altering lysine 171 of the IKBKB gene that encodes (IKK beta), the critical activating kinase in canonical (NF kappa B) signaling, have been described in splenic marginal zone lymphomas and multiple myeloma. Lysine 171 forms part of a cationic pocket that interacts with the activation loop phosphate in the activated wild type kinase. We show here that K171E IKK beta and K171T IKK beta represent kinases that are constitutively active even in the absence of activation loop phosphorylation. Predictive modeling and biochemical studies establish why mutations in a positively charged residue in the cationic pocket of an activation loop phosphorylation-dependent kinase result in constitutive activation. Transcription activator-like effector nuclease-based knock-in mutagenesis provides evidence from a B lymphoid context that K171E IKK beta contributes to lymphomagenesis.	[Kai, Xin; Chellappa, Vasant; Donado, Carlos; Sekigami, Yurie; Ataca, Dalya; Mattoo, Hamid; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Boston, MA 02129 USA; [Reyon, Deepak; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02129 USA; [Louissaint, Abner; Joung, J. Keith] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Louissaint, Abner; Joung, J. Keith] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Boston, MA 02129 USA.	pillai@helix.mgh.harvard.edu	Reyon, Deepak/HCH-3183-2022	Ataca, Dalya/0000-0003-3964-5618	National Institutes of Health [AI 064930, AI 076505]; National Institutes of Health Director's Pioneer Award [DP1 GM105378]; NATIONAL CANCER INSTITUTE [K23CA184279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076505, R01AI064930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants AI 064930 and AI 076505 from the National Institutes of Health (to S. P.) and National Institutes of Health Director's Pioneer Award DP1 GM105378 (to J. K. J.). J. K. J. has a financial interest in Editas Medicine and Transposagen Biopharmaceuticals. J. K. J.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Gupta Madhuja, 2013, Mol Vis, V19, P1017; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Moran ST, 2007, J IMMUNOL, V179, P195, DOI 10.4049/jimmunol.179.1.195; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Pappu BP, 2006, EUR J IMMUNOL, V36, P3033, DOI 10.1002/eji.200535663; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Reyon Deepak, 2013, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1216s103; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012	35	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26960	26972		10.1074/jbc.M114.598763	http://dx.doi.org/10.1074/jbc.M114.598763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107905	hybrid, Green Published			2022-12-28	WOS:000342853900026
J	Streit, AK; Matschke, LA; Dolga, AM; Rinne, S; Decher, N				Streit, Anne K.; Matschke, Lina A.; Dolga, Amalia M.; Rinne, Susanne; Decher, Niels			RNA Editing in the Central Cavity as a Mechanism to Regulate Surface Expression of the Voltage-gated Potassium Channel Kv1.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; AMINO-ACIDS; PORE REGION; RAT-BRAIN; TRAFFICKING; CLATHRIN; SUBUNITS; BINDING	Voltage-gated potassium (Kv) 1.1 channels undergo a specific enzymatic RNA deamination, generating a channel with a single amino acid exchange located in the inner pore cavity (Kv1.1(I400V)). We studied (I400V)-edited Kv1.1 channels in more detail and found that Kv1.1(I400V) gave rise to much smaller whole-cell currents than Kv1.1. To elucidate the mechanism behind this current reduction, we conducted electrophysiological recordings on single-channel level and did not find any differences. Next we examined channel surface expression in Xenopus oocytes and HeLa cells using a chemiluminescence assay and found the edited channels to be less readily expressed at the surface membrane. This reduction in surface expression was verified by fluorescence imaging experiments. Western blot analysis for comparison of protein abundances and glycosylation patterns did not show any difference between Kv1.1 and Kv1.1(I400V), further indicating that changed trafficking of Kv1.1(I400V) is causing the current reduction. Block of endocytosis by dynasore or AP180C did not abolish the differences in current amplitudes between Kv1.1 and Kv1.1(I400V), suggesting that backward trafficking is not affected. Therefore, our data suggest that I400V RNA editing of Kv1.1 leads to a reduced current size by a decreased forward trafficking of the channel to the surface membrane. This effect is specific for Kv1.1 because coexpression of Kv1.4 channel subunits with Kv1.1(I400V) abolishes these trafficking effects. Taken together, we identified RNA editing as a novel mechanism to regulate homomeric Kv1.1 channel trafficking. Fine-tuning of Kv1.1 surface expression by RNA editing might contribute to the complexity of neuronal Kv channel regulation.	[Streit, Anne K.; Matschke, Lina A.; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Fachbereich Med, D-35037 Marburg, Germany; [Dolga, Amalia M.] Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Decher, N (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Decher, Niels/AAF-5002-2020; Dolga, Amalia/C-9664-2018	Dolga, Amalia/0000-0001-5400-5614	Deutsche Forschungsgemeinschaft Grant [DE1432-3/2]; P. E. Kempkes Foundation	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); P. E. Kempkes Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant DE1432-3/2 (to N. D.) and by the P. E. Kempkes Foundation (to A. K. S.).	Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Decher N, 2010, EMBO J, V29, P2101, DOI 10.1038/emboj.2010.88; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Peters CJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03025; Pineda RH, 2008, J NEUROPHYSIOL, V100, P2125, DOI 10.1152/jn.90667.2008; Rajakulendran S, 2007, NEUROTHERAPEUTICS, V4, P258, DOI 10.1016/j.nurt.2007.01.010; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Rinne S, 2014, PFLUG ARCH EUR J PHY, V466, P1559, DOI 10.1007/s00424-013-1384-z; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Streit AK, 2011, EPILEPSIA, V52, P645, DOI 10.1111/j.1528-1167.2011.02986.x; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; Utsunomiya I, 2010, J NEUROCHEM, V112, P913, DOI 10.1111/j.1471-4159.2009.06523.x; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; Zhu J, 2005, BIOCHEM J, V388, P355, DOI 10.1042/BJ20041447; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	26	9	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26762	26771		10.1074/jbc.M113.545731	http://dx.doi.org/10.1074/jbc.M113.545731			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100718	hybrid, Green Published			2022-12-28	WOS:000342853900009
J	Sturzenegger, A; Burdova, K; Kanagaraj, R; Levikova, M; Pinto, C; Cejka, P; Janscak, P				Sturzenegger, Andreas; Burdova, Kamila; Kanagaraj, Radhakrishnan; Levikova, Maryna; Pinto, Cosimo; Cejka, Petr; Janscak, Pavel			DNA2 Cooperates with the WRN and BLM RecQ Helicases to Mediate Long-range DNA End Resection in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; REPAIR; EXO1; PROMOTES; MECHANISM; COMPLEX; SGS1; MRE11-RAD50-XRS2	The 5'-3' resection of DNA ends is a prerequisite for the repair of DNA double strand breaks by homologous recombination, microhomology-mediated end joining, and single strand annealing. Recent studies in yeast have shown that, following initial DNA end processing by the Mre11-Rad50-Xrs2 complex and Sae2, the extension of resection tracts is mediated either by exonuclease 1 or by combined activities of the RecQ family DNA helicase Sgs1 and the helicase/endonuclease Dna2. Although human DNA2 has been shown to cooperate with the BLM helicase to catalyze the resection of DNA ends, it remains a matter of debate whether another human RecQ helicase, WRN, can substitute for BLM in DNA2-catalyzed resection. Here we present evidence that WRN and BLM act epistatically with DNA2 to promote the long-range resection of double strand break ends in human cells. Our biochemical experiments show that WRN and DNA2 interact physically and coordinate their enzymatic activities to mediate 5'-3' DNA end resection in a reaction dependent on RPA. In addition, we present in vitro and in vivo data suggesting that BLM promotes DNA end resection as part of the BLM-TOPOIII alpha-RMI1-RMI2 complex. Our study provides new mechanistic insights into the process of DNA end resection in mammalian cells.	[Sturzenegger, Andreas; Kanagaraj, Radhakrishnan; Levikova, Maryna; Pinto, Cosimo; Cejka, Petr; Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Burdova, Kamila; Janscak, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic	University of Zurich; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Janscak, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch	Janscak, Pavel/Q-3795-2018; Kanagaraj, Raj R./O-3205-2016	Janscak, Pavel/0000-0002-1748-7789; Radhakrishnan, Kanagaraj/0000-0003-0906-5399; Levikova, Maryna/0000-0003-1076-5181; Cejka, Petr/0000-0002-9087-032X; Burdova, Kamila/0000-0003-4402-3688	Swiss National Science Foundation [31003A-129747, 31003A_146206, PP00P3 133636]; Czech Science Foundation [GAP305/10/0281]; Stiftung zur Krebsbekampfung; Forschungskredit of the University of Zurich [FK-13-098]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Czech Science Foundation(Grant Agency of the Czech Republic); Stiftung zur Krebsbekampfung; Forschungskredit of the University of Zurich	This work was supported by Swiss National Science Foundation Grants 31003A-129747 and 31003A_146206, by Czech Science Foundation Grant GAP305/10/0281, and by the Stiftung zur Krebsbekampfung. This work was also supported by Swiss National Science Foundation Grant PP00P3 133636 (to P.C.) and by Forschungskredit of the University of Zurich Grant FK-13-098 (to A.S.).	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen LS, 2003, AGING CELL, V2, P191, DOI 10.1046/j.1474-9728.2003.00052.x; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kanagaraj R, 2012, NUCLEIC ACIDS RES, V40, P8449, DOI 10.1093/nar/gks648; Karanja KK, 2012, CELL CYCLE, V11, P3983, DOI 10.4161/cc.22215; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liao SR, 2012, NUCLEIC ACIDS RES, V40, P4496, DOI 10.1093/nar/gks044; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Melcher R, 2000, CYTOGENET CELL GENET, V91, P180, DOI 10.1159/000056841; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Saydam N, 2007, NUCLEIC ACIDS RES, V35, P5706, DOI 10.1093/nar/gkm500; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Yan H, 2005, J CELL BIOL, V171, P217, DOI 10.1083/jcb.200502077; Yang J, 2012, MOL CELL BIOL, V32, P3054, DOI 10.1128/MCB.00255-12; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	65	128	131	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27314	27326		10.1074/jbc.M114.578823	http://dx.doi.org/10.1074/jbc.M114.578823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25122754	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000342853900052
J	Choi, SS; Kim, ES; Koh, M; Lee, SJ; Lim, D; Yang, YR; Jang, HJ; Seo, KA; Min, SH; Lee, IH; Park, SB; Suh, PG; Choi, JH				Choi, Sun-Sil; Kim, Eun Sun; Koh, Minseob; Lee, Soo-Jin; Lim, Donghyun; Yang, Yong Ryoul; Jang, Hyun-Jun; Seo, Kyung-ah; Min, Sang-Hyun; Lee, In Hee; Park, Seung Bum; Suh, Pann-Ghill; Choi, Jang Hyun			A Novel Non-agonist Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Ligand UHC1 Blocks PPAR gamma Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MACROPHAGES; LIPASE; FAT; THIAZOLIDINEDIONE; INFLAMMATION; RESISTANCE; REGULATOR; COMPLEX; GENES	Thiazolidinedione class of anti-diabetic drugs which are known as peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands have been used to treat metabolic disorders, but thiazolidinediones can also cause several severe side effects, including congestive heart failure, fluid retention, and weight gain. In this study, we describe a novel synthetic PPAR gamma ligand LTNIST HYUNDAI Compound 1 (UH('1) that binds tightly to PPAR gamma without the classical agonism and which blocks cyclin-dependent kinase 5 (CDK5)-mediated PPAR gamma phosphorylation. We modified the non-agonist PPAR gamma ligand SR1664 chemically to improve its solubility and then developed a novel PPAR gamma ligand, UHC1. According to our docking simulation, UHC1 occupied the ligand-binding site of P PARy with a higher docking score than SR1664. In addition, UHC1 more potently blocked CDK5-mediated PPAR gamma phosphorylation at Ser273. Surprisingly, UHC1 treatment effectively ameliorated the inflammatory response both in vitro and in high-fat diet-fed mice. Furthermore, UHC1 treatment dramatically improved insulin sensitivity in high-flit diet-fed mice without causing fluid retention and weight gain. Taken together, compared with SR 1 664, UHC1 exhibited greater beneficial effects on glucose and lipid metabolism by blocking CD K5-mediated PPAR gamma phosphorylation, and these data indicate that UHC1 could be a novel therapeutic agent for use in type 2 diabetes and related metabolic disorders.	[Choi, Sun-Sil; Kim, Eun Sun; Lee, Soo-Jin; Yang, Yong Ryoul; Jang, Hyun-Jun; Suh, Pann-Ghill; Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Dept Biol Sci, Ulsan 689798, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lim, Donghyun; Park, Seung Bum] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu 701310, South Korea; [Seo, Kyung-ah; Min, Sang-Hyun] Seoul Natl Univ, Dept Biophys & Chem Biol, BioMAX Inst, Seoul 151747, South Korea; [Lee, In Hee] Hyundai Pharm Co Ltd, Dept Med Chem, Suwon 443270, Gyonggi, South Korea	Ulsan National Institute of Science & Technology (UNIST); Seoul National University (SNU); Seoul National University (SNU)	Choi, JH (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biol Sci, Ulsan 689798, South Korea.	janghchoi@unist.ac.kr	Suh, Pann-Ghill/F-3610-2010; Choi, Jang Hyun/B-3055-2012; Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433; Koh, Minseob/0000-0003-1935-4776; Lim, Donghyun/0000-0002-6070-198X	Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation	Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation	We thank Dr. Bruce M. Spiegelman for supporting phospho-specific antibody against Ser-273 residue. We thank Dr. Fun g Kyun Kim at UNIST OLYMPUS Biomed Imaging Center (UOBC) for supporting microscopic images. The pharmacokinetic study was supported by the Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Henchoz Y, 2009, ANAL BIOANAL CHEM, V394, P707, DOI 10.1007/s00216-009-2634-y; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696	40	55	55	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26618	26629		10.1074/jbc.M114.566794	http://dx.doi.org/10.1074/jbc.M114.566794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100724	hybrid, Green Published			2022-12-28	WOS:000342128800052
J	Pha, K; Wright, ME; Barr, TM; Eigenheer, RA; Navarro, L				Pha, Khavong; Wright, Matthew E.; Barr, Tasha M.; Eigenheer, Richard A.; Navarro, Lorena			Regulation of Yersinia Protein Kinase A (YpkA) Kinase Activity by Multisite Autophosphorylation and Identification of an N-terminal Substrate-binding Domain in YpkA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION; TYROSINE-PHOSPHATASE; POSTTRANSLATIONAL MODIFICATION; OUTER PROTEINS; SER/THR KINASE; VIRULENCE; ACTIVATION; PHOSPHORYLATION; ACETYLATION; MODULATION	The serine/threonine protein kinase YpkA is an essential virulence factor produced by pathogenic Yersinia species. YpkA is delivered into host mammalian cells via a type III secretion system and localizes to the inner side of the plasma membrane. We have previously shown that YpkA binds to and phosphorylates the alpha subunit of the heterotrimeric G protein complex, G alpha q, resulting in inhibition of G alpha q signaling. To identify residues in YpkA involved in substrate binding activity we generated GFP-YpkA N-terminal deletion mutants and performed coimmunoprecipitation experiments. We located a substrate-binding domain on amino acids 40-49 of YpkA, which lies within the previously identified membrane localization domain on YpkA. Deletion of amino acids 40-49 on YpkA interfered with substrate binding, substrate phosphorylation and substrate inhibition. Autophosphorylation regulates the kinase activity of YpkA. To dissect the mechanism by which YpkA transmits signals, we performed nano liquid chromatography coupled to tandem mass spectrometry to map in vivo phosphorylation sites. Multiple serine phosphorylation sites were identified in the secretion/translocation region, kinase domain, and C-terminal region of YpkA. Using site-directed mutagenesis we generated multiple YpkA constructs harboring specific serine to alanine point mutations. Our results demonstrate that multiple autophosphorylation sites within the N terminus regulate YpkA kinase activation, whereas mutation of serine to alanine within the C terminus of YpkA had no effect on kinase activity. YpkA autophosphorylation on multiple sites may be a strategy used by pathogenic Yersinia to prevent inactivation of this important virulence protein by host proteins.	[Pha, Khavong; Wright, Matthew E.; Barr, Tasha M.; Navarro, Lorena] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Eigenheer, Richard A.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Navarro, L (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	lonavarro@ucdavis.edu			Hellman Fellows Program; ASM Robert D. Watkins Graduate Research Fellowship Program	Hellman Fellows Program; ASM Robert D. Watkins Graduate Research Fellowship Program	This work was supported in part by grants from the Hellman Fellows Program (to L. N.) and the ASM Robert D. Watkins Graduate Research Fellowship Program (to K. P.).	Aepfelbacher M, 2005, REV PHYSIOL BIOCH P, V152, P65, DOI 10.1007/s10254-004-0035-3; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Groves E, 2010, J BIOL CHEM, V285, P4087, DOI 10.1074/jbc.M109.071035; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Sorg I, 2003, INFECT IMMUN, V71, P4623, DOI 10.1128/IAI.71.8.4623-4632.2003; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001	43	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26167	26177		10.1074/jbc.M114.601153	http://dx.doi.org/10.1074/jbc.M114.601153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086045	Green Published, hybrid			2022-12-28	WOS:000342128800013
J	Roston, RL; Wang, K; Kuhn, LA; Benning, C				Roston, Rebecca L.; Wang, Kun; Kuhn, Leslie A.; Benning, Christoph			Structural Determinants Allowing Transferase Activity in SENSITIVE TO FREEZING 2, Classified as a Family I Glycosyl Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER ENVELOPE MEMBRANE; PROTEIN MODEL QUALITY; CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; BETA-GLUCOSIDASE; EVOLUTIONARY CONSERVATION; DISORDER PREDICTION; PREPROTEIN RECEPTOR; ESCHERICHIA-COLI; SCORING FUNCTION	SENSITIVE TO FREEZING 2 (SFR2) is classified as a family I glycosyl hydrolase but has recently been shown to have galactosyltransferase activity in Arabidopsis thaliana. Natural occurrences of apparent glycosyl hydrolases acting as transferases are interesting from a biocatalysis standpoint, and knowledge about the interconversion can assist in engineering SFR2 in crop plants to resist freezing. To understand how SFR2 evolved into a transferase, the relationship between its structure and function are investigated by activity assay, molecular modeling, and site-directed mutagenesis. SFR2 has no detectable hydrolase activity, although its catalytic site is highly conserved with that of family 1 glycosyl hydrolases. Three regions disparate from glycosyl hydrolases are identified as required for transferase activity as follows: a loop insertion, the C-terminal peptide, and a hydrophobic patch adjacent to the catalytic site. Rationales for the effects of these regions on the SFR2 mechanism are discussed.	[Roston, Rebecca L.; Wang, Kun; Kuhn, Leslie A.; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kuhn, Leslie A.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Roston, RL (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr N200, 1901 Vine St, Lincoln, NE 68588 USA.	rroston@unl.edu	Roston, Rebecca/AAQ-5309-2020; Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667; Roston, Rebecca/0000-0002-3063-5002; Wang, Kun/0000-0003-1715-990X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20305]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-98ER20305 (to C. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Assuncao AGL, 2013, METALLOMICS, V5, P1110, DOI 10.1039/c3mt00070b; Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587; Balsera M, 2009, J BIOL CHEM, V284, P2603, DOI 10.1074/jbc.M807134200; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Bodennec J, 2003, J LIPID RES, V44, P218, DOI 10.1194/jlr.D200026-JLR200; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Bruce B.D., 1994, PLANT MOL BIOL MANUA, VJ1, P1; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Cairns J. R. K., 2012, Journal of Applied Glycoscience, V59, P51, DOI 10.5458/jag.jag.JAG-2011_022; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell ZT, 2009, J BIOL CHEM, V284, P32827, DOI 10.1074/jbc.M109.031716; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi YI, 1999, FEBS LETT, V445, P375, DOI 10.1016/S0014-5793(99)00090-3; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Czjzek M, 2001, BIOCHEM J, V354, P37, DOI 10.1042/0264-6021:3540037; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Deckert K, 2012, J AM CHEM SOC, V134, P10055, DOI 10.1021/ja301409g; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fourrier N, 2008, PLANT J, V55, P734, DOI 10.1111/j.1365-313X.2008.03549.x; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Gloster TM, 2004, BIOCHEMISTRY-US, V43, P6101, DOI 10.1021/bi049666m; GREER J, 1981, J MOL BIOL, V153, P1027, DOI 10.1016/0022-2836(81)90465-4; Halperin SJ, 2003, J EXP BOT, V54, P2035, DOI 10.1093/jxb/erg219; HEEMSKERK JW, 1983, BIOCHIM BIOPHYS ACTA, V754, P181, DOI 10.1016/0005-2760(83)90160-1; Heger A, 2007, BIOINFORMATICS, V23, P2361, DOI 10.1093/bioinformatics/btm358; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Luang S, 2013, J BIOL CHEM, V288, P10111, DOI 10.1074/jbc.M112.423533; Lung SC, 2012, PLANT CELL, V24, P1560, DOI 10.1105/tpc.112.096248; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; MONSAN P, 1995, FEMS MICROBIOL REV, V16, P187; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Muckel E, 1996, J BIOL CHEM, V271, P23846, DOI 10.1074/jbc.271.39.23846; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Offredi F, 2003, J MOL BIOL, V325, P163, DOI 10.1016/S0022-2836(02)01206-8; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Roston RL, 2012, J BIOL CHEM, V287, P21406, DOI 10.1074/jbc.M112.370213; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shafii B., 2012, THESIS; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Snyder R.L., 2005, FROST PROTECTION FUN, V1; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Sue M, 2006, PLANT PHYSIOL, V141, P1237, DOI 10.1104/pp.106.077693; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Teze D, 2013, BIOCHEMISTRY-US, V52, P5900, DOI 10.1021/bi400260b; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; van der Veen BA, 2001, J BIOL CHEM, V276, P44557, DOI 10.1074/jbc.M107533200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren G, 1996, PLANT PHYSIOL, V111, P1011, DOI 10.1104/pp.111.4.1011; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Withers SG, 2001, CARBOHYD POLYM, V44, P325, DOI 10.1016/S0144-8617(00)00249-6; Xia LQ, 2012, ACS CHEM BIOL, V7, P226, DOI 10.1021/cb200267w; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	99	17	18	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26089	26106		10.1074/jbc.M114.576694	http://dx.doi.org/10.1074/jbc.M114.576694			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100720	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000342128800007
J	Zhao, X; Rotenberg, SA				Zhao, Xin; Rotenberg, Susan A.			Phosphorylation of Cdc42 Effector Protein-4 (CEP4) by Protein Kinase C Promotes Motility of Human Breast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO FAMILY GTPASES; CANCER CELLS; PKC-ALPHA; SPECIFICITY; ACTIVATION; EXPRESSION; POLARITY; DESIGN; TARGET; RAC	Cdc42 effector protein-4 (CEP4) was recently identified by our laboratory to be a substrate of multiple PKC isoforms in non-transformed MCF-10A human breast cells. The significance of phosphorylated CEP4 to PKC-stimulated motility of MCF-10A cells was evaluated. Single site mutants at Ser residues embedded in potential PKC consensus sites (Ser(18), Ser(77), Ser(80), and Ser(86)) were individually replaced with Asp residues to simulate phosphorylation. Following expression in weakly motile MCF-10A cells, the S18D and S80D mutants each promoted increased motility, and the double mutant (S18D/S80D) produced a stronger effect. MS/MS analysis verified that Ser(18) and Ser(80) were directly phosphorylated by PKC alpha in vitro. Phosphorylation of CEP4 severely diminished its affinity for Cdc42 while promoting Rac activation and formation of filopodia (microspikes). In contrast, the phosphorylation-resistant double mutant S18A/S80A-CEP4 blocked CEP4 phosphorylation and inhibited motility of MCF-10A cells that had been stimulated with PKC activator diacylglycerol lactone. In view of the dissociation of phospho-CEP4 from Cdc42, intracellular binding partners were explored by expressing each CEP4 double mutant from a tandem affinity purification vector followed by affinity chromatography, SDS-PAGE, and identification of protein bands evident only with S18D/S80D-CEP4. One binding partner was identified as tumor endothelial marker-4 (TEM4; ARHGEF17), a guanine nucleotide exchange factor that is involved in migration. In motile cells expressing S18D/S80D-CEP4, knockdown of TEM4 inhibited both Rac activation and motility. These findings support a model in which PKC-mediated phosphorylation of CEP4 at Ser18 and Ser80 causes its dissociation from Cdc42, thereby increasing its affinity for TEM4 and producing Rac activation, filopodium formation, and cell motility.	[Zhao, Xin; Rotenberg, Susan A.] Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Zhao, Xin] CUNY, Grad Ctr, New York, NY 10016 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Rotenberg, SA (corresponding author), CUNY Queens Coll, Dept Chem & Biochem, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	Susan.Rotenberg@qc.cuny.edu		Rotenberg, Susan/0000-0002-6618-686X	National Institutes of Health [CA125632]; NATIONAL CANCER INSTITUTE [R15CA125632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA125632 (to S. A. R.).	Abeyweera TP, 2007, BIOCHEMISTRY-US, V46, P2364, DOI 10.1021/bi0622017; Abeyweera TP, 2009, J BIOL CHEM, V284, P17648, DOI 10.1074/jbc.M902005200; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen XY, 2012, BIOCHEMISTRY-US, V51, P7087, DOI 10.1021/bi300999c; Cunliffe HE, 2012, AM J CANCER RES, V2, P478; De S, 2014, CYTOSKELETON, V71, P257, DOI 10.1002/cm.21167; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; McCracken MA, 2003, MOL CANCER THER, V2, P273; Mitin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066260; Mitin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041876; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Ngok SP, 2013, J CELL SCI, V126, P3271, DOI 10.1242/jcs.123869; Osada N, 2000, J HUM GENET, V45, P374, DOI 10.1007/s100380070012; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Rumenapp U, 2002, BIOCHEM J, V366, P721, DOI 10.1042/BJ20020654; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	35	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25844	25854		10.1074/jbc.M114.577783	http://dx.doi.org/10.1074/jbc.M114.577783			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086031	Green Published, hybrid			2022-12-28	WOS:000342130800041
J	Lee, KW; Bogenhagen, DF				Lee, Ken-Wing; Bogenhagen, Daniel F.			Assignment of 2 '-O-Methyltransferases to Modification Sites on the Mammalian Mitochondrial Large Subunit 16 S Ribosomal RNA (rRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH-ASSOCIATED PROTEIN-3; MODIFIED NUCLEOTIDES; DETECTING SITES; FUNCTIONAL-ROLE; IDENTIFICATION; MUTATION; GENE; METHYLATION; DEMETHYLASE; COMPONENTS	Advances in proteomics and large scale studies of potential mitochondrial proteins have led to the identification of many novel mitochondrial proteins in need of further characterization. Among these novel proteins are three mammalian rRNA methyltransferase family members RNMTL1, MRM1, and MRM2. MRM1 and MRM2 have bacterial and yeast homologs, whereas RNMTL1 appears to have evolved later in higher eukaryotes. We recently confirmed the localization of the three proteins to mitochondria, specifically in the vicinity of mtDNA nucleoids. In this study, we took advantage of the ability of 2'-O-ribose modification to block site-specific cleavage of RNA by DNAzymes to show that MRM1, MRM2, and RNMTL1 are responsible for modification of human large subunit rRNA at residues G(1145), U-1369, and G(1370), respectively.	[Lee, Ken-Wing; Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu			Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This research was supported by a Senior Scholar Award from the Ellison Medical Foundation (to D. F. B.).	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Almajan ER, 2012, J CLIN INVEST, V122, P4048, DOI 10.1172/JCI64604; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; BAER RJ, 1981, NUCLEIC ACIDS RES, V9, P323, DOI 10.1093/nar/9.2.323; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; Blanchard SC, 2001, P NATL ACAD SCI USA, V98, P3720, DOI 10.1073/pnas.051608498; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Buchhaupt M, 2007, ANAL BIOCHEM, V361, P102, DOI 10.1016/j.ab.2006.11.001; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Coulbault L, 2007, BIOCHEM BIOPH RES CO, V362, P601, DOI 10.1016/j.bbrc.2007.08.040; Cruz RPG, 2004, CHEM BIOL, V11, P57, DOI 10.1016/j.chembiol.2003.12.012; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dong ZW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks698; DUBIN DT, 1978, NUCLEIC ACIDS RES, V5, P4385, DOI 10.1093/nar/5.11.4385; Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Hengesbach M, 2014, ANGEW CHEM INT EDIT, V53, P1742, DOI 10.1002/anie.201309604; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; KING MP, 1993, J BIOL CHEM, V268, P10228; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Lapinaite A, 2013, NATURE, V502, P519, DOI 10.1038/nature12581; Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692; Liu Z, 2014, J MED GENET, V51, P176, DOI 10.1136/jmedgenet-2013-101818; Lovgren JM, 2001, J BACTERIOL, V183, P6957, DOI 10.1128/JB.183.23.6957-6960.2001; Maden BEH, 1997, CHROMOSOMA, V105, P391, DOI 10.1007/s004120050200; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Miyazaki T, 2004, J BIOL CHEM, V279, P44667, DOI 10.1074/jbc.M408101200; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Paul MF, 2012, J BIOL CHEM, V287, P24346, DOI 10.1074/jbc.M112.363309; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Purta E, 2009, MOL MICROBIOL, V72, P1147, DOI 10.1111/j.1365-2958.2009.06709.x; Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Saikia M, 2006, RNA, V12, P2025, DOI 10.1261/rna.208906; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SIRUMCONNOLLY K, 1995, BIOCHIMIE, V77, P30, DOI 10.1016/0300-9084(96)88101-6; Suzuki T, 2001, J BIOL CHEM, V276, P33181, DOI 10.1074/jbc.M103236200; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; Uchiumi T, 2010, NUCLEIC ACIDS RES, V38, P5554, DOI 10.1093/nar/gkq305; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vincze E, 2005, ANAL BIOCHEM, V342, P356, DOI 10.1016/j.ab.2005.02.026; Yu YT, 1997, RNA, V3, P324; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	67	53	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24936	24942		10.1074/jbc.C114.581868	http://dx.doi.org/10.1074/jbc.C114.581868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25074936	Green Published, hybrid			2022-12-28	WOS:000341985300018
J	Yang, CH; Yue, JM; Pfeffer, SR; Fan, MY; Paulus, E; Hosni-Ahmed, A; Sims, M; Qayyum, S; Davidoff, AM; Handorf, CR; Pfeffer, LM				Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Fan, Meiyun; Paulus, Elena; Hosni-Ahmed, Amira; Sims, Michelle; Qayyum, Sohail; Davidoff, Andrew M.; Handorf, Charles R.; Pfeffer, Lawrence M.			MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; PROSTATE-CANCER; SIGNALING PATHWAYS; METASTATIC DISEASE; CELLS; EXPRESSION; INVASION; SURVIVAL; MIR-21; OVEREXPRESSION	Despite advances in surgery, imaging, chemotherapy, and radiation, patients with glioblastoma multiforme (GBM), the most common histological subtype of glioma, have an especially dismal prognosis; >70% of GBM patients die within 2 years of diagnosis. In many human cancers, the microRNA miR-21 is overexpressed, and accumulating evidence indicates that it functions as an oncogene. Here, we report that miR-21 is overexpressed in human GBM cell lines and tumor tissue. Moreover, miR-21 expression in GBM patient samples is inversely correlated with patient survival. Knockdown of miR-21 in GBM cells inhibited cell proliferation in vitro and markedly inhibited tumor formation in vivo. A number of known miR-21 targets have been identified previously. By microarray analysis, we identified and validated insulin-like growth factor (IGF)-binding protein-3 (IGFBP3) as a novel miR-21 target gene. Overexpression of IGFBP3 in glioma cells inhibited cell proliferation in vitro and inhibited tumor formation of glioma xenografts in vivo. The critical role that IGFBP3 plays in miR-21-mediated actions was demonstrated by a rescue experiment, in which IGFBP3 knockdown in miR-21KD glioblastoma cells restored tumorigenesis. Examination of tumors from GBM patients showed that there was aninverse relationship between IGFBP3 and miR-21 expression and that increased IGFBP3 expression correlated with better patient survival. Our results identify IGFBP3 as a novel miR-21 target gene in glioblastoma and suggest that the oncogenic miRNA miR-21 down-regulates the expression of IGFBP3, which acts as a tumor suppressor in human glioblastoma.	[Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Fan, Meiyun; Hosni-Ahmed, Amira; Sims, Michelle; Qayyum, Sohail; Davidoff, Andrew M.; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Paulus, Elena] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Yang, Chuan He; Yue, Junming; Pfeffer, Susan R.; Fan, Meiyun; Hosni-Ahmed, Amira; Sims, Michelle; Handorf, Charles R.; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Ctr Canc Res, Memphis, TN 38163 USA; [Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Canc Res Bldg,19 S Manassas St,Rm 154, Memphis, TN 38163 USA.	Lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institute of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from NCI, National Institutes of Health [21766]; Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA133322, R01CA140346] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from NCI, National Institutes of Health; Muirhead Chair Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants CA133322 to L. M. P. and A. M. D.), Department of Defense Award W81XWH-11-1-0533 (to L. M. P.), Cancer Center Support Grant 21766 from NCI, National Institutes of Health (to A. M. D.), and by the Muirhead Chair Endowment (to L. M. P.) at the University of Tennessee Health Science Center.	All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartucci M, 2001, CANCER RES, V61, P6747; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Elstner A, 2011, J NEURO-ONCOL, V102, P71, DOI 10.1007/s11060-010-0284-8; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Fuchs CS, 2008, CLIN CANCER RES, V14, P8263, DOI 10.1158/1078-0432.CCR-08-0480; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hellawell GO, 2002, CANCER RES, V62, P2942; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Nickerson T, 2001, CANCER RES, V61, P6276; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; Schedlich LJ, 2002, MICROSC RES TECHNIQ, V59, P12, DOI 10.1002/jemt.10173; Shariat SF, 2002, J CLIN ONCOL, V20, P833, DOI 10.1200/JCO.20.3.833; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Trojan J, 2007, NEUROSCIENCE, V145, P795, DOI 10.1016/j.neuroscience.2007.01.021; TROJAN J, 1992, P NATL ACAD SCI USA, V89, P4874, DOI 10.1073/pnas.89.11.4874; Turner BC, 1997, CANCER RES, V57, P3079; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HM, 2006, TECHNOL CANCER RES T, V5, P195, DOI 10.1177/153303460600500303; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Yamada PM, 2009, AM J PHYSIOL-CELL PH, V296, pC954, DOI 10.1152/ajpcell.00598.2008; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071130; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yu D, 2003, J BIOL CHEM, V278, P6702, DOI 10.1074/jbc.M209809200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	41	111	114	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25079	25087		10.1074/jbc.M114.593863	http://dx.doi.org/10.1074/jbc.M114.593863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059666	Green Published, hybrid			2022-12-28	WOS:000341985300031
J	An, D; Kim, K; Lu, WG				An, Daniel; Kim, Kyunghwan; Lu, Wange			Defective Entry into Mitosis 1 (Dim1) Negatively Regulates Osteoclastogenesis by Inhibiting the Expression of Nuclear Factor of Activated T-cells, Cytoplasmic, Calcineurin-dependent 1 (NFATc1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS); Gene Expression; NFAT Transcription Factor; Osteoclast; Dim1; NFATc1; Osteoclastogenesis; RANKL; c-Fos	BONE-RESORPTION; CRYSTAL-STRUCTURE; C-FOS; DIFFERENTIATION; RANKL; PROTEIN; LIGAND; GENE; HOMEOSTASIS; INDUCTION	Background: The potential role of Dim1 in RANKL-mediated induction of osteoclast differentiation is unknown. Results: Dim1 directly interacts with c-Fos to diminish the expression of NFATc1 target genes that are essential for RANKL-induced osteoclatogenesis. Conclusion: Dim1 functions as a negative regulator of RANKL-induced osteoclast differentiation. Significance: Understanding of the inhibitory role of Dim1 in RANKL-induced osteoclastogenesis might provide therapeutic benefits for treating various types of bone diseases. Bone remodeling is a continuous process of osteoblastic bone formation and osteoclastic bone resorption to maintain normal bone mass. NFATc1 is the master regulator of osteoclastogensis and transcriptionally activated by c-Fos and NF-B in response to receptor activator of NF-B ligand (RANKL) treatment. Defective entry into mitosis 1 (Dim1) is a nuclear protein that is implicated in pre-mRNA splicing and cell cycle progression, but the possible role of Dim1 in regulating other cellular processes remains unknown. Here, we demonstrate that Dim1 attenuates RANKL-induced osteoclastogenesis by targeting NFATc1 signaling pathway. Expression levels of Dim1 and NFATc1 are significantly increased during the formation of multinucleated osteoclasts. RNAi-mediated knockdown of Dim1 markedly enhances the expression of NFATc1 and its target genes, leading to the increase of RANKL-induced osteoclastogenesis in bone marrow-derived macrophages. Conversely, ectopic expression of Dim1 decreases RANKL-induced osteoclast differentiation by silencing NFATc1 and its target genes, further linking Dim1 to the dynamic regulation of osteoclastogenesis. Consistent with this notion, ChIP and interaction studies show that Dim1 directly associates with c-Fos and prevents c-Fos from binding to the NFATc1 promoter, resulting in targeted inactivation of the NFATc1 gene. Therefore, our studies reveal an unrecognized role for Dim1 as a master modulator of osteoclast differentiation, as well as the molecular mechanism underlying its repressive action toward osteoclastogensis.	[An, Daniel; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Stem Cell Biol & Regenerat Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90089 USA; [Kim, Kyunghwan] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [An, Daniel] Univ So Calif, Neurosci Program, Coll Letters Arts & Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Kim, K (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	kyunghki@usc.edu; wangelu@usc.edu						Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Berry LD, 1999, MOL CELL BIOL, V19, P2535; Chen S., 2013, HEMATOL THROMB DIS, DOI [10.4172/2329-8790.1000102, DOI 10.4172/2329-8790.1000102]; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mehrabadi M, 2013, J INVERTEBR PATHOL, V113, P152, DOI 10.1016/j.jip.2013.02.005; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Simeoni F, 2005, BIOCHEMISTRY-US, V44, P11997, DOI 10.1021/bi050427o; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang YZ, 1999, PHYSIOL GENOMICS, V1, P109, DOI 10.1152/physiolgenomics.1999.1.3.109; Zhang YZ, 2000, GENE, V257, P33, DOI 10.1016/S0378-1119(00)00372-3; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	32	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24366	24373		10.1074/jbc.M114.563817	http://dx.doi.org/10.1074/jbc.M114.563817			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023277	hybrid, Green Published			2022-12-28	WOS:000341505600031
J	Chou, AM; Sem, KP; Wright, GD; Sudhaharan, T; Ahmed, S				Chou, Ai Mei; Sem, Kai Ping; Wright, Graham Daniel; Sudhaharan, Thankiah; Ahmed, Sohail			Dynamin1 Is a Novel Target for IRSp53 Protein and Works with Mammalian Enabled (Mena) Protein and Eps8 to Regulate Filopodial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Biology; Cell Migration; Fluorescence Resonance Energy Transfer (FRET); Imaging; IRSp53; TIRF; Dynamin; Filopodia	ACTIN CYTOSKELETON; N-WASP; NEURITE OUTGROWTH; ARP2/3 COMPLEX; BAR DOMAINS; CELL-SHAPE; CDC42; GROWTH; RAC; REORGANIZATION	Background: IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics through SH3 domain binding partners. Results: Dynamin1 interacts with IRSp53, and its GTPase and actin binding domains are required for filopodial formation. Conclusion: Dynamin1 plays a role in filopodial initiation and assembly. Significance: A novel role for dynamin1 in filopodial dynamics has implications for cell migration and wound healing. Filopodia are dynamic actin-based structures that play roles in processes such as cell migration, wound healing, and axonal guidance. Cdc42 induces filopodial formation through IRSp53, an Inverse-Bin-Amphiphysins-Rvs (I-BAR) domain protein. Previous work from a number of laboratories has shown that IRSp53 generates filopodia by coupling membrane protrusion with actin dynamics through its Src homology 3 domain binding partners. Here, we show that dynamin1 (Dyn1), the large guanosine triphosphatase, is an interacting partner of IRSp53 through pulldown and Forster resonance energy transfer analysis, and we explore its role in filopodial formation. In neuroblastoma cells, Dyn1 localizes to filopodia, associated tip complexes, and the leading edge just behind the anti-capping protein mammalian enabled (Mena). Dyn1 knockdown reduces filopodial formation, which can be rescued by overexpressing wild-type Dyn1 but not the GTPase mutant Dyn1-K44A and the loss-of-function actin binding domain mutant Dyn1-K/E. Interestingly, dynasore, an inhibitor of Dyn GTPase, also reduced filopodial number and increased their lifetime. Using rapid time-lapse total internal reflection fluorescence microscopy, we show that Dyn1 and Mena localize to filopodia only during initiation and assembly. Dyn1 actin binding domain mutant inhibits filopodial formation, suggesting a role in actin elongation. In contrast, Eps8, an actin capping protein, is seen most strongly at filopodial tips during disassembly. Taken together, the results suggest IRSp53 partners with Dyn1, Mena, and Eps8 to regulate filopodial dynamics.	[Chou, Ai Mei; Sem, Kai Ping; Wright, Graham Daniel; Sudhaharan, Thankiah; Ahmed, Sohail] Immunos, Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Immunos, Inst Med Biol, 06-06,8A Biomed Grove, Singapore 138648, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Chou, Amy/0000-0002-6831-0799; Wright, Graham/0000-0003-2362-1312	A-STAR	A-STAR(Agency for Science Technology & Research (A*STAR))	This work was supported by A-STAR.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Disanza A, 2013, EMBO J, V32, P2735, DOI 10.1038/emboj.2013.208; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fierro-Gonzalez JC, 2013, NAT CELL BIOL, V15, P1424, DOI 10.1038/ncb2875; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Funato Y, 2004, CANCER RES, V64, P5237, DOI 10.1158/0008-5472.CAN-04-0327; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McMahon AP, 2013, DEV CELL, V25, P328, DOI 10.1016/j.devcel.2013.05.008; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Mundigl O, 1998, J NEUROSCI, V18, P93; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	53	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24383	24396		10.1074/jbc.M114.553883	http://dx.doi.org/10.1074/jbc.M114.553883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031323	Green Published, hybrid			2022-12-28	WOS:000341505600033
J	Han, XZ; Aslanian, A; Fu, K; Tsuji, T; Zhang, YW				Han, Xiangzi; Aslanian, Aaron; Fu, Kang; Tsuji, Toshiya; Zhang, Youwei			The Interaction between Checkpoint Kinase 1 (Chk1) and the Minichromosome Maintenance (MCM) Complex Is Required for DNA Damage-induced Chk1 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; DNA Damage; DNA Damage Response; Molecular Biology; Signal Transduction	CELL-CYCLE CHECKPOINT; REPLICATION STRESS; PROTEINS; TARGETS; ATR; IDENTIFICATIONS; ACTIVATION; HELICASE	Background: Chk1 is a key mediator protein that regulates replication checkpoint. Results: Chk1 interacts with the MCM complex. Conclusion: The MCM complex facilitates the recruitment of Chk1 onto chromatin. Significance: This study provides mechanistic insights into DNA damage-induced phosphorylation of Chk1, the key step for checkpoint activation. Chk1 is an essential mediator of the DNA damage response and cell cycle checkpoint. However, how exactly Chk1 transduces the checkpoint signaling is not fully understood. Here we report the identification of the heterohexamic minichromosome maintenance (MCM) complex that interacts with Chk1 by mass spectrometry. The interaction between Chk1 and the MCM complex was reduced by DNA damage treatment. We show that the MCM complex, at least partially, contributes to the chromatin association of Chk1, allowing for immediate phosphorylation of Chk1 by ataxia telangiectasia mutated and Rad3-related (ATR) in the presence of DNA damage. Further, phosphorylation of Chk1 at ATR sites reduces the interaction between Chk1 and the MCM complex, facilitating chromatin release of phosphorylated Chk1, a critical step in the initiation and amplification of cell cycle checkpoint. Together, these data provide novel insights into the activation of Chk1 in response to DNA damage.	[Han, Xiangzi; Fu, Kang; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Aslanian, Aaron] Salk Inst Biol Studies, Mol & Cellular Biol Labs, La Jolla, CA 92037 USA; [Tsuji, Toshiya] Celgene Corp, San Diego, CA 92121 USA	Case Western Reserve University; Salk Institute; Bristol-Myers Squibb; Celgene Corporation	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2123 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu			National Institutes of Health/NCI [CA126173]; American Cancer Society (ACS) [ACS IRG-91-022-15]; NCI [R01 CA163214]; ACS [PF-07-279-01-CCG]; NATIONAL CANCER INSTITUTE [K99CA126173, R00CA126173, R01CA163214] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society (ACS)(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/NCI R00 Career Development Award (CA126173), the American Cancer Society (ACS) Pilot Grant (ACS IRG-91-022-15), and NCI Grant R01 CA163214 (to Y. Z.) and ACS Grant PF-07-279-01-CCG (to A. A.).	Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Forsburg SL, 2008, BIOCHEM SOC T, V36, P114, DOI 10.1042/BST0360114; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Liu QH, 2000, GENE DEV, V14, P1448; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takai H, 2000, GENE DEV, V14, P1439; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	27	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24716	24723		10.1074/jbc.M114.575035	http://dx.doi.org/10.1074/jbc.M114.575035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25049228	hybrid, Green Published			2022-12-28	WOS:000341505600060
J	Naegeli, A; Michaud, G; Schubert, M; Lin, CW; Lizak, C; Darbre, T; Reymond, JL; Aebi, M				Naegeli, Andreas; Michaud, Gaelle; Schubert, Mario; Lin, Chia-Wei; Lizak, Christian; Darbre, Tamis; Reymond, Jean-Louis; Aebi, Markus			Substrate Specificity of Cytoplasmic N-Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Glycosylation; Glycosyltransferase; Post-translational Modification (PTM); Substrate Specificity; Actinobacillus Pleuropneumoniae	O-GLCNAC TRANSFERASE; INFLUENZAE HMW1 ADHESIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; PROTEIN GLYCOSYLATION; ACTIVE-SITE; BINDING; OLIGOSACCHARYLTRANSFERASE; MECHANISM; INSIGHTS; ENZYME	Background:N-Glycosyltransferases represent a novel class of N-glycosylation-catalyzing enzymes. Results: A quantitative activity assay allowed us to determine substrate specificities of N-glycosyltransferase. Conclusion:N-Glycosyltransferase exhibits a relaxed sugar substrate specificity and a peptide specificity strikingly similar to that of oligosaccharyltransferase. Significance: This study highlights the convergent evolution of two N-glycosylation systems and might lay the basis for a novel route for glycoengineering in bacteria. N-Linked protein glycosylation is a very common post-translational modification that can be found in all kingdoms of life. The classical, highly conserved pathway entails the assembly of a lipid-linked oligosaccharide and its transfer to an asparagine residue in the sequon NX(S/T) of a secreted protein by the integral membrane protein oligosaccharyltransferase. A few species in the class of -proteobacteria encode a cytoplasmic N-glycosylation system mediated by a soluble N-glycosyltransferase (NGT). This enzyme uses nucleotide-activated sugars to modify asparagine residues with single monosaccharides. As these enzymes are not related to oligosaccharyltransferase, NGTs constitute a novel class of N-glycosylation catalyzing enzymes. To characterize the NGT-catalyzed reaction, we developed a sensitive and quantitative in vitro assay based on HPLC separation and quantification of fluorescently labeled substrate peptides. With this assay we were able to directly quantify glycopeptide formation by Actinobacillus pleuropneumoniae NGT and determine its substrate specificities: NGT turns over a number of different sugar donor substrates and allows for activation by both UDP and GDP. Quantitative analysis of peptide substrate turnover demonstrated a strikingly similar specificity as the classical, oligosaccharyltransferase-catalyzed N-glycosylation, with NX(S/T) sequons being the optimal NGT substrates.	[Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Schubert, Mario; Lizak, Christian] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Schubert, Mario/B-3972-2008	Lin, Chia-wei/0000-0003-4777-2916; Schubert, Mario/0000-0003-0278-4091; Reymond, Jean-Louis/0000-0003-2724-2942; Naegeli, Andreas/0000-0002-5938-9124	Swiss National Science Foundation [CRSII3_12733, 31003A-127098, 200020_140349]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The work was supported in part by the Swiss National Science Foundation Grants CRSII3_12733 and 31003A-127098 (to M. A.) and 200020_140349 (to J. L. R.) and ETH Zurich.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bause E, 1995, BIOCHEM J, V312, P979, DOI 10.1042/bj3120979; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Dorfmueller HC, 2011, AMINO ACIDS, V40, P781, DOI 10.1007/s00726-010-0688-y; Gawthorne JA, 2014, BIOCHEM BIOPH RES CO, V445, P633, DOI 10.1016/j.bbrc.2014.02.044; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Goddard TD, 2008, SPARKY VERSION 3; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kirby AJ, 2001, J CHEM SOC PERK T 2, P522, DOI 10.1039/b008270h; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Landstrom J, 2012, GLYCOCONJUGATE J, V29, P491, DOI 10.1007/s10719-012-9411-4; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Naegeli A, 2014, J BIOL CHEM, V289, P2170, DOI 10.1074/jbc.M113.524462; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	46	41	42	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24521	24532		10.1074/jbc.M114.579326	http://dx.doi.org/10.1074/jbc.M114.579326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24962585	Green Published, hybrid			2022-12-28	WOS:000341505600044
J	Tafesse, FG; Guimaraes, CP; Maruyama, T; Carette, JE; Lory, S; Brummelkamp, TR; Ploegh, HL				Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Carette, Jan E.; Lory, Stephen; Brummelkamp, Thijn R.; Ploegh, Hidde L.			GPR107, a G-protein-coupled Receptor Essential for Intoxication by Pseudomonas aeruginosa Exotoxin A, Localizes to the Golgi and Is Cleaved by Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxin; Furin; G-protein-coupled Receptor (GPCR); Intracellular Trafficking; Sortase A; GPR107; KBM7; Pseudomonas aeruginosa Exotoxin A; Haploid Genetic Screen	ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; DNA-SEQUENCE; HUMAN-CELLS; MEMBRANE; TOXIN; GENE; ACTIVATION; REVEALS; COMPLEX	Background: Bacterial toxins, including P. aeruginosa exotoxin A (PE), are valuable tools to dissect biological processes. Results: A genome-wide genetic screen identifies several novel host factors used by PE, including GPR107. Conclusion: Bacterial toxins can help identify novel host components involved in key intracellular trafficking steps. Significance: GPR107 may be a receptor that associates with G-proteins at the Golgi to regulate membrane transport. A number of toxins, including exotoxin A (PE) of Pseudomonas aeruginosa, kill cells by inhibiting protein synthesis. PE kills by ADP-ribosylation of the translation elongation factor 2, but many of the host factors required for entry, membrane translocation, and intracellular transport remain to be elucidated. A genome-wide genetic screen in human KBM7 cells was performed to uncover host factors used by PE, several of which were confirmed by CRISPR/Cas9-gene editing in a different cell type. Several proteins not previously implicated in the PE intoxication pathway were identified, including GPR107, an orphan G-protein-coupled receptor. GPR107 localizes to the trans-Golgi network and is essential for retrograde transport. It is cleaved by the endoprotease furin, and a disulfide bond connects the two cleaved fragments. Compromising this association affects the function of GPR107. The N-terminal region of GPR107 is critical for its biological function. GPR107 might be one of the long-sought receptors that associates with G-proteins to regulate intracellular vesicular transport.	[Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tafesse, Fikadu G.; Guimaraes, Carla P.; Maruyama, Takeshi; Ploegh, Hidde L.] MIT, Cambridge, MA 02142 USA; [Carette, Jan E.] Stanford Sch Med, Stanford, CA 94305 USA; [Lory, Stephen] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1006 BE Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Harvard Medical School; Netherlands Cancer Institute	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Maruyama, Takeshi/T-7568-2019	Maruyama, Takeshi/0000-0003-0331-4702; Carette, Jan/0000-0002-5187-8070; Tafesse, Fikadu/0000-0002-8575-4164	National Institutes of Health [AI087879]; Netherlands Organization for Scientific Research; New England Regional Center of Excellence Harvard Medical School; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); New England Regional Center of Excellence Harvard Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI087879 (to H. L. P.). This work was also supported by the Netherlands Organization for Scientific Research (to F. G. T.) and New England Regional Center of Excellence Harvard Medical School (to C. P. G.).	Abi-Habib RJ, 2004, BLOOD, V104, P2143, DOI 10.1182/blood-2004-01-0339; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; Arac D, 2005, J MOL BIOL, V346, P589, DOI 10.1016/j.jmb.2004.12.004; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; DEALMEIDA JB, 1993, J CELL SCI, V106, P1239; Edgar AJ, 2007, DNA SEQUENCE, V18, P235, DOI 10.1080/10425170701207182; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gorbushin AM, 2009, EXP PARASITOL, V123, P24, DOI 10.1016/j.exppara.2009.05.004; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; Gu ML, 1996, INFECT IMMUN, V64, P524, DOI 10.1128/IAI.64.2.524-527.1996; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Guimaraes CP, 2011, J CELL BIOL, V195, P751, DOI 10.1083/jcb.201108103; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Humphray SJ, 2004, NATURE, V429, P369, DOI 10.1038/nature02465; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jackson ME, 1999, J CELL SCI, V112, P467; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Pastrana DV, 2005, BBA-MOL BASIS DIS, V1741, P234, DOI 10.1016/j.bbadis.2005.06.007; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Su XY, 2013, CRIT REV BIOCHEM MOL, V48, P515, DOI 10.3109/10409238.2013.831023; Tafesse FG, 2013, P NATL ACAD SCI USA, V110, P6406, DOI 10.1073/pnas.1219909110; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; Weldon JE, 2011, FEBS J, V278, P4683, DOI 10.1111/j.1742-4658.2011.08182.x; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Williams AL, 2004, MOL BIOL CELL, V15, P162, DOI 10.1091/mbc.E03-07-0535; Yosten GLC, 2012, AM J PHYSIOL-REG I, V303, pR941, DOI 10.1152/ajpregu.00336.2012	62	35	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24005	24018		10.1074/jbc.M114.589275	http://dx.doi.org/10.1074/jbc.M114.589275			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031321	hybrid, Green Published			2022-12-28	WOS:000341505600001
J	Berti, F; Campisi, E; Toniolo, C; Morelli, L; Crotti, S; Rosini, R; Romano, MR; Pinto, V; Brogioni, B; Torricelli, G; Janulczyk, R; Grandi, G; Margarit, I				Berti, Francesco; Campisi, Edmondo; Toniolo, Chiara; Morelli, Laura; Crotti, Stefano; Rosini, Roberto; Romano, Maria Rosaria; Pinto, Vittoria; Brogioni, Barbara; Torricelli, Giulia; Janulczyk, Robert; Grandi, Guido; Margarit, Immaculada			Structure of the Type IX Group B Streptococcus Capsular Polysaccharide and Its Evolutionary Relationship with Types V and VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Genetics; Nuclear Magnetic Resonance; Polysaccharide; Streptococcus; Vaccine; Group B Streptococcus; Capsular Polysaccharide	IMMUNOCHEMICAL CHARACTERIZATION; CONFORMATIONAL EPITOPE; MOLECULAR-DYNAMICS; CONJUGATE VACCINE; SIALIC-ACID; AGALACTIAE; EPIDEMIOLOGY; DISEASE; IA; VIRULENCE	Background: The capsule of Group B Streptococcus is an important virulence factor and vaccine target. Results: Analysis of type IX polysaccharide revealed a structure similar to type V and VII structures. Conclusion: The structural and phylogenetic basis for the differentiation between types V, VII, and IX was elucidated. Significance: Determination of the type IX structure is instrumental for the development of a carbohydrate-based vaccine. The Group B Streptococcus capsular polysaccharide type IX was isolated and purified, and the structure of its repeating unit was determined. Type IX capsule 4)[NeupNAc--(23)-Galp--(14)-GlcpNAc--(16)]--GlcpNAc-(14)--Galp-(14)--Glcp-(1 appears most similar to types VII and V, although it contains two GlcpNAc residues. Genetic analysis identified differences in cpsM, cpsO, and cpsI gene sequences as responsible for the differentiation between the three capsular polysaccharide types, leading us to hypothesize that type V emerged from a recombination event in a type IX background.	[Berti, Francesco; Campisi, Edmondo; Toniolo, Chiara; Morelli, Laura; Crotti, Stefano; Rosini, Roberto; Romano, Maria Rosaria; Pinto, Vittoria; Brogioni, Barbara; Torricelli, Giulia; Janulczyk, Robert; Grandi, Guido; Margarit, Immaculada] Novartis Vaccines Res, I-53100 Siena, Italy		Berti, F (corresponding author), Novartis Vaccines Res, Via Fiorentina 1, I-53100 Siena, Italy.	francesco.berti@novartis.com	Morelli, Laura/J-1832-2018; Toniolo, Chiara/ABH-6697-2020	Morelli, Laura/0000-0001-5159-9015; Toniolo, Chiara/0000-0002-2167-2936; Campisi, Edmondo/0000-0002-2250-3798; Grandi, Guido/0000-0001-9724-2185				BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; Brisson JR, 1997, BIOCHEMISTRY-US, V36, P3278, DOI 10.1021/bi961819l; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DIFABIO JL, 1989, CAN J CHEM, V67, P877; Edwards MS, 2008, HUM VACCINES, V4, P444, DOI 10.4161/hv.4.6.6507; Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572; Gonzalez-Outeirino J, 2005, CARBOHYD RES, V340, P1007, DOI 10.1016/j.carres.2004.12.034; Guttormsen HK, 2008, P NATL ACAD SCI USA, V105, P5903, DOI 10.1073/pnas.0710799105; Honsa E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-140; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; JENNINGS HJ, 1983, J BIOL CHEM, V258, P1793; JENNINGS HJ, 1983, BIOCHEMISTRY-US, V22, P1258, DOI 10.1021/bi00274a042; JENNINGS HJ, 1981, BIOCHEMISTRY-US, V20, P4511, DOI 10.1021/bi00519a001; JENNINGS HJ, 1984, PURE APPL CHEM, V56, P893, DOI 10.1351/pac198456070893; KOGAN G, 1995, CARBOHYD RES, V277, P1, DOI 10.1016/0008-6215(95)00195-Y; Kogan G, 1996, J BIOL CHEM, V271, P8786, DOI 10.1074/jbc.271.15.8786; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Le Doare K, 2013, VACCINE, V31, pD7, DOI 10.1016/j.vaccine.2013.01.009; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Pinto V, 2014, J PHARMACEUT BIOMED, V98, P9, DOI 10.1016/j.jpba.2014.05.004; RUBENS CE, 1987, P NATL ACAD SCI USA, V84, P7208, DOI 10.1073/pnas.84.20.7208; Safari D, 2011, GLYCOCONJUGATE J, V28, P557, DOI 10.1007/s10719-011-9354-1; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; VONHUNOLSTEIN C, 1993, INFECT IMMUN, V61, P1272, DOI 10.1128/IAI.61.4.1272-1280.1993; WESSELS MR, 1989, P NATL ACAD SCI USA, V86, P8983, DOI 10.1073/pnas.86.22.8983; WESSELS MR, 1991, J BIOL CHEM, V266, P6714; WESSELS MR, 1990, J CLIN INVEST, V86, P1428, DOI 10.1172/JCI114858; Yao KH, 2013, J CLIN MICROBIOL, V51, P503, DOI 10.1128/JCM.02417-12; Zou W, 1999, J IMMUNOL, V163, P820; Zou W, 2001, ADV EXP MED BIOL, V491, P473	36	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23437	23448		10.1074/jbc.M114.567974	http://dx.doi.org/10.1074/jbc.M114.567974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24990951	Green Published, hybrid			2022-12-28	WOS:000341505000018
J	Shibata, E; Dar, A; Dutta, A				Shibata, Etsuko; Dar, Ashraf; Dutta, Anindya			CRL4(Cdt2) E3 Ubiquitin Ligase and Proliferating Cell Nuclear Antigen (PCNA) Cooperate to Degrade Thymine DNA Glycosylase in S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION; PIP BOX; DESTRUCTION; UBIQUITYLATION; DEAMINATION; EXPRESSION; INHIBITOR; FAMILY; CDT2; GENE	Thymine DNA glycosylase (TDG) is an essential enzyme playing multiple roles in base excision repair, transcription regulation, and DNA demethylation. TDG mediates the cytotoxicity of the anti-cancer chemotherapeutic drug 5-fluorouracil (5-FU) by prolonging S phase, generating DNA strand breaks, and inducing DNA damage signaling. During S phase of the cell cycle, TDG is degraded via the proteasomal pathway. Here we show that CRL4(Cdt2) E3 ubiquitin ligase promotes ubiquitination and proteasomal degradation of TDG in S phase in a reaction that is dependent on the interaction of TDG with proliferating cell nuclear antigen (PCNA). siRNA-mediated depletion of PCNA or components of CRL4(Cdt2), specifically cullin4A/B or substrate adaptor Cdt2, stabilizes TDG in human cells. Mutations in the PCNA-interacting peptide (PIP) motif of TDG that disrupt the interaction of TDG with PCNA or change critical basic residues essential for the action of the PIP degron prevent the ubiquitination and degradation of TDG. Thus physical interaction of TDG with PCNA through the PIP degron is required for targeting TDG to the CRL4(Cdt2) E3 ubiquitin ligase complex. Compared with forced expression of wild type TDG, CRL4(Cdt2)-resistant TDG (Delta PIP) slows cell proliferation and slightly increases the toxicity of 5-FU. Thus, CRL4(Cdt2)-dependent degradation of TDG occurs in S phase because of the requirement for TDG to interact with chromatin-loaded PCNA, and this degradation is important for preventing toxicity from excess TDG.	[Shibata, Etsuko; Dar, Ashraf; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [R01 CA60499, CA166054]; NATIONAL CANCER INSTITUTE [R01CA060499, P30CA044579, R01CA166054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA60499 and CA166054 (to A. D.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dar A, 2013, MOL CELL BIOL, V33, P3309, DOI 10.1128/MCB.00358-13; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terai K, 2013, J BIOL CHEM, V288, P30509, DOI 10.1074/jbc.C113.505586; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728	33	39	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23056	23064		10.1074/jbc.M114.574210	http://dx.doi.org/10.1074/jbc.M114.574210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962565	Green Published, hybrid			2022-12-28	WOS:000341017200043
J	Yamashita, M; Shepherd, M; Booth, WI; Xie, H; Postis, V; Nyathi, Y; Tzokov, SB; Poole, RK; Baldwin, SA; Bullough, PA				Yamashita, Masao; Shepherd, Mark; Booth, Wesley I.; Xie, Hao; Postis, Vincent; Nyathi, Yvonne; Tzokov, Svetomir B.; Poole, Robert K.; Baldwin, Stephen A.; Bullough, Per A.			Structure and Function of the Bacterial Heterodimeric ABC Transporter CydDC STIMULATION OF ATPASE ACTIVITY BY THIOL AND HEME COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL OXIDASE COMPLEX; ESCHERICHIA-COLI; P-GLYCOPROTEIN; MEMBRANE-PROTEINS; BINDING; LOCUS; CRYSTALLIZATION; IDENTIFICATION; BIOSYNTHESIS; GLUTATHIONE	In Escherichia coli, the biogenesis of both cytochrome bd-type quinol oxidases and periplasmic cytochromes requires the ATP-binding cassette-type cysteine/GSH transporter, CydDC. Recombinant CydDC was purified as a heterodimer and found to be an active ATPase both in soluble form with detergent and when reconstituted into a lipid environment. Two-dimensional crystals of CydDC were analyzed by electron cryomicroscopy, and the protein was shown to be made up of two non-identical domains corresponding to the putative CydD and CydC subunits, with dimensions characteristic of other ATP-binding cassette transporters. CydDC binds heme b. Detergent-solubilized CydDC appears to adopt at least two structural states, each associated with a characteristic level of bound heme. The purified protein in detergent showed a weak basal ATPase activity (approximately 100 nmol Pi/min/mg) that was stimulated similar to 3-fold by various thiol compounds, suggesting that CydDC could act as a thiol transporter. The presence of heme (either intrinsic or added in the form of hemin) led to a further enhancement of thiol-stimulated ATPase activity, although a large excess of heme inhibited activity. Similar responses of the ATPase activity were observed with CydDC reconstituted into E. coli lipids. These results suggest that heme may have a regulatory role in CydDC-mediated transmembrane thiol transport.	[Tzokov, Svetomir B.; Poole, Robert K.; Bullough, Per A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England; [Xie, Hao; Postis, Vincent; Nyathi, Yvonne; Baldwin, Stephen A.; Bullough, Per A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	University of Sheffield; University of Leeds	Bullough, PA (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst Biomol Res, Sheffield S10 2TN, S Yorkshire, England.	p.bullough@sheffield.ac.uk	Postis, Vincent/D-7736-2013	Postis, Vincent/0000-0001-9251-4567; Bullough, Per/0000-0001-8147-1127; Tzokov, Svetomir/0000-0001-7256-5279; Shepherd, Mark/0000-0002-7472-2300	Biotechnology and Biological Sciences Research Council [BBS/B/14418]; BBSRC [BB/H016805/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H016805/1, BB/C514174/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council grant BBS/B/14418 (Membrane Protein Structure Initiative).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ANRAKU Y, 1988, ANNU REV BIOCHEM, V57, P101, DOI 10.1146/annurev.bi.57.070188.000533; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHEPURI V, 1990, J BIOL CHEM, V265, P12978; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cook GM, 2002, ARCH MICROBIOL, V178, P358, DOI 10.1007/s00203-002-0467-6; Cook GM, 2000, MICROBIOL-SGM, V146, P527, DOI 10.1099/00221287-146-2-527; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Frawley ER, 2009, P NATL ACAD SCI USA, V106, P10201, DOI 10.1073/pnas.0903132106; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Goldman BS, 1996, J BACTERIOL, V178, P6338, DOI 10.1128/jb.178.21.6338-6347.1996; GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J; GREEN GN, 1988, J BIOL CHEM, V263, P13138; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kadner R. J., 1996, ESCHERICHIA COLI SAL, P58; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; POOLE RK, 1989, J GEN MICROBIOL, V135, P1865; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; WOOD PM, 1984, BIOCHIM BIOPHYS ACTA, V768, P293, DOI 10.1016/0304-4173(84)90020-X	39	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23177	23188		10.1074/jbc.M114.590414	http://dx.doi.org/10.1074/jbc.M114.590414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958725	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000341017200054
J	Friis, S; Sales, KU; Schafer, JM; Vogel, LK; Kataoka, H; Bugge, TH				Friis, Stine; Sales, Katiuchia Uzzun; Schafer, Jeffrey Martin; Vogel, Lotte K.; Kataoka, Hiroaki; Bugge, Thomas H.			The Protease Inhibitor HAI-2, but Not HAI-1, Regulates Matriptase Activation and Shedding through Prostasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND SERINE-PROTEASE; NEURAL-TUBE CLOSURE; MOLECULAR-CLONING; EPITHELIAL-CELLS; EPIDERMAL DIFFERENTIATION; CELLULAR-LOCALIZATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; BARRIER FUNCTION	The membrane-anchored serine proteases, matriptase and prostasin, and the membrane-anchored serine protease inhibitors, hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2, are critical effectors of epithelial development and postnatal epithelial homeostasis. Matriptase and prostasin form a reciprocal zymogen activation complex that results in the formation of active matriptase and prostasin that are targets for inhibition by HAI-1 and HAI-2. Conflicting data, however, have accumulated as to the existence of auxiliary functions for both HAI-1 and HAI-2 in regulating the intracellular trafficking and activation of matriptase. In this study, we, therefore, used genetically engineered mice to determine the effect of ablation of endogenous HAI-1 and endogenous HAI-2 on endogenous matriptase expression, subcellular localization, and activation in polarized intestinal epithelial cells. Whereas ablation of HAI-1 did not affect matriptase in epithelial cells of the small or large intestine, ablation of HAI-2 resulted in the loss of matriptase from both tissues. Gene silencing studies in intestinal Caco-2 cell monolayers revealed that this loss of cell-associated matriptase was mechanistically linked to accelerated activation and shedding of the protease caused by loss of prostasin regulation by HAI-2. Taken together, these data indicate that HAI-1 regulates the activity of activated matriptase, whereas HAI-2 has an essential role in regulating prostasin-dependent matriptase zymogen activation.	[Friis, Stine; Sales, Katiuchia Uzzun; Schafer, Jeffrey Martin; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] NIDCR, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Friis, Stine; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Schafer, Jeffrey Martin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Kataoka, Hiroaki] Miyazaki Univ, Sect Oncopathol & Regenerat Biol, Dept Pathol, Fac Med, Miyazaki 8891692, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University System of Ohio; Ohio State University; University of Miyazaki	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Room 320, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Vogel, Lotte K./0000-0001-9920-0982; sales, katiuchia/0000-0002-3768-5790	Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; NIDCR; National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R93-2011-8735] Funding Source: researchfish	Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the NIDCR, National Institutes of Health, Intramural Research Program (to T. H. B.), by The Harboe Foundation, The Lundbeck Foundation, and The Foundation of 17.12.1981 (to S. F.), and by The Lundbeck Foundation (to L. V.).	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; COLMAN RW, 1979, ANNU REV MED, V30, P359, DOI 10.1146/annurev.me.30.020179.002043; Davis AE, 2005, CLIN IMMUNOL, V114, P3, DOI 10.1016/j.clim.2004.05.007; Faller N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094267; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Miyake Y, 2010, BIOSCI BIOTECH BIOCH, V74, P848, DOI 10.1271/bbb.90696; Miyake Y, 2009, CYTOTECHNOLOGY, V60, P95, DOI 10.1007/s10616-009-9219-7; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	56	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22319	22332		10.1074/jbc.M114.574400	http://dx.doi.org/10.1074/jbc.M114.574400			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962579	Green Published, hybrid			2022-12-28	WOS:000340593500043
J	Longet, S; Vonarburg, C; Lotscher, M; Miescher, S; Zuercher, A; Corthesy, B				Longet, Stephanie; Vonarburg, Cedric; Loetscher, Marius; Miescher, Sylvia; Zuercher, Adrian; Corthesy, Blaise			Reconstituted Human Polyclonal Plasma-derived Secretory-like IgM and IgA Maintain the Barrier Function of Epithelial Cells Infected with an Enteropathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-M ANTIBODIES; SHIGELLA-FLEXNERI; POLYMERIC IGA; IPA PROTEINS; PROTECTION; COMPONENT; DEFICIENT; CLEARANCE; BACTERIA; THERAPY	Intravenous administration of polyclonal and monoclonal antibodies has proven to be a clinically valid approach in the treatment, or at least relief, of many acute and chronic pathologies, such as infection, immunodeficiency, and a broad range of autoimmune conditions. Plasma-derived IgG or recombinant IgG are most frequently used for intravenous or subcutaneous administration, whereas a few IgM-based products are available as well. We have established recently that secretory-like IgA and IgM can be produced upon association of plasma-derived polymeric IgA and IgM with a recombinant secretory component. As a next step toward potential future mucosal administration, we sought to unravel the mechanisms by which these secretory Igs protect epithelial cells located at the interface between the environment and the inside of the body. By using polarized epithelial Caco-2 cell monolayers and Shigella flexneri as a model enteropathogen, we found that polyspecific plasma-derived SIgA and SIgM fulfill many protective functions, including dose-dependent recognition of the antigen via formation of aggregated immune complexes, reduction of bacterial infectivity, maintenance of epithelial cell integrity, and inhibition of proinflammatory cytokine/chemokine production by epithelial cells. In this in vitro model devoid of other cellular or molecular interfering partners, IgM and secretory IgM showed stronger bacterial neutralization than secretory IgA. Together, these data suggest that mucosally delivered antibody preparations may be most effective when combining both secretory-like IgA and IgM, which, together, play a crucial role in preserving several levels of epithelial cell integrity.	[Longet, Stephanie; Corthesy, Blaise] CHU Vaudois, Div Immunol & Allergy, R&D Lab, CH-1011 Lausanne, Switzerland; [Vonarburg, Cedric; Loetscher, Marius; Miescher, Sylvia; Zuercher, Adrian; Corthesy, Blaise] CSL Behring AG, CH-3000 Bern 22, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CSL	Corthesy, B (corresponding author), CHU Vaudois, Div Immunol & Allergy, R&D Lab, Rue Bugnon, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch		Longet, Stephanie/0000-0001-5026-431X	Swiss Science Research Foundation [3100-138422]; CSL Behring Ph.D. scholarship	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); CSL Behring Ph.D. scholarship	This work was supported by Swiss Science Research Foundation Grant 3100-138422.; Recipient of a CSL Behring Ph.D. scholarship.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Baral TN, 2007, J INFECT DIS, V195, P1513, DOI 10.1086/515577; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; BEHRE G, 1992, ANTIMICROB AGENTS CH, V36, P2139, DOI 10.1128/AAC.36.10.2139; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Boes M, 1998, J IMMUNOL, V160, P4776; BRANDTZAEG P, 1987, CLIN EXP IMMUNOL, V67, P626; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00222; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Couper KN, 2005, INFECT IMMUN, V73, P8060, DOI 10.1128/IAI.73.12.8060-8068.2005; Cramer M, 2009, VOX SANG, V96, P219, DOI 10.1111/j.1423-0410.2008.01143.x; Croft NM, 2005, SCAND J GASTROENTERO, V40, P965, DOI 10.1080/00365520510015908; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Fiorentino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085211; Forbes SJ, 2011, MBIO, V2, DOI 10.1128/mBio.00042-11; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Klimovich VB, 2011, BIOCHEMISTRY-MOSCOW+, V76, P534, DOI 10.1134/S0006297911050038; KONISHI E, 1992, PARASITOLOGY, V104, P427, DOI 10.1017/S003118200006368X; Lachmann RA, 2004, EXP LUNG RES, V30, P251, DOI 10.1080/01902140490439013; LAMPERT IA, 1993, J PATHOL, V170, P115, DOI 10.1002/path.1711700204; Longet S, 2013, J BIOL CHEM, V288, P4085, DOI 10.1074/jbc.M112.410811; Mathias A, 2013, INFECT IMMUN, V81, P3027, DOI 10.1128/IAI.00303-13; Mestecky J, 2009, IMMUNOL LETT, V124, P57, DOI 10.1016/j.imlet.2009.03.013; Mueller M, 2013, PHARM RES-DORDR, V30, P735, DOI 10.1007/s11095-012-0914-2; Norrby-Teglund A, 2006, J INTERN MED, V260, P509, DOI 10.1111/j.1365-2796.2006.01726.x; Norrby-Teglund A, 2000, CLIN INFECT DIS, V31, P1175, DOI 10.1086/317423; Orange JS, 2006, J ALLERGY CLIN IMMUN, V117, pS525, DOI 10.1016/j.jaci.2006.01.015; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Rol N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405001; Salinas-Carmona MC, 2004, INFECT IMMUN, V72, P5597, DOI 10.1128/IAI.72.10.5597-5604.2004; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Seiler P, 1998, J VIROL, V72, P2253, DOI 10.1128/JVI.72.3.2253-2258.1998; Singh K, 2014, AUTOIMMUN REV, V13, P163, DOI 10.1016/j.autrev.2013.10.005; Stehr SN, 2008, SHOCK, V29, P167, DOI 10.1097/shk.0b013e318067df15; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; Subramaniam KS, 2010, J IMMUNOL, V184, P5755, DOI 10.4049/jimmunol.0901638; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Yang JY, 2014, J INFECT DIS, V209, P203, DOI 10.1093/infdis/jit399; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	52	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21617	21626		10.1074/jbc.M114.549139	http://dx.doi.org/10.1074/jbc.M114.549139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951593	hybrid, Green Published			2022-12-28	WOS:000340558300036
J	Paton, L; Bitoun, E; Kenyon, J; Priestman, DA; Oliver, PL; Edwards, B; Platt, FM; Davies, KE				Paton, Leigh; Bitoun, Emmanuelle; Kenyon, Janet; Priestman, David A.; Oliver, Peter L.; Edwards, Benjamin; Platt, Frances M.; Davies, Kay E.			A Novel Mouse Model of a Patient Mucolipidosis II Mutation Recapitulates Disease Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; CELL DISEASE; ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; GAIT ANALYSIS; ANIMAL-MODEL; ALPHA/BETA; MICE; RECOGNITION; DEGENERATION; RETARDATION	Mucolipidosis II (MLII) is a lysosomal storage disorder caused by loss of N-acetylglucosamine-1-phosphotransferase, which tags lysosomal enzymes with a mannose 6-phosphate marker for transport to the lysosome. In MLII, the loss of this marker leads to deficiency of multiple enzymes and non-enzymatic proteins in the lysosome, leading to the storage of multiple substrates. Here we present a novel mouse model of MLII homozygous for a patient mutation in the GNPTAB gene. Whereas the current gene knock-out mouse model of MLII lacks some of the characteristic features of the human disease, our novel mouse model more fully recapitulates the human pathology, showing growth retardation, skeletal and facial abnormalities, increased circulating lysosomal enzymatic activities, intracellular lysosomal storage, and reduced life span. Importantly, MLII behavioral deficits are characterized for the first time, including impaired motor function and psychomotor retardation. Histological analysis of the brain revealed progressive neurodegeneration in the cerebellum with severe Purkinje cell loss as the underlying cause of the ataxic gait. In addition, based on the loss of Npc2 (Niemann-Pick type C 2) protein expression in the brain, the mice were treated with 2-hydroxypropyl-beta-cyclodextrin, a drug previously reported to rescue Purkinje cell death in a mouse model of Niemann-Pick type C disease. No improvement in brain pathology was observed. This indicates that cerebellar degeneration is not primarily triggered by loss of Npc2 function. This study emphasizes the value of modeling MLII patient mutations to generate clinically relevant mouse mutants to elucidate the pathogenic molecular pathways of MLII and address their amenability to therapy.	[Paton, Leigh; Bitoun, Emmanuelle; Kenyon, Janet; Oliver, Peter L.; Edwards, Benjamin; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, Med Res Council, Funct Genom Unit, Oxford OX1 3PT, England; [Priestman, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; University of Oxford	Davies, KE (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Med Res Council, Funct Genom Unit, S Parks Rd, Oxford OX1 3PT, England.	kay.davies@dpag.ox.ac.uk	Oliver, Peter/AAS-4022-2020	Platt, Frances/0000-0001-7614-0403; Edwards, Benjamin/0000-0002-0509-2499; Oliver, Peter/0000-0003-3347-2461	Medical Research Council; Mizutani Foundation, Japan; Royal Society Wolfson Research Merit Award; Medical Research Council [MC_U137761449, MC_UU_12021/2] Funding Source: researchfish; MRC [MC_UU_12021/2, MC_U137761449] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Mizutani Foundation, Japan; Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.; Supported by the Mizutani Foundation, Japan.; Recipient of a Royal Society Wolfson Research Merit Award.	Barkus C, 2012, GENES BRAIN BEHAV, V11, P342, DOI 10.1111/j.1601-183X.2012.00767.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boonen M, 2011, MOL BIOL CELL, V22, P1135, DOI 10.1091/mbc.E10-07-0584; Bosshard NU, 1996, VET PATHOL, V33, P1, DOI 10.1177/030098589603300101; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cathey SS, 2010, J MED GENET, V47, P38, DOI 10.1136/jmg.2009.067736; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Fernagut PO, 2004, EXP NEUROL, V185, P47, DOI 10.1016/j.expneurol.2003.09.014; Flanagan-Steet H, 2009, AM J PATHOL, V175, P2063, DOI 10.2353/ajpath.2009.090210; Gelfman CM, 2007, INVEST OPHTH VIS SCI, V48, P5221, DOI 10.1167/iovs.07-0452; GOLDMANRAKIC PS, 1987, ARCH GERONTOL GERIAT, V6, P299, DOI 10.1016/0167-4943(87)90029-X; Gondre-Lewis MC, 2003, CURR BIOL, V13, P1324, DOI 10.1016/S0960-9822(03)00531-1; GOODMAN LA, 1991, P NATL ACAD SCI USA, V88, P11330, DOI 10.1073/pnas.88.24.11330; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HICKMAN S, 1972, BIOCHEM BIOPH RES CO, V49, P992, DOI 10.1016/0006-291X(72)90310-5; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; KAPLAN A, 1977, J CLIN INVEST, V60, P1088, DOI 10.1172/JCI108860; Kollmann K, 2012, BRAIN, V135, P2661, DOI 10.1093/brain/aws209; Kollmann K, 2013, EMBO MOL MED, V5, P1871, DOI 10.1002/emmm.201302979; Kornfeld S., 2001, METAB MOL BASES INHE, DOI [10.1036/ommbid.167, DOI 10.1036/OMMBID.167]; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Lalonde R, 2001, BEHAV BRAIN RES, V125, P103, DOI 10.1016/S0166-4328(01)00276-5; LEROY JG, 1967, SCIENCE, V157, P804, DOI 10.1126/science.157.3790.804; LEROY JG, 1970, NEW ENGL J MED, V283, P598; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; MARTIN JJ, 1975, ACTA NEUROPATHOL, V33, P285, DOI 10.1007/BF00686161; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mazrier H, 2003, J HERED, V94, P363, DOI 10.1093/jhered/esg080; Nufer O, 2002, J CELL SCI, V115, P619; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Otomo Takanobu, 2011, Clin Pediatr Endocrinol, V20, P7, DOI 10.1297/cpe.20.7; Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118; OWADA M, 1982, BIOCHEM BIOPH RES CO, V105, P814, DOI 10.1016/0006-291X(82)91042-7; Petrey AC, 2012, DIS MODEL MECH, V5, P177, DOI 10.1242/dmm.008219; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Sanderson DJ, 2012, HIPPOCAMPUS, V22, P981, DOI 10.1002/hipo.20896; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; SPRANGER JW, 1970, HUMANGENETIK, V9, P113, DOI 10.1007/BF00278928; TANAKA J, 1988, J NEUROPATH EXP NEUR, V47, P291, DOI 10.1097/00005072-198805000-00008; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; TURPIN JC, 1991, DEV NEUROSCI-BASEL, V13, P304, DOI 10.1159/000112177; Ventura P, 2006, J CHILD NEUROL, V21, P776, DOI 10.1177/08830738060210091301; Vogel P, 2009, VET PATHOL, V46, P313, DOI 10.1354/vp.46-2-313; WAHEED A, 1982, BIOCHEM BIOPH RES CO, V105, P1052, DOI 10.1016/0006-291X(82)91076-2; WIESMANN U, 1971, NEW ENGL J MED, V285, P1090	58	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26709	26721		10.1074/jbc.M114.586156	http://dx.doi.org/10.1074/jbc.M114.586156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107912	Green Published, hybrid			2022-12-28	WOS:000342853900004
J	Zanucco, E; El-Nikhely, N; Gotz, R; Weidmann, K; Pfeiffer, V; Savai, R; Seeger, W; Ullrich, A; Rapp, UR				Zanucco, Emanuele; El-Nikhely, Nefertiti; Goetz, Rudolf; Weidmann, Katharina; Pfeiffer, Verena; Savai, Rajkumar; Seeger, Werner; Ullrich, Axel; Rapp, Ulf R.			Elimination of B-RAF in Oncogenic C-RAF-expressing Alveolar Epithelial Type II Cells Reduces MAPK Signal Intensity and Lung Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE; CANCER; BRAF; HETERODIMERIZATION; PROGRESSION; PATHWAY; KINASE; ACTIVATE; MELANOMA; TARGETS	Tumors are often greatly dependent on signaling cascades promoting cell growth or survival and may become hypersensitive to inactivation of key components within these signaling pathways. Ras and RAF mutations found in human cancer confer constitutive activity to these signaling molecules thereby converting them into an oncogenic state. RAF dimerization is required for normal Ras-dependent RAF activation and is required for the oncogenic potential of mutant RAFs. Here we describe a new mouse model for lung tumor development to investigate the role of B-RAF in oncogenic C-RAF-mediated adenoma initiation and growth. Conditional elimination of B-RAF in C-RAF BxB-expressing embryonic alveolar epithelial type II cells did not block adenoma formation. However, loss of B-RAF led to significantly reduced tumor growth. The diminished tumor growth upon B-RAF inactivation was due to reduced cell proliferation in absence of senescence and increased apoptosis. Furthermore, B-RAF elimination inhibited C-RAF BxB-mediated activation of the mitogenic cascade. In line with these data, mutation of Ser-621 in C-RAF BxB abrogated in vitro the dimerization with B-RAF and blocked the ability to activate the MAPK cascade. Taken together these data indicate that B-RAF is an important factor in oncogenic C-RAF-mediated tumorigenesis.	[Zanucco, Emanuele; Ullrich, Axel; Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-85152 Martinsried, Germany; [El-Nikhely, Nefertiti; Savai, Rajkumar; Seeger, Werner] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Goetz, Rudolf; Weidmann, Katharina; Pfeiffer, Verena] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97078 Wurzburg, Germany	Max Planck Society; Max Planck Society; University of Wurzburg	Zanucco, E (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-85152 Martinsried, Germany.	zanucco@biochem.mpg.de; Ulf.Rapp@mpi-bn.mpg.de		Seeger, Werner/0000-0003-1946-0894; El-Nikhely, Nefertiti/0000-0002-6675-234X	institutional grant from the Max Planck Society; UGMLC; Loewe Program; DZL (The German Center for Lung Research); German Excellence Initiative	institutional grant from the Max Planck Society; UGMLC; Loewe Program; DZL (The German Center for Lung Research); German Excellence Initiative	This work was supported by an institutional grant from the Max Planck Society (to U. R. R.) and by the UGMLC and Loewe Program as well as DZL (The German Center for Lung Research).; Supported by a grant from the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Ahlbrecht K, 2008, AM J RESP CELL MOL, V39, P163, DOI 10.1165/rcmb.2007-0231OC; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis MJ, 2012, J CELL BIOL, V199, P15, DOI 10.1083/jcb.201205167; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kramer BW, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-24; McMahon M, 2010, NAT MED, V16, P749, DOI 10.1038/nm0710-749; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Weber CK, 2001, CANCER RES, V61, P3595; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	24	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26804	26816		10.1074/jbc.M114.558999	http://dx.doi.org/10.1074/jbc.M114.558999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096573	Green Published, hybrid			2022-12-28	WOS:000342853900013
J	Zhao, JH; Gao, FD; Zhang, JS; Ogawa, T; Ma, WM				Zhao, Jiaohong; Gao, Fudan; Zhang, Jingsong; Ogawa, Teruo; Ma, Weimin			NdhO, a Subunit of NADPH Dehydrogenase, Destabilizes Medium Size Complex of the Enzyme in Synechocystis sp Strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON-TRANSPORT; CHLOROPLASTIC NAD(P)H DEHYDROGENASE; PYRIDINE-NUCLEOTIDE DEHYDROGENASE; RESPIRATORY COMPLEX; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; PHOTOSYSTEM-I; THERMOSYNECHOCOCCUS-ELONGATUS; TRIOSEPHOSPHATE ISOMERASE; EFFICIENT OPERATION; INTERSYSTEM CHAIN	Two mutants that grew faster than the wild-type (WT) strain under high light conditions were isolated from Synechocystis sp. strain PCC 6803 transformed with a transposon-bearing library. Both mutants had a tag in ssl1690 encoding NdhO. Deletion of ndhO increased the activity of NADPH dehydrogenase (NDH-1)-dependent cyclic electron transport around photosystem I (NDH-CET), while overexpression decreased the activity. Although deletion and overexpression of ndhO did not have significant effects on the amount of other subunits such as NdhH, NdhI, NdhK, and NdhM in the cells, the amount of these subunits in the medium sizeNDH-1(NDH-1M) complex was higher in the ndhO-deletion mutant and much lower in the overexpression strain than in the WT. NdhO strongly interacts with NdhI and NdhK but not with other subunits. NdhI interacts with NdhK and the interaction was blocked by NdhO. The blocking may destabilize the NDH-1M complex and repress the NDH-CET activity. When cells were transferred from growth light to high light, the amounts of NdhI and NdhK increased without significant change in the amount of NdhO, thus decreasing the relative amount of NdhO. This might have decreased the blocking, thereby stabilizing the NDH-1M complex and increasing the NDH-CET activity under high light conditions.	[Zhao, Jiaohong; Gao, Fudan; Zhang, Jingsong; Ma, Weimin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China; [Ogawa, Teruo] Nagoya Univ, Biosci Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Shanghai Normal University; Nagoya University	Ma, WM (corresponding author), Shanghai Normal Univ, Coll Life & Environm Sci, 100 Guilin Rd, Shanghai 200234, Peoples R China.	wma@shnu.edu.cn	Ma, Weimin/A-8158-2015	Ma, Weimin/0000-0003-4964-415X; Zhang, Jingsong/0000-0002-8044-7608	National Natural Science Foundation of China Grant [31370270]; National Basic Research Program of China Grant [2009CB118500]; Shanghai Education Committee [12ZZ132]	National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China Grant(National Basic Research Program of China); Shanghai Education Committee	This work was supported in part by National Natural Science Foundation of China Grant 31370270, National Basic Research Program of China Grant 2009CB118500, and Project of Shanghai Education Committee Grant 12ZZ132.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armbruster U, 2013, PLANT CELL, V25, P3926, DOI 10.1105/tpc.113.114785; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; Brandt U, 2003, FEBS LETT, V545, P9, DOI 10.1016/S0014-5793(03)00387-9; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Dai HL, 2013, PLANT J, V75, P858, DOI 10.1111/tpj.12251; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma W., 2009, FRONT BIOL CHINA, V4, P137, DOI [10.1007/s11515-009-0005-x, DOI 10.1007/S11515-009-0005-X]; Ma WM, 2008, ACTA PHYSIOL PLANT, V30, P897, DOI 10.1007/s11738-008-0182-2; Ma WM, 2008, J APPL PHYCOL, V20, P437, DOI 10.1007/s10811-007-9286-0; Ma WM, 2007, J APPL PHYCOL, V19, P207, DOI 10.1007/s10811-006-9125-8; Ma WM, 2005, PHYSIOL PLANTARUM, V125, P135, DOI 10.1111/j.1399-3054.2005.00555.x; Ma WM, 2005, J APPL PHYCOL, V17, P273, DOI 10.1007/s10811-005-4850-y; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Mi HL, 2001, PHOTOSYNTH RES, V70, P167, DOI 10.1023/A:1017946524199; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Peng LW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001040; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sang Y, 2005, PLANT CELL, V17, P1569, DOI 10.1105/tpc.104.029645; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Wang P, 2006, PLANT PHYSIOL, V141, P465, DOI 10.1104/pp.105.070490; Wei LZ, 2006, J APPL PHYCOL, V18, P153, DOI 10.1007/s10811-006-9086-y; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang JS, 2014, J BIOL CHEM, V289, P18770, DOI 10.1074/jbc.M114.553404; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390	57	21	23	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26669	26676		10.1074/jbc.M114.553925	http://dx.doi.org/10.1074/jbc.M114.553925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107904	hybrid, Green Published			2022-12-28	WOS:000342853900001
J	Zhao, PS; Lieu, T; Barlow, N; Metcalf, M; Veldhuis, NA; Jensen, DD; Kocan, M; Sostegni, S; Haerteis, S; Baraznenok, V; Henderson, I; Lindstrom, E; Guerrero-Alba, R; Valdez-Morales, EE; Liedtke, W; McIntyre, P; Vanner, SJ; Korbmacher, C; Bunnett, NW				Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Metcalf, Matthew; Veldhuis, Nicholas A.; Jensen, Dane D.; Kocan, Martina; Sostegni, Silvia; Haerteis, Silke; Baraznenok, Vera; Henderson, Ian; Lindstrom, Erik; Guerrero-Alba, Raquel; Valdez-Morales, Eduardo E.; Liedtke, Wolfgang; McIntyre, Peter; Vanner, Stephen J.; Korbmacher, Christoph; Bunnett, Nigel W.			Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR(2) and TRPV4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; POTENTIAL VANILLOID 4; MAST-CELL TRYPTASE; ARRESTIN-DEPENDENT ENDOCYTOSIS; PROSTATE-CANCER CELLS; VISCERAL HYPERALGESIA; NEUTROPHIL ELASTASE; CYSTEINE CATHEPSINS; MOLECULAR-CLONING; EPITHELIAL-CELLS	Serine proteases such as trypsin and mast cell tryptase cleave protease-activated receptor-2 (PAR(2)) at R-36 down arrow S-37 and reveal a tethered ligand that excites nociceptors, causing neurogenic inflammation and pain. Whether proteases that cleave PAR(2) at distinct sites are biased agonists that also induce inflammation and pain is unexplored. Cathepsin S (Cat-S) is a lysosomal cysteine protease of antigen-presenting cells that is secreted during inflammation and which retains activity at extracellular pH. We observed that Cat-S cleaved PAR(2) at E-56 down arrow T-57, which removed the canonical tethered ligand and prevented trypsin activation. In HEK and KNRK cell lines and in nociceptive neurons of mouse dorsal root ganglia, Cat-S and a decapeptide mimicking the Cat-S-revealed tethered ligand-stimulated PAR(2) coupling to G alpha s and formation of cAMP. In contrast to trypsin, Cat-S did not mobilize intracellular Ca2+, activate ERK1.2, recruit beta-arrestins, or induce PAR(2) endocytosis. Cat-S caused PAR(2)-dependent activation of transient receptor potential vanilloid 4 (TRPV4) in Xenopus laevis oocytes, HEK cells and nociceptive neurons, and stimulated neuronal hyperexcitability by adenylyl cyclase and protein kinase A-dependent mechanisms. Intraplantar injection of Cat-S caused inflammation and hyperalgesia in mice that was attenuated by PAR(2) or TRPV4 deletion and adenylyl cyclase inhibition. Cat-S and PAR(2) antagonists suppressed formalin-induced inflammation and pain, which implicates endogenous Cat-S and PAR(2) in inflammatory pain. Our results identify Cat-S as a biased agonist of PAR(2) that causes PAR(2)- and TRPV4-dependent inflammation and pain. They expand the role of PAR(2) as a mediator of protease-driven inflammatory pain.	[Zhao, Peishen; Lieu, TinaMarie; Barlow, Nicholas; Metcalf, Matthew; Veldhuis, Nicholas A.; Jensen, Dane D.; Kocan, Martina; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sostegni, Silvia; Haerteis, Silke; Korbmacher, Christoph] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany; [Baraznenok, Vera; Henderson, Ian; Lindstrom, Erik] Medivir AB, S-141 Huddinge, Sweden; [Guerrero-Alba, Raquel; Valdez-Morales, Eduardo E.; Vanner, Stephen J.] Queens Univ, Div Gastroenterol, Gastrointestinal Dis Res Unit, Kingston, ON N7L 3N6, Canada; [Liedtke, Wolfgang] Duke Univ, Div Neurol, Dept Med, Durham, NC 27710 USA; [McIntyre, Peter] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia; [McIntyre, Peter] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Bunnett, Nigel W.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia	University of Erlangen Nuremberg; Medivir; Queens University - Canada; Duke University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Monash University	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu	Barlow, Nicholas/W-8442-2019; Zhao, Peishen/AFQ-6840-2022; Haerteis, Silke/AGS-5314-2022; Lieu, TinaMarie/AAM-7691-2020; Liedtke, Wolfgang/GNH-1878-2022; Valdez-Morales, Eduardo Emmanuel/AAG-7832-2021	Valdez-Morales, Eduardo Emmanuel/0000-0003-3736-7626; Bunnett, Nigel W./0000-0003-3367-0644; Veldhuis, Nicholas/0000-0002-8902-9365; Barlow, Nicholas/0000-0002-5749-3542; Jensen, Dane D./0000-0001-6540-2375; Guerrero-Alba, Raquel/0000-0001-6010-1012; Kocan, Martina/0000-0003-3468-6197; Haerteis, Silke/0000-0002-9440-3307	NHMRC [63303, 1049682, 1031886]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology; Monash University; Bayerische Forschungsstiftung	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Monash University(Monash University); Bayerische Forschungsstiftung	This work was supported by NHMRC 63303, 1049682, 1031886, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and Monash University (to N. W. B.) and by a PhD fellowship from the Bayerische Forschungsstiftung (to S. S.).	Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958; Ayoub Mohammed Akli, 2013, Front Endocrinol (Lausanne), V4, P196, DOI 10.3389/fendo.2013.00196; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Clark AK, 2010, GLIA, V58, P1710, DOI 10.1002/glia.21042; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Denadai-Souza A, 2012, ARTHRITIS RHEUM-US, V64, P1848, DOI 10.1002/art.34345; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Elmariah SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099702; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Haerteis S, 2012, PFLUG ARCH EUR J PHY, V464, P353, DOI 10.1007/s00424-012-1138-3; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Liuzzo JP, 1999, MOL MED, V5, P320, DOI 10.1007/BF03402068; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramsay AJ, 2008, BIOL CHEM, V389, P653, DOI 10.1515/BC.2008.078; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Smith R, 2000, FEBS LETT, V484, P285, DOI 10.1016/S0014-5793(00)02146-3; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Suen JY, 2012, BRIT J PHARMACOL, V165, P1413, DOI 10.1111/j.1476-5381.2011.01610.x; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Vergnolle N, 2010, BRIT J PHARMACOL, V159, P1161, DOI 10.1111/j.1476-5381.2009.00590.x; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066	64	128	133	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27215	27234		10.1074/jbc.M114.599712	http://dx.doi.org/10.1074/jbc.M114.599712			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118282	Green Published, hybrid			2022-12-28	WOS:000342853900045
J	Bhattacharya, A; Parillon, X; Zeng, SY; Han, SH; Eissa, NT				Bhattacharya, Abhisek; Parillon, Xyanthine; Zeng, Shenyan; Han, Shuhua; Eissa, N. Tony			Deficiency of Autophagy in Dendritic Cells Protects against Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; ANTIGEN; EXPRESSION; CNS; HOMEOSTASIS; IMMUNITY; COMPLEX	Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs) in the immune system. DCs present antigens to CD8 and CD4 T cells in the context of class I or II MHC. Recent evidence suggests that autophagy, a conserved intracellular degradation pathway, regulates class II antigen presentation. In vitro studies have shown that deletion of autophagy-related genes reduced antigen presentation by APCs to CD4 T cells. In vivo studies confirmed these findings in the context of infectious diseases. However, the relevance of autophagy-mediated antigen presentation in autoimmunity remains to be elucidated. Here, we report that loss of autophagy-related gene 7 (Atg7) in DCs ameliorated experimental autoimmune encephalomyelitis (EAE), a CD4 T cell-mediated mouse model of multiple sclerosis, by reducing in vivo priming of T cells. In contrast, severity of hapten-induced contact hypersensitivity, in which CD8 T cells and NK cells play major roles, was unaffected. Administration of the autophagy-lysosomal inhibitor chloroquine, before EAE onset, delayed disease progression and, when administered after the onset, reduced disease severity. Our data show that autophagy is required in DCs for induction of EAE and suggest that autophagy might be a potential target for treating CD4 T cell-mediated autoimmune conditions.	[Bhattacharya, Abhisek; Zeng, Shenyan; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bhattacharya, Abhisek; Parillon, Xyanthine; Han, Shuhua; Eissa, N. Tony] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Eissa, NT (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 285 Ste,535E, Houston, TX 77030 USA.	teissa@bcm.edu	Bhattacharya, Abhisek/AAN-6511-2020	Bhattacharya, Abhisek/0000-0002-1667-7169; Parillon, Xyanthine/0000-0002-4780-508X	National Institutes of Health from NHLBI [R01 HL69033]; Cytometry and Cell Sorting Core at Baylor College of Medicine (National Institutes of Health) [AI036211, CA125123, RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cytometry and Cell Sorting Core at Baylor College of Medicine (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL69033 from NHLBI. This work was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine (supported by National Institutes of Health Grants AI036211, CA125123, and RR024574.	Aichinger M, 2013, J EXP MED, V210, P287, DOI 10.1084/jem.20122149; Alirezaei M, 2009, AUTOPHAGY, V5, P152, DOI 10.4161/auto.5.2.7348; Bhattacharya A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00088; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Choi AMK, 2013, NEW ENGL J MED, V368, P1845, DOI 10.1056/NEJMc1303158; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Isaksson M, 2009, EUR J IMMUNOL, V39, P2925, DOI 10.1002/eji.200839179; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; MILLER HG, 1963, BMJ-BRIT MED J, P1436, DOI 10.1136/bmj.2.5370.1436; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Reed M, 2013, J IMMUNOL, V191, P2526, DOI 10.4049/jimmunol.1300477; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shin JN, 2013, J BIOL CHEM, V288, P35886, DOI 10.1074/jbc.M113.514919; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Yogev N, 2012, IMMUNITY, V37, P264, DOI 10.1016/j.immuni.2012.05.025; Zhang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036589; Zhou XJ, 2011, ANN RHEUM DIS, V70, P1330, DOI 10.1136/ard.2010.140111	32	59	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26525	26532		10.1074/jbc.M114.575860	http://dx.doi.org/10.1074/jbc.M114.575860			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25077962	Green Published, hybrid			2022-12-28	WOS:000342128800043
J	Mehla, J; Ernst, R; Moore, R; Wakschlag, A; Marquis, MK; Ambudkar, SV; Golin, J				Mehla, Jitender; Ernst, Robert; Moore, Rachel; Wakschlag, Adina; Marquis, Mary Kate; Ambudkar, Suresh V.; Golin, John			Evidence for a Molecular Diode-based Mechanism in a Multispecific ATP-binding cassette (ABC) Exporter SER-1368 AS A GATEKEEPING RESIDUE IN THE YEAST MULTIDRUG TRANSPORTER Pdr5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG TRANSPORTER PDR5; P-GLYCOPROTEIN; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; DRUG-RESISTANCE; HYDROLYSIS; EFFLUX; INTERMEDIATE; INTERFACE	ATP-binding cassette multidrug efflux pumps transport a wide range of substrates. Current models suggest that a drug binds relatively tightly to a transport site in the transmembrane domains when the protein is in the closed inward facing conformation. Upon binding of ATP, the transporter can switch to an outward facing (drug off or drug releasing) structure of lower affinity. ATP hydrolysis is critically important for remodeling the drug-binding site to facilitate drug release and to reset the transporter for a new transport cycle. We characterized the novel phenotype of an S1368A mutant that lies in the putative drug-binding pocket of the yeast multidrug transporter Pdr5. This substitution created broad, severe drug hypersensitivity, although drug binding, ATP hydrolysis, and intradomain signaling were indistinguishable from the wild-type control. Several different rhodamine 6G efflux and accumulation assays yielded evidence consistent with the possibility that Ser-1368 prevents reentry of the excluded drug.	[Golin, John] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [Ernst, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Catholic University of America; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Golin, J (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	golin@cua.edu	Ernst, Robert/AAW-2967-2020; Mehla, Jitender/M-6165-2016; Ambudkar, Suresh V/L-1317-2016	Ernst, Robert/0000-0002-0283-3490; Mehla, Jitender/0000-0002-7829-557X; Schonbrun, Adina/0000-0002-0831-5053	National Institutes of Health, NCI, Intramural Research Program, Center for Cancer Research; National Science Foundation [MCB1048838]; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Intramural Research Program, Center for Cancer Research; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	work was supported, in whole or in part, by the National Institutes of Health, NCI, Intramural Research Program, Center for Cancer Research (to S. V. A.). This work was also supported by National Science Foundation Grant MCB1048838 (to J. G.).	Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Downes MT, 2013, ANTIMICROB AGENTS CH, V57, P1025, DOI 10.1128/AAC.02133-12; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Furman C, 2013, J BIOL CHEM, V288, P30420, DOI 10.1074/jbc.M113.494682; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Golin J, 2007, BIOCHEMISTRY-US, V46, P13109, DOI 10.1021/bi701414f; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gupta RP, 2014, J BIOL CHEM, V289, P15272, DOI 10.1074/jbc.M114.553065; Gupta RP, 2011, BIOL CHEM, V392, P53, DOI 10.1515/BC.2011.011; Hanson L, 2005, BIOCHEMISTRY-US, V44, P9703, DOI 10.1021/bi0502994; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Kueppers P, 2013, BIOCHEMISTRY-US, V52, P2184, DOI 10.1021/bi3015778; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Mehla J, 2011, APPL ENVIRON MICROB, V77, P786, DOI 10.1128/AEM.01496-10; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200	26	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26597	26606		10.1074/jbc.M114.586032	http://dx.doi.org/10.1074/jbc.M114.586032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25112867	Green Published, hybrid			2022-12-28	WOS:000342128800050
J	Chen, XM; Wang, X; Feng, J; Chen, YH; Fang, Y; Zhao, S; Zhao, AG; Zhang, M; Liu, L				Chen, Xuemin; Wang, Xiao; Feng, Juan; Chen, Yuhong; Fang, Ying; Zhao, Shun; Zhao, Aiguo; Zhang, Min; Liu, Lin			Structural Insights into the Catalytic Mechanism of Synechocystis Magnesium Protoporphyrin IX O-Methyltransferase (ChlM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTINUOUS SPECTROPHOTOMETRIC ASSAY; CHELATASE H SUBUNIT; CRYSTAL-STRUCTURE; TETRAPYRROLE BIOSYNTHESIS; ENZYMES; PROTEIN; SAM; PURIFICATION; EXPRESSION; PORPHYRIN	Magnesium protoporphyrin IX O-methyltransferase (ChlM) catalyzes transfer of the methyl group from S-adenosylmethionine to the carboxyl group of the C13 propionate side chain of magnesium protoporphyrin IX. This reaction is the second committed step in chlorophyll biosynthesis from protoporphyrin IX. Here we report the crystal structures of ChlM from the cyanobacterium Synechocystis sp. PCC 6803 in complex with S-adenosylmethionine and S-adenosylhomocysteine at resolutions of 1.6 and 1.7 angstrom, respectively. The structures illustrate the molecular basis for cofactor and substrate binding and suggest that conformational changes of the two "arm" regions may modulate binding and release of substrates/products to and from the active site. Tyr-28 and His139 were identified to play essential roles for methyl transfer reaction but are not indispensable for cofactor/substrate binding. Based on these structural and functional findings, a catalytic model is proposed.	[Chen, Xuemin; Wang, Xiao; Feng, Juan; Chen, Yuhong; Fang, Ying; Zhao, Shun; Zhao, Aiguo; Liu, Lin] Chinese Acad Sci, Photosynthesis Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China; [Zhang, Min] Anhui Univ, Sch Life Sci, Engn Res Ctr Biomed Mat, Hefei 230601, Anhui, Peoples R China; [Chen, Xuemin; Wang, Xiao; Feng, Juan; Fang, Ying; Zhao, Shun; Zhao, Aiguo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Anhui University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, L (corresponding author), Chinese Acad Sci, Photosynthesis Res Ctr, Key Lab Photobiol, Inst Bot, Beijing 100093, Peoples R China.	liulin@ibcas.ac.cn	Chen, Xuemin/AAW-6728-2020	Chen, Xuemin/0000-0002-1818-9206	National Natural Science Foundation of China [31340044]; National Basic Research Program of China [2011CBA00901]; Hundred Talents Program of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 31340044, National Basic Research Program of China Grant 2011CBA00901, and the Hundred Talents Program of Chinese Academy of Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Alawady AE, 2005, PLANT J, V41, P282, DOI 10.1111/j.1365-313X.2004.02291.x; Ariyawutthiphan O, 2012, ACTA CRYSTALLOGR D, V68, P1558, DOI 10.1107/S0907444912038486; Byrne RT, 2013, ACTA CRYSTALLOGR D, V69, P1090, DOI 10.1107/S0907444913004939; Cakici O, 2010, J MOL BIOL, V404, P874, DOI 10.1016/j.jmb.2010.10.016; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gao YG, 2005, PROTEINS, V61, P1141, DOI 10.1002/prot.20678; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; Johnson ET, 2008, J BIOL CHEM, V283, P27776, DOI 10.1074/jbc.M804486200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kim J, 2013, NATURE, V498, P123, DOI 10.1038/nature12180; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JE, 2001, ACTA CRYSTALLOGR D, V57, P150, DOI 10.1107/S0907444900014669; Lee JH, 2010, P NATL ACAD SCI USA, V107, P17557, DOI 10.1073/pnas.1006848107; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McLean S, 2009, ANAL BIOCHEM, V394, P223, DOI 10.1016/j.ab.2009.07.036; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Miyazaki G, 1999, J MOL BIOL, V292, P1121, DOI 10.1006/jmbi.1999.3124; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng Y, 2011, BIOCHEMISTRY-US, V50, P7800, DOI 10.1021/bi2007614; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pontier D, 2007, J BIOL CHEM, V282, P2297, DOI 10.1074/jbc.M610286200; Qian P, 2012, J BIOL CHEM, V287, P4946, DOI 10.1074/jbc.M111.308239; Richter AS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00371; Richter AS, 2013, PLANT PHYSIOL, V162, P63, DOI 10.1104/pp.113.217141; Sawicki A, 2010, FEBS J, V277, P4709, DOI 10.1111/j.1742-4658.2010.07877.x; Schlicke H, 2014, MOL PLANT, V7, P1211, DOI 10.1093/mp/ssu034; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039	56	14	16	4	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25690	25698		10.1074/jbc.M114.584920	http://dx.doi.org/10.1074/jbc.M114.584920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077963	hybrid, Green Published			2022-12-28	WOS:000342130800028
J	Ikeuchi, Y; Dadakhujaev, S; Chandhoke, AS; Huynh, MA; Oldenborg, A; Ikeuchi, M; Deng, LL; Bennett, EJ; Harper, JW; Bonni, A; Bonni, S				Ikeuchi, Yoshiho; Dadakhujaev, Shorafidinkhuja; Chandhoke, Amrita S.; Mai Anh Huynh; Oldenborg, Anna; Ikeuchi, Mikako; Deng, Lili; Bennett, Eric J.; Harper, J. Wade; Bonni, Azad; Bonni, Shirin			TIF1 gamma Protein Regulates Epithelial-Mesenchymal Transition by Operating as a Small Ubiquitin-like Modifier (SUMO) E3 Ligase for the Transcriptional Regulator SnoN1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MAMMALIAN BRAIN; AXONAL MORPHOGENESIS; NEURONAL MIGRATION; COMPLEX; SMAD4; EXPRESSION; PATHWAY; SWITCH	Epithelial-mesenchymal transition (EMT) is a fundamental cellular process that contributes to epithelial tissue morphogenesis during normal development and in tumor invasiveness and metastasis. The transcriptional regulator SnoN robustly influences EMT in response to the cytokine TGF beta, but the mechanisms that regulate the fundamental role of SnoN in TGF beta-induced EMT are not completely understood. Here we employ interaction proteomics to uncover the signaling protein TIF1 gamma as a specific interactor of SnoN1 but not the closely related isoform SnoN2. A 16-amino acid peptide within a unique region of SnoN1 mediates the interaction of SnoN1 with TIF1 gamma. Strikingly, although TIF1 gamma is thought to act as a ubiquitin E3 ligase, we find that TIF1 gamma operates as a small ubiquitin-like modifier (SUMO) E3 ligase that promotes the sumoylation of SnoN1 at distinct lysine residues. Importantly, TIF1 gamma -induced sumoylation is required for the ability of SnoN1 to suppress TGF beta-induced EMT, as assayed by the disruption of the morphogenesis of acini in a physiologically relevant three-dimensional model of normal murine mammary gland (NMuMG) epithelial cells. Collectively, our findings define a novel TIF1 gamma-SnoN1 sumoylation pathway that plays a critical role in EMT and has important implications for our understanding of TGF beta signaling and diverse biological processes in normal development and cancer biology.	[Ikeuchi, Yoshiho; Oldenborg, Anna; Bonni, Azad] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Ikeuchi, Yoshiho; Mai Anh Huynh; Ikeuchi, Mikako; Bonni, Azad] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dadakhujaev, Shorafidinkhuja; Chandhoke, Amrita S.; Deng, Lili; Bonni, Shirin] Univ Calgary, Southern Alberta Canc Res Inst, Cumming Sch Med, Calgary, AB T2N 4N1, Canada; [Dadakhujaev, Shorafidinkhuja; Chandhoke, Amrita S.; Deng, Lili; Bonni, Shirin] Univ Calgary, Dept Biochem & Mol Biol, Cumming Sch Med, Calgary, AB T2N 4N1, Canada	Washington University (WUSTL); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Calgary; University of Calgary	Bonni, A (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	sbonni@ucalgary.ca; sbonni@ucalgary.ca	Ikeuchi, Yoshiho/N-1057-2019; ikeuchi, yoshiho/C-1713-2014	ikeuchi, yoshiho/0000-0002-2829-3840; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [NS041021, AG011085]; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation-Prairies/Northwest Territories; JSPS; Alberta Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Canadian Breast Cancer Foundation-Prairies/Northwest Territories; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alberta Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS041021 (to A. B.) and AG011085 (to J.W.H.). This work was also supported by the Canadian Institutes of Health Research, Alberta Innovates Health Solutions, and Canadian Breast Cancer Foundation-Prairies/Northwest Territories (to S. B.); by a JSPS postdoctoral fellowship for research abroad (to Y.I.);, and by an Alberta Cancer Foundation graduate studentship (to A. S. D.).	Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eapen SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040684; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; GERWIN BI, 1990, AM J PHYSIOL, V259, pL262, DOI 10.1152/ajplung.1990.259.4.L262; Godde NJ, 2010, J MAMMARY GLAND BIOL, V15, P149, DOI 10.1007/s10911-010-9180-2; Gordon GM, 2009, J CELL PHYSIOL, V221, P402, DOI 10.1002/jcp.21869; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huynh MA, 2011, NEURON, V69, P930, DOI 10.1016/j.neuron.2011.02.008; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Netherton SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013971; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Pot I, 2010, CURR MOL MED, V10, P667, DOI 10.2174/156652410792630616; Pot I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067178; Rogers CD, 2013, J CELL BIOL, V203, P835, DOI 10.1083/jcb.201305050; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021	44	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25067	25078		10.1074/jbc.M114.575878	http://dx.doi.org/10.1074/jbc.M114.575878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059663	Green Published, hybrid			2022-12-28	WOS:000341985300030
J	Kosek, D; Kylarova, S; Psenakova, K; Rezabkova, L; Herman, P; Vecer, J; Obsilova, V; Obsil, T				Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Rezabkova, Lenka; Herman, Petr; Vecer, Jaroslav; Obsilova, Veronika; Obsil, Tomas			Biophysical and Structural Characterization of the Thioredoxin-binding Domain of Protein Kinase ASK1 and Its Interaction with Reduced Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Circular Dichroism (CD); Fluorescence; Small-angle X-ray Scattering (SAXS); Thioredoxin; Apoptosis Signal-regulating Kinase 1 (ASK1)	SECONDARY STRUCTURE; STRUCTURE PREDICTION; CIRCULAR-DICHROISM; ESCHERICHIA-COLI; CELL-DEATH; BIOLOGICAL MACROMOLECULES; ASK1-MEDIATED APOPTOSIS; SOLUTION SCATTERING; INDEPENDENT MANNER; FAMILY PROTEINS	Background: Thioredoxin is a physiological inhibitor of ASK1. Results: The catalytic motif of thioredoxin is essential for its binding to ASK1 and the interaction does not involve intermolecular disulfide bonds. Conclusion: Thioredoxin-binding domain of ASK1 is a rigid domain that interacts with reduced thioredoxin through a large binding interface. Significance: Structural basis of the interaction between ASK1 and reduced thioredoxin. Apoptosis signal-regulating kinase 1 (ASK1), a mitogen-activated protein kinase kinase kinase, plays a key role in the pathogenesis of multiple diseases. Its activity is regulated by thioredoxin (TRX1) but the precise mechanism of this regulation is unclear due to the lack of structural data. Here, we performed biophysical and structural characterization of the TRX1-binding domain of ASK1 (ASK1-TBD) and its complex with reduced TRX1. ASK1-TBD is a monomeric and rigid domain that forms a stable complex with reduced TRX1 with 1:1 molar stoichiometry. The binding interaction does not involve the formation of intermolecular disulfide bonds. Residues from the catalytic WCGPC motif of TRX1 are essential for complex stability with Trp(31) being directly involved in the binding interaction as suggested by time-resolved fluorescence. Small-angle x-ray scattering data reveal a compact and slightly asymmetric shape of ASK1-TBD and suggest reduced TRX1 interacts with this domain through the large binding interface without inducing any dramatic conformational change.	[Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Kosek, Dalibor; Kylarova, Salome; Psenakova, Katarina; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Herman, Petr; Vecer, Jaroslav] Charles Univ Prague, Inst Phys, Fac Math & Phys, CR-12116 Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Hlavova 8, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Kylarova, Salome/M-3414-2017; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012; Obsil, Tomas/B-7142-2012; Psenakova, Katarina/AAG-1857-2021; Košek, Dalibor/AAD-4715-2021; Rezabkova, Lenka/O-8229-2017	Kylarova, Salome/0000-0001-5584-8242; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323; Obsil, Tomas/0000-0003-4602-1272; Psenakova, Katarina/0000-0001-8877-6599; Rezabkova, Lenka/0000-0002-7274-8080	Czech Science Foundation [14-10061S]; Grant Agency of Charles University [568912]; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology [RVO:67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology	This work was supported by Czech Science Foundation Project 14-10061S, Grant Agency of Charles University Project 568912, and Academy of Sciences of the Czech Republic Research Project RVO:67985823 of the Institute of Physiology.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; FORMANKAY JD, 1992, J BIOMOL NMR, V2, P431, DOI 10.1007/BF02192807; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; HUBER HE, 1986, J BIOL CHEM, V261, P5006; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Rezabkova L, 2012, BIOPHYS J, V103, P1960, DOI 10.1016/j.bpj.2012.09.021; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHAUERTE JA, 1989, BIOCHEMISTRY-US, V28, P3948, DOI 10.1021/bi00435a048; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	45	27	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24463	24474		10.1074/jbc.M114.583807	http://dx.doi.org/10.1074/jbc.M114.583807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037217	Green Published, hybrid			2022-12-28	WOS:000341505600039
J	Berezuk, AM; Goodyear, M; Khursigara, CM				Berezuk, Alison M.; Goodyear, Mara; Khursigara, Cezar M.			Site-directed Fluorescence Labeling Reveals a Revised N-terminal Membrane Topology and Functional Periplasmic Residues in the Escherichia coli Cell Division Protein FtsK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Electron Microscopy (EM); Escherichia coli (E; coli); Membrane Protein; Site-directed Mutagenesis; FtsK; Membrane Topology	CHROMOSOME DIMER RESOLUTION; PEPTIDOGLYCAN SYNTHESIS; BACTERIAL CYTOKINESIS; Z-RING; SEGREGATION; LOCALIZATION; TRANSPORTER; SEPTUM; DOMAIN; CYCLE	Background: FtsK is an essential membrane protein that links chromosome segregation and cell division in bacteria. Results: A revised membrane topology of FtsK highlights a large functional periplasmic loop. Conclusion: Key residues in the newly identified periplasmic loop of FtsK couple division of the cytoplasmic and outer membranes. Significance: FtsK functions as a critical checkpoint for the transition between cell growth and septation. In Escherichia coli, FtsK is a large integral membrane protein that coordinates chromosome segregation and cell division. The N-terminal domain of FtsK (FtsK(N)) is essential for division, and the C terminus (FtsK(C)) is a well characterized DNA translocase. Although the function of FtsK(N) is unknown, it is suggested that FtsK acts as a checkpoint to ensure DNA is properly segregated before septation. This may occur through modulation of protein interactions between FtsK(N) and other division proteins in both the periplasm and cytoplasm; thus, a clear understanding of how FtsK(N) is positioned in the membrane is required to characterize these interactions. The membrane topology of FtsK(N) was initially determined using site-directed reporter fusions; however, questions regarding this topology persist. Here, we report a revised membrane topology generated by site-directed fluorescence labeling. The revised topology confirms the presence of four transmembrane segments and reveals a newly identified periplasmic loop between the third and fourth transmembrane domains. Within this loop, four residues were identified that, when mutated, resulted in the appearance of cellular voids. High resolution transmission electron microscopy of these voids showed asymmetric division of the cytoplasm in the absence of outer membrane invagination or visible cell wall ingrowth. This uncoupling reveals a novel role for FtsK in linking cell envelope septation events and yields further evidence for FtsK as a critical checkpoint of cell division. The revised topology of FtsK(N) also provides an important platform for future studies on essential interactions required for this process.	[Berezuk, Alison M.; Goodyear, Mara; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	ckhursig@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada [371639]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant 371639 (to C. M. K.), Postgraduate Scholarship-Doctoral (to A. M. B.), and Undergraduate Student Research Award (to M. G.) from the Natural Sciences and Engineering Research Council of Canada.	Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Allard JF, 2009, P NATL ACAD SCI USA, V106, P145, DOI 10.1073/pnas.0808657106; Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2007, MOL MICROBIOL, V66, P1051, DOI 10.1111/j.1365-2958.2007.05981.x; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; BEGG KJ, 1980, J BACTERIOL, V144, P435, DOI 10.1128/JB.144.1.435-437.1980; Beveridge T.J., 2007, METHODS GEN MOL MICR, P54; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bisicchia P, 2013, MBIO, V4, DOI 10.1128/mBio.00800-13; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Demarre G, 2013, ADV EXP MED BIOL, V973, P245, DOI 10.1007/978-1-4614-5037-5_12; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Diez AA, 1997, J BACTERIOL, V179, P5878, DOI 10.1128/jb.179.18.5878-5883.1997; Dorazi R, 2000, FEBS LETT, V478, P13, DOI 10.1016/S0014-5793(00)01820-2; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Grainge I, 2010, MOL MICROBIOL, V78, P1055, DOI 10.1111/j.1365-2958.2010.07411.x; Grenga L, 2008, FEMS MICROBIOL LETT, V287, P163, DOI 10.1111/j.1574-6968.2008.01317.x; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Larue K, 2011, J BIOL CHEM, V286, P16658, DOI 10.1074/jbc.M111.228221; Lesterlin C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000288; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; NANNINGA N, 1991, MOL MICROBIOL, V5, P791, DOI 10.1111/j.1365-2958.1991.tb00751.x; NORDSTROM K, 1991, MOL MICROBIOL, V5, P769, DOI 10.1111/j.1365-2958.1991.tb00747.x; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Rothfield L, 2003, J BACTERIOL, V185, P1125, DOI 10.1128/JB.185.4.1125-1127.2003; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Thanbichler M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000331; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989; Wood JM, 2005, BIOCHEMISTRY-US, V44, P5634, DOI 10.1021/bi047383o; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Ye LW, 2001, J BACTERIOL, V183, P2490, DOI 10.1128/JB.183.8.2490-2496.2001; Yu XC, 1998, J BACTERIOL, V180, P6424; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	68	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23287	23301		10.1074/jbc.M114.569624	http://dx.doi.org/10.1074/jbc.M114.569624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002583	Green Published, hybrid			2022-12-28	WOS:000341505000003
J	Eichmann, C; Tzitzilonis, C; Bordignon, E; Maslennikov, I; Choe, S; Riek, R				Eichmann, Cedric; Tzitzilonis, Christos; Bordignon, Enrica; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland			Solution NMR Structure and Functional Analysis of the Integral Membrane Protein YgaP from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Membrane Enzyme; Nuclear Magnetic Resonance (NMR); Structural Biology; Sulfotransferase; Three-dimensional Structure; Membrane Protein; Rhodanese; Sulfurtransferase	NUCLEAR-MAGNETIC-RESONANCE; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; TRANSMEMBRANE HELIX; POTASSIUM CHANNEL; SPECTROSCOPY; RHODANESE; DOMAIN; RELAXATION; OMPX	Background:E. coli YgaP is a membrane-bound sulfurtransferase with a cytoplasmic rhodanese domain. Results: The three-dimensional structure is composed of a cytoplasmic rhodanese domain and two transmembrane helices forming the interface of the homodimer. Conclusion: The structure-activity relationship of YgaP suggests a sulfurtransferase activity. Significance: YgaP may have a role in the detoxification of CN- to the less toxic SCN-. The solution NMR structure of the -helical integral membrane protein YgaP from Escherichia coli in mixed 1,2-diheptanoyl-sn-glycerol-3-phosphocholine/1-myristoyl-2-hydroxy-sn-glycero-3-phospho-(1-rac-glycerol) micelles is presented. In these micelles, YgaP forms a homodimer with the two transmembrane helices being the dimer interface, whereas the N-terminal cytoplasmic domain includes a rhodanese-fold in accordance to its sequence homology to the rhodanese family of sulfurtransferases. The enzymatic sulfur transfer activity of full-length YgaP as well as of the N-terminal rhodanese domain only was investigated performing a series of titrations with sodium thiosulfate and potassium cyanide monitored by NMR and EPR. The data indicate the thiosulfate concentration-dependent addition of several sulfur atoms to the catalytic Cys-63, which process can be reversed by the addition of potassium cyanide. The catalytic reaction induces thereby conformational changes within the rhodanese domain, as well as on the transmembrane -helices of YgaP. These results provide insights into a potential mechanism of YgaP during the catalytic thiosulfate activity in vivo.	[Eichmann, Cedric; Tzitzilonis, Christos; Bordignon, Enrica; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Tzitzilonis, Christos; Maslennikov, Innokentiy; Choe, Senyon; Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Salk Institute	Riek, R (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Phys Chem Lab, CH-8093 Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch	Eichmann, Cédric/U-1360-2018	Eichmann, Cédric/0000-0002-8476-1936; Maslennikov, Innokentiy/0000-0003-4292-5821; Bordignon, Enrica/0000-0003-2450-5161; Riek, Roland/0000-0002-6333-066X				Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bayrhuber M, 2011, J MAGN RESON, V209, P310, DOI 10.1016/j.jmr.2011.01.031; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Hilty C, 2002, J BIOMOL NMR, V23, P289, DOI 10.1023/A:1020218419190; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuntz I. D., 1991, J AM CHEM SOC, V105, P5948; Lee D, 2008, J AM CHEM SOC, V130, P13822, DOI 10.1021/ja803686p; Li HW, 2008, BIOCHEMISTRY-US, V47, P4377, DOI 10.1021/bi800039n; Li HW, 2011, BIOMOL NMR ASSIGN, V5, P101, DOI 10.1007/s12104-010-9277-y; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; PENG JW, 1991, J MAGN RESON, V94, P82, DOI 10.1016/0022-2364(91)90296-6; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Shenkarev ZO, 2010, J AM CHEM SOC, V132, P5630, DOI 10.1021/ja909752r; Spallarossa A, 2001, STRUCTURE, V9, P1117, DOI 10.1016/S0969-2126(01)00666-9; Tzitzilonis C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054378; VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P605; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WUTHRICH K, 1986, NMR PROTEINS NUCLEIC, P17; ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042	50	10	11	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23482	23503		10.1074/jbc.M114.571935	http://dx.doi.org/10.1074/jbc.M114.571935			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24958726	hybrid, Green Published			2022-12-28	WOS:000341505000021
J	Liang, XH; Deng, WB; Li, M; Zhao, ZA; Wang, TS; Feng, XH; Cao, YJ; Duan, EK; Yang, ZM				Liang, Xiao-Huan; Deng, Wen-Bo; Li, Ming; Zhao, Zhen-Ao; Wang, Tong-Song; Feng, Xu-Hui; Cao, Yu-Jing; Duan, En-Kui; Yang, Zeng-Ming			Egr1 Protein Acts Downstream of Estrogen-Leukemia Inhibitory Factor (LIF)-STAT3 Pathway and Plays a Role during Implantation through Targeting Wnt4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Early Growth Response Protein 1 (Egr1); Estrogen; Mouse; STAT3; Transcription Factor; Embryo Implantation; Uterus; Decidualization	MOUSE UTERUS; TRANSCRIPTION-3 STAT3; EMBRYO IMPLANTATION; SIGNAL TRANSDUCER; EARLY-PREGNANCY; BLASTOCYST IMPLANTATION; DIFFERENTIAL EXPRESSION; FACTOR LIF; DECIDUALIZATION; MICE	Background: The downstream molecules of estrogen-LIF-STAT3 pathway during implantation are still unclear. Results: Egr1 is regulated by estrogen through LIF-STAT3 pathway in mouse uterus and regulates decidualization by targeting Wnt4. Conclusion: We showed Egr1 as a downstream target of LIF-STAT3 pathway and its involvement in decidualization. Significance: Our data could be a valuable source for future study on embryo implantation. Embryo implantation is a highly synchronized process between an activated blastocyst and a receptive uterus. Successful implantation relies on the dynamic interplay of estrogen and progesterone, but the key mediators underlying embryo implantation are not fully understood. Here we show that transcription factor early growth response 1 (Egr1) is regulated by estrogen as a downstream target through leukemia inhibitory factor (LIF) signal transducer and activator of transcription 3 (STAT3) pathway in mouse uterus. Egr1 is localized in the subluminal stromal cells surrounding the implanting embryo on day 5 of pregnancy. Estrogen rapidly, markedly, and transiently enhances Egr1 expression in uterine stromal cells, which fails in estrogen receptor knock-out mouse uteri. STAT3 is phosphorylated by LIF and subsequently recruited on Egr1 promoter to induce its expression. Our results of Egr1 expression under induced decidualization in vivo and in vitro show that Egr1 is rapidly induced after deciduogenic stimulus. Egr1 knockdown can inhibit in vitro decidualization of cultured uterine stromal cells. Chromatin immunoprecipitation data show that Egr1 is recruited to the promoter of wingless-related murine mammary tumor virus integration site 4 (Wnt4). Collectively, our study presents for the first time that estrogen regulates Egr1 expression through LIF-STAT3 signaling pathway in mouse uterus, and Egr1 functions as a critical mediator of stromal cell decidualization by regulating Wnt4.	[Liang, Xiao-Huan; Deng, Wen-Bo; Yang, Zeng-Ming] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China; [Li, Ming; Feng, Xu-Hui] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China; [Zhao, Zhen-Ao; Cao, Yu-Jing; Duan, En-Kui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Wang, Tong-Song] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China	South China Agricultural University; Xiamen University; Chinese Academy of Sciences; Institute of Zoology, CAS; Shantou University	Yang, ZM (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.	zmyang@scau.edu.cn	feng, xuhui/AAD-9832-2019; feng, xuhui/D-9450-2017	feng, xuhui/0000-0003-4649-183X; Yang, Zeng-Ming/0000-0001-6775-0082	National Basic Research Program of China [2011CB944402, 2013CB910803]; National Natural Science Foundation of China [31071276, 31272263]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB944402 and 2013CB910803 and National Natural Science Foundation of China Grants 31071276 and 31272263.	BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Dimitriadis E, 2006, ENDOCRINOLOGY, V147, P3809, DOI 10.1210/en.2006-0264; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hewitt SC, 2002, BIOL REPROD, V67, P1268, DOI [10.1095/biolreprod67.4.1268, 10.1095/biolreprod.102.002436]; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Laszlo GS, 2003, J BIOL CHEM, V278, P27750, DOI 10.1074/jbc.M303670200; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Lei W, 2012, J BIOL CHEM, V287, P15174, DOI 10.1074/jbc.M111.308023; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Luan LM, 2011, BIOL REPROD, V85, P996, DOI 10.1095/biolreprod.110.090126; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Nakamura H, 2006, FEBS LETT, V580, P2717, DOI 10.1016/j.febslet.2006.04.029; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Saegusa M, 2008, J PATHOL, V216, P521, DOI 10.1002/path.2404; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; White CA, 2007, P NATL ACAD SCI USA, V104, P19357, DOI 10.1073/pnas.0710110104; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321	45	52	58	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23534	23545		10.1074/jbc.M114.588897	http://dx.doi.org/10.1074/jbc.M114.588897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012664	Green Published, hybrid			2022-12-28	WOS:000341505000024
J	Thompson, MR; Sharma, S; Atianand, M; Jensen, SB; Carpenter, S; Knipe, DM; Fitzgerald, KA; Kurt-Jones, EA				Thompson, Mikayla R.; Sharma, Shruti; Atianand, Maninjay; Jensen, Soren B.; Carpenter, Susan; Knipe, David M.; Fitzgerald, Katherine A.; Kurt-Jones, Evelyn A.			Interferon gamma-inducible Protein (IFI) 16 Transcriptionally Regulates Type I Interferons and Other Interferon-stimulated Genes and Controls the Interferon Response to both DNA and RNA Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; Host-Pathogen Interaction; Innate Immunity; Interferon; Pattern Recognition Receptor (PRR); RIG-I-like Receptor (RLR); RNA; Toll-like Receptor (TLR); Transcription Regulation; Virus	CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; CYTOSOLIC-DNA; RIG-I; AIM2 INFLAMMASOME; INTRACELLULAR DNA; CYTOPLASMIC DNA; RECOGNITION; POLYMERASE; ACTIVATION	Background: IFI16 binds dsDNA and elicits a type I interferon response. Results: IFI16 knockdown cells show a decrease in interferon production and ISG expression in response to DNA and RNA ligands and cyclic dinucleotides. Conclusion: IFI16 transcriptionally regulates ISGs to enhance IFN responses to multiple IFN-inducing ligands. Significance: IFI16 has a broader role in the regulation of ISG expression. The interferon -inducible protein 16 (IFI16) has recently been linked to the detection of nuclear and cytosolic DNA during infection with herpes simplex virus-1 and HIV. IFI16 binds dsDNA via HIN200 domains and activates stimulator of interferon genes (STING), leading to TANK (TRAF family member-associated NF-B activator)-binding kinase-1 (TBK1)-dependent phosphorylation of interferon regulatory factor (IRF) 3 and transcription of type I interferons (IFNs) and related genes. To better understand the role of IFI16 in coordinating type I IFN gene regulation, we generated cell lines with stable knockdown of IFI16 and examined responses to DNA and RNA viruses as well as cyclic dinucleotides. As expected, stable knockdown of IFI16 led to a severely attenuated type I IFN response to DNA ligands and viruses. In contrast, expression of the NF-B-regulated cytokines IL-6 and IL-1 was unaffected in IFI16 knockdown cells, suggesting that the role of IFI16 in sensing these triggers was unique to the type I IFN pathway. Surprisingly, we also found that knockdown of IFI16 led to a severe attenuation of IFN- and the IFN-stimulated gene retinoic acid-inducible gene I (RIG-I) in response to cyclic GMP-AMP, a second messenger produced by cyclic GMP-AMP synthase (cGAS) as well as RNA ligands and viruses. Analysis of IFI16 knockdown cells revealed compromised occupancy of RNA polymerase II on the IFN- promoter in these cells, suggesting that transcription of IFN-stimulated genes is dependent on IFI16. These results indicate a broader role for IFI16 in the regulation of the type I IFN response to RNA and DNA viruses in antiviral immunity.	[Thompson, Mikayla R.; Sharma, Shruti; Atianand, Maninjay; Carpenter, Susan; Fitzgerald, Katherine A.; Kurt-Jones, Evelyn A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Jensen, Soren B.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Aarhus University; Harvard University; Harvard Medical School	Kurt-Jones, EA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Lazare Res Bldg,Rm 226,364 Plantat St, Worcester, MA 01605 USA.	evelyn.kurt-jones@umassmed.edu	Atianand, Maninjay/AAF-7823-2019; Fitzgerald, Katherine/ABE-6317-2020	Atianand, Maninjay/0000-0003-4135-2515; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [T32AI095213, U19AI057319, P01AI083215, AI093752, AI083713, AI106934, DE023909]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093752, R01AI083713, U19AI057319, T32AI095213, P01AI083215, R01AI106934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants T32AI095213 (to M. R. T.), U19AI057319 and P01AI083215 (to E. K. J.), AI093752 and AI083713 (to K. A. F.), and AI106934 and DE023909 (to D. M. K.).	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Berg RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084513; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Conrady CD, 2012, MUCOSAL IMMUNOL, V5, P173, DOI 10.1038/mi.2011.63; DAWSON MJ, 1995, BIOCHEM BIOPH RES CO, V214, P152, DOI 10.1006/bbrc.1995.2269; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Johnstone RW, 1998, J BIOL CHEM, V273, P17172, DOI 10.1074/jbc.273.27.17172; Johnstone RW, 2000, ONCOGENE, V19, P6033, DOI 10.1038/sj.onc.1204005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kwak JC, 2003, J BIOL CHEM, V278, P40899, DOI 10.1074/jbc.M308012200; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Luu P, 1997, J VIROL, V71, P6683, DOI 10.1128/JVI.71.9.6683-6691.1997; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schickli JH, 2005, J VIROL, V79, P10678, DOI 10.1128/JVI.79.16.10678-10689.2005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2008, ADV DRUG DELIVER REV, V60, P847, DOI 10.1016/j.addr.2007.12.002; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Ulbrandt ND, 2006, J VIROL, V80, P7799, DOI 10.1128/JVI.00318-06; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	47	86	86	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23568	23581		10.1074/jbc.M114.554147	http://dx.doi.org/10.1074/jbc.M114.554147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002588	hybrid, Green Published			2022-12-28	WOS:000341505000027
J	Lu, B; Kiessling, V; Tamm, LK; Cafiso, DS				Lu, Bin; Kiessling, Volker; Tamm, Lukas K.; Cafiso, David S.			The Juxtamembrane Linker of Full-length Synaptotagmin 1 Controls Oligomerization and Calcium-dependent Membrane Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LABELED SIDE-CHAINS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DOMAIN; FUSION; TRANSMEMBRANE; PROTEIN; SNARE; CA2+; REVEALS; PENETRATION	Synaptotagmin 1 (Syt1) is the calcium sensor for synchronous neurotransmitter release. The two C2 domains of Syt1, which may mediate fusion by bridging the vesicle and plasma membranes, are connected to the vesicle membrane by a 60-residue linker. Here, we use site-directed spin labeling and a novel total internal reflection fluorescence vesicle binding assay to characterize the juxtamembrane linker and to test the ability of reconstituted full-length Syt1 to interact with opposing membrane surfaces. EPR spectroscopy demonstrates that the majority of the linker interacts with the membrane interface, thereby limiting the extension of the C2A and C2B domains into the cytoplasm. Pulse dipolar EPR spectroscopy provides evidence that purified full-length Syt1 is oligomerized in the membrane, and mutagenesis indicates that a glycine zipper/GXXXG motif within the linker helps mediate oligomerization. The total internal reflection fluorescence-based vesicle binding assay demonstrates that full-length Syt1 that is reconstituted into supported lipid bilayers will capture vesicles containing negatively charged lipid in a Ca2+ -dependent manner. Moreover, the rate of vesicle capture increases with Syt1 density, and mutations in the GXXXG motif that inhibit oligomerization of Syt1 reduce the rate of vesicle capture. This work demonstrates that modifications within the 60-residue linker modulate both the oligomerization of Syt1 and its ability to interact with opposing bilayers. In addition to controlling its activity, the oligomerization of Syt1 may play a role in organizing proteins within the active zone of membrane fusion.	[Lu, Bin; Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Kiessling, Volker; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22904 USA; [Lu, Bin; Kiessling, Volker; Tamm, Lukas K.; Cafiso, David S.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22904 USA	University of Virginia; University of Virginia; University of Virginia	Cafiso, DS (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.	cafiso@virginia.edu	Lu, Bin/G-7576-2016	Lu, Bin/0000-0002-0812-293X	National Institutes of Health, NIGMS [P01 GM072694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant P01 GM072694 (to D. S. C. and L. K. T.).	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; Freed DM, 2011, BIOCHEMISTRY-US, V50, P8792, DOI 10.1021/bi200971x; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jimenez RHF, 2010, PROTEIN SCI, V19, P269, DOI 10.1002/pro.305; Kim M, 2006, BIOPHYS J, V90, P2922, DOI 10.1529/biophysj.105.078246; Kim M, 2007, P NATL ACAD SCI USA, V104, P11975, DOI 10.1073/pnas.0702172104; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; Lai AL, 2011, J BIOL CHEM, V286, P25291, DOI 10.1074/jbc.M111.258848; Lai AL, 2011, J MOL BIOL, V405, P696, DOI 10.1016/j.jmb.2010.11.015; Lai Y, 2013, BIOCHEM J, V456, P25, DOI 10.1042/BJ20130949; Lopez CJ, 2012, BIOCHEMISTRY-US, V51, P6568, DOI 10.1021/bi3005686; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; Lu B, 2010, J MOL BIOL, V396, P602, DOI 10.1016/j.jmb.2009.12.020; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Park Y, 2012, NAT STRUCT MOL BIOL, V19, P991, DOI 10.1038/nsmb.2375; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; Vrljic M, 2011, BIOCHEMISTRY-US, V50, P9998, DOI 10.1021/bi200998y; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320	60	19	19	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22161	22171		10.1074/jbc.M114.569327	http://dx.doi.org/10.1074/jbc.M114.569327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973220	Green Published, hybrid			2022-12-28	WOS:000340593500031
J	Qiao, YN; He, WQ; Chen, CP; Zhang, CH; Zhao, W; Wang, P; Zhang, L; Wu, YZ; Yang, X; Peng, YJ; Gao, JM; Kamm, KE; Stull, JT; Zhu, MS				Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Zhang, Lin; Wu, Yan-Ze; Yang, Xiao; Peng, Ya-Jing; Gao, Ji-Min; Kamm, Kristine E.; Stull, James T.; Zhu, Min-Sheng			Myosin Phosphatase Target Subunit 1 (MYPT1) Regulates the Contraction and Relaxation of Vascular Smooth Muscle and Maintains Blood Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; DEPENDENT PROTEIN-KINASE; SALT-INDUCED HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; CYCLIC-GMP; CA2+ SENSITIZATION; SIGNAL-TRANSDUCTION; MYOGENIC RESPONSE; RAT AORTA; I-ALPHA	Myosin light chain phosphatase with its regulatory subunit, myosin phosphatase target subunit 1 (MYPT1) modulates Ca2+ dependent phosphorylation of myosin light chain by myosin light chain kinase, which is essential for smooth muscle contraction. The role of MYPT1 in vascular smooth muscle was investigated in adult MYPT1 smooth muscle specific knock-out mice. MYPT1 deletion enhanced phosphorylation of myosin regulatory light chain and contractile force in isolated mesenteric arteries treated with KCl and various vascular agonists. The contractile responses of arteries from knock-out mice to norepinephrine were inhibited by Rho-associated kinase (ROCK) and protein kinase C inhibitors and were associated with inhibition of phosphorylation of the myosin light chain phosphatase inhibitor CPI-17. Additionally, stimulation of the NO/cGMP/protein kinase G (PKG) signaling pathway still resulted in relaxation of MYPT1-deficient mesenteric arteries, indicating phosphorylation of MYPT1 by PKG is not a major contributor to the relaxation response. Thus, MYPT1 enhances myosin light chain phosphatase activity sufficient for blood pressure maintenance. Rho-associated kinase phosphorylation of CPI-17 plays a significant role in enhancing vascular contractile responses, whereas phosphorylation of MYPT1 in the NO/cGMP/PKG signaling module is not necessary for relaxation.	[Qiao, Yan-Ning; Wu, Yan-Ze] Shaanxi Normal Univ, Key Lab MOE Modern Teaching Technol, Xian 710062, Peoples R China; [Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Qiao, Yan-Ning; He, Wei-Qi; Chen, Cai-Ping; Zhang, Cheng-Hai; Zhao, Wei; Wang, Pei; Peng, Ya-Jing; Zhu, Min-Sheng] Nanjing Univ, MOE Key Lab Anim Models Dis, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Lin; Gao, Ji-Min; Zhu, Min-Sheng] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Peoples R China; [Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	Shaanxi Normal University; Nanjing University; Nanjing University; Wenzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, MS (corresponding author), 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	zhums@nju.edu.cn	He, Weiqi/I-7935-2013; He, Weiqi/L-2502-2019; XIAO, YANG/GPW-5529-2022; Chen, Caiping/HII-8998-2022	He, Weiqi/0000-0003-3137-8420; He, Weiqi/0000-0003-3137-8420; Yang, Xiao/0000-0002-0298-9831; Qiao, Yanning/0000-0002-8092-4662	National Institutes of Health [1R01HL112778, 5P01HL110869]; National Key Scientific Research Program of China [2014CB964701]; National Natural Science Funding of China [31272311, 31330034]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; Fundamental Research Funds for the Central Universities [GK201402057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112778, P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Scientific Research Program of China; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL112778 and 5P01HL110869. This work was also supported by the National Key Scientific Research Program of China (2014CB964701), National Natural Science Funding of China (31272311 and 31330034; to M.-S.Z.), the Moss Heart Fund, the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (to J. T. S.), and the Fundamental Research Funds for the Central Universities (GK201402057 to Y.-N.Q.).	Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dey NB, 2012, MOL CELL BIOCHEM, V368, P27, DOI 10.1007/s11010-012-1339-2; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Endo S, 1999, P NATL ACAD SCI USA, V96, P2467, DOI 10.1073/pnas.96.5.2467; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; HIMPENS B, 1989, J PHYSIOL-LONDON, V413, P489, DOI 10.1113/jphysiol.1989.sp017665; HIRATA M, 1990, J BIOL CHEM, V265, P1268; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moosmang S, 2005, PHARMACOL THERAPEUT, V106, P347, DOI 10.1016/j.pharmthera.2004.12.003; Morgado M, 2012, CELL MOL LIFE SCI, V69, P247, DOI 10.1007/s00018-011-0815-2; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Ogut O, 2003, J MOL CELL CARDIOL, V35, P347, DOI 10.1016/S0022-2828(03)00045-2; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; RAPOPORT RM, 1986, CIRC RES, V58, P407, DOI 10.1161/01.RES.58.3.407; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STRALFORS P, 1989, EUR J BIOCHEM, V180, P143, DOI 10.1111/j.1432-1033.1989.tb14624.x; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200	52	68	69	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22512	22523		10.1074/jbc.M113.525444	http://dx.doi.org/10.1074/jbc.M113.525444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951589	Green Published, hybrid			2022-12-28	WOS:000340593500060
J	Hanenberg, M; McAfoose, J; Kulic, L; Welt, T; Wirth, F; Parizek, P; Strobel, L; Cattepoel, S; Spani, C; Derungs, R; Maier, M; Pluckthun, A; Nitsch, RM				Hanenberg, Michael; McAfoose, Jordan; Kulic, Luka; Welt, Tobias; Wirth, Fabian; Parizek, Petra; Strobel, Lisa; Cattepoel, Susann; Spaeni, Claudia; Derungs, Rebecca; Maier, Marcel; Plueckthun, Andreas; Nitsch, Roger M.			Amyloid-beta Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT PROTEINS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; A-BETA; MOUSE MODEL; TRANSGENIC MICE; COMBINATORIAL LIBRARIES; ALBUMIN-BINDING; IMMUNOTHERAPY; ANTIBODIES	Passive immunization with anti-amyloid-beta peptide (A beta) antibodies is effective in animal models of Alzheimer disease. With the advent of efficient in vitro selection technologies, the novel class of designed ankyrin repeat proteins (DARPins) presents an attractive alternative to the immunoglobulin scaffold. DARPins are small and highly stable proteins with a compact modular architecture ideal for high affinity protein-protein interactions. In this report, we describe the selection, binding profile, and epitope analysis of A beta-specific DARPins. We further showed their ability to delay A beta aggregation and prevent A beta-mediated neurotoxicity in vitro. To demonstrate their therapeutic potential in vivo, mono-and trivalent A beta-specific DARPins (D23 and 3 x D23) were infused intracerebroventricularly into the brains of 11-month-old Tg2576 mice over 4 weeks. Both D23 and 3 x D23 treatments were shown to result in improved cognitive performance and reduced soluble A beta levels. These findings demonstrate the therapeutic potential of A beta-specific DARPins for the treatment of Alzheimer disease.	[Hanenberg, Michael; McAfoose, Jordan; Kulic, Luka; Welt, Tobias; Wirth, Fabian; Strobel, Lisa; Cattepoel, Susann; Spaeni, Claudia; Derungs, Rebecca; Nitsch, Roger M.] Univ Zurich, Div Psychiat Res, CH-8952 Schlieren, Switzerland; [Kulic, Luka] Univ Zurich, Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Kulic, Luka] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Parizek, Petra; Plueckthun, Andreas] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Maier, Marcel] Neurimmune Holding AG, CH-8952 Schlieren, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Nitsch, RM (corresponding author), Univ Zurich, Div Psychiat Res, Wagistr 12, CH-8952 Schlieren, Switzerland.	nitsch@bli.uzh.ch	Plückthun, Andreas/C-2746-2009; Späni, Claudia B./J-3237-2019	Plückthun, Andreas/0000-0003-4191-5306; Späni, Claudia B./0000-0002-7765-6150; Welt, Tobias/0000-0002-4793-9061	Swiss National Science Foundation; Forschungskredit grant of the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit grant of the University of Zurich	This work was supported in part by the Swiss National Science Foundation and a Forschungskredit grant of the University of Zurich. S. Cattepoel is now an employee of CSL Behring AG, but declares no competing interests. M. Maier is now an employee of Neurimmune Holding AG, but declares no competing interests. A. Pluckthun is a shareholder of Molecular Partners, commercializing the DARPin technology.	Amstutz P, 2005, J BIOL CHEM, V280, P24715, DOI 10.1074/jbc.M501746200; Arendash GW, 2001, DNA CELL BIOL, V20, P737, DOI 10.1089/10445490152717604; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Biscaro B, 2009, J NEUROSCI, V29, P14108, DOI 10.1523/JNEUROSCI.2055-09.2009; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Cattepoel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018296; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Colcher D, 1998, Q J NUCL MED, V42, P225; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kohl A, 2005, STRUCTURE, V13, P1131, DOI 10.1016/j.str.2005.04.020; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; Mohajeri MH, 2002, J BIOL CHEM, V277, P33012, DOI 10.1074/jbc.M203193200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nguyen A, 2006, PROTEIN ENG DES SEL, V19, P291, DOI 10.1093/protein/gzl011; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Ramakrishnan M, 2009, BIOCHEMISTRY-US, V48, P10405, DOI 10.1021/bi900523q; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Vitalis A, 2010, J MOL BIOL, V403, P148, DOI 10.1016/j.jmb.2010.08.003; Wang A, 2011, J NEUROSCI, V31, P4124, DOI 10.1523/JNEUROSCI.5077-10.2011; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wilcock DM, 2006, J NEUROSCI, V26, P5340, DOI 10.1523/JNEUROSCI.0695-06.2006; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	47	16	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27080	27089		10.1074/jbc.M114.564013	http://dx.doi.org/10.1074/jbc.M114.564013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118284	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000342853900035
J	Kim, JY; Hwang, JY; Lee, DY; Song, EH; Park, KJ; Kim, GH; Jeong, EA; Lee, YJ; Go, MJ; Kim, DJ; Lee, SS; Kim, BJ; Song, J; Roh, GS; Gao, B; Kim, WH				Kim, Ji Yeon; Hwang, Joo-Yeon; Lee, Dae Yeon; Song, Eun Hyun; Park, Keon Jae; Kim, Gyu Hee; Jeong, Eun Ae; Lee, Yoo Jeong; Go, Min Jin; Kim, Dae Jin; Lee, Seong Su; Kim, Bong-Jo; Song, Jihyun; Roh, Gu Seob; Gao, Bin; Kim, Won-Ho			Chronic Ethanol Consumption Inhibits Glucokinase Transcriptional Activity by Atf3 and Triggers Metabolic Syndrome in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; GENE-EXPRESSION; GLUCOSE; CELLS; PDX-1; DYSFUNCTION; PROGRESSION; ASSOCIATION	Chronic ethanol consumption induces pancreatic beta-cell dysfunction through glucokinase (Gck) nitration and down-regulation, leading to impaired glucose tolerance and insulin resistance, but the underlying mechanism remains largely unknown. Here, we demonstrate that Gck gene expression and promoter activity in pancreatic beta-cells were suppressed by chronic ethanol exposure in vivo and in vitro, whereas expression of activating transcription factor 3 (Atf3) and its binding to the putative Atf/Creb site (from -287 to -158 bp) on the Gck promoter were up-regulated. Furthermore, in vitro ethanol-induced Atf3 inhibited the positive effect of Pdx-1 on Gck transcriptional regulation, enhanced recruitment of Hdac1/2 and histone H3 deacetylation, and subsequently augmented the interaction of Hdac1/Pdx-1 on the Gck promoter, which were diminished by Atf3 siRNA. In vivo Atf3-silencing reversed ethanol-mediated Gck down-regulation and beta-cell dysfunction, followed by the amelioration of impaired glucose tolerance and insulin resistance. Together, we identified that ethanol-induced Atf3 fosters beta-cell dysfunction via Gck down-regulation and that its loss ameliorates metabolic syndrome and could be a potential therapeutic target in treating type 2 diabetes. The Atf3 gene is associated with the induction of type 2 diabetes and alcohol consumption-induced metabolic impairment and thus may be the major negative regulator for glucose homeostasis.	[Kim, Ji Yeon; Lee, Dae Yeon; Song, Eun Hyun; Park, Keon Jae; Kim, Gyu Hee; Jeong, Eun Ae; Lee, Yoo Jeong; Song, Jihyun; Kim, Won-Ho] Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, Cheongwon Gun 363951, Chungbuk, South Korea; [Hwang, Joo-Yeon; Go, Min Jin; Kim, Bong-Jo] Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genom Sci, Cheongwon Gun 363951, Chungbuk, South Korea; [Kim, Dae Jin] Catholic Univ, Coll Med, Dept Psychiat, Puchon 420743, South Korea; [Lee, Seong Su] Catholic Univ, Coll Med, Dept Endocrinol, Puchon 420743, South Korea; [Roh, Gu Seob] Gyeongsang Natl Univ, Inst Hlth Sci, Dept Anat & Neurobiol, Jinju 660751, Gyeongnam, South Korea; [Lee, Dae Yeon] Korea Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Park, Keon Jae] Chungbuk Natl Univ, Div Cardiol, Dept Internal Med, Sch Med, Cheongju 361763, South Korea; [Gao, Bin] NIAAA, Lab Liver Dis, Bethesda, MD 20892 USA	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Catholic University of Korea; Catholic University of Korea; Gyeongsang National University; Korea University; Chungbuk National University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kim, WH (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Div Metab Dis, 187 Osong Saengmyeong2 Ro, Cheongwon Gun 363951, Chungbuk, South Korea.	jhkwh@nih.go.kr		Song, Eun Hyeon/0000-0001-9524-2595; song, jihyun/0000-0003-0420-2374; Kim, Won-Ho/0000-0002-4849-472X	Korean National Institutes of Health [4845-302-210-13]	Korean National Institutes of Health	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Research Grant 4845-302-210-13 from the Korean National Institutes of Health.	Adaramoye OA, 2012, W INDIAN MED J, V61, P3, DOI 10.7727/wimj.2011.111; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bolcato-Bellemin AL, 2007, P NATL ACAD SCI USA, V104, P16050, DOI 10.1073/pnas.0707831104; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Dolganiuc A, 2009, WORLD J GASTROENTERO, V15, P1168, DOI 10.3748/wjg.15.1168; Fueki Y, 2007, CLIN CHIM ACTA, V382, P71, DOI 10.1016/j.cca.2007.03.027; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Kim JY, 2013, CELL SIGNAL, V25, P2348, DOI 10.1016/j.cellsig.2013.07.028; Kim JY, 2010, J BIOL CHEM, V285, P37251, DOI 10.1074/jbc.M110.142315; Kim JY, 2010, J MOL BIOL, V397, P917, DOI 10.1016/j.jmb.2010.02.016; Kim JW, 2012, J BIOL CHEM, V287, P7780, DOI 10.1074/jbc.M111.278465; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim WH, 2001, FASEB J, V15, P2551, DOI 10.1096/fj.01-0217; Kim WH, 2011, BIOCHEM BIOPH RES CO, V414, P681, DOI 10.1016/j.bbrc.2011.09.132; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Matschinsky FM, 2006, DIABETES, V55, P1; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2003, J BIOL CHEM, V278, P19660, DOI 10.1074/jbc.M212375200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Onishi Y, 2003, BIOCHEM BIOPH RES CO, V303, P788, DOI 10.1016/S0006-291X(03)00407-8; Pochareddy S, 2012, ALCOHOL CLIN EXP RES, V36, P1021, DOI 10.1111/j.1530-0277.2011.01677.x; Roh WG, 2009, ALCOHOL, V43, P643, DOI 10.1016/j.alcohol.2009.10.005; Sioud M, 2005, METH MOL B, V309, P237; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Szabo Gyongyi, 2008, V447, P113, DOI 10.1007/978-1-59745-242-7_9; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Zhao LN, 2009, BRIT J NUTR, V101, P1467, DOI 10.1017/S0007114508094646	39	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27065	27079		10.1074/jbc.M114.585653	http://dx.doi.org/10.1074/jbc.M114.585653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074928	hybrid, Green Published			2022-12-28	WOS:000342853900034
J	Kendall, RT; Lee, MH; Pleasant, DL; Robinson, K; Kuppuswamy, D; McDermott, PJ; Luttrell, LM				Kendall, Ryan T.; Lee, Mi-Hye; Pleasant, Dorea L.; Robinson, Katherine; Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.			Arrestin-dependent Angiotensin AT(1) Receptor Signaling Regulates Akt and mTor-mediated Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; PHOSPHORYLATION; ACTIVATION; KINASE; PATHWAYS; ERK; COMPLEX; BETA-ARRESTIN-2; MECHANISMS; CONVERGE	Control of protein synthesis is critical to both cell growth and proliferation. The mammalian target of rapamycin (mTOR) integrates upstream growth, proliferation, and survival signals, including those transmitted via ERK1/2 and Akt, to regulate the rate of protein translation. The angiotensin AT(1) receptor has been shown to activate both ERK1/2 and Akt in arrestin-based signalsomes. Here, we examine the role of arrestin-dependent regulation of ERK1/2 and Akt in the stimulation of mTOR-dependent protein translation by the AT(1) receptor using HEK293 and primary vascular smooth muscle cell models. Nascent protein synthesis stimulated by both the canonical AT(1) receptor agonist angiotensin II (AngII), and the arrestin pathway-selective agonist [Sar(1)-Ile(4)-Ile(8)] AngII (SII), is blocked by shRNA silencing of beta arrestin1/2 or pharmacological inhibition of Akt, ERK1/2, or mTORC1. In HEK293 cells, SII activates a discrete arrestin-bound pool of Akt and promotes Akt-dependent phosphorylation of mTOR and its downstream effector p70/p85 ribosomal S6 kinase (p70/85S6K). In parallel, SII-activated ERK1/2 helps promote mTOR and p70/85S6K phosphorylation, and is required for phosphorylation of the known ERK1/2 substrate p90 ribosomal S6 kinase (p90RSK). Thus, arrestins coordinate AT(1) receptor regulation of ERK1/2 and Akt activity and stimulate protein translation via both Akt-mTOR-p70/85S6K and ERK1/2-p90RSK pathways. These results suggest that in vivo, arrestin pathway-selective AT(1) receptor agonists may promote cell growth or hypertrophy through arrestin-mediated mechanisms despite their antagonism of G protein signaling.	[Kendall, Ryan T.; Lee, Mi-Hye; Pleasant, Dorea L.; Robinson, Katherine; Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Kuppuswamy, Dhandapani; McDermott, Paul J.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, Dept Med, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949; Jenkins, Dorea/0000-0001-9510-8601	National Institutes of Health [5K12GM081265, 5R01DK055524]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643, K12GM081265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5K12GM081265 (to R. T. K.) and 5R01DK055524 (to L. M. L.), and the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kim J, 2008, CIRC RES, V103, P70, DOI 10.1161/CIRCRESAHA.108.172338; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2013, PROG MOL BIOL TRANSL, V118, P115, DOI 10.1016/B978-0-12-394440-5.00005-X; Lymperopoulos A, 2013, PROG MOL BIOL TRANSL, V118, P297, DOI 10.1016/B978-0-12-394440-5.00012-7; Lymperopoulos A, 2011, J AM COLL CARDIOL, V57, P356, DOI [10.1016/j.jacc.2010.08.635, 10.1016/j.yjmcc.2010.08.014]; Lymperopoulos A, 2009, P NATL ACAD SCI USA, V106, P5825, DOI 10.1073/pnas.0811706106; Monasky MM, 2013, AM J PHYSIOL-HEART C, V305, pH856, DOI 10.1152/ajpheart.00327.2013; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	44	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26155	26166		10.1074/jbc.M114.595728	http://dx.doi.org/10.1074/jbc.M114.595728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25081544	Green Published, hybrid			2022-12-28	WOS:000342128800012
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Cysteines Introduced into Extracellular Loops 1 and 4 of Human P-Glycoprotein That Are Close Only in the Open Conformation Spontaneously Form a Disulfide Bond That Inhibits Drug Efflux and ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; TRANSMEMBRANE SEGMENTS; MONOCLONAL-ANTIBODY; ELECTRON-MICROSCOPY; CROSS-LINKING; SITES; HYDROLYSIS	P-glycoprotein (P-gp) is an ATP-binding cassette drug pump that protects us from toxic compounds and confers multidrug resistance. The protein is organized into two halves. The halves contain a transmembrane domain(TMD) with six transmembrane segments and a nucleotide-binding domain (NBD). The drug-and ATP-binding sites reside at the TMD1/TMD2 and NBD1/NBD2 interfaces, respectively. ATP-dependent drug efflux involves changes between the open inward-facing (NBDs apart, extracellular loops (ECLs) close together) and the closed outward-facing (NBDs close together, ECLs apart) conformations. It is controversial, however, whether the open conformation only exists transiently in intact cells because of the presence of high levels of ATP. To test for the presence of an open conformation in intact cells, reporter cysteines were placed in extracellular loops 1 (A80C, N half) and 4 (R741C, Chalf). The rationale was that cysteines A80C/R741C would only come close enough to form a disulfide bond in an open conformation (6.9 angstrom apart) because they are separated widely (30.4 angstrom apart) in the closed conformation. It was observed that the mutant A80C/R741C cross-linked spontaneously (>90%) when expressed in cells. In contrast to previous reports showing that trapping P-gp in a closed conformation highly activated ATPase activity, here we show that A80C/R741C cross-linking inhibited ATPase activity and drug efflux. Both activities were restored when the cross-linked mutant was treated with a thiol-reducing agent. The results show that an open conformation can be readily detected in cells and that cross-linking of cysteines placed in ECLs 1 and 4 inhibits activity.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Cir,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research; Canada Research Chair in Membrane Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Membrane Biology	This work was supported by a grant from the Canadian Institutes of Health Research (to D. M. C.).	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DeLano W.L, PYMOL MOL GRAPHICS S; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Gannon MK, 2009, J MED CHEM, V52, P3328, DOI 10.1021/jm900253g; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, BIOCHEMISTRY-US, V46, P9328, DOI 10.1021/bi700837y; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Loo TW, 2014, J BIOL CHEM, V289, P8484, DOI 10.1074/jbc.M114.552075; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2000, J BIOL CHEM, V275, P19435, DOI 10.1074/jbc.C000222200; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; MICKISCH GH, 1992, CANCER RES, V52, P4427; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; STEVENS R, 1983, BIOCHEM EDUC, V11, P70, DOI 10.1016/0307-4412(83)90048-1; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z	61	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24749	24758		10.1074/jbc.M114.583021	http://dx.doi.org/10.1074/jbc.M114.583021			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053414	hybrid, Green Published			2022-12-28	WOS:000341985300002
J	Emptage, RP; Tonthat, NK; York, JD; Schumacher, MA; Zhou, P				Emptage, Ryan P.; Tonthat, Nam K.; York, John D.; Schumacher, Maria A.; Zhou, Pei			Structural Basis of Lipid Binding for the Membrane-embedded Tetraacyldisaccharide-1-phosphate 4 '-Kinase LpxK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme; Lipid A; Lipid-binding Protein; Lipopolysaccharide (LPS); Membrane Protein; Antibiotic; Lipid Kinase	ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; LIPOPOLYSACCHARIDE; ENDOTOXIN; KINASE; CLASSIFICATION; BIOSYNTHESIS; PRECURSOR; PROTEINS	Background: LpxK is an essential membrane-bound kinase in the lipid A biosynthetic pathway. Results: Structural and kinetic studies reveal the molecular basis of lipid binding. Conclusion: The LpxK active site recognizes the lipid's glucosamine/phosphate headgroups and only accommodates disaccharides. Significance: These studies provide a structural template for designing novel antibiotics and a glimpse of catalysis at the membrane interface. The membrane-bound tetraacyldisaccharide-1-phosphate 4-kinase, LpxK, catalyzes the sixth step of the lipid A (Raetz) biosynthetic pathway and is a viable antibiotic target against emerging Gram-negative pathogens. We report the crystal structure of lipid IVA, the LpxK product, bound to the enzyme, providing a rare glimpse into interfacial catalysis and the surface scanning strategy by which many poorly understood lipid modification enzymes operate. Unlike the few previously structurally characterized proteins that bind lipid A or its precursors, LpxK binds almost exclusively to the glucosamine/phosphate moieties of the lipid molecule. Steady-state kinetic analysis of multiple point mutants of the lipid-binding pocket pinpoints critical residues involved in substrate binding, and characterization of N-terminal helix truncation mutants uncovers the role of this substructure as a hydrophobic membrane anchor. These studies make critical contributions to the limited knowledge surrounding membrane-bound enzymes that act upon lipid substrates and provide a structural template for designing small molecule inhibitors targeting this essential kinase.	[Emptage, Ryan P.; Tonthat, Nam K.; Schumacher, Maria A.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [York, John D.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37205 USA	Duke University; Vanderbilt University	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health Grant [GM-51310, AI-055588]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM051310] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-51310 (to C. R. H. R. and P. Z.) and AI-055588 (to P. Z.). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, and the Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Emptage RP, 2013, BIOCHEMISTRY-US, V52, P2280, DOI 10.1021/bi400097z; Emptage RP, 2012, P NATL ACAD SCI USA, V109, P12956, DOI 10.1073/pnas.1206072109; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Huang CY, 2012, P NATL ACAD SCI USA, V109, P6496, DOI 10.1073/pnas.1203900109; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Lavogina D, 2010, CHEMMEDCHEM, V5, P23, DOI 10.1002/cmdc.200900252; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Mamat U, 2009, J BIOL CHEM, V284, P22248, DOI 10.1074/jbc.M109.033308; Metzger LE, 2012, NAT STRUCT MOL BIOL, V19, P1132, DOI 10.1038/nsmb.2393; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Plotz BM, 2000, J BIOL CHEM, V275, P11222, DOI 10.1074/jbc.275.15.11222; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAY BL, 1987, J BIOL CHEM, V262, P1122; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tresaugues L, 2014, STRUCTURE, V22, P744, DOI 10.1016/j.str.2014.01.013; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	37	8	8	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24059	24068		10.1074/jbc.M114.589986	http://dx.doi.org/10.1074/jbc.M114.589986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023290	Green Published, hybrid			2022-12-28	WOS:000341505600006
J	Howes, JM; Bihan, D; Slatter, DA; Hamaia, SW; Packman, LC; Knauper, V; Visse, R; Farndale, RW				Howes, Joanna-Marie; Bihan, Dominique; Slatter, David A.; Hamaia, Samir W.; Packman, Len C.; Knauper, Vera; Visse, Robert; Farndale, Richard W.			The Recognition of Collagen and Triple-helical Toolkit Peptides by MMP-13 SEQUENCE SPECIFICITY FOR BINDING AND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Matrix Metalloproteinase (MMP); Protease; Protein Conformation; Substrate Specificity; MMP-13; Toolkit Peptides; Collagenolysis; Hemopexin Domain	C-TERMINAL DOMAIN; MATRIX METALLOPROTEINASE-13; MAMMALIAN COLLAGENASES; SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; ACTIVATION; SITES; ORGANIZATION; PROTEOLYSIS; HYDROLYSIS	Background: MMP-13 recognizes poorly-defined sequences in collagens. Results: MMP-13 binds key residues in the canonical cleavage site and another site near the collagen N terminus. Conclusion: MMP-1 and MMP-13 differ in their recognition and cleavage of collagen, which is regulated primarily through the Hpx domain of MMP-13. Significance: Our data explain the preference of MMP-13 for collagen II. Remodeling of collagen by matrix metalloproteinases (MMPs) is crucial to tissue homeostasis and repair. MMP-13 is a collagenase with a substrate preference for collagen II over collagens I and III. It recognizes a specific, well-known site in the tropocollagen molecule where its binding locally perturbs the triple helix, allowing the catalytic domain of the active enzyme to cleave the collagen chains sequentially, at Gly(775)-Leu(776) in collagen II. However, the specific residues upon which collagen recognition depends within and surrounding this locus have not been systematically mapped. Using our triple-helical peptide Collagen Toolkit libraries in solid-phase binding assays, we found that MMP-13 shows little affinity for Collagen Toolkit III, but binds selectively to two triple-helical peptides of Toolkit II. We have identified the residues required for the adhesion of both proMMP-13 and MMP-13 to one of these, Toolkit peptide II-44, which contains the canonical collagenase cleavage site. MMP-13 was unable to bind to a linear peptide of the same sequence as II-44. We also discovered a second binding site near the N terminus of collagen II (starting at helix residue 127) in Toolkit peptide II-8. The pattern of binding of the free hemopexin domain of MMP-13 was similar to that of the full-length enzyme, but the free catalytic subunit bound none of our peptides. The susceptibility of Toolkit peptides to proteolysis in solution was independent of the very specific recognition of immobilized peptides by MMP-13; the enzyme proved able to cleave a range of dissolved collagen peptides.	[Howes, Joanna-Marie; Bihan, Dominique; Slatter, David A.; Hamaia, Samir W.; Packman, Len C.; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Knauper, Vera] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Visse, Robert] Kennedy Inst, London W6 8LH, England	University of Cambridge; Cardiff University; University of Oxford	Farndale, RW (corresponding author), Univ Cambridge, Dept Biochem, Downing Site, Cambridge CB2 1QW, England.	rwf10@cam.ac.uk	Slatter, David/AAV-5771-2020; Slatter, David/AAW-6938-2021	Knauper, Vera/0000-0002-3965-9924	British Heart Foundation Grants [RG/009/003/27122, NH/11/1/28922]; Medical Research Council; Wellcome Trust; British Heart Foundation [RG/09/003/27122, NH/11/1/28922] Funding Source: researchfish	British Heart Foundation Grants; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants RG/009/003/27122 and NH/11/1/28922, and peptide synthesis, by grants from the Medical Research Council and Wellcome Trust.	Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219; Hijova E, 2005, Bratisl Lek Listy, V106, P127; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kennedy AM, 2005, J CLIN INVEST, V115, P2832, DOI 10.1172/JCI22900; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Rawlings ND, 2009, LARGE ACCURATE COLLE; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rosenblum G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011043; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545; Slatter DA, 2012, PEPTIDES, V36, P86, DOI 10.1016/j.peptides.2012.04.013; Steplewski A, 2007, J STRUCT BIOL, V157, P297, DOI 10.1016/j.jsb.2006.10.009; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	41	38	39	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24091	24101		10.1074/jbc.M114.583443	http://dx.doi.org/10.1074/jbc.M114.583443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008319	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000341505600009
J	Kaya, AI; Lokits, AD; Gilbert, JA; Iverson, TM; Meiler, J; Hamm, HE				Kaya, Ali I.; Lokits, Alyssa D.; Gilbert, James A.; Iverson, Tina M.; Meiler, Jens; Hamm, Heidi E.			A Conserved Phenylalanine as a Relay between the alpha 5 Helix and the GDP Binding Region of Heterotrimeric G(i) Protein alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; G Protein-coupled Receptor (GPCR); Heterotrimeric G Protein; Protein Conformation; Rhodopsin; Signal Transduction; GDP Release	CRYSTAL-STRUCTURE; BETA-GAMMA; NUCLEOTIDE EXCHANGE; RECEPTOR; ACTIVATION; G(I-ALPHA-1); TRANSDUCIN; RHODOPSIN; MODEL; GTP	Background: GPCRs regulate heterotrimeric G protein activation. However, the intermediate steps regulating GDP release are still unknown. Results: Energy analysis pinpoints information flow through G-receptor interaction and GDP release. Conclusion: Hydrophobic interactions around 5 helix, 2-3 strands, and 1 helix are key for GDP stability. Significance: G protein activation defines regulation of high affinity receptor interactions and plays a role defining different cellular responses. G protein activation by G protein-coupled receptors is one of the critical steps for many cellular signal transduction pathways. Previously, we and other groups reported that the 5 helix in the G protein subunit plays a major role during this activation process. However, the precise signaling pathway between the 5 helix and the guanosine diphosphate (GDP) binding pocket remains elusive. Here, using structural, biochemical, and computational techniques, we probed different residues around the 5 helix for their role in signaling. Our data showed that perturbing the Phe-336 residue disturbs hydrophobic interactions with the 2-3 strands and 1 helix, leading to high basal nucleotide exchange. However, mutations in strands 5 and 6 do not perturb G protein activation. We have highlighted critical residues that leverage Phe-336 as a relay. Conformational changes are transmitted starting from Phe-336 via 2-3/1 to Switch I and the phosphate binding loop, decreasing the stability of the GDP binding pocket and triggering nucleotide release. When the 1 and 5 helices were cross-linked, inhibiting the receptor-mediated displacement of the C-terminal 5 helix, mutation of Phe-336 still leads to high basal exchange rates. This suggests that unlike receptor-mediated activation, helix 5 rotation and translocation are not necessary for GDP release from the subunit. Rather, destabilization of the backdoor region of the G subunit is sufficient for triggering the activation process.	[Kaya, Ali I.; Gilbert, James A.; Iverson, Tina M.; Meiler, Jens; Hamm, Heidi E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Lokits, Alyssa D.] Vanderbilt Univ, Med Ctr, Dept Neurosci, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.hamm@vanderbilt.edu	Hamm, Heidi E/G-2374-2014	Meiler, Jens/0000-0001-8945-193X	National Institutes of Health [EY006062, GM095633, GM080403, MH090192, GM099842, DK097376, S10 RR026915]; National Institutes of Science [BIO Career 0742762, CHE 1305874]; U.S. Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099842, R01GM080403, R01GM095633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; Division Of Chemistry [1305874] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY006062 (to H. E. H.); GM095633 (to T. M. I.); GM080403, MH090192, GM099842, and DK097376 (to J. M.); and S10 RR026915 (to Vanderbilt Robotic Crystallization Facility). This work was also supported by National Institutes of Science Grants BIO Career 0742762 and CHE 1305874 (to J. M.), U.S. Department of Energy Contract DE-AC02-06CH11357, funds from the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817.	Abdulaev NG, 2005, J BIOL CHEM, V280, P38071, DOI 10.1074/jbc.M505259200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Johnston CA, 2008, PLANT SIGNAL BEHAV, V3, P1067, DOI 10.4161/psb.3.12.7184; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Louet M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002595; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Sovik O, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049361; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thaker TM, 2012, METHODS MOL BIOL, V796, P133, DOI 10.1007/978-1-61779-334-9_8; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	53	33	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24475	24487		10.1074/jbc.M114.572875	http://dx.doi.org/10.1074/jbc.M114.572875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037222	Green Published, hybrid			2022-12-28	WOS:000341505600040
J	Lin, A; Man, HY				Lin, Amy; Man, Heng-Ye			Endocytic Adaptor Epidermal Growth Factor Receptor Substrate 15 (Eps15) Is Involved in the Trafficking of Ubiquitinated alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor (AMPA receptor; AMPAR); Receptor Internalization; Trafficking; Ubiquitylation (Ubiquitination); EPS15; Nedd4	ACTIVITY-DEPENDENT UBIQUITINATION; HOMEOSTATIC REGULATION; GLUTAMATE RECEPTORS; TERMINAL DOMAIN; AMPA RECEPTORS; DEGRADATION; DETERMINANTS; ABUNDANCE; PATHWAYS; BINDING	Background: AMPAR trafficking plays an important role in synaptic plasticity, but how ubiquitinated AMPARs internalize remains largely unknown. Results: The endocytic adaptor EPS15 interacts with ubiquitinated AMPARs and facilitates receptor internalization. Conclusion: EPS15 is required for the internalization of ubiquitinated AMPARs. Significance: Selective targeting of a distinct pool of surface AMPARs for internalization provides novel insights into the mechanisms of synaptic regulation. AMPA-type glutamate receptors (AMPARs) play a critical role in mediating fast excitatory synaptic transmission in the brain. Alterations in receptor expression, distribution, and trafficking have been shown to underlie synaptic plasticity and higher brain functions, including learning and memory, as well as brain dysfunctions such as drug addiction and psychological disorders. Therefore, it is essential to elucidate the molecular mechanisms that regulate AMPAR dynamics. We have shown previously that mammalian AMPARs are subject to posttranslational modification by ubiquitin, with AMPAR ubiquitination enhancing receptor internalization and reducing AMPAR cell surface expression. Here we report a crucial role for epidermal growth factor receptor substrate 15 (Eps15), an endocytic adaptor, in ubiquitination-dependent AMPAR internalization. We find that suppression or overexpression of Eps15 results in changes in AMPAR surface expression. Eps15 interacts with AMPARs, which requires Nedd4-mediated GluA1 ubiquitination and the ubiquitin-interacting motif of Eps15. Importantly, we find that Eps15 plays an important role in AMPAR internalization. Knockdown of Eps15 suppresses the internalization of GluA1 but not the mutant GluA1 that lacks ubiquitination sites, indicating a role of Eps15 for the internalization of ubiquitinated AMPARs. These results reveal a novel molecular mechanism employed specifically for the trafficking of the ubiquitin-modified AMPARs.	[Lin, Amy; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Man, HY (corresponding author), Dept Biol, 5 Cummington Mall, Boston, MA 02115 USA.	hman@bu.edu			National Institutes of Health [MH 079407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH 079407 (to H. Y.M.).	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Jarzylo LA, 2012, J NEUROSCI, V32, P2552, DOI 10.1523/JNEUROSCI.3237-11.2012; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Madshus IH, 2006, TRAFFIC, V7, P258, DOI 10.1111/j.1600-0854.2006.00393.x; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364	42	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24652	24664		10.1074/jbc.M114.582114	http://dx.doi.org/10.1074/jbc.M114.582114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023288	hybrid, Green Published			2022-12-28	WOS:000341505600055
J	Yuyama, K; Sun, H; Sakai, S; Mitsutake, S; Okada, M; Tahara, H; Furukawa, J; Fujitani, N; Shinohara, Y; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Okada, Megumi; Tahara, Hidetoshi; Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro; Igarashi, Yasuyuki			Decreased Amyloid-beta Pathologies by Intracerebral Loading of Glycosphingolipid-enriched Exosomes in Alzheimer Model Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (AB); Exosome; Glycolipid; Microglia	CELLULAR GLYCOMICS; ALPHA-SYNUCLEIN; GM1 GANGLIOSIDE; MOUSE MODEL; IN-VIVO; PROTEIN; DISEASE; BRAIN; ACCUMULATION; CELLS	Background: Exosome, a type of extracellular vesicles, can associate with A in vitro. Results: Intracerebrally injected exosomes trapped A on surface glycosphingolipids and transported it into microglia in AD mouse brains, resulting in reductions in A pathology. Conclusion: Exogenous exosomes act as potent scavengers for A in mouse brains. Significance: The findings provide a novel therapeutic approach for AD. Elevated levels of amyloid- peptide (A) in the human brain are linked to the pathogenesis of Alzheimer disease. Recent in vitro studies have demonstrated that extracellular A can bind to exosomes, which are cell-secreted nanovesicles with lipid membranes that are known to transport their cargos intercellularly. Such findings suggest that the exosomes are involved in A metabolism in brain. Here, we found that neuroblastoma-derived exosomes exogenously injected into mouse brains trapped A and with the associated A were internalized into brain-resident phagocyte microglia. Accordingly, continuous intracerebral administration of the exosomes into amyloid- precursor protein transgenic mice resulted in marked reductions in A levels, amyloid depositions, and A-mediated synaptotoxicity in the hippocampus. In addition, we determined that glycosphingolipids (GSLs), a group of membrane glycolipids, are highly abundant in the exosomes, and the enriched glycans of the GSLs are essential for A binding and assembly on the exosomes both in vitro and in vivo. Our data demonstrate that intracerebrally administered exosomes can act as potent scavengers for A by carrying it on the exosome surface GSLs and suggest a role of exosomes in A clearance in the central nervous system. Improving A clearance by exosome administration would provide a novel therapeutic intervention for Alzheimer disease.	[Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Yuyama, Kohei; Sun, Hui; Sakai, Shota; Mitsutake, Susumu; Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro; Igarashi, Yasuyuki] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0010021, Japan; [Mitsutake, Susumu] Saga Univ, Dept Appl Biochem & Food Sci, Fac Agr, Saga 8408502, Japan; [Okada, Megumi; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima 7348553, Japan; [Furukawa, Jun-ichi; Fujitani, Naoki; Shinohara, Yasuro] Hokkaido Univ, Grad Sch Adv Life Sci, Lab Med & Funct Glyc, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; Saga University; Hiroshima University; Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Grad Sch Adv Life Sci, Lab Biomembrane & Biofunct Chem, Kita21 Nishi11, Sapporo, Hokkaido 000021, Japan.	yigarash@pharm.hokudai.ac.jp	Tahara, Hidetoshi/G-7697-2019; Mitsutake, Susumu/A-4082-2012	Fujitani, Naoki/0000-0002-4035-7317	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [221S0001, 26440041] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of this work was conducted at Hokkaido University, supported by "Nanotechnology Platform" Program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Fujitani N, 2011, J BIOL CHEM, V286, P41669, DOI 10.1074/jbc.M111.301796; Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Takata K, 2007, EUR J NEUROSCI, V26, P2458, DOI 10.1111/j.1460-9568.2007.05852.x; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996; Yanagisawa K, 2002, ANN NY ACAD SCI, V977, P384, DOI 10.1111/j.1749-6632.2002.tb04841.x; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Yuyama K, 2010, NEUROSCI LETT, V481, P168, DOI 10.1016/j.neulet.2010.06.080; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	42	200	205	4	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24488	24498		10.1074/jbc.M114.577213	http://dx.doi.org/10.1074/jbc.M114.577213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037226	hybrid, Green Published			2022-12-28	WOS:000341505600041
J	Kenniston, JA; Faucette, RR; Martik, D; Comeau, SR; Lindberg, AP; Kopacz, KJ; Conley, GP; Chen, J; Viswanathan, M; Kastrapeli, N; Cosic, J; Mason, S; DiLeo, M; Abendroth, J; Kuzmic, P; Ladner, RC; Edwards, TE; TenHoor, C; Adelman, BA; Nixon, AE; Sexton, DJ				Kenniston, Jon A.; Faucette, Ryan R.; Martik, Diana; Comeau, Stephen R.; Lindberg, Allison P.; Kopacz, Kris J.; Conley, Gregory P.; Chen, Jie; Viswanathan, Malini; Kastrapeli, Niksa; Cosic, Janja; Mason, Shauna; DiLeo, Mike; Abendroth, Jan; Kuzmic, Petr; Ladner, Robert C.; Edwards, Thomas E.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.; Sexton, Daniel J.			Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Enzyme Inhibitor; Inflammation; Kallikrein; Protease	MOLECULAR-WEIGHT KININOGEN; INDUCED PAW EDEMA; HEREDITARY ANGIOEDEMA; FACTOR-XII; CONTACT SYSTEM; C1-ESTERASE INHIBITOR; BLOOD-COAGULATION; C1 INHIBITOR; IN-VITRO; ACTIVATION	Background: Unregulated plasma kallikrein proteolytic activity can result from C1-inhibitor deficiency, causing excessive and potentially fatal edema. Results: The antibody DX-2930 potently and specifically inhibits plasma kallikrein and exhibits a long plasma half-life. Conclusion: An antibody protease inhibitor can lead to potent and specific bioactivity. Significance: DX-2930 could be an effective therapeutic for the prophylactic inhibition of plasma kallikrein-mediated diseases. Plasma kallikrein (pKal) proteolytically cleaves high molecular weight kininogen to generate the potent vasodilator and the pro-inflammatory peptide, bradykinin. pKal activity is tightly regulated in healthy individuals by the serpin C1-inhibitor, but individuals with hereditary angioedema (HAE) are deficient in C1-inhibitor and consequently exhibit excessive bradykinin generation that in turn causes debilitating and potentially fatal swelling attacks. To develop a potential therapeutic agent for HAE and other pKal-mediated disorders, we used phage display to discover a fully human IgG1 monoclonal antibody (DX-2930) against pKal. In vitro experiments demonstrated that DX-2930 potently inhibits active pKal (K-i = 0.120 +/- 0.005 nm) but does not target either the zymogen (prekallikrein) or any other serine protease tested. These findings are supported by a 2.1- resolution crystal structure of pKal complexed to a DX-2930 Fab construct, which establishes that the pKal active site is fully occluded by the antibody. DX-2930 injected subcutaneously into cynomolgus monkeys exhibited a long half-life (t(1/2) approximate to 12.5 days) and blocked high molecular weight kininogen proteolysis in activated plasma in a dose- and time-dependent manner. Furthermore, subcutaneous DX-2930 reduced carrageenan-induced paw edema in rats. A potent and long acting inhibitor of pKal activity could be an effective treatment option for pKal-mediated diseases, such as HAE.	[Kenniston, Jon A.; Faucette, Ryan R.; Martik, Diana; Comeau, Stephen R.; Lindberg, Allison P.; Kopacz, Kris J.; Conley, Gregory P.; Chen, Jie; Viswanathan, Malini; Kastrapeli, Niksa; Cosic, Janja; Mason, Shauna; DiLeo, Mike; Ladner, Robert C.; TenHoor, Christopher; Adelman, Burt A.; Nixon, Andrew E.; Sexton, Daniel J.] Dyax Corp, Burlington, MA 01803 USA; [Abendroth, Jan; Edwards, Thomas E.] Beryllium, Bainbridge Isl, WA 98110 USA; [Kuzmic, Petr] Biokin, Watertown, MA 02472 USA		Sexton, DJ (corresponding author), Dyax Corp, 55 Network Dr, Burlington, MA 01803 USA.	dsexton@dyax.com		Kuzmic, Petr/0000-0001-5250-8381; Edwards, Thomas/0000-0002-0474-8003; Nixon, Andrew/0000-0002-6090-0583				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerji A, 2008, ANN ALLERG ASTHMA IM, V100, pS19, DOI 10.1016/S1081-1206(10)60582-0; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; Bernstein JA, 2010, EXPERT REV CLIN IMMU, V6, P29, DOI 10.1586/ECI.09.60; BERRETTINI M, 1986, BLOOD, V68, P455; Bird JE, 2012, THROMB HAEMOSTASIS, V107, P1141, DOI [10.1160/TH11-10-0682, 10.1160/TH-11-10-0682]; BOCK PE, 1985, J BIOL CHEM, V260, P2434; Bork K, 2006, AM J MED, V119, P267, DOI 10.1016/j.amjmed.2005.09.064; Bork K, 2008, ANN ALLERG ASTHMA IM, V100, P153, DOI 10.1016/S1081-1206(10)60424-3; Bork K, 2012, CURR ALLERGY ASTHM R, V12, P273, DOI 10.1007/s11882-012-0273-4; Bork Konrad, 2010, Allergy Asthma Clin Immunol, V6, P15, DOI 10.1186/1710-1492-6-15; Brown EW, 2002, BLOOD COAGUL FIBRIN, V13, P711, DOI 10.1097/00001721-200212000-00007; Caliezi C, 2000, PHARMACOL REV, V52, P91; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chyung Y, 2014, ANN ALLERG ASTHMA IM, V113, P460, DOI 10.1016/j.anai.2014.05.028; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Coppola R, 1996, BLOOD COAGUL FIBRIN, V7, P530, DOI 10.1097/00001721-199607000-00004; Crosby JR, 2013, ARTERIOSCL THROM VAS, V33, P1670, DOI 10.1161/ATVBAHA.113.301282; Cugno M, 1997, BLOOD, V89, P3213, DOI 10.1182/blood.V89.9.3213; Cugno M, 2001, BLOOD COAGUL FIBRIN, V12, P253, DOI 10.1097/00001721-200106000-00005; CUGNO M, 1995, THROMB RES, V78, P277, DOI 10.1016/0049-3848(95)00060-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandhi PK, 2012, PHARMACOTHERAPY, V32, P902, DOI 10.1002/j.1875-9114.2012.01126; Girolami A, 2010, EXPERT REV HEMATOL, V3, P685, DOI [10.1586/ehm.10.69, 10.1586/EHM.10.69]; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; HALL SW, 1991, J BIOL CHEM, V266, P12329; Heeb MJ, 1998, BLOOD CELL MOL DIS, V24, P411; Hekim C, 2006, J BIOL CHEM, V281, P12555, DOI 10.1074/jbc.M600014200; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Jostock T, 2004, J IMMUNOL METHODS, V289, P65, DOI 10.1016/j.jim.2004.03.014; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; KAUFMAN N, 1991, BLOOD, V77, P2660; KRUITHOF EKO, 1984, BLOOD, V64, P907; Kuzmic P, 2000, ANAL BIOCHEM, V286, P45, DOI 10.1006/abio.2000.4685; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; MAKEVNINA LG, 1994, BRAZ J MED BIOL RES, V27, P1955; MARKWARDT F, 1974, BIOCHEM PHARMACOL, V23, P2247, DOI 10.1016/0006-2952(74)90554-1; MARLAR RA, 1993, THROMB HAEMOSTASIS, V69, P16; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; MILLER RL, 1983, J NATL MED ASSOC, V75, P551; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen VG, 2006, J HEART LUNG TRANSPL, V25, P1247, DOI 10.1016/j.healun.2006.06.009; NILSSON T, 1983, EUR J BIOCHEM, V129, P663; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; Phipps JA, 2008, KIDNEY INT, V73, P1114, DOI 10.1038/ki.2008.9; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Porebski G, 2013, ALLERGY, V68, P1207, DOI 10.1111/all.12165; RAHMAN MM, 1995, ANN RHEUM DIS, V54, P345, DOI 10.1136/ard.54.5.345; Renne T, 2012, THROMB HAEMOSTASIS, V107, P1012, DOI 10.1160/TH12-04-0264; Revenko AS, 2011, BLOOD, V118, P5302, DOI 10.1182/blood-2011-05-355248; Sanchez J, 2008, THROMB RES, V122, P257, DOI 10.1016/j.thromres.2007.11.008; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Schousboe I, 2009, FEBS J, V276, P5228, DOI 10.1111/j.1742-4658.2009.07218.x; Sexton DJ, 2009, BIOCHEM J, V422, P383, DOI 10.1042/BJ20090010; Silverberg M, 1995, BLOOD PRINCIPLES PRA, P1127; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Stadnicki A, 1997, DIGEST DIS SCI, V42, P2356, DOI 10.1023/A:1018891323205; STEPHENS RW, 1991, SEMIN THROMB HEMOST, V17, P201, DOI 10.1055/s-2007-1002610; Stolz LE, 2012, EXPERT REV CLIN IMMU, V8, P25, DOI [10.1586/ECI.11.81, 10.1586/eci.11.81]; Sulikowski T, 2001, BLOOD COAGUL FIBRIN, V12, P75, DOI 10.1097/00001721-200101000-00011; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tapper H, 2000, BLOOD, V96, P2329; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; Wassaf D, 2006, ANAL BIOCHEM, V351, P241, DOI 10.1016/j.ab.2006.01.043; Weiser P, 2010, PROG MOL BIOL TRANSL, V93, P443, DOI [10.1016/S1S77-1173(10)93019-6, 10.1016/S1877-1173(10)93019-6]; White-Adams TC, 2010, J THROMB HAEMOST, V8, P1295, DOI 10.1111/j.1538-7836.2010.03850.x; WIRTH KJ, 1992, AGENT ACTION SUPPL, V38, P428; Woodruff RS, 2013, J THROMB HAEMOST, V11, P1364, DOI 10.1111/jth.12302; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Wuillemin WA, 1996, J BIOL CHEM, V271, P12913, DOI 10.1074/jbc.271.22.12913; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	79	73	94	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23596	23608		10.1074/jbc.M114.569061	http://dx.doi.org/10.1074/jbc.M114.569061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24970892	Green Published, hybrid			2022-12-28	WOS:000341505000029
J	Sakaguchi, M; Murata, H; Aoyama, Y; Hibino, T; Putranto, EW; Ruma, IMW; Inoue, Y; Sakaguchi, Y; Yamamoto, K; Kinoshita, R; Futami, J; Kataoka, K; Iwatsuki, K; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Aoyama, Yumi; Hibino, Toshihiko; Putranto, Endy Widya; Ruma, I. Made Winarsa; Inoue, Yusuke; Sakaguchi, Yoshihiko; Yamamoto, Ken-ichi; Kinoshita, Rie; Futami, Junichiro; Kataoka, Ken; Iwatsuki, Keiji; Huh, Nam-ho			DNAX-activating Protein 10 (DAP10) Membrane Adaptor Associates with Receptor for Advanced Glycation End Products (RAGE) and Modulates the RAGE-triggered Signaling Pathway in Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Biology; Keratinocyte; Psoriasis; Receptor for Advanced Glycation End Products (RAGE)	SKIN INFLAMMATION; ANTAGONIST DEFICIENCY; PUSTULAR PSORIASIS; TISSUE HOMEOSTASIS; BREAST-CANCER; CELLS; IL-22; EXPRESSION; S100A9; INTERLEUKIN-22	Background: RAGE receptor plays a critical role in many inflammatory disorders. Results: Functional interaction between RAGE and DAP10 coordinately regulates S100A8/A9-mediated cell survival. Conclusion: DAP10 membrane adaptor is critically involved in RAGE-mediated survival signaling upon S100A8/A9 binding. Significance: This is the first report demonstrating that RAGE-mediated survival signaling is critically regulated by DAP10 interaction. The receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of many inflammatory, degenerative, and hyperproliferative diseases, including cancer. Previously, we revealed mechanisms of downstream signaling from ligand-activated RAGE, which recruits TIRAP/MyD88. Here, we showed that DNAX-activating protein 10 (DAP10), a transmembrane adaptor protein, also binds to RAGE. By artificial oligomerization of RAGE alone or RAGE-DAP10, we found that RAGE-DAP10 heterodimer formation resulted in a marked enhancement of Akt activation, whereas homomultimeric interaction of RAGE led to activation of caspase 8. Normal human epidermal keratinocytes exposed to S100A8/A9, a ligand for RAGE, at a nanomolar concentration mimicked the pro-survival response of RAGE-DAP10 interaction, although at a micromolar concentration, the cells mimicked the pro-apoptotic response of RAGE-RAGE. In transformed epithelial cell lines, A431 and HaCaT, in which endogenous DAP10 was overexpressed, and S100A8/A9, even at a micromolar concentration, led to cell growth and survival due to RAGE-DAP10 interaction. Functional blocking of DAP10 in the cell lines abrogated the Akt phosphorylation from S100A8/A9-activated RAGE, eventually leading to an increase in apoptosis. Finally, S100A8/A9, RAGE, and DAP10 were overexpressed in the psoriatic epidermis. Our findings indicate that the functional interaction between RAGE and DAP10 coordinately regulates S100A8/A9-mediated survival and/or apoptotic response of keratinocytes.	[Sakaguchi, Masakiyo; Murata, Hitoshi; Putranto, Endy Widya; Ruma, I. Made Winarsa; Yamamoto, Ken-ichi; Huh, Nam-ho] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, Okayama 7008558, Japan; [Aoyama, Yumi; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, Okayama 7008558, Japan; [Hibino, Toshihiko] Shiseido Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Inoue, Yusuke] Gunma Univ, Fac Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan; [Kinoshita, Rie; Futami, Junichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Div Chem & Biochem, Dept Biotechnol, Okayama 7008530, Japan; [Kataoka, Ken] Okayama Univ Sci, Dept Life Sci, Fac Sci, Kita Ku, Okayama 7000005, Japan	Okayama University; Okayama University; Shiseido Company, Limited; Gunma University; University of Miyazaki; Okayama University; Okayama University of Science	Sakaguchi, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	masa-s@md.okayama-u.ac.jp	Ruma, I Made Winarsa/L-6118-2016; Inoue, Yusuke/O-6207-2018; MURATA, Hitoshi/B-2327-2011; Ruma, I Made Winarsa/AAV-1375-2021; Sakaguchi, Masakiyo/B-2280-2011; Ruma, I Made Winarsa/AAN-6971-2020; Futami, Junichiro/B-2578-2011	Ruma, I Made Winarsa/0000-0002-9468-1104; Inoue, Yusuke/0000-0002-9710-7482; Ruma, I Made Winarsa/0000-0002-9468-1104; Futami, Junichiro/0000-0002-0020-2855	Ministry of Health, Labor and Welfare (Research for Intractable Diseases); Ministry of Education, Culture, Sports, Science, and Technology of Japan [26290039]; Takeda Science Foundation; Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research [26106725] Funding Source: KAKEN	Ministry of Health, Labor and Welfare (Research for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Research Foundation for Pharmaceutical Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Health, Labor and Welfare (Research for Intractable Diseases) (to N. H.), the Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research (B), 26290039 (to M. S.), the Takeda Science Foundation (to M. S.), and the Research Foundation for Pharmaceutical Sciences (to M. S.).	Anfossi N, 2003, EUR J IMMUNOL, V33, P3514, DOI 10.1002/eji.200324573; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Aochi S, 2011, J AM ACAD DERMATOL, V64, P879, DOI 10.1016/j.jaad.2010.02.049; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Chu PY, 2010, J BIOL CHEM, V285, P29279, DOI 10.1074/jbc.C110.114124; Cowen EW, 2012, ARCH DERMATOL, V148, P381, DOI 10.1001/archdermatol.2011.3014; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gonzalez I, 2013, IMMUNOBIOLOGY, V218, P790, DOI 10.1016/j.imbio.2012.09.005; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hibino T, 2013, CANCER RES, V73, P172, DOI 10.1158/0008-5472.CAN-11-3843; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Horiuchi S, 2005, ANN NY ACAD SCI, V1043, P671, DOI 10.1196/annals.1333.076; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jesus AA, 2011, ARTHRITIS RHEUM-US, V63, P4007, DOI 10.1002/art.30588; Jono T, 2002, FEBS LETT, V511, P170, DOI 10.1016/S0014-5793(01)03325-7; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Minkis K, 2012, ARCH DERMATOL, V148, P747, DOI 10.1001/archdermatol.2011.3208; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Pradip D, 2013, AM J CANCER RES, V3, P173; Pricci F, 2000, KIDNEY INT, V58, pS31, DOI 10.1046/j.1523-1755.2000.07706.x; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rizzo HL, 2011, J IMMUNOL, V186, P1495, DOI 10.4049/jimmunol.1001001; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Shepherd J, 2004, J INVEST DERMATOL, V122, P665, DOI 10.1111/j.0022-202X.2004.22305.x; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Slowik A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-55; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhuang Y, 2012, CANCER IMMUNOL IMMUN, V61, P1965, DOI 10.1007/s00262-012-1241-5; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	64	29	29	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23389	23402		10.1074/jbc.M114.573071	http://dx.doi.org/10.1074/jbc.M114.573071			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002577	Green Published, hybrid			2022-12-28	WOS:000341505000014
J	Strickland, M; Juarez, O; Neehaul, Y; Cook, DA; Barquera, B; Hellwig, P				Strickland, Madeleine; Juarez, Oscar; Neehaul, Yashvin; Cook, Darcie A.; Barquera, Blanca; Hellwig, Petra			The Conformational Changes Induced by Ubiquinone Binding in the Na+-pumping NADH:Ubiquinone Oxidoreductase (Na+-NQR) Are Kinetically Controlled by Conserved Glycines 140 and 141 of the NqrB Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Infrared Spectroscopy (IR spectroscopy); Oxidation-Reduction (redox); Respiratory Chain; Ubiquinone; HQNO; Membrane Proteins; NQR; Sodium Pumping	NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADHQUINONE OXIDOREDUCTASE; MARINE VIBRIO-ALGINOLYTICUS; IRON-SULFUR PROTEINS; ESCHERICHIA-COLI; COMPLEX-I; NADH/QUINONE OXIDOREDUCTASE; DIFFERENCE SPECTROSCOPY; PROSTHETIC GROUPS; ELECTRON-TRANSFER	Background: Na+-pumping NADH:ubiquinone oxidoreductase (Na+-NQR) is a respiratory enzyme which reduces ubiquinone. Results: Two ubiquinone binding sites were found of which only one is catalytically relevant. Conclusion: Gly-140/Gly-141 residues in the NqrB subunit control entry to the catalytic binding site. Significance: Learning how conformational changes are linked to ubiquinone reduction is directly relevant to a large number of respiratory enzymes. Na+-pumping NADH:ubiquinone oxidoreductase (Na+-NQR) is responsible for maintaining a sodium gradient across the inner bacterial membrane. This respiratory enzyme, which couples sodium pumping to the electron transfer between NADH and ubiquinone, is not present in eukaryotes and as such could be a target for antibiotics. In this paper it is shown that the site of ubiquinone reduction is conformationally coupled to the NqrB subunit, which also hosts the final cofactor in the electron transport chain, riboflavin. Previous work showed that mutations in conserved NqrB glycine residues 140 and 141 affect ubiquinone reduction and the proper functioning of the sodium pump. Surprisingly, these mutants did not affect the dissociation constant of ubiquinone or its analog HQNO (2-n-heptyl-4-hydroxyquinoline N-oxide) from Na+-NQR, which indicates that these residues do not participate directly in the ubiquinone binding site but probably control its accessibility. Indeed, redox-induced difference spectroscopy showed that these mutations prevented the conformational change involved in ubiquinone binding but did not modify the signals corresponding to bound ubiquinone. Moreover, data are presented that demonstrate the NqrA subunit is able to bind ubiquinone but with a low non-catalytically relevant affinity. It is also suggested that Na+-NQR contains a single catalytic ubiquinone binding site and a second site that can bind ubiquinone but is not active.	[Strickland, Madeleine; Neehaul, Yashvin; Hellwig, Petra] CNRS Univ Strasbourg, Lab Bioelectrochim & Spect, UMR 7140, F-67000 Strasbourg, France; [Juarez, Oscar; Cook, Darcie A.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	barqub@rpi.edu; hellwig@unistra.fr	Strickland, Madeleine/L-8425-2019	Strickland, Madeleine/0000-0001-8160-070X; hellwig, petra/0000-0001-6294-5163; Juarez, Oscar/0000-0002-2915-8413	Institut Universitaire de France; CNRS; FRC-LABEX CSC; Agence Nationale de la Recherche; National Science Foundation [MCB-1052234]	Institut Universitaire de France; CNRS(Centre National de la Recherche Scientifique (CNRS)); FRC-LABEX CSC; Agence Nationale de la Recherche(French National Research Agency (ANR)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Institut Universitaire de France, the CNRS, the FRC-LABEX CSC and the Agence Nationale de la Recherche (to P. H. and M. S.) and National Science Foundation Grant MCB-1052234 (to B. B., O. J., and D. A. C.).	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; BRETON J, 1994, BIOCHEMISTRY-US, V33, P4953, DOI 10.1021/bi00182a026; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; El Khoury Y, 2011, CHEMPHYSCHEM, V12, P2669, DOI 10.1002/cphc.201100165; FRIEDRICH T, 1994, BIOCHEM SOC T, V22, P226, DOI 10.1042/bst0220226; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P14683, DOI 10.1021/bi991267h; Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a; Hellwig P., 2010, HDB PORPHYRIN SCI AP, P462; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lunin VY, 2012, ACTA CRYSTALLOGR D, V68, P724, DOI 10.1107/S0907444912012012; MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Rahmelow K, 1998, ANAL BIOCHEM, V257, P1, DOI 10.1006/abio.1997.2502; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; TOKUDA H, 1982, J BIOL CHEM, V257, P7; UNEMOTO T, 1993, J GEN MICROBIOL, V139, P2779, DOI 10.1099/00221287-139-11-2779; Wille G, 2003, BIOCHEMISTRY-US, V42, P14814, DOI 10.1021/bi035219f; Yoshikawa K, 1999, J ANTIBIOT, V52, P182, DOI 10.7164/antibiotics.52.182	44	18	18	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23723	23733		10.1074/jbc.M114.574640	http://dx.doi.org/10.1074/jbc.M114.574640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006248	Green Published, hybrid			2022-12-28	WOS:000341505000040
J	Teijido, O; Rappaport, SM; Chamberlin, A; Noskov, SY; Aguilella, VM; Rostovtseva, TK; Bezrukov, SM				Teijido, Oscar; Rappaport, Shay M.; Chamberlin, Adam; Noskov, Sergei Y.; Aguilella, Vicente M.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.			Acidification Asymmetrically Affects Voltage-dependent Anion Channel Implicating the Involvement of Salt Bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Gating; Mitochondria; Molecular Dynamics; pH Regulation; Voltage-dependent Anion Channel (VDAC); -Barrel Channel Reconstitution	MITOCHONDRIAL OUTER-MEMBRANE; REPERFUSION INJURY; PH PARADOX; MOLECULAR-DYNAMICS; INTRACELLULAR PH; RAT HEPATOCYTES; GATED CHANNEL; ATP TRANSPORT; ION-CHANNEL; VDAC	Background: VDAC voltage gating depends on pH. Results: Acidification asymmetrically and reversibly enhances VDAC closure. Conclusion: pH-sensitive formation of stable salt bridges in the cytosolic side of VDAC explains its asymmetrical response to acidification. Significance: The pronounced sensitivity of the cytosolic side of VDAC to acidification provides new insights into the protective effect of cytosolic acidification during ischemia. The voltage-dependent anion channel (VDAC) is the major pathway for ATP, ADP, and other respiratory substrates through the mitochondrial outer membrane, constituting a crucial point of mitochondrial metabolism regulation. VDAC is characterized by its ability to gate between an open and several closed states under applied voltage. In the early stages of tumorigenesis or during ischemia, partial or total absence of oxygen supply to cells results in cytosolic acidification. Motivated by these facts, we investigated the effects of pH variations on VDAC gating properties. We reconstituted VDAC into planar lipid membranes and found that acidification reversibly increases its voltage-dependent gating. Furthermore, both VDAC anion selectivity and single channel conductance increased with acidification, in agreement with the titration of the negatively charged VDAC residues at low pH values. Analysis of the pH dependences of the gating and open channel parameters yielded similar pK(a) values close to 4.0. We also found that the response of VDAC gating to acidification was highly asymmetric. The presumably cytosolic (cis) side of the channel was the most sensitive to acidification, whereas the mitochondrial intermembrane space (trans) side barely responded to pH changes. Molecular dynamic simulations suggested that stable salt bridges at the cis side, which are susceptible to disruption upon acidification, contribute to this asymmetry. The pronounced sensitivity of the cis side to pH variations found here in vitro might provide helpful insights into the regulatory role of VDAC in the protective effect of cytosolic acidification during ischemia in vivo.	[Teijido, Oscar; Rappaport, Shay M.; Noskov, Sergei Y.; Rostovtseva, Tatiana K.; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Chamberlin, Adam; Noskov, Sergei Y.] Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB T2N 2N4, Canada; [Aguilella, Vicente M.] Univ Jaume 1, Dept Phys, Castellon de La Plana 12080, Spain	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Calgary; Universitat Jaume I	Rostovtseva, TK (corresponding author), NICHD, Program Phys Biol, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Aguilella, Vicente M/B-7592-2008	Aguilella, Vicente M/0000-0002-2420-2649; Noskov, Sergei/0000-0001-7769-335X	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD; National Sciences and Engineering Research Council [RGPIN-315019]; Spanish MINECO [FIS2013-40473]; Universitat Jaume I-Fundacio Caixa Castello-Bancaixa [P1-1B2012-03]; Generalitat Valenciana [Prometeu/2012/069]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish MINECO(Spanish Government); Universitat Jaume I-Fundacio Caixa Castello-Bancaixa; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD. This work was also supported by National Sciences and Engineering Research Council Discovery Grant RGPIN-315019 (to S. Y. N.).; Supported by Spanish MINECO Grant FIS2013-40473, Universitat Jaume I-Fundacio Caixa Castello-Bancaixa Grant P1-1B2012-03, and Generalitat Valenciana Grant Prometeu/2012/069.	Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; BEZRUKOV SM, 1993, PHYS REV LETT, V70, P2352, DOI 10.1103/PhysRevLett.70.2352; BING OHL, 1973, SCIENCE, V180, P1297, DOI 10.1126/science.180.4092.1297; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; BOND JM, 1993, AM J PHYSIOL, V265, pC129, DOI 10.1152/ajpcell.1993.265.1.C129; BOND JM, 1994, ANN NY ACAD SCI, V723, P25, DOI 10.1111/j.1749-6632.1994.tb36714.x; BONVENTRE JV, 1985, AM J PHYSIOL, V249, pC149, DOI 10.1152/ajpcell.1985.249.1.C149; BOWEN KA, 1985, J MEMBRANE BIOL, V86, P51, DOI 10.1007/BF01871610; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P279, DOI 10.1016/0005-2736(87)90456-1; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; DORING C, 1985, J MEMBRANE BIOL, V83, P87, DOI 10.1007/BF01868741; DORING C, 1985, J MEMBRANE BIOL, V83, P81, DOI 10.1007/BF01868740; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; ERMISHKIN LN, 1990, BIOCHIM BIOPHYS ACTA, V1021, P161, DOI 10.1016/0005-2736(90)90029-N; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; GORES GJ, 1989, J CLIN INVEST, V83, P386, DOI 10.1172/JCI113896; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karbowski M, 2001, J CELL SCI, V114, P281; KASIANOWICZ JJ, 1995, BIOPHYS J, V69, P94, DOI 10.1016/S0006-3495(95)79879-4; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lemasters J J, 1996, EXS, V76, P99; Levadny V, 2002, BIOPHYS J, V82, P1773, DOI 10.1016/S0006-3495(02)75528-8; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; MIRZABEKOV TA, 1989, FEBS LETT, V249, P375, DOI 10.1016/0014-5793(89)80662-3; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NIEMINEN AL, 1990, BIOCHEM BIOPH RES CO, V167, P600, DOI 10.1016/0006-291X(90)92067-A; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pastorino JG, 2008, J BIOENERG BIOMEMBR, V40, P171, DOI 10.1007/s10863-008-9148-8; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pfoh R, 2012, P NATL ACAD SCI USA, V109, P18809, DOI 10.1073/pnas.1209018109; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rosano C, 2011, MITOCHONDRION, V11, P513, DOI 10.1016/j.mito.2011.01.012; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2000, P NATL ACAD SCI USA, V97, P7819, DOI 10.1073/pnas.140115397; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIZI M, 1994, J BIOL CHEM, V269, P1614; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	71	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23670	23682		10.1074/jbc.M114.576314	http://dx.doi.org/10.1074/jbc.M114.576314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24962576	Green Published, hybrid			2022-12-28	WOS:000341505000035
J	Torres, JA; de las Heras, M; Maroto, AS; Vivanco, F; Sastre, J; Pastor-Vargas, C				Torres, Jose Alberto; de las Heras, Manuel; Maroto, Aroa Sanz; Vivanco, Fernando; Sastre, Joaquin; Pastor-Vargas, Carlos			Molecular and Immunological Characterization of the First Allergenic Lipocalin in Hamster THE MAJOR ALLERGEN FROM SIBERIAN HAMSTER (PHODOPUS SUNGORUS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Allergy; Asthma; Immunoglobulin E (IgE); Inflammation; Hamster; Lipocalin; Pet Allergy	IDENTIFICATION; SENSITIZATION; ANAPHYLAXIS; ALBUMINS; PETS	Background: Exposure to uncommon pets such as a Siberian hamster has been described as a new risk factor for the development of allergic disease. Results: For the first time, we have cloned and characterized an allergen from Siberian hamster. Conclusion: The recombinant allergen shows a similar pattern of IgE binding and biological activity compared with salivary gland extract. Significance: The recombinant form will be useful for clinical applications. The most frequent pet allergy is to cat and dog, but in recent years, it has become increasingly popular to have other pets, and the risk of exposure to new allergens is more prevalent. The list of new pets includes hamsters, and one of the most popular hamsters is the Siberian hamster (Phodopus sungorus). The aim of this study was the characterization and cloning of the major allergen from this hamster. The study of its allergenicity and cross-reactivity could improve the specific diagnosis and treatment for hamster-allergic patients. Thirteen Siberian hamster-allergic patients were recruited at the outpatient clinic. Protein extracts were prepared from the hair, urine, and salivary glands of four hamster species (European, golden, Siberian, and Roborovski). IgE-binding proteins were detected by immunoblotting and identified by mass spectrometry. The recombinant protein was produced in Escherichia coli and then purified by metal chelate affinity chromatography. The allergenic properties of the recombinant protein were tested by ELISA and immunoblotting, and biological activity was tested according to capacity for basophil activation. Three IgE-binding proteins were identified in extracts obtained from Siberian hamster hair, urine, and salivary glands. All proteins corresponded to the same protein, which was identified as a lipocalin. This lipocalin had no cross-reactivity with common and golden hamsters. The recombinant allergen was cloned and purified, showing similar IgE reactivity in vitro to Siberian hamster protein extracts. Also, the recombinant allergen was capable of producing biological activation in vivo. The major Siberian hamster allergen was cloned, and allergenic properties were characterized, providing a new tool for specific diagnosis of allergy to Siberian hamster.	[de las Heras, Manuel] Hosp Fdn Jimenez Diaz, Dept Allergy, Madrid 28040, Spain; [Maroto, Aroa Sanz; Vivanco, Fernando; Pastor-Vargas, Carlos] Univ Autonoma Madrid, Inst Invest Sanitarias, Dept Immunol, Fdn Jiminez Diaz, Madrid 28040, Spain; [Vivanco, Fernando] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Sastre, Joaquin] Inst Salud Carlos III, CIBERES, Madrid 28029, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Pastor-Vargas, C (corresponding author), Hosp Fdn Jimenez Diaz, Dept Immunol, Avda Reyes Catolicos 2, Madrid 28040, Spain.	cpastor@fjd.es	Pastor Vargas, Carlos/B-4112-2010; Vivanco, Fernando/Q-6866-2016	Pastor Vargas, Carlos/0000-0002-4678-7967; S. Maroto, Aroa/0000-0002-4971-2127	RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos [RD12/0013/0013]; Allergopharma (Merck Serono)	RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos; Allergopharma (Merck Serono)	This work was supported by RETIC Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos Grant RD12/0013/0013 and Allergopharma (Merck Serono).	[Anonymous], 1989, ALLERGY, V44, P1; Berto JM, 2002, ALLERGY, V57, P155, DOI 10.1046/j.0105-4538.2001.00001.x; Botros HG, 1996, IMMUNOLOGY, V88, P340, DOI 10.1046/j.1365-2567.1996.d01-669.x; Cases B, 2010, INT ARCH ALLERGY IMM, V153, P215, DOI 10.1159/000314361; Chruszcz M, 2013, BBA-GEN SUBJECTS, V1830, P5375, DOI 10.1016/j.bbagen.2013.06.016; Custovic A, 1998, ALLERGY, V53, P115, DOI 10.1111/j.1398-9995.1998.tb05011.x; Diaz-Perales A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00492; DREBORG S, 1983, ALLERGY, V38, P167, DOI 10.1111/j.1398-9995.1983.tb01602.x; Hilger C, 2011, CLIN EXP ALLERGY, V41, P899, DOI 10.1111/j.1365-2222.2011.03726.x; Liccardi G, 2011, J INVEST ALLERG CLIN, V21, P137; Lim DL, 2004, CLIN EXP ALLERGY, V34, P1122, DOI 10.1111/j.1365-2222.2004.01992.x; Manso L, 2010, J INVEST ALLERG CLIN, V20, P537; Niitsuma T, 2003, ALLERGY, V58, P1081, DOI 10.1034/j.1398-9995.2003.00242.x; Pastor C, 2009, INT ARCH ALLERGY IMM, V149, P291, DOI 10.1159/000205574; Pecquet C, 2012, EUR J DERMATOL, V22, P14, DOI 10.1684/ejd.2011.1555; Torres JA, 2012, INT ARCH ALLERGY IMM, V157, P109, DOI 10.1159/000324956	16	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23382	23388		10.1074/jbc.M114.579060	http://dx.doi.org/10.1074/jbc.M114.579060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993820	hybrid, Green Published			2022-12-28	WOS:000341505000013
J	Silva, BA; Stambaugh, JR; Yokomori, K; Shah, JV; Berns, MW				Silva, Barbara Alcaraz; Stambaugh, Jessica R.; Yokomori, Kyoko; Shah, Jagesh V.; Berns, Michael W.			DNA Damage to a Single Chromosome End Delays Anaphase Onset	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SPINDLE-ASSEMBLY CHECKPOINT; LASER MICROIRRADIATION; MAMMALIAN TELOMERES; CELL-CYCLE; PROTEINS; MITOSIS; ACTIVATION; DYNAMICS; ATM	Chromosome ends contain nucleoprotein structures known as telomeres. Damage to chromosome ends during interphase elicits a DNA damage response (DDR) resulting in cell cycle arrest. However, little is known regarding the signaling from damaged chromosome ends (designated here as "TIPs") during mitosis. In the present study, we investigated the consequences of DNA damage induced at a single TIP in mitosis. We used laser microirradiation to damage mitotic TIPs or chromosome arms (non-TIPs) in PtK2 kidney epithelial cells. We found that damage to a single TIP, but not a non-TIP, delays anaphase onset. This TIP-specific checkpoint response is accompanied by differential recruitment of DDR proteins. Although phosphorylation of H2AX and the recruitment of several repair factors, such as Ku70-Ku80, occur in a comparable manner at both TIP and non-TIP damage sites, DDR factors such as ataxia telangiectasia mutated (ATM), MDC1, WRN, and FANCD2 are specifically recruited to TIPs but not to non-TIPs. In addition, Nbs1, BRCA1, and ubiquitin accumulate at damaged TIPs more rapidly than at damaged non-TIPs. ATR and 53BP1 are not detected at either TIPs or non-TIPs in mitosis. The observed delay in anaphase onset is dependent on the activity of DDR kinases ATM and Chk1, and the spindle assembly checkpoint kinase Mps1. Cells damaged at a single TIP or non-TIP eventually exit mitosis with unrepaired lesions. Damaged TIPs are segregated into micronuclei at a significantly higher frequency than damaged non-TIPs. Together, these findings reveal a mitosisspecific DDR uniquely associated with chromosome ends.	[Silva, Barbara Alcaraz; Stambaugh, Jessica R.; Berns, Michael W.] Beckman Laser Inst & Med Clin, Irvine, CA 92612 USA; [Silva, Barbara Alcaraz] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92617 USA; [Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA; [Yokomori, Kyoko] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Shah, JV (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 4 Blackfan Circle,HIM 564, Boston, MA 02115 USA.	jagesh@hms.harvard.edu; mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health, NIGMS [R01GM077238]; Air Force Office of Scientific Research Grant [FA9550-04-1-0101]; Beckman Laser Institute Inc. Foundation; Beckman Laser Institute Foundation Faculty Fellowship; National Academy of Sciences Ford Foundation Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Air Force Office of Scientific Research Grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Beckman Laser Institute Inc. Foundation; Beckman Laser Institute Foundation Faculty Fellowship; National Academy of Sciences Ford Foundation Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM077238 (to J. V. S.). This work was also supported by Air Force Office of Scientific Research Grant FA9550-04-1-0101), the Beckman Laser Institute Inc. Foundation (to M. W. B.), the Beckman Laser Institute Foundation Faculty Fellowship (to J. V. S.), and the National Academy of Sciences Ford Foundation Fellowship Program (to B. A. S.).	Albrecht DR, 2010, INTEGR BIOL-UK, V2, P278, DOI 10.1039/b923699f; Altmann SCA, 1925, Q J MICROSC SCI, V69, P463; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Baker NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012398; BERNS MW, 1974, SCIENCE, V186, P700, DOI 10.1126/science.186.4165.700; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Botchway SW, 2010, MUTAT RES-REV MUTAT, V704, P38, DOI 10.1016/j.mrrev.2010.01.003; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Chow JPH, 2003, MOL BIOL CELL, V14, P3989, DOI 10.1091/mbc.E03-03-0168; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Duquette ML, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003050; Eliezer Y, 2014, J BIOL CHEM, V289, P8182, DOI 10.1074/jbc.M113.532739; Eller MS, 2006, P NATL ACAD SCI USA, V103, P15073, DOI 10.1073/pnas.0607332103; Fan Q, 2009, NUCLEIC ACIDS RES, V37, P1740, DOI 10.1093/nar/gkn995; Ferrando-May Elisa, 2013, Frontiers in Genetics, V4, P135, DOI 10.3389/fgene.2013.00135; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gomez-Godinez V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq836; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Hartlerode AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049211; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Peterson SE, 2011, J CELL BIOL, V194, P705, DOI 10.1083/jcb.201103103; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; Reynolds P, 2013, MUTAT RES-GEN TOX EN, V756, P14, DOI 10.1016/j.mrgentox.2013.05.006; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shang Z, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.49; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697; Sibon OCM, 2000, NAT CELL BIOL, V2, P90, DOI 10.1038/35000041; Silva BA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.095003; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stout JR, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-26; Su TT, 2001, CURR BIOL, V11, P8, DOI 10.1016/S0960-9822(00)00042-7; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thanasoula M, 2012, EMBO J, V31, P3398, DOI 10.1038/emboj.2012.191; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Valerio-Santiago M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003859; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; Wright WE, 2005, NAT GENET, V37, P116, DOI 10.1038/ng0205-116; Yan QS, 2013, MOL CELL BIOL, V33, P845, DOI 10.1128/MCB.00990-12; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yu B, 2012, CANCER RES, V72, P5448, DOI 10.1158/0008-5472.CAN-12-2354; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	75	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22771	22784		10.1074/jbc.M113.535955	http://dx.doi.org/10.1074/jbc.M113.535955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982423	hybrid, Green Published			2022-12-28	WOS:000341017200022
J	Stocki, P; Chapman, DC; Beach, LA; Williams, DB				Stocki, Pawel; Chapman, Daniel C.; Beach, Lori A.; Williams, David B.			Depletion of Cyclophilins B and C Leads to Dysregulation of Endoplasmic Reticulum Redox Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; VITAMIN-K EPOXIDE; CYCLOSPORINE-A; FK506-BINDING PROTEIN; OXIDATIVE STRESS; REDUCTASE; BINDING; ERP57; NEPHROTOXICITY; SECRETION	Protein folding within the endoplasmic reticulum is assisted by molecular chaperones and folding catalysts that include members of the protein-disulfide isomerase and peptidyl-prolyl isomerase families. In this report, we examined the contributions of the cyclophilin subset of peptidyl-prolyl isomerases to protein folding and identified cyclophilin C as an endoplasmic reticulum (ER) cyclophilin in addition to cyclophilin B. Using albumin and transferrin as models of cis-proline-containing proteins in human hepatoma cells, we found that combined knockdown of cyclophilins B and C delayed transferrin secretion but surprisingly resulted in more efficient oxidative folding and secretion of albumin. Examination of the oxidation status of ER protein-disulfide isomerase family members revealed a shift to a more oxidized state. This was accompanied by a >5-fold elevation in the ratio of oxidized to total glutathione. This "hyperoxidation" phenotype could be duplicated by incubating cells with the cyclophilin inhibitor cyclosporine A, a treatment that triggered efficient ER depletion of cyclophilins B and C by inducing their secretion to the medium. To identify the pathway responsible for ER hyperoxidation, we individually depleted several enzymes that are known or suspected to deliver oxidizing equivalents to the ER: Ero1 alpha beta, VKOR, PRDX4, or QSOX1. Remarkably, none of these enzymes contributed to the elevated oxidized to total glutathione ratio induced by cyclosporine A treatment. These findings establish cyclophilin C as an ER cyclophilin, demonstrate the novel involvement of cyclophilins B and C in ER redox homeostasis, and suggest the existence of an additional ER oxidative pathway that is modulated by ER cyclophilins.	[Stocki, Pawel; Chapman, Daniel C.; Beach, Lori A.; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Williams, DB (corresponding author), Univ Toronto, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca			Canadian Cancer Society; Canadian Institutes of Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Cancer Society and the Canadian Institutes of Health Research.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Bergeron MJ, 2011, J BIOL CHEM, V286, P11242, DOI 10.1074/jbc.M110.171728; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; De Hornedo JP, 2007, NEFROLOGIA, V27, P565; DELORGERIL M, 1994, TRANSPLANTATION, V58, P193; Fearon P, 2011, J INVEST DERMATOL, V131, P1085, DOI 10.1038/jid.2010.415; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; Kang K, 2009, ANTIOXID REDOX SIGN, V11, P2553, DOI [10.1089/ars.2009.2465, 10.1089/ARS.2009.2465]; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Krauskopf A, 2002, BRIT J PHARMACOL, V135, P977, DOI 10.1038/sj.bjp.0704544; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Lee J, 2010, TOX RESEARCH, V26, P163, DOI 10.5487/TR.2010.26.3.163; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LODISH HF, 1991, J BIOL CHEM, V266, P14835; Louhelainen M, 2006, J HYPERTENS, V24, P947, DOI 10.1097/01.hjh.0000222766.37971.9f; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Margittai E, 2010, FEBS LETT, V584, P2995, DOI 10.1016/j.febslet.2010.05.055; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Ruddock LW, 2012, ANTIOXID REDOX SIGN, V16, P1129, DOI 10.1089/ars.2011.4481; Rudolf J, 2013, BIOCHEM J, V454, P181, DOI 10.1042/BJ20130360; RUPP K, 1994, J BIOL CHEM, V269, P2501; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tariq M, 1999, NEPHROL DIAL TRANSPL, V14, P923, DOI 10.1093/ndt/14.4.923; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; WANG CY, 1994, TRANSPLANTATION, V58, P940, DOI 10.1097/00007890-199410270-00014; WATKINS PB, 1990, J AM ACAD DERMATOL, V23, P1301, DOI 10.1016/0190-9622(90)70358-O; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200; Zhong Z, 1998, AM J PHYSIOL-RENAL, V275, pF595, DOI 10.1152/ajprenal.1998.275.4.F595; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	71	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23086	23096		10.1074/jbc.M114.570911	http://dx.doi.org/10.1074/jbc.M114.570911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990953	Green Published, hybrid			2022-12-28	WOS:000341017200046
J	Tang, R; Zhang, G; Chen, SY				Tang, Rui; Zhang, Gui; Chen, Shi-You			Response Gene to Complement 32 Protein Promotes Macrophage Phagocytosis via Activation of Protein Kinase C Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MEDIATED PHAGOCYTOSIS; TUMOR-ASSOCIATED MACROPHAGES; FACTOR-KAPPA-B; F-ACTIN; CUP FORMATION; RGC-32; CELLS; POLARIZATION; MECHANISMS; REGULATOR	Macrophage phagocytosis plays an important role in host defense. The molecular mechanism, especially factors regulating the phagocytosis, however, is not completely understood. In the present study, we found that response gene to complement 32 (RGC-32) is an important regulator of phagocytosis. Although RGC-32 is induced and abundantly expressed in macrophage during monocyte-macrophage differentiation, RGC-32 appears not to be important for this process because RGC-32-deficient bone marrow progenitor can normally differentiate to macrophage. However, both peritoneal macrophages and bone marrow-derived macrophages with RGC-32 deficiency exhibit significant defects in phagocytosis, whereas RGC-32-overexpressed macrophages show increased phagocytosis. Mechanistically, RGC-32 is recruited to macrophage membrane where it promotes F-actin assembly and the formation of phagocytic cups. RGC-32 knock-out impairs F-actin assembly. RGC-32 appears to interact with PKC to regulate PKC-induced phosphorylation of F-actin cross-linking protein myristoylated alanine-rich protein kinase C substrate. Taken together, our results demonstrate for the first time that RGC-32 is a novel membrane regulator for macrophage phagocytosis.	[Tang, Rui; Zhang, Gui; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Shi-You] Hubei Univ Med, Renmin Hosp, Inst Clin Med, Shiyan 442000, Hubei, Peoples R China	University System of Georgia; University of Georgia; Hubei University of Medicine	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	sc229@uga.edu			National Institutes of Health [HL123302, HL119053, HL107526]; National Natural Science Foundation of China [81328002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL107526, R01HL119053] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL123302, HL119053, and HL107526 (to S. Y. C.). This work was also supported by Grant 81328002 from the National Natural Science Foundation of China.	Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Badea T, 2002, J BIOL CHEM, V277, P502, DOI 10.1074/jbc.M109354200; Badea TC, 1998, J BIOL CHEM, V273, P26977, DOI 10.1074/jbc.273.41.26977; Banan A, 2004, AM J PHYSIOL-CELL PH, V286, pC723, DOI 10.1152/ajpcell.00329.2003; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fischer-Posovszky P, 2011, ENDOCRINOLOGY, V152, P3074, DOI 10.1210/en.2011-1031; Fosbrink M, 2009, EXP MOL PATHOL, V86, P87, DOI 10.1016/j.yexmp.2008.12.005; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GREENBERG S, 1990, J EXP MED, V172, P1853, DOI 10.1084/jem.172.6.1853; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Mancino A, 2010, CLIN CANCER RES, V16, P784, DOI 10.1158/1078-0432.CCR-09-1015; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; May RC, 2001, J CELL SCI, V114, P1061; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Oliveira CA, 1996, CHEM-BIOL INTERACT, V100, P141, DOI 10.1016/0009-2797(96)03695-2; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; Schlesinger LS, 2008, HDB TUBERCULOSIS IMM, P1; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; Tsuboi S, 2007, J BIOL CHEM, V282, P34194, DOI 10.1074/jbc.M705999200; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096	42	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22715	22722		10.1074/jbc.M114.566653	http://dx.doi.org/10.1074/jbc.M114.566653			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973210	Green Published, hybrid			2022-12-28	WOS:000341017200017
J	Buhrmann, C; Busch, F; Shayan, P; Shakibaei, M				Buhrmann, Constanze; Busch, Franziska; Shayan, Parviz; Shakibaei, Mehdi			Sirtuin-1 (SIRT1) Is Required for Promoting Chondrogenic Differentiation of Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SMALL-MOLECULE ACTIVATORS; CHONDROCYTES IN-VITRO; HIGH-DENSITY CULTURES; ARTICULAR-CARTILAGE; DEPENDENT TRANSCRIPTION; LEUKEMIA-CELLS; GENE-EXPRESSION; HUMAN TENOCYTES; RESVERATROL	Sirtuin-1 (SIRT1), NAD(+)-dependent deacetylase, has been linked to anabolic effects in cartilage, although the mechanisms of SIRT1 signaling during differentiation of mesenchymal stem cells (MSCs) to chondrocytes are poorly understood. Therefore, we investigated the role of SIRT1-mediated signaling during chondrogenic differentiation of MSCs in vitro. High density and alginate cultures of MSCs were treated with chondrogenic induction medium with/without the SIRT1 inhibitor nicotinamide, antisense oligonucleotides against SIRT1 (SIRT1-ASO), IL-1 beta, and/or resveratrol. Transient transfection of MSCs with SIRT1-antisense oligonucleotides, nicotinamide, and IL-1 beta inhibited chondrogenesis-induced down-regulation of cartilage-specific proteins, cartilage-specific transcription factor Sox9, and enhanced NF-kappa B-regulated gene products involved in the inflammatory and degradative processes in cartilage (MMP-9, COX-2, and caspase-3), and NF-kappa B phosphorylation, acetylation, and activation of I kappa B alpha kinase. In contrast, the SIRT1 activator resveratrol or BMS-345541 (inhibitor of IKK) inhibited IL-1 beta- and NAM-induced suppression of cartilage-specific proteins, Sox9, and up-regulation of NF-kappa B-regulated gene products. Moreover, SIRT1 was found to interact directly with NF-kappa B and resveratrol-suppressed IL-1 beta and NAM but not SIRT1-ASO-induced NF-kappa B phosphorylation, acetylation, and activation of I kappa B alpha kinase. Knockdown of SIRT1 by mRNA abolished the inhibitory effects of resveratrol on inflammatory and apoptotic signaling and Sox9 expression, suggesting the essential role of this enzyme. Finally, the modulatory effects of resveratrol were found to be mediated at least in part by the association between SIRT1 and Sox9. These results indicate for the first time that SIRT1 supports chondrogenic development of MSCs at least in part through inhibition/deacetylation of NF-kappa B and activation of Sox9.	[Buhrmann, Constanze; Busch, Franziska; Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Shayan, Parviz] Investigating Inst Mol Biol Syst Transfer, Tehran 1417863171, Iran; [Shayan, Parviz] Univ Tehran, Dept Parasitol, Fac Vet Med, Tehran 141556453, Iran	University of Munich; University of Tehran	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Buhrmann, Constanze/0000-0002-0786-0463				Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Busch F, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377028; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Csaki C, 2008, ANN ANAT, V190, P395, DOI 10.1016/j.aanat.2008.07.007; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gautam SC, 2000, BONE MARROW TRANSPL, V25, P639, DOI 10.1038/sj.bmt.1702189; Goepfert C, 2010, ADV BIOCHEM ENG BIOT, V123, P163, DOI 10.1007/10_2010_67; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HJ, 2014, BONE JOINT RES, V3, P51, DOI 10.1302/2046-3758.33.2000226; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009; Kotas ME, 2013, ADIPOCYTE, V2, P113, DOI 10.4161/adip.23437; Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305; Leo AJ, 2006, CELLS TISSUES ORGANS, V183, P112, DOI 10.1159/000095985; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Schulze-Tanzil G, 2002, CELL TISSUE RES, V308, P371, DOI 10.1007/s00441-002-0562-7; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 1997, CELL BIOL INT, V21, P75, DOI 10.1006/cbir.1996.0119; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P463; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Shakibaei M, 2011, GENES NUTR, V6, P171, DOI 10.1007/s12263-010-0179-5; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Tsan MF, 2000, BRIT J HAEMATOL, V109, P405, DOI 10.1046/j.1365-2141.2000.01980.x; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Yan H, 2007, ARTHROSCOPY, V23, P178, DOI 10.1016/j.arthro.2006.09.005; Yeh HY, 2013, DIFFERENTIATION, V86, P171, DOI 10.1016/j.diff.2013.11.001; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; ZIMMERMANN B, 1992, CALCIFIED TISSUE INT, V51, P54, DOI 10.1007/BF00296218	69	69	74	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22048	22062		10.1074/jbc.M114.568790	http://dx.doi.org/10.1074/jbc.M114.568790			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962570	Green Published, hybrid			2022-12-28	WOS:000340593500022
J	Harris, G; Ma, WJ; Maurer, LM; Potts, JR; Mosher, DF				Harris, Gemma; Ma, Wenjiang; Maurer, Lisa M.; Potts, Jennifer R.; Mosher, Deane F.			Borrelia burgdorferi Protein BBK32 Binds to Soluble Fibronectin via the N-terminal 70-kDa Region, Causing Fibronectin to Undergo Conformational Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; FUNCTIONAL UPSTREAM DOMAIN; STREPTOCOCCUS-PYOGENES; CRYSTAL-STRUCTURES; SITES; ADHERENCE; COMPLEX; IDENTIFICATION; FRAGMENT; ADHESION	BBK32 is a fibronectin (FN)-binding protein expressed on the cell surface of Borrelia burgdorferi, the causative agent of Lyme disease. There is conflicting information about where and how BBK32 interacts with FN. We have characterized interactions of a recombinant 86-mer polypeptide, "Bbk32," comprising the unstructured FN-binding region of BBK32. Competitive enzyme-linked assays utilizing various FN fragments and epitope-mapped anti-FN monoclonal antibodies showed that Bbk32 binding involves both the fibrin-binding and the gelatin-binding domains of the 70-kDa N-terminal region (FN70K). Crystallographic and NMR analyses of smaller Bbk32 peptides complexed, respectively, with 2-3FNI and 8-9FNI, demonstrated that binding occurs by beta-strand addition. Isothermal titration calorimetry indicated that Bbk32 binds to isolated FN70K more tightly than to intact FN. In a competitive enzyme-linked binding assay, complex formation with Bbk32 enhanced binding of FN with mAbIII-10 to the (FNIII)-F-10 module. Thus, Bbk32 binds to multiple FN type 1 modules of the FN70K region by a tandem beta-zipper mechanism, and in doing so increases accessibility of FNIII modules that interact with other ligands. The similarity in the FN-binding mechanism of BBK32 and previously studied streptococcal proteins suggests that the binding and associated conformational change of FN play a role in infection.	[Harris, Gemma; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ma, Wenjiang; Maurer, Lisa M.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Ma, Wenjiang; Maurer, Lisa M.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of York - UK; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem, 420 Henry Mall, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805; Harris, Gemma/0000-0002-4587-4620	National Institutes of Health [RO1 HL021644]; British Heart Foundation (BHF); BHF [FS/05/083, FS/12/36/29588]; MRC [G1001063] Funding Source: UKRI; British Heart Foundation [PG/09/079/28008, FS/12/36/29588] Funding Source: researchfish; Medical Research Council [G1001063] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899, R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation (BHF)(British Heart Foundation); BHF(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by National Institutes of Health Grant RO1 HL021644 (to D. F. M) and by the British Heart Foundation (BHF).; Supported by a BHF non-clinical Ph. D. studentship (FS/05/083).; Holds a BHF Senior Basic Science Fellowship (FS/12/36/29588). To whom correspondence may be addressed: Dept. of Biology, University of York, Heslington, York YO10 5DD, UK. Tel.: 44-1904-328679; Fax: 44-1904-328825; E-mail: jennifer.potts@york.ac.uk.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Chagnot C, 2012, CELL MICROBIOL, V14, P1687, DOI 10.1111/cmi.12002; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Moussavi-Harami SF, 2013, J PROTEOME RES, V12, P3393, DOI 10.1021/pr400225p; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Ohashi T, 2011, J BIOL CHEM, V286, P39188, DOI 10.1074/jbc.M111.262337; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Prabhakaran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005412; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA T, 1995, THROMB HAEMOSTASIS, V74, P253; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	46	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22490	22499		10.1074/jbc.M114.578419	http://dx.doi.org/10.1074/jbc.M114.578419			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962582	Green Published, hybrid			2022-12-28	WOS:000340593500058
J	Blumenthal, DK; Copps, J; Smith-Nguyen, EV; Zhang, P; Heller, WT; Taylor, SS				Blumenthal, Donald K.; Copps, Jeffrey; Smith-Nguyen, Eric V.; Zhang, Ping; Heller, William T.; Taylor, Susan S.			The Roles of the RII beta Linker and N-terminal Cyclic Nucleotide-binding Domain in Determining the Unique Structures of the Type II beta Protein Kinase A A SMALL ANGLE X-RAY AND NEUTRON SCATTERING STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; CATALYTIC SUBUNIT; ALPHA; MUTATIONS; SYSTEM; PHOSPHORYLATION; HOLOENZYME; ACTIVATION; EXPRESSION; ELEVATION	Protein kinase A (PKA) is ubiquitously expressed and is responsible for regulating many important cellular functions in response to changes in intracellular cAMP concentrations. The PKA holoenzyme is a tetramer (R-2:C-2), with a regulatory subunit homodimer (R-2) that binds and inhibits two catalytic (C) subunits; binding of cAMP to the regulatory subunit homodimer causes activation of the catalytic subunits. Four different R subunit isoforms exist in mammalian cells, and these confer different structural features, subcellular localization, and biochemical properties upon the PKA holoenzymes they form. The holoenzyme containing RII beta is structurally unique in that the type II beta holoenzyme is much more compact than the free RII beta homodimer. We have used small angle x-ray scattering and small angle neutron scattering to study the solution structure and subunit organization of a holoenzyme containing an RII beta C-terminal deletion mutant (RII beta (1-280)), which is missing the C-terminal cAMP-binding domain to better understand the structural organization of the type II beta holoenzyme and the RII beta domains that contribute to stabilizing the holoenzyme conformation. Our results demonstrate that compaction of the type II beta holoenzyme does not require the C-terminal cAMP-binding domain but rather involves large structural rearrangements within the linker and N-terminal cyclic nucleotide-binding domain of the RII beta homodimer. The structural rearrangements are significantly greater than seen previously with RII beta and are likely to be important in mediating short range and long range interdomain and intersubunit interactions that uniquely regulate the activity of the type II beta isoform of PKA.	[Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Copps, Jeffrey; Smith-Nguyen, Eric V.; Zhang, Ping; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Copps, Jeffrey; Smith-Nguyen, Eric V.; Zhang, Ping; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Heller, William T.] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California San Diego	Blumenthal, DK (corresponding author), Univ Utah, Dept Pharmacol & Toxicol, 30 S 2000 E,Rm 201, Salt Lake City, UT 84112 USA.	don.blumenthal@pharm.utah.edu	zhang, ping/G-7165-2015; Heller, William/ABE-1104-2020	Heller, William/0000-0001-6456-2975; Zhang, Ping/0000-0002-0340-281X; Blumenthal, Donald/0000-0002-8614-1167	U.S. Department of Energy [DE-FG02-05ER64026]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [ERKP291]; Scientific User Facilities Division, Basic Energy Sciences. Oak Ridge National Laboratory (ORNL) [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Scientific User Facilities Division, Basic Energy Sciences. Oak Ridge National Laboratory (ORNL); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jill Trewhella for the generous use of small angle x-ray scattering and laboratory facilities at the University of Utah. X-ray scattering data were collected at the University of Utah using facilities that were supported by U.S. Department of Energy Grant DE-FG02-05ER64026 (to Jill Trewhella). The Center for Structural Molecular Biology operates BioSANS and is supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research Project ERKP291. The High Flux Isotope Reactor is sponsored by the Scientific User Facilities Division, Basic Energy Sciences. Oak Ridge National Laboratory (ORNL) is managed by UT-Battelle, LLC, for the U.S. Department of Energy (DOE) under Contract DE-AC05-00OR22725.	Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Cho YS, 2000, P NATL ACAD SCI USA, V97, P835, DOI 10.1073/pnas.97.2.835; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Gordge PC, 1996, EUR J CANCER, V32A, P2120, DOI 10.1016/S0959-8049(96)00255-9; Groussin L, 2002, J CLIN ENDOCR METAB, V87, P4324, DOI 10.1210/jc.2002-020592; Heller WT, 2006, J APPL CRYSTALLOGR, V39, P671, DOI 10.1107/S0021889806029591; Heller WT, 2004, J BIOL CHEM, V279, P19084, DOI 10.1074/jbc.M313405200; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; IBEL K, 1975, J MOL BIOL, V93, P255, DOI 10.1016/0022-2836(75)90131-X; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Marambaud P, 1998, MOL MED, V4, P715, DOI 10.1007/BF03401766; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Naviglio S, 2010, J CELL PHYSIOL, V225, P801, DOI 10.1002/jcp.22288; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SODERLING TR, 1970, J BIOL CHEM, V245, P6317; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tijoe E., 2007, J APPL CRYSTALLOGR, V40, P782; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Wall ME, 2000, ANNU REV PHYS CHEM, V51, P355, DOI 10.1146/annurev.physchem.51.1.355; Wang JQ, 2006, J NEUROSCI RES, V84, P1621, DOI 10.1002/jnr.21050; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; Zhao JK, 1998, J BIOL CHEM, V273, P30448, DOI 10.1074/jbc.273.46.30448	43	3	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28505	28512		10.1074/jbc.M114.584177	http://dx.doi.org/10.1074/jbc.M114.584177			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25112875	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000343765400041
J	Jayakar, SS; Zhou, XJ; Chiara, DC; Dostalova, Z; Savechenkov, PY; Bruzik, KS; Dailey, WP; Miller, KW; Eckenhoff, RG; Cohen, JB				Jayakar, Selwyn S.; Zhou, Xiaojuan; Chiara, David C.; Dostalova, Zuzana; Savechenkov, Pavel Y.; Bruzik, Karol S.; Dailey, William P.; Miller, Keith W.; Eckenhoff, Roderic G.; Cohen, Jonathan B.			Multiple Propofol-binding Sites in a gamma-Aminobutyric Acid Type A Receptor (GABA(A)R) Identified Using a Photoreactive Propofol Analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anesthesia; GABA Receptor; Nicotinic Acetylcholine Receptors (nAChR); Photoaffinity Labeling; Protein Drug Interaction; General Anesthetics; Propofol	NICOTINIC ACETYLCHOLINE-RECEPTOR; GENERAL ANESTHETIC ETOMIDATE; GATED ION CHANNELS; AMINO-ACID; SUBUNIT INTERFACES; LOOP; CHOLESTEROL; BARBITURATE; SENSITIVITY; MODULATION	Background: Propofol binding to GABA(A)R sites of uncertain location potentiates receptor function and produces anesthesia in vivo. Results: A photoreactive propofol analog identifies propofol-binding sites in 13 GABA(A)Rs. Conclusion: Propofol binds to each class of intersubunit sites in the GABA(A)R transmembrane domain. Significance: This study demonstrates that propofol binds to the same sites in a GABA(A)R as etomidate and barbiturates. Propofol acts as a positive allosteric modulator of -aminobutyric acid type A receptors (GABA(A)Rs), an interaction necessary for its anesthetic potency in vivo as a general anesthetic. Identifying the location of propofol-binding sites is necessary to understand its mechanism of GABA(A)R modulation. [H-3]2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (azietomidate) and R-[H-3]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl)barbituric acid (mTFD-MPAB), photoreactive analogs of 2-ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (etomidate) and mephobarbital, respectively, have identified two homologous but pharmacologically distinct classes of intersubunit-binding sites for general anesthetics in the GABA(A)R transmembrane domain. Here, we use a photoreactive analog of propofol (2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol ([H-3]AziPm)) to identify propofol-binding sites in heterologously expressed human 13 GABA(A)Rs. Propofol, AziPm, etomidate, and R-mTFD-MPAB each inhibited [H-3]AziPm photoincorporation into GABA(A)R subunits maximally by approximate to 50%. When the amino acids photolabeled by [H-3]AziPm were identified by protein microsequencing, we found propofol-inhibitable photolabeling of amino acids in the 3-1 subunit interface (3Met-286 in 3M3 and 1Met-236 in 1M1), previously photolabeled by [H-3]azietomidate, and 1Ile-239, located one helical turn below 1Met-236. There was also propofol-inhibitable [H-3]AziPm photolabeling of 3Met-227 in M1, the amino acid in the 1-3 subunit interface photolabeled by R-[H-3]mTFD-MPAB. The propofol-inhibitable [H-3]AziPm photolabeling in the GABA(A)R 3 subunit in conjunction with the concentration dependence of inhibition of that photolabeling by etomidate or R-mTFD-MPAB also establish that each anesthetic binds to the homologous site at the 3-3 subunit interface. These results establish that AziPm as well as propofol bind to the homologous intersubunit sites in the GABA(A)R transmembrane domain that binds etomidate or R-mTFD-MPAB with high affinity.	[Jayakar, Selwyn S.; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Dostalova, Zuzana; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Dailey, William P.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health, USPHS [GM-58448, GM-55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58448 (to J. B. C., K. S. B., and K. W. M.) and GM-55876 (to R. G. E.) from USPHS.	Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bayley H, 1983, PHOTOREGENERATED REA, P40; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertaccini EJ, 2013, ANESTHESIOLOGY, V119, P1087, DOI 10.1097/ALN.0b013e31829e47e3; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BRISTOW DR, 1987, J NEUROCHEM, V49, P1386, DOI 10.1111/j.1471-4159.1987.tb01004.x; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; Chiara DC, 2014, BIOCHEMISTRY-US, V53, P135, DOI 10.1021/bi401492k; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; da Silva G, 2007, J PHYS CHEM A, V111, P7987, DOI 10.1021/jp073335c; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DUNN SMJ, 1989, BIOCHEMISTRY-US, V28, P2545, DOI 10.1021/bi00432a030; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Modica E, 2001, J ORG CHEM, V66, P41, DOI 10.1021/jo0006627; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sooksawate T, 2001, BRIT J PHARMACOL, V134, P1303, DOI 10.1038/sj.bjp.0704360; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	46	90	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27456	27468		10.1074/jbc.M114.581728	http://dx.doi.org/10.1074/jbc.M114.581728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25086038	hybrid, Green Published			2022-12-28	WOS:000342852800009
J	Rothlein, C; Miettinen, MS; Borwankar, T; Burger, J; Mielke, T; Kumke, MU; Ignatova, Z				Roethlein, Christoph; Miettinen, Markus S.; Borwankar, Tejas; Buerger, Joerg; Mielke, Thorsten; Kumke, Michael U.; Ignatova, Zoya			Architecture of Polyglutamine-containing Fibrils from Time-resolved Fluorescence Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; AMYLOID FORMATION; MAMMALIAN-CELLS; STERIC ZIPPERS; AGGREGATION; DISEASE; ORGANIZATION; PROTEIN; MODEL; FRET	The disease risk and age of onset of Huntington disease (HD) and nine other repeat disorders strongly depend on the expansion of CAG repeats encoding consecutive polyglutamines (polyQ) in the corresponding disease protein. PolyQ length-dependent misfolding and aggregation are the hallmarks of CAG pathologies. Despite intense effort, the overall structure of these aggregates remains poorly understood. Here, we used sensitive time-dependent fluorescent decay measurements to assess the architecture of mature fibrils of huntingtin (Htt) exon 1 implicated in HD pathology. Varying the position of the fluorescent labels in the Htt monomer with expanded 51Q (Htt51Q) and using structural models of putative fibril structures, we generated distance distributions between donors and acceptors covering all possible distances between the monomers or monomer dimensions within the polyQ amyloid fibril. Using Monte Carlo simulations, we systematically scanned all possible monomer conformations that fit the experimentally measured decay times. Monomers with four-stranded 51Q stretches organized into five-layered beta-sheets with alternating N termini of the monomers perpendicular to the fibril axis gave the best fit to our data. Alternatively, the core structure of the polyQ fibrils might also be a zipper layer with antiparallel four-stranded stretches as this structure showed the next best fit. All other remaining arrangements are clearly excluded by the data. Furthermore, the assessed dimensions of the polyQ stretch of each monomer provide structural evidence for the observed polyQ length threshold in HD pathology. Our approach can be used to validate the effect of pharmacological substances that inhibit or alter amyloid growth and structure.	[Roethlein, Christoph; Borwankar, Tejas; Ignatova, Zoya] Univ Potsdam, Inst Biochem & Biol, D-14467 Potsdam, Germany; [Kumke, Michael U.] Univ Potsdam, Inst Chem, D-14467 Potsdam, Germany; [Miettinen, Markus S.] Free Univ Berlin, Inst Theoret Phys, Dept Theory Biol Soft Matter Syst, D-14195 Berlin, Germany; [Buerger, Joerg] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Potsdam; University of Potsdam; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Rothlein, C (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14467 Potsdam, Germany.	roethch@uni-potsdam.de; ignatova@uni-potsdam.de	Miettinen, Markus S./A-2214-2013	Miettinen, Markus S./0000-0002-3999-4722; Ignatova, Zoya/0000-0002-9478-8825; Burger, Jorg/0000-0002-4326-5047; Kumke, Michael/0000-0002-3395-9379				Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Corry B, 2005, BIOPHYS J, V89, P3822, DOI 10.1529/biophysj.105.069351; De Los Rios P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/244105; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frederix PLTM, 2002, J PHYS CHEM B, V106, P6793, DOI 10.1021/jp014549b; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kar K, 2013, J MOL BIOL, V425, P1183, DOI 10.1016/j.jmb.2013.01.016; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Miettinen MS, 2014, BIOPHYS J, V106, P1721, DOI 10.1016/j.bpj.2014.02.027; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tanaka M, 2005, J MOL MED, V83, P343, DOI 10.1007/s00109-004-0632-2; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zanuy D, 2006, J MOL BIOL, V358, P330, DOI 10.1016/j.jmb.2006.01.070; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	37	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26817	26828		10.1074/jbc.M114.581991	http://dx.doi.org/10.1074/jbc.M114.581991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25092288	Green Published, hybrid			2022-12-28	WOS:000342853900014
J	Rahman, M; Lovat, F; Romano, G; Calore, F; Acunzo, M; Bell, EH; Nana-Sinkam, P				Rahman, Mohammad; Lovat, Francesca; Romano, Giulia; Calore, Federica; Acunzo, Mario; Bell, Erica Hlavin; Nana-Sinkam, Patrick			miR-15b/16-2 Regulates Factors That Promote p53 Phosphorylation and Augments the DNA Damage Response following Radiation in the Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; IONIZING-RADIATION; CANCER; MICRORNA; TUMOR; PROLIFERATION; MIR-16; WIP1	MicroRNAs (miRNAs) are regulatory RNAs frequently dysregulated in disease and following cellular stress. Investigators have described changes in miR-15b expression following exposure to several stress-inducing anticancer agents, including ionizing radiation (IR), etoposide, and hydrogen peroxide. However, the role for miR-15b as a mediator of cellular injury in organs such as the lung has yet to be explored. In this study, we examined miR-15b expression patterns as well as its potential role in DNA damage and repair in the setting of IR exposure. We showed that miR-15b is up-regulated in a dose-and time-dependent manner in human bronchial epithelial cells following IR. miR-15b expression was highest after 2 h of IR and decreased gradually. Survival rates following IR were also higher in miR-15b/16-2-overexpressing cells. Cell cycle arrest in G(2)/M phase and an increased DNA repair response were observed in IR-exposed miR-15b/16-2 stable cells. We observed an up-regulation of components of the ataxia telangiectasia mutated (ATM)/Chek1/p53 pathway in miR-15b/16-2-overexpressing cells after IR. Moreover, a pathway-based PCR expression array of genes demonstrated that miR-15b/16-2 overexpression significantly induced the expression of genes involved in ATM/ataxia telangiectasia and Rad-3-related (ATR) signaling, apoptosis, the cell cycle, and DNA repair pathways. Here we demonstrated a novel biological link between miR-15b and DNA damage and cellular protection in lung cells. We identified Wip1 (PPM1D) as a functional target for miR-15b and determined that miR-15b induction of the DNA damage response is partially dependent upon suppression of Wip1. Our study suggests that miR-15b/Wip1 could be a potential therapeutic target in radiation-induced lung disease.	[Rahman, Mohammad; Nana-Sinkam, Patrick] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Lovat, Francesca; Romano, Giulia; Calore, Federica; Acunzo, Mario] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Bell, Erica Hlavin] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Bell, Erica Hlavin; Nana-Sinkam, Patrick] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Nana-Sinkam, P (corresponding author), Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, 460 W 12th Ave, Columbus, OH 43210 USA.	patrick.nana-sinkam@osumc.edu	Bell, Erica/J-2950-2015; Acunzo, Mario/ABE-1739-2020	Acunzo, Mario/0000-0002-3942-9061				Chang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054117; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crescenzi E, 2013, J BIOL CHEM, V288, P16212, DOI 10.1074/jbc.M112.435149; DAVIS SD, 1992, AM J ROENTGENOL, V159, P1157, DOI 10.2214/ajr.159.6.1442375; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Lautenschlaeger T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-246; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Ma JL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/794249; Maas C, 2011, ONCOGENE, V30, P3636, DOI 10.1038/onc.2011.75; Martin NT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003505; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Ohta N., 2014, CASE REP OTOLARYNGOL, V2014, P1; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Ouyang WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-491; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Sperk E, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-154; Sugawara K, 2014, RARE TUMORS, V6, P36, DOI 10.4081/rt.2014.5177; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xia LQ, 2004, CANCER RES, V64, P221, DOI 10.1158/0008-5472.CAN-03-0969; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu YY, 2013, FEBS J, V280, P3768, DOI 10.1111/febs.12365; Yamamura S, 2012, CARCINOGENESIS, V33, P294, DOI 10.1093/carcin/bgr286; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3	33	49	53	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26406	26416		10.1074/jbc.M114.573592	http://dx.doi.org/10.1074/jbc.M114.573592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092292	hybrid, Green Published			2022-12-28	WOS:000342128800032
J	Coiro, P; Stoenica, L; Strauss, U; Brauer, AU				Coiro, Pierluca; Stoenica, Luminita; Strauss, Ulf; Braeuer, Anja Ursula			Plasticity-related Gene 5 Promotes Spine Formation in Murine Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINES; ACTIN CYTOSKELETON; PHOSPHATIDIC-ACID; RHO GTPASES; DYNAMICS; MEMBRANE; FILOPODIA; IRSP53; BRAIN; PROTRUSION	The transmembrane protein plasticity-related genes 3 and 5 (PRG3 and PRG5) increase filopodial formation in various cell lines, independently of Cdc42. However, information on the effects of PRG5 during neuronal development is sparse. Here, we present several lines of evidence for the involvement of PRG5 in the genesis and stabilization of dendritic spines. First, PRG5 was strongly expressed during mouse brain development from embryonic day 14 (E14), peaked around the time of birth, and remained stable at least until early adult stages (i.e. P30). Second, on a subcellular level, PRG5 expression shifted from an equal distribution along all neurites toward accumulation only along dendrites during hippocampal development in vitro. Third, overexpression of PRG5 in immature hippocampal neurons induced formation of spine-like structures ahead of time. Proper amino acid sequences in the extracellular domains (D1 to D3) of PRG5 were a prerequisite for trafficking and induction of spine-like structures, as shown by mutation analysis. Fourth, at stages when spines are present, knockdown of PRG5 reduced the number but not the length of protrusions. This was accompanied by a decrease in the number of excitatory synapses and, consequently, by a reduction of miniature excitatory postsynaptic current frequencies, although miniature excitatory postsynaptic current amplitudes remained similar. In turn, overexpressing PRG5 in mature neurons not only increased Homer-positive spine numbers but also augmented spine head diameters. Mechanistically, PRG5 interacts with phosphorylated phosphatidylinositols, phospholipids involved in dendritic spine formation by different lipid-protein assays. Taken together, our data propose that PRG5 promotes spine formation.	[Coiro, Pierluca; Stoenica, Luminita; Strauss, Ulf; Braeuer, Anja Ursula] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brauer, AU (corresponding author), Charite, Ctr Anat, Inst Cell Biol & Neurobiol, Charitepl 1, D-10117 Berlin, Germany.	anja.braeuer@charite.de	Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Strauss, Ulf/I-4146-2012	Strauss, Ulf/0000-0002-1534-6624	Deutsche Forschungsgemeinschaft [BR 2345/1-1]; Sonnenfeld-Stiftung; NaFoG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung; NaFoG	This work was supported by Deutsche Forschungsgemeinschaft Grant BR 2345/1-1 (to A. U. B.) and the Sonnenfeld-Stiftung for sponsoring technical equipment for A. U. B. and U. S. and the NaFoG sponsored P. C.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brauer AU, 2008, BBA-MOL CELL BIOL L, V1781, P595, DOI 10.1016/j.bbalip.2008.04.004; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Broggini T, 2010, MOL BIOL CELL, V21, P521, DOI 10.1091/mbc.E09-06-0506; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Haeckel A, 2008, J NEUROSCI, V28, P10031, DOI 10.1523/JNEUROSCI.0336-08.2008; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Irie F, 2004, FRONT BIOSCI-LANDMRK, V9, P1365, DOI 10.2741/1325; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Shirao T, 2013, J NEUROCHEM, V126, P155, DOI 10.1111/jnc.12313; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Strauss U, 2013, BBA-MOL CELL BIOL L, V1831, P133, DOI 10.1016/j.bbalip.2012.08.010; Sun LY, 2005, MOL CELL BIOCHEM, V272, P91, DOI 10.1007/s11010-005-7640-6; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Velmans T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-36; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	48	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24956	24970		10.1074/jbc.M114.597880	http://dx.doi.org/10.1074/jbc.M114.597880			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25074937	Green Published, hybrid			2022-12-28	WOS:000341985300021
J	Shin, J; Carr, A; Corner, GA; Togel, L; Davaos-Salas, M; Tran, H; Chueh, AC; Al-Obaidi, S; Chionh, F; Ahmed, N; Buchanan, DD; Young, JP; Malo, MS; Hodin, RA; Arango, D; Sieber, OM; Augenlicht, LH; Dhillon, AS; Weber, TK; Mariadason, JM				Shin, Joongho; Carr, Azadeh; Corner, Georgia A.; Toegel, Lars; Davaos-Salas, Mercedes; Hoanh Tran; Chueh, Anderly C.; Al-Obaidi, Sheren; Chionh, Fiona; Ahmed, Naseem; Buchanan, Daniel D. y; Young, Joanne P.; Malo, Madhu S.; Hodin, Richard A.; Arango, Diego; Sieber, Oliver M.; Augenlicht, Leonard H.; Dhillon, Amardeep S.; Weber, Thomas K.; Mariadason, John M.			The Intestinal Epithelial Cell Differentiation Marker Intestinal Alkaline Phosphatase (ALPi) Is Selectively Induced by Histone Deacetylase Inhibitors (HDACi) in Colon Cancer Cells in a Kruppel-like Factor 5 (KLF5)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLAND METHYLATOR PHENOTYPE; CHAIN FATTY-ACIDS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CPG ISLAND; COLORECTAL-CANCER; MYELOID-LEUKEMIA; DNA METHYLATION; CARCINOMA-CELLS; BUTYRATE	The histone deacetylase inhibitor (HDACi) sodium butyrate promotes differentiation of colon cancer cells as evidenced by induced expression and enzyme activity of the differentiation marker intestinal alkaline phosphatase (ALPi). Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity. This differential sensitivity was similarly evident following treatment with the structurally distinct HDACi, MS-275. Resistant cell lines were significantly enriched for those harboring the CpG island methylator phenotype (p = 0.036, Chi square test), and resistant cell lines harbored methylation of the ALPi promoter, particularly of a CpG site within a critical KLF/Sp regulatory element required for butyrate induction of ALPi promoter activity. However, butyrate induction of an exogenous ALPi promoter-reporter paralleled up-regulation of endogenous ALPi expression across the cell lines, suggesting the presence or absence of a key transcriptional regulator is the major determinant of ALPi induction. Through microarray profiling of sensitive and resistant cell lines, we identified KLF5 to be both basally more highly expressed as well as preferentially induced by butyrate in sensitive cell lines. KLF5 overexpression induced ALPi promoter-reporter activity in resistant cell lines, KLF5 knockdown attenuated butyrate induction of ALPi expression in sensitive lines, and butyrate selectively enhanced KLF5 binding to the ALPi promoter in sensitive cells. These findings demonstrate that butyrate induction of the cell differentiation marker ALPi is mediated through KLF5 and identifies subsets of colon cancer cell lines responsive and refractory to this effect.	[Shin, Joongho; Carr, Azadeh; Ahmed, Naseem; Augenlicht, Leonard H.; Mariadason, John M.] Albert Einstein Coll Med, Dept Oncol, Montefiore Med Ctr, Bronx, NY 10461 USA; [Corner, Georgia A.; Toegel, Lars; Davaos-Salas, Mercedes; Hoanh Tran; Chueh, Anderly C.; Al-Obaidi, Sheren; Chionh, Fiona; Mariadason, John M.] Austin Hlth, Ludwig Inst Canc Res, Melbourne, Vic 3084, Australia; [Buchanan, Daniel D. y; Young, Joanne P.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Malo, Madhu S.; Hodin, Richard A.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Arango, Diego] Univ Autonoma Barcelona, Ctr Invest Bioquim & Biol Mol Nanomed, Vall dHebron Univ Hosp, Grp Mol Oncol,Res Inst, Barcelona 08035, Spain; [Arango, Diego] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona, Spain; [Sieber, Oliver M.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Dhillon, Amardeep S.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Weber, Thomas K.] Vet Affairs New York Harbor Hlth Care Syst, Brooklyn, NY 11209 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; QIMR Berghofer Medical Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center	Mariadason, JM (corresponding author), Austin Hlth, Ludwig Inst Canc Res, Level Olivia Newton John Canc & Wellness Ctr 5, 145-163 Studley Rd, Heidelberg, Vic 3084, Australia.	john.mariadason@ludwig.edu.au	Chueh, Anderly/AAF-9375-2022; Sieber, Oliver/ABA-9211-2021; Sieber, Oliver/M-9473-2015; Chueh, Anderly C./D-8615-2015; Arango, Diego/AFW-0125-2022; Arango, Diego/M-5667-2016; Chüeh, Anderly C/AFC-2076-2022	Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Chueh, Anderly C./0000-0003-1140-5516; Arango, Diego/0000-0003-2953-3284; Arango, Diego/0000-0003-2953-3284; Chüeh, Anderly C/0000-0003-1140-5516; Al-Obaidi, Sheren/0000-0002-4390-7564; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Mariadason, John/0000-0001-9123-7684; Dhillon, Amardeep/0000-0002-6065-663X	Operational Infrastructure Support Program (Victorian government, Australia); Spanish Ministry for Economy and Competitiveness [CP05/00256, TRA2009-0093, SAF2008-00789, PI12/03112, PI12/01095]; Association for International Cancer Research Grant [AICR13-0245]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR 157]; Australian Research Council [FT0992234]; National Health and Medical Research Council [1046092]; CONACyT Mexico [186310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Operational Infrastructure Support Program (Victorian government, Australia); Spanish Ministry for Economy and Competitiveness(Spanish Government); Association for International Cancer Research Grant; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CONACyT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Operational Infrastructure Support Program (Victorian government, Australia), Spanish Ministry for Economy and Competitiveness Grants CP05/00256, TRA2009-0093, SAF2008-00789, PI12/03112, and PI12/01095, the Association for International Cancer Research Grant AICR13-0245, Agencia de Gestio d'Ajuts Universitaris i de Recerca SGR 157 (to D. A.), and Australian Research Council Future Fellowship FT0992234 and National Health and Medical Research Council Senior Research Fellowship 1046092 (to J. M. M.).; Supported by a fellowship from CONACyT Mexico (186310).	Alkhoury F, 2005, AM J PHYSIOL-GASTR L, V289, pG285, DOI 10.1152/ajpgi.00037.2005; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boumber YA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000162; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Diakiw SM, 2012, LEUKEMIA RES, V36, P110, DOI 10.1016/j.leukres.2011.09.013; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Hodin RA, 1996, CELL GROWTH DIFFER, V7, P647; ITO F, 1984, J BIOL CHEM, V259, P2526; Kim JH, 1999, AM J PHYSIOL-GASTR L, V276, pG800, DOI 10.1152/ajpgi.1999.276.4.G800; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Mahmood A, 2003, AM J PHYSIOL-GASTR L, V285, pG433, DOI 10.1152/ajpgi.00466.2002; Malo MS, 2006, AM J PHYSIOL-GASTR L, V290, pG737, DOI 10.1152/ajpgi.00394.2005; Mariadason JM, 2003, CANCER RES, V63, P8791; Mariadason JM, 1997, AM J PHYSIOL-GASTR L, V272, pG705, DOI 10.1152/ajpgi.1997.272.4.G705; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; McComb R. B., 1979, ALKALINE PHOSPHATASE, P865; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Meng S, 1999, SURGERY, V126, P293, DOI 10.1067/msy.1999.98927; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Pettersson F, 2011, Cell Death Differ, V18, P1231, DOI 10.1038/cdd.2010.173; Potapova A, 2010, EUR J HAEMATOL, V84, P298, DOI 10.1111/j.1600-0609.2009.01389.x; SILKE J, 1995, FEBS LETT, V370, P170, DOI 10.1016/0014-5793(95)00830-3; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; YOUNG GP, 1984, AM J PHYSIOL, V247, pG419, DOI 10.1152/ajpgi.1984.247.4.G419	41	45	46	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25306	25316		10.1074/jbc.M114.557546	http://dx.doi.org/10.1074/jbc.M114.557546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037223	Green Published, hybrid			2022-12-28	WOS:000341985300049
J	Thakur, RS; Desingu, A; Basavaraju, S; Subramanya, S; Rao, DN; Nagaraju, G				Thakur, Roshan Singh; Desingu, Ambika; Basavaraju, Shivakumar; Subramanya, Shreelakshmi; Rao, Desirazu N.; Nagaraju, Ganesh			Mycobacterium tuberculosis DinG Is a Structure-specific Helicase That Unwinds G4 DNA IMPLICATIONS FOR TARGETING G4 DNA AS A NOVEL THERAPEUTIC APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; G-QUADRUPLEX DNA; SUBSTRATE-SPECIFIC INHIBITION; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; FANCONI-ANEMIA; FUNCTIONALLY DISTINCT; GENOMIC STABILITY; BINDING-PROTEIN; LAGGING-STRAND	The significance of G-quadruplexes and the helicases that resolve G4 structures in prokaryotes is poorly understood. The Mycobacterium tuberculosis genome is GC-rich and contains >10,000 sequences that have the potential to form G4 structures. In Escherichia coli, RecQ helicase unwinds G4 structures. However, RecQ is absent in M. tuberculosis, and the helicase that participates in G4 resolution in M. tuberculosis is obscure. Here, we show that M. tuberculosis DinG (MtDinG) exhibits high affinity for ssDNA and ssDNA translocation with a 5' -> 3' polarity. Interestingly, MtDinG unwinds overhangs, flap structures, and forked duplexes but fails to unwind linear duplex DNA. Our data with DNase I footprinting provide mechanistic insights and suggest that MtDinG is a 5' -> 3' polarity helicase. Notably, in contrast to E. coli DinG, MtDinG catalyzes unwinding of replication fork and Holliday junction structures. Strikingly, we find that MtDinG resolves intermolecular G4 structures. These data suggest that MtDinG is a multifunctional structure-specific helicase that unwinds model structures of DNA replication, repair, and recombination as well as G4 structures. We finally demonstrate that promoter sequences of M. tuberculosis PE_PGRS2, mce1R, and moeB1 genes contain G4 structures, implying that G4 structures may regulate gene expression in M. tuberculosis. We discuss these data and implicate targeting G4 structures and DinG helicase in M. tuberculosis could be a novel therapeutic strategy for culminating the infection with this pathogen.	[Thakur, Roshan Singh; Desingu, Ambika; Basavaraju, Shivakumar; Subramanya, Shreelakshmi; Rao, Desirazu N.; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nagaraju, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nganesh@biochem.iisc.ernet.in		Thakur, Roshan/0000-0001-5284-4975	Department of Atomic Energy [2010/37B/40/BRNS/1437]; Department of Biotechnology [BT/PR11886/BRB/10/695/2008]; Department of Science and Technology [SR/SO/BB-0067/2012]; DBT-IISc Partnership Program [DBT/BF/PR/INS/IISc/2011-12]; Council of Scientific and Industrial Research; Department of Biotechnology (DBT)	Department of Atomic Energy(Department of Atomic Energy (DAE)); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); DBT-IISc Partnership Program; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by Department of Atomic Energy Grant 2010/37B/40/BRNS/1437, Department of Biotechnology Grant BT/PR11886/BRB/10/695/2008, Department of Science and Technology Grant SR/SO/BB-0067/2012, and DBT-IISc Partnership Program Grant DBT/BF/PR/INS/IISc/2011-12.; Supported by a fellowship from the Council of Scientific and Industrial Research.; Supported by a fellowship from the Department of Biotechnology (DBT).	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Balasingham SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036960; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bochman ML, 2011, MOL BIOL CELL, V22, P1955, DOI 10.1091/mbc.E11-01-0045; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2006, CELL CYCLE, V5, P164, DOI 10.4161/cc.5.2.2338; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Cheigh CI, 2010, J INFECT DIS, V202, P752, DOI 10.1086/655224; Chen TA, 2010, MICROB PATHOGENESIS, V49, P311, DOI 10.1016/j.micpath.2010.07.004; Cheng ZS, 2012, FEBS LETT, V586, P3825, DOI 10.1016/j.febslet.2012.09.032; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Ganesh N, 2003, PROTEINS, V53, P6, DOI 10.1002/prot.10433; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Gregg AV, 2002, MOL CELL, V9, P241, DOI 10.1016/S1097-2765(02)00455-0; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Heyer WD, 2004, CURR BIOL, V14, pR895, DOI 10.1016/j.cub.2004.09.073; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; LEWIS LK, 1992, J BACTERIOL, V174, P3377, DOI 10.1128/jb.174.10.3377-3385.1992; LEWIS LK, 1992, J BACTERIOL, V174, P5110, DOI 10.1128/JB.174.15.5110-5116.1992; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MAXAM AM, 1980, FED PROC, V39, P2830; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2002, MOL CELL, V10, P700, DOI 10.1016/S1097-2765(02)00687-1; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Muniyappa K, 2000, MICROBIOL-UK, V146, P2093, DOI 10.1099/00221287-146-9-2093; Ordonez H, 2013, J BIOL CHEM, V288, P14125, DOI 10.1074/jbc.M113.466854; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patil KN, 2011, BBA-PROTEINS PROTEOM, V1814, P1802, DOI 10.1016/j.bbapap.2011.09.011; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Ren B, 2009, J BIOL CHEM, V284, P4829, DOI 10.1074/jbc.M807943200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Sharma R, 2012, FEBS J, V279, P2134, DOI 10.1111/j.1742-4658.2012.08599.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Spies M, 2014, DNA REPAIR, V20, P58, DOI 10.1016/j.dnarep.2014.01.013; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; Wong IN, 2013, NUCLEIC ACIDS RES, V41, P4587, DOI 10.1093/nar/gkt105; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wu X, 2001, NUCLEIC ACIDS RES, V29, P1765, DOI 10.1093/nar/29.8.1765; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Yakovleva L, 2012, NUCLEIC ACIDS RES, V40, P7465, DOI 10.1093/nar/gks417; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	85	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25112	25136		10.1074/jbc.M114.563569	http://dx.doi.org/10.1074/jbc.M114.563569			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059658	Green Published, hybrid			2022-12-28	WOS:000341985300034
J	Wilkins, JM; McConnell, C; Tipton, PA; Hannink, M				Wilkins, Jordan M.; McConnell, Cyrus; Tipton, Peter A.; Hannink, Mark			A Conserved Motif Mediates both Multimer Formation and Allosteric Activation of Phosphoglycerate Mutase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MITOCHONDRIAL DYNAMICS; CELL-DEATH; PGAM5; PHOSPHORYLATION; PHOSPHATASE; FISSION; P62/SQSTM1; MITOPHAGY; APOPTOSIS	Phosphoglycerate mutase 5 (PGAM5) is an atypical mitochondrial Ser/Thr phosphatase that modulates mitochondrial dynamics and participates in both apoptotic and necrotic cell death. The mechanisms that regulate the phosphatase activity of PGAM5 are poorly understood. The C-terminal phosphoglycerate mutase domain of PGAM5 shares homology with the catalytic domains found in other members of the phosphoglycerate mutase family, including a conserved histidine that is absolutely required for catalytic activity. However, this conserved domain is not sufficient for maximal phosphatase activity. We have identified a highly conserved amino acid motif, WDXNWD, located within the unique N-terminal region, which is required for assembly of PGAM5 into large multimeric complexes. Alanine substitutions within the WDXNWD motif abolish the formation of multimeric complexes and markedly reduce phosphatase activity of PGAM5. A peptide containing the WDXNWD motif dissociates the multimeric complex and reduces but does not fully abolish phosphatase activity. Addition of the WDXNWD-containing peptide in trans to a mutant PGAM5 protein lacking the WDXNWD motif markedly increases phosphatase activity of the mutant protein. Our results are consistent with an intermolecular allosteric regulation mechanism for the phosphatase activity of PGAM5, in which the assembly of PGAM5 into multimeric complexes, mediated by the WDX-NWD motif, results in maximal activation of phosphatase activity. Our results suggest the possibility of identifying small molecules that function as allosteric regulators of the phosphatase activity of PGAM5.	[Wilkins, Jordan M.; McConnell, Cyrus; Hannink, Mark] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Tipton, Peter A.; Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Hannink, M (corresponding author), Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr, Bond Life Sci Ctr 440E, Columbia, MO 65211 USA.	hanninkm@missouri.edu			National Institutes of Health [P50AT006273]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant P50AT006273.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Niture SK, 2011, J BIOL CHEM, V286, P44542, DOI 10.1074/jbc.M111.275073; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	24	20	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25137	25148		10.1074/jbc.M114.565549	http://dx.doi.org/10.1074/jbc.M114.565549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012655	Green Published, hybrid			2022-12-28	WOS:000341985300035
J	Chen, M; Yi, B; Sun, JX				Chen, Ming; Yi, Bing; Sun, Jianxin			Inhibition of Cardiomyocyte Hypertrophy by Protein Arginine Methyltransferase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyocyte; Post-translational Modification (PTM); Protein Arginine N-Methyltransferase 5 (PRMT5); Transcription Factor; Transcription Regulation	TRANSCRIPTION FACTORS GATA4; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; SM PROTEINS; IN-VIVO; SIGNALING PATHWAYS; HEART-FAILURE; METHYLATION; PRMT5; IDENTIFICATION	Background: Protein arginine methyltransferase 5 (PRMT5) is a type II protein arginine methyltransferase that catalyzes the symmetrical dimethylation of arginine residues within target proteins. Results: PRMT5 interacts with and methylates GATA4 in cardiomyocytes. Conclusion: PRMT5 suppresses hypertrophic responses in cardiomyocytes by attenuating GATA4 transcriptional activity. Significance: Targeting PRMT5 may represent a novel therapeutic strategy for preventing cardiac hypertrophy and heart failure. Protein arginine methyltransferase 5 (PRMT5), a protein arginine methyltransferase that catalyzes the symmetrical dimethylation of arginine residues within target proteins, has been implicated in many essential cellular processes ranging from the regulation of gene expression to cell proliferation and differentiation. PRMT5 is highly expressed in the heart; the functional role of PRMT5 in the heart, however, remains largely elusive. In the present study, we show that PRMT5 specifically interacts with GATA4 in both co-transfected HEK293T cells and neonatal rat cardiomyocytes by co-immunoprecipitation. Importantly, this interaction leads to the arginine methylation of GATA4 at positions of 229, 265, and 317, which leads to an inhibition of the GATA4 transcriptional activity, predominantly through blocking the p300-mediated acetylation of GATA4 in cardiomyocytes. Moreover, overexpression of PRMT5 substantially inhibited the acetylation of GATA4 and cardiac hypertrophic responses in phenylephrine-stimulated cardiomyocytes, whereas knockdown of PRMT5 induced GATA4 activation and cardiomyocyte hypertrophy. Furthermore, in response to phenylephrine stimulation, PRMT5 translocates into the cytoplasm, thus relieving its repression on GATA4 activity in the nucleus and leading to hypertrophic gene expression in cardiomyocytes. These findings indicate that PRMT5 is an essential regulator of myocardial hypertrophic signaling and suggest that strategies aimed at activating PRMT5 in the heart may represent a potential therapeutic approach for the prevention of cardiac hypertrophy and heart failure.	[Chen, Ming; Yi, Bing; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, Dept Med, Philadelphia, PA 19107 USA	Jefferson University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu			National Institutes of Health [HL103869]; Chinese Natural Science Foundation [381170114, 81370418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103869. This work was also supported from Chinese Natural Science Foundation Grants 381170114 and 81370418 (to J. S.).	Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bevilacqua A, 2014, CARDIOVASC PATHOL, V23, P85, DOI 10.1016/j.carpath.2013.09.003; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Hannan RD, 1996, J BIOL CHEM, V271, P3213, DOI 10.1074/jbc.271.6.3213; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2002, J MOL CELL CARDIOL, V34, P611, DOI 10.1006/jmcc.2002.2011; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	47	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24325	24335		10.1074/jbc.M114.577494	http://dx.doi.org/10.1074/jbc.M114.577494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012667	Green Published, hybrid			2022-12-28	WOS:000341505600028
J	Lin, B; Gupta, D; Heinen, CD				Lin, Bo; Gupta, Dipika; Heinen, Christopher D.			Human Pluripotent Stem Cells Have a Novel Mismatch Repair-dependent Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage Response; DNA Mismatch Repair; DNA Repair; Embryonic Stem Cell; Induced Pluripotent Stem Cells; Pluripotent Stem Cells	DNA-REPAIR; IONIZING-RADIATION; MUTS-ALPHA; APOPTOSIS; ATR; O-6-METHYLGUANINE; PHOSPHORYLATION; METHYLATION; ARREST; AUTOPHOSPHORYLATION	Background: Mismatch repair is involved in the cellular response to DNA-alkylating agents. Results: Alkylation damage causes mismatch repair-dependent apoptosis in human pluripotent stem cells (PSCs) in the first S phase after damage. Conclusion: Human PSCs utilize a unique MMR-dependent damage response to alkylation damage. Significance: Understanding how PSCs respond to DNA damage is crucial for their potential use in regenerative medicine. Human pluripotent stem cells (PSCs) are presumed to have robust DNA repair pathways to ensure genome stability. PSCs likely need to protect against mutations that would otherwise be propagated throughout all tissues of the developing embryo. How these cells respond to genotoxic stress has only recently begun to be investigated. Although PSCs appear to respond to certain forms of damage more efficiently than somatic cells, some DNA damage response pathways such as the replication stress response may be lacking. Not all DNA repair pathways, including the DNA mismatch repair (MMR) pathway, have been well characterized in PSCs to date. MMR maintains genomic stability by repairing DNA polymerase errors. MMR is also involved in the induction of cell cycle arrest and apoptosis in response to certain exogenous DNA-damaging agents. Here, we examined MMR function in PSCs. We have demonstrated that PSCs contain a robust MMR pathway and are highly sensitive to DNA alkylation damage in an MMR-dependent manner. Interestingly, the nature of this alkylation response differs from that previously reported in somatic cell types. In somatic cells, a permanent G(2)/M cell cycle arrest is induced in the second cell cycle after DNA damage. The PSCs, however, directly undergo apoptosis in the first cell cycle. This response reveals that PSCs rely on apoptotic cell death as an important defense to avoid mutation accumulation. Our results also suggest an alternative molecular mechanism by which the MMR pathway can induce a response to DNA damage that may have implications for tumorigenesis.	Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Heinen, CD (corresponding author), UConn Hlth Ctr, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	cheinen@uchc.edu		Gupta, Dipika/0000-0002-6512-5256	National Institutes of Health [CA115783]; State of Connecticut Stem Cell Grant [13SCB-UCHC-06]; NATIONAL CANCER INSTITUTE [R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Stem Cell Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115783. This work was also supported by State of Connecticut Stem Cell Grant 13SCB-UCHC-06.	Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cejka P, 2003, CANCER RES, V63, P8113; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dietmaier W, 1997, CANCER RES, V57, P4749; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kane MF, 1997, CANCER RES, V57, P808; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Mastrocola AS, 2010, HUM MUTAT, V31, pE1699, DOI 10.1002/humu.21333; Mastrocola AS, 2010, DNA REPAIR, V9, P120, DOI 10.1016/j.dnarep.2009.11.003; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Noonan EM, 2012, INTEGR BIOL-UK, V4, P1237, DOI 10.1039/c2ib20091k; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rajesh P, 2010, DNA REPAIR, V9, P458, DOI 10.1016/j.dnarep.2010.01.009; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853; Zhang H, 1999, CANCER RES, V59, P3021; Zhou BS, 2009, ANAL BIOCHEM, V388, P167, DOI 10.1016/j.ab.2009.02.020	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24314	24324		10.1074/jbc.M114.570937	http://dx.doi.org/10.1074/jbc.M114.570937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012654	Green Published, hybrid			2022-12-28	WOS:000341505600027
J	Beenstock, J; Ben-Yehuda, S; Melamed, D; Admon, A; Livnah, O; Ahn, NG; Engelberg, D				Beenstock, Jonah; Ben-Yehuda, Sheer; Melamed, Dganit; Admon, Arie; Livnah, Oded; Ahn, Natalie G.; Engelberg, David			The p38 beta Mitogen-activated Protein Kinase Possesses an Intrinsic Autophosphorylation Activity, Generated by a Short Region Composed of the alpha-G Helix and MAPK Insert	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitogen-activated Protein Kinase (MAPK); p38; p38 MAPK; Phosphorylation; Signal Transduction; Autophosphorylation	P38-ALPHA ACTIVATION; P38; PHOSPHORYLATION; IDENTIFICATION; MECHANISM; VARIANTS; MUTANTS; INDUCE; SPECIFICITY; FEATURES	Background: Kinases, involved in all processes of life, are enzymes capable of self-activation. MAP kinases, a kinase subfamily, do not self-activate. Results: We found that p38 is a unique MAP kinase that can self-activate. Significance: Through this we disclosed the element responsible for self-activation. Conclusion: Minor differences between kinases impose dramatic differences on their self-activation property. Protein kinases are regulated by a large number of mechanisms that vary from one kinase to another. However, a fundamental activation mechanism shared by all protein kinases is phosphorylation of a conserved activation loop threonine residue. This is achieved in many cases via autophosphorylation. The mechanism and structural basis for autophosphorylation are not clear and are in fact enigmatic because this phosphorylation occurs when the kinase is in its inactive conformation. Unlike most protein kinases, MAP kinases are not commonly activated by autophosphorylation but rather by MEK-dependent phosphorylation. Here we show that p38, a p38 isoform that is almost identical to p38, is exceptional and spontaneously autoactivates by autophosphorylation. We identified a 13-residue-long region composed of part of the G-helix and the MAPK insert that triggers the intrinsic autophosphorylation activity of p38. When inserted into p38, this fragment renders it spontaneously active in vitro and in mammalian cells. We further found that an interaction between the N terminus and a particular region of the C-terminal extension suppresses the intrinsic autophosphorylation of p38 in mammalian cells. Thus, this study identified the structural motif responsible for the unique autophosphorylation capability of p38 and the motif inhibiting this activity in living cells. It shows that the MAPK insert and C-terminal extension, structural motifs that are unique to MAPKs, play a critical role in controlling autophosphorylation.	[Beenstock, Jonah; Ben-Yehuda, Sheer; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Melamed, Dganit; Admon, Arie] Technion Israel Inst Technol, Fac Biol, Smoler Prote Ctr, IL-32000 Haifa, Israel; [Ahn, Natalie G.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Engelberg, David] Natl Univ Singapore, Cellular & Mol Mech Inflammat Program, CREATE NUS HUJ, Singapore 138602, Singapore	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; National University of Singapore	Engelberg, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il		Admon, Arie/0000-0003-0504-3950	Israel Science Foundation [180/09, 1772/13]; Bi-national US-Israel Science Foundation [2009116]; Israel Cancer Research Fund; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	Israel Science Foundation(Israel Science Foundation); Bi-national US-Israel Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	This study was supported by the Israel Science Foundation (Center of Excellence Grants 180/09 and 1772/13), the Bi-national US-Israel Science Foundation (Grant 2009116), the Israel Cancer Research Fund, and Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE).	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Maayan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044749; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Patel SB, 2009, ACTA CRYSTALLOGR D, V65, P777, DOI 10.1107/S090744490901600X; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168	44	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23546	23556		10.1074/jbc.M114.578237	http://dx.doi.org/10.1074/jbc.M114.578237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006254	Green Published, hybrid			2022-12-28	WOS:000341505000025
J	Platholi, J; Federman, A; Detert, JA; Heerdt, P; Hemmings, HC				Platholi, Jimcy; Federman, Anna; Detert, Julia A.; Heerdt, Paul; Hemmings, Hugh C., Jr.			Regulation of Protein Phosphatase 1(I) by Cdc25C-associated Kinase 1 (C-TAK1) and PFTAIRE Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Enzyme; Enzyme Mechanism; Ischemia; Protein Phosphorylation; Inhibitor 2	RABBIT SKELETAL-MUSCLE; PHOSPHORYLATES HUMAN CDC25C; PHOSPHOPROTEIN PHOSPHATASE; SYNERGISTIC PHOSPHORYLATION; MODULATOR SUBUNIT; BOVINE HEART; INHIBITOR-2; IDENTIFICATION; ACTIVATION; BRAIN	Background: Protein phosphatases exist as multisubunit complexes. Results: Two protein kinases in endogenous brain protein phosphatase 1(I) were found to regulate its activation in opposing directions through inhibitor 2 phosphorylation. Conclusion: These kinases support a signaling cascade that regulates protein phosphatase 1(I) activation in global cerebral ischemia. Significance: Understanding the signaling pathways regulating the activity of protein phosphatases is critical to elucidating their physiological and pathological roles. Protein phosphatase 1(I) (PP-1(I)) is a major endogenous form of protein phosphatase 1 (PP-1) that consists of the core catalytic subunit PP-1c and the regulatory subunit inhibitor 2 (I-2). Phosphorylation of the Thr-72 residue of I-2 is required for activation of PP-1(I). We studied the effects of two protein kinases identified previously in purified brain PP-1(I) by mass spectrometry, Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE (PFTK1) kinase, for their ability to regulate PP-1(I). Purified C-TAK1 phosphorylated I-2 in reconstituted PP-1(I) (PP-1cI-2) on Ser-71, which resulted in partial inhibition of its ATP-dependent phosphatase activity and inhibited subsequent phosphorylation of Thr-72 by the exogenous activating kinase GSK-3. In contrast, purified PFTK1 phosphorylated I-2 at Ser-86, a site known to potentiate Thr-72 phosphorylation and activation of PP-1(I) phosphatase activity by GSK-3. These findings indicate that brain PP-1(I) associates with and is regulated by the associated protein kinases C-TAK1 and PFTK1. Multisite phosphorylation of the I-2 regulatory subunit of PP-1(I) leads to activation or inactivation of PP-1(I) through bidirectional modulation of Thr-72 phosphorylation, the critical activating residue of I-2.	[Platholi, Jimcy; Federman, Anna; Detert, Julia A.; Heerdt, Paul; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Platholi, Jimcy; Federman, Anna; Heerdt, Paul; Hemmings, Hugh C., Jr.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University; Cornell University	Hemmings, HC (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave, New York, NY 10065 USA.	hchemmi@med.cornell.edu			National Institutes of Health [NS 56315]; Weill Cornell Medical College Department of Anesthesiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Medical College Department of Anesthesiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 56315. This work was also supported by the Weill Cornell Medical College Department of Anesthesiology.	AGOSTINIS P, 1992, FEBS LETT, V305, P121, DOI 10.1016/0014-5793(92)80877-J; Ayllon V, 2002, EUR J IMMUNOL, V32, P1847, DOI 10.1002/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; BALLOU LM, 1986, CONTROL PHOSPHORYLAT, P331; Berggren K, 2000, ELECTROPHORESIS, V21, P2509, DOI 10.1002/1522-2683(20000701)21:12<2509::AID-ELPS2509>3.3.CO;2-0; Besset V, 1998, MOL REPROD DEV, V50, P18, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;18::AID-MRD3&gt;3.0.CO;2-#; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; HEMMINGS BA, 1982, FEBS LETT, V150, P319, DOI 10.1016/0014-5793(82)80760-6; HOLMES CFB, 1987, BIOCHIM BIOPHYS ACTA, V929, P208, DOI 10.1016/0167-4889(87)90178-9; HOLMES CFB, 1986, BIOCHIM BIOPHYS ACTA, V870, P408, DOI 10.1016/0167-4838(86)90248-7; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; JURGENSEN S, 1984, J BIOL CHEM, V259, P5864; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1988, BIOCHEM BIOPH RES CO, V150, P197, DOI 10.1016/0006-291X(88)90505-0; Lazzaro MA, 1997, J NEUROCHEM, V69, P348, DOI 10.1046/j.1471-4159.1997.69010348.x; Leach C, 2003, J BIOL CHEM, V278, P26015, DOI 10.1074/jbc.M300782200; LI HC, 1985, J BIOL CHEM, V260, P6416; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2003, EMBO J, V22, P4431, DOI 10.1093/emboj/cdg426; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; OGG S, 1994, J BIOL CHEM, V269, P30461; ORGAD S, 1987, EUR J BIOCHEM, V164, P31, DOI 10.1111/j.1432-1033.1987.tb10988.x; PARK IK, 1994, J BIOL CHEM, V269, P944; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Platholi J, 2008, J NEUROCHEM, V105, P2029, DOI 10.1111/j.1471-4159.2008.05300.x; PONDAVEN P, 1987, EUR J BIOCHEM, V167, P135, DOI 10.1111/j.1432-1033.1987.tb13314.x; PRICE DJ, 1985, BIOCHEM BIOPH RES CO, V128, P1203, DOI 10.1016/0006-291X(85)91068-X; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; RESINK TJ, 1983, EUR J BIOCHEM, V133, P455, DOI 10.1111/j.1432-1033.1983.tb07485.x; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Tanimukai H, 2004, MOL BRAIN RES, V126, P146, DOI 10.1016/j.molbrainres.2004.04.003; TUNG HYL, 1984, EUR J BIOCHEM, V145, P57, DOI 10.1111/j.1432-1033.1984.tb08521.x; VANDENHEEDE JR, 1985, J BIOL CHEM, V260, P512; VILLAMORUZZI E, 1984, J BIOL CHEM, V259, P5857; WANG QM, 1995, J BIOL CHEM, V270, P18352, DOI 10.1074/jbc.270.31.18352; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; YANG SD, 1986, J BIOL CHEM, V261, P1786; YANG SD, 1985, J BIOL CHEM, V260, P3464	47	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23893	23900		10.1074/jbc.M114.557744	http://dx.doi.org/10.1074/jbc.M114.557744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25028520	hybrid, Green Published			2022-12-28	WOS:000341505000055
J	Swenson, AM; Trivedi, DV; Rauscher, AA; Wang, Y; Takagi, Y; Palmer, BM; Malnasi-Csizmadia, A; Debold, EP; Yengo, CM				Swenson, Anja M.; Trivedi, Darshan V.; Rauscher, Anna A.; Wang, Yuan; Takagi, Yasuharu; Palmer, Bradley M.; Malnasi-Csizmadia, Andras; Debold, Edward P.; Yengo, Christopher M.			Magnesium Modulates Actin Binding and ADP Release in Myosin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Contractile Protein; Enzyme Kinetics; Magnesium; Muscle; Myosin	DEPENDENT ADENOSINE-TRIPHOSPHATASE; CYTOSOLIC-FREE MAGNESIUM; CROSS-BRIDGE CYCLE; SKELETAL-MUSCLE; ATPASE ACTIVITY; POWER STROKE; RAT-HEART; V MOTOR; MG2+; DISSOCIATION	Background: Magnesium may be an important physiological regulator of myosin motor activity. Results: Mg2+ inhibits the ADP release rate constant in the subset of myosins examined and reduces actin affinity in the post-hydrolysis state in myosin V. Conclusion: Mg2+ alters contractile velocity without altering overall tension-generating capacity. Significance: Mg2+-dependent regulation of motor activity is conserved in myosin motors. We examined the magnesium dependence of five class II myosins, including fast skeletal muscle myosin, smooth muscle myosin, -cardiac myosin (CMIIB), Dictyostelium myosin II (DdMII), and nonmuscle myosin IIA, as well as myosin V. We found that the myosins examined are inhibited in a Mg2+-dependent manner (0.3-9.0 mm free Mg2+) in both ATPase and motility assays, under conditions in which the ionic strength was held constant. We found that the ADP release rate constant is reduced by Mg2+ in myosin V, smooth muscle myosin, nonmuscle myosin IIA, CMIIB, and DdMII, although the ADP affinity is fairly insensitive to Mg2+ in fast skeletal muscle myosin, CMIIB, and DdMII. Single tryptophan probes in the switch I (Trp-239) and switch II (Trp-501) region of DdMII demonstrate these conserved regions of the active site are sensitive to Mg2+ coordination. Cardiac muscle fiber mechanic studies demonstrate cross-bridge attachment time is increased at higher Mg2+ concentrations, demonstrating that the ADP release rate constant is slowed by Mg2+ in the context of an activated muscle fiber. Direct measurements of phosphate release in myosin V demonstrate that Mg2+ reduces actin affinity in the MADPP(i) state, although it does not change the rate of phosphate release. Therefore, the Mg2+ inhibition of the actin-activated ATPase activity observed in class II myosins is likely the result of Mg2+-dependent alterations in actin binding. Overall, our results suggest that Mg2+ reduces the ADP release rate constant and rate of attachment to actin in both high and low duty ratio myosins.	[Swenson, Anja M.; Trivedi, Darshan V.; Yengo, Christopher M.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Rauscher, Anna A.; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Wang, Yuan; Palmer, Bradley M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Takagi, Yasuharu] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Debold, Edward P.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 02210 USA; [Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Hungarian Acad Sci, Mol Biophys Res Grp, H-1117 Budapest, Hungary	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eotvos Lorand University; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Massachusetts System; University of Massachusetts Amherst; Eotvos Lorand University; Hungarian Academy of Sciences	Yengo, CM (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	cyengo@hmc.psu.edu	Rauscher, Anna Á/I-3941-2017; Csizmadia, András Málnási/K-7632-2018	Rauscher, Anna Á/0000-0002-4062-960X; Csizmadia, András Málnási/0000-0002-2430-8398; Touma, Anja/0000-0001-9953-9695	National Institutes of Health [R01 EY016419, R01 HL086902]; Pennsylvania Department of Health; National Science Foundation [EPS-1101317]; European Research Council [Ideas 208319]; NATIONAL EYE INSTITUTE [R01EY018141, R03EY016419] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY016419 and Grant R01 HL086902 (to B. M. P.). This work was also supported by a grant from the Pennsylvania Department of Health (to C. M. Y.), National Science Foundation Grant EPS-1101317, and European Research Council Ideas 208319 (to A. M. C.).	BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; BLATTER LA, 1990, PFLUG ARCH EUR J PHY, V416, P238, DOI 10.1007/BF00392059; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; BURI A, 1993, EXP PHYSIOL, V78, P221, DOI 10.1113/expphysiol.1993.sp003682; Cahours X, 1998, CHROMATOGRAPHIA, V48, P739, DOI 10.1007/BF02467641; Chizhov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064797; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Geeves M A, 1995, Biophys J, V68, p194S; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; GUNZEL D, 1991, PFLUG ARCH EUR J PHY, V417, P446, DOI 10.1007/BF00370938; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; HEADRICK JP, 1991, J MOL CELL CARDIOL, V23, P991, DOI 10.1016/0022-2828(91)91635-5; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; Iotti S, 2000, MAGN RESON IMAGING, V18, P607, DOI 10.1016/S0730-725X(00)00132-6; Iotti S, 2008, MAGNESIUM RES, V21, P157, DOI 10.1684/mrh.2008.0142; IRVING M, 1989, J GEN PHYSIOL, V93, P585, DOI 10.1085/jgp.93.4.585; Jackson DR, 2014, ARCH BIOCHEM BIOPHYS, V552, P74, DOI 10.1016/j.abb.2013.12.012; Jacobs DJ, 2011, J MOL BIOL, V407, P716, DOI 10.1016/j.jmb.2011.02.001; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2010, TRENDS BIOCHEM SCI, V35, P684, DOI 10.1016/j.tibs.2010.07.012; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71; MURPHY E, 1989, J BIOL CHEM, V264, P5622; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nagy NT, 2010, FASEB J, V24, P4480, DOI 10.1096/fj.10-163998; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Olivares AO, 2005, P NATL ACAD SCI USA, V102, P13719, DOI 10.1073/pnas.0507068102; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Puchert E, 2003, PFLUG ARCH EUR J PHY, V447, P135, DOI 10.1007/s00424-003-1154-4; PUTKEY JA, 1987, METHOD ENZYMOL, V139, P303; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sanders GT, 1999, CLIN CHEM LAB MED, V37, P1011, DOI 10.1515/CCLM.1999.151; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y; Sun MX, 2008, P NATL ACAD SCI USA, V105, P8631, DOI 10.1073/pnas.0710793105; Sun MX, 2006, J BIOL CHEM, V281, P5711, DOI 10.1074/jbc.M508103200; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Trivedi DV, 2013, BIOCHEMISTRY-US, V52, P4710, DOI 10.1021/bi4004364; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010; Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Zeng W, 2004, PHILOS T R SOC B, V359, P1843, DOI 10.1098/rstb.2004.1527	71	22	22	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23977	23991		10.1074/jbc.M114.562231	http://dx.doi.org/10.1074/jbc.M114.562231			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006251	hybrid, Green Published			2022-12-28	WOS:000341505000062
J	Foster, DA; Salloum, D; Menon, D; Frias, MA				Foster, David A.; Salloum, Darin; Menon, Deepak; Frias, Maria A.			Phospholipase D and the Maintenance of Phosphatidic Acid Levels for Regulation of Mammalian Target of Rapamycin (mTOR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN CANCER-CELLS; RAS-TRANSFORMED CELLS; PROTEIN-KINASE-C; GROWTH-FACTOR; AMINO-ACIDS; DIACYLGLYCEROL KINASE; THERAPEUTIC TARGET; SURVIVAL SIGNALS; OVARIAN-CANCER; V-SRC	Phosphatidic acid (PA) is a critical metabolite at the heart of membrane phospholipid biosynthesis. However, PA also serves as a critical lipid second messenger that regulates several proteins implicated in the control of cell cycle progression and cell growth. Three major metabolic pathways generate PA: phospholipase D (PLD), diacylglycerol kinase (DGK), and lysophosphatidic acid acyltransferase (LPAAT). The LPAAT pathway is integral to de novo membrane phospholipid biosynthesis, whereas the PLD and DGK pathways are activated in response to growth factors and stress. The PLD pathway is also responsive to nutrients. A key target for the lipid second messenger function of PA is mTOR, the mammalian/mechanistic target of rapamycin, which integrates both nutrient and growth factor signals to control cell growth and proliferation. Although PLD has been widely implicated in the generation of PA needed for mTOR activation, it is becoming clear that PA generated via the LPAAT and DGK pathways is also involved in the regulation of mTOR. In this minireview, we highlight the coordinated maintenance of intracellular PA levels that regulate mTOR signals stimulated by growth factors and nutrients, including amino acids, lipids, glucose, and Gln. Emerging evidence indicates compensatory increases in one source of PA when another source is compromised, highlighting the importance of being able to adapt to stressful conditions that interfere with PA production. The regulation of PA levels has important implications for cancer cells that depend on PA and mTOR activity for survival.	[Foster, David A.; Salloum, Darin; Menon, Deepak; Frias, Maria A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Frias, Maria A/0000-0001-7753-6290	National Institutes of Health from the NCI [1R01-CA046677]; Research Centers in Minority Institutions Award from the National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA046677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S03RR003039] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Centers in Minority Institutions Award from the National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01-CA046677 (to D. A. F.) from the NCI. Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Department at Hunter College, is also acknowledged. This is the fourth article in the Thematic Minireview Series "Phospholipase D and Cancer."	Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Banno Y, 2003, BIOCHEM J, V369, P363, DOI 10.1042/BJ20021368; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Blagosklonny MV, 2011, AGING-US, V3, P1130, DOI 10.18632/aging.100422; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Cheng KW, 2009, CANCER TREAT RES, V149, P229, DOI 10.1007/978-0-387-98094-2_11; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Coon M, 2003, MOL CANCER THER, V2, P1067; D'Souza K, 2014, BBA-BIOMEMBRANES, V1838, P1501, DOI 10.1016/j.bbamem.2013.10.003; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Diefenbach CSM, 2006, CANCER-AM CANCER SOC, V107, P1511, DOI 10.1002/cncr.22184; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Duran RV, 2012, EMBO REP, V13, P121, DOI 10.1038/embor.2011.257; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Frankel P, 1999, BIOCHEM BIOPH RES CO, V255, P502, DOI 10.1006/bbrc.1999.0234; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jang YH, 2012, EXP MOL MED, V44, P571, DOI 10.3858/emm.2012.44.10.065; JIANG H, 1995, J BIOL CHEM, V270, P6006, DOI 10.1074/jbc.270.11.6006; JIANG YW, 1994, BIOCHEM BIOPH RES CO, V203, P1195, DOI 10.1006/bbrc.1994.2309; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; MOTOIKE T, 1993, FEBS LETT, V332, P164, DOI 10.1016/0014-5793(93)80505-O; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; PLEVIN R, 1991, BIOCHEM J, V279, P559, DOI 10.1042/bj2790559; Salloum D, 2014, MOL CANCER THER, V13, P733, DOI 10.1158/1535-7163.MCT-13-0762; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; SONG JG, 1994, CELL GROWTH DIFFER, V5, P79; Standaert ML, 1996, ENDOCRINOLOGY, V137, P3014, DOI 10.1210/en.137.7.3014; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Tang WW, 2006, J BIOCHEM MOL BIOL, V39, P626; Thielmann I, 2012, J THROMB HAEMOST, V10, P2361, DOI 10.1111/j.1538-7836.2012.04924.x; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wiczer BM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003019; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	71	77	78	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22583	22588		10.1074/jbc.R114.566091	http://dx.doi.org/10.1074/jbc.R114.566091			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990952	Green Published, hybrid			2022-12-28	WOS:000341017200005
J	Wang, H; Flannery, SM; Dickhofer, S; Huhn, S; George, J; Kubarenko, AV; Lascorz, J; Bevier, M; Willemsen, J; Pichulik, T; Schafmayer, C; Binder, M; Manoury, B; Paludan, SR; Alarcon-Riquelme, M; Bowie, AG; Forsti, A; Weber, ANR				Wang, Hui; Flannery, Sinead M.; Dickhoefer, Sabine; Huhn, Stefanie; George, Julie; Kubarenko, Andriy V.; Lascorz, Jesus; Bevier, Melanie; Willemsen, Joschka; Pichulik, Tica; Schafmayer, Clemens; Binder, Marco; Manoury, Benedicte; Paludan, Soren R.; Alarcon-Riquelme, Marta; Bowie, Andrew G.; Foersti, Asta; Weber, Alexander N. R.			A Coding IRAK2 Protein Variant Compromises Toll-like receptor (TLR) Signaling and Is Associated with Colorectal Cancer Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; MYD88; ACTIVATION; INHIBITORS; REGULATOR; COMPLEX; KINASE; MEMBER; TRAF6	Within innate immune signaling pathways, interleukin-1 receptor-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors and the interleukin-1 receptor. Although human IRAK4 deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-kappa B signaling and Toll-like receptor-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups, and our studies suggested a genetic association of rs35060588 with colorectal cancer survival. This for the first time implicates human IRAK2 in a human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point.	[Wang, Hui; George, Julie; Kubarenko, Andriy V.; Pichulik, Tica; Weber, Alexander N. R.] German Canc Res Ctr, Jr Res Grp Toll Like Receptors & Canc, D-69120 Heidelberg, Germany; [Huhn, Stefanie; Lascorz, Jesus; Bevier, Melanie; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Wang, Hui; Dickhoefer, Sabine; Weber, Alexander N. R.] Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Flannery, Sinead M.; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Willemsen, Joschka; Binder, Marco] Heidelberg Univ, Dept Infect Dis Mol Virol, D-69120 Heidelberg, Germany; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schafmayer, Clemens] Univ Kiel, POPGEN Biobank Project, D-24105 Kiel, Germany; [Manoury, Benedicte] INSERM, U1013, F-75015 Paris, France; [Manoury, Benedicte] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75015 Paris, France; [Paludan, Soren R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Alarcon-Riquelme, Marta] Univ Granada, Pfizer, Junta de Andalucia Ctr Genom & Oncol Res, Granada 18016, Spain; [Alarcon-Riquelme, Marta] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta] European Sci Fdn, BIOLUPUS Network, F-67080 Strasbourg, France; [Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, S-20502 Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Trinity College Dublin; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Aarhus University; Pfizer; University of Granada; Oklahoma Medical Research Foundation; Lund University	Weber, ANR (corresponding author), Univ Tubingen, Dept Immunol, Interfac Inst Cell Biol, Morgenstelle 15, D-72076 Tubingen, Germany.	alexander.weber@uni-tuebingen.de	Binder, Marco/E-9717-2011; Alarcón-Riquelme, Marta E./ABF-8163-2020; Willemsen, Joschka/O-6261-2017	Binder, Marco/0000-0002-5805-6109; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Manoury, Benedicte/0000-0001-7784-3389; Bowie, Andrew/0000-0001-5316-4373; Weber, Alexander/0000-0002-8627-7056; Willemsen, Joschka/0000-0003-3106-6697	German Cancer Research Center DKFZ; Deutsche Forschungsgemeinschaft [We-4195/1-1]; INST [37/888-1 CRC 685]; Chinese Scholarship Council CSC; University of Tubingen; Science Foundation Ireland [07/IN1/B934, 11/PI/1056]	German Cancer Research Center DKFZ(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); INST; Chinese Scholarship Council CSC(China Scholarship Council); University of Tubingen; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from the German Cancer Research Center DKFZ (to H. W., J. G., A. V. K., and A. N. R. W.), Deutsche Forschungsgemeinschaft Grants We-4195/1-1 (to H. W., J. G., A. V. K., and A. N. R. W.) and INST 37/888-1 CRC 685 "Immunotherapy" (to A. N. R. W.), the Chinese Scholarship Council CSC (to H. W.), the University of Tubingen (to H. W., S. D., T. P., and A. N. R. W.), Science Foundation Ireland Grants 07/IN1/B934 and 11/PI/1056 (to S. M. F. and A. G. B.).	Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lofgren SE, 2010, ARTHRITIS RHEUM-US, V62, P3404, DOI 10.1002/art.27677; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Pauls E, 2013, J IMMUNOL, V191, P2717, DOI 10.4049/jimmunol.1203268; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wang ZL, 2009, CURR TOP MED CHEM, V9, P724, DOI 10.2174/156802609789044407; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06	35	17	17	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23123	23131		10.1074/jbc.M113.492934	http://dx.doi.org/10.1074/jbc.M113.492934			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973222	Green Published, hybrid			2022-12-28	WOS:000341017200049
J	Zhang, YQ; Liu, CX; Duan, XL; Ren, FL; Li, S; Jin, Z; Wang, YY; Feng, YR; Liu, ZW; Chang, ZJ				Zhang, Yanquan; Liu, Chunxiao; Duan, Xiaolin; Ren, Fangli; Li, Shan; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Liu, Zewen; Chang, Zhijie			CREPT/RPRD1B, a Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the beta-Catenin center dot TCF4 Transcriptional Activity in Response to Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 GENE; BETA-CATENIN; GROUCHO; TARGET; PHOSPHORYLATION; ACETYLATION; PROMOTER; GROWTH; CANCER; DOMAIN	CREPT (cell cycle-related and expression elevated protein in tumor)/RPRD1B (regulation of nuclear pre-mRNA domain-containing protein 1B), highly expressed during tumorigenesis, was shown to enhance transcription of CCND1 and to promote cell proliferation by interacting with RNA polymerase II. However, which signaling pathway is involved in CREPT-mediated activation of gene transcription remains unclear. In this study, we reveal that CREPT participates in transcription of the Wnt/beta-catenin signaling activated genes through the beta-catenin and the TCF4 complex. Our results demonstrate that CREPT interacts with both beta-catenin and TCF4, and enhances the association of beta-catenin with TCF4, in response to Wnt stimulation. Furthermore, CREPT was shown to occupy at TCF4 binding sites (TBS) of the promoters of Wnt-targeted genes under Wnt stimulation. Interestingly, depletion of CREPT resulted in decreased occupancy of beta-catenin on TBS, and over-expression of CREPT enhances the activity of the beta-catenin center dot TCF4 complex to initiate transcription of Wnt target genes, which results in up-regulated cell proliferation and invasion. Our study suggests that CREPT acts as an activator to promote transcriptional activity of the beta-catenin center dot TCF4 complex in response to Wnt signaling.	[Zhang, Yanquan; Liu, Chunxiao; Ren, Fangli; Li, Shan; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Liu, Zewen; Chang, Zhijie] Tsinghua Univ, Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Sch Med, Beijing 100084, Peoples R China; [Zhang, Yanquan; Liu, Chunxiao; Ren, Fangli; Jin, Zhe; Wang, Yinyin; Feng, Yarui; Chang, Zhijie] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Peoples R China; [Duan, Xiaolin] Second Peoples Hosp Zhuhai, Guangzhou 519000, Guangdong, Peoples R China	Tsinghua University; Sichuan University	Chang, ZJ (corresponding author), Tsinghua Univ, Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci,Sch Med, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Zhang, Yanquan/D-5615-2017; Chang, Zhijie/AAH-8109-2019	Zhang, Yanquan/0000-0003-3527-9972; Chang, Zhijie/0000-0003-1567-3227	973 Project [2011CB910502]; Natural Science Foundation of China [81230044, 81372167]; Tsinghua Science Foundation [20121080018]; Natural Science Foundation of Beijing [511003]; Major Program Grant [2013ZX08011-006]; 863 project in China [2014AA020802, 2012AA021703]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020802] Funding Source: NIH RePORTER	973 Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua Science Foundation; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Major Program Grant; 863 project in China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 973 Project Grant 2011CB910502, National Natural Science Foundation of China Grants 81230044 and 81372167, Tsinghua Science Foundation Grant 20121080018, Natural Science Foundation of Beijing Grant 511003, Major Program Grant 2013ZX08011-006, and 863 project Grants 2014AA020802 and 2012AA021703 in China.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CASTROP J, 1992, NUCLEIC ACIDS RES, V20, P611, DOI 10.1093/nar/20.3.611; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Jung HM, 2009, J CELL BIOCHEM, V106, P703, DOI 10.1002/jcb.22063; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Wang YM, 2014, CARCINOGENESIS, V35, P983, DOI 10.1093/carcin/bgt393; Wang YF, 2014, NORD J BOT, V32, P185, DOI 10.1111/j.1756-1051.2013.00200.x; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400	34	33	34	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22589	22599		10.1074/jbc.M114.560979	http://dx.doi.org/10.1074/jbc.M114.560979			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982424	hybrid, Green Published			2022-12-28	WOS:000341017200006
J	Ell, B; Qiu, Q; Wei, Y; Mercatali, L; Ibrahim, T; Amadori, D; Kang, YB				Ell, Brian; Qiu, Qiong; Wei, Yong; Mercatali, Laura; Ibrahim, Toni; Amadori, Dino; Kang, Yibin			The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; MICRORNAS; CELLS; DIFFERENTIATION; SECRETION; PROTEIN; MIR-23B; P53	MicroRNAs (miRNAs) have been shown to function as key regulators of tumor progression and metastasis. Recent studies have indicated that the miRNAs comprising the miR-23b/27b/24 cluster might influence tumor metastasis, although the precise nature of this regulation remains unclear. Here, expression of the miR-23b/27b/24 cluster is found to correlate with metastatic potential in mouse and human breast cancer cell lines and is elevated in metastatic lung lesions in human breast cancer patients. Ectopic expression of the miRNAs in the weakly metastatic mouse 4TO7 mammary tumor cell line had no effect on proliferation or morphology of tumor cells in vitro but was found to increase lung metastasis in a mouse model of breast cancer metastasis. Furthermore, gene expression profiling analysis of miRNA overexpressing 4TO7 cells revealed the direct targeting of prosaposin (PSAP), which encodes a secreted protein found to be inversely correlated with metastatic progression in human breast cancer patients. Importantly, ectopic expression of PSAP was able to suppress the metastatic phenotype in highly metastatic 4T1 and MDA-MB-231 SCP28 cells, as well as in cells ectopically expressing miR-23b/27b/24. These findings support a metastasis-promoting function of the miR23b/27b/24 cluster of miRNAs, which functions in part through the direct inhibition of PSAP.	[Ell, Brian; Qiu, Qiong; Wei, Yong; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Mercatali, Laura; Ibrahim, Toni; Amadori, Dino] IRCCS Sci Inst Romagna Study & Treatment Canc IRS, Osteoncol & Rare Tumors Ctr, I-47014 Meldola, Italy; [Kang, Yibin] Rutgers Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ 08903 USA	Princeton University; IRCCS Meldola (IRST); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL255 Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu	Mercatali, Laura/J-9154-2016	Mercatali, Laura/0000-0003-2162-8238; Ibrahim, Toni/0000-0003-0259-4167; Kang, Yibin/0000-0002-1626-6730	NIGMS NIH HHS [T32 GM007388] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Campana WM, 1999, BBA-GEN SUBJECTS, V1427, P392, DOI 10.1016/S0304-4165(99)00036-7; Catena R, 2013, CANCER DISCOV, V3, P578, DOI 10.1158/2159-8290.CD-12-0476; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Du WW, 2013, J CELL SCI, V126, P1440, DOI 10.1242/jcs.118299; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ishteiwy RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052106; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060687; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	39	54	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21888	21895		10.1074/jbc.M114.582866	http://dx.doi.org/10.1074/jbc.M114.582866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966325	Green Published, hybrid			2022-12-28	WOS:000340593500007
J	Ruiz, A; Pauls, E; Badia, R; Riveira-Munoz, E; Clotet, B; Ballana, E; Este, JA				Ruiz, Alba; Pauls, Eduardo; Badia, Roger; Riveira-Munoz, Eva; Clotet, Bonaventura; Ballana, Ester; Este, Jose A.			Characterization of the Influence of Mediator Complex in HIV-1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Human Immunodeficiency Virus (HIV); RNA Polymerase II; RNA Silencing; Transcription; Viral Transcription; Host Factor; RNAP II; Tat	RNA-POLYMERASE-II; IN-VITRO; P-TEFB; TAT-TRANSACTIVATION; ELONGATION-FACTORS; INFECTION; REPLICATION; LATENCY; IDENTIFICATION; MACROPHAGES	Background: The transcription Mediator complex was suggested to influence HIV infection, but a more accurate study is needed to define this contribution. Results: Nine Mediator subunits are implicated in early and late HIV transcription, although MED14 plays a major role. Conclusion: HIV transcription needs specific Mediator subunits interacting with HIV Tat. Significance: This work enables further studies on cofactors influencing HIV transcription. HIV-1 exploits multiple host proteins during infection. siRNA-based screenings have identified new proteins implicated in different pathways of the viral cycle that participate in a broad range of cellular functions. The human Mediator complex (MED) is composed of 28 elements and represents a fundamental component of the transcription machinery, interacting with the RNA polymerase II enzyme and regulating its ability to express genes. Here, we provide an evaluation of the MED activity on HIV replication. Knockdown of 9 out of 28 human MED proteins significantly impaired viral replication without affecting cell viability, including MED6, MED7, MED11, MED14, MED21, MED26, MED27, MED28, and MED30. Impairment of viral replication by MED subunits was at a post-integration step. Inhibition of early HIV transcripts was observed by siRNA-mediated knockdown of MED6, MED7, MED11, MED14, and MED28, specifically affecting the transcription of the nascent viral mRNA transactivation-responsive element. In addition, MED14 and MED30 were shown to have special relevance during the formation of unspliced viral transcripts (p < 0.0005). Knockdown of the selected MED factors compromised HIV transcription induced by Tat, with the strongest inhibitory effect shown by siMED6 and siMED14 cells. Co-immunoprecipitation experiments suggested physical interaction between MED14 and HIV-1 Tat protein. A better understanding of the mechanisms and factors controlling HIV-1 transcription is key to addressing the development of new strategies required to inhibit HIV replication or reactivate HIV-1 from the latent reservoirs.	Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, IrsiCaixa, AIDS Res Inst, Badalona 08916, Spain; Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Unit, Badalona 08916, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Este, JA (corresponding author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa, C Canyet S-N, Badalona 08916, Spain.	jaeste@irsicaixa.es	Badia, Roger/T-6929-2017; Guix, Ester Ballana/R-4117-2018; Este, Jose/B-5509-2008	Badia, Roger/0000-0003-3982-7577; Este, Jose/0000-0002-1436-5823; Pauls, Eduardo/0000-0002-2511-0711; Riveira Munoz, Eva/0000-0002-6396-1162; Ballana, Ester/0000-0002-5215-7363	Spanish Ministerio de Economia y Competitividad [BFU2012-31569-06958, PI1301083]; Gala Contra la SIDA	Spanish Ministerio de Economia y Competitividad(Spanish Government); Gala Contra la SIDA	This work was supported in part by Spanish Ministerio de Economia y Competitividad Projects BFU2012-31569-06958 and PI1301083 and Gala Contra la SIDA.	ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Ballana E, 2013, ANTIVIR RES, V100, P473, DOI 10.1016/j.antiviral.2013.09.017; Ballana E, 2011, J IMMUNOL, V186, P464, DOI 10.4049/jimmunol.1002693; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; ESTE JA, 1995, AIDS RES HUM RETROV, V11, P1355, DOI 10.1089/aid.1995.11.1355; Fahey ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-298; Galdieri L, 2012, J MOL BIOL, V415, P464, DOI 10.1016/j.jmb.2011.11.020; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marcello A, 2001, IUBMB LIFE, V51, P175, DOI 10.1080/152165401753544241; Napoli C, 2012, BIOCHIMIE, V94, P579, DOI 10.1016/j.biochi.2011.09.016; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Pauls E, 2013, ANTIVIR RES, V97, P180, DOI 10.1016/j.antiviral.2012.12.009; Permanyer M, 2012, J BIOL CHEM, V287, P32017, DOI 10.1074/jbc.M112.343293; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Tsutsui T, 2013, J BIOL CHEM, V288, P20955, DOI 10.1074/jbc.M113.486746; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vijayalingam S, 2013, J VIROL, V87, P3425, DOI 10.1128/JVI.03046-12; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Witvrouw M, 1997, AIDS RES HUM RETROV, V13, P187, DOI 10.1089/aid.1997.13.187; Zhang Y, 2013, J BIOL CHEM, V288, P14544, DOI 10.1074/jbc.M112.427054; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	42	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27665	27676		10.1074/jbc.M114.570341	http://dx.doi.org/10.1074/jbc.M114.570341			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100719	Green Published, hybrid			2022-12-28	WOS:000342852800026
J	Zhu, H; Yoshimoto, T; Yamashima, T				Zhu, Hong; Yoshimoto, Tanihiro; Yamashima, Tetsumori			Heat Shock Protein 70.1 (Hsp70.1) Affects Neuronal Cell Fate by Regulating Lysosomal Acid Sphingomyelinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Calpain; Cell Death; Ceramide; Lysosome; Neurodegeneration	SPHINGOLIPID ACTIVATOR PROTEINS; TRANSIENT BRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; CALPAIN; DEATH; LIPIDS; HEAT-SHOCK-PROTEIN-70; STIMULATION; DEGRADATION; METABOLISM	Background: The role of Hsp70.1 in neurodegeneration remains unknown. Results: We demonstrate differential profiles in activation of -calpain, bis(monoacylglycero)phosphate (BMP) levels, Hsp70.1-BMP interaction, and acid sphingomyelinase (ASM) activity between motor cortex and CA1 after ischemia/reperfusion. Conclusion: Hsp70.1-mediated ASM activity affects neuronal cell fate by regulating lysosomal membrane stability. Significance: This finding provides new insights into the mechanism of neuronal death. The inducible expression of heat shock protein 70.1 (Hsp70.1) plays cytoprotective roles in its molecular chaperone function. Binding of Hsp70 to an endolysosomal phospholipid, bis(monoacylglycero)phosphate (BMP), has been recently shown to stabilize lysosomal membranes by enhancing acid sphingomyelinase (ASM) activity in cancer cells. Using the monkey experimental paradigm, we have reported that calpain-mediated cleavage of oxidized Hsp70.1 causes neurodegeneration in the hippocampal cornu ammonis 1 (CA1), whereas expression of Hsp70.1 in the motor cortex without calpain activation contributes to neuroprotection. However, the molecular mechanisms of the lysosomal destabilization/stabilization determining neuronal cell fate have not been elucidated. To elucidate whether regulation of lysosomal ASM could affect the neuronal fate, we analyzed Hsp70.1-BMP binding and ASM activity by comparing the motor cortex and the CA1. We show that Hsp70.1 being localized at the lysosomal membrane, lysosomal lipid BMP levels, and the lipid binding domain of Hsp70.1 are crucial for Hsp70.1-BMP binding. In the postischemic motor cortex, Hsp70.1 being localized at the lysosomal membrane could bind to BMP without calpain activation and decreased BMP levels, resulting in increasing ASM activity and lysosomal stability. However, in the postischemic CA1, calpain activation and a concomitant decrease in the lysosomal membrane localization of Hsp70.1 and BMP levels may diminish Hsp70.1-BMP binding, resulting in decreased ASM activity and lysosomal rupture with leakage of cathepsin B into the cytosol. A TUNEL assay revealed the differential neuronal vulnerability between the CA1 and the motor cortex. These results suggest that regulation of ASM activation in vivo by Hsp70.1-BMP affects lysosomal stability and neuronal survival or death after ischemia/reperfusion.	[Zhu, Hong; Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, Kanazawa, Ishikawa, Japan; [Zhu, Hong; Yoshimoto, Tanihiro] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa, Japan; [Yamashima, Tetsumori] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Yamashima, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Restorat Neurosurg, 13-1 Takara Machi, Kanazawa, Ishikawa, Japan.	yamashima215@gmail.com			Japanese Ministry of Education, Culture, Sports, Science, and Technology [18390392, 22390273]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Kiban-Kennkyu (B) Grants 18390392 and 22390273 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; Bouvier J, 2009, J LIPID RES, V50, P243, DOI 10.1194/jlr.M800300-JLR200; Chen ZC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-111; Ellegaard AM, 2013, MOL CANCER THER, V12, P2018, DOI 10.1158/1535-7163.MCT-13-0084; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; KIKUCHI H, 1993, BIOCHIM BIOPHYS ACTA, V1162, P171, DOI 10.1016/0167-4838(93)90144-G; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; Meikle PJ, 2008, BLOOD CELL MOL DIS, V40, P420, DOI 10.1016/j.bcmd.2007.10.004; Neumar RW, 1996, J NEUROCHEM, V66, P421; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Oikawa S, 2009, FREE RADICAL BIO MED, V46, P1472, DOI 10.1016/j.freeradbiomed.2009.02.029; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saftig P, 2013, NATURE, V502, P312, DOI 10.1038/nature12692; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Sultana R, 2010, ANTIOXID REDOX SIGN, V12, P327, DOI 10.1089/ars.2009.2810; Wei JS, 2009, AM J PATHOL, V174, P1891, DOI 10.2353/ajpath.2009.080680; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yamashima T., 2014, J ALZHEIMERS DIS PAR, DOI [10.4172/2161-0460.1000139, DOI 10.4172/2161-0460.1000139]; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zhu H, 2012, J NEUROCHEM, V120, P574, DOI 10.1111/j.1471-4159.2011.07550.x; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	44	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27432	27443		10.1074/jbc.M114.560334	http://dx.doi.org/10.1074/jbc.M114.560334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25074941	Green Published, hybrid			2022-12-28	WOS:000342852800007
J	Umemoto, A; Yagi, H; So, M; Goto, Y				Umemoto, Ayaka; Yagi, Hisashi; So, Masatomo; Goto, Yuji			High-throughput Analysis of Ultrasonication-forced Amyloid Fibrillation Reveals the Mechanism Underlying the Large Fluctuation in the Lag Time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CRYSTALLIZATION; NEURODEGENERATIVE DISEASES; BETA(2)-MICROGLOBULIN; KINETICS; FIBRILS; AGGREGATION; NUCLEATION; EXTENSION; SCRAPIE	Amyloid fibrils form in supersaturated solutions of precursor proteins by a nucleation and growth mechanism characterized by a lag time. Although the lag time provides a clue to understanding the complexity of nucleation events, its long period and low reproducibility have been obstacles for exact analysis. Ultrasonication is known to effectively break supersaturation and force fibrillation. By constructing a Handai amyloid burst inducer, which combines a water bath-type ultrasonicator and a microplate reader, we examined the ultrasonication-forced fibrillation of several proteins, with a focus on the fluctuation in the lag time. Amyloid fibrillation of hen egg white lysozyme was examined at pH 2.0 in the presence of 1.0-5.0 M guanidine hydrochloride (GdnHCl), in which the dominant species varied from the native to denatured conformations. Although fibrillation occurred at various concentrations of GdnHCl, the lag time varied largely, with a minimum being observed at similar to 3.0 M, the concentration at which GdnHCl-dependent denaturation ended. The coefficient of variation of the lag time did not depend significantly on the GdnHCl concentration and was 2-fold larger than that of the ultrasonication-dependent oxidation of iodide, a simple model reaction. These results suggest that the large fluctuation observed in the lag time for amyloid fibrillation originated from a process associated with a common amyloidogenic intermediate, which may have been a relatively compact denatured conformation. We also suggest that the Handai amyloid burst inducer system will be useful for studying the mechanism of crystallization of proteins because proteins form crystals by the same mechanism as amyloid fibrils under supersaturation.	[Umemoto, Ayaka; Yagi, Hisashi; So, Masatomo; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp		So, Masatomo/0000-0002-4815-4995	Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Kansai Bureau of Economy, Trade and Industry; Grants-in-Aid for Scientific Research [13J01079] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kansai Bureau of Economy, Trade and Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, Takeda Science Foundation, and the Kansai Bureau of Economy, Trade and Industry.	Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Cabriolu R, 2011, J MOL BIOL, V411, P275, DOI 10.1016/j.jmb.2011.05.032; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Crespo R, 2010, J APPL CRYSTALLOGR, V43, P1419, DOI 10.1107/S0021889810040951; Durbin SD, 1996, ANNU REV PHYS CHEM, V47, P171, DOI 10.1146/annurev.physchem.47.1.171; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; KAM Z, 1978, J MOL BIOL, V123, P539, DOI 10.1016/0022-2836(78)90206-1; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; Koda S, 2003, ULTRASON SONOCHEM, V10, P149, DOI 10.1016/S1350-4177(03)00084-1; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; THOMAS JR, 1959, J PHYS CHEM-US, V63, P1725, DOI 10.1021/j150580a038; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Webster E., 1963, ULTRASONICS, V1, P39, DOI DOI 10.1016/0041-624X(63)90116-1; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Yoshimura Y, 2010, PROTEIN SCI, V19, P2347, DOI 10.1002/pro.515	36	30	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27290	27299		10.1074/jbc.M114.569814	http://dx.doi.org/10.1074/jbc.M114.569814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118286	Green Published, hybrid			2022-12-28	WOS:000342853900050
J	Weihs, AM; Fuchs, C; Teuschl, AH; Hartinger, J; Slezak, P; Mittermayr, R; Redl, H; Junger, WG; Sitte, HH; Runzler, D				Weihs, Anna M.; Fuchs, Christiane; Teuschl, Andreas H.; Hartinger, Joachim; Slezak, Paul; Mittermayr, Rainer; Redl, Heinz; Junger, Wolfgang G.; Sitte, Harald H.; Ruenzler, Dominik			Shock Wave Treatment Enhances Cell Proliferation and Improves Wound Healing by ATP Release-coupled Extracellular Signal-regulated Kinase (ERK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; SKIN FLAP MODEL; P2X7 RECEPTORS; CARDIAC FIBROBLASTS; SEGMENTAL DEFECT; IL-2 EXPRESSION; FAK ACTIVATION; NITRIC-OXIDE; THERAPY	Shock wave treatment accelerates impaired wound healing in diverse clinical situations. However, the mechanisms underlying the beneficial effects of shock waves have not yet been fully revealed. Because cell proliferation is a major requirement in the wound healing cascade, we used in vitro studies and an in vivo wound healing model to study whether shock wave treatment influences proliferation by altering major extracellular factors and signaling pathways involved in cell proliferation. We identified extracellular ATP, released in an energy-and pulse number-dependent manner, as a trigger of the biological effects of shock wave treatment. Shock wave treatment induced ATP release, increased Erk1/2 and p38 MAPK activation, and enhanced proliferation in three different cell types (C3H10T1/2 murine mesenchymal progenitor cells, primary human adipose tissue-derived stem cells, and a human JurkatTcell line) in vitro. Purinergic signaling-induced Erk1/2 activation was found to be essential for this proliferative effect, which was further confirmed by in vivo studies in a rat wound healing model where shock wave treatment induced proliferation and increased wound healing in an Erk1/2-dependent fashion. In summary, this report demonstrates that shock wave treatment triggers release of cellular ATP, which subsequently activates purinergic receptors and finally enhances proliferation in vitro and in vivo via downstream Erk1/2 signaling. In conclusion, our findings shed further light on the molecular mechanisms by which shock wave treatment exerts its beneficial effects. These findings could help to improve the clinical use of shock wave treatment for wound healing.	[Weihs, Anna M.; Fuchs, Christiane; Teuschl, Andreas H.; Ruenzler, Dominik] Univ Appl Sci Technikum Wien, Dept Biochem Engn, A-1200 Vienna, Austria; [Weihs, Anna M.; Fuchs, Christiane; Teuschl, Andreas H.; Hartinger, Joachim; Slezak, Paul; Mittermayr, Rainer; Redl, Heinz; Ruenzler, Dominik] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Hartinger, Joachim; Slezak, Paul; Mittermayr, Rainer; Redl, Heinz; Junger, Wolfgang G.] Austrian Workers Compensat Board AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria; [Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Ludwig Boltzmann Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Medical University of Vienna	Fuchs, C (corresponding author), Univ Appl Sci Technikum Wien, Dept Biochem Engn, Hochstadtpl 5, A-1200 Vienna, Austria.	fuchsc@technikum-wien.at	Sitte, Harald/N-2681-2013; Junger, Wolfgang G/I-1932-2013; Rünzler, Dominik/G-9393-2014; Redl, Heinz/AAD-8157-2019; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Junger, Wolfgang G/0000-0003-3350-8452; Rünzler, Dominik/0000-0002-6020-3411; Sitte, Harald/0000-0002-1339-7444; Fuchs, Christiane/0000-0002-5052-3198; Weihs, Anna/0000-0003-4802-328X; Teuschl-Woller, Andreas/0000-0002-3817-1572	NewTissue Project (Osterreichische Forschungsforderungsgesellschaft Grant) [818412]; NewTissue Project (City of Vienna) [06-06, MA27]; City of Vienna Competence Team reacTissue Project [MA27, 12-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477, R01GM060475] Funding Source: NIH RePORTER	NewTissue Project (Osterreichische Forschungsforderungsgesellschaft Grant); NewTissue Project (City of Vienna); City of Vienna Competence Team reacTissue Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NewTissue Project (Osterreichische Forschungsforderungsgesellschaft Grant 818412 and City of Vienna MA27 Grant 06-06) and the City of Vienna Competence Team reacTissue Project (MA27 Grant 12-06).	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Baroja-Mazo A, 2013, BBA-BIOMEMBRANES, V1828, P79, DOI 10.1016/j.bbamem.2012.01.002; Burnstock G, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.11; Burnstock G, 2012, J INVEST DERMATOL, V132, P526, DOI 10.1038/jid.2011.344; Chen JB, 2012, BRIT J PHARMACOL, V166, P1140, DOI 10.1111/j.1476-5381.2012.01831.x; Chen YJ, 2004, J ORTHOP RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005; Chen YJ, 2004, BONE, V34, P466, DOI 10.1016/j.bone.2003.11.013; Chi C, 2013, J CELL PHYSIOL, V228, P925, DOI 10.1002/jcp.24268; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Davis TA, 2009, INT WOUND J, V6, P11, DOI 10.1111/j.1742-481X.2008.00540.x; Dumfarth J, 2008, ANN THORAC SURG, V86, P1909, DOI 10.1016/j.athoracsur.2008.07.117; Garcia M, 2010, J ORTHOP RES, V28, P510, DOI 10.1002/jor.21025; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hayashi D, 2012, WOUND REPAIR REGEN, V20, P887, DOI 10.1111/j.1524-475X.2012.00851.x; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; Higuera GA, 2012, TRENDS BIOTECHNOL, V30, P583, DOI 10.1016/j.tibtech.2012.07.007; Hill LM, 2010, J IMMUNOL, V185, P3028, DOI 10.4049/jimmunol.1001298; Holfeld J, 2014, INFLAMMATION, V37, P65, DOI 10.1007/s10753-013-9712-1; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Katz S, 2006, INT J BIOCHEM CELL B, V38, P2082, DOI 10.1016/j.biocel.2006.05.018; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P522, DOI 10.1111/j.1524-475X.2009.00504.x; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P80, DOI 10.1111/j.1524-475X.2008.00444.x; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Leone L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049759; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meirer R, 2007, J RECONSTR MICROSURG, V23, P231, DOI 10.1055/s-2007-981506; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Moretti B, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-54; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Raabe O, 2013, AM J STEM CELLS, V2, P62; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111; Saggini R, 2008, ULTRASOUND MED BIOL, V34, P1261, DOI 10.1016/j.ultrasmedbio.2008.01.010; Schaden W, 2007, J SURG RES, V143, P1, DOI 10.1016/j.jss.2007.01.009; Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048; Schwiebert EM, 2010, AM J PHYSIOL-CELL PH, V298, pC446, DOI 10.1152/ajpcell.00010.2010; Stojadinovic A, 2008, ANGIOGENESIS, V11, P369, DOI 10.1007/s10456-008-9120-6; Sun DH, 2013, STEM CELLS, V31, P1170, DOI 10.1002/stem.1356; Tepekoylu C, 2013, J THORAC CARDIOV SUR, V146, P971, DOI 10.1016/j.jtcvs.2013.01.017; Thiel M, 2001, CLIN ORTHOP RELAT R, P18; Wang Ching-Jen, 2003, Chang Gung Med J, V26, P220; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; Wang FS, 2002, J BIOL CHEM, V277, P10931, DOI 10.1074/jbc.M104587200; Yan XY, 2008, ANN PLAS SURG, V61, P646, DOI 10.1097/SAP.0b013e318172ba1f; Yang G, 2011, TOHOKU J EXP MED, V225, P285, DOI 10.1620/tjem.225.285; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Yu TC, 2010, AM J PHYSIOL-CELL PH, V298, pC457, DOI 10.1152/ajpcell.00342.2009; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao Y, 2013, CYTOTHERAPY, V15, P1449, DOI 10.1016/j.jcyt.2013.08.012; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	62	100	105	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27090	27104		10.1074/jbc.M114.580936	http://dx.doi.org/10.1074/jbc.M114.580936			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118288	Green Published, hybrid			2022-12-28	WOS:000342853900036
J	Zairi, M; Stiege, AC; Nhiri, N; Jacquet, E; Tavares, P				Zairi, Mohamed; Stiege, Asita C.; Nhiri, Naima; Jacquet, Eric; Tavares, Paulo			The Collagen-like Protein gp12 Is a Temperature-dependent Reversible Binder of SPP1 Viral Capsids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILIS BACTERIOPHAGE SPP1; BACILLUS-SUBTILIS; STRUCTURAL ORGANIZATION; STRUCTURE PREDICTION; SCAFFOLDING PROTEIN; SECONDARY STRUCTURE; PORTAL PROTEIN; PHAGE DISPLAY; IN-VITRO; VIRUS	Icosahedral capsids of viruses are lattices of defined geometry and homogeneous size. The (quasi-)equivalent organization of their protein building blocks provides, in numerous systems, the binding sites to assemble arrays of viral polypeptides organized with nanometer precision that protrude from the capsid surface. The capsid of bacterial virus (bacteriophage) SPP1 exposes, at its surface, the 6.6-kDa viral polypeptide gp12 that binds to the center of hexamers of the major capsid protein. Gp12 forms an elongated trimer with collagen-like properties. This is consistent with the fold of eight internal GXY repeats of gp12 to build a stable intersubunit triple helix in a prokaryotic setting. The trimer dissociates and unfolds at near physiological temperatures, as reported for eukaryotic collagen. Its structural organization is reacquired within seconds upon cooling. Interaction with the SPP1 capsid hexamers strongly stabilizes gp12, increasing its Tm to 54 degrees C. Above this temperature, gp12 dissociates from its binding sites and unfolds reversibly. Multivalent binding of gp12 trimers to the capsid is highly cooperative. The capsid lattice also provides a platform to assist folding and association of unfolded gp12 polypeptides. The original physicochemical properties of gp12 offer a thermoswitchable system for multivalent binding of the polypeptide to the SPP1 capsid surface.	[Zairi, Mohamed; Tavares, Paulo] CNRS, Ctr Rech Gif, Unite Virol Mol & Struct, UPR 3296, F-91190 Gif Sur Yvette, France; [Stiege, Asita C.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Nhiri, Naima; Jacquet, Eric] CNRS, Ctr Rech Gif, Inst Chim Subst Nat, UPR 2301, F-91190 Gif Sur Yvette, France; [Jacquet, Eric] Ctr Rech Gif, IMAGIF CTPF & qPCR Platform, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Tavares, P (corresponding author), CNRS, Ctr Rech Gif, Unite Virol Mol & Struct, UPR 3296, Batiment 14B,1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	tavares@vms.cnrs-gif.fr		JACQUET, Eric/0000-0001-6366-8436; Tavares, Paulo/0000-0002-2566-4546	CNRS; Max Planck Institute for Molecular Genetics; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Max Planck Institute for Molecular Genetics; Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT)	This work was supported by institutional funding from the CNRS and from the Max Planck Institute for Molecular Genetics.; Supported by a doctoral fellowship from Ministere de l'Education Nationale, de l'Enseignement superieur et de la Recherche (MNERT).	Alonso JC, 1997, GENE, V204, P201, DOI 10.1016/S0378-1119(97)00547-7; Auzat I, 2008, MOL MICROBIOL, V70, P557, DOI 10.1111/j.1365-2958.2008.06435.x; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Becker B, 1997, J MOL BIOL, V268, P822, DOI 10.1006/jmbi.1997.0997; BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; Cao H, 2008, FOOD CHEM, V108, P439, DOI 10.1016/j.foodchem.2007.09.022; CASJENS S, 1975, ANNU REV BIOCHEM, V44, P555, DOI 10.1146/annurev.bi.44.070175.003011; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; Droge A, 2000, J MOL BIOL, V296, P117, DOI 10.1006/jmbi.1999.3450; Droge A., 1998, THESIS TU BERLIN BER; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ghosh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037872; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Isidro A, 2004, VIROLOGY, V322, P253, DOI 10.1016/j.virol.2004.02.012; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jakutyte L, 2011, J BACTERIOL, V193, P4893, DOI 10.1128/JB.05104-11; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Li Q, 2007, J MOL BIOL, V370, P1006, DOI 10.1016/j.jmb.2007.05.008; Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]; Lurz R, 2001, J MOL BIOL, V310, P1027, DOI 10.1006/jmbi.2001.4800; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; O'Neil A, 2012, BIOMACROMOLECULES, V13, P3902, DOI 10.1021/bm301347x; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Poh SL, 2008, J MOL BIOL, V378, P551, DOI 10.1016/j.jmb.2008.02.028; Prasad BVV, 2012, ADV EXP MED BIOL, V726, P17, DOI 10.1007/978-1-4614-0980-9_3; Prevelige PE, 2012, ADV EXP MED BIOL, V726, P325, DOI 10.1007/978-1-4614-0980-9_14; Qin L, 2010, J MOL BIOL, V395, P728, DOI 10.1016/j.jmb.2009.10.007; Ren ZJ, 1996, PROTEIN SCI, V5, P1833, DOI 10.1002/pro.5560050909; Roos WH, 2009, P NATL ACAD SCI USA, V106, P9673, DOI 10.1073/pnas.0901514106; SEIFTER S, 1962, METHOD ENZYMOL, V5, P659, DOI 10.1016/S0076-6879(62)05292-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steinmetz NF, 2009, CURR TOP MICROBIOL, V327, P23; Strable E, 2009, CURR TOP MICROBIOL, V327, P1; Tao P, 2013, P NATL ACAD SCI USA, V110, P5846, DOI 10.1073/pnas.1300867110; Wallace BA, 2001, CURR OPIN CHEM BIOL, V5, P567, DOI 10.1016/S1367-5931(00)00243-X; White HE, 2012, J VIROL, V86, P6768, DOI 10.1128/JVI.00412-12; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yang F, 2000, NAT STRUCT BIOL, V7, P230; Yang Q, 2008, J MOL BIOL, V383, P1037, DOI 10.1016/j.jmb.2008.08.063	52	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27169	27181		10.1074/jbc.M114.590877	http://dx.doi.org/10.1074/jbc.M114.590877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074929	hybrid, Green Published			2022-12-28	WOS:000342853900042
J	Hansen, DB; Ye, ZC; Calloe, K; Braunstein, TH; Hofgaard, JP; Ransom, BR; Nielsen, MS; MacAulay, N				Hansen, Daniel Bloch; Ye, Zu-Cheng; Calloe, Kirstine; Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Ransom, Bruce R.; Nielsen, Morten Schak; MacAulay, Nanna			Activation, Permeability, and Inhibition of Astrocytic and Neuronal Large Pore (Hemi)channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; CONNEXIN-43 HEMICHANNELS; ATP RELEASE; PANNEXIN 1; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL-PROPERTIES; CX43 HEMICHANNELS; MIMETIC PEPTIDES; CHANNELS; RECEPTOR	Astrocytes and neurons express several large pore (hemi)channels that may open in response to various stimuli, allowing fluorescent dyes, ions, and cytoplasmic molecules such as ATP and glutamate to permeate. Several of these large pore (hemi)channels have similar characteristics with regard to activation, permeability, and inhibitor sensitivity. Consequently, their behaviors and roles in astrocytic and n(e)uronal (patho)physiology remain undefined. We took advantage of the Xenopus laevis expression system to determine the individual characteristics of several large pore channels in isolation. Expression of connexins Cx26, Cx30, Cx36, or Cx43, the pannexins Px1 or Px2, or the purinergic receptor P2X(7) yielded functional (hemi)channels with isoform-specific characteristics. Connexin hemichannels had distinct sensitivity to alterations of extracellular Ca2+ and their permeability to dyes and small atomic ions (conductance) were not proportional. Px1 and Px2 exhibited conductance at positive membrane potentials, but only Px1 displayed detectable fluorescent dye uptake. P2X(7), in the absence of Px1, was permeable to fluorescent dyes in an agonist-dependent manner. The large pore channels displayed overlapping sensitivity to the inhibitors Brilliant Blue, gadolinium, and carbenoxolone. These results demonstrated isoform-specific characteristics among the large pore membrane channels; an open (hemi)channel is not a nonselective channel. With these isoform-specific properties in mind, we characterized the divalent cation-sensitive permeation pathway in primary cultured astrocytes. We observed no activation of membrane conductance or Cx43-mediated dye uptake in astrocytes nor in Cx43-expressing C6 cells. Our data underscore that although Cx43-mediated transport is observed in overexpressing cell systems, such transport may not be detectable in native cells under comparable experimental conditions.	[Hansen, Daniel Bloch; MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Ye, Zu-Cheng; Ransom, Bruce R.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Calloe, Kirstine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg, Denmark; [Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Nielsen, Morten Schak] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2200 Copenhagen, Denmark; [Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Nielsen, Morten Schak] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Washington; University of Washington Seattle; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen	MacAulay, N (corresponding author), Panum Inst, Blegdamsvej 3,Bldg 12-6, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	Ransom, Bruce/ABE-4606-2021; MacAulay, Nanna/AER-7709-2022; Calloe, Kirstine/H-8643-2016; Nielsen, Morten Schak/C-1494-2009; Ye, Zucheng/AFP-8574-2022	MacAulay, Nanna/0000-0002-7800-6600; Calloe, Kirstine/0000-0002-1777-7938; Nielsen, Morten Schak/0000-0002-9718-5421; Hansen, Daniel Bloch/0000-0002-1250-4754; Ransom, Bruce R./0000-0002-9658-0294	Danish Medical Research Foundation; Danish National Research Foundation	Danish Medical Research Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish Medical Research Foundation (to N. M.), and the Danish National Research Foundation (to M. S. N.).	Al-Ubaidi MR, 2000, J NEUROSCI RES, V59, P813, DOI 10.1002/(SICI)1097-4547(20000315)59:6<813::AID-JNR14>3.3.CO;2-R; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chanson M, 2007, PROG BIOPHYS MOL BIO, V94, P233, DOI 10.1016/j.pbiomolbio.2007.03.002; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Cheung KK, 2005, NEUROSCIENCE, V133, P937, DOI 10.1016/j.neuroscience.2005.03.032; Clair C, 2008, EXP CELL RES, V314, P1250, DOI 10.1016/j.yexcr.2007.12.021; Condorelli DF, 2013, GAP JUNCTIONS IN THE BRAIN: PHYSIOLOGICAL AND PATHOLOGICAL ROLES, P69, DOI 10.1016/B978-0-12-415901-3.00005-0; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 2000, J NEUROSCI, V20, P2835; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Dahl G, 2007, CELL COMMUN ADHES, V14, P259, DOI 10.1080/15419060801891018; De Bock M, 2012, J BIOL CHEM, V287, P12250, DOI 10.1074/jbc.M111.299610; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Figueroa XF, 2013, NEUROPHARMACOLOGY, V75, P471, DOI 10.1016/j.neuropharm.2013.02.022; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Hofgaard JP, 2009, AM J PHYSIOL-REG I, V297, pR243, DOI 10.1152/ajpregu.00089.2009; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kubick C, 2011, BBA-BIOMEMBRANES, V1808, P2913, DOI 10.1016/j.bbamem.2011.08.017; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lippiat Jonathan D., 2008, V491, P141, DOI 10.1007/978-1-59745-526-8_11; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Marandykina A, 2013, J PHYSIOL-LONDON, V591, P2087, DOI 10.1113/jphysiol.2013.250910; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Morita M, 2007, GLIA, V55, P508, DOI 10.1002/glia.20471; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orellana JA, 2011, BIOCHEM BIOPH RES CO, V409, P603, DOI 10.1016/j.bbrc.2011.05.031; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Poornima V, 2012, J MOL NEUROSCI, V46, P585, DOI 10.1007/s12031-011-9646-8; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Salas E, 2013, J PHARMACOL EXP THER, V347, P802, DOI 10.1124/jpet.113.209452; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Scemes E, 2008, CELL COMMUN ADHES, V15, P143, DOI 10.1080/15419060802014255; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schalper KA, 2008, MOL BIOL CELL, V19, P3501, DOI 10.1091/mbc.E07-12-1240; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC755, DOI 10.1152/ajpcell.1999.277.4.C755; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Singh D, 2003, CELL COMMUN ADHES, V10, P215, DOI 10.1080/714040430; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Stroud RM, 2003, FEBS LETT, V555, P79, DOI 10.1016/S0014-5793(03)01195-5; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Valiunas V, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00075; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wang N, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0304-2; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007	89	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26058	26073		10.1074/jbc.M114.582155	http://dx.doi.org/10.1074/jbc.M114.582155			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086040	Green Published, hybrid			2022-12-28	WOS:000342128800005
J	Lobato, L; Bouzhir-Sima, L; Yamashita, T; Wilson, MT; Vos, MH; Liebl, U				Lobato, Laura; Bouzhir-Sima, Latifa; Yamashita, Taku; Wilson, Michael T.; Vos, Marten H.; Liebl, Ursula			Dynamics of the Heme-binding Bacterial Gas-sensing Dissimilative Nitrate Respiration Regulator (DNR) and Activation Barriers for Ligand Binding and Escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYMETHYL CYTOCHROME-C; SOLUBLE GUANYLATE-CYCLASE; TRANSCRIPTION FACTOR COOA; NITRIC-OXIDE DYNAMICS; ESCHERICHIA-COLI; CARBON-MONOXIDE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; SENSOR PROTEINS; YEAST ISO-1-CYTOCHROME-C	DNR (dissimilative nitrate respiration regulator) is a heme-binding transcription factor that is involved in the regulation of denitrification in Pseudomonas aeruginosa. In the ferrous deoxy state, the heme is 6-coordinate; external NO and CO can replace an internal ligand. Using fluorescence anisotropy, we show that high-affinity sequence-specific DNA binding occurs only when the heme is nitrosylated, consistent with the proposed function of DNR as NO sensor and transcriptional activator. This role is moreover supported by the NO "trapping" properties revealed by ultrafast spectroscopy that are similar to those of other heme-based NO sensor proteins. Dissociated CO-heme pairs rebind in an essentially barrierless way. This process competes with migration out of the heme pocket. The latter process is thermally activated (E-a similar to 7 kJ/mol). This result is compared with other heme proteins, including the homologous CO sensor/transcription factor CooA, variants of the 5-coordinate mycobacterial sensor DosT and the electron transfer protein cytochrome c. This comparison indicates that thermal activation of ligand escape from the heme pocket is specific for systems where an external ligand replaces an internal one. The origin of this finding and possible implications are discussed.	[Lobato, Laura; Bouzhir-Sima, Latifa; Vos, Marten H.; Liebl, Ursula] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Lobato, Laura; Bouzhir-Sima, Latifa; Vos, Marten H.; Liebl, Ursula] INSERM, U696, F-91128 Palaiseau, France; [Yamashita, Taku] Osaka Univ, Grad Sch Pharmaceut Sci, Analyt Chem Lab, Suita, Osaka 5650871, Japan; [Wilson, Michael T.] Univ Essex, Sch Biol Sci, Colchester C04 3SQ, Essex, England	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Osaka University; University of Essex	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu; ursula.liebl@polytechnique.edu		LIEBL, Ursula/0000-0003-0869-4388; Vos, Marten/0000-0003-0493-4831	Agence National de la Recherche [ANR-09-PIRI-0019]; "La Caixa," Spain	Agence National de la Recherche(French National Research Agency (ANR)); "La Caixa," Spain(La Caixa Foundation)	This work was supported by Agence National de la Recherche Grant ANR-09-PIRI-0019 (to M. H. V. and U. L.).; Recipient of a two-year fellowship from "La Caixa," Spain.	Aono S, 2012, ANTIOXID REDOX SIGN, V16, P678, DOI 10.1089/ars.2011.4248; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Benabbas A, 2012, J BIOL CHEM, V287, P21729, DOI 10.1074/jbc.M112.345090; Bisht NK, 2011, BBA-PROTEINS PROTEOM, V1814, P1042, DOI 10.1016/j.bbapap.2010.09.016; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; BREN KL, 1993, J AM CHEM SOC, V115, P10382, DOI 10.1021/ja00075a073; Bruno S, 2007, J AM CHEM SOC, V129, P2880, DOI 10.1021/ja066638d; Brzezinski P, 1997, P NATL ACAD SCI USA, V94, P6176, DOI 10.1073/pnas.94.12.6176; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Creze C, 2012, J BIOL CHEM, V287, P15648, DOI 10.1074/jbc.M112.346361; Flynn PF, 2001, BIOCHEMISTRY-US, V40, P6559, DOI 10.1021/bi0102252; Gabba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049770; Germani F, 2013, ADV MICROB PHYSIOL, V63, P1, DOI 10.1016/B978-0-12-407693-8.00001-7; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Giardina G, 2009, PROTEINS, V77, P174, DOI 10.1002/prot.22428; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kim J, 2009, J PHYS CHEM B, V113, P260, DOI 10.1021/jp804656t; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Larsen RW, 2003, BBA-GEN SUBJECTS, V1619, P15, DOI 10.1016/S0304-4165(02)00436-1; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; Liebl U, 2013, BBA-PROTEINS PROTEOM, V1834, P1684, DOI 10.1016/j.bbapap.2013.02.025; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Lukacs A, 2006, J PHYS CHEM B, V110, P15654, DOI 10.1021/jp063686b; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; MORRIS RJ, 1980, J BIOL CHEM, V255, P8050; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Rinaldo S, 2012, ANTIOXID REDOX SIGN, V17, P1178, DOI 10.1089/ars.2011.4226; Roberts GP, 2005, J INORG BIOCHEM, V99, P280, DOI 10.1016/j.jinorgbio.2004.10.032; Rubtsov IV, 2001, J AM CHEM SOC, V123, P10056, DOI 10.1021/ja011023w; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Silkstone G, 2005, DALTON T, P3489, DOI 10.1039/b508183c; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; Silkstone G, 2010, J BIOL CHEM, V285, P19785, DOI 10.1074/jbc.M109.067736; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 2012, BIOCHEMISTRY-US, V51, P159, DOI 10.1021/bi201467c; WILSON MT, 1973, J BIOL CHEM, V248, P8162; Yamashita T, 2004, J BIOL CHEM, V279, P21394, DOI 10.1074/jbc.M400512200; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Yoo BK, 2012, J BIOL CHEM, V287, P6851, DOI 10.1074/jbc.M111.299297	56	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26514	26524		10.1074/jbc.M114.571398	http://dx.doi.org/10.1074/jbc.M114.571398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25037216	hybrid, Green Published			2022-12-28	WOS:000342128800042
J	Wurstle, ML; Rehm, M				Wuerstle, Maximilian L.; Rehm, Markus			A Systems Biology Analysis of Apoptosome Formation and Apoptosis Execution Supports Allosteric Procaspase-9 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROXIMITY MODEL; X-LINKED-INHIBITOR; CYTOCHROME-C; CASPASE ACTIVATION; CELL-DEATH; APAF-1/CASPASE-9 APOPTOSOME; MEMBRANE PERMEABILIZATION; SINGLE CELLS; APAF-1; COMPLEX	The protease caspase-9 is activated on the apoptosome, a multiprotein signal transduction platform that assembles in response to mitochondria-dependent apoptosis initiation. Despite extensive molecular research, the assembly of the holoapoptosome and the process of caspase-9 activation remain incompletely understood. Here, we therefore integrated quantitative data on the molecular interactions and proteolytic processes during apoptosome formation and apoptosis execution and conducted mathematical simulations to investigate the resulting biochemical signaling, quantitatively and kinetically. Interestingly, when implementing the homodimerization of procaspase-9 as a prerequisite for activation, the calculated kinetics of apoptosis execution and the efficacy of caspase-3 activation failed to replicate experimental data. In contrast, assuming a scenario in which procaspase-9 is activated allosterically upon binding to the apoptosome backbone, the mathematical simulations quantitatively and kinetically reproduced all experimental data. These data included a XIAP threshold concentration at which apoptosis execution is suppressed in HeLa cervical cancer cells, half-times of procaspase-9 processing, as well as the molecular timer function of the apoptosome. Our study therefore provides novel mechanistic insight into apoptosome-dependent apoptosis execution and suggests that caspase-9 is activated allosterically by binding to the apoptosome backbone. Our findings challenge the currently prevailing dogma that all initiator procaspases require homodimerization for activation.	[Wuerstle, Maximilian L.; Rehm, Markus] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Wuerstle, Maximilian L.; Rehm, Markus] Royal Coll Surgeons Ireland, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Rehm, Markus/C-3398-2012	Rehm, Markus/0000-0001-6149-9261	European Union; National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); Science Foundation Ireland [SFI 09/RFP/BIC2375]	European Union(European Commission); National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the European Union Framework Programme 7 (FP7 APO-DECIDE and FP7 SYS-MEL), the National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4), and Science Foundation Ireland (SFI 09/RFP/BIC2375).	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cozzolino M, 2004, CELL DEATH DIFFER, V11, P1179, DOI 10.1038/sj.cdd.4401476; Ferraro E, 2011, J CELL SCI, V124, P3450, DOI 10.1242/jcs.086298; Freathy C, 2000, HEPATOLOGY, V32, P750, DOI 10.1053/jhep.2000.18329; Garcia-Berrocal JR, 2007, BRIT J PHARMACOL, V152, P1012, DOI 10.1038/sj.bjp.0707405; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Janssens S, 2012, CELL DEATH DIFFER, V19, P13, DOI 10.1038/cdd.2011.162; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kanungo AK, 2008, J BIOL CHEM, V283, P22105, DOI 10.1074/jbc.M800988200; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Kim J, 2012, EMBO J, V31, P1279, DOI 10.1038/emboj.2011.491; Lavrik IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.160; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Murphy AC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.157; Niimi S, 2012, J BIOL CHEM, V287, P18573, DOI 10.1074/jbc.M112.347690; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Palacios-Rodriguez Y, 2011, J BIOL CHEM, V286, P44457, DOI 10.1074/jbc.M111.255364; Passante E, 2013, CELL DEATH DIFFER, V20, P1521, DOI 10.1038/cdd.2013.106; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Purring C, 1999, J AM CHEM SOC, V121, P7435, DOI 10.1021/ja991235h; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Reubold TF, 2009, J BIOL CHEM, V284, P32717, DOI 10.1074/jbc.M109.014027; Reubold TF, 2011, STRUCTURE, V19, P1074, DOI 10.1016/j.str.2011.05.013; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saikumar P, 2007, FRONT BIOSCI-LANDMRK, V12, P3343, DOI 10.2741/2317; Schmid J, 2012, J BIOL CHEM, V287, P41546, DOI 10.1074/jbc.M112.411827; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Vicent MJ, 2006, J MED CHEM, V49, P3763, DOI 10.1021/jm060458x; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wurstle ML, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.36; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Yuan SJ, 2011, STRUCTURE, V19, P1084, DOI 10.1016/j.str.2011.07.001; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; Zermati Y, 2007, MOL CELL, V28, P624, DOI 10.1016/j.molcel.2007.09.030; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	67	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26277	26289		10.1074/jbc.M114.590034	http://dx.doi.org/10.1074/jbc.M114.590034			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25107908	hybrid, Green Published			2022-12-28	WOS:000342128800022
J	Zhuang, YB; Ding, GX; Zhao, M; Bai, M; Yang, LY; Ni, JJ; Wang, R; Jia, ZJ; Huang, SM; Zhang, AH				Zhuang, Yibo; Ding, Guixia; Zhao, Min; Bai, Mi; Yang, Lingyun; Ni, Jiajia; Wang, Rong; Jia, Zhanjun; Huang, Songming; Zhang, Aihua			NLRP3 Inflammasome Mediates Albumin-induced Renal Tubular Injury through Impaired Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; OVERLOAD PROTEINURIA; ACTIVATION; MICE; NEPHROPATHY; CASPASE-1; APOPTOSIS; ISCHEMIA; PATHWAY; DISEASE	Proteinuria serves as a direct causative factor of renal tubular cell injury and is highly associated with the progression of chronic kidney disease via uncertain mechanisms. Recently, evidence demonstrated that both NLRP3 inflammasome and mitochondria are involved in the chronic kidney disease progression. The present study was undertaken to examine the role of NLRP3 inflammasome/mitochondria axis in albumin-induced renal tubular injury. In patients with proteinuria, NLRP3 was significantly up-regulated in tubular epithelial cells and was positively correlated with the severity of proteinuria. In agreement with these results, albumin remarkably activated NLRP3 inflammasome in both in vitro renal tubular cells and in vivo kidneys in parallel with significant epithelial cell phenotypic alteration and cell apoptosis. Genetic disruption of NLRP3 inflammasome remarkably attenuated albumin-induced cell apoptosis and phenotypic changes under both in vitro and in vivo conditions. In addition, albumin treatment resulted in a significant mitochondrial abnormality as evidenced by the impaired function and morphology, which was markedly reversed by invalidation of NLRP3/caspase-1 signaling pathway. Interestingly, protection of mitochondria function by Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP) or cyclosporin A (CsA) robustly attenuated albumin-induced injury in mouse proximal tubular cells. Collectively, these findings demonstrated a pathogenic role of NLRP3 inflammasome/caspase-1/mitochondria axis in mediating albumin-induced renal tubular injury. The discovery of this novel axis provides some potential targets for the treatment of proteinuria-associated renal injury.	[Zhuang, Yibo; Ding, Guixia; Jia, Zhanjun; Huang, Songming; Zhang, Aihua] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Nephrol, Nanjing 210008, Jiangsu, Peoples R China; [Zhuang, Yibo; Zhao, Min; Bai, Mi; Yang, Lingyun; Ni, Jiajia; Wang, Rong; Jia, Zhanjun; Huang, Songming; Zhang, Aihua] Nanjing Med Univ, Inst Pediat, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhang, AH (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Nephrol, 72 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	zhaihua@njmu.edu.cn		Min, Zhao/0000-0003-1352-771X	National Basic Research Program of China 973 Program [2012CB517602, 2013CB530604]; National Natural Science Foundation of China [81325004, 81270797, 81170635]; Natural Science Foundation of Jiangsu Province [BK2012001]; Program for New Century Excellent Talents in University [NCET-12-0738]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Basic Research Program of China 973 Program Grants 2012CB517602 and 2013CB530604; National Natural Science Foundation of China Grants 81325004, 81270797, and 81170635; Natural Science Foundation of Jiangsu Province Grant BK2012001, and Program for New Century Excellent Talents in University Grant NCET-12-0738.	Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; Bakker PJ, 2014, KIDNEY INT, V85, P1112, DOI 10.1038/ki.2013.503; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang SM, 2009, AM J PHYSIOL-RENAL, V296, pF1323, DOI 10.1152/ajprenal.90428.2008; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Kim HJ, 2013, J PHARMACOL EXP THER, V346, P465, DOI 10.1124/jpet.113.205732; Kim JJ, 2013, J KOREAN MED SCI, V28, P1415, DOI 10.3346/jkms.2013.28.10.1415; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Niaudet P, 1996, PEDIATR NEPHROL, V10, P368; Oosting M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4090; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; SHANLEY PF, 1986, AM J PATHOL, V122, P462; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Zhao JJ, 2013, ARTHRITIS RHEUM-US, V65, P3176, DOI 10.1002/art.38174; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zoja C, 2003, J AM SOC NEPHROL, V14, pS36, DOI 10.1097/01.ASN.0000068626.23485.E0	39	67	73	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25101	25111		10.1074/jbc.M114.578260	http://dx.doi.org/10.1074/jbc.M114.578260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059664	Green Published, hybrid			2022-12-28	WOS:000341985300033
J	Michailidis, E; Huber, AD; Ryan, EM; Ong, YT; Leslie, MD; Matzek, KB; Singh, K; Marchand, B; Hagedorn, AN; Kirby, KA; Rohan, LC; Kodama, EN; Mitsuya, H; Parniak, MA; Sarafianos, SG				Michailidis, Eleftherios; Huber, Andrew D.; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.			4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; Enzyme Inhibitor; Human Immunodeficiency Virus (HIV); Nucleoside; Nucleotide Analogue; Reverse Transcription; EFdA; NRTIs; Antivirals; Reverse Transcriptase	HUMAN IMMUNODEFICIENCY VIRUSES; CONNECTION SUBDOMAIN; NUCLEOTIDE ANALOGS; DRUG-RESISTANCE; HEPATITIS-B; IN-VITRO; DNA; TRANSLOCATION; PRIMER; TENOFOVIR	Background: 4-Ethynyl-2-fluoro-2-deoxyadenosine (EFdA) is a highly potent nucleoside analog reverse transcriptase (RT) inhibitor with a 3-OH. Results: EFdA inhibits RT as an immediate or delayed chain terminator depending on the DNA substrate sequence. RT efficiently misincorporates EFdA, producing non-extendable mismatched primers protected from excision. Conclusion: EFdA blocks RT by multiple mechanisms. Significance: Understanding the EFdA inhibition mechanism will help develop better antivirals. 4-Ethynyl-2-fluoro-2-deoxyadenosine (EFdA) is a nucleoside analog that, unlike approved anti-human immunodeficiency virus type 1 (HIV-1) nucleoside reverse transcriptase inhibitors, has a 3-OH and exhibits remarkable potency against wild-type and drug-resistant HIVs. EFdA triphosphate (EFdA-TP) is unique among nucleoside reverse transcriptase inhibitors because it inhibits HIV-1 reverse transcriptase (RT) with multiple mechanisms. (a) EFdA-TP can block RT as a translocation-defective RT inhibitor that dramatically slows DNA synthesis, acting as a de facto immediate chain terminator. Although non-translocated EFdA-MP-terminated primers can be unblocked, they can be efficiently converted back to the EFdA-MP-terminated form. (b) EFdA-TP can function as a delayed chain terminator, allowing incorporation of an additional dNTP before blocking DNA synthesis. In such cases, EFdA-MP-terminated primers are protected from excision. (c) EFdA-MP can be efficiently misincorporated by RT, leading to mismatched primers that are extremely hard to extend and are also protected from excision. The context of template sequence defines the relative contribution of each mechanism and affects the affinity of EFdA-MP for potential incorporation sites, explaining in part the lack of antagonism between EFdA and tenofovir. Changes in the type of nucleotide before EFdA-MP incorporation can alter its mechanism of inhibition from delayed chain terminator to immediate chain terminator. The versatility of EFdA in inhibiting HIV replication by multiple mechanisms may explain why resistance to EFdA is more difficult to emerge.	[Michailidis, Eleftherios; Huber, Andrew D.; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Huber, Andrew D.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Michailidis, Eleftherios; Ryan, Emily M.; Ong, Yee T.; Leslie, Maxwell D.; Matzek, Kayla B.; Singh, Kamalendra; Marchand, Bruno; Hagedorn, Ariel N.; Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Kodama, Eiichi N.] Tohoku Univ, Div Emerging Infect Dis, Sendai, Miyagi 9808575, Japan; [Mitsuya, Hiroaki] Kumamoto Univ, Dept Internal Med, Kumamoto 8608556, Japan; [Mitsuya, Hiroaki] NIH, Expt Retrovirol Sect, HIV AIDS Malignancy Branch, Bethesda, MD 20892 USA; [Parniak, Michael A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tohoku University; Kumamoto University; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sarafianos, SG (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Kirby, Karen A./0000-0003-2468-4796; Michailidis, Eleftherios/0000-0002-9907-4346; Ong, Yee Tsuey/0000-0001-9361-2855; Huber, Andrew/0000-0002-3790-8368	National Institutes of Health [R01AI076119, R01AI076119-S1, R01AI076119-02S1, R01AI099284, R01AI100890, R21AI112417, P01GM103368, AI079801]; Mizzou Advantage; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL CANCER INSTITUTE [ZIASC006738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112417, R01AI100890, R01AI076119, R33AI079801, R01AI099284, R21AI079801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage; Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI076119, R01AI076119-S1, R01AI076119-02S1, R01AI099284, R01AI100890, R21AI112417, and P01GM103368 (to S. G. S.) and AI079801 (to M. A. P.). This work was also supported by Mizzou Advantage and the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea. Coauthors Drs. Hiroaki Mitsuya and Eiichi N. Kodama are inventors of EFdA, and thus there is a potential conflict of interest.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Bauman JD, 2008, NUCLEIC ACIDS RES, V36, P5083, DOI 10.1093/nar/gkn464; Biaglow JE, 1997, RADIAT RES, V148, P181, DOI 10.2307/3579576; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Gentile I, 2013, CURR MED CHEM, V20, P3733, DOI 10.2174/09298673113209990178; Hachiya A, 2013, ANTIMICROB AGENTS CH, V57, P4554, DOI 10.1128/AAC.00283-13; Hachiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016242; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Kageyama M, 2011, ORG LETT, V13, P5264, DOI 10.1021/ol202116k; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kim J, 2012, J MOL BIOL, V415, P866, DOI 10.1016/j.jmb.2011.12.034; Kirby KA, 2013, ANTIMICROB AGENTS CH, V57, P6254, DOI 10.1128/AAC.01703-13; Kirby KA, 2012, ANTIMICROB AGENTS CH, V56, P2048, DOI 10.1128/AAC.06000-11; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; Lansdon EB, 2010, J MOL BIOL, V397, P967, DOI 10.1016/j.jmb.2010.02.019; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Maeda K, 2014, ANTIVIR THER, V19, P179, DOI 10.3851/IMP2697; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Meyer PR, 2004, J BIOL CHEM, V279, P45389, DOI 10.1074/jbc.M405072200; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Michailidis E, 2012, CELL MOL BIOL, V58, P187, DOI 10.1170/T940; Michailidis E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-65; Michailidis E, 2012, INT J BIOCHEM CELL B, V44, P1060, DOI 10.1016/j.biocel.2012.04.006; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Muftuoglu Y, 2014, ANTIVIR RES, V106, P1, DOI 10.1016/j.antiviral.2014.03.001; Murphey-Corb M, 2012, ANTIMICROB AGENTS CH, V56, P4707, DOI 10.1128/AAC.00723-12; Ndongwe TP, 2012, NUCLEIC ACIDS RES, V40, P345, DOI 10.1093/nar/gkr694; Ohrui H, 2006, CHEM REC, V6, P133, DOI 10.1002/tcr.20078; Parniak M A, 2000, Adv Pharmacol, V49, P67; Sarafianos SG, 2004, INT J BIOCHEM CELL B, V36, P1706, DOI 10.1016/j.biocel.2004.02.027; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Singh K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398180; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Vu BC, 2011, ANTIMICROB AGENTS CH, V55, P2379, DOI 10.1128/AAC.01290-10; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042	49	62	64	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24533	24548		10.1074/jbc.M114.562694	http://dx.doi.org/10.1074/jbc.M114.562694			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24970894	Green Published, hybrid			2022-12-28	WOS:000341505600045
J	Zi, M; Maqsood, A; Prehar, S; Mohamed, TMA; Abou-Leisa, R; Robertson, A; Cartwright, EJ; Ray, SG; Oh, S; Lim, DS; Neyses, L; Oceandy, D				Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Ray, Simon G.; Oh, Sangphil; Lim, Dae-Sik; Neyses, Ludwig; Oceandy, Delvac			The Mammalian Ste20-like Kinase 2 (Mst2) Modulates Stress-induced Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; Cardiovascular Disease; Genetic Polymorphism; Signal Transduction; Transgenic Mice	CARDIOMYOCYTE PROLIFERATION; PROTEIN-KINASE; HEART SIZE; PUMP 4B; APOPTOSIS; GROWTH; RAF-1; SUPPRESSION; INHIBITION; REGULATOR	Background: The role of components of the Hippo signaling pathway in mediating pathological cardiac hypertrophy is incompletely understood. Results: Genetic ablation of Mst2 reduces pathological cardiac hypertrophic response in adult mice. Conclusion: Mst2 regulates stress-induced cardiac hypertrophy by modulating the Raf1-ERK1/2 pathway. Significance: Mst2 might become a novel therapeutic target to reduce pathological hypertrophy. The Hippo signaling pathway has recently moved to center stage in cardiac research because of its key role in cardiomyocyte proliferation and regeneration of the embryonic and newborn heart. However, its role in the adult heart is incompletely understood. We investigate here the role of mammalian Ste20-like kinase 2 (Mst2), one of the central regulators of this pathway. Mst2(-/-) mice showed no alteration in cardiomyocyte proliferation. However, Mst2(-/-) mice exhibited a significant reduction of hypertrophy and fibrosis in response to pressure overload. Consistently, overexpression of MST2 in neonatal rat cardiomyocytes significantly enhanced phenylephrine-induced cellular hypertrophy. Mechanistically, Mst2 positively modulated the prohypertrophic Raf1-ERK1/2 pathway. However, activation of the downstream effectors of the Hippo pathway (Yes-associated protein) was not affected by Mst2 ablation. An initial genetic study in mitral valve prolapse patients revealed an association between a polymorphism in the human MST2 gene and adverse cardiac remodeling. These results reveal a novel role of Mst2 in stress-dependent cardiac hypertrophy and remodeling in the adult mouse and likely human heart.	[Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Neyses, Ludwig; Oceandy, Delvac] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9PT, Lancs, England; [Zi, Min; Maqsood, Arfa; Prehar, Sukhpal; Mohamed, Tamer M. A.; Abou-Leisa, Riham; Robertson, Abigail; Cartwright, Elizabeth J.; Neyses, Ludwig; Oceandy, Delvac] Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Ray, Simon G.] Univ S Manchester Hosp, Dept Cardiol, Manchester M23 9LT, Lancs, England; [Ray, Simon G.] Manchester Acad Hlth Sci Ctr, Manchester M23 9LT, Lancs, England; [Oh, Sangphil; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Dept Biol Sci, Natl Creat Res Initiat Ctr, Taejon 305701, South Korea	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Korea Advanced Institute of Science & Technology (KAIST)	Oceandy, D (corresponding author), Univ Manchester, Inst Cardiovasc Sci, 5-002 AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	delvac.oceandy@manchester.ac.uk	Neyses, Ludwig/AGY-7446-2022; Oceandy, Delvac/G-9911-2015; Lim, Dae-Sik/C-1599-2011; Robertson, Abigail/G-7715-2015	Oceandy, Delvac/0000-0002-6242-6491; Lim, Dae-Sik/0000-0003-2356-7555; Robertson, Abigail/0000-0002-2592-8898; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795	British Heart Foundation Intermediate Fellowship Grant [FS/09/046/28043]; British Heart Foundation Project Grants [PG/11/23/28801, PG/13/12/30017]; British Heart Foundation Intermediate Basic Science Research Fellowship; British Heart Foundation [PG/13/12/30017, PG/11/23/28801, FS/09/046/28043] Funding Source: researchfish	British Heart Foundation Intermediate Fellowship Grant; British Heart Foundation Project Grants; British Heart Foundation Intermediate Basic Science Research Fellowship; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Intermediate Fellowship Grant FS/09/046/28043 and British Heart Foundation Project Grants PG/11/23/28801 and PG/13/12/30017 (to D. O.).; A recipient of a British Heart Foundation Intermediate Basic Science Research Fellowship.	Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Oceandy D, 2009, CIRCULATION, V120, P607, DOI 10.1161/CIRCULATIONAHA.109.868554; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; ROKEY R, 1986, J AM COLL CARDIOL, V7, P1273, DOI 10.1016/S0735-1097(86)80146-2; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	23	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24275	24288		10.1074/jbc.M114.562405	http://dx.doi.org/10.1074/jbc.M114.562405			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25035424	Green Published, hybrid			2022-12-28	WOS:000341505600024
J	Avital-Shmilovici, M; Whittaker, J; Weiss, MA; Kent, SBH				Avital-Shmilovici, Michal; Whittaker, Jonathan; Weiss, Michael A.; Kent, Stephen B. H.			Deciphering a Molecular Mechanism of Neonatal Diabetes Mellitus by the Chemical Synthesis of a Protein Diastereomer, [D-Ala(B8)]Human Proinsulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Diabetes; Mutant; Peptide Chemical Synthesis; Protein Folding; Proinsulin; Insulin Receptor	ENDOPLASMIC-RETICULUM STRESS; PHASE PEPTIDE-SYNTHESIS; DISULFIDE-ISOMERASE; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; INSULIN-RECEPTOR; INS GENE; B-CHAIN; LIGATION; MUTATIONS	Background: Human proinsulin provides a model for studies of toxic protein misfolding. Results: Folding efficiency of proinsulin is controlled by stereochemistry at position B8. Conclusion: The sign of a single angle can facilitate or impede disulfide pairing. Significance: A monogenic diabetes syndrome suggests that insulin has evolved to the edge of non-foldability. Misfolding of proinsulin variants in the pancreatic -cell, a monogenic cause of permanent neonatal-onset diabetes mellitus, provides a model for a disease of protein toxicity. A hot spot for such clinical mutations is found at position B8, conserved as glycine within the vertebrate insulin superfamily. We set out to investigate the molecular basis of the aberrant properties of a proinsulin clinical mutant in which residue Gly(B8) is replaced by Ser(B8). Modular total chemical synthesis was used to prepare the wild-type [Gly(B8)]proinsulin molecule and three analogs: [d-Ala(B8)]proinsulin, [l-Ala(B8)]proinsulin, and the clinical mutant [l-Ser(B8)]proinsulin. The protein diastereomer [d-Ala(B8)]proinsulin produced higher folding yields at all pH values compared with the wild-type proinsulin and the other two analogs, but showed only very weak binding to the insulin receptor. The clinical mutant [l-Ser(B8)]proinsulin impaired folding at pH 7.5 even in the presence of protein-disulfide isomerase. Surprisingly, although [l-Ser(B8)]proinsulin did not fold well under the physiological conditions investigated, once folded the [l-Ser(B8)]proinsulin protein molecule bound to the insulin receptor more effectively than wild-type proinsulin. Such paradoxical gain of function (not pertinent in vivo due to impaired secretion of the mutant insulin) presumably reflects induced fit in the native mechanism of hormone-receptor engagement. This work provides insight into the molecular mechanism of a clinical mutation in the insulin gene associated with diabetes mellitus. These results dramatically illustrate the power of total protein synthesis, as enabled by modern chemical ligation methods, for the investigation of protein folding and misfolding.	[Avital-Shmilovici, Michal; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Avital-Shmilovici, Michal; Kent, Stephen B. H.] Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; [Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	University of Chicago; University of Chicago; Case Western Reserve University; Case Western Reserve University	Kent, SBH (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA.	skent@uchicago.edu			National Institutes of Health from the NIDDK [R01 DK069764]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK069764 from the NIDDK (to M. A. W.) with a subcontract to S. B. Kent (University of Chicago). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH) where he serves as Chief Scientific Officer and has also been a consultant to Merck Research Laboratories and DEKA Research and Development Corp.; Supported in part by the American Diabetes Association.	Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Avital-Shmilovici M, 2013, J AM CHEM SOC, V135, P3173, DOI 10.1021/ja311408y; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; CREIGHTON TE, 1992, BIOESSAYS, V14, P195, DOI 10.1002/bies.950140310; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; FREYCHET P, 1974, J CLIN INVEST, V54, P1020, DOI 10.1172/JCI107845; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Luisier S, 2010, CHEM COMMUN, V46, P8177, DOI 10.1039/c0cc03141k; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MITCHELL AR, 1978, J ORG CHEM, V43, P2845, DOI 10.1021/jo00408a022; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Schaeffer RD, 2008, CURR OPIN STRUC BIOL, V18, P4, DOI 10.1016/j.sbi.2007.11.007; Schnolzer M, 2007, INT J PEPT RES THER, V13, P31, DOI 10.1007/s10989-006-9059-7; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shield JPH, 1997, ARCH DIS CHILD-FETAL, V76, pF39, DOI 10.1136/fn.76.1.F39; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sohma Y, 2009, J AM CHEM SOC, V131, P16313, DOI 10.1021/ja9052398; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Villain M, 2001, CHEM BIOL, V8, P673, DOI 10.1016/S1074-5521(01)00044-8; Wang CC, 1998, BIOCHEMISTRY-MOSCOW+, V63, P407; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Winter J, 2002, ANAL BIOCHEM, V310, P148, DOI 10.1016/S0003-2697(02)00287-7; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Zeldovich KB, 2008, ANNU REV PHYS CHEM, V59, P105, DOI 10.1146/annurev.physchem.58.032806.104449; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	58	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23683	23692		10.1074/jbc.M114.572040	http://dx.doi.org/10.1074/jbc.M114.572040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002580	Green Published, hybrid			2022-12-28	WOS:000341505000036
J	Roach, CR; Hall, DE; Zerbe, P; Bohlmann, J				Roach, Christopher R.; Hall, Dawn E.; Zerbe, Philipp; Bohlmann, Joerg			Plasticity and Evolution of (-)-3-Carene Synthase and (-)-Sabinene Synthase Functions of a Sitka Spruce Monoterpene Synthase Gene Family Associated with Weevil Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanism; Enzyme Mutation; Plant; Plant Biochemistry; Plant Defense; Terpenoid; Terpenoid Synthase	WHITE-PINE WEEVIL; TERPENE SYNTHASE; ARISTOLOCHENE SYNTHASE; DIRECTED MUTAGENESIS; ABIES-GRANDIS; BIOSYNTHESIS; (+)-3-CARENE; CATALYSIS; CONIFERS; DEFENSE	Background: (+)-3-Carene/(-)-sabinene synthases are associated with insect resistance in Sitka spruce. Results: Amino acid position 596 is critical for the monoterpene synthase product profile. Conclusion: This work revealed mechanistic underpinnings for patterns of functional evolution of this monoterpene synthase family. Significance: Catalytic plasticity of conifer monoterpene synthases is a major factor in the diversification of the TPS-d family and evolution of insect resistance. The monoterpene (+)-3-carene is associated with resistance of Sitka spruce against white pine weevil, a major North American forest insect pest of pine and spruce. High and low levels of (+)-3-carene in, respectively, resistant and susceptible Sitka spruce genotypes are due to variation of (+)-3-carene synthase gene copy number, transcript and protein expression levels, enzyme product profiles, and enzyme catalytic efficiency. A family of multiproduct (+)-3-carene synthase-like genes of Sitka spruce include the three (+)-3-carene synthases, PsTPS-3car1, PsTPS-3car2, PsTPS-3car3, and the (-)-sabinene synthase PsTPS-sab. Of these, PsTPS-3car2 is responsible for the relatively higher levels of (+)-3-carene in weevil-resistant trees. Here, we identified features of the PsTPS-3car1, PsTPS-3car2, PsTPS-3car3, and PsTPS-sab proteins that determine different product profiles. A series of domain swap and site-directed mutations, supported by structural comparisons, identified the amino acid in position 596 as critical for product profiles dominated by (+)-3-carene in PsTPS-3car1, PsTPS-3car2, and PsTPS-3car3, or (-)-sabinene in PsTPS-sab. A leucine in this position promotes formation of (+)-3-carene, whereas phenylalanine promotes (-)-sabinene. Homology modeling predicts that position 596 directs product profiles through differential stabilization of the reaction intermediate. Kinetic analysis revealed position 596 also plays a role in catalytic efficiency. Mutations of position 596 with different side chain properties resulted in a series of enzymes with different product profiles, further highlighting the inherent plasticity and potential for evolution of alternative product profiles of these monoterpene synthases of conifer defense against insects.	[Roach, Christopher R.; Hall, Dawn E.; Zerbe, Philipp; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Roach, Christopher R.; Bohlmann, Joerg] Univ British Columbia, Genome Sci & Technol Program, Vancouver, BC V5Z 4S6, Canada	University of British Columbia; University of British Columbia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Zerbe, Philipp/H-8348-2015	Zerbe, Philipp/0000-0001-5163-9523	Natural Sciences and Engineering Research Council of Canada; Genome Canada; Genome BC; Genome Quebec; Genome Science and Technology program; British Columbia Epilepsy Society	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada(Genome Canada); Genome BC; Genome Quebec; Genome Science and Technology program; British Columbia Epilepsy Society	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (to J. B.), Genome Canada, Genome BC, and Genome Quebec in support of the SMarTForests Project LSARP Program (to Project Leader J. B.).; Recipient of graduate student scholarship awards from Genome Science and Technology program and the British Columbia Epilepsy Society.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Davis EM, 2000, TOP CURR CHEM, V209, P53; Faldt J, 2003, PLANT MOL BIOL, V51, P119, DOI 10.1023/A:1020714403780; Faraldos JA, 2011, J AM CHEM SOC, V133, P13906, DOI 10.1021/ja205927u; Hall DE, 2011, PLANT J, V65, P936, DOI 10.1111/j.1365-313X.2010.04478.x; Hong YJ, 2014, NAT CHEM, V6, P104, DOI [10.1038/NCHEM.1843, 10.1038/nchem.1843]; Hyatt DC, 2007, P NATL ACAD SCI USA, V104, P5360, DOI 10.1073/pnas.0700915104; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; King JN, 2004, FORESTRY, V77, P269, DOI 10.1093/forestry/77.4.269; Krause ST, 2013, ARCH BIOCHEM BIOPHYS, V529, P112, DOI 10.1016/j.abb.2012.12.003; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Robert JA, 2010, BOTANY, V88, P810, DOI 10.1139/B10-049; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Tantillo DJ, 2010, CHEM SOC REV, V39, P2847, DOI 10.1039/b917107j; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Weitman M, 2010, J AM CHEM SOC, V132, P6349, DOI 10.1021/ja910134x; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Zulak KG, 2009, PLANT J, V60, P1015, DOI 10.1111/j.1365-313X.2009.04020.x	30	37	37	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23859	23869		10.1074/jbc.M114.571703	http://dx.doi.org/10.1074/jbc.M114.571703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016016	Green Published, hybrid			2022-12-28	WOS:000341505000052
J	Dweck, D; Sanchez-Gonzalez, MA; Chang, AN; Dulce, RA; Badger, CD; Koutnik, AP; Ruiz, EL; Griffin, B; Liang, JS; Kabbaj, M; Fincham, FD; Hare, JM; Overton, M; Pinto, JR				Dweck, David; Sanchez-Gonzalez, Marcos A.; Chang, Audrey N.; Dulce, Raul A.; Badger, Crystal-Dawn; Koutnik, Andrew P.; Ruiz, Edda L.; Griffin, Brittany; Liang, Jingsheng; Kabbaj, Mohamed; Fincham, Frank D.; Hare, Joshua M.; Overton, Michael; Pinto, Jose R.			Long Term Ablation of Protein Kinase A (PKA)-mediated Cardiac Troponin I Phosphorylation Leads to Excitation-Contraction Uncoupling and Diastolic Dysfunction in a Knock-in Mouse Model of Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREQUENCY-DEPENDENT ACCELERATION; CA2+ SENSITIVITY; C PHOSPHORYLATION; HEART-FAILURE; CROSS-BRIDGES; CALCIUM; RELAXATION; MUTATIONS; PHOSPHOLAMBAN; BINDING	The cardiac troponin I (cTnI) R21C (cTnI-R21C) mutation has been linked to hypertrophic cardiomyopathy and renders cTnI incapable of phosphorylation by PKA in vivo. Echocardiographic imaging of homozygous knock-in mice expressing the cTnI-R21C mutation shows that they develop hypertrophy after 12 months of age and have abnormal diastolic function that is characterized by longer filling times and impaired relaxation. Electrocardiographic analyses show that older R21C mice have elevated heart rates and reduced cardiovagal tone. Cardiac myocytes isolated from older R21C mice demonstrate that in the presence of isoproterenol, significant delays in Ca2+ decay and sarcomere relaxation occur that are not present at 6 months of age. Although isoproterenol and stepwise increases in stimulation frequency accelerate Ca2+-transient and sarcomere shortening kinetics in R21C myocytes from older mice, they are unable to attain the corresponding WT values. When R21C myocytes from older mice are treated with isoproterenol, evidence of excitation-contraction uncoupling is indicated by an elevation in diastolic calcium that is frequency-dissociated and not coupled to shorter diastolic sarcomere lengths. Myocytes from older mice have smaller Ca2+ transient amplitudes (2.3-fold) that are associated with reductions (2.9-fold) in sarcoplasmic reticulum Ca2+ content. This abnormal Ca2+ handling within the cell may be attributed to a reduction (2.4-fold) in calsequestrin expression in conjunction with an up-regulation (1.5-fold) of Na+-Ca2+ exchanger. Incubation of permeabilized cardiac fibers from R21C mice with PKA confirmed that the mutation prevents facilitation of mechanical relaxation. Altogether, these results indicate that the inability to enhance myofilament relaxation through cTnI phosphorylation predisposes the heart to abnormal diastolic function, reduced accessibility of cardiac reserves, dysautonomia, and hypertrophy.	[Dweck, David; Sanchez-Gonzalez, Marcos A.; Badger, Crystal-Dawn; Koutnik, Andrew P.; Ruiz, Edda L.; Griffin, Brittany; Kabbaj, Mohamed; Overton, Michael; Pinto, Jose R.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Sanchez-Gonzalez, Marcos A.; Fincham, Frank D.] Florida State Univ, Family Inst, Tallahassee, FL 32306 USA; [Chang, Audrey N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Dulce, Raul A.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Liang, Jingsheng] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Miami; University of Miami	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 W Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	Fincham, Frank/A-2357-2008; Pinto, Jose Renato/H-2631-2017; Kabbaj, Mohamed/M-9240-2016; Koutnik, Andrew/U-5194-2017	Fincham, Frank/0000-0001-5081-2283; Pinto, Jose Renato/0000-0001-9092-4976; Koutnik, Andrew/0000-0002-5491-3919	National Institutes of Health, NHLBI [HL103840, 5R01 HL094849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103840, R00HL103840, R01HL094849] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants HL103840 (to J. R. P.) and 5R01 HL094849 (to J. M. H.).	Alves ML, 2010, J MOL CELL CARDIOL, V48, P834, DOI 10.1016/j.yjmcc.2010.01.003; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Baker AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC85, DOI 10.1152/ajpcell.1997.273.1.C85; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; Bayliss CR, 2013, CARDIOVASC RES, V97, P500, DOI 10.1093/cvr/cvs322; Bers Donald M., 2002, Basic Research in Cardiology, V97; Camm AJ, 1996, CIRCULATION, V93, P1043; Chopra N, 2007, CIRC RES, V101, P617, DOI 10.1161/CIRCRESAHA.107.157552; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; de Tombe PP, 1998, CARDIOVASC RES, V37, P367, DOI 10.1016/S0008-6363(97)00275-7; Desai KH, 1997, AM J PHYSIOL-HEART C, V272, pH1053, DOI 10.1152/ajpheart.1997.272.2.H1053; Dulce RA, 2013, J BIOL CHEM, V288, P6522, DOI 10.1074/jbc.M112.412130; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTH K, 1987, J BIOL CHEM, V262, P13627; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Jimenez J, 2011, AM J PHYSIOL-HEART C, V300, pH627, DOI 10.1152/ajpheart.00247.2010; Katarzynska-Szymanska A, 2013, BRIT J CLIN PHARMACO, V75, P1516, DOI 10.1111/bcp.12027; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Khan SA, 2003, CIRC RES, V92, P1322, DOI 10.1161/01.RES.0000078171.52542.9E; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Neumann J, 2002, BASIC RES CARDIOL, V97, P1; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Reis S, 2008, PFLUG ARCH EUR J PHY, V457, P17, DOI 10.1007/s00424-008-0487-4; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Schotten U, 2000, AM J PHYSIOL-HEART C, V278, pH2076, DOI 10.1152/ajpheart.2000.278.6.H2076; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Simnett SJ, 1998, AM J PHYSIOL-HEART C, V275, pH951, DOI 10.1152/ajpheart.1998.275.3.H951; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2010, J MOL CELL CARDIOL, V48, P810, DOI 10.1016/j.yjmcc.2010.02.014; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; STEIN RB, 1988, BIOPHYS J, V54, P705, DOI 10.1016/S0006-3495(88)83006-6; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Syed F, 2005, J AM SOC ECHOCARDIOG, V18, P982, DOI 10.1016/j.echo.2005.05.001; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Varian KD, 2007, AM J PHYSIOL-HEART C, V292, pH2212, DOI 10.1152/ajpheart.00778.2006; Varian KD, 2009, CIRC-HEART FAIL, V2, P472, DOI 10.1161/CIRCHEARTFAILURE.109.853200; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI 10.1021/pr200258m; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhou YQ, 2003, AM J PHYSIOL-HEART C, V285, pH1563, DOI 10.1152/ajpheart.00384.2003; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	78	22	23	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23097	23111		10.1074/jbc.M114.561472	http://dx.doi.org/10.1074/jbc.M114.561472			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973218	Green Published, hybrid			2022-12-28	WOS:000341017200047
J	Hester, AG; Murphy, RC; Uhlson, CJ; Ivester, P; Lee, TC; Sergeant, S; Miller, LR; Howard, TD; Mathias, RA; Chilton, FH				Hester, Austin G.; Murphy, Robert C.; Uhlson, Charis J.; Ivester, Priscilla; Lee, Tammy C.; Sergeant, Susan; Miller, Leslie R.; Howard, Timothy D.; Mathias, Rasika A.; Chilton, Floyd H.			Relationship between a Common Variant in the Fatty Acid Desaturase (FADS) Cluster and Eicosanoid Generation in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; ARACHIDONIC-ACID; GENETIC-VARIANTS; INFLAMMATORY CELLS; AFRICAN-AMERICANS; WHOLE-BLOOD; EXPRESSION; METABOLISM; PHOSPHOLIPIDS; CLONING	Dramatic shifts in the Western diet have led to a marked increase in the dietary intake of the n-6 polyunsaturated fatty acid (PUFA), linoleic acid (LA). Dietary LA can then be converted to arachidonic acid (ARA) utilizing three enzymatic steps. Two of these steps are encoded for by the fatty acid desaturase (FADS) cluster (chromosome 11, 11q12.2-q13) and certain genetic variants within the cluster are highly associated with ARA levels. However, no study to date has examined whether these variants further influence pro-inflammatory, cyclooxygenase and lipoxygenase eicosanoid products. This study examined the impact of a highly influential FADS SNP, rs174537 on leukotriene, HETE, prostaglandin, and thromboxane biosynthesis in stimulated whole blood. Thirty subjects were genotyped at rs174537 (GG, n = 11; GT, n = 13; TT, n = 6), a panel of fatty acids from whole serum was analyzed, and precursor-to-product PUFA ratios were calculated as a marker of the capacity of tissues (particularly the liver) to synthesize long chain PUFAs. Eicosanoids produced by stimulated human blood were measured by LC-MS/MS. We observed an association between rs174537 and the ratio of ARA/LA, leukotriene B-4, and 5-HETE but no effect on levels of cyclooxygenase products. Our results suggest that variation at rs174537 not only impacts the synthesis of ARA but the overall capacity of whole blood to synthesize 5-lipoxygenase products; these genotype-related changes in eicosanoid levels could have important implications in a variety of inflammatory diseases.	[Hester, Austin G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Hester, Austin G.; Ivester, Priscilla; Lee, Tammy C.; Miller, Leslie R.; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol Pharmacol, Winston Salem, NC 27157 USA; [Murphy, Robert C.; Uhlson, Charis J.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Ivester, Priscilla; Lee, Tammy C.; Sergeant, Susan; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Bot Lipids & Inflammatory Dis Prevent, Winston Salem, NC 27157 USA; [Sergeant, Susan] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Howard, Timothy D.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21224 USA; [Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center	Chilton, FH (corresponding author), Wake Forest Sch Med, Dept Physiol Pharmacol, Med Ctr Blvd, Winston Salem, NC 27101 USA.	schilton@wakehealth.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [P50 AT002782]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported, in whole or in part, by National Institutes of Health Grant P50 AT002782. Dr. Chilton is an unpaid consultant for Gene Smart Health and receives no compensation in this role. This information has been disclosed to WFUHS and outside sponsors, as appropriate, and is institutionally managed.	Astudillo AM, 2012, BBA-MOL CELL BIOL L, V1821, P249, DOI 10.1016/j.bbalip.2011.11.006; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; BELLAVITE P, 1983, EUR J CLIN INVEST, V13, P363; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; CATELLA F, 1986, P NATL ACAD SCI USA, V83, P5861, DOI 10.1073/pnas.83.16.5861; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; Chilton FH, 1996, BBA-LIPID LIPID MET, V1299, P1, DOI 10.1016/0005-2760(95)00169-7; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; EATON SB, 1992, LIPIDS, V27, P814, DOI 10.1007/BF02535856; Ensor CM, 1998, BIOCHEM J, V330, P103, DOI 10.1042/bj3300103; FRADIN A, 1989, J IMMUNOL, V143, P3680; Gerrior S., 2004, 56 USDA CTR NUTR POL, P14; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Howard TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097510; HUI KP, 1991, THORAX, V46, P184, DOI 10.1136/thx.46.3.184; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; KUMLIN M, 1986, PROSTAGLANDINS, V32, P741, DOI 10.1016/0090-6980(86)90196-6; LANDS WEM, 1965, J BIOL CHEM, V240, P1905; LANDS WEM, 1992, BIOCHIM BIOPHYS ACTA, V1180, P147, DOI 10.1016/0925-4439(92)90063-S; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Mathias RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044926; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8; Park JH, 2010, PATENTS AND INDUSTRY STANDARDS, P1; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; Reardon HT, 2012, PROSTAG LEUKOTR ESS, V87, P25, DOI 10.1016/j.plefa.2012.04.011; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schwedhelm E, 2004, CIRCULATION, V109, P843, DOI 10.1161/01.CIR.0000116761.93647.30; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Wolfram R, 2005, EUR J HEART FAIL, V7, P167, DOI 10.1016/j.ejheart.2004.05.007; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	54	48	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22482	22489		10.1074/jbc.M114.579557	http://dx.doi.org/10.1074/jbc.M114.579557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962583	Green Published, hybrid			2022-12-28	WOS:000340593500057
J	Ko, CC; Chen, YJ; Chen, CT; Liu, YC; Cheng, FC; Hsu, KC; Chow, LP				Ko, Chia-Chen; Chen, Yun-Ju; Chen, Chih-Ta; Liu, Yu-Chih; Cheng, Fong-Chi; Hsu, Kai-Chao; Chow, Lu-Ping			Chemical Proteomics Identifies Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1 as the Molecular Target of Quercetin in Its Anti-cancer Effects in PC-3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; APOPTOSIS; PROTEINS; EXPRESSION; NUCLEOLIN; SURVIVAL; RELOCALIZATION; PROLIFERATION; INHIBITION; STRATEGIES	Quercetin, a flavonoid abundantly present in plants, is widely used as a phytotherapy in prostatitis and prostate cancer. Although quercetin has been reported to have a number of therapeutic effects, the cellular target(s) responsible for its anti-cancer action has not yet been clearly elucidated. Here, employing affinity chromatography and mass spectrometry, we identified heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) as a direct target of quercetin. A specific interaction between quercetin and hnRNPA1 was validated by immunoblotting and in vitro binding experiments. We found that quercetin bound the C-terminal region of hnRNPA1, impairing the ability of hnRNPA1 to shuttle between the nucleus and cytoplasm and ultimately resulting in its cytoplasmic retention. In addition, hnRNPA1 was recruited to stress granules after treatment of cells with quercetin for up to 48 h, and the levels of cIAP1 (cellular inhibitor of apoptosis), an internal ribosome entry site translation-dependent protein, were reduced by hnRNPA1 regulation. This is the first report that anti-cancer effects of quercetin are mediated, in part, by impairing functions of hnRNPA1, insights that were obtained using a chemical proteomics strategy.	[Ko, Chia-Chen; Chen, Yun-Ju; Chen, Chih-Ta; Liu, Yu-Chih; Hsu, Kai-Chao; Chow, Lu-Ping] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Cheng, Fong-Chi] Eurofins Panlabs Taiwan Ltd, Taipei 112, Taiwan	National Taiwan University	Chow, LP (corresponding author), Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan.	chowip@ntu.edu.tw		CHOW, LU-PING/0000-0002-4420-211X	National Science Council [NSC 101-2325-B-002-065]; Liver Disease Prevention and Treatment Research Foundation; Ministry of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Liver Disease Prevention and Treatment Research Foundation; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This study was supported by National Science Council Grant NSC 101-2325-B-002-065, the Liver Disease Prevention and Treatment Research Foundation, and the Ministry of Education, Taiwan.	Al-Maghrebir M, 2005, ANTICANCER RES, V25, P2573; Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Curtis Nickel J, 2008, Rev Urol, V10, P192; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fleischer TC, 2010, CHEM BIOL, V17, P659, DOI 10.1016/j.chembiol.2010.05.008; Gill C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-39; Ginisty H, 1999, J CELL SCI, V112, P761; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Lamson D W, 2000, Altern Med Rev, V5, P196; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee KM, 2010, J AGR FOOD CHEM, V58, P5815, DOI 10.1021/jf903698s; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Liu HZ, 2010, SCAND J UROL NEPHROL, V44, P277, DOI 10.3109/00365599.2010.492787; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; MARCINKIEWICZ C, 1995, ACTA BIOCHIM POL, V42, P347; Murphy AB, 2009, DRUGS, V69, P71, DOI 10.2165/00003495-200969010-00005; Patry C, 2003, CANCER RES, V63, P7679; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Ruiz C, 2011, J PATHOL, V223, P543, DOI 10.1002/path.2828; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Schimmer AD, 2004, CANCER RES, V64, P7183, DOI 10.1158/0008-5472.CAN-04-1918; Schirle M, 2012, CHEM BIOL, V19, P72, DOI 10.1016/j.chembiol.2012.01.002; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Vijayababu MR, 2005, J CANCER RES CLIN, V131, P765, DOI 10.1007/s00432-005-0005-4; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wang RE, 2011, BIOORGAN MED CHEM, V19, P4710, DOI 10.1016/j.bmc.2011.07.005	35	37	41	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22078	22089		10.1074/jbc.M114.553248	http://dx.doi.org/10.1074/jbc.M114.553248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962584	Green Published, hybrid			2022-12-28	WOS:000340593500024
J	Alidousty, C; Rauen, T; Hanssen, L; Wang, Q; Alampour-Rajabi, S; Mertens, PR; Bernhagen, J; Floege, J; Ostendorf, T; Raffetseder, U				Alidousty, Christina; Rauen, Thomas; Hanssen, Lydia; Wang, Qiang; Alampour-Rajabi, Setareh; Mertens, Peter R.; Bernhagen, Juergen; Floege, Juergen; Ostendorf, Tammo; Raffetseder, Ute			Calcineurin-mediated YB-1 Dephosphorylation Regulates CCL5 Expression during Monocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING PROTEIN-1; BREAST-CANCER CELLS; COLD SHOCK DOMAIN; TRANSCRIPTION FACTORS; MESSENGER-RNA; NUCLEAR IMPORT; T-CELLS; PROMOTER; ATHEROSCLEROSIS; PHOSPHORYLATION	Y-box (YB) protein-1 serves as a master regulator in gene transcription and mRNA translation. YB-1 itself is regulated at various levels, e. g. through post-translational modifications. In our previous work, we identified RANTES/CCL5 as a transcriptional target of YB-1. We previously demonstrated that YB-1 protein is transiently up-regulated during monocyte/macrophage differentiation evidenced in monocytic cells (THP-1 cells) that were differentiated using phorbol myristate acetate (PMA). Here we provide evidence that YB-1 phosphorylation, specifically at its serine residue 102 (Ser-102), increases early on in THP-1 cells following PMA treatment as well as in differentiated primary human monocytes. This process is mediated through the Akt signaling pathway. Ser-102-phosphorylated YB-1 displays stronger binding affinity and trans-activating capacity at the CCL5 gene promoter. Notably, Ser-102-phosphorylated YB-1 disappears at later stages of the monocyte/macrophage differentiation process. We demonstrate that serine-threonine phosphatase calcineurin (CN) dephosphorylates YB-1 preventing it from binding to and trans-activating the CCL5 promoter. Co-immunoprecipitation assays prove a direct YB-1/CN interaction. Furthermore, analyses in kidney tissues from mice that were treated with the CN inhibitor cyclosporine A revealed an in vivo effect of CN on the YB-1 phosphorylation status. We conclude that YB-1 phosphorylation at Ser-102 is an important prerequisite for CCL5 promoter activation during macrophage differentiation. Our findings point to a critical role of YB-1 in the resolution of inflammatory processes which may largely be due to CN-mediated dephosphorylation.	[Alidousty, Christina; Rauen, Thomas; Hanssen, Lydia; Floege, Juergen; Ostendorf, Tammo; Raffetseder, Ute] Univ Hosp RWTH Aachen, Dept Nephrol & Clin Immunol, D-52057 Aachen, Germany; [Wang, Qiang] Nanjing Med Univ, Dept Rheumatol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Alampour-Rajabi, Setareh; Bernhagen, Juergen] Univ Hosp RWTH Aachen, Inst Biochem & Mol Cell Biol, Dept Cell & Mol Biol, D-52057 Aachen, Germany; [Mertens, Peter R.] Otto Von Guericke Univ, Dept Nephrol Hypertens Diabet & Endocrinol, D-39120 Magdeburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Nanjing Medical University; RWTH Aachen University; RWTH Aachen University Hospital; Otto von Guericke University	Raffetseder, U (corresponding author), RWTH Aachen Univ Hosp, Dept Nephrol & Clin Immunol, Pauwelsstr 30, D-52057 Aachen, Germany.	uraffetseder@ukaachen.de	Mertens, Peter/AAI-7310-2020; Rauen, Thomas/GLR-8682-2022		Fritz-Bender-Stiftung; START-Program (Faculty of Medicine, RWTH, Aachen); DFG [SFB-TRR57/A07, FOR809/TP1-Be1977/4-2]; Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University [E6-10];  [SFB/TRR57];  [SFB854];  [Me1365/7-1];  [SFB 542]	Fritz-Bender-Stiftung; START-Program (Faculty of Medicine, RWTH, Aachen); DFG(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University; ; ; ; 	This work was funded by the Fritz-Bender-Stiftung (to T. R. and U. R.), START-Program (Faculty of Medicine, RWTH, Aachen, to T. R. and U. R.), SFB/TRR57 (to T. O. and J. F.), SFB854 and Me1365/7-1 (to P. R. M.) and SFB 542 projects C12 (to U. R. and P. R. M.).; Recipient of funding from DFG Projects SFB-TRR57/A07 and FOR809/TP1-Be1977/4-2.; Recipient of funding from the Interdisciplinary Center for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University (E6-10).	Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Boehlk S, 2000, EUR J IMMUNOL, V30, P1102, DOI 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X; Burke BA, 1995, TRANSPLANTATION, V60, P1413, DOI 10.1097/00007890-199560120-00007; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chen CY, 2000, GENE DEV, V14, P1236; Diamond P, 2001, J BIOL CHEM, V276, P7943, DOI 10.1074/jbc.M009836200; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Hanssen L, 2013, J IMMUNOL, V191, P2604, DOI 10.4049/jimmunol.1300416; Hanssen L, 2011, J IMMUNOL, V187, P298, DOI 10.4049/jimmunol.1100382; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 1999, J AM SOC NEPHROL, V10, P2480; Mihatsch MJ, 1998, CLIN NEPHROL, V49, P356; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Raffetseder U, 2012, EUR J CELL BIOL, V91, P567, DOI 10.1016/j.ejcb.2011.07.001; Raffetseder U, 2009, KIDNEY INT, V75, P185, DOI 10.1038/ki.2008.457; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Sinnberg T, 2012, EXP DERMATOL, V21, P265, DOI 10.1111/j.1600-0625.2012.01448.x; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Wang J, 2003, J NEUROSCI, V23, P826; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Wu Joyce, 2007, Transl Oncogenomics, V2, P49	39	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21401	21412		10.1074/jbc.M114.562991	http://dx.doi.org/10.1074/jbc.M114.562991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24947514	Green Published, hybrid			2022-12-28	WOS:000340558300019
J	Gu, L; Liu, C; Stroud, JC; Ngo, S; Jiang, L; Guo, ZF				Gu, Lei; Liu, Cong; Stroud, James C.; Ngo, Sam; Jiang, Lin; Guo, Zhefeng			Antiparallel Triple-strand Architecture for Prefibrillar A beta 42 Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID FIBRILS; SOLID-STATE NMR; ALZHEIMERS-DISEASE; A-BETA(1-42) OLIGOMERS; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; ESCHERICHIA-COLI; CHAPERONIN GROES; SHEET STRUCTURES; PROTEIN	A beta 42 oligomers play key roles in the pathogenesis of Alzheimer disease, but their structures remain elusive partly due to their transient nature. Here, we show that A beta 42 in a fusion construct can be trapped in a stable oligomer state, which recapitulates characteristics of prefibrillar A beta 42 oligomers and enables us to establish their detailed structures. Site-directed spin labeling and electron paramagnetic resonance studies provide structural restraints in terms of side chain mobility and intermolecular distances at all 42 residue positions. Using these restraints and other biophysical data, we present a novel atomic-level oligomer model. In our model, each A beta 42 protein forms a single beta-sheet with three beta-strands in an antiparallel arrangement. Each beta-sheet consists of four A beta 42 molecules in a head-to-tail arrangement. Four beta-sheets are packed together in a face-to-back fashion. The stacking of identical segments between different beta-sheets within an oligomer suggests that prefibrillar oligomers may interconvert with fibrils via strand rotation, wherein beta-strands undergo an similar to 90 degrees rotation along the strand direction. This work provides insights into rational design of therapeutics targeting the process of interconversion between toxic oligomers and non-toxic fibrils.	[Gu, Lei; Ngo, Sam; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA; [Liu, Cong; Jiang, Lin] Univ Calif Los Angeles, Dept Chem & Biochem, Howard Hughes Med Inst, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Liu, Cong; Jiang, Lin] Univ Calif Los Angeles, Dept Biol Chem, Howard Hughes Med Inst, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Liu, Cong] Chinese Acad Sci, Interdisciplinary Res Ctr Biol & Chem, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China; [Stroud, James C.] Univ New Mexico, Dept Chem & Chem Biol, Ctr Biomed Engn, Albuquerque, NM 87131 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of New Mexico	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013; Gu, Lei/GWQ-6785-2022; Stroud, James C/B-3230-2012	Guo, Zhefeng/0000-0003-1992-7255; Stroud, James C/0000-0003-0850-4812	National Institutes of Health [P50AG016570, R01GM110448]; Alzheimer Association [NIRG-09-133555]; BrightFocus Foundation [A2010362]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); BrightFocus Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants P50AG016570 and R01GM110448, Alzheimer Association (Grant NIRG-09-133555), and BrightFocus Foundation (Grant A2010362).	Agopian A, 2012, BIOCHEM J, V447, P43, DOI 10.1042/BJ20120034; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Boudker O, 1997, J MOL BIOL, V272, P770, DOI 10.1006/jmbi.1997.1263; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Khurana R, 2000, BIOPHYS J, V78, P994, DOI 10.1016/S0006-3495(00)76657-4; Kim W, 2006, NY TIMES BK REV, P1; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Love SG, 1997, BIOCHEM J, V323, P727, DOI 10.1042/bj3230727; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Mustata G. M., 2012, APPL PHYS LETT, V100; Ngo S, 2012, J STRUCT BIOL, V180, P374, DOI 10.1016/j.jsb.2012.08.008; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; Ngo S, 2011, J BIOL CHEM, V286, P29691, DOI 10.1074/jbc.M111.269092; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Pan JX, 2011, ANAL CHEM, V83, P5386, DOI 10.1021/ac200906v; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Scheidt HA, 2012, J BIOL CHEM, V287, P22822, DOI 10.1074/jbc.M112.367474; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shahnawaz M, 2007, BIOCHEM BIOPH RES CO, V359, P801, DOI 10.1016/j.bbrc.2007.05.186; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Yerbury J., 2010, CURR CHEM BIOL, V4, P89; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; ZONDLO J, 1995, BIOCHEMISTRY-US, V34, P10334, DOI 10.1021/bi00033a003	75	52	54	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27300	27313		10.1074/jbc.M114.569004	http://dx.doi.org/10.1074/jbc.M114.569004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25118290	hybrid, Green Published			2022-12-28	WOS:000342853900051
J	Renault, TT; Elkholi, R; Bharti, A; Chipuk, JE				Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.			B Cell Lymphoma-2 (BCL-2) Homology Domain 3 (BH3) Mimetics Demonstrate Differential Activities Dependent upon the Functional Repertoire of Pro-and Anti-apoptotic BCL-2 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL-MEMBRANE; OLIGOMERIZES BAK; DEATH; INHIBITORS; POTENT; DISCOVERY; ADDICTION; CANCERS	The B cell lymphoma-2 (BCL-2) family is the key mediator of cellular sensitivity to apoptosis during pharmacological interventions for numerous human pathologies, including cancer. There is tremendous interest to understand how the proapoptotic BCL-2 effector members (e. g. BCL-2-associated X protein, BAX) cooperate with the BCL-2 homology domain only (BH3-only) subclass (e. g. BCL-2 interacting mediator of death, BIM; BCL-2 interacting-domain death agonist, BID) to induce mitochondrial outer membrane permeabilization (MOMP) and apoptosis and whether these mechanisms may be pharmacologically exploited to enhance the killing of cancer cells. Indeed, small molecule inhibitors of the anti-apoptotic BCL-2 family members have been designed rationally. However, the success of these "BH3 mimetics" in the clinic has been limited, likely due to an incomplete understanding of how these drugs function in the presence of multiple BCL-2 family members. To increase our mechanistic understanding of how BH3 mimetics cooperate with multiple BCL-2 family members in vitro, we directly compared the activity of several BH3-mimetic compounds (i.e. ABT-263, ABT-737, GX15-070, HA14.1, TW-37) in biochemically defined large unilamellar vesicle model systems that faithfully recapitulate BAX-dependent mitochondrial outer membrane permeabilization. Our investigations revealed that the presence of BAX, BID, and BIM differentially regulated the ability of BH3 mimetics to derepress proapoptotic molecules from anti-apoptotic proteins. Using mitochondria loaded with fluorescent BH3 peptides and cells treated with inducers of cell death, these differences were supported. Together, these data suggest that although the presence of anti-apoptotic BCL-2 proteins primarily dictates cellular sensitivity to BH3 mimetics, additional specificity is conferred by proapoptotic BCL-2 proteins.	[Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Elkholi, Rana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chipuk, JE (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	jerry.chipuk@mssm.edu		Chipuk, Jerry Edward/0000-0002-1337-842X; Renault, Thibaud/0000-0002-1530-2613	National Institutes of Health [CA157740, P20AA017067]; JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; March of Dimes Foundation [5-FY11-74, 1-FY13-416]; Developmental Research Pilot Project Program within Department of Oncological Sciences at Mount Sinai; NATIONAL CANCER INSTITUTE [R01CA157740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; March of Dimes Foundation(March of Dimes); Developmental Research Pilot Project Program within Department of Oncological Sciences at Mount Sinai; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants CA157740 (to J. E. C.) and a pilot project from National Institutes of Health P20AA017067 (to J. E. C.); the JJR Foundation (to J. E. C.), the William A. Spivak Fund (to J. E. C.), and the Fridolin Charitable Trust (to J. E. C.). This work was also supported in part by Research Grants 5-FY11-74 and 1-FY13-416 from the March of Dimes Foundation (to J. E. C.) and the Developmental Research Pilot Project Program within the Department of Oncological Sciences at Mount Sinai (to J. E. C.).	Asciolla JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4291; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Elkholi Rana, 2011, Genes Cancer, V2, P523, DOI 10.1177/1947601911417177; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kitada S, 2008, BLOOD, V111, P3211, DOI 10.1182/blood-2007-09-113647; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lickliter JD, 2003, LEUKEMIA, V17, P2074, DOI 10.1038/sj.leu.2403102; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Renault TT, 2013, METHODS, V61, P146, DOI 10.1016/j.ymeth.2013.03.030; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Sun J, 2008, ANTI-CANCER DRUG, V19, P967, DOI 10.1097/CAD.0b013e32831087e8; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2000, GENE DEV, V14, P2060; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	42	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26481	26491		10.1074/jbc.M114.569632	http://dx.doi.org/10.1074/jbc.M114.569632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25096574	Green Published, hybrid			2022-12-28	WOS:000342128800039
J	Reger, AS; Yang, MP; Koide-Yoshida, S; Guo, E; Mehta, S; Yuasa, K; Liu, A; Casteel, DE; Kim, C				Reger, Albert S.; Yang, Matthew P.; Koide-Yoshida, Shizuyo; Guo, Elaine; Mehta, Shrenik; Yuasa, Keizo; Liu, Alan; Casteel, Darren E.; Kim, Choel			Crystal Structure of the cGMP-dependent Protein Kinase II Leucine Zipper and Rab11b Protein Complex Reveals Molecular Details of G-kinase-specific Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; BETA; INTERFACE; RECEPTOR; FAMILY; IDENTIFICATION; TRAFFICKING; RECRUITMENT; CHANNELS; CLONING	cGMP-dependent protein kinase (PKG)-interacting proteins (GKIPs) mediate cellular targeting of PKG isoforms by interacting with their leucine zipper (LZ) domains. These interactions prevent aberrant signaling cross-talk between different PKG isotypes. To gain detailed insight into isotype-specific GKIP recognition by PKG, we analyzed the type II PKG leucine zipper domain and found that residues 40-83 dimerized and specifically interacted with Rab11b. Next, we determined a crystal structure of the PKG II LZ-Rab11b complex. The PKG II LZ domain presents a mostly nonpolar surface onto which Rab11b docks, through van der Waals interactions. Contact surfaces in Rab11b are found in switch I and II, interswitch, and the beta 1/N-terminal regions. This binding surface dramatically differs from that seen in the Rab11 family of interacting protein complex structures. Structural comparison with PKGI alpha and I beta LZs combined with mutagenic analysis reveals that GKIP recognition is mediated through surface charge interactions.	[Reger, Albert S.; Mehta, Shrenik; Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Yang, Matthew P.] Rice Univ, Dept Biochem, Houston, TX 77005 USA; [Guo, Elaine] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Koide-Yoshida, Shizuyo; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 7708506, Japan; [Liu, Alan; Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Rice University; Rice University; Tokushima University; University of California System; University of California San Diego; Baylor College of Medicine	Kim, C (corresponding author), Baylor Coll Med, MS 330 Alkek 520,One Baylor Plaza, Houston, TX 77030 USA.	ckim@bcm.edu			United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Goud, C. Peters, G. Y. Huang, T. Palzkill, and J. J. Kim for critical reading of the manuscript. We appreciate the technical support, advice, and assistance of D. C. Chow and K. Klerec in the Center for Drug Discovery at Baylor College of Medicine. We also thank S. R. Wasserman (Eli Lilly Beamline, Advanced Photon Source) for assistance with data collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Co., which operates the facility.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bussow K, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-21; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; GOLDENRING JR, 1993, J BIOL CHEM, V268, P18419; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; LAI F, 1994, GENOMICS, V22, P610, DOI 10.1006/geno.1994.1434; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Orstavik S, 1997, GENOMICS, V42, P311, DOI 10.1006/geno.1997.4743; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; SAKURADA K, 1991, BIOCHEM BIOPH RES CO, V177, P1224, DOI 10.1016/0006-291X(91)90672-T; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; Scapin SMN, 2006, J STRUCT BIOL, V154, P260, DOI 10.1016/j.jsb.2006.01.007; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071	44	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25393	25403		10.1074/jbc.M114.575894	http://dx.doi.org/10.1074/jbc.M114.575894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070890	Green Published, hybrid			2022-12-28	WOS:000342130800001
J	Wakashima, T; Abe, K; Kihara, A				Wakashima, Takeshi; Abe, Kensuke; Kihara, Akio			Dual Functions of the Trans-2-Enoyl-CoA Reductase TER in the Sphingosine 1-Phosphate Metabolic Pathway and in Fatty Acid Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SJOGREN-LARSSON-SYNDROME; ACYL-COA SYNTHETASES; CERAMIDE SYNTHASE 2; SACCHAROMYCES-CEREVISIAE; ALDEHYDE DEHYDROGENASE; SPHINGOLIPID FORMATION; ENDOPLASMIC-RETICULUM; MENTAL-RETARDATION; CHAIN-LENGTH; GENE	The sphingolipid metabolite sphingosine 1-phosphate (S1P) functions as a lipid mediator and as a key intermediate of the sole sphingolipid to glycerophospholipid metabolic pathway (S1P metabolic pathway). In this pathway, S1P is converted to palmitoyl-CoA through 4 reactions, then incorporated mainly into glycerophospholipids. Although most of the genes responsible for the S1P metabolic pathway have been identified, the gene encoding the trans-2-enoyl-CoA reductase, responsible for the saturation step (conversion of trans-2-hexadecenoyl-CoA to palmitoyl-CoA) remains unidentified. In the present study, we show that TER is the missing gene in mammals using analyses involving yeast cells, deleting the TER homolog TSC13, and TER-knockdown HeLa cells. TER is known to be involved in the production of very long-chain fatty acids (VLCFAs). A significant proportion of the saturated and monounsaturated VLCFAs are used for sphingolipid synthesis. Therefore, TER is involved in both the production of VLCFAs used in the fatty acid moiety of sphingolipids as well as in the degradation of the sphingosine moiety of sphingolipids via S1P.	[Wakashima, Takeshi; Abe, Kensuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science (JSPS) [25116701, 26251010]; Grants-in-Aid for Scientific Research [25116701, 26251010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (25116701) and a Grant-in-Aid for Scientific Research (A) (26251010) (to A. K.) from the Japan Society for the Promotion of Science (JSPS).	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Ashibe B, 2007, J BIOL CHEM, V282, P20763, DOI 10.1074/jbc.M611853200; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brachmann CB, 1998, YEAST, V14, P115; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Epstein S, 2012, MOL MICROBIOL, V84, P1018, DOI 10.1111/j.1365-2958.2012.08087.x; Ernst AM, 2014, BBA-MOL CELL BIOL L, V1841, P665, DOI 10.1016/j.bbalip.2013.10.016; Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hagen-Euteneuer N, 2012, J BIOL CHEM, V287, P9128, DOI 10.1074/jbc.M111.302380; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Iwabuchi K, 2010, FEBS LETT, V584, P1642, DOI 10.1016/j.febslet.2009.10.043; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohkuni A, 2013, BIOCHEM BIOPH RES CO, V442, P195, DOI 10.1016/j.bbrc.2013.11.036; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506; Rizzo WB, 2007, MOL GENET METAB, V90, P1, DOI 10.1016/j.ymgme.2006.08.006; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; SIKORSKI RS, 1989, GENETICS, V122, P19; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; STOFFEL W, 1967, H-S Z PHYSIOL CHEM, V348, P941; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P875, DOI 10.1515/bchm2.1970.351.2.875; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	50	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24736	24748		10.1074/jbc.M114.571869	http://dx.doi.org/10.1074/jbc.M114.571869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25049234	Green Published, hybrid			2022-12-28	WOS:000341985300001
J	Swarbrick, CMD; Roman, N; Cowieson, N; Patterson, EI; Nanson, J; Siponen, MI; Berglund, H; Lehtio, L; Forwood, JK				Swarbrick, Crystall M. D.; Roman, Noelia; Cowieson, Nathan; Patterson, Edward I.; Nanson, Jeffrey; Siponen, Marina I.; Berglund, Helena; Lehtio, Lari; Forwood, Jade K.			Structural Basis for Regulation of the Human Acetyl-CoA Thioesterase 12 and Interactions with the Steroidogenic Acute Regulatory Protein-related Lipid Transfer (START) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A (Acetyl-CoA); ADP; Allosteric Regulation; ATP; Metabolism; ACOT12; START Domain; Thioesterase	RAT-LIVER; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; BETA-OXIDATION; CELL-GROWTH; HYDROLASE; METABOLISM; CHAIN; ENZYMES	Background: The regulation of ACOT12 by ADP and ATP is thought to occur through oligomerization. Results: The structures of apo-ACOT12 and ADP-bound ACOT12 reveal new insights into regulation. Conclusion: ACOT12 is a homotrimer and neither ADP nor ATP alter the oligomeric state of the protein. Significance: These findings provide the first structural insights in the regulation of this enzyme family. Acetyl-CoA plays a fundamental role in cell signaling and metabolic pathways, with its cellular levels tightly controlled through reciprocal regulation of enzymes that mediate its synthesis and catabolism. ACOT12, the primary acetyl-CoA thioesterase in the liver of human, mouse, and rat, is responsible for cleavage of the thioester bond within acetyl-CoA, producing acetate and coenzyme A for a range of cellular processes. The enzyme is regulated by ADP and ATP, which is believed to be mediated through the ligand-induced oligomerization of the thioesterase domains, whereby ATP induces active dimers and tetramers, whereas apo- and ADP-bound ACOT12 are monomeric and inactive. Here, using a range of structural and biophysical techniques, it is demonstrated that ACOT12 is a trimer rather than a tetramer and that neither ADP nor ATP exert their regulatory effects by altering the oligomeric status of the enzyme. Rather, the binding site and mechanism of ADP regulation have been determined to occur through two novel regulatory regions, one involving a large loop that links the thioesterase domains (Phe(154)-Thr(178)), defined here as RegLoop1, and a second region involving the C terminus of thioesterase domain 2 (Gln(304)-Gly(326)), designated RegLoop2. Mutagenesis confirmed that Arg(312) and Arg(313) are crucial for this mode of regulation, and novel interactions with the START domain are presented together with insights into domain swapping within eukaryotic thioesterases for substrate recognition. In summary, these experiments provide the first structural insights into the regulation of this enzyme family, revealing an alternate hypothesis likely to be conserved throughout evolution.	[Swarbrick, Crystall M. D.; Roman, Noelia; Patterson, Edward I.; Nanson, Jeffrey; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia; [Cowieson, Nathan] Australian Synchrotron, Clayton, Vic 3168, Australia; [Siponen, Marina I.; Berglund, Helena; Lehtio, Lari] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden	Charles Sturt University; Karolinska Institutet	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Nanson, Jeffrey D/E-6313-2017	Nanson, Jeffrey D/0000-0003-1306-1948; Swarbrick, Crystall/0000-0002-9337-3361; Forwood, Jade/0000-0003-3267-9997; Lehtio, Lari/0000-0001-7250-832X; Roman, Noelia/0000-0003-0856-2131; Patterson, Edward/0000-0003-3465-0848				Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BROWN MS, 1980, J LIPID RES, V21, P505; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Horibata Y, 2013, J LIPID RES, V54, P2049, DOI 10.1194/jlr.M030163; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; ISOHASHI F, 1983, BIOCHEMISTRY-US, V22, P584, DOI 10.1021/bi00272a010; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; MATSUNAGA T, 1985, EUR J BIOCHEM, V152, P331, DOI 10.1111/j.1432-1033.1985.tb09202.x; Pidugu LS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-37; Rosano C, 2002, ACTA CRYSTALLOGR D, V58, P524, DOI 10.1107/S0907444901021874; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; SOLING HD, 1985, EUR J BIOCHEM, V147, P111, DOI 10.1111/j.1432-1033.1985.tb08726.x; Suematsu N, 2002, ACTA BIOCHIM POL, V49, P937; Suematsu N, 2001, EUR J BIOCHEM, V268, P2700, DOI 10.1046/j.1432-1327.2001.02162.x; Suematsu N, 2006, ACTA BIOCHIM POL, V53, P553; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WIELAND O, 1964, ADV ENZYME REGUL, V2, P85, DOI 10.1016/S0065-2571(64)80007-8; WILLIAMS.DH, 1968, BIOCHEM J, V108, P353, DOI 10.1042/bj1080353; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053	38	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24263	24274		10.1074/jbc.M114.589408	http://dx.doi.org/10.1074/jbc.M114.589408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002576	Green Published, hybrid			2022-12-28	WOS:000341505600023
J	Zeldich, E; Chen, CD; Colvin, TA; Bove-Fenderson, EA; Liang, J; Zhou, TBT; Harris, DA; Abraham, CR				Zeldich, Ella; Chen, Ci-Di; Colvin, Teresa A.; Bove-Fenderson, Erin A.; Liang, Jennifer; Zhou, Tracey B. Tucker; Harris, David A.; Abraham, Carmela R.			The Neuroprotective Effect of Klotho is Mediated via Regulation of Members of the Redox System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Glutamate; Neuroprotection; Oxidative Stress	PROTEIN-KINASE-B; OXIDATIVE STRESS; A-BETA; MICROGLIAL ACTIVATION; MEMBRANE ASYMMETRY; GENE-EXPRESSION; CELL-DEATH; GLUTAMATE; PEROXIREDOXIN; BRAIN	Background: Klotho is an age suppressor protein whose brain function is unknown. Results: Klotho protects hippocampal neurons from glutamate and amyloid -induced oxidative damage through the induction of the thioredoxin/peroxiredoxin system. Conclusion: Klotho is neuroprotective via the regulation of the redox system. Significance: Understanding the mechanism underlying Klotho-induced neuroprotection may lead to the development of novel therapeutic approaches against neurodegeneration. Generation of reactive oxygen species (ROS), leading to oxidative damage and neuronal cell death, plays an important role in the pathogenesis of neurodegenerative disorders, including Alzheimer disease. The present study aimed to examine the mechanism by which the anti-aging protein Klotho exerts neuroprotective effects against neuronal damage associated with neurodegeneration and oxidative stress. Pretreatment of rat primary hippocampal neurons and mouse hippocampal neuronal cell line HT22 with recombinant Klotho protected these cells from glutamate and oligomeric amyloid (oA)-induced cytotoxicity. In addition, primary hippocampal neurons obtained from Klotho-overexpressing mouse embryos were more resistant to both cytotoxic insults, glutamate and oA, compared with neurons from wild-type littermates. An antioxidative stress array analysis of neurons treated with Klotho revealed that Klotho significantly enhances the expression of the thioredoxin/peroxiredoxin (Trx/Prx) system with the greatest effect on the induction of Prx-2, an antioxidant enzyme, whose increase was confirmed at the mRNA and protein levels. Klotho-induced phosphorylation of the PI3K/Akt pathway, a pathway important in apoptosis and longevity, was associated with sustained inhibitory phosphorylation of the transcription factor forkhead box O3a (FoxO3a) and was essential for the induction of Prx-2. Down-regulation of Prx-2 expression using a lentivirus harboring shRNA almost completely abolished the ability of Klotho to rescue neurons from glutamate-induced death and significantly, but not completely, inhibited cell death mediated by oA, suggesting that Prx-2 is a key modulator of neuroprotection. Thus, our results demonstrate, for the first time, the neuroprotective role of Klotho and reveal a novel mechanism underlying this effect.	[Zeldich, Ella; Chen, Ci-Di; Bove-Fenderson, Erin A.; Liang, Jennifer; Harris, David A.; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Colvin, Teresa A.; Abraham, Carmela R.] Boston Univ, Sch Med, Program Mol Med, Boston, MA 02118 USA; [Zhou, Tracey B. Tucker; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio O Conte Bldg K304, Boston, MA 02118 USA.	cabraham@bu.edu	Zeldich, Ella/K-7702-2013	Zeldich, Ella/0000-0002-9946-4512; Harris, David/0000-0002-6985-5790	Alzheimer's Drug Discovery Foundation	Alzheimer's Drug Discovery Foundation	This work was supported by a grant from the Alzheimer's Drug Discovery Foundation (to C. R. A.).	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Arner E S, 2001, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0704s05; Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Behl C, 1997, ENDOCRINOLOGY, V138, P101, DOI 10.1210/en.138.1.101; Bell KFS, 2011, ANTIOXID REDOX SIGN, V14, P1467, DOI 10.1089/ars.2010.3567; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chateau MT, 2010, AGING-US, V2, P567, DOI 10.18632/aging.100195; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Chen W, 2003, INT J DEV NEUROSCI, V21, P209, DOI 10.1016/S0736-5748(03)00037-6; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; Chonga ZZ, 2004, EXP CELL RES, V296, P196, DOI 10.1016/j.yexcr.2004.01.021; Cimini A, 2013, J CELL BIOCHEM, V114, P708, DOI 10.1002/jcb.24412; Clinton SM, 2013, BRAIN RES, V1527, P1, DOI 10.1016/j.brainres.2013.06.044; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Das A, 2010, NEUROCHEM RES, V35, P2175, DOI 10.1007/s11064-010-0321-1; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Fukui M, 2010, MOL CARCINOGEN, V49, P750, DOI 10.1002/mc.20650; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; German DC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.018; HANAOKA K, 1991, DIFFERENTIATION, V48, P183, DOI 10.1111/j.1432-0436.1991.tb00256.x; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Izbeki F, 2010, J PHYSIOL-LONDON, V588, P3101, DOI 10.1113/jphysiol.2010.191023; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Kang JQ, 2003, J NEUROSCI RES, V74, P37, DOI 10.1002/jnr.10740; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim SU, 2011, NEUROBIOL AGING, V32, P1054, DOI 10.1016/j.neurobiolaging.2009.05.017; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; King GD, 2012, BIOCHEM J, V441, P453, DOI 10.1042/BJ20101909; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Kuang X, 2014, NEUROBIOL AGING, V35, P169, DOI 10.1016/j.neurobiolaging.2013.07.019; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kwon KJ, 2010, J CLIN NEUROL, V6, P127, DOI 10.3988/jcn.2010.6.3.127; Lee Young Ju, 2011, Lab Anim Res, V27, P293, DOI 10.5625/lar.2011.27.4.293; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Mishra S, 2011, NEUROREPORT, V22, P23, DOI 10.1097/WNR.0b013e328341e141; Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061; Nagai Taku, 2003, FASEB Journal, V17, P50; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Teocchi MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-53; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Wang CJ, 2010, N-S ARCH PHARMACOL, V381, P73, DOI 10.1007/s00210-009-0470-4; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang YA, 2006, CANCER BIOL THER, V5, P20, DOI 10.4161/cbt.5.1.2430; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zeldich E, 2007, J CELL PHYSIOL, V213, P750, DOI 10.1002/jcp.21142; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhu H, 2012, EXP BIOL MED, V237, P143, DOI 10.1258/ebm.2011.011152	91	133	141	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24700	24715		10.1074/jbc.M114.567321	http://dx.doi.org/10.1074/jbc.M114.567321			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25037225	Green Published, hybrid			2022-12-28	WOS:000341505600059
J	Thomson, SJ; Hansen, A; Sanguinetti, MC				Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.			Concerted All-or-none Subunit Interactions Mediate Slow Deactivation of Human ether-a-go-go-related Gene K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Cooperativity; Gating; hERG; Potassium Channel	HERG POTASSIUM CHANNEL; C-TYPE INACTIVATION; HUMAN INWARD RECTIFIER; LONG QT SYNDROME; I-KR; CARDIAC-ARRHYTHMIA; TERMINAL REGION; EAG DOMAIN; COOPERATIVE INTERACTIONS; CONCATENATED SUBUNITS	Background: The N terminus of hERG1 subunits modulates the rate of channel deactivation. Results: A single mutant subunit in a concatenated hERG1 tetramer accelerates channel deactivation. Conclusion: All four subunits cooperate fully to slow the rate of hERG1 channel deactivation. Significance: A single subunit harboring a mutation in the PAS domain or S6 segment can alter the gating properties of a tetrameric hERG1 channel. During the repolarization phase of a cardiac action potential, hERG1 K+ channels rapidly recover from an inactivated state then slowly deactivate to a closed state. The resulting resurgence of outward current terminates the plateau phase and is thus a key regulator of action potential duration of cardiomyocytes. The intracellular N-terminal domain of the hERG1 subunit is required for slow deactivation of the channel as its removal accelerates deactivation 10-fold. Here we investigate the stoichiometry of hERG1 channel deactivation by characterizing the kinetic properties of concatenated tetramers containing a variable number of wild-type and mutant subunits. Three mutations known to accelerate deactivation were investigated, including R56Q and R4A/R5A in the N terminus and F656I in the S6 transmembrane segment. In all cases, a single mutant subunit induced the same rapid deactivation of a concatenated channel as that observed for homotetrameric mutant channels. We conclude that slow deactivation gating of hERG1 channels involves a concerted, fully cooperative interaction between all four wild-type channel subunits.	[Thomson, Steven J.; Hansen, Angela; Sanguinetti, Michael C.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Sanguinetti, Michael C.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Sanguinetti, Michael C.] Univ Utah, Div Cardiovasc Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sanguinetti, MC (corresponding author), Univ Utah, Dept Internal Med, Div Cardiovasc Med, 95 South 2000 East, Salt Lake City, UT 84112 USA.	sanguinetti@cvrti.utah.edu	Sanguinetti, Michael/AAN-2615-2020		National Institutes of Health [R01 HL055236]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL055236 (to M. C. S.; NHLBI).	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; BRUGGEMANN A, 1993, NATURE, V365, P445, DOI 10.1038/365445a0; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; HURST RS, 1992, J BIOL CHEM, V267, P23742; Hurst RS, 1995, RECEPTOR CHANNEL, V3, P263; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Larsen AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009021; LeesMiller JP, 1997, CIRC RES, V81, P719; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; London B, 1997, CIRC RES, V81, P870; Martinson AS, 2014, P NATL ACAD SCI USA, V111, P5712, DOI 10.1073/pnas.1321716111; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Sack JT, 2008, J GEN PHYSIOL, V131, P415, DOI 10.1085/jgp.200709939; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Schledermann W, 2001, J PHYSIOL-LONDON, V532, P143, DOI 10.1111/j.1469-7793.2001.0143g.x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Trudeau MC, 1999, J NEUROSCI, V19, P2906; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TYTGAT J, 1992, NATURE, V359, P420, DOI 10.1038/359420a0; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wu W, 2014, J GEN PHYSIOL, V143, P499, DOI 10.1085/jgp.201311038; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zandany N, 2008, P NATL ACAD SCI USA, V105, P11697, DOI 10.1073/pnas.0804104105; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zou AR, 2003, AM J PHYSIOL-CELL PH, V285, pC1356, DOI 10.1152/ajpcell.00179.2003	64	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23428	23436		10.1074/jbc.M114.582437	http://dx.doi.org/10.1074/jbc.M114.582437			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008322	Green Published, hybrid			2022-12-28	WOS:000341505000017
J	Rui, XL; Mehrbod, M; Van Agthoven, JF; Anand, S; Xiong, JP; Mofrad, MRK; Arnaout, MA				Rui, Xianliang; Mehrbod, Mehrdad; Van Agthoven, Johannes F.; Anand, Saurabh; Xiong, Jian-Ping; Mofrad, Mohammad R. K.; Arnaout, M. Amin			The alpha-Subunit Regulates Stability of the Metal Ion at the Ligand-associated Metal Ion-binding Site in beta(3) Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; ALPHA(V)BETA(3); ALPHA-V-BETA-3; ACTIVATION; ECTODOMAIN; AFFINITY; DOMAIN	The aspartate in the prototypical integrin-binding motif Arg-Gly-Asp binds the integrin beta A domain of the beta-subunit through a divalent cation at the metal ion-dependent adhesion site (MIDAS). An auxiliary metal ion at a ligand-associated metal ion-binding site (LIMBS) stabilizes the metal ion at MIDAS. LIMBS contacts distinct residues in the alpha-subunits of the two beta 3 integrins alpha(IIb)beta(3) and alpha(V)beta(3), but a potential role of this interaction on stability of the metal ion at LIMBS in beta(3) integrins has not been explored. Equilibrium molecular dynamics simulations of fully hydrated beta 3 integrin ectodomains revealed strikingly different conformations of LIMBS in unliganded alpha(IIb)beta(3) versus alpha(V)beta(3), the result of stronger interactions of LIMBS with alpha(V), which reduce stability of the LIMBS metal ion in alpha(V)beta(3). Replacing the alpha(IIb)-LIMBS interface residue Phe(191) in alpha(IIb) (equivalent to Trp179 in alpha(V)) with Trp strengthened this interface and destabilized the metal ion at LIMBS in alpha(IIb)beta(3); a Trp179 to Phe mutation in alpha(V) produced the opposite but weaker effect. Consistently, an F191/W substitution in cellular alpha(IIb)beta 3 and a W179/F substitution in alpha(V)beta(3) reduced and increased, respectively, the apparent affinity of Mn2+ to the integrin. These findings offer an explanation for the variable occupancy of the metal ion at LIMBS in alpha(V)beta(3) structures in the absence of ligand and provide new insights into the mechanisms of integrin regulation.	[Rui, Xianliang; Anand, Saurabh; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Charlestown, MA 02129 USA; [Van Agthoven, Johannes F.; Xiong, Jian-Ping; Arnaout, M. Amin] Massachusetts Gen Hosp, Struct Biol Program, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Mehrbod, Mehrdad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, 208A Stanley Hall 1762, Berkeley, CA 94720 USA.	mofrad@berkeley.edu; aarnaout1@mgh.harvard.edu			National Institutes of Health [DK088327, DK096334, DK007540]; National Science Foundation CAREER Award [CBET-0955291]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088327, T32DK007540, R21DK096334] Funding Source: NIH RePORTER; Directorate For Engineering [0955291] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grants DK088327, DK096334, and DK007540 (to M. A. A.) and by a National Science Foundation CAREER Award CBET-0955291 (to M. R. K. M.).	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Brandt M, 1986, MANGANESE METABOLISM, P3; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mahalingam B, 2014, J BIOL CHEM, V289, P13801, DOI 10.1074/jbc.M113.546929; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mehrbod M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002948; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Richards J, 2003, J MOL BIOL, V326, P1475, DOI 10.1016/S0022-2836(03)00082-2; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; SMITH JW, 1994, J BIOL CHEM, V269, P960; Valdramidou D, 2008, J BIOL CHEM, V283, P32704, DOI 10.1074/jbc.M802066200; Van Agthoven JF, 2014, NAT STRUCT MOL BIOL, V21, P383, DOI 10.1038/nsmb.2797; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	34	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23256	23263		10.1074/jbc.M114.581470	http://dx.doi.org/10.1074/jbc.M114.581470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24975416	hybrid, Green Published			2022-12-28	WOS:000341017200061
J	Paatero, I; Seagroves, TN; Vaparanta, K; Han, W; Jones, FE; Johnson, RS; Elenius, K				Paatero, Ilkka; Seagroves, Tiffany N.; Vaparanta, Katri; Han, Wen; Jones, Frank E.; Johnson, Randall S.; Elenius, Klaus			Hypoxia-inducible Factor-1 alpha Induces ErbB4 Signaling in the Differentiating Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CANCER-CELL-GROWTH; ESTROGEN-RECEPTOR; INTRACELLULAR DOMAIN; NUCLEAR-LOCALIZATION; NEUREGULIN RECEPTOR; MICE LACKING; ISOFORM; STAT5; ACTIVATION	Conditional knock-out of Hif1a in the mouse mammary gland impairs lobuloalveolar differentiation during lactation. Here, we demonstrate that expression of ErbB4 was reduced in the lobulalveoli of mice with mammary gland-specific deletion of Hif1a. Erbb4 was not, however, a direct target gene for transcriptional regulation by HIF-1 alpha in vitro. HIF-1 alpha overexpression or HIF accumulating prolyl hydroxylase inhibitors reduced ErbB4 endocytosis, promoted transcriptional co-regulatory activity of ErbB4, and stimulated ErbB4-induced differentiation of mammary carcinoma cells. Consistently, RNA interference-mediated down-regulation of HIF-1 alpha resulted in reduced ErbB4 protein amount and reduced mammary carcinoma cell differentiation. These findings indicate that HIF-1 alpha is a physiologically relevant regulator of ErbB4 and that ErbB4 is involved in HIF-regulated differentiation of the mammary gland.	[Paatero, Ilkka; Vaparanta, Katri; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Paatero, Ilkka; Vaparanta, Katri; Elenius, Klaus] Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; [Paatero, Ilkka] Turku Grad Sch Biomed Sci, Turku 20520, Finland; [Seagroves, Tiffany N.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Han, Wen; Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1TN, England; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; University of Turku; University of Turku; University of Tennessee System; University of Tennessee Health Science Center; Tulane University; University of Cambridge; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Seagroves, Tiffany/AAE-3278-2019; Elenius, Klaus/AAI-7594-2021; Paatero, Ilkka/AAE-7542-2019; Johnson, Randall/AAM-1189-2021	Seagroves, Tiffany/0000-0002-6937-943X; Elenius, Klaus/0000-0001-5700-0827; Paatero, Ilkka/0000-0001-5926-2396; Johnson, Randall/0000-0002-4084-6639	Academy of Finland; Finnish Cancer Organisations; Finnish Cultural Foundation; K. Albin Johansson Foundation; Sigrid Juselius Foundation; Turku University Foundation; Turku University Central Hospital; Wellcome Trust [092738/Z/10/Z] Funding Source: researchfish; Cancer Foundation Finland sr [130077] Funding Source: researchfish	Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); K. Albin Johansson Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Foundation; Turku University Central Hospital; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Foundation Finland sr	This work was supported by the Academy of Finland, the Finnish Cancer Organisations, the Finnish Cultural Foundation, the K. Albin Johansson Foundation, the Sigrid Juselius Foundation, the Turku University Foundation, and Turku University Central Hospital.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Das PM, 2010, ONCOGENE, V29, P5214, DOI 10.1038/onc.2010.271; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058; Gullick WJ, 2003, J PATHOL, V200, P279, DOI 10.1002/path.1335; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hollmen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039413; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Muraoka-Cook RS, 2006, MOL BIOL CELL, V17, P4118, DOI 10.1091/mbc.E06-02-0101; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155	46	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22459	22469		10.1074/jbc.M113.533497	http://dx.doi.org/10.1074/jbc.M113.533497			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24966332	hybrid, Green Published			2022-12-28	WOS:000340593500055
J	Bhattacharya, S; Liang, Z; Quek, AJ; Ploplis, VA; Law, R; Castellino, FJ				Bhattacharya, Sarbani; Liang, Zhong; Quek, Adam J.; Ploplis, Victoria A.; Law, Ruby; Castellino, Francis J.			Dimerization Is Not a Determining Factor for Functional High Affinity Human Plasminogen Binding by the Group A Streptococcal Virulence Factor PAM and Is Mediated by Specific Residues within the PAM a1a2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO ACID LIGANDS; M-PROTEIN; SURFACE PROTEIN; INTERNAL SEQUENCE; KRINGLE-2 DOMAIN; ALPHA-AMINO; EXPRESSION; PEPTIDE; IDENTIFICATION; PURIFICATION	A emm53 subclass of Group A Streptococcus pyogenes (GAS) interacts tightly with human plasma plasminogen (hPg) and plasmin (hPm) via the kringle 2 (K2(hPg)) domain of hPg/hPm and the N-terminal a1a2 regions of a GAS coiled-coil M-like protein (PAM). Previous studies have shown that a monomeric PAM fragment, VEK30 (residues 97-125 + Tyr), interacted specifically with isolated K2(hPg). However, the binding strength of VEK30 (K-D = 56 nM) was similar to 60-fold weaker than that of full-length dimeric PAM (K-D = 1nM). To assess whether this attenuated binding was due to the inability of VEK30 to dimerize, we defined the minimal length of PAM required to dimerize using a series of peptides with additional PAM residues placed at the NH2 and COOH termini of VEK30.VEK64 (PAM residues 83-145 + Tyr) was found to be the smallest peptide that adopted an alpha-helical dimer, and was bound to K2(hPg) with nearly the same affinity as PAM (K-D = 1-2 nM). However, addition of two PAM residues (Arg(126)-His(127)) to the COOH terminus of VEK30 (VEK32) maintained a monomeric peptidic structure, but exhibited similar K2(hPg) binding affinity as full-length dimeric PAM. We identified five residues in a1a2 (Arg(113), His(114), Glu(116), Arg(126), His(127)), mutation of which reduced PAM binding affinity for K2(hPg) by similar to 1000-fold. Replacement of these critical residues by Ala in the GAS genome resulted in reduced virulence, similar to the effects of inactivating the PAM gene entirely. We conclude that rather than dimerization of PAM, the five key residues in the binding domain of PAM are essential to mediate the high affinity interaction with hPg, leading to increased GAS virulence.	[Bhattacharya, Sarbani; Liang, Zhong; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Bhattacharya, Sarbani; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Quek, Adam J.; Law, Ruby] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Notre Dame; University of Notre Dame; Monash University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		law, ruby/0000-0001-5432-5781; Quek, Adam/0000-0002-9120-2681	National Institutes of Health [HL03423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL03423.	Agrahari G, 2013, J BIOL CHEM, V288, P27494, DOI 10.1074/jbc.M113.494864; AKERSTROM B, 1992, J IMMUNOL, V148, P3238; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CAPARON MG, 1987, P NATL ACAD SCI USA, V84, P8677, DOI 10.1073/pnas.84.23.8677; Castellino FJ, 2003, PLASMINOGEN: STRUCTURE, ACTIVATION AND REGULATION, P3; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Cheng Y, 2004, BIOCHEM BIOPH RES CO, V317, P401, DOI 10.1016/j.bbrc.2004.03.068; Christen MT, 2010, BIOCHEMISTRY-US, V49, P7131, DOI 10.1021/bi100687f; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; Figuera-Losada M, 2010, BBA-PROTEINS PROTEOM, V1804, P1342, DOI 10.1016/j.bbapap.2010.01.019; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Godier A, 2013, J THROMB HAEMOST, V11, P26, DOI 10.1111/jth.12064; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; MAGNUSSON S, 1975, PROTEASES BIOL CONTR, P123; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MENHART N, 1991, BIOCHEMISTRY-US, V30, P1948, DOI 10.1021/bi00221a031; MENHART N, 1993, BIOCHEMISTRY-US, V32, P8799, DOI 10.1021/bi00085a010; MENHART N, 1995, INT J PEPT PROT RES, V46, P464; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; Sehl L. C., 1991, THESIS U NOTRE DAME; SEHL LC, 1990, J BIOL CHEM, V265, P5482; Shang C, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021401; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; VIOLAND BN, 1975, ARCH BIOCHEM BIOPHYS, V170, P300, DOI 10.1016/0003-9861(75)90121-6; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	48	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21684	21693		10.1074/jbc.M114.570218	http://dx.doi.org/10.1074/jbc.M114.570218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962580	Green Published, hybrid			2022-12-28	WOS:000340558300042
J	Goto, A; Fukuyama, H; Imler, JL; Hoffmann, JA				Goto, Akira; Fukuyama, Hidehiro; Imler, Jean-Luc; Hoffmann, Jules A.			The Chromatin Regulator DMAP1 Modulates Activity of the Nuclear Factor kappa B (NF-kappa B) Transcription Factor Relish in the Drosophila Innate Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; DNA; EXPRESSION; RECEPTORS; BACTERIAL; POLARITY	The host defense of the model organism Drosophila is under the control of two major signaling cascades controlling transcription factors of the NF-kappa B family, the Toll and the immune deficiency (IMD) pathways. The latter shares extensive similarities with the mammalian TNF-R pathway and was initially discovered for its role in anti-Gram-negative bacterial reactions. A previous interactome study from this laboratory reported that an unexpectedly large number of proteins are binding to the canonical components of the IMD pathway. Here, we focus on DNA methyltransferase-associated protein 1 (DMAP1), which this study identified as an interactant of Relish, a Drosophila transcription factor reminiscent of the mammalian p105 NF-kappa B protein. We show that silencing of DMAP1 expression both in S2 cells and in flies results in a significant reduction of Escherichia coli-induced expression of antimicrobial peptides. Epistatic analysis indicates that DMAP1 acts in parallel or downstream of Relish. Co-immunoprecipitation experiments further reveal that, in addition to Relish, DMAP1 also interacts with Akirin and the Brahma-associated protein 55 kDa (BAP55). Taken together, these results reveal that DMAP1 is a novel nuclear modulator of the IMD pathway, possibly acting at the level of chromatin remodeling.	[Goto, Akira; Fukuyama, Hidehiro; Imler, Jean-Luc; Hoffmann, Jules A.] IBMC, INSERM, CNRS UPR9022, F-67084 Strasbourg, France; [Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France; [Hoffmann, Jules A.] Univ Strasbourg, Inst Adv Study, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Goto, A (corresponding author), IBMC, INSERM, CNRS UPR9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	goto@unistra.fr	GOTO, Akira/V-7847-2017; Imler, Jean-Luc/GXH-4323-2022; Fukuyama, Hidehiro/N-5276-2018; Fukuyama, Hidehiro/AAY-6256-2021	GOTO, Akira/0000-0003-3395-484X; Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630	National Institutes of Health [PO1 AI070167]; Agence Nationale de la Recherche [ANR-13-BSV3-0009]; Balzan Foundation; Investissement d'Avenir Programs [ANR-10-LABX-0036, ANR-11-EQPX-0022]; CNRS; INSERM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); Balzan Foundation; Investissement d'Avenir Programs(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AI070167 (to J. L. I. and J. A. H.), the Agence Nationale de la Recherche (Grant ANR-13-BSV3-0009), the Balzan Foundation (to J. A. H.), the Investissement d'Avenir Programs (Grants ANR-10-LABX-0036 and ANR-11-EQPX-0022), CNRS, and INSERM.	ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Ferrandon D, 2013, CURR OPIN IMMUNOL, V25, P59, DOI 10.1016/j.coi.2012.11.008; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Guruharsha KG, 2012, FLY, V6, P246, DOI 10.4161/fly.22108; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lee KZ, 2011, EMBO J, V30, P988, DOI 10.1038/emboj.2011.47; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mohan KN, 2011, MOL CELL BIOL, V31, P1861, DOI 10.1128/MCB.01390-10; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Penicud K, 2014, ONCOGENE, V33, P525, DOI 10.1038/onc.2012.597; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797	37	18	21	9	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20470	20476		10.1074/jbc.C114.553719	http://dx.doi.org/10.1074/jbc.C114.553719			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24947515	Green Published, hybrid			2022-12-28	WOS:000339396600006
J	Ito, S; Akamatsu, Y; Noma, A; Kimura, S; Miyauchi, K; Ikeuchi, Y; Suzuki, T; Suzuki, T				Ito, Satoshi; Akamatsu, Yu; Noma, Akiko; Kimura, Satoshi; Miyauchi, Kenjyo; Ikeuchi, Yoshiho; Suzuki, Takeo; Suzuki, Tsutomu			A Single Acetylation of 18 S rRNA Is Essential for Biogenesis of the Small Ribosomal Subunit in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; PROTEIN; ACETYLTRANSFERASE; IDENTIFICATION; PROLIFERATION; BIOSYNTHESIS; NUCLEOTIDE; DATABASE; CLEAVAGE; ARCHAEA	Biogenesis of eukaryotic ribosome is a complex event involving a number of non-ribosomal factors. During assembly of the ribosome, rRNAs are post-transcriptionally modified by 2'-O-methylation, pseudouridylation, and several base-specific modifications, which are collectively involved in fine-tuning translational fidelity and/or modulating ribosome assembly. By mass-spectrometric analysis, we demonstrated that N-4-acetylcytidine (ac(4)C) is present at position 1773 in the 18 S rRNA of Saccharomyces cerevisiae. In addition, we found an essential gene, KRE33 (human homolog, NAT10), that we renamed RRA1 (ribosomal RNA cytidine acetyltransferase 1) encoding an RNA acetyltransferase responsible for ac(4)C1773 formation. Using recombinant Rra1p, we could successfully reconstitute ac(4)C1773 in a model rRNA fragment in the presence of both acetyl-CoA and ATP as substrates. Upon depletion of Rra1p, the 23 S precursor of 18 S rRNA was accumulated significantly, which resulted in complete loss of 18 S rRNA and small ribosomal subunit (40 S), suggesting that ac(4)C1773 formation catalyzed by Rra1p plays a critical role in processing of the 23 S precursor to yield 18 S rRNA. When nuclear acetyl-CoA was depleted by inactivation of acetyl-CoA synthetase 2 (ACS2), we observed temporal accumulation of the 23 S precursor, indicating that Rra1p modulates biogenesis of 40 S subunit by sensing nuclear acetyl-CoA concentration.	[Ito, Satoshi; Akamatsu, Yu; Noma, Akiko; Kimura, Satoshi; Miyauchi, Kenjyo; Ikeuchi, Yoshiho; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	ikeuchi, yoshiho/C-1713-2014; Suzuki, Tsutomu/J-1776-2015; Ikeuchi, Yoshiho/N-1057-2019	ikeuchi, yoshiho/0000-0002-2829-3840; Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (to T. S.).	Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; BRAND RC, 1978, BIOCHEM J, V169, P71, DOI 10.1042/bj1690071; BRUENGER E, 1993, FASEB J, V7, P196, DOI 10.1096/fasebj.7.1.8422966; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Eschrich D, 2002, CURR GENET, V40, P326, DOI 10.1007/s00294-001-0269-4; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; Page N, 2003, GENETICS, V163, P875; Pendrak ML, 2011, RNA, V17, P2235, DOI 10.1261/rna.028050.111; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Peter A, 2002, EMBO REP, V3, P34, DOI 10.1093/embo-reports/kvf012; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Sanchez-Diaz Alberto, 2004, Sci STKE, V2004, pPL8, DOI 10.1126/stke.2232004pl8; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAN TZ, 2013, EMBO MOL MED, V0005; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waters K, 2010, DEV BIOL, V344, P1011, DOI 10.1016/j.ydbio.2010.06.022; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wurm JP, 2010, NUCLEIC ACIDS RES, V38, P2387, DOI 10.1093/nar/gkp1189	54	42	44	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26201	26212		10.1074/jbc.M114.593996	http://dx.doi.org/10.1074/jbc.M114.593996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086048	hybrid, Green Published			2022-12-28	WOS:000342128800016
J	Kemp, MG; Gaddameedhi, S; Choi, JH; Hu, JC; Sancar, A				Kemp, Michael G.; Gaddameedhi, Shobhan; Choi, Jun-Hyuk; Hu, Jinchuan; Sancar, Aziz			DNA Repair Synthesis and Ligation Affect the Processing of Excised Oligonucleotides Generated by Human Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRRADIATED HUMAN-CELLS; REPLICATION PROTEIN-A; XERODERMA PIGMENTOSUM-CELLS; HUMAN-FIBROBLASTS; ARABINOFURANOSYL CYTOSINE; H2AX PHOSPHORYLATION; POLYMERASE-DELTA; MAMMALIAN-CELLS; THYMINE DIMER; DUAL INCISION	Ultraviolet (UV) photoproducts are removed from genomic DNA by dual incisions in humans in the form of 24- to 32-nucleotide-long oligomers (canonical 30-mers) by the nucleotide excision repair system. How the small, excised, damage-containing DNA oligonucleotides (sedDNAs) are processed in cells following the dual incision event is not known. Here, we demonstrate that sedDNAs are localized to the nucleus in two biochemically distinct forms, which include chromatin-associated, transcription factor II H-bound complexes and more readily solubilized, RPA-bound complexes. Because the nuclear mobility and repair functions of transcription factor II H and RPA are influenced by post-incision gap-filling events, we examined how DNA repair synthesis and DNA ligation affect sedDNA processing. We found that although these gap filling activities are not essential for the dual incision/sedDNA generation event per se, the inhibition of DNA repair synthesis and ligation is associated with a decrease in UV photoproduct removal rate and an accumulation of RPA-sedDNA complexes in the cell. These findings indicate that sedDNA processing and association with repair proteins following the dual incisions may be tightly coordinated with gap filling during nucleotide excision repair in vivo.	[Kemp, Michael G.; Gaddameedhi, Shobhan; Hu, Jinchuan; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Ctr Bioanal, Dept Metrol Qual Life, Taejon 305340, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Korea Research Institute of Standards & Science (KRISS)	Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Hu, Jinchuan/V-9913-2017; GADDAMEEDHI, SHOBHAN/GZM-8298-2022	Kemp, Michael G./0000-0001-8203-0745; GADDAMEEDHI, SHOBHAN/0000-0002-4978-6951; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [GM32833, K99ES022640]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES022640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32833 (to A. S.) and K99ES022640 (to S. G.).	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; CLEAVER JE, 1991, PHOTOCHEM PHOTOBIOL, V54, P393, DOI 10.1111/j.1751-1097.1991.tb02033.x; CLEAVER JE, 1972, BIOCHIM BIOPHYS ACTA, V262, P116, DOI 10.1016/0005-2787(72)90224-9; COLLINS ARS, 1982, NUCLEIC ACIDS RES, V10, P1203, DOI 10.1093/nar/10.4.1203; DOWNES CS, 1982, NUCLEIC ACIDS RES, V10, P5357, DOI 10.1093/nar/10.17.5357; DUNN WC, 1979, MOL PHARMACOL, V15, P367; EHMANN UK, 1978, BIOPHYS J, V22, P249, DOI 10.1016/S0006-3495(78)85487-3; ERIXON K, 1979, MUTAT RES, V59, P257, DOI 10.1016/0027-5107(79)90164-7; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; FRANCIS AA, 1979, BIOCHIM BIOPHYS ACTA, V563, P385, DOI 10.1016/0005-2787(79)90057-1; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; KAYE J, 1980, CANCER RES, V40, P696; Kemp MG, 2012, CELL CYCLE, V11, P2997, DOI 10.4161/cc.21126; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Lindsey-Boltz LA, 2012, J BIOL CHEM, V287, P36123, DOI 10.1074/jbc.M112.407825; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Mirzayans R, 1996, CARCINOGENESIS, V17, P691, DOI 10.1093/carcin/17.4.691; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; MULLENDERS LHF, 1985, BIOCHIM BIOPHYS ACTA, V826, P38, DOI 10.1016/S0167-4781(85)80006-3; NISHIDA C, 1988, J BIOL CHEM, V263, P501; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 1997, NUCLEIC ACIDS RES, V25, P1015, DOI 10.1093/nar/25.5.1015; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Sluss HK, 2010, MOL CANCER RES, V8, P216, DOI 10.1158/1541-7786.MCR-09-0324; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; SNYDER RD, 1982, BIOCHIM BIOPHYS ACTA, V697, P229, DOI 10.1016/0167-4781(82)90081-1; SNYDER RD, 1981, BIOPHYS J, V35, P339, DOI 10.1016/S0006-3495(81)84793-5; SNYDER RD, 1981, BIOCHEM BIOPH RES CO, V99, P1088, DOI 10.1016/0006-291X(81)90730-0; SNYDER RD, 1988, MUTAT RES, V200, P193, DOI 10.1016/0027-5107(88)90082-6; SQUIRES S, 1982, MUTAT RES, V95, P389, DOI 10.1016/0027-5107(82)90273-1; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Treuner K, 1998, J BIOL CHEM, V273, P31744, DOI 10.1074/jbc.273.48.31744; WILLIAMS JI, 1978, BIOPHYS J, V22, P265, DOI 10.1016/S0006-3495(78)85488-5; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	28	29	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26574	26583		10.1074/jbc.M114.597088	http://dx.doi.org/10.1074/jbc.M114.597088			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25107903	hybrid, Green Published			2022-12-28	WOS:000342128800048
J	Zhao, YL; Xiao, M; Sun, BG; Zhang, ZM; Shen, T; Duan, XY; Yu, PB; Feng, XH; Lin, X				Zhao, Yulan; Xiao, Mu; Sun, Baoguo; Zhang, Zhengmao; Shen, Tao; Duan, Xueyan; Yu, Paul Borchyung; Feng, Xin-Hua; Lin, Xia			C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation via Smad Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; IDENTIFICATION; PATHWAYS	The bone morphogenetic protein (BMP) signaling pathway regulates a wide range of cellular responses in metazoans. A key step in the canonical BMP signaling is the phosphorylation and activation of transcription factors Smad1, Smad5, and Smad8 (collectively Smad1/5/8) by the type I BMP receptors. We previously identified PPM1A as a phosphatase toward dephosphorylation of all receptor-regulated Smads (R-Smads), including Smad1/5/8. Here we report another nuclear phosphatase named SCP4/CTDSPL2, belonging to the FCP/SCP family, as a novel Smad phosphatase in the nucleus. SCP4 physically interacts with and specifically dephosphorylates Smad1/5/8, and as a result attenuates BMP-induced transcriptional responses. Knockdown of SCP4 in multipotent mesenchymal C2C12 cells leads to increased expression of BMP target genes and consequently promotes BMP-induced osteogenic differentiation. Collectively, our results demonstrate that SCP4, as a Smad phosphatase, plays a critical role in BMP-induced signaling and cellular functions.	[Zhao, Yulan; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Yulan; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Baoguo; Zhang, Zhengmao; Shen, Tao; Feng, Xin-Hua; Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Sun, Baoguo; Feng, Xin-Hua] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Duan, Xueyan; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Shen, Tao] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Yu, Paul Borchyung] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Massachusetts General Hospital	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xhfeng@zju.edu.cn; xialin@bcm.edu	Zhang, Zhengmao/C-4566-2014; Huang, Xiaoyan/N-2561-2014; Yu, Paul B./J-7540-2019	Zhang, Zhengmao/0000-0002-7968-9968; Yu, Paul B./0000-0003-2145-4944; Xiao, Mu/0000-0003-3058-2905; ZHANG, ZHENGMAO/0000-0003-4035-0331	Ministry of Science and Technology [2012CB966600]; National Natural Science Foundation of China [31090360]; National Institutes of Health [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; Project 111 [B13026]; Project 985; Fundamental Research Funds for the Central Universities; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591, R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 111(Ministry of Education, China - 111 Project); Project 985; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partly supported by grants from the Ministry of Science and Technology (2012CB966600); the National Natural Science Foundation of China (31090360); the National Institutes of Health (R01GM63773, R01AR053591, and R01CA108454 to X.-H. F., and R01DK073932 to X. L.); Project 111 (B13026); Project 985; and the Fundamental Research Funds for the Central Universities.	Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R., 2008, TGF BETA FAMILY; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Reguly T, 2003, TRENDS CELL BIOL, V13, P216, DOI 10.1016/S0962-8924(03)00075-8; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Shen T, 2014, CELL RES, V24, P727, DOI 10.1038/cr.2014.48; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JJ, 2013, J BIOL CHEM, V288, P79, DOI 10.1074/jbc.M112.413856; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027	32	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26441	26450		10.1074/jbc.M114.568964	http://dx.doi.org/10.1074/jbc.M114.568964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100727	hybrid, Green Published			2022-12-28	WOS:000342128800035
J	Higashi, K; Asano, K; Yagi, M; Yamada, K; Arakawa, T; Ehashi, T; Mori, T; Sumida, K; Kushida, M; Ando, S; Kinoshita, M; Kakehi, K; Tachibana, T; Saito, K				Higashi, Kiyoshi; Asano, Kouji; Yagi, Masaki; Yamada, Keita; Arakawa, Tatsuhiko; Ehashi, Tomo; Mori, Takashi; Sumida, Kayo; Kushida, Masahiko; Ando, Satoshi; Kinoshita, Mitsuhiro; Kakehi, Kazuaki; Tachibana, Taro; Saito, Koichi			Expression of the Clustered NeuAc alpha 2-3Gal beta O-Glycan Determines the Cell Differentiation State of the Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; COLON-CANCER CELLS; GENE-EXPRESSION; PLURIPOTENCY; INHIBITOR; TRA-1-60; SURFACE; IDENTIFICATION; PODOCALYXIN; ANTIBODIES	Human embryonic stem cells (hESCs) are pluripotent stem cells from early embryos, and their self-renewal capacity depends on the sustained expression of hESC-specific molecules and the suppressed expression of differentiation-associated genes. To discover novel molecules expressed on hESCs, we generated a panel of monoclonal antibodies against undifferentiated hESCs and evaluated their ability to mark cancer cells, as well as hESCs. MAb7 recognized undifferentiated hESCs and showed a diffuse band with molecular mass of > 239 kDa in the lysates of hESCs. Although some amniotic epithelial cells expressed MAb7 antigen, its expression was barely detected in normal human keratinocytes, fibroblasts, or endothelial cells. The expression of MAb7 antigen was observed only in pancreatic and gastric cancer cells, and its levels were elevated in metastatic and poorly differentiated cancer cell lines. Analyses of MAb7 antigen suggested that the clustered NeuAc alpha 2-3Gal beta O-linked oligosaccharides on DMBT1 (deleted in malignant brain tumors 1) were critical for MAb7 binding in cancer cells. Although features of MAb7 epitope were similar with those of TRA-1-60, distribution of MAb7 antigen in cancer cells was different from that of TRA-1-60 antigen. Exposure of a histone deacetylase inhibitor to differentiated gastric cancer MKN74 cells evoked the expression of MAb7 antigen, whereas DMBT1 expression remained unchanged. Cell sorting followed by DNA microarray analyses identified the down-regulated genes responsible for the biosynthesis of MAb7 antigen in MKN74 cells. In addition, treatment of metastatic pancreatic cancer cells with MAb7 significantly abrogated the adhesion to endothelial cells. These results raised the possibility that MAb7 epitope is a novel marker for undifferentiated cells such as hESCs and cancer stem-like cells and plays a possible role in the undifferentiated cells.	[Higashi, Kiyoshi; Asano, Kouji; Ehashi, Tomo; Mori, Takashi; Sumida, Kayo; Kushida, Masahiko; Ando, Satoshi; Saito, Koichi] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Osaka 5548558, Japan; [Yagi, Masaki; Arakawa, Tatsuhiko; Tachibana, Taro] Osaka City Univ, Grad Sch Engn, Dept Bioengn, Osaka 5588585, Japan; [Yamada, Keita] Osaka Ohtani Univ, Toxicol Lab, Fac Pharm, Tondabaya, Osaka 5848540, Japan; [Kinoshita, Mitsuhiro; Kakehi, Kazuaki] Kinki Univ, Sch Pharm, Higashiosaka, Osaka 5778502, Japan	Sumitomo Chem Co Ltd; Osaka Metropolitan University; Kindai University (Kinki University)	Higashi, K (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugadenaka 3 Chome, Osaka 5548558, Japan.	higashik2@sc.sumitomo-chem.co.jp	EHASHI, Tomo/H-4817-2016	Saito, Koichi/0000-0001-6497-5286; Asano, Koji/0000-0001-5873-8161; HIGASHI, KIYOSHI/0000-0003-3577-0526				Alisson-Silva F, 2014, GLYCOBIOLOGY, V24, P458, DOI 10.1093/glycob/cwu012; Dimitroff CJ, 1999, BIOCHEM BIOPH RES CO, V256, P631, DOI 10.1006/bbrc.1999.0388; Evron Ayelet, 2011, Int J Stem Cells, V4, P123; Fong CY, 2009, STEM CELL REV REP, V5, P72, DOI 10.1007/s12015-009-9054-4; Foster MM, 2003, CANCER RES, V63, P2775; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Gu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015795; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HARVEY BE, 1992, CANCER RES, V52, P1775; Hasegawa M, 2009, ARTHRITIS RHEUM-US, V60, P3465, DOI 10.1002/art.24934; Higashi K, 2012, FEBS LETT, V586, P2300, DOI 10.1016/j.febslet.2012.06.022; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603; Hustinx SR, 2004, CANCER BIOL THER, V3, P1254, DOI 10.4161/cbt.3.12.1238; IKEDA Y, 1990, JPN J CANCER RES, V81, P987, DOI 10.1111/j.1349-7006.1990.tb03336.x; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; Leppanen A, 2002, J BIOL CHEM, V277, P39749, DOI 10.1074/jbc.M206281200; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Sassetti C, 1998, J EXP MED, V187, P1965, DOI 10.1084/jem.187.12.1965; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876; Serrano L, 2013, EXP BIOL MED, V238, P259, DOI 10.1177/1535370213480718; Suzuki N, 2011, J TOXICOL SCI, V36, P569; Tomao F, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-48; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamada K, 2013, ANAL CHEM, V85, P3325, DOI 10.1021/ac303771q; Yamada K, 2010, ANAL BIOCHEM, V396, P161, DOI 10.1016/j.ab.2009.08.021; Yamada K, 2009, J PROTEOME RES, V8, P521, DOI 10.1021/pr800710f; Yokoyama C, 2010, HYBRIDOMA, V29, P53, DOI 10.1089/hyb.2009.0101; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196	40	8	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25833	25843		10.1074/jbc.M114.550848	http://dx.doi.org/10.1074/jbc.M114.550848			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074924	Green Published, hybrid			2022-12-28	WOS:000342130800040
J	Penfield, JS; Worrall, LJ; Strynadka, NC; Eltis, LD				Penfield, Jonathan S.; Worrall, Liam J.; Strynadka, Natalie C.; Eltis, Lindsay D.			Substrate Specificities and Conformational Flexibility of 3-Ketosteroid 9 alpha-Hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN CHOL1; STEROID COMPOUND CHOLATE; ACYL SIDE-CHAIN; MYCOBACTERIUM-TUBERCULOSIS; NAPHTHALENE 1,2-DIOXYGENASE; CARBAZOLE 1,9A-DIOXYGENASE; OXYGENASE COMPONENT; DEGRADATION; RHODOCOCCUS; IRON	KshA is the oxygenase component of 3-ketosteroid 9 alpha-hydroxylase, a Rieske oxygenase involved in the bacterial degradation of steroids. Consistent with its role in bile acid catabolism, KshA1 from Rhodococcus rhodochrous DSM43269 had the highest apparent specificity (k(cat)/K-m) for steroids with an isopropyl side chain at C17, such as 3-oxo-23,24-bisnorcholesta-1,4-diene-22-oate (1,4-BNC). By contrast, the KshA5 homolog had the highest apparent specificity for substrates with no C17 side chain (k(cat)/K-m > 10(5) s(-1) M-1 for 4-estrendione, 5 alpha-androstandione, and testosterone). Unexpectedly, substrates such as 4-androstene-3,17-dione (ADD) and 4-BNC displayed strong substrate inhibition (K-iS similar to 100 mu M). By comparison, the cholesterol-degrading KshA(Mtb) from Mycobacterium tuberculosis had the highest specificity for CoA-thioesterified substrates. These specificities are consistent with differences in the catabolism of cholesterol and bile acids, respectively, in actinobacteria. X-ray crystallographic structures of the KshA(Mtb)center dot ADD, KshA1 center dot 1,4-BNC-CoA, KshA5 center dot ADD, and KshA5 center dot 1,4-BNC-CoA complexes revealed that the enzymes have very similar steroid-binding pockets with the substrate's C17 oriented toward the active site opening. Comparisons suggest Tyr-245 and Phe-297 are determinants of KshA1 specificity. All enzymes have a flexible 16-residue "mouth loop," which in some structures completely occluded the substrate-binding pocket from the bulk solvent. Remarkably, the catalytic iron and alpha-helices harboring its ligands were displaced up to 4.4 angstrom in the KshA5 center dot substrate complexes as compared with substrate-free KshA, suggesting that Rieske oxygenases may have a dynamic nature similar to cytochrome P450.	[Penfield, Jonathan S.; Worrall, Liam J.; Strynadka, Natalie C.; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	Natural Sciences and Engineering Council of Canada; Canadian Institutes for Health Research; National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Research Council Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Drs. Robert van der Geize and Mirjam Petrusma provided kshA1 and kshA5 constructs. X-ray synchrotron data were collected at the Canadian Light Source, which is supported by Natural Sciences and Engineering Council of Canada, Canadian Institutes for Health Research, the National Research Council Canada, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Ashikawa Y, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-15; Birkenmaier A, 2007, J BACTERIOL, V189, P7165, DOI 10.1128/JB.00665-07; Birkenmaier A, 2011, FEMS MICROBIOL LETT, V318, P123, DOI 10.1111/j.1574-6968.2011.02250.x; Capyk JK, 2012, J BIOL INORG CHEM, V17, P425, DOI 10.1007/s00775-011-0865-9; Capyk JK, 2011, J BIOL CHEM, V286, P40717, DOI 10.1074/jbc.M111.289975; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Casabon I, 2013, MOL MICROBIOL, V89, P1201, DOI 10.1111/mmi.12340; Chen HP, 2012, APPL ENVIRON MICROB, V78, P7798, DOI 10.1128/AEM.02120-12; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; DeLano W.L, PYMOL MOL GRAPHICS S; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fernandes P, 2003, ENZYME MICROB TECH, V32, P688, DOI 10.1016/S0141-0229(03)00029-2; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Ge Y, 2003, J BACTERIOL, V185, P5333, DOI 10.1128/JB.185.18.5333-5341.2003; GIBSON DT, 1966, J BIOL CHEM, V241, P551; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; Holert J, 2013, J BACTERIOL, V195, P585, DOI 10.1128/JB.01961-12; Horinouchi M, 2012, J STEROID BIOCHEM, V129, P4, DOI 10.1016/j.jsbmb.2010.10.008; Hu YM, 2010, MOL MICROBIOL, V75, P107, DOI 10.1111/j.1365-2958.2009.06957.x; Inoue K, 2014, APPL ENVIRON MICROB, V80, P2821, DOI 10.1128/AEM.04000-13; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Karlsson A, 2000, J INORG BIOCHEM, V78, P83, DOI 10.1016/S0162-0134(99)00213-5; Lee JK, 2005, J BIOL CHEM, V280, P36719, DOI 10.1074/jbc.M505334200; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mohn WW, 2012, J BACTERIOL, V194, P6712, DOI 10.1128/JB.01169-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nesbitt NM, 2010, INFECT IMMUN, V78, P275, DOI 10.1128/IAI.00893-09; Petrusma M, 2009, APPL ENVIRON MICROB, V75, P5300, DOI 10.1128/AEM.00066-09; Petrusma M, 2012, J BACTERIOL, V194, P115, DOI 10.1128/JB.05838-11; Petrusma M, 2011, J BACTERIOL, V193, P3931, DOI 10.1128/JB.00274-11; Sambrook J., 2002, MOL CLONING LAB MANU; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Swain K, 2012, J BACTERIOL, V194, P6720, DOI 10.1128/JB.01167-12; Tarasev M, 2006, BIOCHEMISTRY-US, V45, P10208, DOI 10.1021/bi060219b; Thomas ST, 2011, J BIOL CHEM, V286, P43668, DOI 10.1074/jbc.M111.313643; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200; Wollam J, 2011, ANNU REV BIOCHEM, V80, P885, DOI 10.1146/annurev-biochem-081308-165917; Yang TC, 2003, J AM CHEM SOC, V125, P7056, DOI 10.1021/ja0214126	50	21	25	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25523	25536		10.1074/jbc.M114.575886	http://dx.doi.org/10.1074/jbc.M114.575886			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25049233	hybrid, Green Published			2022-12-28	WOS:000342130800014
J	De Houwer, S; Demeulemeester, J; Thys, W; Rocha, S; Dirix, L; Gijsbers, R; Christ, F; Debyser, Z				De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Rocha, Susana; Dirix, Lieve; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger			The HIV-1 Integrase Mutant R263A/K264A Is 2-fold Defective for TRN-SR2 Binding and Viral Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINAL DOMAIN; TRANSPORTIN 3; INFECTION; REPLICATION; DNA; TNPO3; IDENTIFICATION; COMPLEX; PROTEIN	Transportin-SR2 (Tnpo3, TRN-SR2), a human karyopherin encoded by the TNPO3 gene, has been identified as a cellular cofactor of HIV-1 replication, specifically interacting with HIV-1 integrase (IN). Whether this interaction mediates the nuclear import of HIV remains controversial. We previously characterized the TRN-SR2 binding interface in IN and introduced mutations at these positions to corroborate the biological relevance of the interaction. The pleiotropic nature of IN mutations complicated the interpretation. Indeed, all previously tested IN interaction mutants also affected RT. Here we report on a virus with a pair of IN mutations, INR263A/K264A, that significantly reduce interaction with TRN-SR2. The virus retains wild-type reverse transcription activity but displays a block in nuclear import and integration, as measured by quantitative PCR. The defect in integration of this mutant resulted in a smaller increase in the number of two-long terminal repeat circles than for virus specifically blocked at integration by raltegravir or catalytic site mutations (IND64N/D116N/E152Q). Finally, using an eGFP-IN-labeled HIV fluorescence-based import assay, the defect in nuclear import was corroborated. These data altogether underscore the importance of the HIV-IN TRN-SR2 protein-protein interaction for HIV nuclear import and validate the IN/TRN-SR2 interaction interface as a promising target for future antiviral therapy.	[De Houwer, Stephanie; Demeulemeester, Jonas; Thys, Wannes; Rocha, Susana; Dirix, Lieve; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium.	zeger.debyser@med.kuleuven.be	Christ, Frauke/H-7513-2018; Rocha, Susana/O-7622-2016; Demeulemeester, Jonas/J-6130-2014; Rocha, Susana/AAH-8343-2020; debyser, zeger/H-1310-2013	Rocha, Susana/0000-0003-1258-9396; Demeulemeester, Jonas/0000-0002-2660-2478; Rocha, Susana/0000-0003-1258-9396; Christ, Frauke/0000-0001-9580-3874; debyser, zeger/0000-0002-3982-1565	Research Foundation Flanders [G.0487.10N]; IAP BelVir; FP7 CHAARM; KU Leuven BOF	Research Foundation Flanders(FWO); IAP BelVir; FP7 CHAARM; KU Leuven BOF	This work was supported by Grant G.0487.10N from the Research Foundation Flanders and grants from the IAP BelVir, FP7 CHAARM, and the KU Leuven BOF.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Cribier A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-104; De Houwer S, 2012, J BIOL CHEM, V287, P34059, DOI 10.1074/jbc.M112.387944; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Debyser Z, 2000, METH MOL B, V160, P139; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fricke T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-46; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hearps AC, 2006, BIOCHEM J, V398, P475, DOI 10.1042/BJ20060466; Jayappa KD, 2011, J MOL BIOL, V410, P847, DOI 10.1016/j.jmb.2011.04.011; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Lu R, 2005, J VIROL, V79, P10356, DOI 10.1128/JVI.79.16.10356-10368.2005; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Nakajima N, 2001, J VIROL, V75, P7944, DOI 10.1128/JVI.75.17.7944-7955.2001; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Piller SC, 2003, CURR DRUG TARGETS, V4, P409, DOI 10.2174/1389450033490984; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Taltynov O, 2013, J BIOL CHEM, V288, P25603, DOI 10.1074/jbc.M113.484345; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Tsirkone VG, 2014, ACTA CRYSTALLOGR F, V70, P723, DOI 10.1107/S2053230X14009492; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	61	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25351	25361		10.1074/jbc.M113.533281	http://dx.doi.org/10.1074/jbc.M113.533281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063804	Green Published, hybrid			2022-12-28	WOS:000341985300053
J	Basu, RS; Warner, BA; Molodtsov, V; Pupov, D; Esyunina, D; Fernandez-Tornero, C; Kulbachinskiy, A; Murakami, KS				Basu, Ritwika S.; Warner, Brittany A.; Molodtsov, Vadim; Pupov, Danil; Esyunina, Daria; Fernandez-Tornero, Carlos; Kulbachinskiy, Andrey; Murakami, Katsuhiko S.			Structural Basis of Transcription Initiation by Bacterial RNA Polymerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Promoter; RNA Polymerase; Transcription; Transcription Initiation Factor; X-ray Crystallography	II-TFIIB COMPLEX; SIGMA-SUBUNIT; X-RAY; ACTIVE-CENTER; ABORTIVE INITIATION; PROMOTER CLEARANCE; GENE-EXPRESSION; SPECIFICITY; NUCLEOTIDE; MECHANISM	Background: Cellular RNA polymerases start transcription by de novo RNA priming. Results: Structures and biochemical studies of initially transcribing complexes elucidate the de novo transcription initiation and early stage of RNA transcription. Conclusion: 5-end of RNA in the transcribing complex starts sigma ejection from core enzyme. Significance: Insights from this study can be applicable to all cellular RNA polymerases. The bacterial RNA polymerase (RNAP) holoenzyme containing sigma factor initiates transcription at specific promoter sites by de novo RNA priming, the first step of RNA synthesis where RNAP accepts two initiating ribonucleoside triphosphates (iNTPs) and performs the first phosphodiester bond formation. We present the structure of de novo transcription initiation complex that reveals unique contacts of the iNTPs bound at the transcription start site with the template DNA and also with RNAP and demonstrate the importance of these contacts for transcription initiation. To get further insight into the mechanism of RNA priming, we determined the structure of initially transcribing complex of RNAP holoenzyme with 6-mer RNA, obtained by in crystallo transcription approach. The structure highlights RNAP-RNA contacts that stabilize the short RNA transcript in the active site and demonstrates that the RNA 5-end displaces sigma region 3.2 from its position near the active site, which likely plays a key role in sigma ejection during the initiation-to-elongation transition. Given the structural conservation of the RNAP active site, the mechanism of de novo RNA priming appears to be conserved in all cellular RNAPs.	[Basu, Ritwika S.; Warner, Brittany A.; Molodtsov, Vadim; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Fernandez-Tornero, Carlos] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Pupov, Danil; Esyunina, Daria; Kulbachinskiy, Andrey] Russian Acad Sci, Inst Mol Genet, Lab Mol Genet Microorganisms, Moscow 123182, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Russian Academy of Sciences	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu	Fernandez-Tornero, Carlos/I-6888-2015; Fernandez-Tornero, Carlos/AAV-8028-2021; Esyunina, Daria/L-7604-2018; Pupov, Danil/CAF-6818-2022; Kulbachinskiy, Andrey/P-5401-2016	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Kulbachinskiy, Andrey/0000-0002-2292-6424; Molodtsov, Vadim/0000-0003-3002-4794; Esyunina, Daria/0000-0002-3706-4425; Pupov, Danil/0000-0003-4961-6888; Basu, Ritwika/0000-0001-6410-7905; Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health [GM087350-A1]; Spanish government [BFU2010-16336]; Russian Foundation for Basic Research [14-04-01696, 14-04-31994]; Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish government(Spanish GovernmentEuropean Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087350-A1 (to K. S. M.). This work was also supported in part by the Spanish government through Grant BFU2010-16336 (to C. F.-T.). This work was also supported by the Russian Foundation for Basic Research (Grants 14-04-01696 and 14-04-31994) and the Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to A. K.).	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen YY, 2011, J AM CHEM SOC, V133, P12544, DOI 10.1021/ja201557w; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cortes T, 2013, CELL REP, V5, P1121, DOI 10.1016/j.celrep.2013.10.031; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gleghorn ML, 2011, P NATL ACAD SCI USA, V108, P3566, DOI 10.1073/pnas.1016691108; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pupov D, 2014, NUCLEIC ACIDS RES, V42, P4494, DOI 10.1093/nar/gkt1384; Pupov D, 2010, NUCLEIC ACIDS RES, V38, P5784, DOI 10.1093/nar/gkq355; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zhang Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02450; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	42	106	107	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24549	24559		10.1074/jbc.M114.584037	http://dx.doi.org/10.1074/jbc.M114.584037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24973216	Green Published, hybrid			2022-12-28	WOS:000341505600046
J	Burgie, ES; Wang, T; Bussell, AN; Walker, JM; Li, HL; Vierstra, RD				Burgie, E. Sethe; Wang, Tong; Bussell, Adam N.; Walker, Joseph M.; Li, Huilin; Vierstra, Richard D.			Crystallographic and Electron Microscopic Analyses of a Bacterial Phytochrome Reveal Local and Global Rearrangements during Photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Photomorphogenesis; Photoreceptor; Phototransduction; Plant Biochemistry; Protein Structure; X-ray Crystallography; Bilin; Photoconversion; Phytochrome	PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; CRYSTAL-STRUCTURE; GROUND-STATE; BILIVERDIN CHROMOPHORE; PLANT PHYTOCHROME; LIGHT; CYANOBACTERIOCHROMES; PHOTORECEPTORS; TRANSDUCTION	Background: Phytochromes are dimeric bili-proteins central to photoperception by plants and microorganisms. Results: An informative perspective on photoconversion from the dark-adapted to the photoactivated state was provided by crystallographic and electron microscopic analyses of a bacterial version. Conclusion: Light-induced conformational changes in the bilin induce a large scale reorientation of the sister output modules. Significance: The structures offer a model for signal transmission by phytochromes. Phytochromes are multidomain photoswitches that drive light perception in plants and microorganisms by coupling photoreversible isomerization of their bilin chromophore to various signaling cascades. How changes in bilin conformation affect output by these photoreceptors remains poorly resolved and might include several species-specific routes. Here, we present detailed three-dimensional models of the photosensing module and a picture of an entire dimeric photoreceptor through structural analysis of the Deinococcus radiodurans phytochrome BphP assembled with biliverdin (BV). A 1.16- resolution crystal structure of the bilin-binding pocket in the dark-adapted red light-absorbing state illuminated the intricate network of bilin/protein/water interactions and confirmed the protonation and ZZZssa conformation of BV. Structural and spectroscopic comparisons with the photochemically compromised D207A mutant revealed that substitutions of Asp-207 allow inclusion of cyclic porphyrins in addition to BV. A crystal structure of the entire photosensing module showed a head-to-head, twisted dimeric arrangement with bowed helical spines and a hairpin protrusion connecting the cGMP phosphodiesterase/adenylyl cyclase/FhlA (GAF) and phytochrome-specific (PHY) domains. A key conserved hairpin feature is its anti-parallel, two -strand stem, which we show by mutagenesis to be critical for BphP photochemistry. Comparisons of single particle electron microscopic images of the full-length BphP dimer in the red light-absorbing state and the photoactivated far-red light-absorbing state revealed a large scale reorientation of the PHY domain relative to the GAF domain, which alters the position of the downstream histidine kinase output module. Together, our data support a toggle model whereby bilin photoisomerization alters GAF/PHY domain interactions through conformational modification of the hairpin, which regulates signaling by impacting the relationship between sister output modules.	[Burgie, E. Sethe; Bussell, Adam N.; Walker, Joseph M.; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Wang, Tong; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu		Li, Huilin/0000-0001-8085-8928	National Institutes of Health [R01 AI070285]; National Science Foundation [MCB-1329956]; Brookhaven National Laboratory Laboratory [10-16]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brookhaven National Laboratory Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI070285 (to H. L.). This work was also supported by National Science Foundation Grant MCB-1329956 (to R. D. V.) and Brookhaven National Laboratory Laboratory-directed Research Project 10-16.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Bussell A.N., 2014, CELL BIOL CYANOBACTE, P149; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornilescu CC, 2014, J BIOL CHEM, V289, P3055, DOI 10.1074/jbc.M113.531053; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Rockwell NC, 2013, P NATL ACAD SCI USA, V110, P806, DOI 10.1073/pnas.1220690110; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892	50	77	78	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24573	24587		10.1074/jbc.M114.571661	http://dx.doi.org/10.1074/jbc.M114.571661			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006244	Green Published, hybrid			2022-12-28	WOS:000341505600048
J	Knyazev, DG; Winter, L; Bauer, BW; Siligan, C; Pohl, P				Knyazev, Denis G.; Winter, Lukas; Bauer, Benedikt W.; Siligan, Christine; Pohl, Peter			Ion Conductivity of the Bacterial Translocation Channel SecYEG Engaged in Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Lipid Bilayer; Membrane Transport; Membrane Transporter Reconstitution; Protein Translocation; Proton Motive Force	PROTEIN TRANSLOCATION; ESCHERICHIA-COLI; PLUG DOMAIN; SMALL MOLECULES; WATER CHANNEL; VOLTAGE-CLAMP; SECA ATPASE; MEMBRANE; PERMEABILITY; CONDUCTANCE	Background: How SecYEG excludes ions during protein translocation is not known. Results: SecYEG gating is voltage-sensitive. Conclusion: Voltage minimizes the ion leak that is induced by stalling a translocation intermediate. Significance: Preservation of the proton motif force requires voltage-driven conformational changes. While engaged in protein transport, the bacterial translocon SecYEG must maintain the membrane barrier to small ions. The preservation of the proton motif force was attributed to (i) cation exclusion, (ii) engulfment of the nascent chain by the hydrophobic pore ring, and (iii) a half-helix partly plugging the channel. In contrast, we show here that preservation of the proton motif force is due to a voltage-driven conformational change. Preprotein or signal peptide binding to the purified and reconstituted SecYEG results in large cation and anion conductivities only when the membrane potential is small. Physiological values of membrane potential close the activated channel. This voltage-dependent closure is not dependent on the presence of the plug domain and is not affected by mutation of 3 of the 6 constriction residues to glycines. Cellular ion homeostasis is not challenged by the small remaining leak conductance.	[Knyazev, Denis G.; Winter, Lukas; Bauer, Benedikt W.; Siligan, Christine; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria	Johannes Kepler University Linz	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Pohl, Peter/A-5361-2008; Knyazev, Denis G/E-5045-2019	Pohl, Peter/0000-0002-1792-2314; Knyazev, Denis G/0000-0003-3197-1849	Austrian Science Fund (FWF) [P20872]; Austrian Science Fund (FWF) [P 20872] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P20872 from the Austrian Science Fund (FWF) (to P. P.).	ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kannan P, 2009, INDIAN J BIOCHEM BIO, V46, P261; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Saparov SM, 2000, BIOPHYS J, V79, P2526, DOI 10.1016/S0006-3495(00)76493-9; Saparov SM, 2005, BIOL CELL, V97, P545; SCHIEBEL E, 1992, J BIOL CHEM, V267, P7505; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WOODBURY DJ, 1988, BIOPHYS J, V54, P1053, DOI 10.1016/S0006-3495(88)83042-X; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182	28	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24611	24616		10.1074/jbc.M114.588491	http://dx.doi.org/10.1074/jbc.M114.588491			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25016015	Green Published, hybrid			2022-12-28	WOS:000341505600051
J	Ouyang, C; Nie, L; Gu, MD; Wu, AL; Han, X; Wang, XJ; Shao, JZ; Xia, ZP				Ouyang, Chuan; Nie, Li; Gu, Meidi; Wu, Ailing; Han, Xu; Wang, Xiaojian; Shao, Jianzhong; Xia, Zongping			Transforming Growth Factor (TGF)-beta-activated Kinase 1 (TAK1) Activation Requires Phosphorylation of Serine 412 by Protein Kinase A Catalytic Subunit alpha (PKAC alpha) and X-linked Protein Kinase (PRKX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Innate Immunity; Mitogen-activated Protein Kinase (MAPK); NF-kappaB; Protein Kinase A (PKA); Serine; Threonine Protein Kinase; Toll-like Receptor (TLR); Tumor Necrosis Factor (TNF); IL-1R; TAK1	NF-KAPPA-B; AMP-INDEPENDENT ACTIVATION; SIGNALING PATHWAYS; POLYUBIQUITIN CHAINS; ADAPTER PROTEIN; IN-VIVO; TAB2; ZEBRAFISH; INNATE; EVOLUTION	Background: Understanding of molecular mechanism of TAK1 activation is incomplete. Results: PKAC and PRKX phosphorylate TAK1 at serine 412 to regulate TAK1 activation in the IL-1 receptor (IL-1R) and Toll-like receptor (TLR) signaling pathways. Conclusion: TAK1 activation requires phosphorylation by PKAC and PRKX. Significance: This study advanced our understanding of the molecular mechanism of TAK1 activation. TGF--activated kinase 1 (TAK1) is a key kinase in mediating Toll-like receptors (TLRs) and interleukin-1 receptor (IL-1R) signaling. Although TAK1 activation involves the phosphorylation of Thr-184 and Thr-187 residues at the activation loop, the molecular mechanism underlying the complete activation of TAK1 remains elusive. In this work, we show that the Thr-187 phosphorylation of TAK1 is regulated by its C-terminal coiled-coil domain-mediated dimerization in an autophosphorylation manner. Importantly, we find that TAK1 activation in mediating downstream signaling requires an additional phosphorylation at Ser-412, which is critical for TAK1 response to proinflammatory stimuli, such as TNF-, LPS, and IL-1. In vitro kinase and shRNA-based knockdown assays reveal that TAK1 Ser-412 phosphorylation is regulated by cAMP-dependent protein kinase catalytic subunit (PKAC) and X-linked protein kinase (PRKX), which is essential for proper signaling and proinflammatory cytokine induction by TLR/IL-1R activation. Morpholino-based in vivo knockdown and rescue studies show that the corresponding site Ser-391 in zebrafish TAK1 plays a conserved role in NF-B activation. Collectively, our data unravel a previously unknown mechanism involving TAK1 phosphorylation mediated by PKAC and PRKX that contributes to innate immune signaling.	[Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Ouyang, Chuan; Wu, Ailing; Han, Xu; Xia, Zongping] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Nie, Li; Shao, Jianzhong] Zhejiang Univ, Sch Med, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gu, Meidi; Wang, Xiaojian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	wangxiaojian@cad.zju.edu.cn; shaojz@zju.edu.cn; xia2010@zju.edu.cn		Ouyang, Chuan/0000-0003-1667-191X	National Basic Research Program of China (973) Grants [2013CB945004, 2011CB910800]; National Natural Science Foundation of China Grant [31071242]; Natural Science Foundation of Zhejiang Province Grant [R2110588]	National Basic Research Program of China (973) Grants(National Basic Research Program of China); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province Grant(Natural Science Foundation of Zhejiang Province)	This work was supported by National Basic Research Program of China (973) Grants 2013CB945004 and 2011CB910800, National Natural Science Foundation of China Grant 31071242, and Natural Science Foundation of Zhejiang Province Grant R2110588.	Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dulin NO, 2001, J BIOL CHEM, V276, P20827, DOI 10.1074/jbc.C100195200; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Gu MD, 2014, J IMMUNOL, V192, P2846, DOI 10.4049/jimmunol.1302537; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; van der Vaart Michiel, 2012, Adv Hematol, V2012, P159807, DOI 10.1155/2012/159807; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiong R, 2012, J IMMUNOL, V188, P2653, DOI 10.4049/jimmunol.1100959; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zieger M, 2001, BIOCHEM BIOPH RES CO, V282, P952, DOI 10.1006/bbrc.2001.4683	35	34	35	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24226	24237		10.1074/jbc.M114.559963	http://dx.doi.org/10.1074/jbc.M114.559963			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028512	Green Published, hybrid			2022-12-28	WOS:000341505600020
J	Roret, T; Tsan, P; Couturier, J; Zhang, B; Johnson, MK; Rouhier, N; Didierjean, C				Roret, Thomas; Tsan, Pascale; Couturier, Jeremy; Zhang, Bo; Johnson, Michael K.; Rouhier, Nicolas; Didierjean, Claude			Structural and Spectroscopic Insights into BolA-Glutaredoxin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutathione; Iron Metabolism; Iron-Sulfur Protein; Redox Regulation; Thiol; BolA; Complexes; Glutaredoxin	MONOTHIOL GLUTAREDOXINS; RESONANCE RAMAN; IRON; CLUSTER; PROTEIN; RIESKE; SYSTEM; STRESS; LIGAND; GRX4	Background: BolA and glutaredoxin interact together in the iron metabolism. Results: They form two types of heterodimers with different binding surfaces depending on the presence or absence of an iron-sulfur cluster. Conclusion: The function of both proteins is likely modulated by the nature of the interaction. Significance: Understanding the molecular mechanisms responsible for iron sensing is crucial for all iron-mediated cellular processes. BolA proteins are defined as stress-responsive transcriptional regulators, but they also participate in iron metabolism. Although they can form [2Fe-2S]-containing complexes with monothiol glutaredoxins (Grx), structural details are lacking. Three Arabidopsis thaliana BolA structures were solved. They differ primarily by the size of a loop referred to as the variable [H/C] loop, which contains an important cysteine (BolA_C group) or histidine (BolA_H group) residue. From three-dimensional modeling and spectroscopic analyses of A. thaliana GrxS14-BolA1 holo-heterodimer (BolA_H), we provide evidence for the coordination of a Rieske-type [2Fe-2S] cluster. For BolA_C members, the cysteine could replace the histidine as a ligand. NMR interaction experiments using apoproteins indicate that a completely different heterodimer was formed involving the nucleic acid binding site of BolA and the C-terminal tail of Grx. The possible biological importance of these complexes is discussed considering the physiological functions previously assigned to BolA and to Grx-BolA or Grx-Grx complexes.	[Roret, Thomas; Tsan, Pascale; Didierjean, Claude] Univ Lorraine, F-54506 Vandoeuvre Les Nancy, France; [Roret, Thomas; Tsan, Pascale; Didierjean, Claude] CNRS, BioMod Grp, UMR 7036 CRM2, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Rouhier, Nicolas] Univ Lorraine, UMR Interact Arbres Microorganismes 1136, F-54500 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Rouhier, Nicolas] INRA, UMR Interact Arbres Microorganismes 1136, F-54280 Champenoux, France; [Zhang, Bo; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Zhang, Bo; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Universite de Lorraine; INRAE; Universite de Lorraine; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Didierjean, C (corresponding author), Univ Lorraine, BioMod Grp, UMR7036 CRM2, F-54506 Vandoeuvre Les Nancy, France.	claude.didierjean@univ-lorraine.fr	Couturier, Jérémy/AAF-6588-2020; DIDIERJEAN, Claude/L-1493-2013	Couturier, Jérémy/0000-0003-3127-2669; DIDIERJEAN, Claude/0000-0002-3176-8974; tsan, pascale/0000-0002-0218-0258; Rouhier, Nicolas/0000-0002-2036-7884	ANR as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE) [2010BLAN1616, ANR-11-LABX-0002-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524] Funding Source: NIH RePORTER	ANR as part of the "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a grant overseen by ANR (Grant 2010BLAN1616) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BERTRAND P, 1985, BIOCHIM BIOPHYS ACTA, V831, P261, DOI 10.1016/0167-4838(85)90044-5; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Couturier J, 2014, MOL PLANT, V7, P187, DOI 10.1093/mp/sst156; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Iwasaki T, 2004, J AM CHEM SOC, V126, P4788, DOI 10.1021/ja031976p; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Johansson C, 2011, BIOCHEM J, V433, P303, DOI 10.1042/BJ20101286; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kounosu A, 2004, J BIOL CHEM, V279, P12519, DOI 10.1074/jbc.M305923200; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li LN, 2010, ACTA CRYSTALLOGR D, V66, P725, DOI 10.1107/S0907444910013119; Li ST, 2011, PLANT PHYSIOL, V157, P2056, DOI 10.1104/pp.111.185199; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rotsaert FAJ, 2003, J BIOL INORG CHEM, V8, P318, DOI 10.1007/s00775-002-0417-4; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Shukla M., 2012, PLOS ONE, V7, P1; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Willems P, 2013, ANTIOXID REDOX SIGN, V18, P129, DOI 10.1089/ars.2011.4253; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yeung N, 2011, BIOCHEMISTRY-US, V50, P8957, DOI 10.1021/bi2008883	58	37	41	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24588	24598		10.1074/jbc.M114.572701	http://dx.doi.org/10.1074/jbc.M114.572701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25012657	Green Published, hybrid			2022-12-28	WOS:000341505600049
J	Roose, JL; Frankel, LK; Bricker, TM				Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.			The PsbP Domain Protein 1 Functions in the Assembly of Lumenal Domains in Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Membrane Protein; Photosynthesis; Plant Biochemistry; Protein Assembly; Photosystem I	SYNECHOCOCCUS SP PCC-7002; ARABIDOPSIS-THALIANA; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC ACCLIMATION; PHOTOAUTOTROPHIC GROWTH; HIGHER-PLANTS; SUBUNIT; GENE; PSI; INACTIVATION	Background: The assembly of Photosystem I requires additional protein factors. Results:Arabidopsis RNAi mutants of PPD1 were characterized for Photosystem I function and assembly. Conclusion: The PPD1 protein serves as a factor to facilitate functional assembly of Photosystem I. Significance: RNAi suppression of PPD1 provides new details on its function in Photosystem I assembly. Photosystem I (PS I) is a multisubunit membrane protein complex that functions as a light-driven plastocyanin-ferredoxin oxidoreductase. The PsbP domain protein 1 (PPD1; At4g15510) is located in the thylakoid lumen of plant chloroplasts and is essential for photoautotrophy, functioning as a PS I assembly factor. In this work, RNAi was used to suppress PPD1 expression, yielding mutants displaying a range of phenotypes with respect to PS I accumulation and function. These PPD1 RNAi mutants showed a loss of assembled PS I that was correlated with loss of the PPD1 protein. In the most severely affected PPD1 RNAi lines, the accumulated PS I complexes exhibited defects in electron transfer from plastocyanin to the oxidized reaction center P-700(+). The defects in PS I assembly in the PPD1 RNAi mutants also had secondary effects with respect to the association of light-harvesting antenna complexes to PS I. Because of the imbalance in photosystem function in the PPD1 RNAi mutants, light-harvesting complex II associated with and acted as an antenna for the PS I complexes. These results provide new evidence for the role of PPD1 in PS I biogenesis, particularly as a factor essential for proper assembly of the lumenal portion of the complex.	[Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.).	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Bricker TM, 2013, PHOTOSYNTH RES, V116, P235, DOI 10.1007/s11120-013-9820-7; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; Dietzel L, 2008, FEBS J, V275, P1080, DOI 10.1111/j.1742-4658.2008.06264.x; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hohmann-Marriott MF, 2010, FEBS LETT, V584, P1021, DOI 10.1016/j.febslet.2010.01.052; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Ihnatowicz A, 2004, PLANT J, V37, P839, DOI 10.1111/j.1365-313X.2004.02011.x; Ihnatowicz A, 2007, PLANTA, V226, P889, DOI 10.1007/s00425-007-0534-y; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naver H, 2001, PLANT CELL, V13, P2731, DOI 10.1105/tpc.010253; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Ozawa S, 2010, J BIOL CHEM, V285, P20072, DOI 10.1074/jbc.M109.098954; Pesaresi P, 2010, PLANT SIGNAL BEHAV, V5, P21, DOI 10.4161/psb.5.1.10198; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yi XP, 2008, PHOTOSYNTH RES, V98, P439, DOI 10.1007/s11120-008-9352-8	43	14	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23776	23785		10.1074/jbc.M114.589085	http://dx.doi.org/10.1074/jbc.M114.589085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008325	hybrid, Green Published			2022-12-28	WOS:000341505000045
J	Wilson, KE; Li, YW; Yang, N; Shen, H; Orillion, AR; Zhang, JM				Wilson, Kayla E.; Li, Ying-Wei; Yang, Nuo; Shen, He; Orillion, Ashley R.; Zhang, Jianmin			PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Migration; Epithelial-Mesenchymal Transition (EMT); Protein Phosphatase; Protein-Protein Interaction	HIPPO SIGNALING PATHWAY; TYROSINE-PHOSPHATASE PEZ; TUMOR-SUPPRESSOR LATS1; COLORECTAL CANCERS; CELL-PROLIFERATION; SIZE CONTROL; DROSOPHILA; KINASE; BETA; INDUCTION	Background: Transcriptional co-activators YAP/TAZ are pivotal effectors of the Hippo pathway and their dysfunction promote epithelial-to-mesenchymal transition (EMT) and malignant transformation. Results: PTPN14 interacts with Kibra and activates LATS1 (upstream negative regulator of YAP). Conclusion: PTPN14 and Kibra activate LATS1 and negatively regulate the YAP oncogenic function. Significance: Study of the YAP regulatory mechanism is crucial for understanding its role in the physiological and pathological processes. The Hippo signaling pathway regulates cellular proliferation and survival, thus exerting profound effects on normal cell fate and tumorigenesis. Pivotal effectors of this pathway are YAP/TAZ, transcriptional co-activators whose dysfunction contributes to epithelial-to-mesenchymal transition and malignant transformation. Therefore, it is of great importance to decipher the mechanisms underlying the regulations of YAP/TAZ at various levels. Here we report that non-receptor tyrosine phosphatase 14 (PTPN14) interacts with the Kibra protein. The interaction between PTPN14 and Kibra is through the PPXY domain of PTPN14 and WW domain of Kibra. PTPN14 and Kibra can induce the LATS1 activation independently and cooperatively. Interestingly, activation of LATS1 by PTPN14 is dependent on the C terminus of PTPN14 and independent of the upstream mammalian STE20-like kinase (MST) proteins. Furthermore, we demonstrate that PTPN14 increases the LAST1 protein stability. Last, overexpression of Kibra rescues the increased cell migration and aberrant three-dimensional morphogenesis induced by knockdown of PTPN14, and this rescue is mediated through the activation of the upstream LATS1 kinase and subsequent cytoplasmic sequestration of YAP. In summary, our results indicate a potential regulatory role of PTPN14 in the Hippo pathway and demonstrate another layer of regulation in the YAP oncogenic function.	[Wilson, Kayla E.; Li, Ying-Wei; Yang, Nuo; Shen, He; Zhang, Jianmin] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Orillion, Ashley R.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Zhang, JM (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St, Buffalo, NY 14263 USA.	jianmin.zhang@roswellpark.org	Zhang, Jianmin/AAN-2931-2020		American Cancer Society Institutional Grant (ACS-IRG); Roswell Park Alliance Grant; National Institutes of Health through the NCI [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	American Cancer Society Institutional Grant (ACS-IRG)(American Cancer Society); Roswell Park Alliance Grant; National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an American Cancer Society Institutional Grant (ACS-IRG) to Roswell Park Cancer Institute (RPCI), a Roswell Park Alliance Grant, and National Institutes of Health Grant P30 CA016056 through the NCI (to J. Z.).	Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Lin JI, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003813; Liu X, 2013, ONCOGENE, V32, P1266, DOI 10.1038/onc.2012.147; Michaloglou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061916; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Niedergethmann M, 2007, BRIT J CANCER, V97, P1432, DOI 10.1038/sj.bjc.6604031; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SMITH AL, 1995, BIOCHEM BIOPH RES CO, V209, P959, DOI 10.1006/bbrc.1995.1591; Varelas X, 2012, TRENDS CELL BIOL, V22, P88, DOI 10.1016/j.tcb.2011.10.002; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wadham C, 2000, J CELL SCI, V113, P3117; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wyatt L, 2007, J CELL BIOL, V178, P1223, DOI 10.1083/jcb.200705035; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	40	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23693	23700		10.1074/jbc.M113.534701	http://dx.doi.org/10.1074/jbc.M113.534701			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023289	Green Published, hybrid			2022-12-28	WOS:000341505000037
J	Eller, CH; Lomax, JE; Raines, RT				Eller, Chelcie H.; Lomax, Jo E.; Raines, Ronald T.			Bovine Brain Ribonuclease Is the Functional Homolog of Human Ribonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC RIBONUCLEASE; DOUBLE-STRANDED-RNA; DIFFERENTIAL SCANNING FLUOROMETRY; SEMINAL RIBONUCLEASE; ENDOTHELIAL-CELLS; EXTRACELLULAR RNA; ANTITUMOR-ACTIVITY; HIGH-THROUGHPUT; EXPRESSION; PROTEIN	Mounting evidence suggests that human pancreatic ribonuclease (RNase 1) plays important roles in vivo, ranging from regulating blood clotting and inflammation to directly counteracting tumorigenic cells. Understanding these putative roles has been pursued with continual comparisons of human RNase 1 to bovine RNase A, an enzyme that appears to function primarily in the ruminant gut. Our results imply a different physiology for human RNase 1. We demonstrate distinct functional differences between human RNase 1 and bovine RNase A. Moreover, we characterize another RNase 1 homolog, bovine brain ribonuclease, and find pronounced similarities between that enzyme and human RNase 1. We report that human RNase 1 and bovine brain ribonuclease share high catalytic activity against double-stranded RNA substrates, a rare quality among ribonucleases. Both human RNase 1 and bovine brain RNase are readily endocytosed by mammalian cells, aided by tight interactions with cell surface glycans. Finally, we show that both human RNase 1 and bovine brain RNase are secreted from endothelial cells in a regulated manner, implying a potential role in vascular homeostasis. Our results suggest that brain ribonuclease, not RNase A, is the true bovine homolog of human RNase 1, and provide fundamental insight into the ancestral roles and functional adaptations of RNase 1 in mammals.	[Eller, Chelcie H.; Raines, Ronald T.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Raines, Ronald T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Lomax, Jo E.] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Raines, RT (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	rtraines@wisc.edu	Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	National Institutes of Health [R01 CA073808]; National Science Foundation Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA073808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA073808.; Supported by an National Science Foundation Graduate Research Fellowship.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AlZahal O, 2008, J DAIRY SCI, V91, P202, DOI 10.3168/jds.2007-0535; Antignani A, 2001, BIOCHEMISTRY-US, V40, P3492, DOI 10.1021/bi002781m; BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; Barrabes S, 2007, GLYCOBIOLOGY, V17, P388, DOI 10.1093/glycob/cwm002; Beintema JJ, 2002, SCIENCE, V297, P1121; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; BRAVO J, 1994, ANAL BIOCHEM, V219, P82, DOI 10.1006/abio.1994.1234; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chao TY, 2011, BIOCHEMISTRY-US, V50, P8374, DOI 10.1021/bi2009079; Chao TY, 2010, BIOCHEMISTRY-US, V49, P10666, DOI 10.1021/bi1013485; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Confalone E, 1995, J MOL EVOL, V41, P850, DOI 10.1007/BF00173164; Cuchillo CM, 2011, BIOCHEMISTRY-US, V50, P7835, DOI 10.1021/bi201075b; D'Avino C, 2014, PROTEIN ENG DES SEL, V27, P83, DOI 10.1093/protein/gzt065; D'Errico G, 2011, BBA-BIOMEMBRANES, V1808, P3007, DOI 10.1016/j.bbamem.2011.08.009; DALESSIO G, 1991, TRENDS BIOCHEM SCI, V16, P104, DOI 10.1016/0968-0004(91)90042-T; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; DELROSAR.EJ, 1969, BIOCHEMISTRY-US, V8, P1884, DOI 10.1021/bi00833a017; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELSON M, 1975, BIOCHEMISTRY-US, V14, P1471, DOI 10.1021/bi00678a019; Esbjorner EK, 2007, BIOCHEMISTRY-US, V46, P13490, DOI 10.1021/bi701075y; Fischer S, 2013, CANCER RES, V73, P5080, DOI 10.1158/0008-5472.CAN-12-4657; Fischer S, 2011, THROMB HAEMOSTASIS, V105, P345, DOI 10.1160/TH10-06-0345; Haigis MC, 2003, J CELL SCI, V116, P313, DOI 10.1242/jcs.00214; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Johnson RJ, 2007, BIOCHEMISTRY-US, V46, P13131, DOI 10.1021/bi701521q; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; KATOH H, 1990, CARBOHYD RES, V195, P273, DOI 10.1016/0008-6215(90)84171-P; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Ladokhin AS, 1997, METHOD ENZYMOL, V278, P474; Landre JBP, 2002, J CELL BIOCHEM, V86, P540, DOI 10.1002/jcb.10234; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; Lee JE, 2005, BIOCHEMISTRY-US, V44, P15760, DOI 10.1021/bi051668z; Libonati M, 2001, METHOD ENZYMOL, V341, P234, DOI 10.1016/S0076-6879(01)41155-4; Lomax J. E., 2014, THESIS U TISONSIN MA; Lomax JE, 2014, J MOL BIOL, V426, P3041, DOI 10.1016/j.jmb.2014.06.007; Lomax JE, 2012, METHOD ENZYMOL, V502, P273, DOI 10.1016/B978-0-12-416039-2.00014-8; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; Matousek J, 2001, COMP BIOCHEM PHYS C, V129, P175, DOI 10.1016/S1532-0456(01)90202-9; MAZZARELLA L, 1987, GAZZ CHIM ITAL, V117, P91; Menzen T, 2013, J PHARM SCI-US, V102, P415, DOI 10.1002/jps.23405; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PETERSON LM, 1979, P NATL ACAD SCI USA, V76, P2630, DOI 10.1073/pnas.76.6.2630; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAPS G, 1947, J DAIRY SCI, V30, P933, DOI 10.3168/jds.S0022-0302(47)92421-1; RIBO M, 1994, BIOL CHEM H-S, V375, P357; Rutkoski TJ, 2008, CURR PHARM BIOTECHNO, V9, P185, DOI 10.2174/138920108784567344; Rutkoski TJ, 2013, TRANSL ONCOL, V6, P392, DOI 10.1593/tlo.13253; SASSO MP, 1991, NUCLEIC ACIDS RES, V19, P6469, DOI 10.1093/nar/19.23.6469; Satkunanathan S, 2014, J VIROL, V88, P2366, DOI 10.1128/JVI.02789-13; Simsekyilmaz S, 2014, CIRCULATION, V129, P598, DOI 10.1161/CIRCULATIONAHA.113.002562; SNOOK JT, 1965, J NUTR, V87, P297, DOI 10.1093/jn/87.3.297; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Strong L. E., 2012, J CLIN ONCOL S, V30, DOI 10.1158/1535-7163.targ-09-c42; Strong LE, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1838; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun XZ, 2013, J IMMUNOL, V190, P2536, DOI 10.4049/jimmunol.1202689; Sundlass NK, 2013, BIOCHEMISTRY-US, V52, P6304, DOI 10.1021/bi400619m; Vallee BL, 1997, CELL MOL LIFE SCI, V53, P803, DOI 10.1007/s000180050101; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; WATANABE H, 1988, J BIOCHEM-TOKYO, V104, P939, DOI 10.1093/oxfordjournals.jbchem.a122587; Wheeler TT, 2012, J MOL EVOL, V74, P237, DOI 10.1007/s00239-012-9502-7; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhao W, 2001, BBA-PROTEIN STRUCT M, V1547, P95, DOI 10.1016/S0167-4838(01)00173-X	77	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					25996	26006		10.1074/jbc.M114.566166	http://dx.doi.org/10.1074/jbc.M114.566166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25078100	Green Published, hybrid			2022-12-28	WOS:000342128800001
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB RECEPTORS; AUTOPHOSPHORYLATION SITES; KINASE ACTIVATION; CRYSTAL-STRUCTURE; BREAST-CANCER; MECHANISM; DOMAIN; BINDING; PROTEIN; IDENTIFICATION	The EGF receptor has seven different cognate ligands. Previous work has shown that these different ligands are capable of inducing different biological effects, even in the same cell. To begin to understand the molecular basis for this variation, we used luciferase fragment complementation to measure ligand-induced dimer formation and radioligand binding to study the effect of the ligands on subunit-subunit interactions in EGF receptor (EGFR) homodimers and EGFR/ErbB2 heterodimers. In luciferase fragment complementation imaging studies, amphiregulin (AREG) functioned as a partial agonist, inducing only about half as much total dimerization as the other three ligands. However, unlike the other ligands, AREG showed biphasic kinetics for dimer formation, suggesting that its path for EGF receptor activation involves binding to both monomers and preformed dimers. EGF, TGF alpha, and betacellulin (BTC) appear to mainly stimulate receptor activation through binding to and dimerization of receptor monomers. In radioligand binding assays, EGF and TGF alpha exhibited increased affinity for EGFR/ErbB2 heterodimers compared with EGFR homodimers. By contrast, BTC and AREG showed a similar affinity for both dimers. Thus, EGF and TGF alpha are biased agonists, whereas BTC and AREG are balanced agonists with respect to selectivity of dimer formation. These data suggest that the differences in biological response to different EGF receptor ligands may result from partial agonism for dimer formation, differences in the kinetic pathway utilized to generate activated receptor dimers, and biases in the formation of heterodimers versus homodimers.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health receptor affinity [R01GM099695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695] Funding Source: NIH RePORTER	National Institutes of Health receptor affinity(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health receptor affinity. Grant R01GM099695 (to L. J. P.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Haslekas C, 2005, MOL BIOL CELL, V16, P5832, DOI 10.1091/mbc.E05-05-0456; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2012, J BIOL CHEM, V287, P31116, DOI 10.1074/jbc.M112.373647; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; SCHUH SM, 1994, MOL BIOL CELL, V5, P739, DOI 10.1091/mbc.5.7.739; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	68	71	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26178	26188		10.1074/jbc.M114.586826	http://dx.doi.org/10.1074/jbc.M114.586826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086039	Green Published, hybrid			2022-12-28	WOS:000342128800014
J	Tan, BH; Suzuki, Y; Takahashi, H; Ying, PHR; Takahashi, C; Han, Q; Chin, WX; Chao, SH; Sawasaki, T; Yamamoto, N; Suzuki, Y				Tan, Beng Hui; Suzuki, Yasutsugu; Takahashi, Hirotaka; Ying, Pamela Ho Rui; Takahashi, Chikako; Han, Qi'En; Chin, Wei Xin; Chao, Sheng-Hao; Sawasaki, Tatsuya; Yamamoto, Naoki; Suzuki, Youichi			Identification of RFPL3 Protein as a Novel E3 Ubiquitin Ligase Modulating the Integration Activity of Human Immunodeficiency Virus, Type 1 Preintegration Complex Using a Microtiter Plate-based Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RET FINGER PROTEIN; RETROVIRAL DNA INTEGRATION; HIV-1 INTEGRASE; IN-VITRO; SYNTHESIS SYSTEM; NUCLEOPROTEIN COMPLEX; VIRAL INTEGRATION; GENOME-WIDE; AUTOINTEGRATION; REPLICATION	Integration, one of the hallmarks of retrovirus replication, is mediated by a nucleoprotein complex called the preintegration complex (PIC), in which viral DNA is associated with many protein components that are required for completion of the early phase of infection. A striking feature of the PIC is its powerful integration activity in vitro. The PICs from a freshly isolated cytoplasmic extract of infected cells are able to insert viral DNA into exogenously added target DNA in vitro. Therefore, a PIC-based in vitro assay is a reliable system for assessing protein factors influencing retroviral integration. In this study, we applied a microtiter plate-based in vitro assay to a screening study using a protein library that was produced by the wheat germ cell-free protein synthesis system. Using a library of human E3 ubiquitin ligases, we identified RFPL3 as a potential stimulator of human immunodeficiency virus, type 1 (HIV-1) PIC integration activity in vitro. This enhancement of PIC activity by RFPL3 was likely to be attributed to its N-terminal RING domain. To further understand the functional role of RFPL3 in HIV infection, we created a human cell line overexpressing RFPL3. Immunoprecipitation analysis revealed that RFPL3 was associated with the human immunodeficiency virus, type 1 PICs in infected cells. More importantly, single-round HIV-1 infection was enhanced significantly by RFPL3 expression. Our proteomic approach displays an advantage in the identification of new cellular proteins affecting the integration activity of the PIC and, therefore, contributes to the understanding of functional interaction between retroviral integration complexes and host factors.	[Tan, Beng Hui; Suzuki, Yasutsugu; Takahashi, Hirotaka; Takahashi, Chikako; Han, Qi'En; Chin, Wei Xin; Yamamoto, Naoki; Suzuki, Youichi] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117599, Singapore; [Ying, Pamela Ho Rui; Suzuki, Youichi] Ngee Ann Polytech, Singapore 599489, Singapore; [Chao, Sheng-Hao] ASTAR, Express Engn Grp, Bioproc Technol Inst, Singapore 138668, Singapore; [Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan; [Suzuki, Youichi] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Ehime University; National University of Singapore	Yamamoto, N (corresponding author), Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, 14 Med Dr,15-02, Singapore 117599, Singapore.	micny@nus.edu.sg; californiacircle@gmail.com	Suzuki, Yasutsugu/Z-2378-2019	Suzuki, Yasutsugu/0000-0002-8202-3032; Sawasaki, Tatsuya/0000-0002-7952-0556; Suzuki, Youichi/0000-0003-3554-0755; CHIN, WEI-XIN/0000-0003-1582-6086	National Medical Research Council (Singapore) [NMRC/BNIG/1079/2012, NMRC/1273/2010]; National University of Singapore SoM Start-up Grants [R-182-000-160-733, R-182-000-160-133]; Healthcare Graduate Studies Award by Ministry of Health, Singapore	National Medical Research Council (Singapore)(National Medical Research Council, Singapore); National University of Singapore SoM Start-up Grants(National University of Singapore); Healthcare Graduate Studies Award by Ministry of Health, Singapore(Ministry of Health-Singapore)	This work was supported by National Medical Research Council (Singapore) Grants NMRC/BNIG/1079/2012 (to Y. S.) and NMRC/1273/2010 (to N. Y.) and by National University of Singapore SoM Start-up Grants R-182-000-160-733 and R-182-000-160-133 (to N. Y.).; Supported by Healthcare Graduate Studies Award by Ministry of Health, Singapore.	Al-Mawsawi LQ, 2007, TRENDS PHARMACOL SCI, V28, P526, DOI 10.1016/j.tips.2007.09.005; Allouch A, 2011, CELL HOST MICROBE, V9, P484, DOI 10.1016/j.chom.2011.05.004; Arribas JR, 2013, CURR OPIN HIV AIDS, V8, P341, DOI 10.1097/COH.0b013e328361fabd; Bonnefont J, 2008, AM J HUM GENET, V83, P208, DOI 10.1016/j.ajhg.2008.07.007; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Cao TY, 1998, J CELL SCI, V111, P1319; Carraher C, 2013, PROTEIN EXPRES PURIF, V90, P160, DOI 10.1016/j.pep.2013.06.002; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Devroe E, 2003, J CELL SCI, V116, P4401, DOI 10.1242/jcs.00747; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Grutter MG, 2012, CURR OPIN VIROL, V2, P142, DOI 10.1016/j.coviro.2012.02.003; Hansen MST, 1999, NAT BIOTECHNOL, V17, P578, DOI 10.1038/9886; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; ISOMURA T, 1992, NUCLEIC ACIDS RES, V20, P5305, DOI 10.1093/nar/20.20.5305; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kawano Y, 2004, J VIROL, V78, P11352, DOI 10.1128/JVI.78.20.11352-11359.2004; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Madono M, 2011, NEW BIOTECHNOL, V28, P211, DOI 10.1016/j.nbt.2010.08.009; Manganaro L, 2010, NAT MED, V16, P329, DOI 10.1038/nm.2102; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Miyakawa K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003212; Mizutani Y, 2013, J IMMUNOL METHODS, V387, P57, DOI 10.1016/j.jim.2012.09.011; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Raghavendra NK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-66; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2004, PHYTOCHEMISTRY, V65, P1549, DOI 10.1016/j.phytochem.2004.04.023; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2005, METH MOL B, V310, P131; Seroussi E, 1999, GENOME RES, V9, P803, DOI 10.1101/gr.9.9.803; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Suzuki Y, 2010, J BIOL CHEM, V285, P24032, DOI 10.1074/jbc.M110.116640; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023; Takahashi H, 2012, FEBS LETT, V586, P3134, DOI 10.1016/j.febslet.2012.08.014; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Zamborlini A, 2011, J BIOL CHEM, V286, P21013, DOI 10.1074/jbc.M110.189274; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zheng YF, 2013, VIRUSES-BASEL, V5, P1787, DOI 10.3390/v5071787; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739	63	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26368	26382		10.1074/jbc.M114.561662	http://dx.doi.org/10.1074/jbc.M114.561662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25107902	Green Published, hybrid			2022-12-28	WOS:000342128800029
J	Xu, HM; Tsang, KS; Wang, YH; Chan, JCN; Xu, G; Gao, WQ				Xu, Huiming; Tsang, Kam Sze; Wang, Yonghui; Chan, Juliana C. N.; Xu, Gang; Gao, Wei-Qiang			Unfolded Protein Response Is Required for the Definitive Endodermal Specification of Mouse Embryonic Stem Cells via Smad2 and beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; PRIMITIVE STREAK; DIFFERENTIATION; WNT; INDUCTION; GROWTH; FATE; MAINTENANCE	Tremendous efforts have been made to elucidate the molecular mechanisms that control the specification of definitive endoderm cell fate in gene knockout mouse models and ES cell (ESC) differentiation models. However, the impact of the unfolded protein response (UPR), because of the stress of the endoplasmic reticulum on endodermal specification, is not well addressed. We employed UPR-inducing agents, thapsigargin and tunicamycin, in vitro to induce endodermal differentiation of mouse ESCs. Apart from the endodermal specification of ESCs, Western blotting demonstrated the enhanced phosphorylation of Smad2 and nuclear translocation of beta-catenin in ESC-derived cells. The inclusion of the endoplasmic reticulum stress inhibitor tauroursodeoxycholic acid to the induction cultures prevented the differentiation of ESCs into definitive endodermal cells even when Activin A was supplemented. Also, the addition of the TGF-beta inhibitor SB431542 and the Wnt/beta-catenin antagonist IWP-2 negated the endodermal differentiation of ESCs mediated by thapsigargin and tunicamycin. These data suggest that the activation of the UPR appears to orchestrate the induction of the definitive endodermal cell fate of ESCs via both the Smad2 and beta-catenin signaling pathways. The prospective regulatory machinery may be helpful for directing ESCs to differentiate into definitive endodermal cells for cellular therapy in the future.	[Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes, Renji MedX Clin Stem Cell Res Ctr,Sch Med, Shanghai 200127, Peoples R China; [Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200127, Peoples R China; [Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200127, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Shenzhen Res Inst, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Rm 605, Hong Kong, Hong Kong, Peoples R China.	gangxu@cuhk.edu.hk; gao.weiqiang@sjtu.edu.cn	Chan, Juliana/B-7918-2016; Gao, Wei/GXH-0380-2022	Chan, Juliana/0000-0003-1325-1194; 	National Basic Research Program of China [2012CB967903, 2012CB966800, 2013CB945600]; National Natural Science Foundation of China [81270438, 81130038, 81372189]; Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Health Bureau Key Discipline and Specialty Foundation [J50208]; Shanghai Education Committee Key Discipline and Specialty Foundation; KC Wong Foundation	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Health Bureau Key Discipline and Specialty Foundation; Shanghai Education Committee Key Discipline and Specialty Foundation; KC Wong Foundation	This work was supported by grants from the National Basic Research Program of China (2012CB967903, 2012CB966800, and 2013CB945600), National Natural Science Foundation of China (81270438, 81130038, and 81372189), Science and Technology Commission of Shanghai Municipality (Pujiang program), Shanghai Health Bureau Key Discipline and Specialty Foundation (J50208), Shanghai Education Committee Key Discipline and Specialty Foundation, and KC Wong Foundation.	Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; CONLON FL, 1994, DEVELOPMENT, V120, P1919; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kim Peter T W, 2012, Results Probl Cell Differ, V55, P303, DOI 10.1007/978-3-642-30406-4_17; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2004, DEV BIOL, V270, P411, DOI 10.1016/j.ydbio.2004.03.017; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Reimold AM, 2000, GENE DEV, V14, P152; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; Treglia AS, 2012, HISTOL HISTOPATHOL, V27, P1, DOI 10.14670/HH-27.1; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2013, CELL TRANSPLANT, V22, P147, DOI 10.3727/096368912X653057; Yang L, 2005, J BIOL CHEM, V280, P31156, DOI 10.1074/jbc.M501069200; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	44	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26290	26301		10.1074/jbc.M114.572560	http://dx.doi.org/10.1074/jbc.M114.572560			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092289	Green Published, hybrid			2022-12-28	WOS:000342128800023
J	Bouvet, M; Lugari, A; Posthuma, CC; Zevenhoven, JC; Bernard, S; Betzi, S; Imbert, I; Canard, B; Guillemot, JC; Lecine, P; Pfefferle, S; Drosten, C; Snijder, EJ; Decroly, E; Morelli, X				Bouvet, Mickael; Lugari, Adrien; Posthuma, Clara C.; Zevenhoven, Jessika C.; Bernard, Stephanie; Betzi, Stephane; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Lecine, Patrick; Pfefferle, Susanne; Drosten, Christian; Snijder, Eric J.; Decroly, Etienne; Morelli, Xavier			Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; NONSTRUCTURAL PROTEIN NSP10; MOUSE HEPATITIS-VIRUS; RNA CAPPING APPARATUS; SARS-CORONAVIRUS; MESSENGER-RNA; MIDDLE-EAST; 2'-O METHYLATION; COV; TRANSCRIPTION	RNA- The RNA-synthesizing machinery of the severe acute respiratory syndrome Coronavirus (SARS-CoV) is composed of 16 nonstructural proteins (nsp1-16) encoded by ORF1a/1b. The 148-amino acid nsp10 subunit contains two zinc fingers and is known to interact with both nsp14 and nsp16, stimulating their respective 3'-5' exoribonuclease and 2'-O-methyltransferase activities. Using alanine-scanning mutagenesis, in cellulo bioluminescence resonance energy transfer experiments, and in vitro pulldown assays, we have now identified the key residues on the nsp10 surface that interact with nsp14. The functional consequences of mutations introduced at these positions were first evaluated biochemically by monitoring nsp14 exoribonuclease activity. Disruption of the nsp10-nsp14 interaction abrogated the nsp10-driven activation of the nsp14 exoribonuclease. We further showed that the nsp10 surface interacting with nsp14 overlaps with the surface involved in the nsp10-mediated activation of nsp16 2'-O-methyltransferase activity, suggesting that nsp10 is a major regulator of SARS-CoV replicase function. In line with this notion, reverse genetics experiments supported an essential role of the nsp10 surface that interacts with nsp14 in SARS-CoV replication, as several mutations that abolished the interaction in vitro yielded a replication-negative viral phenotype. In contrast, mutants in which the nsp10-nsp16 interaction was disturbed proved to be crippled but viable. These experiments imply that the nsp10 surface that interacts with nsp14 and nsp16 and possibly other subunits of the viral replication complex may be a target for the development of antiviral compounds against pathogenic coronaviruses.	[Bouvet, Mickael; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Decroly, Etienne] Aix Marseille Univ, AFMB, UMR 7257, F-13288 Marseille, France; [Bouvet, Mickael; Imbert, Isabelle; Canard, Bruno; Guillemot, Jean-Claude; Decroly, Etienne] CNRS, AFMB, UMR 7257, F-13288 Marseille, France; [Lugari, Adrien; Bernard, Stephanie; Betzi, Stephane; Morelli, Xavier] Aix Marseille Univ, Inst Paoli Calmettes, CRCM, CNRS,UMR7258,INSERM,U1068, F-13009 Marseille, France; [Posthuma, Clara C.; Zevenhoven, Jessika C.; Snijder, Eric J.] Leiden Univ, Med Ctr, Mol Virol Lab, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands; [Lecine, Patrick] Univ Lyon 1, ENS Lyon, CIRI, CNRS,UMR5308,INSERM,U1111, F-69007 Lyon, France; [Pfefferle, Susanne; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, D-53127 Bonn, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Bonn	Decroly, E (corresponding author), Aix Marseille Univ, AFMB, UMR 7257, F-13288 Marseille, France.	decroly@afmb.univ-mrs.fr; xavier.morelli@inserm.fr	morelli, xavier/A-9218-2016; IMBERT, Isabelle/B-1247-2018; Snijder, Eric J./E-6073-2018; Betzi, Stephane/AAC-6103-2022; Lecine, Patrick/H-9338-2016	morelli, xavier/0000-0001-8101-7901; IMBERT, Isabelle/0000-0001-5630-9945; Snijder, Eric J./0000-0003-3297-2309; Betzi, Stephane/0000-0001-5935-5058; DECROLY, Etienne/0000-0002-6046-024X; Lecine, Patrick/0000-0002-8091-7286; Lugari, Adrien/0000-0001-8337-6043; Bouvet-Gueguen, Mickael/0000-0001-6541-689X; Canard, Bruno/0000-0003-4924-1991	French National Research Agency [ANR-08-MIEN-032, ANR 12 BSV3 07-1, ANR 12 BSV3 07-2, ANR 12 BSV3 07-3]; Fondation pour la Recherche Medicale (Programme Equipe FRM); European Union [260644]; Infectiopole Sud; Netherlands Organization for Scientific Research (NWO) [700.10.352]; Direction Generale pour l'Armement; Present address: Helmholtz Zentrum Munchen (GmbH); German Research Center for Environmental Health Haematologikum; Research Unit Gene Vectors, Marchioninistrasse, Munchen, Germany; "Fondation pour la Recherche Medicale" (FRM); Aix-Marseille University	French National Research Agency(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (Programme Equipe FRM)(Fondation pour la Recherche Medicale); European Union(European Commission); Infectiopole Sud; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Direction Generale pour l'Armement; Present address: Helmholtz Zentrum Munchen (GmbH); German Research Center for Environmental Health Haematologikum; Research Unit Gene Vectors, Marchioninistrasse, Munchen, Germany; "Fondation pour la Recherche Medicale" (FRM)(Fondation pour la Recherche Medicale); Aix-Marseille University	This work was supported by French National Research Agency ANR-08-MIEN-032, ANR 12 BSV3 07-1, -2, and -3, Fondation pour la Recherche Medicale (Programme Equipe FRM), by the European Union Seventh Framework Programme FP7/2007-2013 (Project SILVER (small inhibitor leads against emerging RNA viruses) Grant 260644), Infectiopole Sud, and by the Netherlands Organization for Scientific Research (NWO; TOP-GO Grant 700.10.352).; Recipient of a fellowship from the Direction Generale pour l'Armement. Present address: Helmholtz Zentrum Munchen (GmbH), German Research Center for Environmental Health Haematologikum, Research Unit Gene Vectors, Marchioninistrasse 25, 81377 Munchen, Germany.; Recipient if a fellowship from Agence Nationale de Recherche sur le SIDA et les Hepatites virales (ANRS).; Recipient if a fellowship from the "Fondation pour la Recherche Medicale" (FRM).; Recipient of a "Fond Incitatif de la Recherche-Equipe Jeunes Chercheurs" grant from Aix-Marseille University. To whom correspondence may be addressed. E-mail: xavier.morelli@inserm.fr.	Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Chang Guo-hui, 2010, Virologica Sinica, V25, P361, DOI 10.1007/s12250-010-3124-2; Chen Y, 2013, J VIROL, V87, P6296, DOI 10.1128/JVI.00061-13; Chen Y, 2009, P NATL ACAD SCI USA, V106, P3484, DOI 10.1073/pnas.0808790106; Corman VM, 2014, J VIROL, V88, P717, DOI 10.1128/JVI.01600-13; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Debarnot C, 2011, ACTA CRYSTALLOGR F, V67, P404, DOI 10.1107/S1744309111002867; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Decroly E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002059; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Donaldson EF, 2007, J VIROL, V81, P6356, DOI 10.1128/JVI.02805-06; Donaldson EF, 2007, J VIROL, V81, P7086, DOI 10.1128/JVI.00049-07; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Fang Y, 2006, ADV EXP MED BIOL, V581, P153; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham RL, 2012, NAT MED, V18, P1820, DOI 10.1038/nm.2972; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Hussain S, 2005, J VIROL, V79, P5288, DOI 10.1128/JVI.79.9.5288-5295.2005; Imberta I, 2008, VIRUS RES, V133, P136, DOI 10.1016/j.virusres.2007.11.017; Ivanov KA, 2004, J VIROL, V78, P7833, DOI 10.1128/JVI.78.14.7833-7838.2004; Joseph JS, 2006, J VIROL, V80, P7894, DOI 10.1128/JVI.00467-06; Ke M, 2012, VIRUS RES, V167, P322, DOI 10.1016/j.virusres.2012.05.017; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; LAI MMC, 1981, J VIROL, V38, P661, DOI 10.1128/JVI.38.2.661-670.1981; LAI MMC, 1982, J VIROL, V41, P557, DOI 10.1128/JVI.41.2.557-565.1982; Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12; Lugari A, 2010, J BIOL CHEM, V285, P33230, DOI 10.1074/jbc.M110.120014; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Pfefferle S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-131; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2001, COLD SPRING HARB SYM, V66, P301, DOI 10.1101/sqb.2001.66.301; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Su D, 2006, J VIROL, V80, P7902, DOI 10.1128/JVI.00483-06; Subissi L, 2014, ANTIVIR RES, V101, P122, DOI 10.1016/j.antiviral.2013.11.006; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; von Grotthuss M, 2003, CELL, V113, P701, DOI 10.1016/S0092-8674(03)00424-0; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	66	118	123	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25783	25796		10.1074/jbc.M114.577353	http://dx.doi.org/10.1074/jbc.M114.577353			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074927	Green Published, hybrid			2022-12-28	WOS:000342130800036
J	Shulami, S; Shenker, O; Langut, Y; Lavid, N; Gat, O; Zaide, G; Zehavi, A; Sonenshein, AL; Shoham, Y				Shulami, Smadar; Shenker, Ofer; Langut, Yael; Lavid, Noa; Gat, Orit; Zaide, Galia; Zehavi, Arie; Sonenshein, Abraham L.; Shoham, Yuval			Multiple Regulatory Mechanisms Control the Expression of the Geobacillus stearothermophilus Gene for Extracellular Xylanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; FAMILY-52 GLYCOSIDE HYDROLASE; CELL WALL DECONSTRUCTION; QUORUM-SENSING SYSTEM; CODY-BINDING SITES; HUMAN GUT SYMBIONT; X-RAY ANALYSIS; BACILLUS-SUBTILIS; BETA-XYLOSIDASE; ENTEROCOCCUS-FAECALIS	Geobacillus stearothermophilus T-6 produces a single extracellular xylanase (Xyn10A) capable of producing short, decorated xylo-oligosaccharides from the naturally branched polysaccharide, xylan. Gel retardation assays indicated that the master negative regulator, XylR, binds specifically to xylR operators in the promoters of xylose and xylan-utilization genes. This binding is efficiently prevented in vitro by xylose, the most likely molecular inducer. Expression of the extracellular xylanase is repressed in medium containing either glucose or casamino acids, suggesting that carbon catabolite repression plays a role in regulating xynA. The global transcriptional regulator CodY was shown to bind specifically to the xynA promoter region in vitro, suggesting that CodY is a repressor of xynA. The xynA gene is located next to an uncharacterized gene, xynX, that has similarity to the NIF3 (Ngg1p interacting factor 3)-like protein family. XynX binds specifically to a 72-bp fragment in the promoter region of xynA, and the expression of xynA in a xynX null mutant appeared to be higher, indicating that XynX regulates xynA. The specific activity of the extracellular xylanase increases over 50-fold during early exponential growth, suggesting cell density regulation (quorum sensing). Addition of conditioned medium to fresh and low cell density cultures resulted in high expression of xynA, indicating that a diffusible extracellular xynA density factor is present in the medium. The xynA density factor is heat-stable, sensitive to proteases, and was partially purified using reverse phase liquid chromatography. Taken together, these results suggest that xynA is regulated by quorum-sensing at low cell densities.	[Shulami, Smadar; Shenker, Ofer; Langut, Yael; Lavid, Noa; Gat, Orit; Zaide, Galia; Zehavi, Arie; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Sonenshein, Abraham L.] Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, Boston, MA 02111 USA	Technion Israel Institute of Technology; Tufts University	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	yshoham@tx.technion.ac.il	Shoham, Yuval/M-4409-2013		United States-Israel Binational Science Foundation Jerusalem, Israel [96-178]; Israel Science Foundation [500/10, 152/11]; I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program; Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion; Israel Institute of Technology; Weizmann Institute of Science; Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion	United States-Israel Binational Science Foundation Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program; Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion; Israel Institute of Technology; Weizmann Institute of Science; Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion	This work was supported in part by United States-Israel Binational Science Foundation Jerusalem, Israel, Grant 96-178 (to A. L. S. and Y. S.), Israel Science Foundation Grants 500/10 and 152/11, the I-CORE Program of the Planning and Budgeting Committee, the Ministry of Environmental Protection and the Grand Technion Energy Program, and part of The Leona M. and Harry B. Helmsley Charitable Trust reports on Alternative Energy series of the Technion, Israel Institute of Technology, and the Weizmann Institute of Science.; Supported in part by the Russell Berrie Nanotechnology Institute and The Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion. Holds the Erwin and Rosl Pollak Chair in Biotechnology at the Technion. To whom correspondence should be addressed. Tel.: 972-4-8293072; Fax: 972-4-8293399; E-mail:yshoham@tx.technion.ac.il.	Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Ansaldi M, 2002, MOL MICROBIOL, V44, P1561, DOI 10.1046/j.1365-2958.2002.02977.x; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Bayer E., 2000, GLYCOMICROBIOLOGY, P387; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Ben-David A, 2008, CHEM BIOL, V15, P546, DOI 10.1016/j.chembiol.2008.05.005; Bravman T, 2003, BIOCHEMISTRY-US, V42, P10528, DOI 10.1021/bi034505o; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; DAHL MK, 1995, J BACTERIOL, V177, P5467, DOI 10.1128/jb.177.19.5467-5472.1995; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dunny GM, 2007, PHILOS T R SOC B, V362, P1185, DOI 10.1098/rstb.2007.2043; Ferrari Eugenio, 1993, P917; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; GAT O, 1994, APPL ENVIRON MICROB, V60, P1889, DOI 10.1128/AEM.60.6.1889-1896.1994; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Johnson JL, 1981, MANUAL METHODS GENER, P450; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kazanov MD, 2013, NUCLEIC ACIDS RES, V41, P790, DOI 10.1093/nar/gks1184; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; KHASIN A, 1993, APPL ENVIRON MICROB, V59, P1725, DOI 10.1128/AEM.59.6.1725-1730.1993; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kopetz H, 2013, NATURE, V494, P29, DOI 10.1038/494029a; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; Langut Y., 2006, THESIS TECHNION ISRA; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P261, DOI 10.1107/S139900471302840X; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mechaly A, 1997, CARBOHYD RES, V304, P111, DOI 10.1016/S0008-6215(97)00209-7; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Moran C., 1990, MOL BIOL METHODS BAC, P267; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Nakayama J, 2001, MOL MICROBIOL, V41, P145, DOI 10.1046/j.1365-2958.2001.02486.x; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Ouyang Jia, 2006, Biotechnol J, V1, P1266, DOI 10.1002/biot.200600103; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; Rodionov DA, 2001, FEMS MICROBIOL LETT, V205, P305, DOI 10.1016/S0378-1097(01)00494-3; Salama R, 2012, FEBS LETT, V586, P2436, DOI 10.1016/j.febslet.2012.05.062; Sambrook J., 2001, MOL CLONING LAB MANU; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Shoham Yuval, 1992, Biodegradation, V3, P207, DOI 10.1007/BF00129084; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; SMITH H, 1987, J BACTERIOL, V169, P3321, DOI 10.1128/jb.169.7.3321-3328.1987; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Steiner E, 2012, APPL ENVIRON MICROB, V78, P1113, DOI 10.1128/AEM.06376-11; Stevens AM, 2012, J BACTERIOL, V194, P2131, DOI 10.1128/JB.00143-12; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Tascou S, 2003, BIOCHEM BIOPH RES CO, V309, P440, DOI 10.1016/j.bbrc.2003.07.008; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Teplitsky A, 2004, ACTA CRYSTALLOGR D, V60, P836, DOI 10.1107/S0907444904004123; Teplitsky A, 1997, ACTA CRYSTALLOGR D, V53, P608, DOI 10.1107/S0907444997002734; Teplitsky A, 2000, ACTA CRYSTALLOGR D, V56, P181, DOI 10.1107/S0907444999013517; Tomoike F, 2009, PROTEINS, V76, P244, DOI 10.1002/prot.22397; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; WU LJ, 1989, J GEN MICROBIOL, V135, P1315; Yaniv O, 2014, ACTA CRYSTALLOGR D, V70, P522, DOI 10.1107/S139900471302926X; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x	96	25	25	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25957	25975		10.1074/jbc.M114.592873	http://dx.doi.org/10.1074/jbc.M114.592873			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070894	Green Published, hybrid			2022-12-28	WOS:000342130800050
J	Poirier, AC; Schmitt, P; Rosa, RD; Vanhove, AS; Kieffer-Jaquinod, S; Rubio, TP; Charriere, GM; Destoumieux-Garzon, D				Poirier, Aurore C.; Schmitt, Paulina; Rosa, Rafael D.; Vanhove, Audrey S.; Kieffer-Jaquinod, Sylvie; Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine			Antimicrobial Histones and DNA Traps in Invertebrate Immunity EVIDENCES IN CRASSOSTREA GIGAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; INNATE IMMUNITY; PACIFIC OYSTER; INFECTION; HEMOCYTES; DEFENSE; BACTERIA; CAPTURE; SHRIMP; NETS	Although antimicrobial histones have been isolated from multiple metazoan species, their role in host defense has long remained unanswered. We found here that the hemocytes of the oyster Crassostrea gigas release antimicrobial H1-like and H5-like histones in response to tissue damage and infection. These antimicrobial histones were shown to be associated with extracellular DNA networks released by hemocytes, the circulating immune cells of invertebrates, in response to immune challenge. The hemocyte-released DNA was found to surround and entangle vibrios. This defense mechanism is reminiscent of the neutrophil extracellular traps (ETs) recently described in vertebrates. Importantly, oyster ETs were evidenced in vivo in hemocyte-infiltrated interstitial tissues surrounding wounds, whereas they were absent from tissues of unchallenged oysters. Consistently, antimicrobial histones were found to accumulate in oyster tissues following injury or infection with vibrios. Finally, oyster ET formation was highly dependent on the production of reactive oxygen species by hemocytes. This shows that ET formation relies on common cellular and molecular mechanisms from vertebrates to invertebrates. Altogether, our data reveal that ET formation is a defense mechanism triggered by infection and tissue damage, which is shared by relatively distant species suggesting either evolutionary conservation or convergent evolution within Bilateria.	[Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine] Univ Montpellier I, Univ Montpellier 2, IFREMER, Lab Ecol Coastal Marine Syst,CNRS UMR 5119, F-34095 Montpellier, France; [Rubio, Tristan P.; Charriere, Guillaume M.; Destoumieux-Garzon, Delphine] IRD, F-34095 Montpellier, France; [Schmitt, Paulina] Pontificia Univ Catolica Valparaiso, Inst Biol, Lab Genet & Inmunol Mol, Valparaiso 2373223, Chile; [Kieffer-Jaquinod, Sylvie] Univ Grenoble 1, CEA, INSERM, U1038,Etud Dynam Proteomes,Lab Biol Grande Echell, F-38054 Grenoble 9, France	Ifremer; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Pontificia Universidad Catolica de Valparaiso; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Charriere, GM (corresponding author), Univ Montpellier 2, Lab ECOSYM, Equipe Reponse Immunitaire Macroorganismes Marins, CC80,Pl Eugene Bataillon, F-34095 Montpellier, France.	guillaume.charriere@univ-montp2.fr	Rubio, Tristan/O-6022-2014; Poirier, Aurore C./AAB-6795-2019; Rosa, Rafael Diego/L-6944-2019; Destoumieux-Garzón, Delphine/O-3328-2014; Charriere, Guillaume/Z-1574-2019; Charriere, Guillaume M/O-8317-2014	Poirier, Aurore C./0000-0002-9041-7605; Rosa, Rafael Diego/0000-0002-4076-3163; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Charriere, Guillaume/0000-0002-4796-1488; Charriere, Guillaume M/0000-0002-4796-1488; Vanhove, Audrey/0000-0003-2203-8512; Rubio, Tristan/0000-0002-9751-6913; kieffer-jaquinod, Sylvie/0000-0003-1281-758X	Agence Nationale de la Recherche (ANR) (Vibriogen project) [Blanc SVSE7 2011]; Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir); Ministry of Higher Education and Research; Ifremer	Agence Nationale de la Recherche (ANR) (Vibriogen project)(French National Research Agency (ANR)); Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir)(Region Occitanie); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Ifremer	This work was supported by grants from the Agence Nationale de la Recherche (ANR) (Vibriogen project, Blanc SVSE7 2011) and the Languedoc-Roussillon region (REVARESP project, Chercheur(se) d'avenir 2009).; Supported by a fellowship from the Ministry of Higher Education and Research.; Supported by a fellowship from Ifremer.	Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; De Zoysa M, 2009, FISH SHELLFISH IMMUN, V27, P639, DOI 10.1016/j.fsi.2009.08.007; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Dorrington T, 2011, FISH SHELLFISH IMMUN, V30, P94, DOI 10.1016/j.fsi.2010.09.006; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gay M, 2004, DIS AQUAT ORGAN, V62, P65, DOI 10.3354/dao062065; Guimaraes-Costa Anderson B, 2012, J Parasitol Res, V2012, P929743, DOI 10.1155/2012/929743; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; Li CH, 2007, FISH SHELLFISH IMMUN, V22, P663, DOI 10.1016/j.fsi.2006.08.013; Li J, 2013, FISH SHELLFISH IMMUN, V35, P63, DOI 10.1016/j.fsi.2013.04.001; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Miller BF, 1942, SCIENCE, V96, P428, DOI 10.1126/science.96.2497.428; Palic D, 2007, DEV COMP IMMUNOL, V31, P805, DOI 10.1016/j.dci.2006.11.010; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Patat SA, 2004, EUR J BIOCHEM, V271, P4825, DOI 10.1111/j.1432-1033.2004.04448.x; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Sawabe T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00414; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt P, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00160; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Seo JK, 2011, COMP BIOCHEM PHYS B, V158, P223, DOI 10.1016/j.cbpb.2010.11.011; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Ng TH, 2013, DEV COMP IMMUNOL, V41, P644, DOI 10.1016/j.dci.2013.06.014; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	37	66	68	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24821	24831		10.1074/jbc.M114.576546	http://dx.doi.org/10.1074/jbc.M114.576546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25037219	Green Published, hybrid			2022-12-28	WOS:000341985300009
J	Resch, U; Cuapio, A; Sturtzel, C; Hofer, E; de Martin, R; Holper-Schichl, YM				Resch, Ulrike; Cuapio, Angelica; Sturtzel, Caterina; Hofer, Erhard; de Martin, Rainer; Holper-Schichl, Yvonne M.			Polyubiquitinated Tristetraprolin Protects from TNF-induced, Caspase-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ALPHA-INDUCED APOPTOSIS; INDUCED CELL-DEATH; MESSENGER-RNA; SIGNALING COMPLEX; KINASE ACTIVATION; GENE-EXPRESSION; JNK ACTIVATION; IN-VITRO	Binding of TNF to its receptor (TNFR1) elicits the spatiotemporal assembly of two signaling complexes that coordinate the balance between cell survival and cell death. We have shown previously that, following TNF treatment, them RNA decay protein tristetraprolin (TTP) is Lys-63-polyubiquitinated by TNF receptor-associated factor 2 (TRAF2), suggesting a regulatory role in TNFR signaling. Here we demonstrate that TTP interacts with TNFR1 in a TRAF2-dependent manner, thereby initiating the MEKK1/MKK4-dependent activation of JNK activities. This regulatory function toward JNK activation but not NF-kappa B activation depends on lysine 105 of TTP, which we identified as the corresponding TRAF2 ubiquitination site. Disabling TTP polyubiquitination results in enhanced TNF-induced apoptosis in cervical cancer cells. Together, we uncover a novel aspect of TNFR1 signaling where TTP, in alliance with TRAF2, acts as a balancer of JNK-mediated cell survival versus death.	[Resch, Ulrike; Cuapio, Angelica; Sturtzel, Caterina; Hofer, Erhard; de Martin, Rainer; Holper-Schichl, Yvonne M.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria	Medical University of Vienna	Holper-Schichl, YM (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Schwarzspanierstr 17, A-1090 Vienna, Austria.	yvonne.holper-schichl@meduniwien.ac.at		Sturtzel, Caterina/0000-0003-1002-5634; Cuapio, Angelica/0000-0002-9451-1914; Resch, Ulrike/0000-0002-8380-9555	Austrian Science Foundation (FWF) [T511-B20]; Austrian Science Fund (FWF) [T 511] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF) Project T511-B20 (to Y. M. H. S.).	Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Blackwell K, 2009, MOL CELL BIOL, V29, P303, DOI 10.1128/MCB.00699-08; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cao H, 2007, EXPERT REV PROTEOMIC, V4, P711, DOI 10.1586/14789450.4.6.711; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Darnay BG, 1999, ANN RHEUM DIS, V58, P2; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Emmerich CH, 2011, ADV EXP MED BIOL, V691, P115, DOI 10.1007/978-1-4419-6612-4_12; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Resch U, 2008, BIOCHEM BIOPH RES CO, V375, P156, DOI 10.1016/j.bbrc.2008.07.142; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schichl YM, 2011, J BIOL CHEM, V286, P38466, DOI 10.1074/jbc.M111.254888; Schichl YM, 2009, J BIOL CHEM, V284, P29571, DOI 10.1074/jbc.M109.031237; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Worthington MT, 2002, J BIOL CHEM, V277, P48558, DOI 10.1074/jbc.M206505200; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465	51	7	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25088	25100		10.1074/jbc.M114.563312	http://dx.doi.org/10.1074/jbc.M114.563312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25056949	Green Published, hybrid			2022-12-28	WOS:000341985300032
J	Hu, QX; Dong, JH; Du, HB; Zhang, DL; Ren, HZ; Ma, ML; Cai, Y; Zhao, TC; Yin, XL; Yu, X; Xue, T; Xu, ZG; Sun, JP				Hu, Qiao-Xia; Dong, Jun-Hong; Du, Hai-Bo; Zhang, Dao-Lai; Ren, Hong-Ze; Ma, Ming-Liang; Cai, Yuan; Zhao, Tong-Chao; Yin, Xiao-Lei; Yu, Xiao; Xue, Tian; Xu, Zhi-Gang; Sun, Jin-Peng			Constitutive G alpha(i) Coupling Activity of Very Large G Protein-coupled Receptor 1 (VLGR1) and Its Regulation by PDZD7 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Signaling; G Protein; G Protein-coupled Receptor (GPCR); Hearing; VLGR1; PDZD7; GPCR; Adhesion; Usher Syndrome	COCHLEAR HAIR-CELLS; ANKLE-LINK COMPLEX; BETA(2)-ADRENERGIC RECEPTOR; SENSORINEURAL DEAFNESS; GENE; PATHOGENESIS; COMPONENT; NETWORK; TYPE-2; DOMAIN	Background: The signaling and regulatory mechanism of the orphan receptor VLGR1 remains elusive. Results: The cleaved VLGR1 -subunit constitutively coupled to G(i) and was regulated by the VLGR1 -subunit, a disease-associated mutation, and PDZD7. Conclusion: The VLGR1 -subunit signals independently and is regulated at multiple levels. Significance: The identified new signaling mechanism may aid in the design of a VLGR1-targeted therapy. The very large G protein-coupled receptor 1 (VLGR1) is a core component in inner ear hair cell development. Mutations in the vlgr1 gene cause Usher syndrome, the symptoms of which include congenital hearing loss and progressive retinitis pigmentosa. However, the mechanism of VLGR1-regulated intracellular signaling and its role in Usher syndrome remain elusive. Here, we show that VLGR1 is processed into two fragments after autocleavage at the G protein-coupled receptor proteolytic site. The cleaved VLGR1 -subunit constitutively inhibited adenylate cyclase (AC) activity through G(i) coupling. Co-expression of the G(iq) chimera with the VLGR1 -subunit changed its activity to the phospholipase C/nuclear factor of activated T cells signaling pathway, which demonstrates the G(i) protein coupling specificity of this subunit. An R6002A mutation in intracellular loop 2 of VLGR1 abolished G(i) coupling, but the pathogenic VLGR1 Y6236fsx1 mutant showed increased AC inhibition. Furthermore, overexpression of another Usher syndrome protein, PDZD7, decreased the AC inhibition of the VLGR1 -subunit but showed no effect on the VLGR1 Y6236fsx1 mutant. Taken together, we identified an independent G(i) signaling pathway of the VLGR1 -subunit and its regulatory mechanisms that may have a role in the development of Usher syndrome.	[Hu, Qiao-Xia; Zhang, Dao-Lai; Ma, Ming-Liang; Zhao, Tong-Chao; Sun, Jin-Peng] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Hu, Qiao-Xia; Zhang, Dao-Lai; Ma, Ming-Liang; Zhao, Tong-Chao; Sun, Jin-Peng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Shandong, Peoples R China; [Dong, Jun-Hong; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, Jinan 250100, Shandong, Peoples R China; [Dong, Jun-Hong] Weifang Med Univ, Weifang 261053, Shandong, Peoples R China; [Du, Hai-Bo; Ren, Hong-Ze; Yin, Xiao-Lei; Xu, Zhi-Gang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Zhang, Dao-Lai] Binzhou Med Univ, Yantai 264003, Shandong, Peoples R China; [Cai, Yuan; Xue, Tian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Shandong University; Shandong University; Shandong University; Weifang Medical University; Shandong University; Binzhou Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China.	xuzg@sdu.edu.cn; sunjinpeng@sdu.edu.cn	Zhang, Daolai/AAA-4914-2021; Xue, Tian/G-9009-2018; sun, Jinpeng/AAR-9196-2020	Yu, Xiao/0000-0003-1119-8334	National Key Basic Research Program of China Grants [2013CB967700, 2011CB504505, 2012CB910402]; National Natural Science Foundation of China Grants [31371355, 31271505]; Interdiscipline Fund of Shandong University Grants [2012JC021, 2014JC029]; Independence Innovation Foundation of Shandong University Grant [2012TS114]; Program for Changjiang Scholars and Innovative Research Team in University Grant [IRT13028]	National Key Basic Research Program of China Grants(National Basic Research Program of China); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Interdiscipline Fund of Shandong University Grants; Independence Innovation Foundation of Shandong University Grant; Program for Changjiang Scholars and Innovative Research Team in University Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Key Basic Research Program of China Grants 2013CB967700 (to X. Y., T. X., and Z.-G. X.), 2011CB504505 (to Z.-G. X.), and 2012CB910402 (to J.-P. S.); National Natural Science Foundation of China Grants 31371355 (to Z.-G. X.) and 31271505 (to J.-P. S.); Interdiscipline Fund of Shandong University Grants 2012JC021 (to Z.-G. X.) and 2014JC029 (to X. Y.); Independence Innovation Foundation of Shandong University Grant 2012TS114 (to J.-P. S.); and Program for Changjiang Scholars and Innovative Research Team in University Grant IRT13028.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Melo J., 2011, J VIS EXP, V52, pe2847; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Hase M, 2008, J BIOL CHEM, V283, P12747, DOI 10.1074/jbc.M709487200; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holliday Nicholas D, 2011, Front Endocrinol (Lausanne), V2, P112, DOI 10.3389/fendo.2011.00112; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Shin D, 2013, P NATL ACAD SCI USA, V110, P19101, DOI 10.1073/pnas.1318501110; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Sun JP, 2013, J MOL NEUROSCI, V50, P204, DOI 10.1007/s12031-012-9911-5; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; White PC, 2011, ADV EXP MED BIOL, V707, P7, DOI 10.1007/978-1-4419-8002-1_2; Xiao RP, 2003, CIRCULATION, V108, P1633, DOI 10.1161/01.CIR.0000087595.17277.73; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Zallocchi M, 2012, J NEUROSCI, V32, P13841, DOI 10.1523/JNEUROSCI.1242-12.2012; Zallocchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030573; Zou JH, 2014, HUM MOL GENET, V23, P2374, DOI 10.1093/hmg/ddt629	37	48	50	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24215	24225		10.1074/jbc.M114.549816	http://dx.doi.org/10.1074/jbc.M114.549816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24962568	Green Published, hybrid			2022-12-28	WOS:000341505600019
J	Allison, SE; Tuinema, BR; Everson, ES; Sugiman-Marangos, S; Zhang, K; Junop, MS; Coombes, BK				Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.			Identification of the Docking Site between a Type III Secretion System ATPase and a Chaperone for Effector Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chaperone; Crystal Structure; Microbiology; Type III Secretion System (T3SS)	SALMONELLA PATHOGENICITY ISLAND-2; ENTERICA SEROVAR TYPHIMURIUM; PROTON MOTIVE FORCE; PROTEIN TRANSLOCASE; VIRULENCE GENES; FLII ATPASE; HOST; APPARATUS; SSEA; ACTIVATION	Background: Chaperones engage type III secretion system (T3SS) ATPases to facilitate effector secretion. Results: The molecular basis of the chaperone-T3SS ATPase interaction interface was elucidated. Conclusion: The C-terminal region of T3SS ATPases mediates binding with multiple contact points along the chaperone. Significance: The chaperone-T3SS ATPase interaction is important for Salmonella pathogenesis and may be a target for anti-virulence drugs. A number of Gram-negative pathogens utilize type III secretion systems (T3SSs) to inject bacterial effector proteins into the host. An important component of T3SSs is a conserved ATPase that captures chaperone-effector complexes and energizes their dissociation to facilitate effector translocation. To date, there has been limited work characterizing the chaperone-T3SS ATPase interaction despite it being a fundamental aspect of T3SS function. In this study, we present the 2.1 resolution crystal structure of the Salmonella enterica SPI-2-encoded ATPase, SsaN. Our structure revealed a local and functionally important novel feature in helix 10 that we used to define the interaction domain relevant to chaperone binding. We modeled the interaction between the multicargo chaperone, SrcA, and SsaN and validated this model using mutagenesis to identify the residues on both the chaperone and ATPase that mediate the interaction. Finally, we quantified the benefit of this molecular interaction on bacterial fitness in vivo using chromosomal exchange of wild-type ssaN with mutants that retain ATPase activity but no longer capture the chaperone. Our findings provide insight into chaperone recognition by T3SS ATPases and demonstrate the importance of the chaperone-T3SS ATPase interaction for the pathogenesis of Salmonella.	[Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Allison, Sarah E.; Tuinema, Brian R.; Everson, Ellen S.; Sugiman-Marangos, Seiji; Zhang, Kun; Junop, Murray S.; Coombes, Brian K.] Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W,Hlth Sci Ctr Rm 4H17, Hamilton, ON L8S 4K1, Canada.	coombes@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456; Coombes, Brian/0000-0001-9883-1010	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Grant [MOP 82704]; Canada Foundation for Innovation; Canada Research Chair; Canada Graduate Scholarship from the Canadian Institutes of Health Research; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research Grant MOP 82704, the Canada Foundation for Innovation, and a Canada Research Chair (to B. K. C.).; Recipient of a Canada Graduate Scholarship from the Canadian Institutes of Health Research.; Recipient of an Ontario Graduate Scholarship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004; Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9; Baison-Olmo F, 2012, BIOCHEM BIOPH RES CO, V423, P240, DOI 10.1016/j.bbrc.2012.05.095; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Cooper CA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-221; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dai SP, 2004, J BACTERIOL, V186, P5078, DOI 10.1128/jb.186.15.5078-5086.2004; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Ruiz-Albert J, 2003, MICROBIOL-SGM, V149, P1103, DOI 10.1099/mic.0.26190-0; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Swietnicki W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019716; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196; Zurawski DV, 2003, MOL MICROBIOL, V47, P1341, DOI 10.1046/j.1365-2958.2003.03373.x	54	27	27	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23734	23744		10.1074/jbc.M114.578476	http://dx.doi.org/10.1074/jbc.M114.578476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25035427	Green Published, hybrid			2022-12-28	WOS:000341505000041
J	Shen, L; Cui, AF; Xue, Y; Cui, Y; Dong, XY; Gao, Y; Yang, H; Fang, FD; Chang, YS				Shen, Lian; Cui, Anfang; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng			Hepatic Differentiated Embryo-Chondrocyte-expressed Gene 1 (Dec1) Inhibits Sterol Regulatory Element-binding Protein-1c (Srebp-1c) Expression and Alleviates Fatty Liver Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid Synthesis; Liver Metabolism; Metabolic Disease; Metabolism; Transcription Repressor; DEC1; NAFLD; SREBP-1c	CIRCADIAN CLOCK; TRANSCRIPTION FACTOR; NOVO LIPOGENESIS; MOLECULAR CLOCK; LXR-ALPHA; MICE; STEATOSIS; DISEASE; ADIPOGENESIS; INSULIN	Background: Increased SREBP-1c level contributes to excessive triglyceride accumulation in liver of NAFLD patients. Results:Dec1 represses Srebp-1c gene expression, thereby reducing hepatic lipogenesis and ameliorating fatty liver phenotype. Conclusion:Dec1 negatively regulates hepatic lipid synthesis. Significance:Dec1 is a negative regulator of Srebp-1c expression and integrates circadian clock and hepatic lipid metabolism. Hepatic steatosis, characterized by ectopic hepatic triglyceride accumulation, is considered as the early manifestation of non-alcoholic fatty liver diseases (NAFLD). Increased SREBP-1c level and activity contribute to excessive hepatic triglyceride accumulation in NAFLD patients; however, negative regulators of Srebp-1c are not well defined. In this study, we show that Dec1, a critical regulator of circadian rhythm, negatively regulates hepatic Srebp-1c expression. Hepatic Dec1 expression levels are markedly decreased in NAFLD mouse models. Restored Dec1 gene expression levels in NAFLD mouse livers decreased the expression of Srebp-1c and lipogenic genes, subsequently ameliorating the fatty liver phenotype. Conversely, knockdown of Dec1 expression by an adenovirus expressing Dec1-specific shRNA led to an increase in hepatic TG content in normal mouse livers. Correspondingly, expression levels of lipogenic genes, including Srebp-1c, Fas, and Acc, were increased in livers of mice with Dec1 knockdown. Moreover, a functional lipogenesis assay suggested that Dec1 overexpression repressed lipid synthesis in primary hepatocytes. Finally, a luciferase reporter gene assay indicates that DEC1 inhibits Srebp-1c gene transcription via the E-box mapped to the promoter region. Chromatin immunoprecipitation confirmed that DEC1 proteins bound to the identified E-box element. Our studies indicate that DEC1 is an important regulator of Srebp-1c expression and links circadian rhythm to hepatic lipogenesis. Activation of Dec1 can alleviate the nonalcoholic fatty liver phenotype.	[Shen, Lian; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Shen, Lian; Xue, Yuan; Cui, Ying; Dong, Xueyu; Gao, Yong; Yang, Hao; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Cui, Anfang] Jining Med Univ, Dept Biochem, Jining 272067, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jining Medical University	Chang, YS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	changy@ibms.pumc.edu.cn			Major State Basic Research Development Program of China 973 Program [2012CB517504]; National Natural Science Foundation of China [81170763]	Major State Basic Research Development Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major State Basic Research Development Program of China 973 Program Grant 2012CB517504 and National Natural Science Foundation of China Grant 81170763.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Choi SM, 2008, NUCLEIC ACIDS RES, V36, P6372, DOI 10.1093/nar/gkn620; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Nakayama H, 2007, METABOLISM, V56, P470, DOI 10.1016/j.metabol.2006.11.004; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Ozaki N, 2012, GENES CELLS, V17, P109, DOI 10.1111/j.1365-2443.2011.01574.x; Patel DD, 2001, J LIPID RES, V42, P328; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yamada K, 2005, FEBS LETT, V579, P1509, DOI 10.1016/j.febslet.2005.01.060; Yamada K, 2003, J BIOL CHEM, V278, P30719, DOI 10.1074/jbc.M301597200; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230	37	17	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23332	23342		10.1074/jbc.M113.526343	http://dx.doi.org/10.1074/jbc.M113.526343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993831	Green Published, hybrid			2022-12-28	WOS:000341505000009
J	Wang, KX; Sturt-Gillespie, B; Hittle, JC; Macdonald, D; Chan, GK; Yen, TJ; Liu, ST				Wang, Kexi; Sturt-Gillespie, Brianne; Hittle, James C.; Macdonald, Dawn; Chan, Gordon K.; Yen, Tim J.; Liu, Song-Tao			Thyroid Hormone Receptor Interacting Protein 13 (TRIP13) AAA-ATPase Is a Novel Mitotic Checkpoint-silencing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases Associated with Diverse Cellular Activities (AAA); Checkpoint Control; E3 Ubiquitin Ligase; Mitosis; Protein Complex; MAD2; Mitotic Checkpoint Complex (MCC); TRIP13; Anaphase-promoting Complex; Cyclosome (APC; C); p31comet	SPINDLE-ASSEMBLY CHECKPOINT; CLOSED MAD2 C-MAD2; CHROMOSOMAL INSTABILITY; KINETOCHORE ATTACHMENT; QUANTITATIVE PHOSPHOPROTEOMICS; INTERACTION NETWORK; ANAPHASE INHIBITOR; MAMMALIAN-CELLS; IN-VIVO; COMPLEX	Background: How the mitotic checkpoint is silenced is not fully understood. Results: Interference with TRIP13 AAA-ATPase causes delayed activation of the anaphase-promoting complex/cyclosome and stalled metaphase-to-anaphase transition. Conclusion: TRIP13 is a novel mitotic checkpoint-silencing protein. Significance: TRIP13 overexpression may lead to premature chromosome segregation and chromosomal instability. The mitotic checkpoint (or spindle assembly checkpoint) is a fail-safe mechanism to prevent chromosome missegregation by delaying anaphase onset in the presence of defective kinetochore-microtubule attachment. The target of the checkpoint is the E3 ubiquitin ligase anaphase-promoting complex/cyclosome. Once all chromosomes are properly attached and bioriented at the metaphase plate, the checkpoint needs to be silenced. Previously, we and others have reported that TRIP13 AAA-ATPase binds to the mitotic checkpoint-silencing protein p31(comet). Here we show that endogenous TRIP13 localizes to kinetochores. TRIP13 knockdown delays metaphase-to-anaphase transition. The delay is caused by prolonged presence of the effector for the checkpoint, the mitotic checkpoint complex, and its association and inhibition of the anaphase-promoting complex/cyclosome. These results suggest that TRIP13 is a novel mitotic checkpoint-silencing protein. The ATPase activity of TRIP13 is essential for its checkpoint function, and interference with TRIP13 abolished p31(comet)-mediated mitotic checkpoint silencing. TRIP13 overexpression is a hallmark of cancer cells showing chromosomal instability, particularly in certain breast cancers with poor prognosis. We suggest that premature mitotic checkpoint silencing triggered by TRIP13 overexpression may promote cancer development.	[Wang, Kexi; Sturt-Gillespie, Brianne; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Hittle, James C.; Yen, Tim J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Macdonald, Dawn; Chan, Gordon K.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University System of Ohio; University of Toledo; Fox Chase Cancer Center; University of Alberta	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Chan, Gordon/AAN-7784-2020; Liu, Song-Tao/Y-4732-2019	Chan, Gordon/0000-0003-0497-9407; Yen, Tim/0000-0003-2159-0997; Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Health [CA169706, CA06927, R01CA169500]; Canadian Breast Cancer Foundation; Prairies/NWT region; Fox Chase Cancer Center Board of Associates; National Science Foundation [MCB-1052413]; NATIONAL CANCER INSTITUTE [R21CA182651, R21CA169706, R01CA169500, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Prairies/NWT region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Fox Chase Cancer Center Board of Associates; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA169706 and CA06927 (to T. J. Y.) and R01CA169500 (to S. T. L.). This work was also supported by an operating grant from the Canadian Breast Cancer Foundation, Prairies/NWT region (to G. K. C.); the Fox Chase Cancer Center Board of Associates and an appropriation from the Commonwealth of Pennsylvania (to T. J. Y.); and National Science Foundation Grant MCB-1052413 (to S. T. L.).	Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Hardwick Kevin G, 2010, F1000 Biol Rep, V2, P55, DOI 10.3410/B2-55; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Joyce EF, 2009, GENETICS, V181, P39, DOI 10.1534/genetics.108.093112; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maldonado M, 2011, DEV CELL, V20, P733, DOI 10.1016/j.devcel.2011.05.017; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Miao CB, 2013, PLANT CELL, V25, P2998, DOI 10.1105/tpc.113.113175; Miniowitz-Shemtov S, 2012, P NATL ACAD SCI USA, V109, P8056, DOI 10.1073/pnas.1204081109; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neuwald AF, 1999, GENOME RES, V9, P27; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Roig I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001062; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Skinner JJ, 2008, J CELL BIOL, V183, P761, DOI 10.1083/jcb.200808122; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-15; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vanoosthuyse V, 2009, GENE DEV, V23, P2799, DOI 10.1101/gad.1882109; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yasugi T, 1997, J VIROL, V71, P5942, DOI 10.1128/JVI.71.8.5942-5951.1997	70	99	100	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23928	23937		10.1074/jbc.M114.585315	http://dx.doi.org/10.1074/jbc.M114.585315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012665	Green Published, hybrid			2022-12-28	WOS:000341505000058
J	Burns, JR; Baldwin, MR				Burns, Joshua R.; Baldwin, Michael R.			Tetanus Neurotoxin Utilizes Two Sequential Membrane Interactions for Channel Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM NEUROTOXIN; LOW PH; CLOSTRIDIAL NEUROTOXINS; LIGHT-CHAIN; PROTECTIVE ANTIGEN; PROTEIN-RECEPTOR; SYNAPTOTAGMIN-I; CELL ENTRY; TRANSLOCATION; BINDING	Tetanus neurotoxin (TeNT) causes neuroparalytic disease by entering the neuronal soma to block the release of neurotransmitters. However, the mechanism by which TeNT translocates its enzymatic domain (light chain) across endosomal membranes remains unclear. We found that TeNT and a truncated protein devoid of the receptor binding domain (TeNT-LHN) associated with membranes enriched in acidic phospholipids in a pH-dependent manner. Thus, in contrast to diphtheria toxin, the formation of a membrane-competent state of TeNT requires the membrane interface and is modulated by the bilayer composition. Channel formation is further enhanced by tethering of TeNT to the membrane through ganglioside co-receptors prior to acidification. Thus, TeNT channel formation can be resolved into two sequential steps: 1) interaction of the receptor binding domain (heavy chain receptor binding domain) with ganglioside co-receptors orients the translocation domain (heavy chain translocation domain) as the lumen of the endosome is acidified and 2) low pH, in conjunction with acidic lipids within the membrane drives the conformational changes in TeNT necessary for channel formation.	[Burns, Joshua R.; Baldwin, Michael R.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Baldwin, MR (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, 1 Hosp Dr, Columbia, MO 65212 USA.	baldwinmr@missouri.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Burns, Joshua/0000-0003-4245-5524	National Institutes of Health [1-R00-NS-061763]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS061763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R00-NS-061763 (to M. R. B.).	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Benson MA, 2011, J BIOL CHEM, V286, P34015, DOI 10.1074/jbc.M111.272054; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Blum FC, 2014, INFECT IMMUN, V82, P873, DOI 10.1128/IAI.01539-13; BOQUET P, 1982, P NATL ACAD SCI-BIOL, V79, P7614, DOI 10.1073/pnas.79.24.7614; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cai SW, 2006, PROTEIN J, V25, P455, DOI 10.1007/s10930-006-9028-1; Chen C, 2008, BIOCHEMISTRY-US, V47, P7179, DOI 10.1021/bi800640y; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Fischer A, 2012, J BIOL CHEM, V287, P1657, DOI 10.1074/jbc.C111.319400; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Karalewitz APA, 2012, J BIOL CHEM, V287, P40806, DOI 10.1074/jbc.M112.404244; Kyrychenko A, 2009, BIOCHEMISTRY-US, V48, P7584, DOI 10.1021/bi9009264; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lemichez E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013573; MCCROSKEY LM, 1991, J CLIN MICROBIOL, V29, P2618, DOI 10.1128/JCM.29.11.2618-2620.1991; Peng LS, 2012, J CELL SCI, V125, P3233, DOI 10.1242/jcs.103564; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; POULET S, 1992, BIOCHEM BIOPH RES CO, V183, P107, DOI 10.1016/0006-291X(92)91615-W; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1990, J PHYSIOLOGY PARIS, V84, P180; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; ULRICHBOTT B, 1984, J LIPID RES, V25, P1233	43	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22450	22458		10.1074/jbc.M114.559302	http://dx.doi.org/10.1074/jbc.M114.559302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24973217	Green Published, hybrid			2022-12-28	WOS:000340593500054
J	Shan, CL; Kang, HB; Elf, S; Xie, JX; Gu, TL; Aguiar, M; Lonning, S; Hitosugi, T; Chung, TW; Arellano, M; Khoury, HJ; Shin, DM; Khuri, FR; Boggon, TJ; Fan, J				Shan, Changliang; Kang, Hee-Bum; Elf, Shannon; Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott; Hitosugi, Taro; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Boggon, Titus J.; Fan, Jun			Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CANCER-CELLS; METABOLISM; HYPOXIA; COMPLEX; KINASE; ADAPTATION; EXPRESSION; PROTEIN	Many cancer cells rely more on aerobic glycolysis (the Warburg effect) than mitochondrial oxidative phosphorylation and catabolize glucose at a high rate. Such a metabolic switch is suggested to be due in part to functional attenuation of mitochondria in cancer cells. However, how oncogenic signals attenuate mitochondrial function and promote the switch to glycolysis remains unclear. We previously reported that tyrosine phosphorylation activates and inhibits mitochondrial pyruvate dehydrogenase kinase (PDK) and phosphatase (PDP), respectively, leading to enhanced inhibitory serine phosphorylation of pyruvate dehydrogenase (PDH) and consequently inhibition of pyruvate dehydrogenase complex (PDC) in cancer cells. In particular, Tyr-381 phosphorylation of PDP1 dissociates deacetylase SIRT3 and recruits acetyltransferase ACAT1 to PDC, resulting in increased inhibitory lysine acetylation of PDHA1 and PDP1. Here we report that phosphorylation at another tyrosine residue, Tyr-94, inhibits PDP1 by reducing the binding ability of PDP1 to lipoic acid, which is covalently attached to the L2 domain of dihydrolipoyl acetyltransferase (E2) to recruit PDP1 to PDC. We found that multiple oncogenic tyrosine kinases directly phosphorylated PDP1 at Tyr-94, and Tyr-94 phosphorylation of PDP1 was common in diverse human cancer cells and primary leukemia cells from patients. Moreover, expression of a phosphorylation-deficient PDP1 Y94F mutant in cancer cells resulted in increased oxidative phosphorylation, decreased cell proliferation under hypoxia, and reduced tumor growth in mice. Together, our findings suggest that phosphorylation at different tyrosine residues inhibits PDP1 through independent mechanisms, which act in concert to regulate PDC activity and promote the Warburg effect.	[Shan, Changliang; Kang, Hee-Bum; Elf, Shannon; Hitosugi, Taro; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Fan, Jun] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Emory University; Yale University	Fan, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	jfan3@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Shin, Dong Moon/G-9649-2013; Shan, changliang/L-9029-2016	Khuri, Fadlo R./0000-0002-8638-7618; Shin, Dong Moon/0000-0002-8245-4174; Chung, Tae-Wook/0000-0001-5243-5020; Shan, Changliang/0000-0002-4906-1686; Kang, Hee-Bum/0000-0002-3781-6893; Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health; National Institutes of Health SPORE in Head and Neck Cancer [P50CA128613]; Pharmacological Sciences Training Grant [T32 GM008602]; Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SPORE in Head and Neck Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants including the Career Development Fellow Award (to J. F.) from National Institutes of Health SPORE in Head and Neck Cancer P50CA128613 (to D. M. S.), the Pharmacological Sciences Training Grant T32 GM008602 (to S. E.), and the Hematology Tissue Bank of the Emory University School of Medicine and the Georgia Cancer Coalition (to H. J. K.).	Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; MORRISON RS, 1994, CANCER RES, V54, P2794; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pezzato E, 2009, AMINO ACIDS, V36, P449, DOI 10.1007/s00726-008-0099-5; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002	19	36	40	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21413	21422		10.1074/jbc.M114.581124	http://dx.doi.org/10.1074/jbc.M114.581124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962578	Green Published, hybrid			2022-12-28	WOS:000340558300020
J	Shao, ZF; Morser, J; Leung, LLK				Shao, Zhifei; Morser, John; Leung, Lawrence L. K.			Thrombin Cleavage of Osteopontin Disrupts a Pro-chemotactic Sequence for Dendritic Cells, Which Is Compensated by the Release of Its Pro-chemotactic C-terminal Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL; INTEGRIN; EXPRESSION; MIGRATION; BINDING; CD44; PHOSPHORYLATION; ALPHA(9)BETA(1); INFLAMMATION; ACTIVATION	Thrombin cleavage alters the function of osteopontin (OPN) by exposing an integrin binding site and releasing a chemotactic C-terminal fragment. Here, we examined thrombin cleavage of OPN in the context of dendritic cell (DC) migration to define its functional domains. Full-length OPN (OPN-FL), thrombin-cleaved N-terminal fragment (OPN-R), thrombin-and carboxypeptidase B2-double-cleaved N-terminal fragment (OPN-L), and C-terminal fragment (OPN-CTF) did not have intrinsic chemotactic activity, but all potentiated CCL21-induced DC migration. OPN-FL possessed the highest potency, whereas OPNRAA-FL had substantially less activity, indicating the importance of RGD. We identified a conserved (RSKSKKFRR176)-R-168 sequence on OPN-FL that spans the thrombin cleavage site, and it demonstrated potent pro-chemotactic effects on CCL21-induced DC migration. OPN-FLR168A had reduced activity, and the double mutant OPNRAA-FLR168A had even lower activity, indicating that these functional domains accounted for most of the pro-chemotactic activity of OPN-FL. OPN-CTF also possessed substantial pro-chemotactic activity, which was fully expressed upon thrombin cleavage and its release from the intact protein, because OPN-CTF was substantially more active than OPNRAA-FLR168A containing the OPN-CTF sequence within the intact protein. OPN-R and OPN-L possessed similar potency, indicating that the newly exposed C-terminal SVVYGLR sequence in OPN-R was not involved in the pro-chemotactic effect. OPN-FL and OPN-CTF did not directly bind to the CD44 standard form or CD44v6. In conclusion, thrombin cleavage of OPN disrupts a pro-chemotactic sequence in intact OPN, and its loss of pro-chemotactic activity is compensated by the release of OPN-CTF, which assumes a new conformation and possesses substantial activity in enhancing chemokine-induced migration of DCs.	[Shao, Zhifei; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Shao, Zhifei; Morser, John; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Leung, LLK (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Bldg 101,A4-131,3801 Miranda Ave, Palo Alto, CA 94304 USA.	lawrence.leung@stanford.edu			National Institutes of Health [5R01HL057530, 1T32HL098049]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530, T32HL098049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL057530.; Supported by National Institutes of Health Grant 1T32HL098049.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Christensen B, 2012, J BIOL CHEM, V287, P3788, DOI 10.1074/jbc.M111.277996; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Katagiri YU, 1999, CANCER RES, V59, P219; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P925, DOI 10.1002/jcb.21487; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schulz G, 2008, J INVEST DERMATOL, V128, P2541, DOI 10.1038/jid.2008.112; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Smith LL, 1999, J CELL BIOCHEM, V73, P20, DOI 10.1002/(SICI)1097-4644(19990401)73:1<20::AID-JCB3>3.0.CO;2-3; Song JJ, 2011, J CLIN INVEST, V121, P3517, DOI 10.1172/JCI46387; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Toda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072392; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4	31	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27146	27158		10.1074/jbc.M114.572172	http://dx.doi.org/10.1074/jbc.M114.572172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112870	Green Published, hybrid			2022-12-28	WOS:000342853900040
J	Dalal, K; Roshan-Moniri, M; Sharma, A; Li, HF; Ban, FQ; Hessein, M; Hsing, M; Singh, K; LeBlanc, E; Dehm, S; Guns, EST; Cherkasov, A; Rennie, PS				Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hessein, Mohamed; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Dehm, Scott; Guns, Emma S. Tomlinson; Cherkasov, Artem; Rennie, Paul S.			Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3 BF3 SITE; CASTRATION-RESISTANT; STRUCTURAL BASIS; GENE-EXPRESSION; ACTIVATION; ANTAGONISTS; INHIBITION; IDENTIFICATION; ANTIANDROGEN; SUPPRESSION	The androgen receptor (AR) is a transcription factor that has a pivotal role in the occurrence and progression of prostate cancer. The AR is activated by androgens that bind to its ligand-binding domain (LBD), causing the transcription factor to enter the nucleus and interact with genes via its conserved DNA-binding domain (DBD). Treatment for prostate cancer involves reducing androgen production or using anti-androgen drugs to block the interaction of hormones with the AR-LBD. Eventually the disease changes into a castration-resistant form of PCa where LBD mutations render anti-androgens ineffective or where constitutively active AR splice variants, lacking the LBD, become overexpressed. Recently, we identified a surfaced exposed pocket on the AR-DBD as an alternative drug-target site for AR inhibition. Here, we demonstrate that small molecules designed to selectively bind the pocket effectively block transcriptional activity of full-length and splice variant AR forms at low to sub-micromolar concentrations. The inhibition is lost when residues involved in drug interactions are mutated. Furthermore, the compounds did not impede nuclear localization of the AR and blocked interactions with chromatin, indicating the interference of DNA binding with the nuclear form of the transcription factor. Finally, we demonstrate the inhibition of gene expression and tumor volume in mouse xenografts. Our results indicate that the AR-DBD has a surface site that can be targeted to inhibit all forms of the AR, including enzalutamide-resistant and constitutively active splice variants and thus may serve as a potential avenue for the treatment of recurrent and metastatic prostate cancer.	[Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hessein, Mohamed; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Guns, Emma S. Tomlinson; Cherkasov, Artem; Rennie, Paul S.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Dehm, Scott] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Dalal, K (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	kdalal@prostatecentre.com	Cherkasov, Artem/A-2134-2012		National Institutes of Health [R01CA174777-01]; Canadian Institutes of Health Research; Genome BC; Prostate Cancer Canada; Canada Safeway Grant [SP2013-02]; American Cancer Society [RSG-031-01-TBE]; MSFHR; Prostate Cancer Foundation BC; NATIONAL CANCER INSTITUTE [R01CA174777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome BC; Prostate Cancer Canada; Canada Safeway Grant; American Cancer Society(American Cancer Society); MSFHR(Michael Smith Foundation for Health Research); Prostate Cancer Foundation BC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA174777-01 (to the S. D. laboratory). This work was also supported by Canadian Institutes of Health Research, Genome BC, Prostate Cancer Canada with generous support from Canada Safeway Grant SP2013-02, and American Cancer Society Research Scholar Grant RSG-031-01-TBE (to the S. D. laboratory).; Supported by Canadian Institutes of Health Research and MSFHR fellowships. To whom correspondence should be addressed: Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, British Columbia V6H 3Z6, Canada. Tel.: 604-875-4818; Fax: 604-875-5654; E-mail: kdalal@prostatecentre.com.; Supported by a Prostate Cancer Foundation BC grant-in-aid award.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Caboni L, 2013, MED RES REV, V33, P1081, DOI 10.1002/med.21275; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Duke CB, 2011, J MED CHEM, V54, P3973, DOI 10.1021/jm2000097; Ellinger-Ziegelbauer H, 2009, TOXICOL SCI, V110, P341, DOI 10.1093/toxsci/kfp103; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Ferraldeschi R, 2013, ANNU REV MED, V64, P1, DOI 10.1146/annurev-med-121211-091605; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Lack NA, 2011, J MED CHEM, V54, P8563, DOI 10.1021/jm201098n; Lallous N, 2013, INT J MOL SCI, V14, P12496, DOI 10.3390/ijms140612496; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Li HF, 2014, J MED CHEM, V57, P6458, DOI 10.1021/jm500802j; Li HF, 2013, J CHEM INF MODEL, V53, P123, DOI 10.1021/ci300514v; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Lim MY, 2014, ACS CHEM BIOL, V9, P692, DOI 10.1021/cb400759d; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Miyake H, 2000, CANCER RES, V60, P2547; Munuganti RSN, 2013, J MED CHEM, V56, P1136, DOI 10.1021/jm3015712; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Nyquist MD, 2013, HORM CANCER-US, V4, P61, DOI 10.1007/s12672-013-0131-4; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Saad F, 2014, UROL ONCOL-SEMIN ORI, V32, P70, DOI 10.1016/j.urolonc.2013.01.005; Salvati ME, 2005, BIOORG MED CHEM LETT, V15, P389, DOI 10.1016/j.bmcl.2004.10.051; Sato N, 1996, J STEROID BIOCHEM, V58, P139, DOI 10.1016/0960-0760(96)00018-0; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Snoek R, 1998, PROSTATE, V36, P256; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Zhang KX, 2009, CANCER GENE THER, V16, P820, DOI 10.1038/cgt.2009.28	48	85	92	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26417	26429		10.1074/jbc.M114.553818	http://dx.doi.org/10.1074/jbc.M114.553818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086042	Green Published, hybrid			2022-12-28	WOS:000342128800033
J	Shkriabai, N; Dharmarajan, V; Slaughter, A; Kessl, JJ; Larue, RC; Feng, L; Fuchs, JR; Griffin, PR; Kvaratskhelia, M				Shkriabai, Nikoloz; Dharmarajan, Venkatasubramanian; Slaughter, Alison; Kessl, Jacques J.; Larue, Ross C.; Feng, Lei; Fuchs, James R.; Griffin, Patrick R.; Kvaratskhelia, Mamuka			A Critical Role of the C-terminal Segment for Allosteric Inhibitor-induced Aberrant Multimerization of HIV-1 Integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; DNA-BINDING DOMAIN; SMALL-MOLECULE INHIBITORS; CATALYTIC DOMAIN; VIRAL-REPLICATION; ACTIVE-SITE; RETROVIRAL INTEGRASE; MASS-SPECTROMETRY; ZINC-BINDING; CORE DOMAIN	Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a promising class of antiretroviral agents for clinical development. Although ALLINIs promote aberrant IN multimerization and inhibit IN interaction with its cellular cofactor LEDGF/p75 with comparable potencies in vitro, their primary mechanism of action in infected cells is through inducing aberrant multimerization of IN. Crystal structures have shown that ALLINIs bind at the IN catalytic core domain dimer interface and bridge two interacting subunits. However, how these interactions promote higher-order protein multimerization is not clear. Here, we used mass spectrometry-based protein footprinting to monitor surface topology changes in full-length WT and the drug-resistant A128T mutant INs in the presence of ALLINI-2. These experiments have identified protein-protein interactions that extend beyond the direct inhibitor binding site and which lead to aberrant multimerization of WT but not A128T IN. Specifically, we demonstrate that C-terminal residues Lys-264 and Lys-266 play an important role in the inhibitor induced aberrant multimerization of the WT protein. Our findings provide structural clues for exploiting IN multimerization as a new, attractive therapeutic target and are expected to facilitate development of improved inhibitors.	[Shkriabai, Nikoloz; Slaughter, Alison; Kessl, Jacques J.; Larue, Ross C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Shkriabai, Nikoloz; Slaughter, Alison; Kessl, Jacques J.; Larue, Ross C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Dharmarajan, Venkatasubramanian; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Fuchs, James R.] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Scripps Research Institute; University System of Ohio; Ohio State University	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/J-6073-2015; Kessl, Jacques/AAV-2526-2021	Slaughter, Alison/0000-0002-0683-9291; Larue, Ross/0000-0002-0170-7345; Fuchs, James/0000-0002-8743-6389	National Institutes of Health [AI062520, GM103368, AI110310, AI110270]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110270, R01AI110310, R01AI062520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI062520 (to M. K.), GM103368 (to M. K. and P. R. G.), AI110310 (to M. K. and J. R. F.), and AI110270 (to J. J. K.).	Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Bujacz G, 1996, FEBS LETT, V398, P175, DOI 10.1016/S0014-5793(96)01236-7; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; CANNON PM, 1994, J VIROL, V68, P4768, DOI 10.1128/JVI.68.8.4768-4775.1994; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Demeulemeester J, 2014, EXPERT OPIN THER PAT, V24, P609, DOI 10.1517/13543776.2014.898753; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; Engelman A., 2011, HIV 1 INTEGRASE, P67, DOI [10.1002/9781118015377.ch6, DOI 10.1002/9781118015377.CH6]; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Fadel HJ, 2014, J VIROL, V88, P9704, DOI 10.1128/JVI.01397-14; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; JENKINS TM, 1995, P NATL ACAD SCI USA, V92, P6057, DOI 10.1073/pnas.92.13.6057; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Jurado KA, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.15; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Mckee CJ, 2009, METHODS, V47, P304, DOI 10.1016/j.ymeth.2008.10.023; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	56	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26430	26440		10.1074/jbc.M114.589572	http://dx.doi.org/10.1074/jbc.M114.589572			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25118283	hybrid, Green Published			2022-12-28	WOS:000342128800034
J	Ng, CA; Phan, K; Hill, AP; Vandenberg, JI; Perry, MD				Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.			Multiple Interactions between Cytoplasmic Domains Regulate Slow Deactivation of Kv11.1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; AMINO-TERMINAL DOMAIN; SWISS-MODEL; CARDIAC-ARRHYTHMIA; N-TERMINUS; HERG; EAG; REGION; MUTATIONS; ENVIRONMENT	The intracellular domains of many ion channels are important for fine-tuning their gating kinetics. In Kv11.1 channels, the slow kinetics of channel deactivation, which are critical for their function in the heart, are largely regulated by the N-terminal N-Cap and Per-Arnt-Sim (PAS) domains, as well as the C-terminal cyclic nucleotide-binding homology (cNBH) domain. Here, we use mutant cycle analysis to probe for functional interactions between the N-Cap/PAS domains and the cNBH domain. We identified a specific and stable charge-charge interaction between Arg(56) of the PAS domain and Asp(803) of the cNBH domain, as well an additional interaction between the cNBH domain and the N-Cap, both of which are critical for maintaining slow deactivation kinetics. Furthermore, we found that positively charged arginine residues within the disordered region of the N-Cap interact with negatively charged residues of the C-linker domain. Although this interaction is likely more transient than the PAS-cNBD interaction, it is strong enough to stabilize the open conformation of the channel and thus slow deactivation. These findings provide novel insights into the slow deactivation mechanism of Kv11.1 channels.	[Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New S Wales, Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Ng, Chai Ann; Phan, Kevin; Hill, Adam P.; Vandenberg, Jamie I.; Perry, Matthew D.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Programme Cardiac Electro, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Phan, Kevin/0000-0002-5940-3555; Ng, Chai Ann/0000-0002-3120-5450	Heart Foundation of Australia [NHFA G11S 5829S]; National Health and Medical Research Council of Australia [635520, 459401, 1019693]	Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant-in-Aid NHFA G11S 5829S from the Heart Foundation of Australia and National Health and Medical Research Council of Australia Project Grant 635520) and Fellowship Grants 459401 and 1019693 (to J. I. V.).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barros F, 1997, PFLUG ARCH EUR J PHY, V435, P119; Bauer CK, 1998, RECEPTOR CHANNEL, V6, P19; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Case DA, 2012, AMBER 12; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2012, CELL SIGNAL, V24, P1592, DOI 10.1016/j.cellsig.2012.04.004; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Ng CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077032; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Ohya S, 2002, AM J PHYSIOL-CELL PH, V283, pC866, DOI 10.1152/ajpcell.00099.2002; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI 10.1517/14728222.12.7.837 ; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schafer R, 1999, J PHYSIOL-LONDON, V518, P401, DOI 10.1111/j.1469-7793.1999.0401p.x; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	41	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25822	25832		10.1074/jbc.M114.558379	http://dx.doi.org/10.1074/jbc.M114.558379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074935	Green Published, hybrid			2022-12-28	WOS:000342130800039
J	Mokvist, F; Mamedov, F; Styring, S				Mokvist, Fredrik; Mamedov, Fikret; Styring, Stenbjorn			Defining the Far-red Limit of Photosystem I THE PRIMARY CHARGE SEPARATION IS FUNCTIONAL TO 840 nm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Electron Paramagnetic Resonance (EPR); Electron Transport; Photosynthesis; Photosynthetic Pigment; Plant; Photosystem I; Far-red Light; Charge Separation	LIGHT-HARVESTING COMPLEX; PRIMARY ELECTRON-DONOR; CHARGE-TRANSFER STATES; LONG-WAVELENGTH LIMIT; RESONANCE SIGNAL II; ENERGY-TRANSFER; PHYSIOLOGICAL DONOR; THYLAKOID MEMBRANES; REACTION CENTERS; EXCITATION	Background: It is generally accepted that Photosystem I is functional under illumination up to 760 nm. Results: We show that Photosystem I photochemistry is induced by far-red photons up to 840 nm. Conclusion: The limit of Photosystem I is 80 nm more red-shifted than previously thought. Significance: Charge transfer bands associated with P-700 could be responsible for this effect. The far-red limit of photosystem I (PS I) photochemistry was studied by EPR spectroscopy using laser flashes between 730 and 850 nm. In manganese-depleted spinach thylakoid membranes, the primary donor in PS I, P-700, was oxidized simultaneously with tyrosine Z, the secondary donor in PS II. It was found that at 295 K PS I photochemistry, observed as P-700(+) formation, was functional up to 840 nm. This is 30 nm further to the red region than was reported for PS II photochemistry (Thapper, A., Mamedov, F., Mokvist, F., Hammarstrom, L., and Styring, S. (2009) Plant Cell 21, 2391-2401). The same far-red limit for the P-700(+) formation was observed in a PS I reaction center core preparation from Nostoc punctiforme. The reduction of the acceptor side of PS I, observed as reduction of the iron-sulfur centers F-A and F-B by low temperature EPR measurements, was also functional at 15 K with light up to >830 nm. Taken together, these results, obtained from both plants and cyanobacteria, most likely rule out involvement of the red-absorbing antenna chlorophylls in this reaction. Instead we propose the existence of weak charge transfer bands absorbing in the far-red region in the ensemble of excitonically coupled chlorophyll a molecules around P-700 similar to what has been found in the reaction center of PS II. These charge transfer bands could be responsible for the far-red light absorption leading to PS I photochemistry at wavelengths up to 840 nm.	[Mokvist, Fredrik; Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Angstrom Lab, Dept Chem Angstrom, S-75120 Uppsala, Sweden	Uppsala University	Mamedov, F (corresponding author), Uppsala Univ, Angstrom Lab, Dept Chem Angstrom, POB 523, S-75120 Uppsala, Sweden.	Fikret.Mamedov@kemi.uu.se; Stenbjorn.Styring@kemi.uu.se	Styring, Stenbjörn/L-8414-2016; Mamedov, Fikret/A-1761-2016	Styring, Stenbjörn/0000-0002-2803-9244; Mamedov, Fikret/0000-0002-6218-3039	Swedish Research Council; Swedish Energy Agency; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, Swedish Energy Agency, and Knut and Alice Wallenberg Foundation.	BABCOCK GT, 1975, BIOCHIM BIOPHYS ACTA, V376, P315, DOI 10.1016/0005-2728(75)90024-9; BABCOCK GT, 1975, BIOCHIM BIOPHYS ACTA, V376, P329, DOI 10.1016/0005-2728(75)90025-0; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Blankenship R. E., 2008, MOL MECH PHOTOSYNTHE; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Busch A, 2011, BBA-BIOENERGETICS, V1807, P864, DOI 10.1016/j.bbabio.2010.09.009; Byrdin M, 2002, BIOPHYS J, V83, P433, DOI 10.1016/S0006-3495(02)75181-3; Campbell EL, 2008, J BACTERIOL, V190, P7382, DOI 10.1128/JB.00990-08; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Cardona T, 2007, PHYSIOL PLANTARUM, V131, P622, DOI 10.1111/j.1399-3054.2007.00982.x; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; COMMONER B, 1956, P NATL ACAD SCI USA, V42, P710, DOI 10.1073/pnas.42.10.710; Croce R, 2007, BIOPHYS J, V93, P2418, DOI 10.1529/biophysj.107.106955; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; de Weerd FL, 2003, J PHYS CHEM B, V107, P6214, DOI 10.1021/jp027737q; DURRANT JR, 1995, P NATL ACAD SCI USA, V92, P4798, DOI 10.1073/pnas.92.11.4798; Emerson R, 1943, AM J BOT, V30, P165, DOI 10.2307/2437236; EMERSON R, 1957, P NATL ACAD SCI USA, V43, P133, DOI 10.1073/pnas.43.1.133; Frese RN, 2002, BBA-BIOENERGETICS, V1554, P180, DOI 10.1016/S0005-2728(02)00242-6; Fromme R., 2008, PRIMARY PROCESSES 2, P111; Gadjieva R, 1999, BIOCHEMISTRY-US, V38, P10578, DOI 10.1021/bi9904656; GILLIE JK, 1989, PHOTOSYNTH RES, V22, P233, DOI 10.1007/BF00048302; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Gobets B, 2001, BBA-BIOENERGETICS, V1507, P80, DOI 10.1016/S0005-2728(01)00203-1; Golbeck JH, 2006, PHOTOSYSTEM; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hippler Michael, 2006, V24, P499; Hughes JL, 2006, BBA-BIOENERGETICS, V1757, P841, DOI 10.1016/j.bbabio.2006.05.035; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6; KOK B, 1962, BIOCHEM BIOPH RES CO, V9, P349, DOI 10.1016/0006-291X(62)90053-0; KRAWCZYK S, 1991, FEBS LETT, V286, P110, DOI 10.1016/0014-5793(91)80952-Y; MIDDENDORF TR, 1993, BIOCHIM BIOPHYS ACTA, V1143, P223, DOI 10.1016/0005-2728(93)90147-8; Mokvist F., 2013, 16 INT C PHOT ST LOU; Mokvist F, 2014, BIOCHEMISTRY-US, V53, P4228, DOI 10.1021/bi5006392; Muller MG, 2010, P NATL ACAD SCI USA, V107, P4123, DOI 10.1073/pnas.0905407107; Novoderezhkin VI, 2007, BIOPHYS J, V93, P1293, DOI 10.1529/biophysj.106.096867; Palsson LO, 1998, BIOPHYS J, V74, P2611, DOI 10.1016/S0006-3495(98)77967-6; Pettai H, 2005, FEBS LETT, V579, P4017, DOI 10.1016/j.febslet.2005.04.088; Pettai H, 2005, BBA-BIOENERGETICS, V1708, P311, DOI 10.1016/j.bbabio.2005.05.005; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Romero E, 2012, BIOPHYS J, V103, P185, DOI 10.1016/j.bpj.2012.06.026; Romero E, 2009, BIOPHYS J, V96, pL35, DOI 10.1016/j.bpj.2008.11.043; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schlodder E, 1998, BIOCHEMISTRY-US, V37, P9466, DOI 10.1021/bi973182r; Schlodder E, 2014, J AM CHEM SOC, V136, P3904, DOI 10.1021/ja412375j; Schmid VHR, 1997, P NATL ACAD SCI USA, V94, P7667, DOI 10.1073/pnas.94.14.7667; Setif P., 2008, PRIMARY PROCESSES 2, P147; Setif Pierre, 2006, V24, P439; Srinivasan N, 2009, BBA-BIOENERGETICS, V1787, P1057, DOI 10.1016/j.bbabio.2009.04.010; STEFANSSON H, 1995, BBA-BIOENERGETICS, V1231, P323, DOI 10.1016/0005-2728(95)00103-P; Thapper A, 2009, PLANT CELL, V21, P2391, DOI 10.1105/tpc.108.064154; TRISSL HW, 1993, PHOTOSYNTH RES, V35, P247, DOI 10.1007/BF00016556; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; WARDEN JT, 1976, BIOCHIM BIOPHYS ACTA, V423, P462, DOI 10.1016/0005-2728(76)90201-2; Wientjes E, 2012, BBA-BIOENERGETICS, V1817, P711, DOI 10.1016/j.bbabio.2012.02.030; Wientjes E, 2011, BIOPHYS J, V101, P745, DOI 10.1016/j.bpj.2011.06.045; Xu W, 2001, BBA-BIOENERGETICS, V1507, P32, DOI 10.1016/S0005-2728(01)00208-0	63	10	10	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24630	24639		10.1074/jbc.M114.555649	http://dx.doi.org/10.1074/jbc.M114.555649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023284	Green Published, hybrid			2022-12-28	WOS:000341505600053
J	Reitman, ZJ; Duncan, CG; Poteet, E; Winters, A; Yan, LJ; Gooden, DM; Spasojevic, I; Boros, LG; Yang, SH; Yan, H				Reitman, Zachary J.; Duncan, Christopher G.; Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Gooden, David M.; Spasojevic, Ivan; Boros, Laszlo G.; Yang, Shao-Hua; Yan, Hai			Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Glutamine; Metabolic Tracer; Metabolomics; Tumor Metabolism	ALPHA-KETOGLUTARATE; GROWTH; ACID; 2-HYDROXYGLUTARATE; CARBOXYLATION; LIPOGENESIS; INHIBITION; ACTIVATION; GLIOMA; CELLS	Background: Somatic IDH1 mutations are common in several types of cancer. Results: IDH1 mutation increases the proportion of palmitate derived from [C-13]glutamine under hypoxic conditions. Conclusion: IDH1 mutation can stimulate tumor cell reductive glutamine metabolism. Significance: IDH1 mutation may cause the unique glutamine-dependent metabolic phenotype observed in tumors. Mutations in the cytosolic NADP(+)-dependent isocitrate dehydrogenase (IDH1) occur in several types of cancer, and altered cellular metabolism associated with IDH1 mutations presents unique therapeutic opportunities. By altering IDH1, these mutations target a critical step in reductive glutamine metabolism, the metabolic pathway that converts glutamine ultimately to acetyl-CoA for biosynthetic processes. While IDH1-mutated cells are sensitive to therapies that target glutamine metabolism, the effect of IDH1 mutations on reductive glutamine metabolism remains poorly understood. To explore this issue, we investigated the effect of a knock-in, single-codon IDH1-R132H mutation on the metabolism of the HCT116 colorectal adenocarcinoma cell line. Here we report the R132H-isobolome by using targeted C-13 isotopomer tracer fate analysis to trace the metabolic fate of glucose and glutamine in this system. We show that introduction of the R132H mutation into IDH1 up-regulates the contribution of glutamine to lipogenesis in hypoxia, but not in normoxia. Treatment of cells with a d-2-hydroxyglutarate (d-2HG) ester recapitulated these changes, indicating that the alterations observed in the knocked-in cells were mediated by d-2HG produced by the IDH1 mutant. These studies provide a dynamic mechanistic basis for metabolic alterations observed in IDH1-mutated tumors and uncover potential therapeutic targets in IDH1-mutated cancers.	[Reitman, Zachary J.; Duncan, Christopher G.; Yan, Hai] Duke Univ Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gooden, David M.] Duke Univ Med Ctr, Small Mol Synth Facil, Dept Chem, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ Med Ctr, Dept Med, Durham, NC 27710 USA; [Reitman, Zachary J.] MedStar Union Mem Hosp, Dept Med, Baltimore, MD 21218 USA; [Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Yang, Shao-Hua] Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Boros, Laszlo G.] SIDMAP LLC, Los Angeles, CA 90064 USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA	Duke University; Duke University; Duke University; Union Memorial Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Yang, SH (corresponding author), Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu; hai.yan@dm.duke.edu		Reitman, Zachary/0000-0002-9122-9550; Yan, Liang-Jun/0000-0002-5815-5430; Duncan, Christopher/0000-0001-7205-2414	National Institutes of Health [R01CA140316, R01NS054687, R01NS054651]; American Cancer Society [RSG-10-126-01-CCE]; Pediatric Brain Tumor Foundation Institute Grant; Voices Against Brain Cancer Foundation Grant; James S. McDonnell Foundation Grant; V Foundation; Accelerate Brain Cancer Cure Foundation Grant; NIH [T32 CA059365-15, T32 AG020494]; Pediatric Brain Tumor Foundation at Duke; NATIONAL CANCER INSTITUTE [T32CA059365, R01CA140316, P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054687, R01NS054651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Pediatric Brain Tumor Foundation Institute Grant; Voices Against Brain Cancer Foundation Grant; James S. McDonnell Foundation Grant; V Foundation; Accelerate Brain Cancer Cure Foundation Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation at Duke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health Grant R01CA140316, American Cancer Society RSG-10-126-01-CCE, a Pediatric Brain Tumor Foundation Institute Grant, a Voices Against Brain Cancer Foundation Grant, a James S. McDonnell Foundation Grant, The V Foundation, and an Accelerate Brain Cancer Cure Foundation Grant (to H. Y.), as well as by National Institutes of Health Grant R01NS054687 and R01NS054651 (to S. H. Y.). Under agreements between Duke University, Agios Pharmaceuticals, Blueprint Medicines, and Personal Genome Diagnostics, H. Y. and D. D. B. are entitled to a share of the royalties received by the University on sales of products related to genes described in this manuscript. S. H. Y. and H. Y. are co-founders and own stocks of Beijing Pangenomics Technology, Co. Ltd. Z. J. R. receives licensing fees from cell lines reported in this work from Sanofi Aventis. This is managed by a conflict of interest agreement at Duke University.; Supported by NIH Postdoctoral Grant T32 CA059365-15 and by the Pediatric Brain Tumor Foundation at Duke.; Predoctoral trainee supported by NIH Grant T32 AG020494.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Boros LG, 2003, BLOOD, V102, P3556, DOI 10.1182/blood-2003-05-1537; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foster R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045061; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ohka F, 2014, TUMOR BIOL, V35, P5911, DOI 10.1007/s13277-014-1784-5; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	34	65	67	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23318	23328		10.1074/jbc.M114.575183	http://dx.doi.org/10.1074/jbc.M114.575183			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24986863	Green Published, hybrid			2022-12-28	WOS:000341505000005
J	Zahringer, U; Ittig, S; Lindner, B; Moll, H; Schombel, U; Gisch, N; Cornelis, GR				Zaehringer, Ulrich; Ittig, Simon; Lindner, Buko; Moll, Hermann; Schombel, Ursula; Gisch, Nicolas; Cornelis, Guy R.			NMR-based Structural Analysis of the Complete Rough-type Lipopolysaccharide Isolated from Capnocytophaga canimorsus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycolipid Structure; Gram-negative Bacteria; High-performance Liquid Chromatography (HPLC); Lipopolysaccharide (LPS); Nuclear Magnetic Resonance (NMR); Capnocytophaga canimorsus; DHPC Micelles	BORDETELLA-PERTUSSIS ENDOTOXIN; ESCHERICHIA-COLI; FLAVOBACTERIUM-MENINGOSEPTICUM; ANTIMICROBIAL PEPTIDES; BACTERIAL-ENDOTOXINS; CHEMICAL-STRUCTURE; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; SULFONOLIPIDS; CONFIGURATION	Background: Rough-type LPS of C. canimorsus is biologically active, whereas lipid A is not. Results: Purified C. canimorsus rough-type LPS could be analyzed in intact form by NMR. Conclusion: Inactive lipid A becomes active in case the core oligosaccharide is attached. Significance: This study provides evidence that lipid A is not the sole part of the LPS structure responsible for endotoxic activity. We here describe the NMR analysis of an intact lipopolysaccharide (LPS, endotoxin) in water with 1,2-dihexanoyl-sn-glycero-3-phosphocholine as detergent. When HPLC-purified rough-type LPS of Capnocytophaga canimorsus was prepared, C-13,N-15 labeling could be avoided. The intact LPS was analyzed by homonuclear (H-1) and heteronuclear (H-1,C-13, and H-1,P-31) correlated one- and two-dimensional NMR techniques as well as by mass spectrometry. It consists of a penta-acylated lipid A with an -linked phosphoethanolamine attached to C-1 of GlcN (I) in the hybrid backbone, lacking the 4-phosphate. The hydrophilic core oligosaccharide was found to be a complex hexasaccharide with two mannose (Man) and one each of 3-deoxy-d-manno-oct-2-ulosonic acid (Kdo), Gal, GalN, and l-rhamnose residues. Position 4 of Kdo is substituted by phosphoethanolamine, also present in position 6 of the branched Man(I) residue. This rough-type LPS is exceptional in that all three negative phosphate residues are masked by positively charged ethanolamine substituents, leading to an overall zero net charge, which has so far not been observed for any other LPS. In biological assays, the corresponding isolated lipid A was found to be endotoxically almost inactive. By contrast, the intact rough-type LPS described here expressed a 20,000-fold increased endotoxicity, indicating that the core oligosaccharide significantly contributes to the endotoxic potency of the whole rough-type C. canimorsus LPS molecule. Based on these findings, the strict view that lipid A alone represents the toxic center of LPS needs to be reassessed.	[Zaehringer, Ulrich; Lindner, Buko; Moll, Hermann; Schombel, Ursula; Gisch, Nicolas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem Bioanalyt Chem, D-23845 Borstel, Germany; [Ittig, Simon; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Cornelis, Guy R.] Univ Namur, Dept Biol, B-5000 Namur, Belgium	Forschungszentrum Borstel; University of Basel; University of Namur	Ittig, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	simon.ittig@unibas.ch		Gisch, Nicolas/0000-0003-3260-5269	Cluster of Excellence "Inflammation at Interfaces" [EXC306]; Werner Siemens Foundation; European Research Council 5 Grant [AdG 2011-293605-CAPCAN]	Cluster of Excellence "Inflammation at Interfaces"; Werner Siemens Foundation; European Research Council 5 Grant	This work was supported in part by the Cluster of Excellence "Inflammation at Interfaces" (EXC306).; Supported by the Werner Siemens Foundation.; Recipient of European Research Council 5 Grant AdG 2011-293605-CAPCAN.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; BOCK K, 1994, EUR J BIOCHEM, V225, P1029, DOI 10.1111/j.1432-1033.1994.1029b.x; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chamorro C, 2012, BBA-BIOMEMBRANES, V1818, P2171, DOI 10.1016/j.bbamem.2012.04.004; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GODCHAUX W, 1980, J BACTERIOL, V144, P592, DOI 10.1128/JB.144.2.592-602.1980; GODCHAUX W, 1984, J BIOL CHEM, V259, P2982; Gomi K, 2002, J IMMUNOL, V168, P2939, DOI 10.4049/jimmunol.168.6.2939; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HASE S, 1976, EUR J BIOCHEM, V63, P101, DOI 10.1111/j.1432-1033.1976.tb10212.x; HELANDER IM, 1988, EUR J BIOCHEM, V177, P483, DOI 10.1111/j.1432-1033.1988.tb14398.x; Ittig S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002667; Janda JM, 2006, EMERG INFECT DIS, V12, P340, DOI 10.3201/eid1202.050783; JANSSON PE, 1989, CARBOHYD RES, V188, P169, DOI 10.1016/0008-6215(89)84069-8; Kato H, 1998, J BACTERIOL, V180, P3891, DOI 10.1128/JB.180.15.3891-3899.1998; KAWAI Y, 1988, EUR J BIOCHEM, V171, P73, DOI 10.1111/j.1432-1033.1988.tb13760.x; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kohara J, 2006, PROTEIN EXPRES PURIF, V49, P276, DOI 10.1016/j.pep.2006.05.015; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBBAR S, 1994, CARBOHYD RES, V259, P257, DOI 10.1016/0008-6215(94)84061-X; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Liu WC, 1999, B CHEM SOC JPN, V72, P1377, DOI 10.1246/bcsj.72.1377; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Mally M, 2009, MICROBES INFECT, V11, P509, DOI 10.1016/j.micinf.2009.02.005; Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164; Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Meng J, 2011, SCI CHINA PHYS CHEM, V54, P187, DOI 10.1007/s11433-010-4225-5; Moll H, 1997, CARBOHYD RES, V304, P91, DOI 10.1016/S0008-6215(97)00210-3; Oehler RL, 2009, LANCET INFECT DIS, V9, P439, DOI 10.1016/S1473-3099(09)70110-0; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71; PITTA TP, 1989, J BACTERIOL, V171, P952, DOI 10.1128/jb.171.2.952-957.1989; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; Richter W, 2011, INNATE IMMUN-LONDON, V17, P427, DOI 10.1177/1753425910372434; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Schweda EKH, 2008, INNATE IMMUN-LONDON, V14, P199, DOI 10.1177/1753425908095958; Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243; Shin H, 2009, INFECT IMMUN, V77, P2262, DOI 10.1128/IAI.01324-08; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vasl J, 2009, J IMMUNOL, V183, P5138, DOI 10.4049/jimmunol.0901544; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang W, 2008, ANGEW CHEM INT EDIT, V47, P9870, DOI 10.1002/anie.200803474; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; ZAHRINGER U, 1993, TETRAHEDRON, V49, P4193, DOI 10.1016/S0040-4020(01)85737-9; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	52	19	20	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23963	23976		10.1074/jbc.M114.571489	http://dx.doi.org/10.1074/jbc.M114.571489			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993825	hybrid, Green Published			2022-12-28	WOS:000341505000061
J	Cao, Q; Zhao, KX; Zhong, XZ; Zou, YJ; Yu, HC; Huang, P; Xu, TL; Dong, XP				Cao, Qi; Zhao, Kexin; Zhong, Xi Zoe; Zou, Yuanjie; Yu, Haichuan; Huang, Peng; Xu, Tian-Le; Dong, Xian-Ping			SLC17A9 Protein Functions as a Lysosomal ATP Transporter and Regulates Cell Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR NUCLEOTIDE TRANSPORTER; RELEASE; EXOCYTOSIS; STORAGE; MECHANISM; CHANNELS	Lysosomes contain abundant ATP, which is released through lysosomal exocytosis following exposure to various stimuli. However, the molecular mechanisms underlying lysosomal ATP accumulation remain unknown. The vesicular nucleotide transporter, also known as solute carrier family 17 member 9 (SLC17A9), has been shown to function in ATP transport across secretory vesicles/granules membrane in adrenal chromaffin cells, T cells, and pancreatic cells. Here, using mammalian cell lines, we report that SLC17A9 is highly enriched in lysosomes and functions as an ATP transporter in those organelles. SLC17A9 deficiency reduced lysosome ATP accumulation and compromised lysosome function, resulting in cell death. Our data suggest that SLC17A9 activity mediates lysosomal ATP accumulation and plays an important role in lysosomal physiology and cell viability.	[Cao, Qi; Zhao, Kexin; Zhong, Xi Zoe; Zou, Yuanjie; Yu, Haichuan; Huang, Peng; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada; [Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Key Lab Tumor Microenvironm & Inflammat, Shanghai 200025, Peoples R China	Dalhousie University; Shanghai Jiao Tong University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca		Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR) [MOP-119349]; CIHR [201109MSH-261462-208625]; Nova Scotia Health Research Foundation [MED-PRO-2011-7485]; Canada Foundation for Innovation Leaders Opportunity Fund [29291]	Department of Physiology and Biophysics, Dalhousie University; Dalhousie Medical Research Foundation (DMRF); DMRF; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	This work was supported by start-up funds from the Department of Physiology and Biophysics, Dalhousie University (to X. D.), by a Dalhousie Medical Research Foundation (DMRF) equipment grant, by a DMRF new investigator award, by Canadian Institutes of Health Research (CIHR) Grant MOP-119349, by CIHR New Investigator Award 201109MSH-261462-208625, by Nova Scotia Health Research Foundation Establishment Grant MED-PRO-2011-7485, and by Canada Foundation for Innovation Leaders Opportunity Fund Funding for Research Infrastructure Grant 29291.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Dahl Gerhard, 2009, P287, DOI 10.1007/978-1-59745-489-6_12; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Geisler JC, 2013, ENDOCRINOLOGY, V154, P675, DOI 10.1210/en.2012-1818; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Imura Y, 2013, GLIA, V61, P1320, DOI 10.1002/glia.22517; IRVIN JL, 1954, J BIOL CHEM, V210, P45; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Koivusalo M, 2011, TRAFFIC, V12, P972, DOI 10.1111/j.1600-0854.2011.01215.x; LEE C, 1971, BIOCHEMISTRY-US, V10, P4375, DOI 10.1021/bi00800a004; Liu T, 2011, J NEUROSCI, V31, P10593, DOI 10.1523/JNEUROSCI.6401-10.2011; Miyaji T, 2011, J BIOL CHEM, V286, P42881, DOI 10.1074/jbc.M111.277269; Omote H, 2013, PHYSIOLOGY, V28, P39, DOI 10.1152/physiol.00033.2012; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; Oya M, 2013, BIOCHEM BIOPH RES CO, V438, P145, DOI 10.1016/j.bbrc.2013.07.043; PILLAI S, 1985, J BIOL CHEM, V260, P8384; Sathe MN, 2011, J BIOL CHEM, V286, P25363, DOI 10.1074/jbc.M111.232868; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tokunaga A, 2010, J BIOL CHEM, V285, P17406, DOI 10.1074/jbc.M110.112417; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	31	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23189	23199		10.1074/jbc.M114.567107	http://dx.doi.org/10.1074/jbc.M114.567107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24962569	Green Published, hybrid			2022-12-28	WOS:000341017200055
J	Gruning, CSR; Mirecka, EA; Klein, AN; Mandelkow, E; Willbold, D; Marino, SF; Stoldt, M; Hoyer, W				Gruening, Clara S. R.; Mirecka, Ewa A.; Klein, Antonia N.; Mandelkow, Eckhard; Willbold, Dieter; Marino, Stephen F.; Stoldt, Matthias; Hoyer, Wolfgang			Alternative Conformations of the Tau Repeat Domain in Complex with an Engineered Binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; IN-VITRO; SEEDING BARRIER; BETA-HAIRPIN; AGGREGATION; OLIGOMERS; CORE; IDENTIFICATION; STABILIZATION; PROTOFIBRILS	The aggregation of Tau into paired helical filaments is involved in the pathogenesis of several neurodegenerative diseases, including Alzheimer disease. The aggregation reaction is characterized by conformational conversion of the repeat domain, which partially adopts a cross-beta-structure in the resulting amyloid-like fibrils. Here, we report the selection and characterization of an engineered binding protein, beta-wrapin TP4, targeting the Tau repeat domain. TP4 was obtained by phage display using the four-repeat Tau construct K18 Delta K280 as a target. TP4 binds K18 Delta K280 as well as the longest isoform of human Tau, hTau40, with nanomolar affinity. NMR spectroscopy identified two alternative TP4-binding sites in the four-repeat domain, with each including two hexapeptide motifs with high beta-sheet propensity. Both binding sites contain the aggregation- determining PHF6 hexapeptide within repeat 3. In addition, one binding site includes the PHF6* hexapeptide within repeat 2, whereas the other includes the corresponding hexapeptide Tau(337-342) within repeat 4, denoted PHF6**. Comparison of TP4-binding with Tau aggregation reveals that the same regions of Tau are involved in both processes. TP4 inhibits Tau aggregation at substoichiometric concentration, demonstrating that it interferes with aggregation nucleation. This study provides residue-level insight into the interaction of Tau with an aggregation inhibitor and highlights the structural flexibility of Tau.	[Gruening, Clara S. R.; Mirecka, Ewa A.; Willbold, Dieter; Marino, Stephen F.; Stoldt, Matthias; Hoyer, Wolfgang] Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Klein, Antonia N.; Willbold, Dieter; Stoldt, Matthias; Hoyer, Wolfgang] Res Ctr Julich, Inst Struct Biochem ICS 6, D-52425 Julich, Germany; [Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Mandelkow, Eckhard] CAESAR, D-53175 Bonn, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Hoyer, W (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	wolfgang.hoyer@uni-duesseldorf.de	Willbold, Dieter/A-6280-2013; Stoldt, Matthias/G-5738-2013; Hoyer, Wolfgang/H-6193-2013	Willbold, Dieter/0000-0002-0065-7366; Stoldt, Matthias/0000-0002-5060-4844; Hoyer, Wolfgang/0000-0003-4301-5416; Marino, Stephen/0000-0001-5696-9679	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	This work was supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gronwall C, 2007, J BIOTECHNOL, V128, P162, DOI 10.1016/j.jbiotec.2006.09.013; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Macao B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-82; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Mirecka EA, 2014, ANGEW CHEM INT EDIT, V53, P4227, DOI 10.1002/anie.201309001; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P22822, DOI 10.1074/jbc.M112.367474; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875	50	16	16	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23209	23218		10.1074/jbc.M114.560920	http://dx.doi.org/10.1074/jbc.M114.560920			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24966331	Green Published, hybrid			2022-12-28	WOS:000341017200057
J	Laderoute, KR; Calaoagan, JM; Chao, WR; Dinh, D; Denko, N; Duellman, S; Kalra, J; Liu, XH; Papandreou, I; Sambucetti, L; Boros, LG				Laderoute, Keith R.; Calaoagan, Joy M.; Chao, Wan-ru; Dinh, Dominc; Denko, Nicholas; Duellman, Sarah; Kalra, Jessica; Liu, Xiaohe; Papandreou, Ioanna; Sambucetti, Lidia; Boros, Laszlo G.			5 '-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; CELL-GROWTH; NUTRIENT; ISOTOPOMER; METABOLISM	Rapid tumor growth can establish metabolically stressed microenvironments that activate 5'-AMP-activated protein kinase (AMPK), a ubiquitous regulator of ATP homeostasis. Previously, we investigated the importance of AMPK for the growth of experimental tumors prepared from HRAS-transformed mouse embryo fibroblasts and for primary brain tumor development in a rat model of neurocarcinogenesis. Here, we used triple-negative human breast cancer cells in which AMPK activity had been knocked down to investigate the contribution of AMPK to experimental tumor growth and core glucose metabolism. We found that AMPK supports the growth of fast-growing orthotopic tumors prepared from MDA-MB-231 and DU4475 breast cancer cells but had no effect on the proliferation or survival of these cells in culture. We used in vitro and in vivo metabolic profiling with [C-13] glucose tracers to investigate the contribution of AMPK to core glucose metabolism in MDA-MB-231 cells, which have a Warburg metabolic phenotype; these experiments indicated that AMPK supports tumor glucose metabolism in part through positive regulation of glycolysis and the nonoxidative pentose phosphate cycle. We also found that AMPK activity in the MDA-MB-231 tumors could systemically perturb glucose homeostasis in sensitive normal tissues (liver and pancreas). Overall, our findings suggest that the contribution of AMPK to the growth of aggressive experimental tumors has a critical microenvironmental component that involves specific regulation of core glucose metabolism.	[Laderoute, Keith R.; Calaoagan, Joy M.; Chao, Wan-ru; Dinh, Dominc; Duellman, Sarah; Liu, Xiaohe; Sambucetti, Lidia] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA; [Denko, Nicholas; Papandreou, Ioanna] Ohio State Univ, Dept Radiat Oncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Kalra, Jessica] Langara Coll, Dept Biol, Vancouver, BC V5W 2Z6, Canada; [Boros, Laszlo G.] UCLA Sch Med, Dept Pediat, Torrance, CA 90509 USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Boros, Laszlo G.] SIDMAP LLC, Los Angeles, CA 90064 USA	SRI International; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Laderoute, KR (corresponding author), SRI Int, Biosci Div, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	keith.laderoute@sri.com	denko, nicholas/F-8444-2010; Papandreou, Ioanna/G-1703-2014	, Keith/0000-0002-5121-8072	National Institutes of Health from NCI [HHSN261200800001E, CA73807]; NATIONAL CANCER INSTITUTE [R01CA163581, R01CA073807] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants HHSN261200800001E and CA73807 from NCI.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Boren J, 2001, J BIOL CHEM, V276, P37747; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Boros LG, 1997, CANCER RES, V57, P4242; Cairns RA, 2009, CLIN CANCER RES, V15, P7170, DOI 10.1158/1078-0432.CCR-09-1676; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gucalp A, 2011, CHEMOTHER RES PRACT, DOI DOI 10.1155/2011/696208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang TC, 2011, INT J CANCER, V128, P2230, DOI 10.1002/ijc.25558; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Laderoute KR, 2004, MOL CELL BIOL, V24, P4128, DOI 10.1128/MCB.24.10.4128-4137.2004; LANGLOIS AJ, 1979, CANCER RES, V39, P2604; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Lin ZW, 2000, AM J PHYSIOL-ENDOC M, V278, pE958, DOI 10.1152/ajpendo.2000.278.5.E958; Liu HB, 2010, CANCER RES, V70, P6368, DOI 10.1158/0008-5472.CAN-09-4615; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Saggar JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00154; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sonko BJ, 2011, FOOD CHEM TOXICOL, V49, P2968, DOI 10.1016/j.fct.2011.07.047; STACKPOLE CW, 1981, NATURE, V289, P798, DOI 10.1038/289798a0; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu CA, 2013, BBA-MOL CELL RES, V1833, P1147, DOI 10.1016/j.bbamcr.2013.01.025; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zhao J, 2009, NEUROSCI BULL, V25, P94, DOI 10.1007/s12264-009-1113-y	39	44	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22850	22864		10.1074/jbc.M114.576371	http://dx.doi.org/10.1074/jbc.M114.576371			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24993821	Green Published, hybrid			2022-12-28	WOS:000341017200027
J	Rodriguez, M; Domingo, E; Alonso, S; Frade, JG; Eiros, J; Crespo, MS; Fernandez, N				Rodriguez, Mario; Domingo, Esther; Alonso, Sara; Garcia Frade, Javier; Eiros, Jose; Sanchez Crespo, Mariano; Fernandez, Nieves			The Unfolded Protein Response and the Phosphorylations of Activating Transcription Factor 2 in the trans-Activation of il23a Promoter Produced by beta-Glucans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP HOMOLOGOUS PROTEIN; HUMAN DENDRITIC CELLS; MAP KINASE; ANKYLOSING-SPONDYLITIS; BINDING PROTEIN; TYROSINE-PHOSPHATASE; DUAL PHOSPHORYLATION; SIGNALING PATHWAYS; IL-23 EXPRESSION; INNATE IMMUNITY	Current views on the control of IL-23 production focus on the regulation of il23a, the gene encoding IL-23 p19, by NF-kappa B in combination with other transcription factors. C/EBP homologous protein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-binding protein (C/EBP beta), and cAMP-response element-binding protein (CREB) have been involved in response to LPS, but no data are available regarding the mechanism triggered by the fungal mimic and beta-glucan-containing stimulus zymosan, which produces IL-23 and to a low extent the related cytokine IL-12 p70. Zymosan induced the mobilization of CHOP from the nuclear fractions to phagocytic vesicles. Hypha-forming Candida also induced the nuclear disappearance of CHOP. Assay of transcription factor binding to the il23a promoter showed an increase of Thr(P)-71-Thr(P)-69-activating transcription factor 2 (ATF2) binding in response to zymosan. PKC and PKA/mitogen-and stress-activated kinase inhibitors down-regulated Thr(P)-71-ATF2 binding to the il23a promoter and il23a mRNA expression. Consistent with the current concept of complementary phosphorylations on N-terminal Thr-71 and Thr-69 of ATF2 by ERK and p38 MAPK, MEK, and p38 MAPK inhibitors blunted Thr(P)-69-ATF2 binding. Knockdown of atf2 mRNA with siRNA correlated with inhibition of il23a mRNA, but it did not affect the expression of il12/23b and il10 mRNA. These data indicate the following: (i) zymosan decreases nuclear proapoptotic CHOP, most likely by promoting its accumulation in phagocytic vesicles; (ii) zymosan-induced il23a mRNA expression is best explained through coordinated kappa B- and ATF2-dependent transcription; and (iii) il23a expression relies on complementary phosphorylation of ATF2 on Thr-69 and Thr-71 dependent on PKC and MAPK activities.	[Rodriguez, Mario; Fernandez, Nieves] Univ Valladolid, Fac Med, Dept Bioquim & Biol Mol, E-47005 Valladolid, Spain; [Domingo, Esther; Alonso, Sara; Sanchez Crespo, Mariano] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; [Garcia Frade, Javier] Hosp Univ Rio Hortega, Div Hematol, Valladolid 47012, Spain; [Eiros, Jose] Hosp Univ Rio Hortega, Div Microbiol, Valladolid 47012, Spain	Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Hospital del Rio Hortega; Hospital del Rio Hortega	Crespo, MS (corresponding author), Inst Biol & Genet Mol, C Sanz & Fores 3, Valladolid 47003, Spain.	mscres@ibgm.uva.es	Rodríguez, Mario/AAE-9602-2020; Fernández, Nieves/N-5426-2018	Rodríguez, Mario/0000-0002-4587-3863; Fernández, Nieves/0000-0002-9141-3956	Plan Nacional de Salud y Farmacia [SAF2010-15070]; Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III; Junta de Castilla y Leon	Plan Nacional de Salud y Farmacia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Plan Nacional de Salud y Farmacia Grant SAF2010-15070, Fundacion Ramon Areces, Red Tematica de Investigacion Cardiovascular from Instituto de Salud Carlos III, and Junta de Castilla y Leon.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Alvarez Y, 2012, J BIOL CHEM, V287, P35689, DOI 10.1074/jbc.M112.391839; Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; Amanso AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014591; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baan B, 2009, MOL CELL ENDOCRINOL, V311, P94, DOI 10.1016/j.mce.2009.07.023; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen D, 2007, CANCER RES, V67, P8914, DOI 10.1158/0008-5472.CAN-06-4751; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Chooi KP, 2014, J AM CHEM SOC, V136, P1698, DOI 10.1021/ja4095318; Ciccia F, 2014, ANN RHEUM DIS, V73, P1566, DOI 10.1136/annrheumdis-2012-202925; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Clavaud C, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P387; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hale KK, 1999, J IMMUNOL, V162, P4246; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Humphreys JM, 2013, J BIOL CHEM, V288, P23322, DOI 10.1074/jbc.M113.462101; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kocieda VP, 2012, J BIOL CHEM, V287, P36922, DOI 10.1074/jbc.M112.402958; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Molle C, 2013, J EXP MED, V210, P1675, DOI 10.1084/jem.20120707; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Riek AE, 2012, J BIOL CHEM, V287, P38482, DOI 10.1074/jbc.M112.386912; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Wang QW, 2013, J IMMUNOL, V190, P3246, DOI 10.4049/jimmunol.1201484; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	60	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22942	22957		10.1074/jbc.M113.522656	http://dx.doi.org/10.1074/jbc.M113.522656			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24982422	Green Published, hybrid			2022-12-28	WOS:000341017200034
J	Garcia-Sanz, P; Quintanilla, A; Lafita, MC; Moreno-Bueno, G; Garcia-Gutierrez, L; Tabor, V; Varela, I; Shiio, Y; Larsson, LG; Portillo, F; Leon, J				Garcia-Sanz, Pablo; Quintanilla, Andrea; Carmen Lafita, M.; Moreno-Bueno, Gema; Garcia-Gutierrez, Lucia; Tabor, Vedrana; Varela, Ignacio; Shiio, Yuzuru; Larsson, Lars-Gunnar; Portillo, Francisco; Leon, Javier			Sin3b Interacts with Myc and Decreases Myc Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NETWORK; C-MYC; HISTONE DEACETYLASE; GENE-EXPRESSION; CHROMATIN MODIFICATIONS; DIFFERENTIAL REGULATION; PROXIMITY LIGATION; REPRESSION DOMAIN; GENOMIC TARGETS; BREAST-CANCER	Myc expression is deregulated in many human cancers. A yeast two-hybrid screen has revealed that the transcriptional repressor Sin3b interacts with Myc protein. Endogenous Myc and Sin3b colocalize and interact in the nuclei of human and rat cells, as assessed by co-immunoprecipitation, immunofluorescence, and proximity ligation assay. The interaction is Max-independent. A conserved Myc region (amino acids 186 - 203) is required for the interaction with Sin3 proteins. Histone deacetylase 1 is recruited to Myc-Sin3b complexes, and its deacetylase activity is required for the effects of Sin3b on Myc. Myc and Sin3a/b co-occupied many sites on the chromatin of human leukemia cells, although the presence of Sin3 was not associated with gene down-regulation. In leukemia cells and fibroblasts, Sin3b silencing led to Myc up-regulation, whereas Sin3b overexpression induced Myc deacetylation and degradation. An analysis of Sin3b expression in breast tumors revealed an association between low Sin3b expression and disease progression. The data suggest that Sin3b decreases Myc protein levels upon Myc deacetylation. As Sin3b is also required for transcriptional repression by Mxd-Max complexes, our results suggest that, at least in some cell types, Sin3b limits Myc activity through two complementary activities: Mxd-dependent gene repression and reduction of Myc levels.	[Varela, Ignacio; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Sociedad El Desarrollo Cantabria, Santander 39011, Spain; [Varela, Ignacio; Leon, Javier] Univ Cantabria, CSIC, Dept Biol Mol, Santander 39011, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema; Portillo, Francisco] Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Inst Invest Hosp, Madrid 28046, Spain; [Garcia-Sanz, Pablo; Moreno-Bueno, Gema] Fdn MD Anderson Int, Madrid, Spain; [Tabor, Vedrana; Larsson, Lars-Gunnar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Shiio, Yuzuru] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; University of Texas System; University of Texas Health San Antonio	Portillo, F (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC, Inst Invest Biomed Alberto Sols,Inst Invest Hosp, Madrid 28046, Spain.	fportillo@iib.uam.es; leonj@unican.es	Leon, Javier/K-4615-2014; Gutierrez, Lucia Garcia/ABH-3682-2020; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; Moreno-Bueno, Gema/K-9354-2016	Gutierrez, Lucia Garcia/0000-0003-4396-4814; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Moreno-Bueno, Gema/0000-0002-5030-6687; Tabor, Vedrana/0000-0001-9224-208X; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X; Portillo Perez, Francisco/0000-0003-4922-346X; Leon, Javier/0000-0001-5803-0112	Ministerio de Economia y Competitividad (MINECO) [SAF11-23796]; Instituto Carlos III [RETIC/RD012/0036/0033]; MINECO [SAF2010-20175, BFU2008-04285]; Asociacion Espanola Contra el Cancer (AECC) [AECC-2011]; Comunidad de Madrid [ReCaRe S2010/BMD-2303]; European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program; Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education; Cancerfonden; Karolinska Institutet	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); MINECO(Spanish Government); Asociacion Espanola Contra el Cancer (AECC); Comunidad de Madrid(Comunidad de Madrid); European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program; Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education(German Research Foundation (DFG)); Cancerfonden(Swedish Cancer Society); Karolinska Institutet(Karolinska Institutet)	This work was supported by Grants SAF11-23796 from the Ministerio de Economia y Competitividad (MINECO) and RETIC/RD012/0036/0033 from the Instituto Carlos III (to J. L.); SAF2010-20175 from MINECO, AECC-2011 from the Asociacion Espanola Contra el Cancer (AECC), and ReCaRe S2010/BMD-2303 from Comunidad de Madrid (to G. M.-B.); and BFU2008-04285 from MINECO (to F. P.). All Spanish funding, except from the AECC, was co-sponsored by the European Union Fondo de Desarrollo Regional de la Union Europea (FEDER) program.; Recipient of a fellowship from the Formacion de Profesorado Universitario (FPU) program, Spanish Ministry of Education.; Supported by grants from the Cancerfonden and the Karolinska Institutet.	Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; DELGADO MD, 1995, ONCOGENE, V10, P1659; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gibbons RJ, 2005, HUM MOL GENET, V14, pR85, DOI 10.1093/hmg/ddi106; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Kiessling A, 2006, CHEM BIOL, V13, P745, DOI 10.1016/j.chembiol.2006.05.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Leon J, 2009, CELL CYCLE, V8, P1148, DOI 10.4161/cc.8.8.8126; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Martinato F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003650; Mauleon I, 2004, MOL CARCINOGEN, V39, P85, DOI 10.1002/mc.20000; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nascimento EM, 2011, NAT CELL BIOL, V13, P1395, DOI 10.1038/ncb2385; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao G, 1996, ONCOGENE, V12, P1165; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Xu Y, 2006, J BIOL CHEM, V281, P9260, DOI 10.1074/jbc.M511724200; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	60	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22221	22236		10.1074/jbc.M113.538744	http://dx.doi.org/10.1074/jbc.M113.538744			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951594	Green Published, hybrid			2022-12-28	WOS:000340593500036
J	Spadaro, D; Tapia, R; Jond, L; Sudol, M; Fanning, AS; Citi, S				Spadaro, Domenica; Tapia, Rocio; Jond, Lionel; Sudol, Marius; Fanning, Alan S.; Citi, Sandra			ZO Proteins Redundantly Regulate the Transcription Factor DbpA/ZONAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL TIGHT JUNCTIONS; CELL-PROLIFERATION; GENE-EXPRESSION; FACTOR ZONAB/DBPA; HIPPO PATHWAY; FUNCTIONAL INTERACTION; CONTACT INHIBITION; YAP ONCOPROTEIN; ALPHA-CATENIN; CINGULIN	The localization and activities of DbpA/ZONAB and YAP transcription factors are in part regulated by the density-dependent assembly of epithelial junctions. DbpA activity and cell proliferation are inhibited by exogenous overexpression of the tight junction (TJ) protein ZO-1, leading to a model whereby ZO-1 acts by sequestering DbpA at the TJ. However, mammary epithelial cells and mouse tissues knock-out for ZO-1 do not show increased proliferation, as predicted by this model. To address this discrepancy, we examined the localization and activity of DbpA and YAP in Madin-Darby canine kidney cells depleted either of ZO-1, or one of the related proteins ZO-2 and ZO-3 (ZO proteins), or all three together. Depletion of only one ZO protein had no effect on DbpA localization and activity, whereas depletion of ZO-1 and ZO-2, which is associated with reduced ZO-3 expression, resulted in increased DbpA localization in the cytoplasm. Only depletion of ZO-2 reduced the nuclear import of YAP. Mammary epithelial (Eph4) cells KO for ZO-1 showed junctional DbpA, demonstrating that ZO-1 is not required to sequester DbpA at junctions. However, further depletion of ZO-2 in Eph4 ZO-1KO cells, which do not express ZO-3, caused decreased junctional localization and expression of DbpA, which were rescued by the proteasome inhibitor MG132. In vitro binding assays showed that full-length ZO-1 does not interact with DbpA. These results show that ZO-2 is implicated in regulating the nuclear shuttling of YAP, whereas ZO proteins redundantly control the junctional retention and stability of DbpA, without affecting its shuttling to the nucleus.	[Spadaro, Domenica; Tapia, Rocio; Jond, Lionel; Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1211 Geneva, Switzerland; [Sudol, Marius] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Sudol, Marius] Mt Sinai Sch Med, Dept Med Nephrol, New York, NY 10029 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Geneva; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill	Citi, S (corresponding author), 4 Blvd Yvoy, CH-1211 Geneva 4, Switzerland.	sandra.citi@unige.ch		Citi, Sandra/0000-0002-6537-4818	Swiss National Fund [31003A103637, 31003A116763]; Swiss Cancer League [KFS-2813-08-2011]; Section of Biology of the Faculty of Sciences of the University of Geneva; Breast Cancer Coalition from the Pennsylvania Department of Health [RFA 50709, RFA 60707]; National Institutes of Health, NIDDK [DK061397]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, R56DK061397] Funding Source: NIH RePORTER	Swiss National Fund(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Section of Biology of the Faculty of Sciences of the University of Geneva; Breast Cancer Coalition from the Pennsylvania Department of Health; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Swiss National Fund Grants 31003A103637 and 31003A116763, Swiss Cancer League Grant KFS-2813-08-2011 (to S. C.), and the Section of Biology of the Faculty of Sciences of the University of Geneva.; Supported by Breast Cancer Coalition Grants RFA 50709 and RFA 60707 from the Pennsylvania Department of Health. Present address: Dept. of Physiology, National University of Singapore, Laboratory of Cancer Signaling and Domainopathies, Yong Loo Li School of Medicine, Block MD9, 2 Medical Dr. #04-01, Singapore 117597. E-mail: phsms@nus.edu.sg.; Supported by the National Institutes of Health, NIDDK Grant DK061397.	Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Capaldo CT, 2011, MOL BIOL CELL, V22, P1677, DOI 10.1091/mbc.E10-08-0677; Cardellini P, 1996, DEV DYNAM, V207, P104, DOI 10.1002/(SICI)1097-0177(199609)207:1<104::AID-AJA10>3.0.CO;2-0; Citi S, 2001, CELL CELL INTERACTIO, V256, P153; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; D'Atri F, 2002, J BIOL CHEM, V277, P27757, DOI 10.1074/jbc.M203717200; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kavanagh E, 2006, J CELL SCI, V119, P5098, DOI 10.1242/jcs.03297; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Lye MF, 2010, J BIOL CHEM, V285, P13907, DOI 10.1074/jbc.M109.093674; Matter K, 2007, J CELL SCI, V120, P1505, DOI 10.1242/jcs.005975; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Remue E, 2010, FEBS LETT, V584, P4175, DOI 10.1016/j.febslet.2010.09.020; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Spadaro D, 2012, ESSAYS BIOCHEM, V53, P83, DOI [10.1042/BSE0530083, 10.1042/bse0530083]; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	46	23	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22500	22511		10.1074/jbc.M114.556449	http://dx.doi.org/10.1074/jbc.M114.556449			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24986862	hybrid, Green Published			2022-12-28	WOS:000340593500059
J	Lee, N; Duan, HC; Hebert, MF; Liang, CJ; Rice, KM; Wang, J				Lee, Nora; Duan, Haichuan; Hebert, Mary F.; Liang, C. Jason; Rice, Kenneth M.; Wang, Joanne			Taste of a Pill ORGANIC CATION TRANSPORTER-3 (OCT3) MEDIATES METFORMIN ACCUMULATION AND SECRETION IN SALIVARY GLANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MONOAMINE TRANSPORTER; ORGANIC CATION TRANSPORTERS; 3 SLC22A3; PHARMACOKINETICS; DRUGS; EXPRESSION; MICE	Drug-induced taste disturbance is a common adverse drug reaction often triggered by drug secretion into saliva. Very little is known regarding the molecular mechanisms underlying salivary gland transport of xenobiotics, and most drugs are assumed to enter saliva by passive diffusion. In this study, we demonstrate that salivary glands selectively and highly express OCT3 (organic cation transporter-(3) under bar), a polyspecific drug transporter in the solute carrier 22 family. OCT3 protein is localized at both basolateral (blood-facing) and apical (saliva-facing) membranes of salivary gland acinar cells, suggesting a dual role of this transporter in mediating both epithelial uptake and efflux of organic cations in the secretory cells of salivary glands. Metformin, a widely used anti-diabetic drug known to induce taste disturbance, is transported by OCT3/Oct3 in vitro. In vivo, metformin was actively transported with a high level of accumulation in the salivary glands of wild-type mice. In contrast, active uptake and accumulation of metformin in salivary glands were abolished in Oct3(-/-) mice. Oct3(-/-) mice also showed altered metformin pharmacokinetics and reduced drug exposure in the heart. These results demonstrate that OCT3 is responsible for metformin accumulation and secretion in salivary glands. Our study uncovered a novel carrier-mediated pathway for drug entry into saliva and sheds new light on the molecular mechanisms underlying drug-induced taste disorders.	[Lee, Nora; Duan, Haichuan; Wang, Joanne] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Hebert, Mary F.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Hebert, Mary F.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Liang, C. Jason; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, J (corresponding author), Univ Washington, Dept Pharmaceut, H272J Hlth Sci Bldg, Seattle, WA 98195 USA.	jowang@uw.edu			National Institutes of Health [GM066233, GM07750, HD047892]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD047892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066233, T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM066233, GM07750, and HD047892.	Ackerman BH, 1997, PHARMACOTHERAPY, V17, P482; [Anonymous], 2009, GLUC METF HYDR; Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; Cassolato Sandra F, 2003, Gerodontology, V20, P64, DOI 10.1111/j.1741-2358.2003.00064.x; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Doty RL, 2008, DRUG SAFETY, V31, P199, DOI 10.2165/00002018-200831030-00002; Duan HC, 2013, J BIOL CHEM, V288, P3535, DOI 10.1074/jbc.M112.436972; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Efron B., 1994, CHAPMAN HALL CRC MON; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Holsinger F.C., 2007, SALIVARY GLAND DISOR, P1, DOI DOI 10.1007/978-3-540-47072-4_1; Idkaidek N, 2012, MOL PHARMACEUT, V9, P2358, DOI 10.1021/mp300250r; Illsley NP, 2000, PLACENTA, V21, P14, DOI 10.1053/plac.1999.0448; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lee AJ, 1996, PHARMACOTHERAPY, V16, P327; Lee N, 2013, DRUG METAB DISPOS, V41, P2225, DOI 10.1124/dmd.113.054072; Mager H, 1998, J PHARM SCI, V87, P372, DOI 10.1021/js970114h; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; PENTIKAINEN PJ, 1979, EUR J CLIN PHARMACOL, V16, P195, DOI 10.1007/BF00562061; Pinkstaff CA, 1998, EUR J MORPHOL, V36, P31; Quaile MP, 2010, TOXICOL APPL PHARM, V243, P340, DOI 10.1016/j.taap.2009.11.026; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Westfall P.H., 1993, RESAMPLING BASED MUL; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wu XA, 2000, AM J PHYSIOL-RENAL, V279, pF449, DOI 10.1152/ajprenal.2000.279.3.F449; Zhou MY, 2007, DRUG METAB DISPOS, V35, P1956, DOI 10.1124/dmd.107.015495; Zhu HJ, 2010, J NEUROCHEM, V114, P142, DOI 10.1111/j.1471-4159.2010.06738.x; Zwart R, 2001, MOL CELL BIOL, V21, P4188, DOI 10.1128/MCB.21.13.4188-4196.2001	32	55	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27055	27064		10.1074/jbc.M114.570564	http://dx.doi.org/10.1074/jbc.M114.570564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107910	Green Published, hybrid			2022-12-28	WOS:000342853900033
J	Erlejman, AG; De Leo, SA; Mazaira, GI; Molinari, AM; Camisay, MF; Fontana, V; Cox, MB; Piwien-Pilipuk, G; Galigniana, MD				Erlejman, Alejandra G.; De Leo, Sonia A.; Mazaira, Gisela I.; Molinari, Alejandro M.; Camisay, Mar-A Fernanda; Fontana, Vanina; Cox, Marc B.; Piwien-Pilipuk, Graciela; Galigniana, Mario D.			NF-kappa B Transcriptional Activity Is Modulated by FK506-binding Proteins FKBP51 and FKBP52 A ROLE FOR PEPTIDYL-PROLYL ISOMERASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90-BINDING IMMUNOPHILIN FKBP52; GLUCOCORTICOID-RECEPTOR; NUCLEAR TRANSLOCATION; MOLECULAR CHAPERONES; DYNEIN INTERACTION; STEROID-RECEPTORS; EXPRESSION; ACTIVATION; DOMAIN	Hsp90 binding immunophilins FKBP51 and FKBP52 modulate steroid receptor trafficking and hormone-dependent biological responses. With the purpose to expand this model to other nuclear factors that are also subject to nuclear-cytoplasmic shuttling, we analyzed whether these immunophilins modulate NF-kappa B signaling. It is demonstrated that FKBP51 impairs both the nuclear translocation rate of NF-kappa B and its transcriptional activity. The inhibitory action of FKBP51 requires neither the peptidylprolyl-isomerase activity of the immunophilin nor its association with Hsp90. The TPR domain of FKBP51 is essential. On the other hand, FKBP52 favors the nuclear retention time of RelA, its association to a DNA consensus binding sequence, and NF-kappa B transcriptional activity, the latter effect being strongly dependent on the peptidylprolyl-isomerase activity and also on the TPR domain of FKBP52, but its interaction with Hsp90 is not required. In unstimulated cells, FKBP51 forms endogenous complexes with cytoplasmic RelA. Upon cell stimulation with phorbol ester, the NF-kappa B soluble complex exchanges FKBP51 for FKBP52, and the NF-kappa B biological effect is triggered. Importantly, FKBP52 is functionally recruited to the promoter region of NF-kappa B target genes, whereas FKBP51 is released. Competition assays demonstrated that both immunophilins antagonize one another, and binding assays with purified proteins suggest that the association of RelA and immunophilins could be direct. These observations suggest that the biological action of NF-kappa B in different cell types could be positively regulated by a high FKBP52/FKBP51 expression ratio by favoring NF-kappa B nuclear retention, recruitment to the promoter regions of target genes, and transcriptional activity.	[Fontana, Vanina; Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Fontana, Vanina; Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Quim Biol Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Piwien-Pilipuk, Graciela] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Arquitectura Nucl, RA-1033 Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Receptores Nucl, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Galigniana, MD (corresponding author), IBYME CONICET, Vuelta Obligado 2490,Rm 304,C1428ADN, Buenos Aires, DF, Argentina.	mgaligniana@conicet.gov.ar	Erlejman, Alejandra/AAV-5947-2020	Erlejman, Alejandra/0000-0003-3769-4790; Cox, Marc/0000-0001-7854-2676; GALIGNIANA, MARIO/0000-0002-9130-8574	National Institutes of Health [5 G12 RR008124, 8 G12 MD007592]; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina [PICT-2010-1170, PICT-2011-1715, PICT-2010-2215, PICT-2012-2612]; University of Buenos Aires [UBACYT-2011/14-GC, UBACYT 2011/13-IJ, UBACYT 2013/15-IF]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina(ANPCyT); University of Buenos Aires(University of Buenos Aires); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR008124 (Border Biomedical Research Center from the National Center for Research Resources) and 8 G12 MD007592 (National Institute on Minority Health and Health Disparities (to M. B. C.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina Grants PICT-2010-1170 and PICT-2011-1715 (to M. D. G.), PICT-2010-2215 (to A. G. E.), and PICT-2012-2612 (to G. P.-P.) and University of Buenos Aires Grants UBACYT-2011/14-GC (to M. D. G.), UBACYT 2011/13-IJ, and UBACYT 2013/15-IF (to A. G. E.).	Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; Cioffi DL, 2011, CURR OPIN PHARMACOL, V11, P308, DOI 10.1016/j.coph.2011.03.013; Cluning C, 2013, MOL ENDOCRINOL, V27, P1020, DOI 10.1210/me.2012-1023; Colo GP, 2008, ONCOGENE, V27, P2430, DOI 10.1038/sj.onc.1210900; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Erlejman AG, 2008, ARCH BIOCHEM BIOPHYS, V476, P186, DOI 10.1016/j.abb.2008.01.024; Erlejman AG, 2014, BBA-GENE REGUL MECH, V1839, P71, DOI 10.1016/j.bbagrm.2013.12.006; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Fontana V, 2012, J MOL HISTOL, V43, P487, DOI 10.1007/s10735-012-9429-8; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Fujisawa K, 2000, PLACENTA, V21, P354, DOI 10.1053/plac.1999.0494; Gaali S, 2011, CURR MED CHEM, V18, P5355, DOI 10.2174/092986711798194342; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Galigniana MD, 2012, CHEM BIOL, V19, P662, DOI 10.1016/j.chembiol.2012.06.001; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; HOHMANN HP, 1991, MOL CELL BIOL, V11, P259, DOI 10.1128/MCB.11.1.259; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Klenke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065280; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li YF, 2012, HUM REPROD, V27, P2096, DOI 10.1093/humrep/des110; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Nelson G, 2002, J CELL SCI, V115, P1137; Nissinen L, 2014, BBA-GEN SUBJECTS, V1840, P2571, DOI 10.1016/j.bbagen.2014.03.007; Oeckinghaus A., 2009, COLD SPRING HARB PER, V1; Oh J, 2012, J IMMUNOL, V189, P5561, DOI 10.4049/jimmunol.1103415; Oshimo Y, 2004, INT J CANCER, V112, P1003, DOI 10.1002/ijc.20521; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Pilipuk GP, 2007, BIOCHEMISTRY-US, V46, P1389, DOI 10.1021/bi0621819; Quinta HR, 2012, BRIT J PHARMACOL, V166, P637, DOI 10.1111/j.1476-5381.2011.01783.x; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Raghuram N, 2013, J CELL BIOL, V203, P57, DOI 10.1083/jcb.201305159; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Romano S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.109; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salem K, 2013, EXP HEMATOL, V41, P209, DOI 10.1016/j.exphem.2012.10.002; Sanchez ER, 2012, BBA-MOL CELL RES, V1823, P722, DOI 10.1016/j.bbamcr.2011.11.006; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schif B, 2013, ONCOTARGET, V4, P35, DOI 10.18632/oncotarget.774; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Susperreguy S, 2011, EXP CELL RES, V317, P706, DOI 10.1016/j.yexcr.2010.11.008; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tsukihara S, 2004, AM J REPROD IMMUNOL, V52, P218, DOI 10.1111/j.1600-0897.2004.00209.x; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yura S, 1998, J CLIN ENDOCR METAB, V83, P3609, DOI 10.1210/jc.83.10.3609; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395	80	68	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26263	26276		10.1074/jbc.M114.582882	http://dx.doi.org/10.1074/jbc.M114.582882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104352	Green Published, hybrid			2022-12-28	WOS:000342128800021
J	Yoshida, T; Huq, TS; Delafontaine, P				Yoshida, Tadashi; Huq, Tashfin S.; Delafontaine, Patrice			Angiotensin Type 2 Receptor Signaling in Satellite Cells Potentiates Skeletal Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AT(2) RECEPTOR; DEPENDENT MECHANISM; AT2 RECEPTOR; WEIGHT-LOSS; EXPRESSION; SYSTEM; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; INHIBITORS	Patients with advanced congestive heart failure (CHF) or chronic kidney disease (CKD) often have increased angiotensin II (Ang II) levels and cachexia. Ang II infusion in rodents causes sustained skeletal muscle wasting and decreases muscle regenerative potential through Ang II type 1 receptor (AT1R)-mediated signaling, likely contributing to the development of cachexia in CHF and CKD. However, the potential role of Ang II type 2 receptor (AT2R) signaling in skeletal muscle physiology is unknown. We found that AT2R expression was increased robustly in regenerating skeletal muscle after cardiotoxin (CTX)-induced muscle injury in vivo and differentiating myoblasts in vitro, suggesting that the increase in AT2R played an important role in regulating myoblast differentiation and muscle regeneration. To determine the potential role of AT2R in muscle regeneration, we infused C57BL/6 mice with the AT2R antagonist PD123319 during CTX-induced muscle regeneration. PD123319 reduced the size of regenerating myofibers and expression of the myoblast differentiation markers myogenin and embryonic myosin heavy chain. On the other hand, AT2R agonist CGP42112 infusion potentiated CTX injury-induced myogenin and embryonic myosin heavy chain expression and increased the size of regenerating myofibers. In cultured myoblasts, AT2R knockdown by siRNA suppressed myoblast differentiation marker expression and myoblast differentiation via up-regulation of phospho-ERK1/2, and ERK inhibitor treatment completely blocked the effect of AT2R knockdown. These data indicate that AT2R signaling positively regulates myoblast differentiation and potentiates skeletal muscle regenerative potential, providing a new therapeutic target in wasting disorders such as CHF and CKD.	[Yoshida, Tadashi; Huq, Tashfin S.; Delafontaine, Patrice] Tulane Univ Sch Med, Heart & Vasc Inst, New Orleans, LA 70112 USA	Tulane University	Delafontaine, P (corresponding author), Tulane Univ Sch Med, Heart & Vasc Inst, 1430 Tulane Ave,SL-48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Yoshida, Tadashi/0000-0002-4544-1497; Delafontaine, Patrice/0000-0003-3744-3617	NHLBI, National Institutes of Health [R01-HL070241, R01-HL080682]; NIGMS, National Institutes of Health [P20-GM103629, P30-GM103337, U54-GM104940]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080682, R01HL070241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337, U54GM104940, P20GM103629] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grants R01-HL070241 and R01-HL080682 and NIGMS, National Institutes of Health Grants P20-GM103629, P30-GM103337, and U54-GM104940.	Agoudemos MM, 2005, MICROCIRCULATION, V12, P627, DOI 10.1080/10739680500301664; Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Bedair HS, 2008, AM J SPORT MED, V36, P1548, DOI 10.1177/0363546508315470; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Berk Bradford C, 2003, Sci STKE, V2003, pPE16; BLANKLEY CJ, 1991, J MED CHEM, V34, P3248, DOI 10.1021/jm00115a014; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Broderick KE, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.1; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Dalla Libera L, 2001, CIRCULATION, V103, P2195; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Echeverria-Rodriguez O, 2014, PEPTIDES, V51, P26, DOI 10.1016/j.peptides.2013.10.022; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; ICHIKI T, 1995, HYPERTENSION, V25, P720, DOI 10.1161/01.HYP.25.4.720; ICHIKI T, 1995, CIRC RES, V76, P693, DOI 10.1161/01.RES.76.5.693; Johnston APW, 2011, J RENIN-ANGIO-ALDO S, V12, P75, DOI 10.1177/1470320310381795; Johnston APW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015212; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; Masson S, 1998, PHARMACOL RES, V37, P213, DOI 10.1006/phrs.1998.0288; Murphy KT, 2012, AM J PHYSIOL-REG I, V303, pR321, DOI 10.1152/ajpregu.00007.2012; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; Painemal P, 2013, BIOFACTORS, V39, P467, DOI 10.1002/biof.1087; Prasannarong M, 2012, BIOCHEM BIOPH RES CO, V426, P369, DOI 10.1016/j.bbrc.2012.08.093; Reinecke K, 2003, FASEB J, V17, P2094, DOI 10.1096/fj.02-1193fje; Rezk BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030276; Riquelme C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093449; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Russell ST, 2006, CANCER LETT, V231, P290, DOI 10.1016/j.canlet.2005.02.007; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Steckelings UM, 2005, PEPTIDES, V26, P1401, DOI 10.1016/j.peptides.2005.03.010; Tabony AM, 2011, HYPERTENSION, V58, P643, DOI 10.1161/HYPERTENSIONAHA.111.174839; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Werner C, 2010, DRUGS, V70, P1215, DOI 10.2165/11537910-000000000-00000; Widdop RE, 2003, BRIT J PHARMACOL, V140, P809, DOI 10.1038/sj.bjp.0705448; Yablonka-Reuveni Z, 2011, STEM CELLS BIOL REG, P173, DOI 10.1007/978-1-61779-021-8_11; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Yoshida T, 2012, ENDOCRINOLOGY, V153, P1411, DOI 10.1210/en.2011-1764; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	49	19	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26239	26248		10.1074/jbc.M114.585521	http://dx.doi.org/10.1074/jbc.M114.585521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25112871	hybrid, Green Published			2022-12-28	WOS:000342128800019
J	Coulson-Thomas, VJ; Gesteira, TF; Esko, J; Kao, W				Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Esko, Jeffrey; Kao, Winston			Heparan Sulfate Regulates Hair Follicle and Sebaceous Gland Morphogenesis and Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMAL PAPILLA; ROOT SHEATH; STEM-CELLS; EXPRESSION; MOUSE; DIFFERENTIATION; PROTEOGLYCANS; SYNDECAN-1; BIOLOGY; GROWTH	Hair follicle (HF) morphogenesis and cycling are a result of intricate autonomous epithelial-mesenchymal interactions. Once the first HF cycle is complete it repeatedly undergoes cyclic transformations. Heparan sulfate (HS) proteoglycans are found on the cell surface and in the extracellular matrix where they influence a variety of biological processes by interacting with physiologically important proteins, such as growth factors. Inhibition of heparanase (an HS endoglycosidase) in in vitro cultured HFs has been shown to induce a catagen-like process. Therefore, this study aimed to elucidate the precise role of HS in HF morphogenesis and cycling. An inducible tetratransgenic mouse model was generated to excise exostosin glycosyltransferase 1 (Ext1) in keratin 14-positive cells from P21. Interestingly, EXT1(StEpi Delta/StEpi Delta) mice presented solely anagen HFs. Moreover, waxing the fur to synchronize the HFs revealed accelerated hair regrowth in the EXT1(StEpi Delta/StEpi Delta) mice and hindered cycling into catagen. The ablation of HS in the interfollicular epidermal cells of mature skin led to the spontaneous formation of new HFs and an increase in Sonic Hedgehog expression resembling wild-type mice at P0, thereby indicating that the HS/Sonic Hedgehog signaling pathway regulates HF formation during embryogenesis and prevents HF formation in mature skin. Finally, the knock-out of HS also led to the morphogenesis and hyperplasia of sebaceous glands and sweat glands in mature mice, leading to exacerbated sebum production and accumulation on the skin surface. Therefore, our findings clearly show that an intricate control of HS levels is required for HF, sebaceous gland, and sweat gland morphogenesis and HF cycling.	[Coulson-Thomas, Vivien Jane; Gesteira, Tarsis Ferreira; Kao, Winston] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Gesteira, Tarsis Ferreira] Cincinnati Childrens Hosp & Res, Div Dev Biol, Cincinnati, OH 45229 USA; [Esko, Jeffrey] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Diego	Coulson-Thomas, VJ (corresponding author), John van Geest Ctr Brain Repair, Robinson Way, Cambridge CB2 0PY, England.	vcoulsonthomas@gmail.com			National Institutes of Health from the NEI [RO1 EY011845]; NATIONAL EYE INSTITUTE [R01EY011845] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 EY011845 from the NEI.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bayer-Garner IB, 2002, AM J DERMATOPATH, V24, P484, DOI 10.1097/00000372-200212000-00005; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bush KT, 2012, J BIOL CHEM, V287, P42064, DOI 10.1074/jbc.M112.423327; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Cui CY, 2011, CELL CYCLE, V10, P3379, DOI 10.4161/cc.10.19.17669; Delehedde M, 2001, J MAMMARY GLAND BIOL, V6, P253, DOI 10.1023/A:1011367423085; DIETRICH CP, 1977, J CHROMATOGR, V130, P299, DOI 10.1016/S0021-9673(00)89809-X; Dry FW, 1926, J GENET, V16, P287, DOI 10.1007/BF02983004; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lee J, 2012, SEMIN CELL DEV BIOL, V23, P906, DOI 10.1016/j.semcdb.2012.08.003; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Malgouries S, 2008, EXP DERMATOL, V17, P1017, DOI 10.1111/j.1600-0625.2008.00739.x; Malinowska M, 2008, EUR J PEDIATR, V167, P203, DOI 10.1007/s00431-007-0462-7; Meyers JR, 2013, DEV BIOL, V378, P107, DOI 10.1016/j.ydbio.2013.04.002; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nanba D, 2013, J DERMATOL SCI, V72, P81, DOI 10.1016/j.jdermsci.2013.05.009; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Ohlig S, 2012, J BIOL CHEM, V287, P43708, DOI 10.1074/jbc.M112.356667; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Paus Ralf, 1994, Journal of Dermatological Science, V7, P202, DOI 10.1016/0923-1811(94)90096-5; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Podlasek CA, 2003, BIOL REPROD, V68, P423, DOI 10.1095/biolreprod.102.006643; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Qu XX, 2011, J BIOL CHEM, V286, P14435, DOI 10.1074/jbc.M111.225003; Richardson GD, 2009, GENE EXPR PATTERNS, V9, P454, DOI 10.1016/j.gep.2009.04.004; Schlake T, 2007, SEMIN CELL DEV BIOL, V18, P267, DOI 10.1016/j.semcdb.2007.01.005; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shah MM, 2011, DEV BIOL, V356, P19, DOI 10.1016/j.ydbio.2011.05.004; Srivastava AK, 2001, HUM MOL GENET, V10, P2973, DOI 10.1093/hmg/10.26.2973; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Sugawara K, 2010, J DERMATOL SCI, V57, P155, DOI 10.1016/j.jdermsci.2009.12.004; Swee LK, 2009, J BIOL CHEM, V284, P27567, DOI 10.1074/jbc.M109.042259; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Whitbread LA, 1998, EXP CELL RES, V244, P448, DOI 10.1006/excr.1998.4217; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Ye JX, 2013, INT J MED SCI, V10, P691, DOI 10.7150/ijms.6170; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424	58	26	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25211	25226		10.1074/jbc.M114.572511	http://dx.doi.org/10.1074/jbc.M114.572511			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053416	Green Published, hybrid			2022-12-28	WOS:000341985300041
J	Edmunds, LR; Sharma, L; Kang, A; Lu, J; Vockley, J; Basu, S; Uppala, R; Goetzman, ES; Beck, ME; Scott, D; Prochownik, EV				Edmunds, Lia R.; Sharma, Lokendra; Kang, Audry; Lu, Jie; Vockley, Jerry; Basu, Shrabani; Uppala, Radha; Goetzman, Eric S.; Beck, Megan E.; Scott, Donald; Prochownik, Edward V.			c-Myc Programs Fatty Acid Metabolism and Dictates Acetyl-CoA Abundance and Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE M2; TUMOR-CELLS; GLUTAMINE ADDICTION; DEHYDROGENASE; OXIDATION; PHOSPHORYLATION; REGULATOR; CANCER; DEGRADATION; CARBOXYLASE	myc(-/-) rat fibroblasts (KO cells) differ from myc(+/+) (WT) cells and KO cells with enforced Myc re-expression (KO-Myc cells) with respect to mitochondrial structure and function, utilization of glucose and glutamine as energy-generating substrates, and ATP levels. Specifically, KO cells demonstrate low levels of glycolysis and oxidative phosphorylation, dysfunctional mitochondria and electron transport chain complexes, and depleted ATP stores. We examined here how these cells adapt to their energy-deficient state and how they differ in their uptake and utilization of long-and medium-chain fatty acids such as palmitate and octanoate, respectively. Metabolic tracing of these molecules showed that KO cells preferentially utilize them as beta-oxidation substrates and that, rather than directing them into phospholipids, preferentially store them as neutral lipids. KO cell transcriptional profiling and functional assays revealed a generalized up-regulation of pathways involved in fatty acid transport and catabolism as well as evidence that these cells attempt to direct acetyl-CoA into the tricarboxylic acid (TCA) cycle for ATP production rather than utilizing it for anabolic purposes. Additional evidence to support this idea included the finding that AMP-dependent protein kinase was constitutively activated in KO cells. The complex control of pyruvate dehydrogenase, which links glycolysis to the TCA cycle, was also maximized to ensure the conversion of pyruvate to acetyl-CoA. Despite these efforts to maximize acetyl-CoA for energy-generating purposes, its levels remained chronically low in KO cells. This suggests that tumor cells with Myc deregulation might be susceptible to novel therapies that limit acetylCoA availability.	[Edmunds, Lia R.; Sharma, Lokendra; Kang, Audry; Lu, Jie; Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA; [Vockley, Jerry; Basu, Shrabani; Uppala, Radha; Goetzman, Eric S.; Beck, Megan E.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA 15224 USA; [Scott, Donald] Mt Sinai Sch Med, Dept Med, Div Endocrinol Diabet & Bone Dis, New York, NY 10029 USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Div Hematol Oncol, Rm 5124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu	Vockley, Jerry/B-5210-2016; Vockley, Jerry/AAF-8523-2020	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Basu, Shrabani/0000-0001-5096-5490	National Institutes of Health [DK78775, DK090242, DK065149, CA140624-05]; Children's Hospital of Pittsburgh of UPMC Health Systems Research Advisory Committee; NATIONAL CANCER INSTITUTE [R01CA174713, R01CA140624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078775, R56DK065149, R01DK065149, R01DK090242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh of UPMC Health Systems Research Advisory Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants DK78775 (to J. V.), DK090242 (to E. S. G.), DK065149 (to D. S.), and CA140624-05 (to E. V. P.).; Supported by a predoctoral fellowship award from the Children's Hospital of Pittsburgh of UPMC Health Systems Research Advisory Committee.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028981; Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Cuthbert KD, 2005, CURR HYPERTENS REP, V7, P407, DOI 10.1007/s11906-005-0034-z; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CELL CYCLE, V8, P3243, DOI 10.4161/cc.8.20.9522; Delmastro-Greenwood MM, 2013, ANTIOXID REDOX SIGN, V19, P1902, DOI 10.1089/ars.2012.5167; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Goetzman ES, 2011, PROG MOL BIOL TRANSL, V100, P389, DOI 10.1016/B978-0-12-384878-9.00010-8; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Li FR, 2005, POWER ENGINEER, V19, P25, DOI 10.1049/pe:20050104; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PETTIT FH, 1975, BIOCHEM BIOPH RES CO, V65, P575, DOI 10.1016/S0006-291X(75)80185-9; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rodriguez-Enriquez S, 2011, CURR MED CHEM, V18, P3156, DOI 10.2174/092986711796391561; Sato R, 1995, CELL STRUCT FUNCT, V20, P421, DOI 10.1247/csf.20.421; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Vockley J, 2000, METHOD ENZYMOL, V324, P241; Wallace JC, 1998, INT J BIOCHEM CELL B, V30, P1, DOI 10.1016/S1357-2725(97)00147-7; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	50	70	71	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25382	25392		10.1074/jbc.M114.580662	http://dx.doi.org/10.1074/jbc.M114.580662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053415	Green Published, hybrid			2022-12-28	WOS:000341985300056
J	Ovchinnikov, KV; Kristiansen, PE; Uzelac, G; Topisirovic, L; Kojic, M; Nissen-Meyer, J; Nes, IF; Diep, DB				Ovchinnikov, Kirill V.; Kristiansen, Per E.; Uzelac, Gordana; Topisirovic, Ljubisa; Kojic, Milan; Nissen-Meyer, Jon; Nes, Ingolf F.; Diep, Dzung B.			Defining the Structure and Receptor Binding Domain of the Leaderless Bacteriocin LsbB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptide (AMP); Nuclear Magnetic Resonance (NMR); Peptide Interaction; Receptor; Structural Biology; Zn-dependent Protease; Bacteriocin Receptor; Leaderless Bacteriocin	LACTIC-ACID BACTERIA; TORSION ANGLE DYNAMICS; CLASS-II BACTERIOCINS; ANTIMICROBIAL PEPTIDE; 2-PEPTIDE BACTERIOCIN; NMR; ENTEROCOCCUS; PROTEIN; SPECTROSCOPY; MECHANISMS	Background: The bacteriocin LsbB targets a membrane-bound zinc-dependent peptidase. Results: The structure of LsbB was resolved by NMR. The C-terminal unstructured domains of LsbB and several other related bacteriocins were responsible for receptor binding. Conclusion: A subgroup of leaderless bacteriocins has been found to share a similar mechanism in receptor recognition. Significance: The study highlights the structure-function relationship of LsbB. LsbB is a class II leaderless lactococcal bacteriocin of 30 amino acids. In the present work, the structure and function relationship of LsbB was assessed. Structure determination by NMR spectroscopy showed that LsbB has an N-terminal -helix, whereas the C-terminal of the molecule remains unstructured. To define the receptor binding domain of LsbB, a competition assay was performed in which a systematic collection of truncated peptides of various lengths covering different parts of LsbB was used to inhibit the antimicrobial activity of LsbB. The results indicate that the outmost eight-amino acid sequence at the C-terminal end is likely to contain the receptor binding domain because only truncated fragments from this region could antagonize the antimicrobial activity of LsbB. Furthermore, alanine substitution revealed that the tryptophan in position 25 (Trp(25)) is crucial for the blocking activity of the truncated peptides, as well as for the antimicrobial activity of the full-length bacteriocin. LsbB shares significant sequence homology with five other leaderless bacteriocins, especially at their C-terminal halves where all contain a conserved KXXXGXXPWE motif, suggesting that they might recognize the same receptor as LsbB. This notion was supported by the fact that truncated peptides with sequences derived from the C-terminal regions of two LsbB-related bacteriocins inhibited the activity of LsbB, in the same manner as found with the truncated version of LsbB. Taken together, these structure-function studies provide strong evidence that the receptor-binding parts of LsbB and sequence-related bacteriocins are located in their C-terminal halves.	[Ovchinnikov, Kirill V.; Nes, Ingolf F.; Diep, Dzung B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Kristiansen, Per E.; Nissen-Meyer, Jon] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Uzelac, Gordana; Topisirovic, Ljubisa; Kojic, Milan] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade 11000, Serbia	Norwegian University of Life Sciences; University of Oslo; University of Belgrade	Diep, DB (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	dzung.diep@nmbu.no	Nissen-Meyer, Jon/Y-8727-2019; Kristiansen, Per Eugen/L-5798-2019; Diep, Dzung B./AAK-1419-2021; Diệp, Dzũng/ABG-9262-2020; Kojic, Milan/I-4528-2019	Kojic, Milan/0000-0001-5645-750X; Diep, Dzung/0000-0001-7661-5501	Norwegian University of Life Sciences; Norwegian Centennial Chair program; Ministry of Education, Science and Technological Development of the Republic of Serbia [173019]	Norwegian University of Life Sciences; Norwegian Centennial Chair program; Ministry of Education, Science and Technological Development of the Republic of Serbia	This work was supported by a quota scholarship from Norwegian University of Life Sciences and a grant from the Norwegian Centennial Chair program (to K. V. O.) and by Grant 173019 from the Ministry of Education, Science and Technological Development of the Republic of Serbia (to G. U., L. T., and M. K.).	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Benmechernene Zineb, 2013, Recent Pat DNA Gene Seq, V7, P66; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cintas LM, 2000, J BACTERIOL, V182, P6806, DOI 10.1128/JB.182.23.6806-6814.2000; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Diep DB, 1995, MOL MICROBIOL, V18, P631, DOI 10.1111/j.1365-2958.1995.mmi_18040631.x; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; Gajic O, 2003, J BIOL CHEM, V278, P34291, DOI 10.1074/jbc.M211100200; Galvez A, 1998, ARCH MICROBIOL, V171, P59, DOI 10.1007/s002030050678; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haugen HS, 2011, APPL ENVIRON MICROB, V77, P1966, DOI 10.1128/AEM.02488-10; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLO H, 1991, J BACTERIOL, V173, P3879, DOI 10.1128/JB.173.12.3879-3887.1991; HURD RE, 1991, J MAGN RESON, V91, P648, DOI 10.1016/0022-2364(91)90395-A; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Johnsen L, 2005, J BIOL CHEM, V280, P9243, DOI 10.1074/jbc.M412712200; Keeler J., 2010, UNDERSTANDING NMR SP; Keller R., 2004, COMPUTER AIDED RESON, V1; Kjos M, 2011, APPL ENVIRON MICROB, V77, P3335, DOI 10.1128/AEM.02602-10; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kristiansen PE, 2005, J BIOL CHEM, V280, P22945, DOI 10.1074/jbc.M501620200; Liu XJ, 2011, J AGR FOOD CHEM, V59, P5602, DOI 10.1021/jf104751v; Lohans CT, 2014, J ANTIBIOT, V67, P23, DOI 10.1038/ja.2013.81; Lohans CT, 2013, BIOCHEMISTRY-US, V52, P3987, DOI 10.1021/bi400359z; Nes IF, 1996, ANTON LEEUW INT J G, V70, P113, DOI 10.1007/BF00395929; Nes IF, 2007, J BACTERIOL, V189, P1189, DOI 10.1128/JB.01254-06; Nissen-Meyer J, 2009, CURR PHARM BIOTECHNO, V10, P19, DOI 10.2174/138920109787048661; Nissen-Meyer J, 2010, PROBIOTICS ANTIMICRO, V2, P52, DOI 10.1007/s12602-009-9021-z; Oppegard C, 2010, MICROBIOL-SGM, V156, P1883, DOI 10.1099/mic.0.038430-0; Rihakova J, 2009, APPL ENVIRON MICROB, V75, P1811, DOI 10.1128/AEM.02266-08; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder AB, 2014, J SCI FOOD AGR, V94, P28, DOI 10.1002/jsfa.6293; Uzelac G, 2013, J BACTERIOL, V195, P5614, DOI 10.1128/JB.00859-13; Wang YJ, 1999, BIOCHEMISTRY-US, V38, P15438, DOI 10.1021/bi991351x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zendo T, 2013, BIOSCI BIOTECH BIOCH, V77, P893, DOI 10.1271/bbb.130014	42	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23838	23845		10.1074/jbc.M114.579698	http://dx.doi.org/10.1074/jbc.M114.579698			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993828	Green Published, hybrid			2022-12-28	WOS:000341505000050
J	Pandyarajan, V; Phillips, NB; Cox, GP; Yang, YW; Whittaker, J; Ismail-Beigi, F; Weiss, MA				Pandyarajan, Vijay; Phillips, Nelson B.; Cox, Gabriela P.; Yang, Yanwu; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Weiss, Michael A.			Biophysical Optimization of a Therapeutic Protein by Nonstandard Mutagenesis STUDIES OF AN IODO-INSULIN DERIVATIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Hormone; Insulin; Nuclear Magnetic Resonance (NMR); Protein Design; Protein Stability; Nonstandard Mutagenesis; Protein Allostery	RECEPTOR-BINDING; B-CHAIN; LIGAND INTERACTIONS; BIOLOGICAL-ACTIVITY; MONOMERIC INSULINS; CIRCULAR-DICHROISM; PUMP THERAPY; AGE-GROUP; HEXAMER; THYROXINE	Background: Therapeutic engineering of insulin analogs is ordinarily limited by a trade-off between pharmacokinetics and stability. Results: Substitution of Tyr(B26) in a rapid-acting insulin analog by 3-iodo-Tyr(B26) enhances its biophysical and pharmaceutical properties. Conclusion: An unnatural amino acid substitution circumvents insulin pharmacokinetic/stability trade-off. Significance: Nonstandard mutagenesis can optimize the molecular properties of therapeutic proteins. Insulin provides a model for the therapeutic application of protein engineering. A paradigm in molecular pharmacology was defined by design of rapid-acting insulin analogs for the prandial control of glycemia. Such analogs, a cornerstone of current diabetes regimens, exhibit accelerated subcutaneous absorption due to more rapid disassembly of oligomeric species relative to wild-type insulin. This strategy is limited by a molecular trade-off between accelerated disassembly and enhanced susceptibility to degradation. Here, we demonstrate that this trade-off may be circumvented by nonstandard mutagenesis. Our studies employed Lys(B28), Pro(B29)-insulin (lispro) as a model prandial analog that is less thermodynamically stable and more susceptible to fibrillation than is wild-type insulin. We have discovered that substitution of an invariant tyrosine adjoining the engineered sites in lispro (Tyr(B26)) by 3-iodo-Tyr (i) augments its thermodynamic stability (G(u) 0.5 +/- 0.2 kcal/mol), (ii) delays onset of fibrillation (lag time on gentle agitation at 37 degrees C was prolonged by 4-fold), (iii) enhances affinity for the insulin receptor (1.5 +/- 0.1-fold), and (iv) preserves biological activity in a rat model of diabetes mellitus. H-1 NMR studies suggest that the bulky iodo-substituent packs within a nonpolar interchain crevice. Remarkably, the 3-iodo-Tyr(B26) modification stabilizes an oligomeric form of insulin pertinent to pharmaceutical formulation (the R-6 zinc hexamer) but preserves rapid disassembly of the oligomeric form pertinent to subcutaneous absorption (T-6 hexamer). By exploiting this allosteric switch, 3-iodo-Tyr(B26)-lispro thus illustrates how a nonstandard amino acid substitution can mitigate the unfavorable biophysical properties of an engineered protein while retaining its advantages.	[Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Cox, Gabriela P.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem Med & Biomed Engn, Cleveland, OH 44016 USA.	michael.weiss@case.edu		Pandyarajan, Vijay/0000-0002-8835-5601	National Institutes of Health [DK04949, DK079233]; institutional National Institutes of Health (NIH) Grant [T32 GM007250]; individual NIH Fellowship [F30 DK094685-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK079233, F30DK094685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional National Institutes of Health (NIH) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); individual NIH Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK04949 and DK079233 (to M. A. W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology. In relation to unrelated insulin analogs, M. A. W. and F. I.-B. have stock in Thermalin Diabetes, LLC Cleveland, OH, for which N. B. P. and J. W. are consultants. M. A. W. is the Chief Scientific Officer and a Director.; A predoctoral fellow of the Case Western Reserve University Medical Scientist Training Program supported by institutional National Institutes of Health (NIH) Grant T32 GM007250 and individual NIH Fellowship F30 DK094685-04.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Bakaysa DL, 1996, PROTEIN SCI, V5, P2521, DOI 10.1002/pro.5560051215; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barany G., 1980, PEPTIDES, P273; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bharucha T, 2005, J PAEDIATR CHILD H, V41, P522, DOI 10.1111/j.1440-1754.2005.00696.x; Birnbaum DT, 1997, PHARMACEUT RES, V14, P25, DOI 10.1023/A:1012095115151; Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Brange J., 1987, GALENICS INSULIN PHY, V36, P40; BREMS DN, 1992, PROTEIN ENG, V5, P519, DOI 10.1093/protein/5.6.519; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Chemburkar SR, 2010, TETRAHEDRON, V66, P1955, DOI 10.1016/j.tet.2009.12.044; Choh H. L., 1978, HORMONAL PROTEINS PE, V6, P107; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; DEREWENDA U, 1989, BRIT MED BULL, V45, P4, DOI 10.1093/oxfordjournals.bmb.a072320; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; FRANK BH, 1983, DIABETES, V32, P705, DOI 10.2337/diab.32.8.705; FREYCHET P, 1971, BIOCHEM BIOPH RES CO, V43, P400, DOI 10.1016/0006-291X(71)90767-4; Groenhof G, 2013, ANGEW CHEM INT EDIT, V52, P12489, DOI 10.1002/anie.201309174; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; Havelund S, 2004, PHARM RES-DORDR, V21, P1498, DOI 10.1023/B:PHAM.0000036926.54824.37; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; KAARSHOLM NC, 1989, BIOCHEMISTRY-US, V28, P4427, DOI 10.1021/bi00436a046; KUBIAK T, 1986, INT J PEPT PROT RES, V27, P514; Kupper FC, 2011, ANGEW CHEM INT EDIT, V50, P11598, DOI 10.1002/anie.201100028; Landau Z, 2014, DIABETES-METAB RES, V30, P686, DOI 10.1002/dmrr.2536; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; LINDE S, 1981, H-S Z PHYSIOL CHEM, V362, P573, DOI 10.1515/bchm2.1981.362.1.573; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pace CN, 2000, PROTEINS, P1; PEAVY DE, 1984, ENDOCRINOLOGY, V114, P1818, DOI 10.1210/endo-114-5-1818; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; ROY M, 1989, J BIOL CHEM, V264, P19081; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sandler B, 2004, J BIOL CHEM, V279, P55801, DOI 10.1074/jbc.M410124200; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; Shalitin S, 2008, HORM RES, V70, P14, DOI 10.1159/000129673; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; THUROW H, 1984, DIABETOLOGIA, V27, P212; TRUESDALE VW, 1995, MAR CHEM, V48, P143, DOI 10.1016/0304-4203(94)00052-F; Venturi S., 2011, CURR CHEM BIOL, V5, P155, DOI [10.2174/187231311796765012, DOI 10.2174/187231311796765012]; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; West AP, 1997, J PHYS ORG CHEM, V10, P347, DOI 10.1002/(SICI)1099-1395(199705)10:5<347::AID-POC893>3.0.CO;2-X; Wheeler HL, 1909, J BIOL CHEM, V7, P1; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	82	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23367	23381		10.1074/jbc.M114.588277	http://dx.doi.org/10.1074/jbc.M114.588277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993826	hybrid, Green Published			2022-12-28	WOS:000341505000012
J	Yin, LS; Trenh, P; Guce, A; Wieczorek, M; Lange, S; Sticht, J; Jiang, W; Bylsma, M; Mellins, ED; Freund, C; Stern, LJ				Yin, Liusong; Trenh, Peter; Guce, Abigail; Wieczorek, Marek; Lange, Sascha; Sticht, Jana; Jiang, Wei; Bylsma, Marissa; Mellins, Elizabeth D.; Freund, Christian; Stern, Lawrence J.			Susceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Conformational Change; Enzyme Kinetics; Enzyme Mechanism; Major Histocompatibility Complex (MHC); Protein-Protein Interaction; DM Susceptibility	MHC CLASS-II; SMALL-ANGLE SCATTERING; T-CELL EPITOPES; ANTIGEN PRESENTATION; KINETIC STABILITY; BIOLOGICAL MACROMOLECULES; CUTTING EDGE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HYDROGEN-BONDS	Background: HLA-DM-mediated peptide exchange is a key factor in epitope selection, but how HLA-DM selects peptides for editing is not known. Results: Peptide complexes sensitive to HLA-DM editing exhibited conformational alterations. Conclusion: HLA-DM efficiently identifies unstable complexes by sensing MHCII-peptide conformations. Significance: These data emphasize HLA-DM as a conformational editor and provide novel mechanistic insight into its function. HLA-DM mediates the exchange of peptides loaded onto MHCII molecules during antigen presentation by a mechanism that remains unclear and controversial. Here, we investigated the sequence and structural determinants of HLA-DM interaction. Peptides interacting nonoptimally in the P1 pocket exhibited low MHCII binding affinity and kinetic instability and were highly susceptible to HLA-DM-mediated peptide exchange. These changes were accompanied by conformational alterations detected by surface plasmon resonance, SDS resistance assay, antibody binding assay, gel filtration, dynamic light scattering, small angle x-ray scattering, and NMR spectroscopy. Surprisingly, all of those changes could be reversed by substitution of the P9 pocket anchor residue. Moreover, MHCII mutations outside the P1 pocket and the HLA-DM interaction site increased HLA-DM susceptibility. These results indicate that a dynamic MHCII conformational determinant rather than P1 pocket occupancy is the key factor determining susceptibility to HLA-DM-mediated peptide exchange and provide a molecular mechanism for HLA-DM to efficiently target unstable MHCII-peptide complexes for editing and exchange those for more stable ones.	[Yin, Liusong; Trenh, Peter; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Program Immunol & Microbiol, Worcester, MA 01605 USA; [Guce, Abigail; Bylsma, Marissa; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Wieczorek, Marek; Lange, Sascha; Sticht, Jana; Freund, Christian] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Jiang, Wei; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Med Ctr, Stanford, CA 94305 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Free University of Berlin; Stanford University	Stern, LJ (corresponding author), Univ Massachusetts, Sch Med, ASC9 2055, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu		Mellins, Elizabeth/0000-0003-2577-139X	National Institutes of Health from NCRR [AI48833, AI57319, AI095813, UL1 RR025744]; Lucile Packard Foundation for Children's Health; Deutsche Forschungsgemeinschaft [FR 1325/11-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, R21AI095813, R37AI038996, R01AI048833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; Lucile Packard Foundation for Children's Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI48833 and AI57319 (to L. J. S.), AI095813 (to E. D. M.), and UL1 RR025744 from NCRR (to W. J. and E. D. M.). This work was also supported by the Lucile Packard Foundation for Children's Health (to W. J. and E. D. M.) and Deutsche Forschungsgemeinschaft Grant FR 1325/11-1 (to C. F.).	Amria S, 2008, EUR J IMMUNOL, V38, P1961, DOI 10.1002/eji.200738100; Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Anderson MW, 2005, BIOCHEMISTRY-US, V44, P5617, DOI 10.1021/bi048675s; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Busch R, 1998, J IMMUNOL, V160, P734; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Doebele RC, 2003, J IMMUNOL, V170, P4683, DOI 10.4049/jimmunol.170.9.4683; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Ferrante A, 2013, IMMUNOLOGY, V138, P85, DOI 10.1111/imm.12030; Ferrante A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00386; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; Ferrante A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003722; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Hall FC, 2002, EUR J IMMUNOL, V32, P662, DOI 10.1002/1521-4141(200203)32:3<662::AID-IMMU662>3.0.CO;2-5; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; Hanvesakul R, 2007, AM J TRANSPLANT, V7, P1148, DOI 10.1111/j.1600-6143.2007.01743.x; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kremer AN, 2012, BLOOD, V120, P3246, DOI 10.1182/blood-2011-12-399311; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Narayan K, 2009, MOL IMMUNOL, V46, P3157, DOI 10.1016/j.molimm.2009.07.001; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Painter CA, 2012, IMMUNOL REV, V250, P144, DOI 10.1111/imr.12003; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Pu Z, 2004, IMMUNITY, V20, P467, DOI 10.1016/S1074-7613(04)00073-1; Pu Z, 2002, P NATL ACAD SCI USA, V99, P8844, DOI 10.1073/pnas.092260499; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Sadegh-Nasseri S, 2010, IMMUNOL RES, V47, P56, DOI 10.1007/s12026-009-8138-1; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schlundt A, 2012, J MOL BIOL, V423, P294, DOI 10.1016/j.jmb.2012.07.008; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schulze MSED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069228; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Smith HJ, 2011, TRANSPLANTATION, V91, P279, DOI 10.1097/TP.0b013e318203862d; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; SVERGUN DI, 1982, STUD BIOPHYS, V87, P277; Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wolpl A, 1998, TISSUE ANTIGENS, V51, P258; Yin LS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00336; Yin LS, 2014, J IMMUNOL METHODS, V406, P21, DOI 10.1016/j.jim.2014.02.008; Yin LS, 2012, J IMMUNOL, V189, P3983, DOI 10.4049/jimmunol.1200626; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	75	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23449	23464		10.1074/jbc.M114.585539	http://dx.doi.org/10.1074/jbc.M114.585539			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002586	Green Published, hybrid			2022-12-28	WOS:000341505000019
J	Gomez-Cambronero, J; Carman, GM				Gomez-Cambronero, Julian; Carman, George M.			Thematic Minireview Series on Phospholipase D and Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							LIPID PHOSPHATE PHOSPHATASES; SIGNAL-TRANSDUCTION; RAT-BRAIN; CELLS; EXPRESSION; ISOFORM; ACID; METASTASIS; DESIGN; ENZYME	Phospholipase D (PLD) signaling plays a critical role in cell growth and proliferation, vesicular trafficking, secretion, and endocytosis. At the cellular level, PLD and its reaction product, phosphatidate, interact with a large number of protein partners that are directly related to the actin cytoskeleton and cell migration. Cancer invasion and metastasis rely heavily on cellular motility, and as such, they have put PLD at center stage in cancer research. This minireview series highlights some of the molecular mechanisms that provide evidence for the emerging tumorigenic potential of PLD, the role of the microenvironment, and putative connections with inflammation. PLD represents a potential target for the rational development of therapeutics against cancer and other diseases.	[Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	University System of Ohio; Wright State University Dayton; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	julian.cambronero@wright.edu; carman@aesop.rutgers.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	NHLBI NIH HHS [R01 HL056653] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055325; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; EXTON JH, 1990, J BIOL CHEM, V265, P1; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; HANAHAN DJ, 1947, J BIOL CHEM, V168, P233; HANAHAN DJ, 1947, J BIOL CHEM, V169, P699; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Kang DW, 2014, J BIOL CHEM, V289, P22575, DOI 10.1074/jbc.R114.569822; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Marguerite V, 2013, INT J BIOCHEM CELL B, V45, P213, DOI 10.1016/j.biocel.2012.09.018; Pye DS, 2013, J IMMUNOL, V191, P1496, DOI 10.4049/jimmunol.1203484; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; SAITO M, 1973, BIOCHEM BIOPH RES CO, V53, P391, DOI 10.1016/0006-291X(73)90674-8; Saito M, 2007, ONCOL REP, V18, P1329; Schwartz N, 2014, HORM CANCER-US, V5, P22, DOI 10.1007/s12672-013-0161-y; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Son JC, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.75; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Uchida H, 1999, ANTICANCER RES, V19, P671; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WANG XM, 1994, J BIOL CHEM, V269, P20312; Wang XM, 2014, SIGNAL COMMUN PLANTS, V20, P3, DOI 10.1007/978-3-642-42011-5_1; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zhang Y, 2014, J BIOL CHEM, V289, P22567, DOI 10.1074/jbc.R114.576876; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	38	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22554	22556		10.1074/jbc.R114.593137	http://dx.doi.org/10.1074/jbc.R114.593137			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990954	Green Published, hybrid			2022-12-28	WOS:000341017200001
J	Stawikowski, MJ; Aukszi, B; Stawikowska, R; Cudic, M; Fields, GB				Stawikowski, Maciej J.; Aukszi, Beatrix; Stawikowska, Roma; Cudic, Mare; Fields, Gregg B.			Glycosylation Modulates Melanoma Cell alpha 2 beta 1 and alpha 3 beta 1 Integrin Interactions with Type IV Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; AMINO-ACID-SEQUENCE; REPEATING TRIPEPTIDE PATTERN; LYSYL HYDROXYLASE 3; CRYSTAL-STRUCTURE; LIGAND-BINDING; ALPHA(3)BETA(1) INTEGRIN; LYSYL-HYDROXYLASE-3 LH3; ALPHA-1-BETA-1 INTEGRIN; MOLECULAR ARCHITECTURE	Although type IV collagen is heavily glycosylated, the influence of this post-translational modification on integrin binding has not been investigated. In the present study, galactosylated and nongalactosylated triple-helical peptides have been constructed containing the alpha 1(IV)382-393 and alpha 1(IV)531-543 sequences, which are binding sites for the alpha 2 beta 1 and alpha 3 beta 1 integrins, respectively. All peptides had triple-helical stabilities of 37 degrees C or greater. The galactosylation of Hyl(393) in alpha 1(IV)382-393 and Hyl(540) and Hyl(543) in alpha 1(IV) 531-543 had a dose-dependent influence on melanoma cell adhesion that was much more pronounced in the case of alpha 3 beta 1 integrin binding. Molecular modeling indicated that galactosylation occurred on the periphery of alpha 2 beta 1 integrin interaction with alpha 1(IV)382-393 but right in the middle of alpha 3 beta 1 integrin interaction with alpha 1(IV)531-543. The possibility of extracellular deglycosylation of type IV collagen was investigated, but no beta-galactosidase-like activity capable of collagen modification was found. Thus, glycosylation of collagen can modulate integrin binding, and levels of glycosylation could be altered by reduction in expression of glycosylation enzymes but most likely not by extracellular deglycosylation activity.	[Stawikowski, Maciej J.; Stawikowska, Roma; Cudic, Mare; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Aukszi, Beatrix] Nova SE Univ, Ft Lauderdale, FL 33314 USA	Torrey Pines Institute for Molecular Studies, Florida; Nova Southeastern University	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org	Stawikowski, Maciej J./AAH-5790-2021	Stawikowski, Maciej J./0000-0002-6394-459X	National Institutes of Health [CA77402]; NATIONAL CANCER INSTITUTE [R01CA077402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA77402 (to G. B. F.).	Allen BL, 2002, MICROB PATHOGENESIS, V32, P191, DOI 10.1006/mpat.2002.0496; ANBAZHAGAN R, 1995, J PATHOL, V176, P227, DOI 10.1002/path.1711760304; Andersson IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017881; BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BABIARZ B, 1992, EXP CELL RES, V203, P276, DOI 10.1016/0014-4827(92)90065-G; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baronas-Lowell D, 2004, J BIOL CHEM, V279, P43503, DOI 10.1074/jbc.M405979200; Barth L, 2009, ADV EXP MED BIOL, V611, P295, DOI 10.1007/978-0-387-73657-0_132; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Dent WH, 2002, ORG LETT, V4, P1249, DOI 10.1021/ol017241b; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.0.CO;2-U; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hoekstra HJ, 2008, INT J HYPERTHER, V24, P227, DOI 10.1080/02656730701816402; Holm B, 2000, TETRAHEDRON, V56, P1579, DOI 10.1016/S0040-4020(00)00061-2; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Humphries MJ, 2001, SCIENCE, V294, P316, DOI 10.1126/science.1066240; Hwang ES, 2010, PROTEIN SCI, V19, P1053, DOI 10.1002/pro.383; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4; LAFERTE S, 1988, CANCER RES, V48, P4743; Lauer JL, 1998, BIOCHEMISTRY-US, V37, P5279, DOI 10.1021/bi972958l; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Lee MM, 2014, J BIOL CHEM, V289, P8742, DOI 10.1074/jbc.C113.546713; Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Lin ECK, 1997, J BIOL CHEM, V272, P14236, DOI 10.1074/jbc.272.22.14236; Lin ECK, 1997, J BIOL CHEM, V272, P23912, DOI 10.1074/jbc.272.38.23912; LONG CG, 1995, BIOPOLYMERS, V35, P621, DOI 10.1002/bip.360350608; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MARSHALL JF, 1991, INT J CANCER, V49, P924, DOI 10.1002/ijc.2910490621; MELCHIORI A, 1995, EXP CELL RES, V219, P233, DOI 10.1006/excr.1995.1223; MILES AJ, 1994, J BIOL CHEM, V269, P30939; MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047; Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; NAYAK BR, 1991, J BIOL CHEM, V266, P13978; PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P20438, DOI 10.1074/jbc.271.34.20438; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Renner C, 2004, BIOPOLYMERS, V76, P34, DOI 10.1002/bip.10569; Ruoslahti E., 1991, CELL BIOL EXTRACELLU, P343; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sacca B, 2002, CHEMBIOCHEM, V3, P904, DOI 10.1002/1439-7633(20020902)3:9<904::AID-CBIC904>3.0.CO;2-I; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; SEYER JM, 1989, EUR J BIOCHEM, V181, P159, DOI 10.1111/j.1432-1033.1989.tb14707.x; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SPIRO MJ, 1971, J BIOL CHEM, V246, P4910; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; STERNBERG M, 1979, J BIOL CHEM, V254, P329; Syed BM, 2004, TETRAHEDRON, V60, P5571, DOI 10.1016/j.tet.2004.04.081; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; TAKADA Y, 1988, J CELL BIOCHEM, V37, P385, DOI 10.1002/jcb.240370406; TENCHINI ML, 1993, CELL ADHES COMMUN, V1, P55, DOI 10.3109/15419069309095681; Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; URUSHIZAKI Y, 1985, P NATL ACAD SCI USA, V82, P3091, DOI 10.1073/pnas.82.10.3091; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yegorova S, 2013, ANAL BIOCHEM, V439, P123, DOI 10.1016/j.ab.2013.04.028; Yongye AB, 2012, BIOCHEMISTRY-US, V51, P7278, DOI 10.1021/bi300761s; YOSHINAGA IG, 1993, MELANOMA RES, V3, P435, DOI 10.1097/00008390-199311000-00006; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zimina EP, 2007, J BIOL CHEM, V282, P22737, DOI 10.1074/jbc.M701937200; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	102	24	24	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21591	21604		10.1074/jbc.M114.572073	http://dx.doi.org/10.1074/jbc.M114.572073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24958723	Green Published, hybrid			2022-12-28	WOS:000340558300034
J	Wang, S; Linde, MH; Munde, M; Carvalho, VD; Wilson, WD; Poon, GMK				Wang, Shuo; Linde, Miles H.; Munde, Manoj; Carvalho, Victor D.; Wilson, W. David; Poon, Gregory M. K.			Mechanistic Heterogeneity in Site Recognition by the Structurally Homologous DNA-binding Domains of the ETS Family Transcription Factors Ets-1 and PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; OSMOTIC-STRESS; MURINE ETS-1; IN-VIVO; SEQUENCE DISCRIMINATION; SELF-ASSOCIATION; PROTEIN; MACROPHAGES; COMPLEX; AUTOINHIBITION	ETS family transcription factors regulate diverse genes through binding at cognate DNA sites that overlap substantially in sequence. The DNA-binding domains of ETS proteins (ETS domains) are highly conserved structurally yet share limited amino acid homology. To define the mechanistic implications of sequence diversity within the ETS family, we characterized the thermodynamics and kinetics of DNA site recognition by the ETS domains of Ets-1 and PU.1, which represent the extremes in amino acid divergence among ETS proteins. Even though the two ETS domains bind their optimal sites with similar affinities under physiologic conditions, their nature of site recognition differs strikingly in terms of the role of hydration and counter ion release. The data suggest two distinct mechanisms where in Ets-1 follows a "dry" mechanism that rapidly parses sites through electrostatic interactions and direct protein-DNA contacts, whereas PU. 1 utilizes hydration to interrogate sequence-specific sites and form a long-lived complex relative to the Ets-1 counterpart. The kinetic persistence of the high affinity PU.1.DNA complex may be relevant to an emerging role of PU.1, but not Ets-1, as a pioneer transcription factor in vivo. In addition, PU.1 activity is critical to the development and function of macrophages and lymphocytes, which present osmotically variable environments, and hydration-dependent specificity may represent an important regulatory mechanism in vivo, a hypothesis that finds support in gene expression profiles of primary murine macrophages.	[Wang, Shuo; Munde, Manoj; Wilson, W. David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Linde, Miles H.; Carvalho, Victor D.; Poon, Gregory M. K.] Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99210 USA	University System of Georgia; Georgia State University; Washington State University	Wilson, WD (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	wdw@gsu.edu; gpoon@wsu.edu		Linde, Miles/0000-0003-2553-2890; Wilson, W David/0000-0001-5225-5089	National Institutes of Health [AI064200]; National Science Foundation [MCB 1411502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064200 (to W. D. W.). This work was also supported by National Science Foundation Grant MCB 1411502 (to G. M. K. P.).	Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Cheung Chris Yk, 2013, J Mol Signal, V8, P5, DOI 10.1186/1750-2187-8-5; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; De S., 2013, J MOL BIOL, V426, P1390; DEGNAN BM, 1993, NUCLEIC ACIDS RES, V21, P3479, DOI 10.1093/nar/21.15.3479; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2007, METHOD ENZYMOL, V428, P279, DOI 10.1016/S0076-6879(07)28016-4; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gold ES, 2012, J EXP MED, V209, P807, DOI 10.1084/jem.20111202; Graves BJ, 1998, COLD SPRING HARB SYM, V63, P621, DOI 10.1101/sqb.1998.63.621; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holbrook JA, 2001, J MOL BIOL, V310, P379, DOI 10.1006/jmbi.2001.4768; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kopp JL, 2004, J BIOL CHEM, V279, P19407, DOI 10.1074/jbc.M314115200; Lacaze P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-372; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Maallem S, 2008, J NEUROCHEM, V105, P1198, DOI 10.1111/j.1471-4159.2008.05222.x; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Munde M, 2014, NUCLEIC ACIDS RES, V42, P1379, DOI 10.1093/nar/gkt955; Munde M, 2013, J MOL BIOL, V425, P1655, DOI 10.1016/j.jmb.2013.02.010; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Poon GMK, 2004, J MOL BIOL, V335, P113, DOI 10.1016/j.jmb.2003.09.046; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2002, BIOCHEMISTRY-US, V41, P2361, DOI 10.1021/bi015572q; Poon GMK, 2011, THERMODYNAMICS - INTERACTION STUDIES - SOLIDS, LIQUIDS AND GASES, P871; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Poon GMK, 2010, ANAL BIOCHEM, V400, P229, DOI 10.1016/j.ab.2010.01.025; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Ross IL, 1998, J BIOL CHEM, V273, P6662, DOI 10.1074/jbc.273.12.6662; Sharp KA, 1997, J PHYS CHEM B, V101, P4343, DOI 10.1021/jp9702457; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	68	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21605	21616		10.1074/jbc.M114.575340	http://dx.doi.org/10.1074/jbc.M114.575340			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24952944	Green Published, hybrid			2022-12-28	WOS:000340558300035
J	Galea, GL; Meakin, LB; Williams, CM; Hulin-Curtis, SL; Lanyon, LE; Poole, AW; Price, JS				Galea, Gabriel L.; Meakin, Lee B.; Williams, Christopher M.; Hulin-Curtis, Sarah L.; Lanyon, Lance E.; Poole, Alastair W.; Price, Joanna S.			Protein Kinase C alpha (PKC alpha) Regulates Bone Architecture and Osteoblast Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; SOST DOWN-REGULATION; GROWTH-FACTOR-I; OSTEOGENIC RESPONSE; MECHANICAL STRAIN; ADAPTIVE RESPONSE; GAUCHER-DISEASE; BETA-CATENIN; PROLIFERATIVE RESPONSES; GENE-EXPRESSION	Bones' strength is achieved and maintained through adaptation to load bearing. The role of the protein kinase PKC alpha in this process has not been previously reported. However, we observed a phenotype in the long bones of Prkca(-/-) female but not male mice, in which bone tissue progressively invades the medullary cavity in the mid-diaphysis. This bone deposition progresses with age and is prevented by disuse but unaffected by ovariectomy. Castration of male Prkca(-/-) but not WT mice results in the formation of small amounts of intramedullary bone. Osteoblast differentiation markers and Wnt target gene expression were up-regulated in osteoblast-like cells derived from cortical bone of female Prkca(-/-) mice compared with WT. Additionally, although osteoblastic cells derived from WT proliferate following exposure to estradiol or mechanical strain, those from Prkca(-/-) mice do not. Female Prkca(-/-) mice develop splenomegaly and reduced marrow GBA1 expression reminiscent of Gaucher disease, in which PKC involvement has been suggested previously. From these data, we infer that in female mice, PKC alpha normally serves to prevent endosteal bone formation stimulated by load bearing. This phenotype appears to be suppressed by testicular hormones in male Prkca(-/-) mice. Within osteoblastic cells, PKC alpha enhances proliferation and suppresses differentiation, and this regulation involves the Wnt pathway. These findings implicate PKC alpha as a target gene for therapeutic approaches in low bone mass conditions.	[Galea, Gabriel L.; Meakin, Lee B.; Hulin-Curtis, Sarah L.; Lanyon, Lance E.; Price, Joanna S.] Univ Bristol, Sch Vet Sci, Bristol BS2 8EJ, Avon, England; [Williams, Christopher M.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Galea, GL (corresponding author), Univ Bristol, Sch Vet Sci, Southwell St, Bristol BS2 8EJ, Avon, England.	gabriel.galea@bristol.ac.uk	Meakin, Lee/H-7726-2019; Curtis, Sarah/AAM-5290-2020; Galea, Gabriel/I-9374-2019	Meakin, Lee/0000-0002-2161-9414; Galea, Gabriel/0000-0003-2515-1342; Poole, Alastair/0000-0002-0868-297X	Wellcome Trust [092045/Z/10/Z, 088560/Z/09/Z]; British Heart Foundation [RG/10/006/28299]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust Grants 092045/Z/10/Z and 088560/Z/09/Z (to G. L. G. and L. B. M.) and by British Heart Foundation Grant RG/10/006/28299 (to A. P.).	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Callewaert F, 2010, J BONE MINER RES, V25, P124, DOI 10.1359/jbmr.091001; Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014; Cheng MZ, 2002, J BONE MINER RES, V17, P593, DOI 10.1359/jbmr.2002.17.4.593; Galea Gabriel L, 2013, Bonekey Rep, V2, P413, DOI 10.1038/bonekey.2013.147; Galea GL, 2013, J BIOL CHEM, V288, P9035, DOI 10.1074/jbc.M112.405456; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Geng WD, 2001, J CELL PHYSIOL, V189, P216, DOI 10.1002/jcp.10019; Gillis S, 1999, AM J HEMATOL, V61, P103, DOI 10.1002/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.3.CO;2-M; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Haughian JM, 2009, INT J CANCER, V125, P2556, DOI 10.1002/ijc.24633; Javaheri B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035726; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Kido S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013090; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Lahooti H, 1998, J MOL ENDOCRINOL, V20, P245, DOI 10.1677/jme.0.0200245; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; Marenzana M, 2007, BONE, V41, P206, DOI 10.1016/j.bone.2007.04.184; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; MIGLIACCIO S, 1993, MOL ENDOCRINOL, V7, P1133, DOI 10.1210/me.7.9.1133; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Nakura A, 2011, BONE, V48, P476, DOI 10.1016/j.bone.2010.09.238; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; PEAD MJ, 1988, J BONE MINER RES, V3, P647; Piran S, 2009, BLOOD CELL MOL DIS, V43, P289, DOI 10.1016/j.bcmd.2009.08.002; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Skerry T. M., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P122; Sokolowska B, 2011, FOLIA HISTOCHEM CYTO, V49, P352, DOI 10.5603/FHC.2011.0048; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Sugiyama T, 2010, ENDOCRINOLOGY, V151, P5582, DOI 10.1210/en.2010-0645; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Swift JM, 2013, MED SCI SPORT EXER, V45, P1665, DOI 10.1249/MSS.0b013e31828d39bc; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; UHTHOFF HK, 1978, J BONE JOINT SURG BR, V60, P420, DOI 10.1302/0301-620X.60B3.681422; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203; Wang Y, 2013, AM J PHYSIOL-RENAL, V304, pF233, DOI 10.1152/ajprenal.00484.2012; Wenstrup RJ, 2002, BRIT J RADIOL, V75, pA2, DOI 10.1259/bjr.75.suppl_1.750002; Williams CM, 2014, PLATELETS, V25, P62, DOI 10.3109/09537104.2012.761686; Windahl SH, 2013, J BONE MINER RES, V28, P291, DOI 10.1002/jbmr.1754; Yang JZ, 2008, STEROIDS, V73, P1110, DOI 10.1016/j.steroids.2008.04.012; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	70	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25509	25522		10.1074/jbc.M114.580365	http://dx.doi.org/10.1074/jbc.M114.580365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070889	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000342130800013
J	Kobayashi, Y; Shiga, T; Shibata, T; Sako, M; Maenaka, K; Koshiba, T; Mizumura, H; Oda, T; Kawabata, S				Kobayashi, Yuki; Shiga, Takafumi; Shibata, Toshio; Sako, Miyuki; Maenaka, Katsumi; Koshiba, Takumi; Mizumura, Hikaru; Oda, Toshio; Kawabata, Shun-ichiro			The N-terminal Arg Residue Is Essential for Autocatalytic Activation of a Lipopolysaccharide-responsive Protease Zymogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYPLEUS-TRIDENTATUS HEMOCYTES; SERINE-PROTEASE; FACTOR-C; HORSESHOE-CRAB; CRYSTAL-STRUCTURE; STAPHYLOCOAGULASE; PLASMINOGEN; RECOGNITION; CASPASE-9; MECHANISM	Factor C, a serine protease zymogen involved in innate immune responses in horseshoe crabs, is known to be autocatalytically activated on the surface of bacterial lipopolysaccharides, but the molecular mechanism of this activation remains unknown. In this study, we show that wild-type factor C expressed in HEK293S cells exhibits a lipopolysaccharide-induced activity equivalent to that of native factor C. Analysis of the N-terminal addition, deletion, or substitution mutants shows that the N-terminal Arg residue and the distance between the N terminus and the tripartite of lipopolysaccharide-binding site are essential factors for autocatalytic activation, and that the positive charge of the N terminus may interact with an acidic amino acid(s) of the molecule to convert the zymogen into an active form. Chemical cross-linking experiments indicate that the N terminus is required to form a complex of the factor C molecules in a sufficiently close vicinity to be chemically cross-linked on the surface of lipopolysaccharides. We propose a molecular mechanism of the autocatalytic activation of the protease zymogen on lipopolysaccharides functioning as a platform to induce specific protein-protein interaction between the factor C molecules.	[Kobayashi, Yuki; Shiga, Takafumi; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128581, Japan; [Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8128581, Japan; [Shibata, Toshio] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Sako, Miyuki; Maenaka, Katsumi] Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Mizumura, Hikaru; Oda, Toshio] Seikagaku Corp, LAL Res & Dev Grp, Tokyo 2070021, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	skawascb@kyudai.jp	Shibata, Toshio/AAE-1694-2020; Koshiba, Takumi/A-3996-2013	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Seikagaku Corporation	Seikagaku Corporation	This work was supported by the joint research fund from Seikagaku Corporation.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; CORNISHBOWDEN A, 1978, BIOCHIM BIOPHYS ACTA, V523, P268, DOI 10.1016/0005-2744(78)90030-X; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Higashi S, 1997, J BIOL CHEM, V272, P25724, DOI 10.1074/jbc.272.41.25724; Kawabata S, 2009, ISJ-INVERT SURVIV J, V6, P59; KAWABATA S, 1986, J BIOL CHEM, V261, P1427; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; MIURA Y, 1992, J BIOCHEM-TOKYO, V112, P476, DOI 10.1093/oxfordjournals.jbchem.a123924; MUTA T, 1991, J BIOL CHEM, V266, P6554; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; NAKAMURA T, 1988, J BIOCHEM, V103, P370, DOI 10.1093/oxfordjournals.jbchem.a122276; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Park HH, 2012, INT J MOL SCI, V13, P4807, DOI 10.3390/ijms13044807; RANBY M, 1982, THROMB RES, V27, P175, DOI 10.1016/0049-3848(82)90197-9; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; TOKUNAGA F, 1991, J BIOCHEM, V109, P150, DOI 10.1093/oxfordjournals.jbchem.a123337; Wang J, 2002, J BIOL CHEM, V277, P36363, DOI 10.1074/jbc.M202837200	30	10	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25987	25995		10.1074/jbc.M114.586933	http://dx.doi.org/10.1074/jbc.M114.586933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077965	hybrid, Green Published			2022-12-28	WOS:000342130800052
J	Cordek, DG; Croom-Perez, TJ; Hwang, J; Hargittai, MRS; Subba-Reddy, CV; Han, QX; Lodeiro, MF; Ning, G; McCrory, TS; Arnold, JJ; Koc, H; Lindenbach, BD; Showalter, SA; Cameron, CE				Cordek, Daniel G.; Croom-Perez, Tayler J.; Hwang, Jungwook; Hargittai, Michele R. S.; Subba-Reddy, Chennareddy V.; Han, Qingxia; Lodeiro, Maria Fernanda; Ning, Gang; McCrory, Thomas S.; Arnold, Jamie J.; Koc, Hasan; Lindenbach, Brett D.; Showalter, Scott A.; Cameron, Craig E.			Expanding the Proteome of an RNA Virus by Phosphorylation of an Intrinsically Disordered Viral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis C Virus (HCV); Intrinsically Disordered Protein; Phosphorylation; RNA Virus; Viral Replication; NMR; Non-structural Protein 5A	HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN; NS5A PROTEIN; POTENT INHIBITORS; KINASE-C; REPLICATION; BINDING; DOMAIN; 5A; IDENTIFICATION	Background: How can HCV require only 10 proteins for decades-long evasion of the immune system? Results: Phosphorylation of the intrinsically disordered domain (IDD) of NS5A changes its dynamics, inducing unique structure and function. Conclusion: IDD phosphorylation expands the HCV proteome. Significance: Post-translational modification of a viral IDD represents a strategy to expand a viral proteome when coding capacity is limited. The human proteome contains myriad intrinsically disordered proteins. Within intrinsically disordered proteins, polyproline-II motifs are often located near sites of phosphorylation. We have used an unconventional experimental paradigm to discover that phosphorylation by protein kinase A (PKA) occurs in the intrinsically disordered domain of hepatitis C virus non-structural protein 5A (NS5A) on Thr-2332 near one of its polyproline-II motifs. Phosphorylation shifts the conformational ensemble of the NS5A intrinsically disordered domain to a state that permits detection of the polyproline motif by using N-15-, C-13-based multidimensional NMR spectroscopy. PKA-dependent proline resonances were lost in the presence of the Src homology 3 domain of c-Src, consistent with formation of a complex. Changing Thr-2332 to alanine in hepatitis C virus genotype 1b reduced the steady-state level of RNA by 10-fold; this change was lethal for genotype 2a. The lethal phenotype could be rescued by changing Thr-2332 to glutamic acid, a phosphomimetic substitution. Immunofluorescence and transmission electron microscopy showed that the inability to produce Thr(P)-2332-NS5A caused loss of integrity of the virus-induced membranous web/replication organelle. An even more extreme phenotype was observed in the presence of small molecule inhibitors of PKA. We conclude that the PKA-phosphorylated form of NS5A exhibits unique structure and function relative to the unphosphorylated protein. We suggest that post-translational modification of viral proteins containing intrinsic disorder may be a general mechanism to expand the viral proteome without a corresponding expansion of the genome.	[Cordek, Daniel G.; Croom-Perez, Tayler J.; Han, Qingxia; Lodeiro, Maria Fernanda; McCrory, Thomas S.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Hwang, Jungwook] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Hargittai, Michele R. S.] St Francis Univ, Dept Chem, Loretto, PA 15940 USA; [Subba-Reddy, Chennareddy V.; Lindenbach, Brett D.] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Koc, Hasan] Marshall Univ, Dept Pharmaceut Sci & Res, Sch Pharm, Huntington, WV 25755 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hanyang University; Yale University; Marshall University	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 201, University Pk, PA 16802 USA.	cec9@psu.edu	Showalter, Scott A/A-1655-2012; han, qingxia/G-6260-2015; Hwang, Jungwook/P-1614-2015	Showalter, Scott A/0000-0001-5179-032X; Hwang, Jungwook/0000-0002-2290-1649; Croom-Perez, Tayler/0000-0002-7096-1515	National Institutes of Health, NIGMS [R01GM0089001]; National Institutes of Health, NIAID [R21 AI100590]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089001] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM0089001 (to Kevin D. Raney and C. E. C.) and National Institutes of Health, NIAID, Grant R21 AI100590 (to C. E. C.).	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Cordek DC, 2011, DRUG FUTURE, V36, P691, DOI 10.1358/dof.2011.036.09.1641618; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elam WA, 2013, PROTEIN SCI, V22, P405, DOI 10.1002/pro.2217; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gilliver AN, 2010, J GEN VIROL, V91, P2428, DOI 10.1099/vir.0.023614-0; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Goddard T. D., 2006, SPARKY VERSION 3 113; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Hanoulle X, 2009, BIOCHEM BIOPH RES CO, V381, P634, DOI 10.1016/j.bbrc.2009.02.108; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; Ide Y, 1997, GENE, V201, P151, DOI 10.1016/S0378-1119(97)00440-X; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Liang Y, 2006, MOL CELLS, V22, P13; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2005, J GEN VIROL, V86, P1035, DOI 10.1099/vir.0.80734-0; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Martin-Garcia JM, 2012, ACTA CRYSTALLOGR D, V68, P1030, DOI 10.1107/S0907444912019798; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Reed KE, 1999, J BIOL CHEM, V274, P28011, DOI 10.1074/jbc.274.39.28011; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Sahu D, 2014, ANAL BIOCHEM, V449, P17, DOI 10.1016/j.ab.2013.12.005; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yi M, 2014, J VIROL, V88, P3678, DOI 10.1128/JVI.03540-13; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	61	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24397	24416		10.1074/jbc.M114.589911	http://dx.doi.org/10.1074/jbc.M114.589911			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25031324	hybrid, Green Published			2022-12-28	WOS:000341505600034
J	Groveman, BR; Dolan, MA; Taubner, LM; Kraus, A; Wickner, RB; Caughey, B				Groveman, Bradley R.; Dolan, Michael A.; Taubner, Lara M.; Kraus, Allison; Wickner, Reed B.; Caughey, Byron			Parallel In-register Intermolecular beta-Sheet Architectures for Prion-seeded Prion Protein (PrP) Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Molecular Dynamics; Nuclear Magnetic Resonance (NMR); Prion; Protein Structure	SOLID-STATE NMR; SCRAPIE; CONVERSION; FIBRILS; STRAIN; CONFORMATION; ORGANIZATION; RESIDUES; HELICES; DOMAIN	Background: The structures of infectious mammalian prions remain unclear. Results: Based in part on NMR data, we developed models with single PrP molecules spanning the entire cross-section of prion fibrils. Conclusion: These models are consistent with many empirical features of prion amyloids. Significance: We provide a new basis for conceptualizing and experimentally evaluating the structures and propagation of infectious prions. Structures of the infectious form of prion protein (e.g. PrPSc or PrP-Scrapie) remain poorly defined. The prevalent structural models of PrPSc retain most of the native -helices of the normal, noninfectious prion protein, cellular prion protein (PrPC), but evidence is accumulating that these helices are absent in PrPSc amyloid. Moreover, recombinant PrPC can form amyloid fibrils in vitro that have parallel in-register intermolecular -sheet architectures in the domains originally occupied by helices 2 and 3. Here, we provide solid-state NMR evidence that the latter is also true of initially prion-seeded recombinant PrP amyloids formed in the absence of denaturants. These results, in the context of a primarily -sheet structure, led us to build detailed models of PrP amyloid based on parallel in-register architectures, fibrillar shapes and dimensions, and other available experimentally derived conformational constraints. Molecular dynamics simulations of PrP(90-231) octameric segments suggested that such linear fibrils, which are consistent with many features of PrPSc fibrils, can have stable parallel in-register -sheet cores. These simulations revealed that the C-terminal residues approximate to 124-227 more readily adopt stable tightly packed structures than the N-terminal residues approximate to 90-123 in the absence of cofactors. Variations in the placement of turns and loops that link the -sheets could give rise to distinct prion strains capable of faithful template-driven propagation. Moreover, our modeling suggests that single PrP monomers can comprise the entire cross-section of fibrils that have previously been assumed to be pairs of laterally associated protofilaments. Together, these insights provide a new basis for deciphering mammalian prion structures.	[Groveman, Bradley R.; Taubner, Lara M.; Kraus, Allison; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dolan, Michael A.] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA; [Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov			National Institutes of Health Intramural Program of the NIAID; National Institutes of Health Intramural Program of the NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the NIAID; National Institutes of Health Intramural Program of the NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Programs of the NIAID and the NIDDK.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; GABIZON R, 1988, J BIOL CHEM, V263, P4950; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Herrmann LM, 1998, NEUROREPORT, V9, P2457, DOI 10.1097/00001756-199808030-00006; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MCKINLEY MP, 1991, LAB INVEST, V65, P622; MERZ PA, 1981, ACTA NEUROPATHOL, V54, P63, DOI 10.1007/BF00691333; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Onisko B, 2005, BIOCHEMISTRY-US, V44, P10100, DOI 10.1021/bi0501582; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Petkova AT, 2002, J MAGN RESON, V155, P293, DOI 10.1006/jmre.2002.2519; Piro JR, 2011, BIOCHEMISTRY-US, V50, P7111, DOI 10.1021/bi200786p; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vazquez-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050111; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Welker E, 2002, J BIOL CHEM, V277, P33477, DOI 10.1074/jbc.M204273200; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55	68	118	118	0	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24129	24142		10.1074/jbc.M114.578344	http://dx.doi.org/10.1074/jbc.M114.578344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25028516	hybrid, Green Published			2022-12-28	WOS:000341505600012
J	Salvi, F; Agniswamy, J; Yuan, HL; Vercammen, K; Pelicaen, R; Cornelis, P; Spain, JC; Weber, IT; Gadda, G				Salvi, Francesca; Agniswamy, Johnson; Yuan, Hongling; Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre; Spain, Jim C.; Weber, Irene T.; Gadda, Giovanni			The Combined Structural and Kinetic Characterization of a Bacterial Nitronate Monooxygenase from Pseudomonas aeruginosa PAO1 Establishes NMO Class I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Structure; Flavoprotein; Pseudomonas Aeruginosa (P; Aeruginosa); Toxin; 3-Nitropropionate; TIM Barrel; Nitronate Monooxygenase; Oxidoreductase; Propionate 3-Nitronate	3-NITROPROPIONIC ACID; 2-NITROPROPANE DIOXYGENASE; OXIDATION; ALIGNMENT; SEQUENCE; DETOXIFICATION; GENERATION; INHIBITOR; SUBSTRATE; MODEL	Background: The annotation of >4,900 genes for nitronate monooxygenase, which detoxifies a deadly toxin, is inaccurate due to the lack of functional data. Results: The protein PA4202 from Pseudomonas aeruginosa is characterized structurally and biochemically as the first bacterial nitronate monooxygenase. Conclusion: Four conserved motifs are identified in PA4202. Significance: New classes of enzymes are established based on the functional annotation of PA4202. Nitronate monooxygenase (NMO) oxidizes the mitochondrial toxin propionate 3-nitronate (P3N) to malonate semialdehyde. The enzyme has been previously characterized biochemically in fungi, but no structural information is available. Based on amino acid similarity 4,985 genes are annotated in the GenBank(TM) as NMO. Of these, 4,424 (i.e. 89%) are bacterial genes, including several Pseudomonads that have been shown to use P3N as growth substrate. Here, we have cloned and expressed the gene pa4202 of Pseudomonas aeruginosa PAO1, purified the resulting protein, and characterized it. The enzyme is active on P3N and other alkyl nitronates, but cannot oxidize nitroalkanes. P3N is the best substrate at pH 7.5 and atmospheric oxygen with k(cat)(app)/K-m(app) of 12 x 10(6) m(-1) s(-1), k(cat)(app) of 1300 s(-1), and K-m(app) of 110 m. Anerobic reduction of the enzyme with P3N yields a flavosemiquinone, which is formed within 7.5 ms, consistent with this species being a catalytic intermediate. Absorption spectroscopy, mass spectrometry, and x-ray crystallography demonstrate a tightly, non-covalently bound FMN in the active site of the enzyme. Thus, PA4202 is the first NMO identified and characterized in bacteria. The x-ray crystal structure of the enzyme was solved at 1.44 , showing a TIM barrel-fold. Four motifs in common with the biochemically characterized NMO from Cyberlindnera saturnus are identified in the structure of bacterial NMO, defining Class I NMO, which includes bacterial, fungal, and two animal NMOs. Notably, the only other NMO from Neurospora crassa for which biochemical evidence is available lacks the four motifs, defining Class II NMO.	[Salvi, Francesca; Yuan, Hongling; Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA; [Agniswamy, Johnson; Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Weber, Irene T.; Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA; [Spain, Jim C.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30302 USA; [Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre] Vrije Univ Brussel, Dept Bioengn Sci, Brussels, Belgium; [Vercammen, Ken; Pelicaen, Rudy; Cornelis, Pierre] VIB, Dept Struct Biol Brussels, B-1050 Brussels, Belgium	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia Institute of Technology; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Weber, IT (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30302 USA.	iweber@gsu.edu; ggadda@gsu.edu	Cornelis, Pierre/H-3058-2019; Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Agniswamy, Johnson/0000-0002-3053-5677; Pelicaen, Rudy/0000-0002-0890-6320; Salvi, Francesca/0000-0001-5294-1310	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092602] Funding Source: NIH RePORTER; Direct For Biological Sciences [1121695] Funding Source: National Science Foundation	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	X-ray data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) beamline BM-22 at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. We thank Shirley Nishino for the construct of pa4202 and Chung-Dar Lu, Crystal Smitherman, and Jacob Ball for critically reading the manuscript.	Allison R D, 1979, Methods Enzymol, V63, P3; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Chomeheon P, 2005, J NAT PROD, V68, P1103, DOI 10.1021/np050036a; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzpatrick PF, 2005, ARCH BIOCHEM BIOPHYS, V433, P157, DOI 10.1016/j.abb.2004.08.021; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Francis K, 2008, BIOCHEMISTRY-US, V47, P9136, DOI 10.1021/bi801013e; Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195; Francis K, 2012, ARCH BIOCHEM BIOPHYS, V521, P84, DOI 10.1016/j.abb.2012.03.015; Gadda G, 2000, ARCH BIOCHEM BIOPHYS, V382, P138, DOI 10.1006/abbi.2000.2009; Gadda G, 2010, ARCH BIOCHEM BIOPHYS, V493, P53, DOI 10.1016/j.abb.2009.06.018; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Hamilton BF, 2000, CONT NEUROS, P21; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li YH, 2011, BIOCHEM BIOPH RES CO, V405, P344, DOI 10.1016/j.bbrc.2010.12.050; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Mathews F. P., 1940, POISONING SHEEP GOAT; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mijatovic S, 2008, ARCH BIOCHEM BIOPHYS, V473, P61, DOI 10.1016/j.abb.2008.02.029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Nielsen A. T., 1969, CHEM NITRO NITROSO G; Nishino SF, 2010, APPL ENVIRON MICROB, V76, P3590, DOI 10.1128/AEM.00267-10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panter K. E., 2011, USDA B, V415; Parry R, 2011, NAT PROD REP, V28, P152, DOI 10.1039/c0np00024h; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Segel I.H., 1975, ENZYME KINETICS; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smitherman C, 2013, BIOCHEMISTRY-US, V52, P2694, DOI 10.1021/bi400030d; TARAZONA JV, 1987, VET HUM TOXICOL, V29, P437; Tsang TM, 2009, NEUROCHEM RES, V34, P1261, DOI 10.1007/s11064-008-9904-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMS MC, 1979, AM J VET RES, V40, P403; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	50	29	32	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23764	23775		10.1074/jbc.M114.577791	http://dx.doi.org/10.1074/jbc.M114.577791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002579	Green Published, hybrid			2022-12-28	WOS:000341505000044
J	Mao, FF; Yang, XF; Fu, L; Lv, XD; Zhang, Z; Wu, WQ; Yang, SQ; Zhou, ZC; Zhang, L; Zhao, Y				Mao, Feifei; Yang, Xiaofeng; Fu, Lin; Lv, Xiangdong; Zhang, Zhao; Wu, Wenqing; Yang, Siqi; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun			The Kto-Skd Complex Can Regulate ptc Expression by Interacting with Cubitus interruptus (Ci) in the Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MEDIATOR COMPLEX; TRANSCRIPTIONAL ACTIVATION; TARGET GENES; COMPARTMENT BOUNDARIES; DROSOPHILA; PROTEIN; SUBUNITS; REPRESSOR; YEAST; BINDING	The hedgehog (Hh) signaling pathway plays a very important role in metazoan development by controlling pattern formation. Drosophila imaginal discs are subdivided into anterior and posterior compartments that derive from adjacent cell populations. The anterior/posterior (A/P) boundaries, which are critical to maintaining the position of organizers, are established by a complex mechanism involving Hh signaling. Here, we uncover the regulation of ptc in the Hh signaling pathway by two subunits of mediator complex, Kto and Skd, which can also regulate boundary location. Collectively, we provide further evidence that Kto-Skd affects the A/P-axial development of the whole wing disc. Kto can interact with Cubitus interruptus (Ci), bind to the Ci-binding region on ptc promoter, which are both regulated by Hh signals to down-regulate ptc expression.	[Mao, Feifei; Yang, Xiaofeng; Fu, Lin; Lv, Xiangdong; Zhang, Zhao; Wu, Wenqing; Yang, Siqi; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhao, Y (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yunzhao@sibcb.ac.cn	Zhang, Zhao/S-2072-2016; Lv, Xiangdong/S-9034-2019	Zhang, Zhao/0000-0001-9345-3663; Lv, Xiangdong/0000-0001-5310-5816	National Basic Research Program of China (973 Program) [2010CB912101, 2011CB943902, 2012CB945001]; Chinese Academy of Sciences [XDA01010405]; National Natural Science Foundation of China [31171414, 31371492]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program: 2010CB912101, 2011CB943902, 2012CB945001), the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010405), and also from the National Natural Science Foundation of China (31171414, 31371492).	Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Harada J, 2003, J BIOL CHEM, V278, P38998, DOI 10.1074/jbc.M307112200; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Janody F, 2011, DEV DYNAM, V240, P2051, DOI 10.1002/dvdy.22705; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2002, GENE DEV, V16, P2315, DOI 10.1101/gad.1027902; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lim J, 2007, DEV BIOL, V308, P322, DOI 10.1016/j.ydbio.2007.05.029; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Muller B, 2000, DEVELOPMENT, V127, P2999; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Nestoras K, 1997, GENETICS, V147, P1203; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Treisman JE, 2001, DEVELOPMENT, V128, P603; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zhang YY, 2011, CELL RES, V21, P1436, DOI 10.1038/cr.2011.136; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	56	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22333	22341		10.1074/jbc.M114.560995	http://dx.doi.org/10.1074/jbc.M114.560995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24962581	Green Published, hybrid			2022-12-28	WOS:000340593500044
J	Yao, JW; Abdelrahman, YM; Robertson, RM; Cox, JV; Belland, RJ; White, SW; Rock, CO				Yao, Jiangwei; Abdelrahman, Yasser M.; Robertson, Rosanna M.; Cox, John V.; Belland, Robert J.; White, Stephen W.; Rock, Charles O.			Type II Fatty Acid Synthesis Is Essential for the Replication of Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; ENOYL-ACP REDUCTASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LIPID-A; INHIBITOR AFN-1252; FABI INHIBITOR; HOST-CELL; LIPOPOLYSACCHARIDE; BIOSYNTHESIS	The major phospholipid classes of the obligate intracellular bacterial parasite Chlamydia trachomatis are the same as its eukaryotic host except that they also contain chlamydiamade branched-chain fatty acids in the 2-position. Genomic analysis predicts that C. trachomatis is capable of type II fatty acid synthesis (FASII). AFN-1252 was deployed as a chemical tool to specifically inhibit the enoyl-acyl carrier protein reductase (FabI) of C. trachomatis to determine whether chlamydial FASII is essential for replication within the host. The C. trachomatis FabI (CtFabI) is a homotetramer and exhibited typical FabI kinetics, and its expression complemented an Escherichia coli fabI(Ts) strain. AFN-1252 inhibited CtFabI by binding to the FabI.NADH complex with an IC50 of 0.9 mu M at saturating substrate concentration. The x-ray crystal structure of the CtFabI.NADH.AFN-1252 ternary complex revealed the specific interactions between the drug, protein, and cofactor within the substrate binding site. AFN-1252 treatment of C. trachomatis-infected HeLa cells at any point in the infectious cycle caused a decrease in infectious titers that correlated with a decrease in branched-chain fatty acid biosynthesis. AFN-1252 treatment at the time of infection prevented the first cell division of C. trachomatis, although the cell morphology suggested differentiation into a metabolically active reticulate body. These results demonstrate that FASII activity is essential for C. trachomatis proliferation within its eukaryotic host and validate CtFabI as a therapeutic target against C. trachomatis.	[Yao, Jiangwei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Robertson, Rosanna M.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Abdelrahman, Yasser M.; Cox, John V.; Belland, Robert J.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Abdelrahman, Yasser M.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo 11562, Egypt	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Egyptian Knowledge Bank (EKB); Cairo University	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	White, Stephen W/N-8164-2018	Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496, AI070693]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM034496 (to C. O. R.), AI070693 (to R. J. B), and Cancer Center Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Girard G, 2006, J BACTERIOL, V188, P8283, DOI 10.1128/JB.00893-06; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; Heine H, 2007, J ENDOTOXIN RES, V13, P126, DOI 10.1177/0968051907079122; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Kosma P, 1999, BBA-MOL BASIS DIS, V1455, P387, DOI 10.1016/S0925-4439(99)00061-7; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Nguyen BD, 2011, P NATL ACAD SCI USA, V108, P10284, DOI 10.1073/pnas.1107478108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Qiu XY, 1999, PROTEIN SCI, V8, P2529, DOI 10.1110/ps.8.11.2529; Qureshi N, 1997, J BIOL CHEM, V272, P10594; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Suh MC, 1999, PLANT J, V17, P679, DOI 10.1046/j.1365-313X.1999.00418.x; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905	48	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22365	22376		10.1074/jbc.M114.584185	http://dx.doi.org/10.1074/jbc.M114.584185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24958721	Green Published, hybrid			2022-12-28	WOS:000340593500047
J	Lemaire, PA; Huang, LY; Zhuo, Y; Lu, J; Bahnck, C; Stachel, SJ; Carroll, SS; Duong, LT				Lemaire, Peter A.; Huang, Lingyi; Zhuo, Ya; Lu, Jun; Bahnck, Carolyn; Stachel, Shawn J.; Carroll, Steve S.; Duong, Le T.			Chondroitin Sulfate Promotes Activation of Cathepsin K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLASTIC BONE-RESORPTION; DEFICIENT-MICE; COLLAGENOLYTIC ACTIVITY; EXTRACELLULAR-MATRIX; CYSTEINE PROTEASES; PROCATHEPSIN-B; IN-VITRO; GLYCOSAMINOGLYCANS; PYCNODYSOSTOSIS; EXPRESSION	Cathepsin K (CatK), a major lysosomal collagenase produced by osteoclasts, plays an important role in bone resorption. Evidence exists that the collagenase activity of CatK is promoted by chondroitin sulfate (CS), a sulfated glycosaminoglycan. This study examines the role of CS in facilitating CatK activation. We have demonstrated that chondroitin 4-sulfate (C4-S) promotes autoprocessing of the pro-domain of CatK at pH <= 5, leading to a fully matured enzyme with collagenase and peptidase activities. We present evidence to demonstrate this autoactivation process is a trans-activation event that is efficiently inhibited by both the covalent cysteine protease inhibitor E-64 and the reversible selective CatK inhibitor L-006,235. During bone resorption, CatK and C4-S are co-localized at the ruffled border between osteoclast bone interface, supporting the proposal that CatK activation is accomplished through the combined action of the acidic environment together with the presence of a high concentration of C4-S. Formation of a multimeric complex between C4-S and pro-CatK has been speculated to accelerate CatK autoactivation and promote efficient collagen degradation. Together, these results demonstrate that CS plays an important role in contributing to the enhanced efficiency of CatK collagenase activity in vivo.	Merck Res Labs, Dept In Vitro Pharmacol, West Point, PA 19486 USA; [Huang, Lingyi; Zhuo, Ya; Duong, Le T.] Merck Res Labs, Dept Bone Biol, West Point, PA 19486 USA; [Lu, Jun] Merck Res Labs, Dept Struct Chem, West Point, PA 19486 USA; [Stachel, Shawn J.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Duong, LT (corresponding author), Merck Res Labs, Dept Bone Biol, West Point, PA 19486 USA.	le_duong@merck.com			Merck Co.	Merck Co.(Merck & Company)	This work was supported by Merck & Co. All authors are employees of Merck, the studies' sponsor, and may own stock/stock options in this company.	BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; Billington CJ, 2000, BIOCHEM BIOPH RES CO, V276, P924, DOI 10.1006/bbrc.2000.3553; Borel O, 2012, CALCIFIED TISSUE INT, V91, P32, DOI 10.1007/s00223-012-9604-7; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Cherney MM, 2011, J BIOL CHEM, V286, P8988, DOI 10.1074/jbc.M110.126706; COSCARELLI PG, 1991, MEM I OSWALDO CRUZ, V86, P99, DOI 10.1590/S0074-02761991000700014; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Everts V, 2003, CALCIFIED TISSUE INT, V73, P380, DOI 10.1007/s00223-002-2092-4; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Falgueyret JP, 2005, J MED CHEM, V48, P7535, DOI 10.1021/jm0504961; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Haylock-Jacobs S, 2011, AUTOIMMUN REV, V10, P766, DOI 10.1016/j.autrev.2011.05.019; Horkay F, 2012, MACROMOLECULES, V45, P2882, DOI 10.1021/ma202693s; Hou WS, 1999, J CLIN INVEST, V103, P731, DOI 10.1172/JCI653; HUNTER GK, 1987, ANAL BIOCHEM, V165, P435, DOI 10.1016/0003-2697(87)90293-4; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; Leung P, 2011, BONE, V49, P623, DOI 10.1016/j.bone.2011.06.014; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Morko J, 2009, BONE, V44, P717, DOI 10.1016/j.bone.2008.11.019; MOURAO PAS, 1988, ARTHRITIS RHEUM, V31, P1028, DOI 10.1002/art.1780310814; Novinec M, 2010, BIOCHEM J, V429, P379, DOI 10.1042/BJ20100337; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; TOOLE BP, 1977, CLIN ORTHOP RELAT R, P258; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; VERNET T, 1990, J BIOL CHEM, V265, P16661; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x	47	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21562	21572		10.1074/jbc.M114.559898	http://dx.doi.org/10.1074/jbc.M114.559898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24958728	Green Published, hybrid			2022-12-28	WOS:000340558300031
J	Neundlinger, I; Puntheeranurak, T; Wildling, L; Rankl, C; Wang, LX; Gruber, HJ; Kinne, RKH; Hinterdorfer, P				Neundlinger, Isabel; Puntheeranurak, Theeraporn; Wildling, Linda; Rankl, Christian; Wang, Lai-Xi; Gruber, Hermann J.; Kinne, Rolf K. H.; Hinterdorfer, Peter			Forces and Dynamics of Glucose and Inhibitor Binding to Sodium Glucose Co-transporter SGLT1 Studied by Single Molecule Force Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHLORHIZIN-BINDING; SUGAR-TRANSPORT; TEMPERATURE-DEPENDENCE; CONFORMATIONAL-CHANGES; RECOGNITION EVENTS; MECHANISM; ADHESION; PROTEIN; HSGLT1; SITE	Single molecule force spectroscopy was employed to investigate the dynamics of the sodium glucose co-transporter (SGLT1) upon substrate and inhibitor binding on the single molecule level. CHO cells stably expressing rbSGLT1 were probed by using atomic force microscopy tips carrying either thioglucose, 2'aminoethyl beta-D-glucopyranoside, or aminophlorizin. Poly(ethylene glycol) (PEG) chains of different length and varying end groups were used as tether. Experiments were performed at 10, 25 and 37 degrees C to address different conformational states of SGLT1. Unbinding forces between ligands and SGLT1 were recorded at different loading rates by changing the retraction velocity, yielding binding probability, width of energy barrier of the binding pocket, and the kinetic off rate constant of the binding reaction. With increasing temperature, width of energy barrier and average life time increased for the interaction of SGLT1 with thioglucose (coupled via acrylamide to a long PEG) but decreased for aminophlorizin binding. The former indicates that in the membrane-bound SGLT1 the pathway to sugar translocation involves several steps with different temperature sensitivity. The latter suggests that also the aglucon binding sites for transport inhibitors have specific, temperature-sensitive conformations.	[Neundlinger, Isabel; Puntheeranurak, Theeraporn; Wildling, Linda; Gruber, Hermann J.; Hinterdorfer, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Puntheeranurak, Theeraporn] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand; [Puntheeranurak, Theeraporn] Nanotec MU Ctr Excellence Intelligent Mat & Syst, Bangkok 10400, Thailand; [Rankl, Christian] Agilent Technol, A-4020 Linz, Austria; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kinne, Rolf K. H.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Johannes Kepler University Linz; Mahidol University; Agilent Technologies; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Max Planck Society	Hinterdorfer, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.hinterdorfer@jku.at	Wang, Lai-Xi/E-8790-2019; Gruber, Hermann J./C-4234-2013; Hinterdorfer, Peter/C-4235-2013; Wang, Lai-Xi/E-8755-2019; wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; wang, xiao/0000-0002-4088-3341; Wang, Xin/0000-0002-4457-7376; Rankl, Christian/0000-0002-7354-7651; Hinterdorfer, Peter/0000-0003-2583-1305	State of Upper Austria; Austrian Science Fund [SFB35]; Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand through program of Center of Excellence Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	State of Upper Austria; Austrian Science Fund(Austrian Science Fund (FWF)); Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand through program of Center of Excellence Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the State of Upper Austria and the Austrian Science Fund (Project SFB35) and supported in part by the Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology, Thailand, through its program of Center of Excellence Network.	ARONSON PS, 1978, J MEMBRANE BIOL, V42, P81, DOI 10.1007/BF01870395; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Castaneda F, 2005, MOL CELL BIOCHEM, V280, P91, DOI 10.1007/s11010-005-8235-y; Castaneda Francisco, 2007, Int J Med Sci, V4, P131; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; DACRUZ MEM, 1983, BIOCHIM BIOPHYS ACTA, V732, P691, DOI 10.1016/0005-2736(83)90248-1; DESMEDT H, 1981, BIOCHIM BIOPHYS ACTA, V648, P247, DOI 10.1016/0005-2736(81)90040-7; DIEDRICH DF, 1966, ARCH BIOCHEM BIOPHYS, V117, P248, DOI 10.1016/0003-9861(66)90409-7; Ebner A, 2007, ULTRAMICROSCOPY, V107, P922, DOI 10.1016/j.ultramic.2007.02.035; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hirayama BA, 2001, BRIT J PHARMACOL, V134, P484, DOI 10.1038/sj.bjp.0704274; Hirayama BA, 2007, BIOCHEMISTRY-US, V46, P13391, DOI 10.1021/bi701562k; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Kamruzzahan ASM, 2006, BIOCONJUGATE CHEM, V17, P1473, DOI 10.1021/bc060252a; Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.0.CO;2-3; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Kipp H, 1996, Biochim Biophys Acta, V1282, P125; Kumar A, 2007, BIOPHYS CHEM, V127, P69, DOI 10.1016/j.bpc.2006.12.006; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Lin JT, 1998, BBA-BIOMEMBRANES, V1373, P309, DOI 10.1016/S0005-2736(98)00116-3; Lin JT, 1999, J MEMBRANE BIOL, V170, P243, DOI 10.1007/s002329900553; LIN JT, 1982, BIOCHIM BIOPHYS ACTA, V693, P379, DOI 10.1016/0005-2736(82)90445-X; Loo DDF, 2005, J GEN PHYSIOL, V125, P13, DOI 10.1085/jgp.200409150; Maitra A, 2011, PHYS CHEM CHEM PHYS, V13, P1836, DOI 10.1039/c0cp01528h; Nestorovich EM, 2012, P NATL ACAD SCI USA, V109, P18453, DOI 10.1073/pnas.1208771109; Ni JH, 2003, BIOCONJUGATE CHEM, V14, P232, DOI 10.1021/bc025617f; Novakova R, 2001, J MEMBRANE BIOL, V184, P55, DOI 10.1007/s00232-001-0073-6; Oulianova N, 2001, J MEMBRANE BIOL, V179, P223, DOI 10.1007/s002320010049; Panayotova-Heiermann M, 1999, FEBS LETT, V459, P386, DOI 10.1016/S0014-5793(99)01292-2; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; Puntheeranurak T, 2008, J KOREAN PHYS SOC, V52, P1336, DOI 10.3938/jkps.52.1336; Puntheeranurak T, 2007, J BIOL CHEM, V282, P25222, DOI 10.1074/jbc.M704190200; Puntheeranurak T, 2007, BIOCHEMISTRY-US, V46, P2797, DOI 10.1021/bi061917z; Puntheeranurak T, 2006, J CELL SCI, V119, P2960, DOI 10.1242/jcs.03035; Raja MM, 2005, BIOCHEMISTRY-US, V44, P9123, DOI 10.1021/bi050323d; Raja MM, 2004, BIOCHEMISTRY-US, V43, P10944, DOI 10.1021/bi049106n; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; RESTREPO D, 1986, J MEMBRANE BIOL, V89, P269, DOI 10.1007/BF01870669; Rico F, 2007, J MOL RECOGNIT, V20, P495, DOI 10.1002/jmr.841; Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9; Sala-Rabanal M, 2012, AM J PHYSIOL-CELL PH, V302, pC1293, DOI 10.1152/ajpcell.00397.2011; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Tyagi NK, 2007, BIOCHEMISTRY-US, V46, P13616, DOI 10.1021/bi701193x; Tyagi NK, 2011, BBA-BIOMEMBRANES, V1808, P1, DOI 10.1016/j.bbamem.2010.07.028; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wielert-Badt S, 2000, J MED CHEM, V43, P1692, DOI 10.1021/jm9905460; Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8; Wildling L., 2008, THESIS J KEPLER U LI; Wildling L., 2005, THESIS J KEPLER U LI; Wildling L, 2012, J BIOL CHEM, V287, P105, DOI 10.1074/jbc.M111.304873; Wimmer B, 2009, J BIOL CHEM, V284, P983, DOI 10.1074/jbc.M805082200; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 1998, AM J PHYSIOL-GASTR L, V275, pG879, DOI 10.1152/ajpgi.1998.275.5.G879; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wruss J, 2009, J AM CHEM SOC, V131, P5478, DOI 10.1021/ja807917t; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604	65	16	16	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21673	21683		10.1074/jbc.M113.529875	http://dx.doi.org/10.1074/jbc.M113.529875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24962566	Green Published, hybrid			2022-12-28	WOS:000340558300041
J	Ferecatu, I; Goncalves, S; Golinelli-Cohen, MP; Clemancey, M; Martelli, A; Riquier, S; Guittet, E; Latour, JM; Puccio, H; Drapier, JC; Lescop, E; Bouton, C				Ferecatu, Ioana; Goncalves, Sergio; Golinelli-Cohen, Marie-Pierre; Clemancey, Martin; Martelli, Alain; Riquier, Sylvie; Guittet, Eric; Latour, Jean-Marc; Puccio, Helene; Drapier, Jean-Claude; Lescop, Ewen; Bouton, Cecile			The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; MITOCHONDRIAL-MEMBRANE PROTEIN; AZOTOBACTER-VINELANDII (NIF)ISCA; NITRIC-OXIDE; ESCHERICHIA-COLI; OXIDATIVE STRESS; 2FE-2S CLUSTER; FUNCTIONAL-CHARACTERIZATION; INSULIN SENSITIVITY; SCAFFOLD PROTEIN	In eukaryotes, mitochondrial iron-sulfur cluster (ISC), export and cytosolic iron-sulfur cluster assembly (CIA) machineries carry out biogenesis of iron-sulfur (Fe-S) clusters, which are critical for multiple essential cellular pathways. However, little is known about their export out of mitochondria. Here we show that Fe-S assembly of mitoNEET, the first identified Fe-S protein anchored in the mitochondrial outer membrane, strictly depends on ISC machineries and not on the CIA or CIAPIN1. We identify a dedicated ISC/export pathway in which augmenter of liver regeneration, a mitochondrial Mia40-dependent protein, is specific to mitoNEET maturation. Wheninserted, the Fe-S cluster confers mitoNEET folding and stability in vitro and in vivo. The holo-form of mitoNEET is resistant to NO and H2O2 and is capable of repairing oxidatively damaged Fe-S of iron regulatory protein 1 (IRP1), a master regulator of cellular iron that has recently been involved in the mitochondrial iron supply. Therefore, our findings point to IRP1 as the missing link to explain the function of mitoNEET in the control of mitochondrial iron homeostasis.	[Ferecatu, Ioana; Goncalves, Sergio; Golinelli-Cohen, Marie-Pierre; Riquier, Sylvie; Guittet, Eric; Drapier, Jean-Claude; Lescop, Ewen; Bouton, Cecile] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91190 Gif Sur Yvette, France; [Clemancey, Martin; Latour, Jean-Marc] Univ Grenoble 1, Direct Sci Vivant, Inst Life Sci Res & Technol,CEA Grenoble, Chem & Biol Met Lab,UMR 5249,CEA,CNRS,Equipe Phys, F-38054 Grenoble 09, France; [Martelli, Alain; Puccio, Helene] IGBMC, F-67400 Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Martelli, Alain; Puccio, Helene] Univ Strasbourg, F-67000 Strasbourg, France; [Martelli, Alain; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Golinelli-Cohen, Marie-Pierre] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, F-75205 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Bouton, C (corresponding author), CNRS, Inst Chim Subst Nat, UPR 2301, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	cecile.bouton@cnrs.fr	Lescop, Ewen/AAA-8700-2019; Ferecatu, Ioana/AAW-5055-2021; Puccio, Hélène/G-1717-2013; Golinelli, Marie-Pierre/K-4287-2013	Ferecatu, Ioana/0000-0001-6842-9506; Puccio, Hélène/0000-0003-4711-2248; Golinelli, Marie-Pierre/0000-0002-6738-8631; Guittet, Eric/0000-0002-8368-6719; Lescop, Ewen/0000-0002-2623-9365; Martelli, Alain/0000-0001-5246-565X	ICSN-CNRS; Fondation de la Recherche Medicale [ING20101220983]; Agence Nationale de la Recherche [ANR-13-BSV8-0017-01]	ICSN-CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an ICSN-CNRS fellowship (to I. F.), by the Fondation de la Recherche Medicale (ING20101220983 to S. G.), and by the Agence Nationale de la Recherche (ANR-13-BSV8-0017-01).	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Aniya Y, 2011, DRUG METAB REV, V43, P292, DOI 10.3109/03602532.2011.552913; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Bouton C., 2003, SCI STKE, pe17; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Carboni M, 2012, INORG CHEM, V51, P10447, DOI 10.1021/ic301725z; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Fillebeen C, 2002, REDOX REP, V7, P15, DOI 10.1179/135100002125000136; Fischer Manuel, 2013, Int J Cell Biol, V2013, P742923, DOI 10.1155/2013/742923; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8056, DOI 10.1021/bi300664j; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Markley JL, 2013, FEBS LETT, V587, P1172, DOI 10.1016/j.febslet.2013.01.003; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nicolet Y, 2013, P NATL ACAD SCI USA, V110, P7188, DOI 10.1073/pnas.1302388110; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Peleh V, 2014, MICROB CELL, V1, P81, DOI 10.15698/mic2014.01.130; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Qi WB, 2014, CHEM COMMUN, V50, P3795, DOI 10.1039/c3cc48239a; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; TA DT, 1992, J BIOL CHEM, V267, P11120; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	75	73	75	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28070	28086		10.1074/jbc.M114.548438	http://dx.doi.org/10.1074/jbc.M114.548438			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25012650	Green Published, hybrid			2022-12-28	WOS:000343765400002
J	Diver, MM; Long, SB				Diver, Melinda M.; Long, Stephen B.			Mutational Analysis of the Integral Membrane Methyltransferase Isoprenylcysteine Carboxyl Methyltransferase (ICMT) Reveals Potential Substrate Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; SMALL-MOLECULE INHIBITOR; KINETIC MECHANISM; K-RAS; FARNESYLTRANSFERASE INHIBITORS; CANCER-CELLS; CARBOXYLMETHYLTRANSFERASE; INACTIVATION; METHYLATION; PROTEINS	The eukaryotic integral membrane enzyme isoprenylcysteine carboxyl methyltransferase (ICMT) methylates the carboxylate of a lipid-modified cysteine at the C terminus of its protein substrates. This is the final post-translational modification of proteins containing a CAAX motif, including the oncoprotein Ras, and therefore, ICMT may serve as a therapeutic target in cancer development. ICMT has no discernible sequence homology with soluble methyltransferases, and aspects of its catalytic mechanism are unknown. For example, how both the methyl donor S-adenosyl-L-methionine (AdoMet), which is water-soluble, and the methyl acceptor isoprenylcysteine, which is lipophilic, are recognized within the same active site is not clear. To identify regions of ICMT critical for activity, we combined scanning mutagenesis with methyltransferase assays. We mutated nearly half of the residues of the ortholog of human ICMT from Anopheles gambiae and observed reduced or undetectable catalytic activity for 62 of the mutants. The crystal structure of a distantly related prokaryotic methyltransferase (Ma Mtase), which has sequence similarity with ICMT in its AdoMet binding site but methylates different substrates, provides context for the mutational analysis. The data suggest that ICMT and Ma MTase bind AdoMet in a similar manner. With regard to residues potentially involved in isoprenylcysteine binding, we identified numerous amino acids within transmembrane regions of ICMT that dramatically reduced catalytic activity when mutated. Certain substitutions of these caused substrate inhibition by isoprenylcysteine, suggesting that they contribute to the isoprenylcysteine binding site. The data provide evidence that the active site of ICMT spans both cytosolic and membrane-embedded regions of the protein.	[Diver, Melinda M.; Long, Stephen B.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Diver, Melinda M.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Biochem & Struct Biol Cell & Dev Bio, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Long, SB (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Diver, Melinda/0000-0001-5037-7322	Burroughs Wellcome Fund Career Award in the Biomedical Sciences; American Heart Association Pre-doctoral Fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); American Heart Association Pre-doctoral Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Burroughs Wellcome Fund Career Award in the Biomedical Sciences (to S. B. L.) and an American Heart Association Pre-doctoral Fellowship (to M. M. D.).	Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chaplin M. F., 1990, ENZYME TECHNOLOGY, P31; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cox AD, 2002, CURR OPIN PHARMACOL, V2, P388, DOI 10.1016/S1471-4892(02)00181-9; Cox AD, 1997, BBA-REV CANCER, V1333, pF51, DOI 10.1016/S0304-419X(97)00011-5; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Griggs AM, 2010, J BIOL CHEM, V285, P13380, DOI 10.1074/jbc.M109.061366; Hoglund C, 2011, STEROIDS, V76, P1465, DOI 10.1016/j.steroids.2011.07.017; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Judd WR, 2011, J MED CHEM, V54, P5031, DOI 10.1021/jm200249a; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kubiak RL, 2012, BIOCHEMISTRY-US, V51, P867, DOI 10.1021/bi201650c; Lau HY, 2014, CANCER BIOL THER, V15, P1280, DOI 10.4161/cbt.29692; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Lu LY, 2008, MOL PHARMACOL, V73, P660, DOI 10.1124/mol.107.041038; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SHI YQ, 1992, J BIOL CHEM, V267, P9547; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; TAN EW, 1991, J BIOL CHEM, V266, P10719; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08; Xiong Y, 2006, BIOCHEMISTRY-US, V45, P2322, DOI 10.1021/bi0519001; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Young S. G., 2000, PROTEIN LIPIDATION, P155	44	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26007	26020		10.1074/jbc.M114.585125	http://dx.doi.org/10.1074/jbc.M114.585125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25059662	hybrid, Green Published			2022-12-28	WOS:000342128800002
J	Wang, Y; Xiao, C; Indersmitten, T; Freedman, R; Leonard, S; Lester, HA				Wang, Ying; Xiao, Cheng; Indersmitten, Tim; Freedman, Robert; Leonard, Sherry; Lester, Henry A.			The Duplicated alpha 7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length alpha 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-7-NICOTINIC ACETYLCHOLINE-RECEPTOR; MAMMALIAN-CELLS; GENE CHRNA7; COPY NUMBER; IN-VITRO; SCHIZOPHRENIA; RIC-3; ALPHA-4-BETA-2; STOICHIOMETRY; VARENICLINE	The alpha 7 nicotinic acetylcholine receptor gene (CHRNA7) is linked to schizophrenia. A partial duplication of CHRNA7 (CHRFAM7A) is found in humans on 15q13-14. Exon 6 of CHRFAM7 A harbors a 2-bp deletion polymorphism, CHRFAM7A-Delta 2bp, which is also associated with schizophrenia. To understand the effects of the duplicated subunits on alpha 7 receptors, we fused alpha 7, dup alpha 7, and dup Delta alpha 7 subunits with various fluorescent proteins. The duplicated subunits co-localized with full-length alpha 7 subunits in mouse neuroblastoma cells (Neuro2a) as well as rat hippocampal neurons. We investigated the interaction between the duplicated subunits and full-length alpha 7 by measuring Forster resonance energy transfer using donor recovery after photobleaching and fluorescence lifetime imaging microscopy. The results revealed that the duplicated proteins co-assemble with alpha 7. In electrophysiological studies, Leu at the 9'-position in the M2 membrane-spanning segment was replaced with Cys in dup alpha 7 or dup Delta alpha 7, and constructs were co-transfected with full-length alpha 7 in Neuro2a cells. Exposure to ethylammonium methanethiosulfonate inhibited acetylcholine-induced currents, showing that the assembled functional nicotinic acetylcholine receptors (nAChRs) included the duplicated subunit. Incorporation of dup alpha 7 and dup Delta alpha 7 subunits modestly changes the sensitivity of receptors to choline and varenicline. Thus, the duplicated proteins are assembled and transported to the cell membrane together with full-length alpha 7 subunits and alter the function of the nAChRs. The characterization of dup alpha 7 and dup Delta alpha 7 as well as their influence on alpha 7 nAChRs may help explain the pathophysiology of schizophrenia and may suggest therapeutic strategies.	[Wang, Ying; Xiao, Cheng; Indersmitten, Tim; Lester, Henry A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Freedman, Robert; Leonard, Sherry] Univ Colorado, Dept Psychiat, Denver, CO 80045 USA	California Institute of Technology; University of Colorado System; University of Colorado Denver	Lester, HA (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	lester@caltech.edu	Xiao, Cheng/O-5696-2015	Xiao, Cheng/0000-0001-9649-7450; Freedman, Robert/0000-0002-2181-2898	National Institutes of Health [MH088550]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH088550.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alexander JK, 2010, J NEUROSCI, V30, P10112, DOI 10.1523/JNEUROSCI.6344-09.2010; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Castillo M, 2009, J NEUROCHEM, V108, P1399, DOI 10.1111/j.1471-4159.2009.05924.x; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Court J, 1999, J NEUROCHEM, V73, P1590, DOI 10.1046/j.1471-4159.1999.0731590.x; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Drenan RM, 2008, MOL PHARMACOL, V73, P27, DOI 10.1124/mol.107.039180; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Flomen RH, 2008, EUR J HUM GENET, V16, P1364, DOI 10.1038/ejhg.2008.112; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Freedman R, 2001, AM J MED GENET, V105, P794, DOI 10.1002/ajmg.10100; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; GARCIAGUZMAN M, 1994, BIOCHEMISTRY-US, V33, P15198, DOI 10.1021/bi00254a031; Gault J, 2003, AM J MED GENET B, V123B, P39, DOI 10.1002/ajmg.b.20061; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gershon ES, 2000, BIOL PSYCHIAT, V47, P240, DOI 10.1016/S0006-3223(99)00299-1; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; King C, 2014, BIOPHYS J, V106, P1309, DOI 10.1016/j.bpj.2014.01.039; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Leonard S, 2006, BIOL PSYCHIAT, V60, P115, DOI 10.1016/j.biopsych.2006.03.054; Libert C, 2003, NATURE, V421, P328, DOI 10.1038/421328a; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Miles TF, 2013, BIOPHYS J, V105, P887, DOI 10.1016/j.bpj.2013.07.015; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Murray TA, 2009, ACTA PHARMACOL SIN, V30, P828, DOI 10.1038/aps.2009.78; Nashmi R, 2003, J NEUROSCI, V23, P11554; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Raux G, 2002, MOL PSYCHIATR, V7, P1006, DOI 10.1038/sj.mp.4001140; Richards CI, 2012, NANO LETT, V12, P3690, DOI 10.1021/nl301480h; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Ross RG, 2013, AM J PSYCHIAT, V170, P290, DOI 10.1176/appi.ajp.2012.12070940; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Simonson PD, 2010, BIOPHYS J, V99, pL81, DOI 10.1016/j.bpj.2010.08.076; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Slimko EM, 2002, J NEUROSCI, V22, P7373; Srinivasan R, 2012, INT J MOL SCI, V13, P10022, DOI 10.3390/ijms130810022; Srinivasan R, 2012, MOL PHARMACOL, V81, P759, DOI 10.1124/mol.112.077792; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; SUMIKAWA K, 1994, MOL BRAIN RES, V25, P257, DOI 10.1016/0169-328X(94)90161-9; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang Y, 2009, J NEUROSCI, V29, P12625, DOI 10.1523/JNEUROSCI.1776-09.2009; Wing VC, 2013, SCHIZOPHR RES, V149, P190, DOI 10.1016/j.schres.2013.06.032; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777; Zoli M, 2002, J NEUROSCI, V22, P8785	67	50	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26451	26463		10.1074/jbc.M114.582858	http://dx.doi.org/10.1074/jbc.M114.582858			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25056953	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000342128800036
J	Welsby, I; Hutin, D; Gueydan, C; Kruys, V; Rongvaux, A; Leo, O				Welsby, Iain; Hutin, David; Gueydan, Cyril; Kruys, Veronique; Rongvaux, Anthony; Leo, Oberdan			PARP12, an Interferon-stimulated Gene Involved in the Control of Protein Translation and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STRESS GRANULE FORMATION; POLY(ADP-RIBOSE) POLYMERASE; MESSENGER-RNA; ADP-RIBOSYLATION; HUMAN-CELLS; AUTOPHAGY; FAMILY; DOMAIN; VIRUS	Transcriptome analyses have recently identified PARP12, a member of a large family of ADP-ribosyl transferases, as an interferon-induced gene (ISG), whose function remains incompletely characterized. We demonstrate herein that PARP12 is a genuine ISG, whose expressed protein displays at least two distinct subcellular locations and related functions. Upon ectopic expression or exposure to oxidative stress, PARP12 is recruited to stress-granules (SGs), known sites of mRNA translational arrest. Accordingly, PARP12 was found to block mRNA translation, possibly upon association to the translational machinery. Both the N-terminal domain (containing an RNA-binding domain characterized by the presence of five CCCH-type Zn-fingers) and integrity of the catalytic domain are required for this suppressive function. In contrast, stimulation with LPS leads to the localization of PARP12 to p62/SQSTM1 (an adaptor protein involved in innate signaling and autophagy) containing structures, unrelated to SGs. Deletion of the N-terminal domain promotes the association of the protein to p62/SQSTM1, suggesting that the RNA-binding domain is responsible for the subcellular localization of PARP12. Association to p62/ SQSTM1 was found to correlate with increased NF-kappa B signaling, suggesting a role for PARP12 in inflammation. Collectively, these observations suggest that PARP12 can alternate between two distinct subcellular compartments associated to two distinct cellular functions. The present work therefore identifies PARP12 as an ISG with a potential role in cellular defenses against viral infections.	[Welsby, Iain; Hutin, David; Leo, Oberdan] Univ Libre Bruxelles, Lab Immunobiol, B-6041 Gosselies, Belgium; [Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Lab Biol Mol Gene, B-6041 Gosselies, Belgium; [Welsby, Iain; Leo, Oberdan] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Gosselies, Belgium; [Kruys, Veronique] CMMI, B-6041 Gosselies, Belgium; [Rongvaux, Anthony] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Yale University	Leo, O (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Immunobiol, B-6041 Gosselies, Belgium.	oleo@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Welsby, Iain/0000-0003-3034-8326; Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403	Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium; Research Concerted Action; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles"; Fonds David et Alice Van Buuren; Walloon Region	Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium; Research Concerted Action; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles"(Fonds de la Recherche Scientifique - FNRS); Fonds David et Alice Van Buuren; Walloon Region	This work was supported by the Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium, the Research Concerted Action and the "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles," the "Fonds David et Alice Van Buuren," and the Walloon Region.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13; Barreau C, 2006, BIOCHEM BIOPH RES CO, V347, P723, DOI 10.1016/j.bbrc.2006.06.177; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Coller J, 2002, METHODS, V26, P142, DOI 10.1016/S1046-2023(02)00016-6; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ferreyra GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088756; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gu TL, 2010, LEUKEMIA, V24, P861, DOI 10.1038/leu.2009.293; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Johansson HE, 1997, SEMIN VIROL, V8, P176, DOI 10.1006/smvy.1997.0120; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Kleine H, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-28; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Loseva O, 2010, J BIOL CHEM, V285, P8054, DOI 10.1074/jbc.M109.077834; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Morello LG, 2011, NUCLEIC ACIDS RES, V39, P648, DOI 10.1093/nar/gkq758; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	62	63	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26642	26657		10.1074/jbc.M114.589515	http://dx.doi.org/10.1074/jbc.M114.589515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086041	Green Published, hybrid			2022-12-28	WOS:000342128800054
J	Abrol, N; Smolin, N; Armanious, G; Ceholski, DK; Trieber, CA; Young, HS; Robia, SL				Abrol, Neha; Smolin, Nikolai; Armanious, Gareth; Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.; Robia, Seth L.			Phospholamban C-terminal Residues Are Critical Determinants of the Structure and Function of the Calcium ATPase Regulatory Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL DILATED CARDIOMYOPATHY; MOLECULAR-DYNAMICS METHOD; PARTICLE MESH EWALD; SARCOPLASMIC-RETICULUM; CARDIAC CONTRACTILITY; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; ENDOPLASMIC-RETICULUM; FORCE-FIELDS; MUTATION	To determine the structural and regulatory role of the C-terminal residues of phospholamban (PLB) in the membranes of living cells, we fused fluorescent protein tags to PLB and sarco/endoplasmic reticulum calcium ATPase (SERCA). Alanine substitution of PLB C-terminal residues significantly altered fluorescence resonance energy transfer (FRET) from PLB to PLB and SERCA to PLB, suggesting a change in quaternary conformation of PLB pentamer and SERCA-PLB regulatory complex. Val to Ala substitution at position 49 (V49A) had particularly large effects on PLB pentamer structure and PLB-SERCA regulatory complex conformation, increasing and decreasing probe separation distance, respectively. We also quantified a decrease in oligomerization affinity, an increase in binding affinity of V49A-PLB for SERCA, and a gain of inhibitory function as quantified by calcium-dependent ATPase activity. Notably, deletion of only a few C-terminal residues resulted in significant loss of PLB membrane anchoring and mislocalization to the cytoplasm and nucleus. C-terminal truncations also resulted in progressive loss of PLB-PLB FRET due to a decrease in the apparent affinity of PLB oligomerization. We quantified a similar decrease in the binding affinity of truncated PLB for SERCA and loss of inhibitory potency. However, despite decreased SERCA-PLB binding, intermolecular FRET for Val(49)-stop (V49X) truncation mutant was paradoxically increased as a result of an 11.3-angstrom decrease in the distance between donor and acceptor fluorophores. We conclude that PLB C-terminal residues are critical for localization, oligomerization, and regulatory function. In particular, the PLB C terminus is an important determinant of the quaternary structure of the SERCA regulatory complex.	[Abrol, Neha; Smolin, Nikolai; Robia, Seth L.] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Armanious, Gareth; Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	Loyola University Chicago; University of Alberta	Robia, SL (corresponding author), Loyola Univ, Dept Cell & Mol Physiol, 2160 S First Ave, Maywood, IL 60153 USA.	srobia@luc.edu	Smolin, Nikolai/C-6606-2008	Young, Howard/0000-0002-5990-8422; Trieber, Catharine/0000-0002-1336-1126	National Institutes of Health [R01 HL092321]; National Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Innovates-Technology Futures; Heart and Stroke Foundation of Canada; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL092321. This work was also supported by a gift from the McCormick Foundation to Loyola University Chicago.; Supported by a Canada graduate scholarship from the National Sciences and Engineering Research Council of Canada.; Supported by a Canada graduate scholarship from the Canadian Institutes of Health Research and Alberta Innovates-Technology Futures. Present address: Mount Sinai Hospital, Icahn School of Medicine, Leon and Norma Hess Center for Science and Medicine, New York, NY 10029.; Supported by the Heart and Stroke Foundation of Canada.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bluhm WF, 2000, AM J PHYSIOL-HEART C, V278, pH249, DOI 10.1152/ajpheart.2000.278.1.H249; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chiu C, 2007, J MOL CELL CARDIOL, V43, P337, DOI 10.1016/j.yjmcc.2007.06.009; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUJII J, 1989, J BIOL CHEM, V264, P12950; Gadella T. W., 2009, FRET FLIM TECHNIQUES, P193; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Lopez-Sendon J., 2011, MEDICOGRAPHIA, V33, P363; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; Park WJ, 2013, BMB REP, V46, P237, DOI 10.5483/BMBRep.2013.46.5.077; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Towbin Jeffrey A, 2002, Expert Rev Mol Diagn, V2, P587, DOI 10.1586/14737159.2.6.587; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Verardi R, 2011, P NATL ACAD SCI USA, V108, P9101, DOI 10.1073/pnas.1016535108; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 1997, BIOPHYS J, V72, P2545, DOI 10.1016/S0006-3495(97)78898-2; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	65	13	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25855	25866		10.1074/jbc.M114.562579	http://dx.doi.org/10.1074/jbc.M114.562579			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25074938	hybrid, Green Published			2022-12-28	WOS:000342130800042
J	Saita, S; Shirane, M; Ishitani, T; Shimizu, N; Nakayama, KI				Saita, Shotaro; Shirane, Michiko; Ishitani, Tohru; Shimizu, Nobuyuki; Nakayama, Keiichi I.			Role of the ANKMY2-FKBP38 Axis in Regulation of the Sonic Hedgehog (Shh) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE EXTENSION; MEMBRANE-PROTEIN; TRANSGENIC MICE; PRIMARY CILIUM; GLI PROTEINS; FKBP38; EXPRESSION; P27(KIP1); RECEPTOR; IMMUNOPHILINS	Sonic hedgehog (Shh) is a secreted morphogen that controls the patterning and growth of various tissues in the developing vertebrate embryo, including the central nervous system. Ablation of the FK506-binding protein 38 (FKBP38) gene results in activation of the Shh signaling pathway in mouse embryos, but the molecular mechanism by which FKBP38 suppresses Shh signaling has remained unclear. With the use of a proteomics approach, we have now identified ANKMY2, a protein with three ankyrin repeats and a MYND (myeloid, Nervy, and DEAF-1)-type Zn2+ finger domain, as a molecule that interacts with FKBP38. Co-immunoprecipitation analysis confirmed that endogenous FKBP38 and ANKMY2 interact in the mouse brain. Depletion or overexpression of ANKMY2 resulted in down- and up-regulation of Shh signaling, respectively, in mouse embryonic fibroblasts. Furthermore, combined depletion of both FKBP38 and ANKMY2 attenuated Shh signaling in these cells, suggesting that ANKMY2 acts downstream of FKBP38 to activate the Shh signaling pathway. Targeting of the zebrafish ortholog of mouse Ankmy2 (ankmy2a) in fish embryos with an antisense morpholino oligonucleotide conferred a phenotype reflecting loss of function of the Shh pathway, suggesting that the regulation of Shh signaling by ANKMY2 is conserved between mammals and fish. Our findings thus indicate that the FKBP38-ANKMY2 axis plays a key role in regulation of Shh signaling in vivo.	[Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Div Cell Biol, Higashi Ku, Fukuoka 8128582, Japan; [Ishitani, Tohru; Shimizu, Nobuyuki] Kyushu Univ, Med Inst Bioregulat, Div Cell Regulat Syst, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Shirane, M (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	smichi@bioreg.kyushu-u.ac.jp	Ishitani, Tohru/E-9781-2014; , Tohru/AAH-8979-2020	, Tohru/0000-0002-6200-7043; Shirane, Michiko/0000-0002-8297-9245; Saita, Shotaro/0000-0002-7406-8361	Japan Society for the Promotion of Science (JSPS) fellowship	Japan Society for the Promotion of Science (JSPS) fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Japan Society for the Promotion of Science (JSPS) fellowship (to S. S.).	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fujiwara M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001211; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ishitani T, 2005, NAT CELL BIOL, V7, P1106, DOI 10.1038/ncb1311; Jensen VL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001199; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; LAM E, 1995, GENE, V160, P297, DOI 10.1016/0378-1119(95)00216-S; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Ota S, 2012, EMBO J, V31, P1904, DOI 10.1038/emboj.2012.46; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Robertson CP, 2001, DEV BIOL, V238, P157, DOI 10.1006/dbio.2001.0392; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2008, GENES CELLS, V13, P635, DOI 10.1111/j.1365-2443.2008.01194.x; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Susaki E, 2010, J BIOL CHEM, V285, P15538, DOI 10.1074/jbc.M110.105841; Yamamoto T, 2005, J BIOL CHEM, V280, P16979, DOI 10.1074/jbc.M412433200	39	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25639	25654		10.1074/jbc.M114.558635	http://dx.doi.org/10.1074/jbc.M114.558635			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25077969	Green Published, hybrid			2022-12-28	WOS:000342130800024
J	Baertschi, S; Baur, N; Lueders-Lefevre, V; Voshol, J; Keller, H				Baertschi, Stefan; Baur, Nina; Lueders-Lefevre, Valerie; Voshol, Johannes; Keller, Hansjoerg			Class I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MEF2 TRANSCRIPTION FACTORS; MYOCYTE ENHANCER FACTOR-2; NUCLEAR EXPORT; PARATHYROID-HORMONE; TRICHOSTATIN-A; BONE-FORMATION; INHIBITORS; DIFFERENTIATION; SOST	Adult bone mass is controlled by the bone formation repressor sclerostin (SOST). Previously, we have shown that intermittent parathyroid hormone (PTH) bone anabolic therapy involves SOST expression reduction by inhibiting myocyte enhancer factor 2 (MEF2), which activates a distant bone enhancer. Here, we extended our SOST gene regulation studies by analyzing a role of class I and IIa histone deacetylases (HDACs), which are known regulators of MEF2s. Expression analysis using quantitative PCR (qPCR) showed high expression of HDACs 1 and 2, lower amounts of HDACs 3, 5, and 7, low amounts of HDAC4, and no expression of HDACs 8 and 9 in constitutively SOST-expressing UMR106 osteocytic cells. PTH-induced Sost suppression was associated with specific rapid nuclear accumulation of HDAC5 and co-localization with MEF2s in nuclear speckles requiring serine residues 259 and 498, whose phosphorylations control nucleocytoplasmic shuttling. Increasing nuclear levels of HDAC5 in UMR106 by blocking nuclear export with leptomycin B (LepB) or overexpression in transient transfection assays inhibited endogenous Sost transcription and reporter gene expression, respectively. This repressor effect of HDAC5 did not require catalytic activity using specific HDAC inhibitors. In contrast, inhibition of class I HDAC activities and expression using RNA interference suppressed constitutive Sost expression in UMR106 cells. An unbiased comprehensive search for involved HDAC targets using an acetylome analysis revealed several non-histone proteins as candidates. These findings suggest that PTH-mediated Sost repression involves nuclear accumulation of HDAC inhibiting the MEF2-dependent Sost bone enhancer, and class I HDACs are required for constitutive Sost expression in osteocytes.	[Baertschi, Stefan; Lueders-Lefevre, Valerie; Keller, Hansjoerg] Novartis Inst BioMed Res, Musculoskeletal Dis Area, CH-4056 Basel, Switzerland; [Baur, Nina; Voshol, Johannes] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland	Novartis; Novartis	Keller, H (corresponding author), WSJ 360-6-05, CH-4056 Basel, Switzerland.	hansjoerg.keller@novartis.com						Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Buglio D, 2010, BRIT J HAEMATOL, V151, P387, DOI 10.1111/j.1365-2141.2010.08342.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Johnson ML, 2007, CURR OPIN RHEUMATOL, V19, P376, DOI 10.1097/BOR.0b013e32816e06f9; Jung HM, 2010, BIOMATERIALS, V31, P29, DOI 10.1016/j.biomaterials.2009.09.019; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kwon YJ, 2007, J BIOMOL SCREEN, V12, P621, DOI 10.1177/1087057107301319; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Moester MJC, 2010, CALCIFIED TISSUE INT, V87, P99, DOI 10.1007/s00223-010-9372-1; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Ontoria JM, 2009, J MED CHEM, V52, P6782, DOI 10.1021/jm900555u; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Soragni E, 2012, J CHILD NEUROL, V27, P1164, DOI 10.1177/0883073812448533; Thomas EA, 2014, PHARMACEUTICALS, V7, P634, DOI 10.3390/ph7060634; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu XA, 2010, J BIOL CHEM, V285, P18139, DOI 10.1074/jbc.C110.131599; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058	58	30	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24995	25009		10.1074/jbc.M114.564997	http://dx.doi.org/10.1074/jbc.M114.564997			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25012661	Green Published, hybrid			2022-12-28	WOS:000341985300024
J	Stiegler, AL; Zhang, R; Liu, WZ; Boggon, TJ				Stiegler, Amy L.; Zhang, Rong; Liu, Weizhi; Boggon, Titus J.			Structural Determinants for Binding of Sorting Nexin 17 (SNX17) to the Cytoplasmic Adaptor Protein Krev Interaction Trapped 1 (KRIT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; FERM DOMAIN; RAP1; INTERNALIZATION; PATHOGENESIS; DEGRADATION; TRAFFICKING; RECOGNITION; INTEGRINS; COMPLEX	Sorting nexin 17 (SNX17) is a member of the family of cytoplasmic sorting nexin adaptor proteins that regulate endosomal trafficking of cell surface proteins. SNX17 localizes to early endosomes where it directly binds NPX(Y/F) motifs in the cytoplasmic tails of its target receptors to mediate their rates of endocytic internalization, recycling, and/or degradation. SNX17 has also been implicated in mediating cell signaling and can interact with cytoplasmic proteins. KRIT1 (Krev interaction trapped 1), a cytoplasmic adaptor protein associated with cerebral cavernous malformations, has previously been shown to interact with SNX17. Here, we demonstrate that SNX17 indeed binds directly to KRIT1 and map the binding to the second Asn-Pro-Xaa-Tyr/Phe (NPX(Y/F)) motif in KRIT1. We further characterize the interaction as being mediated by the FERM domain of SNX17. We present the co-crystal structure of SNX17-FERM with the KRIT1-NPXF2 peptide to 3.0 resolution and demonstrate that the interaction is highly similar in structure and binding affinity to that between SNX17 and P-selectin. We verify the molecular details of the interaction by site-directed mutagenesis and pulldown assay and thereby confirm that the major binding site for SNX17 is confined to the NPXF2 motif in KRIT1. Taken together, our results verify a direct interaction between SNX17 and KRIT1 and classify KRIT1 as a SNX17 binding partner.	[Stiegler, Amy L.; Zhang, Rong; Liu, Weizhi; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Stiegler, AL (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B-302,333 Cedar St, New Haven, CT 06520 USA.	amy.stiegler@yale.edu; titus.boggon@yale.edu			National Institutes of Health [R01 NS085078]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS085078 (to T. J. B.).	Adachi H, 2010, BBA-MOL CELL RES, V1803, P553, DOI 10.1016/j.bbamcr.2010.02.011; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balana B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059800; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Czubayko M, 2006, BIOCHEM BIOPH RES CO, V345, P1264, DOI 10.1016/j.bbrc.2006.04.129; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Florian V, 2001, BIOCHEM BIOPH RES CO, V281, P1045, DOI 10.1006/bbrc.2001.4467; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghai Rajesh, 2011, Small GTPases, V2, P259; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gingras AR, 2013, J BIOL CHEM, V288, P23639, DOI 10.1074/jbc.M113.462911; Gingras AR, 2012, J CELL BIOL, V199, P39, DOI 10.1083/jcb.201205109; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Knauth P, 2005, J MOL BIOL, V347, P813, DOI 10.1016/j.jmb.2005.02.004; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Seog DH, 2008, KOREAN J PHYSIOL PHA, V12, P199, DOI 10.4196/kjpp.2008.12.4.199; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Sotelo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093672; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Yadla S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10121; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83	53	17	17	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25362	25373		10.1074/jbc.M114.584011	http://dx.doi.org/10.1074/jbc.M114.584011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059659	Green Published, hybrid			2022-12-28	WOS:000341985300054
J	Geillon, F; Gondcaille, C; Charbonnier, S; Van Roermund, CW; Lopez, TE; Dias, AMM; de Barros, JPP; Arnould, C; Wanders, RJ; Trompier, D; Savary, S				Geillon, Flore; Gondcaille, Catherine; Charbonnier, Soeli; Van Roermund, Carlo W.; Lopez, Tatiana E.; Dias, Alexandre M. M.; de Barros, Jean-Paul Pais; Arnould, Christine; Wanders, Ronald J.; Trompier, Doriane; Savary, Stephane			Structure-Function Analysis of Peroxisomal ATP-binding Cassette Transporters Using Chimeric Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Fatty Acid; Peroxisome; Protein Chimera; Protein-Protein Interaction	X-LINKED ADRENOLEUKODYSTROPHY; CHAIN FATTY-ACID; ABC-TRANSPORTER; MEMBRANE-PROTEIN; PMP70 ABCD3; EXPRESSION; METABOLISM; MOUSE; ALDP; COA	Background: Peroxisomal ABC transporters are predicted to function as homodimers in mammals. Results: ABCD1 interacts with ABCD2. Chimeric proteins mimicking full-length dimers represent novel tools for functional study. Artificial homodimers and heterodimers are functional. Conclusion: Interchangeability between ABCD1 and ABCD2 is confirmed, but PUFA transport depends on ABCD2. Significance: For the first time, heterodimers in mammals are proven to be functional. ABCD1 and ABCD2 are two closely related ATP-binding cassette half-transporters predicted to homodimerize and form peroxisomal importers for fatty acyl-CoAs. Available evidence has shown that ABCD1 and ABCD2 display a distinct but overlapping substrate specificity, although much remains to be learned in this respect as well as in their capability to form functional heterodimers. Using a cell model expressing an ABCD2-EGFP fusion protein, we first demonstrated by proximity ligation assay and co-immunoprecipitation assay that ABCD1 interacts with ABCD2. Next, we tested in the pxa1/pxa2 yeast mutant the functionality of ABCD1/ABCD2 dimers by expressing chimeric proteins mimicking homo- or heterodimers. For further structure-function analysis of ABCD1/ABCD2 dimers, we expressed chimeric dimers fused to enhanced GFP in human skin fibroblasts of X-linked adrenoleukodystrophy patients. These cells are devoid of ABCD1 and accumulate very long-chain fatty acids (C26:0 and C26:1). We checked that the chimeric proteins were correctly expressed and targeted to the peroxisomes. Very long-chain fatty acid levels were partially restored in transfected X-linked adrenoleukodystrophy fibroblasts regardless of the chimeric construct used, thus demonstrating functionality of both homo- and heterodimers. Interestingly, the level of C24:6 n-3, the immediate precursor of docosahexaenoic acid, was decreased in cells expressing chimeric proteins containing at least one ABCD2 moiety. Our data demonstrate for the first time that both homo- and heterodimers of ABCD1 and ABCD2 are functionally active. Interestingly, the role of ABCD2 (in homo- and heterodimeric forms) in the metabolism of polyunsaturated fatty acids is clearly evidenced, and the chimeric dimers provide a novel tool to study substrate specificity of peroxisomal ATP-binding cassette transporters.	[Geillon, Flore; Gondcaille, Catherine; Charbonnier, Soeli; Lopez, Tatiana E.; Dias, Alexandre M. M.; Trompier, Doriane; Savary, Stephane] Univ Bourgogne, Lab BioperoxIL, EA7270, F-21000 Dijon, France; [Van Roermund, Carlo W.; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [de Barros, Jean-Paul Pais] Univ Bourgogne, Lipid Analyt Platform INSERM U866, F-21079 Dijon, France; [Arnould, Christine] Univ Bourgogne, INRA, ERL CNRS6300, Ctr Microscopie,Agroecol UMR1347, F-21000 Dijon, France	Universite de Bourgogne; University of Amsterdam; Academic Medical Center Amsterdam; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Savary, S (corresponding author), Univ Bourgogne, Lab BioperoxIL, EA7270, 6 Bd Gabriel, F-21000 Dijon, France.	stsavary@u-bourgogne.fr	TROMPIER, Doriane/D-5862-2017; Savary, Stephane/C-8137-2011; Charbonnier, Soëli/H-7003-2017	Savary, Stephane/0000-0002-9237-1727; Charbonnier, Soëli/0000-0002-3185-635X; Trompier, Doriane/0000-0002-0746-1753; Lopez, Tatiana/0000-0002-3658-682X; PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283	regional council of Burgundy	regional council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the regional council of Burgundy.	Baarine M, 2012, NEUROSCIENCE, V213, P1, DOI 10.1016/j.neuroscience.2012.03.058; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Bons JAP, 2008, CLIN CHIM ACTA, V387, P59, DOI 10.1016/j.cca.2007.09.002; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Footitt S, 2002, EMBO J, V21, P2912, DOI 10.1093/emboj/cdf300; Fouquet F, 1997, NEUROBIOL DIS, V3, P271, DOI 10.1006/nbdi.1997.0127; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2005, J HUM GENET, V50, P99, DOI 10.1007/s10038-004-0226-4; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Jimenez-Sanchez G, 1999, PEDIATR RES, V45, p139A, DOI 10.1203/00006450-199904020-00824; Jimenez-Sanchez G., 2000, J INHERIT METAB DIS, V23, P256; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Landgraf P, 2003, EUR J CELL BIOL, V82, P401, DOI 10.1078/0171-9335-00331; Leclercq S, 2008, BIOCHIMIE, V90, P1602, DOI 10.1016/j.biochi.2008.05.022; Liu JJ, 2012, J LIPID RES, V53, P1071, DOI 10.1194/jlr.M022160; Liu J, 2010, J LIPID RES, V51, P162, DOI 10.1194/jlr.M900237-JLR200; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Nyathi Y, 2012, FEBS LETT, V586, P2280, DOI 10.1016/j.febslet.2012.05.065; Nyathi Y, 2010, J BIOL CHEM, V285, P29892, DOI 10.1074/jbc.M110.151225; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Tanaka AR, 2002, J BIOL CHEM, V277, P40142, DOI 10.1074/jbc.M205079200; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Trompier D., 2013, X LINKED ADRENOLEUKO, V2, P1; Trompier D, 2014, BIOCHEM BIOPH RES CO, V446, P651, DOI 10.1016/j.bbrc.2014.01.025; van Roermund CWT, 2014, BBA-MOL CELL BIOL L, V1841, P563, DOI 10.1016/j.bbalip.2013.12.001; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Zhang XB, 2011, BIOCHEM J, V436, P547, DOI 10.1042/BJ20110249; Zoghbi ME, 2014, BIOCHEM BIOPH RES CO, V443, P97, DOI 10.1016/j.bbrc.2013.11.050	51	19	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24511	24520		10.1074/jbc.M114.575506	http://dx.doi.org/10.1074/jbc.M114.575506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25043761	Green Published, hybrid			2022-12-28	WOS:000341505600043
J	Maeda, S; Wada, H; Naito, Y; Nagano, H; Simmons, S; Kagawa, Y; Naito, A; Kikuta, J; Ishii, T; Tomimaru, Y; Hama, N; Kawamoto, K; Kobayashi, S; Eguchi, H; Umeshita, K; Ishii, H; Doki, Y; Mori, M; Ishii, M				Maeda, Sakae; Wada, Hiroshi; Naito, Yoko; Nagano, Hiroaki; Simmons, Szandor; Kagawa, Yoshinori; Naito, Atsushi; Kikuta, Junichi; Ishii, Taeko; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Eguchi, Hidetoshi; Umeshita, Koji; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Ishii, Masaru			Interferon-alpha Acts on the S/G(2)/M Phases to Induce Apoptosis in the G(1) Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Cycle; Cell Death; Hepatocellular Carcinoma; Interferon; Fucci	PORTAL-VEIN THROMBOSIS; MUTATIONAL ANALYSIS; CYCLE ARREST; P53; 5-FLUOROURACIL; RECEPTOR; THERAPY; GROWTH; PHOSPHORYLATION; COMBINATION	Background: The mode of action of interferon- has been unknown. Results: Its point of action in the cell cycle was analyzed by single cell tracking using time lapse confocal imaging. Conclusion: Interferon- activates p63 in S/G(2)/M and induces apoptosis and cell cycle arrest in the subsequent G(1). Significance: Tracking cell cycle progression is crucial for understanding the mechanisms of interferon-. Interferon- (IFN-) is used clinically to treat hepatocellular carcinoma (HCC), although the detailed therapeutic mechanisms remain elusive. In particular, IFN- has long been implicated in control of the cell cycle, but its actual point of action has not been clarified. Here, using time lapse imaging analyses of the human HCC cell line HuH7 carrying a fluorescence ubiquitination-based cell cycle indicator (Fucci), we found that IFN- induced cell cycle arrest in the G(0)/G(1) phases, leading to apoptosis through an IFN- type-2 receptor (IFNAR2)-dependent signaling pathway. Detailed analyses by time lapse imaging and biochemical assays demonstrated that the IFN-/IFNAR2 axis sensitizes cells to apoptosis in the S/G(2)/M phases in preparation for cell death in the G(0)/G(1) phases. In summary, this study is the first to demonstrate the detailed mechanism of IFN- as an anticancer drug, using Fucci-based time lapse imaging, which will be informative for treating HCC with IFN- in clinical practice.	[Maeda, Sakae; Naito, Yoko; Simmons, Szandor; Kagawa, Yoshinori; Naito, Atsushi; Kikuta, Junichi; Ishii, Taeko; Ishii, Masaru] Osaka Univ, Dept Immunol, Grad Sch Med & Frontier Biosci, Suita, Osaka 5650871, Japan; [Maeda, Sakae; Wada, Hiroshi; Nagano, Hiroaki; Kagawa, Yoshinori; Naito, Atsushi; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Eguchi, Hidetoshi; Umeshita, Koji; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, Suita, Osaka 5650871, Japan; [Simmons, Szandor; Kikuta, Junichi; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Mori, M (corresponding author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med & Frontier Biosci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	mmori@gesrug.med.osaka-u.ac.jp; mishii@icb.med.osaka-u.ac.jp	Ishii, Hideshi/AAV-5317-2020; Kikuta, Junichi/HHS-8875-2022	Simmons, Szandor/0000-0002-5309-9863	FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan; International Human Frontier Science Program [RGY0077/2011]; Cell Science Research Foundation; Japan Society for the Promotion of Science KAKENHI [24791414];  [22113007];  [25253070]; Grants-in-Aid for Scientific Research [22113007] Funding Source: KAKEN	FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Human Frontier Science Program(Human Frontier Science Program); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas 22113007; by Grant-in-Aid for Scientific Research (A) 25253070; by the FIRST Program from the Ministry of Education, Science, Sports, and Culture of Japan; by grants from the International Human Frontier Science Program (RGY0077/2011); and by grants from the Cell Science Research Foundation. This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant 24791414.	Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Cagatay T, 2002, ONCOGENE, V21, P7971, DOI 10.1038/sj.onc.1205919; COPELAND NG, 1995, GENOMICS, V29, P225, DOI 10.1006/geno.1995.1235; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fogal V, 2005, EMBO J, V24, P2768, DOI 10.1038/sj.emboj.7600735; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; Hagiwara K, 1999, CANCER RES, V59, P4165; HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8; Kondo M, 2005, CLIN CANCER RES, V11, P1277; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy D, 2001, HEPATOLOGY, V33, P346, DOI 10.1053/jhep.2001.21749; Nagano H, 2007, CANCER-AM CANCER SOC, V110, P2493, DOI 10.1002/cncr.23033; Nagano H, 2011, ONCOLOGY-BASEL, V80, P63, DOI 10.1159/000328281; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sangfelt O, 2000, FRONT BIOSCI-LANDMRK, V5, pD479, DOI 10.2741/Sangfelt; Sangfelt O, 1997, CELL GROWTH DIFFER, V8, P343; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Waltermann A, 2003, ONCOGENE, V22, P5686, DOI 10.1038/sj.onc.1206859; Yano H, 2006, J GASTROEN HEPATOL, V21, P1720, DOI 10.1111/j.1440-1746.2006.04357.x; Yoshikawa H, 1999, ONCOGENE, V18, P3415, DOI 10.1038/sj.onc.1202677	32	28	32	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23786	23795		10.1074/jbc.M114.551879	http://dx.doi.org/10.1074/jbc.M114.551879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25012666	Green Published, hybrid			2022-12-28	WOS:000341505000046
J	Samad, A; James, A; Wong, J; Mankad, P; Whitehouse, J; Patel, W; Alves-Simoes, M; Siriwardena, AK; Bruce, JIE				Samad, Aysha; James, Andrew; Wong, James; Mankad, Parini; Whitehouse, John; Patel, Waseema; Alves-Simoes, Marta; Siriwardena, Ajith K.; Bruce, Jason I. E.			Insulin Protects Pancreatic Acinar Cells from Palmitoleic Acid-induced Cellular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium ATPase; Calcium Transport; Insulin; Pancreas; PMCA; Pancreatitis	PLASMA-MEMBRANE CA2+-ATPASE; ALCOHOLIC PANCREATITIS; DIABETIC RATS; ETHYL-ESTERS; CA2+ UPTAKE; L-ARGININE; ATP; PHOSPHORYLATION; METABOLISM; RECEPTORS	Background: Palmitoleic acid is a major pancreatitis-inducing agent. Results: Insulin protected cells from palmitoleic acid (POA)-induced ATP depletion, inhibition of the plasma membrane calcium pump (PMCA), cytotoxic Ca2+ overload and necrosis. Conclusion: Insulin protects against acinar cell injury induced by pancreatitis-inducing agents. Significance: This provides an important therapeutic strategy for treating pancreatitis with insulin therapy. Acute pancreatitis is a serious and sometimes fatal inflammatory disease where the pancreas digests itself. The non-oxidative ethanol metabolites palmitoleic acid (POA) and POA-ethylester (POAEE) are reported to induce pancreatitis caused by impaired mitochondrial metabolism, cytosolic Ca2+ ([Ca2+](i)) overload and necrosis of pancreatic acinar cells. Metabolism and [Ca2+](i) are linked critically by the ATP-driven plasma membrane Ca2+-ATPase (PMCA) important for maintaining low resting [Ca2+](i). The aim of the current study was to test the protective effects of insulin on cellular injury induced by the pancreatitis-inducing agents, ethanol, POA, and POAEE. Rat pancreatic acinar cells were isolated by collagenase digestion and [Ca2+](i) was measured by fura-2 imaging. An in situ [Ca2+](i) clearance assay was used to assess PMCA activity. Magnesium green (MgGreen) and a luciferase-based ATP kit were used to assess cellular ATP depletion. Ethanol (100 mm) and POAEE (100 m) induced a small but irreversible Ca2+ overload response but had no significant effect on PMCA activity. POA (50-100 m) induced a robust Ca2+ overload, ATP depletion, inhibited PMCA activity, and consequently induced necrosis. Insulin pretreatment (100 nm for 30 min) prevented the POA-induced Ca2+ overload, ATP depletion, inhibition of the PMCA, and necrosis. Moreover, the insulin-mediated protection of the POA-induced Ca2+ overload was partially prevented by the phosphoinositide-3-kinase (PI3K) inhibitor, LY294002. These data provide the first evidence that insulin directly protects pancreatic acinar cell injury induced by bona fide pancreatitis-inducing agents, such as POA. This may have important therapeutic implications for the treatment of pancreatitis.	[Samad, Aysha; James, Andrew; Wong, James; Mankad, Parini; Whitehouse, John; Patel, Waseema; Alves-Simoes, Marta; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk		James, Andrew/0000-0002-2432-5948; Alves Simoes, Marta/0000-0002-5228-5584	BBSRC New Investigator Grant; Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	BBSRC New Investigator Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a BBSRC New Investigator Grant (to J. I. E. B.) and a Central Manchester Foundation Trust (CMFT)/NIHR Manchester Biological Research Centre (BRC) pump priming fund (to A. K. S. and J. I. E. B.).	Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Chu HY, 2012, P NATL ACAD SCI USA, V109, P12794, DOI 10.1073/pnas.1209014109; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Daly ME, 1998, AM J CLIN NUTR, V67, P1186, DOI 10.1093/ajcn/67.6.1186; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Diczfalusy MA, 2001, J LIPID RES, V42, P1025; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; HALLBERG D, 1977, ACTA CHIR SCAND, V143, P451; HARDIN CD, 1993, AM J PHYSIOL, V265, pH1326, DOI 10.1152/ajpheart.1993.265.4.H1326; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hardt PD, 2008, DIABETES CARE, V31, pS165, DOI 10.2337/dc08-s244; Hegyi P, 2000, J PHYSIOLOGY-PARIS, V94, P51, DOI 10.1016/S0928-4257(99)00103-5; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; Kaphalia B. S., 2001, Cellular and Molecular Biology Online Papers, V47, pOL173; Koizumi M, 1998, PANCREAS, V16, P385, DOI 10.1097/00006676-199804000-00028; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE766, DOI 10.1152/ajpendo.00468.2003; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE234, DOI 10.1152/ajpendo.00274.2003; LEVY P, 1989, GASTROENTEROLOGY, V96, P1165, DOI 10.1016/0016-5085(89)91637-5; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; Mentula P, 2008, PANCREAS, V36, pE21, DOI 10.1097/mpa.0b013e31814b22b5; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Owyang C, 1993, PANCREAS BIOL PATHOB; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Pandol SJ, 2011, ALCOHOL CLIN EXP RES, V35, P830, DOI 10.1111/j.1530-0277.2010.01408.x; Peter H, 2004, WORLD J GASTROENTERO, V10, P2275; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Petersen OH, 2006, TRENDS PHARMACOL SCI, V27, P113, DOI 10.1016/j.tips.2005.12.006; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; RENNER IG, 1985, DIGEST DIS SCI, V30, P1005, DOI 10.1007/BF01308298; Roberts Susan R, 2004, Crit Care Nurs Clin North Am, V16, P537, DOI 10.1016/S0899-5885(04)00068-1; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SANKARAN H, 1981, AM J PHYSIOL, V240, pG63, DOI 10.1152/ajpgi.1981.240.1.G63; Seicean Andrada, 2006, J Gastrointestin Liver Dis, V15, P21; Shalbueva N, 2013, GASTROENTEROLOGY, V144, P437, DOI 10.1053/j.gastro.2012.10.037; SVENSSON JO, 1975, SCAND J GASTROENTERO, V10, P487; Takacs T, 2001, PHARMACOL RES, V44, P363, DOI 10.1006/phrs.2001.0843; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Werner J, 1997, GASTROENTEROLOGY, V113, P286, DOI 10.1016/S0016-5085(97)70106-9; WILLIAMS JA, 1984, AM J PHYSIOL, V246, pG96, DOI 10.1152/ajpgi.1984.246.1.G96; WILLIAMS JA, 1985, DIABETES, V34, P980, DOI 10.2337/diabetes.34.10.980; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zancan P, 2005, MOL GENET METAB, V86, P401, DOI 10.1016/j.ymgme.2005.06.011; Zechner D, 2012, DIABETOLOGIA, V55, P1526, DOI 10.1007/s00125-012-2479-3	61	32	34	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23582	23595		10.1074/jbc.M114.589440	http://dx.doi.org/10.1074/jbc.M114.589440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24993827	Green Published, hybrid			2022-12-28	WOS:000341505000028
J	Salminen, A; Anashkin, VA; Lahti, M; Tuominen, HK; Lahti, R; Baykov, AA				Salminen, Anu; Anashkin, Viktor A.; Lahti, Matti; Tuominen, Heidi K.; Lahti, Reijo; Baykov, Alexander A.			Cystathionine beta-Synthase (CBS) Domains Confer Multiple Forms of Mg2+-dependent Cooperativity to Family II Pyrophosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; STREPTOCOCCUS-GORDONII; MOORELLA-THERMOACETICA; FLUORIDE INHIBITION; BACILLUS-SUBTILIS; PROTEIN-KINASE; DRTGG DOMAINS; BINDING; MECHANISM; KINETICS	Regulated family II pyrophosphatases (CBS-PPases) contain a nucleotide-binding insert comprising a pair of cystathionine beta-synthase (CBS) domains, termed a Bateman module. By binding with high affinity to the CBS domains, AMP and ADP usually inhibit the enzyme, whereas ATP activates it. Here, we demonstrate that AMP, ADP, and ATP bind in a positively cooperative manner to CBS-PPases from four bacteria: Desulfitobacterium hafniense, Clostridium novyi, Clostridium perfringens, and Eggerthella lenta. Enzyme interaction with substrate as characterized by the Michaelis constant (K-m) also exhibited positive catalytic cooperativity that decreased in magnitude upon nucleotide binding. The degree of both types of cooperativity increased with increasing concentration of the cofactor Mg2+ except for the C. novyi PPase where Mg2+ produced the opposite effect on kinetic cooperativity. Further exceptions from these general rules were ADP binding to C. novyi PPase and AMP binding to E. lenta PPase, neither of which had any effect on activity. A genetically engineered deletion variant of D. hafniense PPase lacking the regulatory insert was fully active but differed from the wild-type enzyme in that it was insensitive to nucleotides and bound substrate non-cooperatively and with a smaller K-m value. These results indicate that the regulatory insert acts as an internal inhibitor and confers dual positive cooperativity to CBS domain-containing PPases, making them highly sensitive regulators of the PPi level in response to the changes in cell energy status that control adenine nucleotide distribution. These regulatory features may be common among other CBS domain-containing proteins.	[Salminen, Anu; Lahti, Matti; Tuominen, Heidi K.; Lahti, Reijo] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Anashkin, Viktor A.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University	Lahti, R (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	reijo.lahti@utu.fi; baykov@genebee.msu.su	Baykov, Alexander/AAH-5301-2021; Tuominen, Heidi/A-7075-2010; Baykov, Alexander A/C-7981-2012; Anashkin, Viktor/C-1893-2014	Tuominen, Heidi/0000-0003-2412-7658; Baykov, Alexander/0000-0002-2495-8200	Russian Foundation for Basic Research [12-04-01002]; Academy of Finland [139031]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grant 139031 and Russian Foundation for Basic Research Grant 12-04-01002.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Ahn S, 2001, J MOL BIOL, V313, P797, DOI 10.1006/jmbi.2001.5070; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov A A, 1999, Prog Mol Subcell Biol, V23, P127; BAYKOV AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P238, DOI 10.1016/0003-9861(92)90163-Q; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2013, MICROBIOL MOL BIOL R, V77, P267, DOI 10.1128/MMBR.00003-13; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bisswanger H., 2008, ENZYME KINETICS PRIN; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; FORSEN S, 1995, TRENDS BIOCHEM SCI, V20, P495, DOI 10.1016/S0968-0004(00)89115-X; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Heinonen JK, 2001, BIOL ROLE INORGANIC, P1, DOI DOI 10.1007/978-1-4615-1433-6_1; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jamsen J, 2012, BIOCHEMISTRY-MOSCOW+, V77, P165, DOI 10.1134/S0006297912020071; Jamsen J, 2011, BIOCHEM J, V433, P497, DOI 10.1042/BJ20101204; Jamsen J, 2010, BIOCHEMISTRY-US, V49, P1005, DOI 10.1021/bi9019737; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jeong BC, 2013, J STRUCT BIOL, V183, P40, DOI 10.1016/j.jsb.2013.04.013; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-21; Kuhn NJ, 2000, ARCH BIOCHEM BIOPHYS, V379, P292, DOI 10.1006/abbi.2000.1860; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; MADSEN T, 1992, APPL ENVIRON MICROB, V58, P2874, DOI 10.1128/AEM.58.9.2874-2878.1992; Merckel MC, 2001, STRUCTURE, V9, P289, DOI 10.1016/S0969-2126(01)00587-1; Ok SH, 2012, PLANT SIGNAL BEHAV, V7, P664, DOI 10.4161/psb.19945; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; Ricard J, 1989, ALLOSTERIC ENZYMES, P1; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Smith R. M., 1995, NIST CRITICAL STABIL; SPRINGS B, 1981, BIOCHEMISTRY-US, V20, P6384, DOI 10.1021/bi00525a016; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Zyryanov AB, 2004, BIOCHEMISTRY-US, V43, P1065, DOI 10.1021/bi0357513	45	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22865	22876		10.1074/jbc.M114.589473	http://dx.doi.org/10.1074/jbc.M114.589473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24986864	Green Published, hybrid			2022-12-28	WOS:000341017200028
J	Kim, H; Choi, JA; Kim, JH				Kim, Hyunju; Choi, Jung-A; Kim, Jae-Hong			Ras Promotes Transforming Growth Factor-beta (TGF-beta)-induced Epithelial-Mesenchymal Transition via a Leukotriene B-4 Receptor-2-linked Cascade in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TGF-BETA; CANCER CELLS; BREAST-CANCER; PANCREATIC-CANCER; TUMOR PROGRESSION; SIGNALING PATHWAY; MOLECULAR-WEIGHT; OVARIAN-CANCER; UP-REGULATION	Inflammation and inflammatory mediators are inextricably linked with epithelial-mesenchymal transition (EMT) through complex pathways in the tumor microenvironment. However, the mechanism by which inflammatory mediators, such as the lipid inflammatory mediators, eicosanoids, contribute to EMT is largely unknown. In the present study we observed that BLT2, leukotriene B-4 receptor-2, is markedly up-regulated by oncogenic Ras and promotes EMT in response to transforming growth factor-beta (TGF-beta) in mammary epithelial cells. Blockade of BLT2 by the BLT2 inhibitor LY255283 or by siRNA reduced EMT induced by Ras in the presence of TGF-beta. In addition, stimulation of BLT2 by the addition of a BLT2 ligand, such as leukotriene B-4, restored EMT in the presence of TGF-beta in human immortalized mammary epithelial MCF-10A cells. We further searched BLT2 downstream components and identified reactive oxygen species and nuclear factor kappa B as critical components that contribute to EMT. Taken together, these results demonstrate for the first time that a BLT2-linked inflammatory pathway contributes to EMT. This provides valuable insight into the mechanism of EMT in mammary epithelial cells. In addition, considering the implications of EMT with the stemness of cancer cells, our finding may contribute to a better understanding of tumor progression.	[Kim, Hyunju; Choi, Jung-A; Kim, Jae-Hong] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	National Research Foundation - Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea [2012M3A9C5048709, 2012R1A2A2A01044526]; National Research and Development Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1220020]	National Research Foundation - Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by Bio and Medical Technology Development Program Grant 2012M3A9C5048709, Basic Science Research Program Grant 2012R1A2A2A01044526 through the National Research Foundation funded by the Ministry of Science, Information, and Communication Technologies (ICT) and Future Planning, Republic of Korea, and the National Research and Development Program for Cancer Control Grant 1220020, Ministry for Health and Welfare, Republic of Korea.	Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Boudreau HE, 2012, FREE RADICAL BIO MED, V53, P1489, DOI 10.1016/j.freeradbiomed.2012.06.016; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; CLAIR T, 1987, CANCER RES, V47, P5290; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Donaldson AE, 2009, STEM CELLS DEV, V18, P1003, DOI 10.1089/scd.2008.0300; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kabashima-Niibe A, 2013, CANCER SCI, V104, P157, DOI 10.1111/cas.12059; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049186; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P1506, DOI 10.1016/j.bcp.2010.01.018; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pan Y, 2011, J PHARMACOL EXP THER, V339, P82, DOI 10.1124/jpet.111.182055; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Safina AF, 2009, CELL CYCLE, V8, P284, DOI 10.4161/cc.8.2.7590; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Seo JM, 2011, EXP MOL MED, V43, P129, DOI 10.3858/emm.2011.43.3.014; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Teicher BA, 2001, CANCER METAST REV, V20, P133, DOI 10.1023/A:1013177011767; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151	43	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22151	22160		10.1074/jbc.M114.556126	http://dx.doi.org/10.1074/jbc.M114.556126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24990945	Green Published, hybrid			2022-12-28	WOS:000340593500030
J	Nagalingam, RS; Sundaresan, NR; Noor, M; Gupta, MP; Solaro, RJ; Gupta, M				Nagalingam, Raghu S.; Sundaresan, Nagalingam R.; Noor, Mariam; Gupta, Mahesh P.; Solaro, R. John; Gupta, Madhu			RETRACTED: Deficiency of Cardiomyocyte-specific MicroRNA-378 Contributes to the Development of Cardiac Fibrosis Involving a Transforming Growth Factor beta (TGF beta 1)-dependent Paracrine Mechanism (Retracted article. See vol. 292, pg. 5124, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							MYOCARDIAL FIBROSIS; ENRICHED MICRORNA; HYPERTROPHY; EXPRESSION; RAS; RECEPTOR; MIR-378; GROWTH-FACTOR-BETA-1; REPRESSION; PATHWAYS	Understanding the regulation of cardiac fibrosis is critical for controlling adverse cardiac remodeling during heart failure. Previously we identified miR-378 as a cardiomyocyte-abundant miRNA down-regulated in several experimental models of cardiac hypertrophy and in patients with heart failure. To understand the consequence of miR-378 down-regulation during cardiac remodeling, our current study employed a locked nucleic acid-modified antimiR to target miR-378 in vivo. Results showed development of cardiomyocyte hypertrophy and fibrosis in mouse hearts. Mechanistically, miR-378 depletion was found to induce TGF beta 1 expression in mouse hearts and in cultured cardiomyocytes. Among various secreted cytokines in the conditioned-media of miR-378-depleted cardiomyocytes, only TGF beta 1 levels were found to be increased. The increase was prevented by miR-378 expression. Treatment of cardiac fibroblasts with the conditioned media of miR-378-depleted myocytes activated pSMAD2/3 and induced fibrotic gene expression. This effect was counteracted by including a TGF beta 1-neutralizing antibody in the conditioned-medium. In cardiomyocytes, adenoviruses expressing dominant negative N-Ras or c-Jun prevented anti-miR-mediated induction of TGF beta 1 mRNA, documenting the importance of Ras and AP-1 signaling in this response. Our study demonstrates that reduction of miR-378 during pathological conditions contributes to cardiac remodeling by promoting paracrine release of profibrotic cytokine, TGF beta 1 from cardiomyocytes. Our data imply that the presence in cardiomyocyte of miR-378 plays a critical role in the protection of neighboring fibroblasts from activation by pro-fibrotic stimuli.	[Nagalingam, Raghu S.; Noor, Mariam; Solaro, R. John; Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, M-C 901 Rm 2051 COMRB,835 South Wolcott Ave, Chicago, IL 60612 USA; [Nagalingam, Raghu S.; Noor, Mariam; Solaro, R. John; Gupta, Madhu] Univ Illinois, Ctr Cardiovasc Res, Chicago, IL 60612 USA; [Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Dept Cardiothorac Surg, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Gupta, M (corresponding author), Univ Illinois, Dept Physiol & Biophys, M-C 901 Rm 2051 COMRB,835 South Wolcott Ave, Chicago, IL 60612 USA.	guptam@uic.edu			National Institutes of Health Multiple Principal Grant [RO1 HL 22231, RO1 HL-117041, HL-111455, PO1 HL 062426]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022231, R01HL117041, R01HL111455, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health Multiple Principal Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Multiple Principal Grant RO1 HL 22231 (to M. G. and R. J. S.) and Grants RO1 HL-117041, HL-111455 (to M. P. G.), and PO1 HL 062426 (to R. J. S.).	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRAND T, 1995, J MOL CELL CARDIOL, V27, P5, DOI 10.1016/S0022-2828(08)80003-X; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Crinelli R, 2002, NUCLEIC ACIDS RES, V30, P2435, DOI 10.1093/nar/30.11.2435; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048910; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hennersdorf MG, 2001, J HYPERTENS, V19, P167, DOI 10.1097/00004872-200102000-00002; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Li RK, 1997, CIRCULATION, V96, P874; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nagalingam RS, 2012, CIRCULATION, V126; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Pillai JB, 2005, AM J PHYSIOL-HEART C, V288, pH486, DOI 10.1152/ajpheart.00437.2004; Pillai VB, 2013, AM J PHYSIOL-HEART C, V304, pH415, DOI 10.1152/ajpheart.00468.2012; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; TAKAHASHI N, 1994, J CLIN INVEST, V94, P1470, DOI 10.1172/JCI117485; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; WESTWICK JK, 1994, P NATL ACAD SCI USA, V91, P6030, DOI 10.1073/pnas.91.13.6030; Yar S, 2013, J BIOL CHEM, V288, P16235, DOI 10.1074/jbc.M113.458695; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	41	40	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27199	27214		10.1074/jbc.M114.580977	http://dx.doi.org/10.1074/jbc.M114.580977			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25104350	Green Published, hybrid			2022-12-28	WOS:000342853900044
J	Takahashi, Y; Moiseyev, G; Ma, JX				Takahashi, Yusuke; Moiseyev, Gennadiy; Ma, Jian-xing			Identification of Key Residues Determining Isomerohydrolase Activity of Human RPE65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; OCULAR GENE-TRANSFER; SUBRETINAL INJECTION; RETINAL DYSTROPHY; CHILDHOOD-ONSET; CANINE MODEL; VISUAL CYCLE; IN-VIVO; MUTATIONS; THERAPY	RPE65 is the retinoid isomerohydrolase that converts all-trans-retinyl ester to 11-cis-retinol, a key reaction in the retinoid visual cycle. We have previously reported that cone-dominant chicken RPE65 (cRPE65) shares 90% sequence identity with human RPE65 (hRPE65) but exhibits substantially higher isomerohydrolase activity than that of bovine RPE65 or hRPE65. In this study, we sought to identify key residues responsible for the higher enzymatic activity of cRPE65. Based on the amino acid sequence comparison of mammalian and other lower vertebrates' RPE65, including cone-dominant chicken, 8 residues of hRPE65 were separately replaced by their counterparts of cRPE65 using site-directed mutagenesis. The enzymatic activities of cRPE65, hRPE65, and its mutants were measured by in vitro isomerohydrolase activity assay, and the retinoid products were analyzed by HPLC. Among the mutants analyzed, two single point mutants, N170K and K297G, and a double mutant, N170K/K297G, of hRPE65 exhibited significantly higher catalytic activity than WT hRPE65. Further, when an amino-terminal fragment (Met1-Arg33) of the N170K/K297G double mutant of hRPE65 was replaced with the corresponding cRPE65 fragment, the isomerohydrolase activity was further increased to a level similar to that of cRPE65. This finding contributes to the understanding of the structural basis for isomerohydrolase activity. This highly efficient human isomerohydrolase mutant can be used to improve the efficacy of RPE65 gene therapy for retinal degeneration caused by RPE65 mutations.	[Takahashi, Yusuke] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Takahashi, Yusuke; Moiseyev, Gennadiy; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu			National Institutes of Health Grants [EY012231, EY018659, EY019309, GM104934]; International Retinal Research Foundation; Oklahoma Center for the Advancement of Science and Technology (OCAST) Grants [HR12-103, HR13-076]; NATIONAL EYE INSTITUTE [R01EY019309, R01EY018659, R01EY012231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; Oklahoma Center for the Advancement of Science and Technology (OCAST) Grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012231, EY018659, EY019309, and GM104934. This work was also supported by a grant from the International Retinal Research Foundation and Oklahoma Center for the Advancement of Science and Technology (OCAST) Grants HR12-103 and HR13-076.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; BENNETT J, 1994, INVEST OPHTH VIS SCI, V35, P2535; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Crabb JW, 1998, METH MOL B, V89, P91; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Gal A., 1998, IOVS, V39, pS901; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Johnson CJ, 2008, MOL VIS, V14, P2211; Kachi S, 2005, GENE THER, V12, P843, DOI 10.1038/sj.gt.3302475; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1998, EUR J HUM GENET, V6, P527, DOI 10.1038/sj.ejhg.5200205; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Pang JJ, 2008, VISION RES, V48, P377, DOI 10.1016/j.visres.2007.08.009; Pittler SJ, 1999, INVEST OPHTH VIS SCI, V40, pS471; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Simovich M J, 2001, Hum Mutat, V18, P164, DOI 10.1002/humu.1168; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2011, FEBS J, V278, P973, DOI 10.1111/j.1742-4658.2011.08019.x; Thompson DA, 1999, INVEST OPHTH VIS SCI, V40, pS575; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Wada Y, 2000, INVEST OPHTH VIS SCI, V41, pS617; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yokoi K, 2007, INVEST OPHTH VIS SCI, V48, P3324, DOI 10.1167/iovs.06-1306; Yzer S, 2003, J MED GENET, V40, P709, DOI 10.1136/jmg.40.9.709; Zhang SH, 2008, CURR EYE RES, V33, P81, DOI 10.1080/02713680701799408	52	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26743	26751		10.1074/jbc.M114.558619	http://dx.doi.org/10.1074/jbc.M114.558619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25112876	Green Published, hybrid			2022-12-28	WOS:000342853900007
J	Vidaurre, S; Fitzpatrick, C; Burzio, VA; Briones, M; Villota, C; Villegas, J; Echenique, J; Oliveira-Cruz, L; Araya, M; Borgna, V; Socias, T; Lopez, C; Avila, R; Burzio, LO				Vidaurre, Soledad; Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Echenique, Javiera; Oliveira-Cruz, Luciana; Araya, Mariela; Borgna, Vincenzo; Socias, Teresa; Lopez, Constanza; Avila, Rodolfo; Burzio, Luis O.			Down-regulation of the Antisense Mitochondrial Non-coding RNAs (ncRNAs) Is a Unique Vulnerability of Cancer Cells and a Potential Target for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; REPLICATION SLIPPAGE; DNA-POLYMERASES; APOPTOSIS; SURVIVIN; EXPRESSION; PROTEIN; COMPLEX; IMPORT; IAP	Hallmarks of cancer are fundamental principles involved in cancer progression. We propose an additional generalized hallmark of malignant transformation corresponding to the differential expression of a family of mitochondrial ncRNAs (ncmtRNAs) that comprises sense and antisense members, all of which contain stem-loop structures. Normal proliferating cells express sense (SncmtRNA) and antisense (ASncmtRNA) transcripts. In contrast, the ASncmtRNAs are down-regulated in tumor cells regardless of tissue of origin. Here we show that knockdown of the low copy number of the ASncmtRNAs in several tumor cell lines induces cell death by apoptosis without affecting the viability of normal cells. In addition, knockdown of ASncmtRNAs potentiates apoptotic cell death by inhibiting survivin expression, a member of the inhibitor of apoptosis (IAP) family. Down-regulation of survivin is at the translational level and is probably mediated by microRNAs generated by dicing of the double-stranded stem of the ASncmtRNAs, as suggested by evidence presented here, in which the ASncmtRNAs are bound to Dicer and knockdown of the ASncmtRNAs reduces reporter luciferase activity in a vector carrying the 3'-UTR of survivin mRNA. Taken together, down-regulation of the ASncmtRNAs constitutes a vulnerability or Achilles' heel of cancer cells, suggesting that the ASncmtRNAs are promising targets for cancer therapy.	[Vidaurre, Soledad; Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Echenique, Javiera; Oliveira-Cruz, Luciana; Araya, Mariela; Borgna, Vincenzo; Socias, Teresa; Lopez, Constanza; Avila, Rodolfo; Burzio, Luis O.] Andes Biotechnol SA, Santiago 7780272, Chile; [Fitzpatrick, Christopher; Burzio, Veronica A.; Villota, Claudio; Villegas, Jaime; Oliveira-Cruz, Luciana; Burzio, Luis O.] Fdn Ciencia Vida, Santiago 7780272, Chile; [Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Burzio, Luis O.] Univ Andres Bello, Fac Ciencias Biol, Santiago 8370134, Chile; [Borgna, Vincenzo] Univ Andres Bello, Fac Med, Santiago 8370134, Chile; [Vidaurre, Soledad] Univ Bernardo OHiggins, Dept Ciencias Quim & Biol, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad  Bernardo O'Higgins	Burzio, VA (corresponding author), Andes Biotechnol SA, Zanartu 1482, Santiago 7780272, Chile.	vburzio@gmail.com; lburzio@gmail.com	Borgna, Vincenzo/AAZ-8414-2020; Oliveira-Cruz, Luciana/N-7756-2014; Fitzpatrick, Christopher/AAU-1679-2020; Villegas, Jaime/AAW-5938-2020	Fitzpatrick, Christopher/0000-0002-5598-8111; Villegas, Jaime/0000-0002-9556-4655	Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt)) [1110835, 1140345]; Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondecyt) [11090060, 1085210]; Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile [Fondef-D04I1338, CCTE-PFB16]; Universidad Andres Bello, Chile [DI-34-09/R, DI-31-09/R, DI-28-09/R4, DI-06-09/R]	Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt))(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Andres Bello, Chile	This work was supported by Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt) 1110835 and 1140345 (to V. A. B.), Fondecyt 11090060 (to C. V.), Fondecyt 1085210 (to J. V.), Fondef-D04I1338 (to J. V.), and CCTE-PFB16), and Universidad Andres Bello, Chile (DI-34-09/R, DI-31-09/R, DI-28-09/R4, and DI-06-09/R).	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Benoit MPMH, 2013, NUCLEIC ACIDS RES, V41, P4241, DOI 10.1093/nar/gkt086; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Dias N, 2002, MOL CANCER THER, V1, P347; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Houston MA, 2011, INT J CELL BIOL, V2011; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Rodriguez OC, 2012, CELL CYCLE, V11, P4436, DOI 10.4161/cc.22778; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Viguera E, 2001, J MOL BIOL, V312, P323, DOI 10.1006/jmbi.2001.4943; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	73	47	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27182	27198		10.1074/jbc.M114.558841	http://dx.doi.org/10.1074/jbc.M114.558841			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100722	Green Published, hybrid			2022-12-28	WOS:000342853900043
J	Yoshida, CA; Kawane, T; Moriishi, T; Purushothaman, A; Miyazaki, T; Komori, H; Mori, M; Qin, X; Hashimoto, A; Sugahara, K; Yamana, K; Takada, K; Komori, T				Yoshida, Carolina Andrea; Kawane, Tetsuya; Moriishi, Takeshi; Purushothaman, Anurag; Miyazaki, Toshihiro; Komori, Hisato; Mori, Masako; Qin, Xin; Hashimoto, Ayako; Sugahara, Kazuyuki; Yamana, Kei; Takada, Kenji; Komori, Toshihisa			Overexpression of Galnt3 in Chondrocytes Resulted in Dwarfism Due to the Increase of Mucin-type O-Glycans and Reduction of Glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; CHONDROITIN SULFATE; INDIAN HEDGEHOG; COLLAGEN GENE; GLYCOSYLATION; DIFFERENTIATION; PROTEOGLYCANS; EXPRESSION; CARTILAGE; SITE	Galnt3, UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetyl-galactosaminyltransferase 3, transfers N-acetyl-D-galactosamine to serine and threonine residues, initiating mucin type O-glycosylation of proteins. We searched the target genes of Runx2, which is an essential transcription factor for chondrocyte maturation, in chondrocytes and found that Galnt3 expression was up-regulated by Runx2 and severely reduced in Runx2(-/-) cartilaginous skeletons. To investigate the function of Galnt3 in chondrocytes, we generated Galnt3(-/-) mice and chondrocyte-specific Galnt3 transgenic mice under the control of the Col2a1 promoter-enhancer. Galnt3(-/-) mice showed a delay in endochondral ossification and shortened limbs at embryonic day 16.5, suggesting that Galnt3 is involved in chondrocyte maturation. Galnt3 transgenic mice presented dwarfism, the chondrocyte maturation was retarded, the cell cycle in chondrocytes was accelerated, premature chondrocyte apoptosis occurred, and the growth plates were disorganized. The binding of Vicia villosa agglutinin, which recognizes the Tn antigen (GalNAc-O-Ser/Thr), was drastically increased in chondrocytes, and aggrecan (Acan) was highly enriched with Tn antigen. However, safranin O staining, which recognizes glycosaminoglycans (GAGs), and Acan were severely reduced. Chondroitin sulfate was reduced in amount, but the elongation of chondroitin sulfate chains had not been severely disturbed in the isolated GAGs. These findings indicate that overexpression of Galnt3 in chondrocytes caused dwarfism due to the increase of mucin-type O-glycans and the reduction of GAGs, probably through competition with xylosyltransferases, which initiate GAG chains by attaching O-linked xylose to serine residues, suggesting a negative effect of Galnt family proteins on Acan deposition in addition to the positive effect of Galnt3 on chondrocyte maturation.	[Yoshida, Carolina Andrea; Kawane, Tetsuya; Moriishi, Takeshi; Miyazaki, Toshihiro; Komori, Hisato; Mori, Masako; Qin, Xin; Hashimoto, Ayako; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Cell Biol, Nagasaki 8528588, Japan; [Purushothaman, Anurag; Sugahara, Kazuyuki; Komori, Toshihisa] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6580003, Japan; [Hashimoto, Ayako; Takada, Kenji] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Suita, Osaka 5650871, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Proteoglycan Signaling & Therapeut Res Grp, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci,Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Yamana, Kei] Teijin Ltd, Teijin Inst Biomed Res, Tokyo 1918512, Japan	Nagasaki University; Kobe Pharmaceutical University; Osaka University; Hokkaido University; Teijin Limited	Komori, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Cell Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	komorit@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Nagasaki University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagasaki University	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the President's Discretionary Fund of Nagasaki University.	Alonso M, 1996, BIOCHEM J, V316, P487, DOI 10.1042/bj3160487; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Breuza L, 2002, EXP CELL RES, V273, P178, DOI 10.1006/excr.2001.5442; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200; Frishberg Y, 2007, J BONE MINER RES, V22, P235, DOI 10.1359/JBMR.061105; Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garner B, 2001, J BIOL CHEM, V276, P22200, DOI 10.1074/jbc.M102150200; Gentili C, 2009, CURR PHARM DESIGN, V15, P1334, DOI 10.2174/138161209787846739; GERLITZ B, 1993, BIOCHEM J, V295, P131, DOI 10.1042/bj2950131; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kato K, 2008, BIOCHEM BIOPH RES CO, V371, P698, DOI 10.1016/j.bbrc.2008.04.120; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; KIVIRANTA I, 1985, HISTOCHEMISTRY, V83, P303, DOI 10.1007/BF00684375; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krebsbach PH, 1996, J BIOL CHEM, V271, P4298, DOI 10.1074/jbc.271.8.4298; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; Miyazaki T, 2013, HISTOCHEM CELL BIOL, V139, P339, DOI 10.1007/s00418-012-1031-3; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; Olauson H, 2008, EUR J ENDOCRINOL, V158, P929, DOI 10.1530/EJE-08-0011; Patsos G, 2007, BIOCHEM SOC T, V35, P1372, DOI 10.1042/BST0351372; Sato T, 2011, J BIOL CHEM, V286, P5803, DOI 10.1074/jbc.M110.159244; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Varki A., 2009, ESSENTIALS GLYCOBIOL, P229; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wu A M, 1988, Adv Exp Med Biol, V228, P819; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zheng XL, 2002, J BIOL CHEM, V277, P6858, DOI 10.1074/jbc.M109857200; ZHOU G, 1995, J CELL SCI, V108, P3677	49	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26584	26596		10.1074/jbc.M114.555987	http://dx.doi.org/10.1074/jbc.M114.555987			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25107907	Green Published, hybrid			2022-12-28	WOS:000342128800049
J	Anders, K; Gutt, A; Gartner, W; Essen, LO				Anders, Katrin; Gutt, Alexander; Gaertner, Wolfgang; Essen, Lars-Oliver			Phototransformation of the Red Light Sensor Cyanobacterial Phytochrome 2 from Synechocystis Species Depends on Its Tongue Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT PHYTOCHROME; P-R; THERMODYNAMIC ANALYSIS; CHROMOPHORE; FEMTOSECOND; TEMPERATURE; KINETICS; PHOTOCONVERSION; ISOMERIZATION; SPECTROSCOPY	Phytochromes are photoreceptors using a bilin tetrapyrrole as chromophore, which switch in canonical phytochromes between red (P-r) and far red (P-fr) light-absorbing states. Cph2 from Synechocystis sp., a noncanonical phytochrome, harbors besides a cyanobacteriochrome domain a second photosensory module, a P-r/P-fr-interconverting GAF-GAF bidomain (SynCph2(1-2)). As in the canonical phytochromes, a unique motif of the second GAF domain, the tongue region, seals the bilin-binding site in the GAF1 domain from solvent access. Time-resolved spectroscopy of the SynCph2(1-2) module shows four intermediates during P-r -> P-fr phototransformation and three intermediates during P-fr -> P-r back-conversion. A mutation in the tongue's conserved PRXSF motif, S385A, affects the formation of late intermediate R3 and of a P-fr-like state but not the back-conversion to P-r via a lumi-F-like state. In contrast, a mutation in the likewise conserved WXE motif, W389A, changes the photocycle at intermediate R2 and causes an alternative red light-adapted state. Here, back-conversion to P-r proceeds via intermediates differing from SynCph2(1-2). Replacement of this tryptophan that is similar to 15 angstrom distant from the chromophore by another aromatic amino acid, W389F, restores native P-r -> P-fr phototransformation. These results indicate large scale conformational changes within the tongue region of GAF2 during the final processes of phototransformation. We propose that in early intermediates only the chromophore and its nearest surroundings are altered, whereas late changes during R2 formation depend on the distant WXE motifs of the tongue region. Ser-385 within the PRXSF motif affects only late intermediate R3, when refolding of the tongue and docking to the GAF1 domain are almost completed.	[Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Dept Chem, D-35032 Marburg, Germany; [Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Dept Biol, D-35032 Marburg, Germany; [Gutt, Alexander; Gaertner, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany	Philipps University Marburg; Philipps University Marburg; Max Planck Society	Gartner, W (corresponding author), Max Planck Inst Chem Energy Convers, Stiftstr 34-36, D-45470 Mulheim, Germany.	wolfgang.gaertner@cec.mpg.de; essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026; Gartner, Wolfgang/0000-0002-6898-7011	Deutsche Forschungsgemeinschaft [ES152/9, ES152/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants ES152/9 and ES152/10.	Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Andel F, 1997, BIOSPECTROSCOPY, V3, P421, DOI 10.1002/(SICI)1520-6343(1997)3:6<421::AID-BSPY1>3.0.CO;2-3; Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Anders K, 2011, PHOTOCHEM PHOTOBIOL, V87, P160, DOI 10.1111/j.1751-1097.2010.00845.x; Bischoff M, 2001, BIOCHEMISTRY-US, V40, P181, DOI 10.1021/bi0011734; Borucki B, 2006, PHOTOCH PHOTOBIO SCI, V5, P553, DOI 10.1039/b603846h; BRANDLMEIER T, 1981, Z NATURFORSCH C, V36, P431; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Chizhov I, 2001, BIOPHYS J, V81, P1600, DOI 10.1016/S0006-3495(01)75814-6; Chizhov I, 2013, BIOPHYS J, V105, P2210, DOI 10.1016/j.bpj.2013.09.033; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Gartner W, 1996, EUR J BIOCHEM, V236, P978, DOI 10.1111/j.1432-1033.1996.00978.x; Heyes DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052418; Heyne K, 2002, BIOPHYS J, V82, P1004, DOI 10.1016/S0006-3495(02)75460-X; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Kim PW, 2013, J PHYS CHEM LETT, V4, P2605, DOI 10.1021/jz401443q; MARGULIES L, 1979, J AM CHEM SOC, V101, P743, DOI 10.1021/ja00497a046; Michler I, 2001, PHOTOCHEM PHOTOBIOL, V74, P624, DOI 10.1562/0031-8655(2001)074&lt;0624:TRTAOT&gt;2.0.CO;2; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Remberg A, 1999, EUR J BIOCHEM, V266, P201, DOI 10.1046/j.1432-1327.1999.00844.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Remberg A, 1998, BIOCHEMISTRY-US, V37, P9983, DOI 10.1021/bi980575x; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Schwinte P, 2009, PHOTOCHEM PHOTOBIOL, V85, P239, DOI 10.1111/j.1751-1097.2008.00426.x; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Song C, 2013, PHOTOCHEM PHOTOBIOL, V89, P259, DOI 10.1111/php.12029; Stanek M, 1998, CHEM-EUR J, V4, P1653, DOI 10.1002/(SICI)1521-3765(19980904)4:9<1653::AID-CHEM1653>3.0.CO;2-K; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang Y, 2012, J AM CHEM SOC, V134, P1408, DOI 10.1021/ja209413d; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548	39	17	17	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25590	25600		10.1074/jbc.M114.562082	http://dx.doi.org/10.1074/jbc.M114.562082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25012656	Green Published, hybrid			2022-12-28	WOS:000342130800020
J	Budhidarmo, R; Day, CL				Budhidarmo, Rhesa; Day, Catherine L.			The Ubiquitin-associated Domain of Cellular Inhibitor of Apoptosis Proteins Facilitates Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RETICULUM-ASSOCIATED DEGRADATION; ALPHA-DEPENDENT APOPTOSIS; UBA DOMAIN; E3 LIGASE; POLYUBIQUITIN CHAINS; STRUCTURAL BASIS; RING DOMAIN; CUE DOMAIN; MOLECULAR DETERMINANTS	The cellular inhibitor of apoptosis (cIAP) proteins are essential RING E3 ubiquitin ligases that regulate apoptosis and inflammatory responses. cIAPs contain a ubiquitin-associated (UBA) domain that binds ubiquitin and is implicated in the regulation of cell survival and proteasomal degradation. Here we show that mutation of the MGF and LL motifs in the UBA domain of cIAP1 caused unfolding and increased cIAP1 multi-monoubiquitylation. By developing a UBA mutant that disrupted ubiquitin binding but not the structure of the UBA domain, we found that the UBA domain enhances cIAP1 and cIAP2 ubiquitylation. We demonstrate that the UBA domain binds to the UbcH5b similar to Ub conjugate, and this promotes RING domain-dependent monoubiquitylation. This study establishes ubiquitin-binding modules, such as the UBA domain, as important regulatory modules that can fine tune the activity of E3 ligases.	[Budhidarmo, Rhesa; Day, Catherine L.] Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin 9054, New Zealand	University of Otago	Day, CL (corresponding author), Univ Otago, Dept Biochem, Otago Sch Med Sci, Dunedin 9054, New Zealand.	catherine.day@otago.ac.nz		Day, Catherine/0000-0003-1571-4367	Otago University Doctoral Scholarship; Marsden Fund (New Zealand)	Otago University Doctoral Scholarship; Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Otago University Doctoral Scholarship and the Marsden Fund (New Zealand).	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heinen C, 2010, FEBS LETT, V584, P1585, DOI 10.1016/j.febslet.2010.03.018; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Liu S, 2012, STRUCTURE, V20, P2138, DOI 10.1016/j.str.2012.09.020; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Sasaki T, 2005, BIOCHEM BIOPH RES CO, V336, P530, DOI 10.1016/j.bbrc.2005.08.126; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Schumacher FR, 2013, J MOL BIOL, V425, P4099, DOI 10.1016/j.jmb.2013.06.039; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tse MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028511; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walinda E, 2014, J BIOL CHEM, V289, P13890, DOI 10.1074/jbc.M114.555441; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Williamson A, 2011, MOL CELL, V42, P744, DOI 10.1016/j.molcel.2011.04.022; Wilson RC, 2009, ACTA CRYSTALLOGR F, V65, P440, DOI 10.1107/S1744309109011117; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	59	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25721	25736		10.1074/jbc.M113.545475	http://dx.doi.org/10.1074/jbc.M113.545475			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25065467	Green Published, hybrid			2022-12-28	WOS:000342130800031
J	Lee, CS; Georgiou, DK; Dagnino-Acosta, A; Xu, JJ; Ismailov, II; Knoblauch, M; Monroe, TO; Ji, RR; Hanna, AD; Joshi, AD; Long, C; Oakes, J; Tran, T; Corona, BT; Lorca, S; Ingalls, CP; Narkar, VA; Lanner, JT; Bayle, JH; Durham, WJ; Hamilton, SL				Lee, Chang Seok; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Xu, Jianjun; Ismailov, Iskander I.; Knoblauch, Mark; Monroe, Tanner O.; Ji, RuiRui; Hanna, Amy D.; Joshi, Aditya D.; Long, Cheng; Oakes, Joshua; Ted Tran; Corona, Benjamin T.; Lorca, Sabina; Ingalls, Christopher P.; Narkar, Vihang A.; Lanner, Johanna T.; Bayle, J. Henri; Durham, William J.; Hamilton, Susan L.			Ligands for FKBP12 Increase Ca2+ Influx and Protein Synthesis to Improve Skeletal Muscle Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENDS LIFE-SPAN; ENERGY-METABOLISM; MOUSE MODEL; FIBER-TYPE; S6 KINASE; ERR-ALPHA; RAPAMYCIN; MICE; MTOR; RECEPTOR	Rapamycin at high doses (2-10 mg/kg body weight) inhibits mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis in mice. In contrast, low doses of rapamycin (10 mu g/kg) increase mTORC1 activity and protein synthesis in skeletal muscle. Similar changes are found with SLF (synthetic ligand for FKBP12, which does not inhibit mTORC1) and in mice with a skeletal muscle-specific FKBP12 deficiency. These interventions also increase Ca2+ influx to enhance refilling of sarcoplasmic reticulum Ca2+ stores, slow muscle fatigue, and increase running endurance without negatively impacting cardiac function. FKBP12 deficiency or longer treatments with low dose rapamycin or SLF increase the percentage of type I fibers, further adding to fatigue resistance. We demonstrate that FKBP12 and its ligands impact multiple aspects of muscle function.	[Lee, Chang Seok; Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Xu, Jianjun; Ismailov, Iskander I.; Knoblauch, Mark; Monroe, Tanner O.; Ji, RuiRui; Hanna, Amy D.; Joshi, Aditya D.; Long, Cheng; Oakes, Joshua; Ted Tran; Lanner, Johanna T.; Bayle, J. Henri; Hamilton, Susan L.] Baylor Coll Med, Houston, TX 77030 USA; [Corona, Benjamin T.; Ingalls, Christopher P.] Georgia State Univ, Dept Kinesiol & Hlth, Muscle Biol Lab, Atlanta, GA 30302 USA; [Lorca, Sabina; Narkar, Vihang A.] Univ Texas Hlth Sci Ctr Houston, Ctr Metab & Degenerat Dis, Houston, TX 77030 USA; [Durham, William J.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	Baylor College of Medicine; University System of Georgia; Georgia State University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.	susanh@bcm.tmc.edu	Dagnino-Acosta, Adan/K-6786-2012; Monroe, Tanner O./AAQ-5901-2021	Hanna, Amy/0000-0001-6418-6666; Lanner, Johanna/0000-0002-1222-9473; Jianjun, XU/0000-0002-1855-8462; Hamilton, Susan/0000-0003-0241-9369; Monroe, Tanner/0000-0001-9117-2227; Dagnino-Acosta, Adan/0000-0001-8903-807X	National Institutes of Health [AR41802, AR053349]; Muscular Dystrophy Association; United States Department of Defense; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R01AR053349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United States Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR41802 and AR053349 (to S. L. H.). This work was also supported in part by grants from the Muscular Dystrophy Association and the United States Department of Defense.	Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Allen DG, 2002, CAN J APPL PHYSIOL, V27, P83, DOI 10.1139/h02-006; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braun PD, 2003, J AM CHEM SOC, V125, P7575, DOI 10.1021/ja035176q; Chan S, 2004, BRIT J CANCER, V91, P1420, DOI 10.1038/sj.bjc.6602162; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Corona BT, 2008, J APPL PHYSIOL, V105, P527, DOI 10.1152/japplphysiol.01145.2007; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; FRANZINIARMSTRONG C, 1991, DEV BIOL, V146, P353, DOI 10.1016/0012-1606(91)90237-W; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; GARCIA J, 1994, J GEN PHYSIOL, V103, P107, DOI 10.1085/jgp.103.1.107; Graves LM, 1997, J BIOL CHEM, V272, P1920, DOI 10.1074/jbc.272.3.1920; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hannan KM, 2003, BIOCHEM J, V370, P469, DOI 10.1042/BJ20021709; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Komarova EA, 2012, AGING-US, V4, P709, DOI 10.18632/aging.100498; LaBarge S, 2014, FASEB J, V28, P1082, DOI 10.1096/fj.13-229211; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; Marks AR, 1996, TRENDS CARDIOVAS MED, V6, P130, DOI 10.1016/1050-1738(96)00035-7; Mercan F, 2013, MOL CELL BIOL, V33, P293, DOI 10.1128/MCB.01285-12; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Ramos FJ., 2012, SCI TRANSL MED, V4; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rastogi R, 2013, J BIOL CHEM, V288, P33966, DOI 10.1074/jbc.M113.492702; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schreiber S L, 1995, Harvey Lect, V91, P99; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25556	25570		10.1074/jbc.M114.586289	http://dx.doi.org/10.1074/jbc.M114.586289			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25053409	Green Published, hybrid			2022-12-28	WOS:000342130800017
J	Li, LW; Zhang, YW; Qiao, JJ; Yang, JJ; Liu, ZR				Li, Liangwei; Zhang, Yinwei; Qiao, Jingjuan; Yang, Jenny J.; Liu, Zhi-Ren			Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; TU M2-PK; MARKER; CANCER; PKM2; TRANSCRIPTION; PROTEIN; PLASMA	It is long known that pyruvate kinase isoform M2 (PKM2) is released into the circulation of cancer patients. The PKM2 levels in patients have been suggested as a diagnostic marker for many types of cancers. However, it is not known how PKM2 is released in the blood, and whether the circulating PKM2 has any physiological function(s) in tumor progression. In this report, we demonstrate that PKM2 in the blood facilitates tumor growth by promoting tumor angiogenesis. Our experiments show that PKM2 promotes tumor angiogenesis by increasing endothelial cell proliferation, migration, and cell-ECM adhesion. Only the dimeric PKM2 possess the activity in promoting tumor angiogenesis, which is consistent with the observations that PKM2 in circulation of cancer patients is a dimer form.	[Li, Liangwei; Zhang, Yinwei; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Qiao, Jingjuan; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Liu, ZR (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza, Atlanta, GA 30303 USA.	zliu8@gsu.edu			National Institutes of Health [CA118113]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA118113 (to Z.-R. L.). This work was also supported by the Georgia Cancer Coalition (to Z.-R. L.).	Ahmed AS, 2007, EUR J GYNAECOL ONCOL, V28, P83; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Boros LG, 2002, DRUG DISCOV TODAY, V7, P364, DOI 10.1016/S1359-6446(02)02179-7; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Duan HF, 2007, J NATL CANCER I, V99, P1551, DOI 10.1093/jnci/djm132; ELBERS JRJ, 1991, CANCER-AM CANCER SOC, V67, P2552, DOI 10.1002/1097-0142(19910515)67:10<2552::AID-CNCR2820671027>3.0.CO;2-K; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Hacker HJ, 1998, CARCINOGENESIS, V19, P99, DOI 10.1093/carcin/19.1.99; Hathurusinghe HR, 2007, ANN SURG ONCOL, V14, P2714, DOI 10.1245/s10434-007-9481-x; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hugo F, 1999, ANTICANCER RES, V19, P2753; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Schneider J, 2006, ADV CLIN CHEM, V42, P1, DOI 10.1016/S0065-2423(06)42001-1; Ugurel S, 2005, INT J CANCER, V117, P825, DOI 10.1002/ijc.21073; Wechsel HW, 1999, ANTICANCER RES, V19, P2583; Weinberger R, 2007, EUR J CANCER CARE, V16, P333, DOI 10.1111/j.1365-2354.2006.00753.x; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	23	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25812	25821		10.1074/jbc.M114.576934	http://dx.doi.org/10.1074/jbc.M114.576934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25070887	Green Published, hybrid			2022-12-28	WOS:000342130800038
J	Hatakeyama, D; Shoji, M; Yamayoshi, S; Hirota, T; Nagae, M; Yanagisawa, S; Nakano, M; Ohmi, N; Noda, T; Kawaoka, Y; Kuzuhara, T				Hatakeyama, Dai; Shoji, Masaki; Yamayoshi, Seiya; Hirota, Takenori; Nagae, Monami; Yanagisawa, Shin; Nakano, Masahiro; Ohmi, Naho; Noda, Takeshi; Kawaoka, Yoshihiro; Kuzuhara, Takashi			A Novel Functional Site in the PB2 Subunit of Influenza A Virus Essential for Acetyl-CoA Interaction, RNA Polymerase Activity, and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; PROTEIN; TRANSCRIPTION; INHIBITION; BINDING; DOMAIN; AUTOACETYLATION; COENZYME; DEFICIENT; REPRESSES	The PA, PB1, and PB2 subunits, components of the RNA-dependent RNA polymerase of influenza A virus, are essential for viral transcription and replication. The PB2 subunit binds to the host RNA cap (7-methylguanosine triphosphate (m(7)GTP)) and supports the endonuclease activity of PA to "snatch" the cap from host pre-mRNAs. However, the structure of PB2 is not fully understood, and the functional sites remain unknown. In this study, we describe a novel Val/Arg/Gly (VRG) site in the PB2 cap-binding domain, which is involved in interaction with acetyl-CoA found in eukaryotic histone acetyltransferases (HATs). In vitro experiments revealed that the recombinant PB2 cap-binding domain that includes the VRG site interacts with acetyl-CoA; moreover, it was found that this interaction could be blocked by CoA and various HAT inhibitors. Interestingly, m7GTP also inhibited this interaction, suggesting that the same active pocket is capable of interacting with acetyl-CoA and m7GTP. To elucidate the importance of the VRG site on PB2 function and viral replication, we constructed a PB2 recombinant protein and recombinant viruses including several patterns of amino acid mutations in the VRG site. Substitutions of the valine and arginine residues or of all 3 residues of the VRG site to alanine significantly reduced the binding ability of PB2 to acetyl-CoA and its RNA polymerase activity. Recombinant viruses containing the same mutations could not be replicated in cultured cells. These results indicate that the PB2 VRG sequence is a functional site that is essential for acetyl-CoA interaction, RNA polymerase activity, and viral replication.	[Hatakeyama, Dai; Shoji, Masaki; Hirota, Takenori; Nagae, Monami; Yanagisawa, Shin; Ohmi, Naho; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Yamayoshi, Seiya; Nakano, Masahiro; Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan; [Nakano, Masahiro; Noda, Takeshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53711 USA	Tokushima Bunri University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp	Yamayoshi, Seiya/C-1982-2013; Yamayoshi, Seiya/Y-7430-2019; ハタケヤマ, ダイ/HHS-5095-2022	Yamayoshi, Seiya/0000-0001-7768-5157; Yamayoshi, Seiya/0000-0001-7768-5157; ハタケヤマ, ダイ/0000-0001-6047-7124; Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [26460562, 22590422, 25460574, 23780051, 26860083]; Tokushima Bunri University for Educational Reform and Collaborative Research Grant [TBU2013-2-1]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University for Educational Reform and Collaborative Research Grant	This work was supported in part by The Japan Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research (C) 26460562 (to D. H.) and 22590422 and 25460574 (to T. K.), Grants-in-Aid for Young Scientists (B) 23780051 (to D. H.) and 26860083 (to M. S.), and Tokushima Bunri University for Educational Reform and Collaborative Research Grant TBU2013-2-1 (to M. S.).	Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bansal S, 2009, APPL BIOCHEM BIOTECH, V157, P285, DOI 10.1007/s12010-008-8357-2; Barak R, 2006, J MOL BIOL, V359, P251, DOI 10.1016/j.jmb.2006.03.033; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Choi CH, 2003, NATURE, V424, P965, DOI 10.1038/nature01899; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chuang C, 2010, J PROTEOME RES, V9, P4554, DOI 10.1021/pr100281h; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Galasinski SK, 2000, MOL CELL BIOL, V20, P1923, DOI 10.1128/MCB.20.6.1923-1930.2000; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gastaminza P, 2003, J VIROL, V77, P5098, DOI 10.1128/JVI.77.9.5098-5108.2003; Ghizzoni M, 2012, EUR J MED CHEM, V47, P337, DOI 10.1016/j.ejmech.2011.11.001; Ghizzoni M, 2010, BIOORGAN MED CHEM, V18, P5826, DOI 10.1016/j.bmc.2010.06.089; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hastings JC, 1996, ANTIMICROB AGENTS CH, V40, P1304, DOI 10.1128/AAC.40.5.1304; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Jankowska-Kulawy A, 2010, J NEUROCHEM, V115, P333, DOI 10.1111/j.1471-4159.2010.06919.x; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kuzuhara Takashi, 2009, PLoS Curr, V1, pRRN1052; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Kuzuhara T, 2009, ACTA CRYSTALLOGR F, V65, P144, DOI 10.1107/S1744309108042942; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; LI XQ, 1994, J VIROL, V68, P1245, DOI 10.1128/JVI.68.2.1245-1249.1994; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Maxwell SRJ, 2007, BRIT MED J, V334, P1232, DOI 10.1136/bmj.39240.497025.80; MCALISTER LE, 1981, J BACTERIOL, V146, P200, DOI 10.1128/JB.146.1.200-208.1981; Michno A, 2005, CLIN CHEM, V51, P1673, DOI 10.1373/clinchem.2005.050328; Murakami S, 2008, J VIROL, V82, P1605, DOI 10.1128/JVI.01876-07; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pereira JM, 2008, BIOORGAN MED CHEM, V16, P8889, DOI 10.1016/j.bmc.2008.08.057; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Sugita Y, 2013, J VIROL, V87, P12879, DOI 10.1128/JVI.02096-13; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Tomassini JE, 1996, ANTIMICROB AGENTS CH, V40, P1189, DOI 10.1128/AAC.40.5.1189; Vreede FT, 2007, J VIROL, V81, P2196, DOI 10.1128/JVI.02187-06; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang SJ, 2010, J BIOL CHEM, V285, P41194, DOI 10.1074/jbc.M110.130062	67	14	14	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24980	24994		10.1074/jbc.M114.559708	http://dx.doi.org/10.1074/jbc.M114.559708			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25063805	Green Published, hybrid			2022-12-28	WOS:000341985300023
J	Matono, R; Miyano, K; Kiyohara, T; Sumimoto, H				Matono, Rumi; Miyano, Kei; Kiyohara, Takuya; Sumimoto, Hideki			Arachidonic Acid Induces Direct Interaction of the p67(phox)-Rac Complex with the Phagocyte Oxidase Nox2, Leading to Superoxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); UNSATURATED FATTY-ACIDS; PROTEIN-KINASE-C; CELL-FREE SYSTEM; PHOSPHORYLATION-INDUCED ACTIVATION; INDUCED CONFORMATIONAL-CHANGES; CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; SRC HOMOLOGY-3 DOMAINS; FAMILY NADPH OXIDASES	The phagocyte NADPH oxidase Nox2, heterodimerized with p22(phox) in the membrane, is dormant in resting cells but becomes activated upon cell stimulation to produce superoxide, a precursor of microbicidal oxidants. Nox2 activation requires two switches to be turned on simultaneously: a conformational change of the cytosolic protein p47(phox) and GDP/GTP exchange on the small GTPase Rac. These proteins, in an active form, bind to their respective targets, p22(phox) and p67(phox), leading to productive oxidase assembly at the membrane. Although arachidonic acid (AA) efficiently activates Nox2 both in vivo and in vitro, the mechanism has not been fully understood, except that AA induces p47(phox) conformational change. Here we show that AA elicits GDP-to-GTP exchange on Rac at the cellular level, consistent with its role as a potent Nox2 activator. However, even when constitutively active forms of p47(phox) and Rac1 are both expressed in HeLa cells, superoxide production by Nox2 is scarcely induced in the absence of AA. These active proteins also fail to effectively activate Nox2 in a cell-free reconstituted system without AA. Without affecting Rac-GTP binding to p67(phox), AA induces the direct interaction of Rac-GTP-bound p67(phox) with the C-terminal cytosolic region of Nox2. p67(phox)-Rac-Nox2 assembly and superoxide production are both abrogated by alanine substitution for Tyr-198, Leu-199, and Val-204 in the p67(phox) activation domain that localizes the C-terminal to the Rac-binding domain. Thus the "third" switch (AA-inducible interaction of p67(phox).Rac-GTP with Nox2) is required to be turned on at the same time for Nox2 activation.	[Matono, Rumi; Miyano, Kei; Kiyohara, Takuya; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp		Kiyohara, Takuya/0000-0002-8819-1109	MEXT (the Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant [26111009]; Uehara Memorial Foundation	MEXT (the Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by MEXT (the Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant 26111009 and by the Uehara Memorial Foundation.	ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Ambruso DR, 2012, BBA-MOL CELL RES, V1823, P306, DOI 10.1016/j.bbamcr.2011.11.014; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1983, CELL IMMUNOL, V79, P240, DOI 10.1016/0008-8749(83)90067-9; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Glick J, 1996, J BIOL CHEM, V271, P2949, DOI 10.1074/jbc.271.6.2949; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Grizot S, 2001, J BIOL CHEM, V276, P21627, DOI 10.1074/jbc.M100893200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hata K, 1997, BIOCHEM BIOPH RES CO, V241, P226, DOI 10.1006/bbrc.1997.7807; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Kim C, 2006, J LEUKOCYTE BIOL, V79, P223, DOI 10.1189/jlb.0705371; Kim C, 2003, J IMMUNOL, V171, P4425, DOI 10.4049/jimmunol.171.8.4425; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; KOIDE H, 1992, P NATL ACAD SCI USA, V89, P1149, DOI 10.1073/pnas.89.4.1149; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Maehara Y, 2010, J BIOL CHEM, V285, P31435, DOI 10.1074/jbc.M110.161166; Miyano K, 2001, BIOCHEMISTRY-US, V40, P14089, DOI 10.1021/bi010882u; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Miyano K, 2012, METHODS MOL BIOL, V827, P195, DOI 10.1007/978-1-61779-442-1_14; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mizrahi A, 2010, J BIOL CHEM, V285, P25485, DOI 10.1074/jbc.M110.113779; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nigorikawa K, 2004, J BIOCHEM, V136, P463, DOI 10.1093/jb/mvh142; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Pick E, 2014, METHODS MOL BIOL, V1124, P339, DOI 10.1007/978-1-62703-845-4_22; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Quinn MT, 2006, CLIN SCI, V111, P1, DOI 10.1042/cs20060059; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; SAWAI T, 1993, BIOCHEM BIOPH RES CO, V195, P264, DOI 10.1006/bbrc.1993.2039; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Souabni H, 2012, BBA-BIOMEMBRANES, V1818, P2314, DOI 10.1016/j.bbamem.2012.04.018; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Swain SD, 1997, J BIOL CHEM, V272, P29502, DOI 10.1074/jbc.272.47.29502; Takeya R, 2006, METHOD ENZYMOL, V406, P456, DOI 10.1016/S0076-6879(06)06034-4; Taylor RM, 2004, BBA-BIOMEMBRANES, V1663, P201, DOI 10.1016/j.bbamem.2004.03.009; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	64	31	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24874	24884		10.1074/jbc.M114.581785	http://dx.doi.org/10.1074/jbc.M114.581785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25056956	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000341985300013
J	Zhang, L; Wei, YL; Pushel, I; Heinze, K; Elenbaas, J; Henry, RW; Arnosti, DN				Zhang, Liang; Wei, Yiliang; Pushel, Irina; Heinze, Karolin; Elenbaas, Jared; Henry, R. William; Arnosti, David N.			Integrated Stability and Activity Control of the Drosophila Rbf1 Retinoblastoma Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; CYCLIN-DEPENDENT KINASES; CELL-CYCLE; PHOSPHOPROTEOMIC ANALYSIS; PHOSPHORYLATION; PRB; GROWTH; GENE; MDM2; P130	The retinoblastoma (RB) family transcriptional corepressors regulate diverse cellular events including cell cycle, senescence, and differentiation. The activity and stability of these proteins are mediated by post-translational modifications; however, we lack a general understanding of how distinct modifications coordinately impact both of these properties. Previously, we showed that protein turnover and activity are tightly linked through an evolutionarily conserved C-terminal instability element (IE) in the Drosophila RB-related protein Rbf1; surprisingly, mutant proteins with enhanced stability were less, not more active. To better understand how activity and turnover are controlled in this model RB protein, we assessed the impact of Cyclin-Cdk kinase regulation on Rbf1. An evolutionarily conserved N-terminal threonine residue is required for Cyclin-Cdk response and showed a dominant impact on turnover and activity; however, specific residues in the C-terminal IE differentially impacted Rbf1 activity and turnover, indicating an additional level of regulation. Strikingly, specific IE mutations that impaired turnover but not activity induced dramatic developmental phenotypes in the Drosophila eye. Mutation of the highly conserved Lys-774 residue induced hypermorphic phenotypes that mimicked the loss of phosphorylation control; mutation of the corresponding codon of the human RBL2 gene has been reported in lung tumors. Our data support a model in which closely intermingled residues within the conserved IE govern protein turnover, presumably through interactions with E3 ligases, and protein activity via contacts with E2F transcription partners. Such functional relationships are likely to similarly impact mammalian RB family proteins, with important implications for development and disease.	[Zhang, Liang; Henry, R. William; Arnosti, David N.] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Wei, Yiliang; Pushel, Irina; Elenbaas, Jared; Henry, R. William; Arnosti, David N.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Heinze, Karolin] Univ Jena, Biochem & Mol Biol Program, D-07743 Jena, Germany	Michigan State University; Michigan State University; Friedrich Schiller University of Jena	Henry, RW (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 409 Biochem Bldg, E Lansing, MI 48824 USA.	henryrw@msu.edu; arnosti@msu.edu	Wei, Yiliang/S-7723-2018	Wei, Yiliang/0000-0001-8956-2955; Pushel, Irina/0000-0002-0862-1923; Elenbaas, Jared/0000-0002-9612-7764	National Institutes of Health [GM 079098]; College of Natural Sciences, MSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Natural Sciences, MSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 079098 (to R. W. H. and DNA). This work was also supported by dissertation completion fellowship from the College of Natural Sciences, MSU (to L. Z.).	Acharya P, 2010, MOL BIOL CELL, V21, P3890, DOI 10.1091/mbc.E10-06-0520; Adams PD, 1999, MOL CELL BIOL, V19, P1068; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Carr SM, 2011, EMBO J, V30, P317, DOI 10.1038/emboj.2010.311; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Claudio PP, 2000, CANCER RES, V60, P372; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Frolov MV, 2003, GENE DEV, V17, P723, DOI 10.1101/gad.1031803; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gilbert MK, 2006, GENETICS, V173, P1365, DOI 10.1534/genetics.106.056002; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Leng XH, 2002, MOL CELL BIOL, V22, P2242, DOI 10.1128/MCB.22.7.2242-2254.2002; Lents NH, 2006, CELL CYCLE, V5, P1699, DOI 10.4161/cc.5.15.3126; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Modi S, 2000, ONCOGENE, V19, P4632, DOI 10.1038/sj.onc.1203815; Munro S, 2012, ONCOGENE, V31, P4343, DOI 10.1038/onc.2011.603; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Raj N, 2012, J BIOL CHEM, V287, P41835, DOI 10.1074/jbc.M112.422428; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Ryu JR, 2003, NUCLEIC ACIDS RES, V31, P4654, DOI 10.1093/nar/gkg491; Saeed M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046174; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Xin SJ, 2002, DEVELOPMENT, V129, P1345; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a	44	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24863	24873		10.1074/jbc.M114.586818	http://dx.doi.org/10.1074/jbc.M114.586818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25049232	hybrid, Green Published			2022-12-28	WOS:000341985300012
J	Silvent, J; Gasse, B; Mornet, E; Sire, JY				Silvent, Jeremie; Gasse, Barbara; Mornet, Etienne; Sire, Jean-Yves			Molecular Evolution of the Tissue-nonspecific Alkaline Phosphatase Allows Prediction and Validation of Missense Mutations Responsible for Hypophosphatasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioinformatics; Genetic Disease; Human Genetics; Mammal; Molecular Evolution	STRUCTURAL EVIDENCE; LETHAL FORM; GENE; MECHANISM; IDENTIFICATION; DIVERGENCE; HYPOTHESIS; COLLAGEN; ISOZYME; CLONING	Background: We used evolutionary analysis of alkaline phosphatase (tissue nonspecific alkaline phosphatase, TNSALP) to predict missense mutations leading to hypophosphatasia. Results: We found 469 sensitive positions and validated 99% of the 204 known mutations. Conclusion: It is a more powerful method than in silico models to validate missense mutations in TNSALP. Significance: Such an approach should be widely used to support genetic diagnostics. ALPL encodes the tissue nonspecific alkaline phosphatase (TNSALP), which removes phosphate groups from various substrates. Its function is essential for bone and tooth mineralization. In humans, ALPL mutations lead to hypophosphatasia, a genetic disorder characterized by defective bone and/or tooth mineralization. To date, 275 ALPL mutations have been reported to cause hypophosphatasia, of which 204 were simple missense mutations. Molecular evolutionary analysis has proved to be an efficient method to highlight residues important for the protein function and to predict or validate sensitive positions for genetic disease. Here we analyzed 58 mammalian TNSALP to identify amino acids unchanged, or only substituted by residues sharing similar properties, through 220 millions years of mammalian evolution. We found 469 sensitive positions of the 524 residues of human TNSALP, which indicates a highly constrained protein. Any substitution occurring at one of these positions is predicted to lead to hypophosphatasia. We tested the 204 missense mutations resulting in hypophosphatasia against our predictive chart, and validated 99% of them. Most sensitive positions were located in functionally important regions of TNSALP (active site, homodimeric interface, crown domain, calcium site, ...). However, some important positions are located in regions, the structure and/or biological function of which are still unknown. Our chart of sensitive positions in human TNSALP (i) enables to validate or invalidate at low cost any ALPL mutation, which would be suspected to be responsible for hypophosphatasia, by contrast with time consuming and expensive functional tests, and (ii) displays higher predictive power than in silico models of prediction.	[Silvent, Jeremie; Gasse, Barbara; Sire, Jean-Yves] Univ Paris 06, IBPS, Evolut Paris Seine, F-75005 Paris, France; [Mornet, Etienne] Univ Versailles St Quentin Yvelines, EA2493, Unite Pathol Cellulaire & Genet, Versailles, France; [Mornet, Etienne] Ctr Hosp Versailles, Unite Genet Constitut, F-78150 Le Chesnay, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Sire, JY (corresponding author), Univ Paris 06, IBPS, Evolut Paris Seine, 7 Quai St Bernard,Case 05, F-75005 Paris, France.	jean-yves.sire@upmc.fr			CNRS; Universite Pierre Marie Curie; patients' support group Hypophosphatasie Europe; "Societe Francaise de Biologie des Tissus Mineralises" student award	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre Marie Curie; patients' support group Hypophosphatasie Europe; "Societe Francaise de Biologie des Tissus Mineralises" student award	This work was supported in part by grants from the CNRS, Universite Pierre & Marie Curie, and the patients' support group Hypophosphatasie Europe.; Supported by a "Societe Francaise de Biologie des Tissus Mineralises" student award.	Al-Hashimi N, 2009, J MOL EVOL, V69, P635, DOI 10.1007/s00239-009-9302-x; Bardet C, 2010, CELL MOL LIFE SCI, V67, P305, DOI 10.1007/s00018-009-0185-1; BERGER J, 1987, P NATL ACAD SCI USA, V84, P695, DOI 10.1073/pnas.84.3.695; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BOSSI M, 1993, J BIOL CHEM, V268, P25409; Delgado S, 2007, J DENT RES, V86, P326, DOI 10.1177/154405910708600405; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; FEDDE KN, 1990, AM J HUM GENET, V47, P767; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Goseki-Sone M, 1998, HUM MUTAT, pS263; GREENBERG CR, 1993, GENOMICS, V17, P215, DOI 10.1006/geno.1993.1305; HENTHORN PS, 1992, CLIN CHEM, V38, P2501; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hoylaerts MF, 2006, BIOCHEMISTRY-US, V45, P9756, DOI 10.1021/bi052471+; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kozlenkov A, 2002, J BIOL CHEM, V277, P22992, DOI 10.1074/jbc.M202298200; Kumar S, 2011, TRENDS GENET, V27, P377, DOI 10.1016/j.tig.2011.06.004; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Le Du MH, 2002, J BIOL CHEM, V277, P49808, DOI 10.1074/jbc.M207394200; Llinas P, 2005, J MOL BIOL, V350, P441, DOI 10.1016/j.jmb.2005.04.068; MATSUURA S, 1990, BIOCHEM BIOPH RES CO, V168, P993, DOI 10.1016/0006-291X(90)91127-E; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Millan J. L., 2007, MAMMALIAN ALKALINE P; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; Mornet E, 1998, EUR J HUM GENET, V6, P308, DOI 10.1038/sj.ejhg.5200190; Mornet E, 2000, HUM MUTAT, V15, P309, DOI 10.1002/(SICI)1098-1004(200004)15:4<309::AID-HUMU2>3.0.CO;2-C; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003; Nosjean O, 1997, BIOCHEM J, V321, P297, DOI 10.1042/bj3210297; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; STUDER M, 1991, BIOCHEM BIOPH RES CO, V179, P1352, DOI 10.1016/0006-291X(91)91722-O; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERAO M, 1990, BIOCHEM J, V268, P641, DOI 10.1042/bj2680641; VITTUR F, 1984, EXPERIENTIA, V40, P836, DOI 10.1007/BF01951980; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WU LNY, 1991, J BIOL CHEM, V266, P1195; Yang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00314	50	40	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24168	24179		10.1074/jbc.M114.576843	http://dx.doi.org/10.1074/jbc.M114.576843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023282	Green Published, hybrid			2022-12-28	WOS:000341505600015
J	Stiban, J; Farnum, GA; Hovde, SL; Kaguni, LS				Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.			The N-terminal Domain of the Drosophila Mitochondrial Replicative DNA Helicase Contains an Iron-Sulfur Cluster and Binds DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Helicase; DNA Replication; Drosophila; Iron-Sulfur Protein; Mitochondria; Mitochondrial DNA (mtDNA)	SECONDARY STRUCTURE ANALYSES; 4FE-4S CLUSTER; PROTEIN; TWINKLE; PRIMASE; MUTATIONS; SEQUENCE; FNR; DEFECTS; REGION	Background: Despite high evolutionary conservation, the function of the N-terminal domain (NTD) of mtDNA helicase remains elusive. Results:Drosophila NTD contains an iron-sulfur cluster and binds DNA. Conclusion: The iron-sulfur cluster in mtDNA helicase enhances protein stability, and may regulate its biological functions. Significance: Discovery of an Fe-S cluster in insect mtDNA helicase presents a novel opportunity to explore species-specific relationships in the replisome. The metazoan mitochondrial DNA helicase is an integral part of the minimal mitochondrial replisome. It exhibits strong sequence homology with the bacteriophage T7 gene 4 protein primase-helicase (T7 gp4). Both proteins contain distinct N- and C-terminal domains separated by a flexible linker. The C-terminal domain catalyzes its characteristic DNA-dependent NTPase activity, and can unwind duplex DNA substrates independently of the N-terminal domain. Whereas the N-terminal domain in T7 gp4 contains a DNA primase activity, this function is lost in metazoan mtDNA helicase. Thus, although the functions of the C-terminal domain and the linker are partially understood, the role of the N-terminal region in the metazoan replicative mtDNA helicase remains elusive. Here, we show that the N-terminal domain of Drosophila melanogaster mtDNA helicase coordinates iron in a 2Fe-2S cluster that enhances protein stability in vitro. The N-terminal domain binds the cluster through conserved cysteine residues (Cys(68), Cys(71), Cys(102), and Cys(105)) that are responsible for coordinating zinc in T7 gp4. Moreover, we show that the N-terminal domain binds both single- and double-stranded DNA oligomers, with an apparent K-d of approximate to 120 nm. These findings suggest a possible role for the N-terminal domain of metazoan mtDNA helicase in recruiting and binding DNA at the replication fork.	[Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Stiban, Johnny; Farnum, Gregory A.; Hovde, Stacy L.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA; [Stiban, Johnny] Birzeit Univ, Dept Biol & Biochem, IL-627 West Bank, Israel	Michigan State University; Michigan State University; Birzeit University	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lskaguni@msu.edu	Stiban, Johnny/AAB-3468-2019; Stiban, Johnny/AAC-1515-2019	Stiban, Johnny/0000-0002-3748-9976; Farnum, Gregory/0000-0002-0192-8252	National Institutes of Health [GM45295]; office of the Vice President for academic affairs at Birzeit University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); office of the Vice President for academic affairs at Birzeit University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM45295 (to L. S. K.).; Recipient of a career development award from the office of the Vice President for academic affairs at Birzeit University.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Chen DW, 2001, BIOCHEMISTRY-US, V40, P596, DOI 10.1021/bi002265w; Chinnery PF, 2013, BRIT MED BULL, V106, P135, DOI 10.1093/bmb/ldt017; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ding HG, 1998, BIOCHEMISTRY-US, V37, P17280, DOI 10.1021/bi980532g; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Ferrer M, 2007, NATURE, V445, P91, DOI 10.1038/nature05362; Frick DN, 1999, J BIOL CHEM, V274, P35889, DOI 10.1074/jbc.274.50.35889; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; GASTEIGER EHC, 2005, PROTEOMICS PROTOCOLS, P38; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Huang QQ, 2008, FEBS LETT, V582, P1431, DOI 10.1016/j.febslet.2008.03.028; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KHOROSHILOVA N, 1995, P NATL ACAD SCI USA, V92, P2499, DOI 10.1073/pnas.92.7.2499; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kusakabe T, 1999, P NATL ACAD SCI USA, V96, P4295, DOI 10.1073/pnas.96.8.4295; Lane MD, 2004, ENCY BIOL CHEM, P482; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Makowska-Grzyska MM, 2010, METHODS, V51, P411, DOI 10.1016/j.ymeth.2010.03.005; Matsushima Y, 2007, J BIOL CHEM, V282, P9436, DOI 10.1074/jbc.M610550200; Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rabinowitz J C, 1978, Methods Enzymol, V53, P275; Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Sanchez-Martinez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043954; Shutt TE, 2006, J MOL EVOL, V62, P588, DOI 10.1007/s00239-005-0162-8; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; White MF, 2009, BIOCHEM SOC T, V37, P547, DOI 10.1042/BST0370547; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	52	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24032	24042		10.1074/jbc.M114.587774	http://dx.doi.org/10.1074/jbc.M114.587774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023283	hybrid, Green Published			2022-12-28	WOS:000341505600004
J	Teichmann, A; Gibert, A; Lampe, A; Grzesik, P; Rutz, C; Furkert, J; Schmoranzer, J; Krause, G; Wiesner, B; Schulein, R				Teichmann, Anke; Gibert, Arthur; Lampe, Andre; Grzesik, Paul; Rutz, Claudia; Furkert, Jens; Schmoranzer, Jan; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf			The Specific Monomer/Dimer Equilibrium of the Corticotropin-releasing Factor Receptor Type 1 Is Established in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Endoplasmic Reticulum (ER); Fluorescence Correlation Spectroscopy (FCS); G Protein-coupled Receptor (GPCR); Plasma Membrane; Corticotropin-releasing Factor Receptors; Fluorescence Cross-correlation Spectroscopy; Monomer; Oligomer Equilibrium; Receptor Oligomerization	FLUORESCENCE CORRELATION SPECTROSCOPY; DELTA-OPIOID RECEPTORS; ENDOTHELIN-B RECEPTOR; PSEUDO SIGNAL PEPTIDE; MONOMERIC RHODOPSIN; PROTEIN; HETERODIMERIZATION; HOMODIMERIZATION; DIMER; BIOSYNTHESIS	Background: GPCRs may be expressed in a monomer/dimer equilibrium at the plasma membrane. Results: For the dimeric CRF1R, we found a constant monomer/dimer equilibrium not only at the plasma membrane but also in the ER. Conclusion: The monomer/dimer equilibrium of the CRF1R is established already in the ER. Significance: Our findings shed new light on the monomer/dimer equilibrium of GPCRs and on ER functions. G protein-coupled receptors (GPCRs) represent the most important drug targets. Although the smallest functional unit of a GPCR is a monomer, it became clear in the past decades that the vast majority of the receptors form dimers. Only very recently, however, data were presented that some receptors may in fact be expressed as a mixture of monomers and dimers and that the interaction of the receptor protomers is dynamic. To date, equilibrium measurements were restricted to the plasma membrane due to experimental limitations. We have addressed the question as to where this equilibrium is established for the corticotropin-releasing factor receptor type 1. By developing a novel approach to analyze single molecule fluorescence cross-correlation spectroscopy data for intracellular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a specific monomer/dimer equilibrium that is already established in the endoplasmic reticulum (ER). It remains constant at the plasma membrane even following receptor activation. Moreover, we demonstrate for seven additional GPCRs that they are expressed in specific but substantially different monomer/dimer ratios. Although it is well known that proteins may dimerize in the ER in principle, our data show that the ER is also able to establish the specific monomer/dimer ratios of GPCRs, which sheds new light on the functions of this compartment.	[Teichmann, Anke; Gibert, Arthur; Lampe, Andre; Grzesik, Paul; Rutz, Claudia; Furkert, Jens; Schmoranzer, Jan; Krause, Gerd; Wiesner, Burkhard; Schuelein, Ralf] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wiesner, B (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	wiesner@fmp-berlin.de; schuelein@fmp-berlin.de		Schmoranzer, Jan/0000-0002-4482-7080; Lampe, Andre/0000-0003-0750-4757				Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Beyermann M, 1996, J MED CHEM, V39, P3324, DOI 10.1021/jm960116z; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Charles AC, 2003, MOL PHARMACOL, V63, P89, DOI 10.1124/mol.63.1.89; Cottet M, 2010, CURR OPIN PHARMACOL, V10, P59, DOI 10.1016/j.coph.2009.10.003; Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Gregan B, 2004, J CARDIOVASC PHARM, V44, pS30, DOI 10.1097/01.fjc.0000166218.35168.79; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kraetke O, 2005, J RECEPT SIG TRANSD, V25, P251, DOI 10.1080/10799890500468838; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Murat B, 2012, MOL ENDOCRINOL, V26, P502, DOI 10.1210/me.2011-1202; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Schmidt V, 2012, EMBO J, V31, P187, DOI 10.1038/emboj.2011.352; Schulz K, 2010, J BIOL CHEM, V285, P32878, DOI 10.1074/jbc.M110.129627; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Teichmann A, 2012, J BIOL CHEM, V287, P27265, DOI 10.1074/jbc.M112.360594; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Thielen A, 2005, FEBS LETT, V579, P5227, DOI 10.1016/j.febslet.2005.08.043; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Westendorf C, 2011, J BIOL CHEM, V286, P35588, DOI 10.1074/jbc.M111.239244; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zampatis DE, 2012, FEBS LETT, V586, P2351, DOI 10.1016/j.febslet.2012.05.042	53	34	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24250	24262		10.1074/jbc.M114.553644	http://dx.doi.org/10.1074/jbc.M114.553644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24966326	Green Published, hybrid			2022-12-28	WOS:000341505600022
J	Caceres, PS; Mendez, M; Ortiz, PA				Caceres, Paulo S.; Mendez, Mariela; Ortiz, Pablo A.			Vesicle-associated Membrane Protein 2 (VAMP2) but Not VAMP3 Mediates cAMP-stimulated Trafficking of the Renal Na+-K+-2Cl(-) Co-transporter NKCC2 in Thick Ascending Limbs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); Epithelial Cell; Exocytosis; Kidney; Membrane Trafficking; SNARE Proteins; Na-K-Cl Co-transporter 2 (NKCC2); Epithelial Sodium Transport	K-CL COTRANSPORTER; SNARE-COMPLEX; CALCIUM-CHANNELS; COLLECTING DUCT; RAT-KIDNEY; N-TYPE; NA-K-2CL COTRANSPORTER; FUNCTIONAL IMPACT; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE	Background: Exocytic delivery of the renal co-transporter NKCC2 to the cell surface is a major mechanism for NaCl reabsorption. Results: We describe a mechanism that mediates cAMP-stimulated NKCC2 delivery in renal cells. Conclusion: Vesicle fusion protein VAMP2 interacts with NKCC2 and mediates cAMP-stimulated NKCC2 exocytic delivery. Significance: The molecular mechanism mediating NKCC2 exocytic delivery could provide new targets for treatment of hypertension. In the kidney, epithelial cells of the thick ascending limb (TAL) reabsorb NaCl via the apical Na+/K+/2Cl(-) co-transporter NKCC2. Steady-state surface NKCC2 levels in the apical membrane are maintained by a balance between exocytic delivery, endocytosis, and recycling. cAMP is the second messenger of hormones that enhance NaCl absorption. cAMP stimulates NKCC2 exocytic delivery via protein kinase A (PKA), increasing steady-state surface NKCC2. However, the molecular mechanism involved has not been studied. We found that several members of the SNARE family of membrane fusion proteins are expressed in TALs. Here we report that NKCC2 co-immunoprecipitates with VAMP2 in rat TALs, and they co-localize in discrete domains at the apical surface. cAMP stimulation enhanced VAMP2 exocytic delivery to the plasma membrane of renal cells, and stimulation of PKA enhanced VAMP2-NKCC2 co-immunoprecipitation in TALs. In vivo silencing of VAMP2 but not VAMP3 in TALs blunted cAMP-stimulated steady-state surface NKCC2 expression and completely blocked cAMP-stimulated NKCC2 exocytic delivery. VAMP2 was not involved in constitutive NKCC2 delivery. We concluded that VAMP2 but not VAMP3 selectively mediates cAMP-stimulated NKCC2 exocytic delivery and surface expression in TALs. We also demonstrated that cAMP stimulation enhances VAMP2 exocytosis and promotes VAMP2 interaction with NKCC2.	[Caceres, Paulo S.; Mendez, Mariela; Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA.	portiz1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272; Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [RO1 HL080409]; National Research Service Award [F32 HL096346-01]; American Heart Association [13IRG14770033, 10PRE3710001, 12PRE12070224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, F32HL096346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL080409 (to P. A. O.) and National Research Service Award F32 HL096346-01 (to M. M.). This work was also supported by American Heart Association Grant 13IRG14770033 (to P. A. O.) and American Heart Association Predoctoral Fellowships 10PRE3710001 and 12PRE12070224 (to P. S. C.).	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Breton S, 2002, AM J PHYSIOL-RENAL, V282, pF523, DOI 10.1152/ajprenal.00128.2001; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Fujita-Yoshigaki J, 1999, J BIOL CHEM, V274, P23642, DOI 10.1074/jbc.274.33.23642; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Haque MZ, 2011, AM J PHYSIOL-RENAL, V300, pF1096, DOI 10.1152/ajprenal.00600.2010; Inoue T, 1998, AM J PHYSIOL-RENAL, V275, pF752, DOI 10.1152/ajprenal.1998.275.5.F752; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Kaplan MR, 1996, KIDNEY INT, V49, P40, DOI 10.1038/ki.1996.6; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Mandon B, 1997, AM J PHYSIOL-RENAL, V273, pF718, DOI 10.1152/ajprenal.1997.273.5.F718; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MartinMoutot N, 1996, J BIOL CHEM, V271, P6567, DOI 10.1074/jbc.271.12.6567; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Mistry AC, 2007, J BIOL CHEM, V282, P30097, DOI 10.1074/jbc.M705866200; Mistry AC, 2010, AM J PHYSIOL-CELL PH, V298, pC1431, DOI 10.1152/ajpcell.00497.2009; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sevilla L, 1997, ENDOCRINOLOGY, V138, P3006, DOI 10.1210/en.138.7.3006; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonalker PA, 2004, J PHARMACOL EXP THER, V311, P1052, DOI 10.1124/jpet.104.071209; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsuk S, 2008, BIOCHEMISTRY-US, V47, P8342, DOI 10.1021/bi800512p; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Yokoyama CT, 1997, J NEUROSCI, V17, P6929; Yoshihara M, 1999, J NEUROSCI, V19, P2432; Zhu LQ, 2010, J NEUROSCI, V30, P3624, DOI 10.1523/JNEUROSCI.5223-09.2010	59	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23951	23962		10.1074/jbc.M114.589333	http://dx.doi.org/10.1074/jbc.M114.589333			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25008321	Green Published, hybrid			2022-12-28	WOS:000341505000060
J	Keov, P; Lopez, L; Devine, SM; Valant, C; Lane, JR; Scammells, PJ; Sexton, PM; Christopoulos, A				Keov, Peter; Lopez, Laura; Devine, Shane M.; Valant, Celine; Lane, J. Robert; Scammells, Peter J.; Sexton, Patrick M.; Christopoulos, Arthur			Molecular Mechanisms of Bitopic Ligand Engagement with the M-1 Muscarinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Drug Discovery; Mutagenesis; Pharmacology; Receptor Structure-Function; Bitopic Ligand; Muscarinic Acetylcholine Receptors	2ND EXTRACELLULAR LOOP; SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; ALLOSTERIC AGONIST; AMINO-ACIDS; PHARMACOLOGICAL AGONISM; FUNCTIONAL SELECTIVITY; SCANNING MUTAGENESIS; N-DESMETHYLCLOZAPINE; FORCE-FIELD	Background: Bitopic ligands bind concomitantly to orthosteric and allosteric receptor sites. Results: Residues affecting binding and biased signaling of the selective agonists TBPB and 77-LH-28-1 were identified at the M-1 muscarinic receptor. Conclusion: Novel bitopic ligand binding poses and mechanisms of receptor activation were identified. Significance: Understanding the basis of bitopic ligand mechanisms can enable the design of selective ligands. TBPB and 77-LH-28-1 are selective agonists of the M-1 muscarinic acetylcholine receptor (mAChR) that may gain their selectivity through a bitopic mechanism, interacting concomitantly with the orthosteric site and part of an allosteric site. The current study combined site-directed mutagenesis, analytical pharmacology,and molecular modeling to gain further insights into the structural basis underlying binding and signaling by these agonists. Mutations within the orthosteric binding site caused similar reductions in affinity and signaling efficacy for both selective and prototypical orthosteric ligands. In contrast, the mutation of residues within transmembrane helix (TM) 2 and the second extracellular loop (ECL2) discriminated between the different classes of ligand. In particular, ECL2 appears to be involved in the selective binding of bitopic ligands and in coordinating biased agonism between intracellular calcium mobilization and ERK1/2 phosphorylation. Molecular modeling of the interaction between TBPB and the M-1 mAChR revealed a binding pose predicted to extend from the orthosteric site up toward a putative allosteric site bordered by TM2, TM3, and TM7, thus consistent with a bitopic mode of binding. Overall, these findings provide valuable structural and mechanistic insights into bitopic ligand actions and receptor activation and support a role for ECL2 in dictating the active states that can be adopted by a G protein-coupled receptor. This may enable greater selective ligand design and development for mAChRs and facilitate improved identification of bitopic ligands.	[Keov, Peter; Lopez, Laura; Valant, Celine; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia; [Keov, Peter; Lopez, Laura; Valant, Celine; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia; [Devine, Shane M.; Scammells, Peter J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem Theme, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	arthur.christopoulos@monash.edu	Keov, Peter/AGE-7936-2022; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Devine, Shane/AAO-5994-2020	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Devine, Shane/0000-0001-8727-7392; Valant, Celine/0000-0002-2509-7465; Keov, Peter/0000-0002-3829-6455; Lane, J. Robert/0000-0002-7361-7875; Scammells, Peter/0000-0003-2930-895X	Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne [VR0024]	Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne	We are grateful for the assistance of Dr. Nathan E. Hall for help with the selection of some of the mutations for this study and to Drs. Michael Crouch and Ron Osmond (TGR Biosciences) for the generous supply of the SureFire ERK1/2 kit. The computational studies were supported by Resource Allocation Scheme Grant VR0024 from the Victorian Life Sciences Computation Initiative (VLSCI) on its Peak Computing Facility at the University of Melbourne.	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Babaoglu K, 2006, NAT CHEM BIOL, V2, P720, DOI 10.1038/nchembio831; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bee MS, 2007, J BIOL CHEM, V282, P32471, DOI 10.1074/jbc.M703909200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLACK JW, 1985, BRIT J PHARMACOL, V84, P561, DOI 10.1111/j.1476-5381.1985.tb12941.x; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Bridges TM, 2008, BIOORG MED CHEM LETT, V18, P5439, DOI 10.1016/j.bmcl.2008.09.023; Budzik B, 2010, ACS MED CHEM LETT, V1, P244, DOI 10.1021/ml100105x; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Disingrini T, 2006, J MED CHEM, V49, P366, DOI 10.1021/jm050769s; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Gregory KJ, 2012, J BIOL CHEM, V287, P37066, DOI 10.1074/jbc.M112.408534; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Jacobson MA, 2010, MOL PHARMACOL, V78, P648, DOI 10.1124/mol.110.065771; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Keov P, 2013, MOL PHARMACOL, V84, P425, DOI 10.1124/mol.113.087320; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Koole C, 2012, J BIOL CHEM, V287, P3659, DOI 10.1074/jbc.M111.309369; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Krejci A, 2001, MOL PHARMACOL, V60, P761; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Lebois EP, 2010, ACS CHEM NEUROSCI, V1, P104, DOI 10.1021/cn900003h; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANSOUR A, 1992, EUR J PHARM-MOLEC PH, V227, P205, DOI 10.1016/0922-4106(92)90129-J; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Narlawar R, 2010, J MED CHEM, V53, P3028, DOI 10.1021/jm901252a; Nathan PJ, 2013, INT J NEUROPSYCHOPH, V16, P721, DOI 10.1017/S1461145712000752; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Steinfeld T, 2007, MOL PHARMACOL, V72, P291, DOI 10.1124/mol.106.033746; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; WANG CD, 1993, MOL PHARMACOL, V43, P931; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031	62	45	46	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23817	23837		10.1074/jbc.M114.582874	http://dx.doi.org/10.1074/jbc.M114.582874			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25006252	hybrid, Green Published			2022-12-28	WOS:000341505000049
J	Liu, DH; He, XC; Qian, PX; Barker, N; Trainor, PA; Clevers, H; Liu, HW; Li, LH				Liu, Donghua; He, Xi C.; Qian, Pengxu; Barker, Nick; Trainor, Paul A.; Clevers, Hans; Liu, Huiwen; Li, Linheng			Leucine-rich Repeat-containing G-protein-coupled Receptor 5 Marks Short-term Hematopoietic Stem and Progenitor Cells during Mouse Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo; Hematopoiesis; Proliferation; Stem Cells; Transplantation; Lgr5; Hematopoietic Stem Cells; Progenitor Cells	GONAD-MESONEPHROS REGION; SELF-RENEWAL; IN-VITRO; EXPRESSION; AORTA; HSCS; LGR5; ENDOTHELIUM; GENERATION; EMERGENCE	Background: Lgr5 was shown to mark proliferating stem cells in several adult organs. Results: Lgr5 expression was detected in proliferating hematopoietic stem and progenitor cells (HSPCs) at the early stage of hematopoiesis. Conclusion: Lgr5 marks short-term (ST) hematopoietic stem and progenitor cells during the embryonic and fetal hematopoiesis. Significance: Extending Lgr5 as a HSPC marker into the hematopoietic system during development. Lgr5 is a marker for proliferating stem cells in adult intestine, stomach, and hair follicle. However, Lgr5 is not expressed in adult hematopoietic stem and progenitor cells (HSPCs). Whether Lgr5 is expressed in the embryonic and fetal HSPCs that undergo rapid proliferation is unknown. Here we report the detection of Lgr5 expression in HSPCs in the aorta-gonad-mesonephros (AGM) and fetal liver. We also found that a portion of Lgr5(+) cells expressed the Runx1 gene that is critical for the ontogeny of HSPCs. A small portion of Lgr5(+) cells also expressed HSPC surface markers c-Kit and CD34 in AGM or CD41 in fetal liver. Furthermore, the majority of Lgr5(+) cells expressed Ki67, indicating their proliferating state. Transplantation of fetal liver-derived Lgr5-GFP(+) cells (E12.5) demonstrated that Lgr5-GFP(+) cells were able to reconstitute myeloid and lymphoid lineages in adult recipients, but the engraftment was short-term (4-8 weeks) and 20-fold lower compared with the Lgr5-GFP(-) control. Our data show that Lgr5-expressing cells mark short-term hematopoietic stem and progenitor cells, consistent with the role of Lgr5 in supporting HSPCs rapid proliferation during embryonic and fetal development.	[Liu, Donghua; Liu, Huiwen] Harbin Med Univ, Dept Histol & Embryol, Harbin 150086, Heilongjiang, Peoples R China; [Liu, Donghua; He, Xi C.; Qian, Pengxu; Trainor, Paul A.; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Barker, Nick] Inst Med Biol, Singapore 138648, Singapore; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Trainor, Paul A.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA	Harbin Medical University; Stowers Institute for Medical Research; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Liu, HW (corresponding author), Harbin Med Univ, Dept Histol & Embryol, 157 Baojian Rd Nangang Dist, Harbin 150086, Heilongjiang, Peoples R China.	liuhw_11@126.com; lil@stowers.org	Barker, Nick/A-5535-2011; Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Qian, Pengxu/B-9376-2016	Barker, Nick/0000-0003-3566-4475; Li, Linheng/0000-0001-9963-430X; Trainor, Paul/0000-0003-2774-3624; Qian, Pengxu/0000-0001-5636-6704	China Scholarship Council; Stowers Institute for Medical Research	China Scholarship Council(China Scholarship Council); Stowers Institute for Medical Research	This work was supported by the China Scholarship Council and the Stowers Institute for Medical Research.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Dzierzak E, 2003, CURR OPIN HEMATOL, V10, P229, DOI 10.1097/00062752-200305000-00006; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Li LH, 2005, DEV CELL, V8, P297, DOI 10.1016/j.devcel.2005.02.005; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Ma XQ, 2002, BRIT J HAEMATOL, V116, P401, DOI 10.1046/j.1365-2141.2002.03250.x; Mascarenhas MI, 2009, BLOOD, V114, P4645, DOI 10.1182/blood-2009-06-230037; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ohneda O, 1998, BLOOD, V92, P908; Pietras EM, 2013, NAT CELL BIOL, V15, P885, DOI 10.1038/ncb2817; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rodrigues NP, 2012, INT J BIOCHEM CELL B, V44, P457, DOI 10.1016/j.biocel.2011.12.004; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Yoder MC, 2004, ONCOGENE, V23, P7161, DOI 10.1038/sj.onc.1207931; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441	35	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23809	23816		10.1074/jbc.M114.568170	http://dx.doi.org/10.1074/jbc.M114.568170			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24966324	hybrid, Green Published			2022-12-28	WOS:000341505000048
J	Saeed, AA; Genove, G; Li, T; Lutjohann, D; Olin, M; Mast, N; Pikuleva, IA; Crick, P; Wang, YQ; Griffiths, W; Betsholtz, C; Bjorkhem, I				Saeed, Ahmed A.; Genove, Guillem; Li, Tian; Luetjohann, Dieter; Olin, Maria; Mast, Natalia; Pikuleva, Irina A.; Crick, Peter; Wang, Yuqin; Griffiths, William; Betsholtz, Christer; Bjorkhem, Ingemar			Effects of a Disrupted Blood-Brain Barrier on Cholesterol Homeostasis in the Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Metabolism; Cholesterol Regulation; Hydroxylase; Neurodegeneration; Sterol	CHAIN OXIDIZED OXYSTEROLS; IN-VIVO; HUMAN CIRCULATION; PLANT STEROLS; RECEPTOR; 24S-HYDROXYCHOLESTEROL; PLASMA; LIVER; MICE; METABOLISM	Background: The role of the blood-brain barrier for cholesterol homeostasis in the brain is not known. Results: Significant influx of cholesterol into the brain and increased efflux of 24(S)-hydroxycholesterol were observed in mice with a defect blood-brain barrier. Conclusion: A defect blood-brain barrier increases permeability for steroid flux in both directions. Significance: Elucidation of the role of the blood-brain barrier for brain cholesterol turnover. The presence of the blood-brain barrier (BBB) is critical for cholesterol metabolism in the brain, preventing uptake of lipoprotein-bound cholesterol from the circulation. The metabolic consequences of a leaking BBB for cholesterol metabolism have not been studied previously. Here we used a pericyte-deficient mouse model, Pdgfb(ret/ret), shown to have increased permeability of the BBB to a range of low-molecular mass and high-molecular mass tracers. There was a significant accumulation of plant sterols in the brains of the Pdgfb(ret/ret) mice. By dietary treatment with 0.3% deuterium-labeled cholesterol, we could demonstrate a significant flux of cholesterol from the circulation into the brains of the mutant mice roughly corresponding to about half of the measured turnover of cholesterol in the brain. We expected the cholesterol flux into the brain to cause a down-regulation of cholesterol synthesis. Instead, cholesterol synthesis was increased by about 60%. The levels of 24(S)-hydroxycholesterol (24S-OHC) were significantly reduced in the brains of the pericyte-deficient mice but increased in the circulation. After treatment with 1% cholesterol in diet, the difference in cholesterol synthesis between mutants and controls disappeared. The findings are consistent with increased leakage of 24S-OHC from the brain into the circulation in the pericyte-deficient mice. This oxysterol is an efficient suppressor of cholesterol synthesis, and the results are consistent with a regulatory role of 24S-OHC in the brain. To our knowledge, this is the first demonstration that a defective BBB may lead to increased flux of a lipophilic compound out from the brain. The relevance of the findings for the human situation is discussed.	[Saeed, Ahmed A.; Olin, Maria; Bjorkhem, Ingemar] Karolinska Inst, Div Clin Chem, Dept Lab Med, Karolinska Univ Hosp, S-14186 Stockholm, Sweden; [Saeed, Ahmed A.] Univ Khartoum, Dept Biochem, Fac Med, Khartoum 11111, Sudan; [Genove, Guillem; Li, Tian; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Crick, Peter; Wang, Yuqin; Griffiths, William] Swansea Univ, Inst Mass Spectrometry, Coll Med, Swansea SA2 8PP, W Glam, Wales	Karolinska Institutet; Karolinska University Hospital; University of Khartoum; Karolinska Institutet; University of Bonn; Case Western Reserve University; Swansea University	Bjorkhem, I (corresponding author), Karolinska Inst, Div Clin Chem, Dept Lab Med, Karolinska Univ Hosp, S-14186 Stockholm, Sweden.	ingemar.bjorkhem@karolinska.se	Griffiths, William/N-4641-2016	Griffiths, William/0000-0002-4129-6616; Pikuleva, Irina/0000-0001-9742-6232; Bjorkhem, Ingemar/0000-0002-0575-9425; wang, yuqin/0000-0002-3063-3066; Genove, Guillem/0000-0002-8558-3107; Bjorkhem, Ingemar/0000-0001-6087-9190; Crick, Peter/0000-0002-3282-1239	National Institutes of Health [GM 62282]; Swedish Research Council; Brain Power; Biotechnology and Biological Sciences Research Council [BB/I001735/1, BBH0010181]; BBSRC [BB/H001018/1, BB/I001735/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001018/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882, R01GM062282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Brain Power; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 62282. This work was also supported by grants from the Swedish Research Council and Brain Power. Work in Swansea was supported by Biotechnology and Biological Sciences Research Council Grants BB/I001735/1 and BBH0010181.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050; Ali Z, 2013, J LIPID RES, V54, P1033, DOI 10.1194/jlr.M034124; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Babiker A, 1998, BBA-LIPID LIPID MET, V1392, P333, DOI 10.1016/S0005-2760(98)00047-2; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; CHOBANIAN AV, 1962, J CLIN INVEST, V41, P1732, DOI 10.1172/JCI104631; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Diraison F, 1996, METABOLISM, V45, P817, DOI 10.1016/S0026-0495(96)90152-3; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Griffiths WJ, 2013, FREE RADICAL BIO MED, V59, P69, DOI 10.1016/j.freeradbiomed.2012.07.027; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; LANGE Y, 1995, J LIPID RES, V36, P1092; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUND E, 1992, J BIOL CHEM, V267, P25092; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Meaney S, 2000, BBA-MOL CELL BIOL L, V1486, P293, DOI 10.1016/S1388-1981(00)00070-6; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Raines SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE517, DOI 10.1152/ajpendo.00241.2011; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Turley SD, 1996, J LIPID RES, V37, P1953; Vanmierlo T, 2012, J LIPID RES, V53, P726, DOI 10.1194/jlr.M017244; Wang YQ, 2008, J PROTEOME RES, V7, P1606, DOI 10.1021/pr7006076; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	40	59	60	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23712	23722		10.1074/jbc.M114.556159	http://dx.doi.org/10.1074/jbc.M114.556159			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	24973215	Green Published, hybrid			2022-12-28	WOS:000341505000039
J	Mayle, S; Boyle, JP; Sekine, E; Zurek, B; Kufer, TA; Monie, TP				Mayle, Sophie; Boyle, Joseph P.; Sekine, Eiki; Zurek, Birte; Kufer, Thomas A.; Monie, Tom P.			Engagement of Nucleotide-binding Oligomerization Domain-containing Protein 1 (NOD1) by Receptor-interacting Protein 2 (RIP2) Is Insufficient for Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ACTIVATION; RECRUITMENT; RECOGNITION; MECHANISM; RESPONSES; FILAMENT; MEMBRANE; ERBIN	Following activation, the cytoplasmic pattern recognition receptor nucleotide-binding oligomerization domain-containing protein 1 (NOD1) interacts with its adaptor protein receptor-interacting protein 2 (RIP2) to propagate immune signaling and initiate a proinflammatory immune response. This interaction is mediated by the caspase recruitment domain (CARD) of both proteins. Polymorphisms in immune proteins can affect receptor function and predispose individuals to specific autoinflammatory disorders. In this report, we show that mutations in helix 2 of the CARD of NOD1 disrupted receptor function but did not interfere with RIP2 interaction. In particular, N43S, a rare polymorphism, resulted in receptor dysfunction despite retaining normal cellular localization, protein folding, and an ability to interact with RIP2. Mutation of Asn-43 resulted in an increased tendency to form dimers, which we propose is the source of this dysfunction. We also demonstrate that mutation of Lys-443 and Tyr-474 in RIP2 disrupted the interaction with NOD1. Mapping the key residues involved in the interaction between NOD1 and RIP2 to the known structures of CARD complexes revealed the likely involvement of both type I and type III interfaces in the NOD1.RIP2 complex. Overall we demonstrate that the NOD1-RIP2 signaling axis is more complex than previously assumed, that simple engagement of RIP2 is insufficient to mediate signaling, and that the interaction between NOD1 and RIP2 constitutes multiple CARD-CARD interfaces.	[Mayle, Sophie; Boyle, Joseph P.; Sekine, Eiki; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Zurek, Birte; Kufer, Thomas A.] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany; [Monie, Tom P.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge; University of Cologne; University of Cambridge	Monie, TP (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	tpm22@cam.ac.uk	Monie, Tom/H-4662-2019; Kufer, Thomas A/I-5146-2015	Monie, Tom/0000-0003-4097-1680; Kufer, Thomas A/0000-0003-4563-0412; Sekine, Eiki/0000-0001-6555-7879; Zurek, PhD, Birte/0000-0002-8200-7542	Wellcome Trust [WT085090MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Wellcome Trust Career Development Fellowship WT085090MA (to T.P.M.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kufer TA, 2006, INFECT IMMUN, V74, P3115, DOI 10.1128/IAI.00035-06; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Philpott DJ, 2010, CURR OPIN IMMUNOL, V22, P428, DOI 10.1016/j.coi.2010.04.010; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	50	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22900	22914		10.1074/jbc.M114.557900	http://dx.doi.org/10.1074/jbc.M114.557900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24958724	Green Published, hybrid			2022-12-28	WOS:000341017200031
J	Matange, N; Podobnik, M; Visweswariah, SS				Matange, Nishad; Podobnik, Marjetka; Visweswariah, Sandhya S.			The Non-catalytic "Cap Domain" of a Mycobacterial Metallophosphoesterase Regulates Its Expression and Localization in the Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; PROTEIN; WALL; GENE; TRANSLOCATION; SECRETION; MEMBRANE; REVEAL; SYSTEM; FOLD	Despite highly conserved core catalytic domains, members of the metallophosphoesterase (MPE) superfamily perform diverse and crucial functions ranging from nucleotide and nucleic acid metabolism to phospholipid hydrolysis. Unique structural elements outside of the catalytic core called "cap domains" are thought to provide specialization to these enzymes; however, no directed study has been performed to substantiate this. The cap domain of Rv0805, an MPE from Mycobacterium tuberculosis, is located C-terminal to its catalytic domain and is dispensable for the catalytic activity of this enzyme in vitro. We show here that this C-terminal extension (CTE) mediates in vivo localization of the protein to the cell membrane and cell wall as well as modulates expression levels of Rv0805 in mycobacteria. We also demonstrate that Rv0805 interacts with the cell wall of mycobacteria, possibly with the mycolyl-arabinogalactan-peptidoglycan complex, by virtue of its C terminus, a hitherto unknown property of this MPE. Using a panel of mutant proteins, we identify interactions between active site residues of Rv0805 and the CTE that determine its association with the cell wall. Finally, we show that Rv0805 and a truncated mutant devoid of the CTE produce different phenotypic effects when expressed in mycobacteria. Our study thus provides a detailed dissection of the functions of the cap domain of an MPE and suggests that the repertoire of cellular functions of MPEs cannot be understood without exploring the modulatory effects of these subdomains.	[Matange, Nishad; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Podobnik, Marjetka] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana 1000, Slovenia	Indian Institute of Science (IISC) - Bangalore; National Institute of Chemistry - Slovenia	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	matange, nishad/AAF-9653-2020; Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Matange, Nishad/0000-0002-2947-3931	Department of Biotechnology, Government of India; Council for Scientific and Industrial Research, Government of India; Indian Institute of Science, Bangalore	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore	This work was supported by the Department of Biotechnology, Government of India.; Recipient of a Senior Research Fellowship from the Council for Scientific and Industrial Research, Government of India and a Research Associate Fellowship from the Indian Institute of Science, Bangalore.	Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; Daumann LJ, 2014, DALTON T, V43, P910, DOI 10.1039/c3dt52287c; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Dermol U, 2011, J MOL BIOL, V412, P481, DOI 10.1016/j.jmb.2011.07.060; Feltcher ME, 2013, J BACTERIOL, V195, P672, DOI 10.1128/JB.02032-12; Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; Jackson CJ, 2007, J MOL BIOL, V367, P1047, DOI 10.1016/j.jmb.2007.01.032; Keppetipola Niroshika, 2008, J Biol Chem, V283, P30942, DOI 10.1074/jbc.M805064200; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; Kim YG, 2011, PROTEINS, V79, P1205, DOI 10.1002/prot.22954; Kocincova D, 2004, FEMS MICROBIOL LETT, V231, P191, DOI 10.1016/S0378-1097(03)00964-9; Li J, 2012, J MOL BIOL, V415, P382, DOI 10.1016/j.jmb.2011.11.016; Matange N, 2013, TUBERCULOSIS, V93, P492, DOI 10.1016/j.tube.2013.05.004; McLoughlin SY, 2004, APPL ENVIRON MICROB, V70, P404, DOI 10.1128/AEM.70.1.404-412.2004; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Monteferrante CG, 2012, J BIOL CHEM, V287, P29789, DOI 10.1074/jbc.M112.378190; Muller JP, 1999, FEMS MICROBIOL LETT, V180, P287; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Richter W, 2002, PROTEINS, V46, P278, DOI 10.1002/prot.10049; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Tyagi R, 2009, J BIOL CHEM, V284, P5217, DOI 10.1074/jbc.M805996200; Wang LK, 2013, NUCLEIC ACIDS RES, V41, P5864, DOI 10.1093/nar/gkt221; Yao Y, 2012, J MOL BIOL, V416, P208, DOI 10.1016/j.jmb.2011.12.030	43	7	7	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22470	22481		10.1074/jbc.M114.578328	http://dx.doi.org/10.1074/jbc.M114.578328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24970891	Green Published, hybrid			2022-12-28	WOS:000340593500056
J	Perry, DM; Newcomb, B; Adada, M; Wu, BX; Roddy, P; Kitatani, K; Siskind, L; Obeid, LM; Hannun, YA				Perry, David M.; Newcomb, Benjamin; Adada, Mohamad; Wu, Bill X.; Roddy, Patrick; Kitatani, Kazuyuki; Siskind, Leah; Obeid, Lina M.; Hannun, Yusuf A.			Defining a Role for Acid Sphingomyelinase in the p38/Interleukin-6 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; DELTA-MEDIATED PHOSPHORYLATION; BETA-GLUCOSIDASE 1; SALVAGE PATHWAY; BREAST-CANCER; KAPPA-B; LYSOSOMAL SPHINGOMYELINASE; INFLAMMATORY CYTOKINES; INTERLEUKIN-6 GENE	Acid sphingomyelinase (ASM) is one of the key enzymes involved in regulating the metabolism of the bioactive sphingolipid ceramide in the sphingolipid salvage pathway, yet defining signaling pathways by which ASM exerts its effects has proven difficult. Previous literature has implicated sphingolipids in the regulation of cytokines such as interleukin-6 (IL-6), but the specific sphingolipid pathways and mechanisms involved in inflammatory signaling need to be further elucidated. In this work, we sought to define the role of ASM in IL-6 production because our previous work showed that a parallel pathway of ceramide metabolism, acid beta-glucosidase 1, negatively regulates IL-6. First, silencing ASM with siRNA abrogated IL-6 production in response to the tumor promoter, 4 beta-phorbol 12-myristate 13-acetate (PMA), in MCF-7 cells, in distinction to acid beta-glucosidase 1 and acid ceramidase, suggesting specialization of the pathways. Moreover, treating cells with siRNA to ASM or with the indirect pharmacologic inhibitor desipramine resulted in significant inhibition of TNF alpha- and PMA-induced IL-6 production in MDA-MB-231 and HeLa cells. Knockdown of ASM was found to significantly inhibit PMA-dependent IL-6 induction at the mRNA level, probably ruling out mechanisms of translation or secretion of IL-6. Further, ASM knockdown or desipramine blunted p38 MAPK activation in response to TNF alpha, revealing a key role for ASM in activating p38, a signaling pathway known to regulate IL-6 induction. Last, knockdown of ASM dramatically blunted invasion of HeLa and MDA-MB-231 cells through Matrigel. Taken together, these results demonstrate that ASM plays a critical role in p38 signaling and IL-6 synthesis with implications for tumor pathobiology.	[Perry, David M.; Wu, Bill X.; Roddy, Patrick] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kitatani, Kazuyuki] Tohoku Univ, Grad Sch Med, Tohoku Med Megabank Org, Sendai, Miyagi 9808575, Japan; [Kitatani, Kazuyuki] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808575, Japan; [Siskind, Leah] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Newcomb, Benjamin; Adada, Mohamad; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Hosp, Northport, NY 11768 USA	Medical University of South Carolina; Tohoku University; Tohoku University; University of Louisville; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Hlth Sci Ctr, L-4,182, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847; Adada, Mohamad/0000-0002-2988-2081	National Institutes of Health [CA 097132, GM097741]; Veterans Affairs merit award; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741, T32GM008444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA 097132 (to Y. A. H. and L. M. O.) and GM097741 (to L. M. O.). This work was also supported by a Veterans Affairs merit award (to L. M. O.).	Adada MM, 2013, J BIOL CHEM, V288, P27667, DOI 10.1074/jbc.M113.489443; Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; Bauer J, 2009, FEBS LETT, V583, P915, DOI 10.1016/j.febslet.2009.02.008; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Charruyer A, 2007, BIOCHEM J, V405, P77, DOI 10.1042/BJ20061528; Faggioli L, 1996, EUR J BIOCHEM, V239, P624, DOI 10.1111/j.1432-1033.1996.0624u.x; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Feng YD, 2009, ARCH PATHOL LAB MED, V133, P1850, DOI 10.1043/1543-2165-133.11.1850; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Ion G, 2006, CELL SIGNAL, V18, P1887, DOI 10.1016/j.cellsig.2006.02.007; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jin J., 2013, AM J PHYSIOL-ENDOC M, V305, pE853; Kato Y, 2007, FEBS J, V274, P3171, DOI 10.1111/j.1742-4658.2007.05848.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kondo A, 2001, J INTERF CYTOK RES, V21, P943, DOI 10.1089/107999001753289550; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kumagai T, 2012, ARCH BIOCHEM BIOPHYS, V519, P8, DOI 10.1016/j.abb.2011.12.015; LAULEDERKIND SJF, 1995, J EXP MED, V182, P599, DOI 10.1084/jem.182.2.599; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Manthey CL, 1998, CYTOKINE, V10, P654, DOI 10.1006/cyto.1998.0344; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Oh K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3034; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pena LA, 2000, CANCER RES, V60, P321; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; Sakata A, 2007, IMMUNOLOGY, V122, P54, DOI 10.1111/j.1365-2567.2007.02612.x; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62; Zhang Y, 2008, J IMMUNOL, V181, P4247, DOI 10.4049/jimmunol.181.6.4247	46	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22401	22412		10.1074/jbc.M114.589648	http://dx.doi.org/10.1074/jbc.M114.589648			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24951586	Green Published, hybrid			2022-12-28	WOS:000340593500050
J	Liang, XW; Dickman, MB; Becker, DF				Liang, Xinwen; Dickman, Martin B.; Becker, Donald F.			Proline Biosynthesis Is Required for Endoplasmic Reticulum Stress Tolerance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Biosynthesis; Endoplasmic Reticulum Stress (ER Stress); Metabolism; Redox; Glutathione; Proline	UNFOLDED PROTEIN RESPONSE; ENCODING DELTA(1)-PYRROLINE-5-CARBOXYLATE SYNTHASE; YAP-1 TRANSCRIPTIONAL REGULATION; DISULFIDE-BOND FORMATION; OXIDATIVE STRESS; AMINO-ACID; CELL-DEATH; GENE-EXPRESSION; COLLETOTRICHUM-TRIFOLII; GLUTATHIONE-REDUCTASE	Background: Proline is an important amino acid for stress resistance in different organisms. Results: Depletion of proline biosynthesis disrupts redox homeostasis and increases sensitivity to endoplasmic reticulum (ER) stress in yeast. Conclusion: Proline biosynthesis is critical for maintaining the intracellular redox environment and the UPR during ER stress. Significance: Proline metabolism is shown to have an important role in ER stress tolerance that was previously unknown. The amino acid proline is uniquely involved in cellular processes that underlie stress response in a variety of organisms. Proline is known to minimize protein aggregation, but a detailed study of how proline impacts cell survival during accumulation of misfolded proteins in the endoplasmic reticulum (ER) has not been performed. To address this we examined in Saccharomyces cerevisiae the effect of knocking out the PRO1, PRO2, and PRO3 genes responsible for proline biosynthesis. The null mutants pro1, pro2, and pro3 were shown to have increased sensitivity to ER stress relative to wild-type cells, which could be restored by proline or the corresponding genetic complementation. Of these mutants, pro3 was the most sensitive to tunicamycin and was rescued by anaerobic growth conditions or reduced thiol reagents. The pro3 mutant cells have higher intracellular reactive oxygen species, total glutathione, and a NADP(+)/NADPH ratio than wild-type cells under limiting proline conditions. Depletion of proline biosynthesis also inhibits the unfolded protein response (UPR) indicating proline protection involves the UPR. To more broadly test the role of proline in ER stress, increased proline biosynthesis was shown to partially rescue the ER stress sensitivity of a hog1 null mutant in which the high osmolality pathway is disrupted.	[Liang, Xinwen; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Liang, Xinwen; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Dickman, Martin B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Texas A&M University System; Texas A&M University College Station	Becker, DF (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dbecker3@unl.edu			National Institutes of Health [GM079393, P30GM103335]; University of Nebraska Agricultural Research Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM079393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Agricultural Research Division; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079393 and P30GM103335. This work was also supported by the University of Nebraska Agricultural Research Division.	Ando A, 2007, FEMS YEAST RES, V7, P244, DOI 10.1111/j.1567-1364.2006.00162.x; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; BARNES G, 1984, MOL CELL BIOL, V4, P2381, DOI 10.1128/MCB.4.11.2381; Baumgartner MR, 2000, HUM MOL GENET, V9, P2853, DOI 10.1093/hmg/9.19.2853; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Bicknell AA, 2010, J BIOL CHEM, V285, P17545, DOI 10.1074/jbc.M109.084681; Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BRANDRISS MC, 1981, J BACTERIOL, V145, P1359, DOI 10.1128/JB.145.3.1359-1364.1981; BRANDRISS MC, 1979, J BACTERIOL, V138, P816, DOI 10.1128/JB.138.3.816-822.1979; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chen CB, 2005, P NATL ACAD SCI USA, V102, P3459, DOI 10.1073/pnas.0407960102; Chen CB, 2004, MOL MICROBIOL, V51, P1493, DOI 10.1111/j.1365-2958.2003.03932.x; Chen CB, 2006, APPL ENVIRON MICROB, V72, P4001, DOI 10.1128/AEM.02428-05; Chen JG, 2011, AMINO ACIDS, V40, P1473, DOI 10.1007/s00726-010-0757-2; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Delaney JR, 2013, AGING CELL, V12, P156, DOI 10.1111/acel.12032; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Grant CM, 1998, BIOCHEM BIOPH RES CO, V253, P893, DOI 10.1006/bbrc.1998.9864; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; HAGEDORN CH, 1986, ARCH BIOCHEM BIOPHYS, V248, P166, DOI 10.1016/0003-9861(86)90413-3; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Jariwala U, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-39; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Kumar TKS, 1998, BIOCHEM MOL BIOL INT, V46, P509; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Okabe H, 2001, CANCER RES, V61, P2129; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Perez-Arellano I, 2010, J MOL BIOL, V404, P890, DOI 10.1016/j.jmb.2010.10.019; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413; Rouschop KM, 2013, P NATL ACAD SCI USA, V110, P4622, DOI 10.1073/pnas.1210633110; Samuel D, 2000, PROTEIN SCI, V9, P344; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sekine T, 2007, APPL ENVIRON MICROB, V73, P4011, DOI 10.1128/AEM.00730-07; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Steffen KK, 2012, GENETICS, V191, P107, DOI 10.1534/genetics.111.136549; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takagi H, 2008, APPL MICROBIOL BIOT, V81, P211, DOI 10.1007/s00253-008-1698-5; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; TOMENCHOK DM, 1987, J BACTERIOL, V169, P5364, DOI 10.1128/jb.169.12.5364-5372.1987; Torres-Quiroz F, 2010, J BIOL CHEM, V285, P20088, DOI 10.1074/jbc.M109.063578; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832; Yildirim Y, 2011, AM J MED GENET A, V155A, P134, DOI 10.1002/ajmg.a.33747; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	79	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27794	27806		10.1074/jbc.M114.562827	http://dx.doi.org/10.1074/jbc.M114.562827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25112878	hybrid, Green Published			2022-12-28	WOS:000342852800036
J	Luo, JH; Warmlander, SKTS; Graslund, A; Abrahams, JP				Luo, Jinghui; Warmlander, Sebastian K. T. S.; Graslund, Astrid; Abrahams, Jan Pieter			Non-chaperone Proteins Can Inhibit Aggregation and Cytotoxicity of Alzheimer Amyloid beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (AB); Protein Aggregation; Protein-Protein Interaction; Spectroscopy; Aggregates; Fibrillation; Toxicity	HUMAN SERUM-ALBUMIN; A-BETA; ALPHA-SYNUCLEIN; TOXICITY; DISEASE; FIBRILLIZATION; STABILIZATION; FIBRILLATION; AFFINITY; BINDING	Background: A amyloid formation is associated with Alzheimer disease. Results: Non-chaperone proteins prevent amyloid formation and reduce the cytotoxicity of the A peptide. Conclusion: Non-chaperone proteins may affect the onset and development of Alzheimer disease by interfering with A peptide aggregation. Significance: Non-chaperone proteins can function as a chaperone protein to regulate the pathway of the A fibrillation in proteostasis providing a new strategy in the treatment of Alzheimer disease. Many factors are known to influence the oligomerization, fibrillation, and amyloid formation of the A peptide that is associated with Alzheimer disease. Other proteins that are present when A peptides deposit in vivo are likely to have an effect on these aggregation processes. To separate specific versus broad spectrum effects of proteins on A aggregation, we tested a series of proteins not reported to have chaperone activity: catalase, pyruvate kinase, albumin, lysozyme, -lactalbumin, and -lactoglobulin. All tested proteins suppressed the fibrillation of Alzheimer A(1-40) peptide at substoichiometric ratios, albeit some more effectively than others. All proteins bound non-specifically to A, stabilized its random coils, and reduced its cytotoxicity. Surprisingly, pyruvate kinase and catalase were at least as effective as known chaperones in inhibiting A aggregation. We propose general mechanisms for the broad-spectrum inhibition A fibrillation by proteins. The mechanisms we discuss are significant for prognostics and perhaps even for prevention and treatment of Alzheimer disease.	[Luo, Jinghui; Abrahams, Jan Pieter] Leiden Univ, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands; [Warmlander, Sebastian K. T. S.; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Leiden University; Leiden University - Excl LUMC; Stockholm University	Abrahams, JP (corresponding author), Leiden Univ, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands.	Abrahams@chem.leidenuniv.nl	Abrahams, Jan Pieter/G-7287-2016; Abrahams, Jan Pieter/AAE-4319-2020	Abrahams, Jan Pieter/0000-0001-8216-1868; Abrahams, Jan Pieter/0000-0001-8216-1868; Luo, Jinghui/0000-0002-7014-8153				Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Divsalar A, 2012, J DAIRY RES, V79, P209, DOI 10.1017/S0022029912000167; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Luo JH, 2014, BIOMACROMOLECULES, V15, P1985, DOI 10.1021/bm401874j; Luo JH, 2014, CHEM-EUR J, V20, P2410, DOI 10.1002/chem.201304253; Luo JH, 2013, CHEM-EUR J, V19, P17338, DOI 10.1002/chem.201301535; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Luo JH, 2013, ACS CHEM NEUROSCI, V4, P454, DOI 10.1021/cn300170x; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; VANDAEL H, 1992, BIOPHYS CHEM, V42, P235, DOI 10.1016/0301-4622(92)80015-W; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Yamamoto K, 2014, GERIATR GERONTOL INT, V14, P716, DOI 10.1111/ggi.12147; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	46	43	44	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27766	27775		10.1074/jbc.M114.574947	http://dx.doi.org/10.1074/jbc.M114.574947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100721	hybrid, Green Published			2022-12-28	WOS:000342852800034
J	Biswas, C; Shah, N; Muthu, M; La, P; Fernando, AP; Sengupta, S; Yang, G; Dennery, PA				Biswas, Chhanda; Shah, Nidhi; Muthu, Manasa; La, Ping; Fernando, Amal P.; Sengupta, Shaon; Yang, Guang; Dennery, Phyllis A.			Nuclear Heme Oxygenase-1 (HO-1) Modulates Subcellular Distribution and Activation of Nrf2, Impacting Metabolic and Anti-oxidant Defenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-E2-RELATED FACTOR-2 NRF2; SIGNALING PATHWAY; GENE-EXPRESSION; PROTEIN; PHOSPHORYLATION; KINASE; STRESS; DEGRADATION; INDUCTION; CARCINOMA	With oxidative injury as well as in some solid tumors and myeloid leukemia cells, heme oxygenase-1 (HO-1), the anti-oxidant, anti-inflammatory, and anti-apoptotic microsomal stress protein, migrates to the nucleus in a truncated and enzymatically inactive form. However, the function of HO-1 in the nucleus is not completely clear. Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor and master regulator of numerous antioxidants and anti-apoptotic proteins, including HO-1, also accumulates in the nucleus with oxidative injury and in various types of cancer. Here we demonstrate that in oxidative stress, nuclear HO-1 interacts with Nrf2 and stabilizes it from glycogen synthase kinase 3 beta (GSK3 beta)-mediated phosphorylation coupled with ubiquitin-proteasomal degradation, thereby prolonging its accumulation in the nucleus. This regulation of Nrf2 post-induction by nuclear HO-1 is important for the preferential transcription of phase II detoxification enzymes such as NQO1 as well as glucose-6-phosphate dehydrogenase (G6PDH), a regulator of the pentose phosphate pathway. Using Nrf2 knock-out cells, we further demonstrate that nuclear HO-1-associated cytoprotection against oxidative stress depends on an HO-1/Nrf2 interaction. Although it is well known that Nrf2 induces HO-1 leading to mitigation of oxidant stress, we propose a novel mechanism by which HO-1, by modulating the activation of Nrf2, sets an adaptive reprogramming that enhances antioxidant defenses.	[Biswas, Chhanda; Sengupta, Shaon; Dennery, Phyllis A.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Biswas, Chhanda; Shah, Nidhi; Muthu, Manasa; La, Ping; Fernando, Amal P.; Sengupta, Shaon; Yang, Guang; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Dennery, PA (corresponding author), Univ Penn, Dept Pediat, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	dennery@email.chop.edu	Dennery, Phyllis/GQG-9113-2022; Shah, Nidhi G/AAV-3285-2020	Dennery, Phyllis/0000-0001-5745-1855	National Institutes of Health Grants from the National Institutes of Health [HL-58752, HL-11190]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058752] Funding Source: NIH RePORTER	National Institutes of Health Grants from the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-58752 and HL-11190 from the National Institutes of Health (to P. A. D.)	Agarwal Anupam, 2013, Trans Am Clin Climatol Assoc, V124, P111; ALAM J, 1989, J BIOL CHEM, V264, P6371; APPLEGATE LA, 1991, CANCER RES, V51, P974; BABA M, 1989, INT J CANCER, V43, P892, DOI 10.1002/ijc.2910430526; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boros LG, 1997, CANCER RES, V57, P4242; CADENAS E, 1990, METHOD ENZYMOL, V186, P180; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Das BN, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/839409; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181; Dennery PA, 2014, ANTIOXID REDOX SIGN, V20, P1743, DOI 10.1089/ars.2013.5674; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; He XQ, 2009, MOL PHARMACOL, V76, P1265, DOI 10.1124/mol.109.058453; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jung NH, 2003, IUBMB LIFE, V55, P525, DOI 10.1080/15216540310001620968; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; KOUDSTAAL J, 1975, EUR J CANCER, V11, P111, DOI 10.1016/0014-2964(75)90188-7; Kuo WY, 1998, FREE RADICAL BIO MED, V24, P1130, DOI 10.1016/S0891-5849(97)00413-9; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; PRETLOW TG, 1982, CANCER RES, V42, P4842; PRETLOW TG, 1985, CANCER RES, V45, P442; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Soriano FX, 2009, MOL CELLS, V27, P279, DOI 10.1007/s10059-009-0050-y; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Sunamura Makoto, 2003, Angiogenesis, V6, P15, DOI 10.1023/A:1025803600840; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; WILKS A, 1993, J BIOL CHEM, V268, P22357; Wright CJ, 2009, PEDIATR RES, V66, P3, DOI 10.1203/PDR.0b013e3181a2c184; Yang G, 2013, REDOX BIOL, V1, P234, DOI 10.1016/j.redox.2013.01.013; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; YOSHIDA T, 1989, BIOCHEM BIOPH RES CO, V163, P1086, DOI 10.1016/0006-291X(89)92332-2	64	170	177	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26882	26894		10.1074/jbc.M114.567685	http://dx.doi.org/10.1074/jbc.M114.567685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25107906	Green Published, hybrid			2022-12-28	WOS:000342853900019
J	Overkamp, KE; Gasper, R; Kock, K; Herrmann, C; Hofmann, E; Frankenberg-Dinkel, N				Overkamp, Kristina E.; Gasper, Raphael; Kock, Klaus; Herrmann, Christian; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Insights into the Biosynthesis and Assembly of Cryptophycean Phycobiliproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIN-BINDING-PROTEIN; AMINO-ACID-SEQUENCE; FERREDOXIN OXIDOREDUCTASE; ALPHA-SUBUNIT; CHROMOPHORE ATTACHMENT; RADICAL MECHANISM; CRYSTAL-STRUCTURE; PIERIS-BRASSICAE; BETA-PHYCOCYANIN; CPCS-I	Phycobiliproteins are employed by cyanobacteria, red algae, glaucophytes, and cryptophytes for light-harvesting and consist of apoproteins covalently associated with open-chain tetrapyrrole chromophores. Although the majority of organisms assemble the individual phycobiliproteins into larger aggregates called phycobilisomes, members of the cryptophytes use a single type of phycobiliprotein that is localized in the thylakoid lumen. The cryptophyte Guillardia theta (Gt) uses phycoerythrin PE545 utilizing the uncommon chromophore 15,16-dihydro-biliverdin (DHBV) in addition to phycoerythrobilin (PEB). Both the biosynthesis and the attachment of chromophores to the apophycobiliprotein have not yet been investigated for cryptophytes. In this study, we identified and characterized enzymes involved in PEB biosynthesis. In addition, we present the first in-depth biochemical characterization of a eukaryotic phycobiliprotein lyase (GtCPES). Plastid-encoded HO (GtHo) was shown to convert heme into biliverdin IX alpha providing the substrate with a putative nucleus-encoded DHBV: ferredoxin oxidoreductase (GtPEBA). A PEB: ferredoxin oxidoreductase (GtPEBB) was found to convert DHBV to PEB, which is the substrate for the phycobiliprotein lyase GtCPES. The x-ray structure of GtCPES was solved at 2.0 angstrom revealing 10-stranded beta-barrel with a modified lipocalin fold. GtCPES is an S-type lyase specific for binding of phycobilins with reduced C15=C16 double bonds (DHBV and PEB). Site-directed mutagenesis identified residues Glu-136 and Arg-146 involved in phycobilin binding. Based on the crystal structure, a model for the interaction of GtCPES with the apophycobiliprotein CpeB is proposed and discussed.	[Overkamp, Kristina E.; Gasper, Raphael; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Kock, Klaus; Herrmann, Christian] Ruhr Univ Bochum, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Hofmann, Eckhard/GPF-5024-2022; Frankenberg-Dinkel, Nicole/C-1058-2011	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X	Studienstiftung des Deutschen Volkes e.V.; Deutsche Forschungsgemeinschaft	Studienstiftung des Deutschen Volkes e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a Ph.D. scholarship from the Studienstiftung des Deutschen Volkes e.V.; Supported by a grant from the Deutsche Forschungsgemeinschaft.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Busch AWU, 2011, BIOCHEM J, V433, P469, DOI 10.1042/BJ20101642; Chen YR, 2012, P NATL ACAD SCI USA, V109, P8310, DOI 10.1073/pnas.1201744109; Colyer C, 2005, ANAL BIOANAL CHEM, V382, P559, DOI 10.1007/s00216-004-3020-4; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Doust AB, 2004, J MOL BIOL, V344, P135, DOI 10.1016/j.jmb.2004.09.044; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR, P401; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; GANTT E, 1971, J CELL BIOL, V48, P280, DOI 10.1083/jcb.48.2.280; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1977, J BIOL CHEM, V252, P32; Glazer AN, 1995, PHOTOSYNTH RES, V46, P93, DOI 10.1007/BF00020420; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; Gould SB, 2007, J BIOL CHEM, V282, P30295, DOI 10.1074/jbc.M701869200; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; HILL DRA, 1989, PHYCOLOGIA, V28, P455, DOI 10.2216/i0031-8884-28-4-455.1; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KROIS D, 1993, J CHEM SOC PERK T 2, P1351, DOI 10.1039/p29930001351; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; MacColl R., 1987, PHYCOBILIPROTEINS; North A. C., 1990, BIOCHEM SOC SYMP, V57, P35; Overkamp K. E., 2014, PORPHYRIN HDB, P187; Samsonoff WA, 2001, ARCH MICROBIOL, V176, P400, DOI 10.1007/s002030100346; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; SNYDER SH, 1988, J BIOL CHEM, V263, P13971; Stoebe B, 2002, PROTOPLASMA, V219, P123, DOI 10.1007/s007090200013; SUTER F, 1988, BIOL CHEM H-S, V369, P497, DOI 10.1515/bchm3.1988.369.1.497; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velankar S, 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [10.1093/nar/gkq985, 10.1093/nar/gkp916]; WAGNIERE G, 1976, J AM CHEM SOC, V98, P7806, DOI 10.1021/ja00440a056; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; Wilk KE, 1999, P NATL ACAD SCI USA, V96, P8901, DOI 10.1073/pnas.96.16.8901; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	76	24	26	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26691	26707		10.1074/jbc.M114.591131	http://dx.doi.org/10.1074/jbc.M114.591131			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096577	hybrid, Green Published			2022-12-28	WOS:000342853900003
J	Zhou, W; Ding, WL; Zeng, XL; Dong, LL; Zhao, B; Zhou, M; Scheer, H; Zhao, KH; Yang, XJ				Zhou, Wei; Ding, Wen-Long; Zeng, Xiao-Li; Dong, Liang-Liang; Zhao, Bin; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong; Yang, Xiaojing			Structure and Mechanism of the Phycobiliprotein Lyase CpcT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE-MEMBRANE LINKER; CHROMOPHORE ATTACHMENT; BILIN LYASE; FREMYELLA-DIPLOSIPHON; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; C-PHYCOCYANIN; PROTEIN; BINDING; PHYCOVIOLOBILIN	Pigmentation of light-harvesting phycobiliproteins of cyanobacteria requires covalent attachment of open-chain tetrapyrroles, bilins, to the apoproteins. Thioether formation via addition of a cysteine residue to the 3-ethylidene substituent of bilins is mediated by lyases. T-type lyases are responsible for attachment to Cys-155 of phycobiliprotein beta-subunits. We present crystal structures of CpcT (All5339) from Nostoc (Anabaena) sp. PCC7120 and its complex with phycocyanobilin at 1.95 and 2.50 angstrom resoluti, respectively. CpcT forms a dimer and adopts a calyx-shaped beta-barrel fold. Although the overall structure of CpcT is largely retained upon chromophore binding, arginine residues at the opening of the binding pocket undergo major rotameric rearrangements anchoring the propionate groups of phycocyanobilin. Based on the structure and mutational analysis, a reaction mechanism is proposed that accounts for chromophore stabilization and regio- and stereospecificity of the addition reaction. At the dimer interface, a loop extending from one subunit partially shields the opening of the phycocyanobilin binding pocket in the other subunit. Deletion of the loop or disruptions of the dimer interface significantly reduce CpcT lyase activity, suggesting functional relevance of the dimer. Dimerization is further enhanced by chromophore binding. The chromophore is largely buried in the dimer, but in the monomer, the 3-ethylidene group is accessible for the apophycobili-protein, preferentially from the chromophore beta-side. Asp-163 and Tyr-65 at the beta- and beta-face near the E-configured ethylidene group, respectively, support the acid-catalyzed nucleo-philic Michael addition of cysteine 155 of the apoprotein to an N-acylimmonium intermediate proposed by Grubmayr and Wagner (Grubmayr, K., and Wagner, U. G. (1988) Monatsh. Chem. 119, 965-983).	[Zhou, Wei; Ding, Wen-Long; Zeng, Xiao-Li; Dong, Liang-Liang; Zhao, Bin; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Yang, Xiaojing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Yang, Xiaojing] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Huazhong Agricultural University; University of Munich; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com; xiaojing@uic.edu		Zeng, Xiaoli/0000-0001-7616-0535	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [R01EY024363] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BONNETT R, 1976, NATURE, V262, P326, DOI 10.1038/262326a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASLAVSKY SE, 1983, ANGEW CHEM INT EDIT, V22, P656, DOI 10.1002/anie.198306561; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Brockmann H., 1978, PORPHYRINS, P288; David L, 2011, J MOL BIOL, V405, P201, DOI 10.1016/j.jmb.2010.10.036; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Go YM, 2013, CRIT REV BIOCHEM MOL, V48, P173, DOI 10.3109/10409238.2013.764840; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; GRUBMAYR K, 1988, MONATSH CHEM, V119, P965, DOI 10.1007/BF00810106; HAIDL E, 1985, J CHEM SOC PERK T 2, P421, DOI 10.1039/p29850000421; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; Lehner H., 1979, LIEBIGS ANN CHEM, V1979, P1798; Muller K, 2013, CHEM COMMUN, V49, P8970, DOI 10.1039/c3cc45065a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overkamp KE, 2014, J BIOL CHEM, V289, P26691, DOI 10.1074/jbc.M114.591131; PERSON RV, 1994, J AM CHEM SOC, V116, P42, DOI 10.1021/ja00080a006; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHEER H, 1976, Z NATURFORSCH C, V31, P413; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Scheer H., 1982, LIGHT REACTION PATH, P7; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Schultz LW, 2005, P NATL ACAD SCI USA, V102, P1378, DOI 10.1073/pnas.0409335102; Schuster-Bockler B, 2005, BIOINFORMATICS, V21, P2912, DOI 10.1093/bioinformatics/bti434; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Tang K, 2012, BBA-BIOENERGETICS, V1817, P1030, DOI 10.1016/j.bbabio.2012.03.018; Tu JM, 2008, PHOTOSYNTH RES, V95, P163, DOI 10.1007/s11120-007-9251-4; Tu JM, 2009, J AM CHEM SOC, V131, P5399, DOI 10.1021/ja9002348; Vopel S, 2005, BIOL CHEM, V386, P1097, DOI 10.1515/BC.2005.126; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2012, GENE, V511, P88, DOI 10.1016/j.gene.2012.09.004; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	68	26	28	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26677	26689		10.1074/jbc.M114.586743	http://dx.doi.org/10.1074/jbc.M114.586743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25074932	Green Published, hybrid			2022-12-28	WOS:000342853900002
J	Kobayashi, D; Hirayama, M; Komohara, Y; Mizuguchi, S; Morifuji, MW; Ihn, H; Takeya, M; Kuramochi, A; Araki, N				Kobayashi, Daiki; Hirayama, Mio; Komohara, Yoshihiro; Mizuguchi, Souhei; Morifuji, Masayo Wilson; Ihn, Hironobu; Takeya, Motohiro; Kuramochi, Akira; Araki, Norie			Translationally Controlled Tumor Protein Is a Novel Biological Target for Neurofibromatosis Type 1-associated Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DIFFERENTIATION; SCHWANN-CELLS; MOUSE MODEL; TCTP; GROWTH; NF1; ARTEMISININ; CANCER; PROLIFERATION; MICROTUBULES	Neurofibromatosis type 1 (NF1) is an autosomal dominant disease that predisposes individuals to develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs). Due to the lack of information on the molecular mechanism of NF1-associated tumor pathogenesis or biomarkers/therapeutic targets, an effective treatment for NF1 tumors has not been established. In this study, the novel NF1-associated protein, translationally controlled tumor protein (TCTP), was identified by integrated proteomics and found to be up-regulated via activated MAPK/PI3K-AKT signaling in response to growth factors in NF1-deficient Schwann cells. Immunohistochemical analysis of NF1-associated tumors revealed that the TCTP expression level correlated with tumorigenicity. In NF1-deficient MPNST cells, TCTP protein but not mRNA was down-regulated by NF1 GTPase-activating protein-related domain or MAPK/PI3K inhibitors, and this correlated with suppression of mammalian target of rapamycin (mTOR) signaling. mTOR inhibition by rapamycin also down-regulated TCTP protein expression, whereas knockdown or overexpression of TCTP suppressed or activated mTOR signaling, respectively, and affected cell viability. These results suggest that a positive feedback loop between TCTP and mTOR contributes to NF1-associated tumor formation. Last, the anti-tumor effect of artesunate, which binds to and degrades TCTP, was evaluated. Artesunate significantly suppressed the viability of MPNST cells but not normal Schwann cells, and the TCTP level inversely correlated with artesunate sensitivity. Moreover, combinational use of artesunate and rapamycin enhanced the cytotoxic effect on MPNST cells. These findings suggest that TCTP is functionally implicated in the progression of NF1-associated tumors and could serve as a biological target for their therapy.	[Kobayashi, Daiki; Hirayama, Mio; Mizuguchi, Souhei; Morifuji, Masayo Wilson; Araki, Norie] Kumamoto Univ, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; [Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan; [Kuramochi, Akira] Saitama Med Univ, Dept Dermatol, Saitama 3500495, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Saitama Medical University	Araki, N (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nori@gpo.kumamoto-u.ac.jp		Kobayashi, Daiki/0000-0003-4131-5220	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS) [25293312, 22390281, 25640068, 24700981, 26830097]; Centers of Excellence Project B of Kumamoto University for proteomic research and education; Grants-in-Aid for Scientific Research [26830079, 25293312, 14F04099] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS); Centers of Excellence Project B of Kumamoto University for proteomic research and education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (to N. A.); by Grant-in-Aid for Scientific Research (B) 25293312 and 22390281 (to N. A.), Grant-in-Aid for Exploratory Research 25640068 (to N. A.), and Grant-in-Aid for Young Scientists (B) 24700981 and 26830097 (to D. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS); and by the Centers of Excellence Project B of Kumamoto University for proteomic research and education (to N. A.).	Berdelle N, 2011, MOL CANCER THER, V10, P2224, DOI 10.1158/1535-7163.MCT-11-0534; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; BOHM H, 1989, BIOCHEM INT, V19, P277; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bottillo I, 2009, J PATHOL, V217, P693, DOI 10.1002/path.2494; Burgess A, 2008, ONCOGENE, V27, P5554, DOI 10.1038/onc.2008.167; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chae J, 2006, ARCH PHARM RES, V29, P50, DOI 10.1007/BF02977468; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gachet Y, 1999, J CELL SCI, V112, P1257; Hirayama M, 2013, MOL CELL PROTEOMICS, V12, P1377, DOI 10.1074/mcp.M112.024802; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Kim DK, 2012, DIABETOLOGIA, V55, P1205, DOI 10.1007/s00125-012-2467-7; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tsai MJ, 2014, ENDOCRINOLOGY, V155, P392, DOI 10.1210/en.2013-1663; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Watabe K, 2003, NEUROPATHOLOGY, V23, P68, DOI 10.1046/j.1440-1789.2003.00478.x; YENOFSKY R, 1982, P NATL ACAD SCI-BIOL, V79, P5876, DOI 10.1073/pnas.79.19.5876; Yunoue S, 2003, J BIOL CHEM, V278, P26958, DOI 10.1074/jbc.M209413200	38	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26314	26326		10.1074/jbc.M114.568253	http://dx.doi.org/10.1074/jbc.M114.568253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092287	hybrid, Green Published			2022-12-28	WOS:000342128800025
J	Wu, Y; Schellinger, JN; Huang, CL; Rodan, AR				Wu, Yipin; Schellinger, Jeffrey N.; Huang, Chou-Long; Rodan, Aylin R.			Hypotonicity Stimulates Potassium Flux through the WNK-SPAK/OSR1 Kinase Cascade and the Ncc69 Sodium-Potassium-2-Chloride Cotransporter in the Drosophila Renal Tubule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-CL; BASOLATERAL ION-TRANSPORT; REGULATED ANION CHANNEL; CELL-VOLUME REGULATION; ALANINE-RICH KINASE; MALPIGHIAN TUBULES; PROTEIN-KINASES; BLOOD-PRESSURE; WNK KINASES; NA+-K+-2CL(-) COTRANSPORTER	The ability to osmoregulate is fundamental to life. Adult Drosophila melanogaster maintain hemolymph osmolarity within a narrow range. Osmolarity modulates transepithelial ion and water flux in the Malpighian (renal) tubules of the fly, which are in direct contact with hemolymph in vivo, but the mechanisms causing increased transepithelial flux in response to hypotonicity are unknown. Fly renal tubules secrete a KCl-rich fluid. We have previously demonstrated a requirement for Ncc69, the fly sodium-potassium-2-chloride cotransporter (NKCC), in tubule K+ secretion. Mammalian NKCCs are regulated by a kinase cascade consisting of the with-no-lysine (WNK) and Ste20-related proline/alanine-rich (SPAK)/oxidative stress response (OSR1) kinases. Here, we show that decreasing Drosophila WNK activity causes a reduction in K+ flux. Similarly, knocking down the SPAK/OSR1 homolog fray also decreases K+ flux. We demonstrate that a hierarchical WNK-Fray signaling cascade regulates K+ flux through Ncc69, because (i) a constitutively active Fray mutant rescues the wnk knockdown phenotype, (ii) Fray directly phosphorylates Ncc69 in vitro, and (iii) the effect of wnk and fray knockdown is abolished in Ncc69 mutants. The stimulatory effect of hypotonicity on K+ flux is absent in wnk, fray, or Ncc69 mutant tubules, suggesting that the Drosophila WNK-SPAK/OSR1-NKCC cascade is an essential molecular pathway for osmoregulation, through its effect on transepithelial ion flux and fluid generation by the renal tubule.	[Wu, Yipin; Schellinger, Jeffrey N.; Huang, Chou-Long; Rodan, Aylin R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rodan, AR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	aylin.rodan@utsouthwestern.edu		Rodan, Aylin/0000-0001-9202-2378	National Institutes of Health, NIDDK [DK091316, DK007257, DK59530, DK079328]; American Society of Nephrology Gottschalk Award; National Institutes of Health [2P40OD010949-10A1]; National Institutes of Health, NIGMS [R01-GM084947]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007257, R01DK059530, K08DK091316, P30DK079328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology Gottschalk Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK091316 (to A. R. R.), DK007257 (institutional T32), DK59530 (to C. L. H.), and DK079328 (University of Texas Southwestern O'Brien Center P30). This work was also supported by the American Society of Nephrology Gottschalk Award (to A. R. R.). The Drosophila Genomics Resource Center is supported by National Institutes of Health Grant 2P40OD010949-10A1, and the TRiP project at Harvard Medical School is supported by National Institutes of Health, NIGMS, Grant R01-GM084947.	Albers MA, 2004, J EXP BIOL, V207, P2313, DOI 10.1242/jeb.01024; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blumenthal EM, 2005, AM J PHYSIOL-CELL PH, V289, pC1261, DOI 10.1152/ajpcell.00026.2005; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Cheng CJ, 2012, AM J PHYSIOL-RENAL, V303, pF667, DOI 10.1152/ajprenal.00290.2012; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DELLASEGA M, 1973, AM J PHYSIOL, V224, P1288, DOI 10.1152/ajplegacy.1973.224.6.1288; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOW JAT, 1994, J EXP BIOL, V197, P421; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; GUPTA BL, 1980, J EXP BIOL, V88, P21; Hisamoto N, 2008, EMBO REP, V9, P70, DOI 10.1038/sj.embor.7401128; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ianowski JP, 2004, J EXP BIOL, V207, P2599, DOI 10.1242/jeb.01058; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Larsen EH, 2014, COMPR PHYSIOL, V4, P405, DOI 10.1002/cphy.c130004; Leader J. P., 1997, J INSECT PHYSL, V44, P39; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Linton SM, 1999, J EXP BIOL, V202, P1561; Liu W, 2011, AM J PHYSIOL-RENAL, V301, pF1088, DOI 10.1152/ajprenal.00347.2011; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; MADDRELL SHP, 1993, J EXP BIOL, V177, P273; Messerli MA, 2008, ANAL BIOANAL CHEM, V390, P1355, DOI 10.1007/s00216-007-1804-z; Miyazaki H, 2007, AM J PHYSIOL-RENAL, V292, pF1411, DOI 10.1152/ajprenal.00244.2006; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Naito S, 2011, CLIN EXP NEPHROL, V15, P195, DOI 10.1007/s10157-010-0378-9; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039, DOI 10.1152/ajpregu.1998.274.4.R1039; ODONNELL MJ, 1995, J EXP BIOL, V198, P1647; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Pacheco-Alvarez D, 2012, CELL PHYSIOL BIOCHEM, V29, P291, DOI 10.1159/000337610; Pacheco-Alvarez D, 2011, CELL PHYSIOL BIOCHEM, V28, P1123, DOI 10.1159/000335848; Pech V, 2012, AM J PHYSIOL-RENAL, V303, pF45, DOI 10.1152/ajprenal.00030.2012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILLIPS J, 1981, AM J PHYSIOL, V241, pR241, DOI 10.1152/ajpregu.1981.241.5.R241; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rheault MR, 2001, J EXP BIOL, V204, P2289; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rodan AR, 2012, AM J PHYSIOL-CELL PH, V303, pC883, DOI 10.1152/ajpcell.00201.2012; Rosay P, 1997, J CELL SCI, V110, P1683; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Spring JH, 2009, J EXP BIOL, V212, P358, DOI 10.1242/jeb.024794; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; te Velde J. H., 1988, J EVOLUTION BIOL, V2, P139; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wall SM, 2001, AM J PHYSIOL-RENAL, V280, pF913, DOI 10.1152/ajprenal.2001.280.5.F913; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yamamoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P212, DOI 10.1016/j.bbrc.2007.11.128; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	85	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26131	26142		10.1074/jbc.M114.577767	http://dx.doi.org/10.1074/jbc.M114.577767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086033	hybrid, Green Published			2022-12-28	WOS:000342128800010
J	Enomoto, G; Nomura, R; Shimada, T; Ni-Ni-Win; Narikawa, R; Ikeuchi, M				Enomoto, Gen; Nomura, Ryouhei; Shimada, Takashi; Ni-Ni-Win; Narikawa, Rei; Ikeuchi, Masahiko			Cyanobacteriochrome SesA Is a Diguanylate Cyclase That Induces Cell Aggregation in Thermosynechococcus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC DI-GMP; THERMOPHILIC CYANOBACTERIUM; NEGATIVE PHOTOTAXIS; CELLULOSE SYNTHESIS; RESPONSE REGULATOR; BLUE; PHOTOCONVERSION; PHYCOVIOLOBILIN; TEPIXJ; PHOSPHODIESTERASE	Cyanobacteria have unique photoreceptors, cyanobacterio-chromes, that show diverse spectral properties to sense near-UV/visible lights. Certain cyanobacteriochromes have been shown to regulate cellular phototaxis or chromatic acclimation of photosynthetic pigments. Some cyanobacteriochromes have output domains involved in bacterial signaling using a second messenger cyclic dimeric GMP (c-di-GMP), but its role in cyanobacteria remains elusive. Here, we characterize the recombinant Tlr0924 from a thermophilic cyanobacterium Thermosynechococcus elongatus, which was expressed in a cyanobacterial system. The protein reversibly photoconverts between blue-and green-absorbing forms, which is consistent with the protein prepared from Escherichia coli, and has diguanylate cyclase activity, which is enhanced 38-fold by blue light compared with green light. Therefore, Tlr0924 is a blue light-activated diguanylate cyclase. The protein's relatively low affinity (10.5 mM) for Mg2+, which is essential for diguanylate cyclase activity, suggests that Mg2+ might also regulate c-di-GMP signaling. Finally, we show that blue light irradiation under low temperature is responsible for Thermosynechococcus vulcanus cell aggregation, which is abolished when tlr0924 is disrupted, suggesting that Tlr0924 mediates blue light-induced cell aggregation by producing c-di-GMP. Given our results, we propose the name "sesA (sessility-A)" for tlr0924. This is the first report for cyanobacteriochrome-dependent regulation of a sessile/planktonic lifestyle in cyanobacteria via c-di-GMP.	[Enomoto, Gen; Ni-Ni-Win; Narikawa, Rei; Ikeuchi, Masahiko] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Nomura, Ryouhei; Ikeuchi, Masahiko] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Meguro Ku, Tokyo 1538902, Japan; [Shimada, Takashi] Shimadzu Co Ltd, Life Sci Res Ctr, Chiyoda Ku, Tokyo 1088639, Japan; [Narikawa, Rei] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ikeuchi, Masahiko] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Shimadzu Corporation; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ikeuchi, M (corresponding author), Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	mikeuchi@bio.c.u-tokyo.ac.jp	Narikawa, Rei/AAA-5829-2021; Enomoto, Gen/ABE-4194-2021; Win, Ni-Ni-/GSM-9249-2022	Enomoto, Gen/0000-0002-9492-7557; Win, Ni-Ni-/0000-0002-5499-4210	GCOE Program "From the Earth to Earths" from the Ministry of Education and Science; PRESTO, Japan Science and Technology Agency; CREST, Japan Science and Technology Agency	GCOE Program "From the Earth to Earths" from the Ministry of Education and Science; PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by scientific research grants (to M. I. and R. N.), the GCOE Program "From the Earth to Earths" from the Ministry of Education and Science (to M. I.), by PRESTO, Japan Science and Technology Agency (to R. N.), and by CREST, Japan Science and Technology Agency (to M. I.).	Agostoni M, 2013, MBIO, V4, DOI 10.1128/mBio.00451-13; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Bonomi HR, 2012, P NATL ACAD SCI USA, V109, P12135, DOI 10.1073/pnas.1121292109; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Cao Z, 2010, PHOTOCHEM PHOTOBIOL, V86, P606, DOI 10.1111/j.1751-1097.2010.00724.x; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; Fukushima Y, 2011, BIOCHEMISTRY-US, V50, P6328, DOI 10.1021/bi101799w; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Hirano A., 1997, PLANT CELL PHYSL, V38, ps37; Hirose Y, 2008, P NATL ACAD SCI USA, V105, P9528, DOI 10.1073/pnas.0801826105; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Hirose Y, 2010, P NATL ACAD SCI USA, V107, P8854, DOI 10.1073/pnas.1000177107; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; Kanazawa T, 2010, BIOCHEMISTRY-US, V49, P10647, DOI 10.1021/bi101448t; Kandhavelu M, 2012, BIOSYSTEMS, V107, P129, DOI 10.1016/j.biosystems.2011.11.001; Kawano Y, 2011, PLANT CELL PHYSIOL, V52, P957, DOI 10.1093/pcp/pcr047; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Narikawa R, 2011, PLANT CELL PHYSIOL, V52, P2214, DOI 10.1093/pcp/pcr155; Neunuebel MR, 2008, J BACTERIOL, V190, P6829, DOI 10.1128/JB.00701-08; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; O'Shea TM, 2006, J BACTERIOL, V188, P8196, DOI 10.1128/JB.00728-06; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2013, P NATL ACAD SCI USA, V110, P806, DOI 10.1073/pnas.1220690110; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2000, PLANT CELL PHYSIOL, V41, P1299, DOI 10.1093/pcp/pce010	59	76	77	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24801	24809		10.1074/jbc.M114.583674	http://dx.doi.org/10.1074/jbc.M114.583674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25059661	Green Published, hybrid			2022-12-28	WOS:000341985300007
J	Erlendsson, S; Rathje, M; Heidarsson, PO; Poulsen, FM; Madsen, KL; Teilum, K; Gether, U				Erlendsson, Simon; Rathje, Mette; Heidarsson, Petur O.; Poulsen, Flemming M.; Madsen, Kenneth L.; Teilum, Kaare; Gether, Ulrik			Protein Interacting with C-kinase 1 (PICK1) Binding Promiscuity Relies on Unconventional PSD-95/Discs-Large/ZO-1 Homology (PDZ) Binding Modes for Nonclass II PDZ Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SUBUNIT GLUR2; SURFACE EXPRESSION; NMR-SPECTROSCOPY; DOMAIN; RECOGNITION; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; ORGANIZATION; ARCHITECTURE	PDZ domain proteins control multiple cellular functions by governing assembly of protein complexes. It remains unknown why individual PDZ domains can bind the extreme C terminus of very diverse binding partners and maintain selectivity. By employing NMR spectroscopy, together with molecular modeling, mutational analysis, and fluorescent polarization binding experiments, we identify here three structural mechanisms explaining why the PDZ domain of PICK1 selectively binds >30 receptors, transporters, and kinases. Class II ligands, including the dopamine transporter, adopt a canonical binding mode with promiscuity obtained via differential packing in the binding groove. Class I ligands, such as protein kinase C alpha, depend on residues upstream from the canonical binding sequence that are likely to interact with flexible loop residues of the PDZ domain. Finally, we obtain evidence that the unconventional ligand ASIC1a has a dual binding mode involving a canonical insertion and a noncanonical internal insertion with the two C-terminal residues forming interactions outside the groove. Together with an evolutionary analysis, the data show how unconventional binding modes might evolve for a protein recognition domain to expand the repertoire of functionally important interactions.	[Erlendsson, Simon; Rathje, Mette; Madsen, Kenneth L.; Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol Lab,Panum Inst 18 6, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol,Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Erlendsson, Simon; Heidarsson, Petur O.; Poulsen, Flemming M.; Teilum, Kaare] Univ Copenhagen, Fac Sci, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark	Lundbeckfonden; University of Copenhagen; University of Copenhagen	Teilum, K (corresponding author), Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kaare.teilum@bio.ku.dk; gether@sund.ku.dk	Rathje, Mette/GZL-1300-2022; Teilum, Kaare/S-8410-2019; Teilum, Kaare/K-4340-2014; Madsen, Kenneth/C-7778-2012; Heidarsson, Petur/A-5299-2015	Teilum, Kaare/0000-0001-6919-1982; Madsen, Kenneth/0000-0001-9274-6691; Erlendsson, Simon/0000-0002-6378-870X; Heidarsson, Petur/0000-0003-2027-5434; Gether, Ulrik/0000-0002-0020-3807	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC0002181] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.). This work was also supported by the Danish Medical Research Council (to U. G., K. T., and K. L. M.), University of Copenhagen BioScaRT Program of Excellence (to U. G.), Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the Novo Nordisk Foundation (to U. G.), and Fabrikant Vilhelm Pedersen og Hustrus Mindelegat (to U. G.).	Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Bhattacharya S, 2013, J MOL BIOL, V425, P2509, DOI 10.1016/j.jmb.2013.04.001; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Bolia A, 2012, PROTEINS, V80, P1393, DOI 10.1002/prot.24034; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Cao MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001541; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Chi CN, 2012, BIOCHEMISTRY-US, V51, P8971, DOI 10.1021/bi300792h; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holst B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001542; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Hultqvist G, 2013, STRUCTURE, V21, P1193, DOI 10.1016/j.str.2013.05.010; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2005, J BIOL CHEM, V280, P20539, DOI 10.1074/jbc.M500577200; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mostarda S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002429; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Terrien E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002941; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Tyler RC, 2010, BIOCHEMISTRY-US, V49, P951, DOI 10.1021/bi9017335; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Williams ME, 2003, J NEUROSCI, V23, P11279; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	60	31	32	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					25327	25340		10.1074/jbc.M114.548743	http://dx.doi.org/10.1074/jbc.M114.548743			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25023278	Green Published, hybrid			2022-12-28	WOS:000341985300051
J	Pavlin, MR; Brunzelle, JS; Fernandez, EJ				Pavlin, Mark Remec; Brunzelle, Joseph S.; Fernandez, Elias J.			Agonist Ligands Mediate the Transcriptional Response of Nuclear Receptor Heterodimers through Distinct Stoichiometric Assemblies with Coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; SMALL-ANGLE SCATTERING; STRUCTURAL BASIS; BINDING DOMAIN; RXR-ALPHA; ALLOSTERIC CONTROL; DRUG-METABOLISM; CAR; ACTIVATION; ACID	The constitutive androstane (CAR) and retinoid X receptors (RXR) are ligand-mediated transcription factors of the nuclear receptor protein superfamily. Functional CAR: RXR heterodimers recruit coactivator proteins, such as the steroid receptor coactivator-1 (SRC1). Here, we show that agonist ligands can potentiate transactivation through both coactivator binding sites on CAR: RXR, which distinctly bind two SRC1 molecules. We also observe that SRC1 transitions from a structurally plastic to a compact form upon binding CAR: RXR. Using small angle x-ray scattering (SAXS) we show that the CAR(tcp): RXR(9c).SRC1 complex can encompass two SRC1 molecules compared with the CAR(tcp): RXR.SRC1, which binds only a single SRC1. Moreover, sedimentation coefficients and molecular weights determined by analytical ultracentrifugation confirm the SAXS model. Cell-based transcription assays show that disrupting the SRC1 binding site on RXR alters the transactivation by CAR: RXR. These data suggest a broader role for RXR within heterodimers, whereas offering multiple strategies for the assembly of the transcription complex.	[Pavlin, Mark Remec; Fernandez, Elias J.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA; [Brunzelle, Joseph S.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Feinberg Sch Med, Chicago, IL 60611 USA	University of Tennessee System; University of Tennessee Knoxville; Northwestern University; Feinberg School of Medicine	Fernandez, EJ (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	elias.fernandez@utk.edu	Fernandez, Elias/AAX-8405-2021		National Institutes of Health [DK097337-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK097337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK097337-01 (to E. J. F.).	BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Billas I, 2013, J MOL BIOL, V425, P2317, DOI 10.1016/j.jmb.2013.03.017; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Gill RQ, 2001, J CLIN GASTROENTEROL, V33, P191, DOI 10.1097/00004836-200109000-00005; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100; Hwang JY, 2012, J MED CHEM, V55, P2301, DOI 10.1021/jm201546m; Ito M, 2008, J PHYS CHEM A, V112, P1986, DOI 10.1021/jp075430r; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Millard CJ, 2013, J MOL ENDOCRINOL, V51, pT23, DOI 10.1530/JME-13-0227; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Osz J, 2012, P NATL ACAD SCI USA, V109, pE588, DOI 10.1073/pnas.1118192109; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Putcha BDK, 2012, P NATL ACAD SCI USA, V109, P6084, DOI 10.1073/pnas.1119852109; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHULMAN IG, 1995, P NATL ACAD SCI USA, V92, P8288, DOI 10.1073/pnas.92.18.8288; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Volakakis N, 2009, BIOCHEM BIOPH RES CO, V390, P1186, DOI 10.1016/j.bbrc.2009.10.116; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Westin S, 2000, ADV PHARMACOL, V47, P89; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wright E, 2007, BIOCHEMISTRY-US, V46, P862, DOI 10.1021/bi061627i; Wright E, 2011, STRUCTURE, V19, P37, DOI 10.1016/j.str.2010.11.008; Wu ZD, 2007, EXPERT OPIN THER TAR, V11, P1329, DOI 10.1517/14728222.11.10.1329; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502	60	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	2014	289	36					24771	24778		10.1074/jbc.M114.575423	http://dx.doi.org/10.1074/jbc.M114.575423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP3OH	25053412	Green Published, hybrid			2022-12-28	WOS:000341985300004
J	Geetha-Loganathan, P; Nimmagadda, S; Fu, K; Richman, JM				Geetha-Loganathan, Poongodi; Nimmagadda, Suresh; Fu, Katherine; Richman, Joy M.			Avian Facial Morphogenesis Is Regulated by c-Jun N-terminal Kinase/Planar Cell Polarity (JNK/PCP) Wingless-related (WNT) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Craniofacial Development; Embryo; Morphogenesis; Retrovirus; Cleft Lip; Disheveled; Luciferase Reporter Assay; Micromass Culture; Optical Projection Tomography	RECESSIVE ROBINOW-SYNDROME; SYNDROMIC CLEFT-LIP; CHICK-EMBRYO; PRIMARY PALATE; FRONTONASAL MORPHOGENESIS; CRANIOFACIAL DEVELOPMENT; MOLECULAR-MECHANISMS; NONCANONICAL WNT; GENE-EXPRESSION; TOOTH AGENESIS	Background: Numerous genes contribute to the increased risk of facial clefting, but the cellular mechanisms involved are not well understood. Results: JNK/PCP wingless-related signaling is demonstrated as a major regulator of face shape. Conclusion: WNT11 induces clefting via inhibiting proliferation, compressing facial prominences, and changing cell behavior. Significance: JNK/PCP WNT signaling is implicated in the pathophysiology underlying craniofacial abnormalities. Wingless-related proteins (WNTs) regulate extension of the central axis of the vertebrate embryo (convergent extension) as well as morphogenesis of organs such as limbs and kidneys. Here, we asked whether WNT signaling directs facial morphogenesis using a targeted approach in chicken embryos. WNT11 is thought to mainly act via -catenin-independent pathways, and little is known about its role in craniofacial development. RCAS::WNT11 retrovirus was injected into the maxillary prominence, and the majority of embryos developed notches in the upper beak or the equivalent of cleft lip. Three-dimensional morphometric analysis revealed that WNT11 prevented lengthening of the maxillary prominence, which was due in part to decreased proliferation. We next determined, using a series of luciferase reporters, that WNT11 strongly induced JNK/planar cell polarity signaling while repressing the -catenin-mediated pathway. The activation of the JNK-ATF2 reporter was mediated by the DEP domain of Dishevelled. The impacts of altered signaling on the mesenchyme were assessed by implanted Wnt11- or Wnt3a-expressing cells (activates -catenin pathway) into the maxillary prominence or by knocking down endogenous WNT11 with RNAi. Host cells were attracted to Wnt11 donor cells. In contrast, cells exposed to Wnt3a or the control cells did not migrate. Cells in which endogenous WNT11 was knocked down were more oriented and shorter than those exposed to exogenous WNT11. The data suggest that JNK/planar cell polarity WNT signaling operates in the face to regulate several morphogenetic events leading to lip fusion.	[Geetha-Loganathan, Poongodi; Nimmagadda, Suresh; Fu, Katherine; Richman, Joy M.] Univ British Columbia, Fac Dent, Inst Life Sci, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Richman, JM (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	richman@dentistry.ubc.ca	Richman, Joy/AAD-9445-2020; Richman, Joy M./C-3111-2018	Richman, Joy/0000-0002-1409-8163; Richman, Joy M./0000-0002-1409-8163	Michael Smith Foundation for Health Research; MSFHR; Canadian Institutes of Health Research; Canadian Institutes of Health Research [MOP-123536, MOP-102671]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by postdoctoral awards from Michael Smith Foundation for Health Research (to P. G.-L.), MSFHR and Canadian Institutes of Health Research (to S. N.), and Operating Grants MOP-123536 and MOP-102671 from Canadian Institutes of Health Research (to J. M. R.).	Abramyan J, 2014, J EXP ZOOL PART B, V322, P73, DOI 10.1002/jez.b.22547; Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Ashique AM, 2002, DEVELOPMENT, V129, P4647; BAILEY LJ, 1988, J CRAN GENET DEV BIO, V8, P167; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chiquet BT, 2008, HUM MOL GENET, V17, P2212, DOI 10.1093/hmg/ddn121; COULY GF, 1993, DEVELOPMENT, V117, P409; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; DIEWERT VM, 1993, J CRAN GENET DEV BIO, V13, P162; DIEWERT VM, 1992, CRIT REV ORAL BIOL M, V4, P111, DOI 10.1177/10454411920040010201; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Economou AD, 2013, DEVELOPMENT, V140, P4740, DOI 10.1242/dev.096545; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Geetha-Loganathan P, 2011, DEV DYNAM, V240, P2108, DOI 10.1002/dvdy.22708; Geetha-Loganathan P, 2009, DEV DYNAM, V238, P1150, DOI 10.1002/dvdy.21934; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Higashihori N, 2010, DEV DYNAM, V239, P458, DOI 10.1002/dvdy.22182; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hosseini-Farahabadi S, 2013, MATRIX BIOL, V32, P252, DOI 10.1016/j.matbio.2013.02.005; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jagomagi T, 2010, EUR J ORAL SCI, V118, P213, DOI 10.1111/j.1600-0722.2010.00729.x; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lee SH, 2004, DEV BIOL, V276, P207, DOI 10.1016/j.ydbio.2004.08.045; Li H, 2008, DEV BIOL, V316, P458, DOI 10.1016/j.ydbio.2008.01.001; Li X, 2013, HUM MOL GENET, V22, P5160, DOI 10.1093/hmg/ddt369; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Logan Cairine, 2008, V461, P363, DOI 10.1007/978-1-60327-483-8_26; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; McGonnell IM, 1998, DEV DYNAM, V212, P102, DOI 10.1002/(SICI)1097-0177(199805)212:1<102::AID-AJA10>3.0.CO;2-9; Menezes R, 2010, BIRTH DEFECTS RES A, V88, P995, DOI 10.1002/bdra.20720; MINKOFF R, 1978, J EMBRYOL EXP MORPH, V46, P65; MINKOFF R, 1977, J EMBRYOL EXP MORPH, V40, P101; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Morosan-Puopolo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092679; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; PATTERSON SB, 1985, ANAT RECORD, V212, P90, DOI 10.1002/ar.1092120113; Pauws E, 2009, HUM MOL GENET, V18, P4171, DOI 10.1093/hmg/ddp368; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Plant MR, 2000, DEV BIOL, V222, P12, DOI 10.1006/dbio.2000.9706; RICHMAN JM, 1990, DEVELOPMENT, V109, P341; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Salahshourifar I, 2011, J HUM GENET, V56, P755, DOI 10.1038/jhg.2011.95; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Tadic T, 2002, J BONE MINER RES, V17, P1008, DOI 10.1359/jbmr.2002.17.6.1008; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WANG KY, 1995, J CRAN GENET DEV BIO, V15, P99; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	82	20	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24153	24167		10.1074/jbc.M113.522003	http://dx.doi.org/10.1074/jbc.M113.522003			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25008326	hybrid, Green Published			2022-12-28	WOS:000341505600014
J	Iyer, S; Han, L; Bartell, SM; Kim, HN; Gubrij, I; de Cabo, R; O'Brien, CA; Manolagas, SC; Almeida, M				Iyer, Srividhya; Han, Li; Bartell, Shoshana M.; Kim, Ha-Neui; Gubrij, Igor; de Cabo, Rafael; O'Brien, Charles A.; Manolagas, Stavros C.; Almeida, Maria			Sirtuin1 (Sirt1) Promotes Cortical Bone Formation by Preventing beta-Catenin Sequestration by FoxO Transcription Factors in Osteoblast Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Model; Apoptosis; Cell Proliferation; Osteoporosis; Wnt Signaling	LIFE-SPAN; MUSCLE ATROPHY; DISEASE; REGULATOR; MAINTENANCE; RESVERATROL; PROTEINS; ESTROGEN; INSIGHTS; PROTECTS	Background: Sirt1 activity, like osteoblast number and bone mass, declines with age. Results: Mice with Sirt1 deletion in osteoprogenitor cells have low cortical bone mass due to decreased bone formation resulting from increased -catenin sequestration by FoxOs. Conclusion: Sirt1 increases Wnt signaling and bone formation by a mechanism involving FoxOs. Significance: Sirt1 in osteoprogenitor cells could be a therapeutic target for osteoporosis. A decline of the levels and activity of Sirtuin1 (Sirt1), a NAD(+) class III histone deacetylase, with age contributes to the development of several diseases including type 2 diabetes, neurodegeneration, inflammation, and cancer. The anti-aging effects of Sirt1 evidently result from the deacetylation of many transcription factors and co-factors including members of the Forkhead box O (FoxO) family and -catenin. Wnt/-catenin is indispensable for osteoblast generation. FoxOs, on the other hand, sequester -catenin and inhibit osteoprogenitor proliferation. Here, we have deleted Sirt1 in osteoprogenitors expressing Osterix1 (Osx1)-Cre and their descendants. Sirt1(Osx1) mice had lower cortical thickness in femora and vertebrae because of reduced bone formation at the endocortical surface. In line with this, osteoprogenitor cell cultures from the Sirt1(Osx1) mice exhibited lower alkaline phosphatase activity and mineralization, as well as decreased proliferation and increased apoptosis. These changes were associated with decreased Wnt/-catenin signaling and expression of cyclin D1 and resulted from increased binding of FoxOs to -catenin. These findings demonstrate that Sirt1-induced deacetylation of FoxOs unleashes Wnt signaling. A decline in Sirt1 activity in osteoblast progenitors with aging may, therefore, contribute to the age-related loss of bone mass. Together with evidence that Sirt1 activators increase bone mass in aged mice, our results also suggest that Sirt1 could be a therapeutic target for osteoporosis.	[Iyer, Srividhya; Han, Li; Bartell, Shoshana M.; Kim, Ha-Neui; O'Brien, Charles A.; Manolagas, Stavros C.; Almeida, Maria] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Gubrij, Igor] Univ Arkansas Med Sci, Div Pulm & Crit Care, Little Rock, AR 72205 USA; [de Cabo, Rafael] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Almeida, M (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, 4301 W Markham St 587, Little Rock, AR 72205 USA.	schullermaria@uams.edu	de Cabo, Rafael/E-7996-2010; O'Brien, Charles A./AAL-5078-2020; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Iyer, Srividhya/0000-0002-8953-373X; Almeida, Maria/0000-0002-6722-9200; Warren, Aaron D./0000-0002-0042-9021	National Institutes of Health Grants [R01 AR56679, P01 AG13918, F32 AR061956-02]; Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant [I01 BX001405]; University of Arkansas for Medical Sciences Tobacco Funds; Translational Research Institute Grant [1UL1RR029884]; Intramural Research Program of the NIA, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061956, R01AR056679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918, ZIAAG000361, ZIAAG000363] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001405] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant; University of Arkansas for Medical Sciences Tobacco Funds; Translational Research Institute Grant; Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR56679 (to M. A.), P01 AG13918 (to S. C. M.), F32 AR061956-02 (to S. M. B.); Biomedical Laboratory Research and Development Service of the Veteran's Administration Office of Research and Development Grant I01 BX001405 (to S. C. M.); and University of Arkansas for Medical Sciences Tobacco Funds and Translational Research Institute Grant 1UL1RR029884.; Supported by the Intramural Research Program of the NIA, National Institutes of Health.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Almeida M, 2011, BONE, V49, P319, DOI 10.1016/j.bone.2011.05.023; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lee D, 2013, J BIOL CHEM, V288, P30515, DOI 10.1074/jbc.M113.489716; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Moore RL, 2012, J ENDOCRINOL, V213, P37, DOI 10.1530/JOE-11-0217; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Trinei M, 2009, AGING-US, V1, P503, DOI 10.18632/aging.100057; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083	45	88	93	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24069	24078		10.1074/jbc.M114.561803	http://dx.doi.org/10.1074/jbc.M114.561803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25002589	hybrid, Green Published			2022-12-28	WOS:000341505600007
J	Redka, DS; Morizumi, T; Elmslie, G; Paranthaman, P; Shivnaraine, RV; Ellis, J; Ernst, OP; Wells, JW				Redka, Dar'ya S.; Morizumi, Takefumi; Elmslie, Gwendolynne; Paranthaman, Pranavan; Shivnaraine, Rabindra V.; Ellis, John; Ernst, Oliver P.; Wells, James W.			Coupling of G Proteins to Reconstituted Monomers and Tetramers of the M-2 Muscarinic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Cooperativity; G Protein-coupled Receptor (GPCR); Membrane Reconstitution; Phospholipid Vesicle; G Protein Coupling; Monomers; Nanodiscs; Oligomers; Ternary Complex Model	BETA-ADRENERGIC-RECEPTOR; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGHER-ORDER OLIGOMERS; TERNARY COMPLEX MODEL; ADENYLATE-CYCLASE; PHOSPHOLIPID-BILAYER; CHOLINERGIC-RECEPTOR; GUANINE-NUCLEOTIDES; ACETYLCHOLINE-RECEPTORS; CONSTITUTIVE ACTIVATION	Background: The allosteric interaction between agonists and guanylyl nucleotides reports on the interaction between G protein-coupled receptors and G proteins. Results: Such allostery differs in kind between reconstituted monomers and tetramers of the M-2 muscarinic receptor. Conclusion: Monomers and tetramers mediate allostery via different mechanisms. Significance: Only tetramers resemble muscarinic receptors in myocardial membranes in the nature of their sensitivity to guanylyl nucleotides. G protein-coupled receptors can be reconstituted as monomers in nanodiscs and as tetramers in liposomes. When reconstituted with G proteins, both forms enable an allosteric interaction between agonists and guanylyl nucleotides. Both forms, therefore, are candidates for the complex that controls signaling at the level of the receptor. To identify the biologically relevant form, reconstituted monomers and tetramers of the purified M-2 muscarinic receptor were compared with muscarinic receptors in sarcolemmal membranes for the effect of guanosine 5-[,-imido]triphosphate (GMP-PNP) on the inhibition of N-[H-3]methylscopolamine by the agonist oxotremorine-M. With monomers, a stepwise increase in the concentration of GMP-PNP effected a lateral, rightward shift in the semilogarithmic binding profile (i.e. a progressive decrease in the apparent affinity of oxotremorine-M). With tetramers and receptors in sarcolemmal membranes, GMP-PNP effected a vertical, upward shift (i.e. an apparent redistribution of sites from a state of high affinity to one of low affinity with no change in affinity per se). The data were analyzed in terms of a mechanistic scheme based on a ligand-regulated equilibrium between uncoupled and G protein-coupled receptors (the ternary complex model). The model predicts a rightward shift in the presence of GMP-PNP and could not account for the effects at tetramers in vesicles or receptors in sarcolemmal membranes. Monomers present a special case of the model in which agonists and guanylyl nucleotides interact within a complex that is both constitutive and stable. The results favor oligomers of the M-2 receptor over monomers as the biologically relevant state for coupling to G proteins.	[Redka, Dar'ya S.; Paranthaman, Pranavan; Shivnaraine, Rabindra V.; Wells, James W.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada; [Morizumi, Takefumi; Ernst, Oliver P.] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON M5S 1A8, Canada; [Elmslie, Gwendolynne; Ellis, John] Penn State Univ, Dept Psychiat, Coll Med, Hershey Med Ctr, Hershey, PA 17033 USA; [Elmslie, Gwendolynne; Ellis, John] Penn State Univ, Dept Pharmacol, Coll Med, Hershey Med Ctr, Hershey, PA 17033 USA; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Fac Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto	Ellis, J (corresponding author), Penn State Univ, Dept Psychiat, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	johnellis@psu.edu; oliver.ernst@utoronto.ca; jwells@phm.utoronto.ca	Morizumi, Takefumi/AAA-2063-2021	Morizumi, Takefumi/0000-0002-2785-209X	Canadian Institutes of Health Research [MOP97978]; Heart and Stroke Foundation of Ontario [T6280, NA7168]; National Institutes of Health [R01AG05214]; Canada Excellence Research Chair Program; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; NATIONAL INSTITUTE ON AGING [R01AG005214] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Excellence Research Chair Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Canadian Institutes of Health Research Grant MOP97978 (to J. W. W.), Heart and Stroke Foundation of Ontario Grants T6280 and NA7168 (to J. W. W.), National Institutes of Health Grant R01AG05214 (to J. E.), and the Canada Excellence Research Chair Program (to O. P. E.).; Recipient of a scholarship from the Natural Sciences and Engineering Research Council of Canada and an Ontario Graduate Scholarship.	Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BERRIE CP, 1979, BIOCHEM BIOPH RES CO, V87, P1000, DOI 10.1016/S0006-291X(79)80006-6; Bieri C, 1999, NAT BIOTECHNOL, V17, P1105, DOI 10.1038/15090; BIRDSALL NJM, 1977, ADV BEHAV BIOL, V24, P25; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chidiac P, 1997, BIOCHEMISTRY-US, V36, P7361, DOI 10.1021/bi961939t; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; EHLERT FJ, 1990, MOL PHARMACOL, V38, P148; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; EHLERT FJ, 1980, J SUPRAMOL STR CELL, V14, P149, DOI 10.1002/jss.400140204; Ellis J, 2000, MOL PHARMACOL, V58, P1451, DOI 10.1124/mol.58.6.1451; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; Green MA, 1997, BIOCHEMISTRY-US, V36, P7380, DOI 10.1021/bi961940s; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HAGA K, 1986, J BIOL CHEM, V261, P133; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Heyse S, 1998, BIOCHEMISTRY-US, V37, P507, DOI 10.1021/bi971564r; HULME EC, 1981, EUR J PHARMACOL, V73, P137, DOI 10.1016/0014-2999(81)90085-6; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; KENT RS, 1980, MOL PHARMACOL, V17, P14; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; LEE TWT, 1986, BIOCHEMISTRY-US, V25, P7009, DOI 10.1021/bi00370a038; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; LIMBIRD LE, 1978, P NATL ACAD SCI USA, V75, P228, DOI 10.1073/pnas.75.1.228; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Ma AWS, 2008, BIOCHEM BIOPH RES CO, V374, P128, DOI 10.1016/j.bbrc.2008.06.105; Ma AWS, 2007, BIOCHEMISTRY-US, V46, P7907, DOI 10.1021/bi6026105; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; MATESIC DF, 1991, MOL PHARMACOL, V40, P347; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; MINTON AP, 1990, BIOCHEMISTRY-US, V29, P1586, DOI 10.1021/bi00458a033; NEUBIG RR, 1985, MOL PHARMACOL, V28, P475; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Park PSH, 2002, BIOCHEMISTRY-US, V41, P5588, DOI 10.1021/bi011746s; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Rasband W., 2006, IMAGEJ; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Redka DS, 2008, MOL PHARMACOL, V74, P834, DOI 10.1124/mol.108.048074; Redka DS, 2013, BIOCHEMISTRY-US, V52, P7405, DOI 10.1021/bi4003869; REN Q, 1993, J BIOL CHEM, V268, P16483; ROSS EM, 1977, J BIOL CHEM, V252, P5761; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Spalding TA, 1997, BIOCHEMISTRY-US, V36, P10109, DOI 10.1021/bi970565g; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Vidi PA, 2008, FEBS LETT, V582, P3985, DOI 10.1016/j.febslet.2008.09.062; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wells J. W., 1992, RECEPTOR LIGAND INTE, P289; WELLS JW, 1990, EUR J PHARMACOL, V183, P1731, DOI 10.1016/0014-2999(90)92036-I; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WONG HMS, 1986, BIOCHEMISTRY-US, V25, P6995, DOI 10.1021/bi00370a037; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; WREGGETT KA, 1995, J BIOL CHEM, V270, P22488, DOI 10.1074/jbc.270.38.22488; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yu LL, 2006, ANAL CHIM ACTA, V556, P216, DOI 10.1016/j.aca.2005.09.008; ZORICH NL, 1987, BIOCHIM BIOPHYS ACTA, V919, P181, DOI 10.1016/0005-2760(87)90206-2	73	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24347	24365		10.1074/jbc.M114.559294	http://dx.doi.org/10.1074/jbc.M114.559294			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25023280	Green Published, hybrid			2022-12-28	WOS:000341505600030
J	Soki, FN; Koh, AJ; Jones, JD; Kim, YW; Dai, JL; Keller, ET; Pienta, KJ; Atabai, K; Roca, H; McCauley, LK				Soki, Fabiana N.; Koh, Amy J.; Jones, Jacqueline D.; Kim, Yeo Won; Dai, Jinlu; Keller, Evan T.; Pienta, Kenneth J.; Atabai, Kamran; Roca, Hernan; McCauley, Laurie K.			Polarization of Prostate Cancer-associated Macrophages Is Induced by Milk Fat Globule-EGF Factor 8 (MFG-E8)-mediated Efferocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone Marrow; Macrophage; Phagocytosis; Prostate Cancer; Alternative Activation; MFG-E8; Skeletal Metastasis; Tumor-associated Macrophages; Efferocytosis	PARATHYROID-HORMONE; APOPTOTIC CELLS; IN-VITRO; OSTEAL MACROPHAGES; TUMOR PROGRESSION; ANABOLIC ACTIONS; BONE; INFLAMMATION; ACTIVATION; MICROENVIRONMENT	Background: The growing body of data on tumor-associated macrophages largely neglects phagocytosis of apoptotic cells. Results: MFG-E8, induced during efferocytosis, contributes to macrophage polarization with STAT3/SOCS3 pathway involvement. Conclusion: Efferocytosis induces macrophage polarization into tumor-associated macrophages mediated by MFG-E8. Significance: A novel tumor-promoting mechanism for macrophage polarization through efferocytosis and MFG-E8 and its corresponding signaling pathway were identified. Tumor cells secrete factors that modulate macrophage activation and polarization into M2 type tumor-associated macrophages, which promote tumor growth, progression, and metastasis. The mechanisms that mediate this polarization are not clear. Macrophages are phagocytic cells that participate in the clearance of apoptotic cells, a process known as efferocytosis. Milk fat globule- EGF factor 8 (MFG-E8) is a bridge protein that facilitates efferocytosis and is associated with suppression of proinflammatory responses. This study investigated the hypothesis that MFG-E8-mediated efferocytosis promotes M2 polarization. Tissue and serum exosomes from prostate cancer patients presented higher levels of MFG-E8 compared with controls, a novel finding in human prostate cancer. Coculture of macrophages with apoptotic cancer cells increased efferocytosis, elevated MFG-E8 protein expression levels, and induced macrophage polarization into an alternatively activated M2 phenotype. Administration of antibody against MFG-E8 significantly attenuated the increase in M2 polarization. Inhibition of STAT3 phosphorylation using the inhibitor Stattic decreased efferocytosis and M2 macrophage polarization in vitro, with a correlating increase in SOCS3 protein expression. Moreover, MFG-E8 knockdown tumor cells cultured with wild-type or MFG-E8-deficient macrophages resulted in increased SOCS3 expression with decreased STAT3 activation. This suggests that SOCS3 and phospho-STAT3 act in an inversely dependent manner when stimulated by MFG-E8 and efferocytosis. These results uncover a unique role of efferocytosis via MFG-E8 as a mechanism for macrophage polarization into tumor-promoting M2 cells.	[Soki, Fabiana N.; Koh, Amy J.; Jones, Jacqueline D.; Kim, Yeo Won; Roca, Hernan; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Dai, Jinlu; Keller, Evan T.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Dai, Jinlu; Keller, Evan T.; McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21287 USA; [Atabai, Kamran] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu	Dai, Jin/GVT-2414-2022; Keller, Evan T/M-1446-2016	Dai, Jin/0000-0003-3063-746X; Keller, Evan T/0000-0002-7592-7535	Fund for Cancer Research; National Cancer Institute [P01-CA093900, F32 CA 168269]; American Cancer Society [U01CA143055, U54CA143803]; NATIONAL CANCER INSTITUTE [F32CA168269, P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904] Funding Source: NIH RePORTER	Fund for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Fund for Cancer Research grants and by National Cancer Institute Grants P01-CA093900 (to L. K. M., K. J.P., and E. T. K.) and F32 CA 168269 (to F. S.).; Supported as an American Cancer Society Clinical Research Professor by Grants U01CA143055 and U54CA143803.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Fujii T, 2013, PATHOBIOLOGY, V80, P119, DOI 10.1159/000342396; Gregory CD, 2011, J PATHOL, V223, P177, DOI 10.1002/path.2792; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hiwatashi K, 2011, CANCER LETT, V308, P172, DOI 10.1016/j.canlet.2011.04.024; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jinushi M, 2009, J EXP MED, V206, P1317, DOI 10.1084/jem.20082614; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Koh AJ, 2011, ENDOCRINOLOGY, V152, P4525, DOI 10.1210/en.2011-1515; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Loberg RD, 2005, J CELL BIOCHEM, V96, P439, DOI 10.1002/jcb.20522; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Miksa M, 2008, INT J MOL MED, V22, P743, DOI 10.3892/ijmm_00000080; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Novince CM, 2012, J BONE MINER RES, V27, P11, DOI 10.1002/jbmr.508; Park SI, 2011, CANCER MICROENVIRON, V4, P237, DOI 10.1007/s12307-011-0081-8; Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Reiter I, 1999, J IMMUNOL, V163, P1730; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wang XH, 2012, J BIOL CHEM, V287, P18376, DOI 10.1074/jbc.M112.355164; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang J, 2010, CYTOKINE GROWTH F R, V21, P41, DOI 10.1016/j.cytogfr.2009.11.009	54	109	113	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24560	24572		10.1074/jbc.M114.571620	http://dx.doi.org/10.1074/jbc.M114.571620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	25006249	Green Published, hybrid			2022-12-28	WOS:000341505600047
J	Khoury, E; Nikolajev, L; Simaan, M; Namkung, Y; Laporte, SA				Khoury, Etienne; Nikolajev, Ljiljana; Simaan, May; Namkung, Yoon; Laporte, Stephane A.			Differential Regulation of Endosomal GPCR/beta-Arrestin Complexes and Trafficking by MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Cell Signaling; G Protein-coupled Receptor (GPCR); Mitogen-activated Protein Kinase (MAPK); Trafficking; Bradykinin B2 Receptor	PROTEIN-COUPLED RECEPTORS; II TYPE-1 RECEPTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; VISUAL ARRESTIN; ERK ACTIVATION; HEART-FAILURE; BIASED LIGAND; BINDING STATE; PHOSPHORYLATION	Background: Regulation between GPCRs and -arrestins in endosomes has never been reported. Results: A novel ERK regulatory site in -arrestin-2 controls the binding to GPCRs in endosomes, and receptor trafficking and signaling. Conclusion: Differential MAPK-dependent regulation of endosomal complexes exists among -arrestin subtypes and species. Significance: Such divergent mode of regulation may help understanding the physiological role of the endosomal GPCR/-arrestins signaling axis. -Arrestins are signaling adaptors that bind to agonist-occupied G protein-coupled receptors (GPCRs) and target them for endocytosis; however, the mechanisms regulating receptor/-arrestin complexes and trafficking in endosomes, remain ill defined. Here we show, in live cells, differential dynamic regulation of endosomal bradykinin B2 receptor (B2R) complexes with either -arrestin-1 or -2. We find a novel role for MAPK in the B2R/-arrestin-2 complex formation, receptor trafficking and signaling mediated by an ERK1/2 regulatory motif in the hinge domain of the rat -arrestin-2 ((PETP)-P-178), but not rat -arrestin-1 ((PERP)-P-177). While the ERK1/2 regulatory motif is conserved between rat and mouse -arrestin-2, it is surprisingly not conserved in human -arrestin-2 ((PEKP)-P-178). However, mutation of lysine 178 to threonine is sufficient to confer MAPK sensitivity to the human -arrestin-2. Furthermore, substitution for a phosphomimetic residue in both the rat and the human -arrestin-2 (T/K178D) significantly stabilizes B2R/-arrestin complexes in endosomes, delays receptor recycling to the plasma membrane and maintains intracellular MAPK signaling. Similarly, the endosomal trafficking of 2-adrenergic, angiotensin II type 1 and vasopressin V2 receptors was altered by the -arrestin-2 T178D mutant. Our findings unveil a novel subtype specific mode of MAPK-dependent regulation of -arrestins in intracellular trafficking and signaling of GPCRs, and suggest differential endosomal receptor/-arrestin-2 signaling roles among species.	[Khoury, Etienne; Simaan, May; Namkung, Yoon; Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Med, Montreal, PQ H3A 2B2, Canada; [Nikolajev, Ljiljana; Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3A 2B2, Canada; [Laporte, Stephane A.] McGill Univ, McGill Univ Hlth Ctr Res Inst, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	McGill University; McGill University; McGill University	Laporte, SA (corresponding author), McGill Univ, Polypeptide Lab, Strathcona Anat & Dent Bldg,3640 Univ St, Montreal, PQ H3A 2B2, Canada.	stephane.laporte@mcgill.ca	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; 	Canadian Institutes of Health Research (CIHR) [MOP-74603]; McGill Division of Endocrinology and Metabolism; "Le Fonds de recherche du Quebec - Sante" (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill Division of Endocrinology and Metabolism; "Le Fonds de recherche du Quebec - Sante" (FRQS)	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants (to S. A. L.) (MOP-74603).; Recipient of a studentship from the McGill Division of Endocrinology and Metabolism.; Recipient of a Chercheur Boursier Senior scholarship from "Le Fonds de recherche du Quebec - Sante" (FRQS). To whom correspondence should be addressed: Polypeptide Laboratory, McGill University, Strathcona Anatomy & Dentistry Bldg., 3640 University St., Room W315, Montreal, QC H3A 2B2, Canada. Tel.: 514-398-4487; Fax: 514-398-3923; E-mail: stephane.laporte@mcgill.ca.	Aguila B, 2011, METHODS MOL BIOL, V756, P371, DOI 10.1007/978-1-61779-160-4_23; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Chen YS, 2008, J VIROL, V82, P9345, DOI 10.1128/JVI.00656-08; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gousseva V, 2008, BIOPHYS J, V94, P679, DOI 10.1529/biophysj.107.115188; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Hagai T, 2012, MOL BIOSYST, V8, P1865, DOI 10.1039/c2mb25052g; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma P, 2002, NAT REV DRUG DISCOV, V1, P571, DOI 10.1038/nrd884; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Violin JD, 2010, J CARD FAIL, V16, pS72, DOI 10.1016/j.cardfail.2010.06.247; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	45	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23302	23317		10.1074/jbc.M114.568147	http://dx.doi.org/10.1074/jbc.M114.568147			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25016018	hybrid, Green Published			2022-12-28	WOS:000341505000004
J	Ogasawara, Y; Itakura, E; Kono, N; Mizushima, N; Arai, H; Nara, A; Mizukami, T; Yamamoto, A				Ogasawara, Yuta; Itakura, Eisuke; Kono, Nozomu; Mizushima, Noboru; Arai, Hiroyuki; Nara, Atsuki; Mizukami, Tamio; Yamamoto, Akitsugu			Stearoyl-CoA Desaturase 1 Activity Is Required for Autophagosome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Endoplasmic Reticulum (ER); Fatty Acid; Lipid Metabolism; Membrane; SCD1	FRACTURE ELECTRON-MICROSCOPY; STARVATION-INDUCED AUTOPHAGY; ENDOPLASMIC-RETICULUM; FREEZE-FRACTURE; INDUCED AUTOPHAGOCYTOSIS; SIGNALING PATHWAY; FORMATION SITE; LIPID KINASE; HUMAN CANCER; FATTY-ACIDS	Background: Autophagosome membranes are believed to have a high content of unsaturated fatty acids, but the roles of unsaturated fatty acids in autophagy are not clear. Results: Stearoyl-CoA desaturase 1 inhibitor 28c suppressed autophagy at the earliest stage of autophagosome formation. Conclusion: Unsaturated fatty acids are required for autophagosome formation. Significance: This study clarifies the importance of fatty acid desaturation in the autophagosome formation. Autophagy is one of the major degradation pathways for cytoplasmic components. The autophagic isolation membrane is a unique membrane whose content of unsaturated fatty acids is very high. However, the molecular mechanisms underlying formation of this membrane, including the roles of unsaturated fatty acids, remain to be elucidated. From a chemical library consisting of structurally diverse compounds, we screened for novel inhibitors of starvation-induced autophagy by measuring LC3 puncta formation in mouse embryonic fibroblasts stably expressing GFP-LC3. One of the inhibitors we identified, 2,5-pyridinedicarboxamide, N2,N5-bis[5-[(dimethylamino)carbonyl]-4-methyl-2-thiazolyl], has a molecular structure similar to that of a known stearoyl-CoA desaturase (SCD) 1 inhibitor. To determine whether SCD1 inhibition influences autophagy, we examined the effects of the SCD1 inhibitor 28c. This compound strongly inhibited starvation-induced autophagy, as determined by LC3 puncta formation, immunoblot analyses of LC3, electron microscopic observations, and p62/SQSTM1 accumulation. Overexpression of SCD1 or supplementation with oleic acid, which is a catalytic product of SCD1 abolished the inhibition of autophagy by 28c. Furthermore, 28c suppressed starvation-induced autophagy without affecting mammalian target of rapamycin activity, and also inhibited rapamycin-induced autophagy. In addition to inhibiting formation of LC3 puncta, 28c also inhibited formation of ULK1, WIPI1, Atg16L, and p62/SQSTM1 puncta. These results suggest that SCD1 activity is required for the earliest step of autophagosome formation.	[Ogasawara, Yuta; Nara, Atsuki; Mizukami, Tamio; Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan; [Itakura, Eisuke; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; University of Tokyo	Yamamoto, A (corresponding author), 1266 Tamura, Nagahama, Shiga 5260829, Japan.	a_yamamoto@nagahama-i-bio.ac.jp	Itakura, Eisuke/AAY-7977-2021; Mizushima, Noboru/C-3635-2009; Ogasawara, Yuta/C-4021-2016; Nara, Atsuki/ABD-4772-2021; KONO, nozomu/AAM-3178-2020	Itakura, Eisuke/0000-0001-7248-9333; Mizushima, Noboru/0000-0002-6258-6444; Nara, Atsuki/0000-0002-4115-3017; Ogasawara, Yuta/0000-0001-5345-6472	Japan Science Society	Japan Science Society	This work was supported by a Sasakawa Scientific Research Grant from the Japan Science Society.	Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HIRSIMAKI Y, 1982, EUR J CELL BIOL, V27, P298; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kohler K, 2009, AUTOPHAGY, V5, P980; lida T., 2008, [No title captured], Patent No. [WO 2008/123469 A1, 2008123469]; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ohsumi Y, 1999, PHILOS T ROY SOC B, V354, P1577, DOI 10.1098/rstb.1999.0501; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; REUNANEN H, 1985, HISTOCHEMISTRY, V83, P513, DOI 10.1007/BF00492453; REZ G, 1980, LAB INVEST, V43, P269; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tan SH, 2014, AUTOPHAGY, V10, P226, DOI 10.4161/auto.27003; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	49	48	48	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23938	23950		10.1074/jbc.M114.591065	http://dx.doi.org/10.1074/jbc.M114.591065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25023287	Green Published, hybrid			2022-12-28	WOS:000341505000059
J	Roach, EJ; Kimber, MS; Khursigara, CM				Roach, Elyse J.; Kimber, Matthew S.; Khursigara, Cezar M.			Crystal Structure and Site-directed Mutational Analysis Reveals Key Residues Involved in Escherichia coli ZapA Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cell Division; Crystal Structure; Electron Microscopy (EM); Escherichia coli (E coli)	CELL-DIVISION PROTEIN; FTSZ-RING; DIVISOME; PROTOFILAMENTS; DYNAMICS; PROMOTES	Background: ZapA and FtsZ interact prior to bacterial cell division to stabilize the Z-ring. Results: The structure of E. coli ZapA reveals a charged -helix important for FtsZ interactions. Conclusion: Key residues in the charged -helix of ZapA are important for FtsZ filament bundling. Significance: ZapA facilitates FtsZ filament bundling and Z-ring stability in dividing bacterial cells. FtsZ is an essential cell division protein in Escherichia coli, and its localization, filamentation, and bundling at the mid-cell are required for Z-ring stability. Once assembled, the Z-ring recruits a series of proteins that comprise the bacterial divisome. Zaps (FtsZ-associated proteins) stabilize the Z-ring by increasing lateral interactions between individual filaments, bundling FtsZ to provide a scaffold for divisome assembly. The x-ray crystallographic structure of E. coli ZapA was determined, identifying key structural differences from the existing ZapA structure from Pseudomonas aeruginosa, including a charged -helix on the globular domains of the ZapA tetramer. Key helix residues in E. coli ZapA were modified using site-directed mutagenesis. These ZapA variants significantly decreased FtsZ bundling in protein sedimentation assays when compared with WT ZapA proteins. Electron micrographs of ZapA-bundled FtsZ filaments showed the modified ZapA variants altered the number of FtsZ filaments per bundle. These in vitro results were corroborated in vivo by expressing the ZapA variants in an E. coli zapA strain. In vivo, ZapA variants that altered FtsZ bundling showed an elongated phenotype, indicating improper cell division. Our findings highlight the importance of key ZapA residues that influence the extent of FtsZ bundling and that ultimately affect Z-ring formation in dividing cells.	[Roach, Elyse J.; Kimber, Matthew S.; Khursigara, Cezar M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Khursigara, CM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	ckhursig@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Roach, Elyse/0000-0003-0079-8510; Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada [371639, 327280]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada Discovery Grants 371639 (to C. M. K.) and 327280 (to M. S. K.).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Buddelmeijer N, 2002, CURR OPIN MICROBIOL, V5, P553, DOI 10.1016/S1369-5274(02)00374-0; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Vicente M, 1996, MOL MICROBIOL, V20, P1, DOI 10.1111/j.1365-2958.1996.tb02482.x; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; WARD JE, 1985, CELL, V42, P941, DOI 10.1016/0092-8674(85)90290-9	51	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2014	289	34					23276	23286		10.1074/jbc.M114.561928	http://dx.doi.org/10.1074/jbc.M114.561928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AT	25002581	Green Published, hybrid			2022-12-28	WOS:000341505000002
J	Kang, DW; Choi, KY; Min, DS				Kang, Dong Woo; Choi, Kang-Yell; Min, Do Sik			Functional Regulation of Phospholipase D Expression in Cancer and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; INDUCED DOWN-REGULATION; PLD1 GENE-EXPRESSION; INHIBITS PROLIFERATION; SELECTIVE INDUCTION; THROMBUS FORMATION; MAMMALIAN TARGET; CHOLINE KINASE; CELL INVASION; PHORBOL-ESTER	Phospholipase D (PLD) regulates downstream effectors by generating phosphatidic acid. Growing links of dysregulation of PLD to human disease have spurred interest in therapeutics that target its function. Aberrant PLD expression has been identified in multiple facets of complex pathological states, including cancer and inflammatory diseases. Thus, it is important to understand how the signaling network of PLD expression is regulated and contributes to progression of these diseases. Interestingly, small molecule PLD inhibitors can suppress PLD expression as well as enzymatic activity of PLD and have been shown to be effective in pathological mice models, suggesting the potential for use of PLD inhibitors as therapeutics against cancer and inflammation. Here, we summarize recent scientific developments regarding the regulation of PLD expression and its role in cancer and inflammatory processes.	[Kang, Dong Woo; Min, Do Sik] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Pusan 609735, South Korea; [Choi, Kang-Yell] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Choi, Kang-Yell; Min, Do Sik] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Pusan National University; Yonsei University; Yonsei University	Min, DS (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MEST) [2012002009]; Translational Research Center for Protein Function Control Grant [NSF 2009-0083522]; National R&D program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [0920050]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Translational Research Center for Protein Function Control Grant; National R&D program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (Grant 2012002009), a Translational Research Center for Protein Function Control Grant (NSF 2009-0083522), and National R&D program for Cancer Control, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant 0920050. This is the third article in the Thematic Minireview Series "Phospholipase D and Cancer."	Akagi I, 2008, ANN SURG ONCOL, V15, P2965, DOI 10.1245/s10434-008-9986-y; Arakawa T, 1998, DIGEST DIS SCI, V43, p5S; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Bluth M, 2008, ARCH SURG-CHICAGO, V143, P227, DOI 10.1001/archsurg.2007.73; Bruntz RC, 2014, J BIOL CHEM, V289, P600, DOI 10.1074/jbc.M113.532978; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen ZG, 2014, MOL MED REP, V9, P503, DOI 10.3892/mmr.2013.1814; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; De Jesus ML, 2006, J BIOL CHEM, V281, P21837, DOI 10.1074/jbc.M604156200; Elvers M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000551; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gadiya M, 2014, CANCER BIOL THER, V15, P593, DOI 10.4161/cbt.28165; Gao SQ, 2009, NAGOYA J MED SCI, V71, P127; Hagerstrand D, 2013, CANCER DISCOV, V3, P1044, DOI 10.1158/2159-8290.CD-12-0592; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Heering J, 2012, CANCER RES, V72, P2855, DOI 10.1158/0008-5472.CAN-11-3069; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2013, CELL SIGNAL, V25, P198, DOI 10.1016/j.cellsig.2012.08.010; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Janardhan S, 2006, CURR MED CHEM, V13, P1169, DOI 10.2174/092986706776360923; Jin JK, 2007, NEUROBIOL AGING, V28, P1015, DOI 10.1016/j.neurobiolaging.2006.05.022; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kang DW, 2013, ONCOGENE, V32, P3531, DOI 10.1038/onc.2012.358; Kang DW, 2008, J BIOL CHEM, V283, P4094, DOI 10.1074/jbc.M707416200; Kang DW, 2013, MOL CELL BIOL, V33, P2760, DOI 10.1128/MCB.01519-12; Kang DW, 2011, CANCER RES, V71, P293, DOI 10.1158/0008-5472.CAN-10-2463; Kang DW, 2011, INT J CANCER, V128, P805, DOI 10.1002/ijc.25402; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Kang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012109; Kang DW, 2010, CANCER LETT, V294, P125, DOI 10.1016/j.canlet.2010.01.031; Kang DW, 2010, CANCER RES, V70, P4233, DOI 10.1158/0008-5472.CAN-09-3470; Kang DW, 2009, EXP MOL MED, V41, P678, DOI 10.3858/emm.2009.41.9.074; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; LaLonde M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-60; Lee MY, 2000, GLIA, V30, P311, DOI 10.1002/(SICI)1098-1136(200005)30:3<311::AID-GLIA10>3.0.CO;2-K; Locati M, 2001, BIOCHEM J, V358, P119, DOI 10.1042/0264-6021:3580119; Lu ZM, 2000, MOL CELL BIOL, V20, P462, DOI 10.1128/MCB.20.2.462-467.2000; Matthies DS, 2006, J NEUROSCI, V26, P6200, DOI 10.1523/JNEUROSCI.5036-05.2006; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Norton LJ, 2011, J CELL SCI, V124, P1973, DOI 10.1242/jcs.082008; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; O'Reilly MC, 2013, J MED CHEM, V56, P2695, DOI 10.1021/jm301782e; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; Park MH, 2013, BIOCHEM BIOPH RES CO, V442, P1, DOI 10.1016/j.bbrc.2013.09.105; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Park MK, 2011, IMMUNOL LETT, V139, P42, DOI 10.1016/j.imlet.2011.04.013; Powner DJ, 2005, J CELL SCI, V118, P2975, DOI 10.1242/jcs.02432; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Saito M, 2007, ONCOL REP, V18, P1329; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Sethu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010506; Speranza FJ, 2013, J LEUKOCYTE BIOL, V94, P953, DOI 10.1189/jlb.0313174; Stegner D, 2013, ARTERIOSCL THROM VAS, V33, P2212, DOI 10.1161/ATVBAHA.113.302030; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sulzmaier FJ, 2012, ONCOGENE, V31, P3547, DOI 10.1038/onc.2011.514; Tabatabaian F, 2010, J BIOL CHEM, V285, P18991, DOI 10.1074/jbc.M110.111542; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Waksman M, 1996, J BIOL CHEM, V271, P2361, DOI 10.1074/jbc.271.5.2361; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Xu CZ, 2013, INT J CLIN EXP PATHO, V6, P2745; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yanase Y, 2010, BIOCHEM J, V425, P179, DOI 10.1042/BJ20091122; Yang TTC, 2006, J BIOL CHEM, V281, P11541, DOI 10.1074/jbc.M511214200; Zeng XXI, 2009, DEV BIOL, V328, P363, DOI 10.1016/j.ydbio.2009.01.035; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	81	39	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22575	22582		10.1074/jbc.R114.569822	http://dx.doi.org/10.1074/jbc.R114.569822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990948	hybrid, Green Published			2022-12-28	WOS:000341017200004
J	Rahbek-Clemmensen, T; Bay, T; Eriksen, J; Gether, U; Jorgensen, TN				Rahbek-Clemmensen, Troels; Bay, Tina; Eriksen, Jacob; Gether, Ulrik; Jorgensen, Trine Nygaard			The Serotonin Transporter Undergoes Constitutive Internalization and Is Primarily Sorted to Late Endosomes and Lysosomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DOPAMINE TRANSPORTER; MONOAMINE TRANSPORTERS; RECEPTOR; TRAFFICKING; PHOSPHORYLATION; ACTIVATION; REVEALS; FAMILY; CELLS	The serotonin transporter (SERT) plays a critical role in regulating serotonin signaling by mediating reuptake of serotonin from the extracellular space. The molecular and cellular mechanisms controlling SERT levels in the membrane remain poorly understood. To study trafficking of the surface resident SERT, two functional epitope-tagged variants were generated. Fusion of a FLAG-tagged one-transmembrane segment protein Tac to the SERT N terminus generated a transporter with an extracellular epitope suited for trafficking studies (TacSERT). Likewise, a construct with an extracellular antibody epitope was generated by introducing an HA (hemagglutinin) tag in the extracellular loop 2 of SERT (HA-SERT). By using TacSERT and HA-SERT in antibody-based internalization assays, we show that SERT undergoes constitutive internalization in a dynamin-dependent manner. Confocal images of constitutively internalized SERT demonstrated that SERT primarily co-localized with the late endosomal/lysosomal marker Rab7, whereas little co-localization was observed with the Rab11, a marker of the "long loop" recycling pathway. This sorting pattern was distinct from that of a prototypical recycling membrane protein, the beta(2)-adrenergic receptor. Furthermore, internalized SERT co-localized with the lysosomal marker LysoTracker and not with transferrin. The sorting pattern was further confirmed by visualizing internalization of SERT using the fluorescent cocaine analog JHC1-64 and by reversible and pulse-chase biotinylation assays showing evidence for lysosomal degradation of the internalized transporter. Finally, we found that SERT internalized in response to stimulation with 12-myristate 13-acetate co-localized primarily with Rab7- and LysoTracker-positive compartments. We conclude that SERT is constitutively internalized and that the internalized transporter is sorted mainly to degradation.	[Rahbek-Clemmensen, Troels; Bay, Tina; Eriksen, Jacob; Gether, Ulrik; Jorgensen, Trine Nygaard] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Mol Neuropharmacol Lab,Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Rahbek-Clemmensen, Troels; Eriksen, Jacob; Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, DK-2200 Copenhagen, Denmark	University of Copenhagen; Lundbeckfonden; University of Copenhagen	Gether, U (corresponding author), Panum Inst 18 6, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	gether@sund.ku.dk		Rahbek-Clemmensen, Troels/0000-0003-2067-5411; Gether, Ulrik/0000-0002-0020-3807; Eriksen, Jacob/0000-0003-0726-9769	National Institutes of Health [P01 DA 12408]; Danish Medical Research Council; University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen BioScaRT Program of Excellence; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Mindelegat; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408. This work was also supported by the Danish Medical Research Council, University of Copenhagen BioScaRT Program of Excellence, Lundbeck Foundation Center for Biomembranes in Nanomedicine, Novo Nordisk Foundation, and Fabrikant Vilhelm Pedersen og Hustrus Mindelegat.	Adachi K, 2007, ARCH VIROL, V152, P2217, DOI 10.1007/s00705-007-1061-7; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jayanthi LD, 2005, MOL PHARMACOL, V67, P2077, DOI 10.1124/mol.104.009555; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Li Y, 2012, J NEUROSCI, V32, P7178, DOI 10.1523/JNEUROSCI.0008-12.2012; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qi YP, 1997, J NEUROSCI, V17, P1217; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; RAMAMOORTHY JD, 1995, J BIOL CHEM, V270, P17189, DOI 10.1074/jbc.270.29.17189; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Ramamoorthy S, 2011, PHARMACOL THERAPEUT, V129, P220, DOI 10.1016/j.pharmthera.2010.09.009; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Rasmussen TN, 2009, NEUROPHARMACOLOGY, V57, P287, DOI 10.1016/j.neuropharm.2009.05.009; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tao-Cheng JH, 1999, NEUROSCIENCE, V94, P821, DOI 10.1016/S0306-4522(99)00373-5; TATE CG, 1994, J BIOL CHEM, V269, P26303; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	47	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23004	23019		10.1074/jbc.M113.495754	http://dx.doi.org/10.1074/jbc.M113.495754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24973209	Green Published, hybrid			2022-12-28	WOS:000341017200039
J	Zheng, SD; Lan, PF; Liu, XM; Ye, KQ				Zheng, Sanduo; Lan, Pengfei; Liu, Ximing; Ye, Keqiong			Interaction between Ribosome Assembly Factors Krr1 and Faf1 Is Essential for Formation of Small Ribosomal Subunit in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KH-DOMAIN; FUNCTIONAL-ANALYSIS; 90S PRERIBOSOME; RNA-BINDING; U3 SNORNA; BOX C/D; PROTEIN; BIOGENESIS; PROCESSOME; HOMOLOG	Ribosome formation in Saccharomyces cerevisiae requires a large number of transiently associated assembly factors that coordinate processing and folding of pre-rRNA and binding of ribosomal proteins. Krr1 and Faf1 are two interacting proteins present in early 90 S precursor particles of the small ribosomal subunit. Here, we determined a co-crystal structure of the core domain of Krr1 bound to a 19-residue fragment of Faf1 at 2.8 angstrom resolution. The structure reveals that Krr1 consists of two packed K homology (KH) domains, KH1 and KH2, and resembles archaeal Dim2-like proteins. We show that KH1 is a divergent KH domain that lacks the RNA-binding GXXG motif and is involved in binding another assembly factor, Kri1. KH2 contains a canonical RNA-binding surface and additionally associates with an alpha-helix of Faf1. Specific disruption of the Krr1-Faf1 interaction impaired early 18 S rRNA processing at sites A0, A1, and A2 and caused cell lethality, but it did not prevent incorporation of the two proteins into pre-ribosomes. The Krr1-Faf1 interaction likely maintains a critical conformation of 90 S pre-ribosomes required for pre-rRNA processing. Our results illustrate the versatility of KH domains in protein interaction and provide insight into the role of Krr1-Faf1 interaction in ribosome biogenesis.	[Zheng, Sanduo] Beijing Normal Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Lan, Pengfei; Ye, Keqiong] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Lan, Pengfei; Ye, Keqiong] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zheng, Sanduo; Lan, Pengfei; Liu, Ximing; Ye, Keqiong] Natl Inst Biol Sci Beijing, Beijing 102206, Peoples R China; [Ye, Keqiong] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China	Beijing Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ye, KQ (corresponding author), Natl Inst Biol Sci Beijing, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn		Liu, Ximing/0000-0001-8617-2943	National Natural Science Foundation of China [31325007]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010203]; Ministry of Science and Technology of China (National Basic Research Program of China) [2010CB835402]; Beijing Municipal Government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China (National Basic Research Program of China)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Beijing Municipal Government	This work was supported by National Natural Science Foundation of China Grant 31325007, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010203, Ministry of Science and Technology of China (National Basic Research Program of China) Grant 2010CB835402, and the Beijing Municipal Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bohnsack MT, 2009, MOL CELL, V36, P583, DOI 10.1016/j.molcel.2009.09.039; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chan HYE, 2001, MOL BIOL CELL, V12, P1409, DOI 10.1091/mbc.12.5.1409; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Gromadka R, 2000, ACTA BIOCHIM POL, V47, P993, DOI 10.18388/abp.2000_3953; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jia MZ, 2007, PROTEINS, V69, P428, DOI 10.1002/prot.21381; Jia MZ, 2010, J MOL BIOL, V398, P774, DOI 10.1016/j.jmb.2010.03.055; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Karkusiewicz W, 2004, BIOCHEM BIOPH RES CO, V319, P349, DOI 10.1016/j.bbrc.2004.05.012; Kondoh H, 2000, GENES CELLS, V5, P525, DOI 10.1046/j.1365-2443.2000.00344.x; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu J, 2013, RNA, V19, P1815, DOI 10.1261/rna.040808.113; Merl J, 2010, NUCLEIC ACIDS RES, V38, P3068, DOI 10.1093/nar/gkp1244; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Rempola B, 2006, BIOCHEM BIOPH RES CO, V346, P546, DOI 10.1016/j.bbrc.2006.05.140; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Segerstolpe A, 2013, NUCLEIC ACIDS RES, V41, P1178, DOI 10.1093/nar/gks1129; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Shirai C, 2004, J BIOL CHEM, V279, P25353, DOI 10.1074/jbc.M403338200; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Yamada H, 2007, RNA, V13, P1977, DOI 10.1261/rna.553807; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540; Zhang LM, 2013, RNA, V19, P701, DOI 10.1261/rna.037580.112	63	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					22692	22703		10.1074/jbc.M114.584490	http://dx.doi.org/10.1074/jbc.M114.584490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24990943	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000341017200015
J	Li, JB; Bi, LP; Hulke, M; Li, TG				Li, Jibiao; Bi, Lipeng; Hulke, Michelle; Li, Tiangang			Fish Oil and Fenofibrate Prevented Phosphorylation-dependent Hepatic Sortilin 1 Degradation in Western Diet-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; INDUCED INSULIN-RESISTANCE; DENSITY-LIPOPROTEIN RECEPTOR; BETA-CELL DYSFUNCTION; VASCULAR FUNCTION; VLDL PRODUCTION; T-CELLS; INFLAMMATION; ALPHA; ATHEROSCLEROSIS	Obesity and diabetes are associated with hepatic triglyceride overproduction and hypertriglyceridemia. Recent studies have found that the cellular trafficking receptor sortilin 1 (Sort1) inhibits hepatic apolipoprotein B secretion and reduces plasma lipid levels in mice, and its hepatic expression was negatively associated with plasma lipids in humans. This study investigated the regulation of hepatic Sort1 under diabetic conditions and by lipid-lowering fish oil and fenofibrate. Results showed that hepatic Sort1 protein, but not mRNA, was markedly lower in Western diet-fed mice. Knockdown of hepatic Sort1 increased plasma triglyceride in mice. Feeding mice a fish oil-enriched diet completely restored hepatic Sort1 levels in Western diet-fed mice. Fenofibrate also restored hepatic Sort1 protein levels in Western diet-fed wild type mice, but not in peroxisome proliferator-activated receptor alpha(PPAR alpha) knock-out mice. PPAR alpha ligands did not induce Sort1 in hepatocytes in vitro. Instead, fish oil and fenofibrate reduced circulating and hepatic fatty acids in mice, and n-3 polyunsaturated fatty acids prevented palmitate inhibition of Sort1 protein in HepG2 cells. LC/MS/MS analysis revealed that Sort1 phosphorylation at serine 793 was increased in obese mice and in palmitate-treated HepG2 cells. Mutations that abolished phosphorylation at Ser-793 increased Sort1 stability and prevented palmitate inhibition of Sort1 ubiquitination and degradation in HepG2 cells. In summary, therapeutic strategies that prevent posttranslational hepatic Sort1 down-regulation in obesity and diabetes may be beneficial in improving dyslipidemia.	[Li, Jibiao; Bi, Lipeng; Hulke, Michelle; Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Li, TG (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	tli@kumc.edu	Li, Jibiao/A-5627-2017		National Institutes of Health (NIH); NCRR [5P20RR021940-07]; NIH; NIGMS [8 P20 GM103549-07]; Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics; American Diabetes Association Junior Faculty Award; National Institutes of Health [U24 DK059630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102487, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics; American Diabetes Association Junior Faculty Award(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NCRR, Grant 5P20RR021940-07 and NIH, NIGMS, Grant 8 P20 GM103549-07 (to T. L.) and the Cell Isolation Core laboratory at the University of Kansas Medical Center Department of Pharmacology, Toxicology and Therapeutics. This work was also supported by an American Diabetes Association Junior Faculty Award (to T. L.). The University of Cincinnati Mouse Metabolic Phenotyping Center is supported by National Institutes of Health Grant U24 DK059630.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bordin P, 1998, EUR J CLIN NUTR, V52, P104, DOI 10.1038/sj.ejcn.1600522; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Denys A, 2001, J LIPID RES, V42, P2015; Ding YL, 2012, ARTERIOSCL THROM VAS, V32, P1596, DOI 10.1161/ATVBAHA.112.249847; Dumaresq-Doiron K, 2013, BIOCHEM BIOPH RES CO, V433, P90, DOI 10.1016/j.bbrc.2013.02.059; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gervois P, 2012, EXPERT OPIN THER TAR, V16, P1113, DOI 10.1517/14728222.2012.715633; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gustafsen C, 2014, CELL METAB, V19, P310, DOI 10.1016/j.cmet.2013.12.006; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Mikami N, 2012, J FOOD SCI, V77, pH114, DOI 10.1111/j.1750-3841.2012.02687.x; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Murali G, 2012, J LIPID RES, V53, P2186, DOI 10.1194/jlr.M029843; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Park Y, 2003, J LIPID RES, V44, P455, DOI 10.1194/jlr.M200282-JLR200; Reaven GM, 2002, DIABETES OBES METAB, V4, pS13, DOI 10.1046/j.1462-8902.2001.00037.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Steinberg HO, 2002, DIABETOLOGIA, V45, P623, DOI 10.1007/s00125-002-0800-2; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tripathy D, 2003, DIABETOLOGIA, V46, P300, DOI 10.1007/s00125-002-1027-y; Weitz D, 2010, CARDIOL REV, V18, P258, DOI 10.1097/CRD.0b013e3181ea0de0; Whyte C, 2012, J NUTR BIOCHEM, V23, P1378, DOI 10.1016/j.jnutbio.2011.08.005; Yaqoob P, 2010, CURR OPIN CLIN NUTR, V13, P156, DOI 10.1097/MCO.0b013e328335725b; Zuliani G, 2009, CURR PHARM DESIGN, V15, P4087, DOI 10.2174/138161209789909773	50	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22437	22449		10.1074/jbc.M114.548933	http://dx.doi.org/10.1074/jbc.M114.548933			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24986865	hybrid, Green Published			2022-12-28	WOS:000340593500053
J	Sachelaru, I; Petriman, NA; Kudva, R; Koch, HG				Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka; Koch, Hans-Georg			Dynamic Interaction of the Sec Translocon with the Chaperone PpiD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; MEMBRANE-PROTEIN INSERTION; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; INNER MEMBRANE; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; TRANSPORT PATHWAYS; RIBOSOME BINDING; SRP RECEPTOR	The Sec translocon constitutes a ubiquitous protein transport channel that consists in bacteria of the three core components: SecY, SecE, and SecG. Additional proteins interact with SecYEG during different stages of protein transport. During targeting, SecYEG interacts with SecA, the SRP receptor, or the ribosome. Protein transport into or across the membrane is then facilitated by the interaction of SecYEG with YidC and the SecDFYajC complex. During protein transport, SecYEG is likely to interact also with the protein quality control machinery, but details about this interaction are missing. By in vivo and in vitro site-directed cross-linking, we show here that the periplasmic chaperone PpiD is located in front of the lateral gate of SecY, through which transmembrane domains exit the SecY channel. The strongest contacts were found to helix 2b of SecY. Blue native PAGE analyses verify the presence of a SecYEG-PpiD complex in native Escherichia coli membranes. The PpiD-SecY interaction was not influenced by the addition of SecA and only weakly influenced by binding of nontranslating ribosomes to SecYEG. In contrast, PpiD lost contact to the lateral gate of SecY during membrane protein insertion. These data identify PpiD as an additional and transient subunit of the bacterial SecYEG translocon. The data furthermore demonstrate the highly modular and versatile composition of the Sec translocon, which is probably essential for its ability to transport a wide range of substrates across membranes in bacteria and eukaryotes.	[Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, ZBMZ, D-79104 Freiburg, Germany; [Sachelaru, Ilie; Petriman, Narcis-Adrian; Kudva, Renuka] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Kudva, Renuka/0000-0003-0426-3716; Petriman, Narcis Adrian/0000-0002-3189-7530	Deutsche Forschungsgemeinschaft [GRK1478, DFG-FOR967, DFG-FOR929]; Excellence Initiative of the German Federal and State Governments Spemann Graduate School of Biology and Medicine [GSC-4]; Deutscher Akademischer Austauschdienst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments Spemann Graduate School of Biology and Medicine; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK1478, DFG-FOR967, and DFG-FOR929 (to H.-G. K.), funds from the Excellence Initiative of the German Federal and State Governments GSC-4 Spemann Graduate School of Biology and Medicine (to H.-G. K.), and a Ph.D. fellowship from the Deutscher Akademischer Austauschdienst (to N.-A. P.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Di Cola A, 2005, BIOCHEM SOC T, V33, P1024, DOI 10.1042/BST20051024; Drew D, 2003, BBA-BIOMEMBRANES, V1610, P3, DOI 10.1016/S0005-2736(02)00707-1; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Echizen Y, 2011, ACTA CRYSTALLOGR F, V67, P1367, DOI 10.1107/S1744309111031885; Erdmann F, 2011, EMBO J, V30, P17, DOI 10.1038/emboj.2010.284; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Manting EH, 1997, J BACTERIOL, V179, P5699, DOI 10.1128/jb.179.18.5699-5704.1997; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Weski J, 2012, J BACTERIOL, V194, P3225, DOI 10.1128/JB.00221-12; Wickstrom D, 2011, J MOL BIOL, V409, P124, DOI 10.1016/j.jmb.2011.03.068; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	67	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21706	21715		10.1074/jbc.M114.577916	http://dx.doi.org/10.1074/jbc.M114.577916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24951590	Green Published, hybrid			2022-12-28	WOS:000340558300044
